PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Peverelli, MG; da Costa, TPS; Kirby, N; Perugini, MA				Peverelli, Martin G.; da Costa, Tatiana P. Soares; Kirby, Nigel; Perugini, Matthew A.			Dimerization of Bacterial Diaminopimelate Decarboxylase Is Essential for Catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIZE-DISTRIBUTION ANALYSIS; SCATTERING DATA-ANALYSIS; RAY SOLUTION SCATTERING; ORNITHINE-DECARBOXYLASE; BIOLOGICAL MACROMOLECULES; PROTEIN INTERACTIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; DRUG DISCOVERY; ENZYME	Diaminopimelate decarboxylase (DAPDC) catalyzes the final step in the diaminopimelate biosynthesis pathway of bacteria. The product of the reaction is the essential amino acid L-lysine, which is an important precursor for the synthesis of the peptidoglycan cell wall, housekeeping proteins, and virulence factors of bacteria. Accordingly, the enzyme is a promising antibacterial target. Previous structural studies demonstrate that DAPDC exists as monomers, dimers, and tetramers in the crystal state. However, the active oligomeric form has not yet been determined. We show using analytical ultracentrifugation, small angle x-ray scattering, and enzyme kinetic analyses in solution that the active form of DAPDC from Bacillus anthracis, Escherichia coli, Mycobacterium tuberculosis, and Vibrio cholerae is a dimer. The importance of dimerization was probed further by generating dimerization interface mutants (N381A and R385A) of V. cholerae DAPDC. Our studies indicate that N381A and R385A are significantly attenuated in catalytic activity, thus confirming that dimerization of DAPDC is essential for function. These findings provide scope for the development of new antibacterial agents that prevent DAPDC dimerization.	[Peverelli, Martin G.; da Costa, Tatiana P. Soares; Perugini, Matthew A.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia; [Peverelli, Martin G.; Perugini, Matthew A.] Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Kirby, Nigel] Australian Synchrotron, 800 Blackburn Rd, Clayton, Vic 3168, Australia	La Trobe University	Perugini, MA (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Biochem & Genet, Melbourne, Vic 3086, Australia.	M.Perugini@latrobe.edu.au	Kirby, Nigel/AAC-3846-2021	Soares da Costa, Tatiana P./0000-0002-6275-7485; Kirby, Nigel/0000-0002-2791-4684; Perugini, Matthew/0000-0001-8052-5584	Australian Research Council (ARC) [DP150103313]; National Health and Medical Research Council of Australia [APP1091976]	Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by Australian Research Council (ARC) Discovery Project DP150103313. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by National Health and Medical Research Council of Australia Grant APP1091976 for fellowship support.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; ASADA Y, 1981, BIOCHEMISTRY-US, V20, P6881, DOI 10.1021/bi00527a022; Atkinson SC, 2014, PROTEINS, V82, P1869, DOI 10.1002/prot.24539; Atkinson SC, 2013, PLANT MOL BIOL, V81, P431, DOI 10.1007/s11103-013-0014-7; Atkinson SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038318; Brand IL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039248; Burgess BR, 2008, J BIOL CHEM, V283, P27598, DOI 10.1074/jbc.M804231200; COLEMAN CS, 1993, J BIOL CHEM, V268, P24572; da Costa TPS, 2015, METHOD ENZYMOL, V562, P205, DOI 10.1016/bs.mie.2015.06.020; DEWEY DL, 1952, NATURE, V169, P533, DOI 10.1038/169533a0; Dogovski C., 2009, BIOTECHNOLOGY, P116; Dogovski C, 2012, BIOCHEMISTRY-US, P225, DOI DOI 10.85772/34121; Dogovski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083419; Gerrard JA, 2007, MINI-REV MED CHEM, V7, P151, DOI 10.2174/138955707779802561; Gokulan K, 2003, J BIOL CHEM, V278, P18588, DOI 10.1074/jbc.M301549200; Hor L, 2013, J BIOL CHEM, V288, P9238, DOI 10.1074/jbc.M113.450148; Hu TC, 2008, J BIOL CHEM, V283, P21284, DOI 10.1074/jbc.M801823200; Hutton CA, 2003, MINI-REV MED CHEM, V3, P115, DOI 10.2174/1389557033405359; KELLAND JG, 1985, BIOCHEMISTRY-US, V24, P3263, DOI 10.1021/bi00334a028; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LABER B, 1989, ANAL BIOCHEM, V181, P297, DOI 10.1016/0003-2697(89)90246-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Momany C, 2002, ACTA CRYSTALLOGR D, V58, P549, DOI 10.1107/S0907444902000148; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; OSTERMAN A, 1994, BIOCHEMISTRY-US, V33, P13662, DOI 10.1021/bi00250a016; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Peverelli MG, 2015, BIOCHIMIE, V115, P78, DOI 10.1016/j.biochi.2015.05.004; Ray SS, 2002, STRUCTURE, V10, P1499, DOI 10.1016/S0969-2126(02)00880-8; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TSIRKA S, 1992, J BIOL CHEM, V267, P23057; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Voss JE, 2010, J BIOL CHEM, V285, P5188, DOI 10.1074/jbc.M109.038166; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Weyand Simone, 2009, Journal of Structural and Functional Genomics, V10, P209, DOI 10.1007/s10969-009-9065-z; WHITE PJ, 1965, BIOCHEM J, V96, P75, DOI 10.1042/bj0960075	43	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9785	9795		10.1074/jbc.M115.696591	http://dx.doi.org/10.1074/jbc.M115.696591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921318	Green Published, hybrid			2022-12-26	WOS:000375602300035
J	Cohen, A; Kupiec, M; Weisman, R				Cohen, Adiel; Kupiec, Martin; Weisman, Ronit			Gad8 Protein Is Found in the Nucleus Where It Interacts with the MluI Cell Cycle Box-binding Factor (MBF) Transcriptional Complex to Regulate the Response to DNA Replication Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NITROGEN STARVATION; GENOME STABILITY; S-PHASE; G(1)/S TRANSCRIPTION; MAMMALIAN TARGET; KINASE PATHWAY; TOR	The target of rapamycin (TOR) kinase is found at the core of two evolutionarily conserved complexes known as TOR complexes 1 and 2 (TORC1 and TORC2). In fission yeast, TORC2 is dispensable for proliferation under optimal growth conditions but is required for starvation and stress responses. We have previously reported that loss of function of TORC2 renders cells highly sensitive to DNA replication stress; however, the mechanism underlying this sensitivity is unknown. TORC2 has one known direct substrate, the kinase Gad8, which is related to AKT in human cells. Here we show that both TORC2 and its substrate Gad8 are found in the nucleus and are bound to the chromatin. We also demonstrate that Gad8 physically interacts with the MluI cell cycle box-binding factor (MBF) transcription complex that regulates the G(1)/S progression and the response to DNA stress. In mutant cells lacking TORC2 or Gad8, the binding of the MBF complex to its cognate promoters is compromised, and the induction of MBF target genes in response to DNA replication stress is reduced. Consistently, the protein levels of Cdt2 and Cig2, two MBF target genes, are reduced in the absence of TORC2-Gad8 signaling. Taken together, our findings highlight critical functions of TORC2 in the nucleus and suggest a role in surviving DNA replication stress via transcriptional regulation of MBF target genes.	[Cohen, Adiel; Weisman, Ronit] Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Raanana, Israel; [Kupiec, Martin] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Open University Israel; Tel Aviv University	Weisman, R (corresponding author), Open Univ Israel, Dept Nat & Life Sci, Univ Rd 1, IL-4353701 Raanana, Israel.	ronitwe@openu.ac.il	weisman, ronit/R-6969-2016		Israel Science Foundation [688/14]; Open University of Israel Grant [31040]	Israel Science Foundation(Israel Science Foundation); Open University of Israel Grant	This work was supported by Israel Science Foundation Grant 688/14 and Open University of Israel Grant 31040) (to R. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Aligianni S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000626; Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241; Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200; Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Caetano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017211; Cohen A, 2014, J BIOL CHEM, V289, P21727, DOI 10.1074/jbc.M114.573824; Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004; Davie E, 2015, CURR BIOL, V25, P445, DOI 10.1016/j.cub.2014.12.034; de Bruin RAM, 2008, P NATL ACAD SCI USA, V105, P11230, DOI 10.1073/pnas.0801106105; de Bruin RAM, 2009, CELL CYCLE, V8, P214, DOI 10.4161/cc.8.2.7412; Dutta C, 2008, MOL CELL BIOL, V28, P5977, DOI 10.1128/MCB.00596-08; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Furuya K, 2004, GENE DEV, V18, P1154, DOI 10.1101/gad.291104; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Hatano T, 2015, CELL CYCLE, V14, P848, DOI 10.1080/15384101.2014.1000215; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245; Ivanova T, 2013, MOL BIOL CELL, V24, P3350, DOI 10.1091/mbc.E13-05-0257; Ivanova T, 2011, CELL CYCLE, V10, P912, DOI 10.4161/cc.10.6.14963; Kawai M, 2001, CURR GENET, V39, P166; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898; KOCH C, 1993, SCIENCE, V261, P1551, DOI 10.1126/science.8372350; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Loewith R, 2011, BIOCHEM SOC T, V39, P437, DOI 10.1042/BST0390437; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Malik AR, 2013, BBA-PROTEINS PROTEOM, V1834, P1434, DOI 10.1016/j.bbapap.2012.12.010; Martelli AM, 2012, BBA-MOL CELL RES, V1823, P2168, DOI 10.1016/j.bbamcr.2012.08.017; Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646; Purtill FS, 2011, CELL CYCLE, V10, P664, DOI 10.4161/cc.10.4.14824; Ralph E, 2006, EMBO REP, V7, P1134, DOI 10.1038/sj.embor.7400827; Rosner M, 2008, HUM MOL GENET, V17, P2934, DOI 10.1093/hmg/ddn192; Rosner M, 2012, METHODS MOL BIOL, V821, P105, DOI 10.1007/978-1-61779-430-8_8; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Schonbrun M, 2013, J BIOL CHEM, V288, P19649, DOI 10.1074/jbc.M113.464974; Schonbrun M, 2009, MOL CELL BIOL, V29, P4584, DOI 10.1128/MCB.01879-08; Shimada K, 2013, MOL CELL, V51, P829, DOI 10.1016/j.molcel.2013.08.019; Stevens C, 2004, DNA REPAIR, V3, P1071, DOI 10.1016/j.dnarep.2004.03.034; Tatebe H, 2010, CURR BIOL, V20, P1975, DOI 10.1016/j.cub.2010.10.026; Vazquez-Martin A, 2011, CELL CYCLE, V10, P3140, DOI 10.4161/cc.10.18.17376; Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983; Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200; Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170; Weisman R, 2014, EMBO MOL MED, V6, P995, DOI 10.15252/emmm.201403959; Workman JJ, 2014, CELL CYCLE, V13, P714, DOI 10.4161/cc.28112; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	54	20	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9371	9381		10.1074/jbc.M115.705251	http://dx.doi.org/10.1074/jbc.M115.705251			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912660	hybrid, Green Published			2022-12-26	WOS:000374849000044
J	Rojo-Bartolome, I; de Cerio, OD; Diez, G; Cancio, I				Rojo-Bartolome, Iratxe; de Cerio, Oihane Diaz; Diez, Guzman; Cancio, Ibon			Identification of Sex and Female's Reproductive Stage in Commercial Fish Species through the Quantification of Ribosomal Transcripts in Gonads	PLOS ONE			English	Article							FACTOR-IIIA; REVERSE TRANSCRIPTION; ENDOCRINE DISRUPTION; BIOCHEMICAL RESEARCH; GENE-EXPRESSION; RNA; XENOPUS; TFIIIA; OOGENESIS; OOCYTES	The estimation of maturity and sex of fish stocks in European waters is a requirement of the EU Data Collection Framework as part of the policy to improve fisheries management. On the other hand, research on fish biology is increasingly focused in molecular approaches, researchers needing correct identification of fish sex and reproductive stage without necessarily having in house the histological know-how necessary for the task. Taking advantage of the differential gene transcription occurring during fish sex differentiation and gametogenesis, the utility of 5S ribosomal RNA (5S rRNA) and General transcription factor IIIA (gtf3a) in the molecular identification of sex and gametogenic stage was tested in different economically-relevant fish species from the Bay of Biscay. Gonads of 9 fish species (, Atlantic, Atlantic-chub and horse mackerel, blue whiting, bogue, European anchovy, hake and pilchard and megrim), collected from local commercial fishing vessels were histologically sexed and 5S and 18S rRNA concentrations were quantified by capillary electrophoresis to calculate a 5S/18S rRNA index. Degenerate primers permitted cloning and sequencing of gtf3a fragments in 7 of the studied species. 5S rRNA and gtf3a transcript levels, together with 5S/18S rRNA index, distinguished clearly ovaries from testis in all of the studied species. The values were always higher in females than in males. 5S/18S rRNA index values in females were always highest when fish were captured in early phases of ovary development whilst, in later vitellogenic stages, the values decreased significantly. In megrim and European anchovy, where gonads in different oogenesis stages were obtained, the 5S/18S rRNA index identified clearly gametogenic stage. This approach, to the sexing and the quantitative non-subjective identification of the maturity stage of female fish, could have multiple applications in the study of fish stock dynamics, fish reproduction and fecundity and fish biology in general.	[Rojo-Bartolome, Iratxe; de Cerio, Oihane Diaz; Cancio, Ibon] Univ Basque Country UPV EHU, Res Ctr Expt Marine Biol & Biotechnol Plentzia PI, Dept Zool & Anim Cell Biol, CBET Res Grp, Areatza Z-G, E-48620 Plentzia, Basque Country, Spain; [Diez, Guzman] AZTI, Div Marine Res, Txatxarramendi S-N, E-48395 Bizkaia, Basque Country, Spain	University of Basque Country; AZTI	Cancio, I (corresponding author), Univ Basque Country UPV EHU, Res Ctr Expt Marine Biol & Biotechnol Plentzia PI, Dept Zool & Anim Cell Biol, CBET Res Grp, Areatza Z-G, E-48620 Plentzia, Basque Country, Spain.	ibon.cancio@ehu.es	Cancio, Ibon/M-4594-2019; de cerio, Oihane Diaz/H-3336-2015; Cancio, Ibon/I-2821-2015	Cancio, Ibon/0000-0003-4841-0079; de cerio, Oihane Diaz/0000-0002-5605-8434; Cancio, Ibon/0000-0003-4841-0079	University of the Basque Country, Basque Government; Spanish MINECO [UFI 11/3, S-PE11UN007, S-PE12UN086, S-PE13UN101, IT810-13, AGL2012-33477]; Basque Government	University of the Basque Country, Basque Government(Basque Government); Spanish MINECO(Spanish Government); Basque Government(Basque Government)	This work was funded by the University of the Basque Country, Basque Government and the Spanish MINECO through projects: UFI 11/3, S-PE11UN007, S-PE12UN086, S-PE13UN101, IT810-13 and AGL2012-33477. IR is recipient of a grant for predoctoral studies of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1995, DEV BIOL, V168, P284, DOI 10.1006/dbio.1995.1080; Armstrong MJ, 2012, FISH RES, V117, P35, DOI 10.1016/j.fishres.2010.12.028; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; Damstra T, 2002, WHOIPCSEDC022; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; DENIS H, 1977, DEV BIOL, V59, P228, DOI 10.1016/0012-1606(77)90256-1; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; de Cerio OD, 2012, ENVIRON SCI TECHNOL, V46, P7763, DOI 10.1021/es301132b; Espigares F, 2015, GEN COMP ENDOCR, V224, P176, DOI 10.1016/j.ygcen.2015.08.013; Fan ZF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/291067; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Gornung E, 2007, GENOME, V50, P787, DOI 10.1139/G07-058; Kroupova H, 2011, COMP BIOCHEM PHYS A, V159, P141, DOI 10.1016/j.cbpa.2011.02.007; Layat E, 2013, BBA-GENE REGUL MECH, V1829, P274, DOI 10.1016/j.bbagrm.2012.10.013; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Manousaki T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-655; MAZABRAUD A, 1975, DEV BIOL, V44, P326, DOI 10.1016/0012-1606(75)90403-0; McDonough CJ, 2005, FISH B-NOAA, V103, P601; Mittelholzer C, 2007, J MOL ENDOCRINOL, V39, P319, DOI 10.1677/JME-07-0070; Morgan M. Joanne, 2009, Journal of Northwest Atlantic Fishery Science, V41, P37; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Ogilvie MK, 1997, GENE, V203, P103, DOI 10.1016/S0378-1119(97)00499-X; Ortiz-Zarragoitia M, 2014, MAR DRUGS, V12, P4756, DOI 10.3390/md12094756; Penberthy WT, 2003, GENE, V305, P205, DOI 10.1016/S0378-1119(03)00384-6; PFAFF SL, 1991, DEV BIOL, V145, P241, DOI 10.1016/0012-1606(91)90123-K; Prager MH, 2003, N AM J FISH MANAGE, V23, P349, DOI 10.1577/1548-8675(2003)023<0349:TALFMO>2.0.CO;2; Puy-Azurmendi E, 2013, SCI TOTAL ENVIRON, V443, P233, DOI 10.1016/j.scitotenv.2012.10.078; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Roger B, 2002, BIOCHEM BIOPH RES CO, V290, P1151, DOI 10.1006/bbrc.2001.6304; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Wischnewski J, 2004, EUR J CELL BIOL, V83, P55, DOI 10.1078/0171-9335-00358; Witthames PR, 2009, FISH B-NOAA, V107, P148	38	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149711	10.1371/journal.pone.0149711	http://dx.doi.org/10.1371/journal.pone.0149711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918444	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400038
J	Fernandez-Marcelo, T; Sanchez-Pernaute, A; Pascua, I; De Juan, C; Head, J; Torres-Garcia, AJ; Iniesta, P				Fernandez-Marcelo, Tamara; Sanchez-Pernaute, Andres; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Torres-Garcia, Antonio-Jose; Iniesta, Pilar			Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer	PLOS ONE			English	Article							NONSMALL CELL LUNG; COLON-CANCER; LENGTH; EXPRESSION; PROGNOSIS; CARCINOMA; SURVIVAL; TUMORS; INSTABILITY; PROGRESSION	The role of telomeres and telomerase in colorectal cancer (CRC) is well established as the major driving force in generating chromosomal instability. However, their potential as prognostic markers remains unclear. We investigated the outcome implications of telomeres and telomerase in this tumour type. We considered telomere length (TL), ratio of telomere length in cancer to non-cancer tissue (T/N ratio), telomerase activity and TERT levels; their relation with clinical variables and their role as prognostic markers. We analyzed 132 CRCs and paired non-cancer tissues. Kaplan-Meier curves for disease-free survival were calculated for TL, T/N ratio, telomerase activity and TERT levels. Overall, tumours had shorter telomeres than non-tumour tissues (P < 0.001) and more than 80% of CRCs displayed telomerase activity. Telomere lengths of non-tumour tissues and CRCs were positively correlated (P < 0.001). Considering telomere status and clinical variables, the lowest degree of telomere shortening was shown by tumours located in the rectum (P = 0.021). Regarding prognosis studies, patients with tumours showing a mean TL < 6.35 Kb experienced a significantly better clinical evolution (P < 0.001) and none of them with the highest degree of tumour telomere shortening relapsed during the follow-up period (P = 0.043). The mean TL in CRCs emerged as an independent prognostic factor in the Cox analysis (P = 0.017). Telomerase-positive activity was identified as a marker that confers a trend toward a poor prognosis. In CRC, our results support the use of telomere status as an independent prognostic factor. Telomere status may contribute to explaining the different molecular identities of this tumour type.	[Fernandez-Marcelo, Tamara; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Iniesta, Pilar] Univ Complutense, Fac Pharm 2, Dept Biochem & Mol Biol 2, E-28040 Madrid, Spain; [Sanchez-Pernaute, Andres; Torres-Garcia, Antonio-Jose] San Carlos Hosp, Serv Gen Surg & Digest Tract, Madrid 28040, Spain; [Fernandez-Marcelo, Tamara; Sanchez-Pernaute, Andres; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Torres-Garcia, Antonio-Jose; Iniesta, Pilar] Sanitary Res Inst San Carlos Hosp IdISSC, Madrid 28040, Spain	Complutense University of Madrid; San Paolo-Polo Universitaria Hospital	Iniesta, P (corresponding author), Univ Complutense, Fac Pharm 2, Dept Biochem & Mol Biol 2, E-28040 Madrid, Spain.; Iniesta, P (corresponding author), Sanitary Res Inst San Carlos Hosp IdISSC, Madrid 28040, Spain.	insepi@ucm.es	Sánchez-Pernaute, Andrés/J-9588-2016; Fernández-Marcelo, Tamara/Y-9067-2019; Fernández-Marcelo, Tamara/N-9196-2018; Torres, Antonio/AAH-9479-2020	Fernández-Marcelo, Tamara/0000-0001-6550-3838; Fernández-Marcelo, Tamara/0000-0001-6550-3838; Torres, Antonio/0000-0002-9472-854X	Fundacion de Investigacion Medica Mutua Madrilena; Santander-UCM	Fundacion de Investigacion Medica Mutua Madrilena; Santander-UCM	This work was supported by grants from Fundacion de Investigacion Medica Mutua Madrilena and Santander-UCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine TA, 2015, BRIT J CANCER, V112, P313, DOI 10.1038/bjc.2014.561; Ayiomamitis GD, 2014, CAN J SURG, V57, P199, DOI 10.1503/cjs.031312; Baichoo E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00158; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; Bertorelle R, 2014, WORLD J GASTROENTERO, V20, P1940, DOI 10.3748/wjg.v20.i8.1940; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boardman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080015; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Ferlay J, 2012, IARC CANC BASE; Fernandez-Marcelo T, 2012, ONCOLOGY-BASEL, V82, P153, DOI 10.1159/000335678; Frias C, 2008, LUNG CANCER, V60, P416, DOI 10.1016/j.lungcan.2007.11.001; Garcia-Aranda C, 2006, CANCER-AM CANCER SOC, V106, P541, DOI 10.1002/cncr.21625; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Giunco S, 2015, CURR PATHOBIOL REP, DOI [10.1007/s40139-015-0097-x, DOI 10.1007/S40139-015-0097-X]; Gonzalez-Quevedo R, 2002, J CLIN ONCOL, V20, P254, DOI 10.1200/JCO.20.1.254; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao XD, 2013, ONCOL REP, V29, P226, DOI 10.3892/or.2012.2098; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Lu YM, 2013, FRONT MED-PRC, V7, P411, DOI 10.1007/s11684-013-0293-z; Malaska J, 2004, NEOPLASMA, V51, P90; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mzahma R, 2015, TUMOR BIOL, V36, P8703, DOI 10.1007/s13277-015-3545-5; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pancione Massimo, 2012, Patholog Res Int, V2012, P509348, DOI 10.1155/2012/509348; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tanaka H, 2014, NEOPLASIA, V16, P814, DOI 10.1016/j.neo.2014.08.009; TURNBULL RB, 1967, ANN SURG, V166, P420; Valls C, 2011, COLORECTAL DIS, V13, P1265, DOI 10.1111/j.1463-1318.2010.02433.x; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; World Cancer Research Fund / American Institute for Cancer Research, 2011, CONT UPD PROJ REP FO; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31	42	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149626	10.1371/journal.pone.0149626	http://dx.doi.org/10.1371/journal.pone.0149626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913901	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700023
J	Xue, Y; Wilkes, JG; Moskal, TJ; Williams, AJ; Cooper, WM; Nayak, R; Rafii, F; Buzatu, DA				Xue, Yong; Wilkes, Jon G.; Moskal, Ted J.; Williams, Anna J.; Cooper, Willie M.; Nayak, Rajesh; Rafii, Fatemeh; Buzatu, Dan A.			Development of a Flow Cytometry-Based Method for Rapid Detection of Escherichia coli and Shigella Spp. Using an Oligonucleotide Probe	PLOS ONE			English	Article							FOOD MATRIX INTERFERENCE; COMBINATION; PROTEIN	Standard methods to detect Escherichia coli contamination in food use the polymerase chain reaction (PCR) and agar culture plates. These methods require multiple incubation steps and take a long time to results. An improved rapid flow-cytometry based detection method was developed, using a fluorescence-labeled oligonucleotide probe specifically binding a16S rRNA sequence. The method positively detected 51 E. coli isolates as well as 4 Shigella species. All 27 non-E. coli strains tested gave negative results. Comparison of the new genetic assay with a total plate count (TPC) assay and agar plate counting indicated similar sensitivity, agreement between cytometry cell and colony counts. This method can detect a small number of E. coli cells in the presence of large numbers of other bacteria. This method can be used for rapid, economical, and stable detection of E. coli and Shigella contamination in the food industry and other contexts.	[Xue, Yong; Wilkes, Jon G.; Williams, Anna J.; Cooper, Willie M.; Buzatu, Dan A.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Nayak, Rajesh; Rafii, Fatemeh] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Xue, Y (corresponding author), US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA.	Yong.Xue@fda.hhs.gov		Xue, Yong/0000-0002-9091-3772	US federal government	US federal government	This work was supported by the US federal government.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Besser RE, 1999, ANNU REV MED, V50, P355, DOI 10.1146/annurev.med.50.1.355; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Buzatu DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094254; Buzatu DA, 2013, FOOD MICROBIOL, V36, P416, DOI 10.1016/j.fm.2013.07.007; CDC, 2011, E COL OUTBR INV; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P975; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Doherty SB, 2010, J MICROBIOL METH, V82, P301, DOI 10.1016/j.mimet.2010.07.003; EWING WH, 1949, J BACTERIOL, V57, P633, DOI 10.1128/JB.57.6.633-638.1949; Feng P.D., BAM DIARRHEAGENIC ES; FSIS, 2010, PROC US ESCH COL O15; Joachimsthal EL, 2003, WORLD J MICROB BIOT, V19, P527, DOI 10.1023/A:1025122032762; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Neil KP, 2012, CLIN INFECT DIS, V54, P511, DOI 10.1093/cid/cir831; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Rangel JM, 2005, EMERGING INFECT DIS, V11; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Vogt RL, 2005, PUBLIC HEALTH REP, V120, P174, DOI 10.1177/003335490512000211; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wilkes JG, 2012, FOOD MICROBIOL, V30, P281, DOI 10.1016/j.fm.2011.11.002	23	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150038	10.1371/journal.pone.0150038	http://dx.doi.org/10.1371/journal.pone.0150038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913737	gold, Green Published			2022-12-26	WOS:000371175700048
J	Chu, YH; Hsu, YC; Keil, B; Kuo, WJ; Lin, FH				Chu, Ying-Hua; Hsu, Yi-Cheng; Keil, Boris; Kuo, Wen-Jui; Lin, Fa-Hsuan			A 32-Channel Head Coil Array with Circularly Symmetric Geometry for Accelerated Human Brain Imaging	PLOS ONE			English	Article							TO-NOISE RATIO; 3 TESLA; PHASED-ARRAY; PARALLEL MRI; DESIGN; ACQUISITION; RECONSTRUCTION; GRADIENTS; FIELDS; SENSE	The goal of this study is to optimize a 32-channel head coil array for accelerated 3T human brain proton MRI using either a Cartesian or a radial k-space trajectory. Coils had curved trapezoidal shapes and were arranged in a circular symmetry (CS) geometry. Coils were optimally overlapped to reduce mutual inductance. Low-noise pre-amplifiers were used to further decouple between coils. The SNR and noise amplification in accelerated imaging were compared to results from a head coil array with a soccer-ball (SB) geometry. The maximal SNR in the CS array was about 120% (1070 vs. 892) and 62% (303 vs. 488) of the SB array at the periphery and the center of the FOV on a transverse plane, respectively. In onedimensional 4-fold acceleration, the CS array has higher averaged SNR than the SB array across the whole FOV. Compared to the SB array, the CS array has a smaller g-factor at head periphery in all accelerated acquisitions. Reconstructed images using a radial k-space trajectory show that the CS array has a smaller error than the SB array in 2- to 5-fold accelerations.	[Chu, Ying-Hua; Hsu, Yi-Cheng; Lin, Fa-Hsuan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Keil, Boris] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Keil, Boris] Mittelhessen Univ Appl Sci, Dept Life Sci Engn, Inst Med Phys & Radiat Safety, Giessen, Germany; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	National Taiwan University; Harvard University; Massachusetts General Hospital; National Yang Ming Chiao Tung University	Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	fhlin@ntu.edu.tw	Keil, Boris/AAX-9557-2020; Keil, Boris/P-1411-2014; Lin, Fa-Hsuan/G-6988-2012	Lin, Fa-Hsuan/0000-0002-9539-1731; Keil, Boris/0000-0003-0805-8330	National Science Council, Taiwan [NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046]; Academy of Finland (the FiDiPro program); Ministry of Science and Technology, Taiwan [MOST 103-2628-B-002-002-MY3, MOST 104-2314-B-002 -238, MOST 102-2410-H-010-004 -MY2]; Ministry of Economic Affairs, Taiwan [100-EC-17-A-19-S1-175]; National Health Research Institute, Taiwan [NHRI-EX103-10247EI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academy of Finland (the FiDiPro program)(Academy of Finland); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046 (National Science Council, Taiwan), and Academy of Finland (the FiDiPro program). This work was also partially supported by MOST 103-2628-B-002-002-MY3, MOST 104-2314-B-002 -238, MOST 102-2410-H-010-004 -MY2 (Ministry of Science and Technology, Taiwan), 100-EC-17-A-19-S1-175 (Ministry of Economic Affairs, Taiwan), and NHRI-EX103-10247EI (National Health Research Institute, Taiwan). The funders had no role in study design,	AHN CB, 1986, IEEE T MED IMAGING, V5, P2, DOI 10.1109/TMI.1986.4307732; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Cohen-Adad J, 2011, MAGN RESON MED, V66, P1198, DOI 10.1002/mrm.22906; De Zanche N, 2008, NMR BIOMED, V21, P644, DOI 10.1002/nbm.1237; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; Deppe MH, 2011, MAGN RESON MED, V66, P1788, DOI 10.1002/mrm.22962; Duan Q, 2009, SPIE MED IMAGING; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hergt M, 2007, P 15 ANN M ISMRM BER; Keil B, 2013, MAGN RESON MED, V70, P248, DOI 10.1002/mrm.24427; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Lin FH, 2006, MAGN RESON MED, V56, P787, DOI 10.1002/mrm.20997; Lin FH, 2012, MAGN RESON MED, V68, P1145, DOI 10.1002/mrm.24115; McDougall MP, 2005, MAGN RESON MED, V54, P386, DOI 10.1002/mrm.20568; Mispelter J, 2006, NMR PROBEHEADS BIOPH; NOLL DC, 1991, IEEE T MED IMAGING, V10, P629, DOI 10.1109/42.108599; Nordmeyer-Massner JA, 2009, MAGN RESON MED, V61, P429, DOI 10.1002/mrm.21868; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Ohliger MA, 2006, NMR BIOMED, V19, P300, DOI 10.1002/nbm.1046; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Possanzini C, 2008, P 16 ANN M ISMRM TOR; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schmitt M, 2008, MAGN RESON MED, V59, P1431, DOI 10.1002/mrm.21598; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Sodickson DK, 2001, MED PHYS, V28, P1629, DOI 10.1118/1.1386778; Stockmann JP, 2010, MAGN RESON MED, V64, P447, DOI 10.1002/mrm.22425; Stollberger R, 1996, MAGNET RESON MED, V35, P246, DOI 10.1002/mrm.1910350217; Wiesinger F, 2004, MAGNET RESON MED, V52, P376, DOI 10.1002/mrm.20183; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149446	10.1371/journal.pone.0149446	http://dx.doi.org/10.1371/journal.pone.0149446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909652	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700034
J	Davies, AB; Tambling, CJ; Kerley, GIH; Asner, GP				Davies, Andrew B.; Tambling, Craig J.; Kerley, Graham I. H.; Asner, Gregory P.			Effects of Vegetation Structure on the Location of Lion Kill Sites in African Thicket	PLOS ONE			English	Article							NATIONAL-PARK; HUNTING SUCCESS; PREDATION RISK; SOUTH-AFRICA; SEMIARID ENVIRONMENT; FORAGING BEHAVIOR; PREY PREFERENCES; EASTERN-CAPE; PANTHERA-LEO; VIGILANCE	Predator-prey relationships are integral to ecosystem stability and functioning. These relationships are, however, difficult to maintain in protected areas where large predators are increasingly being reintroduced and confined. Where predators make kills has a profound influence on their role in ecosystems, but the relative importance of environmental variables in determining kill sites, and how these might vary across ecosystems is poorly known. We investigated kill sites for lions in South Africa's thicket biome, testing the importance of vegetation structure for kill site locations compared to other environmental variables. Kill sites were located over four years using GPS telemetry and compared to non-kill sites that had been occupied by lions, as well as to random sites within lion ranges. Measurements of 3D vegetation structure obtained from Light Detection and Ranging (LiDAR) were used to calculate the visible area (viewshed) around each site and, along with wind and moonlight data, used to compare kill sites between lion sexes, prey species and prey sexes. Viewshed area was the most important predictor of kill sites (sites in dense vegetation were twice as likely to be kill sites compared to open areas), followed by wind speed and, less so, moonlight. Kill sites for different prey species varied with vegetation structure, and male prey were killed when wind speeds were higher compared to female prey of the same species. Our results demonstrate that vegetation structure is an important component of predator-prey interactions, with varying effects across ecosystems. Such differences require consideration in terms of the ecological roles performed by predators, and in predator and prey conservation.	[Davies, Andrew B.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, 260 Panama St, Stanford, CA 94305 USA; [Tambling, Craig J.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, ZA-6031 Port Elizabeth, South Africa	Carnegie Institution for Science; Nelson Mandela University	Davies, AB (corresponding author), Carnegie Inst Sci, Dept Global Ecol, 260 Panama St, Stanford, CA 94305 USA.	adavies@carnegiescience.edu	Tambling, Craig/H-3554-2019; Asner, Gregory/G-9268-2013	Tambling, Craig/0000-0001-9830-5985; Asner, Gregory/0000-0001-7893-6421; Davies, Andrew/0000-0002-0003-1435	Andrew Mellon Foundation; International Foundation for Science; Avatar Alliance Foundation; Gordon and Betty Moore Foundation; John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation; Margaret A. Cargill Foundation; Bidvest Car Rental; Eveready; National Research Foundation; Claude Leon Foundation; Nelson Mandela Metropolitan University	Andrew Mellon Foundation; International Foundation for Science(International Foundation for Science); Avatar Alliance Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation(W.M. Keck Foundation); Margaret A. Cargill Foundation; Bidvest Car Rental; Eveready; National Research Foundation; Claude Leon Foundation; Nelson Mandela Metropolitan University	This study has been supported by the Andrew Mellon Foundation, The International Foundation for Science, Avatar Alliance Foundation, Gordon and Betty Moore Foundation, John D. and Catherine R. MacArthur Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., William R. Hearst III, Bidvest Car Rental and Eveready. C.J. Tambling was funded by Post-Doctoral Fellowships from the National Research Foundation, the Claude Leon Foundation and the Nelson Mandela Metropolitan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Asner GP, 2016, ECOGRAPHY, V39, P240, DOI 10.1111/ecog.01640; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beale CM, 2013, BIOL CONSERV, V167, P224, DOI 10.1016/j.biocon.2013.08.025; Britten GL, 2014, ECOL LETT, V17, P1518, DOI 10.1111/ele.12354; BURGER J, 1994, BEHAVIOUR, V131, P153, DOI 10.1163/156853994X00415; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Davies AB, 2014, TRENDS ECOL EVOL, V29, P681, DOI 10.1016/j.tree.2014.10.005; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Hall LK, 2013, BEHAV PROCESS, V94, P76, DOI 10.1016/j.beproc.2012.12.007; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hayward M. W., 2009, REINTRODUCTION TOP O; Hayward MW, 2007, J WILDLIFE MANAGE, V71, P1567, DOI 10.2193/2006-264; Hayward MW, 2007, AFR J ECOL, V45, P135, DOI 10.1111/j.1365-2028.2006.00686.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Kerley GIH, 2006, S AFR J SCI, V102, P395; Landman M, 2014, BIOTROPICA, V46, P42, DOI 10.1111/btp.12066; Landman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045334; Leuthold W, 1977, AFRICAN UNGULATES A; Levick SR, 2009, BIOL CONSERV, V142, P1693, DOI 10.1016/j.biocon.2009.03.004; Loarie SR, 2013, ANIM BEHAV, V85, P899, DOI 10.1016/j.anbehav.2013.01.018; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Parr CL, 2012, DIVERS DISTRIB, V18, P493, DOI 10.1111/j.1472-4642.2012.00882.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Schaller G. B., 1972, SERENGETI LION STUDY; Scheel D, 1991, ANIM BEHAV, V41, P467; SMUTS G L, 1977, East African Wildlife Journal, V15, P81; STANDER PE, 1992, CAN J ZOOL, V70, P8, DOI 10.1139/z92-002; STANDER PE, 1993, SYM ZOOL S, P127; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Tambling CJ, 2005, J APPL ECOL, V42, P431, DOI 10.1111/j.1365-2664.2005.01039.x; Tambling CJ, 2013, BASIC APPL ECOL, V14, P694, DOI 10.1016/j.baae.2013.09.010; Tambling CJ, 2012, ECOLOGY, V93, P1297; Tambling CJ, 2010, J WILDLIFE MANAGE, V74, P549, DOI 10.2193/2009-010; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	59	59	61	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149098	10.1371/journal.pone.0149098	http://dx.doi.org/10.1371/journal.pone.0149098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910832	Green Submitted, gold, Green Published			2022-12-26	WOS:000371164700022
J	Obersteiner, A; Gilles, S; Frank, U; Beck, I; Haring, F; Ernst, D; Rothballer, M; Hartmann, A; Traidl-Hoffmann, C; Schmid, M				Obersteiner, Andrea; Gilles, Stefanie; Frank, Ulrike; Beck, Isabelle; Haering, Franziska; Ernst, Dietrich; Rothballer, Michael; Hartmann, Anton; Traidl-Hoffmann, Claudia; Schmid, Michael			Pollen-Associated Microbiome Correlates with Pollution Parameters and the Allergenicity of Pollen	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; AIRBORNE POLLEN; BACTERIA; DIVERSITY; ALLERGY; BIODIVERSITY; POLLUTANTS; PRIMERS; DEFENSE; ADULTS	Pollen allergies have been rapidly increasing over the last decades. Many allergenic proteins and non-allergenic adjuvant compounds of pollen are involved in the plant defense against environmental or microbial stress. The first aim of this study was to analyze and compare the colonizing microbes on allergenic pollen. The second aim was to investigate detectable correlations between pollen microbiota and parameters of air pollution or pollen allergenicity. To reach these aims, bacterial and fungal DNA was isolated from pollen samples of timothy grass (Phleum pratense, n = 20) and birch trees (Betula pendula, n = 55). With this isolated DNA, a terminal restriction fragment length polymorphism analysis was performed. One result was that the microbial diversity on birch tree and timothy grass pollen samples (Shannon/Simpson diversity indices) was partly significantly correlated to allergenicity parameters (Bet v 1/Phl p 5, pollen-associated lipid mediators). Furthermore, the microbial diversity on birch pollen samples was correlated to on-site air pollution (nitrogen dioxide (NO2), ammonia (NH3), and ozone (O-3)). What is more, a significant negative correlation was observed between the microbial diversity on birch pollen and the measured NO2 concentrations on the corresponding trees. Our results showed that the microbial composition of pollen was correlated to environmental exposure parameters alongside with a differential expression of allergen and pollen-associated lipid mediators. This might translate into altered allergenicity of pollen due to environmental and microbial stress.	[Obersteiner, Andrea; Rothballer, Michael; Hartmann, Anton; Schmid, Michael] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Microbe Plant Interact, Neuherberg, Germany; [Gilles, Stefanie; Beck, Isabelle; Haering, Franziska; Traidl-Hoffmann, Claudia] Tech Univ Munich, UNIKA T, Inst Environm Med, Augsburg, Germany; [Gilles, Stefanie; Traidl-Hoffmann, Claudia] CK Care, Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland; [Frank, Ulrike; Ernst, Dietrich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Biochem Plant Pathol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schmid, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Microbe Plant Interact, Neuherberg, Germany.	michael.schmid@helmholtz-muenchen.de	Rothballer, Michael/B-5219-2015; Schmid, Michael/D-7105-2013; Gilles-Stein, Stefanie/AAA-3741-2021; Hartmann, Anton/AAN-8922-2020; Ernst, Dieter/M-7336-2014	Rothballer, Michael/0000-0003-4881-2705; Gilles-Stein, Stefanie/0000-0002-5159-2558; Traidl-Hoffmann, Claudia/0000-0001-5085-5179; Ernst, Dieter/0000-0003-0503-0228; Kolek, Franziska/0000-0001-8703-1894				Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; [Anonymous], 2007, BIOSTATISTIK EINFUHR; Avnery S, 2013, GLOBAL CHANGE BIOL, V19, P1285, DOI 10.1111/gcb.12118; Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Beck I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080147; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Boehme MWJ, 2013, DEUT MED WOCHENSCHR, V138, P1651, DOI 10.1055/s-0033-1343330; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Buters J, 2015, J ALLERGY CLIN IMMUN, V136, P87, DOI 10.1016/j.jaci.2015.01.049; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen Z, 2009, WATER AIR SOIL POLL, V198, P189, DOI 10.1007/s11270-008-9838-1; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COLLDAHL H, 1968, ACTA ALLERGOL, V23, P387, DOI 10.1111/j.1398-9995.1968.tb04071.x; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Diaz-Sanchez D, 2005, AM J PHYSIOL-LUNG C, V289, pL722, DOI 10.1152/ajplung.00217.2005; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; Finkel OM, 2012, APPL ENVIRON MICROB, V78, P6187, DOI 10.1128/AEM.00888-12; Gilles S, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-014-0054-8; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Heinrich J, 2004, CURR OPIN ALLERGY CL, V4, P341, DOI 10.1097/00130832-200410000-00003; Heydenreich B, 2012, CLIN EXP ALLERGY, V42, P76, DOI 10.1111/j.1365-2222.2011.03888.x; Hu Y, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1831-x; Jacquard C, 2009, PLANTA, V229, P393, DOI 10.1007/s00425-008-0838-6; Khodai-Kalaki M, 2015, MBIO, V6, DOI 10.1128/mBio.00679-15; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Lord NS, 2002, FEMS MICROBIOL ECOL, V42, P327, DOI 10.1111/j.1574-6941.2002.tb01022.x; Madmony A, 2005, FOLIA MICROBIOL, V50, P209, DOI 10.1007/BF02931568; Mattina MI, 2003, ENVIRON POLLUT, V124, P375, DOI 10.1016/S0269-7491(03)00060-5; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nowak D, 1996, EUR RESPIR J, V9, P2541, DOI 10.1183/09031936.96.09122541; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oeder S, 2015, ALLERGY; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Reisberg EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078613; Ring J, 2014, ALLERGY, V69, P978, DOI 10.1111/all.12406; Scagel CF, 1997, NEW PHYTOL, V136, P627, DOI 10.1046/j.1469-8137.1997.00779.x; Strunk O, 1997, ARB SOFTWARE PROGRAM; SWOBODA I, 1994, BBA-GENE STRUCT EXPR, V1219, P457, DOI 10.1016/0167-4781(94)90072-8; SWOBODA I, 1995, PROTOPLASMA, V187, P103, DOI 10.1007/BF01280237; Takahashi M, 2005, NEW PHYTOL, V168, P149, DOI 10.1111/j.1469-8137.2005.01493.x; Team RDC, 2014, R LANG ENV STAT COMP; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thoma I, 2004, CHEM PHYS LIPIDS, V128, P135, DOI 10.1016/j.chemphyslip.2003.10.002; Tiwari S, 2006, ENVIRON MONIT ASSESS, V119, P15, DOI 10.1007/s10661-005-9001-z; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trda L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00219; Wang XL, 2009, BIOCHEM BIOPH RES CO, V387, P430, DOI 10.1016/j.bbrc.2009.07.020; Wimmer M, 2015, ALLERGY; Zhao F, 2015, PLANT CELL ENV, DOI 10.1111/pce.12601.; Zinkl GM, 1999, DEVELOPMENT, V126, P5431; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	62	45	48	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149545	10.1371/journal.pone.0149545	http://dx.doi.org/10.1371/journal.pone.0149545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910418	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700040
J	Senter, P; Juengst, SL				Senter, Phil; Juengst, Sara L.			Record-Breaking Pain: The Largest Number and Variety of Forelimb Bone Maladies in a Theropod Dinosaur	PLOS ONE			English	Article							NUTRITIONAL SECONDARY HYPERPARATHYROIDISM; NATURALLY-OCCURRING NEOPLASMS; MUSTELA-PUTORIUS-FURO; BIRDS; INFECTION; STATE; PALEOPATHOLOGY; OSTEOARTHRITIS; AUSTRALIA; PATHOLOGY	Bone abnormalities are common in theropod dinosaur skeletons, but before now no specimen was known with more than four afflicted bones of the pectoral girdle and/or forelimb. Here we describe the pathology of a specimen of the theropod dinosaur Dilophosaurus wetherilli with eight afflicted bones of the pectoral girdle and forelimb. On its left side the animal has a fractured scapula and radius and large fibriscesses in the ulna and the proximal thumb phalanx. On its right side the animal has abnormal torsion of the humeral shaft, bony tumors on the radius, a truncated distal articular surface of metacarpal III, and angular deformities of the first phalanx of the third finger. Healing and remodeling indicates that the animal survived for months and possibly years after its ailments began, but its right third finger was permanently deformed and lacked the capability of flexion. The deformities of the humerus and the right third finger may be due to developmental osteodysplasia, a condition known in extant birds but unreported in non-avian dinosaurs before now.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Juengst, Sara L.] Appalachian State Univ, Dept Anthropol, Boone, NC 28608 USA	University of North Carolina; Fayetteville State University; University of North Carolina; Appalachian State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu		Juengst, Sara/0000-0002-2207-6095				Allen ME, 2003, BIOLOGY, HUSBANDRY, AND MEDICINE OF THE GREEN IGUANA, P47; Angel C. Roselina, 1996, P11; [Anonymous], 2012, COMPLETE DINOSAUR; Bennett R. Avery, 1996, P281; Blondiaux J, 2012, INT J PALEOPATHOL, V2, P223, DOI 10.1016/j.ijpp.2012.10.002; Boyer Thomas H., 1996, P385; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brownstein D.G., 1984, P1; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Chitty J, 2013, ESSENTIALS OF TORTOISE MEDICINE AND SURGERY, P1, DOI 10.1002/9781118656372; Crabill Mark R., 1996, P95; Crespo R, 2002, AVIAN DIS, V46, P245, DOI 10.1637/0005-2086(2002)046[0245:AOTCRI]2.0.CO;2; Crespo R., 2013, DIS POULTRY, V13th, P1233; Farrow C.S, 2003, VET DIAGNOSTIC IMAGI, P481; Frye F.L., 1984, P633; Frye FL., 1991, REPTILE CARE ATLAS D; FRYE FL, 1973, HUSBANDRY MED SURG C; Gilsleider Ed, 1994, Seminars in Avian and Exotic Pet Medicine, V3, P81; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Hanna RR, 2002, J VERTEBR PALEONTOL, V22, P76, DOI 10.1671/0272-4634(2002)022[0076:MIAIIA]2.0.CO;2; Harcourt-Brown Nigel H, 2002, Vet Clin North Am Exot Anim Pract, V5, P49, DOI 10.1016/S1094-9194(03)00046-X; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Huchzermeyer FW, 2002, REV SCI TECH OIE, V21, P265, DOI 10.20506/rst.21.2.1334; Ippen R, 1966, Zentralbl Allg Pathol, V108, P424; Isaza R, 2000, J ZOO WILDLIFE MED, V31, P20, DOI 10.1638/1042-7260(2000)031[0020:POAOIS]2.0.CO;2; Johnson JG, 2014, J EXOT PET MED, V23, P266, DOI 10.1053/j.jepm.2014.06.007; KALIN J. A., 1937, ZEITSCHR MORPH U OKOL TIERE, V32, P327, DOI 10.1007/BF00403078; Kirkwood J, 2000, AVIAN MED, P173; Kirkwood J, 2000, AVIAN MED, P170; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Krautwald-Junghanns M. E., 2011, Diagnostic imaging of exotic pets: birds, small mammals, reptiles, P70; KREEGER T J, 1984, Journal of Wildlife Diseases, V20, P245; Lipkin C., 2008, TYRANNOSAURUS REX TY, P166; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Mader D.R, 2006, REPTILE MED SURG; Mader Douglas R., 1996, P374; Mills DL, 2003, TXB SMALL ANIMAL SUR, V1, P1849; Mitchell Mark A., 2002, Veterinary Clinics of North America Exotic Animal Practice, V5, P97, DOI 10.1016/S1094-9194(03)00048-3; Molnar R.E., 2001, P337; Moodie RL., 1923, PALEOPATHOLOGY INTRO; Nair V., 2013, DIS POULTRY, P553; Nesbitt SJ, 2015, ACTA PALAEONTOL POL, V60, P513, DOI 10.4202/app.00143.2014; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Osmolska H, 1972, PALAEONTOL POL, V27, P5; Perpinan D, 2008, J EXOT PET MED, V17, P144, DOI 10.1053/j.jepm.2008.03.013; PETERSEN K, 1972, Proceedings of the Utah Academy of Sciences Arts and Letters, V49, P44; REECE RL, 1992, AVIAN PATHOL, V21, P3, DOI 10.1080/03079459208418815; Reece RL, 1996, AVIAN PATHOL, V25, P407, DOI 10.1080/03079459608419153; Reese S, 2011, DIAGNOSTIC IMAGING E, P244; Reptiles Pees M., 2011, DIAGNOSTIC IMAGING E, P378; RIDDELL C, 1981, ADV VET SCI COMP MED, V25, P277; Roberts C., 2007, ARCHAEOLOGY DIS; Rothschild B, 2005, LIFE O PAST, P351; Rothschild BM, 2007, J VET MED A, V54, P265, DOI 10.1111/j.1439-0442.2007.00937.x; Rothschild BM, 1997, NATURE, V387, P357, DOI 10.1038/387357a0; Rothschild BM, 1993, PALEOPATHOLOGY DIS F; Rothschild Bruce, 2001, P331; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144036; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; SILLER WG, 1959, BRIT J CANCER, V13, P642, DOI 10.1038/bjc.1959.70; Silverman Sam, 1996, P258; SOKOLOFF L, 1959, LAB INVEST, V8, P1209; Speer Brian L., 1996, P147; Trully Jr TN, 2002, VET CLIN N AM EXOT A, V5, P23; Walker P., 1997, TROUBLED TIMES VIOLE, P145; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Wallach J. D., 1982, Noninfectious diseases of wildlife, P113; WALLACH JD, 1969, J AM VET MED ASSOC, V155, P1046; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P880; Welles DP, 1984, PALAEONTOGR ABT A, V185, P85; Williams Jamie, 2002, Veterinary Clinics of North America Exotic Animal Practice, V5, P1, DOI 10.1016/S1094-9194(03)00043-4; Wolff EDS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007288	75	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149140	10.1371/journal.pone.0149140	http://dx.doi.org/10.1371/journal.pone.0149140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909701	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700024
J	Steenweg, R; Hebblewhite, M; Gummer, D; Low, B; Hunt, B				Steenweg, Robin; Hebblewhite, Mark; Gummer, David; Low, Brian; Hunt, Bill			Assessing Potential Habitat and Carrying Capacity for Reintroduction of Plains Bison (Bison bison bison) in Banff National Park	PLOS ONE			English	Article							FREE-RANGING BISON; FORAGE AVAILABILITY; WOOD BISON; ELK; HETEROGENEITY; COMPETITION; SELECTION; PATTERNS; SCALE	Interest in bison (Bison bison, B. bonasus) conservation and restoration continues to grow globally. In Canada, plains bison (B. b. bison) are threatened, occupying less than 0.5% of their former range. The largest threat to their recovery is the lack of habitat in which they are considered compatible with current land uses. Fences and direct management make range expansion by most bison impossible. Reintroduction of bison into previously occupied areas that remain suitable, therefore, is critical for bison recovery in North America. Banff National Park is recognized as historical range of plains bison and has been identified as a potential site for reintroduction of a wild population. To evaluate habitat quality and assess if there is sufficient habitat for a breeding population, we developed a Habitat Suitability Index (HSI) model for the proposed reintroduction and surrounding areas in Banff National Park (Banff). We then synthesize previous studies on habitat relationships, forage availability, bison energetics and snowfall scenarios to estimate nutritional carrying capacity. Considering constraints on nutritional carrying capacity, the most realistic scenario that we evaluated resulted in an estimated maximum bison density of 0.48 bison/km2. This corresponds to sufficient habitat to support at least 600 to 1000 plains bison, which could be one of the largest 10 plains bison populations in North America. Within Banff, there is spatial variation in predicted bison habitat suitability and population size that suggests one potential reintroduction site as the most likely to be successful from a habitat perspective. The successful reintroduction of bison into Banff would represent a significant global step towards conserving this iconic species, and our approach provides a useful template for evaluating potential habitat for other endangered species reintroductions into their former range.	[Steenweg, Robin; Hebblewhite, Mark] Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Gummer, David; Low, Brian; Hunt, Bill] Pk Canada, Banff Natl Pk, Resource Conservat, Banff, AB, Canada	University of Montana System; University of Montana	Hebblewhite, M (corresponding author), Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA.	mark.hebblewhite@umontana.edu	Hebblewhite, Mark/AAI-8101-2020; hebblewhite, mark/G-6164-2013	Hebblewhite, Mark/0000-0001-5382-1361; 	University of Montana; Parks Canada	University of Montana; Parks Canada	Funding was provided by the University of Montana and Parks Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IUCN RED LIST THREAT, DOI 10. 2305/iucn. uk. 2008. rlts. t40637a10346312. en; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Beck JL, 2006, J WILDLIFE MANAGE, V70, P283, DOI 10.2193/0022-541X(2006)70[283:EOESRN]2.0.CO;2; Bjornlie DD, 2001, J WILDLIFE MANAGE, V65, P560, DOI 10.2307/3803109; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2003, WILDLIFE SOC B, V31, P670; Bruggeman JE, 2009, TERR ECOL SER, V3, P623, DOI 10.1016/S1936-7961(08)00228-5; Campbell B.H., 1983, Wildlife Society Bulletin, V11, P16; CARBYN LN, 1988, ARCTIC, V41, P297; Caughley G., 1979, P2; COSEWIC, 2004, COSEWIC ASS STAT REP; Coughenour MB, 2005, BISON ELK YELLOWSTON; Dancose K, 2011, ECOL APPL, V21, P1871, DOI 10.1890/10-0779.1; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Fortin D, 2003, WILDLIFE SOC B, V31, P804; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin ME, 2007, GROUP SIZE EFFECTS M; Franklin S.E., 2001, REMOTE SENSING SUSTA, DOI 10.1201/9781420032857; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P1924, DOI 10.2193/2006-200; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gardner CL, 2007, ARCTIC, V43, P231; Gates C., 2008, IUCN RED LIST THREAT; Gates CC, 2010, AM BISON STATUS SURV; Geremia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016848; Gross J. E., 2005, EFFECTS POPULATION C; Hamilton SG, 2005, ESTIMATING WINTER CA; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite M, 2006, WILDLIFE SOC B, V34, P1280, DOI 10.2193/0091-7648(2006)34[1280:ITMBOM]2.0.CO;2; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOBBS NT, 1985, J WILDLIFE MANAGE, V49, P814, DOI 10.2307/3801716; Holechek J.L., 2010, RANGE MANAGEMENT PRI; Holland W, 1983, ECOLOGICAL LAND CLAS; Hurd TE, 2011, BISON RESTORAT UNPUB; Hutto R.L., 1985, P455; IUCN, INT UN CONS NAT GUID; Kay CE, 2001, CROSSING BOUNDARIES IN PARK MANAGEMENT: PROCEEDINGS OF THE 11TH CONFERENCE ON RESEARCH AND RESOURCE MANAGEMENT IN PARKS AND ON PUBLIC LANDS, P143; Keller BJ, 2011, FACTORS AFFECTING SP; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuzyk Gerald W., 2009, Open Conservation Biology Journal, V3, P24, DOI 10.2174/1874839200903010024; Langemann E. Gwyn, 2004, P79; Larter NC, 1988, DIET HABITAT SELECTI; Leverkus SER, 2012, SEASONAL RANGE USE W; McDermid G. J., 2005, REMOTE SENSING LARGE; Ministry of Environment, 2005, SI200572 MIN ENV; Mitchell JA, 2002, 38 ALB CONS ASS ALB; National Operational Hydrologic Remote Sensing Center, 2004, SNOW DATA ASSIMILATI, DOI [10.7265/N5TB14TC, DOI 10.7265/N5TB14TC]; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Parks Canada, 2013, PLAN REINTR PLAINS B; Parks Canada, 2010, BANFF NAT PARK MAN P; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Ranglack DH, 2015, RANGELAND ECOL MANAG, V68, P349, DOI 10.1016/j.rama.2015.05.008; Ranglack DH, 2015, J APPL ECOL, V52, P467, DOI 10.1111/1365-2664.12386; Roe FG., 1970, N AM BUFFALO CRITICA; Roloff GJ, 1999, WILDLIFE SOC B, V27, P973; Sachro LL, 2005, J ENVIRON MANAGE, V77, P183, DOI 10.1016/j.jenvman.2005.04.003; Sanderson EW, 2008, CONSERV BIOL, V22, P252, DOI 10.1111/j.1523-1739.2008.00899.x; SHAW JH, 1989, J WILDLIFE MANAGE, V53, P896, DOI 10.2307/3809584; SINCLAIR A. R. E., 2005, WILDLIFE ECOLOGY MAN; Strong WL, 2009, J ENVIRON MANAGE, V90, P434, DOI 10.1016/j.jenvman.2007.11.002; TURNER MG, 1994, ECOL APPL, V4, P472, DOI 10.2307/1941951; US Fish and WIdllife Service, 1981, STAND DEV HAB SUIT I; Van Vuren D. H., 2001, Animal Biodiversity and Conservation, V24, P117; WALLACE LL, 1995, LANDSCAPE ECOL, V10, P75, DOI 10.1007/BF00153825; White CA, 2001, PLAINS BISON RESTORA, P143; WYDEVEN AP, 1985, J WILDLIFE MANAGE, V49, P805, DOI 10.2307/3801715; Zeigenfuss LC, 2003, ECOLOGY NATIVE UNGUL	71	36	36	7	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150065	10.1371/journal.pone.0150065	http://dx.doi.org/10.1371/journal.pone.0150065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910226	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700060
J	Cordara, G; van Eerde, A; Grahn, EM; Winter, HC; Goldstein, IJ; Krengel, U				Cordara, Gabriele; van Eerde, Andre; Grahn, Elin M.; Winter, Harry C.; Goldstein, Irwin J.; Krengel, Ute			An Unusual Member of the Papain Superfamily: Mapping the Catalytic Cleft of the Marasmius oreades agglutinin (MOA) with a Caspase Inhibitor	PLOS ONE			English	Article							CYSTEINE PROTEASES; CRYSTAL-STRUCTURE; OXYANION HOLE; ACTIVE-SITE; COMPLEX; PROTEIN; LECTIN; SPECIFICITY; SUBSTRATE; MECHANISM	Papain-like cysteine proteases (PLCPs) constitute the largest group of thiol-based protein degrading enzymes and are characterized by a highly conserved fold. They are found in bacteria, viruses, plants and animals and involved in a number of physiological and pathological processes, parasitic infections and host defense, making them interesting targets for drug design. The Marasmius oreades agglutinin (MOA) is a blood group B-specific fungal chimerolectin with calcium-dependent proteolytic activity. The proteolytic domain of MOA presents a unique structural arrangement, yet mimicking the main structural elements in known PLCPs. Here we present the X-ray crystal structure of MOA in complex with Z-VAD-fmk, an irreversible caspase inhibitor known to cross-react with PLCPs. The structural data allow modeling of the substrate binding geometry and mapping of the fundamental enzyme-substrate interactions. The new information consolidates MOA as a new, yet strongly atypical member of the papain superfamily. The reported complex is the first published structure of a PLCP in complex with the well characterized caspase inhibitor Z-VAD-fmk.	[Cordara, Gabriele; van Eerde, Andre; Grahn, Elin M.; Krengel, Ute] Univ Oslo, Dept Chem, Oslo, Norway; [Cordara, Gabriele] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Winter, Harry C.; Goldstein, Irwin J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Oslo; University of Oslo; University of Michigan System; University of Michigan	Cordara, G; Krengel, U (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.; Cordara, G (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway.	gabriele.cordara@kjemi.uio.no; ute.krengel@kjemi.uio.no		Krengel, Ute/0000-0001-6688-8151	University of Oslo; Norwegian Research Council [216625]; BioStruct-X	University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); BioStruct-X	The work was funded by the University of Oslo and carried out as part of the GlycoNor consortium. This work was supported in part by the Norwegian Research Council (grant number: 216625; www.forskningsradet.no no) and BioStruct-X (www.biostruct-x.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BROMME D, 1994, J BIOL CHEM, V269, P30238; Bromme D, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2102s21; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cordara G, 2014, BIOCHEM BIOPH RES CO, V447, P586, DOI 10.1016/j.bbrc.2014.04.043; Cordara G, 2011, BIOCHEM BIOPH RES CO, V408, P405, DOI 10.1016/j.bbrc.2011.04.031; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dubey VK, 2007, AFR J BIOTECHNOL, V6, P1077; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GAUTHIER F, 1993, ARCH BIOCHEM BIOPHYS, V306, P304, DOI 10.1006/abbi.1993.1516; Gomes MTR, 2012, AMINO ACIDS, V43, P2381, DOI 10.1007/s00726-012-1318-7; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Gul S, 2008, BIOCHEMISTRY-US, V47, P2025, DOI 10.1021/bi702126p; HEINEMANN U, 1982, J MOL BIOL, V161, P591, DOI 10.1016/0022-2836(82)90410-7; Hofmann B, 1993, ACTA CRYSTALLOGR A S, V2, pc102; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruger RP, 2002, J BIOL CHEM, V277, P15002, DOI 10.1074/jbc.M200165200; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; MENARD R, 1995, BIOCHEMISTRY-US, V34, P464, DOI 10.1021/bi00002a010; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; O'Farrell PA, 2007, BIOCHEM J, V401, P421, DOI 10.1042/BJ20060641; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P59, DOI 10.1107/S0108768191006572; POLGAR L, 1982, BIOCHEM J, V207, P1; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; Smith R.F., 1976, INTEGRATED PEST MANA, P1, DOI DOI 10.1007/978-1-4615-7269-5_1; STORER AC, 1994, METHOD ENZYMOL, V244, P486; TAYLOR MAJ, 1994, PROTEIN ENG, V7, P1267, DOI 10.1093/protein/7.10.1267; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Turk B, 1997, BIOL CHEM, V378, P141; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200	64	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149407	10.1371/journal.pone.0149407	http://dx.doi.org/10.1371/journal.pone.0149407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901797	Green Published, gold			2022-12-26	WOS:000371276100071
J	Jayaratne, YSN; Zwahlen, RA				Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur			The Oropharyngeal Airway in Young Adults with Skeletal Class II and Class III Deformities: A 3-D Morphometric Analysis	PLOS ONE			English	Article							VOLUME	Objectives 1) To determine the accuracy and reliability of an automated anthropometric measurement software for the oropharyngeal airway and 2) To compare the anthropometric dimensions of the oropharyngeal airway in skeletal class II and III deformity patients. Methods Cone-beam CT (CBCT) scans of 62 patients with skeletal class II or III deformities were used for this study. Volumetric, linear and surface area measurements retroglossal (RG) and retropalatal (RP) compartments of the oropharyngeal airway was measured with the 3dMDVultus software. Accuracy of automated anthropometric pharyngeal airway measurements was assessed using an airway phantom. Results The software was found to be reasonably accurate for measuring dimensions of air passages. The total oropharyngeal volume was significantly greater in the skeletal class III deformity group (16.7 +/- 9.04 mm(3)) compared with class II subjects (11.87 +/- 4.01 mm(3)). The average surface area of both the RG and RP compartments were significantly larger in the class III deformity group. The most constricted area in the RG and RP airway was significantly larger in individuals with skeletal class III deformity. The anterior-posterior (AP) length of this constriction was significantly greater in skeletal class III individuals in both compartments, whereas the width of the constriction was not significantly different between the two groups in both compartments. The RP compartment was larger but less uniform than the RG compartment in both skeletal deformities. Conclusion Significant differences were observed in morphological characteristics of the oropharyngeal airway in individuals with skeletal class II and III deformities. This information may be valuable for surgeons in orthognathic treatment planning, especially for mandibular setback surgery that might compromise the oropharyngeal patency.	[Jayaratne, Yasas Shri Nalaka] Univ Connecticut, Sch Dent Med, Dept Craniofacial Sci, Div Orthodont, Farmington, CT 06032 USA; [Jayaratne, Yasas Shri Nalaka; Zwahlen, Roger Arthur] Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China	University of Connecticut; University of Hong Kong	Zwahlen, RA (corresponding author), Univ Hong Kong, Fac Dent, Discipline Oral & Maxillofacial Surg, Sai Ying Pun, Hong Kong, Peoples R China.	zwahlen@hku.hk		Jayaratne, Yasas/0000-0002-4813-648X				Abramson ZR, 2010, J ORAL MAXIL SURG, V68, P363, DOI 10.1016/j.joms.2009.09.086; Athanasiou AE., 1995, ORTHODONTIC CEPHALOM; Caufield P.W., 2006, RADIOGRAPHIC CEPHALO; Demetriades N, 2010, J ORAL MAXIL SURG, V68, P2431, DOI 10.1016/j.joms.2010.02.033; El H, 2011, AM J ORTHOD DENTOFAC, V139, pE511, DOI 10.1016/j.ajodo.2011.02.015; Enacar A, 1994, Int J Adult Orthodon Orthognath Surg, V9, P285; Foltan R, 2009, INT J ORAL MAX SURG, V38, P1036, DOI 10.1016/j.ijom.2009.06.001; Foltan R, 2011, ORAL SURG ORAL MED O, V111, P3, DOI 10.1016/j.tripleo.2010.09.077; Foltan R, 2011, INT J ORAL MAX SURG, V40, P146, DOI 10.1016/j.ijom.2010.10.006; Grauer D, 2009, AM J ORTHOD DENTOFAC, V136, P805, DOI 10.1016/j.ajodo.2008.01.020; Guijarro-Martinez R, 2011, INT J ORAL MAXILLOFA; Harris EF, 2009, ARCH ORAL BIOL, V54; Hasebe D, 2011, INT J ORAL MAX SURG, V40, P584, DOI 10.1016/j.ijom.2011.01.011; Hong JS, 2011, AM J ORTHOD DENTOFAC, V140, pE161, DOI 10.1016/j.ajodo.2011.04.020; Iwasaki T, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.04.010; Kim YJ, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2009.10.025; Lye KW, 2008, ANN ACAD MED SINGAP, V37, P677; Ma CM, 1999, PHYS MED BIOL, V44, P131, DOI 10.1088/0031-9155/44/1/011; Schwab RJ, 1998, OTOLARYNG CLIN N AM, V31, P931, DOI 10.1016/S0030-6665(05)70100-6; Sittitavornwong S, 2009, ORAL MAXIL SURG CLIN, V21, P389, DOI 10.1016/j.coms.2009.08.004; Swennen GRJ, 2005, 3 DIMENSIONAL CEPHAL; Tso HH, 2009, ORAL SURG ORAL MED O, V108, P768, DOI 10.1016/j.tripleo.2009.05.026; Yi B, 1999, Chin J Dent Res, V2, P59; Zhao Y, 2010, AM J ORTHOD DENTOFAC, V137, pS71, DOI 10.1016/j.ajodo.2008.08.026	24	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148086	10.1371/journal.pone.0148086	http://dx.doi.org/10.1371/journal.pone.0148086			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901313	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100013
J	Park, S; Lee, J; Son, Y				Park, Saerom; Lee, Jaewook; Son, Youngdoo			Predicting Market Impact Costs Using Nonparametric Machine Learning Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LARGE TRADES; FLUCTUATIONS; PRICES	Market impact cost is the most significant portion of implicit transaction costs that can reduce the overall transaction cost, although it cannot be measured directly. In this paper, we employed the state-of-the-art nonparametric machine learning models: neural networks, Bayesian neural network, Gaussian process, and support vector regression, to predict market impact cost accurately and to provide the predictive model that is versatile in the number of variables. We collected a large amount of real single transaction data of US stock market from Bloomberg Terminal and generated three independent input variables. As a result, most nonparametric machine learning models outperformed a-state-of-the-art benchmark parametric model such as I-star model in four error measures. Although these models encounter certain difficulties in separating the permanent and temporary cost directly, nonparametric machine learning models can be good alternatives in reducing transaction costs by considerably improving in prediction performance.	[Park, Saerom; Lee, Jaewook] Seoul Natl Univ, Dept Ind Engn, Seoul 151742, South Korea; [Son, Youngdoo] Seoul Natl Univ, Res Inst Engn & Entrepreneurship, Seoul 151742, South Korea; [Son, Youngdoo] Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA; [Park, Saerom; Lee, Jaewook] Seoul Natl Univ, 39-311,1 Gwanak Ro, Seoul 151742, South Korea; [Son, Youngdoo] Rutgers State Univ, A203,Engn Bldg A Wing, Piscataway, NJ 08854 USA	Seoul National University (SNU); Seoul National University (SNU); Rutgers State University New Brunswick; Seoul National University (SNU); Rutgers State University New Brunswick	Son, Y (corresponding author), Seoul Natl Univ, Res Inst Engn & Entrepreneurship, Seoul 151742, South Korea.; Son, Y (corresponding author), Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA.; Son, Y (corresponding author), Rutgers State Univ, A203,Engn Bldg A Wing, Piscataway, NJ 08854 USA.	hand02@snu.ac.kr		Son, Youngdoo/0000-0002-1912-5853	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0017657]; National Science Foundation [CCF-1144502]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/nrf_eng_cms/) grant funded the Korean government (MEST) (No. 2011-0017657). This work was also conducted during a visit of the second author to DIMACS, partially enabled through support from the National Science Foundation under grant number CCF-1144502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren R., 2005, RISK, V18, P58; [Anonymous], 2013, SCI ALGORITHMIC TRAD; [Anonymous], [No title captured]; Bershova N, 2013, QUANT FINANC, V13, P1759, DOI 10.1080/14697688.2013.861076; Bhattacharyya S, 2002, IEEE T EVOLUT COMPUT, V6, P169, DOI 10.1109/4235.996016; Bikker JA, 2008, J FORECASTING, V27, P21, DOI 10.1002/for.1052; Bikker JA, 2007, J INT MONEY FINANC, V26, P974, DOI 10.1016/j.jimonfin.2007.01.007; Bouchaud JP, 2004, QUANT FINANC, V4, P176, DOI 10.1088/1469-7688/4/2/007; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Chen W.H., 2006, INT J ELECT FINANCE, V1, P49, DOI DOI 10.1504/IJEF.2006.008837; Cressie N., 2011, STAT SPATIO TEMPORAL; Drucker H, 1997, ADV NEUR IN, V9, P155; Foresee FD, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1930, DOI 10.1109/ICNN.1997.614194; Frino A, 2008, J FUTURES MARKETS, V28, P1147, DOI 10.1002/fut.20366; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gunduz Y, 2011, QUANT FINANC, V11, P1709, DOI 10.1080/14697688.2010.531041; Han GS, 2008, EXPERT SYST APPL, V35, P515, DOI 10.1016/j.eswa.2007.07.041; Huberman G., 2005, Review of Finance, V9, P165, DOI 10.1007/s10679-005-7591-5; HUTCHINSON JM, 1994, J FINANC, V49, P851, DOI 10.2307/2329209; Kato T, 2014, FINANC STOCH, V18, P695, DOI 10.1007/s00780-014-0232-0; Kim KJ, 2012, COMPUT OPER RES, V39, P1800, DOI 10.1016/j.cor.2011.06.023; Kim SH, 1997, EXPERT SYST APPL, V13, P85, DOI 10.1016/S0957-4174(97)00010-9; Lee YC, 2007, EXPERT SYST APPL, V33, P67, DOI 10.1016/j.eswa.2006.04.018; Liao SH, 2013, EXPERT SYST APPL, V40, P1542, DOI 10.1016/j.eswa.2012.08.075; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Osuna E, 1997, P 1997 IEEE WORKSH N; Park H, 2014, EXPERT SYST APPL, V41, P5227, DOI 10.1016/j.eswa.2014.01.032; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; Rasmussen C.E., 1996, THESIS U TORONTO; Rasmussen CE, 2006, GAUSSAIN PROCESSES M; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D.E., 1985, LEARNING INTERNAL RE; Son Y, 2012, EXPERT SYST APPL, V39, P11607, DOI 10.1016/j.eswa.2012.04.015; Ticknor JL, 2013, EXPERT SYST APPL, V40, P5501, DOI 10.1016/j.eswa.2013.04.013	35	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150243	10.1371/journal.pone.0150243	http://dx.doi.org/10.1371/journal.pone.0150243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5WU	26926235	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200031
J	Attia, EF; Jolley, SE; Crothers, K; Schnapp, LM; Liles, WC				Attia, Engi F.; Jolley, Sarah E.; Crothers, Kristina; Schnapp, Lynn M.; Liles, W. Conrad			Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Elevated in Bronchoalveolar Lavage Fluid of Patients with Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE LUNG INJURY; ENDOTHELIAL ACTIVATION BIOMARKERS; CRITICALLY-ILL; EXPRESSION; PLASMA; ARDS; ANGIOPOIETIN-2; ASSOCIATION; MORTALITY	Introduction Pulmonary vascular endothelial activation has been implicated in acute respiratory distress syndrome (ARDS), yet little is known about the presence and role of endothelial activation markers in the alveolar space in ARDS. We hypothesized that endothelial activation biomarkers would be differentially expressed in bronchoalveolar lavage fluid from patients with ARDS compared with healthy volunteers, and that biomarker concentrations would be associated with ARDS severity. Methods We performed a cross-sectional analysis of data from 26 intubated patients with ARDS undergoing evaluation for clinically suspected ventilator-associated pneumonia and five healthy volunteers. Patients underwent bronchoalveolar lavage a median of five days after intubation. Healthy volunteers also underwent bronchoalveolar lavage. Endothelial activation biomarkers (soluble vascular cell adhesion molecule-1 [sVCAM-1], soluble endothelial selectin [sESEL], angiopoietin-1 [Ang-1] and angiopoietin-2 [Ang-2]) were measured in bronchoalveolar lavage fluid. Clinically suspected ventilator-associated pneumonia was confirmed with microbiologic culture data. Results Patients with ARDS had significantly higher median sVCAM-1 concentrations in the bronchoalveolar lavage fluid compared with healthy volunteers (985 vs 119 pg/mL, p = 0.03). Additionally, there was a trend toward greater bronchoalveolar lavage fluid sVCAM-1 concentrations among patients with moderate/severe compared to mild ARDS (1395 vs 209 pg/mL, p = 0.06). We did not detect significant differences in bronchoalveolar lavage fluid levels of sESEL, Ang-1 or Ang-2 between patients with ARDS and healthy volunteers. Median bronchoalveolar lavage fluid biomarker levels did not differ between patients with and without microbiologically-confirmed ventilator-associated pneumonia. Conclusions sVCAM-1 concentrations were significantly higher in the bronchoalveolar lavage fluid of patients with ARDS compared to healthy controls, and tended to be higher in moderate/severe ARDS compared to mild ARDS. Our findings add to the growing evidence supporting the concept that endothelial activation plays an important mechanistic role in the pathogenesis of ARDS. Further studies are necessary to characterize the role and/or clinical significance of sVCAM-1 and other endothelial activation markers present in the alveolar space in ARDS.	[Attia, Engi F.; Crothers, Kristina] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Jolley, Sarah E.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Crit Care & Allergy Immunol, New Orleans, LA USA; [Schnapp, Lynn M.] Med Univ S Carolina, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC 29425 USA; [Liles, W. Conrad] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA; [Liles, W. Conrad] Univ Washington, Dept Pathol, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, W. Conrad] Univ Washington, Dept Pharmacol, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, W. Conrad] Univ Washington, Dept Global Hlth, Ctr Lung Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Liles, WC (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA.; Liles, WC (corresponding author), Univ Washington, Dept Pathol, Ctr Lung Biol, Seattle, WA 98195 USA.; Liles, WC (corresponding author), Univ Washington, Dept Pharmacol, Ctr Lung Biol, Seattle, WA 98195 USA.; Liles, WC (corresponding author), Univ Washington, Dept Global Hlth, Ctr Lung Biol, Seattle, WA 98195 USA.	wcliles@uw.edu	Attia, Engi Farouk/J-7793-2019	Attia, Engi Farouk/0000-0002-5044-9602; Crothers, Kristina/0000-0001-9702-0371	University of Washington Department of Medicine; National Institutes of Health [F32 HL125031]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940];  [K24 HL068796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	University of Washington Department of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided in part by research funds from the University of Washington Department of Medicine. Dr. Schnapp is supported by K24 HL068796. Dr. Attia received a grant (F32 HL125031) from the National Institutes of Health. Dr. Jolley is supported in part by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhargava M, 2012, TRANSL RES, V159, P205, DOI 10.1016/j.trsl.2012.01.007; Binnie A, 2014, CURR OPIN CRIT CARE, V20, P47, DOI 10.1097/MCC.0000000000000048; BOCHNER BS, 1995, J IMMUNOL, V154, P799; Burnham EL, 2004, CRIT CARE MED, V32, P675, DOI 10.1097/01.CCM.0000114824.65158.4E; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Etter H, 1998, CYTOKINE, V10, P395, DOI 10.1006/cyto.1997.0308; Forel JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11312; Graham SM, 2013, AIDS, V27, P1803, DOI 10.1097/QAD.0b013e328360e9fb; Graham SM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-263; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Lee KS, 2007, EXP MOL MED, V39, P733, DOI 10.1038/emm.2007.80; Markowicz P, 2000, AM J RESP CRIT CARE, V161, P1942, DOI 10.1164/ajrccm.161.6.9909122; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Muller AM, 2002, J PATHOL, V198, P270, DOI 10.1002/path.1186; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Nguyen EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058782; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Palazzo SJ, 2012, RESP CARE, V57, P2052, DOI 10.4187/respcare.01703; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149687	10.1371/journal.pone.0149687	http://dx.doi.org/10.1371/journal.pone.0149687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919714	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400034
J	Farasat, H; Akmali, V; Sharifi, M				Farasat, Hossein; Akmali, Vahid; Sharifi, Mozafar			Population Genetic Structure of the Endangered Kaiser's Mountain Newt, Neurergus kaiseri (Amphibia: Salamandridae)	PLOS ONE			English	Article							ECOLOGICAL SPECIATION; ENVIRONMENTAL-FACTORS; WESTERN IRAN; CONSERVATION; DIFFERENTIATION; ABUNDANCE; GEOGRAPHY; PATTERNS; INSIGHTS; DISTANCE	Species often exhibit different levels of genetic structuring correlated to their environment. However, understanding how environmental heterogeneity influences genetic variation is difficult because the effects of gene flow, drift and selection are confounded. We investigated the genetic variation and its ecological correlates in an endemic and critically endangered stream breeding mountain newt, Neurergus kaiseri, within its entire range in southwestern Iran. We identified two geographic regions based on phylogenetic relationships using Bayesian inference and maximum likelihood of 779 bp mtDNA (D-loop) in 111 individuals from ten of twelve known breeding populations. This analysis revealed a clear divergence between northern populations, located in more humid habitats at higher elevation, and southern populations, from drier habitats at lower elevations regions. From seven haplotypes found in these populations none was shared between the two regions. Analysis of molecular variance (AMOVA) of N. kaiseri indicates that 94.03% of sequence variation is distributed among newt populations and 5.97% within them. Moreover, a high degree of genetic subdivision, mainly attributable to the existence of significant variance among the two regions is shown (theta(CT) = 0.94, P = 0.002). The positive and significant correlation between geographic and genetic distances (r = 0.61, P = 0.002) following controlling for environmental distance suggests an important influence of geographic divergence of the sites in shaping the genetic variation and may provide tools for a possible conservation based prioritization policy for the endangered species.	[Farasat, Hossein; Akmali, Vahid; Sharifi, Mozafar] Razi Univ, Dept Biol, Fac Sci, Ctr Environm Studies, Bagheabrisham 6714967346, Kermanshah, Iran	Razi University	Sharifi, M (corresponding author), Razi Univ, Dept Biol, Fac Sci, Ctr Environm Studies, Bagheabrisham 6714967346, Kermanshah, Iran.	sharifimozafar2012@gmail.com	Farasat, Hussein/AAG-2534-2019	Farasat, Hussein/0000-0001-7457-9965; Akmali, Vahid/0000-0001-8946-3527; /0000-0003-0826-3000	Razi University; Iran National Science Foundation [91057377]	Razi University; Iran National Science Foundation(Iran National Science Foundation (INSF))	This study was financially supported by Razi University and the Iran National Science Foundation (Project No: 91057377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Bekkevold D, 2005, EVOLUTION, V59, P2656; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Excoffier, 2007, HDB STAT GENETICS, P980; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farasat H, 2015, J HERPETOL; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2015, BIOL J LINN SOC, V115, P1, DOI 10.1111/bij.12481; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helfer V, 2012, MOL ECOL, V21, P4706, DOI 10.1111/j.1365-294X.2012.05742.x; Hendrix R, 2014, AMPHIBIA-REPTILIA, V35, P173, DOI 10.1163/15685381-00002939; Hendrix R, 2010, MOL ECOL RESOUR, V10, P1038, DOI 10.1111/j.1755-0998.2010.02861.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; James PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025359; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Khafagi O., 2012, Universal Journal of Environmental Research and Technology, V2, P515; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kittlein MJ, 2008, P ROY SOC B-BIOL SCI, V275, P2633, DOI 10.1098/rspb.2008.0816; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Mota-Vargas C, 2012, J NAT CONSERV, V20, P10, DOI 10.1016/j.jnc.2011.07.002; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A., 2018, FIGTREE; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt BR, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-19; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schulte U, 2007, AMPHIBIA-REPTILIA, V28, P531, DOI 10.1163/156853807782152543; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; Sharifi M, IUCN 2009 IUCN RED L; Sharifi M, 2014, HERPETOZOA, V27, P77; Sharifi M, 2013, HERPETOL CONSERV BIO, V8, P724; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Wang BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067345; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Watanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093055; Welch JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081226, 10.1371/journal.pone.0083443, 10.1371/journal.pone.0059853]; Wellenreuther M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020440; Wielstra B, 2015, BIOL J LINN SOC, V114, P574, DOI 10.1111/bij.12446; WRIGHT HE, 1967, J ECOL, V55, P415, DOI 10.2307/2257886; Wright S, 1943, GENETICS, V28, P114; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	56	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149596	10.1371/journal.pone.0149596	http://dx.doi.org/10.1371/journal.pone.0149596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918642	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400026
J	Bayarri-Lara, C; Ortega, FG; de Guevara, ACL; Puche, JL; Zafra, JR; de Miguel-Perez, D; Ramos, ASP; Giraldo-Ospina, CF; Gomez, JAN; Delgado-Rodriguez, M; Lorente, JA; Serrano, MJ				Bayarri-Lara, Clara; Ortega, Francisco G.; Ladron de Guevara, Antonio Cueto; Puche, Jose L.; Ruiz Zafra, Javier; de Miguel-Perez, Diego; Sanchez-Palencia Ramos, Abel; Fernando Giraldo-Ospina, Carlos; Navajas Gomez, Juan A.; Delgado-Rodriguez, Miguel; Lorente, Jose A.; Jose Serrano, Maria			Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EGFR; EXPRESSION; SURVIVAL	Background Surgery is the treatment of choice for patients with non-small cell lung cancer (NSCLC) stages I-IIIA. However, more than 20% of these patients develop recurrence and die due to their disease. The release of tumor cells into peripheral blood (CTCs) is one of the main causes of recurrence of cancer. The objectives of this study are to identify the prognostic value of the presence and characterization of CTCs in peripheral blood in patients undergoing radical resection for NSCLC. Patients and Methods 56 patients who underwent radical surgery for previously untreated NSCLC were enrolled in this prospective study. Peripheral blood samples for CTC analysis were obtained before and one month after surgery. In addition CTCs were phenotypically characterized by epidermal growth factor receptor (EGFR) expression. Results 51.8% of the patients evaluated were positive with the presence of CTCs at baseline. A decrease in the detection rate of CTCs was observed in these patients one month after surgery (32.1%) (p = 0.035). The mean number of CTCs was 3.16 per 10 ml (range 0-84) preoperatively and 0.66 (range 0-3) in postoperative determination. EGFR expression was found in 89.7% of the patients at baseline and in 38.9% patients one month after surgery. The presence of CTCs after surgery was significantly associated with early recurrence (p = 0.018) and a shorter disease free survival (DFS) (p =.008). In multivariate analysis CTC presence after surgery (HR = 5.750, 95% CI: 1.50-21.946, p = 0.010) and N status (HR = 0.296, 95% CI: 0.091-0.961, p = 0.043) were independent prognostic factors for DFS. Conclusion CTCs can be detected and characterized in patients undergoing radical resection for non-small cell lung cancer. Their presence might be used to identify patients with increased risk of early recurrence.	[Bayarri-Lara, Clara; Ladron de Guevara, Antonio Cueto; Ruiz Zafra, Javier; Sanchez-Palencia Ramos, Abel; Fernando Giraldo-Ospina, Carlos; Navajas Gomez, Juan A.] Virgen de las Nieves Univ Hosp, Dept Thorac Surg, Ave Fuerzas Armadas 2, Granada 18014, Spain; [Ortega, Francisco G.; Puche, Jose L.; de Miguel-Perez, Diego; Lorente, Jose A.; Jose Serrano, Maria] Univ Granada, GENYO, Ctr Genom & Oncol Res, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain; [Puche, Jose L.; Jose Serrano, Maria] San Cecilio Clin Univ Hosp, Integral Oncol Div, Ave Dr Oloriz 16, Granada 18012, Spain; [Delgado-Rodriguez, Miguel] Univ Jaen, CIBERESP, Div Prevent Med & Publ Hlth, Campus Lagunillas, Jaen 23071, Spain; [Lorente, Jose A.] Univ Granada, Dept Legal Med, Lab Genet Identificat, Avda Madrid 11, Granada 18012, Spain	Hospital Universitario Virgen de las Nieves; Pfizer; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Jaen; University of Granada	Serrano, MJ (corresponding author), Univ Granada, GENYO, Ctr Genom & Oncol Res, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain.; Serrano, MJ (corresponding author), San Cecilio Clin Univ Hosp, Integral Oncol Div, Ave Dr Oloriz 16, Granada 18012, Spain.	mjose.serrano@genyo.es	De Miguel Pérez, Diego/AAW-3113-2020; LORENTE, JOSE A./B-8372-2008	De Miguel Pérez, Diego/0000-0002-2822-4466; LORENTE, JOSE A./0000-0002-9892-7386; Ortega Sanchez, Francisco Gabriel/0000-0003-0563-2237	Fundacion de Investigacion Basica Alenjando Otero	Fundacion de Investigacion Basica Alenjando Otero	This work was supported by Fundacion de Investigacion Basica Alenjando Otero (www.Fibao.es) (MJS). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Hofman V, 2014, CURR MOL MED, V14, P440, DOI 10.2174/1566524014666140414205455; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; Serrano MJ, 2009, CANCER BIOL THER, V8, P671, DOI 10.4161/cbt.8.8.7834; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Nadal R, 2013, INT J CANCER, V133, P2398, DOI 10.1002/ijc.28263; Nadal R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3180; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Sawabata N, 2007, GEN THORAC CARDIOVAS, V55, P189, DOI 10.1007/s11748-007-0101-2; Serrano MJ, 2011, ANN ONCOL, V22, P2150, DOI 10.1093/annonc/mdr322; Serrano MJ, 2014, ONCOTARGET, V5, P7486, DOI 10.18632/oncotarget.2217; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song IH, 2014, EUR J CARDIO-THORAC, V45, P262, DOI 10.1093/ejcts/ezt333; Sundaresan TK, 2015, CLIN CANCER RES IN P; Traynor AM, 2013, LUNG CANCER, V81, P138, DOI 10.1016/j.lungcan.2013.03.020	21	84	90	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148659	10.1371/journal.pone.0148659	http://dx.doi.org/10.1371/journal.pone.0148659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913536	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700008
J	D'Abramo, A; Zingaropoli, MA; Oliva, A; D'Agostino, C; Al Moghazi, S; De Luca, G; Iannetta, M; d'Ettorre, G; Ciardi, MR; Mastroianni, CM; Vullo, V				D'Abramo, Alessandra; Zingaropoli, Maria Antonella; Oliva, Alessandra; D'Agostino, Claudia; Al Moghazi, Samir; De Luca, Giulia; Iannetta, Marco; d'Ettorre, Gabriella; Ciardi, Maria Rosa; Mastroianni, Claudio Maria; Vullo, Vincenzo			Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients	PLOS ONE			English	Article							VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; INFECTED PATIENTS; T-LYMPHOCYTES; ACTIVATION; OSTEOPOROSIS; INFLAMMATION; IMMUNOSENESCENCE; ATHEROSCLEROSIS; BIOMARKERS	HIV-infected patients appear to have a significantly greater risk of non-AIDS comorbidities such as osteoporosis and atherosclerosis. Subjects with osteoporosis are at a higher risk of developing cardiovascular disease than those with normal bone mass, therefore a possible relation between these two conditions can be hypothesized. In the setting of HIV infection, several factors might contribute to bone disease and endothelial dysfunction. The aim of our study was to evaluate the relationship between bone and cardiovascular disease and to investigate the role of traditional factors, T-cell phenotype and osteoprotegerin in HIV positive subjects on effective antiretroviral therapy. We included 94 HIV positive subjects on antiretroviral therapy with virological suppression and 41 healthy subjects matched for age and gender as a control group. Carotid-Intima Media Thickness (c-IMT) and bone mineral density (BMD) were performed by ultrasound and DEXA, respectively. CD4(+)/CD8(+) T-cell activation, senescence and osteoprotegerin plasma levels were measured by flow-cytometry and ELISA, respectively. Among HIV positive patients, 56.4% had osteopenia/osteoporosis and 45.7% had pathological c-IMT (>0.9mm). Subjects with pathological c-IMT and BMD exhibited higher CD4(+) and CD8(+) activated, CD8(+) senescent and osteoprotegerin than subjects with normal c-IMT and BMD. HIV positive subjects with osteopenia/osteoporosis had higher c-IMT than subjects with normal BMD, and linear regression analysis showed a negative correlation between BMD and c-IMT. Several factors are implicated in the pathogenesis of non-AIDS comorbidities in HIV positive patients. Osteoprotegerin together with inflammation and immunosenescence in HIV positive patients could affect bone and vascular system and could be considered as a possible common link between these two diseases.	[D'Abramo, Alessandra; Zingaropoli, Maria Antonella; Oliva, Alessandra; D'Agostino, Claudia; Al Moghazi, Samir; De Luca, Giulia; Iannetta, Marco; d'Ettorre, Gabriella; Ciardi, Maria Rosa; Mastroianni, Claudio Maria; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome	D'Abramo, A (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alessandra.dabramo@uniroma1.it	MASTROIANNI, Claudio Maria/O-9741-2019; Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017; d'Ettorre, Gabriella/K-4511-2016; D'Abramo, Alessandra/AAA-3054-2019; Oliva, Alessandra/C-1708-2019	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; D'Abramo, Alessandra/0000-0002-5160-9743; Oliva, Alessandra/0000-0003-0832-7975; ciardi, maria rosa/0000-0002-0894-6496; D'Agostino, Caudia/0000-0002-4399-8785; d'Ettorre, Gabriella/0000-0002-3571-5677; Zingaropoli, Maria Antonella/0000-0001-9479-8559	Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome	Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome	The present project was supported by the Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome.	Aberg Judith A, 2012, Top Antivir Med, V20, P101; Anagnostis P, 2009, OSTEOPOROSIS INT, V20, P197, DOI 10.1007/s00198-008-0648-5; [Anonymous], 1994, ASS FRACT RISK ITS A, V843, P1; Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2013, JAIDS-J ACQ IMM DEF, V63, P323, DOI 10.1097/QAI.0b013e318295eb1d; Chakravarti A, 2008, LAB INVEST, V88, P171, DOI 10.1038/labinvest.3700701; Coll B, 2007, STROKE, V38, P2477, DOI 10.1161/STROKEAHA.106.479030; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Compston J, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.3; D'Abramo A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/192594; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Divers J, 2011, J BONE MINER RES, V26, P1554, DOI 10.1002/jbmr.389; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Erlandson KM, 2014, JAIDS-J ACQ IMM DEF, V65, P290, DOI 10.1097/QAI.0000000000000005; Freedman BI, 2009, J BONE MINER RES, V24, P1719, DOI [10.1359/JBMR.090501, 10.1359/jbmr.090501]; Guzman-Fulgencio M, 2011, J INFECTION, V63, P382, DOI 10.1016/j.jinf.2011.08.006; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hunt PW, 2014, CURR OPIN HIV AIDS, V9, P302, DOI 10.1097/COH.0000000000000072; Hwang JJ, 2012, JAIDS-J ACQ IMM DEF, V61, P359, DOI 10.1097/QAI.0b013e31826a6c16; Jeong SJ, 2013, YONSEI MED J, V54, P990, DOI 10.3349/ymj.2013.54.4.990; Kelesidis T, 2014, AIDS REV, V16, P123; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Kiechl Stefan, 2006, Expert Rev Cardiovasc Ther, V4, P801, DOI 10.1586/14779072.4.6.801; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Le Saux S, 2012, ANN NY ACAD SCI, V1247, P69, DOI 10.1111/j.1749-6632.2011.06297.x; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Reid P, 2009, EUR J CELL BIOL, V88, P1, DOI 10.1016/j.ejcb.2008.06.004; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rubin MR, 2004, J CLIN ENDOCR METAB, V89, P4243, DOI 10.1210/jc.2004-1324; Sprini D, 2014, CLIN CASES MINER BON, V11, P117, DOI 10.11138/ccmbm/2014.11.2.117; Stejskal David, 2001, Biomedical Papers (Olomouc), V145, P61; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Tincati C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110287; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Worm SW, 2010, CURR OPIN HIV AIDS, V5, P467, DOI 10.1097/COH.0b013e32833f2ea6; Wright HL, 2009, CURR REV MUSCULOSKE, V2, P56, DOI 10.1007/s12178-009-9046-7	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149601	10.1371/journal.pone.0149601	http://dx.doi.org/10.1371/journal.pone.0149601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913505	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700021
J	Nithyamathi, K; Chandramathi, S; Kumar, S				Nithyamathi, Kalimuthu; Chandramathi, Samudi; Kumar, Suresh			Predominance of Blastocystis sp Infection among School Children in Peninsular Malaysia	PLOS ONE			English	Article							ORANG-ASLI; PARASITIC INFECTIONS; INTESTINAL PARASITES; MOLECULAR EPIDEMIOLOGY; DRINKING-WATER; SUBTYPE 3; HOMINIS; ASSOCIATION; PREVALENCE; COMMUNITIES	Background One of the largest cross-sectional study in recent years was carried out to investigate the prevalence of intestinal parasitic infections among urban and rural school children from five states namely Selangor, Perak, Pahang, Kedah and Johor in Peninsula Malaysia. This information would be vital for school authorities to influence strategies for providing better health especially in terms of reducing intestinal parasitism. Methods and Principal Findings A total of 3776 stool cups was distributed to 26 schools throughout the country. 1760 (46.61%) responded. The overall prevalence of intestinal parasitic infection in both rural and urban areas was 13.3%, with Blastocystis sp (10.6%) being the most predominant, followed by Trichuris trichiura (3.4%), Ascaris lumbricoides (1.5%) and hook worm infection (0.9%). Only rural school children had helminthic infection. In general Perak had the highest infection (37.2%, total, n = 317), followed by Selangor (10.4%, total, n = 729), Pahang (8.6%, total, n = 221), Kedah (6.2%, total, n = 195) and Johor (3.4%, total, n = 298). School children from rural schools had higher infection (13.7%, total, n = 922) than urban school children (7.2%, total, n = 838). Subtype (ST) 3 (54.3%) is the most predominant ST with persons infected with only ST1 and ST3 showing symptoms. Blastocystis sp infection significantly associated with low household income, low parent's education and presence of symptoms (p< 0.05). Conclusion It is critical that we institute deworming and treatment to eradicate the parasite especially in rural school children.	[Nithyamathi, Kalimuthu; Kumar, Suresh] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Chandramathi, Samudi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	Samudi, Chandramathi/G-5937-2012; samudi@raju, Chandramathi/AAR-1595-2021		High Impact Research (HIR) Grant - Ministry of High Education (MOHE) [UM.C/625/1/HIR/044]; Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya [PV133-2012A]	High Impact Research (HIR) Grant - Ministry of High Education (MOHE); Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya	This research was supported by High Impact Research (HIR) Grant - Ministry of High Education (MOHE) - (Project UM.C/625/1/HIR/044) and Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya - (PV133-2012A).	Abdulsalam AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084372; Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Aini UN, 2007, ASIA PAC J CLIN NUTR, V16, P724; Al-Mekhlafi HM, 2011, ANN TROP MED PARASIT, V105, P135, DOI 10.1179/136485911X12899838683368; Amin OM, 2002, AM J TROP MED HYG, V66, P799, DOI 10.4269/ajtmh.2002.66.799; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Anuar TS, 2012, INT J PARASITOL, V42, P871, DOI 10.1016/j.ijpara.2012.07.003; Asma L, 2011, TROP BIOMED, V28, P400; Azian MYN, 2007, TROP BIOMED, V24, P55; Balint A, 2014, PARASITOL RES, V113, P1585, DOI 10.1007/s00436-014-3805-0; Bundy D, 1990, REPORT TO THE; Dogruman-Al F, 2008, PARASITOL RES, V103, P685, DOI 10.1007/s00436-008-1031-3; El Safadi D, 2013, AM J TROP MED HYG, V88, P1203, DOI 10.4269/ajtmh.12-0777; Elshazly Atef M., 2006, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V36, P655; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Hakim S. Lokman, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P415; Hartini Y, 2013, TROP BIOMED, V30, P596; Ithoi Init, 2011, Journal of Parasitology Research, V2011; Jamaiah I., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P68; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; KAN SP, 1987, PUBLIC HEALTH, V101, P243, DOI 10.1016/S0033-3506(87)80075-6; Kaya Selcuk, 2007, Turkiye Parazitoloji Dergisi, V31, P184; Kumarasamy V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-162; Lee IL, 2012, PARASITOL RES, V110, P1553, DOI 10.1007/s00436-011-2665-0; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Leelayoova S, 2008, AM J TROP MED HYG, V79, P401, DOI 10.4269/ajtmh.2008.79.401; Li LH, 2007, PARASITOL RES, V102, P83, DOI 10.1007/s00436-007-0727-0; Lim Y A L, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P30; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Mahdy AKM, 2008, T ROY SOC TROP MED H, V102, P465, DOI 10.1016/j.trstmh.2008.02.004; Menon BS, 1999, J TROP PEDIATRICS, V45, P241, DOI 10.1093/tropej/45.4.241; Motazedian H, 2008, ANN TROP MED PARASIT, V102, P85, DOI 10.1179/136485908X252197; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Norhayati M., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P735; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Rahmah N, 1997, Med J Malaysia, V52, P412; Rajamanikam A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-295; Rajeswari B, 1994, Asia Pac J Public Health, V7, P21; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Sagin D. D., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P18; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; SHEEHAN DJ, 1986, J CLIN MICROBIOL, V24, P548, DOI 10.1128/JCM.24.4.548-550.1986; Shekhar K C, 1996, Med J Malaysia, V51, P475; Sinniah B, 2012, TROP BIOMED, V29, P200; Slifko TR, 2000, INT J PARASITOL, V30, P1379, DOI 10.1016/S0020-7519(00)00128-4; Souppart L, 2009, PARASITOL RES, V105, P413, DOI 10.1007/s00436-009-1398-9; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; SUN T, 1989, AM J GASTROENTEROL, V84, P1543; Suresh K, 2005, APPL ENVIRON MICROB, V71, P5619, DOI 10.1128/AEM.71.9.5619-5620.2005; Suresh K, 2004, EUR J CLIN MICROBIOL, V23, P509, DOI 10.1007/s10096-004-1123-7; Suresh K, 2001, T ROY SOC TROP MED H, V95, P377, DOI 10.1016/S0035-9203(01)90186-5; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2009, PARASITOL RES, V105, P1283, DOI 10.1007/s00436-009-1551-5; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Thathaisong U, 2003, J CLIN MICROBIOL, V41, P967, DOI 10.1128/JCM.41.3.967-975.2003; Vennila GD, 1999, PARASITOL RES, V85, P162, DOI 10.1007/s004360050528; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2	63	36	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0136709	10.1371/journal.pone.0136709	http://dx.doi.org/10.1371/journal.pone.0136709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914483	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700001
J	Jia, YF; Sun, HJ; Wu, HQ; Zhang, HL; Zhang, XP; Xiao, DJ; Ma, XL; Wang, YS				Jia, Yanfei; Sun, Haiji; Wu, Hongqiao; Zhang, Huilin; Zhang, Xiuping; Xiao, Dongjie; Ma, Xiaoli; Wang, Yunshan			Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating alpha 5-nAChR/AKT Signaling in Human Gastric Cancer Cells	PLOS ONE			English	Article							LUNG-CANCER; CIGARETTE-SMOKING; TOBACCO SMOKING; IN-VITRO; PROLIFERATION; RECEPTOR; ACTIVATION; EXPRESSION; CYCLOOXYGENASE-2; INVASION	Gastric cancer incidence demonstrates a strong etiologic association with smoking. Nicotine, the major component in tobacco, is a survival agonist that inhibits apoptosis induced by certain chemotherapeutic agents, but the precise mechanisms involved remain largely unknown. Recently studies have indicated that alpha 5-nicotinic acetylcholine receptor (alpha 5-nAChR) is highly associated with lung cancer risk and nicotine dependence. Nevertheless, no information has been available about whether nicotine also affects proliferation of human gastric cancer cells through regulation of alpha 5-nAChR. To evaluate the hypothesis that alpha 5-nAChR may play a role in gastric cancer, we investigated its expression in gastric cancer tissues and cell lines. The expression of alpha 5-nAChR increased in gastric cancer tissue compared with para-carcinoma tissues. In view of the results, we proceeded to investigate whether nicotine inhibits cisplatin-induced apoptosis via regulating alpha 5-nAChR in gastric cancer cell. The results showed that nicotine significantly promoted cell proliferation in a dose and time-dependent manner through alpha 5-nAChR activation in human gastric cells. Furthermore, nicotine inhibited apoptosis induced by cisplatin. Silence of alpha 5-nAChR ablated the protective effects of nicotine. However, when co-administrating LY294002, an inhibitor of PI3K/AKT pathway, an increased apoptosis was observed. This effect correlated with the induction of Bcl-2, Bax, Survivin and Caspase-3 by nicotine in gastric cell lines. These results suggest that exposure to nicotine might negatively impact the apoptotic potential of chemotherapeutic drugs and that alpha 5-nAChR/AKT signaling plays a key role in the anti-apoptotic activity of nicotine induced by cisplatin.	[Jia, Yanfei; Wu, Hongqiao; Zhang, Huilin; Zhang, Xiuping; Xiao, Dongjie; Ma, Xiaoli; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China; [Sun, Haiji] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong Normal University	Ma, XL; Wang, YS (corresponding author), Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China.	mxl7125@126.com; w_yunshan@126.com			National Natural Science Foundation of China [81272588]; Shandong Provincial Natural Science Foundation of China [ZR2012HM061, ZR2013CM010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This work is supported by the National Natural Science Foundation of China (No. 81272588) and Shandong Provincial Natural Science Foundation of China (No. ZR2012HM061 and ZR2013CM010).	Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Boezen H Marike, 2009, Proc Am Thorac Soc, V6, P701, DOI 10.1513/pats.200907-058DP; Checinska A, 2007, EXP CELL RES, V313, P1215, DOI 10.1016/j.yexcr.2006.12.011; Cheng YA, 1999, ARCH ORAL BIOL, V44, P843, DOI 10.1016/S0003-9969(99)00073-4; Cucina A, 2012, J SURG RES, V178, P233, DOI 10.1016/j.jss.2011.12.029; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; De Dosso S, 2013, CANCER CHEMOTH PHARM, V72, P159, DOI 10.1007/s00280-013-2181-2; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gourlay SG, 1997, EUR J CLIN PHARMACOL, V51, P407, DOI 10.1007/s002280050222; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; Kanetaka K, 2012, ANTICANCER RES, V32, P3495; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lawson GM, 1998, J CLIN PHARMACOL, V38, P510, DOI 10.1002/j.1552-4604.1998.tb05788.x; Lien YC, 2011, ANN SURG ONCOL, V18, P2671, DOI 10.1245/s10434-011-1598-2; Liu Y, 2011, WORLD J GASTROENTERO, V17, P2674, DOI 10.3748/wjg.v17.i21.2674; Ma XL, 2014, TOXICOL APPL PHARM, V278, P172, DOI 10.1016/j.taap.2014.04.023; MacQueen DA, 2014, PHARMACOGENOMICS J, V14, P70, DOI 10.1038/tpj.2012.50; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Mayer B, 2014, ARCH TOXICOL, V88, P5, DOI 10.1007/s00204-013-1127-0; Nakada T, 2012, J TOXICOL SCI, V37, P555; Nishino Y, 2006, JPN J CLIN ONCOL, V36, P800, DOI 10.1093/jjco/hyl112; Nishioka T, 2010, J CELL BIOCHEM, V109, P152, DOI 10.1002/jcb.22392; Pasini F, 2011, ANTICANCER RES, V31, P3543; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shin VY, 2008, TOXICOL APPL PHARM, V233, P254, DOI 10.1016/j.taap.2008.08.012; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2005, ALCOHOL, V35, P259, DOI 10.1016/j.alcohol.2005.04.007; Shin VY, 2004, TOXICOL APPL PHARM, V195, P103, DOI 10.1016/j.taap.2003.10.009; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Sun HJ, 2015, EXP TOXICOL PATHOL, V67, P477, DOI 10.1016/j.etp.2015.07.001; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Takahari D, 2011, CANCER CHEMOTH PHARM, V67, P1423, DOI 10.1007/s00280-010-1432-8; Tanida S., 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/862879, DOI 10.1155/2012/862879]; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; Wang W, 2012, ANN SURG ONCOL, V19, pS580, DOI 10.1245/s10434-011-2064-x; Wang YY, 2014, ONCOL REP, V31, P1480, DOI 10.3892/or.2013.2962; Wojas-Krawczyk K, 2012, EUR J CANCER PREV, V21, P111, DOI 10.1097/CEJ.0b013e32834c9b40; Xu J, 2007, INT J ORAL MAX SURG, V36, P739, DOI 10.1016/j.ijom.2007.05.016; Yu LL, 2010, ONCOL REP, V24, P113, DOI 10.3892/or_00000835; Zeng F, 2012, MED ONCOL, V29, P364, DOI 10.1007/s12032-010-9792-9; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC; Zhang LL, 2013, MOL MED REP, V7, P1387, DOI 10.3892/mmr.2013.1400; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC; Zhou W, 2012, REGUL PEPTIDES, V176, P13, DOI 10.1016/j.regpep.2012.02.003; Zovko A, 2013, MAR DRUGS, V11, P2574, DOI 10.3390/md11072574	50	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149120	10.1371/journal.pone.0149120	http://dx.doi.org/10.1371/journal.pone.0149120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909550	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700023
J	Tschopp, E				Tschopp, Emanuel			Nomenclature of Vertebral Laminae in Lizards, with Comments on Ontogenetic and Serial Variation in Lacertini (Squamata, Lacertidae)	PLOS ONE			English	Article							OSTEOLOGY; DINOSAURIA; NUMBER	Vertebral laminae are bony ridges or sheets that connect important morphological landmarks on the vertebrae, like diapophyses or zygapophyses. They usually exhibit some serial variation throughout the column. A consistent terminology facilitates the morphological description of this variation, and the recognition of patterns that could be taxonomically significant and could serve as phylogenetic characters. Such a terminology was designed for saurischian dinosaurs, and has also been applied to other members of Archosauriformes. Herein, this terminology is applied for the first time to lizards (Squamata). Probably due to their generally smaller size compared to saurischian dinosaurs, lizards have less developed vertebral laminae. Some laminae could not be recognized in this group and others require new names to account for differences in basic vertebral morphology. For instance, the fusion of diapophysis and parapophysis in lacertids into a structure called synapophysis necessitates the creation of the new term synapophyseal laminae for both diapophyseal and parapophyseal laminae. An assessment of occurrence and serial variation in a number of lacertid species shows that some laminae develop throughout ontogeny or only occur in large-sized species, whereas the distribution of other laminae might prove to be taxonomically significant in future.	[Tschopp, Emanuel] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Tschopp, Emanuel] Univ Nova Lisboa, FCT, GeoBioTec, Caparica, Portugal; [Tschopp, Emanuel] Museu Lourinha, Lourinha, Portugal	University of Turin; Universidade Nova de Lisboa	Tschopp, E (corresponding author), Univ Turin, Dipartimento Sci Terra, Turin, Italy.; Tschopp, E (corresponding author), Univ Nova Lisboa, FCT, GeoBioTec, Caparica, Portugal.; Tschopp, E (corresponding author), Museu Lourinha, Lourinha, Portugal.	etschopp@unito.it	Tschopp, Emanuel/H-2723-2019	Tschopp, Emanuel/0000-0002-5245-6910	European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant [609402-2020]	European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant	This project has received funding from the European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 609402-2020 researchers: Train to Move (T2M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Barbadillo L.J., 1984, Amphibia-Reptilia, V4, P215; BARBADILLO LJ, 1994, HERPETOL J, V4, P166; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Blain HA, 2008, GEOL ACTA, V6, P345; Bohmer C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0077; Burnell A, 2012, B SOC GEOL FR, V183, P151, DOI 10.2113/gssgfbull.183.2.151; CAPUTO V, 1995, TROP ZOOL, V8, P95, DOI 10.1080/03946975.1995.10539275; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Chamero B, 2014, ANAT REC, V297, P1278, DOI 10.1002/ar.22926; Cope E. D., 1892, Proceedings of the American Philosophical Society, Vxxx, P185; de Queiroz K., 1987, University of California Publications in Zoology, V118, P1; ETHERIDGE R, 1967, COPEIA, P699, DOI 10.2307/1441880; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Greer AE, 2000, AMPHIBIA-REPTILIA, V21, P121; Hoffstetter R., 1969, P201; Kuhne K, 1913, GEGENBAURS MORPHOLOG, V46, P563; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Parmley D., 1988, Journal of Vertebrate Paleontology, V8, P334; Polly PD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P197; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; RIEPPEL O, 1980, Amphibia-Reptilia, V1, P95, DOI 10.1163/156853880X00105; Salgado L, 2012, J VERTEBR PALEONTOL, V32, P603, DOI 10.1080/02724634.2012.661004; Sarris I, 2012, INT J MORPHOL, V30, P1363, DOI 10.4067/S0717-95022012000400018; Schwarz Daniela, 2007, Historical Biology, V19, P225, DOI 10.1080/08912960601118651; Sookias RB, 2014, PEERJ, V2, DOI 10.7717/peerj.658; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Tschopp E, 2013, J SYST PALAEONTOL, V11, P853, DOI 10.1080/14772019.2012.746589; Venczel Marton, 2006, Nymphaea, V33, P25; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA., 2012, CONTRIB MUS PALEONTO, V32, P91	36	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149445	10.1371/journal.pone.0149445	http://dx.doi.org/10.1371/journal.pone.0149445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907769	Green Submitted, Green Published, gold			2022-12-26	WOS:000371163000011
J	de Groot, MH; van Campen, JPCM; Kosse, NM; de Vries, OJ; Beijnen, JH; Lamoth, CJC				de Groot, Maartje H.; van Campen, Jos P. C. M.; Kosse, Nienke M.; de Vries, Oscar J.; Beijnen, Jos H.; Lamoth, Claudine J. C.			The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients	PLOS ONE			English	Article							RISK-INCREASING DRUGS; MINI-MENTAL-STATE; POSTURAL CONTROL; ELDERLY-PATIENTS; WALKING SPEED; FALLS; VARIABILITY; PEOPLE; METAANALYSIS; POPULATION	The increased fall risk associated with the use of psychotropic drugs might be caused by underlying problems in postural control that are induced by sedative side-effects of these drugs. The current literature on the effects of psychotropics on postural control only examined acute single-drug effects, and included relatively healthy young elderly. Consequently, it is unclear what the impact of the long-term use of these drugs is on gait in frail older persons with polypharmacy. Therefore, it was aimed in the present study to explore the association between the use of psychotropics, multiple other medications, frailty-related parameters and gait performance in older patients. Eighty older persons (79 +/- 5.6 years) were recruited. Comorbid diseases, frailty-related parameters, and medication-use were registered. Trunk accelerations during a 3-minute-walking-task were recorded, whereof walking speed, mean stride times, coefficient of variation (CV) of stride times, and step consistency were determined. Multivariate Partial Least Squares (PLS) regression analysis was used to examine the association between population characteristics and medication-use, versus gait parameters. A PLS-model existing of four latent variables was built, explaining 45% of the variance in four gait parameters. Frailty-related factors, being female, and laxative-use were most strongly associated with lower walking speed, higher mean stride times, higher CV of stride times, and less consistent steps. In conclusion, frailty-related parameters were stronger associated with impaired gait performance than the use of psychotropic drugs. Possibly, at a certain frailty-level, the effect of the deterioration in physical functioning in frailty is so large, that the instability-provoking side-effects of psychotropic drugs have less impact on gait.	[de Groot, Maartje H.; van Campen, Jos P. C. M.] MC Slotervaart, Dept Geriatr Med, Amsterdam, Netherlands; [de Groot, Maartje H.] The Hague Univ Appl Sci, Fac Hlth Nutr & Sport, The Hague, Netherlands; [Kosse, Nienke M.; Lamoth, Claudine J. C.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kosse, Nienke M.] Univ Grenoble Alpes, CNRS UJF UPMF EPHE, FRE AGIM Lab 3405, La Tronche, France; [de Vries, Oscar J.] OLVG, Dept Internal Med, Amsterdam, Netherlands; [Beijnen, Jos H.] MC Slotervaart, Dept Pharm & Pharmacol, Amsterdam, Netherlands; [Beijnen, Jos H.] Univ Utrecht, Dept Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	Slotervaart Hospital; University of Groningen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Slotervaart Hospital; Utrecht University	Lamoth, CJC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.	C.J.C.Lamoth@umcg.nl	Lamoth, Claudine JC/N-4325-2013	Lamoth, Claudine JC/0000-0002-6495-2823				Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Allali G, 2015, ARCH GERONTOL GERIAT, V60, P389, DOI 10.1016/j.archger.2015.02.009; Askari M, 2013, DRUG AGING, V30, P845, DOI 10.1007/s40266-013-0110-z; Beauchet O, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-32; Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277; Boulesteix AL, 2007, BRIEF BIOINFORM, V8, P32, DOI 10.1093/bib/bb1016; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Groot MH, 2014, GAIT POSTURE, V39, P767, DOI 10.1016/j.gaitpost.2013.10.015; de Groot MH, 2013, DRUG AGING, V30, P901, DOI 10.1007/s40266-013-0113-9; de Vries OJ, 2013, OSTEOPOROSIS INT, V24, P2397, DOI 10.1007/s00198-013-2303-z; Ellis G, 2004, BRIT MED BULL, V71, P45, DOI 10.1093/bmb/ldh033; Eriksson L., 2006, MULTI AND MEGAVARIAT; Eriksson S, 2008, ARCH GERONTOL GERIAT, V46, P293, DOI 10.1016/j.archger.2007.05.002; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Haenlein M., 2004, UNDERSTANDING STAT, V3, P283, DOI [10.1207/s15328031us0304_4, DOI 10.1207/S15328031US0304_4]; Ham AC, 2014, DRUG AGING, V31, P917, DOI 10.1007/s40266-014-0225-x; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hartikainen S, 2007, J GERONTOL A-BIOL, V62, P1172, DOI 10.1093/gerona/62.10.1172; Ijmker T, 2012, GAIT POSTURE, V35, P126, DOI 10.1016/j.gaitpost.2011.08.022; Kang HG, 2008, GAIT POSTURE, V27, P572, DOI 10.1016/j.gaitpost.2007.07.009; Kosse NM, 2015, INT PSYCHOGERIATR, V27, P803, DOI 10.1017/S104161021400249X; Kwok CS, 2011, BONE, V48, P768, DOI 10.1016/j.bone.2010.12.015; Lader M, 2009, CNS DRUGS, V23, P19, DOI 10.2165/0023210-200923010-00002; Lamoth CJ, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-2; Lewis JR, 2014, J BONE MINER RES, V29, P2489, DOI 10.1002/jbmr.2279; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Marzetti E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032829; Menant JC, 2014, AGEING RES REV, V16, P83, DOI 10.1016/j.arr.2014.06.001; Montero-Odasso M, 2011, J GERONTOL A-BIOL, V66, P568, DOI 10.1093/gerona/glr007; Mouli V Pratap, 2011, Trop Gastroenterol, V32, P175; Papegaaij S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00028; Plotnik M, 2007, EXP BRAIN RES, V181, P561, DOI 10.1007/s00221-007-0955-7; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Roerdink M, 2007, PHYS THER, V87, P1009, DOI 10.2522/ptj.20050394; Schwenk M, 2014, GERONTOLOGY, V60, P79, DOI 10.1159/000354211; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; Teramura-Gronblad M, 2010, SCAND J PRIM HEALTH, V28, P154, DOI 10.3109/02813432.2010.493315; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; WALD A, 1993, DRUG AGING, V3, P220, DOI 10.2165/00002512-199303030-00003; WHO Collaborating Centre for Drug Statistics Methodology, 2013, GUID ATC CLASS DDD A; WOLD H., 1966, MULTIVARIATE ANAL, P391, DOI DOI 10.1007/S00423-022-02505-9; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357	46	20	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149888	10.1371/journal.pone.0149888	http://dx.doi.org/10.1371/journal.pone.0149888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901048	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100176
J	Li, KQ; Xu, XY; Huang, XS				Li, Kong-Qing; Xu, Xiao-Yong; Huang, Xiao-San			Identification of Differentially Expressed Genes Related to Dehydration Resistance in a Highly Drought-Tolerant Pear, Pyrus betulaefolia, as through RNA-Seq	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; TRANSCRIPTION FACTOR; ABSCISIC-ACID; PONCIRUS-TRIFOLIATA; ARABIDOPSIS; PLANT; RESPONSES; PROFILES; ABA; GENOME	Drought is a major abiotic stress that affects plant growth, development and productivity. Pear is one of the most important deciduous fruit trees in the world, but the mechanisms of drought tolerance in this plant are still unclear. To better understand the molecular basis regarding drought stress response, RNA-seq was performed on samples collected before and after dehydration in Pyrus betulaefolia. In total, 19,532 differentially expressed genes (DEGs) were identified. These genes were annotated into 144 Gene Ontology (GO) terms and 18 clusters of orthologous groups (COG) involved in 129 Kyoto Encyclopedia of Genes and Genomes (KEGG) defined pathways. These DEGs comprised 49 (26 up-regulated, 23 down-regulated), 248 (166 up-regulated, 82 down-regulated), 3483 (1295 up-regulated, 2188 down-regulated), 1455 (1065 up-regulated, 390 down-regulated) genes from the 1 h, 3 h and 6 h dehydration-treated samples and a 24 h recovery samples, respectively. RNA-seq was validated by analyzing the expresson patterns of randomly selected 16 DEGs by quantitative real-time PCR. Photosynthesis, signal transduction, innate immune response, protein phosphorylation, response to water, response to biotic stimulus, and plant hormone signal transduction were the most significantly enriched GO categories amongst the DEGs. A total of 637 transcription factors were shown to be dehydration responsive. In addition, a number of genes involved in the metabolism and signaling of hormones were significantly affected by the dehydration stress. This dataset provides valuable information regarding the Pyrus betulaefolia transcriptome changes in response to dehydration and may promote identification and functional analysis of potential genes that could be used for improving drought tolerance via genetic engineering of non-model, but economically-important, perennial species.	[Li, Kong-Qing] Nanjing Agr Univ, Coll Rural Dev, Nanjing 210095, Jiangsu, Peoples R China; [Huang, Xiao-San] Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China; [Xu, Xiao-Yong] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou 225009, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Yangzhou University	Huang, XS (corresponding author), Nanjing Agr Univ, Coll Hort, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing 210095, Jiangsu, Peoples R China.	huangxs@njau.edu.cn			National Natural Science Foundation of China [31301758]; Fundamental Research Funds for the Central Universities [KYTZ201401, SK2014007]; Ministry of Education of Humanities and Social Science project [14YJC630058]; Research Fund for the Doctoral Program of Higher Education [130600661]; Jiangsu Provincial Natural Science Foundation [BK20130689, BK20150681]; National Postdoctoral Fund [2013T60545, 2012M521092, 2014M551615]; Jiangsu Provincial Postdoctoral Fund [1201019B, 1401125C]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of Humanities and Social Science project; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); National Postdoctoral Fund(China Postdoctoral Science Foundation); Jiangsu Provincial Postdoctoral Fund	This work was supported by the National Natural Science Foundation of China (31301758), the Fundamental Research Funds for the Central Universities (KYTZ201401, SK2014007), the Ministry of Education of Humanities and Social Science project (14YJC630058), the Research Fund for the Doctoral Program of Higher Education (130600661), the Jiangsu Provincial Natural Science Foundation (BK20130689, BK20150681), the National Postdoctoral Fund (2013T60545, 2012M521092, 2014M551615), and the Jiangsu Provincial Postdoctoral Fund (1201019B, 1401125C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Aswath CR, 2005, PLANT GROWTH REGUL, V47, P129, DOI 10.1007/s10725-005-3380-6; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bailly C, 2001, J EXP BOT, V52, P701, DOI 10.1093/jexbot/52.357.701; Boudsocq M, 2007, PLANT MOL BIOL, V63, P491, DOI 10.1007/s11103-006-9103-1; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Chaves M, 2007, PHOTOSYNTH RES, V91, P300; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Colebrook EH, 2014, J EXP BIOL, V217, P67, DOI 10.1242/jeb.089938; Cominelli E, 2005, CURR BIOL, V15, P1196, DOI 10.1016/j.cub.2005.05.048; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eulgem T, 2005, TRENDS PLANT SCI, V10, P71, DOI 10.1016/j.tplants.2004.12.006; Fernandez-Calvo P, 2011, PLANT CELL, V23, P701, DOI 10.1105/tpc.110.080788; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Fujii H, 2011, P NATL ACAD SCI USA, V108, P1717, DOI 10.1073/pnas.1018367108; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gong PJ, 2010, J EXP BOT, V61, P3563, DOI 10.1093/jxb/erq167; GORTON HL, 1987, PLANT PHYSIOL, V83, P945, DOI 10.1104/pp.83.4.945; Guo PG, 2009, J EXP BOT, V60, P3531, DOI 10.1093/jxb/erp194; Hanin M, 2011, PLANT SIGNAL BEHAV, V6, P1503, DOI 10.4161/psb.6.10.17088; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hayano-Kanashiro C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007531; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang DQ, 2008, J EXP BOT, V59, P2991, DOI 10.1093/jxb/ern155; Huang XS, 2013, PLANT PHYSIOL, V162, P1178, DOI 10.1104/pp.112.210740; Huang XS, 2011, J EXP BOT, V62, P5191, DOI 10.1093/jxb/err229; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Huang XS, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2233-6; Huang XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17620; Huang Y, 2015, MOL BIOL REP, V42, P893, DOI 10.1007/s11033-014-3826-x; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Lenka SK, 2011, PLANT BIOTECHNOL J, V9, P315, DOI 10.1111/j.1467-7652.2010.00560.x; Li HM, 2007, PLANT MOL BIOL, V65, P655, DOI 10.1007/s11103-007-9230-3; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu JH, 2014, PLANT MOL BIOL REP, V32, P303, DOI 10.1007/s11105-013-0667-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mare C, 2004, PLANT MOL BIOL, V55, P399, DOI 10.1007/s11103-004-0906-7; Miao WG, 2010, J EXP BOT, V61, P4263, DOI 10.1093/jxb/erq227; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nakagami H, 2005, TRENDS PLANT SCI, V10, P339, DOI 10.1016/j.tplants.2005.05.009; Ning J, 2010, PLANT PHYSIOL, V152, P876, DOI 10.1104/pp.109.149856; Okubo M, 2000, SCI HORTIC-AMSTERDAM, V85, P85, DOI 10.1016/S0304-4238(99)00141-7; Pratt LH, 2005, PLANT PHYSIOL, V139, P869, DOI 10.1104/pp.105.066134; Qi XX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-727; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rong W, 2014, PLANT BIOTECHNOL J, V12, P468, DOI 10.1111/pbi.12153; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sharp RE, 2002, J EXP BOT, V53, P33, DOI 10.1093/jexbot/53.366.33; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Song CP, 2005, PLANT CELL, V17, P2384, DOI 10.1105/tpc.105.033043; Storozhenko S, 1998, PLANT PHYSIOL, V118, P1005, DOI 10.1104/pp.118.3.1005; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Tena G, 2001, CURR OPIN PLANT BIOL, V4, P392, DOI 10.1016/S1369-5266(00)00191-6; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang YC, 2006, PLANT SCI, V171, P655, DOI 10.1016/j.plantsci.2006.06.011; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei W, 2008, PLANT CELL REP, V27, P795, DOI 10.1007/s00299-007-0499-0; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng XN, 2009, BIOCHEM BIOPH RES CO, V379, P985, DOI 10.1016/j.bbrc.2008.12.163; Zong Y, 2014, TREE GENET GENOMES, V10, P739, DOI 10.1007/s11295-014-0718-0; Zou XL, 2007, PLANT SCI, V172, P997, DOI 10.1016/j.plantsci.2007.02.003	72	52	56	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149352	10.1371/journal.pone.0149352	http://dx.doi.org/10.1371/journal.pone.0149352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900681	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100063
J	Lo Gullo, A; Koster, MJ; Crowson, CS; Makol, A; Ytterberg, SR; Saitta, A; Salvarani, C; Matteson, EL; Warrington, KJ				Lo Gullo, Alberto; Koster, Matthew J.; Crowson, Cynthia S.; Makol, Ashima; Ytterberg, Steven R.; Saitta, Antonino; Salvarani, Carlo; Matteson, Eric L.; Warrington, Kenneth J.			Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study	PLOS ONE			English	Article							CRANIAL ISCHEMIC COMPLICATIONS; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; ANGIOGENIC ACTIVITY; PULMONARY-EMBOLISM; RISK-FACTORS; STROKE; THROMBOSIS; DIAGNOSIS; SERIES	Objective To investigate the incidence of venous thromboembolism (VTE) and cerebrovascular events in a community-based incidence cohort of patients with giant cell arteritis (GCA) compared to the general population. Methods A population-based inception cohort of patients with incident GCA between January 1, 1950 and December 31, 2009 in Olmsted County, Minnesota and a cohort of non-GCA subjects from the same population were assembled and followed until December 31, 2013. Confirmed VTE and cerebrovascular events were identified through direct medical record review. Results The study population included 244 patients with GCA with a mean +/- SD age at diagnosis of 76.2 +/- 8.2 years (79% women) and an average length of follow-up of 10.2 +/- 6.8 years. Compared to non-GCA subjects of similar age and sex, patients diagnosed with GCA had a higher incidence (%) of amaurosis fugax (cumulative incidence +/- SE: 2.1 +/- 0.9 versus 0, respectively; p = 0.014) but similar rates of stroke, transient ischemic attack (TIA), and VTE. Among patients with GCA, neither baseline characteristics nor laboratory parameters at diagnosis reliably predicted risk of VTE or cerebrovascular events. Conclusion In this population-based study, the incidence of VTE, stroke and TIA was similar in patients with GCA compared to non-GCA subjects.	[Lo Gullo, Alberto; Saitta, Antonino] Univ Messina, Dept Clin & Expt Med, Messina, ME, Italy; [Koster, Matthew J.; Crowson, Cynthia S.; Makol, Ashima; Ytterberg, Steven R.; Matteson, Eric L.; Warrington, Kenneth J.] Mayo Clin, Coll Med, Div Rheumatol, Dept Med, Rochester, MN USA; [Crowson, Cynthia S.] Mayo Clin, Coll Med, Div Biomed Stat, Dept Hlth Sci Res, Rochester, MN USA; [Matteson, Eric L.] Mayo Clin, Coll Med, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Salvarani, Carlo] Azienda Osped ASMN, Rheumatol Unit, Dept Internal Med, Reggio Emilia, Italy	University of Messina; Mayo Clinic; Mayo Clinic; Mayo Clinic; IRCCS Arcispedale S. Maria Nuova	Koster, MJ (corresponding author), Mayo Clin, Coll Med, Div Rheumatol, Dept Med, Rochester, MN USA.	koster.matthew@mayo.edu	Warrington, Kenneth/CAG-1626-2022; Gullo, Alberto Lo/AAC-2766-2019; Salvarani, Carlo/K-2431-2018	Warrington, Kenneth/0000-0001-7708-2487; Makol, Ashima/0000-0002-8748-898X; Lo Gullo, Alberto/0000-0003-4383-0314; Salvarani, Carlo/0000-0001-5426-5133	US National Institute on Aging of the National Institutes of Health (NIH) [R01AG034676]; National Center for Advancing Translational Sciences (NCATS) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034676] Funding Source: NIH RePORTER	US National Institute on Aging of the National Institutes of Health (NIH); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the resources of the Rochester Epidemiology Project, which is supported by the US National Institute on Aging of the National Institutes of Health (NIH) under Award Number R01AG034676 and by Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the listed authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach Y, 2009, ANN RHEUM DIS, V68, P564, DOI 10.1136/ard.2008.099051; Ames PRJ, 2001, RHEUMATOLOGY, V40, P652, DOI 10.1093/rheumatology/40.6.652; Amiri N, 2016, RHEUMATOLOGY, V55, P33, DOI 10.1093/rheumatology/kev262; Avina-Zubieta JA, 2016, ANN RHEUM DIS, V75, P148, DOI 10.1136/annrheumdis-2014-205665; Bacani AK, 2012, ARTHRITIS RHEUM-US, V64, P53, DOI 10.1002/art.33322; Berger CT, 2009, RHEUMATOLOGY, V48, P258, DOI 10.1093/rheumatology/ken480; Bhavsar SV, 2014, ARTHRITIS RHEUMATOL, V66, pS351; CASELLI RJ, 1988, NEUROLOGY, V38, P352, DOI 10.1212/WNL.38.3.352; Chung WS, 2014, J THROMB HAEMOST, V12, P452, DOI 10.1111/jth.12518; Cid MC, 2002, CIRCULATION, V106, P1664, DOI 10.1161/01.CIR.0000030185.67510.C0; Cid MC, 1998, ARTHRITIS RHEUM-US, V41, P26, DOI 10.1002/1529-0131(199801)41:1<26::AID-ART4>3.0.CO;2-0; Cohen R, 2010, OPTOMETRY, V81, P359, DOI 10.1016/j.optm.2009.10.013; Faurschou M, 2014, ARTHRIT CARE RES, V66, P1910, DOI 10.1002/acr.22423; FUTRELL N, 1989, STROKE, V20, P583, DOI 10.1161/01.STR.20.5.583; Gonzalez-Gay MA, 2000, MEDICINE, V79, P283, DOI 10.1097/00005792-200009000-00001; Gonzalez-Gay MA, 2004, MEDICINE, V83, P342, DOI 10.1097/01.md.0000145369.25558.b5; Gonzalez-Gay MA, 2009, MEDICINE, V88, P227, DOI 10.1097/MD.0b013e3181af4518; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hernandez-Rodriguez J, 2003, CIRCULATION, V107, P2428, DOI 10.1161/01.CIR.0000066907.83923.32; Hernandez-Rodriguez J, 2007, MEDICINE, V86, P233, DOI 10.1097/MD.0b013e318145275c; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Isene R, 2014, SCAND J GASTROENTERO, V49, P820, DOI 10.3109/00365521.2014.910545; Lopez-Diaz MJ, 2008, SEMIN ARTHRITIS RHEU, V38, P116, DOI 10.1016/j.semarthrit.2007.10.014; Nadareishvili Z, 2008, ARTHRIT RHEUM-ARTHR, V59, P1090, DOI 10.1002/art.23935; Nesher G, 2004, ARTHRITIS RHEUM, V50, P1332, DOI 10.1002/art.20171; Pego-Reigosa R, 2004, CLIN EXP RHEUMATOL, V22, pS13; Ray JG, 2005, HEART, V91, P324, DOI 10.1136/hrt.2004.037481; Salvarani C, 2009, RHEUMATOLOGY, V48, P250, DOI 10.1093/rheumatology/ken465; Samson M, 2015, J NEUROL NEUROSUR PS, V86, P216, DOI 10.1136/jnnp-2014-307614; Sarica-Kucukoglu R, 2006, INT J DERMATOL, V45, P919, DOI 10.1111/j.1365-4632.2006.02832.x; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; St Sauver JL, 2011, AM J EPIDEMIOL, V173, P1059, DOI 10.1093/aje/kwq482; Stassen PM, 2008, RHEUMATOLOGY, V47, P530, DOI 10.1093/rheumatology/ken035; Timlin H, 2013, LUPUS, V22, P1251, DOI 10.1177/0961203313497416; Tomasson G, 2014, ANN INTERN MED, V160, P73, DOI 10.7326/M12-3046; Udayakumar PD, 2015, ARTHRIT CARE RES, V67, P396, DOI 10.1002/acr.22416; Unizony S, 2015, RHEUMATOLOGY, V54, P1360, DOI 10.1093/rheumatology/keu483; WILKINSON IM, 1972, ARCH NEUROL-CHICAGO, V27, P378, DOI 10.1001/archneur.1972.00490170010003; Wiszniewska M, 2007, CEREBROVASC DIS, V24, P226, DOI 10.1159/000104482; Zenone T, 2013, RHEUMATOL INT, V33, P3017, DOI 10.1007/s00296-013-2814-0	41	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149579	10.1371/journal.pone.0149579	http://dx.doi.org/10.1371/journal.pone.0149579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901431	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100102
J	Sakurai, T; Isogaya, K; Sakai, S; Morikawa, M; Morishita, Y; Ehata, S; Miyazono, K; Koinuma, D				Sakurai, T.; Isogaya, K.; Sakai, S.; Morikawa, M.; Morishita, Y.; Ehata, S.; Miyazono, K.; Koinuma, D.			RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma	ONCOGENE			English	Article							FACTOR-BETA; MESENCHYMAL TRANSITION; EXPRESSION; DEGRADATION; LIGASE; RBM47	RNA-binding proteins provide a new layer of posttranscriptional regulation of RNA during cancer progression. We identified RNA-binding motif protein 47 (RBM47) as a target gene of transforming growth factor (TGF)-beta in mammary gland epithelial cells (NMuMG cells) that have undergone the epithelial-to-mesenchymal transition. TGF-beta repressed RBM47 expression in NMuMG cells and lung cancer cell lines. Expression of RBM47 correlated with good prognosis in patients with lung, breast and gastric cancer. RBM47 suppressed the expression of cell metabolism-related genes, which were the direct targets of nuclear factor erythroid 2-related factor 2 (Nrf2; also known as NFE2L2). RBM47 bound to KEAP1 and Cullin 3 mRNAs, and knockdown of RBM47 inhibited their protein expression, which led to enhanced binding of Nrf2 to target genomic regions. Knockdown of RBM47 also enhanced the expression of some Nrf2 activators, p21/CDKN1A and MafK induced by TGF-beta. Both mitochondrial respiration rates and the side population cells in lung cancer cells increased in the absence of RBM47. Our findings, together with the enhanced tumor formation and metastasis of xenografted mice by knockdown of the RBM47 expression, suggested tumor-suppressive roles for RBM47 through the inhibition of Nrf2 activity.	[Sakurai, T.; Isogaya, K.; Sakai, S.; Morishita, Y.; Ehata, S.; Miyazono, K.; Koinuma, D.] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo, Japan; [Morikawa, M.] Uppsala Univ, Ludwig Inst Canc Res, Sci Life Lab, Uppsala, Sweden	University of Tokyo; Ludwig Institute for Cancer Research; Uppsala University	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	Koinuma, Daizo/Y-8716-2018; Morikawa, Masato/D-1932-2011	Koinuma, Daizo/0000-0001-5611-2122; Morikawa, Masato/0000-0002-6191-7176; Ehata, Shogo/0000-0002-6740-9391	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [22112002, 15K06831, 15H05774, 24890039]; Japan Agency for Medical Research and Development (AMED) [15ak0101001h0005]; Kanae Foundation for Research Abroad; Japan Society for the Promotion of Science (JSPS); ITO Genboku and SAGARA Chian Memorial Scholarship; Grants-in-Aid for Scientific Research [15K08393, 15H05774, 22112002] Funding Source: KAKEN	KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Kanae Foundation for Research Abroad; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ITO Genboku and SAGARA Chian Memorial Scholarship; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to Dr Hiroyuki Aburatani, Shuichi Tsutsumi and Aya Nonaka (The University of Tokyo) for the ChIP-seq data and advice regarding RIP-seq analysis, and to Dr Hiroyuki Suzuki (Tsukuba University) for discussion and advice. We also thank Akiyoshi Komuro for a lentiviral luciferase expression plasmid and Keiko Yuki for technical assistance, and members of the Miyazono laboratory for discussion and advice. This work was supported by KAKENHI grants-in-aid for scientific research in Innovative Area (Integrative Research on Cancer Microenvironment Network, (22112002) to KM), Scientific Research (C) ((15K06831) to DK) and (S) ((15H05774) to KM), a Research Activity Start-up grant ((24890039), KI) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); and a grant from the Japan Agency for Medical Research and Development (AMED) (15ak0101001h0005 to DK). This study was performed as a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), AMED; MM is supported by the Kanae Foundation for Research Abroad and the ITO Genboku and SAGARA Chian Memorial Scholarship; TS is supported by a grant from the Japan Society for the Promotion of Science (JSPS).	Arase M, 2014, CANCER SCI, V105, P974, DOI 10.1111/cas.12454; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Ehata S, 2011, ONCOGENE, V30, P1693, DOI 10.1038/onc.2010.546; Fossat N, 2014, EMBO REP, V15, P903, DOI 10.15252/embr.201438450; Guan R, 2013, DEV DYNAM, V242, P1395, DOI 10.1002/dvdy.24039; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hast BE, 2014, CANCER RES, V74, P808, DOI 10.1158/0008-5472.CAN-13-1655; Hayes JD, 2012, CELL METAB, V16, P139, DOI 10.1016/j.cmet.2012.07.009; Horiguchi K, 2012, ONCOGENE, V31, P3190, DOI 10.1038/onc.2011.493; Isogaya K, 2014, CELL RES, V24, P994, DOI 10.1038/cr.2014.97; Katayama R, 2009, CANCER SCI, V100, P2060, DOI 10.1111/j.1349-7006.2009.01288.x; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Koinuma D, 2011, J BIOL CHEM, V286, P32502, DOI 10.1074/jbc.M111.227561; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Mizutani A, 2011, J BIOL CHEM, V286, P29848, DOI 10.1074/jbc.M110.217745; Morikawa M, 2013, ONCOGENE, V32, P1609, DOI 10.1038/onc.2012.191; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Petit V, 2009, J MOL BIOL, V385, P65, DOI 10.1016/j.jmb.2008.10.043; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Saito RA, 2009, CANCER RES, V69, P2783, DOI 10.1158/0008-5472.CAN-08-3490; Shirai Y, 2011, AM J PATHOL, V179, P2920, DOI 10.1016/j.ajpath.2011.08.022; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2006, AM J RESP CELL MOL, V35, P639, DOI 10.1165/rcmb.2005-0325OC; Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung JM, 2008, BIOCHEM BIOPH RES CO, V371, P163, DOI 10.1016/j.bbrc.2008.04.038; Valdmanis PN, 2015, ONCOGENE, V34, P94, DOI 10.1038/onc.2013.523; Vanharanta S, 2014, ELIFE, V3, DOI 10.7554/eLife.02734; Yang PY, 2012, CANCER CELL, V22, P291, DOI 10.1016/j.ccr.2012.07.023; Yatabe Y, 2002, AM J SURG PATHOL, V26, P767, DOI 10.1097/00000478-200206000-00010; Yeganeh M, 2013, MOL BIOL REP, V40, P4391, DOI 10.1007/s11033-013-2528-0; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	39	41	41	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					5000	5009		10.1038/onc.2016.35	http://dx.doi.org/10.1038/onc.2016.35			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	26923328	hybrid, Green Published			2022-12-26	WOS:000383965300004
J	de Albuquerque, CP; Liang, J; Gaut, NJ; Zhou, HL				de Albuquerque, Claudio Ponte; Liang, Jason; Gaut, Nathaniel James; Zhou, Huilin			Molecular Circuitry of the SUMO (Small Ubiquitin-like Modifier) Pathway in Controlling Sumoylation Homeostasis and Suppressing Genome Rearrangements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cysteine protease; DNA helicase; DNA recombination; DNA replication; small ubiquitin-like modifier (SUMO)	CELL-CYCLE PROGRESSION; DNA-DAMAGE; PROTEASE; REPLICATION; ENCODES; COMPLEX; LOCALIZATION; ACCUMULATION; ISOPEPTIDASE; DOMAINS	Small ubiquitin-like modifier (SUMO) E3 ligases are known to have a major role in preventing gross chromosomal rearrangements (GCRs); however, relatively little is known about the role of SUMO isopeptidases in genome maintenance and their role in controlling intracellular sumoylation homeostasis. Here we show the SUMO isopeptidase Ulp2 in Saccharomyces cerevisiae does not prevent the accumulation of GCRs, and interestingly, its loss causes subunit-specific changes of sumoylated minichromosome maintenance (MCM) helicase in addition to drastic accumulation of sumoylated nucleolar RENT and inner kinetochore complexes. In contrast, loss of Ulp1 or its mis-localization from the nuclear periphery causes substantial accumulations of GCRs and elevated sumoylation of most proteins except for Ulp2 targets. Interestingly, the E3 ligase Mms21, which has a major role in genome maintenance, preferentially controls the sumoylation of Mcm3 during DNA replication. These findings reveal distinct roles for Ulp1 and Ulp2 in controlling homeostasis of intracellular sumoylation and show that sumoylation of MCM is controlled in a subunit-specific and cell cycle dependent manner.	[de Albuquerque, Claudio Ponte; Liang, Jason; Gaut, Nathaniel James; Zhou, Huilin] Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Liang, Jason] Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA; [Zhou, Huilin] Univ Calif San Diego, Moores Canc Ctr, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhou, HL (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr,CMM-East 2055, La Jolla, CA 92093 USA.	huzhou@ucsd.edu		Liang, Jason/0000-0001-8742-8824; Zhou, Huilin/0000-0002-1350-4430	National Institutes of Health [T32 CA009523, GM116897]; Ludwig Cancer Research; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116897] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grant T32 CA009523 (NCI; to J. L.) and GM116897 (NIGMS; to H. Z.). This work was also supported by Ludwig Cancer Research. We declare that there is no conflict of interest for this study.	Albuquerque CP, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003670; Bell SD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012807; Boos D, 2012, CURR OPIN CELL BIOL, V24, P423, DOI 10.1016/j.ceb.2012.01.011; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Davey MJ, 2003, J BIOL CHEM, V278, P4491, DOI 10.1074/jbc.M210511200; Frigola J, 2013, NATURE, V495, P339, DOI 10.1038/nature11920; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hornung P, 2014, J CELL BIOL, V206, P509, DOI 10.1083/jcb.201403081; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 2003, J CELL BIOL, V160, P1069, DOI 10.1083/jcb.200212052; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; MAINE GT, 1984, GENETICS, V106, P365; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; MELUH PB, 1995, MOL BIOL CELL, V6, P793, DOI 10.1091/mbc.6.7.793; Mukhopadhyay D, 2010, J CELL BIOL, V188, P681, DOI 10.1083/jcb.200909008; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; O'Donnell M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010108; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123; Panse VG, 2003, NAT CELL BIOL, V5, P21, DOI 10.1038/ncb893; Pelisch F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6485; Putnam CD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004277; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Srikumar T, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.23; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Strunnikov AV, 2001, GENETICS, V158, P95; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	39	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8825	8835		10.1074/jbc.M116.716399	http://dx.doi.org/10.1074/jbc.M116.716399			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26921322	Green Published, hybrid			2022-12-26	WOS:000374773200043
J	Koh, S; Hwang, J; Guchhait, K; Lee, EG; Kim, SY; Kim, S; Lee, S; Chung, JM; Jung, HS; Lee, SJ; Ryu, CM; Lee, SG; Oh, TK; Kwon, O; Kim, MH				Koh, Serry; Hwang, Jungwon; Guchhait, Koushik; Lee, Eun-Gyeong; Kim, Sang-Yoon; Kim, Sujin; Lee, Sangmin; Chung, Jeong Min; Jung, Hyun Suk; Lee, Sang Jun; Ryu, Choong-Min; Lee, Seung-Goo; Oh, Tae-Kwang; Kwon, Ohsuk; Kim, Myung Hee			Molecular Insights into Toluene Sensing in the TodS/TodT Signal Transduction System	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial signal transduction; biodegradation; histidine kinase; Pseudomonas; x-ray crystallography	PSEUDOMONAS-PUTIDA F1; SENSOR KINASE TODS; BETA-GALACTOSIDASE ACTIVITY; 2-COMPONENT SYSTEM; EXPRESSION VECTORS; ESCHERICHIA-COLI; STRUCTURAL BASIS; CLONING VECTORS; OPERON PROMOTER; PAS DOMAINS	TodS is a sensor kinase that responds to various monoaromatic compounds, which either cause an agonistic or antagonistic effect on phosphorylation of its cognate response regulator TodT, and controls tod operon expression in Pseudomonas putida strains. We describe a molecular sensing mechanism of TodS that is activated in response to toluene. The crystal structures of the TodS Per-Arnt-Sim (PAS) 1 sensor domain (residues 43-164) and its complex with toluene (agonist) or 1,2,4-trimethylbenzene (antagonist) show a typical 233 PAS fold structure (residues 45-149), forming a hydrophobic ligand-binding site. A signal transfer region (residues 150-163) located immediately after the canonical PAS fold may be intrinsically flexible and disordered in both apo-PAS1 and antagonist-bound forms and dramatically adapt an -helix upon toluene binding. This structural change in the signal transfer region is proposed to result in signal transmission to activate the TodS/TodT two-component signal transduction system. Site-directed mutagenesis and -galactosidase assays using a P. putida reporter strain system verified the essential residues involved in ligand sensing and signal transfer and suggest that the Phe(46) residue acts as a ligand-specific switch.	[Koh, Serry; Hwang, Jungwon; Guchhait, Koushik; Lee, Sang Jun; Oh, Tae-Kwang; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Ctr, Daejeon 305806, South Korea; [Lee, Eun-Gyeong; Kim, Sang-Yoon; Kim, Sujin; Lee, Seung-Goo; Kwon, Ohsuk] Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Daejeon 305806, South Korea; [Ryu, Choong-Min] Korea Res Inst Biosci & Biotechnol, Mol Phytobacteriol Lab, Daejeon 305806, South Korea; [Lee, Sangmin; Chung, Jeong Min; Jung, Hyun Suk] Kangwon Natl Univ, Coll Nat Sci, Dept Biochem, Chunchon 200701, Gangwon Do, South Korea; [Guchhait, Koushik; Lee, Eun-Gyeong; Lee, Sang Jun; Ryu, Choong-Min; Lee, Seung-Goo; Oh, Tae-Kwang; Kwon, Ohsuk; Kim, Myung Hee] Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 305350, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Kangwon National University; University of Science & Technology (UST)	Koh, S; Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol, Infect & Immun Res Ctr, Daejeon 305806, South Korea.; Kwon, O (corresponding author), Korea Res Inst Biosci & Biotechnol, Biochem & Synthet Biol Res Ctr, Daejeon 305806, South Korea.; Kwon, O; Kim, MH (corresponding author), Univ Sci & Technol, Biosyst & Bioengn Program, Daejeon 305350, South Korea.	skohtn@kribb.re.kr; oskwon@kribb.re.kr; mhk8n@kribb.re.kr	Lee, Seung-Goo/AAS-1613-2021; Kim, Sang-Yoon/Q-1259-2015; Lee, Seung-Goo/AAR-9823-2021	Kim, Sang-Yoon/0000-0002-6918-0607; Lee, Seung-Goo/0000-0003-4539-9812; Ryu, Choong-Min/0000-0002-7276-1189; Lee, Sang Jun/0000-0002-2803-753X	Rural Development Administration, Korea [PJ00817002, PJ00952403, PJ011118]; Korea Research Institute of Bioscience and Biotechnology Research Initiative [KGM4541622, KGM2111622]	Rural Development Administration, Korea(Rural Development Administration (RDA), Republic of Korea); Korea Research Institute of Bioscience and Biotechnology Research Initiative	This work was supported by Next-Generation Biogreen 21 Program Grants PJ00817002, PJ00952403, and PJ011118, Rural Development Administration, Korea; and Korea Research Institute of Bioscience and Biotechnology Research Initiative Grants KGM4541622 and KGM2111622. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAGDASARIAN M, 1981, GENE, V16, P237, DOI 10.1016/0378-1119(81)90080-9; Busch A, 2007, P NATL ACAD SCI USA, V104, P13774, DOI 10.1073/pnas.0701547104; Busch A, 2010, J BACTERIOL, V192, P4246, DOI 10.1128/JB.00379-10; Busch A, 2009, J BIOL CHEM, V284, P10353, DOI 10.1074/jbc.M900521200; Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30; Cohen J, 1997, HUM REPROD, V12, P1742, DOI 10.1093/humrep/12.8.1742; Diaz LF, 2008, BIODEGRADATION, V19, P197, DOI 10.1007/s10532-007-9126-6; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Fedorov R, 2003, BIOPHYS J, V84, P2474, DOI 10.1016/S0006-3495(03)75052-8; Griffith KL, 2002, BIOCHEM BIOPH RES CO, V290, P397, DOI 10.1006/bbrc.2001.6152; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; Krell T, 2010, ANNU REV MICROBIOL, V64, P539, DOI 10.1146/annurev.micro.112408.134054; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacal J, 2008, J MOL BIOL, V376, P325, DOI 10.1016/j.jmb.2007.12.004; Lacal J, 2006, P NATL ACAD SCI USA, V103, P8191, DOI 10.1073/pnas.0602902103; Lacal J, 2008, J MOL BIOL, V384, P1037, DOI 10.1016/j.jmb.2008.10.011; Lau PCK, 1997, P NATL ACAD SCI USA, V94, P1453, DOI 10.1073/pnas.94.4.1453; Lee J, 2008, BIOCHEMISTRY-US, V47, P4051, DOI 10.1021/bi7021156; LEE JY, 1994, BIOTECHNOL BIOENG, V43, P1146, DOI 10.1002/bit.260431120; Ma XL, 2008, J BIOL CHEM, V283, P1167, DOI 10.1074/jbc.M706218200; Mosqueda G, 1999, GENE, V232, P69, DOI 10.1016/S0378-1119(99)00113-4; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; RAMOS JL, 1995, J BACTERIOL, V177, P3911, DOI 10.1128/jb.177.14.3911-3916.1995; Ramos-Gonzalez MI, 2002, J BACTERIOL, V184, P7062, DOI 10.1128/JB.184.24.7062-7067.2002; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Silva-Jimenez H, 2015, MICROB BIOTECHNOL, V8, P103, DOI 10.1111/1751-7915.12142; Silva-Jimenez H, 2012, MICROB BIOTECHNOL, V5, P489, DOI 10.1111/j.1751-7915.2011.00322.x; Silva-Jimenez H, 2012, PROTEIN ENG DES SEL, V25, P159, DOI 10.1093/protein/gzs001; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; Thibodeau SA, 2004, BIOTECHNIQUES, V36, P410, DOI 10.2144/04363BM07; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vick JE, 2011, APPL MICROBIOL BIOT, V92, P1275, DOI 10.1007/s00253-011-3633-4; Vidal-Aroca F, 2006, BIOTECHNIQUES, V40, P433, DOI 10.2144/000112145; Winnen B, 2013, J BACTERIOL, V195, P2349, DOI 10.1128/JB.00096-13; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Yu HB, 2001, BIODEGRADATION, V12, P465, DOI 10.1023/A:1015012913426; ZYLSTRA GJ, 1989, APPL ENVIRON MICROB, V55, P3162, DOI 10.1128/AEM.55.12.3162-3166.1989; ZYLSTRA GJ, 1988, APPL ENVIRON MICROB, V54, P1498, DOI 10.1128/AEM.54.6.1498-1503.1988	47	14	14	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8575	8590		10.1074/jbc.M116.718841	http://dx.doi.org/10.1074/jbc.M116.718841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903514	hybrid, Green Published			2022-12-26	WOS:000374773200022
J	Silvaroli, JA; Arne, JM; Chelstowska, S; Kiser, PD; Banerjee, S; Golczak, M				Silvaroli, Josie A.; Arne, Jason M.; Chelstowska, Sylwia; Kiser, Philip D.; Banerjee, Surajit; Golczak, Marcin			Ligand Binding Induces Conformational Changes in Human Cellular Retinol-binding Protein 1 (CRBP1) Revealed by Atomic Resolution Crystal Structures	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid transport; retinal metabolism; retinoid-binding protein; retinol; vitamin A	ESCHERICHIA-COLI; VITAMIN-A; MASS-SPECTROMETRY; RAT-LIVER; HOLO; APO; DYNAMICS; FAMILY; POTENT; ACYLTRANSFERASE	Important in regulating the uptake, storage, and metabolism of retinoids, cellular retinol-binding protein 1 (CRBP1) is essential for trafficking vitamin A through the cytoplasm. However, the molecular details of ligand uptake and targeted release by CRBP1 remain unclear. Here we report the first structure of CRBP1 in a ligand-free form as well as ultra-high resolution structures of this protein bound to either all-trans-retinol or retinylamine, the latter a therapeutic retinoid that prevents light-induced retinal degeneration. Superpositioning of human apo- and holo-CRBP1 revealed major differences within segments surrounding the entrance to the retinoid-binding site. These included -helix II and hairpin turns between -strands C-D and E-F as well as several side chains, such as Phe-57, Tyr-60, and Ile-77, that change their orientations to accommodate the ligand. Additionally, we mapped hydrogen bond networks inside the retinoid-binding cavity and demonstrated their significance for the ligand affinity. Analyses of the crystallographic B-factors indicated several regions with higher backbone mobility in the apoprotein that became more rigid upon retinoid binding. This conformational flexibility of human apo-CRBP1 facilitates interaction with the ligands, whereas the more rigid holoprotein structure protects the labile retinoid moiety during vitamin A transport. These findings suggest a mechanism of induced fit upon ligand binding by mammalian cellular retinol-binding proteins.	[Silvaroli, Josie A.; Arne, Jason M.; Chelstowska, Sylwia; Kiser, Philip D.; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA; [Golczak, Marcin] Case Western Reserve Univ, Sch Med, Cleveland Ctr Membrane & Struct Biol, Cleveland, OH 44106 USA; [Chelstowska, Sylwia] Mil Inst Med, Dept Hematol, Lab Hematol & Flow Cytometry, PL-04141 Warsaw, Poland; [Kiser, Philip D.] Louis Stokes Cleveland Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Banerjee, Surajit] Cornell Univ, Dept Chem & Chem Biol, Ithaca, NY 14850 USA; [Banerjee, Surajit] Argonne Natl Lab, Northeastern Collaborat Access Team, 9700 S Cass Ave, Argonne, IL 60439 USA	Case Western Reserve University; Case Western Reserve University; Military Institute of Aviation Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Golczak, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	mxg149@case.edu		Silvaroli, Josie/0000-0002-4505-3670	NIGMS, National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIGMS, NIH [P41GM103393]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY023948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103403] Funding Source: NIH RePORTER; Veterans Affairs [IK2BX002683] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; DOE Office of Science(United States Department of Energy (DOE)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	We thank L. T. Webster, Jr. for help in editing the manuscript. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by NIGMS, National Institutes of Health (NIH), Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-C beamline is funded by NIH-ORIP HEI Grant S10 RR029205. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We also thank the staff of the SLAC National Accelerator Laboratory (Menlo Park, CA), operated by Stanford University for the DOE Office of Science. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the DOE Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIGMS, NIH, Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al Tanoury Z, 2013, J LIPID RES, V54, P1761, DOI 10.1194/jlr.R030833; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; BRIDGES CDB, 1975, VISION RES, V15, P1311, DOI 10.1016/0042-6989(75)90183-2; BURGER A, 1993, FEBS LETT, V329, P25, DOI 10.1016/0014-5793(93)80185-W; Calderone V, 2002, J MOL BIOL, V321, P527, DOI 10.1016/S0022-2836(02)00628-9; Careri M, 2006, RAPID COMMUN MASS SP, V20, P1973, DOI 10.1002/rcm.2547; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHYTIL F, 1983, ADV NUTR RES, V5, P13; COWAN SW, 1993, J MOL BIOL, V230, P1225, DOI 10.1006/jmbi.1993.1238; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON U, 1984, J BIOL CHEM, V259, P3464; Folli C, 2002, J BIOL CHEM, V277, P41970, DOI 10.1074/jbc.M207124200; Folli C, 2001, P NATL ACAD SCI USA, V98, P3710, DOI 10.1073/pnas.061455898; Franzoni L, 2002, J BIOL CHEM, V277, P21983, DOI 10.1074/jbc.M201994200; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Golczak M, 2015, NAT CHEM BIOL, V11, P26, DOI 10.1038/nchembio.1687; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; KATO M, 1984, J CELL BIOL, V98, P1696, DOI 10.1083/jcb.98.5.1696; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kono N, 2015, TRAFFIC, V16, P19, DOI 10.1111/tra.12231; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P53; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LEVIN MS, 1988, J BIOL CHEM, V263, P17715; LI E, 1986, P NATL ACAD SCI USA, V83, P5779, DOI 10.1073/pnas.83.16.5779; LI E, 1990, J BIOL CHEM, V265, P11549; Lu JY, 2003, J MOL BIOL, V330, P799, DOI 10.1016/S0022-2836(03)00629-6; Lu JY, 1999, J MOL BIOL, V286, P1179, DOI 10.1006/jmbi.1999.2544; MACDONALD PN, 1987, J BIOL CHEM, V262, P10550; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2006, MOL PHARMACOL, V70, P1220, DOI 10.1124/mol.106.026823; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1997, DOI 10.1107/S0907444999011853; NEWCOMER ME, 1981, J BIOL CHEM, V256, P8162; Nossoni Z, 2014, ACTA CRYSTALLOGR D, V70, P3226, DOI 10.1107/S1399004714023839; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; ONG DE, 1978, J BIOL CHEM, V253, P828; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROSENFIELD RE, 1978, ACTA CRYSTALLOGR A, V34, P828, DOI 10.1107/S0567739478001692; SAARI JC, 1984, VISION RES, V24, P1595, DOI 10.1016/0042-6989(84)90317-1; Saari JC, 2002, INVEST OPHTH VIS SCI, V43, P1730; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schneider B, 2014, ACTA CRYSTALLOGR D, V70, P2413, DOI 10.1107/S1399004714014631; Tarter M, 2008, PROTEINS, V70, P1626, DOI 10.1002/prot.21848; Torta F, 2004, BBA-PROTEINS PROTEOM, V1703, P21, DOI 10.1016/j.bbapap.2004.09.004; Trueblood KN, 1996, ACTA CRYSTALLOGR A, V52, P770, DOI 10.1107/S0108767396005697; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER NS, 1993, J MOL BIOL, V230, P1247, DOI 10.1006/jmbi.1993.1239; Xiao H, 2005, J AM SOC MASS SPECTR, V16, P869, DOI 10.1016/j.jasms.2005.02.020; Zhang JY, 2015, MOL PHARMACOL, V87, P477, DOI 10.1124/mol.114.096560	61	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8528	8540		10.1074/jbc.M116.714535	http://dx.doi.org/10.1074/jbc.M116.714535			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26900151	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000374773200018
J	St-Pierre, S; Jiang, W; Roy, P; Champigny, C; LeBlanc, E; Morley, BJ; Hao, JW; Simard, AR				St-Pierre, Stephanie; Jiang, Wei; Roy, Patrick; Champigny, Camille; LeBlanc, Eric; Morley, Barbara J.; Hao, Junwei; Simard, Alain R.			Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; HEMATOPOIETIC SYSTEM; ATTENUATION; SUBSETS; ALPHA-7; CELLS; HETEROGENEITY; EXPRESSION; TISSUES; CCR2	It is increasingly clear that nicotinic acetylcholine receptors (nAChRs) are involved in immune regulation, and that their activation can protect against inflammatory diseases. Previous data have shown that nicotine diminishes the numbers of peripheral monocytes and macrophages, especially those of the pro-inflammatory phenotype. The goal of the present study was to determine if nicotine modulates the production of bone marrow-derived monocytes/macrophages. In this study, we first found that murine bone marrow cells express multiple nAChR subunits, and that the alpha 7 and alpha 9 nAChRs most predominant subtypes found in immune cells and their precursors. Using primary cultures of murine bone marrow cells, we then determined the effect of nicotine on monocyte colony-stimulating factor and interferon gamma (IFN gamma)-induced monocyte production. We found that nicotine lowered the overall number of monocytes, and more specifically, inhibited the IFN gamma-induced increase in proinflammatory monocytes by reducing cell proliferation and viability. These data suggested that nicotine diminishes the ratio of pro-inflammatory versus anti-inflammatory monocyte produced in the bone marrow. We thus confirmed this hypothesis by measuring cytokine expression, where we found that nicotine inhibited the production of the pro-inflammatory cytokines TNF alpha, IL-1 beta and IL-12, while stimulating the secretion of IL-10, an anti-inflammatory cytokine. Finally, nicotine also reduced the number of pro-inflammatory monocytes in the bone marrow of LPS-challenged mice. Overall, our data demonstrate that both alpha 7 and alpha 9 nAChRs are involved in the regulation of pro-inflammatory M1 monocyte numbers.	[St-Pierre, Stephanie; Roy, Patrick; LeBlanc, Eric; Simard, Alain R.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Jiang, Wei; Hao, Junwei] Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin, Peoples R China; [Jiang, Wei; Hao, Junwei] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China; [Champigny, Camille; Simard, Alain R.] Ctr Format Med Nouveau Brunswick, Moncton, NB, Canada; [Morley, Barbara J.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Moncton; Tianjin Medical University; Tianjin Medical University; National Research Council Canada; Boys Town National Research Hospital	Simard, AR (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.; Simard, AR (corresponding author), Ctr Format Med Nouveau Brunswick, Moncton, NB, Canada.	alain.simard@umoncton.ca	Morley, Barbara/AAB-7980-2019; Simard, Alain/E-1493-2013	Simard, Alain/0000-0002-3499-6235; Hao, Junwei/0000-0002-3075-5434	Multiple Sclerosis Society of Canada [EGID1639]; New Brunswick Health Research Foundation [2013-MSOP-500]; New Brunswick Innovation Foundation [RIF2014-006]	Multiple Sclerosis Society of Canada; New Brunswick Health Research Foundation; New Brunswick Innovation Foundation	This work was funded by the Multiple Sclerosis Society of Canada (EGID1639; www.mssociety.ca), the New Brunswick Health Research Foundation (2013-MSOP-500; www.nbhrf.com) and the New Brunswick Innovation Foundation RIF2014-006; www.nbif.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afan AM, 1997, BRIT J HAEMATOL, V98, P569, DOI 10.1046/j.1365-2141.1997.2733092.x; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bruchfeld A, 2010, J INTERN MED, V268, P94, DOI 10.1111/j.1365-2796.2010.02226.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Koval LA, 2008, INT J BIOCHEM CELL B, V40, P980, DOI 10.1016/j.biocel.2007.11.006; Lee RH, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.189; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serobyan N, 2007, LIFE SCI, V80, P2352, DOI 10.1016/j.lfs.2007.04.017; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Simard AR, 2013, IMMUNOL CELL BIOL, V91, P195, DOI 10.1038/icb.2013.1; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Terrando N, 2014, MOL MED, V20, P667, DOI 10.2119/molmed.2014.00143; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; van Maanen MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116227; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	36	48	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150230	10.1371/journal.pone.0150230	http://dx.doi.org/10.1371/journal.pone.0150230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925951	Green Submitted, gold, Green Published			2022-12-26	WOS:000371424200029
J	Koefoed, M; Kromann, CB; Juliussen, SR; Hvidtfeldt, D; Ekelund, B; Frandsen, NE; Marckmann, P				Koefoed, Mette; Kromann, Charles Boy; Juliussen, Sophie Ryberg; Hvidtfeldt, Danni; Ekelund, Bo; Frandsen, Niels Erik; Marckmann, Peter			Nutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CHRONIC KIDNEY-DISEASE; FAT MASS; HEMODIALYSIS; MORTALITY; ESRD	Background and Aims Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. Methods In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean body mass index and obesity in these patients. Results Seventy-nine eligible maintenance dialysis patients participated. The prevalence of protein-energy wasted patients was 4% (95% CI: 2-12) as assessed by the coexistence of low lean body mass index and low fat mass index. Low lean body mass index was seen in 32% (95% CI: 22-44). Obesity prevalence as assessed from fat mass index was 43% (95% CI: 32-55). Coexistence of low lean body mass index and obesity was seen in 10% (95% CI: 5-19). The prevalence of protein-energy wasting and obesity varied considerably, depending on nutritional assessment methodology. Conclusions Our data indicate that protein-energy wasting is uncommon, whereas low lean body mass index and obesity are frequent conditions among patients in maintenance dialysis. A focus on how to increase and preserve lean body mass in dialysis patients is suggested in the future. In order to clearly distinguish between shortage, sufficiency and abundance of protein and/or fat deposits in maintenance dialysis patients, we suggest the simple measurements of lean body mass index and fat mass index.	[Koefoed, Mette] Univ Copenhagen, Dept Internal Med, Nephrol Sect, Holbaek Hosp,Hlth Sci Fac, Holbaek, Denmark; [Kromann, Charles Boy] Univ Copenhagen, Dept Dermatol, Roskilde Hosp, Fac Hlth Sci, Roskilde, Denmark; [Juliussen, Sophie Ryberg; Hvidtfeldt, Danni] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen N, Denmark; [Ekelund, Bo; Frandsen, Niels Erik; Marckmann, Peter] Univ Copenhagen, Dept Internal Med, Nephrol Sect, Roskilde Hosp,Hlth Sci Fac, Roskilde, Denmark	Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Koefoed, M (corresponding author), Univ Copenhagen, Dept Internal Med, Nephrol Sect, Holbaek Hosp,Hlth Sci Fac, Holbaek, Denmark.	mkof@regionsjaelland.dk						Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Carrero JJ, 2011, KIDNEY INT, V79, P749, DOI 10.1038/ki.2010.487; Carrero JJ, 2015, SEMIN DIALYSIS, V28, P48, DOI 10.1111/sdi.12287; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Corish CA, 2003, BRIT J NUTR, V89, P137, DOI 10.1079/BJN2002748; Cuppari L, 2013, NEPHROL DIAL TRANSPL, V28, P119, DOI 10.1093/ndt/gft266; Danish Society of Nephrology, 2014, DAN NEFROL SELSK; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Frisancho AR, 1990, APPENDIX B TABLE 12, P175; Gotch FA, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_6.10; Gracia-Iguacel C, 2013, NEPHROL DIAL TRANSPL, V28, P175, DOI 10.1093/ndt/gft024; Gracia-Iguacel C, 2013, NEFROLOGIA, V33, P495, DOI 10.3265/Nefrologia.pre2013.Apr.11979; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Jindal KK, 1988, SEMIN DIALYSIS, V1, P82, DOI DOI 10.1111/J.1525-139X.1988.TB00710.X; Jones CH, 2004, J RENAL NUTR, V14, P26, DOI 10.1053/j.jrn.2003.09.006; Kamimura MA, 2003, NEPHROL DIAL TRANSPL, V18, P101, DOI 10.1093/ndt/18.1.101; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Laegreid IK, 2014, RENAL FAILURE, V36, P9, DOI 10.3109/0886022X.2013.830206; Rodrigues NCL, 2012, J RENAL NUTR, V22, P409, DOI 10.1053/j.jrn.2012.01.024; MARCKMANN P, 1988, CLIN NEPHROL, V29, P75; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; NFK-K/DOQI, 2001, CLIN PRACT GUID NUTR, P82; OSTERKAMP LK, 1995, J AM DIET ASSOC, V95, P215, DOI 10.1016/S0002-8223(95)00050-X; Parikh C, 2003, RENAL FAILURE, V25, P787, DOI 10.1081/JDI-120024294; Portney L, 2009, FDN CLIN RES APPL PR, V1; Rhee CM, 2014, J CACHEXIA SARCOPENI, V5, P177, DOI 10.1007/s13539-014-0160-z; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Sousa AS, 2014, J HUM NUTR DIET, V27, P80, DOI 10.1111/jhn.12093; van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P2620, DOI 10.1093/ndt/gft296; World Health Organization, 2008, WAIST CIRCUMFERENCE; Zoccali C, 2009, NEPHROL DIAL TRANSPL, V24, P376, DOI 10.1093/ndt/gfn589	37	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150012	10.1371/journal.pone.0150012	http://dx.doi.org/10.1371/journal.pone.0150012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919440	Green Published, gold			2022-12-26	WOS:000371274400069
J	Liang, DC; Zuo, AJ; Zhao, RL; Shao, H; Born, WK; O'Brien, RL; Kaplan, HJ; Sun, DM				Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Shao, Hui; Born, Willi K.; O'Brien, Rebecca L.; Kaplan, Henry J.; Sun, Deming			CD73 Expressed on gamma delta T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis	PLOS ONE			English	Article							DENDRITIC CELLS; ISOPENTENYL PYROPHOSPHATE; CANCER-IMMUNOTHERAPY; ADENOSINE RECEPTORS; PURINE METABOLISM; EXTRACELLULAR ATP; TUMOR-GROWTH; ACTIVATION; GENERATION; LYMPHOCYTES	gamma delta T cells can either enhance or inhibit an adaptive immune response, but the mechanisms involved are not fully understood. Given that CD73 is the main enzyme responsible for conversion of AMP into the immunosuppressive molecule adenosine, we investigated its role in the regulatory function of gamma delta T cells in experimental autoimmune uveitis ( EAU). We found that gamma delta T cells expressed different amounts of CD73 during the different stages of EAU and that low CD73 expression on gamma delta T cells correlated with enhanced Th17 response-promoting activity. Functional comparison of CD73-deficient and wild-type B6 (CD73(+/+)) mice showed that failure to express CD73 decreased both the enhancing and suppressive effects of gamma delta T cells on EAU. We also demonstrated that gamma delta T cells expressed different amounts of CD73 when activated by different pathways, which enabled them to either enhance or inhibit an adaptive immune response. Our results demonstrate that targeting CD73 expression on gamma delta T cells may allow us to manipulate their pro- or anti-inflammatory effect on Th17 responses.	[Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Sun, Deming] UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Sun, Deming] UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40202 USA; [Born, Willi K.; O'Brien, Rebecca L.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Zhao, Ronglan] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Shandong 261053, Peoples R China	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Louisville; National Jewish Health; Weifang Medical University	Sun, DM (corresponding author), UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA.; Sun, DM (corresponding author), UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.	dsun@doheny.org			NIH [EY0022403, EY018827]; NATIONAL EYE INSTITUTE [R01EY018827, R01EY022403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY0022403 and EY018827.	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Bhardwaj R, 2009, TRENDS PARASITOL, V25, P256, DOI 10.1016/j.pt.2009.03.004; Bonner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034730; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen MJZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132348; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chiplunkar S, 2009, IMMUNOTHERAPY-UK, V1, P663, DOI [10.2217/IMT.09.27, 10.2217/imt.09.27]; Conter LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092009; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Liang DC, 2012, J IMMUNOL, V188, P5785, DOI 10.4049/jimmunol.1200109; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nian H, 2012, INVEST OPHTH VIS SCI, V53, P897, DOI 10.1167/iovs.11-8297; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Paul S, 2014, J LEUKOCYTE BIOL, V97, P295; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Shao H, 2005, J IMMUNOL, V175, P1851, DOI 10.4049/jimmunol.175.3.1851; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Spencer CT, 2008, J IMMUNOL, V181, P4471, DOI 10.4049/jimmunol.181.7.4471; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Wang LS, 2001, J IMMUNOL, V167, P6195, DOI 10.4049/jimmunol.167.11.6195; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 1997, EUR J IMMUNOL, V27, P952, DOI 10.1002/eji.1830270422; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2015, EUR J IMMUNOL, V45, P562, DOI 10.1002/eji.201444856; Yoshida Y, 2011, SURG TODAY, V41, P606, DOI 10.1007/s00595-010-4478-7; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108156; Zuo AJ, 2012, MOL IMMUNOL, V50, P125, DOI 10.1016/j.molimm.2011.12.013	73	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150078	10.1371/journal.pone.0150078	http://dx.doi.org/10.1371/journal.pone.0150078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919582	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400083
J	Machado, D; Pires, D; Perdigao, J; Couto, I; Portugal, I; Martins, M; Amaral, L; Anes, E; Viveiros, M				Machado, Diana; Pires, David; Perdigao, Joao; Couto, Isabel; Portugal, Isabel; Martins, Marta; Amaral, Leonard; Anes, Elsa; Viveiros, Miguel			Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; IN-VITRO; SUSCEPTIBILITY; THIORIDAZINE; VERAPAMIL; MECHANISM; OFLOXACIN; GENE; TB	Given the ability of M. tuberculosis to survive as an intracellular pathogen and its propensity to develop resistance to the existing antituberculosis drugs, its treatment requires new approaches. Here the antimycobacterial properties of verapamil, thioridazine, chlorpromazine, flupenthixol and haloperidol were investigated against a panel of drug resistant M. tuberculosis strains, both in vitro and on human-infected macrophages. These compounds are efflux inhibitors that share among them the characteristic of being ion channel blockers. In vitro, all compounds exhibited synergistic inhibitory activities when combined with isoniazid and rifampicin, and were able to inhibit active efflux, demonstrating their role as efflux inhibitors. Gene expression analysis showed that M. tuberculosis efflux genes were overexpressed in response to antibiotic exposure, in vitro and within macrophages, irrespective of their resistance pattern. These compounds displayed a rapid and high killing activity against M. tuberculosis, associated with a decrease in intracellular ATP levels demonstrating that the bactericidal action of the ion channel blockers against M. tuberculosis clinical strains is associated with their interference with energy metabolism. The compounds led to a decrease in the intracellular mycobacterial load by increasing phagosome acidification and activating lysosomal hydrolases. The results presented in this study enable us to propose the following mechanism of action for these compounds: a) in the bacteria, the compounds generate a cascade of events involving the inhibition of the respiratory chain complexes and energy production for efflux activity. Indirectly, this reduce the resistance level to antituberculosis drugs potentiating their activity; b) on the host cell, the treatment with the ion channel blockers increases phagosome acidification and induces the expression of phagosomal hydrolases, leading to bacterial growth restriction irrespective of their resistance pattern. This work highlights the potential value ion channel blockers as adjuvants of tuberculosis chemotherapy, in particular for the development of new therapeutic strategies, with strong potential for treatment shortening against drug susceptible and resistant forms of tuberculosis. Medicinal chemistry studies are now needed to improve the properties of these compounds, increasing their M. tuberculosis efflux-inhibition and killing-enhancement activity and reduce their toxicity for humans, therefore optimizing their potential for clinical usage.	[Machado, Diana; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, IHMT, Unidade Microbiol Med, P-1200 Lisbon, Portugal; [Machado, Diana; Couto, Isabel; Amaral, Leonard; Viveiros, Miguel] Univ Nova Lisboa, IHMT, GHTM, P-1200 Lisbon, Portugal; [Pires, David; Perdigao, Joao; Portugal, Isabel; Anes, Elsa] Univ Lisbon, Fac Farm, IMed ULisboa Inst Invest Medicamento, P-1699 Lisbon, Portugal; [Pires, David; Anes, Elsa] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Martins, Marta] Natl Univ Ireland Univ Coll Dublin, UCD Ctr Mol Innovat & Drug Discovery, Sch Publ Hlth Physiotherapy & Sports Sci, UCD Ctr Food Safety, Dublin 4, Ireland	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Universidade de Lisboa; University College Dublin	Viveiros, M (corresponding author), Univ Nova Lisboa, IHMT, Unidade Microbiol Med, P-1200 Lisbon, Portugal.; Viveiros, M (corresponding author), Univ Nova Lisboa, IHMT, GHTM, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Portugal, Isabel/B-1491-2008; Machado, Diana/L-7027-2013; iMed.ULisboa, M2B/B-5277-2014; iMed.ULisboa, HPI/B-4239-2014; Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Anes, Elsa/K-3124-2013; Pires, David/D-8245-2012; Perdigão, João/L-6893-2013	Portugal, Isabel/0000-0002-7843-0006; Machado, Diana/0000-0003-2375-2726; iMed.ULisboa, M2B/0000-0002-1245-3715; iMed.ULisboa, HPI/0000-0001-5934-0198; Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Anes, Elsa/0000-0001-5934-0198; Pires, David/0000-0001-9602-1516; Perdigão, João/0000-0002-0339-1305; Martins, Marta/0000-0002-0323-2857	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/SAU-FCF/102807/2008, PTDC/BIA-MIC/121859/2010, PTDC/SAU-MII/098024/2008, PTDC/BIA-BCM/102123/2008]; Fundacao Calouste Gulbenkian (Portugal) [SDH49]; Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-MIC/121859/2010, GHTM UID/Multi/04413/2013, SFRH/BD/65060/2009, SFRH/BD/63747/2009, SFRH/BD/45388/2008]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (Portugal); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants PTDC/SAU-FCF/102807/2008 (MV) and PTDC/BIA-MIC/121859/2010 (IC), partially supported by grants PTDC/SAU-MII/098024/2008 (EA) and PTDC/BIA-BCM/102123/2008 (EA) from Fundacao para a Ciencia e a Tecnologia (Portugal; http://www.fct.pt/index.phtml.en), Project Ref<SUP>a</SUP> SDH49 (IC) from Fundacao Calouste Gulbenkian (Portugal; http://www.gulbenkian.pt/Institucional/en/Homepage) and GHTM UID/Multi/04413/2013 (DM IC MV) from Fundacao para a Ciencia e a Tecnologia. DM was supported by grants SFRH/BD/65060/2009 and PTDC/BIA-MIC/121859/2010, from Fundacao para a Ciencia e a Tecnologia. DP and JP were supported by grants SFRH/BD/63747/2009 and SFRH/BD/45388/2008, respectively, from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Black PA, 2014, ANTIMICROB AGENTS CH, V58, P2491, DOI 10.1128/AAC.02293-13; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Cambau E, 2015, J ANTIMICROB CHEMOTH, V70, P686, DOI 10.1093/jac/dku438; Daniel WA, 1999, TOXICOL APPL PHARM, V158, P115, DOI 10.1006/taap.1999.8688; de Knegt GJ, 2014, TUBERCULOSIS, V94, P701, DOI 10.1016/j.tube.2014.09.002; Elliott WJ, 2011, J CLIN HYPERTENS, V13, P687, DOI 10.1111/j.1751-7176.2011.00513.x; Filippini P, 2010, ANTIMICROB AGENTS CH, V54, P2712, DOI 10.1128/AAC.01736-09; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Gumbo T, 2013, NAT GENET, V45, P720, DOI 10.1038/ng.2675; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Leung ETY, 2006, ANTIMICROB AGENTS CH, V50, P1075, DOI 10.1128/AAC.50.3.1075-1078.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Lu P, 2014, J ANTIBIOT, V67, P835, DOI 10.1038/ja.2014.74; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Machado L, 2011, IN VIVO, V25, P769; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Martins M, 2009, INT J TUBERC LUNG D, V13, P569; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Modica-Napolitano JS, 2003, ARCH PHARM RES, V26, P951, DOI 10.1007/BF02980205; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Perdigao J, 2013, J ANTIMICROB CHEMOTH, V68, P27, DOI 10.1093/jac/dks371; Pieroni M, 2015, J MED CHEM, V58, P5842, DOI 10.1021/acs.jmedchem.5b00428; PROKESCH RC, 1982, ANTIMICROB AGENTS CH, V21, P373, DOI 10.1128/AAC.21.3.373; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rodrigues Liliana, 2015, Methods Mol Biol, V1285, P227, DOI 10.1007/978-1-4939-2450-9_13; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; SINGH BN, 1978, DRUGS, V15, P169, DOI 10.2165/00003495-197815030-00001; Singh M, 2011, INDIAN J MED RES, V133, P535; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Viveiros M, 2012, EXPERT REV ANTI-INFE, V10, P983, DOI [10.1586/eri.12.89, 10.1586/ERI.12.89]; Warman AJ, 2013, J ANTIMICROB CHEMOTH, V68, P869, DOI 10.1093/jac/dks483; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102	51	50	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149326	10.1371/journal.pone.0149326	http://dx.doi.org/10.1371/journal.pone.0149326			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919135	Green Submitted, gold, Green Published			2022-12-26	WOS:000371274400017
J	Nair, SA; Raizada, N; Sachdeva, KS; Denkinger, C; Schumacher, S; Dewan, P; Kulsange, S; Boehme, C; Paramsivan, CN; Arinaminpathy, N				Nair, Sreenivas Achuthan; Raizada, Neeraj; Sachdeva, Kuldeep Singh; Denkinger, Claudia; Schumacher, Samuel; Dewan, Puneet; Kulsange, Shubhangi; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan; Arinaminpathy, Nimalan			Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis	PLOS ONE			English	Article							ASSAY	Background Tuberculosis remains a major public health challenge for India. Various studies have documented different levels of TB and multi-drug resistant (MDR) TB among diverse groups of the population. In view of renewed targets set under the End TB strategy by 2035, there is an urgent need for TB diagnosis to be strengthened. Drawing on data from a recent, multi-site study, we address key questions for TB diagnosis amongst symptomatics presenting for care: are there subgroups of patients that are more likely than others, to be positive for TB? In turn, amongst these positive cases, are there factors-apart from treatment history -that may be predictive for multi-drug resistance? Methods We used data from a multi-centric prospective demonstration study, conducted from March 2012 to December 2013 in 18 sub-district level TB programme units (TUs) in India and covering a population of 8.8 million. In place of standard diagnostic tests, upfront Xpert MTB/RIF testing was offered to all presumptive TB symptomatics. Here, using data from this study, we used logistic regression to identify association between risk factors and TB and Rifampicin-Resistant TB among symptomatics enrolled in the study. Results We find that male gender; history of TB treatment; and adult age compared with either children or the elderly are risk factors associated with high TB detection amongst symptomatics, across the TUs. While treatment history is found be a significant risk factor for rifampicin-resistant TB, elderly (65+ yrs) people have significantly lower risk than other age groups. However, pediatric TB cases have no less risk of rifampicin resistance as compared with adults (OR 1.23 (95% C. I. 0.85-1.76)). Similarly, risk of rifampicin resistance among both the genders was the same. These patterns applied across the study sites involved. Notably in Mumbai, amongst those patients with microbiological confirmation of TB, female patients showed a higher risk of having MDR-TB than male patients. Conclusion Our results cast fresh light on the characteristics of symptomatics presenting for care who are most likely to be microbiologically positive for TB, and for rifampicin resistance. The challenges posed by TB control are complex and multifactorial: evidence from diverse sources, including retrospective studies such as that addressed here, can be invaluable in informing future strategies to accelerate declines in TB burden.	[Nair, Sreenivas Achuthan] World Hlth Org, Country Off India, New Delhi, India; [Raizada, Neeraj; Denkinger, Claudia; Schumacher, Samuel; Kulsange, Shubhangi; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Cent TB Div, New Delhi, India; [Dewan, Puneet] Bill & Melinda Gates Fdn, New Delhi, India; [Arinaminpathy, Nimalan] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	World Health Organization; Foundation For Innovative New Diagnostics; Imperial College London	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	neeraj.raizada@finddx.org		Schumacher, Samuel G/0000-0002-6136-206X; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Arinaminpathy, Nimalan/0000-0001-9502-6876	United States Agency for International Development; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	United States Agency for International Development(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida D, 2003, CLIN INFECT DIS, V36, pE152, DOI 10.1086/374931; [Anonymous], INT UNION TUBERCULOS; [Anonymous], 2015, RNTCP ANN STAT REP R; [Anonymous], 2012, FAC REAL DRUG RES TU; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; COMSTOCK GW, 1959, PUBLIC HEALTH REP, V74, P621, DOI 10.2307/4590524; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Das J, 2015, USE STANDARDISED PAT; Enarson RM, 2005, INT J TUBERC LUNG D, V9, P1299; Institute of Medicine (US), 2012, JOINT WORKSH I MED I; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Tolani MP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-9; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, REP PROP POST 2015 T	18	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150054	10.1371/journal.pone.0150054	http://dx.doi.org/10.1371/journal.pone.0150054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918818	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400077
J	Oliveira, WS; Teixeira, JV; Ren, TI; Cavalcanti, GDC; Sijbers, J				Oliveira, Wendeson S.; Teixeira, Joyce Vitor; Ren, Tsang Ing; Cavalcanti, George D. C.; Sijbers, Jan			Unsupervised Retinal Vessel Segmentation Using Combined Filters	PLOS ONE			English	Article							BLOOD-VESSELS; MATCHED-FILTER; GRAY-LEVEL; IMAGES; CLASSIFICATION; EXTRACTION	Image segmentation of retinal blood vessels is a process that can help to predict and diagnose cardiovascular related diseases, such as hypertension and diabetes, which are known to affect the retinal blood vessels' appearance. This work proposes an unsupervised method for the segmentation of retinal vessels images using a combined matched filter, Frangi's filter and Gabor Wavelet filter to enhance the images. The combination of these three filters in order to improve the segmentation is the main motivation of this work. We investigate two approaches to perform the filter combination: weighted mean and median ranking. Segmentation methods are tested after the vessel enhancement. Enhanced images with median ranking are segmented using a simple threshold criterion. Two segmentation procedures are applied when considering enhanced retinal images using the weighted mean approach. The first method is based on deformable models and the second uses fuzzy C-means for the image segmentation. The procedure is evaluated using two public image databases, Drive and Stare. The experimental results demonstrate that the proposed methods perform well for vessel segmentation in comparison with state-of-the-art methods.	[Oliveira, Wendeson S.; Teixeira, Joyce Vitor; Ren, Tsang Ing; Cavalcanti, George D. C.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil; [Sijbers, Jan] Univ Antwerp, Dept Phys, IMinds Vis Lab, Antwerp, Belgium	Universidade Federal de Pernambuco; IMEC; University of Antwerp	Oliveira, WS (corresponding author), Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil.	wso@cin.ufpe.br	Sijbers, Jan/C-4214-2011; Cavalcanti, George DC/C-2364-2017; Ren, Tsang Ing/AAD-3221-2022; Sijbers, Jan/H-4324-2015	Sijbers, Jan/0000-0003-4225-2487; Cavalcanti, George DC/0000-0001-7714-2283; Sijbers, Jan/0000-0003-4225-2487	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [IBPG-0152-1.03/12]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project; CNPq; Capes; Facepe	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The sources of funding that have supported this work are: Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (http://www.facepe.br/), grant number IBPG-0152-1.03/12, author WSO; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), authors TIR, GDCC, JVT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), authors TIR, GDCC; and Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project (http://www.iwt.be/), author JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by Brazilian agencies CNPq (Ciencias Sem Fronteiras), Capes, Facepe and by the Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project.	Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; BELKIN NJ, 1995, INFORM PROCESS MANAG, V31, P431, DOI 10.1016/0306-4573(94)00057-A; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; bons ID, 2003, STAT SERIES TXB MONO; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Gegundez-Arias ME, 2012, IEEE T MED IMAGING, V31, P231, DOI 10.1109/TMI.2011.2167982; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Jiang XY, 2003, IEEE T PATTERN ANAL, V25, P131, DOI 10.1109/TPAMI.2003.1159954; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li Q, 2012, EXPERT SYST APPL, V39, P7600, DOI 10.1016/j.eswa.2011.12.046; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez M. E., 1999, Proceedings 1999 International Conference on Image Processing (Cat. 99CH36348), P173, DOI 10.1109/ICIP.1999.822878; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Oliveira WS, 2012, PROC INT C TOOLS ART, P750, DOI 10.1109/ICTAI.2012.106; Oliveira WS, 2012, IEEE IMAGE PROC, P2017, DOI 10.1109/ICIP.2012.6467285; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Yin XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095943; Zana F, 2001, IEEE T IMAGE PROCESS, V10, P1010, DOI 10.1109/83.931095; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332; Zheng YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109765, 10.1371/journal.pone.0093624]	38	52	53	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149943	10.1371/journal.pone.0149943	http://dx.doi.org/10.1371/journal.pone.0149943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919587	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400059
J	Peters, T; Hermans-Beijnsberger, S; Beqqali, A; Bitsch, N; Nakagawa, S; Prasanth, KV; de Windt, LJ; van Oort, RJ; Heymans, S; Schroen, B				Peters, Tim; Hermans-Beijnsberger, Steffie; Beqqali, Abdelaziz; Bitsch, Nicole; Nakagawa, Shinichi; Prasanth, Kannanganattu V.; de Windt, Leon J.; van Oort, Ralph J.; Heymans, Stephane; Schroen, Blanche			Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; XIST GENE; CARDIOMYOPATHY; METASTASIS; INHIBITION; EXPRESSION; MICRORNAS; LNCRNA	Background Long non-coding RNAs (lncRNAs) are a class of RNA molecules with diverse regulatory functions during embryonic development, normal life, and disease in higher organisms. However, research on the role of lncRNAs in cardiovascular diseases and in particular heart failure is still in its infancy. The exceptionally well conserved nuclear lncRNA Metastasis associated in lung adenocarcinoma transcript 1 (Malat-1) is a regulator of mRNA splicing and highly expressed in the heart. Malat-1 modulates hypoxia-induced vessel growth, activates ERK/MAPK signaling, and scavenges the anti-hypertrophic microRNA-133. We therefore hypothesized that Malat-1 may act as regulator of cardiac hypertrophy and failure during cardiac pressure overload induced by thoracic aortic constriction (TAC) in mice. Results Absence of Malat-1 did not affect cardiac hypertrophy upon pressure overload: Heart weight to tibia length ratio significantly increased in WT mice (sham: 5.78 +/- 0.55, TAC 9.79 +/- 1.82 g/mm; p<0.001) but to a similar extend also in Malat-1 knockout (KO) mice (sham: 6.21 +/- 1.12, TAC 8.91 +/- 1.74 g/mm; p<0.01) with no significant difference between genotypes. As expected, TAC significantly reduced left ventricular fractional shortening in WT (sham: 38.81 +/- 6.53%, TAC: 23.14 +/- 11.99%; p<0.01) but to a comparable degree also in KO mice (sham: 37.01 +/- 4.19%, TAC: 25.98 +/- 9.75%; p<0.05). Histological hallmarks of myocardial remodeling, such as cardiomyocyte hypertrophy, increased interstitial fibrosis, reduced capillary density, and immune cell infiltration, did not differ significantly between WT and KO mice after TAC. In line, the absence of Malat-1 did not significantly affect angiotensin II-induced cardiac hypertrophy, dysfunction, and overall remodeling. Above that, pressure overload by TAC significantly induced mRNA levels of the hypertrophy marker genes Nppa, Nppb and Acta1, to a similar extend in both genotypes. Alternative splicing of Ndrg2 after TAC was apparent in WT (isoform ratio; sham: 2.97 +/- 0.26, TAC 1.57 +/- 0.40; p<0.0001) and KO mice (sham: 3.64 +/- 0.37; TAC: 2.24 +/- 0.76; p<0.0001) and interestingly differed between genotypes both at baseline and after pressure overload (p<0.05 each). Conclusion These findings confirm a role for the lncRNA Malat-1 in mRNA splicing. However, no critical role for Malat-1 was found in pressure overload-induced heart failure in mice, despite its reported role in vascularization, ERK/MAPK signaling, and regulation of miR-133.	[Peters, Tim; Hermans-Beijnsberger, Steffie; Heymans, Stephane; Schroen, Blanche] Maastricht Univ, Ctr Heart Failure Res, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands; [Beqqali, Abdelaziz; van Oort, Ralph J.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bitsch, Nicole; de Windt, Leon J.] Maastricht Univ, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands; [Nakagawa, Shinichi] RIKEN, RNA Biol Lab, Wako, Saitama, Japan; [Prasanth, Kannanganattu V.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Heymans, Stephane] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Heymans, Stephane] Katholieke Univ Leuven, Dept Cardiovasc Sci, CMVB, Leuven, Belgium	Maastricht University; University of Amsterdam; Maastricht University; RIKEN; University of Illinois System; University of Illinois Urbana-Champaign; KU Leuven	Schroen, B (corresponding author), Maastricht Univ, Ctr Heart Failure Res, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands.	B.Schroen@maastrichtuniversity.nl	van Oort, Ralph/C-5713-2011; Beqqali, Abdelaziz/F-8568-2013; Nakagawa, Shinichi/I-4192-2014; de Windt, Leon/AAO-6395-2020	Beqqali, Abdelaziz/0000-0003-1390-5821; Nakagawa, Shinichi/0000-0002-6806-7493; de Windt, Leon/0000-0002-7793-2856; Heymans, Stephane/0000-0001-9477-7803	Dutch Heart Foundation [2009B025, 2012T094]; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development (ZonMW); Royal Netherlands Academy of Sciences (CVON-ARENA); Netherlands Organization for Scientific Research (NWO) [Vidi 91714363]; European Union Commission [261409]; European Research Council [311549]; Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [26113005]; National Institutes of Health [GM088252]; American Cancer Society [RSG-11-174-01-RMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088252] Funding Source: NIH RePORTER	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences (CVON-ARENA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union Commission(European Commission); European Research Council(European Research Council (ERC)European Commission); Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research leading to these results has received funding from the Dutch Heart Foundation (2009B025 to BS and 2012T094 to RJVO, www.hartstichting.nl); the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development (ZonMW) and the Royal Netherlands Academy of Sciences (CVON-ARENA to SH and LJDW and CVON-ARENA young talent grant to AB, www.cvonarena.nl); from the Netherlands Organization for Scientific Research (NWO Vidi 91714363 to BS, www.nwo.nl); from the European Union Commission's Seventh Framework program (261409, ec.europa.eu/research/fp7/index_en.cfm); from the European Research Council (311549 to LJDW, erc.europa.eu); from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT, Grant-in-Aid for Scientific Research on Innovative Areas 26113005 to SN, www.mext.go.jp/english); from the National Institutes of Health (GM088252 to KVP, www.nih.gov); and from the American Cancer Society (RSG-11-174-01-RMC to KVP, www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Grote P, 2015, TRENDS GENET, V31, P329, DOI 10.1016/j.tig.2015.02.002; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kurdi M, 2011, HYPERTENSION, V57, P1034, DOI 10.1161/HYPERTENSIONAHA.111.172700; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakagawa S, 2016, BBA-GENE REGUL MECH, V1859, P177, DOI 10.1016/j.bbagrm.2015.06.011; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Peters T, 2014, PFLUG ARCH EUR J PHY, V466, P1177, DOI 10.1007/s00424-014-1479-1; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Watts R, 2013, AM J PHYSIOL-CELL PH, V304, pC995, DOI 10.1152/ajpcell.00392.2012; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu XS, 2014, CANCER BIOL THER, V15, P806, DOI 10.4161/cbt.28584; Wu YH, 2016, TUMOR BIOL, V37, P897, DOI 10.1007/s13277-015-3870-8; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang MY, 2016, INT J CARDIOL, V203, P214, DOI 10.1016/j.ijcard.2015.10.136; Zhang MY, 2016, INT J CARDIOL, V202, P753, DOI 10.1016/j.ijcard.2015.10.019; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	42	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150236	10.1371/journal.pone.0150236	http://dx.doi.org/10.1371/journal.pone.0150236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919721	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400108
J	Treffel, L; Dmitrieva, L; Gauquelin-Koch, G; Custaud, MA; Blanc, S; Gharib, C; Millet, C				Treffel, Loic; Dmitrieva, Liubov; Gauquelin-Koch, Guillemette; Custaud, Marc-Antoine; Blanc, Stephane; Gharib, Claude; Millet, Catherine			Craniomandibular System and Postural Balance after 3-Day Dry Immersion	PLOS ONE			English	Article							BITE FORCE; MUSCLE TONE; BED REST; MASTICATORY MUSCLES; FOOD CONSISTENCY; MASSETER MUSCLE; LIMB MUSCLE; JAW; COUNTERMEASURE; PRESSURE	The objective of the study was to determine the influence of simulated microgravity by exposure to dry immersion on the craniomandibular system. Twelve healthy male volunteers participated in a 3-day dry immersion study. Before and immediately after exposure we measured maximal bite force using piezoresistive sensors. The mechanical properties of the jaw and cervical muscles were evaluated before, during, and after dry immersion using MyotonPRO. Because recent studies reported the effects of jaw motor activity on the postural stability of humans, stabilometric measurements of center of pressure were performed before and after dry immersion in two mandibular positions: rest position without jaw clenching, and intercuspidal position during voluntary teeth clenching. Results revealed no significant changes of maximal bite force after dry immersion. All postural parameters were significantly altered by dry immersion. There were however no significant differences in stabilometric data according to mandibular position. Moreover the masseter tonicity increased immediately after the end of dry immersion period. Dry immersion could be used as a valid model for studying the effects of microgravity on human subjects. However, 3 days appear insufficient in duration to evaluate the effects of weightlessness on maximal bite force. Our research suggests a link between postural disturbance after dry immersion and masseter tonicity.	[Treffel, Loic; Gharib, Claude; Millet, Catherine] Univ Lyon 1, F-69365 Lyon, France; [Treffel, Loic; Blanc, Stephane] Univ Strasbourg, Ctr Natl Rech Sci, Unite Mixte Rech 7178, Strasbourg, France; [Dmitrieva, Liubov] Moscow Biomed Problems Inst, Moscow, Russia; [Dmitrieva, Liubov; Custaud, Marc-Antoine] Univ Angers, Ctr Natl Rech Sci, Unite Mixte Rech 6214, Inst Natl Sante & Rech Med 1083, Angers, France; [Gauquelin-Koch, Guillemette] Ctr Natl Etud Spatiales, Paris, France; [Custaud, Marc-Antoine] CHU Angers, Ctr Rech Clin, Angers, France; [Gharib, Claude] Ctr Int Osteopathie, St Etienne, France; [Millet, Catherine] Hosp Civils Lyon, Serv Odontol, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Lyon	Millet, C (corresponding author), Univ Lyon 1, F-69365 Lyon, France.; Millet, C (corresponding author), Hosp Civils Lyon, Serv Odontol, Lyon, France.	catherine.millet@univ-lyon1.fr	Amirova, Liubov/V-7924-2017	Amirova, Liubov/0000-0002-9464-6413; Treffel, Loic/0000-0001-7962-1026	Centre National d'Etudes Spatiales [2015 48 0000079]	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This work was supported by Contract CNES Number 2015 48 0000079, Centre National d'Etudes Spatiales, https://cnes.fr/fr (LT, LD, GGK, MAC, SB, CG and CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Aird L, 2012, ARCH GERONTOL GERIAT, V55, pE31, DOI 10.1016/j.archger.2012.03.005; Al-Omiri MK, 2014, J ORAL REHABIL, V41, P624, DOI 10.1111/joor.12174; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Arima T, 2013, J ORAL REHABIL, V40, P900, DOI 10.1111/joor.12097; BAKKE M, 1989, SCAND J DENT RES, V97, P539; Baldini A, 2013, AVIAT SPACE ENVIR MD, V84, P823, DOI 10.3357/ASEM.3541.2013; Bloomberg JJ, 1997, J VESTIBUL RES-EQUIL, V7, P161, DOI 10.1016/S0957-4271(96)00169-3; Boroojerdi B, 2000, CLIN NEUROPHYSIOL, V111, P988, DOI 10.1016/S1388-2457(00)00279-0; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Buisseret-Delmas C, 1999, J COMP NEUROL, V409, P153, DOI 10.1002/(SICI)1096-9861(19990621)409:1<153::AID-CNE11>3.0.CO;2-#; Caiani EG, 2014, J APPL PHYSIOL, V117, P624, DOI 10.1152/japplphysiol.00122.2014; Caron O, 2000, J APPL BIOMECH, V16, P234, DOI 10.1123/jab.16.3.234; Chuang LL, 2012, ARCH PHYS MED REHAB, V93, P532, DOI 10.1016/j.apmr.2011.09.014; Clement G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111107; Cuccia AM, 2011, J BODYW MOV THER, V15, P242, DOI 10.1016/j.jbmt.2010.10.007; Custodio W, 2011, J APPL ORAL SCI, V19, P343, DOI 10.1590/S1678-77572011005000008; Dahlberg G, 1940, STAT METHODS MED BIO; Deriu F, 2010, CLIN NEUROPHYSIOL, V121, P1690, DOI 10.1016/j.clinph.2009.11.093; Diagne M, 2006, J COMP NEUROL, V496, P759, DOI 10.1002/cne.20964; Dietsch AM, 2014, J REHABIL RES DEV, V51, P1127, DOI 10.1682/JRRD.2013.07.0167; Fernandes CP, 2003, DENT MATER, V19, P118, DOI 10.1016/S0109-5641(02)00020-9; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Gangloff P, 2002, NEUROSCI LETT, V330, P179, DOI 10.1016/S0304-3940(02)00779-6; Gavronski G, 2007, PHYSIOL MEAS, V28, P625, DOI 10.1088/0967-3334/28/6/002; Giannakopoulos NN, 2013, ARCH ORAL BIOL, V58, P1751, DOI 10.1016/j.archoralbio.2013.09.002; Goto TK, 2001, ANAT RECORD, V262, P293, DOI 10.1002/1097-0185(20010301)262:3<293::AID-AR1043>3.0.CO;2-B; Hellmann D, 2015, HUM MOVEMENT SCI, V43, P125, DOI 10.1016/j.humov.2015.08.009; Hichijo N, 2014, J ORAL REHABIL, V41, P581, DOI 10.1111/joor.12171; HICKENBOTTOM RS, 1985, EXP NEUROL, V89, P442, DOI 10.1016/0014-4886(85)90103-7; Iwase S, 2000, J AUTONOM NERV SYST, V79, P156, DOI 10.1016/S0165-1838(99)00076-4; Kawai N, 2010, J ANAT, V216, P717, DOI 10.1111/j.1469-7580.2010.01235.x; Kozlovskaia I B, 2008, Aviakosm Ekolog Med, V42, P3; Layne CS, 2001, J APPL PHYSIOL, V90, P997, DOI 10.1152/jappl.2001.90.3.997; Lee HM, 2004, J ELECTROMYOGR KINES, V14, P577, DOI 10.1016/j.jelekin.2004.02.002; Linnarsson D, 2015, J APPL PHYSIOL, V118, P29, DOI 10.1152/japplphysiol.00061.2014; Lion A, 2014, INT J NEUROSCI, V124, P558, DOI 10.3109/00207454.2013.864288; MARFURT CF, 1991, J COMP NEUROL, V303, P489, DOI 10.1002/cne.903030313; Marini I, 2015, J ELECTROMYOGR KINES, V25, P531, DOI 10.1016/j.jelekin.2015.02.001; Miura H, 1997, J ORAL REHABIL, V24, P457, DOI 10.1046/j.1365-2842.1997.00530.x; Monemi M, 1999, ACTA PHYSIOL SCAND, V167, P339; Muir J, 2011, GAIT POSTURE, V33, P429, DOI 10.1016/j.gaitpost.2010.12.019; Mulder E, 2014, J MUSCULOSKEL NEURON, V14, P359; Navasiolava NM, 2011, AUTON NEUROSCI-BASIC, V160, P64, DOI 10.1016/j.autneu.2010.10.003; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Pereira LJ, 2006, ACTA ODONTOL SCAND, V64, P193, DOI 10.1080/00016350600703459; Perinetti Giuseppe, 2012, Prog Orthod, V13, P273, DOI 10.1016/j.pio.2011.12.003; Perinetti G, 2011, J ELECTROMYOGR KINES, V21, P877, DOI 10.1016/j.jelekin.2011.05.014; Philippou A, 2015, FASEB J, V29, P2769, DOI 10.1096/fj.14-267336; Ringhof S, 2015, J ORAL REHABIL, V42, P173, DOI 10.1111/joor.12247; Ringhof S, 2015, GAIT POSTURE, V42, P598, DOI 10.1016/j.gaitpost.2015.09.002; SCHNEIDER SM, 2006, ACSMS ADV EXERCISE P; Schneider S, 2015, MED BIOL ENG COMPUT, V53, P57, DOI 10.1007/s11517-014-1211-5; Sforza C, 2006, CRANIO, V24, P43, DOI 10.1179/crn.2006.008; SHULZHENKO EB, 1976, KOSM BIOL AVIAK MED+, V10, P82; Souvestre PA, 2008, HIPPOKRATIA, V12, P41; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Tolu E, 1993, J Vestib Res, V3, P163; Varga S, 2011, EUR J ORTHODONT, V33, P427, DOI 10.1093/ejo/cjq097; Viguier M, 2009, GAIT POSTURE, V29, P188, DOI 10.1016/j.gaitpost.2008.08.001; Wood SJ, 2015, AEROSP MED HUM PERF, V86, pA45, DOI 10.3357/AMHP.EC07.2015	62	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150052	10.1371/journal.pone.0150052	http://dx.doi.org/10.1371/journal.pone.0150052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913867	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700049
J	Agarwal, A; Zhang, W; Kuo, YF; Sharma, G				Agarwal, Amitesh; Zhang, Wei; Kuo, YongFang; Sharma, Gulshan			Process and Outcome Measures among COPD Patients with a Hospitalization Cared for by an Advance Practice Provider or Primary Care Physician	PLOS ONE			English	Article							NURSE-PRACTITIONERS; GENERAL-PRACTITIONERS; ASSISTANTS; READMISSION; COST	Objectives To examine the process and outcomes of care of COPD patients by Advanced Practice Providers (APPs) and primary care physicians. Methods We conducted a cross sectional retrospective cohort study of Medicare beneficiaries with COPD who had at least one hospitalization in 2010. We examined the process measures of receipt of spirometry evaluation, influenza and pneumococcal vaccine, use of COPD medications, and referral to a pulmonary specialist visit. Outcome measures were emergency department (ER) visit, number of hospitalizations and 30-day readmission in 2010. Results A total of 7,257 Medicare beneficiaries with COPD were included. Of these, 1,999 and 5,258 received primary care from APPs and primary care physicians, respectively. Patients in the APP group were more likely to be white, younger, male, residing in non-metropolitan areas and have fewer comorbidities. In terms of process of care measures, APPs were more likely to prescribe short acting bronchodilators (adjusted odds ratio [aOR] = 1.18, 95% Confidence Interval [CI] 1.05-1.32), oxygen therapy (aOR = 1.25, 95% CI 1.12-1.40) and consult a pulmonary specialist (aOR = 1.39, 95% CI 1.23-1.56), but less likely to give influenza and pneumococcal vaccinations. Patients receiving care from APPs had lower rates of ER visits for COPD (aOR = 0.84, 95% CI 0.71-0.98) and had a higher follow-up rate with pulmonary specialist within 30 days of hospitalization for COPD (aOR = 1.25, 95% CI 1.07-1.48) than those cared for by physicians. Conclusions Compared to patients cared for by physicians, patients cared for by APPs were more likely to receive short acting bronchodilator, oxygen therapy and been referred to pulmonologist, however they had lower rates of vaccination probably due to lower age group. Patients cared for by APPs were less like to visit an ER for COPD compared to patients care for by physicians, conversely there was no differences in hospitalization or readmission for COPD between MDs and APPs.	[Agarwal, Amitesh; Zhang, Wei; Sharma, Gulshan] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA; [Kuo, YongFang] Univ Texas Med Branch, Off Biostat, Galveston, TX 77555 USA; [Kuo, YongFang; Sharma, Gulshan] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Agarwal, A (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA.	anagarwa@utmb.edu	Sharma, Gulshan/AAC-5804-2019		Agency for Healthcare Research and Quality [R01-HS020642, R24-HS022134]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020642, R24HS022134] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the Agency for Healthcare Research and Quality R01-HS020642 and R24-HS022134.	Chen PGC, 2014, MED CARE, V52, P95, DOI 10.1097/MLR.0000000000000046; Costa DK, 2014, CHEST, V146, P1566, DOI 10.1378/chest.14-0566; DesRoches CM, 2013, NURS OUTLOOK, V61, P400, DOI 10.1016/j.outlook.2013.05.005; Dierick-van Daele ATM, 2009, J ADV NURS, V65, P391, DOI 10.1111/j.1365-2648.2008.04888.x; Everett C, 2013, HEALTH AFFAIR, V32, P1942, DOI 10.1377/hlthaff.2013.0506; Fairman JA, 2011, NEW ENGL J MED, V364, P193, DOI 10.1056/NEJMp1012121; Fordyce MA., 2007, 2005 PHYS SUPPLY DIS; Gavish R, 2015, CHEST, V148, P375, DOI 10.1378/chest.14-1453; Hollinghurst S, 2006, BRIT J GEN PRACT, V56, P530; Hooker RS, 2012, HEALTH SOC CARE COMM, V20, P20, DOI 10.1111/j.1365-2524.2011.01021.x; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Huang ES, 2013, HEALTH AFFAIR, V32, P614, DOI 10.1377/hlthaff.2012.0913; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Iglehart JK, 2013, NEW ENGL J MED, V368, P1935, DOI 10.1056/NEJMhpr1301084; Jennings JH, 2014, CHEST J; Kuo YF, 2013, HEALTH AFFAIR, V32, P1236, DOI 10.1377/hlthaff.2013.0072; Laurant M, 1996, COCHRANE DATABASE OF; Lenz ER, 2002, DIABETES EDUCATOR, V28, P590, DOI 10.1177/014572170202800413; Litaker David, 2003, J Interprof Care, V17, P223, DOI 10.1080/1356182031000122852; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Mittman DE, 2002, BMJ-BRIT MED J, V325, P485, DOI 10.1136/bmj.325.7362.485; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; Newhouse R. P., 2011, NURSING EC, V29, P230; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Phillips RL, 2014, MED CARE, V52, P97, DOI 10.1097/MLR.0000000000000047; Prieto-Centurion Valentin, 2014, Ann Am Thorac Soc, V11, P417, DOI 10.1513/AnnalsATS.201308-254OC; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Venning P, 2000, BMJ-BRIT MED J, V320, P1048, DOI 10.1136/bmj.320.7241.1048	28	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148522	10.1371/journal.pone.0148522	http://dx.doi.org/10.1371/journal.pone.0148522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910566	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700008
J	Yang, N; Friedl, A				Yang, Ning; Friedl, Andreas			Syndecan-1-Induced ECM Fiber Alignment Requires Integrin alpha v beta 3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains	PLOS ONE			English	Article							CELL-SURFACE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; BREAST-CARCINOMA; FIBRONECTIN RECEPTOR; ACTIN-FILAMENTS; BINDING-SITE; SYNERGY SITE; EXPRESSION; COLLAGEN; DOMAIN	Expression of the cell surface proteoglycan syndecan-1 (Sdc1) is frequently induced in stromal fibroblasts of invasive breast carcinomas. We have recently identified a correlation between stromal Sdc1 expression and extracellular matrix (ECM) fiber alignment, both in vitro and in vivo. ECMs derived from Sdc1-positive human mammary fibroblasts (HMF) showed an aligned fiber architecture, which contrasted markedly with the more random fiber arrangement in the ECM produced by Sdc1-negative HMFs. We further demonstrated that aligned fiber architecture promotes the directional migration and invasion of breast carcinoma cells. To decipher the molecular mechanisms governing the formation of an aligned, invasion-permissive ECM, a series of Sdc1 mutants was introduced into HMF. We found that both the ectodomain and heparan sulfate chains of Sdc1 were required for full activity of Sdc1 in regulating ECM alignment, while transmembrane and cytoplasmic domains were dispensable. Sdc1 regulates the activities of several integrins via its ectodomain. Integrins are key players in the assembly of fibronectin-rich ECM. In addition, integrins are capable of regulating cell morphology and cell shape and orientation may affect ECM architecture. Therefore, we investigated the role of integrins in Sdc1-mediated ECM fiber alignment. Sdc1-overexpressing HMF gained an enhanced spindle-shaped morphology when cultured in an overconfluent state under conditions permissive for ECM production, which was partially reversed by siRNA-mediated silencing of beta 3 integrin expression. Moreover, suppression of alpha v beta 3 integrin activity by a function-blocking antibody or beta 3 knockdown largely abolished the aligned ECM fiber architecture and consequently the invasion-permissive properties of the ECM induced by Sdc1. The results suggest that Sdc1 may modulate fibronectin fibrillogenesis and/or alter cell morphology during ECM production through alpha v beta 3 integrin, thereby mediating ECM fiber alignment. Understanding the mechanisms governing ECM organization may lead to the development of novel stroma-targeted therapy for breast cancer, aiming at converting an invasion-permissive to an invasion-restrictive microenvironment.	[Yang, Ning; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA; [Friedl, Andreas] UW Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System	Friedl, A (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.; Friedl, A (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.; Friedl, A (corresponding author), UW Carbone Canc Ctr, Madison, WI USA.	afriedl@wisc.edu			National Cancer Institute [R01 CA107012-06]; NIH/NCI [R01 CA107012]; NATIONAL CANCER INSTITUTE [R01CA107012, P30CA014520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, R01 CA107012-06 (http://www.cancer.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH/NCI grant R01 CA107012. The authors are grateful to other members of the Friedl lab, especially Kristy Key Meyer, for help with experiments. The authors also thank the University of Wisconsin Carbone Cancer Center (P30 CA014520 40) for use of its facilities and Flow Cytometry Laboratory. The contents do not represent the views of the Dept. of Veterans Affairs or the United States Government.	Altemeier WA, 2012, J BIOL CHEM, V287, P34927, DOI 10.1074/jbc.M112.376814; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Anttonen A, 1999, BRIT J CANCER, V79, P558, DOI 10.1038/sj.bjc.6690088; AOTA S, 1994, J BIOL CHEM, V269, P24756; Baba F, 2006, BREAST CANCER RES TR, V98, P91, DOI 10.1007/s10549-005-9135-2; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; FOGERTY FJ, 1990, CELL DIFFER DEV, V32, P439, DOI 10.1016/0922-3371(90)90061-Z; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Hashimoto Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-185; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Klass CM, 2000, J CELL SCI, V113, P493; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lim HC, 2014, BBA-GEN SUBJECTS, V1840, P2482, DOI 10.1016/j.bbagen.2014.01.018; Locker J, 2011, AM J PATHOL, V178, P966, DOI 10.1016/j.ajpath.2010.12.013; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mao Y, 2006, CELL COMMUN ADHES, V13, P267, DOI 10.1080/15419060601072215; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Stepp MA, 2010, MOL CARCINOGEN, V49, P363, DOI 10.1002/mc.20609; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; VAINIO S, 1992, DEV BIOL, V152, P221, DOI 10.1016/0012-1606(92)90130-9; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Yang N, 2011, AM J PATHOL, V178, P325, DOI 10.1016/j.ajpath.2010.11.039	81	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150132	10.1371/journal.pone.0150132	http://dx.doi.org/10.1371/journal.pone.0150132			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909794	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700069
J	Albers, C; Westkott, M; Pawelzik, K				Albers, Christian; Westkott, Maren; Pawelzik, Klaus			Learning of Precise Spike Times with Homeostatic Membrane Potential Dependent Synaptic Plasticity	PLOS ONE			English	Article							LONG-TERM POTENTIATION; VISUAL-CORTEX; NEURAL-NETWORKS; PYRAMIDAL CELLS; NEURONS; SYNAPSES; INHIBITION; DEPRESSION; EXCITATION; DENDRITES	Precise spatio-temporal patterns of neuronal action potentials underly e.g. sensory representations and control of muscle activities. However, it is not known how the synaptic efficacies in the neuronal networks of the brain adapt such that they can reliably generate spikes at specific points in time. Existing activity-dependent plasticity rules like Spike-Timing-Dependent Plasticity are agnostic to the goal of learning spike times. On the other hand, the existing formal and supervised learning algorithms perform a temporally precise comparison of projected activity with the target, but there is no known biologically plausible implementation of this comparison. Here, we propose a simple and local unsupervised synaptic plasticity mechanism that is derived from the requirement of a balanced membrane potential. Since the relevant signal for synaptic change is the postsynaptic voltage rather than spike times, we call the plasticity rule Membrane Potential Dependent Plasticity (MPDP). Combining our plasticity mechanism with spike after-hyperpolarization causes a sensitivity of synaptic change to pre- and postsynaptic spike times which can reproduce Hebbian spike timing dependent plasticity for inhibitory synapses as was found in experiments. In addition, the sensitivity of MPDP to the time course of the voltage when generating a spike allows MPDP to distinguish between weak (spurious) and strong (teacher) spikes, which therefore provides a neuronal basis for the comparison of actual and target activity. For spatio-temporal input spike patterns our conceptually simple plasticity rule achieves a surprisingly high storage capacity for spike associations. The sensitivity of the MPDP to the subthreshold membrane potential during training allows robust memory retrieval after learning even in the presence of activity corrupted by noise. We propose that MPDP represents a biophysically plausible mechanism to learn temporal target activity patterns.	[Albers, Christian; Westkott, Maren; Pawelzik, Klaus] Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany	University of Bremen	Albers, C (corresponding author), Univ Bremen, Inst Theoret Phys, D-28359 Bremen, Germany.	calbers@neuro.uni-bremen.de			German Bundesministerium fur Bildung und Forschung (BMBF) [01GQ0964]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	CA and MW were supported by the German Bundesministerium fur Bildung und Forschung (BMBF), grant number 01GQ0964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Brea J, 2013, J NEUROSCI, V33, P9565, DOI 10.1523/JNEUROSCI.4098-12.2013; BRESSLOFF PC, 1992, J PHYS A-MATH GEN, V25, P833, DOI 10.1088/0305-4470/25/4/020; Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; D'Haene M, 2009, NEURAL COMPUT, V21, P1068, DOI 10.1162/neco.2008.02-08-707; D'Souza P, 2010, P NATL ACAD SCI USA, V107, P4722, DOI 10.1073/pnas.0909394107; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fino E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006557; Florian RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040233; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Froemke RC, 2015, ANNU REV NEUROSCI, V38, P195, DOI 10.1146/annurev-neuro-071714-034002; Gerstner W, 2002, SPIKING NEURON MODEL; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Haas JS, 2006, J NEUROPHYSIOL, V96, P3305, DOI 10.1152/jn.00551.2006; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hertz J., 1991, SANTA FE I SERIES, V1; Holthoff K, 2010, J PHYSIOL-LONDON, V588, P1085, DOI 10.1113/jphysiol.2009.184960; Lamsa KP, 2007, SCIENCE, V315, P1262, DOI 10.1126/science.1137450; Legenstein R, 2005, NEURAL COMPUT, V17, P2337, DOI 10.1162/0899766054796888; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00007; Memmesheimer RM, 2014, NEURON, V82, P925, DOI 10.1016/j.neuron.2014.03.026; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Pfister JP, 2006, NEURAL COMPUT, V18, P1318, DOI 10.1162/neco.2006.18.6.1318; Ponulak F, 2010, NEURAL COMPUT, V22, P467, DOI 10.1162/neco.2009.11-08-901; Popovic MA, 2014, CEREB CORTEX, V24, P385, DOI 10.1093/cercor/bhs320; Porr B, 2003, NEURAL COMPUT, V15, P831, DOI 10.1162/08997660360581921; Shouval HZ, 2002, P NATL ACAD SCI USA, V99, P10831, DOI 10.1073/pnas.152343099; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Verhoog MB, 2013, J NEUROSCI, V 33, P17197, DOI 10.1523/JNEUROSCI.3158-13.2013; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Woodin MA, 2003, NEURON, V39, P807, DOI 10.1016/S0896-6273(03)00507-5; Xie XH, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041909; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Xu Y, 2013, NEURAL COMPUT, V25, P1472, DOI 10.1162/NECO_a_00450; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yger P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003272	46	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148948	10.1371/journal.pone.0148948	http://dx.doi.org/10.1371/journal.pone.0148948			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900845	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100031
J	Bejugam, PR; Singh, S				Bejugam, Pruthvi Raj; Singh, Shailza			Computing Molecular Devices in L.major through Transcriptome Analysis: Structured Simulation Approach	PLOS ONE			English	Article							NUCLEIC-ACIDS; FORCE-FIELD; RNA	In the modern era of post genomics and transcriptomics, non-coding RNAs and non-coding regions of many RNAs are a big puzzle when we try deciphering their role in specific gene function. Gene function assessment is a main task wherein high throughput technologies provide an impressive body of data that enables the design of hypotheses linking genes to phenotypes. Gene knockdown technologies and RNA-dependent gene silencing are the most frequent approaches to assess the role of key effectors in a particular scenario. Ribozymes are effective modulators of gene expression because of their simple structure, site-specific cleavage activity, and catalytic potential. In our study, after an extensive transcriptomic search of Leishmania major transcriptome we found a Putative ATP dependent DNA helicase (Lmjf_09_0590) 3' UTR which has a structural signature similar to well-known HDV hammerhead ribozyme, even though they have variable sequence motifs. Henceforth, to determine their structural stability and sustainability we analyzed our predicted structural model of this 3' UTR with a 30ns MD simulation, further confirmed with 100ns MD simulation in presence of 5mM MgCl2 ionic environment. In this environment, structural stability was significantly improved by bonded interactions between a RNA backbone and Mg2+ ions. These predictions were further validated in silico using RNA normal mode analysis and anisotropic network modelling (ANM) studies. The study may be significantly imparted to know the functional importance of many such 3'UTRs to predict their role in a mechanistic manner.	[Bejugam, Pruthvi Raj; Singh, Shailza] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Singh, S (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	shailza_iitd@yahoo.com	Bejugam, Pruthvi raj/AAU-1244-2020	Bejugam, Pruthvi raj/0000-0002-0802-9153	University Grants Commission (UGC); Department of Biotechnology, Ministry of Science and Technology, Government of India; University Grants Commission (UGC), Government of India	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	Pruthvi Raj Bejugam has acknowledged University Grants Commission (UGC) for the fellowship. The funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Department of Biotechnology, Ministry of Science and Technology, Government of India for support. Pruthvi Raj Bejugam acknowledges University Grants Commission (UGC), Government of India, for the fellowship. The authors would also like to thank the Director, National Centre for Cell Science (NCCS) for supporting the Bioinformatics and High Performance Computing Facility (BHPCF) at NCCS, Pune, India.	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Atsushi Narita, 2005, NUCELIC ACIDS SYM, P271; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dumas C, 2006, EUKARYOT CELL, V5, P2033, DOI 10.1128/EC.00147-06; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Farrow AL, 2011, MOL CELL BIOCHEM, V350, P47, DOI 10.1007/s11010-010-0681-5; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta SK, 2013, J BIOL CHEM, V288, P4991, DOI 10.1074/jbc.M112.416578; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Klauser B, 2013, NUCLEIC ACIDS RES, V41, P5542, DOI 10.1093/nar/gkt253; Krasovska MV, 2006, BIOPHYS J, V91, P626, DOI 10.1529/biophysj.105.079368; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Matsumoto A, 1999, DYNAMICAL STRUCTURE, P369; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Rana T, 2011, J BIOL CHEM, V286, P6614, DOI 10.1074/jbc.M110.181735; Veeraraghavan N, 2011, J PHYS CHEM B, V115, P8346, DOI 10.1021/jp203202e; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Westrop GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136891; Zacharias M, 2000, BIOPHYS J, V78, P2528, DOI 10.1016/S0006-3495(00)76798-1; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148909	10.1371/journal.pone.0148909	http://dx.doi.org/10.1371/journal.pone.0148909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901858	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100029
J	Harris, DP; Chandrasekharan, UM; Bandyopadhyay, S; Willard, B; DiCorleto, PE				Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.			PRMT5-Mediated Methylation of NF-kappa B p65 at Arg(174) Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-alpha and IFN-gamma Costimulation	PLOS ONE			English	Article							ARGININE METHYLTRANSFERASE 5; INDUCIBLE T-CELL; POSTTRANSLATIONAL MODIFICATION CODES; SMOOTH-MUSCLE-CELLS; I-TAC; CRYSTAL-STRUCTURE; SM PROTEINS; PRMT5; CXCR3; ATHEROSCLEROSIS	Inflammatory agonists differentially activate gene expression of the chemokine family of proteins in endothelial cells (EC). TNF is a weak inducer of the chemokine CXCL11, while TNF and IFN-gamma costimulation results in potent CXCL11 induction. The molecular mechanisms underlying TNF plus IFN-gamma-mediated CXCL11 induction are not fully understood. We have previously reported that the protein arginine methyltransferase PRMT5 catalyzes symmetrical dimethylation of the NF-kappa B subunit p65 in EC at multiple arginine residues. Methylation of Arg(30) and ArWg(35) on p65 is critical for TNF induction of CXCL10 in EC. Here we show that PRMT5-mediated methylation of p65 at Arg(174) is required for induction of CXCL11 when EC are costimulated with TNF and IFN-gamma. Knockdown of PRMT5 by RNAi reduced CXCL11 mRNA and protein levels in costimulated cells. Reconstitution of p65 Arg(174)Ala or Arg(174)Lys mutants into EC that were depleted of endogenous p65 blunted TNF plus IFN-gamma mediated CXCL11 induction. Mass spectrometric analyses showed that p65 Arg(174) arginine methylation is enhanced by TNF plus IFN-gamma costimulation, and is catalyzed by PRMT5. Chromatin immunoprecipitation assays (ChIP) demonstrated that PRMT5 is necessary for p65 association with the CXCL11 promoter in response to TNF plus IFN-gamma. Further, reconstitution of p65 Arg(174)Lys mutant in EC abrogated this p65 association with the CXCL11 promoter. Finally, ChIP and Re-ChIP assays revealed that symmetrical dimethylarginine-containing proteins complexed with the CXCL11 promoter were diminished in p65 Arg(174)Lys-reconstituted EC stimulated with TNF and IFN-gamma. In total, these results indicate that PRMT5-mediated p65 methylation at Arg(174) is essential for TNF plus IFN-gamma-mediated CXCL11 gene induction. We therefore suggest that the use of recently developed small molecule inhibitors of PRMT5 may present a therapeutic approach to moderating chronic inflammatory pathologies.	[Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Harris, Daniel P.; DiCorleto, Paul E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.; DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; DiCorleto, PE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	dicorlp@ccf.org			National Heart, Lung, and Blood Institute (NHLBI) [P01-HL29582]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000439]; National Center for Research Resources (NCRR) [1S10RR031537-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Advancing Translational Sciences (NCATS); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (NHLBI, http://www.nhlbi.nih.gov/) grant P01-HL29582 (to P.E.D.). Support for the collection of HUVEC was made possible by the Case Western Reserve University/Cleveland Clinic CTSA Grant UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS, https://ncats.nih.gov/). The Orbitrap Elite instrument was purchased with a National Center for Research Resources (NCRR, http://www.nih.gov/about/almanac/organization/NCRR.htm) shared instrument grant (1S10RR031537-01). NHLBI, NCATS, and NCRR are components of the United States National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Azzouz TN, 2005, J BIOL CHEM, V280, P34435, DOI 10.1074/jbc.M505077200; BALDWIN GS, 1971, BIOCHEM J, V123, P69, DOI 10.1042/bj1230069; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; BROSTOFF S, 1971, P NATL ACAD SCI USA, V68, P765, DOI 10.1073/pnas.68.4.765; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gerszten RE, 2000, J LAB CLIN MED, V136, P87, DOI 10.1067/mlc.2000.108154; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harris DP, 2014, J BIOL CHEM, V289, P15328, DOI 10.1074/jbc.M114.547349; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Kraft M, 2001, CLIN EXP IMMUNOL, V126, P474, DOI 10.1046/j.1365-2249.2001.01634.x; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Lothrop AP, 2013, FEBS LETT, V587, P1247, DOI 10.1016/j.febslet.2013.01.047; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Majumder S, 1998, J IMMUNOL, V161, P4736; Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Mohan K, 2002, J IMMUNOL, V168, P6420, DOI 10.4049/jimmunol.168.12.6420; Nussinov R, 2012, TRENDS BIOCHEM SCI, V37, P447, DOI 10.1016/j.tibs.2012.07.001; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Scarpati EM, 1996, J BIOL CHEM, V271, P3025, DOI 10.1074/jbc.271.6.3025; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smil D, 2015, ACS MED CHEM LETT, V6, P408, DOI 10.1021/ml500467h; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Venne AS, 2014, PROTEOMICS, V14, P513, DOI 10.1002/pmic.201300344; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039	62	19	19	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148905	10.1371/journal.pone.0148905	http://dx.doi.org/10.1371/journal.pone.0148905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901772	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100028
J	Korolev, IO; Symonds, LL; Bozoki, AC				Korolev, Igor O.; Symonds, Laura L.; Bozoki, Andrea C.		Alzheimer's Dis Neuroimaging Initi	Predicting Progression from Mild Cognitive Impairment to Alzheimer's Dementia Using Clinical, MRI, and Plasma Biomarkers via Probabilistic Pattern Classification	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; DISEASE; CONVERSION; DIAGNOSIS; MODEL; RISK; SELECTION; BRAIN; SEGMENTATION; METAANALYSIS	Background Individuals with mild cognitive impairment (MCI) have a substantially increased risk of developing dementia due to Alzheimer's disease (AD). In this study, we developed a multi-variate prognostic model for predicting MCI-to-dementia progression at the individual patient level. Methods Using baseline data from 259 MCI patients and a probabilistic, kernel-based pattern classification approach, we trained a classifier to distinguish between patients who progressed to AD-type dementia (n = 139) and those who did not (n = 120) during a three-year follow-up period. More than 750 variables across four data sources were considered as potential predictors of progression. These data sources included risk factors, cognitive and functional assessments, structural magnetic resonance imaging (MRI) data, and plasma proteomic data. Predictive utility was assessed using a rigorous cross-validation framework. Results Cognitive and functional markers were most predictive of progression, while plasma proteomic markers had limited predictive utility. The best performing model incorporated a combination of cognitive/functional markers and morphometric MRI measures and predicted progression with 80% accuracy (83% sensitivity, 76% specificity, AUC = 0.87). Predictors of progression included scores on the Alzheimer's Disease Assessment Scale, Rey Auditory Verbal Learning Test, and Functional Activities Questionnaire, as well as volume/cortical thickness of three brain regions (left hippocampus, middle temporal gyrus, and inferior parietal cortex). Calibration analysis revealed that the model is capable of generating probabilistic predictions that reliably reflect the actual risk of progression. Finally, we found that the predictive accuracy of the model varied with patient demographic, genetic, and clinical characteristics and could be further improved by taking into account the confidence of the predictions. Conclusions We developed an accurate prognostic model for predicting MCI-to-dementia progression over a three-year period. The model utilizes widely available, cost-effective, non-invasive markers and can be used to improve patient selection in clinical trials and identify high-risk MCI patients for early treatment.	[Korolev, Igor O.; Symonds, Laura L.; Bozoki, Andrea C.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA; [Korolev, Igor O.] Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA; [Bozoki, Andrea C.] Michigan State Univ, Dept Neurol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University College of Osteopathic Medicine; Michigan State University	Korolev, IO (corresponding author), Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA.; Korolev, IO (corresponding author), Michigan State Univ, Coll Osteopath Med, E Lansing, MI 48824 USA.	korolevi@msu.edu			DO/PhD Program; Department of Neurology at Michigan State University; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; Michigan State University High Performance Computing Center; Institute for Cyber-Enabled Research; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	DO/PhD Program; Department of Neurology at Michigan State University; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michigan State University High Performance Computing Center; Institute for Cyber-Enabled Research; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Stipend support was provided to IOK by the DO/PhD Program, the Graduate School, and the Department of Neurology at Michigan State University. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (http://adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. We would like to thank Dr. Rong Jin, Dr. David Zhu, Dr. Justin McCormick, Dr. Kevin Berger, Bethany Heinlen, and Suzanne Kohler for helpful discussions and feedback; and Monica Gentchev for help with data coding. We wish to acknowledge the support of the Michigan State University High Performance Computing Center and the Institute for Cyber-Enabled Research. We are grateful to the patients and their families who participated in the ADNI.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; Backman L, 2005, NEUROPSYCHOLOGY, V19, P520, DOI 10.1037/0894-4105.19.4.520; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beach TG, 2012, J NEUROPATH EXP NEUR, V71, P266, DOI 10.1097/NEN.0b013e31824b211b; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Bouckaert R. R., 2003, P 20 INT C MACH LEAR, P51, DOI DOI 10.5555/3041838.3041845; Bouwmeester W, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001221; Bozoki A, 2001, ARCH NEUROL-CHICAGO, V58, P411, DOI 10.1001/archneur.58.3.411; Bozoki AC, 2012, HUM BRAIN MAPP, V33, P1792, DOI 10.1002/hbm.21320; Brown G, 2012, J MACH LEARN RES, V13, P27; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Chen R, 2010, NEUROIMAGE, V52, P234, DOI 10.1016/j.neuroimage.2010.03.084; Cui Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021896; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Damoulas T, 2008, BIOINFORMATICS, V24, P1264, DOI 10.1093/bioinformatics/btn112; Damoulas T, 2009, PATTERN RECOGN LETT, V30, P46, DOI 10.1016/j.patrec.2008.08.016; Damoulas T, 2009, PATTERN RECOGN, V42, P2671, DOI 10.1016/j.patcog.2009.04.002; DAVATZIKOS C, 2011, NEUROBIOL AGING, V32, P2322, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2010.05.023, DOI 10.1016/J.NEUROBIOLAGING.2010.05.023]; DELEON MJ, 1989, LANCET, V2, P672; DELEON MJ, 1993, AM J NEURORADIOL, V14, P897; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Desikan RS, 2009, BRAIN, V132, P2048, DOI 10.1093/brain/awp123; Devanand D P, 2012, Int J Alzheimers Dis, V2012, P483469, DOI 10.1155/2012/483469; Devanand DP, 2008, BIOL PSYCHIAT, V64, P871, DOI 10.1016/j.biopsych.2008.06.020; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FLICKER C, 1991, NEUROLOGY, V41, P1006, DOI 10.1212/WNL.41.7.1006; Gomar J.J., 2014, ALZHEIMERS DEMENTIA; Gomar JJ, 2011, ARCH GEN PSYCHIAT, V68, P961, DOI 10.1001/archgenpsychiatry.2011.96; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Haller S, 2011, J ALZHEIMERS DIS, V26, P389, DOI 10.3233/JAD-2011-0014; Hansson O, 2010, NEUROBIOL AGING, V31, P357, DOI 10.1016/j.neurobiolaging.2008.03.027; Herbei R, 2006, CAN J STAT, V34, P709, DOI 10.1002/cjs.5550340410; Hinrichs C, 2011, NEUROIMAGE, V55, P574, DOI 10.1016/j.neuroimage.2010.10.081; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397; Johnstone D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034341; Karow DS, 2010, RADIOLOGY, V256, P932, DOI 10.1148/radiol.10091402; Kim KI, 2011, BIOSTATISTICS, V12, P399, DOI 10.1093/biostatistics/kxq069; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kloppel S, 2012, NEUROIMAGE, V61, P457, DOI 10.1016/j.neuroimage.2011.11.002; Kluger A, 1999, J GERIATR PSYCH NEUR, V12, P168, DOI 10.1177/089198879901200402; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; KOROLEV IO, 2014, MED STUDENT RES J, V4, P24, DOI DOI 10.3402/MSRJ.V3I0.201333; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2008, J NEUROL NEUROSUR PS, V79, P1386, DOI 10.1136/jnnp.2007.142679; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Nordberg A, 2013, EUR J NUCL MED MOL I, V40, P104, DOI 10.1007/s00259-012-2237-2; Palmqvist S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038639; Perrin RJ, 2009, NATURE, V461, P916, DOI 10.1038/nature08538; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Ray S, 2007, NAT MED, V13, P1359, DOI 10.1038/nm1653; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Salat DH, 2009, NEUROIMAGE, V44, P1247, DOI 10.1016/j.neuroimage.2008.10.030; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P58, DOI 10.1001/archneurol.2010.343; Shen L, 2010, BRAIN IMAGING BEHAV, V4, P86, DOI 10.1007/s11682-010-9088-x; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Soares HD, 2012, ARCH NEUROL-CHICAGO, V69, P1310, DOI 10.1001/archneurol.2012.1070; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Stricker NH, 2011, NEUROLOGY, V77, P713, DOI 10.1212/WNL.0b013e31822b0004; Thompson PM, 2003, J NEUROSCI, V23, P994; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Westman E, 2012, NEUROIMAGE, V62, P229, DOI 10.1016/j.neuroimage.2012.04.056; Westover MB, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-20; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Yang H., 1999, P INT ICSC S ADV INT, P22; Ye JP, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-46; Young J, 2013, NEUROIMAGE-CLIN, V2, P735, DOI 10.1016/j.nicl.2013.05.004; Zhang DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033182; Zhang DQ, 2012, NEUROIMAGE, V59, P895, DOI 10.1016/j.neuroimage.2011.09.069; Zhu DC, 2013, J ALZHEIMERS DIS, V34, P969, DOI 10.3233/JAD-121879	88	113	114	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0138866	10.1371/journal.pone.0138866	http://dx.doi.org/10.1371/journal.pone.0138866			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901338	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100002
J	Lim, SM; Jang, HY; Lee, JE; Shin, JS; Park, SH; Yoon, BH; Kim, GJ				Lim, Seung Mook; Jang, Hee Yeon; Lee, Ji Eun; Shin, Joong Sik; Park, Sun-Hwa; Yoon, Bo Hyun; Kim, Gi Jin			Alteration of Pituitary Tumor Transforming Gene-1 Regulates Trophoblast Invasion via the Integrin/Rho-Family Signaling Pathway	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; CANCER-CELLS; LUNG ADENOCARCINOMA; RHO GTPASES; IGF-II; EXPRESSION; MIGRATION; MICRORNA; MIR-186; TARGETS	Trophoblast invasion ability is an important factor in early implantation and placental development. Recently, pituitary tumor transforming gene 1 (PTTG1) was shown to be involved in invasion and proliferation of cancer. However, the role of PTTG1 in trophoblast invasion remains unknown. Thus, in this study we analyzed PTTG1 expression in trophoblasts and its effect on trophoblast invasion activity and determined the mechanism through which PTTG1 regulates trophoblast invasion. Trophoblast proliferation and invasion abilities, regardless of PTTG1 expression, were analyzed by quantitative real-time polymerase chain reaction, fluorescence-activated cell sorting analysis, invasion assay, western blot, and zymography after treatment with small interfering RNA against PTTG1 (siPTTG1). Additionally, integrin/Rho-family signaling in trophoblasts by PTTG1 alteration was analyzed. Furthermore, the effect of PTTG1 on trophoblast invasion was evaluated by microRNA (miRNA) mimic and inhibitor treatment. Trophoblast invasion was significantly reduced through decreased matrix metalloproteinase (MMP)-2 and MMP-9 expression when PTTG1 expression was inhibited by siPTTG1 (p < 0.05). Furthermore, knockdown of PTTG1 increased expression of integrin alpha 4 (ITGA4), ITGA5, and integrin beta 1 (ITGB1); otherwise, RhoA expression was significantly decreased (p < 0.05). Treatment of miRNA-186-5p mimic and inhibitor controlled trophoblast invasion ability by altering PTTG1 and MMP expression. PTTG1 can control trophoblast invasion ability via regulation of MMP expression through integrin/Rho-family signaling. In addition, PTTG1 expression and its function were regulated by miRNA-186-5p. These results help in understanding the mechanism through which PTTG1 regulates trophoblast invasion and thereby implantation and placental development.	[Lim, Seung Mook; Jang, Hee Yeon; Kim, Gi Jin] CHA Univ, Dept Biomed Sci, Songnam 463400, South Korea; [Lee, Ji Eun; Shin, Joong Sik] CHA Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Sun-Hwa] Korea Univ, Coll Med, Dept Anat, Inst Human Genet, Seoul 136705, South Korea; [Yoon, Bo Hyun] Seoul Natl Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Kim, GJ (corresponding author), CHA Univ, Dept Biomed Sci, Songnam 463400, South Korea.	gjkim@cha.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A13009776]; Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea [A120855]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea; Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, Republic of Korea (2012R1A13009776) and a grant of Korea health Technology R & D project, Ministry of Health & Welfare, Republic of Korea (A120855).	Anin Sheba Anin, 2004, Hum Fertil (Camb), V7, P169, DOI 10.1080/14647270400006911; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Caccavari F, 2010, CELL ADHES MIGR, V4, P124, DOI 10.4161/cam.4.1.10976; Cai JC, 2013, CANCER RES, V73, P756, DOI 10.1158/0008-5472.CAN-12-2651; Cross JC, 1998, ANN NY ACAD SCI, V857, P23, DOI 10.1111/j.1749-6632.1998.tb10104.x; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Halasz M, 2013, J REPROD IMMUNOL, V97, P43, DOI 10.1016/j.jri.2012.10.011; Hamid T, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-3; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Holtan SG, 2009, MAYO CLIN PROC, V84, P985, DOI 10.1016/S0025-6196(11)60669-1; Hsu YH, 2010, J BIOL CHEM, V285, P22630, DOI 10.1074/jbc.M109.096255; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Iyer V, 2005, J CELL SCI, V118, P1185, DOI 10.1242/jcs.01708; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Jovanovic M, 2010, REPRODUCTION, V139, P789, DOI 10.1530/REP-09-0341; Kim SY, 2012, BIOCHEM BIOPH RES CO, V429, P173, DOI 10.1016/j.bbrc.2012.10.117; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li ZR, 2012, CANCER LETT, V323, P41, DOI 10.1016/j.canlet.2012.03.029; Liu Z, 2008, INT J MOL SCI, V9, P978, DOI 10.3390/ijms9060978; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Malik MT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-61; Na KH, 2012, J CELL BIOCHEM, V113, P685, DOI 10.1002/jcb.23398; Norwitz Errol R, 2007, Reprod Biomed Online, V14 Spec No 1, P101, DOI 10.1016/S1472-6483(10)61464-2; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Peleg D, 1998, AM FAM PHYSICIAN, V58, P453; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roberts DJ, 2008, J CLIN PATHOL, V61, P1254, DOI 10.1136/jcp.2008.055236; Roomi MW, 2009, ONCOL REP, V21, P821, DOI 10.3892/or_00000290; Saso J, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094698; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Shah PP, 2012, ONCOGENE, V31, P3124, DOI 10.1038/onc.2011.488; Shields SK, 2007, ENDOCRINOLOGY, V148, P4906, DOI 10.1210/en.2007-0476; Spessotto P, 2006, J CELL SCI, V119, P4574, DOI 10.1242/jcs.03232; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takao T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021990; Tong YG, 2009, J MOL ENDOCRINOL, V43, P179, DOI 10.1677/JME-08-0176; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Wondergem B, 2012, CANCER RES, V72, P4361, DOI 10.1158/0008-5472.CAN-11-2330; Zhang J, 2002, MOL HUM REPROD, V8, P659, DOI 10.1093/molehr/8.7.659; Zhang J, 2010, ONCOL REP, V24, P1217, DOI 10.3892/or_00000975; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	50	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149371	10.1371/journal.pone.0149371	http://dx.doi.org/10.1371/journal.pone.0149371			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900962	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100065
J	Rantasalo, A; Czeizler, E; Virtanenl, R; Rousu, J; Landesmaki, H; Penttila, M; Jantti, J; Mojzita, D				Rantasalo, Anssi; Czeizler, Elena; Virtanenl, Riitta; Rousu, Juho; Landesmaki, Harri; Penttila, Merja; Jantti, Jussi; Mojzita, Dominik			Synthetic Transcription Amplifier System for Orthogonal Control of Gene Expression in Saccharomyces cerevisiae	PLOS ONE			English	Article							LEXA REPRESSOR; DNA-BINDING; CIRCUIT-DESIGN; IN-VIVO; YEAST; PROMOTER; BIOLOGY; SEQUENCE; PROTEIN; SPECIFICITY	This work describes the development and characterization of a modular synthetic expression system that provides a broad range of adjustable and predictable expression levels in S. cerevisiae. The system works as a fixed-gain transcription amplifier, where the input signal is transferred via a synthetic transcription factor (sTF) onto a synthetic promoter, containing a defined core promoter, generating a transcription output signal. The system activation is based on the bacterial LexA-DNA-binding domain, a set of modified, modular LexA-binding sites and a selection of transcription activation domains. We show both experimentally and computationally that the tuning of the system is achieved through the selection of three separate modules, each of which enables an adjustable output signal: 1) the transcription-activation domain of the sTF, 2) the binding-site modules in the output promoter, and 3) the core promoter modules which define the transcription initiation site in the output promoter. The system has a novel bidirectional architecture that enables generation of compact, yet versatile expression modules for multiple genes with highly diversified expression levels ranging from negligible to very strong using one synthetic transcription factor. In contrast to most existing modular gene expression regulation systems, the present system is independent from externally added compounds. Furthermore, the established system was minimally affected by the several tested growth conditions. These features suggest that it can be highly useful in large scale biotechnology applications.	[Rantasalo, Anssi; Virtanenl, Riitta; Penttila, Merja; Jantti, Jussi; Mojzita, Dominik] VTT Tech Res Ctr Finland, POB 1000, FI-02044 Espoo, Finland; [Landesmaki, Harri] Aalto Univ, Dept Comp Sci, POB 15400, FI-00076 Espoo, Finland; [Czeizler, Elena; Rousu, Juho] Aalto Univ, Dept Comp Sci, HIIT, POB 15400, FI-00076 Espoo, Finland	VTT Technical Research Center Finland; Aalto University; Aalto University	Mojzita, D (corresponding author), VTT Tech Res Ctr Finland, POB 1000, FI-02044 Espoo, Finland.	dominik.mojzita@vtt.fi	Penttilä, Merja E/A-4710-2013; Rousu, Juho/E-8195-2012	Rousu, Juho/0000-0002-0705-4314; Mojzita, Dominik/0000-0001-6078-4503; Penttila, Merja/0000-0002-6929-1032; Czeizler, Elena/0000-0003-4250-3979	Academy of Finland [SA-Modubio - 260957]; TEKES [40128/14]	Academy of Finland(Academy of Finland); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	Funding provided by Academy of Finland (www.aka.fi) grant SA-Modubio - 260957 and TEKES (www.tekes.fi) grant Living Factories/LiF - 40128/14.	Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; [Anonymous], 2011, BIO PROTOCOL BIO, V101, pe24; Babiskin AH, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.4; Belli G, 1998, NUCLEIC ACIDS RES, V26, P942, DOI 10.1093/nar/26.4.942; BITTER GA, 1991, MOL GEN GENET, V231, P22, DOI 10.1007/BF00293817; Blount BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033279; Brophy JAN, 2014, NAT METHODS, V11, P508, DOI [10.1038/NMETH.2926, 10.1038/nmeth.2926]; Cardinale S, 2012, BIOTECHNOL J, V7, P856, DOI 10.1002/biot.201200085; Chelliah V, 2015, NUCLEIC ACIDS RES, V43, pD542, DOI 10.1093/nar/gku1181; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; Curran KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5002; Curran KA, 2013, METAB ENG, V19, P88, DOI 10.1016/j.ymben.2013.07.001; Da Silva NA, 2011, FEMS YEAST RES; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Frolova E, 1999, NUCLEIC ACIDS RES, V27, P1350, DOI 10.1093/nar/27.5.1350; GILBERT DM, 1993, MOL CELL BIOL, V13, P462, DOI 10.1128/MCB.13.1.462; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; Guldberg CM, 1879, ERDMANNS J PRAKTISCH, V19, P69; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HUIE MA, 1992, MOL CELL BIOL, V12, P2690, DOI 10.1128/MCB.12.6.2690; Ito Y, 2015, ACS SYNTH BIOL, V4, P12, DOI 10.1021/sb500096y; Jensen MK, 2014, FEMS YEAST RES; Khalil AS, 2012, CELL, V150, P647, DOI 10.1016/j.cell.2012.05.045; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Liang J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1293; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Little MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008915; Mazumder M, 2014, NUCLEIC ACIDS RES, V42, P9514, DOI 10.1093/nar/gku651; McIsaac RS, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1402; McIsaac RS, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1313; Mojzita D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-763; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nevoigt E, 2006, APPL ENVIRON MICROB, V72, P5266, DOI 10.1128/AEM.00530-06; Nielsen AAK, 2013, CURR OPIN CHEM BIOL, V17, P878, DOI 10.1016/j.cbpa.2013.10.003; Ottoz DSM, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku616; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; Relan NK, 1997, BIOCHEMISTRY-US, V36, P1077, DOI 10.1021/bi9618427; RUDEN DM, 1988, P NATL ACAD SCI USA, V85, P4262, DOI 10.1073/pnas.85.12.4262; SCHNARR M, 1991, BIOCHIMIE, V73, P423, DOI 10.1016/0300-9084(91)90109-E; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Teste MA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-99; Valkonen M, 2013, APPL ENV MICROBIOL; Waage P., 1864, STUDIES CONCERNING A, P35; Wang BJ, 2014, NUCLEIC ACIDS RES, V42, P9484, DOI 10.1093/nar/gku593; Wang BJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1516; WERTMAN KF, 1985, J BACTERIOL, V163, P376, DOI 10.1128/JB.163.1.376-384.1985	47	22	23	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148320	10.1371/journal.pone.0148320	http://dx.doi.org/10.1371/journal.pone.0148320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901642	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100016
J	Sharma, G; Narwani, T; Subramanian, S				Sharma, Gaurav; Narwani, Tarun; Subramanian, Srikrishna			Complete Genome Sequence and Comparative Genomics of a Novel Myxobacterium Myxococcus hansupus	PLOS ONE			English	Article							GLIDING MOTILITY; GENE DUPLICATION; ANNOTATION; EVOLUTION; DATABASE; TREE	Myxobacteria, a group of Gram-negative aerobes, belong to the class delta-proteobacteria and order Myxococcales. Unlike anaerobic delta-proteobacteria, they exhibit several unusual physiogenomic properties like gliding motility, desiccation-resistant myxospores and large genomes with high coding density. Here we report a 9.5 Mbp complete genome of Myxococcus hansupus that encodes 7,753 proteins. Phylogenomic and genome-genome distance based analysis suggest that Myxococcus hansupus is a novel member of the genus Myxococcus. Comparative genome analysis with other members of the genus Myxococcus was performed to explore their genome diversity. The variation in number of unique proteins observed across different species is suggestive of diversity at the genus level while the overrepresentation of several Pfam families indicates the extent and mode of genome expansion as compared to non-Myxococcales delta-proteobacteria.	[Sharma, Gaurav; Narwani, Tarun; Subramanian, Srikrishna] CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Subramanian, S (corresponding author), CSIR Inst Microbial Technol, Sect 39A, Chandigarh, India.	krishna@imtech.res.in	Sharma, Gaurav/H-8483-2019; subramanian, srikrishna/N-3018-2019; Narwani, Tarun Jairaj/U-7818-2019	Sharma, Gaurav/0000-0002-2861-7446; subramanian, srikrishna/0000-0002-3263-1048; Narwani, Tarun Jairaj/0000-0002-8560-9880	project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC)"; Council of Scientific and Industrial Research (CSIR) [BSC0402]; Department of Biotechnology (DBT) Govt. of India [BT/PR7368/INF/22/177/2012]; CSIR [GENESIS-CSIR-BSC-0121]; CSIR network program [GENESIS-CSIR-BSC-0121]	project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC)"; Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT) Govt. of India(Department of Biotechnology (DBT) India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR network program	This work is supported by a project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC) jointly supported by Council of Scientific and Industrial Research (CSIR) Grant No. BSC0402 and Department of Biotechnology (DBT) Govt. of India Grant No. BT/PR7368/INF/22/177/2012". GS acknowledges CSIR for research fellowship. TN is supported by the CSIR network program GENESIS-CSIR-BSC-0121.; This work is supported by a project "Expansion and modernization of Microbial Type Culture Collection and Gene Bank (MTCC) jointly supported by Council of Scientific and Industrial Research (CSIR) Grant No. BSC0402 and Department of Biotechnology (DBT) Govt. of India Grant No. BT/PR7368/INF/22/177/2012". GS acknowledges CSIR for research fellowship. TN is supported by the CSIR network program GENESIS-CSIR-BSC-0121. We also thank Dr. Ramya TNC for providing us workspace and guidance in myxobacterial culturing. We thank the Genome Quebec Innovation Center, McGill University, Canada for help in obtaining Pac-Bio sequencing data. We also thank CSIR-IMTECH Electron Microscopy facility for SEM data.	Aggarwal G, 2002, J BIOSCIENCES, V27, P7, DOI 10.1007/BF02703679; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Auch AF, 2010, DIGITAL DNA DNA HYBR; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berleman JE, 2009, FEMS MICROBIOL REV, V33, P942, DOI 10.1111/j.1574-6976.2009.00185.x; Bratlie MS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-588; Brenner DJ KN, 2005, BERGEYS MANUAL SYSTE; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Goldman B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001329; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02101; Huntley S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00100-13; Huntley S, 2011, MOL BIOL EVOL, V28, P1083, DOI 10.1093/molbev/msq292; Kaiser D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000380; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lang E, 2009, INT J SYST EVOL MICR, V59, P2122, DOI 10.1099/ijs.0.003566-0; Lang E, 2008, INT J SYST EVOL MICR, V58, P2607, DOI 10.1099/ijs.0.2008/001859-0; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li ZF, 2011, J BACTERIOL, V193, P5015, DOI 10.1128/JB.05516-11; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mauriello EMF, 2010, MICROBIOL MOL BIOL R, V74, P229, DOI 10.1128/MMBR.00043-09; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Miyashita M, 2008, FEMS MICROBIOL LETT, V282, P241, DOI 10.1111/j.1574-6968.2008.01127.x; Muller S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00217-13; Muller S, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00392-13; Nan B, 2011, ANNU REV GENET, V45, P21, DOI 10.1146/annurev-genet-110410-132547; Richardson EJ, 2013, BRIEF BIOINFORM, V14, P1, DOI 10.1093/bib/bbs007; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Sanford RA, 2002, APPL ENVIRON MICROB, V68, P893, DOI 10.1128/AEM.68.2.893-900.2002; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Serres MH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-46; SHIMKETS LJ, 1990, MICROBIOL REV, V54, P473, DOI 10.1128/MMBR.54.4.473-501.1990; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thaxter R, 1904, BOT GAZ, V37, P0405, DOI 10.1086/328505; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029149; Whitworth DE, 2007, MYXOBACTERIA: MULTICELLULARITY AND DIFFERENTIATION, P1; Wolgemuth C, 2002, CURR BIOL, V12, P369, DOI 10.1016/S0960-9822(02)00716-9; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Wu YL, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/5/055003; Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770	53	18	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148593	10.1371/journal.pone.0148593	http://dx.doi.org/10.1371/journal.pone.0148593			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900859	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100020
J	Ucchesu, M; Orru, M; Grillo, O; Venora, G; Paglietti, G; Ardu, A; Bacchetta, G				Ucchesu, Mariano; Orru, Martino; Grillo, Oscar; Venora, Gianfranco; Paglietti, Giacomo; Ardu, Andrea; Bacchetta, Gianluigi			Predictive Method for Correct Identification of Archaeological Charred Grape Seeds: Support for Advances in Knowledge of Grape Domestication Process	PLOS ONE			English	Article							IMAGE-ANALYSIS; VITIS-VINIFERA; ANOXIC CONDITIONS; COMPUTER VISION; PLANT REMAINS; WILD; L.; LANDRACES; SHAPES; EXPLOITATION	The identification of archaeological charred grape seeds is a difficult task due to the alteration of the morphological seeds shape. In archaeobotanical studies, for the correct discrimination between Vitis vinifera subsp. sylvestris and Vitis vinifera subsp. vinifera grape seeds it is very important to understand the history and origin of the domesticated grapevine. In this work, different carbonisation experiments were carried out using a hearth to reproduce the same burning conditions that occurred in archaeological contexts. In addition, several carbonisation trials on modern wild and cultivated grape seeds were performed using a muffle furnace. For comparison with archaeological materials, modern grape seed samples were obtained using seven different temperatures of carbonisation ranging between 180 and 340 degrees C for 120 min. Analysing the grape seed size and shape by computer vision techniques, and applying the stepwise linear discriminant analysis (LDA) method, discrimination of the wild from the cultivated charred grape seeds was possible. An overall correct classification of 93.3% was achieved. Applying the same statistical procedure to compare modern charred with archaeological grape seeds, found in Sardinia and dating back to the Early Bronze Age (2017-1751 2s cal. BC), allowed 75.0% of the cases to be identified as wild grape. The proposed method proved to be a useful and effective procedure in identifying, with high accuracy, the charred grape seeds found in archaeological sites. Moreover, it may be considered valid support for advances in the knowledge and comprehension of viticulture adoption and the grape domestication process. The same methodology may also be successful when applied to other plant remains, and provide important information about the history of domesticated plants.	[Ucchesu, Mariano; Orru, Martino; Grillo, Oscar; Bacchetta, Gianluigi] Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente DISVA, Vle S Ignazio da Laconi 11-13, I-09123 Cagliari, Italy; [Grillo, Oscar; Paglietti, Giacomo] Univ Cagliari, Dipartimento Storia Beni Culturali & Terr, Sez Archeol, Piazza Arsenale 1, I-09124 Cagliari, Italy; [Grillo, Oscar; Venora, Gianfranco] Stn Consorziale Sperimentale Granicoltura Sicilia, Via Sirio 1, I-95041 Borgo San Pietro Caltagi, CT, Italy; [Ardu, Andrea] Univ Cagliari, Dipartimento Sci Chim & Geol, Cittadella Univ,SP Monserrato Sestu Km 0-7, Monserrato, Italy	University of Cagliari; University of Cagliari; University of Cagliari	Ucchesu, M (corresponding author), Univ Cagliari, CCB, Dipartimento Sci Vita & Ambiente DISVA, Vle S Ignazio da Laconi 11-13, I-09123 Cagliari, Italy.	marianoucchesu_@gmail.com	Bacchetta, Gianluigi/AAD-5329-2020	Orru, Martino/0000-0002-5149-5491; BACCHETTA, GIANLUIGI/0000-0002-1714-3978; UCCHESU, Mariano/0000-0002-1587-9842	Regione Autonoma Sardegna [CRP-78809, CUPF2I1500067002]	Regione Autonoma Sardegna(Regione Sardegna)	This research has been supported by the Regione Autonoma Sardegna, project (Analisi morfocolorimetrica, ecofisiologica e omica di Vitis vinifera e Vitis sylvestris in Sardegna) funds on the basis of the Legge Regionale 7 agosto 2007, (L.7 Grant Agreement no. CRP-78809, CUPF2I1500067002).	Bacchetta G., 2008, CONSERVACION EX SITU; Bacchetta G., 2006, GUINEANA, V12, P1; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; Braadbaart F, 2005, VEG HIST ARCHAEOBOT, V14, P67, DOI 10.1007/s00334-004-0050-y; Braadbaart F, 2005, ARCHAEOMETRY, V47, P103, DOI 10.1111/j.1475-4754.2005.00190.x; Braadbaart F, 2004, J THERM ANAL CALORIM, V77, P957, DOI 10.1023/B:JTAN.0000041672.45140.e9; Braadbaart F, 2004, CARBONISATION PEAS W; Braadbaart F, 2007, ECON BOT, V61, P137, DOI 10.1663/0013-0001(2007)61[137:CIMADO]2.0.CO;2; Braadbaart F, 2008, VEG HIST ARCHAEOBOT, V17, P155, DOI 10.1007/s00334-007-0134-6; Buosi C, 2015, ARCHAEOMETRY, V57, P212, DOI 10.1111/arcm.12132; Castelletti L, 1996, 13 INT C PREH PROT S, P11; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Fukunaga K., 2013, INTRO STAT PATTERN R; Grillo O, 2011, SEED SCI TECHNOL, V39, P490, DOI 10.15258/sst.2011.39.2.20; Haruta O, 2011, ANN FOR RES, V54, P99; Hastie T, 2013, ELEMENTS STAT LEARNI; Hastorf C. A., 1988, CURRENT PALEOETHNOBO; HILLMAN G, 1993, WORLD ARCHAEOL, V25, P94, DOI 10.1080/00438243.1993.9980230; Hillman G.C., 1996, J ASS ENV ARCHAEOL, V12, P195; Hillman GC., 1981, FARMING PRACTICE BRI, P123; Holden JE, 2011, EDUC PSYCHOL MEAS, V71, P870, DOI 10.1177/0013164411398357; HOPF M., 1955, BER DEUTSCH BOT GES, V68, P191; Iwata H, 2002, J HERED, V93, P384, DOI 10.1093/jhered/93.5.384; Iwata H, 2010, MOL BREEDING, V25, P203, DOI 10.1007/s11032-009-9319-2; Jacomet S., 1999, ARCHAOBOTANIK AUFGAB; Jacquat C, 1999, VEG HIST ARCHAEOBOT, V8, P25, DOI 10.1007/BF02042839; Jones GEM., 1996, CIRCAEA, V12, P177; Jones Glynis, 1984, PLANTS ANCIENT MAN S, P43; Kawabata S, 2009, SCI HORTIC-AMSTERDAM, V121, P206, DOI 10.1016/j.scienta.2009.01.024; Kilic K, 2007, J FOOD ENG, V78, P897, DOI 10.1016/j.jfoodeng.2005.11.030; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Kuhn M., 2013, APPL PREDICTIVE MODE, P275, DOI DOI 10.1007/978-1-4614-6849-3_12; Landini Gabriel, 2006, Head Face Med, V2, P4, DOI 10.1186/1746-160X-2-4; Logothetis B, 1974, CONTRIBUTION VINE WI, V17, P5; Logothetis B, 1970, DEV VINE VITICULTURE, V13, P167; Lootens P, 2007, COMPUT ELECTRON AGR, V58, P164, DOI 10.1016/j.compag.2007.03.014; Mangafa M, 1996, J ARCHAEOL SCI, V23, P409, DOI 10.1006/jasc.1996.0036; McGovern PE, 1995, ORIGINS ANCIENT HIST; MCGOVERN PE, 1997, EXPEDITION, V39, P3; NUNEZ DR, 1989, REV PALAEOBOT PALYNO, V61, P205, DOI 10.1016/0034-6667(89)90033-X; Olmo HP, 1995, ORIGINS ANCIENT HIST, P31; Orru M, 2013, VEG HIST ARCHAEOBOT, V22, P231, DOI 10.1007/s00334-012-0362-2; Orru M, 2012, CR BIOL, V335, P602, DOI 10.1016/j.crvi.2012.08.002; Pagnoux C, 2014, VEG HIST ARCHAEOBOT, V24, P1; Pearsall D, 2016, PALEOETHNOBOTANY HDB; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rencher A.C., 2012, METHODS MULTIVARIATE, DOI DOI 10.1002/9781118391686; Renfrew A.C., 1972, EMERGENCE CIVILISATI; SMITH H, 1990, J ARCHAEOL SCI, V17, P317, DOI 10.1016/0305-4403(90)90026-2; SPSS, 2006, APPL GUID; Stummer A, 1911, MITTEILUNGEN ANTHR G, V61, P283; Sugiyama M, 2007, J MACH LEARN RES, V8, P1027; Tanda G, 2012, ATT 44 RIUN SCI PREI, P635; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; Ucchesu M, 2015, VEG HIST ARCHAEOBOT, V24, P587, DOI 10.1007/s00334-014-0512-9; Ucchesu M, 2015, VEG HIST ARCHAEOBOT, V24, P343, DOI 10.1007/s00334-014-0470-2; Valamoti SM, 2007, ANTIQUITY, V81, P54, DOI 10.1017/S0003598X00094837; Valamoti SM, 2015, VEG HIST ARCHAEOBOT, V24, P35, DOI 10.1007/s00334-014-0487-6; van der Veen M, 2007, J ARCHAEOL SCI, V34, P968, DOI 10.1016/j.jas.2006.09.007; Venora G, 2007, AGROCHIMICA, V51, P254; Venora G, 2007, FOOD RES INT, V40, P161, DOI 10.1016/j.foodres.2006.09.001; Venora G, 2009, J CEREAL SCI, V49, P429, DOI 10.1016/j.jcs.2008.12.006; Venora G, 2009, SCI HORTIC-AMSTERDAM, V121, P410, DOI 10.1016/j.scienta.2009.03.014; Willcox G, 2005, VEG HIST ARCHAEOBOT, V14, P534, DOI 10.1007/s00334-005-0075-x; Willcox G., 2007, ORIGINS SPREAD DOMES, P21; Wright P, 2003, J ARCHAEOL SCI, V30, P577, DOI 10.1016/S0305-4403(02)00203-0; YOSHIOKA Y, 2004, ANN BOT, V94, P1, DOI 10.1093/aoblmch190.; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001; ZOHARY D, 1975, SCIENCE, V187, P319, DOI 10.1126/science.187.4174.319; ZOHARY D, 1995, ORIGINS ANCIENT HIST, P23	71	37	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149814	10.1371/journal.pone.0149814	http://dx.doi.org/10.1371/journal.pone.0149814			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901361	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100156
J	Randles, L; Anchoori, RK; Roden, RBS; Walters, KJ				Randles, Leah; Anchoori, Ravi K.; Roden, Richard B. S.; Walters, Kylie J.			The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell proliferation; proteasome; ubiquitin; ubiquitylation (ubiquitination); RA190; Uch37; cell cycle progression; hRpn13; p27Kip1	CDK INHIBITOR P27; 26S PROTEASOME; BORTEZOMIB RESISTANCE; REGULATORY PARTICLE; ANTICANCER THERAPY; MULTIPLE-MYELOMA; SUBUNIT; CANCER; RPN13; ACTIVATION	Recently, we reported that bisbenzylidine piperidone RA190 adducts to Cys-88 of the proteasome ubiquitin receptor hRpn13, triggering accumulation of ubiquitinated proteins and endoplasmic reticulum stress-related apoptosis in various cancer cell lines. hRpn13 contains an N-terminal pleckstrin-like receptor for ubiquitin domain that binds ubiquitin and docks it into the proteasome as well as a C-terminal deubiquitinase adaptor (DEUBAD) domain that binds the deubiquitinating enzyme Uch37. Here we report that hRpn13 and Uch37 are required for proper cell cycle progression and that their protein knockdown leads to stalling at G(0)/G(1). Moreover, serum-starved cells display reduced hRpn13 and Uch37 protein levels with hallmarks of G(0)/G(1) stalling and recovery to their steady-state protein levels following release from nutrient deprivation. Interestingly, loss of hRpn13 correlates with a small but statistically significant reduction in Uch37 protein levels, suggesting that hRpn13 interaction may stabilize this deubiquitinating enzyme in human cells. We also find that RA190 treatment leads to a loss of S phase, suggesting a block of DNA replication, and G(2) arrest by using fluorescence-activated cell sorting. Uch37 deprivation further indicated a reduction of DNA replication and G(0)/G(1) stalling. Overall, this work implicates hRpn13 and Uch37 in cell cycle progression, providing a rationale for their function in cellular proliferation and for the apoptotic effect of the hRpn13-targeting molecule RA190.	[Randles, Leah; Walters, Kylie J.] NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res,NIH, Frederick, MD 21702 USA; [Anchoori, Ravi K.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21231 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21231 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Gynecol & Obstet, Baltimore, MD 21231 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Walters, KJ (corresponding author), NCI, Prot Proc Sect, Struct Biophys Lab, Ctr Canc Res, Ft Detrick, MD 21702 USA.	kylie.walters@nih.gov			NCI, National Institutes of Health Center for Cancer Research; NCI, National Institutes of Health [P50 CA098252]; Alleghany Health Network-Johns Hopkins Cancer Research Fund; PI therapeutics; NATIONAL CANCER INSTITUTE [P50CA098252, ZIABC011490] Funding Source: NIH RePORTER	NCI, National Institutes of Health Center for Cancer Research; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alleghany Health Network-Johns Hopkins Cancer Research Fund; PI therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the NCI, National Institutes of Health Center for Cancer Research (to K. J. W.), NCI, National Institutes of Health Grant P50 CA098252 (to R. B. S. R.), and the Alleghany Health Network-Johns Hopkins Cancer Research Fund (to R. B. S. R.). R. K. A. and R. B. S. R. are inventors of intellectual property licensed to Pontifax/PI therapeutics and have received research funding from PI therapeutics. Under a licensing agreement between Pontifax/PI therapeutics and the Johns Hopkins University, Drs. Roden and Anchoori are entitled to a share of royalty received by the University on an invention described in this article. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict of interest policies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amador V, 2007, MOL CELL, V27, P462, DOI 10.1016/j.molcel.2007.06.013; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Asano S, 2015, SCIENCE, V347, P439, DOI 10.1126/science.1261197; Berko D, 2014, J BIOL CHEM, V289, P5609, DOI 10.1074/jbc.M113.509380; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Chen W, 2009, ONCOL REP, V21, P531, DOI 10.3892/or_00000254; Chen X, 2015, MOL CELL, V57, P767, DOI 10.1016/j.molcel.2015.02.025; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Chen YJ, 2012, DIGEST DIS SCI, V57, P2310, DOI 10.1007/s10620-012-2181-9; Choudhury S, 2013, CELL STEM CELL, V13, P117, DOI 10.1016/j.stem.2013.05.004; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Cuddihy AR, 2003, INT REV CYTOL, V222, P99; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dulic V, 1998, MOL CELL BIOL, V18, P546, DOI 10.1128/MCB.18.1.546; Ehlinger A, 2013, BIOCHEMISTRY-US, V52, P3618, DOI 10.1021/bi400417a; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Fejzo MS, 2013, INT J MOL SCI, V14, P3094, DOI 10.3390/ijms14023094; Finley D, 2016, TRENDS BIOCHEM SCI, V41, P77, DOI 10.1016/j.tibs.2015.10.009; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Grigoreva TA, 2015, ONCOTARGET, V6, P24733, DOI 10.18632/oncotarget.4619; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Jacobson AD, 2014, MOL BIOL CELL, V25, P1824, DOI 10.1091/mbc.E13-10-0585; Jang SH, 2014, CLIN EXP METASTAS, V31, P727, DOI 10.1007/s10585-014-9663-4; Karisson-Rosenthal C, 2006, TRENDS CELL BIOL, V16, P285, DOI 10.1016/j.tcb.2006.04.002; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kisselev AF, 2012, CHEM BIOL, V19, P99, DOI 10.1016/j.chembiol.2012.01.003; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Larson MH, 2013, NAT PROTOC, V8, P2180, DOI 10.1038/nprot.2013.132; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lu XX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140518; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Maytal-Kivity V, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-28; Michael WM, 1998, SCIENCE, V282, P1886, DOI 10.1126/science.282.5395.1886; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Perry JA, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-12; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Randles L, 2012, FRONT BIOSCI-LANDMRK, V17, P2140, DOI 10.2741/4042; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ruschak AM, 2011, J NATL CANCER I, V103, P1007, DOI 10.1093/jnci/djr160; Ryu H, 2014, CELL REP, V7, P1842, DOI 10.1016/j.celrep.2014.05.009; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Sahtoe DD, 2015, MOL CELL, V57, P887, DOI 10.1016/j.molcel.2014.12.039; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Shirley M, 2016, DRUGS, V76, P405, DOI 10.1007/s40265-016-0548-5; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Stewart ZA, 2003, TRENDS PHARMACOL SCI, V24, P139, DOI 10.1016/S0165-6147(03)00026-9; Tian Z, 2014, BLOOD, V123, P706, DOI 10.1182/blood-2013-05-500033; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010; Zheng XH, 2015, ACTA HAEMATOL-BASEL, V134, P88, DOI 10.1159/000369916; Zhou BB, 1998, P NATL ACAD SCI USA, V95, P6785, DOI 10.1073/pnas.95.12.6785	77	38	42	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8773	8783		10.1074/jbc.M115.694588	http://dx.doi.org/10.1074/jbc.M115.694588			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907685	hybrid, Green Published			2022-12-26	WOS:000374773200038
J	Devulapalli, S; Shoirah, H; Dhamoon, MS				Devulapalli, Saravana; Shoirah, Hazem; Dhamoon, Mandip S.			Ideal Cardiovascular Health Metrics Are Associated with Disability Independently of Vascular Conditions	PLOS ONE			English	Article							WHITE-MATTER; DISEASE; IMPACT	Background Vascular risk factors may be associated with disability independently of vascular events. We examined whether the American Heart Association's 7 ideal cardiovascular health (CVH) metrics were independently associated with disability in a nationally representative cohort. Methods Adults age >= 20 years from the National Health and Nutrition Examination Survey 20052012 were included. Ideal CVH was calculated as a composite of 7 measures, each scored 0-2. Primary predictors were number of ideal CVH metrics and score of CVH metrics. The outcome was a dichotomous score from 20 activities of daily living (ADL) and instrumental ADLs. Unadjusted and adjusted weighted logistic models estimated associations between ideal CVH and disability. The data were analyzed in 2015. Results Among 22692 participants, mean age was 46.9 years. Cardiac disease and stroke were present in 6.6% and 2.8%; 90.3% had poor physical activity and 89.9% poor diet. Among 3975 individuals with full CVH data, in fully adjusted models, OR for disability was 0.90 (95% CI 0.83-0.98) per point increase in ideal CVH score, and 0.84 (0.73-0.97) per additional number of ideal CVH metrics. Conclusions CVH metrics were strongly and significantly associated with reduced odds of disability independently of vascular and non-vascular conditions. Poorer CVH may cause subclinical vascular disease resulting in disability.	[Devulapalli, Saravana; Shoirah, Hazem; Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dhamoon, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	mandip.dhamoon@mssm.edu						Appel LJ, 2012, CIRCULATION, V125, P973, DOI 10.1161/CIRCULATIONAHA.111.088542; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P266, DOI 10.1177/0891988709342722; BRAULT MW, 2008, AM DISABILITIES 2005; Centers for Disease Control and Prevention, 2015, NHANES SPEC WEIGHT P; Centers for Disease Control and Prevention, 2015, NHANES SURV METH; Crichton GE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089317, 10.1371/journal.pone.0099829]; Dhamoon MS, 2015, J AM HEART ASSOC, P4; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Hollar Jr DW, 2015, DISABILITY HLTH J, V8, P51, DOI [10. 1016/ j. dhjo. 2014.07.007, DOI 10.1016/J.DHJ0.2014.07.007]; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wolfson L, 2005, J NEUROL SCI, V232, P23, DOI 10.1016/j.jns.2004.12.017; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273	17	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150282	10.1371/journal.pone.0150282	http://dx.doi.org/10.1371/journal.pone.0150282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926808	gold, Green Published, Green Submitted			2022-12-26	WOS:000371424200034
J	Salyer, ACD; Caruso, G; Khetani, KK; Fox, LM; Malladi, SS; David, SA				Salyer, Alex C. D.; Caruso, Giuseppe; Khetani, Karishma K.; Fox, Lauren M.; Malladi, Subbalakshmi S.; David, Sunil A.			Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; STRUCTURE-BASED DESIGN; RECEPTOR 7 AGONISTS; INNATE IMMUNITY; 8-OXOADENINE DERIVATIVES; INFLUENZA VACCINE; RECOGNITION; ACTIVATION; LIGANDS; SAFETY	Small-molecule agonists have been identified for TLR7, TLR8, TLR4 and TLR2 thus far, and chemotypes other than those of canonical ligands are yet to be explored for a number of innate immune receptors. The discovery of novel immunostimulatory molecules would enhance the repertoire of tools available for interrogating innate immune effector mechanisms, and provide additional venues for vaccine adjuvant development. A multiplexed, reporter gene-based high-throughput assay capable of detecting agonists of TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, NOD1 and NOD2 was utilized in screening 123,943 compounds, in which amphotericin B (AmpB) and nystatin were identified as prominent hits. The polyene antifungal agents act as TLR2- and TLR4-agonists. The TLR4-stimulatory activity of AmpB was similar to that of monophosphoryl lipid A, suggestive of TRIF-biased signaling. The adjuvantic activity of AmpB, at a dose of 100 micrograms, was comparable to several other candidate adjuvants in rabbit models of immunization. These results point to its potential applicability as a safe and effective adjuvant for human vaccines.	[Salyer, Alex C. D.; Caruso, Giuseppe; Khetani, Karishma K.; Fox, Lauren M.; Malladi, Subbalakshmi S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Salyer, Alex C. D.; David, Sunil A.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	University of Kansas; University of Minnesota System; University of Minnesota Twin Cities	David, SA (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	sdavid@umn.edu	Caruso, Giuseppe/C-1435-2018	Caruso, Giuseppe/0000-0003-1571-5327	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN27220140056C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN27220140056C (SD).	Adediran SA, 2009, MOL PHARMACEUT, V6, P1582, DOI 10.1021/mp9001602; Agnihotri G, 2011, J MED CHEM, V54, P1490, DOI 10.1021/jm101535e; Agnolon V, 2015, INT J PHARMACEUT, V492, P169, DOI 10.1016/j.ijpharm.2015.06.030; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bazin HG, 2015, BIOORG MED CHEM LETT, V25, P1318, DOI 10.1016/j.bmcl.2015.01.037; Beesu M, 2015, J MED CHEM, V58, P7833, DOI 10.1021/acs.jmedchem.5b01087; Beesu M, 2014, J MED CHEM, V57, P7325, DOI 10.1021/jm500701q; Birmingham K, 1999, NAT MED, V5, P469, DOI 10.1038/8332; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chan M, 2013, J MED CHEM, V56, P4206, DOI 10.1021/jm301694x; Cheng K, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400139; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Day TP, 2011, MOL PHARMACEUT, V8, P297, DOI 10.1021/mp100363f; Del Giudice G, 2015, CURR TOP MICROBIOL, V386, P151, DOI 10.1007/82_2014_406; DUTCHER JD, 1968, DIS CHEST, VS 54, P296, DOI 10.1378/chest.54.Supplement_1.296; Eng NF, 2013, HUM VACC IMMUNOTHER, V9, P1661, DOI 10.4161/hv.24715; Esposito S, 2011, PEDIATR INFECT DIS J, V30, pE49, DOI 10.1097/INF.0b013e318206c26e; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Garcon N, 2011, VACCINE, V29, P4453, DOI 10.1016/j.vaccine.2011.04.046; Gerster JF, 2005, J MED CHEM, V48, P3481, DOI 10.1021/jm049211v; Glenny A, 1926, J PATHOL BACTERIOL, V29, P38; Goff PH, 2015, J VIROL, V89, P3221, DOI 10.1128/JVI.03337-14; GRANT JP, 1991, J TROP PEDIATRICS, V37, P272, DOI 10.1093/tropej/37.6.272; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hayashi T, 2014, J PHARMACOL EXP THER, V350, P330, DOI 10.1124/jpet.114.214312; Henderson D A, 1980, Henry E Sigerist Suppl Bull Hist Med, P99; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hoffmann J, 2013, CURR OPIN IMMUNOL, V25, P1, DOI 10.1016/j.coi.2013.01.008; Hussein IH, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00269; Irvine KL, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-50; Janeway CA, 1998, J IMMUNOL, V161, P539; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; KHOO SH, 1994, J ANTIMICROB CHEMOTH, V33, P203, DOI 10.1093/jac/33.2.203; Knuf M, 2015, HUM VACC IMMUNOTHER, V11, P358, DOI 10.4161/21645515.2014.987014; Knuf M, 2015, VACCINE, V33, P174, DOI 10.1016/j.vaccine.2014.10.085; Kokatla HP, 2014, CHEMMEDCHEM, V9, P719, DOI 10.1002/cmdc.201300573; Kokatla HP, 2013, J MED CHEM, V56, P6871, DOI 10.1021/jm400694d; Kokatla HP, 2013, ORG BIOMOL CHEM, V11, P1179, DOI 10.1039/c2ob26705e; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Kumar D, 2015, TRANSPLANTATION; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; Lan T, 2009, J MED CHEM, V52, P6871, DOI 10.1021/jm901145s; Levine MM, 2009, IMMUNOL CELL BIOL, V87, P274, DOI 10.1038/icb.2009.15; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malito E, 2012, P NATL ACAD SCI USA, V109, P5229, DOI 10.1073/pnas.1201964109; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Nakamura T, 2013, BIOORG MED CHEM LETT, V23, P669, DOI 10.1016/j.bmcl.2012.11.114; Nour A, 2014, BIOORG MED CHEM LETT, V24, P4931, DOI 10.1016/j.bmcl.2014.09.039; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P1617, DOI 10.1128/AAC.49.4.1617-1621.2005; ROBBINS A, 1993, AM J DIS CHILD, V147, P152, DOI 10.1001/archpedi.1993.02160260042019; Rodriguez KR, 2014, J VIROL, V88, P8194, DOI 10.1128/JVI.00640-14; Roethle PA, 2013, J MED CHEM, V56, P7324, DOI 10.1021/jm400815m; Salunke DB, 2013, J MED CHEM, V56, P5885, DOI 10.1021/jm400620g; Salunke DB, 2012, J MED CHEM, V55, P8137, DOI 10.1021/jm301066h; Salunke DB, 2012, J MED CHEM, V55, P3353, DOI 10.1021/jm3000533; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Schiaffo CE, 2014, J MED CHEM, V57, P339, DOI 10.1021/jm4004957; Shukla NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043612; Shukla NM, 2012, J MED CHEM, V55, P1106, DOI 10.1021/jm2010207; Shukla NM, 2011, BIOORGAN MED CHEM, V19, P3801, DOI 10.1016/j.bmc.2011.04.052; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Shukla NM, 2009, BIOORG MED CHEM LETT, V19, P2211, DOI 10.1016/j.bmcl.2009.02.100; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Tagliabue A, 2008, HUM VACCINES, V4, P347, DOI 10.4161/hv.4.5.6438; Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Ukani R, 2012, BIOORG MED CHEM LETT, V22, P293, DOI 10.1016/j.bmcl.2011.11.014; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Wu WY, 2010, J MED CHEM, V53, P3198, DOI 10.1021/jm901839g; Yoo E, 2014, J MED CHEM, V57, P7955, DOI 10.1021/jm500744f; Yoo E, 2013, ORG BIOMOL CHEM, V11, P6526, DOI 10.1039/c3ob40816g; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	94	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149848	10.1371/journal.pone.0149848	http://dx.doi.org/10.1371/journal.pone.0149848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919709	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400048
J	Tao, H; Wang, MM; Zhang, M; Zhang, SP; Wang, CH; Yuan, WJ; Sun, T; He, LJ; Hu, QK				Tao, Hong; Wang, Meng-meng; Zhang, Man; Zhang, Shao-ping; Wang, Chun-hui; Yuan, Wen-jun; Sun, Tao; He, Lan-jie; Hu, Qi-kuan			MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 beta Cells	PLOS ONE			English	Article							DISRUPTION	Background Increasing evidence suggests that miR-126 participates in the glucose homeostasis through its target molecules. Although bioinformatics analysis predicts that miR-126 can bind with the insulin receptor substrate-2(IRS-2) mRNA at the "seed sequence", but there are still no definitely reports to support it. In this study, we provided evidences that IRS-2 was one of the target genes of miR-126. And miR-126 has a proliferation inhibiting effects in INS-1 beta cells, mainly through the suppression of IRS-2. Methods The 3'-UTR of IRS-2 regulated by miR-126 was analyzed by the luciferase assay and western blot. Furthermore, proliferation of INS-1 beta cells stimulated by glucose was tested, and the association between IRS-2 and miR-126 were analyzed. Results We found that mutation of only three of the 6 "seed sequences" can eliminate the inhibition effect of miR-126. In INS-1 beta cells, administration of miR-126 suppresses the proliferation, together with the unbalanced down-regulation of IRS-2 and IRS-1. Over-expression of IRS-2 can reverse the proliferation effect of miR-126, while not of IRS-1. These results suggested that miR-126 inhibited the beta-cell proliferation via the inhibition of IRS-2 instead of IRS-1. Additionally, we also found that high glucose and insulin could stimulate the rapid production of endogenous miR-126 within 6 hours, together with the short term suppression of IRS-1 and IRS-2 expression, and intensify the unbalanced expression of IRS-1 and IRS-2. Conclusions IRS-2 was one of the targets of miR-126. MiR-126 inhibited the beta-cell proliferation through IRS-2 instead of IRS-1. MiR-126 may take part in the glucose homeostasis both through its target IRS-2 and IRS-1. The unbalance between IRS-1 and IRS-2 caused by miR-126 may play an important role in type 2 diabetes.	[Tao, Hong; Wang, Meng-meng; Zhang, Man; Yuan, Wen-jun; Hu, Qi-kuan] Ningxia Med Univ, Dept Physiol, Yinchuan, Peoples R China; [Wang, Meng-meng] Jiamusi Cent Hosp, Dept Epilepsy, Jiamusi, Hei Long Jiang, Peoples R China; [Zhang, Shao-ping; Sun, Tao; Hu, Qi-kuan] Natl Key Lab Incubat Base, Ningxia Key Lab Cerebrocranial Dis, Yinchuan, Peoples R China; [Wang, Chun-hui; He, Lan-jie] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China; [Yuan, Wen-jun] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China	Ningxia Medical University; Ningxia Medical University; Naval Medical University	Hu, QK (corresponding author), Ningxia Med Univ, Dept Physiol, Yinchuan, Peoples R China.; Hu, QK (corresponding author), Natl Key Lab Incubat Base, Ningxia Key Lab Cerebrocranial Dis, Yinchuan, Peoples R China.	huqikuan@163.com			National Natural Science Foundation of China [81270880, 30960150, 31260246, 31460300, 81360130]; National Basic Research Program of China (973 program) [2012CB722408]; Ningxia Natural Science Foundation of China [NZ13135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Ningxia Natural Science Foundation of China	This study was supported by grants of the National Natural Science Foundation of China to Wenjun Yuan (81270880), to Qikuan Hu (30960150, 31260246, 31460300), and to Lanjie He (81360130), http://www.nsfc.gov.cn/; the National Basic Research Program of China (973 program, 2012CB722408), http://www.most.gov.cn/cxfw/; the Ningxia Natural Science Foundation of China to Lanjie He (NZ13135), http://www.nxkjt.gov.cn/.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Hu Yan, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P12, DOI 10.11817/j.issn.1672-7347.2015.01.003; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Li HM, 2014, ONCOL REP, V32, P1225, DOI 10.3892/or.2014.3327; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Oliveira JM, 2014, CAN J PHYSIOL PHARM, V92, P613, DOI 10.1139/cjpp-2014-0114; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhang T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761617; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	14	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149954	10.1371/journal.pone.0149954	http://dx.doi.org/10.1371/journal.pone.0149954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919700	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400060
J	Navaza, B; Abarca, B; Bisoffi, F; Pool, R; Roura, M				Navaza, Barbara; Abarca, Bruno; Bisoffi, Federico; Pool, Robert; Roura, Maria			Provider-Initiated HIV Testing for Migrants in Spain: A Qualitative Study with Health Care Workers and Foreign-Born Sexual Minorities	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; TRANSGENDER WOMEN; HUMAN-RIGHTS; RECOMMENDATIONS; RISK; PREVALENCE; COMMUNITY; ATTITUDES; AFRICA; EXCEPTIONALISM	Introduction Provider-initiated HIV testing (PITC) is increasingly adopted in Europe. The success of the approach at identifying new HIV cases relies on its effectiveness at testing individuals most at risk. However, its suitability to reach populations facing overlapping vulnerabilities is under researched. This qualitative study examined HIV testing experiences and perceptions amongst Latin-American migrant men who have sex with men and transgender females in Spain, as well as health professionals' experiences offering HIV tests to migrants in Barcelona and Madrid. Methods We conducted 32 in-depth interviews and 8 discussion groups with 38 Latin-American migrants and 21 health professionals. We imported verbatim transcripts and detailed field work notes into the qualitative software package Nvivo-10 and applied to all data a coding framework to examine systematically different HIV testing dimensions and modalities. The dimensions analysed were based on the World Health Organization "5 Cs" principles: Consent, Counselling, Connection to treatment, Correctness of results and Confidentiality. Results Health professionals reported that PITC was conceptually acceptable for them, although their perceived inability to adequately communicate HIV+ results and resulting bottle necks in the flow of care were recurrent concerns. Endorsement and adherence to the principles underpinning the rights-based response to HIV varied widely across health settings. The offer of an HIV test during routine consultations was generally appreciated by users as a way of avoiding the embarrassment of asking for it. Several participants deemed compulsory testing as acceptable on public health grounds. In spite of-and sometimes because of-partial endorsement of rights-based approaches, PITC was acceptable in a population with high levels of internalised stigma. Conclusion PITC is a promising approach to reach sexual minority migrants who hold high levels of internalised stigma but explicit extra efforts are needed to safeguard the rights of the most vulnerable.	[Navaza, Barbara; Abarca, Bruno; Bisoffi, Federico; Roura, Maria] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam	Roura, M (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	maria.roura@isglobal.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940	Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship [RYC-2011-08428]; "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR) [2014SGR26]; European Commission [FP7-GA-261495]	Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship; "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study has been funded by the Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship awarded to Dr. Maria Roura (RYC-2011-08428, http://www.idi.mineco.gob.es/portal/site/MICINN), who has also received funds from the "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR Grant 2014SGR26). The group activities with Latin American migrants were conducted as part of the COHEMI project, supported by the European Commission 7th Framework Program, Grant Agreement no FP7-GA-261495 (http://ec.europa.eu/research/health/public-health/public-health-and-health-systems/projects/cohemi_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African HIV Policy Network, 2008, GUID HIV TEST WEB CO; Alvarez-del Arco D, 2014, EUR J PUBLIC HEALTH, V24, P139, DOI 10.1093/eurpub/ckt108; Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Angotti N, 2011, HEALTH POLICY PLANN, V26, P307, DOI 10.1093/heapol/czq066; [Anonymous], 2015, PAIS; [Anonymous], 2021, HIV TESTING NEW HIV; April MD, 2010, B WORLD HEALTH ORGAN, V88, P703, DOI 10.2471/BLT.09.073049; Arya M, 2012, AIDS PATIENT CARE ST, V26, P256, DOI 10.1089/apc.2011.0402; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Bayer R, 2009, J HEALTH POLIT POLIC, V34, P301, DOI 10.1215/03616878-2009-002; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; Celada MT, 2011, AM J BIOETHICS, V11, P31, DOI 10.1080/15265161.2011.560339; Csete J, 2004, LANCET, V363, P493, DOI 10.1016/S0140-6736(04)15509-8; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Deblonde J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2571-y; Deblonde J, 2011, HEALTH POLICY, V103, P101, DOI 10.1016/j.healthpol.2011.06.012; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; DeMarco RF, 2012, NURS OUTLOOK, V60, P72, DOI 10.1016/j.outlook.2011.06.002; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; ECDC, 2012, MIGR HLTH HIV TEST C; Elmahdi R, 2014, SEX TRANSM INFECT, V90, P119, DOI 10.1136/sextrans-2013-051312; Esteban-Vasallo MD, 2014, INT J INFECT DIS, V19, P39, DOI 10.1016/j.ijid.2013.10.006; European Centre for Disease Prevention and Control (ECDC), 2014, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control (ECDC), 2010, HIV TEST INCR UPT EF; Frye V, 2015, AIDS BEHAV, V19, P257, DOI 10.1007/s10461-014-0937-2; Glew S, 2014, BRIT J GEN PRACT, V64, pE60, DOI 10.3399/bjgp14X677103; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guionnet A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1115; Hardon A, 2011, MED ANTHROPOL, V30, P183, DOI 10.1080/01459740.2011.552455; Haute Autorite de Sante, 2009, DEP INF VIH FRANC ST; Hernando Victoria, 2015, J Acquir Immune Defic Syndr, V70, P204, DOI 10.1097/QAI.0000000000000717; Hoyos J, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18560; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Kaiser Family Foundation, 2011, SURV AM HIV AIDS TOP; Lang N, 2015, ONE GROUP PEOPLE IS; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Leon N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-97; Lifson AR, 2007, LANCET, V369, P539, DOI 10.1016/S0140-6736(07)60249-9; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Lorenc T, 2011, HEALTH EDUC RES, V26, P834, DOI 10.1093/her/cyr064; Manirankunda L, 2012, AIDS EDUC PREV, V24, P456, DOI 10.1521/aeap.2012.24.5.456; Ministerio de Sanidad Servicios Sociales e Igualdad, 2014, GUIA REC DIAGN PREC; Mizuno Y, 2012, AIDS BEHAV, V16, P724, DOI 10.1007/s10461-011-9967-1; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Navaza B, 2012, AIDS BEHAV, V16, P30, DOI 10.1007/s10461-010-9871-0; Pebody R, 2014, HIV PREVENTION BLACK; Perez-Molina JA, 2012, ENFERM INFEC MICR CL, V30, P472, DOI 10.1016/j.eimc.2012.07.004; Pharris A, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.47.30071; Pollard A, 2013, INT J STD AIDS, V24, P307, DOI 10.1177/0956462412472424; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Prost A, 2009, SEX TRANSM INFECT, V85, P326, DOI 10.1136/sti.2008.033233; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Roura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136315; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Sibanda Euphemia L, 2012, BMC Health Serv Res, V12, P131, DOI 10.1186/1472-6963-12-131; Societat Catalana de Medicina Familiar i Comunitaria, 2011, GUIA AT PRIM PAC IMM; The International HIV/AIDS Alliance, 2006, TOOLS TOG NOW; Tiittala PJ, 2015, SCAND J PUBLIC HEALT, V43, P393, DOI 10.1177/1403494815573604; Topp Stephanie M, 2012, J Int AIDS Soc, V15, P17352, DOI 10.7448/IAS.15.2.17352; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2013, UNAIDS REPORT ON THE; Valenti SE, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.06.005; van Griensven F, 2013, LANCET INFECT DIS, V13, P185, DOI 10.1016/S1473-3099(12)70326-2; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO/UNAIDS, 2007, GUID PROV IN HIV COU; World Health Organization, 2012, SERV DEL APPR HIV TE; World Health Organization, 2015, WHO CONS GUID HIV TE	73	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150223	10.1371/journal.pone.0150223	http://dx.doi.org/10.1371/journal.pone.0150223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26914023	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700063
J	Mo, ZW; Huang, JX; Xiao, D; Ashraf, U; Duan, MY; Pan, SG; Tian, H; Xiao, LZ; Zhong, KY; Tang, XR				Mo, Zhaowen; Huang, Jinxia; Xiao, Di; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Xiao, Lizhong; Zhong, Keyou; Tang, Xiangru			Supplementation of 2-Ap, Zn and La Improves 2-Acetyl-1-Pyrroline Concentrations in Detached Aromatic Rice Panicles In Vitro	PLOS ONE			English	Article							ODOR-ACTIVE COMPOUNDS; PROLINE DEHYDROGENASE; FRAGRANCE; GROWTH; GENE; BIOSYNTHESIS; COMPOUND	Aromatic rice is highly prized by consumers worldwide due to its special aromatic character. 2-acetyl-1-pyrroline (2-AP) is considered to be the single most important volatile compound responsible for aroma in aromatic rice. The present study demonstrated the effects of 2-AP, zinc (Zn) and lanthanum (La) on the 2-AP concentration of detached aromatic rice panicles in vitro. Detached panicles from three well-known aromatic cultivars, Guixiangzhan, Pin14, and Pin 15, were cultured separately in basic culture medium supplemented with 2-AP, Zn and La, and 2-AP concentrations were assessed at 7 and 14 days after culture (DAC). The results show that supplementation of 2-AP, Zn and La in the basic culture medium significantly increases the accumulation of proline. 2-AP concentration and the activity of proline dehydrogenase (ProDH) were also increased in rice grains. Zn concentrations were also found to be higher when Zn was added to the basic culture medium, and La concentrations in grains were too low to be measured. Additionally, grain 2-AP concentrations were significantly and positively correlated with proline concentrations, ProDH activities in grains and 2-AP in culture medium. In summary, higher grain 2-AP concentrations might be due to Znand La-induced increases in proline concentrations and ProDH activities, as well as the direct uptake and transportation of 2-AP from the culture medium. Furthermore, application of both Zn and La might be helpful for improving aroma formation in rice. However, interactions of both these elements with the complex process of 2-AP formation remain to be explored.	[Mo, Zhaowen; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Xiao, Lizhong; Zhong, Keyou; Tang, Xiangru] South China Agr Univ, Coll Agr, Dept Crop Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Mo, Zhaowen; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Zhong, Keyou; Tang, Xiangru] Minist Agr, Sci Observing & Expt Stn Crop Cultivat South Chin, Guangzhou, Guangdong, Peoples R China; [Huang, Jinxia] Wuzhou Municipal Bur Agr, Wuzhou, Guangxi, Peoples R China; [Xiao, Di] Jiaying Univ, Sch Life Sci, Meizhou, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Jiaying University	Tang, XR (corresponding author), South China Agr Univ, Coll Agr, Dept Crop Sci & Technol, Guangzhou, Guangdong, Peoples R China.; Tang, XR (corresponding author), Minist Agr, Sci Observing & Expt Stn Crop Cultivat South Chin, Guangzhou, Guangdong, Peoples R China.	tangxr@scau.edu.cn	Ashraf, Umair/R-2496-2017; 潘, 圣刚/AAD-2832-2021; Ashraf, Umair/AAJ-1585-2020	Ashraf, Umair/0000-0003-0041-7706; Ashraf, Umair/0000-0003-0041-7706	National Natural Science Foundation of China [31271646]; Natural Science Foundation of Guangdong Province [8151064201000017]; Agricultural Research Projects of Guangdong Province [2011AO20202001]; Agricultural Standardization Project of Guangdong Province [4100 F10003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Agricultural Research Projects of Guangdong Province; Agricultural Standardization Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (31271646), Natural Science Foundation of Guangdong Province (8151064201000017), Agricultural Research Projects of Guangdong Province (2011AO20202001), and Agricultural Standardization Project of Guangdong Province (4100 F10003).	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhattacharjee P, 2002, INT J FOOD SCI TECH, V37, P1, DOI 10.1046/j.1365-2621.2002.00541.x; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; BUTTERY RG, 1983, J AGR FOOD CHEM, V31, P823, DOI 10.1021/jf00118a036; BUTTERY RG, 1988, J AGR FOOD CHEM, V36, P1006, DOI 10.1021/jf00083a025; Champagne EI, 2008, CEREAL CHEM, V85, P447, DOI 10.1094/CCHEM-85-4-0445; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; [段美洋 DUAN Mei-yang], 2009, [华南农业大学学报, Journal of South China Agricultural University], V30, P1; Fang F, 2001, J WENZHOU MED COLL, V31, P398; Fitzgerald MA, 2008, PLANT BIOTECHNOL J, V6, P416, DOI 10.1111/j.1467-7652.2008.00327.x; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Fitzgerald TL, 2010, ENVIRON EXP BOT, V68, P292, DOI 10.1016/j.envexpbot.2010.01.001; Goufo Piebiep, 2010, Frontiers of Agriculture in China, V4, P1, DOI 10.1007/s11703-009-0087-x; Goufo P, 2011, AGRON SUSTAIN DEV, V31, P349, DOI 10.1051/agro/2010011; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hashemi FSG, 2013, CRIT REV PLANT SCI, V32, P445, DOI 10.1080/07352689.2013.807716; Hu S, 2001, CROP RES, V15, P14; HU S, 2002, CROP RES, V16, P14; Huang J, 2010, TILLAGE CULTIVATION, P5; Huang JX, 2008, ACTA AGR BOREALI SIN, V23, P290; Huang TC, 2007, J AGR FOOD CHEM, V55, P5097, DOI 10.1021/jf0700576; Itani T, 2004, PLANT PROD SCI, V7, P178, DOI 10.1626/pps.7.178; Jezussek M, 2002, J AGR FOOD CHEM, V50, P1101, DOI 10.1021/jf0108720; Liang J. S., 1993, Chinese Journal of Rice Science, V7, P77; LING D H, 1983, Plant Cell Reports, V2, P172, DOI 10.1007/BF00270095; Maraval I, 2008, J AGR FOOD CHEM, V56, P5291, DOI 10.1021/jf7037373; Maraval I, 2010, ANAL CHIM ACTA, V675, P148, DOI 10.1016/j.aca.2010.07.024; Mo ZW, 2015, RICE, V8, DOI 10.1186/s12284-015-0040-y; Ncube B, 2013, PLANT PHYSIOL BIOCH, V65, P102, DOI 10.1016/j.plaphy.2013.01.001; Pan XiaoHua, 2000, Acta Agriculturae Universitatis Jiangxiensis, V22, P1; Poonlaphdecha J, 2012, J AGR FOOD CHEM, V60, P3824, DOI 10.1021/jf205130y; Sakthivel K, 2009, BIOTECHNOL ADV, V27, P468, DOI 10.1016/j.biotechadv.2009.04.001; SRINIVAS P, 2004, Patent No. 6723856; Sriseadka T, 2006, J AGR FOOD CHEM, V54, P8183, DOI 10.1021/jf0614490; SUN S, 1991, Acta Agronomica Sinica, V17, P430; Suwanarit A., 1996, Kasetsart Journal, Natural Sciences, V30, P458; [唐湘如 Tang Xiangru], 2006, [杂交水稻, Hybrid Rice], V21, P69; Tateishi Y, 2005, PHYSIOL PLANTARUM, V125, P224, DOI 10.1111/j.1399-3054.2005.00553.x; Wakte Kantilal V., 2011, Physiology and Molecular Biology of Plants, V17, P231, DOI 10.1007/s12298-011-0075-5; [王培 Wang Pei], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P103; Widjaja R, 1996, J SCI FOOD AGR, V70, P151, DOI [10.1002/(SICI)1097-0010(199602)70:2<151::AID-JSFA478>3.0.CO;2-U, 10.1002/(SICI)1097-0010(199602)70:2&lt;151::AID-JSFA478&gt;3.0.CO;2-U]; Wijerathna YMAM, 2014, J EXP BIOL AGRIC SCI, V2, P7; Xiao D, 2009, J AGR SCI, V22, P364; Xiao Di, 2010, Journal of South China Agricultural University, V31, P115; Xie ZB, 2003, J RARE EARTH, V21, P86; Yang DS, 2008, J AGR FOOD CHEM, V56, P2780, DOI 10.1021/jf072685t; Yang SY, 2012, FIELD CROP RES, V125, P151, DOI 10.1016/j.fcr.2011.09.002; [杨晓娟 Yang Xiaojuan], 2014, [华北农学报, Acta Agriculturae Boreali-Sinica], V29, P128; Yoshihashi T, 2002, J AGR FOOD CHEM, V50, P2001, DOI 10.1021/jf011268s; Yoshihashi T., 2005, JAPAN INT RES CTR AG	51	46	50	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149523	10.1371/journal.pone.0149523	http://dx.doi.org/10.1371/journal.pone.0149523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910246	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700038
J	Stuntz, M; Perlaky, A; des Vignes, F; Kyriakides, T; Glass, D				Stuntz, Mark; Perlaky, Anna; des Vignes, Franka; Kyriakides, Tassos; Glass, Dan			The Prevalence of Peyronie's Disease in the United States: A Population-Based Study	PLOS ONE			English	Article							MEN; ASSOCIATION	Peyronie's disease (PD) is a connective tissue disorder which can result in penile deformity. The prevalence of diagnosed PD in the United States (US) has been estimated to be 0.5% in adult males, but there is limited additional information comparing definitive and probable PD cases. We conducted a population-based survey to assess PD prevalence using a convenience-sample of adult men participating in the Research Now general population panel. Respondents were categorized according to PD status (definitive, probable, no PD) and segmented by US geographic region, education, and income levels. Of the 7,711 respondents, 57 (0.7%) had definitive PD while 850 (11.0%) had probable PD. Using univariate logistic regression modeling, older age (18-24 vs 24+) (OR = 0.721; 95% CI = 0.570,0.913), Midwest/Northeast/West geographic region (South vs Midwest/Northeast/West) (OR = 0.747; 95% CI = 0.646,0.864), and higher income level (<25K vs 25K+) (OR = 0.820; 95% CI = 0.673,0.997) were each significantly associated with reduced odds of having a definitive/probable PD diagnosis compared with no PD diagnosis. When all three variables were entered in a stepwise multivariable logistic regression, only age (OR = 0.642; 95% CI = 0.497, 0.828) and region (OR = 0.752; 95% CI = 0.647, 0.872) remained significant. This study is the first to report PD prevalence by geographic region and income, and it advocates that the prevalence of PD in the US may be higher than previously cited. Further, given the large discrepancy between definitive PD cases diagnosed by a physician and probable cases not diagnosed by a physician, much more needs to be done to raise awareness of this disease.	[Stuntz, Mark; Perlaky, Anna; des Vignes, Franka; Glass, Dan] Deerfield Inst, New York, NY USA; [Kyriakides, Tassos] Yale Univ, Sch Publ Hlth, Yale Ctr Analyt Serv, New Haven, CT USA	Yale University	Stuntz, M (corresponding author), Deerfield Inst, New York, NY USA.	mstuntz@deerfield.com	Kyriakides, Tassos/E-4980-2013	Kyriakides, Tassos/0000-0001-8913-108X; Stuntz, Mark/0000-0001-9646-1781	Deerfield Management, a healthcare investment firm; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Deerfield Management, a healthcare investment firm; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Financial support for this research was funded by the Deerfield Management, a healthcare investment firm dedicated to advancing healthcare through investment, information and philanthropy. The funder provided support in the form of salaries for authors (MS, AP, FDV, DG) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abernethy J, 1828, CONSEQUENCES GONORRH, V1, P205; Arafa M, 2007, INT J IMPOT RES, V19, P213, DOI 10.1038/sj.ijir.3901518; Deveci S, 2007, J SEX MED, V4, P485, DOI 10.1111/j.1743-6109.2006.00344.x; Devine CJ, 1997, J UROLOGY, V157, P285, DOI 10.1016/S0022-5347(01)65361-8; DiBenedetti DB, 2011, ADV UROL, V2011, P1; El-Sakka AI, 2006, EUR UROL, V49, P564, DOI 10.1016/j.eururo.2005.10.026; El-Sakka AI, 2005, J UROLOGY, V174, P1026, DOI 10.1097/01.ju.0000170231.51306.32; ElSakka AI, 1997, J UROLOGY, V158, P1391, DOI 10.1016/S0022-5347(01)64223-X; Hauck EW, 2001, LANCET, V357, P2049, DOI 10.1016/S0140-6736(00)05119-9; Hellstrom WJG, 2013, J UROLOGY, V190, P627, DOI 10.1016/j.juro.2013.01.090; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Levine LA, 1997, J UROLOGY, V158, P1395, DOI 10.1016/S0022-5347(01)64224-1; LINDSAY MB, 1991, J UROLOGY, V146, P1007, DOI 10.1016/S0022-5347(17)37988-0; LING RSM, 1963, J BONE JOINT SURG BR, V45, P709, DOI 10.1302/0301-620X.45B4.709; Mulhall JP, 2006, J UROLOGY, V175, P2115, DOI 10.1016/S0022-5347(06)00270-9; Musitelli S, 2008, J SEX MED, V5, P1737, DOI 10.1111/j.1743-6109.2007.00692.x; Nugteren HM, 2011, INT J IMPOT RES, V23, P142, DOI 10.1038/ijir.2011.18; NYBERG LM, 1982, J UROLOGY, V128, P48, DOI 10.1016/S0022-5347(17)52751-2; Pawlowska E, 2011, POL J RADIOL, V76, P33; Pryor JP, 2002, INT J IMPOT RES, V14, P414, DOI 10.1038/sj.ijir.3900877; Ralph DJ, 1997, J UROLOGY, V157, P291, DOI 10.1016/S0022-5347(01)65362-X; Rhoden EL, 2001, INT J IMPOT RES, V13, P291, DOI 10.1038/sj.ijir.3900727; Romero FR, 2013, INT BRAZ J UROL, V39, P55, DOI 10.1590/S1677-5538.IBJU.2013.01.08; Schwarzer U, 2001, BJU INT, V88, P727, DOI 10.1046/j.1464-4096.2001.02436.x; Shiraishi K, 2012, J SEX MED, V9, P2716, DOI 10.1111/j.1743-6109.2012.02868.x; Sommer F, 2002, INT J IMPOT RES, V14, P379, DOI 10.1038/sj.ijir.3900863; Tal R, 2012, J SEX MED, V9, P302, DOI 10.1111/j.1743-6109.2011.02502.x; Tefekli A, 2001, INT J IMPOT RES, V13, P18, DOI 10.1038/sj.ijir.3900635; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015	29	58	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150157	10.1371/journal.pone.0150157	http://dx.doi.org/10.1371/journal.pone.0150157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907743	Green Published, Green Submitted, gold			2022-12-26	WOS:000371163000032
J	Sundstrom, KB; Hoang, ATN; Gupta, S; Ahlm, C; Svensson, M; Klingstrom, J				Sundstrom, Karin B.; Hoang, Anh Thu Nguyen; Gupta, Shawon; Ahlm, Clas; Svensson, Mattias; Klingstrom, Jonas			Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PULMONARY SYNDROME; PATHOGENESIS; SECRETION	Andes virus (ANDV) causes hantavirus pulmonary syndrome (HPS), a severe acute disease with a 40% case fatality rate. Humans are infected via inhalation, and the lungs are severely affected during HPS, but little is known regarding the effects of ANDV-infection of the lung. Using a 3-dimensional air-exposed organotypic human lung tissue model, we analyzed progeny virus production and cytokine-responses after ANDV-infection. After a 7-10 day period of low progeny virus production, a sudden peak in progeny virus levels was observed during approximately one week. This peak in ANDV-production coincided in time with activation of innate immune responses, as shown by induction of type I and III interferons and ISG56. After the peak in ANDV production a low, but stable, level of ANDV progeny was observed until 39 days after infection. Compared to uninfected models, ANDV caused long-term elevated levels of eotaxin-1, IL-6, IL-8, IP-10, and VEGF-A that peaked 20-25 days after infection, i.e., after the observed peak in progeny virus production. Notably, eotaxin-1 was only detected in supernatants from infected models. In conclusion, these findings suggest that ANDV replication in lung tissue elicits a late proinflammatory immune response with possible long-term effects on the local lung cytokine milieu. The change from an innate to a proinflammatory response might be important for the transition from initial asymptomatic infection to severe clinical disease, HPS.	[Sundstrom, Karin B.; Gupta, Shawon] Karolinska Insitutet, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hoang, Anh Thu Nguyen; Gupta, Shawon; Svensson, Mattias; Klingstrom, Jonas] Karolinska Univ Hosp Huddinge, Karolinska Insitutet Stockholm, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Ahlm, Clas] Umea Univ, Dept Clin Microbiol, Div Infect Dis, Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University	Klingstrom, J (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Insitutet Stockholm, Dept Med, Ctr Infect Med, Stockholm, Sweden.	Jonas.Klingstrom@ki.se		Gupta, Shawon/0000-0002-8501-6962; Klingstrom, Jonas/0000-0001-9076-1441	Swedish Research Council [K2014-99X-22624-01-4, K2015-56X-22774-01-3]; Swedish Foundation [SB12-0003]; Karolinska Institutet; Stockholm County Council; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	This work was supported by grants from the Swedish Research Council (Projects K2014-99X-22624-01-4 and K2015-56X-22774-01-3, www.vr.se) and the Swedish Foundation for Strategic Research (Project SB12-0003, www.stratresearch.se), Karolinska Institutet, Stockholm County Council, Ake Wibergs Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hoang ATN, 2014, J LEUKOCYTE BIOL, V96, P481, DOI 10.1189/jlb.3TA0513-303R; Borges AA, 2008, MICROBES INFECT, V10, P1150, DOI 10.1016/j.micinf.2008.06.006; Castillo C, 2001, CHEST, V120, P548, DOI 10.1378/chest.120.2.548; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Gavrilovskaya I, 2012, ADV VIROL, V2012, DOI 10.1155/2012/674360; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003272; Hardestam J, 2009, EMERG INFECT DIS, V15, P1140, DOI 10.3201/eid1507.090097; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIM SG, 1993, AM J CLIN PATHOL, V100, P398, DOI 10.1093/ajcp/100.4.398; Klingstrom J, 2006, EUR J IMMUNOL, V36, P2649, DOI 10.1002/eji.200535587; Ma Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/812386; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Martinez VP, 2010, EMERG INFECT DIS, V16, P1853, DOI 10.3201/eid1612.091170; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Martinez-Valdebenito C, 2014, EMERG INFECT DIS, V20, P1629, DOI 10.3201/eid2010.140353; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Morzunov SP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00432; Nguyen Hoang A. T., 2012, AM J PHYSIOL-LUNG C, V302, P226; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; Parasa VR, 2014, DIS MODEL MECH, V7, P281, DOI 10.1242/dmm.013854; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; Rasmuson J, 2011, EUR J CLIN MICROBIOL, V30, P685, DOI 10.1007/s10096-010-1141-6; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rowe RK, 2006, J VIROL, V80, P1087, DOI 10.1128/JVI.80.3.1087-1097.2006; Safronetz D, 2014, P NATL ACAD SCI USA, V111, P7114, DOI 10.1073/pnas.1401998111; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Shambat SM, 2015, DIS MODEL MECH, V8, P1413, DOI 10.1242/dmm.021923; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Shrivastava-Ranjan P, 2010, J VIROL, V84, P11227, DOI 10.1128/JVI.01405-10; Spengler JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055310; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Tischler ND, 2008, VIRUS RES, V135, P1, DOI 10.1016/j.virusres.2008.01.013; Tsergouli K, 2013, VIRUSES-BASEL, V5, P3109, DOI 10.3390/v5123109; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Young JC, 2000, AM J TROP MED HYG, V62, P714, DOI 10.4269/ajtmh.2000.62.714; ZAKI SR, 1995, AM J PATHOL, V146, P552	40	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149354	10.1371/journal.pone.0149354	http://dx.doi.org/10.1371/journal.pone.0149354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907493	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000009
J	Itz, ML; Schweinberger, SR; Kaufmann, JM				Itz, Marlena L.; Schweinberger, Stefan R.; Kaufmann, Juergen M.			Effects of Caricaturing in Shape or Color on Familiarity Decisions for Familiar and Unfamiliar Faces	PLOS ONE			English	Article							OWN-RACE BIAS; SURFACE REFLECTANCE; PROCESSING STAGES; RECOGNITION; BRAIN; PERCEPTION; REPRESENTATIONS; DISTINCTIVENESS; ATTRACTIVENESS; DISCRIMINATION	Recent evidence suggests that while reflectance information (including color) may be more diagnostic for familiar face recognition, shape may be more diagnostic for unfamiliar face identity processing. Moreover, event-related potential (ERP) findings suggest an earlier onset for neural processing of facial shape compared to reflectance. In the current study, we aimed to explore specifically the roles of facial shape and color in a familiarity decision task using pre-experimentally familiar (famous) and unfamiliar faces that were caricatured either in shape-only, color-only, or both (full; shape + color) by 15%, 30%, or 45%. We recorded accuracies, mean reaction times, and face-sensitive ERPs. Performance data revealed that shape caricaturing facilitated identity processing for unfamiliar faces only. In the ERP data, such effects of shape caricaturing emerged earlier than those of color caricaturing. Unsurprisingly, ERP effects were accentuated for larger levels of caricaturing. Overall, our findings corroborate the importance of shape for identity processing of unfamiliar faces and demonstrate an earlier onset of neural processing for facial shape compared to color.	[Itz, Marlena L.; Schweinberger, Stefan R.; Kaufmann, Juergen M.] Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany; [Schweinberger, Stefan R.] Univ Jena, DFG Res Unit Person Percept, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Itz, ML (corresponding author), Univ Jena, Dept Gen Psychol & Cognit Neurosci, Jena, Germany.	marlena.itz@uni-jena.de	Schweinberger, Stefan/A-1860-2009; Itz, Marlena/GOP-0516-2022	Schweinberger, Stefan/0000-0001-5762-0188; 	Deutsche Forschungsgemeinschaft (DFG) [KA 2997/2-1, KA 2997/3-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (DFG; http://www.dfg.de/) Grant KA 2997/2-1 to JMK, and Grant KA 2997/3-2 to JMK and SRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2007, ENCYCLOPEDIA OF MEAS; Allen H, 2009, PERCEPTION, V38, P1821, DOI 10.1068/p6424; Bach M, 1997, VISION RES, V37, P1845, DOI 10.1016/S0042-6989(96)00317-3; Barragan-Jason G, 2015, NEUROPSYCHOLOGIA, V75, P390, DOI 10.1016/j.neuropsychologia.2015.06.017; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BENSON PJ, 1994, PERCEPTION, V23, P75, DOI 10.1068/p230075; Bentin S, 2000, COGN NEUROPSYCHOL, V17, P35, DOI 10.1080/026432900380472; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Burton AM, 2015, PERSPECT PSYCHOL SCI, V10, P482, DOI 10.1177/1745691615583129; Burton AM, 2013, Q J EXP PSYCHOL, V66, P1467, DOI 10.1080/17470218.2013.800125; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Caharel S, 2009, NEUROIMAGE, V47, P1809, DOI 10.1016/j.neuroimage.2009.05.065; Chen J, 2010, INT J ROBOT AUTOM, V25, P162, DOI 10.2316/Journal.206.2010.2.206-3386; Dzhelyova M, 2014, J VISION, V14, DOI 10.1167/14.14.15; Eimer M, 2000, CLIN NEUROPHYSIOL, V111, P694, DOI 10.1016/S1388-2457(99)00285-0; Eimer M., 2012, OXFORD HDB FACE PERC, DOI [10.1093/oxfordhb/9780199559053.013.0017, DOI 10.1093/OXFORDHB/9780199559053.013.0017]; Gosling A, 2011, NEUROPSYCHOLOGIA, V49, P2736, DOI 10.1016/j.neuropsychologia.2011.05.025; Hancock PJB, 2000, TRENDS COGN SCI, V4, P330, DOI 10.1016/S1364-6613(00)01519-9; Henke K, 1998, CORTEX, V34, P289, DOI 10.1016/S0010-9452(08)70756-1; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; Irons J, 2014, J VISION, V14, DOI 10.1167/14.2.12; Itz ML, 2014, NEUROIMAGE, V102, P736, DOI 10.1016/j.neuroimage.2014.08.042; Johnston RA, 2009, MEMORY, V17, P577, DOI 10.1080/09658210902976969; Kaufmann JM, 2008, BRAIN RES, V1228, P177, DOI 10.1016/j.brainres.2008.06.092; Kaufmann JM, 2013, NEUROPSYCHOLOGIA, V51, P1310, DOI 10.1016/j.neuropsychologia.2013.03.015; Kaufmann JM, 2012, BIOL PSYCHOL, V89, P21, DOI 10.1016/j.biopsycho.2011.08.011; Kaufmann JM, 2009, J COGNITIVE NEUROSCI, V21, P625, DOI 10.1162/jocn.2009.21080; Keil A, 2014, PSYCHOPHYSIOLOGY, V51, P1, DOI 10.1111/psyp.12147; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Latinus M, 2006, BRAIN RES, V1123, P179, DOI 10.1016/j.brainres.2006.09.031; Lee KJ, 1997, PERCEPTION, V26, P733, DOI 10.1068/p260733; Lee KJ, 2000, PERCEPTION, V29, P1291, DOI 10.1068/p2792; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; McIntyre AH, 2013, APPL COGNITIVE PSYCH, V27, P725, DOI 10.1002/acp.2966; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Perkins D., 1975, STUD VIS COMMUN, V2, P1, DOI [10.1525/var.1975.2.1.1, DOI 10.1525/VAR.1975.2.1.1]; Perrett DI, 2002, P ROY SOC B-BIOL SCI, V269, P873, DOI 10.1098/rspb.2002.1971; Phillips PJ, 2000, IEEE T PATTERN ANAL, V22, P1090, DOI 10.1109/34.879790; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; RHODES G, 1987, COGNITIVE PSYCHOL, V19, P473, DOI 10.1016/0010-0285(87)90016-8; Rhodes G, 1996, SUPERPORTRAITS CARIC; Richler JJ, 2009, VISION RES, V49, P2856, DOI 10.1016/j.visres.2009.08.025; Russell R, 2007, VISION RES, V47, P157, DOI 10.1016/j.visres.2006.11.002; Schulz C, 2012, NEUROIMAGE, V63, P491, DOI 10.1016/j.neuroimage.2012.06.080; Schulz C, 2012, NEUROPSYCHOLOGIA, V50, P2426, DOI 10.1016/j.neuropsychologia.2012.06.013; Schweinberger S. R, 2011, OXFORD HDB FACE PERC, P345, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0018; Schweinberger SR, 1996, J EXP PSYCHOL LEARN, V22, P1383, DOI 10.1037/0278-7393.22.6.1383; Schweinberger SR, 2003, CORTEX, V39, P9, DOI 10.1016/S0010-9452(08)70071-6; Schweinberger SR, CORTEX IN PRESS; Stahl J, 2008, NEUROREPORT, V19, P583, DOI 10.1097/WNR.0b013e3282f97b4d; STEVENAGE SV, 1995, BRIT J PSYCHOL, V86, P127, DOI 10.1111/j.2044-8295.1995.tb02550.x; Sutherland C, 2015, A BASIC GUIDE TO PSY; Tanaka JW, 2006, J COGNITIVE NEUROSCI, V18, P1488, DOI 10.1162/jocn.2006.18.9.1488; Vakli P, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00426; VALENTINE T, 1991, Q J EXP PSYCHOL-A, V43, P161, DOI 10.1080/14640749108400966; Van den Stock J, 2013, J NEUROPSYCH CLIN N, V25, pE52, DOI 10.1176/appi.neuropsych.12120390; Van den Stock J, 2012, CORTEX, V48, P1088, DOI 10.1016/j.cortex.2012.03.003; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; Wiese H, 2014, NEUROPSYCHOLOGIA, V56, P26, DOI 10.1016/j.neuropsychologia.2013.12.023; Wiese H, 2014, CEREB CORTEX, V24, P826, DOI 10.1093/cercor/bhs369; Zimmermann FGS, 2013, NEUROPSYCHOLOGIA, V51, P1320, DOI 10.1016/j.neuropsychologia.2013.03.028	63	14	16	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149796	10.1371/journal.pone.0149796	http://dx.doi.org/10.1371/journal.pone.0149796			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900690	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100151
J	Ma, JH; Thabane, L; Beyene, J; Raina, P				Ma, Jinhui; Thabane, Lehana; Beyene, Joseph; Raina, Parminder			Power Analysis for Population-Based Longitudinal Studies Investigating Gene-Environment Interactions in Chronic Diseases: A Simulation Study	PLOS ONE			English	Article							HAZARDS REGRESSION-MODEL; SAMPLE-SIZE; MISCLASSIFICATION; ASSOCIATIONS; EPIGENETICS; SURVIVAL; AGE	Conventional methods for sample size calculation for population-based longitudinal studies tend to overestimate the statistical power by overlooking important determinants of the required sample size, such as the measurement errors and unmeasured etiological determinants, etc. In contrast, a simulation-based sample size calculation, if designed properly, allows these determinants to be taken into account and offers flexibility in accommodating complex study design features. The Canadian Longitudinal Study on Aging (CLSA) is a Canada-wide, 20-year follow-up study of 30,000 people between the ages of 45 and 85 years, with in-depth information collected every 3 years. A simulation study, based on an illness-death model, was conducted to: (1) investigate the statistical power profile of the CLSA to detect the effect of environmental and genetic risk factors, and their interaction on age-related chronic diseases; and (2) explore the design alternatives and implementation strategies for increasing the statistical power of population-based longitudinal studies in general. The results showed that the statistical power to identify the effect of environmental and genetic risk exposures, and their interaction on a disease was boosted when: (1) the prevalence of the risk exposures increased; (2) the disease of interest is relatively common in the population; and (3) risk exposures were measured accurately. In addition, the frequency of data collection every three years in the CLSA led to a slightly lower statistical power compared to the design assuming that participants underwent health monitoring continuously. The CLSA had sufficient power to detect a small (1< hazard ratio (HR) <= 1.5) or moderate effect (1.5< HR <= 2.0) of the environmental risk exposure, as long as the risk exposure and the disease of interest were not rare. It had enough power to detect a moderate or large (2.0< HR <= 3.0) effect of the genetic risk exposure when the prevalence of the risk exposure was not very low (>= 0.1) and the disease of interest was not rare (such as diabetes and dementia). The CLSA had enough power to detect a large effect of the gene-environment interaction only when both risk exposures had relatively high prevalence (0.2) and the disease of interest was very common (such as diabetes). The minimum detectable hazard ratios (MDHR) of the CLSA for the environmental and genetic risk exposures obtained from this simulation study were larger than those calculated according to the conventional sample size calculation method. For example, the MDHR for the environmental risk exposure was 1.15 according to the conventional method if the prevalence of the risk exposure was 0.1 and the disease of interest was dementia. In contrast, the MDHR was 1.61 if the same exposure was measured every 3 years with a misclassification rate of 0.1 according to this simulation study. With a given sample size, higher statistical power could be achieved by increasing the measuring frequency in participants with high risk of declining health status or changing risk exposures, and by increasing measurement accuracy of diseases and risk exposures. A properly designed simulation-based sample size calculation is superior to conventional methods when rigorous sample size calculation is necessary.	[Ma, Jinhui; Thabane, Lehana; Beyene, Joseph; Raina, Parminder] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Ma, Jinhui; Raina, Parminder] McMaster Univ, Evidence Based Practice Ctr, Hamilton, ON, Canada; [Ma, Jinhui; Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Hamilton, ON, Canada; [Thabane, Lehana] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada; [Thabane, Lehana] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Ma, Jinhui] Univ Ottawa, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Ma, Jinhui] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada	McMaster University; McMaster University; McMaster University; McMaster University; McMaster University; Population Health Research Institute; University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Raina, P (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Raina, P (corresponding author), McMaster Univ, Evidence Based Practice Ctr, Hamilton, ON, Canada.	praina@mcmaster.ca			Canadian Longitudinal Study on Aging - Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN) program; Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program	Canadian Longitudinal Study on Aging - Canadian Institutes of Health Research (CIHR); Canadian Network and Centre for Trials Internationally (CANNeCTIN) program; Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program	This study was supported in part by funds from the Canadian Longitudinal Study on Aging (which is funded in part by the Canadian Institutes of Health Research (CIHR)), Canadian Network and Centre for Trials Internationally (CANNeCTIN) program, and the Drug Safety and Effectiveness Cross-Disciplinary Training (DSECT) Program in the form of studentship and training awards for the first author.	Barsh GS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002812; Blair A, 2007, AM J IND MED, V50, P199, DOI 10.1002/ajim.20281; Calvanese V, 2009, AGEING RES REV, V8, P268, DOI 10.1016/j.arr.2009.03.004; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Garcia-Closas M, 1999, CANCER EPIDEM BIOMAR, V8, P1043; Grigorenko EL, 2005, J GERONTOL B-PSYCHOL, V60, P53, DOI 10.1093/geronb/60.Special_Issue_1.53; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Khoury MJ, 2007, INT J EPIDEMIOL, V36, P439, DOI 10.1093/ije/dyl253; LACHIN JM, 1986, BIOMETRICS, V42, P507, DOI 10.2307/2531201; Lamarca R, 1998, J GERONTOL A-BIOL, V53, pM337, DOI 10.1093/gerona/53A.5.M337; Meira-Machado L, 2009, STAT METHODS MED RES, V18, P195, DOI 10.1177/0962280208092301; Raina PS, 2009, CAN J AGING, V28, P221, DOI 10.1017/S0714980809990055; SCHOENFELD DA, 1983, BIOMETRICS, V39, P499, DOI 10.2307/2531021; Thompson EA, 2002, BIOSTATISTICAL GENET, P386; van den Hout A, 2009, STAT METHODS MED RES, V18, P145, DOI 10.1177/0962280208089090	17	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149940	10.1371/journal.pone.0149940	http://dx.doi.org/10.1371/journal.pone.0149940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901422	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100190
J	Lopez-Bertoni, H; Lal, B; Michelson, N; Guerrero-Cazares, H; Quinones-Hinojosa, A; Li, Y; Laterra, J				Lopez-Bertoni, H.; Lal, B.; Michelson, N.; Guerrero-Cazares, H.; Quinones-Hinojosa, A.; Li, Y.; Laterra, J.			Epigenetic modulation of a miR-296-5p:HMGA1 axis regulates Sox2 expression and glioblastoma stem cells	ONCOGENE			English	Article							HMGA PROTEINS; CANCER; PROLIFERATION; MICRORNAS; MIR-296; TRANSCRIPTION; MOBILITY; RENEWAL; PATHWAY; TARGETS	Solid malignancies contain subsets of multipotent cells that grow as spheres and efficiently propagate tumors in xenograft models, reflecting a stem-like, self-renewing and tumor-propagating phenotype. These cancer 'stem cells (SCs)' have been shown to maintain tumor growth, contribute to resistance and drive tumor recurrence. Cancer cell stemness is dynamically influenced by epigenetic mechanisms and differentially regulated coding and noncoding RNAs. How these mechanisms specifically contribute to the generation and/or maintenance of cancer SCs remains unclear. This study identifies a novel epigenetically regulated circuit that integrates microRNA, chromatin remodeling and the reprogramming transcription factor Sox2 to regulate glioblastoma (GBM)-propagating SCs. We show that miR-296-5p expression is repressed in a DNA methylation-dependent manner under conditions that promote GBM cell stemness and that miR-296-5p inhibits GBM cell stemness and their capacity to self-renew as spheres and propagate glioma xenografts in vivo. We show that the chromatin remodeling protein HMGA1 functions as a downstream effector of these biological responses to miR-296-5p and regulates Sox2 expression, a master driver of cell stemness, by modifying chromatin architecture at the Sox2 promoter. These results show for the first time that miR-296-5p inhibits transcriptional mechanisms that support GBM SCs and identify a miR-296-5p: HMGA1: Sox2 axis as a novel regulator of GBM SCs and candidate pathway for targeting therapies directed at depleting tumors of their tumor-propagating stem cell subsets.	[Lopez-Bertoni, H.; Lal, B.; Michelson, N.; Li, Y.; Laterra, J.] Hugo W Moser Res Inst Kennedy Krieger, Baltimore, MD USA; [Lopez-Bertoni, H.; Lal, B.; Li, Y.; Laterra, J.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Guerrero-Cazares, H.; Quinones-Hinojosa, A.] Johns Hopkins Sch Med, Dept Neurosurg, Baltimore, MD USA; [Quinones-Hinojosa, A.; Laterra, J.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Quinones-Hinojosa, A.; Laterra, J.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Laterra, J (corresponding author), Johns Hopkins Sch Med, Kennedy Krieger Inst, Dept Neurol, 707 North Broadway, Baltimore, MD 21205 USA.	Laterra@kennedykrieger.org	Lopez, Hernando/AAY-7655-2020	Lopez, Hernando/0000-0001-6618-1092; Guerrero-Cazares, Hugo/0000-0003-1307-719X	American Brain Tumor Association; United States NIH [R01NS073611, R01NS070024]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073611, R01NS070024] Funding Source: NIH RePORTER	American Brain Tumor Association; United States NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the American Brain Tumor Association (to HL-B), and the United States NIH Grants R01NS073611 (to JL) and R01NS070024 (to AQ-H).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Catez F, 2006, NAT STRUCT MOL BIOL, V13, P305, DOI 10.1038/nsmb1077; Choi Jae Duk, 2013, Genomics & Informatics, V11, P164, DOI 10.5808/GI.2013.11.4.164; Cleynen I, 2008, INT J ONCOL, V32, P289; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fanelli M, 2008, ONCOGENE, V27, P358, DOI 10.1038/sj.onc.1210642; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Glas M, 2010, ANN NEUROL, V68, P264, DOI 10.1002/ana.22036; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gohel PH, 2012, INT J PHARM RES ALLI, V1, P1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Lee KH, 2014, BBA-MOL CELL RES, V1843, P2055, DOI 10.1016/j.bbamcr.2014.06.001; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YQ, 2005, CANCER RES, V65, P9355, DOI 10.1158/0008-5472.CAN-05-1946; Li YQ, 2012, CANCER RES, V72, P576, DOI 10.1158/0008-5472.CAN-11-3070; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lopez-Bertoni H, 2015, ONCOGENE, V34, P3994, DOI 10.1038/onc.2014.334; LUND T, 1983, FEBS LETT, V152, P163, DOI 10.1016/0014-5793(83)80370-6; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Rajendran G, 2011, J NEURO-ONCOL, V104, P483, DOI 10.1007/s11060-010-0520-2; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Robson JE, 2012, RNA, V18, P135, DOI 10.1261/rna.029561.111; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Shivapurkar N, 2013, INT J COLORECTAL DIS, V28, P887, DOI 10.1007/s00384-012-1560-1; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh RP, 2009, CELL TRANSPLANT, V18, P1197, DOI 10.3727/096368909X12483162197204; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wei JJ, 2011, CLIN CANCER RES, V17, P1297, DOI 10.1158/1078-0432.CCR-10-0993; Wolffe AP, 2001, ONCOGENE, V20, P2988, DOI 10.1038/sj.onc.1204322; Xia HP, 2012, J BIOL CHEM, V287, P9962, DOI 10.1074/jbc.M111.332627; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044	46	42	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4903	4913		10.1038/onc.2016.22	http://dx.doi.org/10.1038/onc.2016.22			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26898758	Green Accepted			2022-12-26	WOS:000383330700008
J	Kook, S; Wang, P; Young, LR; Schwake, M; Saftig, P; Weng, XL; Meng, Y; Neculai, D; Marks, MS; Gonzales, L; Beers, MF; Guttentag, S				Kook, Seunghyi; Wang, Ping; Young, Lisa R.; Schwake, Michael; Saftig, Paul; Weng, Xialian; Meng, Ying; Neculai, Dante; Marks, Michael S.; Gonzales, Linda; Beers, Michael F.; Guttentag, Susan			Impaired Lysosomal Integral Membrane Protein 2-dependent Peroxiredoxin 6 Delivery to Lamellar Bodies Accounts for Altered Alveolar Phospholipid Content in Adaptor Protein-3-deficient pearl Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; lung; peroxiredoxin; phospholipid metabolism; trafficking; AP-3; Hermansky Pudlak syndrome; alveolar epithelial type 2 cell; lamellar body; peroxiredoxin 6	HERMANSKY-PUDLAK-SYNDROME; CHEDIAK-HIGASHI-SYNDROME; PULMONARY SURFACTANT; LUNG SURFACTANT; AP-3 ADAPTER; MOUSE MODEL; 1-CYS PEROXIREDOXIN; BODY DEGENERATION; EPITHELIAL-CELLS; BETA-3A SUBUNIT	The Hermansky Pudlak syndromes (HPS) constitute a family of disorders characterized by oculocutaneous albinism and bleeding diathesis, often associated with lethal lung fibrosis. HPS results from mutations in genes of membrane trafficking complexes that facilitate delivery of cargo to lysosome-related organelles. Among the affected lysosome-related organelles are lamellar bodies (LB) within alveolar type 2 cells (AT2) in which surfactant components are assembled, modified, and stored. AT2 from HPS patients and mouse models of HPS exhibit enlarged LB with increased phospholipid content, but the mechanism underlying these defects is unknown. We now show that AT2 in the pearl mouse model of HPS type 2 lacking the adaptor protein 3 complex (AP-3) fails to accumulate the soluble enzyme peroxiredoxin 6 (PRDX6) in LB. This defect reflects impaired AP-3-dependent trafficking of PRDX6 to LB, because pearl mouse AT2 cells harbor a normal total PRDX6 content. AP-3-dependent targeting of PRDX6 to LB requires the transmembrane protein LIMP-2/SCARB2, a known AP-3-dependent cargo protein that functions as a carrier for lysosomal proteins in other cell types. Depletion of LB PRDX6 in AP-3- or LIMP-2/SCARB2-deficient mice correlates with phospholipid accumulation in lamellar bodies and with defective intraluminal degradation of LB disaturated phosphatidylcholine. Furthermore, AP-3-dependent LB targeting is facilitated by protein/protein interaction between LIMP-2/SCARB2 and PRDX6 in vitro and in vivo. Our data provide the first evidence for an AP-3-dependent cargo protein required for the maturation of LB in AT2 and suggest that the loss of PRDX6 activity contributes to the pathogenic changes in LB phospholipid homeostasis found HPS2 patients.	[Kook, Seunghyi; Wang, Ping; Guttentag, Susan] Vanderbilt Univ, Sch Med, Dept Pediat, Div Neonatol, Nashville, TN 37232 USA; [Young, Lisa R.] Vanderbilt Univ, Sch Med, Dept Pediat, Div Pediat Pulm Med, Nashville, TN 37232 USA; [Schwake, Michael] Univ Bielefeld, Dept Chem Biochem 3, D-33615 Bielefeld, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, Olshausenstr 40, D-24098 Kiel, Germany; [Weng, Xialian; Meng, Ying; Neculai, Dante] Zhejiang Univ, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China; [Marks, Michael S.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Marks, Michael S.] Univ Penn, Perelman Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Gonzales, Linda; Beers, Michael F.] Univ Penn, Perelman Sch Med, Dept Med, Div Adult Pulm & Crit Care Med, Philadelphia, PA 19104 USA	Vanderbilt University; Vanderbilt University; University of Bielefeld; University of Kiel; Zhejiang University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Guttentag, S (corresponding author), 11111 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	susan.guttentag@vanderbilt.edu	Neculai, Dante/A-9923-2011; Saftig, Paul/A-7966-2010; Guttentag, Susan H/D-8705-2013; Guttentag, Susan/ABE-7405-2020; Marks, Michael S/Q-7223-2019	Neculai, Dante/0000-0001-8887-9168; Guttentag, Susan H/0000-0003-4420-5879; Guttentag, Susan/0000-0003-4420-5879; Marks, Michael S/0000-0001-7435-7262; Schwake, Michael/0000-0002-4173-2166	American Heart Association [12GRNT 12050265, 13GRNT17070104]; National Institutes of Health [HL059959, HL119503, HL119436, GM108807]; Department of Veterans Affairs Merit Award [BX001176]; Hermansky-Pudlak Syndrome Network; Deutsche Forschungsgemeinschaft [GRK1459]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119503, R01HL059959, R01HL119436, R56HL059959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108807] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001176] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); Hermansky-Pudlak Syndrome Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by American Heart Association Grants 12GRNT 12050265 (to S. G.) and 13GRNT17070104 (to M. F. B.), National Institutes of Health Grants HL059959 (to S. G.), HL119503 (to L. Y.), HL119436 (to M. F. B.), and GM108807 (to S. G. and M. M.), Department of Veterans Affairs Merit Award BX001176 (to M. F. B.), the Hermansky-Pudlak Syndrome Network, and Deutsche Forschungsgemeinschaft Grant GRK1459. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atochina-Vasserman EN, 2011, AM J RESP CRIT CARE, V184, P449, DOI 10.1164/rccm.201011-1882OC; Bachli EB, 2004, AM J MED GENET A, V127A, P201, DOI 10.1002/ajmg.a.20683; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bates SR, 2008, AM J PHYSIOL-LUNG C, V295, pL658, DOI 10.1152/ajplung.90233.2008; Bultema JJ, 2012, J BIOL CHEM, V287, P19550, DOI 10.1074/jbc.M112.351908; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chapuy B, 2008, TRAFFIC, V9, P1157, DOI 10.1111/j.1600-0854.2008.00745.x; Cheong N, 2007, J BIOL CHEM, V282, P23811, DOI 10.1074/jbc.M703927200; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; FISHER AB, 1987, J APPL PHYSIOL, V62, P2295, DOI 10.1152/jappl.1987.62.6.2295; FISHER AB, 1992, BIOCHEM J, V288, P407, DOI 10.1042/bj2880407; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200; Gautam R, 2006, TRAFFIC, V7, P779, DOI 10.1111/j.1600-0854.2006.00431.x; Gochuico BR, 2012, MOL MED, V18, P56, DOI 10.2119/molmed.2011.00198; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Janvier K, 2003, J CELL BIOL, V163, P1281, DOI 10.1083/jcb.200307157; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Le Borgne R, 1998, J BIOL CHEM, V273, P29451, DOI 10.1074/jbc.273.45.29451; Li ZJ, 2013, P NATL ACAD SCI USA, V110, P5004, DOI 10.1073/pnas.1218620110; Lyerla TA, 2003, AM J PHYSIOL-LUNG C, V285, pL643, DOI 10.1152/ajplung.00024.2003; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Manevich Y, 2009, ARCH BIOCHEM BIOPHYS, V485, P139, DOI 10.1016/j.abb.2009.02.008; MARINETTI GV, 1962, BIOCHEMISTRY-US, V1, P350, DOI 10.1021/bi00908a024; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; McGarry MP, 1999, P SOC EXP BIOL MED, V220, P162, DOI 10.1046/j.1525-1373.1999.d01-24.x; Meng RH, 2010, EXP HEMATOL, V38, P104, DOI 10.1016/j.exphem.2009.09.010; Nakatani Y, 2000, VIRCHOWS ARCH, V437, P304, DOI 10.1007/s004280000241; Neculai D, 2013, NATURE, V504, P172, DOI 10.1038/nature12684; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Osanai K, 2008, AM J PATHOL, V173, P1265, DOI 10.2353/ajpath.2008.080056; Osanai K, 2010, AM J PHYSIOL-LUNG C, V298, pL243, DOI 10.1152/ajplung.00242.2009; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Postle AD, 2011, CHEM PHYS LIPIDS, V164, P549, DOI 10.1016/j.chemphyslip.2011.04.004; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Reczek D, 2007, CELL, V131, P770, DOI 10.1016/j.cell.2007.10.018; Ridsdale R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016482; ROONEY SA, 1994, FASEB J, V8, P957, DOI 10.1096/fasebj.8.12.8088461; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Sitaram A, 2012, MOL BIOL CELL, V23, P3178, DOI 10.1091/mbc.E11-06-0509; Sitaram A, 2012, PHYSIOLOGY, V27, P85, DOI 10.1152/physiol.00043.2011; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Tang XY, 2005, PATHOL INT, V55, P137, DOI 10.1111/j.1440-1827.2005.01811.x; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Weaver TE, 2002, SEMIN CELL DEV BIOL, V13, P263, DOI 10.1016/S1084952102000551; Wei AH, 2013, PIGM CELL MELANOMA R, V26, DOI 10.1111/pcmr.12051; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; Yang W, 2000, J CELL SCI, V113, P4077; Young LR, 2012, AM J RESP CRIT CARE, V186, P1014, DOI 10.1164/rccm.201207-1206OC; Zhang LH, 2011, AM J PHYSIOL-LUNG C, V301, pL461, DOI 10.1152/ajplung.00056.2011	67	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8414	8427		10.1074/jbc.M116.720201	http://dx.doi.org/10.1074/jbc.M116.720201			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907692	Green Published, hybrid			2022-12-26	WOS:000374773200009
J	Barisione, C; Garibaldi, S; Furfaro, AL; Nitti, M; Palmieri, D; Passalacqua, M; Garuti, A; Verzola, D; Parodi, A; Ameri, P; Altieri, P; Fabbi, P; Ferrar, PF; Brunelli, C; Arsenescu, V; Balbi, M; Palombo, D; Ghigliotti, G				Barisione, Chiara; Garibaldi, Silvano; Furfaro, Anna Lisa; Nitti, Mariapaola; Palmieri, Daniela; Passalacqua, Mario; Garuti, Anna; Verzola, Daniela; Parodi, Alessia; Ameri, Pietro; Altieri, Paola; Fabbi, Patrizia; Ferrar, Pier Francesco; Brunelli, Claudio; Arsenescu, Violeta; Balbi, Manrico; Palombo, Domenico; Ghigliotti, Giorgio			Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; UREMIC TOXIN; CARDIOVASCULAR-DISEASE; AORTIC-ANEURYSMS; ARTERY-DISEASE; ACTIVATION; EXPRESSION; DIFFERENTIATION; INFLAMMATION; SUBSETS	Objective The uremic toxin Indoxyl-3-sulphate (IS), a ligand of Aryl hydrocarbon Receptor (AhR), raises in blood during early renal dysfunction as a consequence of tubular damage, which may be present even when eGFR is normal or only moderately reduced, and promotes cardiovascular damage and monocyte-macrophage activation. We previously found that patients with abdominal aortic aneurysms (AAAs) have higher CD14(+) CD16(+) monocyte frequency and prevalence of moderate chronic kidney disease (CKD) than age-matched control subjects. Here we aimed to evaluate the IS levels in plasma from AAA patients and to investigate in vitro the effects of IS concentrations corresponding to mild-to-moderate CKD on monocyte polarization and macrophage differentiation. Methods Free IS plasma levels, monocyte subsets and laboratory parameters were evaluated on blood from AAA patients and eGFR-matched controls. THP-1 monocytes, treated with IS 1, 10, 20 mu M were evaluated for CD163 expression, AhR signaling and then induced to differentiate intomacrophages by PMA. Their phenotype was evaluated both at the stage of semi-differentiated and fully differentiatedmacrophages. AAA and control sera were similarly used to treat THP-1 monocytes and the resulting macrophage phenotype was analyzed. Results IS plasma concentration correlated positively with CD14(+) CD16(+) monocytes and was increased in AAA patients. In THP-1 cells, IS promoted CD163 expression and transition to macrophages with hallmarks of classical (IL-6, CCL2, COX2) and alternative phenotype (IL10, PPAR gamma, TGF-beta, TIMP-1), via AhR/Nrf2 activation. Analogously, AAA sera induced differentiation of macrophages with enhanced IL-6, MCP1, TGF-beta, PPAR gamma and TIMP-1 expression. Conclusion IS skews monocyte differentiation toward low-inflammatory, profibrotic macrophages and may contribute to sustain chronic inflammation and maladaptive vascular remodeling.	[Barisione, Chiara; Garibaldi, Silvano; Ameri, Pietro; Altieri, Paola; Fabbi, Patrizia; Brunelli, Claudio; Balbi, Manrico; Ghigliotti, Giorgio] Univ Genoa, IRCCS Univ Hosp San Martino, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy; [Furfaro, Anna Lisa] Giannina Gaslini Inst, Genoa, Italy; [Nitti, Mariapaola; Passalacqua, Mario] Univ Genoa, Dept Expt Med, Genoa, Italy; [Palmieri, Daniela; Palombo, Domenico] Univ Genoa, Unit Vasc & Endovasc Surg, Genoa, Italy; [Garuti, Anna] Univ Genoa, IRCCS Univ Hosp San Martino, Dept Internal Med, Genoa, Italy; [Verzola, Daniela] Univ Genoa, IRCCS Univ Hosp San Martino, Div Nephrol, Dept Internal Med, Genoa, Italy; [Parodi, Alessia] Univ Genoa, CEBR, Genoa, Italy; [Ferrar, Pier Francesco] Univ Genoa, Dept Civil Chem & Environm Engn, Genoa, Italy; [Arsenescu, Violeta] Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Genoa; University System of Ohio; Ohio State University	Barisione, C (corresponding author), Univ Genoa, IRCCS Univ Hosp San Martino, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy.	chiara.barisione@unige.it	balbi, manrico/AAC-9676-2019; Nitti, Mariapaola/ABB-1067-2020; Passalacqua, Mario/W-1973-2019; Ameri, Pietro/K-8556-2016; Verzola, Daniela/U-2761-2019	Passalacqua, Mario/0000-0003-2779-6259; Ameri, Pietro/0000-0001-7167-7287; Ghigliotti, Giorgio/0000-0001-8484-542X; VERZOLA, Daniela/0000-0002-2790-5876				Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778; Amoruso A, 2007, LIFE SCI, V81, P906, DOI 10.1016/j.lfs.2007.07.017; Arsenescu R, 2011, INFLAMM BOWEL DIS, V17, P1149, DOI 10.1002/ibd.21463; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Azizzadeh A, 2006, J VASC SURG, V43, P14, DOI 10.1016/j.jvs.2005.08.037; Bahr IN, 2011, HYPERTENSION, V58, P725, DOI 10.1161/HYPERTENSIONAHA.111.173542; Barisione C, 2015, CURR DRUG TARGETS, V16, P366, DOI 10.2174/1389450116666141230114500; Barisione C, 2010, DIS MARKERS, V28, P115, DOI [10.1155/2010/236405, 10.3233/DMA-2010-0691]; Bolati D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-56; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Boyle JJ, 2011, ARTERIOSCL THROM VAS, V31, P2685, DOI 10.1161/ATVBAHA.111.225813; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Damman K, 2011, EUR HEART J, V32, P2705, DOI 10.1093/eurheartj/ehr190; Dawson J, 2006, ANN NY ACAD SCI, V1085, P320, DOI 10.1196/annals.1383.009; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Gasiewicz TA, 2010, CHEM-BIOL INTERACT, V184, P246, DOI 10.1016/j.cbi.2009.10.019; Ghigliotti G, 2013, DIS MARKERS, V34, P131, DOI 10.1155/2013/836849; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Lin CJ, 2012, ATHEROSCLEROSIS, V225, P173, DOI 10.1016/j.atherosclerosis.2012.07.012; Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456; Majkova Z, 2009, TOXICOL APPL PHARM, V237, P1, DOI 10.1016/j.taap.2009.02.016; Medjakovic S, 2010, NUTRIENTS, V2, P241, DOI 10.3390/nu2030241; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Phillips RJ, 2005, J INFLAMM-LOND, V31, P2; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Shantsila E, 2014, ATHEROSCLEROSIS, V234, P4, DOI 10.1016/j.atherosclerosis.2014.02.009; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Takada Y, 2010, J IMMUNOL, V184, P2671, DOI 10.4049/jimmunol.0804012; Tang WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119545; Ugocsai P, 2006, CYTOM PART A, V69A, P203, DOI 10.1002/cyto.a.20235; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; Virzi GM, 2015, AM J NEPHROL, V41, P474, DOI 10.1159/000438459; Wang MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016653; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	54	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149276	10.1371/journal.pone.0149276	http://dx.doi.org/10.1371/journal.pone.0149276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925780	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200008
J	Miyata, S; Kurachi, M; Okano, Y; Sakurai, N; Kobayashi, A; Harada, K; Yamagata, H; Matsuo, K; Takahashi, K; Narita, K; Fukuda, M; Ishizaki, Y; Mikuni, M				Miyata, Shigeo; Kurachi, Masashi; Okano, Yoshiko; Sakurai, Noriko; Kobayashi, Ayumi; Harada, Kenichiro; Yamagata, Hirotaka; Matsuo, Koji; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Ishizaki, Yasuki; Mikuni, Masahiko			Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; LATE-LIFE DEPRESSION; GENE-EXPRESSION; ANIMAL-MODELS; RIBONUCLEASES; BIOMARKERS; PURIFICATION; DISABILITY; SIGNATURES; PATHWAYS	We investigated transcriptomic markers of late-onset major depressive disorder (LOD; onset age of first depressive episode >= 50 years) from the genes expressed in blood cells and identified state-dependent transcriptomic markers in these patients. We assessed the genes expressed in blood cells by microarray and found that the expression levels of 3,066 probes were state-dependently changed in the blood cells of patients with LOD. To select potential candidates from those probes, we assessed the genes expressed in the blood of an animal model of depression, ovariectomized female mice exposed to chronic ultra-mild stress, by microarray and cross-matched the differentially expressed genes between the patients and the model mice. We identified 14 differentially expressed genes that were similarly changed in both patients and the model mice. By assessing statistical significance using real-time quantitative PCR (RT-qPCR), the following 4 genes were selected as candidates: cell death-inducing DFFA-like effector c (CIDEC), ribonuclease 1 (RNASE1), solute carrier family 36 member-1 (SLC36A1), and serine/threonine/tyrosine interacting-like 1 (STYXL1). The discriminating ability of these 4 candidate genes was evaluated in an independent cohort that was validated. Among them, CIDEC showed the greatest discriminant validity (sensitivity 91.3% and specificity 87.5%). Thus, these 4 biomarkers should be helpful for properly diagnosing LOD.	[Miyata, Shigeo; Okano, Yoshiko; Sakurai, Noriko; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat, Maebashi, Gunma 371, Japan; [Miyata, Shigeo; Okano, Yoshiko; Sakurai, Noriko; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Neurosci, Maebashi, Gunma 371, Japan; [Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan; [Kobayashi, Ayumi; Harada, Kenichiro; Yamagata, Hirotaka; Matsuo, Koji] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi 755, Japan	Gunma University; Gunma University; Gunma University; Yamaguchi University	Miyata, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Psychiat, Maebashi, Gunma 371, Japan.; Miyata, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurosci, Maebashi, Gunma 371, Japan.	s_miyata@gunma-u.ac.jp	Miyata, Shigeo/AAQ-6584-2021; Ishizaki, Yasuki/AAB-1209-2020	Miyata, Shigeo/0000-0003-1713-805X; 	Grants-in-Aid for Scientific Research [25670509] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Belzeaux R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.112; Chan MK, 2014, PROG NEUROBIOL, V122, P45, DOI 10.1016/j.pneurobio.2014.08.002; Cho Peter, 2004, Implant Dent, V13, P79, DOI 10.1097/01.ID.0000116456.76235.BC; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gansler J, 2014, FASEB J, V28, P752, DOI 10.1096/fj.13-238600; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; Guilloux JP, 2015, NEUROPSYCHOPHARMACOL, V40, P701, DOI 10.1038/npp.2014.226; Hepgul N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-28; Hu C, 2015, J AFFECT DISORDERS, V170, P266, DOI 10.1016/j.jad.2014.09.008; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Isrie M, 2015, EUR J MED GENET, V58, P205, DOI 10.1016/j.ejmg.2015.02.006; Ito M, 2011, J LIPID RES, V52, P1450, DOI 10.1194/jlr.M012427; Janssen J, 2006, INT J GERIATR PSYCH, V21, P86, DOI 10.1002/gps.1428; Kendler KS, 2009, BIOL PSYCHIAT, V65, P808, DOI 10.1016/j.biopsych.2008.11.015; Keri S, 2014, J AFFECT DISORDERS, V164, P118, DOI 10.1016/j.jad.2014.04.030; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Liu ML, 2004, INT J CARDIOL, V97, P485, DOI 10.1016/j.ijcard.2003.11.046; Maciejak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0149-z; MIZUTA K, 1990, ARCH BIOCHEM BIOPHYS, V281, P144, DOI 10.1016/0003-9861(90)90424-W; Muhonen LH, 2009, PSYCHIAT RES, V167, P115, DOI 10.1016/j.psychres.2008.05.001; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Nakagawasai O, 2009, LIFE SCI, V84, P512, DOI 10.1016/j.lfs.2009.01.009; Nielsen CU, 2013, BRIT J PHARMACOL, V170, P1041, DOI 10.1111/bph.12341; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pajer K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.26; Park SC, 2014, YONSEI MED J, V55, P1712, DOI 10.3349/ymj.2014.55.6.1712; Pereira PA, 2014, INT J GERIATR PSYCH, V29, P399, DOI 10.1002/gps.4018; Redei EE, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.66; Redei EE, 2015, ANN NY ACAD SCI, V1344, P37, DOI 10.1111/nyas.12748; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; SATO S, 2013, CNS DRUGS S1, V27, pS; Sharma V, 2005, J AFFECT DISORDERS, V84, P251, DOI 10.1016/j.jad.2004.01.015; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sung SC, 2013, PSYCHOL MED, V43, P945, DOI 10.1017/S0033291712001742; Do TTH, 2014, AM J PHYSIOL-ENDOC M, V306, pE668, DOI 10.1152/ajpendo.00437.2013; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Walker DK, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.238; YASUDA T, 1993, BIOCHEM J, V296, P617, DOI 10.1042/bj2960617; Yi ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031283; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zhang Y, 2014, BIOMED ENVIRON SCI, V27, P462, DOI 10.3967/bes2014.074; Zisook S, 2004, PSYCHIAT RES, V129, P127, DOI 10.1016/j.psychres.2004.07.004	50	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150262	10.1371/journal.pone.0150262	http://dx.doi.org/10.1371/journal.pone.0150262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926397	Green Submitted, gold, Green Published			2022-12-26	WOS:000371424200032
J	Black, CM; Yu, E; McCann, E; Kachroo, S				Black, Christopher M.; Yu, Eric; McCann, Eilish; Kachroo, Sumesh			Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data	PLOS ONE			English	Article							MAINTAINS CLINICAL REMISSION; EFFICACY; SAFETY; ALPHA	Objective To describe the real-world use of adalimumab for maintenance treatment of ulcerative colitis (UC) and associated healthcare costs in English hospitals. Design Retrospective cohort study. Setting Analysis of NHS Hospital Episode Statistics linked with pharmacy dispensing data in English hospitals. Patients Adult UC patients receiving >= 240mg during adalimumab treatment induction, subsequently maintained on adalimumab. Outcomes Frequency and pattern of adalimumab use and dose escalation during maintenance treatment and associated healthcare costs (prescriptions and hospital visits). Results 191 UC patients completed adalimumab treatment induction. 83 (43.46%) dose escalated during maintenance treatment by >= 100% (equivalent to weekly dosing) (median time to dose escalation: 139 days). 56 patients (67.47%) subsequently de-escalated by >= 50% (median time to dose de-escalation: 21 days). Mean all-cause healthcare costs for all patients <= 12 months of index were 13,892 pound. Dose escalators incurred greater mean healthcare costs than non-escalators <= 12 months of index (14,596 pound vs. 13,351) pound. Prescriptions accounted for 96.49% of UC-related healthcare costs (11,090 pound of 11,494 pound in all patients). Conclusions Within the cohort, 43.46% of UC patients escalated their adalimumab dose by >= 100% and incurred greater costs than non-escalators. The apparent underestimation of adalimumab dose escalation in previous studies may have resulted in underestimated costs in healthcare systems.	[Black, Christopher M.; Kachroo, Sumesh] Merck & Co Inc, Kenilworth, NJ USA; [Yu, Eric] IMS Hlth Ltd, London, England; [McCann, Eilish] Merck Sharp & Dohme Ltd, Hoddesdon, England	Merck & Company; Merck & Company	Kachroo, S (corresponding author), Merck & Co Inc, Kenilworth, NJ USA.	sumesh.kachroo@merck.com		Black, Christopher/0000-0003-2934-108X	Merck & Co., Inc., Kenilworth, NJ, USA	Merck & Co., Inc., Kenilworth, NJ, USA	This study was funded by Merck & Co., Inc., Kenilworth, NJ, USA. EY is a consultant to Merck & Co., Inc. through his employment at IMS Health Ltd. All authors, including the sponsor, played a role in study design, data analysis, interpretation of data, decision to publish and preparation of the manuscript.	Baert F, 2013, J CROHNS COLITIS, V7, P154, DOI 10.1016/j.crohns.2012.03.018; Baki E, 2015, WORLD J GASTROENTERO, V21, P3282, DOI 10.3748/wjg.v21.i11.3282; Colombel JF, 2014, AM J GASTROENTEROLOG; Fausel R, 2015, THER CLIN RISK MANAG, V11, P63, DOI 10.2147/TCRM.S55506; National Institute for Health Care and Excellence (NICE), 2015, INFL AD GOL TREAT MO; NICE, 2015, COST STAT ULC COL IM; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Royal College of Physicians, 2014, NAT CLIN AUD BIOL TH; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; SPC, 2015, SIMP 100MG SOL INJ; SPC, 2015, HUM PREF PEN PREF SY; SPC, 2015, REM 100MG POWD CONC; Suzuki Y, 2014, J GASTROENTEROL, V49, P283, DOI 10.1007/s00535-013-0922-y; UK Government Department of Health, 2015, PAYM RES NHS TAR 201; Warner B, 2012, GASTROENTEROLOGY, V143, pE42, DOI 10.1053/j.gastro.2012.03.055; Wolf D, 2014, ALIMENT PHARM THER, V40, P486, DOI 10.1111/apt.12863	16	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149692	10.1371/journal.pone.0149692	http://dx.doi.org/10.1371/journal.pone.0149692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919745	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400036
J	McLean, S; Kerherve, H; Lovell, GP; Gorman, AD; Solomon, C				McLean, Scott; Kerherve, Hugo; Lovell, Geoff P.; Gorman, Adam D.; Solomon, Colin			The Effect of Recovery Duration on Vastus Lateralis Oxygenation, Heart Rate, Perceived Exertion and Time Motion Descriptors during Small Sided Football Games	PLOS ONE			English	Article							PLAYERS PHYSIOLOGICAL-RESPONSES; INTENSITY INTERMITTENT EXERCISE; NEAR-INFRARED SPECTROSCOPY; YOUTH SOCCER PLAYERS; PACING STRATEGIES; TECHNICAL ACTIVITIES; MUSCLE OXYGENATION; PASSIVE RECOVERY; PERFORMANCE; DEMANDS	Purpose Small sided games (SSG) of football are an effective and efficient format to simultaneously train the physiological, technical, and tactical components of football. The duration of the recovery period between bouts of SSG will affect the physiological response to subsequent bouts. It was hypothesised that decreasing the duration of recovery periods separating serial SSG bouts would increase physiological, and perceptual responses, and decrease high speed running, and distance during SSG bouts. Methods Twelve experienced footballers (mean +/- SD; age 21 +/- 3 yrs; VO2peak 64 +/- 7 ml.min.kg(-1); playing experience 15 +/- 3 yrs) completed two SSG sessions. Each SSG consisted of 3 vs. 3 players and 6 bouts of 2 min duration, with bouts separated by either 30 s recovery (REC-30) or 120 s recovery (REC-120). Deoxygenated haemoglobin (HHb) in the vastus lateralis (VL) (using near infrared spectroscopy), heart rate (HR) and time motion descriptors (TMD) (speed and distance) were measured continuously during the SSG sessions and perceived exertion (RPE) was measured for each bout. Results During the recovery periods, in REC-30 compared to REC-120, there was a significant (p < 0.05) main effect of a higher HHb and HR. During the bouts, in REC-30 compared to REC-120, there were no significant differences in HHb, HR, RPE, or TMD, but within both REC-30 and REC-120 there were significant increases as a function of bout number in RPE. Conclusions Although a four-fold increase in recovery period allowed a significant increase in the recovery of HHb and HR, this did not increase the physiological, and perceptual responses, or time motion descriptors during the bouts. These results could have been due to the regulation of effort (pacing), in these experienced players performing an exercise task to which they were well adapted.	[McLean, Scott; Kerherve, Hugo; Gorman, Adam D.; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Exercise Sci, Sippy Downs, Qld 4556, Australia; [Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Sippy Downs, Qld 4556, Australia; [Kerherve, Hugo] Univ Lyon, Lab Physiol Exercice, F-42023 St Etienne, France	University of the Sunshine Coast; University of the Sunshine Coast	McLean, S (corresponding author), Univ Sunshine Coast, Sch Hlth & Exercise Sci, Sippy Downs, Qld 4556, Australia.	smclean@usc.edu.au	Gorman, Adam/K-2415-2016; McLean, Scott/AAA-3891-2020	Gorman, Adam/0000-0003-2847-7268; McLean, Scott/0000-0002-7269-5847				Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Aroso J, 2004, J SPORT SCI, V22, P522; Aslan A, 2013, J HUM KINET, V38, P95, DOI 10.2478/hukin-2013-0049; BALSOM PD, 1992, INT J SPORTS MED, V13, P528, DOI 10.1055/s-2007-1021311; Bangsbo J, 1994, Acta Physiol Scand Suppl, V619, P1; Billaut F, 2011, MED SCI SPORT EXER, V43, P665, DOI 10.1249/MSS.0b013e3181f6ee3b; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Buchheit M, 2010, INT J SPORTS MED, V31, P402, DOI 10.1055/s-0030-1249620; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Castellano J, 2013, J STRENGTH COND RES, V27, P1295, DOI 10.1519/JSC.0b013e318267a5d1; CHANCE B, 1992, AM J PHYSIOL, V262, pC766, DOI 10.1152/ajpcell.1992.262.3.C766; Dellal A, 2011, INT J SPORT PHYSIOL, V6, P322, DOI 10.1123/ijspp.6.3.322; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Dorge HC, 1999, SCAND J MED SCI SPOR, V9, P195; Fanchini M, 2011, J STRENGTH COND RES, V25, P453, DOI 10.1519/JSC.0b013e3181c1f8a2; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Gabbett TJ, 2015, INT J SPORT PHYSIOL, V10, P298, DOI 10.1123/ijspp.2013-0543; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gibson ASC, 2006, SPORTS MED, V36, P705; Hamaoka T, 2011, PHILOS T R SOC A, V369, P4591, DOI 10.1098/rsta.2011.0298; Hanson AM, 2008, J ATHL TRAINING, V43, P133, DOI 10.4085/1062-6050-43.2.133; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hill-Haas SV, 2010, J STRENGTH COND RES, V24, P2149, DOI 10.1519/JSC.0b013e3181af5265; HIRVONEN J, 1987, EUR J APPL PHYSIOL O, V56, P253, DOI 10.1007/BF00690889; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Johnston RD, 2015, INT J SPORTS PHYSL P, V10; Katis A, 2009, J SPORT SCI MED, V8, P374; Kawaguchi K, 2001, EUR J APPL PHYSIOL, V84, P158, DOI 10.1007/s004210000352; Kelly DA, 2009, J SCI MED SPORT, V12, P475, DOI 10.1016/j.jsams.2008.01.010; Koklu Y, 2015, J SPORT MED PHYS FIT, V55, P430; Koklu Y, 2011, J STRENGTH COND RES, V25, P1522, DOI 10.1519/JSC.0b013e3181e06ee1; Little T, 2006, J STRENGTH COND RES, V20, P316; Mallo J, 2008, J SPORT MED PHYS FIT, V48, P166; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Micklewright D, 2010, BRIT J SPORT MED, V44, P952, DOI 10.1136/bjsm.2009.057315; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Muthalib M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3309746; Ohya T, 2013, INT J SPORTS MED, V34, P616, DOI 10.1055/s-0032-1331717; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Sampaio J, 2007, J SPORTS SCI MED S10, V6, P121; Sampson JA, 2015, J SPORT SCI, V33, P85, DOI 10.1080/02640414.2014.925571; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Seiler S, 2004, SCAND J MED SCI SPOR, V14, P318, DOI 10.1046/j.1600-0838.2003.00353.x; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Stolen T, 2005, SPORTS MED, V35, P501; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; Williams K, 2007, J SPORTS SCI MED S10, V6, P100; Yoshida Takayoshi, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P247, DOI 10.2114/jpa.21.247	54	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150201	10.1371/journal.pone.0150201	http://dx.doi.org/10.1371/journal.pone.0150201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919064	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400102
J	Sakurada, Y; Yoneyama, S; Sugiyama, A; Tanabe, N; Kikushima, W; Mabuchi, F; Kume, A; Kubota, T; Iijima, H				Sakurada, Yoichi; Yoneyama, Seigo; Sugiyama, Atsushi; Tanabe, Naohiko; Kikushima, Wataru; Mabuchi, Fumihiko; Kume, Atsuki; Kubota, Takeo; Iijima, Hiroyuki			Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; GENOME-WIDE ASSOCIATION; RETICULAR PSEUDODRUSEN; POPULATION; MACULOPATHY; SUBTYPES; EYES	Objective To investigate the prevalence and genetic characteristics of geographic atrophy (GA) among elderly Japanese with advanced age-related macular degeneration (AMD) in a clinic-based study. Methods Two-hundred and ninety consecutive patients with advanced AMD were classified into typical neovascular AMD, polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP) or geographic atrophy (GA). Genetic variants of ARMS2 A69S (rs10490924) and CFH I62V (rs800292) were genotyped using TaqMan Genotyping Assays. The clinical and genetic characteristics were compared between patients with and without GA. Results The number of patients diagnosed as having typical neovascular AMD, PCV, RAP and GA were 98 (33.8%), 151 (52.1%), 22 (7.5%) and 19 (6.6%), respectively. Of 19 patients with GA, 13 patients (68.4%) had unilateral GA with exudative AMD in the contralateral eye. Patients with GA were significantly older, with a higher prevalence of reticular pseudodrusen, bilateral involvement of advanced AMD and T-allele frequency of ARMS2 A69S compared with those with typical AMD and PCV; although there were no differences in the genetic and clinical characteristics among patients with GA and RAP. Conclusions The prevalence of GA was 6.6% among elderly Japanese with AMD. Patients with GA and RAP exhibited genetic and clinical similarities.	[Sakurada, Yoichi; Yoneyama, Seigo; Sugiyama, Atsushi; Tanabe, Naohiko; Kikushima, Wataru; Mabuchi, Fumihiko; Kume, Atsuki; Iijima, Hiroyuki] Univ Yamanashi, Dept Ophthalmol, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan; [Kubota, Takeo] Univ Yamanashi, Dept Epigenet, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Sakurada, Y (corresponding author), Univ Yamanashi, Dept Ophthalmol, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan.	sakurada@yamanashi.ac.jp			Japan Society for the Promotion of Science KAKENHI [23791972]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23791972 (YS).	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chang YC, 2009, OPHTHAL SURG LAS IM, V40, P576, DOI 10.3928/15428877-20091030-07; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Fuse N, 2011, AM J OPHTHALMOL, V151, P550, DOI 10.1016/j.ajo.2010.08.048; Garg A, 2013, INVEST OPHTH VIS SCI, V54, P7075, DOI 10.1167/iovs.13-12474; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; McBain VA, 2011, RETINA-J RET VIT DIS, V31, P1043, DOI 10.1097/IAE.0b013e3181fe54c7; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; SCHATZ H, 1989, OPHTHALMOLOGY, V96, P1541; Scholl HPN, 2007, MOL VIS, V13, P196; Sobrin L, 2012, OPHTHALMOLOGY, V119, P1874, DOI 10.1016/j.ophtha.2012.03.014; Sunness JS, 1997, OPHTHALMOLOGY, V104, P1677, DOI 10.1016/S0161-6420(97)30079-7; Sunness JS, 1999, INVEST OPHTH VIS SCI, V40, P1761; Tamura H, 2012, AM J OPHTHALMOL, V154, P542, DOI 10.1016/j.ajo.2012.03.042; Tanaka K, 2011, MOL VIS, V17, P2751; Ueda-Arakawa N, 2014, AM J OPHTHALMOL, V157, P994, DOI 10.1016/j.ajo.2014.01.018; Ueda-Arakawa N, 2013, AM J OPHTHALMOL, V155, P260, DOI 10.1016/j.ajo.2012.08.011; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yoneyama S, 2014, GRAEF ARCH CLIN EXP, V252, P1435, DOI 10.1007/s00417-014-2601-y; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	25	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149978	10.1371/journal.pone.0149978	http://dx.doi.org/10.1371/journal.pone.0149978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918864	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400065
J	Wittenberg, AD; Azar, S; Klochendler, A; Stolovich-Rain, M; Avraham, S; Birnbaum, L; Gallimidi, AB; Katz, M; Dor, Y; Meyuhas, O				Wittenberg, Avigail Dreazen; Azar, Shahar; Klochendler, Agnes; Stolovich-Rain, Miri; Avraham, Shlomit; Birnbaum, Lea; Gallimidi, Adi Binder; Katz, Maximiliano; Dor, Yuval; Meyuhas, Oded			Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic beta-Cells	PLOS ONE			English	Article							MTOR PATHWAY; KINASE 1; EXPRESSION; GROWTH; ROLES; SIZE; SURVIVAL; REVEALS; PROLIFERATION; DISRUPTION	Constitutive expression of active Akt (Akt(tg)) drives hyperplasia and hypertrophy of pancreatic beta-cells, concomitantly with increased insulin secretion and improved glucose tolerance, and at a later stage the development of insulinoma. To determine which functions of Akt are mediated by ribosomal protein S6 (rpS6), an Akt effector, we generated mice that express constitutive Akt in beta-cells in the background of unphosphorylatable ribosomal protein S6 (rpS6(P-/-)). rpS6 phosphorylation deficiency failed to block Akt(tg)-induced hypertrophy and aneuploidy in beta-cells, as well as the improved glucose homeostasis, indicating that Akt carries out these functions independently of rpS6 phosphorylation. In contrast, rpS6 phosphorylation deficiency efficiently restrained the reduction in nuclear localization of the cell cycle inhibitor p27, as well as the development of Akt(tg)-driven hyperplasia and tumor formation in beta-cells. In vitro experiments with Akt(tg) and rpS6P-/-; Akt(tg) fibroblasts demonstrated that rpS6 phosphorylation deficiency leads to reduced translation fidelity, which might underlie its anti-tumorigenic effect in the pancreas. However, the role of translation infidelity in tumor suppression cannot simply be inferred from this heterologous experimental model, as rpS6 phosphorylation deficiency unexpectedly elevated the resistance of Akt(tg) fibroblasts to proteotoxic, genotoxic as well as autophagic stresses. In contrast, rpS6(P-/-) fibroblasts exhibited a higher sensitivity to these stresses upon constitutive expression of oncogenic Kras. The latter result provides a possible mechanistic explanation for the ability of rpS6 phosphorylation deficiency to enhance DNA damage and protect mice from Kras-induced neoplastic transformation in the exocrine pancreas. We propose that Akt1 and Kras exert their oncogenic properties through distinct mechanisms, even though both show addiction to rpS6 phosphorylation.	[Wittenberg, Avigail Dreazen; Azar, Shahar; Avraham, Shlomit; Birnbaum, Lea; Gallimidi, Adi Binder; Katz, Maximiliano; Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Klochendler, Agnes; Stolovich-Rain, Miri; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel.	meyuhas@cc.huji.ac.il			US-Israel Binational Science Foundation [2009054]; Israel Cancer Research Fund; Otto Stieber Foundation	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund; Otto Stieber Foundation	This work was supported by US-Israel Binational Science Foundation (No. 2009054), Israel Cancer Research Fund, and the Otto Stieber Foundation (to OM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by US-Israel Binational Science Foundation (No. 2009054); Israel Cancer Research Fund, and the Otto Stieber Foundation (to O.M.). We thank Dr. Dror Kolodkin-Gal from Hadassah Medical Center for the histochemical analysis of pancreatic slides for cleaved caspase 3, Dr. Morris J. Birnbaum from University of Pennsylvania School of Medicine for providing us with the RIP-myr-Akt1-expressing mice and the pLCNX myr-Akt expression plasmid; Dr. Tamar Ziv from the Smoler Proteomics Center at the TechnionIsrael Institute of Technology for conducting the proteomic analysis; Dr. Shu-Bing Qian from Cornell University for the firefly expression vectors [Fluc(WT), Fluc(R218S) and Fluc (Stop)]; Dr. Valery Krizhanovsky from the Weizmann Institute of Science for the pBABE-Kras<SUP>G12D</SUP> plasmid; and Dr. Lily Vardimon from Tel Aviv University for the Renilla luciferase expression vector.	Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Balcazar N, 2009, J BIOL CHEM, V284, P7832, DOI 10.1074/jbc.M807458200; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Calvo E, 2009, ONCOTARGETS THER, V2, P135; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chen JK, 2009, AM J PHYSIOL-RENAL, V297, pF585, DOI 10.1152/ajprenal.00186.2009; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Fontaniere S, 2006, FAM CANCER, V5, P49, DOI 10.1007/s10689-005-2575-3; Grabocka E, 2015, CLIN CANCER RES, V21, P1243, DOI 10.1158/1078-0432.CCR-14-0650; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hogan B, 1994, MANIPULATING MOUSE E; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Kelsey I, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004632; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Khalaileh A, 2013, CANCER RES, V73, P1811, DOI 10.1158/0008-5472.CAN-12-2014; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; OLIVER MH, 1989, J CELL SCI, V92, P513; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Patursky-Polischuk I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109410; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Ripka S, 2010, GUT, V59, P1101, DOI 10.1136/gut.2009.189720; Roy SK, 2010, J MOL SIGNALING, V5; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Volovelsky O, 2016, J AM SOC NEPHROL, V27, P1091, DOI 10.1681/ASN.2015040339; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Xu JX, 2015, KIDNEY INT, V87, P543, DOI 10.1038/ki.2014.302; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yao Z, 2002, PANCREAS, V24, P42, DOI 10.1097/00006676-200201000-00006	68	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149995	10.1371/journal.pone.0149995	http://dx.doi.org/10.1371/journal.pone.0149995			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919188	gold, Green Published			2022-12-26	WOS:000371274400067
J	Donati, M; Balboni, A; Laroucau, K; Aaziz, R; Vorimore, F; Borel, N; Morandi, F; Nepita, EV; Di Francesco, A				Donati, Manuela; Balboni, Andrea; Laroucau, Karine; Aaziz, Rachid; Vorimore, Fabien; Borel, Nicole; Morandi, Federico; Nepita, Edoardo Vecchio; Di Francesco, Antonietta			Tetracycline Susceptibility in Chlamydia suis Pig Isolates	PLOS ONE			English	Article							RESISTANCE	The aims of the present study were to assess the prevalence of Chlamydia suis in an Italian pig herd, determine the tetracycline susceptibility of C. suis isolates, and evaluate tet(C) and tetR(C) gene expression. Conjunctival swabs from 20 pigs were tested for C. suis by real-time polymerase chain reaction, and 55% (11) were positive. C. suis was then isolated from 11 conjunctival swabs resampled from the same herd. All positive samples and isolates were positive for the tet(C) resistance gene. The in vitro susceptibility to tetracycline of the C. suis isolates showed MIC values ranging from 0.5 to 4 mu g/mL. Tet(C) and tetR(C) transcripts were found in all the isolates, cultured both in the absence and presence of tetracycline. This contrasts with other Gram-negative bacteria in which both genes are repressed in the absence of the drug. Further investigation into tet gene regulation in C. suis is needed.	[Donati, Manuela; Nepita, Edoardo Vecchio] Univ Bologna, DIMES, Microbiol, I-40138 Bologna, Italy; [Balboni, Andrea; Di Francesco, Antonietta] Univ Bologna, Dept Vet Med Sci, Ozzano Emilia, Bologna, Italy; [Laroucau, Karine; Aaziz, Rachid; Vorimore, Fabien] Univ Paris Est, Anim Hlth Lab, Bacterial Zoonoses Unit, Anses, Maisons Alfort, France; [Borel, Nicole] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, CH-8057 Zurich, Switzerland; [Morandi, Federico] Parco Nazl Monti Sibillini, Visso, Macerata, Italy	University of Bologna; University of Bologna; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); University of Zurich	Di Francesco, A (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Emilia, Bologna, Italy.	antoniet.difrancesco@unibo.it	Balboni, Andrea/T-9418-2019; Borel, Nicole/GPP-1073-2022; Laroucau, Karine/GSO-1980-2022; Borel, Nicole/M-6204-2016; Aaziz, Rachid/GOE-4376-2022	Balboni, Andrea/0000-0002-8049-6645; Borel, Nicole/0000-0002-1556-9262; Laroucau, Karine/0000-0001-7605-8602; Borel, Nicole/0000-0002-1556-9262; 				Andersen A, 1998, CHLAMYDIAL INFECTION, P313, DOI DOI 10.1016/J.TTBDIS.2012.11.013; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Di Francesco A, 2006, VET REC, V159, P849; Donati M, 2002, J ANTIMICROB CHEMOTH, V50, P407, DOI 10.1093/jac/dkf145; Donati M, 2010, ANTIMICROB AGENTS CH, V54, P5379, DOI 10.1128/AAC.00553-10; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; SAYADA C, 1995, RES MICROBIOL, V146, P155, DOI 10.1016/0923-2508(96)80893-X; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Wanninger S, 2015, 3 EUR M AN CHLAM ZOO	17	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149914	10.1371/journal.pone.0149914	http://dx.doi.org/10.1371/journal.pone.0149914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913523	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700034
J	Garfin, PM; Nguyen, T; Sage, J				Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien			Loss of Pten Disrupts the Thymic Epithelium and Alters Thymic Function	PLOS ONE			English	Article							T-CELL DEVELOPMENT; AXON REGENERATION; COWDEN-DISEASE; FOXN1; GENE; BREAST; GROWTH; PROLIFERATION; INVOLUTION; MUTATIONS	The thymus is the site of T cell development and selection. In addition to lymphocytes, the thymus is composed of several types of stromal cells that are exquisitely organized to create the appropriate environment and microenvironment to support the development and selection of maturing T cells. Thymic epithelial cells (TECs) are one of the more important cell types in the thymic stroma, and they play a critical role in selecting functional T cell clones and supporting their development. In this study, we used a mouse genetics approach to investigate the consequences of deleting the Pten tumor suppressor gene in the TEC compartment of the developing thymus. We found that PTEN deficiency in TECs results in a smaller thymus with significantly disordered architecture and histology. Accordingly, loss of PTEN function also results in decreased T cells with a shift in the distribution of T cell subtypes towards CD8(+) T cells. These experiments demonstrate that PTEN is critically required for the development of a functional thymic epithelium in mice. This work may help better understand the effects that certain medical conditions or clinical interventions have upon the thymus and immune function.	[Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Garfin, Phillip M.] Seattle Genet, Bothell, WA USA	Stanford University; Stanford University; Seattle Genetics	Sage, J (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Sage, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	julsage@stanford.edu			National Institutes of Health [1S10RR02933801]; Lucile Packard Foundation for Children's Health; Alex's Lemonade Stanford Foundation; NIH [1S10RR02933801]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; Alex's Lemonade Stanford Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some of the flow cytometry was performed on a BD FACS ARIA II purchased with an National Institutes of Health S10 Shared Instrument Grant (grant number: 1S10RR02933801). Research reported in this manuscript was supported by the Lucile Packard Foundation for Children's Health and the Alex's Lemonade Stanford Foundation. J.S is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.; Some of the flow cytometry was performed on a BD FACS ARIA II purchased with an NIH S10 Shared Instrument Grant (grant number: 1S10RR02933801). We would like to thank Qiaozhi Wei for advice regarding immunofluorescence protocols and Nancy Manley and Lauren Ehrlich for their critical reading of the manuscript. Research reported in this manuscript was supported by the Lucile Packard Foundation for Children's Health and the Alex's Lemonade Stanford Foundation. J.S is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases. The authors declare no conflict of interest.	Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cunliffe VT, 2002, MAMM GENOME, V13, P245, DOI 10.1007/s00335-001-3079-6; FARR AG, 1985, J IMMUNOL, V134, P2971; Garfin PM, 2013, J EXP MED, V210, P1087, DOI 10.1084/jem.20121716; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; McLelland BT, 2011, J IMMUNOL METHODS, V367, P85, DOI 10.1016/j.jim.2011.02.008; Miller JFAP, 2011, NAT REV IMMUNOL, V11, P489, DOI 10.1038/nri2993; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nabarra Bernadette, 2002, Dev Immunol, V9, P223, DOI 10.1080/10446670310001593532; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Rossi SW, 2007, BLOOD, V109, P3803, DOI 10.1182/blood-2006-10-049767; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; St-Pierre C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01860; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun LN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/206929; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018; Ventevogel MS, 2013, CURR OPIN IMMUNOL, V25, P516, DOI 10.1016/j.coi.2013.06.002; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149430	10.1371/journal.pone.0149430	http://dx.doi.org/10.1371/journal.pone.0149430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914657	Green Published, gold			2022-12-26	WOS:000371175700015
J	da Silva, M; Pinho, DB; Pereira, OL; Fernandes, FM; Barreto, RW				da Silva, Meiriele; Pinho, Danilo B.; Pereira, Olinto L.; Fernandes, Fernando M.; Barreto, Robert W.			Naming Potentially Endangered Parasites: Foliicolous Mycobiota of Dimorphandra wilsonii, a Highly Threatened Brazilian Tree Species	PLOS ONE			English	Article							BAYESIAN-INFERENCE; MYCOSPHAERELLA; LIKELIHOOD; FUNGI; MODEL	A survey of foliicolous fungi associated with Dimorphandra wilsonii and Dimorphandra mollis (Fabaceae) was conducted in the state of Minas Gerais, Brazil. Dimorphandra wilsonii is a tree species native to the Brazilian Cerrado that is listed as critically endangered. Fungi strictly depending on this plant species may be on the verge of co-extinction. Here, results of the pioneering description of this mycobiota are provided to contribute to the neglected field of microfungi conservation. The mycobiota of D. mollis, which is a common species with a broad geographical distribution that co-occurs with D. wilsonii, was examined simultaneously to exclude fungal species occurring on both species from further consideration for conservation because microfungi associated with D. wilsonii should not be regarded as under threat of co-extinction. Fourteen ascomycete fungal species were collected, identified, described and illustrated namely: Byssogene wilsoniae sp. nov., Geastrumia polystigmatis, Janetia dimorphandra-mollis sp. nov., Janetia wilsoniae sp. nov., Johansonia chapadiensis, Microcalliopsis dipterygis, Phillipsiella atra, Piricauda paraguayensis, Pseudocercospora dimorphandrae sp. nov., Pseudocercosporella dimorphandrae sp. nov., Ramichloridiopsis wilsoniae sp. and gen. nov., Stomiopeltis suttoniae, Trichomatomyces byrsonimae and Vesiculohyphomyces cerradensis. Three fungi were exclusively found on D. wilsonii and were regarded as potentially threatened of extinction: B. wilsoniae, J. wilsoniae and R. wilsoniae.	[da Silva, Meiriele; Pinho, Danilo B.; Pereira, Olinto L.; Barreto, Robert W.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Fernandes, Fernando M.] Fundacao Zoo Bot Belo Horizonte, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa	Barreto, RW (corresponding author), Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil.	rbarreto@ufv.br	Pinho, Danilo Batista/D-3481-2014	Pinho, Danilo Batista/0000-0003-2624-302X	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil)	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil)	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil) provided the scholarship for MS; Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil) provided funding for field and laboratory work to RWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzanlou M, 2007, STUD MYCOL, P57, DOI 10.3114/sim.2007.58.03; BARR ME, 1979, MYCOLOGIA, V71, P935, DOI 10.2307/3759283; Batista AC, 1962, PUB I MICOL U RECIFE, V343, P1; Batista AC., 1959, PUBLICACOES I MICOLO, V56, P1; Braun U, 1995, MONOGRAPH CERCOSPORE; Braun U, 2013, IMA FUNGUS, V4, P265, DOI 10.5598/imafungus.2013.04.02.12; Calduch M, 2002, MYCOLOGIA, V94, P355, DOI 10.2307/3761812; Carnegie AJ, 1997, MYCOL RES, V101, P843, DOI 10.1017/S095375629600305X; CHUPP C., 1954, A monograph of the fungus genus Cercospoia.; Cooke MC, 1878, GREVILLEA, V6, P129; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Crous PW, 2010, IMA FUNGUS, V1, P117, DOI 10.5598/imafungus.2010.01.02.03; Crous Pedro W., 2000, Studies in Mycology, P107; Crous PW, 1996, MYCOLOGIA, V88, P441, DOI 10.2307/3760885; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; da Silva M, 2012, MYCOTAXON, V119, P109, DOI 10.5248/119.109; Deighton FC, 1973, MYCOL PAP, V133, P1; Dhingra O.D., 1996, BASIC PLANT PATHOLOG; Dornelo-Silva D, 2004, MYCOLOGIA, V96, P879, DOI 10.2307/3762120; Dornelo-Silva D, 2003, MYCOLOGIA, V95, P1239, DOI 10.2307/3761924; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis M. B., 1976, More dematiaceous hyphomycetes.; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; ERIKSSON O, 1981, OPERA BOT, V60, P1, DOI DOI 10.1111/J.1756-1051.1981.TB01167.X; Farr DF, FUNGAL DATABASES SYS; Fernandes FM, 2014, ACTA BOT BRAS, V28, P434, DOI 10.1590/0102-33062014abb3409; Fernandes FM, 2007, RECUPERANDO VERDE CI, P87; Goh TK, 1996, MYCOLOGIA, V88, P1014, DOI 10.2307/3761066; Griffith GW, 2012, TRENDS ECOL EVOL, V27, P1, DOI 10.1016/j.tree.2011.10.002; Hall T., BIOEDIT V7 0 9 BIOL; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hohnel F von, 1909, KAISERL AKAD WISS MN, V118, P349; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUGHES S. J., 1960, CANADIAN JOUR BOT, V38, P921; HUGHES SJ, 1983, NEW ZEAL J BOT, V21, P177, DOI 10.1080/0028825X.1983.10428542; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; KATUMOTO K, 1986, T MYCOL SOC JPN, V27, P1; Kirk PM., 2008, DICT FUNGI, V10th ed; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Lenza Eddie, 2011, Braz. J. Bot., V34, P247, DOI 10.1590/S0100-84042011000300002; LINK C. A., 2005, MEGADIVERSIDADE, V1, P147, DOI DOI 10.1590/S0100-69912009000400001; LUTTRELL ES, 1946, MYCOLOGIA, V38, P565, DOI 10.2307/3754996; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; Minter D., 2010, FROM ANOTHER KINGDOM, P143; MULLER E., 1962, BEITR KRYPTOGAMENFL, V11, P1; Pereira JM, 2003, BIOL CONTROL, V26, P21, DOI 10.1016/S1049-9644(02)00112-3; Pereira-Carvalho RC, 2009, MYCOL RES, V113, P261, DOI 10.1016/j.mycres.2008.11.005; PIROZYNS.KA, 1971, MYCOLOGIA, V63, P897, DOI 10.2307/3758057; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Quaedvlieg W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Rayner RW, 1970, MYCOLOGICAL COLOR CH; Reddy BS, 2004, PHILIPP J SCI, V133, P71; Rocha FB, 2010, MYCOLOGIA, V102, P1240, DOI 10.3852/09-178; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez RJ, 2004, MOL METHODS DISCRIMI, P77; Saccardo PA, 1882, SYLLOGE FUNGORUM OMN, V8, P844; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Sierra AM, 2005, MYCOL RES, V109, P723, DOI 10.1017/S0953756205002522; SUTTON B C, 1988, Australian Systematic Botany, V1, P127, DOI 10.1071/SB9880127; Sydow H, 1922, ROBISSON PHILIPP J S, V21, P131; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JE, 2000, MYCOL RES, V104, P618, DOI 10.1017/S0953756299001768; Thacker JI, 2006, ORYX, V40, P233, DOI 10.1017/S0030605306000123; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; VONARX JA, 1975, STUD MYCOL, V9, P1; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yuan ZQ, 1996, AUST SYST BOT, V9, P337, DOI 10.1071/SB9960337	70	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147895	10.1371/journal.pone.0147895	http://dx.doi.org/10.1371/journal.pone.0147895			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910334	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700006
J	Chen, Y; Zheng, JF; Huang, QN; Deng, FY; Huang, RL; Zhao, WJ; Yin, JP; Song, LN; Chen, J; Gao, X; Liu, ZG; Petersen, F; Yu, XH				Chen, Yan; Zheng, Junfeng; Huang, Qiaoniang; Deng, Fengyuan; Huang, Renliang; Zhao, Wenjie; Yin, Junping; Song, Lina; Chen, Juan; Gao, Xing; Liu, Zuguo; Petersen, Frank; Yu, Xinhua			Autoantibodies against the Second Extracellular Loop of M3R Do neither Induce nor Indicate Primary Sjogren's Syndrome	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR; T-CELLS; ANTIBODIES; PEPTIDES; SERUM; IGG	Objectives Anti-muscarinic acetylcholine type-3 receptor (anti-M3R) autoantibodies have been suggested to be pathogenic for primary Sjogren's syndrome (pSS), and the second extracellular loop of M3R is suspected to carry a disease-promoting epitope. In this study, we aimed to evaluate the pathogenicity of autoantibodies against peptides derived from the second extracellular loop of M3R in mice and to determine whether those autoantibodies could be used as biomarker for pSS. Methods BALB/c mice were immunized with modified linear or cyclic peptides of the second extracellular loop of M3R. The function of exocrine glands was evaluated by measuring the secretion of saliva and tears. The histological evaluations were performed by using H&E staining or direct immunofluorescence staining. Autoantibodies against linear or cyclic peptides of the second extracellular loop of M3R in human and mice were determined using ELISA. Results Immunization induced mice to produce autoantibodies against the linear or cyclic peptides of the second extracellular loop of M3R, and those autoantibodies could bind onto salivary glands. However, those mice showed neither impairment in the secretion of tears or saliva nor histological abnormality in the exocrine glands. Furthermore, passive transfer of the IgG isolated from the immunized mice into healthy mice did not induced the dysfunction of the exocrine glands. The prevalence of autoantibodies against the peptides of the second extracellular loop of M3R was low in pSS patients, and it did not differ significantly from that in healthy controls. Conclusions Our results suggest that the autoantibodies against peptides of the second extracellular loop of M3R are not pathogenic in vivo and they are not suitable as biomarkers for pSS diagnosis.	[Chen, Yan; Zheng, Junfeng; Huang, Qiaoniang; Deng, Fengyuan; Huang, Renliang; Zhao, Wenjie; Yin, Junping; Yu, Xinhua] Xiamen Univ, Coll Med, Lab Autoimmun, Xiamen, Peoples R China; [Chen, Yan] Xinxiang Med Univ, Affiliated Hosp 1, Dept Pharm, Xinxiang, Henan, Peoples R China; [Song, Lina; Chen, Juan] Xiamen Univ, Afflict Hosp 1, Dept Rheumatol, Xiamen, Peoples R China; [Gao, Xing] Xiamen Univ, Xiamen Univ Hosp, Dept Clin Lab, Xiamen, Peoples R China; [Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Peoples R China; [Liu, Zuguo] Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Peoples R China; [Petersen, Frank; Yu, Xinhua] ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany	Xiamen University; Xinxiang Medical University; Xiamen University; Xiamen University; Xiamen University; Xiamen University; Forschungszentrum Borstel	Yu, XH (corresponding author), Xiamen Univ, Coll Med, Lab Autoimmun, Xiamen, Peoples R China.; Yu, XH (corresponding author), ARCN, Res Ctr Borstel, Prior Area Asthma & Allergy, Borstel, Germany.	xinhuayu@fz-borstel.de			National Natural Science Foundation of China [81371325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81371325).	Cavill D, 2004, SCAND J IMMUNOL, V59, P261, DOI 10.1111/j.0300-9475.2004.01395.x; Cavill D, 2002, J RHEUMATOL, V29, P1342; Dawson LJ, 2006, ARTHRITIS RHEUM, V54, P1165, DOI 10.1002/art.21764; Dawson LJ, 2004, RHEUMATOLOGY, V43, P1488, DOI 10.1093/rheumatology/keh389; Gao JH, 2004, ARTHRITIS RHEUM-US, V50, P2615, DOI 10.1002/art.20371; He J, 2012, CLIN EXP RHEUMATOL, V30, P322; He J, 2011, RHEUMATOLOGY, V50, P879, DOI 10.1093/rheumatology/keq420; HULME EC, 1990, ANNU REV PHARMACOL, V30, P633, DOI 10.1146/annurev.pa.30.040190.003221; Iizuka M, 2010, J AUTOIMMUN, V35, P383, DOI 10.1016/j.jaut.2010.08.004; Koo NY, 2008, RHEUMATOLOGY, V47, P828, DOI 10.1093/rheumatology/ken064; Kovacs L, 2005, RHEUMATOLOGY, V44, P1021, DOI 10.1093/rheumatology/keh672; Kyriakidis NC, 2014, J AUTOIMMUN, V51, P67, DOI 10.1016/j.jaut.2013.11.001; Li HM, 2004, IMMUNITY, V21, P551, DOI 10.1016/j.immuni.2004.08.013; Mavragani CP, 2010, AUTOIMMUN REV, V9, pA305, DOI 10.1016/j.autrev.2009.11.004; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; Moutsopoulos HM, 2014, J AUTOIMMUN, V51, P1, DOI 10.1016/j.jaut.2014.01.001; Nakamura Y, 2008, ANN RHEUM DIS, V67, P136, DOI 10.1136/ard.2007.072421; Nguyen KHT, 2000, ARTHRITIS RHEUM-US, V43, P2297, DOI 10.1002/1529-0131(200010)43:10<2297::AID-ANR18>3.0.CO;2-X; Patel R, 2014, CLIN EPIDEMIOL, V6, P247, DOI 10.2147/CLEP.S47399; Pringle S, 2011, JOVE-J VIS EXP, DOI 10.3791/2484; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Roescher N, 2011, ANN RHEUM DIS, V70, P235, DOI 10.1136/ard.2010.129049; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; Sumida T, 2014, J AUTOIMMUN, V51, P44, DOI 10.1016/j.jaut.2013.12.012; Tsuboi H, 2010, CLIN EXP IMMUNOL, V162, P53, DOI 10.1111/j.1365-2249.2010.04188.x; Tsuboi H, 2012, MOD RHEUMATOL, V22, P264, DOI 10.1007/s10165-011-0514-8; Uchida T, 1998, DEV BIOL STAND, V92, P353; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; Yu XH, 2015, CURR PHARM DESIGN, V21, P2308, DOI 10.2174/1381612821666150316115412	30	8	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149485	10.1371/journal.pone.0149485	http://dx.doi.org/10.1371/journal.pone.0149485			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901532	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100081
J	Dalsgaard, L; Astrup, R; Anton-Fernandez, C; Borgen, SK; Breidenbach, J; Lange, H; Lehtonen, A; Liski, J				Dalsgaard, Lise; Astrup, Rasmus; Anton-Fernandez, Clara; Borgen, Signe Kynding; Breidenbach, Johannes; Lange, Holger; Lehtonen, Aleksi; Liski, Jari			Modeling Soil Carbon Dynamics in Northern Forests: Effects of Spatial and Temporal Aggregation of Climatic Input Data	PLOS ONE			English	Article							EARTH SYSTEM MODELS; FINE-ROOT TURNOVER; NORWAY SPRUCE; PICEA-ABIES; UNDERSTOREY VEGETATION; C SEQUESTRATION; LINKING PLANT; STOCK CHANGES; BIOMASS; DECOMPOSITION	Boreal forests contain 30% of the global forest carbon with the majority residing in soils. While challenging to quantify, soil carbon changes comprise a significant, and potentially increasing, part of the terrestrial carbon cycle. Thus, their estimation is important when designing forest-based climate change mitigation strategies and soil carbon change estimates are required for the reporting of greenhouse gas emissions. Organic matter decomposition varies with climate in complex nonlinear ways, rendering data aggregation nontrivial. Here, we explored the effects of temporal and spatial aggregation of climatic and litter input data on regional estimates of soil organic carbon stocks and changes for upland forests. We used the soil carbon and decomposition model Yasso07 with input from the Norwegian National Forest Inventory (11275 plots, 1960-2012). Estimates were produced at three spatial and three temporal scales. Results showed that a national level average soil carbon stock estimate varied by 10% depending on the applied spatial and temporal scale of aggregation. Higher stocks were found when applying plot-level input compared to country-level input and when long-term climate was used as compared to annual or 5-year mean values. A national level estimate for soil carbon change was similar across spatial scales, but was considerably (60-70%) lower when applying annual or 5-year mean climate compared to long-term mean climate reflecting the recent climatic changes in Norway. This was particularly evident for the forest-dominated districts in the southeastern and central parts of Norway and in the far north. We concluded that the sensitivity of model estimates to spatial aggregation will depend on the region of interest. Further, that using long-term climate averages during periods with strong climatic trends results in large differences in soil carbon estimates. The largest differences in this study were observed in central and northern regions with strongly increasing temperatures.	[Dalsgaard, Lise; Astrup, Rasmus; Anton-Fernandez, Clara; Borgen, Signe Kynding; Breidenbach, Johannes; Lange, Holger] Norwegian Inst Bioecon Res NIBIO, As, Norway; [Lehtonen, Aleksi] Nat Resources Inst Finland LUKE, Helsinki, Finland; [Liski, Jari] Finnish Environm Inst SYKE, Helsinki, Finland	Norwegian Institute of Bioeconomy Research; Natural Resources Institute Finland (Luke); Finnish Environment Institute	Dalsgaard, L (corresponding author), Norwegian Inst Bioecon Res NIBIO, As, Norway.	lise.dalsgaard@nibio.no	Antón-Fernández, Clara/C-2427-2009; Liski, Jari/O-8494-2016; Lange, Holger/A-2458-2012	Antón-Fernández, Clara/0000-0001-5545-3320; Liski, Jari/0000-0002-0847-8207; Lange, Holger/0000-0001-7099-8740; Lehtonen, Aleksi/0000-0003-1388-0388	Norwegian Research Council [210464/O10]; Norwegian Environment Agency; Academy of Finland [138359]; Ministry of Environment in Finland	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Environment Agency; Academy of Finland(Academy of Finland); Ministry of Environment in Finland	This work was funded by the Norwegian Research Council (grant no. 210464/O10), the Norwegian Environment Agency, the Academy of Finland (decision 138359), and the Ministry of Environment in Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2003, FOREST ECOL MANAG, V174, P25, DOI 10.1016/S0378-1127(02)00025-7; Agren GI, 2008, BIOGEOCHEMISTRY, V89, P139, DOI 10.1007/s10533-007-9151-x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Andreassen K, 2006, FOREST ECOL MANAG, V222, P211, DOI 10.1016/j.foreco.2005.10.029; [Anonymous], 2014, M137 NORW ENV AG; Anton-Fernandez C, 2012, SCAND J FOREST RES, V27, P379, DOI 10.1080/02827581.2011.644576; Berg B, 2009, CAN J FOREST RES, V39, P962, DOI 10.1139/X09-022; Black K, 2014, GEODERMA, V232, P487, DOI 10.1016/j.geoderma.2014.05.022; CALE WG, 1983, J THEOR BIOL, V100, P539, DOI 10.1016/0022-5193(83)90446-0; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen JM, 2003, TELLUS B, V55, P622, DOI 10.1034/j.1600-0889.2003.00036.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Davi H, 2006, AGR FOREST METEOROL, V139, P269, DOI 10.1016/j.agrformet.2006.07.007; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2014, GLOBAL CHANGE BIOL, V20, P3610, DOI 10.1111/gcb.12718; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; de Wit HA, 2006, FOREST ECOL MANAG, V225, P15, DOI 10.1016/j.foreco.2005.12.023; de Wit HA, 2015, BIOGEOCHEMISTRY, V123, P147, DOI 10.1007/s10533-014-0060-5; DeAngelis D. L., 1981, Dynamic properties of forest ecosystems., P567; Didion M, 2014, ECOL MODEL, V291, P58, DOI 10.1016/j.ecolmodel.2014.07.028; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Genet H, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045016; Goll DS, 2015, GLOBAL BIOGEOCHEM CY, V29, P1511, DOI 10.1002/2014GB004988; Hakkinen M, 2011, BIOGEOSCIENCES, V8, P1279, DOI 10.5194/bg-8-1279-2011; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; KICKLIGHTER DW, 1994, J GEOPHYS RES-ATMOS, V99, P1303, DOI 10.1029/93JD02964; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Kleja DB, 2008, BIOGEOCHEMISTRY, V89, P7, DOI 10.1007/s10533-007-9136-9; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lehtonen A, 2004, ECOL MODEL, V180, P305, DOI 10.1016/j.ecolmodel.2004.04.024; Liski J, 1998, EUR J SOIL SCI, V49, P407, DOI 10.1046/j.1365-2389.1998.4930407.x; Liski J, 2005, ECOL MODEL, V189, P168, DOI 10.1016/j.ecolmodel.2005.03.005; Liski J, 2002, FOREST ECOL MANAG, V169, P159, DOI 10.1016/S0378-1127(02)00306-7; Marklund LG, 1988, 45 SLU I SKOGST; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Meyn A, 2013, REG ENVIRON CHANGE, V13, P165, DOI 10.1007/s10113-012-0319-0; Miller BA, 2015, GEODERMA, V239, P97, DOI 10.1016/j.geoderma.2014.09.018; Monni S, 2007, CLIMATIC CHANGE, V81, P391, DOI 10.1007/s10584-006-9140-4; Muukkonen P, 2004, CAN J FOREST RES, V34, P2517, DOI [10.1139/x04-133, 10.1139/X04-133]; Muukkonen P, 2006, SILVA FENN, V40, P231, DOI 10.14214/sf.340; Muukkonen P, 2006, BOREAL ENVIRON RES, V11, P355; Nilsen P, 2008, FOREST ECOL MANAG, V256, P201, DOI 10.1016/j.foreco.2008.04.001; Nilsen P, 2013, SILVA FENN, V47, DOI 10.14214/sf.1024; Ortiz C, 2011, ECOL MODEL, V222, P3020, DOI 10.1016/j.ecolmodel.2011.05.034; Ortiz CA, 2013, ECOL MODEL, V251, P221, DOI 10.1016/j.ecolmodel.2012.12.017; Palosuo T, 2012, ENVIRON MODELL SOFTW, V35, P38, DOI 10.1016/j.envsoft.2012.02.004; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peltoniemi M, 2004, GLOBAL CHANGE BIOL, V10, P2078, DOI 10.1111/j.1365-2486.2004.00881.x; Peltoniemi M, 2006, FOREST ECOL MANAG, V232, P75, DOI 10.1016/j.foreco.2006.05.045; Petersson H, 2006, SCAND J FOREST RES, V21, P84, DOI 10.1080/14004080500486864; R Core Team, 2021, R LANGUAGE ENV STAT; Rantakari M, 2012, FOREST ECOL MANAG, V286, P137, DOI 10.1016/j.foreco.2012.08.041; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Reichstein M, 2014, P NATL ACAD SCI USA, V111, P13697, DOI 10.1073/pnas.1216065111; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rypdal K, 2005, 1105 CICERO NIJOS SS; Saby NPA, 2008, GLOBAL CHANGE BIOL, V14, P2432, DOI 10.1111/j.1365-2486.2008.01658.x; Shaw CH, 2014, ECOL MODEL, V272, P323, DOI 10.1016/j.ecolmodel.2013.10.005; Solberg S, 2015, BOREAL ENVIRON RES, V20, P335; Svensson M, 2008, BIOGEOCHEMISTRY, V89, P95, DOI 10.1007/s10533-007-9134-y; Thum T, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001612; Thurig E, 2005, FOREST ECOL MANAG, V210, P337, DOI 10.1016/j.foreco.2005.02.030; Tierney GL, 2002, CAN J FOREST RES, V32, P1692, DOI [10.1139/x02-123, 10.1139/X02-123]; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Tomter SM, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P411, DOI 10.1007/978-90-481-3233-1_26; Tuomi M, 2011, ENVIRON MODELL SOFTW, V26, P1358, DOI 10.1016/j.envsoft.2011.05.009; Tuomi M, 2011, ECOL MODEL, V222, P709, DOI 10.1016/j.ecolmodel.2010.10.025; Tuomi M, 2009, ECOL MODEL, V220, P3362, DOI 10.1016/j.ecolmodel.2009.05.016; US Environmental Protection Agency, 2014, GREENHOUSE GAS EMISS; Vasques GM, 2010, SOIL SCI SOC AM J, V74, P870, DOI 10.2136/sssaj2009.0242; Vesterdal L, 2013, FOREST ECOL MANAG, V309, P4, DOI 10.1016/j.foreco.2013.01.017; Wang DD, 2010, PEDOSPHERE, V20, P525, DOI 10.1016/S1002-0160(10)60042-2; Zhang LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088622	77	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149902	10.1371/journal.pone.0149902	http://dx.doi.org/10.1371/journal.pone.0149902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901763	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100182
J	Gosmann, J; Eliasmith, C				Gosmann, Jan; Eliasmith, Chris			Optimizing Semantic Pointer Representations for Symbol-Like Processing in Spiking Neural Networks	PLOS ONE			English	Article							MODEL	The Semantic Pointer Architecture (SPA) is a proposal of specifying the computations and architectural elements needed to account for cognitive functions. By means of the Neural Engineering Framework (NEF) this proposal can be realized in a spiking neural network. However, in any such network each SPA transformation will accumulate noise. By increasing the accuracy of common SPA operations, the overall network performance can be increased considerably. As well, the representations in such networks present a trade-off between being able to represent all possible values and being only able to represent the most likely values, but with high accuracy. We derive a heuristic to find the near-optimal point in this trade-off. This allows us to improve the accuracy of common SPA operations by up to 25 times. Ultimately, it allows for a reduction of neuron number and a more efficient use of both traditional and neuromorphic hardware, which we demonstrate here.	[Gosmann, Jan; Eliasmith, Chris] Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Gosmann, J (corresponding author), Univ Waterloo, Ctr Theoret Neurosci, Waterloo, ON N2L 3G1, Canada.	jgosmann@uwaterloo.ca			Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada [261453]; Air Force Office of Scientific Research [FA8655-13-1-3084]; Canada Foundation for Innovation; Ontario Innovation Trust	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	This work was supported by the Canada Research Chairs program (http://www.chairs-chaires.gc.ca/), the Natural Sciences and Engineering Research Council of Canada Discovery grant 261453 (http://www.nserc-crsng.gc.ca/), Air Force Office of Scientific Research grant FA8655-13-1-3084 (http://www.afosr.af.mil/), Canada Foundation for Innovation (http://www.innovation.ca/), and Ontario Innovation Trust. All funding was received by CE. This work made also use of SHARCNET (https://www.sharcnet.ca) and Compute Canada (https://www.computecanada.ca/) computer resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, NEURAL ENG COMPUTATI; Bekolay T, 2014, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00048; Bekolay T, 2014, J NEUROSCI, V34, P1892, DOI 10.1523/JNEUROSCI.2421-13.2014; Benjamin B, 2014, P IEEE, V102, P699, DOI 10.1109/JPROC.2014.2313565; Choudhary Swadesh, 2012, Artificial Neural Networks and Machine Learning - ICANN 2012. Proceedings of the 22nd International Conference on Artificial Neural Networks, P121, DOI 10.1007/978-3-642-33269-2_16; Conklin J, 2005, J COMPUT NEUROSCI, V18, P183, DOI 10.1007/s10827-005-6558-z; Eliasmith C, 2005, 27 ANN M COGN SCI SO; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Fischer BJ, 2005, MODEL COMPUTATIONS L; Fischer BJ, 2007, J NEUROPHYSIOL, V98, P1181, DOI 10.1152/jn.00370.2007; Furber SB, 2014, P IEEE, V102, P652, DOI 10.1109/JPROC.2014.2304638; Gayler RW, 2003, INT C COGN SCI; Gosmann J., 2015, P 37 ANN M COGN SCI, P812; Gosmann Jan, 2015, PRECISE MULTIPLICATI; Kuo PD, 2005, BIOL CYBERN, V93, P178, DOI 10.1007/s00422-005-0576-9; Litt A, 2008, COGN SYST RES, V9, P252, DOI 10.1016/j.cogsys.2007.11.001; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Mundy A, 2015, IEEE IJCNN; PLATE TA, 1995, IEEE T NEURAL NETWOR, V6, P623, DOI 10.1109/72.377968; Rasmussen D, 2014, INTELLIGENCE, V42, P53, DOI 10.1016/j.intell.2013.10.003; Serrano-Gotarredona R, 2009, IEEE T NEURAL NETWOR, V20, P1417, DOI 10.1109/TNN.2009.2023653; Singh R, 2006, J NEUROSCI, V26, P3667, DOI 10.1523/JNEUROSCI.4864-05.2006; Stewart T. C., 2014, PROC ANN M COGN SCI, P1533; Wang R, 2015, NEUROMORPHIC HARDWAR	25	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149928	10.1371/journal.pone.0149928	http://dx.doi.org/10.1371/journal.pone.0149928			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900931	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100186
J	Hoffmann, M; Hernandez, MG; Berger, E; Marzi, A; Pohlmann, S				Hoffmann, Markus; Hernandez, Mariana Gonzalez; Berger, Elisabeth; Marzi, Andrea; Poehlmann, Stefan			The Glycoproteins of All Filovirus Species Use the Same Host Factors for Entry into Bat and Human Cells but Entry Efficiency Is Species Dependent	PLOS ONE			English	Article							EBOLA-VIRUS GLYCOPROTEIN; VESICULAR STOMATITIS-VIRUS; ACUTE RESPIRATORY SYNDROME; LECTINS DC-SIGN; MARBURG VIRUS; FRUIT BATS; PROTEOLYTIC ACTIVATION; ENVELOPE GLYCOPROTEIN; PROTEASE INHIBITORS; SPIKE PROTEIN	Ebola and marburgviruses, members of the family Filoviridae, can cause severe hemorrhagic fever in humans. The ongoing Ebola virus (EBOV) disease epidemic in Western Africa claimed more than 11,300 lives and was associated with secondary cases outside Africa, demonstrating that filoviruses pose a global health threat. Bats constitute an important natural reservoir of filoviruses, including viruses of the recently identified Cuevavirus genus within the Filoviridae family. However, the interactions of filoviruses with bat cells are incompletely understood. Here, we investigated whether filoviruses employ different strategies to enter human and bat cells. For this, we examined host cell entry driven by glycoproteins (GP) from all filovirus species into cell lines of human and fruit bat origin. We show that all GPs were able to mediate entry into human and most fruit bat cell lines with roughly comparable efficiency. In contrast, the efficiency of entry into the cell line EidNi/41 derived from a straw-colored fruit bat varied markedly between the GPs of different filovirus species. Furthermore, inhibition studies demonstrated that filoviruses employ the same host cell factors for entry into human, non-human primate and fruit bat cell lines, including cysteine proteases, two pore channels and NPC1 (Niemann-Pick C1 molecule). Finally, processing of GP by furin and the presence of the mucin-like domain in GP were dispensable for entry into both human and bat cell lines. Collectively, these results show that filoviruses rely on the same host cell factors for entry into human and fruit bat cells, although the efficiency of the usage of these factors might differ between filovirus species.	[Hoffmann, Markus; Hernandez, Mariana Gonzalez; Berger, Elisabeth; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Marzi, Andrea] NIAID, Lab Virol Div Intramural Res, NIH, Hamilton, MT USA	Deutsches Primatenzentrum (DPZ); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Marzi, Andrea/AAF-4617-2020; Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Marzi, Andrea/0000-0003-0186-9587; Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Gonzalez Hernandez, Mariana/0000-0001-7019-2165	BMBF (EBOKON Verbund); Leibniz foundation (Graduate School for Emerging Infectious Diseases); Division of Intramural Research, NIAID, NIH; DAAD (Deutscher Akademischer Austauschdienst); CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico	BMBF (EBOKON Verbund)(Federal Ministry of Education & Research (BMBF)); Leibniz foundation (Graduate School for Emerging Infectious Diseases); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD)); CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico	This study was funded by BMBF (EBOKON Verbund) (https://www.bmbf.de/presse/bmbf-staerkt-forschung-zu-ebola-721.html), the Leibniz foundation (Graduate School for Emerging Infectious Diseases) (http://www.dpz.eu/en/career/graduate-training/emerging-infectious-diseases/leibniz-graduate-school-for-emerging-infectious-diseases-eidis.html) and partly by the Division of Intramural Research, NIAID, NIH. MGH is supported within a German-Mexican cooperation program of the DAAD (Deutscher Akademischer Austauschdienst) and CONACYT (Consejo Nacional de Ciencia y Tecnologia) by the National Council for Science and Technology in Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Amman BR, 2015, J WILDLIFE DIS, V51, P113, DOI 10.7589/2014-08-198; Amman BR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002877; Barrette RW, 2009, SCIENCE, V325, P204, DOI 10.1126/science.1172705; Biek R, 2006, PLOS PATHOG, V2, P885, DOI 10.1371/journal.ppat.0020090; Biesold SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028131; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Brudner M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060838; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Dahlmann F, 2015, J INFECT DIS, V212, pS247, DOI 10.1093/infdis/jiv140; Diederich S, 2008, VIROLOGY, V375, P391, DOI 10.1016/j.virol.2008.02.019; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Gnirss K, 2012, VIROLOGY, V424, P3, DOI 10.1016/j.virol.2011.11.031; Groseth A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002847; Hanika A, 2005, J GEN VIROL, V86, P1455, DOI 10.1099/vir.0.80788-0; He B, 2015, EMERG INFECT DIS, V21, P1675, DOI 10.3201/eid2109.150260; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hofmann-Winkler H, 2015, J INFECT DIS, V212, pS172, DOI 10.1093/infdis/jiv101; Hofmann-Winkler H, 2012, VIRUSES-BASEL, V4, P3336, DOI 10.3390/v4123336; HOSOYA M, 1992, ANTIMICROB AGENTS CH, V36, P1432, DOI 10.1128/AAC.36.7.1432; Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09; Jayme SI, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0331-3; Jeffers SA, 2002, J VIROL, V76, P12463, DOI 10.1128/JVI.76.24.12463-12472.2002; Jones MEB, 2015, VIRUSES-BASEL, V7, P3420, DOI 10.3390/v7072779; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Kruger N, 2014, J VIROL, V88, P11973, DOI 10.1128/JVI.01561-14; Kuhl A, 2011, J INFECT DIS, V204, pS840, DOI 10.1093/infdis/jir306; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2004, J INFECT DIS, V190, P1895, DOI 10.1086/425421; Leroy EM, 2004, SCIENCE, V303, P387, DOI 10.1126/science.1092528; Lu FR, 2015, ELIFE, V4, DOI 10.7554/eLife.12177; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Marzi A, 2007, J INFECT DIS, V196, pS237, DOI 10.1086/520607; Marzi A, 2006, J VIROL, V80, P6305, DOI 10.1128/JVI.02545-05; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Medina MF, 2003, MOL THER, V8, P777, DOI 10.1016/S1525-0016(03)00266-1; Moratelli R, 2015, MEM I OSWALDO CRUZ, V110, P1, DOI 10.1590/0074-02760150048; Muller MA, 2012, MBIO, V3, DOI 10.1128/mBio.00515-12; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Neumann G, 2002, J VIROL, V76, P406, DOI 10.1128/JVI.76.1.406-410.2002; Neumann G, 2007, J VIROL, V81, P2995, DOI 10.1128/JVI.02486-06; Ng M, 2015, ELIFE, V4, DOI 10.7554/eLife.11785; Ng M, 2014, VIROLOGY, V468, P637, DOI 10.1016/j.virol.2014.08.019; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nkoghe D, 2005, B SOC PATHOL EXOT, V98, P224; Paweska JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045479; Redlist I, IUCN RED LIST THREAT; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Schornberg KL, 2009, P NATL ACAD SCI USA, V106, P8003, DOI 10.1073/pnas.0807578106; Shah PP, 2010, MOL PHARMACOL, V78, P319, DOI 10.1124/mol.110.064261; Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shoemaker CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056265; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Simmons G, 2002, J VIROL, V76, P2518, DOI 10.1128/JVI.76.5.2518-2528.2002; Smith I, 2013, CURR OPIN VIROL, V3, P84, DOI 10.1016/j.coviro.2012.11.006; Swanepoel R, 2007, EMERG INFECT DIS, V13, P1847, DOI 10.3201/eid1312.071115; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Takada A, 2001, TRENDS MICROBIOL, V9, P506, DOI 10.1016/S0966-842X(01)02201-6; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taniguchi S, 2011, EMERG INFECT DIS, V17, P1559, DOI 10.3201/eid1708.101693; Towner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000764; Towner JS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000536; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wool-Lewis RJ, 1999, J VIROL, V73, P1419, DOI 10.1128/JVI.73.2.1419-1426.1999; Wool-Lewis RJ, 1998, J VIROL, V72, P3155, DOI 10.1128/JVI.72.4.3155-3160.1998; Wrensch F, 2015, J INFECT DIS, V212, pS210, DOI 10.1093/infdis/jiv255; Yao Y, 2003, VIROLOGY, V310, P319, DOI 10.1016/S0042-6822(03)00146-6; Yuan JF, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-236; Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011; Zimmer G, 2014, J GEN VIROL, V95, P1634, DOI 10.1099/vir.0.065201-0	79	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149651	10.1371/journal.pone.0149651	http://dx.doi.org/10.1371/journal.pone.0149651			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901159	Green Published, gold			2022-12-26	WOS:000371276100122
J	Zhao, YX; Zhang, X; Li, JN; Bian, Y; Sheng, MM; Liu, B; Fu, ZD; Zhang, Y; Yang, BF				Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng			Jujuboside B Reduces Vascular Tension by Increasing Ca2+ Influx and Activating Endothelial Nitric Oxide Synthase	PLOS ONE			English	Article							POTASSIUM CHANNEL; DEPENDENT VASORELAXATION; MYOCARDIAL-ISCHEMIA; CELLS; RATS; NO; PHOSPHORYLATION; CALCIUM; MICE; HYPERTENSION	Jujuboside B has been reported to have protective effect on many cardiovascular diseases. However, the effects of Jujuboside B on vascular tension and endothelial function are unknown. The present study investigated the effects of Jujuboside B on reducing vascular tension, protecting endothelial function and the potential mechanisms. The tension of isolated rat thoracic aorta ring was measured by Wire myograph system. The concentration of nitric oxide (NO) and the activity of endothelial nitric oxide synthase (eNOS) in human aortic endothelial cells (HAECs) were determined by Griess reagent method and enzyme-linked immune sorbent assay. The protein levels of eNOS and p-eNOS at Serine-1177 were determined by western blot analysis. Intracellular Ca2+ concentration in HAECs was measured by laser confocal imaging microscopy. Results showed that Jujuboside B reduced the tension of rat thoracic aorta rings with intact endothelium in a dose-dependent manner. L-AME, KN93, EGTA, SKF96365, iberiotoxin and glibenclamide significantly attenuated Jujuboside B-induced vasodilation in endothelium-intact tissues. In contrast, indometacin and 4-DAMP had no such effects. Jujuboside B also promoted NO generation and increased eNOS activity, which were attenuated by L-NAME, EGTA and SKF96365. Moreover, Jujuboside B increased intracellular Ca2+ concentration dose-dependently, which was inhibited by EGTA and SKF96365. Besides, Jujuboside B induced a rapid Ca2+ influx instantaneously after depleting intracellular Ca2+ store, which was significantly inhibited by SKF96365. In conclusion, this study preliminarily confirmed that Jujuboside B reduced vascular tension endothelium-dependently. The underlying mechanisms involved that Jujuboside B increased extracellular Ca2+ influx through endothelial transient receptor potential cation (TRPC) channels, phosphorylated eNOS and promoted NO generation in vascular endothelial cells. In addition, Jujuboside B-induced vasodilation involved endothelium-dependent hyperpolarizaiton through endothelial potassium channels. Jujuboside B is a natural compound with new pharmacological effects on improving endothelial dysfunction and treating vascular diseases.	[Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng] Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China; [Zhao, Yixiu; Zhang, Xin; Li, Jiannan; Bian, Yu; Sheng, Miaomiao; Liu, Bin; Fu, Zidong; Zhang, Yan; Yang, Baofeng] Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China	Harbin Medical University; Harbin Medical University	Zhang, Y; Yang, BF (corresponding author), Harbin Med Univ, Dept Pharmacol, Harbin, Heilongjiang, Peoples R China.; Zhang, Y; Yang, BF (corresponding author), Harbin Med Univ, Minist Educ, Key Lab Cardiovasc Med Res, Harbin, Heilongjiang, Peoples R China.	zhangyan@ems.hrbmu.edu.cn; yangbf@ems.hrbmu.edu.cn	Fu, Zidong/A-2703-2017	bian, yu/0000-0002-6741-1192				Bi CWC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051670; Busse R, 2002, TRENDS PHARMACOL SCI, V23, P374, DOI 10.1016/S0165-6147(02)02050-3; Cai H, 2008, CARDIOVASC RES, V77, P30, DOI 10.1093/cvr/cvm010; Carrier GO, 1997, AM J PHYSIOL-HEART C, V273, pH76, DOI 10.1152/ajpheart.1997.273.1.H76; CHANG J, 1987, BIOCHEM PHARMACOL, V36, P2429, DOI 10.1016/0006-2952(87)90512-0; CHEN XJ, 1990, ACTA PHARM SINIC, V11, P153; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cheng J, 2010, J PHARMACOL EXP THER, V332, P57, DOI 10.1124/jpet.109.159863; Cordellini S, 1998, GEN PHARMACOL-VASC S, V30, P79, DOI 10.1016/S0306-3623(97)00074-8; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Emerson GG, 2000, CIRC RES, V87, P474; Fleming I, 1999, CARDIOVASC RES, V43, P532, DOI 10.1016/S0008-6363(99)00094-2; Ford RJ, 2011, AM J PHYSIOL-HEART C, V300, pH64, DOI 10.1152/ajpheart.00597.2010; Freichel M, 2001, NAT CELL BIOL, V3, P121, DOI 10.1038/35055019; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; Garcia-Morales V, 2014, VASC PHARMACOL, V60, P95, DOI 10.1016/j.vph.2014.01.004; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Govers R, 2001, AM J PHYSIOL-RENAL, V280, pF193, DOI 10.1152/ajprenal.2001.280.2.F193; Gu WX, 1987, DI YI JUN YI DA XUE, V7, P8; Gutterman DD, 2005, ARTERIOSCL THROM VAS, V25, P671, DOI 10.1161/01.ATV.0000158497.09626.3b; Halcox JPJ, 2001, CORONARY ARTERY DIS, V12, P475, DOI 10.1097/00019501-200109000-00006; Hottinger Daniel G, 2014, J Anaesthesiol Clin Pharmacol, V30, P462, DOI 10.4103/0970-9185.142799; Huang KC, 1999, PHARM CHINESE HERBS; Huang Y, 1999, BBA-GEN SUBJECTS, V1427, P322, DOI 10.1016/S0304-4165(99)00034-3; Isenovic ER, 2003, METABOLISM, V52, P482, DOI 10.1053/meta.2003.50079; Jackson WF, 2005, MICROCIRCULATION, V12, P113, DOI 10.1080/10739680590896072; Kang KT, 2014, TOX RESEARCH, V30, P141, DOI 10.5487/TR.2014.30.3.141; Khurana S, 2004, EUR J PHARMACOL, V493, P127, DOI 10.1016/j.ejphar.2004.04.012; KUKOVETZ WR, 1979, J CYCLIC NUCL PROT, V5, P469; Kwan HY, 2007, TRP CHANNELS ENDOTHE, V17772, P907; Leeya Y, 2010, EUR J PHARMACOL, V649, P301, DOI 10.1016/j.ejphar.2010.09.038; Li LM, 2005, J INTEGR PLANT BIOL, V47, P494, DOI 10.1111/j.1744-7909.2005.00060.x; Luscher TF, 1997, CLIN CARDIOL, V20, P3; Munzel T, 1997, J MOL MED-JMM, V75, P891, DOI 10.1007/s001090050181; Orii R, 2010, BIOSCI TRENDS, V4, P260; Qian J., 2013, FRONT PHYSIOL, V4, P1; ROZANSKI A, 1988, NEW ENGL J MED, V318, P1005, DOI 10.1056/NEJM198804213181601; Sandow SL, 2012, ADV EXP MED BIOL, V740, P811, DOI 10.1007/978-94-007-2888-2_36; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Sorensen CM, 2012, AM J PHYSIOL-RENAL, V302, pF505, DOI 10.1152/ajprenal.00052.2011; Stankevicius Edgaras, 2003, Medicina (Kaunas), V39, P333; Steinkamp-Fenske K, 2007, J PHARMACOL EXP THER, V322, P836, DOI 10.1124/jpet.107.123356; Sullivan MN, 2013, AM J PHYSIOL-CELL PH, V305, pC999, DOI 10.1152/ajpcell.00273.2013; Taddei S, 1998, CIRCULATION, V97, P2222, DOI 10.1161/01.CIR.97.22.2222; Tang EHC, 2010, PFLUG ARCH EUR J PHY, V459, P995, DOI 10.1007/s00424-010-0786-4; Tiruppathi C, 2002, VASC PHARMACOL, V39, P173, DOI 10.1016/S1537-1891(03)00007-7; Tran QK, 2000, CARDIOVASC RES, V48, P13, DOI 10.1016/S0008-6363(00)00172-3; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Wang GG, 2015, CROAT MED J, V56, P4, DOI 10.3325/cmj.2015.56.4; Wang H, 2007, CARDIOVASC RES, V73, P497, DOI 10.1016/j.cardiores.2006.10.007; Wang Xiao-liang, 2005, Zhongguo Zhongyao Zazhi, V30, P753; Yu Y, 2012, FREE RADICAL RES, V46, P1346, DOI 10.3109/10715762.2012.715369; Zhao J, 2006, J CHROMATOGR A, V1108, P188, DOI 10.1016/j.chroma.2005.12.104	55	20	23	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149386	10.1371/journal.pone.0149386	http://dx.doi.org/10.1371/journal.pone.0149386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901291	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100066
J	Feldman, RD; Ding, QM; Hussain, Y; Limbird, LE; Pickering, JG; Gros, R				Feldman, Ross D.; Ding, Qingming; Hussain, Yasin; Limbird, Lee E.; Pickering, J. Geoffrey; Gros, Robert			Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER)	FASEB JOURNAL			English	Article						mineralocorticoid; tumor; RENCA	BREAST-CANCER; OVARIAN-CANCER; CELL-PROLIFERATION; ENDOTHELIAL-CELLS; RISK-FACTORS; GPR30; EPIDEMIOLOGY; EXPRESSION; CARCINOMA; 17-BETA-ESTRADIOL	Although aldosterone is a known regulator of renal and cardiovascular function, its role as a regulator of cancer growth and spread has not been widely considered. This study tested the hypothesis that aldosterone regulates cancer cell growth/spread via G protein-coupled estrogen receptor (GPER) activation. In vitro in murine renal cortical adenocarcinoma (RENCA) cells, a widely used murine in vitro model for the study of renal cell adenocarcinoma, aldosterone increased RENCA cell proliferation to a maximum of 125 +/- 3% of control at a concentration of 10 nM, an effect blocked by the GPER antagonist G15 or by GPER knockdown using short interfering (sh) RNA techniques. Further, aldosterone increased RENCA cell migration to a maximum of 170 +/- 20% of control at a concentration of 100 nM, an effect also blocked by G15 or by GPER down-regulation. In vivo, after orthotopic RENCA cell renal transplantation, pulmonary tumor spread was inhibited by pharmacologic blockade of aldosterone effects with spironolactone (percentage of lung occupied by metastasis: control = 68 +/- 13, spironolactone = 26 +/- 8, P < 0.05) or inhibition of aldosterone synthesis with a high dietary salt diet (percentage of lung: control = 44 +/- 6, high salt = 12 +/- 3, P < 0.05), without reducing primary tumor size. Additionally, adrenalectomy significantly reduced the extent of pulmonary tumor spread, whereas aldosterone infusion recovered pulmonary metastatic spread toward baseline levels. Finally, inhibition of GPER either with the GPER antagonist G15 or by GPER knockdown comparably inhibited RENCA cell pulmonary metastatic cancer spread. Taken together, these findings provide strong evidence for aldosterone serving a causal role in renal cell cancer regulation via its GPER receptor; thus, antagonism of GPER represents a potential new target for treatment to reduce metastatic spread.Feldman, R. D., Ding, Q., Hussain, Y., Limbird, L. E., Pickering, J. G., Gros, R. Aldosterone mediates metastatic spread of renal cancer via the G protein-coupled estrogen receptor (GPER).	[Feldman, Ross D.; Ding, Qingming] Mem Univ Newfoundland, Discipline Med, St John, NF, Canada; [Feldman, Ross D.; Ding, Qingming; Hussain, Yasin; Pickering, J. Geoffrey; Gros, Robert] Robarts Res Inst, Mol Med Grp, London, ON N6A 5C1, Canada; [Limbird, Lee E.] Fisk Univ, Dept Life & Phys Sci, Nashville, TN USA	Memorial University Newfoundland; Western University (University of Western Ontario); Fisk University	Feldman, RD (corresponding author), Hlth Sci Ctr, Discipline Med, Room 5306,300 Prince Philip Dr, St John, NF A1B 3V6, Canada.	ross.feldman@med.mun.ca	Pickering, J. Geoffrey/G-3341-2011; Gros, Robert/A-3010-2009; Gros, Robert/AAV-2237-2020	Pickering, J. Geoffrey/0000-0001-6474-3274; Gros, Robert/0000-0002-3667-8011; Gros, Robert/0000-0002-3667-8011	Heart and Stroke Foundation of Canada; Canadian Cancer Society [701080]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported in part by grants from the Heart and Stroke Foundation of Canada ( to R. D. F.) and the Canadian Cancer Society ( Grant 701080 to J.G.P.).	Ahola TM, 2002, ENDOCRINOLOGY, V143, P3376, DOI 10.1210/en.2001-211445; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Brailoiu GC, 2013, J PHYSIOL-LONDON, V591, P4223, DOI 10.1113/jphysiol.2013.257204; Broughton BRS, 2014, STROKE, V45, P835, DOI 10.1161/STROKEAHA.113.001499; Carmeci C, 1997, GENOMICS, V45, P607, DOI 10.1006/geno.1997.4972; Cho E, 2011, HEMATOL ONCOL CLIN N, V25, P651, DOI 10.1016/j.hoc.2011.04.002; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Ding Q, 2015, MOL CELL ENDOCRINOL, V399, P60, DOI 10.1016/j.mce.2014.07.023; Dorresteijn JAN, 2012, OBES REV, V13, P17, DOI 10.1111/j.1467-789X.2011.00914.x; Feldman RD, 2013, CLIN EXP PHARMACOL P, V40, P916, DOI 10.1111/1440-1681.12157; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fujiwara S, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-35; Gromotowicz A, 2011, J RENIN-ANGIO-ALDO S, V12, P430, DOI 10.1177/1470320310397405; Gros R, 2002, AM J PHYSIOL-HEART C, V282, pH380, DOI 10.1152/ajpheart.2002.282.1.H380; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Guan BZ, 2018, CELL ADHES MIGR, V12, P109, DOI 10.4161/19336918.2014.990781; Hasbi A, 2005, MOL INTERV, V5, P158, DOI 10.1124/mi.5.3.5; He YY, 2009, CANCER SCI, V100, P1051, DOI 10.1111/j.1349-7006.2009.01148.x; Heath CW, 1997, AM J EPIDEMIOL, V145, P607, DOI 10.1093/oxfordjournals.aje.a009157; HIATT RA, 1994, CANCER CAUSE CONTROL, V5, P319, DOI 10.1007/BF01804982; Huang LL, 2012, NEPHRON EXP NEPHROL, V120, pE115, DOI 10.1159/000339500; Huang SM, 2009, AM J PHYSIOL-RENAL, V296, pF1323, DOI 10.1152/ajprenal.90428.2008; Isobe A, 2010, GYNECOL ENDOCRINOL, V26, P372, DOI 10.3109/09513590903511521; Kanesvaran Ravindran, 2014, J Carcinog, V13, P3, DOI 10.4103/1477-3163.127638; Kang SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048185; Lin BC, 2009, CANCER RES, V69, P5415, DOI 10.1158/0008-5472.CAN-08-1622; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Luo HJ, 2011, J BREAST CANCER, V14, P185, DOI 10.4048/jbc.2011.14.3.185; McEneaney V, 2010, J STEROID BIOCHEM, V118, P18, DOI 10.1016/j.jsbmb.2009.09.014; O'Dowd BF, 1998, GENOMICS, V47, P310, DOI 10.1006/geno.1998.5095; Ohshiro K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030725; Pandey DP, 2009, EMBO J, V28, P523, DOI 10.1038/emboj.2008.304; Queisser N, 2014, ANTIOXID REDOX SIGN, V21, P2126, DOI 10.1089/ars.2013.5565; Ren YL, 2014, AM J PHYSIOL-RENAL, V307, pF427, DOI 10.1152/ajprenal.00072.2014; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Smith HO, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2007.01.004; Stengel D, 2006, BIOCHEM BIOPH RES CO, V346, P693, DOI 10.1016/j.bbrc.2006.05.210; SWARTZ SL, 1980, J CLIN ENDOCR METAB, V50, P1071, DOI 10.1210/jcem-50-6-1071; Takada Y, 1997, BIOCHEM BIOPH RES CO, V240, P737, DOI 10.1006/bbrc.1997.7734; Vivacqua A, 2006, MOL ENDOCRINOL, V20, P631, DOI 10.1210/me.2005-0280; Wang C, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.397; Wendler A, 2012, STEROIDS, V77, P1002, DOI 10.1016/j.steroids.2011.12.023; Xanthakis V, 2013, CURR HYPERTENS REP, V15, P102, DOI 10.1007/s11906-013-0330-y; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yu Qianli, 2004, Cardiovasc Toxicol, V4, P37	47	27	29	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2086	2096		10.1096/fj.15-275552	http://dx.doi.org/10.1096/fj.15-275552			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26911792				2022-12-26	WOS:000376878300003
J	Hsu, WCJ; Scala, F; Nenov, MN; Wildburger, NC; Elferink, H; Singh, AK; Chesson, CB; Buzhdygan, T; Sohail, M; Shavkunov, AS; Panova, NI; Nilsson, CL; Rudra, JS; Lichti, CF; Laezza, F				Hsu, Wei-Chun J.; Scala, Federico; Nenov, Miroslav N.; Wildburger, Norelle C.; Elferink, Hannah; Singh, Aditya K.; Chesson, Charles B.; Buzhdygan, Tetyana; Sohail, Maveen; Shavkunov, Alexander S.; Panova, Neli I.; Nilsson, Carol L.; Rudra, Jai S.; Lichti, Cheryl F.; Laezza, Fernanda			CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability	FASEB JOURNAL			English	Article						electrophysiology; bioluminescence screenings; intracellular signaling; GSK-3; mass spectrometry	AXON INITIAL SEGMENT; PROTEIN-KINASE CK2; MICE LACKING FIBROBLAST-GROWTH-FACTOR-14; CEREBELLAR PURKINJE NEURONS; GLYCOGEN-SYNTHASE KINASE-3; ANKYRIN-G; ION CHANNELS; MODULATION; PLASTICITY; ATAXIA	Recent data shows that fibroblast growth factor 14 (FGF14) binds to and controls the function of the voltage-gated sodium (Nav) channel with phenotypic outcomes on neuronal excitability. Mutations in the FGF14 gene in humans have been associated with brain disorders that are partially recapitulated in Fgf14(-/-) mice. Thus, signaling pathways that modulate the FGF14:Nav channel interaction may be important therapeutic targets. Bioluminescence-based screening of small molecule modulators of the FGF14:Nav1.6 complex identified 4,5,6,7-tetrabromobenzotriazole (TBB), a potent casein kinase 2 (CK2) inhibitor, as a strong suppressor of FGF14:Nav1.6 interaction. Inhibition of CK2 through TBB reduces the interaction of FGF14 with Nav1.6 and Nav1.2 channels. Mass spectrometry confirmed direct phosphorylation of FGF14 by CK2 at S228 and S230, and mutation to alanine at these sites modified FGF14 modulation of Nav1.6-mediated currents. In 1 d in vitro hippocampal neurons, TBB induced a reduction in FGF14 expression, a decrease in transient Na+ current amplitude, and a hyperpolarizing shift in the voltage dependence of Nav channel steady-state inactivation. In mature neurons, TBB reduces the axodendritic polarity of FGF14. In cornu ammonis area 1 hippocampal slices from wild-type mice, TBB impairs neuronal excitability by increasing action potential threshold and lowering firing frequency. Importantly, these changes in excitability are recapitulated in Fgf14(-/-) mice, and deletion of Fgf14 occludes TBB-dependent phenotypes observed in wild-type mice. These results suggest that a CK2-FGF14 axis may regulate Nav channels and neuronal excitability.Hsu, W.-C. J., Scala, F., Nenov, M. N., Wildburger, N. C., Elferink, H., Singh, A. K., Chesson, C. B., Buzhdygan, T., Sohail, M., Shavkunov, A. S., Panova, N. I., Nilsson, C. L., Rudra, J. S., Lichti, C. F., Laezza, F. CK2 activity is required for the interaction of FGF14 with voltage-gated sodium channels and neuronal excitability.	[Hsu, Wei-Chun J.; Scala, Federico; Nenov, Miroslav N.; Wildburger, Norelle C.; Singh, Aditya K.; Buzhdygan, Tetyana; Shavkunov, Alexander S.; Panova, Neli I.; Nilsson, Carol L.; Rudra, Jai S.; Lichti, Cheryl F.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Elferink, Hannah] Univ Texas Med Branch, Ctr Environm Toxicol, Galveston, TX 77555 USA; [Chesson, Charles B.] Univ Texas Med Branch, Inst Translat Sci, Human Pathophysiol & Translat Med, Galveston, TX 77555 USA; [Sohail, Maveen] Univ Texas Med Branch, Grad Sch Biomed Sci, Galveston, TX 77555 USA; [Nilsson, Carol L.] Univ Texas Med Branch, Sealy Ctr Mol Med, Galveston, TX 77555 USA; [Lichti, Cheryl F.; Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA; [Scala, Federico] Univ Cattolica, Inst Human Physiol, Rome, Italy; [Wildburger, Norelle C.] Univ Sch Med, Dept Neurol, St Louis, MO USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Buzhdygan, Tetyana/AAN-4245-2021; Laezza, Fernanda/X-4076-2019; Nenov, Miroslav/C-5252-2008; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Nenov, Miroslav/0000-0001-6000-2372; Laezza, Fernanda/0000-0003-1141-1852; Singh, Aditya/0000-0001-7549-8163; Hsu, Wei-Chun/0000-0003-4803-4819; Wildburger, Norelle C./0000-0002-0036-8927; Shavkunov, Alexander/0000-0003-2390-9391; Lichti, Cheryl/0000-0003-4099-4954	U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant [R01MH095995]; predoctoral Kempner fellowship; Wiktor W. Nowinski Endowment Fund travel award; University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine; UTMB Biochemistry and Molecular Biology Graduate Program; Universita a Cattolica Biophysics Graduate Program; UTMB Neuroscience Graduate Program; UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services) [P30ES006676/ES]; UTMB Summer Undergraduate Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant; predoctoral Kempner fellowship; Wiktor W. Nowinski Endowment Fund travel award; University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine; UTMB Biochemistry and Molecular Biology Graduate Program; Universita a Cattolica Biophysics Graduate Program; UTMB Neuroscience Graduate Program; UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services); UTMB Summer Undergraduate Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by U.S. National Institutes of Health (NIH)/National Institute of Mental Health Grant R01MH095995 (to F. L.), predoctoral Kempner fellowship (to W. J. H.), Wiktor W. Nowinski Endowment Fund travel award (to W. J. H.), University of Texas Medical Branch (UTMB) Sealy Center for Molecular Medicine (to W. J. H.), UTMB Biochemistry and Molecular Biology Graduate Program (to W. J. H.), Universita a Cattolica Biophysics Graduate Program (to F. S.), UTMB Neuroscience Graduate Program (to N. C. W. and T. B.), UTMB Bench Tutorials Program: Scientific Research and Design (NIH/National Institute of Environmental Health Sciences/Department of Health and Human Services Grant P30ES006676/ES) (to H. E.), and UTMB Summer Undergraduate Research Program (to M. S.). The authors declare no conflicts of interest.	Adachi R, 2015, NEUROSCIENTIST, V21, P255, DOI 10.1177/1073858414535986; Akin EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124397; Ali S, 2014, CNS NEUROL DISORD-DR, V13, P1559, DOI 10.2174/1871527313666141126103309; Bosch MK, 2015, J NEUROSCI, V35, P6752, DOI 10.1523/JNEUROSCI.2663-14.2015; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Brechet A, 2008, J CELL BIOL, V183, P1101, DOI 10.1083/jcb.200805169; Brusse E, 2006, MOVEMENT DISORD, V21, P396, DOI 10.1002/mds.20708; Casaday RJ, 2004, J VIROL, V78, P13501, DOI 10.1128/JVI.78.24.13501-13511.2004; Castillo MA, 2010, BIOL PSYCHIAT, V67, P208, DOI 10.1016/j.biopsych.2009.07.029; Chand AN, 2015, J NEUROSCI, V35, P1573, DOI 10.1523/JNEUROSCI.3515-14.2015; Farghaian H, 2011, J BIOL CHEM, V286, P25274, DOI 10.1074/jbc.M111.251629; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2007, NEURON, V55, P449, DOI 10.1016/j.neuron.2007.07.006; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hien YE, 2014, FEBS LETT, V588, P3403, DOI 10.1016/j.febslet.2014.07.032; Hong JY, 2007, ACS CHEM BIOL, V2, P171, DOI 10.1021/cb600435t; Hsu WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117246; Ishii A, 2007, FEBS LETT, V581, P4711, DOI 10.1016/j.febslet.2007.08.067; James TF, 2015, BBA-GEN SUBJECTS, V1850, P832, DOI 10.1016/j.bbagen.2015.01.011; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Laezza F, 2007, J NEUROSCI, V27, P12033, DOI 10.1523/JNEUROSCI.2282-07.2007; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Nenov MN, 2015, J NEUROPHYSIOL, V113, P1712, DOI 10.1152/jn.00419.2014; Niefind K, 2009, CELL MOL LIFE SCI, V66, P1800, DOI 10.1007/s00018-009-9149-8; Papandreou MJ, 2015, J NEUROCHEM, V134, P527, DOI 10.1111/jnc.13158; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Sanchez-Ponce D, 2011, MOL CELL NEUROSCI, V46, P222, DOI 10.1016/j.mcn.2010.09.005; Sarno S, 2005, MOL CELL BIOCHEM, V274, P69, DOI 10.1007/s11010-005-3079-z; Scala F, 2015, NEUROBIOL AGING, V36, P886, DOI 10.1016/j.neurobiolaging.2014.10.034; Shakkottai VG, 2009, NEUROBIOL DIS, V33, P81, DOI 10.1016/j.nbd.2008.09.019; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2015, METHODS MOL BIOL, V1278, P497, DOI 10.1007/978-1-4939-2425-7_33; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; St-Denis N, 2015, J PROTEOMICS, V118, P49, DOI 10.1016/j.jprot.2014.10.020; STOILOVAMCPHIE S, 2013, AUSTIN J PHARM THER, V1, P1; Tempia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00205; Thome C, 2014, NEURON, V83, P1418, DOI 10.1016/j.neuron.2014.08.013; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wildburger NC, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00080; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Xu MX, 2015, J BIOL CHEM, V290, P16619, DOI 10.1074/jbc.M115.638932; Yoshimura T, 2014, CURR OPIN NEUROBIOL, V27, P96, DOI 10.1016/j.conb.2014.03.004	51	22	23	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2171	2186		10.1096/fj.201500161	http://dx.doi.org/10.1096/fj.201500161			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26917740	Green Published			2022-12-26	WOS:000376878300011
J	Cvetesic, N; Dulic, M; Bilus, M; Sostaric, N; Lenhard, B; Gruic-Sovulj, I				Cvetesic, Nevena; Dulic, Morana; Bilus, Mirna; Sostaric, Nikolina; Lenhard, Boris; Gruic-Sovulj, Ita			Naturally Occurring Isoleucyl-tRNA Synthetase without tRNA-dependent Pre-transfer Editing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; antibiotic resistance; protein evolution; protein synthesis; transfer RNA (tRNA); isoleucyl-tRNA synthetase; mupirocin; proofreading; tRNA-dependent pre-transfer editing	PSEUDOMONIC ACID; ESCHERICHIA-COLI; STRUCTURAL BASIS; QUALITY-CONTROL; GENETIC-CODE; MUPIROCIN RESISTANCE; AMINO-ACID; COMPLEX; RECOGNITION; MECHANISMS	Isoleucyl-tRNA synthetase (IleRS) is unusual among aminoacyl-tRNA synthetases in having a tRNA-dependent pre-transfer editing activity. Alongside the typical bacterial IleRS (such as Escherichia coli IleRS), some bacteria also have the enzymes (eukaryote-like) that cluster with eukaryotic IleRSs and exhibit low sensitivity to the antibiotic mupirocin. Our phylogenetic analysis suggests that the ileS1 and ileS2 genes of contemporary bacteria are the descendants of genes that might have arisen by an ancient duplication event before the separation of bacteria and archaea. We present the analysis of evolutionary constraints of the synthetic and editing reactions in eukaryotic/eukaryote-like IleRSs, which share a common origin but diverged through adaptation to different cell environments. The enzyme from the yeast cytosol exhibits tRNA-dependent pre-transfer editing analogous to E. coli IleRS. This argues for the presence of this proofreading in the common ancestor of both IleRS types and an ancient origin of the synthetic site-based quality control step. Yet surprisingly, the eukaryote-like enzyme from Streptomyces griseus IleRS lacks this capacity; at the same time, its synthetic site displays the 10(3)-fold drop in sensitivity to antibiotic mupirocin relative to the yeast enzyme. The discovery that pre-transfer editing is optional in IleRSs lends support to the notion that the conserved post-transfer editing domain is the main checkpoint in these enzymes. We substantiated this by showing that under error-prone conditions S. griseus IleRS is able to rescue the growth of an E. coli lacking functional IleRS, providing the first evidence that tRNA-dependent pre-transfer editing in IleRS is not essential for cell viability.	[Cvetesic, Nevena; Dulic, Morana; Bilus, Mirna; Sostaric, Nikolina; Gruic-Sovulj, Ita] Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia; [Lenhard, Boris] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Computat Regulatory Genom Grp, London W12 0NN, England	University of Zagreb; Imperial College London	Gruic-Sovulj, I (corresponding author), Univ Zagreb, Fac Sci, Dept Chem, Horvatovac 102a, Zagreb 10000, Croatia.	gruic@chem.pmf.hr		Sostaric, Nikolina/0000-0002-1470-7846; Lenhard, Boris/0000-0002-1114-1509; Cvetesic, Nevena/0000-0002-1575-5612	Unity through Knowledge Fund [8/13]; Croatian Science Foundation [09.01/293]; European Community [315997]; MRC [MC_UP_1102/1] Funding Source: UKRI; Medical Research Council [MC_UP_1102/1] Funding Source: researchfish	Unity through Knowledge Fund; Croatian Science Foundation; European Community(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Unity through Knowledge Fund Grant 8/13 (to I. G.-S.), in part by Croatian Science Foundation Grant 09.01/293 (to I. G.-S.), and the European Community's Seventh Framework Programme FP7RegPot/IntegraLife, Grant 315997. The authors declare that they have no conflicts of interest with the contents of this article.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; An S, 2005, J BIOL CHEM, V280, P34465, DOI 10.1074/jbc.M507550200; BALDWIN AN, 1966, J BIOL CHEM, V241, P839; Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Bishop AC, 2002, P NATL ACAD SCI USA, V99, P585, DOI 10.1073/pnas.012611299; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Brown JR, 1998, CURR BIOL, V8, pR365, DOI 10.1016/S0960-9822(98)70238-6; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; Cvetesic N, 2015, J BIOL CHEM, V290, P13981, DOI 10.1074/jbc.M115.648568; Cvetesic N, 2014, EMBO J, V33, P1639, DOI 10.15252/embj.201488199; Cvetesic N, 2013, CROAT CHEM ACTA, V86, P73, DOI 10.5562/cca2173; Cvetesic N, 2012, J BIOL CHEM, V287, P25381, DOI 10.1074/jbc.M112.372151; Doolittle RF, 1998, CURR OPIN GENET DEV, V8, P630, DOI 10.1016/S0959-437X(98)80030-0; Dulic M, 2014, BIOCHEMISTRY-US, V53, P6189, DOI 10.1021/bi5007699; Dulic M, 2010, J BIOL CHEM, V285, P23799, DOI 10.1074/jbc.M110.133553; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERSHT AR, 1977, BIOCHEMISTRY-US, V16, P1025, DOI 10.1021/bi00624a034; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Fukunaga R, 2006, J MOL BIOL, V359, P901, DOI 10.1016/j.jmb.2006.04.025; FULLER AT, 1971, NATURE, V234, P416, DOI 10.1038/234416a0; Glasfeld E, 1996, BIOCHEMISTRY-US, V35, P4139, DOI 10.1021/bi9527810; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Hetem DJ, 2013, J HOSP INFECT, V85, P249, DOI 10.1016/j.jhin.2013.09.006; HUGHES J, 1980, BIOCHEM J, V191, P209, DOI 10.1042/bj1910209; Hussain T, 2006, EMBO J, V25, P4152, DOI 10.1038/sj.emboj.7601278; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; Jones David T., 2005, P3, DOI 10.1201/9780203489819.pt1; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lin L, 1996, NATURE, V384, P33, DOI 10.1038/384033b0; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Novoa EM, 2015, J BIOL CHEM, V290, P10495, DOI 10.1074/jbc.M115.640060; Minajigi A, 2010, J BIOL CHEM, V285, P23810, DOI 10.1074/jbc.M110.105320; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nordin B. E., 2005, AMINOACYL TRNA SYNTH, P24; Nureki O, 1998, SCIENCE, V280, P578, DOI 10.1126/science.280.5363.578; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paulander W, 2007, MOL MICROBIOL, V64, P1038, DOI 10.1111/j.1365-2958.2007.05713.x; Perona JJ, 2014, TOP CURR CHEM, V344, P1, DOI 10.1007/128_2013_456; RACHER KI, 1991, J BIOL CHEM, V266, P17158; Reynolds NM, 2010, P NATL ACAD SCI USA, V107, P4063, DOI 10.1073/pnas.0909640107; Sassanfar M, 1996, BIOCHEMISTRY-US, V35, P9995, DOI 10.1021/bi9603027; Serafini F, 2011, APPL ENVIRON MICROB, V77, P3141, DOI 10.1128/AEM.02540-10; Shiba K, 1997, TRENDS BIOCHEM SCI, V22, P453, DOI 10.1016/S0968-0004(97)01135-3; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Spang A, 2015, NATURE, V521, P173, DOI 10.1038/nature14447; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; SternJohn J, 2007, P NATL ACAD SCI USA, V104, P2127, DOI 10.1073/pnas.0611110104; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; Nguyen TH, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-12; Thomas CM, 2010, NAT REV MICROBIOL, V8, P281, DOI 10.1038/nrmicro2278; Vargas-Rodriguez O, 2013, J BIOL CHEM, V288, P14391, DOI 10.1074/jbc.M113.467795; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolfson AD, 2002, P NATL ACAD SCI USA, V99, P5965, DOI 10.1073/pnas.092152799; Yanagisawa T, 2003, J BIOL CHEM, V278, P25887, DOI 10.1074/jbc.M302633200; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Yokogawa T, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1182	61	6	6	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8618	8631		10.1074/jbc.M115.698225	http://dx.doi.org/10.1074/jbc.M115.698225			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26921320	Green Published, hybrid			2022-12-26	WOS:000374773200025
J	Lim, HK; Park, ST; Ha, H; Choi, SY				Lim, Hyun Kyung; Park, Sung Tae; Ha, Hongil; Choi, Seo-youn			Thyroid Nodules Detected by Contrast-Enhanced Magnetic Resonance Angiography: Prevalence and Clinical Significance	PLOS ONE			English	Article							SYSTEM; CT; MR; 3T	Background and Purpose Incidental thyroid lesions are frequently found on contrast-enhanced magnetic resonance (CE-MR) angiography. The purpose of this study is to determine the prevalence of thyroid incidentalomas detected by CE-MR angiography and to evaluate their clinical significance by correlation with ultrasound (US) and cytopathological results. Materials and Methods We retrospectively reviewed 3,299 consecutive CE-MR angiography examinations performed at our institution between January 2010 and March 2013. Two radiologists evaluated the CE-MR angiography imaging in consensus regarding the presence, location, and vascularity of thyroid incidentaloma. We correlated these findings with follow-up US and cytopathologic results. Results The prevalence of thyroid incidentalomas detected by CE-MR angiography was 4.6% (152/3,299 patients). CE-MR angiography showed hypervascularity in 86.8% (145/167), isovascularity in 8.4% (14/167), and hypovascularity in 4.8% (8/167) of thyroid nodules compared to vascularity of thyroid parenchyma. Among the patients with thyroid incidentaloma, 34 patients (22.4%) were followed by US examination, and all 36 nodules on CE-MR angiography were detected on follow-up US. Of these nodules, 9 (25%) nodules were classified as probably benign, 26 (72.2%) as indeterminate, and 1 (2.8%) as suspicious malignant nodule. Among the 16 nodules with available cytopathologic results, 12 nodules were benign, 2 nodules were follicular neoplasm, and 2 nodules showed non-diagnostic results. Conclusion Incidental thyroid nodules were found in 4.6% of CE-MR angiography examinations. Because the high incidence of indeterminate US feature among thyroid incidentaloma, when a thyroid incidentaloma is detected on CE-MR angiography, further evaluation with US should be performed.	[Lim, Hyun Kyung; Park, Sung Tae] Soonchunhyang Univ, Dept Radiol, Neuroradiol Sect, Seoul Hosp,Coll Med, Seoul, South Korea; [Ha, Hongil] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Med Ctr, Anyang, South Korea; [Choi, Seo-youn] Soonchunhyang Univ, Coll Med, Dept Radiol, Sect Neuroradiol,Bucheon Hosp, Bucheon, South Korea	Soonchunhyang University; Hallym University; Soonchunhyang University	Park, ST (corresponding author), Soonchunhyang Univ, Dept Radiol, Neuroradiol Sect, Seoul Hosp,Coll Med, Seoul, South Korea.	stpark@schmc.ac.kr			Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund (fund number: none). There was no additional external funding received for this study.	Bae JS, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-63; Chen WG, 2009, NUCL MED COMMUN, V30, P240, DOI 10.1097/MNM.0b013e328324b431; Choi N, 2012, KOREAN J RADIOL, V13, P275, DOI 10.3348/kjr.2012.13.3.275; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Jin J, 2009, AM J SURG, V197, P320, DOI 10.1016/j.amjsurg.2008.10.006; Kwak JY, 2008, AM J ROENTGENOL, V191, P598, DOI 10.2214/AJR.07.3443; Kwak JY, 2013, KOREAN J RADIOL, V14, P110, DOI 10.3348/kjr.2013.14.1.110; Lohan DG, 2008, AM J ROENTGENOL, V190, pW255, DOI 10.2214/AJR.07.3137; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Shetty SK, 2006, AM J ROENTGENOL, V187, P1349, DOI 10.2214/AJR.05.0468; Yoon DY, 2008, J COMPUT ASSIST TOMO, V32, P810, DOI 10.1097/RCT.0b013e318157fd38; Yousem DM, 1997, AM J NEURORADIOL, V18, P1423	14	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149811	10.1371/journal.pone.0149811	http://dx.doi.org/10.1371/journal.pone.0149811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919607	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400047
J	Salas, A; Acosta, D; Ferri, CP; Guerra, M; Huang, YQ; Jacob, KS; Jimenez-Velazquez, IZ; Rodriguez, JJL; Sosa, AL; Uwakwe, R; Williams, JD; Jotheeswaran, AT; Liu, ZR; Medina, AML; Salinas-Contreras, RM; Prince, MJ				Salas, Aquiles; Acosta, Daisy; Ferri, Cleusa P.; Guerra, Mariella; Huang, Yueqin; Jacob, K. S.; Jimenez-Velazquez, Ivonne Z.; Llibre Rodriguez, Juan J.; Sosa, Ana L.; Uwakwe, Richard; Williams, Joseph D.; Jotheeswaran, A. T.; Liu, Zhaorui; Lopez Medina, A. M.; Maria Salinas-Contreras, Rosa; Prince, Martin J.			The Prevalence, Correlates, Detection and Control of Diabetes among Older People in Low and Middle Income Countries. A 10/66 Dementia Research Group Population-Based Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; NATIONAL-HEALTH; ELDERLY-PEOPLE; RISK; COMMUNITY; MORTALITY; ADULTS	Background Little is known of the epidemiology of diabetes among older people in low and middle income countries. We aimed to study and compare prevalence, social patterning, correlates, detection, treatment and control of diabetes among older people in Latin America, India, China and Nigeria. Methods Cross-sectional surveys in 13 catchment area sites in nine countries. Diagnosed diabetes was assessed in all sites through self-reported diagnosis. Undiagnosed diabetes was assessed in seven Latin American sites through fasting blood samples (glucose > = 7mmol/L). Results Total diabetes prevalence in catchment sites in Cuba (prevalence 24.2%, SMR 116), Puerto Rico (43.4%, 197), and urban (27.0%, 125), and rural Mexico (23.7%, 111) already exceeds that in the USA, while that in Venezuela (20.9%, 100) is similar. Diagnosed diabetes prevalence varied very widely, between low prevalences in sites in rural China (0.9%), rural India (6.6%) and Nigeria (6.0%). and 32.1% in Puerto Rico, explained mainly by access to health services. Treatment coverage varied substantially between sites. Diabetes control (40 to 61% of those diagnosed) was modest in the Latin American sites where this was studied. Diabetes was independently associated with less education, but more assets. Hypertension, central obesity and hypertriglyceridaemia, but not hypercholesterolaemia were consistently associated with total diabetes. Conclusions Diabetes prevalence is already high in most sites. Identifying undiagnosed cases is essential to quantify population burden, particularly in least developed settings where diagnosis is uncommon. Metabolic risk factors and associated lifestyles may play an important part in aetiology, but this requires confirmation with longitudinal data. Given the high prevalence among older people, more population research is indicated to quantify the impact of diabetes, and to monitor the effect of prevention and health system strengthening on prevalence, treatment and control.	[Salas, Aquiles] Cent Univ Venezuela, Fac Med, Univ Hosp, Dept Med, Caracas, Venezuela; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Ferri, Cleusa P.] Univ Fedral Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Jimenez-Velazquez, Ivonne Z.] Univ Puerto Rico, Sch Med, Geriatr Program, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA; [Llibre Rodriguez, Juan J.] Med Univ Havana, Fac Med Finlay Albarran, Havana, Cuba; [Sosa, Ana L.; Maria Salinas-Contreras, Rosa] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Uwakwe, Richard] Nnamdi Azikiwe Univ, Teaching Hosp, Nnewi, Anambra State, Nigeria; [Williams, Joseph D.] Voluntary Hlth Serv, Dept Community Hlth, Madras, Tamil Nadu, India; [Jotheeswaran, A. T.] Publ Hlth Fdn India, New Delhi, India; [Lopez Medina, A. M.] Policlin 19 Abril, Havana, Cuba; [Prince, Martin J.] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England	University of Central Venezuela; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Nacional Autonoma de Mexico; Public Health Foundation of India; University of London; King's College London	Prince, MJ (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England.	martin.prince@kcl.ac.uk	Ferri, Cleusa Pinheiro/B-2922-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prince, Martin J/A-9170-2010; Llibre Rodriguez, Juan/D-2380-2010	Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Liu, Zhaorui/0000-0002-6536-7503; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Llibre Rodriguez, Juan/0000-0002-8215-3160; Guerra, Mariella/0000-0001-8923-349X	Wellcome Trust [GR066133, GR080002]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; FONACIT/CDCH/UCV; Puerto Rico Legislature; Pfizer Co., USA	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Puerto Rico Legislature; Pfizer Co., USA	Funded by Wellcome Trust (GR066133- Prevalence phase in Cuba; GR080002- Incidence phase in Peru, Mexico, Cuba, Dominican Republic, Venezuela and China and data analysis across all centres) - http://www.wellcome.ac.uk/, World Health Organization (data collection in India, Dominican Republic and China) - www.who.int, US Alzheimer's Association (IIRG - 04 - 1286 - data collection in Peru, and Mexico) - http://www.alz.org/research/alzheimers_grants/, FONACIT/CDCH/UCV (data collection in Venezuela) - http://www.fonacit.gob.ve/, Puerto Rico Legislature (data collection in Puerto Rico), and Pfizer Co., USA (blood sample collection in Puerto Rico) - www.pfizer.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2003, DIABETES CARE, V26, P2021, DOI 10.2337/diacare.26.7.2021; Barcelo A, 2006, J AGING HEALTH, V18, P224, DOI 10.1177/0898264305285728; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Liu LJ, 2011, ANN EPIDEMIOL, V21, P26, DOI 10.1016/j.annepidem.2010.10.012; Nyenwe EA, 2003, DIABETES RES CLIN PR, V62, P177, DOI 10.1016/j.diabres.2003.07.002; Olaiz G, 2003, ENCUESTA NACL SALUD; Pabon-Nau LP, 2010, J GEN INTERN MED, V25, P847, DOI 10.1007/s11606-010-1335-8; Perez CM, 2008, ETHNIC DIS, V18, P434; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	19	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149616	10.1371/journal.pone.0149616	http://dx.doi.org/10.1371/journal.pone.0149616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913752	gold, Green Published, Green Submitted			2022-12-26	WOS:000371175700022
J	Das, NM; Hatsell, S; Nannuru, K; Huang, L; Wen, XL; Wang, LL; Wang, LH; Idone, V; Meganck, JA; Murphy, A; Economides, A; Xie, LQ				Das, Nanditha Mohan; Hatsell, Sarah; Nannuru, Kalyan; Huang, Lily; Wen, Xialing; Wang, Lili; Wang, Li-Hsien; Idone, Vincent; Meganck, Jeffrey A.; Murphy, Andrew; Economides, Aris; Xie, LiQin			In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse Model	PLOS ONE			English	Article							MICRO-CT; COMPUTED-TOMOGRAPHY; CONTRAST AGENTS; TUMOR ANGIOGENESIS; SMALL ANIMALS; SOFT-TISSUE; RADIATION; VCT	Non-bone in vivo micro-CT imaging has many potential applications for preclinical evaluation. Specifically, the in vivo quantification of changes in the vascular network and organ morphology in small animals, associated with the emergence and progression of diseases like bone fracture, inflammation and cancer, would be critical to the development and evaluation of new therapies for the same. However, there are few published papers describing the in vivo vascular imaging in small animals, due to technical challenges, such as low image quality and low vessel contrast in surrounding tissues. These studies have primarily focused on lung, cardiovascular and brain imaging. In vivo vascular imaging of mouse hind limbs has not been reported. We have developed an in vivo CT imaging technique to visualize and quantify vasculature and organ structure in disease models, with the goal of improved quality images. With 1-2 minutes scanning by a high speed in vivo micro-CT scanner (Quantum CT), and injection of a highly efficient contrast agent (Exitron nano 12000), vasculature and organ structure were semi-automatically segmented and quantified via image analysis software (Analyze). Vessels of the head and hind limbs, and organs like the heart, liver, kidneys and spleen were visualized and segmented from density maps. In a mouse model of bone metastasis, neoangiogenesis was observed, and associated changes to vessel morphology were computed, along with associated enlargement of the spleen. The in vivo CT image quality, voxel size down to 20 mu m, is sufficient to visualize and quantify mouse vascular morphology. With this technique, in vivo vascular monitoring becomes feasible for the preclinical evaluation of small animal disease models.	[Das, Nanditha Mohan; Hatsell, Sarah; Nannuru, Kalyan; Huang, Lily; Wen, Xialing; Wang, Lili; Wang, Li-Hsien; Idone, Vincent; Murphy, Andrew; Economides, Aris; Xie, LiQin] Regeneron Pharmaceut Inc, Therapeut Focus Areas, Dept Skeletal Dis, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Meganck, Jeffrey A.] PerkinElmer, Res & Dev, Hopkinton, MA USA	Regeneron	Xie, LQ (corresponding author), Regeneron Pharmaceut Inc, Therapeut Focus Areas, Dept Skeletal Dis, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	LiQin.Xie@regeneron.com	wang, lili/HDL-7210-2022	Economides, Aris/0000-0002-6508-8942; Hatsell, Sarah/0000-0003-1103-6087; Idone, Vincent/0000-0002-5622-2011; Murphy, Andrew/0000-0003-4152-4081	Regeneron Pharmaceuticals Inc.; PerkinElmer	Regeneron Pharmaceuticals Inc.(Regeneron); PerkinElmer	This study received internal funding from Regeneron Pharmaceuticals Inc. and PerkinElmer, who provided support in the form of salaries for authors LX, NMD, SH, KN, LH, XW, LW, LHW, VI, AM, AE and JAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Annapragada Ananth V, 2012, Methodist Debakey Cardiovasc J, V8, P18; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; Bauerle T, 2008, NEOPLASIA, V10, P511, DOI 10.1593/neo.08220; Bazalova M, 2010, WORLD MOLECULAR IMAG; Boll H, 2013, ACAD RADIOL, V20, P1137, DOI 10.1016/j.acra.2013.06.002; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; Brasch RC, 2000, ACAD RADIOL, V7, P812, DOI 10.1016/S1076-6332(00)80630-3; Chien CC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-10; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; Cole HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097381; Conway EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-207; Detombe SA, 2013, ACTA RADIOL, V54, P435, DOI 10.1177/0284185113475608; Dinkel J, 2008, CIRC-CARDIOVASC IMAG, V1, P235, DOI 10.1161/CIRCIMAGING.108.784702; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; Ford NL, 2003, MED PHYS, V30, P2869, DOI 10.1118/1.1617353; Gabra P, 2010, PHYSIOL MEAS, V31, P249, DOI 10.1088/0967-3334/31/2/010; Ghaghada KB, 2011, ACAD RADIOL, V18, P20, DOI 10.1016/j.acra.2010.09.003; Gregory LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068103; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Justice MJ, 2011, DIS MODEL MECH, V4, P305, DOI 10.1242/dmm.000901; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kass DA, 1998, CIRC RES, V82, P519, DOI 10.1161/01.RES.82.4.519; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Kiessling F, 2010, EUR J NUCL MED MOL I, V37, pS4, DOI 10.1007/s00259-010-1450-0; Kraehenbuehl TP, 2010, BIOMED TECH, V55, P245, DOI 10.1515/BMT.2010.031; Lee S, 2014, MICROCIRCULATION, V21, P159, DOI 10.1111/micc.12102; Li X, 2013, BIOMATERIALS, V34, P481, DOI 10.1016/j.biomaterials.2012.09.026; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Missbach-Guentner J, 2011, INT J DEV BIOL, V55, P535, DOI 10.1387/ijdb.103229jm; Nebuloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086562; Nebuloni L, 2013, ACAD RADIOL, V20, P1247, DOI 10.1016/j.acra.2013.06.003; Nyangoga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017336; Rothe JH, 2015, ACAD RADIOL, V22, P169, DOI 10.1016/j.acra.2014.07.022; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Vasquez SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019099; Wathen CA, 2013, SENSORS-BASEL, V13, P6957, DOI 10.3390/s130606957; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Xie LQ, 2012, ARTHRITIS RHEUM-US, V64, P1899, DOI 10.1002/art.34370	46	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150085	10.1371/journal.pone.0150085	http://dx.doi.org/10.1371/journal.pone.0150085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910759	gold, Green Submitted, Green Published			2022-12-26	WOS:000371164700064
J	Munilla, I; Genovart, M; Paiva, VH; Velando, A				Munilla, Ignacio; Genovart, Meritxell; Paiva, Vitor H.; Velando, Alberto			Colony Foundation in an Oceanic Seabird	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; POLYMORPHIC MICROSATELLITE MARKERS; POPULATION-STRUCTURE; CORYS SHEARWATER; COLONIZATION SUCCESS; DISPERSAL PATTERNS; PUBLIC INFORMATION; HABITAT SELECTION; GENETIC DIVERSITY; PELAGIC SEABIRD	Seabirds are colonial vertebrates that despite their great potential for long-range dispersal and colonization are reluctant to establish in novel locations, often recruiting close to their natal colony. The foundation of colonies is therefore a rare event in most seabird species and little is known about the colonization process in this group. The Cory's shearwater (Calonectris diomedea) is a pelagic seabird that has recently established three new colonies in Galicia (NE Atlantic) thus expanding its distribution range 500 km northwards. This study aimed to describe the establishment and early progress of the new Galician populations and to determine the genetic and morphometric characteristics of the individuals participating in these foundation events. Using 10 microsatellite loci, we tested the predictions supported by different seabird colonization models. Possibly three groups of non-breeders, adding up to around 200 birds, started visiting the Galician colonies in the mid 2000' s and some of them eventually laid eggs and reproduced, thus establishing new breeding colonies. The Galician populations showed a high genetic diversity and a frequency of private alleles similar to or even higher than some of the large historical populations. Most individuals were assigned to several Atlantic populations and a few (if any) to Mediterranean colonies. Our study suggests that a large and admixed population is settling in Galicia, in agreement with predictions from island metapopulation models of colonization. Multiple source colonies imply that some birds colonizing Galicia were dispersing from very distant colonies (>1500 km). Long-distance colonizations undertaken by relatively large and admixed groups of colonizers can help to explain the low levels of genetic structure over vast areas that are characteristic of most oceanic seabird species.	[Munilla, Ignacio; Genovart, Meritxell] Univ Santiago de Compostela, Fac Biol, Dept Bot, Santiago De Compostela, Galicia, Spain; [Paiva, Vitor H.] Univ Coimbra, Dept Life Sci, Marine & Environm Sci Ctr, Coimbra, Portugal; [Velando, Alberto] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Galicia, Spain; [Genovart, Meritxell] Inst Mediterrani Estudis Avancats, Populat Ecol Grp, Esporles, Illes Balears, Spain	Universidade de Santiago de Compostela; Universidade de Coimbra; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Munilla, I (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Bot, Santiago De Compostela, Galicia, Spain.; Velando, A (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Galicia, Spain.	ignacio.munilla@gmx.es; avelando@uvigo.es	Genovart, Meritxell/L-4873-2014; Paiva, Vitor H./J-1092-2019; Velando, Alberto/B-1701-2009; Paiva, Vitor Hugo/GRX-9179-2022	Genovart, Meritxell/0000-0003-2919-1288; Paiva, Vitor H./0000-0001-6368-9579; Velando, Alberto/0000-0001-8909-0724; 	Organismo Autonomo de Parques Nacionales of Spain [079/2009]; EU project [LIFE04NAT/PT/000213, LIFE09NAT/PT/000041]; BirdLife International partner in Portugal; Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/21557/2005, SFRH/BPD/85024/2012]	Organismo Autonomo de Parques Nacionales of Spain; EU project(European Commission); BirdLife International partner in Portugal; Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This study was funded annually (20102013) by the Organismo Autonomo de Parques Nacionales of Spain (http://www.magrama.gob.es/es/parques-nacionales-oapn/programa-investigacion/) through the research project 079/2009. Financial support for the fieldwork in Azores, Madeira, Selvagens and Berlengas was provided by the EU project LIFE04NAT/PT/000213, coordinated by SPEA (Sociedade Portuguesa para o Estudo das Aves), the BirdLife International partner in Portugal. HP acknowledges the support given by the Fundacao para a Ciencia e Tecnologia (Portugal, SFRH/BD/21557/2005 and SFRH/BPD/85024/2012). Financial support for the fieldwork in Cima Islet was provided by the EU project LIFE09NAT/PT/000041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Santiago Barciela, Alvaro Barros, Paula Dominguez and David Alvarez were contracted for field data collection in Galicia.	Afan I, 2014, MAR BIOL, V161, P657, DOI 10.1007/s00227-013-2368-4; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Barbraud C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140456; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Bicknell AWJ, 2014, DIVERS DISTRIB, V20, DOI 10.1111/ddi.12137; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Breton AR, 2006, ECOL MONOGR, V76, P133, DOI 10.1890/05-0704; Bried J, 2008, MOL ECOL RESOUR, V8, P602, DOI 10.1111/j.1471-8286.2007.02009.x; Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101; Burg TM, 2003, P ROY SOC B-BIOL SCI, V270, P979, DOI 10.1098/rspb.2002.2322; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Cadiou B, 2011, CINQUIEME RECENSEMEN; Calabuig G, 2010, ANIM BEHAV, V80, P975, DOI 10.1016/j.anbehav.2010.08.016; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Fisher J., 1952, THE FULMAR; FORBES LS, 1994, OIKOS, V70, P377, DOI 10.2307/3545775; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Furness R.W., 1987, SEABIRD ECOLOGY; Gallo-Reynoso Juan-Pablo, 1996, Western Birds, V27, P70; Genovart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070711; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez EG, 2009, MOL ECOL RESOUR, V9, P1044, DOI 10.1111/j.1755-0998.2009.02563.x; Granadeiro J.P., 1991, Seabird, P30; Greene CM, 2001, ECOLOGY, V82, P2091; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hood G.M., 2010, POPTOOLS VERSION 3 2; Hufbauer RA, 2013, J EVOLUTION BIOL, V26, P1691, DOI 10.1111/jeb.12167; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kildaw S. Dean, 2005, Marine Ornithology, V33, P49; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lisovski S, 2009, POLAR BIOL, V32, P1811, DOI 10.1007/s00300-009-0705-3; Luczak C, 2012, BIOL LETT; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; MARIN AM, 1984, AUK, V101, P192; Martinez-Abrain A, 2002, WATERBIRDS, V25, P221, DOI 10.1675/1524-4695(2002)025[0221:ACSBIA]2.0.CO;2; Mays Gilles, 2006, Ornithos, V13, P316; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; MOUGIN JL, 1992, CR ACAD SCI III-VIE, V315, P27; Munilla I, 2008, PLAN INTEGRAL RECUPE; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; NEI M, 1978, GENETICS, V89, P583; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Oro D, 2001, J ANIM ECOL, V70, P527, DOI 10.1046/j.1365-2656.2001.00511.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paiva VH, 2013, MAR ECOL PROG SER, V486, P277, DOI 10.3354/meps10332; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peery MZ, 2006, ECOL APPL, V16, P1516, DOI 10.1890/1051-0761(2006)016[1516:CDACAT]2.0.CO;2; Peron G, 2010, J ANIM ECOL, V79, P317, DOI 10.1111/j.1365-2656.2009.01635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pitman RL, 2002, WILSON BULL, V114, P11, DOI 10.1676/0043-5643(2002)114[0011:TCSOMB]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2005, MOL ECOL, V14, P1421, DOI 10.1111/j.1365-294X.2005.02493.x; Rabouam C, 1998, AUK, V115, P483; Ramirez O, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-28; Ramos R, 2013, DIVERS DISTRIB, V19, P1284, DOI 10.1111/ddi.12088; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rannala B., 2007, BAYESASS VERSION 3 0; Reed J. Michael, 1999, VVolume 15, P189; Reyes-Gonzalez JM, 2011, ENCICLOPEDIA VIRTUAL; RISTOW D, 1990, Vogelwelt, V111, P172; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Robb M, 2008, PETRELS NIGHT DAY; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Schippers P, 2011, ECOL MODEL, V222, P3061, DOI 10.1016/j.ecolmodel.2011.05.022; Stamps JA, 1990, AM NAT, V131, P329; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STOREY AE, 1985, AUK, V102, P395; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tait WC, 1887, IBIS, V5, P372; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Thibault JC, 1998, IBIS, V140, P523, DOI 10.1111/j.1474-919X.1998.tb04615.x; VANEERDEN MR, 1995, ARDEA, V83, P61; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Whittington PA, 1999, IBIS, V141, P327, DOI 10.1111/j.1474-919X.1999.tb07555.x; Wilson GA, 2003, GENETICS, V163, P1177; Young LC, 2010, J ZOOL, V281, P232, DOI 10.1111/j.1469-7998.2010.00698.x; Zador SG, 2009, MAR ECOL PROG SER, V376, P283, DOI 10.3354/meps07797	100	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147222	10.1371/journal.pone.0147222	http://dx.doi.org/10.1371/journal.pone.0147222			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909694	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700002
J	Renzi, C; Vadilonga, V; Gandini, S; Perinel, G; Rotmensz, N; Didier, F; Rescigno, M; Pravettoni, G				Renzi, Chiara; Vadilonga, Valeria; Gandini, Sara; Perinel, Giada; Rotmensz, Nicole; Didier, Florence; Rescigno, Maria; Pravettoni, Gabriella			Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; LIFE EVENTS; ATTACHMENT; RISK; METASTASIS; EXPRESSION; RESPONSES; HEALTH	Objective Life stress exposure may impact on health and disease. Previous literature showed that stressful life events are associated with cancer incidence, survival and mortality. In animal models, patterns of maternal care have been shown to critically affect stress sensitivity and immunity trajectories later in life, by modifying DNA methylation during critical periods early in life. However, the role of parental care in breast cancer progression and survival has only limitedly been explored. Here, we investigated whether these factors may be linked to biological prognostic variables. Methods One hundred twenty-three women hospitalized for surgery of primary breast cancer completed a questionnaire assessing parental bonding. Stressful events throughout the life span were also assessed. Results We found that the absence of optimal parental relationships is significantly associated with an increased risk of lymph node involvement, adjusting for confounders, while cumulative stress in the area of sentimental relationships is borderline significantly associated with the same prognostic factor. Conclusions Our results suggest that parental bonding and sentimental relations may have a role in breast cancer progression. These variables represent an important evolutionary aspect which may modulate cancer progression through psycho-physiological stress pathways and influence the immune system.	[Renzi, Chiara; Vadilonga, Valeria; Perinel, Giada; Didier, Florence; Pravettoni, Gabriella] European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy; [Gandini, Sara; Rotmensz, Nicole] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Rescigno, Maria] European Inst Oncol, Immunobiol Dendrit Cells & Immunotherapy Unit, Milan, Italy; [Rescigno, Maria; Pravettoni, Gabriella] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Renzi, C (corresponding author), European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy.	chiara.renzi@ieo.it	didier, florence/AAS-4178-2020; Pravettoni, Gabriella/AAC-3500-2022; Renzi, Chiara/AAG-5403-2019; Pravettoni, Gabriella/C-6915-2011; gandini, sara/J-4916-2018; Rescigno, Maria/J-9704-2012	Renzi, Chiara/0000-0002-3451-0792; Pravettoni, Gabriella/0000-0002-4843-4663; gandini, sara/0000-0002-1348-4548; Rescigno, Maria/0000-0002-6464-509X	Fondazione Umberto Veronesi; Fondazione Istituto Europeo di Oncologia	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Fondazione Istituto Europeo di Oncologia	CR was supported by a Fellowship of the Fondazione Umberto Veronesi. VV was supported by a Fellowship of the Fondazione Istituto Europeo di Oncologia.	Adenzato M, 2005, PSICOLOGIA EVOLUZION; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Chen E, 2011, MOL PSYCHIATR, V16, P729, DOI 10.1038/mp.2010.53; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Donegan WL, 1997, CA-CANCER J CLIN, V47, P28, DOI 10.3322/canjclin.47.1.28; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Fava GA, 1982, NUOVI METODI PSICOME, P9; FEENEY JA, 1994, HEALTH PSYCHOL, V13, P334, DOI 10.1037/0278-6133.13.4.334; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; GRASSI L, 1986, Journal of Psychosocial Oncology, V4, P53; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hilakivi-Clarke L, 2003, BREAST CANC RES TREA, V29, P141; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; LUBACH GR, 1995, BRAIN BEHAV IMMUN, V9, P31, DOI 10.1006/brbi.1995.1004; Lutgendorf SK, 2011, PSYCHOSOM MED, V73, P724, DOI 10.1097/PSY.0b013e318235be76; Manassis K, 1999, AUST NZ J PSYCHIAT, V33, P559, DOI 10.1080/j.1440-1614.1999.00560.x; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McKenna MC, 1999, HEALTH PSYCHOL, V18, P520, DOI 10.1037/0278-6133.18.5.520; McLaughlin KA, 2000, DEPRESS ANXIETY, V27, P1087; Metcalfe C, 2007, EUR J CANCER, V43, P1060, DOI 10.1016/j.ejca.2007.01.027; Miller GE, 2009, PSYCHOSOM MED, V71, P57, DOI 10.1097/PSY.0b013e318190d7de; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PAYKEL ES, 1971, ARCH GEN PSYCHIAT, V25, P340, DOI 10.1001/archpsyc.1971.01750160052010; Quirin M, 2008, PSYCHONEUROENDOCRINO, V33, P581, DOI 10.1016/j.psyneuen.2008.01.013; Sarason IG, 1975, EMOTIONS THEIR PARAM, P499; Scinto A, 1999, Epidemiol Psichiatr Soc, V8, P276; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Tacon A, 2001, FAM SYST HEALTH, V19, P319, DOI [10.1037/h0089455, DOI 10.1037/H0089455]; Tacon Anna M, 2002, Integr Cancer Ther, V1, P371, DOI 10.1177/1534735402238188; THOMAS CB, 1979, PSYCHOSOM MED, V41, P287, DOI 10.1097/00006842-197906000-00003; Thomas CB, 1998, ADV MIND BODY MED, V5, P42; Tripsianis G, 2014, NEOPLASMA, V61, P205, DOI 10.4149/neo_2014_026; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149443	10.1371/journal.pone.0149443	http://dx.doi.org/10.1371/journal.pone.0149443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910901	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700033
J	Alves, KA; Alves, BG; Gastal, GDA; de Tarso, SGS; Gastal, MO; Figueiredo, JR; Gambarini, ML; Gastal, EL				Alves, Kele A.; Alves, Benner G.; Gastal, Gustavo D. A.; de Tarso, Saulo G. S.; Gastal, Melba O.; Figueiredo, Jose R.; Gambarini, Maria L.; Gastal, Eduardo L.			The Mare Model to Study the Effects of Ovarian Dynamics on Preantral Follicle Features	PLOS ONE			English	Article							PRIMORDIAL FOLLICLES; IN-VITRO; DOMINANT FOLLICLE; CELL-INTERACTIONS; BIOPSY; GROWTH; BOVINE; DENSITY; MORPHOLOGY; ENDOCRINE	Ovarian tissue collected by biopsy procedures allows the performance ofmany studies with clinical applications in the field of female fertility preservation. The aim of the present study was to investigate the influence of reproductive phase (anestrous vs. diestrous) and ovarian structures (antral follicles and corpus luteum) on the quality, class distribution, number, and density of preantral follicles, and stromal cell density. Ovarian fragments were harvested by biopsy pick-up procedures from mares and submitted to histological analysis. Themean preantral follicle and ovarian stromal cell densities were greater in the diestrous phase and a positive correlation of stromal cell density with the number and density of preantral follicles was observed. Themean area (mm2) of ovarian structures increased in the diestrous phase and had positive correlations with number of preantral follicles, follicle density, and stromal cell density. Biopsy fragments collected from ovaries containing an active corpus luteum had a higher follicle density, stromal cell density, and proportion of normal preantral follicles. In conclusion, our results showed: (1) the diestrous phase influenced positively the preantral follicle quality, class distribution, and follicle and stromal cell densities; (2) the area of ovarian structures was positively correlated with the follicle and stromal cell densities; and (3) the presence of an active corpus luteum had a positive effect on the quality of preantral follicles, and follicle and stromal densities. Therefore, herein we demonstrate that the presence of key ovarian structures favors the harvest of ovarian fragments containing an appropriate number of healthy preantral follicles.	[Alves, Kele A.; Alves, Benner G.; Gastal, Gustavo D. A.; de Tarso, Saulo G. S.; Gastal, Melba O.; Gastal, Eduardo L.] So Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA; [Alves, Kele A.; Gambarini, Maria L.] Univ Fed Goias, Coll Vet & Anim Sci, Ctr Studies & Res Anim Reprod Biol, Goiania, Go, Brazil; [Figueiredo, Jose R.] Univ Estadual Ceara, Fac Vet Med, Lab Manipulat Oocytes & Preantral Follicles LAMOF, Fortaleza, Ceara, Brazil	Southern Illinois University System; Southern Illinois University; Universidade Federal de Goias; Universidade Estadual do Ceara	Gastal, EL (corresponding author), So Illinois Univ, Dept Anim Sci Food & Nutr, Carbondale, IL 62901 USA.	egastal@siu.edu	Gastal, Eduardo Leite/O-8359-2019; Alves, Benner/D-3599-2014; Gastal, Gustavo Desire Antunes/K-7424-2013; Alves, Kele Amaral A/P-8422-2015; Gastal, Eduardo Leite/Q-9854-2017	Gastal, Eduardo Leite/0000-0002-8855-6980; Alves, Benner/0000-0001-9465-8054; Gastal, Gustavo Desire Antunes/0000-0002-5317-2207; Alves, Kele Amaral A/0000-0001-7359-3570; Gastal, Eduardo Leite/0000-0002-8855-6980; Figueiredo, Jose Ricardo/0000-0002-5139-0964; Gambarini, Maria Lucia/0000-0003-0517-7270	Southern Illinois University (SIU), USA; Foundation for Research Support of the State of Goias (FAPEG), Brazil [201210267001032]; National Council for Scientific and Technological Development (CNPq), Brazil [203563/2013-1]	Southern Illinois University (SIU), USA; Foundation for Research Support of the State of Goias (FAPEG), Brazil; National Council for Scientific and Technological Development (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Research was supported by Southern Illinois University (SIU), USA, and Foundation for Research Support of the State of Goias (FAPEG; 201210267001032), Brazil. KAA was the recipient of a PhD sandwich scholarship from The National Council for Scientific and Technological Development (CNPq; 203563/2013-1), Brazil.	Aerts JMJ, 2005, THERIOGENOLOGY, V64, P947, DOI 10.1016/j.theriogenology.2005.01.011; Al-zi'abil MO, 2003, REPRODUCTION, V125, P259, DOI 10.1530/rep.0.1250259; ALGUBORY KH, 1987, ANIM REPROD SCI, V13, P269, DOI 10.1016/0378-4320(87)90064-9; Alves KA, 2015, THERIOGENOLOGY, V83, P1048, DOI 10.1016/j.theriogenology.2014.12.004; Araujo VR, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-78; AULETTA FJ, 1987, AM J OBSTET GYNECOL, V157, P1010, DOI 10.1016/S0002-9378(87)80107-2; Baerwald A. R., 2009, Animal Reproduction, V6, P20; Baerwald AR, 2009, FERTIL STERIL, V91, P440, DOI 10.1016/j.fertnstert.2007.11.054; Carnevale EM, 2008, THERIOGENOLOGY, V69, P23, DOI 10.1016/j.theriogenology.2007.09.011; Commin L, 2012, REPROD FERT DEVELOP, V24, P461, DOI 10.1071/RD11166; Dath C, 2011, HUM REPROD, V26, P1431, DOI 10.1093/humrep/der073; Donadeu FX, 2007, ANIM REPROD SCI, V100, P225, DOI 10.1016/j.anireprosci.2006.12.001; Faustino LR, 2010, ANIM REPROD SCI, V122, P90, DOI 10.1016/j.anireprosci.2010.08.001; Forabosco A, 2007, FERTIL STERIL, V88, P675, DOI 10.1016/j.fertnstert.2006.11.191; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Fransolet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091073; Gao JianMing, 2001, Chinese Journal of Veterinary Science, V21, P181; Gastal E. L., 2009, Animal Reproduction, V6, P144; Gastal EL, 1997, BIOL REPROD, V57, P1320, DOI 10.1095/biolreprod57.6.1320; Gastal EL., 2011, ACTA SCI VET, V39, ps57; Gerritse R, 2011, REPROD BIOMED ONLINE, V23, P755, DOI 10.1016/j.rbmo.2011.08.008; Gilchrist RB, 2004, ANIM REPROD SCI, V82-3, P431, DOI 10.1016/j.anireprosci.2004.05.017; Ginther OJ, 2012, THERIOGENOLOGY, V77, P818, DOI 10.1016/j.theriogenology.2011.09.025; Ginther OJ, 2005, REPRODUCTION, V130, P379, DOI 10.1530/rep.1.00757; Ginther OJ, 2004, BIOL REPROD, V71, P1195, DOI 10.1095/biolreprod.104.031054; Gupta PSP, 2007, ANIM REPROD SCI, V101, P145, DOI 10.1016/j.anireprosci.2006.11.011; Haag KT, 2013, THERIOGENOLOGY, V79, P911, DOI 10.1016/j.theriogenology.2013.01.001; Haag KT, 2013, THERIOGENOLOGY, V79, P735, DOI 10.1016/j.theriogenology.2012.10.023; Haag KT, 2013, THERIOGENOLOGY, V79, P599, DOI 10.1016/j.theriogenology.2012.11.012; Jorssen EPA, 2014, THERIOGENOLOGY, V82, P387, DOI 10.1016/j.theriogenology.2014.04.019; Kezele P, 2003, ENDOCRINOLOGY, V144, P3329, DOI 10.1210/en.2002-0131; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Kwok R, 2012, REPROD BIOMED ONLINE, V24, P492, DOI 10.1016/j.rbmo.2012.01.020; Lass A, 1997, HUM REPROD, V12, P1028; Lass A, 2001, HUM REPROD, V16, P1055, DOI 10.1093/humrep/16.6.1055; Martelli A, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-72; Mihm M, 2008, REPROD DOMEST ANIM, V43, P48, DOI 10.1111/j.1439-0531.2008.01142.x; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Orisaka M, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-9; Palermo R, 2007, REPROD BIOMED ONLINE, V15, P326, DOI 10.1016/S1472-6483(10)60347-1; Qiu MN, 2013, J STEROID BIOCHEM, V138, P325, DOI 10.1016/j.jsbmb.2013.06.005; Robinson RS, 2009, REPRODUCTION, V138, P869, DOI 10.1530/REP-09-0283; Schmidt KLT, 2003, HUM REPROD, V18, P1158, DOI 10.1093/humrep/deg246; Silva JRV, 2000, THERIOGENOLOGY, V54, P809, DOI 10.1016/S0093-691X(00)00392-7; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Telfer EE, 2013, FERTIL STERIL, V99, P1523, DOI 10.1016/j.fertnstert.2013.03.043; Thomas FH, 2003, HUM REPROD UPDATE, V9, P541, DOI 10.1093/humupd/dmg042; Thorne JT, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121368; Tingen CM, 2011, REPRODUCTION, V141, P809, DOI 10.1530/REP-10-0483; Vanacker J, 2013, FERTIL STERIL, V99, P1363, DOI 10.1016/j.fertnstert.2012.12.016; Yang MY, 2007, MOL REPROD DEV, V74, P1095, DOI 10.1002/mrd.20633; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094	52	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149693	10.1371/journal.pone.0149693	http://dx.doi.org/10.1371/journal.pone.0149693			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900687	Green Published, gold			2022-12-26	WOS:000371276100129
J	Bageshwar, UK; VerPlank, L; Baker, D; Dong, W; Hamsanathan, S; Whitaker, N; Sacchettini, JC; Musser, SM				Bageshwar, Umesh K.; VerPlank, Lynn; Baker, Dwight; Dong, Wen; Hamsanathan, Shruthi; Whitaker, Neal; Sacchettini, James C.; Musser, Siegfried M.			High Throughput Screen for Escherichia coli Twin Arginine Translocation (Tat) Inhibitors	PLOS ONE			English	Article							SEC-INDEPENDENT PROTEIN; SIGNAL PEPTIDE; TRANSPORT SYSTEM; EXPORT PATHWAY; COMPLEX-I; TRICLOSAN; MEMBRANE; VIRULENCE; EXPRESSION; EVOLUTION	The twin arginine translocation (Tat) pathway transports fully-folded and assembled proteins in bacteria, archaea and plant thylakoids. The Tat pathway contributes to the virulence of numerous bacterial pathogens that cause disease in humans, cattle and poultry. Thus, the Tat pathway has the potential to be a novel therapeutic target. Deciphering the Tat protein transport mechanism has been challenging since the active translocon only assembles transiently in the presence of substrate and a proton motive force. To identify inhibitors of Tat transport that could be used as biochemical tools and possibly as drug development leads, we developed a high throughput screen (HTS) to assay the effects of compounds in chemical libraries against protein export by the Escherichia coli Tat pathway. The primary screen is a live cell assay based on a fluorescent Tat substrate that becomes degraded in the cytoplasm when Tat transport is inhibited. Consequently, low fluorescence in the presence of a putative Tat inhibitor was scored as a hit. Two diverse chemical libraries were screened, yielding average Z'-factors of 0.74 and 0.44, and hit rates of similar to 0.5% and 0.04%, respectively. Hits were evaluated by a series of secondary screens. Electric field gradient (Delta psi) measurements were particularly important since the bacterial Tat transport requires a Delta psi. Seven low IC50 hits were eliminated by Delta psi assays, suggesting ionophore activity. As Delta psi collapse is generally toxic to animal cells and efficient membrane permeability is generally favored during the selection of library compounds, these results suggest that secondary screening of hits against electrochemical effects should be done early during hit validation. Though none of the short-listed compounds inhibited Tat transport directly, the screening and follow-up assays developed provide a roadmap to pursue Tat transport inhibitors.	[Bageshwar, Umesh K.; Hamsanathan, Shruthi; Whitaker, Neal; Musser, Siegfried M.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA; [VerPlank, Lynn] Broad Inst, Cambridge, MA USA; [Baker, Dwight; Dong, Wen; Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Texas A&M University System; Texas A&M University College Station	Musser, SM (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Mol & Cellular Med, College Stn, TX USA.	smusser@tamhsc.edu		Musser, Siegfried/0000-0002-7793-2557	National Institutes of Health [GM065534, NS063904, U54 HG005032, R21 NS063904-01]; Welch Foundation grant [A-0015]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation grant(The Welch Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the National Institutes of Health (GM065534 & NS063904 to SMM; U54 HG005032 & R21 NS063904-01 to Molecular Libraries Probe Development Network) and the Welch Foundation grant (A-0015 to JCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Aldridge C, 2014, J CELL BIOL, V205, P51, DOI 10.1083/jcb.201311057; Bageshwar UK, 2007, J CELL BIOL, V179, P87, DOI 10.1083/jcb.200702082; Bageshwar UK, 2009, MOL MICROBIOL, V74, P209, DOI 10.1111/j.1365-2958.2009.06862.x; Behrendt J, 2004, FEMS MICROBIOL LETT, V234, P303, DOI 10.1016/j.femsle.2004.03.048; Berks BC, 2005, CURR OPIN MICROBIOL, V8, P174, DOI 10.1016/j.mib.2005.02.010; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Chen GZ, 2003, ANTIMICROB AGENTS CH, V47, P3485, DOI 10.1128/AAC.47.11.3485-3493.2003; CLINE K, 1992, J BIOL CHEM, V267, P2688; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; de Keyzer J, 2003, CELL MOL LIFE SCI, V60, P2034, DOI 10.1007/s00018-003-3006-y; De Leeuw E, 2001, FEBS LETT, V506, P143, DOI 10.1016/S0014-5793(01)02904-0; DeLisa MP, 2002, J BIOL CHEM, V277, P29825, DOI 10.1074/jbc.M201956200; Dhillon GS, 2015, INT J ENV RES PUB HE, V12, P5657, DOI 10.3390/ijerph120505657; Durant JL, 2002, J CHEM INF COMP SCI, V42, P1273, DOI 10.1021/ci010132r; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Forman SA, 2015, NEUROPHARMACOLOGY, V96, P169, DOI 10.1016/j.neuropharm.2014.10.002; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; HORWITZ AH, 1984, J BACTERIOL, V158, P141, DOI 10.1128/JB.158.1.141-147.1984; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jeong KJ, 2004, J MOL BIOL, V341, P901, DOI 10.1016/j.jmb.2004.05.078; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; KIN E, 1974, J BIOCHEM-TOKYO, V76, P667, DOI 10.1093/oxfordjournals.jbchem.a130612; Koch S, 2012, J BIOL CHEM, V287, P14420, DOI 10.1074/jbc.M112.354555; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Liang FC, 2009, MOL BIOL CELL, V20, P4256, DOI 10.1091/mbc.E09-01-0075; Lindenstrauss U, 2010, FEBS LETT, V584, P3644, DOI 10.1016/j.febslet.2010.07.039; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; Moody AJ, 1997, BIOCHEM J, V324, P743; MOULD RM, 1991, J BIOL CHEM, V266, P12189; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Pereira DA, 2007, BRIT J PHARMACOL, V152, P53, DOI 10.1038/sj.bjp.0707373; Pett W, 2013, INTEGR COMP BIOL, V53, P495, DOI 10.1093/icb/ict079; Pradel N, 2003, INFECT IMMUN, V71, P4908, DOI 10.1128/IAI.71.9.4908-4916.2003; Price CE, 2010, BBA-MOL CELL RES, V1803, P748, DOI 10.1016/j.bbamcr.2010.01.019; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Ramasamy S, 2013, STRUCTURE, V21, P777, DOI 10.1016/j.str.2013.03.004; Rollauer SE, 2012, NATURE, V492, P210, DOI 10.1038/nature11683; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Thomas JD, 2001, MOL MICROBIOL, V39, P47, DOI 10.1046/j.1365-2958.2001.02253.x; Tu LC, 2013, EMBO J, V32, P3220, DOI 10.1038/emboj.2013.239; Vasil ML, 2012, ANTIMICROB AGENTS CH, V56, P6223, DOI 10.1128/AAC.01575-12; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Wang XH, 2013, CHEM SOC REV, V42, P4859, DOI 10.1039/c3cs60039d; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Whitaker N, 2012, J BIOL CHEM, V287, P11252, DOI 10.1074/jbc.M111.324525; Wu LF, 2000, J MOL MICROB BIOTECH, V2, P179; Yahr TL, 2001, EMBO J, V20, P2472, DOI 10.1093/emboj/20.10.2472; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Yueh MF, 2014, P NATL ACAD SCI USA, V111, P17200, DOI 10.1073/pnas.1419119111; ZAFAR AB, 1995, AM J INFECT CONTROL, V23, P200, DOI 10.1016/0196-6553(95)90042-X; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	64	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149659	10.1371/journal.pone.0149659	http://dx.doi.org/10.1371/journal.pone.0149659			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901445	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100124
J	Biggs, BT; Tang, T; Krimm, RF				Biggs, Bradley T.; Tang, Tao; Krimm, Robin F.			Insulin-Like Growth Factors Are Expressed in the Taste System, but Do Not Maintain Adult Taste Buds	PLOS ONE			English	Article							PAPILLA DEVELOPMENT; NEUROTROPHIC FACTOR; RECEPTOR-CELLS; FUNGIFORM PAPILLA; SOFT PALATE; TONGUE; MOUSE; RAT; BDNF; INNERVATION	Growth factors regulate cell growth and differentiation in many tissues. In the taste system, as yet unknown growth factors are produced by neurons to maintain taste buds. A number of growth factor receptors are expressed at greater levels in taste buds than in the surrounding epithelium and may be receptors for candidate factors involved in taste bud maintenance. We determined that the ligands of eight of these receptors were expressed in the E14.5 geniculate ganglion and that four of these ligands were expressed in the adult geniculate ganglion. Of these, the insulin-like growth factors (IGF1, IGF2) were expressed in the ganglion and their receptor, insulin-like growth factor receptor 1 (IGF1R), were expressed at the highest levels in taste buds. To determine whether IGF1R regulates taste bud number or structure, we conditionally eliminated IGF1R from the lingual epithelium of mice using the keratin 14 (K14) promoter (K14-Cre::Igf1r(lox/lox)). While K14-Cre:: Igf1r(lox/lox) mice had significantly fewer taste buds at P30 compared with control mice (Igf1r(lox/lox)), this difference was not observed by P80. IGF1R removal did not affect taste bud size or cell number, and the number of phospholipase C beta 2-(PLC beta 2)and carbonic anhydrase 4-(Car4) positive taste receptor cells did not differ between genotypes. Taste buds at the back of the tongue fungiform taste field were larger and contained more cells than those at the tongue tip, and these differences were diminished in K14-Cre:: Igf1r(lox/lox) mice. The epithelium was thicker at the back versus the tip of the tongue, and this difference was also attenuated in K14-Cre:: Igf1r(lox/lox) mice. We conclude that, although IGFs are expressed at high levels in the taste system, they likely play little or no role in maintaining adult taste bud structure. IGFs have a potential role in establishing the initial number of taste buds, and there may be limits on epithelial thickness in the absence of IGF1R signaling.	[Biggs, Bradley T.; Tang, Tao; Krimm, Robin F.] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA	University of Louisville	Krimm, RF (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA.	rfkrim01@louisville.edu	Krimm, Robin/AAK-3014-2020; Tang, Tao/T-4998-2017		National Institutes of Health [DC007176, 8P30GM103507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grant DC007176 (R.F.K.). The statistical core facility, used for data analysis, is supported by National Institutes of Health grant 8P30GM103507.	Annenkov A, 2009, MOL NEUROBIOL, V40, P195, DOI 10.1007/s12035-009-8081-0; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Clapp TR, 2004, J COMP NEUROL, V468, P311, DOI 10.1002/cne.10963; COLLINGS VB, 1974, PERCEPT PSYCHOPHYS, V16, P169, DOI 10.3758/BF03203270; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; Finger TE, 2005, CHEM SENSES, V30, pI54, DOI 10.1093/chemse/bjh110; Gaillard D, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005208; GUTH L, 1957, ANAT REC, V128, P715, DOI 10.1002/ar.1091280406; Harlow DE, 2011, DEV DYNAM, V240, P309, DOI 10.1002/dvdy.22527; Huang T, 2014, DEV BIOL, V386, P308, DOI 10.1016/j.ydbio.2013.12.031; Huang T, 2010, DEV DYNAM, V239, P2637, DOI 10.1002/dvdy.22412; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Iwatsuki K, 2007, P NATL ACAD SCI USA, V104, P2253, DOI 10.1073/pnas.0607399104; Kapsimali M, 2013, SEMIN CELL DEV BIOL, V24, P200, DOI 10.1016/j.semcdb.2012.11.002; Kataoka S, 2008, CHEM SENSES, V33, P243, DOI 10.1093/chemse/bjm083; Liebl DJ, 1999, DEV BIOL, V213, P378, DOI 10.1006/dbio.1999.9385; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Liu HX, 2013, DEV BIOL, V382, P82, DOI 10.1016/j.ydbio.2013.07.022; Liu HX, 2008, DEV DYNAM, V237, P2378, DOI 10.1002/dvdy.21657; Liu HX, 2012, DEV BIOL, V361, P39, DOI 10.1016/j.ydbio.2011.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez GF, 2006, J NEUROBIOL, V66, P1033, DOI 10.1002/neu.20289; Ma LQ, 2009, J NEUROSCI, V29, P3354, DOI 10.1523/JNEUROSCI.3970-08.2009; McLaughlin SK, 2000, J NEUROSCI, V20, P5679, DOI 10.1523/JNEUROSCI.20-15-05679.2000; MISTRETTA CM, 1988, J NEUROSCI, V8, P73; Mistretta CM, 1998, ANN NY ACAD SCI, V855, P1, DOI 10.1111/j.1749-6632.1998.tb10542.x; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; MURRAY R G, 1969, Journal of Ultrastructure Research, V27, P444, DOI 10.1016/S0022-5320(69)80043-2; MURRAY RG, 1967, J ULTRA MOL STRUCT R, V19, P327, DOI 10.1016/S0022-5320(67)80224-7; Nosrat CA, 1996, J COMP NEUROL, V376, P587, DOI 10.1002/(SICI)1096-9861(19961223)376:4<587::AID-CNE7>3.0.CO;2-Y; Nosrat IV, 2004, J NEUROCYTOL, V33, P607, DOI 10.1007/s11068-005-3330-2; OAKLEY B, 1990, NEUROSCIENCE, V36, P831, DOI 10.1016/0306-4522(90)90026-Z; Oakley B, 2004, J NEUROCYTOL, V33, P631, DOI 10.1007/s11068-005-3332-0; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Patel AV, 2012, DEV BIOL, V365, P50, DOI 10.1016/j.ydbio.2012.02.008; Patel AV, 2010, J COMP NEUROL, V518, P3290, DOI 10.1002/cne.22400; Patel AV, 2010, DEV BIOL, V340, P419, DOI 10.1016/j.ydbio.2010.01.024; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Petersen CI, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002098; Stachelscheid H, 2008, EMBO J, V27, P2091, DOI 10.1038/emboj.2008.141; Sullivan JM, 2010, EUR J NEUROSCI, V31, P1549, DOI 10.1111/j.1460-9568.2010.07184.x; Sun H, 2002, DEV BIOL, V242, P31, DOI 10.1006/dbio.2001.0526; Suzuki Y, 2005, J COMP NEUROL, V482, P74, DOI 10.1002/cne.20379; Yang RB, 2000, J COMP NEUROL, V425, P139, DOI 10.1002/1096-9861(20000911)425:1<139::AID-CNE12>3.0.CO;2-#; Yang RB, 2000, J COMP NEUROL, V424, P205, DOI 10.1002/1096-9861(20000821)424:2<205::AID-CNE2>3.0.CO;2-F; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148315	10.1371/journal.pone.0148315	http://dx.doi.org/10.1371/journal.pone.0148315			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901525	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100015
J	El Ayadi, AM; Nathan, HL; Seed, PT; Butrick, EA; Hezelgrave, NL; Shennan, AH; Miller, S				El Ayadi, Alison M.; Nathan, Hannah L.; Seed, Paul T.; Butrick, Elizabeth A.; Hezelgrave, Natasha L.; Shennan, Andrew H.; Miller, Suellen			Vital Sign Prediction of Adverse Maternal Outcomes in Women with Hypovolemic Shock: The Role of Shock Index	PLOS ONE			English	Article							BLOOD-PRESSURE DEVICE; POSTPARTUM HEMORRHAGE; EMERGENCY-DEPARTMENT; OBSTETRIC HEMORRHAGE; MANAGEMENT; PREGNANCY; GARMENT; DEATH	Objective To determine the optimal vital sign predictor of adverse maternal outcomes in women with hypovolemic shock secondary to obstetric hemorrhage and to develop thresholds for referral/intensive monitoring and need for urgent intervention to inform a vital sign alert device for low-resource settings. Study Design We conducted secondary analyses of a dataset of pregnant/postpartum women with hypovolemic shock in low-resource settings (n = 958). Using receiver-operating curve analysis, we evaluated the predictive ability of pulse, systolic blood pressure, diastolic blood pressure, shock index, mean arterial pressure, and pulse pressure for three adverse maternal outcomes: (1) death, (2) severe maternal outcome (death or severe end organ dysfunction morbidity); and (3) a combined severe maternal and critical interventions outcome comprising death, severe end organ dysfunction morbidity, intensive care admission, blood transfusion >= 5 units, or emergency hysterectomy. Two threshold parameters with optimal rule-in and rule-out characteristics were selected based on sensitivities, specificities, and positive and negative predictive values. Results Shock index was consistently among the top two predictors across adverse maternal outcomes. Its discriminatory ability was significantly better than pulse and pulse pressure for maternal death (p<0.05 and p<0.01, respectively), diastolic blood pressure and pulse pressure for severe maternal outcome (p<0.01), and systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for severe maternal outcome and critical interventions (p<0.01). A shock index threshold of >= 0.9 maintained high sensitivity (100.0) with clinical practicality, >= 1.4 balanced specificity (range 70.0-74.8) with negative predictive value (range 93.2-99.2), and >= 1.7 further improved specificity (range 80.7-90.8) without compromising negative predictive value (range 88.8-98.5). Conclusions For women with hypovolemic shock from obstetric hemorrhage, shock index was consistently a strong predictor of all adverse outcomes. In lower-level facilities in low resource settings, we recommend a shock index threshold of >= 0.9 indicating need for referral, >= 1.4 indicating urgent need for intervention in tertiary facilities and >= 1.7 indicating high chance of adverse outcome. The vital sign alert device incorporated values 0.9 and 1.7; however, all thresholds will be prospectively validated and clinical pathways for action appropriate to setting established prior to clinical implementation.	[El Ayadi, Alison M.; Butrick, Elizabeth A.; Miller, Suellen] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA USA; [Nathan, Hannah L.; Seed, Paul T.; Hezelgrave, Natasha L.; Shennan, Andrew H.] Kings Coll London, Womens Hlth Acad Ctr, London, England	University of California System; University of California San Francisco; University of London; King's College London	El Ayadi, AM (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Bixby Ctr Global Reprod Hlth, San Francisco, CA USA.	alison.elayadi@ucsf.edu	Seed, Paul T/C-4435-2008	Seed, Paul T/0000-0001-7904-7933; Shennan, Andrew/0000-0001-5273-3132	Bill & Melinda Gates Foundation [OPP1086183, 48541]; MacArthur Foundation [05-84956-000-GSS]; National Institutes of Health [R01HD053129]; MRC [MR/N006240/1] Funding Source: UKRI; Medical Research Council [MR/N006240/1] Funding Source: researchfish; National Institute for Health Research [ACF-2015-17-014, ACF-2009-17-019, DRF-2013-06-171] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053129] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); MacArthur Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The current work was supported by the Bill & Melinda Gates Foundation (AS; OPP1086183; www.gatesfoundation.org). The original data collection was supported by grants from the MacArthur Foundation (SM; 05-84956-000-GSS; www.macfound.org), National Institutes of Health (SM; R01HD053129; www.nih.gov), and the Bill & Melinda Gates Foundation (SM; 48541; www.gatesfoundation.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2010, ENCY MEASUREMENT STA; AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Al-Foudri H, 2010, BJA EDUC, V10, P81, DOI 10.1093/bjaceaccp/mkq009; [Anonymous], 2014, Obstet Gynecol, V123, P722, DOI 10.1097/01.AOG.0000444442.04111.c6; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Birkhahn RH, 2003, AM J OBSTET GYNECOL, V189, P1293, DOI 10.1067/S0002-9378(03)00663-X; Bonanno Fabrizio Giuseppe, 2012, J Emerg Trauma Shock, V5, P285, DOI 10.4103/0974-2700.102357; Carroli G, 2008, BEST PRACT RES CL OB, V22, P999, DOI 10.1016/j.bpobgyn.2008.08.004; Cecconi M, 2014, INTENS CARE MED, V40, P1795, DOI 10.1007/s00134-014-3525-z; de Greeff A, 2008, BLOOD PRESS MONIT, V13, P342, DOI 10.1097/MBP.0b013e32830fd07c; Gregory Kim, 2009, EARLY RECOGNITION RA; Le Bas A, 2014, INT J GYNECOL OBSTET, V124, P253, DOI 10.1016/j.ijgo.2013.08.020; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; McAuley DF, 2005, CLIN ULTIMATE REFERE; Mcnab A, 2012, SURGERY, V152, P473, DOI 10.1016/j.surg.2012.07.010; Miller S, 2006, BJOG-INT J OBSTET GY, V113, P424, DOI 10.1111/j.1471-0528.2006.00873.x; Miller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076477; Miller S, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-64; Nathan HL, 2015, BJOG-INT J OBSTET GY, V122, P268, DOI 10.1111/1471-0528.13206; Nathan HL, 2015, BLOOD PRESS MONIT, V20, P52, DOI 10.1097/MBP.0000000000000086; Nathan HL, BLOOD PRESS IN PRESS; Nathan HL, 2015, PREGNANCY HYPERTENSI, V5, P104; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Onah H E, 2006, J Obstet Gynaecol, V26, P445, DOI 10.1080/01443610600747314; Pacagnella RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057594; Pepe MS, 2004, STAT EVALUATION MED; RADY MY, 1992, RESUSCITATION, V23, P227, DOI 10.1016/0300-9572(92)90006-X; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; RADY MY, 1992, AM J EMERG MED, V10, P538, DOI 10.1016/0735-6757(92)90178-Z; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Sloan EP, 2014, WEST J EMERG MED, V15, P795, DOI 10.5811/westjem.2014.7.21304; Sohn CH, 2013, SHOCK, V40, P101, DOI 10.1097/SHK.0b013e31829b1778; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; WHO, 2003, MAN COMPL PREGN CILD; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	36	57	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148729	10.1371/journal.pone.0148729	http://dx.doi.org/10.1371/journal.pone.0148729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901161	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100023
J	Guo, H; Liu, JM; Zhang, JY; Ma, RL; Ding, YS; Zhang, M; He, J; Xu, SZ; Li, SG; Yan, YZ; Mu, LT; Rui, DS; Niu, Q; Guo, SX				Guo, Heng; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Ding, Yusong; Zhang, Mei; He, Jia; Xu, Shangzhi; Li, Shugang; Yan, Yizhong; Mu, Lati; Rui, Dongsheng; Niu, Qiang; Guo, Shuxia			The Prevalence of Metabolic Syndrome Using Three Different Diagnostic Criteria among Low Earning Nomadic Kazakhs in the Far Northwest of China: New Cut-Off Points of Waist Circumference to Diagnose MetS and Its Implications	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; ABDOMINAL OBESITY; XINJIANG PROVINCE; BODY-COMPOSITION; RISK-FACTORS; ADULTS; POPULATIONS; OVERWEIGHT; HAN	Background Although the epidemic of metabolic syndrome (MetS) has aroused wide public concern, most studies on MetS tend to examine urban and high income settings, and few studies cover nomadic areas and low earning populations. This research aims to investigate the prevalence of MetS and explore the cut-off point of waist circumference in a nomadic minority typical of low income populations in the remote northwest region of China. Methods A cross-sectional study was performed in a representative sample of 3900 Kazakh adults aged 18-84 years from 2009-2010. Three widely used criteria (ATP III\IDF\JIS)were employed to estimate the prevalence of MetS in Kazakhs to compare them with other populations. Receiver operator characteristic (ROC) curve analysis was used to explore the optimal cut-off values of waist circumference. Results The age-adjusted prevalence of MetS was 13.8%, 20.9%, and 24.8% based on the ATP III, IDF, and JIS criteria, respectively. The prevalence of MetS was higher in women and increased with age. Except for reduced HDL-cholesterol, the risk of other components of MetS increased with waist circumference enlargement. The cut-off point of waist circumference in screening at least two other components of MetS was 88 cm in men (Sensitivity = 61.1%, Specificity = 62.1%, ROC Curve Distance = 0.54) and 83 cm in women (Sensitivity = 60.0%, Specificity = 59.6%, ROC Curve Distance = 0.57). Conclusion The prevalence of MetS in Kazakhs is higher than the national level of China and falls in between the Euro-American and Asia levels, as their cut-off points of waist circumference differ from that recommended for Chinese. We suggest a cost-effective strategy to screen for MetS and prevent cardiovascular disease using new cut-off points of waist circumference in low earning nomadic Kazakhs.	[Guo, Heng; Liu, Jiaming; Zhang, Jingyu; Ma, Rulin; Ding, Yusong; Zhang, Mei; He, Jia; Xu, Shangzhi; Li, Shugang; Yan, Yizhong; Mu, Lati; Rui, Dongsheng; Niu, Qiang; Guo, Shuxia] Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi 832000, Xinjiang, Peoples R China	Shihezi University	Guo, SX (corresponding author), Shihezi Univ, Sch Med, Dept Prevent Med, Shihezi 832000, Xinjiang, Peoples R China.	pge88@sina.com		zhong, yan/0000-0003-1957-5421	National Key Technology R&D Program of China [2009BAI82B04]; National Natural Science Foundation of China [81560551]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Key Technology R&D Program of China (Grant No. 2009BAI82B04) and National Natural Science Foundation of China (GrantNo.81560551), http://isisn.nsfc.gov.cn/egrantweb/. The funders contributed to study design, data collection, preparation of the manuscript, decision to publish.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arai H, 2006, J ATHEROSCLER THROMB, V13, P202, DOI 10.5551/jat.13.202; Banerji MA, 1999, J CLIN ENDOCR METAB, V84, P137, DOI 10.1210/jc.84.1.137; Black ML, 2006, HUM BIOL, V78, P277, DOI 10.1353/hub.2006.0041; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Du H, 2013, AM J CLIN NUTR, V97, P487, DOI DOI 10.3945/AJCN.112.046854; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ford ES, 2010, J DIABETES, V2, P180, DOI 10.1111/j.1753-0407.2010.00078.x; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; Hara K, 2006, DIABETES CARE, V29, P1123, DOI 10.2337/dc05-2540; Jiang JM, 2015, INT J CARDIOL, V179, P558, DOI 10.1016/j.ijcard.2014.10.077; Kaya E, 2015, J SEX MED, V12, P856, DOI 10.1111/jsm.12828; Kim HK, 2009, DIABETES RES CLIN PR, V85, P35, DOI 10.1016/j.diabres.2009.04.009; Liu F, 2014, BLOOD PRESSURE, V23, P154, DOI 10.3109/08037051.2013.838827; Lu Qingli, 2009, J Cardiometab Syndr, V4, P120, DOI 10.1111/j.1559-4572.2008.00045.x; Lu ZS, 2009, HYPERTENS RES, V32, P1097, DOI 10.1038/hr.2009.159; Ma X, 2014, ETHNIC DIS, V24, P316; Marcuello C, 2013, ACTA DIABETOL, V50, P615, DOI 10.1007/s00592-013-0468-8; Misra A, 2005, NUTRITION, V21, P969, DOI 10.1016/j.nut.2005.01.007; Misra A, 2004, NUTRITION, V20, P482, DOI 10.1016/j.nut.2004.01.020; Molarius A, 1999, J CLIN EPIDEMIOL, V52, P1213, DOI 10.1016/S0895-4356(99)00114-6; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; National Bureau of Statistics of China, TAB 2000 POP CENS PO; Ntandou G, 2009, NUTR RES, V29, P180, DOI 10.1016/j.nutres.2009.02.001; Saito I, 2012, CIRC J, V76, P1066, DOI 10.1253/circj.CJ-11-1519; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Song MY, 2002, J APPL PHYSIOL, V92, P2285, DOI 10.1152/japplphysiol.01066.2001; Song QB, 2015, DIABETES VASC DIS RE, V12, P189, DOI 10.1177/1479164114562410; Statistic Bureau of Xinjiang Uyghur Autonomous Region, XINJ STAT YB 2014; Wagner DR, 2000, AM J CLIN NUTR, V71, P1392; Wang F, 2009, NUTR METAB CARDIOVAS, V19, P542, DOI 10.1016/j.numecd.2008.11.006; Wang W, 2003, HUM GENET, V113, P244, DOI 10.1007/s00439-003-0948-y; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Yan WL, 2015, ETHNIC HEALTH, V20, P365, DOI 10.1080/13557858.2014.921894; Zhai Fengying, 2007, Wei Sheng Yan Jiu, V36, P539; Zhou Bei-fan, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P81; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148976	10.1371/journal.pone.0148976	http://dx.doi.org/10.1371/journal.pone.0148976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901035	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100033
J	Kelly, JD; Schlough, GW; Conteh, S; Barrie, MB; Kargbo, B; Giordano, TP				Kelly, J. Daniel; Schlough, Gabriel Warren; Conteh, Suleiman; Barrie, M. Bailor; Kargbo, Brima; Giordano, Thomas P.			The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis	PLOS ONE			English	Article							INFECTED PATIENTS; THERAPY; PREVENTION; RETENTION; CONTINUUM; MORTALITY; PROGRAMS; AFRICA; UGANDA	Background The heterogeneity of the pre-antiretroviral (pre-ART) population calls for more granular depictions of the cascade of HIV care. Methods We studied a prospective cohort of persons newly diagnosed with HIV infection from a single center in Freetown, Sierra Leone, over a 12-month period and then traced those persons who were lost to follow-up (LTFU) during pre-ART care (before ART initiation). ART eligibility was based on a CD4 cell count result of <= 350 mm/cells and/or WHO clinical stage 3 or 4. Persons who attended an appointment in the final three months were considered to be retained in care. Adherence to ART was measured using pharmacy refill dates. "Effective HIV care" was defined as completion of the cascade of care at 12-months regardless of whether patients are on ART. Tracing outcomes were obtained for those who were LTFU during pre-ART care. Results 408 persons newly diagnosed with HIV infection were screened, 338 were enrolled, and 255 persons were staged for ART. ART-ineligible persons had higher retention rates than ART-eligible persons (59.6% vs 41.8%, p = 0.03). 77 (22.8%) of 338 persons received effective HIV care. Most attrition (61.9%) occurred with persons during pre-ART care. 123 of 138 persons (89.1%) who were LTFU prior to ART initiation were found, and 91 of those 123 (74.0%) were alive. Of the 74 persons who were alive and described their engagement in care, 40 (54.1%) stopped care. Nearly half (42.5%) of those 40 stopped after assessment of ART-eligibility but before ART initiation. The main limitation of this study was the lack of tracing outcomes for those lost during ART care. Conclusions The majority of the pre-ART LTFU population stopped their care, particularly after ART-eligibility but before ART initiation. Interventions to hasten ART initiation and retain this at-risk group may have significant downstream impact on effective HIV care.	[Kelly, J. Daniel; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kelly, J. Daniel; Schlough, Gabriel Warren; Barrie, M. Bailor] Wellbody Alliance, Koidu Town, Sierra Leone; [Kelly, J. Daniel; Conteh, Suleiman; Kargbo, Brima] Natl HIV AIDS Secretariat, Freetown, Sierra Leone; [Conteh, Suleiman] Univ Sierra Leone, Coll Med & Allied Hlth Sci, Freetown, Sierra Leone	Baylor College of Medicine	Kelly, JD (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Kelly, JD (corresponding author), Wellbody Alliance, Koidu Town, Sierra Leone.; Kelly, JD (corresponding author), Natl HIV AIDS Secretariat, Freetown, Sierra Leone.	dan@wellbodyalliance.org		Giordano, Thomas/0000-0002-9346-5530	Fulbright Commission [48421297]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER	Fulbright Commission; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Fulbright Commission supported this work (Grant ID 48421297; http://www.cies.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Giordano Thomas P, 2005, Curr HIV/AIDS Rep, V2, P177, DOI 10.1007/s11904-005-0013-7; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Namusobya J, 2013, CLIN INFECT DIS, V57, P1343, DOI 10.1093/cid/cit490; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; World Health Organization, 2008, UN ACC SCAL PRIOR HI	19	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149584	10.1371/journal.pone.0149584	http://dx.doi.org/10.1371/journal.pone.0149584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901765	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100105
J	Martinez, M; Hinojosa, M; Trombly, D; Morin, V; Stein, J; Stein, G; Javed, A; Gutierrez, SE				Martinez, Milka; Hinojosa, Marcelo; Trombly, Daniel; Morin, Violeta; Stein, Janet; Stein, Gary; Javed, Amjad; Gutierrez, Soraya E.			Transcriptional Auto-Regulation of RUNX1 P1 Promoter	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; T-CELL DEVELOPMENT; ACUTE MYELOGENOUS LEUKEMIA; GENOME-WIDE ANALYSIS; HEMATOPOIETIC DEVELOPMENT; DEFINITIVE HEMATOPOIESIS; RUNX/CBFA/AML FACTORS; TARGETED DISRUPTION; AML1/RUNX1 GENE; SCL GENE	RUNX1 a member of the family of runt related transcription factors (RUNX), is essential for hematopoiesis. The expression of RUNX1 gene is controlled by two promoters; the distal P1 promoter and the proximal P2 promoter. Several isoforms of RUNX1 mRNA are generated through the use of both promoters and alternative splicing. These isoforms not only differs in their temporal expression pattern but also exhibit differences in tissue specificity. The RUNX1 isoforms derived from P2 are expressed in a variety of tissues, but expression of P1-derived isoform is restricted to cells of hematopoietic lineage. However, the control of hematopoietic-cell specific expression is poorly understood. Here we report regulation of P1-derived RUNX1 mRNA by RUNX1 protein. In silico analysis of P1 promoter revealed presence of two evolutionary conserved RUNX motifs, 0.6kb upstream of the transcription start site, and three RUNX motifs within 170bp of the 5'UTR. Transcriptional contribution of these RUNX motifs was studied in myeloid and T-cells. RUNX1 genomic fragment containing all sites show very low basal activity in both cell types. Mutation or deletion of RUNX motifs in the UTR enhances basal activity of the RUNX1 promoter. Chromatin immunoprecipitation revealed that RUNX1 protein is recruited to these sites. Overexpression of RUNX1 in non-hematopoietic cells results in a dose dependent activation of the RUNX1 P1 promoter. We also demonstrate that RUNX1 protein regulates transcription of endogenous RUNX1 mRNA in T-cell. Finally we show that SCL transcription factor is recruited to regions containing RUNX motifs in the promoter and the UTR and regulates activity of the RUNX1 P1 promoter in vitro. Thus, multiple lines of evidence show that RUNX1 protein regulates its own gene transcription.	[Martinez, Milka; Hinojosa, Marcelo; Morin, Violeta; Gutierrez, Soraya E.] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Trombly, Daniel; Stein, Janet; Stein, Gary] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 55 Lake Ave North, Worcester, MA 01655 USA; [Stein, Janet; Stein, Gary] Univ Vermont, Coll Med, Dept Biochem, 89 Beaumont Ave, Burlington, VT 05405 USA; [Stein, Janet; Stein, Gary] Univ Vermont, Coll Med, Vermont Canc Ctr, 89 Beaumont Ave, Burlington, VT 05405 USA; [Javed, Amjad] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA	Universidad de Concepcion; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont; University of Vermont; University of Alabama System; University of Alabama Birmingham	Gutierrez, SE (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile.	sgutierr@udec.cl		Javed, Amjad/0000-0002-0847-8266	SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130697]; AJ National Institute of Health [R01AR062091]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030228] Funding Source: NIH RePORTER	SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico; AJ National Institute of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico grant number 1130697 and AJ National Institute of Health grant number R01AR062091.	Bakshi R, 2008, J CELL SCI, V121, P3981, DOI 10.1242/jcs.033431; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ferjoux G, 2007, DEV BIOL, V305, P726, DOI 10.1016/j.ydbio.2007.03.010; Fujita Y, 2001, BIOCHEM BIOPH RES CO, V281, P1248, DOI 10.1006/bbrc.2001.4513; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ichikawa M, 2013, INT J HEMATOL, V97, P726, DOI 10.1007/s12185-013-1347-3; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li XG, 2005, J CELL BIOCHEM, V96, P795, DOI 10.1002/jcb.20548; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Mangan James K., 2011, Critical Reviews in Oncogenesis, V16, P77; Markova EN, 2011, J CELL BIOCHEM, V112, P1997, DOI 10.1002/jcb.23117; Michaud J, 2003, CANCER INVEST, V21, P105, DOI 10.1081/CNV-120018821; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; North T, 1999, DEVELOPMENT, V126, P2563; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Ohgami RS, 2015, INT J LAB HEMATOL, V37, P122, DOI 10.1111/ijlh.12367; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Seo W, 2012, IMMUNOL CELL BIOL, V90, P827, DOI 10.1038/icb.2012.6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Stuardo M, 2009, J CELL PHYSIOL, V218, P343, DOI 10.1002/jcp.21599; Sun LS, 2004, BLOOD, V103, P948, DOI 10.1182/blood-2003-07-2299; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Tijssen MR, 2013, J THROMB HAEMOST, V11, P593, DOI 10.1111/jth.12131; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100	59	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149119	10.1371/journal.pone.0149119	http://dx.doi.org/10.1371/journal.pone.0149119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901859	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100040
J	Nabokina, SM; Ramos, MB; Said, HM				Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.			Mechanism(S) Involved in the Colon-Specific Expression of the Thiamine Pyrophosphate (Tpp) Transporter	PLOS ONE			English	Article							WATER-SOLUBLE VITAMINS; INTESTINAL EPITHELIAL-CELLS; CPG ISLANDS; DNA METHYLATION; TRANSCRIPTION FACTOR; GENE; MICRORNAS; CHROMATIN; DIFFERENTIATION; PROMOTERS	Microbiota of the large intestine synthesizes considerable amount of vitamin B1 (thiamine) in the form of thiamine pyrophosphate (TPP). We have recently demonstrated the existence of an efficient and specific carrier-mediated uptake process for TPP in human colonocytes, identified the TPP transporter (TPPT) involved (product of the SLC44A4 gene), and shown that expression of TPPT along the gastrointestinal (GI) tract is restricted to the colon. Our aim in this study was to determine the molecular basis of the colon-specific expression of TPPT focusing on a possible epigenetic mechanism. Our results showed that the CpG island predicted in the SLC44A4 promoter is non-methylated in the human colonic epithelial NCM460 cells, but is hyper-methylated in the human duodenal epithelial HuTu80 cells (as well as in the human retinal pigment epithelial ARPE19 cells). In the mouse (where TPPT expression in the GI tract is also restricted to the colon), the CpG island predicted in the Slc44a4 promoter is non-methylated in both the jejunum and colon, thus arguing against possible contribution of DNA methylation in the colon-specific expression of TPPT. A role for histone modifications in the tissue-specific pattern of Slc44a4 expression, however, was suggested by the findings that in mouse colon, histone H3 in the 5'-regulatory region of Slc44a4 is tri-methylated at lysine 4 and acetylated at lysine 9, whereas the tri-methylation at lysine 27 modification was negligible. In contrast, in the mouse jejunum, histone H3 is hyper-trimethylated at lysine 27 (repressor mark). Similarly, possible involvement of miRNA (s) in the tissue-specific expression of TPPT was also suggested by the findings that the 3'-UTR of SLC44A4 is targeted by specific miRNAs/RNA binding proteins in non-colonic, but not in colonic, epithelial cells. These studies show, for the first time, epigenetic mechanisms (histone modifications) play a role in determining the tissue-specific pattern of expression of TPPT in the GI tract.	[Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Nabokina, Svetlana M.; Ramos, Mel Brendan; Said, Hamid M.] Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92697 USA; [Said, Hamid M.] Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Said, HM (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA.; Said, HM (corresponding author), Univ Calif Irvine, Dept Physiol Biophys, Irvine, CA 92697 USA.; Said, HM (corresponding author), Dept Vet Affairs Med Ctr, Long Beach, CA 90822 USA.	hmsaid@uci.edu			DVA; NIH [DK56061, DK58057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK056061, R01DK058057, R01DK056061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA018071] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001142] Funding Source: NIH RePORTER	DVA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Veterans Affairs(US Department of Veterans Affairs)	Supported by grants from the DVA and the NIH (DK56061 and DK58057).	Anbazhagan AN, 2014, AM J PHYSIOL-GASTR L, V306, pG123, DOI 10.1152/ajpgi.00222.2013; ANTEQUERA F, 1990, CELL, V62, P503, DOI 10.1016/0092-8674(90)90015-7; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Ayyadurai S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087614; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berdanier C.D., 1998, ADV NUTR MICRONUTRIE, P183; Bettendorff L, 2009, FEBS J, V276, P2917, DOI 10.1111/j.1742-4658.2009.07019.x; Blackledge NP, 2011, EPIGENETICS-US, V6, P147, DOI 10.4161/epi.6.2.13640; Calingasan NY, 1999, J NEUROPATH EXP NEUR, V58, P946, DOI 10.1097/00005072-199909000-00005; Dalmasso G, 2010, DIFFERENTIATION, V80, P147, DOI 10.1016/j.diff.2010.06.005; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Imai S, 2009, MOL PHARMACOL, V75, P568, DOI 10.1124/mol.108.052589; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kikuchi R, 2007, MOL PHARMACOL, V72, P1619, DOI 10.1124/mol.107.039701; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Malhotra P, 2014, J BIOL CHEM, V289, P23132, DOI 10.1074/jbc.M113.546283; Maruyama R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001369; McKenna LB, 2010, GASTROENTEROLOGY, V139, P1654, DOI 10.1053/j.gastro.2010.07.040; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nabokina SM, 2015, AM J PHYSIOL-CELL PH, V308, pC750, DOI 10.1152/ajpcell.00381.2014; Nabokina SM, 2014, J BIOL CHEM, V289, P4405, DOI 10.1074/jbc.M113.528257; Nabokina SM, 2012, AM J PHYSIOL-GASTR L, V303, pG389, DOI 10.1152/ajpgi.00151.2012; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oettgen P, 1997, MOL CELL BIOL, V17, P4419, DOI 10.1128/MCB.17.8.4419; Pekow JR, 2012, INFLAMM BOWEL DIS, V18, P187, DOI 10.1002/ibd.21691; Portari GV, 2008, BASIC CLIN PHARMACOL, V103, P482, DOI 10.1111/j.1742-7843.2008.00311.x; Qiao H, 2011, BIOCHEM J, V440, P73, DOI 10.1042/BJ20110392; Reidling JC, 2007, AM J PHYSIOL-GASTR L, V292, pG275, DOI 10.1152/ajpgi.00327.2006; Rindi G, 2000, P SOC EXP BIOL MED, V224, P246, DOI 10.1046/j.1525-1373.2000.22428.x; Said HM, 2015, WORLD REV NUTR DIET, V111, P30, DOI 10.1159/000362294; Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013; Said HM, 2011, BIOCHEM J, V437, P357, DOI 10.1042/BJ20110326; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singleton Charles K., 2001, Current Molecular Medicine (Hilversum), V1, P197, DOI 10.2174/1566524013363870; Tanphaichitr V., 1994, MODERN NUTR HLTH DIS, P359; Tumer E, 2013, J BIOL CHEM, V288, P33813, DOI 10.1074/jbc.M113.482760; Victor M., 1989, WERNICKE KORSAKOFF S, V2nd	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149255	10.1371/journal.pone.0149255	http://dx.doi.org/10.1371/journal.pone.0149255			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901654	Green Published, gold			2022-12-26	WOS:000371276100049
J	Tagawa, M; Maekawa, N; Konnai, S; Takagi, S				Tagawa, Michihito; Maekawa, Naoya; Konnai, Satoru; Takagi, Satoshi			Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma	PLOS ONE			English	Article							T-CELLS; CTLA-4; EXPRESSION; DOGS; CD152; FAMILY; PD-1; CD28; CCNU	Histiocytic sarcoma is a rapidly progressive and fatal neoplastic disease in dogs. It is unclear whether costimulatory molecules, including CD28, cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), and programmed death-1 (PD-1), are expressed on peripheral blood lymphocytes (PBLs) of canine patients with histiocytic sarcoma. The objective of this study was to evaluate the expression of CD28, CTLA-4, and PD-1 molecules on PBLs of patients with histiocytic sarcoma, patients with other tumors, and healthy controls. Twenty-six dogs were included in the study, with eight, ten, and eight dogs in the histiocytic sarcoma, other tumor, and healthy control groups, respectively. PBLs and serum were prospectively obtained from patients diagnosed histopathologically with histiocytic sarcoma, other tumors and healthy controls. The surface expression of CTLA-4, CD28, and PD-1 on T lymphocytes was examined using flow cytometric analysis. Serum samples were frozen at -30 degrees C until serum interferon-gamma (IFN-gamma) was measured by enzyme-linked immunosorbent assay. The expression level of CTLA-4 on CD4+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the control group. The expression of CTLA-4 on CD8+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the other two groups. In addition, the expression of PD-1 on CD8+ lymphocytes was significantly higher in the histiocytic sarcoma group than in the control group. However, no significant differences in CD28 expressions and serum IFN-gamma levels were observed. The present results provided evidence showing that the expression levels of CTLA-4 on both CD4+ and CD8+ lymphocytes and PD-1 on CD8+ lymphocytes in peripheral blood obtained from dogs with histiocytic sarcoma were upregulated. The overexpressions of CTLA 4 and PD-1 suggested that antitumor immunity may be suppressed in dogs with histiocytic sarcoma.	[Tagawa, Michihito] Obihiro Univ Agr & Vet Med, Ctr Vet Med, Dept Vet Clin Sci, Obihiro, Hokkaido 080, Japan; [Maekawa, Naoya; Konnai, Satoru] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sappro, Hokkaido, Japan; [Takagi, Satoshi] Hokkaido Univ, Dept Vet Clin Sci, Grad Sch Vet Med, Vet Teaching Hosp, Sappro, Hokkaido, Japan	Obihiro University of Agriculture & Veterinary Medicine; Hokkaido University; Hokkaido University	Takagi, S (corresponding author), Hokkaido Univ, Dept Vet Clin Sci, Grad Sch Vet Med, Vet Teaching Hosp, Sappro, Hokkaido, Japan.	stake@vetmed.hokudai.ac.jp		TAKAGI, Satoshi/0000-0001-6653-5890; Satoru, Konnai/0000-0002-3230-7109	JSPS [26450420]; Grants-in-Aid for Scientific Research [26450420, 25257415] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (https://www.jsps.go.jp/j-grantsinaid/index.html) Grant Numbers 26450420. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayukawa H, 2004, CLIN EXP IMMUNOL, V137, P151, DOI 10.1111/j.1365-2249.2004.02502.x; Brzezinska A, 2004, EXP GERONTOL, V39, P539, DOI 10.1016/j.exger.2003.09.026; Callahan MK, 2013, J LEUKOCYTE BIOL, V94, P41, DOI 10.1189/jlb.1212631; Capece D, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/926321; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Choi SY, 2005, PEDIAT ALLERG IMM-UK, V16, P422, DOI 10.1111/j.1399-3038.2005.00274.x; Craig LE, 2002, VET PATHOL, V39, P66, DOI 10.1354/vp.39-1-66; Erfani N, 2012, LUNG CANCER, V77, P306, DOI 10.1016/j.lungcan.2012.04.011; Esch KJ, 2013, J IMMUNOL, V191, P5542, DOI 10.4049/jimmunol.1301810; Folk A, 2010, VET IMMUNOL IMMUNOP, V134, P33, DOI 10.1016/j.vetimm.2009.10.006; Friedrichs KR, 2010, J VET INTERN MED, V24, P904, DOI 10.1111/j.1939-1676.2010.0543.x; Fulmer AK, 2007, CAN VET J, V48, P1041; Gardner D, 2014, AM J TRANSPLANT, V14, P1985, DOI 10.1111/ajt.12834; Graves SS, 2011, TRANSPLANTATION, V91, P833, DOI 10.1097/TP.0b013e31820f07ff; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; KOL R, 1983, RADIAT RES, V95, P108, DOI 10.2307/3576075; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Li J, 2014, ONCOL LETT, V8, P1682, DOI 10.3892/ol.2014.2391; Moore PF, 2006, VET PATHOL, V43, P632, DOI 10.1354/vp.43-5-632; Moore PF, 2014, VET PATHOL, V51, P167, DOI 10.1177/0300985813510413; Motta M, 2005, LEUKEMIA, V19, P1788, DOI 10.1038/sj.leu.2403907; Nielsen LN, 2012, VET COMP ONCOL, V10, P124, DOI 10.1111/j.1476-5829.2011.00285.x; Nielsen LN, 2013, VET J, V198, P424, DOI 10.1016/j.tvjl.2013.07.030; Ott PA, 2013, CLIN CANCER RES, V19, P5300, DOI 10.1158/1078-0432.CCR-13-0143; Rassnick KM, 2010, J VET INTERN MED, V24, P1528, DOI 10.1111/j.1939-1676.2010.0588.x; Saito H, 2013, J SURG ONCOL, V107, P517, DOI 10.1002/jso.23281; Sakai M, 2006, J VET MED SCI, V68, P1219, DOI 10.1292/jvms.68.1219; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Skorupski KA, 2007, J VET INTERN MED, V21, P121, DOI 10.1892/0891-6640(2007)21[121:CFTTOD]2.0.CO;2; Takahashi M, 2014, J VET MED SCI, V76, P661, DOI 10.1292/jvms.13-0414; Tosti G, 2013, CLIN COSMET INVESTI, V6, P245, DOI 10.2147/CCID.S24246; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wulfing C, 2014, NAT IMMUNOL, V15, P408, DOI 10.1038/ni.2870; Yamazaki H, 2014, J VET INTERN MED, V28, P204, DOI 10.1111/jvim.12244	38	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150030	10.1371/journal.pone.0150030	http://dx.doi.org/10.1371/journal.pone.0150030			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901565	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100202
J	Teng, JA; Wu, SG; Chen, JX; Li, Q; Peng, F; Zhu, Z; Qin, J; He, ZY				Teng, Jia-An; Wu, San-Gang; Chen, Jia-Xin; Li, Qiang; Peng, Fang; Zhu, Zhou; Qin, Jian; He, Zhen-Yu			The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							GROWTH-FACTOR-I; COLORECTAL-CANCER; DOWN-REGULATION; RODENT MODELS; RISK-FACTOR; PROLIFERATION; METAANALYSIS; PATHWAYS; P38	Previous studies showed that type 2 diabetes mellitus (T2DM) is linked to increased risk of developing colon cancer. Insulin and insulin-like growth factor 1 (IGF-1) are increased in patients with T2DM. The increased insulin and IGF-1 may be responsible for the developing of colon cancer. In this study, we investigated the effects and mechanisms of insulin and IGF-1 in colon cancer development in vitro and in vivo. Insulin and IGF-1 alone or together elevated proliferation and reduced apoptosis in colon cancer MC38 cells. Meanwhile, insulin and IGF-1 promoted the phosphorylation of extracellular-signal regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK). Treatment with ERK1/2 or JNK inhibitor in the presence of insulin and IGF-1 significantly decreased B-cell lymphoma 2 (Bcl-2) and increased Bcl-2-associated X protein (Bax) expression and finally increased apoptosis and inhibited the proliferation. Accelerative colon tumor growth was found in a mouse model of T2DM with db/db mice which got high level of endogenous insulin and IGF-1. Furthermore, the inhibition of ERK1/2 or JNK suppressed the development of colon tumor in vivo. These results suggest that the activation of ERK1/2 and JNK signaling by insulin and IGF-1, at least in part, is responsible for the development of colon cancer with T2DM.	[Teng, Jia-An] Peoples Hosp Guangxi Zhuang Autonomous Reg, Div Endocrinol & Metab, Dept Cadre Med, Nanning, Peoples R China; [Wu, San-Gang] Xiamen Univ, Dept Radiat Oncol, Xiamen Canc Ctr, Affiliated Hosp 1, Xiamen, Peoples R China; [Chen, Jia-Xin; Qin, Jian] Peoples Hosp Guangxi Zhuang Autonomous Reg, Ctr Clin Canc, Dept Radiat Oncol, Nanning, Peoples R China; [Li, Qiang] Cent S Univ, Xiangya Hosp 2, Dept Surg, Organ Transplantat Ctr, Changsha, Hunan, Peoples R China; [Peng, Fang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Zhou] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastrointestinal & Peripheral Vasc Surg, Nanning, Peoples R China; [He, Zhen-Yu] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Xiamen University; Central South University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Qin, J (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Ctr Clin Canc, Dept Radiat Oncol, Nanning, Peoples R China.; He, ZY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	janusy@126.com; hezhy@sysucc.org.cn	Wu, San-Gang/AAA-8959-2022		National Natural Science Foundation of China [81160107]; Guangxi Science Research and Technique Development Plan Foundation [1104003B-69]; Guangxi Natural Science Foundation [2010GXNSFB013083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Research and Technique Development Plan Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study is supported by the National Natural Science Foundation of China (No. 81160107, JAT), Guangxi Science Research and Technique Development Plan Foundation (No. 1104003B-69, JQ), and Guangxi Natural Science Foundation (No. 2010GXNSFB013083, JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Badrick E, 2014, EUR J CANCER, V50, P2119, DOI 10.1016/j.ejca.2014.04.032; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; CORBETT TH, 1975, CANCER RES, V35, P2434; Dasari A, 2010, CLIN CANCER RES, V16, P3811, DOI 10.1158/1078-0432.CCR-09-2283; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Gogg S, 2009, DIABETES, V58, P2238, DOI 10.2337/db08-0961; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; Hirose Y, 2004, CARCINOGENESIS, V25, P821, DOI 10.1093/carcin/bgh059; Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513; Karlstad O, 2013, CURR DRUG SAF, V8, P333, DOI 10.2174/15680266113136660067; Khalili H, 2012, DIGEST DIS SCI, V57, P1427, DOI 10.1007/s10620-012-2175-7; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; LEROITH D, 1995, ANN INTERN MED, V122, P54, DOI 10.7326/0003-4819-122-1-199501010-00009; Li DH, 2011, CANCER CAUSE CONTROL, V22, P189, DOI 10.1007/s10552-010-9686-3; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; MCLAUGHLIN JK, 2013, FALSE POSITIVES CANC, V22, P11, DOI DOI 10.1158/1055-9965.EPI-12-0995; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Qin J, 2015, HORM METAB RES, V47, P861, DOI 10.1055/s-0034-1398564; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Teng JA, 2011, HORM METAB RES, V43, P519, DOI 10.1055/s-0031-1280780; [滕家安 TENG Jiaan], 2010, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V37, P152; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Urosevic J, 2014, CELL CYCLE, V13, P2641, DOI 10.4161/15384101.2014.946374; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vigneri PG, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00230; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7; Zhu CF, 2011, J CANCER RES CLIN, V137, P1587, DOI 10.1007/s00432-011-1049-2	44	35	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149822	10.1371/journal.pone.0149822	http://dx.doi.org/10.1371/journal.pone.0149822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901856	gold, Green Submitted, Green Published			2022-12-26	WOS:000371276100160
J	Wen, SW; Guo, YF; Rodger, M; White, RR; Yang, QY; Smith, GN; Perkins, SL; Walker, MC				Wen, Shi Wu; Guo, Yanfang; Rodger, Marc; White, Ruth Rennicks; Yang, Qiuying; Smith, Graeme N.; Perkins, Sherry L.; Walker, Mark C.			Folic Acid Supplementation in Pregnancy and the Risk of Pre-Eclampsia-A Cohort Study	PLOS ONE			English	Article							PERICONCEPTIONAL MULTIVITAMIN USE; HYPERTENSIVE DISORDERS; PREECLAMPSIA; WOMEN; FOLATE; COMPLICATIONS; MORTALITY; MOTHERS	This prospective cohort study designed to assess the effect of folic acid supplementation in pregnancy on the risk of preeclampsia (PE) took place in Ottawa, ON and Kingston, ON, Canada, from September 1, 2002 to August 31, 2008. Pregnant women, less than 20 weeks gestational age were recruited and delivered in the Ottawa region and the Kingston General Hospital. Demographic characteristics of the study participants and the patterns of supplementation of folic acid were described and occurrence of PE between women with folic acid supplementation during pregnancy and women without were compared. Multiple logistic regression was used in the estimation of the independent effect of supplementation of folic acid. Additional analyses assessing the effect of low RBC and serum folate and dose-response relationship were performed. Analyses were performed in all study participants, and then in high risk and low risk sub-groups, respectively. A total of 7,669 participants were included in the final analysis. Ninety five percent of the study participants were taking folic acid supplementation in early second trimester. The rate of PE was lower in the supplementation group than in the no supplementation group, and the difference was statistically significant in high risk women. Similar patterns of associations were observed in analysis by RBC and serum folate levels and in dose-response analysis. Folic acid supplementation in pregnancy may reduce PE risk in pregnant women, especially in those women with increased risk of developing PE.	[Wen, Shi Wu; Guo, Yanfang; White, Ruth Rennicks; Walker, Mark C.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, OMNI Res Grp, Ottawa, ON, Canada; [Wen, Shi Wu; Guo, Yanfang; Rodger, Marc; White, Ruth Rennicks; Walker, Mark C.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Wen, Shi Wu; Rodger, Marc; Walker, Mark C.] Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada; [Rodger, Marc] Univ Ottawa, Fac Med, Div Hematol, Dept Med, Ottawa, ON, Canada; [Yang, Qiuying] Publ Hlth Agcy Canada, Ottawa, ON, Canada; [Smith, Graeme N.] Kingston Gen Hosp, Queens Perinatal Res Unit, Kingston, ON K7L 2V7, Canada; [Smith, Graeme N.] Queens Univ, Dept Obstet & Gynecol, Sch Med, Kingston, ON, Canada; [Perkins, Sherry L.] Ottawa Hosp, Div Biochem, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Public Health Agency of Canada; Queens University - Canada; Queens University - Canada; University of Ottawa; Ottawa Hospital Research Institute	Wen, SW (corresponding author), Univ Ottawa, Fac Med, Dept Obstet & Gynecol, OMNI Res Grp, Ottawa, ON, Canada.; Wen, SW (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Wen, SW (corresponding author), Univ Ottawa, Fac Med, Sch Epidemiol Publ Hlth & Prevent Med, Ottawa, ON, Canada.	swwen@ohri.ca	Smith, Graeme Neil/ABB-6863-2021	Smith, Graeme Neil/0000-0002-3128-4523; Rodger, Marc/0000-0001-8166-3487	Canadian Institute for Health Research [MOP 82802]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant from the Canadian Institute for Health Research (grant #MOP 82802).	ACOG Task Force on Hypertension in Pregnancy, 2013, OBSTET GYNECOLOGY, V122, DOI [10.1097/01.AOG.0000437382.03963.88, DOI 10.1097/01.AOG.0000437382.03963.88]; ALES KL, 1988, J CLIN EPIDEMIOL, V41, P1095, DOI 10.1016/0895-4356(88)90079-0; BARKER DJP, 1989, LANCET, V2, P577; Bodnar LM, 2006, AM J EPIDEMIOL, V164, P470, DOI 10.1093/aje/kwj218; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Catov JM, 2009, AM J EPIDEMIOL, V169, P1304, DOI 10.1093/aje/kwp052; de la Calle M, 2003, EUROPEAN J OBSTET GY, V107, P125; Dekker GA, 1998, AM J OBSTET GYNECOL, V179, P1359, DOI 10.1016/S0002-9378(98)70160-7; GOLDENBERG RL, 1992, OBSTET GYNECOL, V79, P719; Hernandez-Diaz S, 2002, AM J EPIDEMIOL, V156, P806, DOI 10.1093/aje/kwf129; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001; Kupferminc MJ, 1999, NEW ENGL J MED, V340, P9, DOI 10.1056/NEJM199901073400102; Liu AZ, 2009, HYPERTENS PREGNANCY, V28, P76, DOI 10.1080/10641950802366252; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Nilsen RM, 2008, AM J EPIDEMIOL, V167, P867, DOI 10.1093/aje/kwm373; Paul DA, 2009, AM J PERINAT, V26, P467, DOI 10.1055/s-0029-1214246; Peek MJ, 1995, MED J AUSTR, V162; Ray JG, 1999, PLACENTA, V20, P519, DOI 10.1053/plac.1999.0417; Roberts JM, 2002, PLACENTA, V23, P359, DOI 10.1053/plac.2002.0819; Sen S, 2014, J PERINATOL, V34, P105, DOI 10.1038/jp.2013.153; Smith GN, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.06.035; Timmermans S, 2011, NUTR METAB CARDIOVAS, V21, P54, DOI 10.1016/j.numecd.2009.07.002; Vogel JP1, 2014, BMC PREGNANCY CHILDB, V14; Vollset SE, 2000, AM J CLIN NUTR, V71, P962; Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859; Wen SW, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.067; Whitfield MF, 1997, ADC FETAL NEONATAL E, V77; World Health Organization, 2015, OPT SER RED BLOOD CE; Yaremco E, 2013, BIRTH DEFECTS RES A, V97, P416, DOI 10.1002/bdra.23144; Zhang J, 2003, HYPERTENS PREGNANCY, V22, P203, DOI 10.1081/PRG-120021066	31	29	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149818	10.1371/journal.pone.0149818	http://dx.doi.org/10.1371/journal.pone.0149818			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901463	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100157
J	Schele, E; Bake, T; Rabasa, C; Dickson, SL				Schele, Erik; Bake, Tina; Rabasa, Cristina; Dickson, Suzanne L.			Centrally Administered Ghrelin Acutely Influences Food Choice in Rodents	PLOS ONE			English	Article							INCREASES; REWARD; EXPRESSION; DIET; PREFERENCES; SELECTION; PEPTIDE; MEAL	We sought to determine whether the orexigenic hormone, ghrelin, is involved in the intrinsic regulation of food choice in rats. Ghrelin would seem suited to serve such a role given that it signals hunger information from the stomach to brain areas important for feeding control, including the hypothalamus and reward system (e. g. ventral tegmental area, VTA). Thus, in rats offered a choice of palatable foods (sucrose pellets and lard) superimposed on regular chow for 2 weeks, we explored whether acute central delivery of ghrelin (intracerebroventricular (ICV) or intra-VTA) is able to redirect their dietary choice. The major unexpected finding is that, in rats with high baseline lard intake, acute ICV ghrelin injection increased their chow intake over 3-fold, relative to vehicle-injected controls, measured at both 3 hr and 6 hr after injection. Similar effects were observed when ghrelin was delivered to the VTA, thereby identifying the VTA as a likely contributing neurobiological substrate for these effects. We also explored food choice after an overnight fast, when endogenous ghrelin levels are elevated, and found similar effects of dietary choice to those described for ghrelin. These effects of fasting on food choice were suppressed in models of suppressed ghrelin signaling (i. e. peripheral injection of a ghrelin receptor antagonist to rats and ghrelin receptor (GHSR) knock-out mice), implicating a role for endogenous ghrelin in the changes in food choice that occur after an overnight fast. Thus, in line with its role as a gut-brain hunger hormone, ghrelin appears to be able to acutely alter food choice, with notable effects to promote "healthy" chow intake, and identify the VTA as a likely contributing neurobiological substrate for these effects.	[Schele, Erik; Bake, Tina; Rabasa, Cristina; Dickson, Suzanne L.] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Dickson, SL (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	Suzanne.Dickson@gu.se	Dickson, Suzanne L/U-4628-2019	Bake, Tina/0000-0003-0500-5129; Dickson, Suzanne/0000-0002-3822-5294	EC project "Nudge-it" [607310]; Swedish Research Council for Medicine (Vetenskapsradet) [2012-1758]; Avtal om Lakarutbildning och Forskning [ALFBGB-138741]; Novo Nordisk Fonden [NNF12OC1016479, NNF13OC0004819] Funding Source: researchfish	EC project "Nudge-it"; Swedish Research Council for Medicine (Vetenskapsradet); Avtal om Lakarutbildning och Forskning; Novo Nordisk Fonden(Novo Nordisk Foundation)	Research supported by the EC project "Nudge-it" ( grant agreement number 607310), by the Swedish Research Council for Medicine (Vetenskapsradet, grant number 2012-1758) and by Avtal om Lakarutbildning och Forskning (ALFBGB-138741). (SLD) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Bagnasco M, 2002, ENDOCRINOLOGY, V143, P726, DOI 10.1210/en.143.2.726; Bomberg EM, 2007, NEUROREPORT, V18, P591, DOI 10.1097/WNR.0b013e3280b07bb5; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Druce MR, 2006, INT J OBESITY, V30, P293, DOI 10.1038/sj.ijo.0803158; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; King SJ, 2011, HORM BEHAV, V60, P572, DOI 10.1016/j.yhbeh.2011.08.006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; la Fleur SE, 2010, INT J OBESITY, V34, P537, DOI 10.1038/ijo.2009.257; Laurenius A, 2013, EUR J CLIN NUTR, V67, P168, DOI 10.1038/ejcn.2012.208; Lucas F, 1996, CHEM SENSES, V21, P169, DOI 10.1093/chemse/21.2.169; Mela DJ, 1999, P NUTR SOC, V58, P513, DOI 10.1017/S0029665199000683; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Perello M, 2015, J NEUROENDOCRINOL, V27, P424, DOI 10.1111/jne.12236; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2013, NEUROPHARMACOLOGY, V73, P274, DOI 10.1016/j.neuropharm.2013.06.004; Skibicka KP, 2012, ENDOCRINOLOGY, V153, P1194, DOI 10.1210/en.2011-1606; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Smith BK, 1997, PEPTIDES, V18, P207, DOI 10.1016/S0196-9781(96)00318-X; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P384, DOI 10.1016/j.euroneuro.2010.06.005; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	34	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149456	10.1371/journal.pone.0149456	http://dx.doi.org/10.1371/journal.pone.0149456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925974	Green Submitted, gold, Green Published			2022-12-26	WOS:000371424200010
J	Keskin, I; Forsgren, E; Lange, DJ; Weber, M; Birve, A; Synofzik, M; Gilthorpe, JD; Andersen, PM; Marklund, SL				Keskin, Isil; Forsgren, Elin; Lange, Dale J.; Weber, Markus; Birve, Anna; Synofzik, Matthis; Gilthorpe, Jonathan D.; Andersen, Peter M.; Marklund, Stefan L.			Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SUPEROXIDE DISMUTASE-1; MOTOR-NEURON DISEASE; WILD-TYPE; OXIDATIVE-PHOSPHORYLATION; CULTURE MODEL; SPINAL-CORD; MOUSE MODEL; SOD1; MUTATIONS	Mutations in superoxide dismutase-1 (SOD1) are a common known cause of amyotrophic lateral sclerosis (ALS). The neurotoxicity of mutant SOD1s is most likely caused by misfolded molecular species, but disease pathogenesis is still not understood. Proposed mechanisms include impaired mitochondrial function, induction of endoplasmic reticulum stress, reduction in the activities of the proteasome and autophagy, and the formation of neurotoxic aggregates. Here we examined whether perturbations in these cellular pathways in turn influence levels of misfolded SOD1 species, potentially amplifying neurotoxicity. For the study we used fibroblasts, which express SOD1 at physiological levels under regulation of the native promoter. The cells were derived from ALS patients expressing 9 different SOD1 mutants of widely variable molecular characteristics, as well as from patients carrying the GGGGCC-repeat-expansion in C9orf72 and from non-disease controls. A specific ELISA was used to quantify soluble, misfolded SOD1, and aggregated SOD1 was analysed by western blotting. Misfolded SOD1 was detected in all lines. Levels were found to be much lower in non-disease control and the non-SOD1 C9orf72 ALS lines. This enabled us to validate patient fibroblasts for use in subsequent perturbation studies. Mitochondrial inhibition, endoplasmic reticulum stress or autophagy inhibition did not affect soluble misfolded SOD1 and in most cases, detergent-resistant SOD1 aggregates were not detected. However, proteasome inhibition led to uniformly large increases in misfolded SOD1 levels in all cell lines and an increase in SOD1 aggregation in some. Thus the ubiquitin-proteasome pathway is a principal determinant of misfolded SOD1 levels in cells derived both from patients and controls and a decline in activity with aging could be one of the factors behind the mid-to late-life onset of inherited ALS.	[Keskin, Isil; Forsgren, Elin; Birve, Anna; Gilthorpe, Jonathan D.; Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Lange, Dale J.] Hosp Special Surg, Dept Neurol, New York, NY USA; [Lange, Dale J.] Weill Cornell Med Ctr, New York, NY USA; [Weber, Markus] Kantonsspital St Gallen, ALS Clin, Neuromusucular Dis Unit, St Gallen, Switzerland; [Synofzik, Matthis] Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Clin Chem, Umea, Sweden	Umea University; Cornell University; Kantonsspital St. Gallen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Umea University	Marklund, SL (corresponding author), Umea Univ, Dept Med Biosci, Clin Chem, Umea, Sweden.	stefan.marklund@umu.se	Weber, Markus/AAI-7138-2020	KESKIN, ISIL/0000-0003-3690-3116; Gilthorpe, Jonathan/0000-0002-6884-4774; Synofzik, Matthis/0000-0002-2280-7273	Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Torsten and Ragnar Soderberg Foundation; Swedish Brain Foundation; Stratneuro initiative; Vasterbotten County Council; Kempe Foundation; Neuroforbundet; Ulla-Carin Lindquist Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Torsten and Ragnar Soderberg Foundation; Swedish Brain Foundation; Stratneuro initiative; Vasterbotten County Council; Kempe Foundation; Neuroforbundet; Ulla-Carin Lindquist Foundation	The study was supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, the Torsten and Ragnar Soderberg Foundation, the Swedish Brain Foundation, the Stratneuro initiative, the Vasterbotten County Council, the Kempe Foundation, Neuroforbundet and the Ulla-Carin Lindquist Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Allen SP, 2014, NEUROBIOL AGING, V35, P1499, DOI 10.1016/j.neurobiolaging.2013.11.025; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Charcot JM, 1873, LECONS MALADIES SYST, P163; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2012, AMYOTROPH LATERAL SC, V13, P367, DOI 10.3109/17482968.2012.686511; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Marklund SL, 1997, J NEUROCHEM, V69, P675; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Paramore A, 2003, NAT REV DRUG DISCOV, V2, P611, DOI 10.1038/nrd1159; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Synofzik M, 2012, HUM MOL GENET, V21, P3568, DOI 10.1093/hmg/dds188; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Zetterstrom P, 2013, NEUROMOL MED, V15, P147, DOI 10.1007/s12017-012-8204-z; Zetterstrom P, 2011, J NEUROCHEM, V117, P91, DOI 10.1111/j.1471-4159.2011.07177.x; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150133	10.1371/journal.pone.0150133	http://dx.doi.org/10.1371/journal.pone.0150133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919046	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400090
J	Shah, JD; Desai, PT; Zhang, Y; Scharber, SK; Baller, J; Xing, ZS; Cardona, CJ				Shah, Jigna D.; Desai, Prerak T.; Zhang, Ying; Scharber, Sarah K.; Baller, Joshua; Xing, Zheng S.; Cardona, Carol J.			Development of the Intestinal RNA Virus Community of Healthy Broiler Chickens	PLOS ONE			English	Article							ENTERIC VIRUSES; COMMERCIAL CHICKEN; POULT ENTERITIS; ROTAVIRUS	Several RNA viruses such as astrovirus, rotavirus, reovirus and parvovirus have been detected in both healthy and diseased commercial poultry flocks. The aim of this study was to characterize (a) the development of the RNA viral community in the small intestines of healthy broiler chickens from hatch through 6 weeks of age (market age) and (b) the contribution of the breeder source vs. bird age in development of the community structure. Intestinal tissue samples were harvested from breeders and their progeny, processed for viral RNA extraction and sequenced using Illumina Hiseq sequencing technology resulting in 100 bp PE reads. The results from this study indicated that the breeder source influenced the RNA viral community only at hatch but later environment i.e. bird age had the more significant effect. The most abundant RNA viral family detected at 2, 4 and 6 weeks of age was Astroviridae, which decreased in abundance with age while the abundance of Picornaviridae increased with age.	[Shah, Jigna D.; Scharber, Sarah K.; Xing, Zheng S.; Cardona, Carol J.] Univ Minnesota, Vet & Biomed Sci, St Paul, MN 55108 USA; [Zhang, Ying; Baller, Joshua] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA; [Desai, Prerak T.] Univ Calif Irvine, Microbiol & Mol Genet, Irvine, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	Cardona, CJ (corresponding author), Univ Minnesota, Vet & Biomed Sci, St Paul, MN 55108 USA.	ccardona@umn.edu	Xing, Zheng/O-3137-2015; Desai, Prerak/ABF-8529-2020	Xing, Zheng/0000-0002-7288-0268; Knack, Sarah/0000-0002-4220-0866; Zhang, Ying/0000-0003-3764-7329; Baller, Joshua/0000-0003-3936-7953	Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota	Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota	This work was partially supported by the funding received from the Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Canelli E, 2012, AVIAN DIS, V56, P173, DOI 10.1637/9831-061311-Reg.1; Ciarlet M, 2001, CURR OPIN MICROBIOL, V4, P435, DOI 10.1016/S1369-5274(00)00232-0; Dhama K, 2015, VET QUART, V35, P211, DOI 10.1080/01652176.2015.1063023; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Gagic M, 1999, AVIAN DIS, V43, P293, DOI 10.2307/1592620; Heggen-Peay CL, 2002, AVIAN DIS, V46, P32, DOI 10.1637/0005-2086(2002)046[0032:IOARFP]2.0.CO;2; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Koo BS, 2013, POULTRY SCI, V92, P2876, DOI 10.3382/ps.2013-03280; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P674, DOI 10.1637/0005-2086(2007)51[674:PMOCTF]2.0.CO;2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah JD, 2014, J VIROL METHODS, V209, P15, DOI 10.1016/j.jviromet.2014.08.011; Tamehiro CY, 2003, BRAZ J MICROBIOL, V34, P349, DOI 10.1590/S1517-83822003000400013; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Zsak L, 2008, AVIAN PATHOL, V37, P435, DOI 10.1080/03079450802210648	19	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150094	10.1371/journal.pone.0150094	http://dx.doi.org/10.1371/journal.pone.0150094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914580	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700053
J	Shorter, SK; Schnell, FJ; McMaster, SR; Pinelli, DF; Andargachew, R; Evavold, BD				Shorter, Shayla K.; Schnell, Frederick J.; McMaster, Sean R.; Pinelli, David F.; Andargachew, Rakieb; Evavold, Brian D.			Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses	PLOS ONE			English	Article							ALTERED PEPTIDE LIGANDS; REGULATORY FACTOR 4; EFFECTOR FUNCTION; CLONAL EXPANSION; SIGNALING PATHWAYS; CHRONIC INFECTION; RECEPTOR; ACTIVATION; DIFFERENTIATION; PROLIFERATION	T cells have the remarkable ability to recognize antigen with great specificity and in turn mount an appropriate and robust immune response. Critical to this process is the initial T cell antigen recognition and subsequent signal transduction events. This antigen recognition can be modulated at the site of TCR interaction with peptide: major histocompatibility (pMHC) or peptide interaction with the MHC molecule. Both events could have a range of effects on T cell fate. Though responses to antigens that bind sub-optimally to TCR, known as altered peptide ligands (APL), have been studied extensively, the impact of disrupting antigen binding to MHC has been highlighted to a lesser extent and is usually considered to result in complete loss of epitope recognition. Here we present a model of viral evasion from CD8 T cell immuno-surveillance by a lymphocytic choriomeningitis virus (LCMV) escape mutant with an epitope for which TCR affinity for pMHC remains high but where the antigenic peptide binds sub optimally to MHC. Despite high TCR affinity for variant epitope, levels of interferon regulatory factor-4 (IRF4) are not sustained in response to the variant indicating differences in perceived TCR signal strength. The CD8+ T cell response to the variant epitope is characterized by early proliferation and up-regulation of activation markers. Interestingly, this response is not maintained and is characterized by a lack in IL-2 and IFN. production, increased apoptosis and an abrogated glycolytic response. We show that disrupting the stability of peptide in MHC can effectively disrupt TCR signal strength despite unchanged affinity for TCR and can significantly impact the CD8+ T cell response to a viral escape mutant.	[Shorter, Shayla K.; Schnell, Frederick J.; McMaster, Sean R.; Pinelli, David F.; Andargachew, Rakieb; Evavold, Brian D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Evavold, BD (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	bevavol@emory.edu		Evavold, Brian/0000-0002-3561-3494	National Institute of Neurological Disorders and Stroke (NINDS) [5R01NS071518-03]; National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI096879-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096879, T32AI007610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016388] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/) 5R01NS071518-03 and the National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/) 1R01AI096879-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Benczik M, 2004, IMMUNOL INVEST, V33, P109, DOI 10.1081/IMM-120030732; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Brodovitch A, 2015, EUR J IMMUNOL, V45, P1635, DOI 10.1002/eji.201445214; Bronke C, 2013, AIDS, V27, P899, DOI 10.1097/QAD.0b013e32835e1616; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buhrman JD, 2013, IMMUNOL RES, V55, P34, DOI 10.1007/s12026-012-8348-9; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Edwards LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00086; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Katsara M, 2008, EXPERT OPIN BIOL TH, V8, P1873, DOI 10.1517/14712590802494501 ; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Ream RM, 2010, J IMMUNOL, V184, P2401, DOI 10.4049/jimmunol.0902448; Rosenthal KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032562; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Schnell FJ, 2009, J IMMUNOL, V182, P1829, DOI 10.4049/jimmunol.0801798; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Sereti I, 2000, CLIN IMMUNOL, V97, P266, DOI 10.1006/clim.2000.4929; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wasserman HA, 2008, J IMMUNOL, V181, P6843, DOI 10.4049/jimmunol.181.10.6843; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149582	10.1371/journal.pone.0149582	http://dx.doi.org/10.1371/journal.pone.0149582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915099	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700020
J	Pivovarciova, A; Durdiakova, J; Babinska, K; Kubranska, A; Vokalova, L; Minarik, G; Celec, P; Murin, M; Ostatnikova, D				Pivovarciova, Anna; Durdiakova, Jaroslava; Babinska, Katarina; Kubranska, Aneta; Vokalova, Lenka; Minarik, Gabriel; Celec, Peter; Murin, Marianna; Ostatnikova, Daniela			Testosterone and Androgen Receptor Sensitivity in Relation to Hyperactivity Symptoms in Boys with Autism Spectrum Disorders	PLOS ONE			English	Article							BEHAVIOR RATING FORM; PERVASIVE DEVELOPMENTAL DISORDERS; SALIVARY TESTOSTERONE; DIGIT RATIO; CAG REPEAT; YOUNG-PEOPLE; CHILDREN; ADHD; GENE; ADOLESCENTS	Introduction Autism spectrum disorders (ASD) and hyperactivity symptoms exhibit an incidence that is male-biased. Thus androgen activity can be considered a plausible biological risk factor for these disorders. However, there is insufficient information about the association between increased androgen activity and hyperactivity symptoms in children with ASD. Methods In the present study, the relationship between parameters of androgenicity (plasmatic testosterone levels and androgen receptor sensitivity) and hyperactivity in 60 boys (age 3-15) with ASD is investigated. Given well documented differences in parent and trained examiners ratings of symptom severity, we employed a standardized parent's questionnaire (Nisonger Child Behavior Rating Form) as well as a direct examiner's rating (Autism diagnostic observation schedule) for assessment of hyperactivity symptoms. Results Although it was found there was no significant association between actual plasmatic testosterone levels and hyperactivity symptoms, the number of CAG triplets was significantly negatively correlated with hyperactivity symptoms (R-2 = 0.118, p = 0.007) in the sample, indicating increased androgen receptor sensitivity in association with hyperactivity symptoms. Direct trained examiner's assessment appeared to be a relevant method for evaluating of behavioral problems in the investigation of biological underpinnings of these problems in our study. Conclusions A potential ASD subtype characterized by increased rates of hyperactivity symptoms might have distinct etiopathogenesis and require a specific behavioral and pharmacological approach. We propose an increase of androgen receptor sensitivity as a biomarker for a specific ASD subtype accompanied with hyperactivity symptoms. Findings are discussed in terms of their implications for practice and future research.	[Pivovarciova, Anna; Durdiakova, Jaroslava; Babinska, Katarina; Kubranska, Aneta; Vokalova, Lenka; Ostatnikova, Daniela] Comenius Univ, Fac Med, Inst Physiol, Acad Res Ctr Autism, Bratislava, Slovakia; [Minarik, Gabriel] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Celec, Peter] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Murin, Marianna] Great Ormond St Hosp Sick Children, Social Commun Disorders Clin, Dept Child & Adolescent Mental Hlth, Great Ormond St, London WC1N 3JH, England	Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; Comenius University Bratislava; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Pivovarciova, A (corresponding author), Comenius Univ, Fac Med, Inst Physiol, Acad Res Ctr Autism, Bratislava, Slovakia.	anna.pivovarciova@gmail.com	Ostatnikova, Daniela/AAD-1359-2019; Celec, Peter/I-7103-2012; Babinská, Katarína/AAC-9817-2019	Celec, Peter/0000-0001-5883-3580; Babkova, Jaroslava/0000-0003-2492-8391; Babinska, Katarina/0000-0002-0385-025X; Ostatnikova, Daniela/0000-0002-4960-5057	University Science Park for Biomedicine Bratislava [ITMS 26240220087]; Slovak research and development agency [APVV 0254-11]; Ministry of Education of the Slovak Republic; Slovak Academy of Sciences [VEGA 1/0052/15]	University Science Park for Biomedicine Bratislava; Slovak research and development agency(Slovak Research and Development Agency); Ministry of Education of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences)	This study was supported by grants: University Science Park for Biomedicine Bratislava (ITMS 26240220087): JD, DO; Slovak research and development agency (APVV 0254-11) [http://www.apvv.sk/agentura]: AP, JD, KB, AK; The Scientific grant agency of the Ministry of Education of the Slovak Republic and of Slovak Academy of Sciences (VEGA 1/0052/15): DO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Aman MG, 1996, RES DEV DISABIL, V17, P41, DOI 10.1016/0891-4222(95)00039-9; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; Anckarsater H, 2006, AM J PSYCHIAT, V163, P1239, DOI 10.1176/appi.ajp.163.7.1239; Attermann J, 2012, EUR CHILD ADOLES PSY, V21, P503, DOI 10.1007/s00787-012-0287-4; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brown EC, 2002, RES DEV DISABIL, V23, P45, DOI 10.1016/S0891-4222(01)00091-9; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012; Comings DE, 1999, NEUROREPORT, V10, P1589, DOI 10.1097/00001756-199905140-00036; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; Davies W, 2014, FRONT NEUROENDOCRIN, V35, P331, DOI 10.1016/j.yfrne.2014.03.003; De Los Reyes A, 2009, J ABNORM CHILD PSYCH, V37, P637, DOI 10.1007/s10802-009-9307-3; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Durdiakova J, 2015, INTELLIGENCE, V48, P76, DOI 10.1016/j.intell.2014.11.002; Fairthorne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113430; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Gadow KD, 2008, J AUTISM DEV DISORD, V38, P1710, DOI 10.1007/s10803-008-0556-8; Gadow KD, 2006, J AUTISM DEV DISORD, V36, P271, DOI 10.1007/s10803-005-0060-3; Giovannucci E, 1999, UROLOGY, V53, P121, DOI 10.1016/S0090-4295(98)00468-3; Greaves-Lord K, 2013, J AUTISM DEV DISORD, V43, P1784, DOI 10.1007/s10803-012-1724-4; Grzadzinski R, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-12; Hampson E, 2012, EVOL HUM BEHAV, V33, P557, DOI 10.1016/j.evolhumbehav.2012.02.003; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Horlin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106552; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; James WH, 2008, DEV MED CHILD NEUROL, V50, P15, DOI 10.1111/j.1469-8749.2007.02001.x; Kalyva E, 2010, J AUTISM DEV DISORD, V40, P1202, DOI 10.1007/s10803-010-0978-y; Kanne SM, 2009, J AUTISM DEV DISORD, V39, P827, DOI 10.1007/s10803-008-0688-x; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Krithivas K, 1999, J ENDOCRINOL, V162, P137, DOI 10.1677/joe.0.1620137; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lecavalier L, 2004, J AUTISM DEV DISORD, V34, P709, DOI 10.1007/s10803-004-5291-1; Lecavalier L, 2006, J AUTISM DEV DISORD, V36, P1101, DOI 10.1007/s10803-006-0147-5; Lemiere J, 2010, DEV MED CHILD NEUROL, V52, pE202, DOI 10.1111/j.1469-8749.2010.03684.x; Lord C, 2014, PATHOL BIOL, V62, P302, DOI 10.1016/j.patbio.2014.07.005; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2012, AUTISM DIAGNOSTIC OB; Majewska MD, 2014, EUR CHILD ADOLES PSY, V23, P485, DOI 10.1007/s00787-013-0472-0; Manning JT, 2002, MED HYPOTHESES, V59, P334, DOI 10.1016/S0306-9877(02)00181-0; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Martel MM, 2009, HORM BEHAV, V55, P465, DOI 10.1016/j.yhbeh.2009.02.004; Meriggiola MC, 1996, HUM REPROD, V11, P248, DOI 10.1093/HUMREP/11.2.248; Miller DC, 1997, DEV PSYCHOL, V33, P814, DOI 10.1037/0012-1649.33.5.814; Neef NA, 2005, J APPL BEHAV ANAL, V38, P135, DOI 10.1901/jaba.2005.116-02; Neef NA, 2005, J APPL BEHAV ANAL, V38, P23, DOI 10.1901/jaba.2005.146-02; Offord DR, 1996, J AM ACAD CHILD PSY, V35, P1078, DOI 10.1097/00004583-199608000-00019; Pivovarciova A, 2015, PHYSIOL RES, V64, pS595, DOI 10.33549/physiolres.933221; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polderman TJC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.84; Rajender S, 2008, INT J LEGAL MED, V122, P367, DOI 10.1007/s00414-008-0225-7; Rettew DC, 2011, J CHILD ADOL PSYCHOP, V21, P389, DOI 10.1089/cap.2010.0153; ROJAHN J, 1991, J AUTISM DEV DISORD, V21, P17, DOI 10.1007/BF02206994; Romero-Martinez A, 2017, J ATTEN DISORD, V21, P938, DOI 10.1177/1087054713482685; Rowe R, 2004, BIOL PSYCHIAT, V55, P546, DOI 10.1016/j.biopsych.2003.10.010; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; SCERBO AS, 1994, J AM ACAD CHILD PSY, V33, P1174, DOI 10.1097/00004583-199410000-00013; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Stanford JL, 1997, CANCER RES, V57, P1194; STANGER C, 1993, J CLIN CHILD PSYCHOL, V22, P107, DOI 10.1207/s15374424jccp2201_11; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Tasse MJ, 1996, RES DEV DISABIL, V17, P59, DOI 10.1016/0891-4222(95)00037-2; Teatero ML, 2013, J AUTISM DEV DISORD, V43, P2664, DOI 10.1007/s10803-013-1819-6; TORDJMAN S, 1995, J AUTISM DEV DISORD, V25, P295, DOI 10.1007/BF02179290; Tordjman S, 1997, AM J PSYCHIAT, V154, P1626; Wang LJ, 2011, WORLD J BIOL PSYCHIA, V12, P99, DOI 10.3109/15622975.2010.512090; Youngstrom E, 2000, J CONSULT CLIN PSYCH, V68, P1038, DOI 10.1037/0022-006X.68.6.1038	72	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149657	10.1371/journal.pone.0149657	http://dx.doi.org/10.1371/journal.pone.0149657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910733	gold, Green Published			2022-12-26	WOS:000371164700042
J	Ho, MF; Low, LM; Rose'Meyer, RB				Ho, Ming-Fen; Low, Leanne M.; Rose'Meyer, Roselyn B.			Pharmacology of the Adenosine A(3) Receptor in the Vasculature and Essential Hypertension	PLOS ONE			English	Article							A(2B) RECEPTORS; A(2A) RECEPTORS; SPLICE VARIANTS; BLOOD-PRESSURE; CORONARY FLOW; GROWTH; HEART; VASODILATION; INFLAMMATION; STIMULATION	Background Essential hypertension is considered to be a multifactorial disorder and its aetiology has yet to be clearly identified. As the adenosine receptors have a significant role in mediating vasodilation, alterations in their structures or signalling pathways may be involved in the development of hypertension. This study aimed to measure the expression of adenosine A(3) receptors in a range of cardiovascular tissues and determine whether they could be altered with essential hypertension, and to functionally test responses to adenosine A(3) receptor agonists in coronary blood vessels using the isolated perfused heart preparation. Methods mRNA samples from cardiovascular tissues and a range of blood vessels were collected from 10 week old male spontaneously hypertensive rats and age-gender matched Wistar rats (n = 8). The Langendorff heart perfusion preparation was used to characterise adenosine A(3) receptor mediated coronary vasodilation in the rat heart. Results Adenosine A(3) receptor agonists induced coronary vasodilation. The expression of adenosine A(3) receptors in cardiovascular tissues was altered in a tissue-specific pattern. Specifically, down-regulation of adenosine A(3) receptor expression occurred in hypertensive hearts, which might be associated with attenuated vasodilator responses observed in coronary vessels to adenosine A(3) receptor agonists. Conclusions This study demonstrated alterations in the expression of adenosine A(3) receptors occurred in a tissue specific mode, and reduced adenosine A(3) receptor mediated coronary vasodilation in hearts from spontaneously hypertensive rats. Our findings with regard to changes in the adenosine A(3) receptor in hypertensive hearts suggest that adenosine A(3) receptor might play a role in the physiopathology of essential hypertension and potentially open the way to pharmacologic manipulation of vasomotor activity by the use of adenosine A(3) receptor agonists.	[Ho, Ming-Fen; Low, Leanne M.; Rose'Meyer, Roselyn B.] Griffith Univ, Sch Med Sci, Heart Fdn Res Ctr, Gold Coast, Qld, Australia	Griffith University	Rose'Meyer, RB (corresponding author), Griffith Univ, Sch Med Sci, Heart Fdn Res Ctr, Gold Coast, Qld, Australia.	r.rosemeyer@griffith.edu.au	Low, Leanne/AAD-3310-2020; Low, Leanne/HGT-7958-2022	Low, Leanne/0000-0002-1976-3767; Low, Leanne/0000-0002-1976-3767	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS)	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS)	This research is supported by a Griffith University International Postgraduate Research Scholarship (GUIPRS) and a Griffith University Postgraduate Research Scholarship (GUPRS).	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Auchampach JA, 2003, AM J PHYSIOL-HEART C, V285, DOI [10.1152/ajpheart.01001.02002, DOI 10.1152/AJPHEART.01001.02002]; AUTELITANO DJ, 1995, NEUROSCI LETT, V195, P1, DOI 10.1016/0304-3940(95)11756-M; Badyal D. K., 2003, Indian Journal of Pharmacology, V35, P349; CARRUTHERS AM, 1993, DRUG DEVELOP RES, V30, P147, DOI 10.1002/ddr.430300307; Chandrasekera PC, 2010, AM J PHYSIOL-HEART C, V299, pH2082, DOI 10.1152/ajpheart.00511.2010; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; CLUBB FJ, 1987, LAB INVEST, V56, P189; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dankelman J, 1999, MED BIOL ENG COMPUT, V37, P742, DOI 10.1007/BF02513377; Dobson JG, 2008, AM J PHYSIOL-HEART C, V295, pH2364, DOI 10.1152/ajpheart.00927.2008; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Feoktistov I, 1998, DRUG DEVELOP RES, V45, P198, DOI 10.1002/(SICI)1098-2299(199811/12)45:3/4<198::AID-DDR17>3.0.CO;2-#; Fresco P, 2004, CARDIOVASC RES, V63, P739, DOI 10.1016/j.cardiores.2004.05.015; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; HAYNES J, 1995, AM J PHYSIOL-HEART C, V268, pH1862; Ho MF, 2013, CURR VASC PHARMACOL, V11, P327, DOI 10.2174/1570161111311030007; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jenner TL, 2006, MECH AGEING DEV, V127, P264, DOI 10.1016/j.mad.2005.10.005; Kokubo M, 2005, HYPERTENS RES, V28, P601, DOI 10.1291/hypres.28.601; Kreth S, 2008, FASEB J, V22, P3276, DOI 10.1096/fj.07-101097; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lerman LO, 2005, J LAB CLIN MED, V146, P160, DOI 10.1016/j.lab.2005.05.005; LIANG BT, 1995, CIRC RES, V76, P242, DOI 10.1161/01.RES.76.2.242; Martin TC, 2008, W INDIAN MED J, V57, P337; Montecucco F, 2011, J NEPHROL, V24, P23, DOI 10.5301/JN.2010.4729; Nishat Shamama, 2012, Recent Pat Cardiovasc Drug Discov, V7, P59; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Okamoto K, 1966, Jpn Circ J, V30, P703; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Sofola OA, 2002, J PHYSIOL-LONDON, V543, P255, DOI 10.1113/jphysiol.2002.022277; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; TAPPARELLI C, 1993, TRENDS PHARMACOL SCI, V14, P366, DOI 10.1016/0165-6147(93)90095-2; Tawfik HE, 2005, AM J PHYSIOL-HEART C, V288, pH1411, DOI 10.1152/ajpheart.00684.2004; Wallen WJ, 2000, HYPERTENSION, V36, P774, DOI 10.1161/01.HYP.36.5.774; Willems L, 2007, PFLUG ARCH EUR J PHY, V453, P433, DOI 10.1007/s00424-006-0119-9; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432; Zucchi R, 2001, CARDIOVASC RES, V50, P56, DOI 10.1016/S0008-6363(00)00318-7	41	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150021	10.1371/journal.pone.0150021	http://dx.doi.org/10.1371/journal.pone.0150021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907173	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000029
J	Ding, GL; Chen, JL; Chopp, M; Li, L; Yan, T; Li, QJ; Cui, CC; Davarani, SPN; Jiang, Q				Ding, Guangliang; Chen, Jieli; Chopp, Michael; Li, Lian; Yan, Tao; Li, Qingjiang; Cui, Chengcheng; Davarani, Siamak P. N.; Jiang, Quan			Cell Treatment for Stroke in Type Two Diabetic Rats Improves Vascular Permeability Measured by MRI	PLOS ONE			English	Article							MARROW STROMAL CELLS; CONTRAST-ENHANCED MRI; ANGIOGENESIS; INJURY; MODEL; TRANSPLANTATION; STREPTOZOTOCIN; PATHOGENESIS; MELLITUS; DAMAGE	Treatment of stroke with bone marrow stromal cells (BMSC) significantly enhances brain remodeling and improves neurological function in non-diabetic stroke rats. Diabetes is a major risk factor for stroke and induces neurovascular changes which may impact stroke therapy. Thus, it is necessary to test our hypothesis that the treatment of stroke with BMSC has therapeutic efficacy in the most common form of diabetes, type 2 diabetes mellitus (T2DM). T2DM was induced in adult male Wistar rats by administration of a high fat diet in combination with a single intraperitoneal injection (35mg/kg) of streptozotocin. These rats were then subjected to 2h of middle cerebral artery occlusion (MCAo). T2DM rats received BMSC (5x10(6), n = 8) or an equal volume of phosphate-buffered saline (PBS) (n = 8) via tail-vein injection at 3 days after MCAo. MRI was performed one day and then weekly for 5 weeks post MCAo for all rats. Compared with vehicle treated control T2DM rats, BMSC treatment of stroke in T2DM rats significantly (p<0.05) decreased blood-brain barrier disruption starting at 1 week post stroke measured using contrast enhanced T-1-weighted imaging with gadopentetate, and reduced cerebral hemorrhagic spots starting at 3 weeks post stroke measured using susceptibility weighted imaging, although BMSC treatment did not reduce the ischemic lesion volumes as demarcated by T-2 maps. These MRI measurements were consistent with histological data. Thus, BMSC treatment of stroke in T2DM rats initiated at 3 days after stroke significantly reduced ischemic vascular damage, although BMSC treatment did not change infarction volume in T2DM rats, measured by MRI.	[Ding, Guangliang; Chen, Jieli; Chopp, Michael; Li, Lian; Yan, Tao; Li, Qingjiang; Cui, Chengcheng; Davarani, Siamak P. N.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48309 USA; [Yan, Tao] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China	Henry Ford Health System; Henry Ford Hospital; Oakland University; Tianjin Medical University	Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, 2799 West Grand Blvd, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Nejad-Davarani, Siamak/AAH-8399-2021; Yan, Tao/B-2930-2012	Yan, Tao/0000-0003-3138-4468; Ding, Guangliang/0000-0003-1286-5901; Nejad-Davarani, Siamak/0000-0002-2415-6689; Li, Lian/0000-0003-0097-1184	NIH [RO1 NS083078, NS064134, AG037506, R41 S080329]; American Heart Association (AHA) [14GRNT20460026]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R41NS080329, R01NS083078, R01NS064134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was financially supported by NIH RO1 NS083078 (JC), NS064134 (QJ), AG037506 (MC), R41 S080329 (JC), and American Heart Association (AHA) 14GRNT20460026 (JC). The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Aryal MP, 2014, NMR BIOMED, V27, P1230, DOI 10.1002/nbm.3178; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cameron N, 2003, DIABETES RES CLIN PR, V61, pS35, DOI 10.1016/S0168-8227(03)00123-2; Chen JL, 2011, STROKE, V42, P3551, DOI 10.1161/STROKEAHA.111.627174; Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Ding G, 2014, NEUROSCIENCE, V271, P1, DOI 10.1016/j.neuroscience.2014.04.025; Ding GL, 2008, STROKE, V39, P1563, DOI 10.1161/STROKEAHA.107.502146; Ding GL, 2017, J CEREBR BLOOD F MET, V37, P241, DOI 10.1177/0271678X15622464; Ding GL, 2015, STROKE, V46, P507, DOI 10.1161/STROKEAHA.114.007538; Ergul A, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-33; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Ewing JR, 2013, NMR BIOMED, V26, P1028, DOI 10.1002/nbm.2996; Haacke EM, 2009, AM J NEURORADIOL, V30, P19, DOI 10.3174/ajnr.A1400; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liberman G, T1 MAPPING USING VAR; Martini SR, 2007, J CEREBR BLOOD F MET, V27, P435, DOI 10.1038/sj.jcbfm.9600355; Piotrowski P, 2003, FOLIA NEUROPATHOL, V41, P167; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Skovso S, 2014, J DIABETES INVEST, V5, P349, DOI 10.1111/jdi.12235; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wei N, 2013, CNS NEUROSCI THER, V19, P753, DOI 10.1111/cns.12123; Yan T, 2015, STROKE, V46, P2599, DOI 10.1161/STROKEAHA.115.009870; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Yu DY, 2001, CLIN EXP OPHTHALMOL, V29, P164; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475; Zhang C, 2006, NEUROSCIENCE, V141, P687, DOI 10.1016/j.neuroscience.2006.04.054	31	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149147	10.1371/journal.pone.0149147	http://dx.doi.org/10.1371/journal.pone.0149147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900843	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100042
J	Ebou, MH; Singh-Estivalet, A; Launay, JM; Callebert, J; Tronche, F; Ferre, P; Gautier, JF; Guillemain, G; Breant, B; Blondeau, B; Riveline, JP				Ebou, Moina Hasni; Singh-Estivalet, Amrit; Launay, Jean-Marie; Callebert, Jacques; Tronche, Francois; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre			Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells	PLOS ONE			English	Article							INSULIN-SECRETION; GENE-EXPRESSION; FRONTAL-CORTEX; ISLET FUNCTION; TRYPTOPHAN; COUNTERACTS; EXPANSION; INSIGHTS; MASS	Diabetes is a major complication of chronic Glucocorticoids (GCs) treatment. GCs induce insulin resistance and also inhibit insulin secretion from pancreatic beta cells. Yet, a full understanding of this negative regulation remains to be deciphered. In the present study, we investigated whether GCs could inhibit serotonin synthesis in beta cell since this neurotransmitter has been shown to be involved in the regulation of insulin secretion. To this aim, serotonin synthesis was evaluated in vitro after treatment with GCs of either islets from CD1 mice or MIN6 cells, a beta-cell line. We also explored the effect of GCs on the stimulation of serotonin synthesis by several hormones such as prolactin and GLP 1. We finally studied this regulation in islet in two in vivo models: mice treated with GCs and with liraglutide, a GLP1 analog, and mice deleted for the glucocorticoid receptor in the pancreas. We showed in isolated islets and MIN6 cells that GCs decreased expression and activity of the two key enzymes of serotonin synthesis, Tryptophan Hydroxylase 1 (Tph1) and 2 (Tph2), leading to reduced serotonin contents. GCs also blocked the induction of serotonin synthesis by prolactin or by a previously unknown serotonin activator, the GLP-1 analog exendin-4. In vivo, activation of the Glucagon-like-Peptide-1 receptor with liraglutide during 4 weeks increased islet serotonin contents and GCs treatment prevented this increase. Finally, islets from mice deleted for the GR in the pancreas displayed an increased expression of Tph1 and Tph2 and a strong increased serotonin content per islet. In conclusion, our results demonstrate an original inhibition of serotonin synthesis by GCs, both in basal condition and after stimulation by prolactin or activators of the GLP-1 receptor. This regulation may contribute to the deleterious effects of GCs on beta cells.	[Ebou, Moina Hasni; Singh-Estivalet, Amrit; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Ctr Rech Cordeliers, INSERM, UMR S 1138, F-75006 Paris, France; [Ebou, Moina Hasni; Singh-Estivalet, Amrit; Tronche, Francois; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Ebou, Moina Hasni; Singh-Estivalet, Amrit; Ferre, Pascal; Gautier, Jean-Francois; Guillemain, Ghislaine; Breant, Bernadette; Blondeau, Bertrand; Riveline, Jean-Pierre] Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France; [Launay, Jean-Marie; Callebert, Jacques] Hop Lariboisiere, AP HP, Serv Biochim, INSERM,U942, F-75475 Paris, France; [Tronche, Francois] CNRS, INSERM, UMR 952, CNRS 7224, Paris, France; [Gautier, Jean-Francois; Riveline, Jean-Pierre] Hop Lariboisiere, AP HP, Dept Endocrinol & Diabet, F-75475 Paris, France; [Gautier, Jean-Francois] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Blondeau, B (corresponding author), Ctr Rech Cordeliers, INSERM, UMR S 1138, F-75006 Paris, France.; Blondeau, B (corresponding author), Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France.; Blondeau, B (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Ctr Rech Cordeliers, UMR S 1138, F-75006 Paris, France.	bertrand.blondeau@crc.jussieu.fr	Ferré, Pascal/K-1250-2013; callebert, jacques/L-4569-2017; TRONCHE, François/F-3895-2011; Guillemain, Ghislaine/P-7740-2017	Ferré, Pascal/0000-0003-0115-7045; Guillemain, Ghislaine/0000-0002-8256-9545; Blondeau, Bertrand/0000-0002-1106-1509	Inserm (Institut National de la Sante et de la Recherche Medicale); CNRS (Centre National de la Recherche Scientifique); Fondation pour la Recherche Medicale (Equipe FRM) [DEQ20140329504]; European Union [QLK1-CT-2000-00083, Food-CT-2005-007036]; Agence Nationale de la Recherche [A05245DS]; Societe Francophone du Diabete (SFD); Lilly; European Association for the Study on Diabetes (EASD); Institut Benjamin Delessert	Inserm (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale (Equipe FRM)(Fondation pour la Recherche Medicale); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Societe Francophone du Diabete (SFD); Lilly(Eli Lilly); European Association for the Study on Diabetes (EASD); Institut Benjamin Delessert	Supports for these studies were provided by Inserm (Institut National de la Sante et de la Recherche Medicale), CNRS (Centre National de la Recherche Scientifique), Fondation pour la Recherche Medicale (Equipe FRM DEQ20140329504), the European Union (FP5 Nutrix QLK1-CT-2000-00083 and FP6 Earnest Food-CT-2005-007036 programs), the Agence Nationale de la Recherche (Grant Gramsy No A05245DS), Societe Francophone du Diabete (SFD) and Lilly to JP Riveline, European Association for the Study on Diabetes (EASD) to B Breant, and Institut Benjamin Delessert to B Blondeau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2006, CURR DRUG TARGETS, V7, P649, DOI 10.2174/138945006777435344; Borboni P, 1996, MOL CELL ENDOCRINOL, V117, P175, DOI 10.1016/0303-7207(95)03745-4; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brunetti L, 2008, PEPTIDES, V29, P1377, DOI 10.1016/j.peptides.2008.04.007; Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Clark JA, 2008, MOL PSYCHIATR, V13, P498, DOI 10.1038/sj.mp.4002041; Di Dalmazi G, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/525093; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; El-Merahbi R, 2015, FEBS LETT, V589, P1728, DOI 10.1016/j.febslet.2015.05.054; Fransson L, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-3; Garcia-Osta A, 2004, MOL BRAIN RES, V126, P181, DOI 10.1016/j.molbrainres.2004.04.006; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Gremlich S, 1997, J BIOL CHEM, V272, P3216, DOI 10.1074/jbc.272.6.3216; HAMAMDZIC D, 1995, AM J PHYSIOL-ENDOC M, V269, pE162, DOI 10.1152/ajpendo.1995.269.1.E162; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hirschfeld RMA, 2000, J CLIN PSYCHIAT, V61, P4; JAIMETCH.G, 1968, ENDOCRINOLOGY, V83, P917, DOI 10.1210/endo-83-5-917; KEMA IP, 1993, CLIN CHIM ACTA, V221, P143, DOI 10.1016/0009-8981(93)90029-4; Khan IA, 2001, BIOL REPROD, V64, P955, DOI 10.1095/biolreprod64.3.955; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nesan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080726; OHNEDA M, 1993, J CLIN INVEST, V92, P1950, DOI 10.1172/JCI116788; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Pivonello R, 2010, NEUROENDOCRINOLOGY, V92, P77, DOI 10.1159/000314319; Protzek AOP, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/983453; Resmini E, 2009, ACTA DIABETOL, V46, P85, DOI 10.1007/s00592-009-0112-9; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; Valtat B, 2013, DIABETES, V62, P1206, DOI 10.2337/db12-0314; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2011, DIABETES CARE, V34, P412, DOI 10.2337/dc10-1677; Weinhaus AJ, 2000, ENDOCRINOLOGY, V141, P1384, DOI 10.1210/en.141.4.1384; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Zawalich WS, 2006, METABOLISM, V55, P35, DOI 10.1016/j.metabol.2005.06.023	40	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149343	10.1371/journal.pone.0149343	http://dx.doi.org/10.1371/journal.pone.0149343			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901633	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100060
J	Gutierrez-Heredia, L; Benzoni, F; Murphy, E; Reynaud, EG				Gutierrez-Heredia, Luis; Benzoni, Francesca; Murphy, Emma; Reynaud, Emmanuel G.			End to End Digitisation and Analysis of Three-Dimensional Coral Models, from Communities to Corallites	PLOS ONE			English	Article							SURFACE-AREAS; RECONSTRUCTION; PHOTOGRAMMETRY; DENSITY; FIELD	Coral reefs hosts nearly 25% of all marine species and provide food sources for half a billion people worldwide while only a very small percentage have been surveyed. Advances in technology and processing along with affordable underwater cameras and Internet availability gives us the possibility to provide tools and softwares to survey entire coral reefs. Holistic ecological analyses of corals require not only the community view (10s to 100s of meters), but also the single colony analysis as well as corallite identification. As corals are three-dimensional, classical approaches to determine percent cover and structural complexity across spatial scales are inefficient, time-consuming and limited to experts. Here we propose an end-to-end approach to estimate these parameters using low-cost equipment (GoPro, Canon) and freeware (123D Catch, Meshmixer and Netfabb), allowing every community to participate in surveys and monitoring of their coral ecosystem. We demonstrate our approach on 9 species of underwater colonies in ranging size and morphology. 3D models of underwater colonies, fresh samples and bleached skeletons with high quality texture mapping and detailed topographic morphology were produced, and Surface Area and Volume measurements (parameters widely used for ecological and coral health studies) were calculated and analysed. Moreover, we integrated collected sample models with micro-photogrammetry models of individual corallites to aid identification and colony and polyp scale analysis.	[Gutierrez-Heredia, Luis; Murphy, Emma; Reynaud, Emmanuel G.] Univ Coll Dublin, UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 2, Ireland; [Benzoni, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University College Dublin; University of Milano-Bicocca	Reynaud, EG (corresponding author), Univ Coll Dublin, UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 2, Ireland.	emmanuel.reynaud@ucd.ie	Benzoni, Francesca/G-1304-2010; Reynaud, Emamnuel/H-2928-2019	Benzoni, Francesca/0000-0001-8906-1309; Reynaud, Emamnuel/0000-0003-1502-661X; Gutierrez Heredia, Luis/0000-0002-9380-8900	Consejo Nacional de Ciencia y Tecnologia, Mexico [215551]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Consejo Nacional de Ciencia y Tecnologia, Mexico, Abroad doctoral scholarship, ID: 215551, LGH, http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2006, J EXP MAR BIOL ECOL, V339, P120, DOI 10.1016/j.jembe.2006.07.015; Andono PN, 2012, INT CONF MULTIMED, P803, DOI 10.1109/ICMCS.2012.6320131; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berquist RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034499; Brager S, 1999, PHOTOGRAMM REC, V16, P503, DOI 10.1111/0031-868X.00139; Brandou V., 2007, OCEANS 2007 - Europe, P1, DOI 10.1109/OCEANSE.2007.4302315; Bucher DJ, 1998, J EXP MAR BIOL ECOL, V228, P117, DOI 10.1016/S0022-0981(98)00020-3; Burns JHR, 2015, PEERJ, V3, DOI 10.7717/peerj.1077; Bythell JC, 2001, CORAL REEFS, V20, P193; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Cocito S, 2003, J EXP MAR BIOL ECOL, V297, P57, DOI 10.1016/S0022-0981(03)00369-1; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; Done T.J., 1982, Proceedings of the International Coral Reef Symposium, P315; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fisher WS, 2007, ENVIRON MONIT ASSESS, V125, P347, DOI 10.1007/s10661-006-9527-8; Gutierrez-Heredia L, 2015, LIMNOL OCEANOGR-METH, V13, P178, DOI 10.1002/lom3.10017; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; He H., 2012, P 12 INT COR REEF S, P1; Hogue A, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P5351, DOI 10.1109/IROS.2006.282097; Holmes G, 2008, J EXP MAR BIOL ECOL, V365, P67, DOI 10.1016/j.jembe.2008.07.045; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; Jancosek M., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3121, DOI 10.1109/CVPR.2011.5995693; Johnson-Roberson M, 2010, J FIELD ROBOT, V27, P21, DOI 10.1002/rob.20324; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Knudby A, 2007, PROG PHYS GEOG, V31, P421, DOI 10.1177/0309133307081292; Knudby A, 2013, REMOTE SENS-BASEL, V5, P1311, DOI 10.3390/rs5031311; Lavy A, 2015, METHODS ECOL EVOL, V6, P521, DOI 10.1111/2041-210X.12331; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; Maeder J, 2000, INT CORAL REEF S BAL, V2, P23; MCKINNON D, 2011, P OCEANS 2011 WAIK H, P1, DOI DOI 10.23919/OCEANS.2011.6106982; Mumby PJ, 1997, MAR BIOL, V130, P193, DOI 10.1007/s002270050238; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; NOAA, 2008, COR REEFS IMP PART O; Pennisi E, 1997, SCIENCE, V277, P491, DOI 10.1126/science.277.5325.491; Pittman Simon J., 2013, P145; Pizarro O, 2009, IEEE J OCEANIC ENG, V34, P150, DOI 10.1109/JOE.2009.2016071; Sedlazeck A, 2009, OCEANS 2009 EUROPE, P1, DOI DOI 10.1109/OCEANSE.2009.5278305; Shortis M.R., 1998, INT ARCH PHOTOGRAMM, V32, P792, DOI DOI 10.1017/CB09781107415324.004; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stone R, 2007, SCIENCE, V316, P678, DOI 10.1126/science.316.5825.678; Todd PA, 2001, RAFFLES B ZOOL, V49, P191; UNEP-WCMC, 2006, FRONT LIN SHOR PROT, P33; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; Wilkinson C, 2008, STATUS CORAL REEFS W; Wu CC, 2013, 2013 INTERNATIONAL CONFERENCE ON 3D VISION (3DV 2013), P127, DOI 10.1109/3DV.2013.25	47	35	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149641	10.1371/journal.pone.0149641	http://dx.doi.org/10.1371/journal.pone.0149641			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901845	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100116
J	Lapointe-Shaw, L; Tran, KL; Coyte, PC; Hancock-Howard, RL; Powis, J; Poutanen, SM; Hota, S				Lapointe-Shaw, Lauren; Tran, Kim L.; Coyte, Peter C.; Hancock-Howard, Rebecca L.; Powis, Jeff; Poutanen, Susan M.; Hota, Susy			Cost-Effectiveness Analysis of Six Strategies to Treat Recurrent Clostridium difficile Infection	PLOS ONE			English	Article							FECAL MICROBIOTA TRANSPLANTATION; ORAL VANCOMYCIN; 1ST RECURRENCE; DISEASE; FIDAXOMICIN; THERAPY; EPIDEMIOLOGY; COLONOSCOPY; METRONIDAZOLE; DIARRHEA	Objective To assess the cost-effectiveness of six treatment strategies for patients diagnosed with recurrent Clostridium difficile infection (CDI) in Canada: 1. oral metronidazole; 2. oral vancomycin; 3. oral fidaxomicin; 4. fecal transplantation by enema; 5. fecal transplantation by nasogastric tube; and 6. fecal transplantation by colonoscopy. Perspective Public insurer for all hospital and physician services. Setting Ontario, Canada. Methods A decision analytic model was used to model costs and lifetime health effects of each strategy for a typical patient experiencing up to three recurrences, over 18 weeks. Recurrence data and utilities were obtained from published sources. Cost data was obtained from published sources and hospitals in Toronto, Canada. The willingness-to-pay threshold was $50,000/QALY gained. Results Fecal transplantation by colonoscopy dominated all other strategies in the base case, as it was less costly and more effective than all alternatives. After accounting for uncertainty in all model parameters, there was an 87% probability that fecal transplantation by colonoscopy was the most beneficial strategy. If colonoscopy was not available, fecal transplantation by enema was cost-effective at $1,708 per QALY gained, compared to metronidazole. In addition, fecal transplantation by enema was the preferred strategy if the probability of recurrence following this strategy was below 8.7%. If fecal transplantation by any means was unavailable, fidaxomicin was cost-effective at an additional cost of $25,968 per QALY gained, compared to metronidazole. Conclusion Fecal transplantation by colonoscopy (or enema, if colonoscopy is unavailable) is cost-effective for treating recurrent CDI in Canada. Where fecal transplantation is not available, fidaxomicin is also cost-effective.	[Lapointe-Shaw, Lauren; Powis, Jeff; Poutanen, Susan M.; Hota, Susy] Univ Toronto, Dept Med, Toronto, ON, Canada; [Lapointe-Shaw, Lauren; Tran, Kim L.; Poutanen, Susan M.; Hota, Susy] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Coyte, Peter C.; Hancock-Howard, Rebecca L.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Powis, Jeff] Toronto East Gen Hosp, Dept Med, Toronto, ON, Canada; [Poutanen, Susan M.] Mt Sinai Hosp, Dept Med & Med Microbiol, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Toronto East General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Lapointe-Shaw, L (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Lapointe-Shaw, L (corresponding author), Univ Hlth Network, Dept Med, Toronto, ON, Canada.	lauren.lapointe.shaw@mail.utoronto.ca	Hota, Susy/L-1903-2019; Poutanen, Susan M/F-9640-2012; Poutanen, Susan M./N-8066-2019; Hancock-Howard, Rebecca Laura/AIE-8302-2022; Lapointe-Shaw, Lauren/ABG-2601-2021	Poutanen, Susan M/0000-0003-4747-2550; Poutanen, Susan M./0000-0003-4747-2550; Hancock-Howard, Rebecca Laura/0000-0002-0997-988X; Lapointe-Shaw, Lauren/0000-0003-4485-6719; Powis, Jeff/0000-0003-2053-6083	University of Toronto; Cubist Pharmaceuticals	University of Toronto(University of Toronto); Cubist Pharmaceuticals	This project did not utilize any specific project-related financial support. Dr. Lauren Lapointe-Shaw is supported by the Clinician Scientist Training Program at the University of Toronto. Dr. Susy Hota has received clinic funding and advisory honoraria from Cubist Pharmaceuticals, the makers of fidaxomicin. Dr. Susan Poutanen has received advisory board and/or speaker honoraria from Optimer, Merck, Cubist, Sunovian, Hoffman-LaRoche, Paladin Labs, Pathogenica, and Accelerate Diagnostics.	Aas J, 2003, CLIN INFECT DIS, V36, P580, DOI 10.1086/367657; Ahmad A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-133; Allen-Vercoe E, 2012, CAN J GASTROENTEROL, V26, P457, DOI 10.1155/2012/213828; [Anonymous], 2013, MONTHLY AVERAGE EXCH; BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431; Bartsch SM, 2013, CLIN INFECT DIS, V57, P555, DOI 10.1093/cid/cit346; Belmares J, 2007, J INFECTION, V55, P495, DOI 10.1016/j.jinf.2007.09.015; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Canadian Agency for Drugs and Technologies in Health (CADTH), 2017, GUID EC EV HLTH TECH; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Collins CE, 2014, J AM COLL SURGEONS, V218, P1141, DOI 10.1016/j.jamcollsurg.2014.01.053; Comely OA, 2012, CLIN INFECT DIS, V55, pS154, DOI 10.1093/cid/cis462; Cornely OA, 2012, LANCET INFECT DIS, V12, P281, DOI 10.1016/S1473-3099(11)70374-7; Crook DW, 2012, CLIN INFECT DIS, V55, pS93, DOI 10.1093/cid/cis499; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Eyre DW, 2012, CLIN INFECT DIS, V55, pS77, DOI 10.1093/cid/cis356; Garborg K, 2010, SCAND J INFECT DIS, V42, P857, DOI 10.3109/00365548.2010.499541; Gold MR, 1998, MED CARE, V36, P778, DOI 10.1097/00005650-199806000-00002; Government of Canada, 2013, EXPL CAR WAG REP; Gravel D, 2004, CLOSTRIDIUM DIFFICIL; Gravel D, 2009, CLIN INFECT DIS, V48, P568, DOI 10.1086/596703; Halabi WJ, 2013, J AM COLL SURGEONS, V217, P802, DOI 10.1016/j.jamcollsurg.2013.05.028; Health Canada, 2015, FEC MICR THER US TRE; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Kassam Z, 2012, ARCH INTERN MED, V172, P191, DOI 10.1001/archinte.172.2.191; Kelly CR, 2012, J CLIN GASTROENTEROL, V46, P145, DOI 10.1097/MCG.0b013e318234570b; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Konijeti GG, 2014, CLIN INFECT DIS, V58, P1507, DOI 10.1093/cid/ciu128; Law Michael R, 2013, Healthc Policy, V8, P17; Levin TR, 2006, ANN INTERN MED, V145, P880, DOI 10.7326/0003-4819-145-12-200612190-00004; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Lund-Tonnesen Stein, 1998, Tidsskrift for den Norske Laegeforening, V118, P1027; Lynne V., 1999, INFECT CONT HOSP EP, V20, P43, DOI [10.1086/501553, DOI 10.1086/501553]; Macconnachie AA, 2009, QJM-INT J MED, V102, P781, DOI 10.1093/qjmed/hcp118; Mattila E, 2012, GASTROENTEROLOGY, V142, P490, DOI 10.1053/j.gastro.2011.11.037; McFarland LV, 1999, INFECT CONT HOSP EP, V20, P43, DOI 10.1086/501553; McFarland LV, 2002, AM J GASTROENTEROL, V97, P1769, DOI 10.1111/j.1572-0241.2002.05839.x; MCFARLAND LV, 1995, AM J INFECT CONTROL, V23, P295, DOI 10.1016/0196-6553(95)90060-8; MCFARLAND LV, 1994, JAMA-J AM MED ASSOC, V271, P1913, DOI 10.1001/jama.271.24.1913; Mellow Mark H, 2011, J Okla State Med Assoc, V104, P89; Ministry of Health and Long Term Care, 2013, SCHED OF BEN; Ministry of Health and Long-term Care, EXEPTIONAL ACCES PRO; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Mohseninejad L, 2013, EUR J HEALTH ECON, V14, P947, DOI 10.1007/s10198-012-0441-4; Naimark DMJ, 2013, MED DECIS MAKING, V33, P961, DOI 10.1177/0272989X13501558; O'Brien JA, 2007, INFECT CONT HOSP EP, V28, P1219, DOI 10.1086/522676; Patel NC, 2013, MAYO CLIN PROC, V88, P799, DOI 10.1016/j.mayocp.2013.04.022; Pepin J, 2006, CLIN INFECT DIS, V42, P758, DOI 10.1086/501126; Poutanen SM, 2004, CAN MED ASSOC J, V171, P51, DOI 10.1503/cmaj.1031189; Rassias, 1998, Crit Care, V2, P25, DOI 10.1186/cc120; Roberts M, 2012, VALUE HEALTH, V15, P804, DOI 10.1016/j.jval.2012.06.016; Rohlke F, 2010, J CLIN GASTROENTEROL, V44, P567, DOI 10.1097/MCG.0b013e3181dadb10; Sharara N, 2008, CAN J GASTROENTEROL, V22, P565, DOI 10.1155/2008/854984; Statistics Canada, 2015, CONS PRIC IND HLTH P; Statistics Canada, 2015, TABL 7A COMPL LIF TA; Stranges PM, 2013, VALUE HEALTH, V16, P297, DOI 10.1016/j.jval.2012.11.004; U.S. National Institutes of Health, 2013, OR VANC FOLL FEC TRA; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Vardakas KZ, 2012, INT J ANTIMICROB AG, V40, P1, DOI 10.1016/j.ijantimicag.2012.01.004; Wagner M, 2014, CAN J INFECT DIS MED, V25, P87, DOI 10.1155/2014/793532; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Wenisch C, 1996, CLIN INFECT DIS, V22, P813, DOI 10.1093/clinids/22.5.813; Yoon SS, 2010, J CLIN GASTROENTEROL, V44, P562, DOI 10.1097/MCG.0b013e3181dac035; Zipursky JS, 2014, CAN J GASTROENTEROL, V28, P319, DOI 10.1155/2014/403828	64	41	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149521	10.1371/journal.pone.0149521	http://dx.doi.org/10.1371/journal.pone.0149521			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901316	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100090
J	Yang, J; Zhu, FM; Wang, XH; Yao, WQ; Wang, M; Pei, GC; Hu, ZZ; Guo, YJ; Zhao, Z; Wang, P; Mou, JY; Sun, J; Zeng, R; Xu, G; Liao, WH; Yao, Y				Yang, Juan; Zhu, Fengming; Wang, Xiaohui; Yao, Weiqi; Wang, Meng; Pei, Guangchang; Hu, Zhizhi; Guo, Yujiao; Zhao, Zhi; Wang, Pengge; Mou, Jingyi; Sun, Jie; Zeng, Rui; Xu, Gang; Liao, Wenhui; Yao, Ying			Continuous AMD3100 Treatment Worsens Renal Fibrosis through Regulation of Bone Marrow Derived Pro-Angiogenic Cells Homing and T-Cell-Related Inflammation	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; ISCHEMIA-REPERFUSION INJURY; CHRONIC KIDNEY-DISEASE; MOUSE MODEL; ANTAGONIST AMD3100; CXCR4 ANTAGONIST; STEM-CELLS; TRANSPLANTATION; MOBILIZATION; SURVIVAL	AMD3100 is a small molecule inhibitor of chemokine receptor type 4 (CXCR4), which is located in the cell membranes of CD34+ cells and a variety of inflammatory cells and has been reported to reduce organ fibrosis in the lung, liver and myocardium. However, the effect of AMD3100 on renal fibrosis is unknown. This study investigated the impact of AMD3100 on renal fibrosis. C57bl/6 mice were subjected to unilateral ureteral obstruction (UUO) surgery with or without AMD3100 administration. Tubular injury, collagen deposition and fibrosis were detected and analyzed by histological staining, immunocytochemistry and Western Blot. Bone marrow derived pro-angiogenic cells (CD45+, CD34+ and CD309+ cells) and capillary density (CD31+) were measured by flow cytometry (FACS) and immunofluorescence (IF). Inflammatory cells, chemotactic factors and T cell proliferation were characterized. We found that AMD3100 treatment did not alleviate renal fibrosis but, rather, increased tissue damage and renal fibrosis. Continuous AMD3100 administration did not improve bone marrow derived pro-angiogenic cells mobilization but, rather, inhibited the migration of bone marrow derived pro-angiogenic cells into the fibrotic kidney. Additionally, T cell infiltration was significantly increased in AMD3100-treated kidneys compared to untreated kidneys. Thus, treatment of UUO mice with AMD3100 led to an increase in T cell infiltration, suggesting that AMD3100 aggravated renal fibrosis.	[Yang, Juan; Zhu, Fengming; Wang, Meng; Pei, Guangchang; Hu, Zhizhi; Guo, Yujiao; Zhao, Zhi; Wang, Pengge; Mou, Jingyi; Sun, Jie; Zeng, Rui; Xu, Gang; Yao, Ying] Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China; [Wang, Xiaohui] Fifth Hosp Wuhan, Dept Nephrol, 122 Xianzheng St, Wuhan 430050, Hubei, Peoples R China; [Yao, Weiqi] Wuhan Hamilton Biotechnol Co LTD, Wuhan Inst Biotechnol, B6-4,666 Gaoxin Rd, Wuhan 430073, Hubei, Peoples R China; [Liao, Wenhui] Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yao, Y (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Div Nephrol, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.; Liao, WH (corresponding author), Huazhong Univ Sci & Technol, Dept Geriatr, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Hubei, Peoples R China.	liaowh126@126.com; yaoyingkk@126.com	Yang, Juan/ABF-4433-2021; Zeng, Rui/GRY-0646-2022; Zeng, RUI/AAF-7238-2019	Zeng, Rui/0000-0003-1188-3198; 	National Natural Sciences Foundation of China [81270770, 81270771, 81170686]; Health and Family Planning Commission of Hubei Province [WJ2015MB011]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Family Planning Commission of Hubei Province	This work was funded by National Natural Sciences Foundation of China, URL: http://www.nsfc.gov.cn/, (Grants 81270770 received by G.X., 81270771 received by R.Z. and 81170686 received by Y.Y.) with additional funding from Health and Family Planning Commission of Hubei Province project, URL: http://www.hbwsjs.gov.cn/ (Grant WJ2015MB011 received by Y.Y.).	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Ballermann BJ, 2014, KIDNEY INT SUPPL, V4, P45, DOI 10.1038/kisup.2014.9; Basile DP, 2014, J CELL PHYSIOL, V229, P10, DOI 10.1002/jcp.24423; Broxmeyer HE, 2008, CURR OPIN HEMATOL, V15, P49, DOI 10.1097/MOH.0b013e3282f29012; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Cantaluppi V, 2015, NEPHROL DIAL TRANSPL, V30, P410, DOI 10.1093/ndt/gfu364; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Chade AR, 2009, CIRCULATION, V119, P547, DOI 10.1161/CIRCULATIONAHA.108.788653; Chang FC, 2012, J FORMOS MED ASSOC, V111, P589, DOI 10.1016/j.jfma.2012.09.008; Chen B, 2013, TRANSPL P, V45, P2034, DOI 10.1016/j.transproceed.2013.01.096; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Chou YH, 2014, J FORMOS MED ASSOC, V113, P201, DOI 10.1016/j.jfma.2013.12.001; Cui X. Y., 2014, CHINESE GEN PRACTICE, V21, P1929, DOI [10.3969/j.issn.1674-4748.2014.21.005, DOI 10.3969/J.ISSN.1674-4748.2014.21.005, DOI 10.1002/HEP.27665]; Decleves AE, 2014, NAT REV NEPHROL, V10, P257, DOI 10.1038/nrneph.2014.31; Fan YF, 2010, ANN NEUROL, V67, P488, DOI 10.1002/ana.21919; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Guo Y, 2005, STEM CELLS, V23, P1324, DOI 10.1634/stemcells.2005-0085; Huang TH, 2015, AM J TRANSL RES, V7, P804; Jujo K, 2010, P NATL ACAD SCI USA, V107, P11008, DOI 10.1073/pnas.0914248107; Kean LS, 2011, BLOOD, V118, P6580, DOI 10.1182/blood-2011-06-359331; Kim BJ, 2013, CELL TISSUE RES, V354, P395, DOI 10.1007/s00441-013-1689-4; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kuksin CA, 2015, BLOOD, V125, P2087, DOI 10.1182/blood-2014-08-594796; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Li HQ, 2013, INT J CARDIOL, V162, P100, DOI 10.1016/j.ijcard.2011.05.074; Liu LL, 2012, AM J NEPHROL, V36, P386, DOI 10.1159/000343283; Liu Q, 2015, EUR J IMMUNOL, V45, P1855, DOI 10.1002/eji.201445245; Ma YY, 2010, LIFE SCI, V86, P798, DOI 10.1016/j.lfs.2010.03.013; MacDonald KPA, 2014, J IMMUNOL, V192, P3180, DOI 10.4049/jimmunol.1302315; Nishimura Y, 2012, J INVEST DERMATOL, V132, P711, DOI 10.1038/jid.2011.356; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pleniceanu O, 2010, STEM CELLS, V28, P1649, DOI 10.1002/stem.486; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roncalli J, 2011, J AM COLL CARDIOL, V57, P2444, DOI 10.1016/j.jacc.2010.11.069; Shen L, 2011, MED HYPOTHESES, V76, P256, DOI 10.1016/j.mehy.2010.10.014; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Snelgrove SL, 2012, AM J PATHOL, V180, P91, DOI 10.1016/j.ajpath.2011.09.039; Song JS, 2010, EXP MOL MED, V42, P465, DOI 10.3858/emm.2010.42.6.048; Sradnick J, 2016, J AM SOC NEPHROL, V27, P1714, DOI 10.1681/ASN.2015030321; Watanabe M, 2007, J IMMUNOL, V178, P5888, DOI 10.4049/jimmunol.178.9.5888	45	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149926	10.1371/journal.pone.0149926	http://dx.doi.org/10.1371/journal.pone.0149926			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900858	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100185
J	Qian, XL; Hamid, FM; El Sahili, A; Darwis, DA; Wong, YH; Bhushan, S; Makeyev, EV; Lescar, J				Qian, Xinlei; Hamid, Fursham M.; El Sahili, Abbas; Darwis, Dina Amallia; Wong, Yee Hwa; Bhushan, Shashi; Makeyev, Eugene V.; Lescar, Julien			Functional Evolution in Orthologous Cell-encoded RNA-dependent RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSIC ANTIVIRAL IMMUNITY; SMALL INTERFERING RNAS; SECONDARY; BIOGENESIS; NEUROSPORA; MECHANISMS; CRYSTALLIZATION; TRANSCRIPTION; POPULATIONS; INITIATION	Many eukaryotic organisms encode more than one RNA-dependent RNA polymerase (RdRP) that probably emerged as a result of gene duplication. Such RdRP paralogs often participate in distinct RNA silencing pathways and show characteristic repertoires of enzymatic activities in vitro. However, to what extent members of individual paralogous groups can undergo functional changes during speciation remains an open question. We show that orthologs of QDE-1, an RdRP component of the quelling pathway in Neurospora crassa, have rapidly diverged in evolution at the amino acid sequence level. Analyses of purified QDE-1 polymerases from N. crassa (QDE-1(Ncr)) and related fungi, Thielavia terrestris (QDE-1(Tte)) and Myceliophthora thermophila (QDE-1(Mth)), show that all three enzymes can synthesize RNA, but the precise modes of their action differ considerably. Unlike their QDE-1(Ncr) counterpart favoring processive RNA synthesis, QDE-1(Tte) and QDE-1(Mth) produce predominantly short RNA copies via primer-independent initiation. Surprisingly, a 3.19 angstrom resolution crystal structure of QDE-1(Tte) reveals a quasisymmetric dimer similar to QDE-1(Ncr). Further electron microscopy analyses confirm that QDE-1(Tte) occurs as a dimer in solution and retains this status upon interaction with a template. We conclude that divergence of orthologous RdRPs can result in functional innovation while retaining overall protein fold and quaternary structure.	[Qian, Xinlei; Hamid, Fursham M.; El Sahili, Abbas; Darwis, Dina Amallia; Wong, Yee Hwa; Bhushan, Shashi; Makeyev, Eugene V.; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore; [Makeyev, Eugene V.] Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; [Lescar, Julien] CHU Pitie Salpetriere, UPMC, UMRS CNRS ERL INSERM U1135 8255 CR7, Ctr Immunol & Malad Infect,Fac Med Pierre & Marie, F-75031 Paris, France; [Qian, Xinlei] Singapore MIT Alliance Res & Technol, Singapore 138602, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Singapore-MIT Alliance for Research & Technology Centre (SMART)	Makeyev, EV; Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore 138673, Singapore.; Makeyev, EV (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England.; Lescar, J (corresponding author), CHU Pitie Salpetriere, UPMC, UMRS CNRS ERL INSERM U1135 8255 CR7, Ctr Immunol & Malad Infect,Fac Med Pierre & Marie, F-75031 Paris, France.	eugene.makeyev@kcl.ac.uk; julien@ntu.edu.sg		Wong, Yee Hwa/0000-0002-2751-9721; qian, xinlei/0000-0002-2032-0736; Makeyev, Eugene/0000-0001-6034-6896; El Sahili, Abbas/0000-0003-3973-686X; Bhushan, Shashi/0000-0002-8514-5959	Ministry of Education Singapore Academic Research Fund Tier 1 [RG62/12, RGC2/14]; National Medical Research Council [NMRC/CBRG/0028/2013]; Biotechnology and Biological Sciences Research Council [BB/M001199/1, BB/M007103/1]; Nanyang President Graduate Scholarship; BBSRC [BB/M001199/1, BB/M007103/1] Funding Source: UKRI	Ministry of Education Singapore Academic Research Fund Tier 1(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Nanyang President Graduate Scholarship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Ministry of Education Singapore Academic Research Fund Tier 1 Grants RG62/12 and RGC2/14 (to J. L.), National Medical Research Council Grant NMRC/CBRG/0028/2013 (to E. V. M.), Biotechnology and Biological Sciences Research Council Grants BB/M001199/1 and BB/M007103/1 (to E. V. M.), and the Nanyang President Graduate Scholarship (to F. M. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aalto AP, 2010, J BIOL CHEM, V285, P29367, DOI 10.1074/jbc.M110.139121; Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bagijn MP, 2012, SCIENCE, V337, P574, DOI 10.1126/science.1220952; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Bologna NG, 2014, ANNU REV PLANT BIOL, V65, P473, DOI 10.1146/annurev-arplant-050213-035728; Burroughs AM, 2014, WIRES RNA, V5, P141, DOI 10.1002/wrna.1210; Calo S, 2014, NATURE, V513, P555, DOI 10.1038/nature13575; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; Carradec Q, 2015, NUCLEIC ACIDS RES, V43, P1818, DOI 10.1093/nar/gku1331; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Chen SD, 2013, NAT REV GENET, V14, P645, DOI 10.1038/nrg3521; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Curaba JL, 2008, J BIOL CHEM, V283, P3059, DOI 10.1074/jbc.M708983200; Devert A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120100; Dumesic PA, 2014, TRENDS BIOCHEM SCI, V39, P25, DOI 10.1016/j.tibs.2013.10.003; Dumesic PA, 2013, CELL, V152, P957, DOI 10.1016/j.cell.2013.01.046; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; GOTTLIEB P, 1992, J VIROL, V66, P2611, DOI 10.1128/JVI.66.5.2611-2616.1992; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Haag JR, 2012, MOL CELL, V48, P811, DOI 10.1016/j.molcel.2012.09.027; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Ipsaro JJ, 2015, NAT STRUCT MOL BIOL, V22, P20, DOI 10.1038/nsmb.2931; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kriventseva EV, 2015, NUCLEIC ACIDS RES, V43, pD250, DOI 10.1093/nar/gku1220; Kuo HC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05135; Lee HC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000496; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Lee SR, 2007, NAT STRUCT MOL BIOL, V14, P604, DOI 10.1038/nsmb1262; Long MY, 2013, ANNU REV GENET, V47, P307, DOI 10.1146/annurev-genet-111212-133301; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nayak A, 2013, CURR TOP MICROBIOL, V371, P183, DOI 10.1007/978-3-642-37765-5_7; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Salgado PS, 2006, PLOS BIOL, V4, P2274, DOI 10.1371/journal.pbio.0040434; Santos SP, 2012, PROTEIN EXPRES PURIF, V81, P193, DOI 10.1016/j.pep.2011.10.001; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Shrestha Binesh, 2008, V439, P269, DOI 10.1007/978-1-59745-188-8_19; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Studer RA, 2009, TRENDS GENET, V25, P210, DOI 10.1016/j.tig.2009.03.004; Szittya G, 2013, CURR TOP MICROBIOL, V371, P153, DOI 10.1007/978-3-642-37765-5_6; Talsky KB, 2010, J BIOL CHEM, V285, P27614, DOI 10.1074/jbc.M110.142273; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Toth-Petroczy A, 2014, CURR OPIN STRUC BIOL, V26, P131, DOI 10.1016/j.sbi.2014.06.007; Turner BC, 2001, FUNGAL GENET BIOL, V32, P67, DOI 10.1006/fgbi.2001.1247; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Yang QY, 2015, GENE DEV, V29, P526, DOI 10.1101/gad.255828.114; Zhou R, 2013, IMMUNOL REV, V253, P97, DOI 10.1111/imr.12053; Zong J, 2009, GENE, V447, P29, DOI 10.1016/j.gene.2009.07.004	65	9	9	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9295	9309		10.1074/jbc.M115.685933	http://dx.doi.org/10.1074/jbc.M115.685933			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26907693	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000374849000038
J	Ristic, G; Tsou, WL; Guzi, E; Kanack, AJ; Scaglione, KM; Todi, SV				Ristic, Gorica; Tsou, Wei-Ling; Guzi, Ermal; Kanack, Adam J.; Scaglione, Kenneth Matthew; Todi, Sokol V.			USP5 Is Dispensable for Monoubiquitin Maintenance in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; ISOPEPTIDASE-T; DEUBIQUITINATING ENZYMES; UNANCHORED UBIQUITIN; POLYUBIQUITIN CHAINS; GENE-EXPRESSION; NERVOUS-SYSTEM; ATAXIA MICE; IN-VITRO; DEGRADATION	Ubiquitination is a post-translational modification that regulates most cellular pathways and processes, including degradation of proteins by the proteasome. Substrate ubiquitination is controlled at various stages, including through its reversal by deubiquitinases (DUBs). Acritical outcome of this process is the recycling of monoubiquitin. One DUB whose function has been proposed to include monoubiquitin recycling is USP5. Here, we investigated whether Drosophila USP5 is important for maintaining monoubiquitin in vivo. We found that the fruit fly orthologue of USP5 has catalytic preferences similar to its human counterpart and that this DUB is necessary during fly development. Our biochemical and genetic experiments indicate that reduction of USP5 does not lead to monoubiquitin depletion in developing flies. Also, introduction of exogenous ubiquitin does not suppress developmental lethality caused by loss of endogenous USP5. Our work indicates that a primary physiological role of USP5 is not to recycle monoubiquitin for reutilization, but that it may involve disassembly of conjugated ubiquitin to maintain proteasome function.	[Ristic, Gorica; Tsou, Wei-Ling; Guzi, Ermal; Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; [Todi, Sokol V.] Wayne State Univ, Sch Med, Dept Neurol, Detroit, MI 48201 USA; [Kanack, Adam J.; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Kanack, Adam J.; Scaglione, Kenneth Matthew] Med Coll Wisconsin, Neurosci Res Ctr, Milwaukee, WI 53226 USA	Wayne State University; Wayne State University; Medical College of Wisconsin; Medical College of Wisconsin	Todi, SV (corresponding author), 540 E Canfield,Scott Hall,Rm 3108, Detroit, MI 48201 USA.	stodi@med.wayne.edu	Tsou, Wei-Ling/AAI-2655-2021	Tsou, Wei-Ling/0000-0001-9136-2581; Scaglione, Kenneth/0000-0002-3858-9418; TODI, SOKOL/0000-0003-4399-5549	National Institutes of Health [P40OD018537, R01GM084947]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086778, R00NS073936] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Udai Pandey (University of Pittsburgh), Daniel Eberl (University of Iowa), and R. J. Wessells (Wayne State University) for fly stocks, as well as Dr. Lori Pile (Wayne State University) for the anti-Sin3 antibody. We also thank the Bloomington Drosophila Stock Center (funded by National Institutes of Health Grant P40OD018537), the Vienna Drosophila RNAi Center, the FlyORF, and the TRiP at Harvard Medical School (funded by National Institutes of Health Grant R01GM084947) for transgenic stocks.	Amerik AY, 1997, EMBO J, V16, P4826; Anderson C, 2005, J NEUROCHEM, V95, P724, DOI 10.1111/j.1471-4159.2005.03409.x; Avvakumov GV, 2012, BIOCHEMISTRY-US, V51, P1188, DOI 10.1021/bi200854q; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chen PC, 2009, J NEUROSCI, V29, P10909, DOI 10.1523/JNEUROSCI.2635-09.2009; Chen W, 2004, CANCER RES, V64, P3949, DOI 10.1158/0008-5472.CAN-03-3906; Clague MJ, 2013, PHYSIOL REV, V93, P1289, DOI 10.1152/physrev.00002.2013; Clague MJ, 2012, J CELL SCI, V125, P277, DOI 10.1242/jcs.090985; Crimmins S, 2006, J NEUROSCI, V26, P11423, DOI 10.1523/JNEUROSCI.3600-06.2006; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FALQUET L, 1995, FEBS LETT, V359, P73, DOI 10.1016/0014-5793(94)01451-6; Garcia-Caballero A, 2014, NEURON, V83, P1144, DOI 10.1016/j.neuron.2014.07.036; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grou CP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12836; Hallengren J, 2013, CELL BIOCHEM BIOPHYS, V67, P67, DOI 10.1007/s12013-013-9634-4; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Kaiser SE, 2011, NAT METHODS, V8, P691, DOI [10.1038/NMETH.1649, 10.1038/nmeth.1649]; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kong QH, 2010, BIOCHEM BIOPH RES CO, V393, P708, DOI 10.1016/j.bbrc.2010.02.066; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120875; Lee FKM, 2009, J NEUROCHEM, V110, P208, DOI 10.1111/j.1471-4159.2009.06124.x; Lu CG, 2013, DEVELOPMENT, V140, P3522, DOI 10.1242/dev.098947; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Oh C, 2013, ANAL BIOCHEM, V443, P153, DOI 10.1016/j.ab.2013.09.011; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Ristic G, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00072; Scaglione KM, 2011, MOL CELL, V43, P599, DOI 10.1016/j.molcel.2011.05.036; Scaglione KM, 2013, J BIOL CHEM, V288, P18784, DOI 10.1074/jbc.C113.477596; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Todi SV, 2011, TRENDS NEUROSCI, V34, P370, DOI 10.1016/j.tins.2011.05.004; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; Tsou WL, 2015, HUM MOL GENET, V24, P4385, DOI 10.1093/hmg/ddv174; Tsou WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043112; Wang CH, 2014, BIOCHEM BIOPH RES CO, V452, P369, DOI 10.1016/j.bbrc.2014.08.069; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9161	9172		10.1074/jbc.M115.703504	http://dx.doi.org/10.1074/jbc.M115.703504			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917723	Green Published, hybrid			2022-12-26	WOS:000374849000027
J	Chang, YM; Hadox, E; Szladovits, B; Garden, OA				Chang, Yu-Mei; Hadox, Erin; Szladovits, Balazs; Garden, Oliver A.			Serum Biochemical Phenotypes in the Domestic Dog	PLOS ONE			English	Article							AGE-RELATED-CHANGES; REFERENCE INTERVALS; CREATININE CONCENTRATIONS; VALUES; GREYHOUNDS; HEMATOLOGY; HEALTHY; ASSOCIATION; ANALYTES; PLASMA	The serum or plasma biochemical profile is essential in the diagnosis and monitoring of systemic disease in veterinary medicine, but current reference intervals typically take no account of breed-specific differences. Breed-specific hematological phenotypes have been documented in the domestic dog, but little has been published on serum biochemical phenotypes in this species. Serum biochemical profiles of dogs in which all measurements fell within the existing reference intervals were retrieved from a large veterinary database. Serum biochemical profiles from 3045 dogs were retrieved, of which 1495 had an accompanying normal glucose concentration. Sixty pure breeds plus a mixed breed control group were represented by at least 10 individuals. All analytes, except for sodium, chloride and glucose, showed variation with age. Total protein, globulin, potassium, chloride, creatinine, cholesterol, total bilirubin, ALT, CK, amylase, and lipase varied between sexes. Neutering status significantly impacted all analytes except albumin, sodium, calcium, urea, and glucose. Principal component analysis of serum biochemical data revealed 36 pure breeds with distinctive phenotypes. Furthermore, comparative analysis identified 23 breeds with significant differences from the mixed breed group in all biochemical analytes except urea and glucose. Eighteen breeds were identified by both principal component and comparative analysis. Tentative reference intervals were generated for breeds with a distinctive phenotype identified by comparative analysis and represented by at least 120 individuals. This is the first large-scale analysis of breed-specific serum biochemical phenotypes in the domestic dog and highlights potential genetic components of biochemical traits in this species.	[Chang, Yu-Mei] Univ London Royal Vet Coll, Res Off, Camden Campus,Royal Coll St, London NW1 OTU, England; [Hadox, Erin; Garden, Oliver A.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory T Cell Lab, Camden Campus,Royal Coll St, London NW1 OTU, England; [Szladovits, Balazs] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Campus, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Garden, OA (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory T Cell Lab, Camden Campus,Royal Coll St, London NW1 OTU, England.	ogarden@rvc.ac.uk						Adler JA, 2007, J VET INTERN MED, V21, P1168, DOI 10.1892/06-270.1; Aroch I, 2007, VET CLIN PATH, V36, P40, DOI 10.1111/j.1939-165X.2007.tb00180.x; Bourdel-Marchasson I, 2010, MATURITAS, V66, P39, DOI 10.1016/j.maturitas.2010.02.004; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Choi So-Young, 2011, Lab Anim Res, V27, P283, DOI 10.5625/lar.2011.27.4.283; Comazzi S, 2004, J SMALL ANIM PRACT, V45, P343, DOI 10.1111/j.1748-5827.2004.tb00246.x; Concordet D, 2008, VET CLIN PATH, V37, P96, DOI 10.1111/j.1939-165X.2008.00007.x; Cortadellas O, 2009, VET REC, V164, P487, DOI 10.1136/vr.164.16.487; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Dunlop MM, 2011, J SMALL ANIM PRACT, V52, P4, DOI 10.1111/j.1748-5827.2010.01008.x; Elliott J., 2007, BSAVA MANUAL CANINE, P1; Feeman WE, 2003, VET CLIN PATH, V32, P40, DOI 10.1111/j.1939-165X.2003.tb00312.x; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Griffin PM, 2014, J CLIN PATHOL, V67, P529, DOI 10.1136/jclinpath-2013-202155; GUO YS, 1989, J STEROID BIOCHEM, V33, P459, DOI 10.1016/0022-4731(89)90337-3; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; Harper JE H R, 2003, JAVMA-J AM VET MED A, V223, P1435; HILPPO M, 1986, NORD VET MED, V38, P148; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; IKEUCHI J, 1991, Journal of Toxicological Sciences, V16, P49; JENSEN AL, 1994, RES VET SCI, V56, P24, DOI 10.1016/0034-5288(94)90191-0; Jones Graham, 2008, Clin Biochem Rev, V29 Suppl 1, pS93; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Lavoue R, 2013, VET CLIN PATH, V42, P346, DOI 10.1111/vcp.12067; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Levy JK, 2006, JAVMA-J AM VET MED A, V228, P1033, DOI 10.2460/javma.228.7.1033; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lopez I, 2005, VET REC, V157, P344, DOI 10.1136/vr.157.12.344; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Miyagawa Y, 2010, J VET MED SCI, V72, P1129, DOI 10.1292/jvms.09-0443; NAP RC, 1994, VET QUART, V16, P50, DOI 10.1080/01652176.1994.9694417; Nielsen L, 2010, VET CLIN PATH, V39, P20, DOI 10.1111/j.1939-165X.2009.00186.x; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Park HS, 2007, PANCREAS, V34, P373, DOI 10.1097/MPA.0b013e3180327c2b; Roman VRG, 2012, CLIN VACCINE IMMUNOL, V19, P1322, DOI 10.1128/CVI.00170-12; Rortveit R, 2015, VET CLIN PATH, V44, P47, DOI 10.1111/vcp.12220; Rosset E, 2012, VET CLIN PATH, V41, P272, DOI 10.1111/j.1939-165X.2012.00415.x; Rubio AV, 2014, J ZOO WILDLIFE MED, V45, P589, DOI 10.1638/2013-0280R2.1; Sharkey L, 2009, VET CLIN PATH, V38, P375, DOI 10.1111/j.1939-165X.2009.00134.x; Steele AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097171; Stockham S, 2013, FUNDAMENTALS VET CLI; Thrall M. A., 2012, VET HEMATOLOGY CLIN, V2nd; Tiao JYH, 2002, CARDIOVASC SURG, V10, P445, DOI 10.1016/S0967-2109(02)00056-X; Uhrikova I, 2013, AUST VET J, V91, P452, DOI 10.1111/avj.12117; Ulleberg T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-25; Visser M, 2005, AM J CLIN NUTR, V82, P531; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Walton RM, 2012, VET CLIN PATH, V41, P175, DOI 10.1111/j.1939-165X.2012.00414.x; Watts M, 2006, VET REC, V159, P128, DOI 10.1136/vr.159.4.128-b; WILDING P, 1972, CLIN CHIM ACTA, V41, P375, DOI 10.1016/0009-8981(72)90534-7; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x; ZHAN Y, 1991, JPN J VET RES, V39, P39	58	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149650	10.1371/journal.pone.0149650	http://dx.doi.org/10.1371/journal.pone.0149650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919479	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000371274400032
J	Gerrits, NJHM; van Loenhoud, AC; van den Berg, SF; Berendse, HW; Foncke, EMJ; Klein, M; Stoffers, D; van der Werf, YD; van den Heuvel, OA				Gerrits, Niels J. H. M.; van Loenhoud, Anita C.; van den Berg, Stan F.; Berendse, Henk W.; Foncke, Elisabeth M. J.; Klein, Martin; Stoffers, Diederick; van der Werf, Ysbrand D.; van den Heuvel, Odile A.			Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MINI-MENTAL-STATE; IMPAIRMENT; DEMENTIA; INVENTORY; ATROPHY; MRI	Parkinson's disease (PD) is often associated with cognitive deficits, although their severity varies considerably between patients. Recently, we used voxel-based morphometry (VBM) to show that individual differences in gray matter (GM) volume relate to cognitive heterogeneity in PD. VBM does, however, not differentiate between cortical thickness (CTh) and surface area (SA), which might be independently affected in PD. We therefore re-analyzed our cohort using the surface-based method FreeSurfer, and investigated (i) CTh, SA, and (sub) cortical GM volume differences between 93 PD patients and 45 matched controls, and (ii) the relation between these structural measures and cognitive performance on six neuropsychological tasks within the PD group. We found cortical thinning in PD patients in the left pericalcarine gyrus, extending to cuneus, precuneus and lingual areas and left inferior parietal cortex, bilateral rostral middle frontal cortex, and right cuneus, and increased cortical surface area in the left pars triangularis. Within the PD group, we found negative correlations between (i) CTh of occipital areas and performance on a verbal memory task, (ii) SA and volume of the frontal cortex and visuospatial memory performance, and, (iii) volume of the right thalamus and scores on two verbal fluency tasks. Our primary findings illustrate that i) CTh and SA are differentially affected in PD, and ii) VBM and FreeSurfer yield non-overlapping results in an identical dataset. We argue that this discrepancy is due to technical differences and the subtlety of the PD-related structural changes.	[Gerrits, Niels J. H. M.; van Loenhoud, Anita C.; van den Berg, Stan F.; van den Heuvel, Odile A.] Vrije Univ Amsterdam, Med Ctr VUmc, Dept Anat & Neurosci, Amsterdam, Netherlands; [Berendse, Henk W.; Foncke, Elisabeth M. J.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Stoffers, Diederick] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Klein, Martin] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [van Loenhoud, Anita C.; van den Heuvel, Odile A.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Gerrits, Niels J. H. M.; Berendse, Henk W.; van der Werf, Ysbrand D.; van den Heuvel, Odile A.] Neurosci Campus Amsterdam NCA, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gerrits, NJHM (corresponding author), Vrije Univ Amsterdam, Med Ctr VUmc, Dept Anat & Neurosci, Amsterdam, Netherlands.; Gerrits, NJHM (corresponding author), Neurosci Campus Amsterdam NCA, Amsterdam, Netherlands.	njhmgerrits@gmail.com	Klein, Martin/C-4192-2012	Klein, Martin/0000-0003-4160-5746; Berendse, Henk/0000-0002-9189-3662; Klein, Martin/0000-0001-5553-7911; van der Werf, Ysbrand/0000-0003-2370-9584; van den Heuvel, Odile/0000-0002-9804-7653				Aganj I, 2009, HUM BRAIN MAPP, V30, P3188, DOI 10.1002/hbm.20740; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Compta Y, 2013, PARKINSONISM RELAT D, V19, P717, DOI 10.1016/j.parkreldis.2013.03.009; CUMMINGS JL, 1993, JAMA-J AM MED ASSOC, V269, P2420, DOI 10.1001/jama.269.18.2420; Dalaker TO, 2011, MOVEMENT DISORD, V26, P297, DOI 10.1002/mds.23443; Dalaker TO, 2010, MOVEMENT DISORD, V25, P629, DOI 10.1002/mds.22867; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Eggert LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045081; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Focke NK, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00039; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Gerrits NJ, 2013, EUR J NEUROL; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hanganu A, 2013, MOVEMENT DISORD, V28, P1360, DOI 10.1002/mds.25541; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ibarretxe-Bilbao N, 2011, J NEUROL SCI, V310, P70, DOI 10.1016/j.jns.2011.07.054; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Klostermann F, 2013, FUNCTIONAL ROLES THA; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Menke RAL, 2014, HUM BRAIN MAPP, V35, P1681, DOI 10.1002/hbm.22282; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; O'Mara SM, 2013, ANTERIOR THALAMUS PR; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Pagonabarraga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054980; Pardoe HR, 2013, HUM BRAIN MAPP, V34, P3000, DOI 10.1002/hbm.22120; Pellicano C, 2012, EUR J NEUROL; Pereira JB, 2014, NEUROLOGY, P82; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rey A, 1964, LEXAMEN CLINIQUE PSY; Segura B, 2012, MOVEMENT DISORD, V29, P1495; Segura B, 2014, MOVEMENT DISORD, V29, P1495, DOI 10.1002/mds.25982; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; Van der Werf YD, 2001, COGNITIVE BRAIN RES, V11, P377, DOI 10.1016/S0926-6410(01)00010-6; Verhage F., 1983, CODEREN OPLEIDINGSNI; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028	64	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148852	10.1371/journal.pone.0148852	http://dx.doi.org/10.1371/journal.pone.0148852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919667	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400011
J	Arruda, BL; Arruda, PH; Magstadt, DR; Schwartz, KJ; Dohlman, T; Schleining, JA; Patterson, AR; Visek, CA; Victoria, JG				Arruda, Bailey L.; Arruda, Paulo H.; Magstadt, Drew R.; Schwartz, Kent J.; Dohlman, Tyler; Schleining, Jennifer A.; Patterson, Abby R.; Visek, Callie A.; Victoria, Joseph G.			Identification of a Divergent Lineage Porcine Pestivirus in Nursing Piglets with Congenital Tremors and Reproduction of Disease following Experimental Inoculation	PLOS ONE			English	Article							CEREBROSPINAL HYPOMYELINOGENESIS; DOMESTIC PIG; SWINE-FEVER	Congenital tremors is a sporadic disease of neonatal pigs characterized by action-related repetitive myoclonus. A majority of outbreaks of congenital tremors have been attributed to an unidentified virus. The objectives of this project were to 1) detect potential pathogen(s) in samples from piglets with congenital tremors and 2) develop an infection model to reproduce disease. Using next-generation sequencing, a divergent lineage pestivirus was detected in piglets with congenital tremors. The virus was originally most closely related to a bat pestivirus but is now more closely related to a recently published novel porcine pestivirus provisionally named atypical porcine pestivirus. A quantitative real-time PCR detected the virus in samples from neonatal piglets with congenital tremors from two separate farms, but not in samples from unaffected piglets from the same farm. To fulfill the second objective, pregnant sows were inoculated with either serum containing the pestivirus or PBS (control) by intravenous and intranasal routes simultaneously with direct inoculation of fetal amniotic vesicles by ultrasound-guided surgical technique. Inoculations were performed at either 45 or 62 days of gestation. All sows inoculated with the novel pestivirus farrowed piglets affected with congenital tremors while PBS-inoculated control piglets were unaffected. Tremor severity for each piglet was scored from videos taken 0, 1 and 2 days post-farrowing. Tremor severity remained relatively constant from 0 to 2 days post-farrowing for a majority of piglets. The prevalence of congenital tremors in pestivirus-inoculated litters ranged from 57% (4 out of 7 affected piglets) to 100% (10 out of 10 affected piglets). The virus was consistently detected by PCR in tissues from piglets with congenital tremors but was not detected in control piglets. Samples positive by PCR in greater than 90% of piglets sampled included brainstem (37 out of 41), mesenteric lymph node (37 out of 41), tracheobronchial lymph node (37 out of 41), and whole blood (19 out of 20). Although the first description of congenital tremors was in 1922, this is the first reported reproduction of congenital tremors following experimental inoculation with a divergent lineage porcine pestivirus. Studies investigating disease mechanism, epidemiology, and diagnostic assay development are needed to better understand the pathophysiology of congenital tremors due to this pestivirus.	[Arruda, Bailey L.; Arruda, Paulo H.; Magstadt, Drew R.; Schwartz, Kent J.; Dohlman, Tyler; Schleining, Jennifer A.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Patterson, Abby R.; Visek, Callie A.; Victoria, Joseph G.] Boehringer Ingelheim Vetmed Inc, Ames, IA USA	Iowa State University; Boehringer Ingelheim	Arruda, BL (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA.	wilberts@iastate.edu		Schleining, Jennifer/0000-0003-4536-6658	Boehringer Ingelheim Vetmedica, Inc	Boehringer Ingelheim Vetmedica, Inc(Boehringer Ingelheim)	The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Boehringer Ingelheim Vetmedica, Inc provided support in the form of salary for authors ARP, CAV, and JGV. A provisional patent on which authors ARP and JGV are named is pending relating to material pertinent to this article.	Bolin S. R., 1992, DIS SWINE, P247; Done S., 2012, DIS SWINE, P294; Fasano A, 2015, MOVEMENT DISORD, V30, P1557, DOI 10.1002/mds.26383; Govert F, 2015, CURR OPIN NEUROL, V28, P393, DOI 10.1097/WCO.0000000000000211; HARDING JDJ, 1973, VET REC, V92, P527, DOI 10.1136/vr.92.20.527; HARDING JDJ, 1966, VET REC, V79, P388, DOI 10.1136/vr.79.14.388; Hause BM, 2015, J GEN VIROL, V96, P2994, DOI 10.1099/jgv.0.000251; Hindmarch WL, 1973, AUST VET J, V13, P249; Kinsley A., 1922, VET MED, V17, P123; Kirkland P.D., 2012, DIS SWINE, P538; KNOX B, 1978, NORD VET MED, V30, P538; Lohse L, 2012, VET MICROBIOL, V159, P327, DOI 10.1016/j.vetmic.2012.04.026; Murphy F.A., 1999, VET VIROLOGY, V3rd ed., P555; Papatsiros V. G., 2012, American Journal of Animal and Veterinary Sciences, V7, P80; PATTERSON DS, 1973, J NEUROCHEM, V21, P397, DOI 10.1111/j.1471-4159.1973.tb04259.x; PAYEN BALLOT, 1934, Recueil de Medecine Veterinaire, V110, P84; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; STROMBERG MW, 1958, AM J VET RES, V19, P377; SWEASEY D, 1976, J NEUROCHEM, V27, P375, DOI 10.1111/j.1471-4159.1976.tb12256.x; Truyen U., 2012, DIS SWINE, P447; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09	21	96	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150104	10.1371/journal.pone.0150104	http://dx.doi.org/10.1371/journal.pone.0150104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909691	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700068
J	Bruni, R; Taffon, S; Equestre, M; Chionne, P; Madonna, E; Rizzo, C; Tosti, ME; Alfonsi, V; Ricotta, L; De Medici, D; Di Pasquale, S; Scavia, G; Pavoni, E; Losio, MN; Romano, L; Zanetti, AR; Morea, A; Pacenti, M; Palu, G; Capobianchi, MR; Chironna, M; Pompa, MG; Ciccaglione, AR				Bruni, Roberto; Taffon, Stefania; Equestre, Michele; Chionne, Paola; Madonna, Elisabetta; Rizzo, Caterina; Tosti, Maria Elena; Alfonsi, Valeria; Ricotta, Lara; De Medici, Dario; Di Pasquale, Simona; Scavia, Gaia; Pavoni, Enrico; Losio, Marina Nadia; Romano, Luisa; Zanetti, Alessandro Remo; Morea, Anna; Pacenti, Monia; Palu, Giorgio; Capobianchi, Maria Rosaria; Chironna, Maria; Pompa, Maria Grazia; Ciccaglione, Anna Rita		Italian Natl Task Force Hepatitis	Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013	PLOS ONE			English	Article							EPIDEMIOLOGY; REGION	Background Foodborne Hepatitis A Virus (HAV) outbreaks are being recognized as an emerging public health problem in industrialized countries. In 2013 three foodborne HAV outbreaks occurred in Europe and one in USA. During the largest of the three European outbreaks, most cases occurred in Italy (>1,200 cases as of March 31, 2014). A national Task Force was established at the beginning of the outbreak by the Ministry of Health. Mixed frozen berries were early demonstrated to be the source of infection by the identity of viral sequences in patients and in food. In the present study the molecular characterization of HAV isolates from 355 Italian cases is reported. Methods Molecular characterization was carried out by PCR/sequencing (VP1/2A region), comparison with reference strains and phylogenetic analysis. Results A unique strain was responsible for most characterized cases (235/355, 66.1%). Molecular data had a key role in tracing this outbreak, allowing 110 out of the 235 outbreak cases (46.8%) to be recognized in absence of any other link. The data also showed background circulation of further unrelated strains, both autochthonous and travel related, whose sequence comparison highlighted minor outbreaks and small clusters, most of them unrecognized on the basis of epidemiological data. Phylogenetic analysis showed most isolates from travel related cases clustering with reference strains originating from the same geographical area of travel. Conclusions In conclusion, the study documents, in a real outbreak context, the crucial role of molecular analysis in investigating an old but re-emerging pathogen. Improving the molecular knowledge of HAV strains, both autochthonous and circulating in countries from which potentially contaminated foods are imported, will become increasingly important to control outbreaks by supporting trace back activities, aiming to identify the geographical source(s) of contaminated food, as well as public health interventions.	[Bruni, Roberto; Taffon, Stefania; Chionne, Paola; Madonna, Elisabetta; Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy; [Equestre, Michele] Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy; [Rizzo, Caterina; Tosti, Maria Elena; Alfonsi, Valeria; Ricotta, Lara] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy; [De Medici, Dario; Di Pasquale, Simona; Scavia, Gaia] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy; [Pavoni, Enrico; Losio, Marina Nadia] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Reparto Tecnol Acidi Nucl Applicata Alimenti, Brescia, Italy; [Romano, Luisa; Zanetti, Alessandro Remo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Morea, Anna; Chironna, Maria] Azienda Osped Univ Policlin Bari, Bari, Italy; [Pacenti, Monia] Padua Univ Hosp, Microbiol & Virol Unit, Padua, Italy; [Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Capobianchi, Maria Rosaria] Ist Nazl Malattie Infett L Spallanzani, Virol Lab, Rome, Italy; [Pompa, Maria Grazia] Minist Hlth, Directorate Gen Prevent Hlth Care, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IZS Lombardia e Emilia; University of Milan; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; IRCCS Lazzaro Spallanzani	Bruni, R (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	roberto.bruni@iss.it	MADONNA, ELISABETTA/M-2962-2015; ricotta, lara/AAA-6399-2020; Equestre, Michele/AAC-2129-2019; Pavoni, Enrico/AAC-2849-2019; Tosti, Maria Elena/K-1424-2018; Di Pasquale, Simona/AAC-9150-2021; Rizzo, Caterina/H-4092-2012; Losio, Marina-Nadia/AAC-2797-2019; Bruni, Roberto/ABA-8555-2021; CICCAGLIONE, ANNA RITA/M-2956-2015; De Medici, Dario/C-4835-2015; Equestre, Michele/AAV-4993-2020; TAFFON, STEFANIA/M-2965-2015; DI PASQUALE, SIMONA/C-4841-2015; BRUNI, ROBERTO/M-2957-2015; Scognamiglio, Paola/B-4754-2017	MADONNA, ELISABETTA/0000-0003-3288-2346; ricotta, lara/0000-0002-3241-0261; Tosti, Maria Elena/0000-0003-1392-9874; Di Pasquale, Simona/0000-0002-7339-3736; Rizzo, Caterina/0000-0002-5583-7508; Bruni, Roberto/0000-0002-3035-5510; CICCAGLIONE, ANNA RITA/0000-0002-3791-3781; De Medici, Dario/0000-0002-6917-8478; Equestre, Michele/0000-0001-7883-1371; TAFFON, STEFANIA/0000-0002-5008-093X; DI PASQUALE, SIMONA/0000-0002-7339-3736; BRUNI, ROBERTO/0000-0002-3035-5510; Pavoni, Enrico/0000-0003-4367-0381; Losio, Marina Nadia/0000-0002-7434-6536; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Pacenti, Monia/0000-0002-9792-9195; MOREA, ANNA/0000-0002-3692-864X; Alfonsi, Valeria/0000-0003-1920-6773; Scognamiglio, Paola/0000-0002-7938-6457; chironna, maria/0000-0002-1043-1256				Capobianchi MR, 2014, MICROBES INFECT, V16, P362, DOI 10.1016/j.micinf.2014.01.003; Castkova J, 2009, EUROSURVEILLANCE, V14, P4; Chiapponi Chiara, 2014, Food Environ Virol, V6, P202, DOI 10.1007/s12560-014-9149-1; Collier MG, 2014, LANCET INFECT DIS, V14, P976, DOI 10.1016/S1473-3099(14)70883-7; Costa-Mattioli M, 2003, J GEN VIROL, V84, P3191, DOI 10.1099/vir.0.19532-0; European Centre for Disease Prevention and Control, 2014, OUTBR HEP A EU EEA C; European Centre for Disease Prevention and Control and European Food Safety Authority, 2013, EN459 EUR CDCP EUR F; European Centre for Disease Prevention and Control (ECDC) European Food Safety Authority (EFSA), 2013, OUTBR HEP A VIR INF; Gossner CM, 2014, EURO SURVEILL, V19; Holmberg SD, 2012, CLIN INFECT DIS, V54, P782, DOI 10.1093/cid/cir945; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Montano-Remacha C, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.37.20906; Petrignani M, 2014, EMERG INFECT DIS, V20, P596, DOI 10.3201/eid2004.130753; Rizzo C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.7.20518; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023	16	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149642	10.1371/journal.pone.0149642	http://dx.doi.org/10.1371/journal.pone.0149642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901877	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100117
J	Jones, BA; Rich, KM; Mariner, JC; Anderson, J; Jeggo, M; Thevasagayam, S; Cai, Y; Peters, AR; Roeder, P				Jones, Bryony A.; Rich, Karl M.; Mariner, Jeffrey C.; Anderson, John; Jeggo, Martyn; Thevasagayam, Sam; Cai, Yi; Peters, Andrew R.; Roeder, Peter			The Economic Impact of Eradicating Peste des Petits Ruminants: A Benefit-Cost Analysis	PLOS ONE			English	Article							RINDERPEST CONTROL; SOCIOECONOMIC IMPACTS; VIRUS; OUTBREAK; STRATEGIES; ANTIBODIES; INFECTION; DIAGNOSIS; DISEASES; LOSSES	Peste des petits ruminants (PPR) is an important cause of mortality and production loss among sheep and goats in the developing world. Despite control efforts in a number of countries, it has continued to spread across Africa and Asia, placing an increasing burden on the livelihoods of livestock keepers and on veterinary resources in affected countries. Given the similarities between PPR and rinderpest, and the lessons learned from the successful global eradication of rinderpest, the eradication of PPR seems appealing, both eliminating an important disease and improving the livelihoods of the poor in developing countries. We conducted a benefit-cost analysis to examine the economic returns from a proposed programme for the global eradication of PPR. Based on our knowledge and experience, we developed the eradication strategy and estimated its costs. The benefits of the programme were determined from (i) the averted mortality costs, based on an analysis of the literature, (ii) the downstream impact of reduced mortality using a social accounting matrix, and (iii) the avoided control costs based on current levels of vaccination. The results of the benefit-cost analysis suggest strong economic returns from PPR eradication. Based on a 15-year programme with total discounted costs of US$2.26 billion, we estimate discounted benefits of US$76.5 billion, yielding a net benefit of US$74.2 billion. This suggests a benefit cost ratio of 33.8, and an internal rate of return (IRR) of 199%. As PPR mortality rates are highly variable in different populations, we conducted a sensitivity analysis based on lower and higher mortality scenarios. All the scenarios examined indicate that investment in PPR eradication would be highly beneficial economically. Furthermore, removing one of the major constraints to small ruminant production would be of considerable benefit to many of the most vulnerable communities in Africa and Asia.	[Jones, Bryony A.] Univ London, Royal Vet Coll, Prod & Populat Hlth Dept, Hatfield, Herts, England; [Rich, Karl M.] Lab 863 Ltd, Edgware, Middx, England; [Rich, Karl M.] Norwegian Inst Int Affairs, Oslo, Norway; [Mariner, Jeffrey C.] Tufts Cummings Sch Vet Med, North Grafton, MA USA; [Anderson, John] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Jeggo, Martyn] Deakin Univ, Fac Med, Geelong Ctr Emerging Infect Dis, Geelong, Vic 3217, Australia; [Thevasagayam, Sam; Cai, Yi] Bill & Melinda Gates Fdn, Seattle, WA USA; [Peters, Andrew R.] Scotlands Rural Coll, Edinburgh, Midlothian, Scotland; [Roeder, Peter] Taurus Anim Hlth, Headley Down, Hants, England; [Rich, Karl M.] Lincoln Univ, Fac Agribusiness & Commerce, Christchurch, New Zealand	University of London; University of London Royal Veterinary College; Nelson Mandela African Institution of Science & Technology; Deakin University; Bill & Melinda Gates Foundation; Scotland's Rural College; Lincoln University - New Zealand	Jones, BA (corresponding author), Univ London, Royal Vet Coll, Prod & Populat Hlth Dept, Hatfield, Herts, England.	bajones@rvc.ac.uk		Jones, Bryony/0000-0003-4383-2504	Bill & Melinda Gates Foundation; Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gates Foundation(Bill & Melinda Gates Foundation)	This paper is based on research funded by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. ST and YC are employees of The Bill and Melinda Gates Foundation. BAJ, KMR, JCM, JA, MJ, ARP and PR were funded by the Gates Foundation to carry out the study. There was no additional external funding received for this study. The funder provided support in the form of salaries (ST, YC) or honoraria (BAJ, KMR, JCM, JA, MJ, ARP and PR) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abu Elzein EME, 2004, J VET MED B, V51, P68, DOI 10.1111/j.1439-0450.2004.00731.x; Abubakar M, 2014, TRANSBOUND EMERG DIS, V61, P7, DOI 10.1111/tbed.12192; AKEREJOLA O O, 1979, Bulletin of Animal Health and Production in Africa, V27, P65; ANDERSON J, 1994, EPIDEMIOL INFECT, V112, P225, DOI 10.1017/S0950268800057599; Anderson J, 2011, VET REC, V169, P10, DOI 10.1136/vr.d4011; [Anonymous], 1999, RECOGNIZING PESTE PE; Awa DN, 2000, TROP ANIM HEALTH PRO, V32, P391, DOI 10.1023/A:1005233703331; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2011, RES VET SCI, V90, P238, DOI 10.1016/j.rvsc.2010.05.031; Baron J, 2014, TRANSBOUND EMERG DIS, V61, P390, DOI 10.1111/tbed.12266; Baron MD, 2011, VET REC, V169, P16, DOI 10.1136/vr.d3947; Battena CA, 2011, J VIROL METHODS, V171, P401, DOI 10.1016/j.jviromet.2010.11.022; Ekboir J. M., 1999, POTENTIAL IMPACT FOO; Elsawalhy A. A., 2010, Bulletin of Animal Health and Production in Africa, V58, P193; FAO, 2008, PEST PET RUM PPR MOR; FAO, 2008, THE IMPACT OF PESTE, P59; Felton M.R., 1978, STUDIES CONTROL RIND; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; GARNER MG, 1995, PREV VET MED, V23, P9, DOI 10.1016/0167-5877(94)00433-J; Govindarajan R, 1997, VET REC, V141, P573, DOI 10.1136/vr.141.22.573; Hoffmann B, 2012, TRANSBOUND EMERG DIS, V59, P173, DOI 10.1111/j.1865-1682.2011.01270.x; Khalafalla AI, 2010, ACTA TROP, V116, P161, DOI 10.1016/j.actatropica.2010.08.002; Kinne J, 2010, EPIDEMIOL INFECT, V138, P1211, DOI 10.1017/S0950268809991592; Kiringai J, 2006, 2003 SOCIAL AC UNPUB; LEWIS BD, 1992, WORLD DEV, V20, P881, DOI 10.1016/0305-750X(92)90058-4; LIBEAU G, 1994, VET REC, V134, P300, DOI 10.1136/vr.134.12.300; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Mariner JC, 2012, SCIENCE, V337, P1309, DOI 10.1126/science.1223805; Miller M, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1163; Miller R., 2009, INPUT OUTPUT ANAL FD; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; OIE FAO., 2015, GLOB STRAT CONTR ER; OPASINA BA, 1985, TROP ANIM HEALTH PRO, V17, P219, DOI 10.1007/BF02356980; Perry B. D, 2003, IMPACT POVERTY REDUC; Rich KM, 2014, FOOD POLICY, V44, P248, DOI 10.1016/j.foodpol.2013.09.018; Rich KM, 2010, AM J TROP MED HYG, V83, P52, DOI 10.4269/ajtmh.2010.09-0291; Rich KM, 1997, WORLD DEV, V25, P2105, DOI 10.1016/S0305-750X(97)00099-5; Roeder P, 2009, IFPRI DISCUSSION PAP; Sadoulet E., 1995, QUANTITATIVE DEV POL; Singh B, 2014, VET WORLD, V7, P194, DOI 10.14202/vetworld.2014.194-199; Singh B, 2009, INDIAN J ANIM SCI, V79, P1265; Singh B., 2008, AGR EC RES REV, V21, P297, DOI DOI 10.22004/ag.econ.47686; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Tambi EN, 2004, REV SCI TECH OIE, V23, P737; Tambi EN, 1999, REV SCI TECH OIE, V18, P458, DOI 10.20506/rst.18.2.1164; Thombare N.N., 2009, AGR EC RES REV, V22, P319, DOI 10.22004/ag.econ.57469; Venkataramanan R, 2005, INDIAN J ANIM SCI, V75, P456; Wu X, 2016, TRANSBOUND EMERG DIS, V63, pE441, DOI 10.1111/tbed.12308	50	68	72	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149982	10.1371/journal.pone.0149982	http://dx.doi.org/10.1371/journal.pone.0149982			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900944	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100197
J	Stocker, AM; O'Leary, DDM				Stocker, Adam M.; O'Leary, Dennis D. M.			Emx1 Is Required for Neocortical Area Patterning	PLOS ONE			English	Article							DEVELOPING CEREBRAL-CORTEX; THALAMOCORTICAL AXONS; MAMMALIAN NEOCORTEX; HOMEOBOX GENES; COUP-TFI; ROR-BETA; EXPRESSION; SPECIFICATION; REGIONALIZATION; DIFFERENTIATION	Establishing appropriate area patterning in the neocortex is a critical developmental event, and transcription factors whose expression is graded across the developing neural axes have been implicated in this process. While previous reports suggested that the transcription factor Emx1 does not contribute to neocortical area patterning, those studies were performed at perinatal ages prior to the emergence of primary areas. We therefore examined two different Emx1 deletion mouse lines once primary areas possess mature features. Following the deletion of Emx1, the frontal and motor areas were expanded while the primary visual area was reduced, and overall the areas shifted posterio-medially. This patterning phenotype was consistent between the two Emx1 deletion strategies. The present study demonstrates that Emx1 is an area patterning transcription factor and is required for the specification of the primary visual area.	[Stocker, Adam M.; O'Leary, Dennis D. M.] Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Stocker, Adam M.] Minnesota State Univ Moorhead, Biosci Dept, 1104 7th Ave South, Moorhead, MN 56563 USA	Salk Institute; Minnesota State Colleges & Universities; Minnesota State University Moorhead	Stocker, AM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Stocker, AM (corresponding author), Minnesota State Univ Moorhead, Biosci Dept, 1104 7th Ave South, Moorhead, MN 56563 USA.	stocker@mnstate.edu	Stocker, Adam/R-6580-2016	Stocker, Adam/0000-0002-7629-5170	National Institute of Mental Health [5 R01 MH086147]; National Institute of Neurological Disorders and Stroke [5 R01 NS031558 21]; National Eye Institute [T32 EY 020503]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031558] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institute of Mental Health, grant number 5 R01 MH086147, awarded to DDMO (https://www.nimh.nih.gov/index.shtml), and National Institute of Neurological Disorders and Stroke, grant number 5 R01 NS031558 21, awarded to DDMO (http://www.ninds.nih.gov/). AMS was a trainee on the National Eye Institute training grant number T32 EY 020503 (https://nei.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6632; Alfano C, 2013, DEV NEUROBIOL, V73, P411, DOI 10.1002/dneu.22067; Armentano M, 2007, NAT NEUROSCI, V10, P1277, DOI 10.1038/nn1958; Beckmann J, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-35; Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bishop KM, 2000, SCIENCE, V288, P344, DOI 10.1126/science.288.5464.344; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Chou SJ, 2013, SCIENCE, V340, P1239, DOI 10.1126/science.1232806; Force A, 1999, GENETICS, V151, P1531; FUJIMIYA M, 1986, J COMP NEUROL, V246, P191, DOI 10.1002/cne.902460205; Gangemi RMR, 2006, EUR J NEUROSCI, V23, P325, DOI 10.1111/j.1460-9568.2005.04559.x; Gorski JA, 2002, J NEUROSCI, V22, P6309; Guido W, 2008, J PHYSIOL-LONDON, V586, P4357, DOI 10.1113/jphysiol.2008.157115; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; Hamasaki T, 2004, NEURON, V43, P359, DOI 10.1016/j.neuron.2004.07.016; Hoch RV, 2009, SEMIN CELL DEV BIOL, V20, P378, DOI 10.1016/j.semcdb.2009.02.005; Hong SM, 2007, EXP NEUROL, V206, P24, DOI 10.1016/j.expneurol.2007.03.028; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Kaas JH, 2001, CURR OPIN NEUROBIOL, V11, P498, DOI 10.1016/S0959-4388(00)00240-3; Korematsu K, 1997, J COMP NEUROL, V387, P291; Leingartner A, 2007, P NATL ACAD SCI USA, V104, P4153, DOI 10.1073/pnas.0611723104; Li H, 2006, MOL CELL NEUROSCI, V33, P136, DOI 10.1016/j.mcn.2006.06.012; Lim JWC, 2015, DEVELOPMENT, V142, P3746, DOI 10.1242/dev.119909; Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630; Miyamoto N, 1997, DEVELOPMENT, V124, P1653; Molnar Z, 2012, EUR J NEUROSCI, V35, P1573, DOI 10.1111/j.1460-9568.2012.08119.x; Muzio L, 2003, CEREB CORTEX, V13, P641, DOI 10.1093/cercor/13.6.641; Nakagawa Y, 2003, DEV NEUROSCI-BASEL, V25, P234, DOI 10.1159/000072271; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 2013, COMPREHENSIVE DEVELOPMENTAL NEUROSCIENCE: PATTERNING AND CELL TYPE SPECIFICATION IN THE DEVELOPING CNS AND PNS, P61, DOI 10.1016/B978-0-12-397265-1.00021-6; Pellegrini M, 1997, ANAT EMBRYOL, V196, P427, DOI 10.1007/s004290050110; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; Pellegrini M, 2001, DEV BIOL, V232, P149, DOI 10.1006/dbio.2001.0159; Price DJ, 2006, EUR J NEUROSCI, V23, P910, DOI 10.1111/j.1460-9568.2006.04620.x; Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207; R Core Team, 2021, R LANGUAGE ENV STAT; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Sahara S, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-10; Sansom SN, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002519; Schaeren-Wiemers N, 1997, EUR J NEUROSCI, V9, P2687, DOI 10.1111/j.1460-9568.1997.tb01698.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0; Tank EM, 2009, EVOL DEV, V11, P343, DOI 10.1111/j.1525-142X.2009.00341.x; Torre ER, 2010, MOL CELL NEUROSCI, V44, P135, DOI 10.1016/j.mcn.2010.03.003; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vue TY, 2013, J NEUROSCI, V33, P8442, DOI 10.1523/JNEUROSCI.5786-12.2013; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Yoshida M, 1997, DEVELOPMENT, V124, P101; Zembrzycki A, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-8; Zembrzycki A, 2015, ELIFE, V4, DOI 10.7554/eLife.11416; Zembrzycki A, 2015, P NATL ACAD SCI USA, V112, P6736, DOI 10.1073/pnas.1424440112; Zembrzycki A, 2013, NAT NEUROSCI, V16, P1060, DOI 10.1038/nn.3454; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	57	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149900	10.1371/journal.pone.0149900	http://dx.doi.org/10.1371/journal.pone.0149900			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901526	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100180
J	Zhang, CY; Bruce, H; Yang, TF; Charagu, P; Kemp, RA; Boddicker, N; Miar, Y; Wang, ZQ; Plastow, G				Zhang, Chunyan; Bruce, Heather; Yang, Tianfu; Charagu, Patrick; Kemp, Robert Alan; Boddicker, Nicholas; Miar, Younes; Wang, Zhiquan; Plastow, Graham			Genome Wide Association Studies (GWAS) Identify QTL on SSC2 and SSC17 Affecting Loin Peak Shear Force in Crossbred Commercial Pigs	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SINGLE-NUCLEOTIDE POLYMORPHISMS; CAST GENETIC POLYMORPHISMS; DRY-CURED HAMS; CANDIDATE GENES; PORK QUALITY; CALPASTATIN GENE; MUSCLE; TENDERNESS; LOCI	Of all the meat quality traits, tenderness is considered the most important with regard to eating quality and market value. In this study we have utilised genome wide association studies (GWAS) for peak shear force (PSF) of loin muscle as a measure of tenderness for 1,976 crossbred commercial pigs, genotyped for 42,721 informative SNPs using the Illumina Por-cineSNP60 Beadchip. Four 1 Mb genomic regions, three on SSC2 (at 4 Mb, 5 Mb and 109 Mb) and one on SSC17 (at 20 Mb), were detected which collectively explained about 15.30% and 3.07% of the total genetic and phenotypic variance for PSF respectively. Markers ASGA0008566, ASGA0008695, DRGA0003285 and ASGA0075615 in the four regions were strongly associated with the effects. Analysis of the reference genome sequence in the region with the most important SNPs for SSC2_5 identified FRMD8, SLC25A45 and LTBP3 as potential candidate genes for meat tenderness on the basis of functional annotation of these genes. The region SSC2_109 was close to a previously reported candidate gene CAST; however, the very weak LD between DRGA0003285 (the best marker representing region SSC2_109) and CAST indicated the potential for additional genes which are distinct from, or interact with, CAST to affect meat tenderness. Limited information of known genes in regions SSC2_109 and SSC17_20 restricts further analysis. Re-sequencing of these regions for informative animals may help to resolve the molecular architecture and identify new candidate genes and causative mutations affecting this trait. These findings contribute significantly to our knowledge of the genomic regions affecting pork shear force and will potentially lead to new insights into the molecular mechanisms regulating meat tenderness.	[Zhang, Chunyan; Bruce, Heather; Yang, Tianfu; Miar, Younes; Wang, Zhiquan; Plastow, Graham] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Charagu, Patrick] Hypor Inc, Regina, SK, Canada; [Kemp, Robert Alan; Boddicker, Nicholas] Genesus Inc, Oakville, MB, Canada	University of Alberta	Plastow, G (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	plastow@ualberta.ca	Bruce, Heather/GNP-7840-2022	Bruce, Heather/0000-0002-8522-813X; Miar, Younes/0000-0001-9933-5414; Plastow, Graham/0000-0002-3774-3110	Natural Sciences and Engineering Research Council of Canada (NSERC) [CRDPJ 379911]; Hypor Inc.; Genesus Inc.; CZ and GP Mitacs Elevate Program [IT03418]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hypor Inc.; Genesus Inc.; CZ and GP Mitacs Elevate Program	GP acknowledges the financial support from Natural Sciences and Engineering Research Council of Canada (NSERC) CRDPJ 379911: www.nserc-crsng.gc.ca; Hypor Inc. www.hypor.com/; Genesus Inc. www.genesus.com/; and CZ and GP Mitacs Elevate Program IT03418: https://www.mitacs.ca/en/progra,s/elevate. The industry funders (Hypor Inc. and Genesus Inc.) provided support in the form of salaries for authors (PC, RAK, and NB), and data collection at the commercial units, but did not have any additional role in the study design and analysis, or decision to publish. The specific roles of these authors are articulated in the "author contributions" section. The other funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bernevic B, 2011, INT J MASS SPECTROM, V305, P217, DOI 10.1016/j.ijms.2010.11.010; Bredahl L, 1998, FOOD QUAL PREFER, V9, P273, DOI 10.1016/S0950-3293(98)00007-X; Cepica S, 2013, MEAT SCI, V95, P368, DOI 10.1016/j.meatsci.2013.05.002; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; Ciobanu DC, 2004, J ANIM SCI, V82, P2829; Dong Q, 2014, FRONT AGRIC SCI ENG, V1, P137, DOI 10.15302/J-FASE-2014014; Fortomaris P, 2006, MEAT SCI, V72, P688, DOI 10.1016/j.meatsci.2005.09.019; Gandolfi G, 2011, MEAT SCI, V88, P694, DOI 10.1016/j.meatsci.2011.02.031; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Gou P, 2012, MEAT SCI, V92, P346, DOI 10.1016/j.meatsci.2012.06.018; Grunert KG, 2004, MEAT SCI, V66, P259, DOI 10.1016/S0309-1740(03)00130-X; Haitina T, 2006, GENOMICS, V88, P779, DOI 10.1016/j.ygeno.2006.06.016; Harper GS, 1999, AUST J AGR RES, V50, P1105, DOI 10.1071/AR98191; Hu Zhi-Liang, 2011, Frontiers in Genetics, V2, P43, DOI 10.3389/fgene.2011.00043; Kapelanski Wojciech, 2004, Animal Science Papers and Reports, V22, P435; Kemp CM, 2006, J ANIM SCI, V84, P2841, DOI 10.2527/jas.2006-163; Koohmaraie M, 2002, MEAT SCI, V62, P345, DOI 10.1016/S0309-1740(02)00127-4; KOOHMARAIE M, 1991, J ANIM SCI, V69, P617; Lindholm-Perry AK, 2009, ANIM GENET, V40, P713, DOI 10.1111/j.1365-2052.2009.01903.x; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Liu GS, 2008, MAMM GENOME, V19, P429, DOI 10.1007/s00335-008-9132-y; Ma JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064047; Malek M, 2001, MAMM GENOME, V12, P637, DOI 10.1007/s003350020019; Markljung E, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-22; McClure MC, 2012, ANIM GENET, V43, P662, DOI 10.1111/j.1365-2052.2012.02323.x; MCCORMICK RJ, 1994, MEAT SCI, V36, P79, DOI 10.1016/0309-1740(94)90035-3; Melody JL, 2004, J ANIM SCI, V82, P1195; Miar Y, 2014, J ANIM SCI, V92, P2869, DOI 10.2527/jas.2014-7685; Nonneman D, 2011, J ANIM SCI, V89, P2663, DOI 10.2527/jas.2010-3556; Nonneman DJ, 2013, J ANIM SCI, V91, P4043, DOI 10.2527/jas.2013-6255; Olfert ED, 1993, GUIDE CARE USE EXPT; Page BT, 2002, J ANIM SCI, V80, P3077; Paredi G, 2012, J PROTEOMICS, V75, P4275, DOI 10.1016/j.jprot.2012.04.011; Parr T, 1999, J ANIM SCI, V77, P661; Ponsuksili S, 2014, INT J BIOL SCI, V10, P327, DOI 10.7150/ijbs.8134; Promeyrat A, 2011, FOOD CHEM, V127, P1097, DOI 10.1016/j.foodchem.2011.01.108; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohrer GA, 2012, MEAT SCI, V92, P511, DOI 10.1016/j.meatsci.2012.05.020; Rohrer GA, 2006, ANIM GENET, V37, P17, DOI 10.1111/j.1365-2052.2005.01368.x; Ropka-Molik K, 2014, MEAT SCI, V97, P143, DOI 10.1016/j.meatsci.2014.01.021; Sanchez MP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-12; Sante-Lhoutellier V, 2012, MEAT SCI, V92, P354, DOI 10.1016/j.meatsci.2012.06.022; Sargolzaei M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-478; Sieczkowska H, 2010, MEAT SCI, V84, P137, DOI 10.1016/j.meatsci.2009.08.038; Skrlep M, 2012, MEAT SCI, V92, P360, DOI 10.1016/j.meatsci.2012.06.021; Warner RD, 2010, MEAT SCI, V86, P171, DOI 10.1016/j.meatsci.2010.04.042; Wimmers K, 2007, ANIM GENET, V38, P474, DOI 10.1111/j.1365-2052.2007.01639.x; Zhang CY, 2014, ANIM GENET, V45, P508, DOI 10.1111/age.12155	50	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0145082	10.1371/journal.pone.0145082	http://dx.doi.org/10.1371/journal.pone.0145082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901498	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100004
J	Zhou, J; Li, X; Huang, KC; Jia, Y; Tang, FX; Sun, HY; Zhang, Y; Zhang, QH; Ma, D; Li, S				Zhou, Jin; Li, Xiong; Huang, Kecheng; Jia, Yao; Tang, Fangxu; Sun, Haiying; Zhang, Yuan; Zhang, Qinghua; Ma, Ding; Li, Shuang			Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery	PLOS ONE			English	Article							STAGE IB; ONCOLOGY-GROUP; CARCINOMA; WOMEN; TRIAL; HYSTERECTOMY; PROGNOSIS; SURVIVAL; JAPAN; AGE	Objective To evaluate the effects of age and the clinical response to neoadjuvant chemotherapy (NACT) in patients with cervical cancer who received neoadjuvant chemotherapy followed by radical surgery. Methods A total of 1,014 patients with advanced cervical cancer who received NACT followed by radical surgery were retrospectively selected. Patients were divided into young (aged <= 35 years, n = 177) and older (aged >35 years, n = 837) groups. We compared the short-term responses and survival rates between the groups. The five-year disease-free survival (DFS) and overall survival (OS) rates were stratified by age, NACT response, and FIGO stage. Results The overall response rate was 86.8% in the young group and 80.9% in the older group. The young patients had an earlier FIGO stage (P<0.001), a higher rate of adenocarcinoma (P = 0.022), and more lymph node metastasis (P = 0.033) than the older patients. The presence of adenocarcinoma as the histological type (P = 0.024) and positive lymph node metastasis (P<0.001) were identified as independent risk factors for survival. When stratified by age and clinical response, young patients with no response to NACT had a worse clinicopathological condition compared with the other subgroups. Compared with non-responders, responders to NACT had a higher five-year DFS rate (80.1% versus 71.8%; P = 0.019) and OS rate (82.6% versus 71.8%; P = 0.003) among the young patients but not among the older patients. Conclusions Responders to NACT aged 35 years or younger benefitted the most from NACT, while the young non-responders benefitted the least. Age might represent an important factor to consider when performing NACT in patients with cervical cancer.	[Zhou, Jin; Li, Xiong; Huang, Kecheng; Jia, Yao; Tang, Fangxu; Sun, Haiying; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhou, Jin] Wuhan Univ, Ctr Canc, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Li, Xiong; Zhang, Qinghua] Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China; [Zhang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology	Ma, D; Li, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.; Zhang, QH (corresponding author), Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China.	zhangqh66@qq.com; dma@tjh.tjmu.edu.cn; lee5190008@126.com	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2015CB553903]; National Natural Science Foundation of China [91529102, 81572571, 81402160, 81302267, 81230038, 81230052, 30973472, 81001151, 81071663, 30973205, 30973184, 81090414, 81272422, 81172464, 81101964]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2015CB553903) and was supported by grants from the National Natural Science Foundation of China (NO. 91529102; 81572571; 81402160; 81302267; 81230038; 81230052; 30973472; 81001151; 81071663; 30973205; 30973184; 81090414; 81272422; 81172464; 81101964).	[Anonymous], 2012, GLOBACAN 2012 DAT CE; Aoki Y, 2001, GYNECOL ONCOL, V83, P263, DOI 10.1006/gyno.2001.6371; Bamias A, 2005, ANN ONCOL, V16, P307, DOI 10.1093/annonc/mdi039; Benedetti-Panici P, 2002, J CLIN ONCOL, V20, P179, DOI 10.1200/JCO.20.1.179; Buda A, 2015, INT J GYNECOL CANCER, V25, P1468, DOI 10.1097/IGC.0000000000000515; Cai HB, 2010, INT J GYNECOL CANCER, V20, P1240, DOI 10.1111/IGC.0b013e3181ecec79; Chang TC, 2000, J CLIN ONCOL, V18, P1740, DOI 10.1200/JCO.2000.18.8.1740; Chemoradiotherapy for cervical cancer meta-analysis collaboration, 2008, J CLIN ONCOL, V26, P5802, DOI DOI 10.1200/JCO.2008.16.4368; Chen HJ, 2008, GYNECOL ONCOL, V110, P308, DOI 10.1016/j.ygyno.2008.05.026; deSouza NM, 2004, BRIT J CANCER, V90, P2326, DOI 10.1038/sj.bjc.6601870; HALL SW, 1983, LANCET, V2, P731; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Huang HJ, 2003, INT J GYNECOL CANCER, V13, P204, DOI 10.1046/j.1525-1438.2003.13004.x; Katsumata N, 2013, BRIT J CANCER, V108, P1957, DOI 10.1038/bjc.2013.179; Kokawa K, 2010, EUR J GYNAECOL ONCOL, V31, P37; Lai CH, 1999, INT J GYNECOL CANCER, V9, P28; Lau HY, 2009, INT J GYNECOL OBSTET, V107, P220, DOI 10.1016/j.ijgo.2009.07.029; Li S, 2013, ONCOLOGIST, V18, P1101, DOI 10.1634/theoncologist.2013-0123; Look KY, 1997, GYNECOL ONCOL, V67, P255, DOI 10.1006/gyno.1997.4886; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; POKA R, 1994, INT J GYNECOL OBSTET, V46, P33, DOI 10.1016/0020-7292(94)90306-9; STANHOPE CR, 1980, GYNECOL ONCOL, V10, P188, DOI 10.1016/0090-8258(80)90080-3; Wang J, 2015, MOL CLIN ONCOL, V3, P363, DOI 10.3892/mco.2014.465; Wen H, 2012, INT J GYNECOL CANCER, V22, P296, DOI 10.1097/IGC.0b013e31823610a1; World Health Organization, 1979, WHO HDB REP RES CANC, P16	25	2	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149534	10.1371/journal.pone.0149534	http://dx.doi.org/10.1371/journal.pone.0149534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901776	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100094
J	Guillet, V; Galandrin, S; Maveyraud, L; Ladeveze, S; Mariaule, V; Bon, C; Eynard, N; Daffe, M; Marrakchi, H; Mourey, L				Guillet, Valerie; Galandrin, Segolene; Maveyraud, Laurent; Ladeveze, Simon; Mariaule, Vincent; Bon, Cecile; Eynard, Nathalie; Daffe, Mamadou; Marrakchi, Hedia; Mourey, Lionel			Insight into Structure-Function Relationships and Inhibition of the Fatty Acyl-AMP Ligase (FadD32) Orthologs from Mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						crystal structure; drug design; enzyme inhibitor; mycobacteria; tuberculosis; fatty acyl ACP-synthase; fatty acyl-AMP ligase	MYCOLIC ACID BIOSYNTHESIS; CRYSTAL-STRUCTURE; TUBERCULOSIS; SYNTHETASE; ACTIVATION; ENVELOPE; PROGRAM; ENZYMES; KEY	Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is one of the targets of first-line antituberculous drugs. This pathway contains a number of potential targets, including some that have been identified only recently and have yet to be explored. One such target, FadD32, is required for activation of the long meromycolic chain and is essential for mycobacterial growth. We report here an in-depth biochemical, biophysical, and structural characterization of four FadD32 orthologs, including the very homologous enzymes from Mycobacterium tuberculosis and Mycobacterium marinum. Determination of the structures of two complexes with alkyl adenylate inhibitors has provided direct information, with unprecedented detail, about the active site of the enzyme and the associated hydrophobic tunnel, shedding new light on structure-function relationships and inhibition mechanisms by alkyl adenylates and diarylated coumarins. This work should pave the way for the rational design of inhibitors of FadD32, a highly promising drug target.	[Guillet, Valerie; Galandrin, Segolene; Maveyraud, Laurent; Ladeveze, Simon; Mariaule, Vincent; Bon, Cecile; Eynard, Nathalie; Daffe, Mamadou; Marrakchi, Hedia; Mourey, Lionel] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, F-31077 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Guillet, V; Marrakchi, H (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	valerie.guillet@ipbs.fr; hedia.marrakchi@ipbs.fr	Mourey, Lionel/B-5662-2009; Marrakchi, Hedia/AAF-2657-2020; BON, cecile C/F-9231-2018; Maveyraud, Laurent/C-6066-2011	Mourey, Lionel/0000-0002-8259-1259; Maveyraud, Laurent/0000-0003-4610-8319; Marrakchi, Hedia/0000-0003-2749-5966; Bon, Cecile/0000-0002-3700-2646; Mariaule, Vincent/0000-0003-2655-0580	European Community New Medicines for Tuberculosis Program [LSHP-CT-2005-018923]	European Community New Medicines for Tuberculosis Program	This work was supported by European Community New Medicines for Tuberculosis Program Grant LSHP-CT-2005-018923. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andersson CS, 2012, STRUCTURE, V20, P1062, DOI 10.1016/j.str.2012.03.012; Arora P, 2009, NAT CHEM BIOL, V5, P166, DOI 10.1038/nchembio.143; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bricogne G., 2011, BUSTER VERSION 2 10; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosby HA, 2012, APPL ENVIRON MICROB, V78, P6619, DOI 10.1128/AEM.01733-12; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Daffe M, 2014, BACTERIAL MEMBRANES, P179; Daffe M, 2015, TUBERCULOSIS, V95, pS155, DOI 10.1016/j.tube.2015.02.024; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Goyal A, 2012, J MOL BIOL, V416, P221, DOI 10.1016/j.jmb.2011.12.031; Gulick AM, 2004, BIOCHEMISTRY-US, V43, P8670, DOI 10.1021/bi049384m; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15493; Liu Z, 2013, J BIOL CHEM, V288, P18473, DOI 10.1074/jbc.M113.466912; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Neyrolles O, 2011, TUBERCULOSIS, V91, P187, DOI 10.1016/j.tube.2011.01.002; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schmelz S, 2009, CURR OPIN STRUC BIOL, V19, P666, DOI 10.1016/j.sbi.2009.09.004; Smart O. S., 2011, GRADE VERSION 1 1 1; Stanley SA, 2013, P NATL ACAD SCI USA, V110, P11565, DOI 10.1073/pnas.1302114110; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Zhang ZN, 2011, J MOL BIOL, V406, P313, DOI 10.1016/j.jmb.2010.12.011	54	15	16	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					7973	7989		10.1074/jbc.M115.712612	http://dx.doi.org/10.1074/jbc.M115.712612			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26900152	Green Published, hybrid			2022-12-26	WOS:000374056700019
J	Beall, RF; Nickerson, JW; Kaplan, WA; Attaran, A				Beall, Reed F.; Nickerson, Jason W.; Kaplan, Warren A.; Attaran, Amir			Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?	PLOS ONE			English	Article							ALBUTEROL INHALERS	Background Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement. This phenomenon, pejoratively known as "evergreening", can allow manufacturers to preserve market exclusivity, but without significantly bettering the standard of care. Other studies speculate that evergreening is especially problematic for medicine/device combination products, because patents on the device component may outlast expired patents on the medicine component, and thereby keep competing, possibly less-expensive generic products off the market. Materials and Methods We focused on four common conditions that are often treated by medicine/device product combinations: asthma and chronic obstructive pulmonary disease (COPD), diabetes, and severe allergic reactions. The patent data for a sample of such products (n = 49) for treating these conditions was extracted fromthe United States Food and Drug Administration's Orange Book. Additional patent-related data (abstracts, claims, etc) were retrieved using LexisNexis TotalPatent. Comparisons were thenmade between each product's device patents and medicine patents. Results Unexpired device patents exist for 90 percent of the 49 medicine/device product combinations studied, and were the only sort of unexpired patent for 14 products. Overall, 55 percent of the 235 patents found by our study were device patents. Comparing the last-to-expire device patent to that of the last-to-expire active ingredient patent, the median additional years of patent protection afforded by device patents was 4.7 years (range: 1.3-15.2 years). Conclusion Incremental, patentable innovation in devices to extend the overall patent protection of medicine/device product combinations is very common. Whether this constitutes "evergreening" depends on whether these incremental innovations and the years of extra patent protection they confer are proportionately matched by therapeutic improvements in the standard of care, which is highly debatable.	[Beall, Reed F.; Attaran, Amir] Univ Ottawa, Fac Med, Populat Hlth Program, Ottawa, ON, Canada; [Beall, Reed F.; Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Nickerson, Jason W.] Bruyere Res Inst, Ottawa, ON, Canada; [Kaplan, Warren A.] Boston Univ, Sch Publ Hlth, WHO Collaborating Ctr Pharmaceut Policy, Ctr Global Hlth & Dev,Dept Global Hlth, Boston, MA USA	University of Ottawa; University of Ottawa; University of Ottawa; Boston University	Beall, RF (corresponding author), Univ Ottawa, Fac Med, Populat Hlth Program, Ottawa, ON, Canada.; Beall, RF (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON, Canada.	Reed.Beall@uottawa.ca	Nickerson, Jason/AAP-6026-2021	Nickerson, Jason/0000-0003-3692-999X; Kaplan, Warren/0000-0001-6127-4820	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This article is a part of RFB's PhD dissertation research, which is funded through a Vanier Doctoral Scholarship by the Canadian Institutes of Health Research (CIHR). No direct funding was received for this project.	Attaran A, 2014, LANCET, V384, P477, DOI 10.1016/S0140-6736(13)60845-4; Bartholow M, 2013, TOP 200 DRUGS 2012 P; Burgt JAV, 2000, J ALLERGY CLIN IMMUN, V106, P1209, DOI [10.1067/mai.2000.111582, DOI 10.1067/MAI.2000.111582]; Drugs.com, 2014, US PHARM SAL TOP 100; Freudenheim M, 1991, NY TIMES; Gross NJ, 2007, NEW ENGL J MED, V356, P2749; Gupta H, 2010, J PHARM BIOALLIED SC, V2, P2, DOI 10.4103/0975-7406.62694; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; HURWITZ MA, 1991, COLUMBIA LAW REV, V91, P1188, DOI 10.2307/1122848; Luo J, 2015, LANCET DIABETES ENDO, V3, P835, DOI 10.1016/S2213-8587(15)00364-2; MAHN TERRY G., 2013, ORANGE BOOK LISTING; Martin B, 2008, United States patent, Patent No. [US8387615, 8387615]; Rosenthal E., 2013, SOARING COST SIMPLE; ROSENTHAL E, 2014, EVEN SMALL MED ADV C; Ross S, 2015, HEALTH POLICY TECHN, V4, P168, DOI 10.1016/j.hlpt.2015.02.008; Ross S, 2008, J OBSTET GYNAECOL CA, V30, P508, DOI 10.1016/S1701-2163(16)32867-5; RxList, TOP 200 DRUGS US ONL; Steckel H, 2004, INT J PHARMACEUT, V284, P75, DOI 10.1016/j.ijpharm.2004.07.005; U.S. National Library of Medicine, 2015, PHARM STAT; United States Food and Drug Administration, 2015, OR BOOK APPR DRUG PR; United States Food and Drug Administration, 2015, DRUG TREATM ASTHM CH	22	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148939	10.1371/journal.pone.0148939	http://dx.doi.org/10.1371/journal.pone.0148939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910128	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700016
J	Boodhoo, N; Sharif, S; Behboudi, S				Boodhoo, Nitish; Sharif, Shayan; Behboudi, Shahriar			1 alpha, 25(OH)(2) Vitamin D3 Modulates Avian T Lymphocyte Functions without Inducing CTL Unresponsiveness	PLOS ONE			English	Article							D-RECEPTOR EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; IN-VITRO; TRANSCRIPTIONAL REPRESSION; DIHYDROXYVITAMIN D-3; DENDRITIC CELLS; DOWN-REGULATION; MESSENGER-RNA; NITRIC-OXIDE; IFN-GAMMA	1,25-Dihydroxyvitamin D3 (Vitamin D) is a naturally synthesized fat soluble vitamin shown to have immunomodulatory, anti-inflammatory and cancer prevention properties in human and murine models. Here, we studied the effects of Vitamin D on the functional abilities of avian T lymphocytes using chicken Interferon (IFN)-gamma ELISPOT assay, BrdU proliferation assay, Annexin V apoptosis assay and PhosFlow for detecting phosphorylated signalling molecules. The results demonstrate that Vitamin D significantly inhibited the abilities of T lymphocytes to produce IFN-gamma and proliferate in vitro (P <= 0.05), but retained their ability to undergo degranulation, which is a maker for cytotoxicity of these cells. Similarly, Vitamin D did not inhibit Extracellular signal-Regulated Kinase (ERK) 1/2 phosphorylation, a key mediator in T cell signalling, in the stimulated T lymphocytes population, while reduced ERK1/2 phosphorylation levels in the unstimulated cells. Our data provide evidence that Vitamin D has immuno-modulatory properties on chicken T lymphocytes without inducing unresponsiveness and by limiting immuno-pathology can promote protective immunity against infectious diseases of poultry.	[Boodhoo, Nitish; Behboudi, Shahriar] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Sharif, Shayan] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Guelph	Behboudi, S (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.	shahriar.behboudi@pirbright.ac.uk		behboudi, shahriar/0000-0001-6455-4086	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001825]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00002529] Funding Source: researchfish; BBSRC [BBS/E/I/00001825, BBS/E/I/00002529] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (award nos. BBS/E/I/00001825) to SB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alagarasu K, 2012, HUM IMMUNOL, V73, P1194, DOI 10.1016/j.humimm.2012.08.007; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Chan KS, 2007, J IMMUNOL METHODS, V325, P20, DOI 10.1016/j.jim.2007.05.011; Chen J, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-6; Chen LF, 2005, J IMMUNOL, V174, P6144, DOI 10.4049/jimmunol.174.10.6144; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Di Rosa M, 2011, IMMUNOLOGY, V134, P123, DOI 10.1111/j.1365-2567.2011.03482.x; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gardner DH, 2015, J IMMUNOL, V195, P2657, DOI 10.4049/jimmunol.1500306; Gottfried E, 2006, BIOCHEM BIOPH RES CO, V349, P209, DOI 10.1016/j.bbrc.2006.08.034; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Heaney RP, 2008, CLIN J AM SOC NEPHRO, V3, P1535, DOI 10.2215/CJN.01160308; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jiang F, 2004, J BIOL CHEM, V279, P53213, DOI 10.1074/jbc.M410395200; KIZAKI M, 1991, BLOOD, V77, P1238; Kongsbak M, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0035-2; Kuhn J, 2015, J STEROID BIOCHEM, V148, P7, DOI 10.1016/j.jsbmb.2014.10.015; Kuhn J, 2014, NUTRITION, V30, P481, DOI 10.1016/j.nut.2013.10.002; Lang P.O., 2012, J AGING RES, V2012, P1, DOI [10.1155/2012/806198, DOI 10.1155/2012/806198]; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Morris A, 2014, VET IMMUNOL IMMUNOP, V161, P265, DOI 10.1016/j.vetimm.2014.08.008; OHTA M, 1985, FEBS LETT, V185, P9, DOI 10.1016/0014-5793(85)80730-4; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Praslickova D, 2008, POULTRY SCI, V87, P1112, DOI 10.3382/ps.2008-00006; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Shanmugasundaram R, 2012, POULTRY SCI, V91, P1819, DOI 10.3382/ps.2011-02129; Shojadoost B, 2015, RES VET SCI, V100, P45, DOI 10.1016/j.rvsc.2015.03.009; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tiosano D, 2013, J CLIN ENDOCR METAB, V98, P1685, DOI 10.1210/jc.2012-3858; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vervelde L, 2013, VET IMMUNOL IMMUNOP, V151, P337, DOI 10.1016/j.vetimm.2012.11.012; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wattrang E, 2015, J IMMUNOL METHODS, V419, P35, DOI 10.1016/j.jim.2015.02.011; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Yao X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/953974; Ylikomi T, 2002, VITAM HORM, V64, P357, DOI 10.1016/S0083-6729(02)64010-5; Yuzefpolskiy Y, 2014, J NUTR, V144, P2073, DOI 10.3945/jn.114.202895; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	71	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150134	10.1371/journal.pone.0150134	http://dx.doi.org/10.1371/journal.pone.0150134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910045	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700070
J	Chaddad, A; Desrosiers, C; Bouridane, A; Toews, M; Hassan, L; Tanougast, C				Chaddad, Ahmad; Desrosiers, Christian; Bouridane, Ahmed; Toews, Matthew; Hassan, Lama; Tanougast, Camel			Multi Texture Analysis of Colorectal Cancer Continuum Using Multispectral Imagery	PLOS ONE			English	Article							INDIVIDUAL PATIENT DATA; COLON-CANCER; CT TEXTURE; FEATURES; LIVER	Purpose This paper proposes to characterize the continuum of colorectal cancer (CRC) using multiple texture features extracted from multispectral optical microscopy images. Three types of pathological tissues (PT) are considered: benign hyperplasia, intraepithelial neoplasia and carcinoma. Materials and Methods In the proposed approach, the region of interest containing PT is first extracted from multispectral images using active contour segmentation. This region is then encoded using texture features based on the Laplacian-of-Gaussian (LoG) filter, discrete wavelets (DW) and gray level co-occurrence matrices (GLCM). To assess the significance of textural differences between PT types, a statistical analysis based on the Kruskal-Wallis test is performed. The usefulness of texture features is then evaluated quantitatively in terms of their ability to predict PT types using various classifier models. Results Preliminary results show significant texture differences between PT types, for all texture features (p-value < 0.01). Individually, GLCM texture features outperform LoG and DW features in terms of PT type prediction. However, a higher performance can be achieved by combining all texture features, resulting in a mean classification accuracy of 98.92%, sensitivity of 98.12%, and specificity of 99.67%. Conclusions These results demonstrate the efficiency and effectiveness of combining multiple texture features for characterizing the continuum of CRC and discriminating between pathological tissues in multispectral images.	[Chaddad, Ahmad; Desrosiers, Christian; Toews, Matthew] Ecole Technol Super, Lab Imagery Vis & Artificial Intelligence, Montreal, PQ, Canada; [Chaddad, Ahmad; Hassan, Lama; Tanougast, Camel] Univ Lorraine, Lab Concept Optimizat & Modelling Syst, Metz, Lorraine, France; [Bouridane, Ahmed] Northumbria Univ, Sch Comp Engn & Informat Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Lorraine; Northumbria University	Chaddad, A (corresponding author), Ecole Technol Super, Lab Imagery Vis & Artificial Intelligence, Montreal, PQ, Canada.; Chaddad, A (corresponding author), Univ Lorraine, Lab Concept Optimizat & Modelling Syst, Metz, Lorraine, France.	achaddad@livia.etsmtl.ca	Chaddad, Ahmad/AAG-3730-2020; Tanougast, Camel/V-7936-2018	Chaddad, Ahmad/0000-0003-3402-9576; Tanougast, Camel/0000-0002-5399-1683; Hassan, Lama/0000-0002-2368-0366				Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P457; AKAY M, 1995, ANN BIOMED ENG, V23, P529, DOI 10.1007/BF02584452; Belongie S, 2002, IEEE T PATTERN ANAL, V24, P509, DOI 10.1109/34.993558; Breiman L., 2017, CLASSIFICATION REGRE; Chaddad A, 2013, PR SOUTH BIOMED ENG, P129, DOI 10.1109/SBEC.2013.73; Chaddad A., 2011, 2011 IEEE International Conference on Computer Applications and Industrial Electronics (ICCAIE 2011), P87, DOI 10.1109/ICCAIE.2011.6162110; Chaddad Ahmad, 2011, WSEAS Transactions on Biology and Biomedicine, V8, P39; Chaddad A, 2015, HEALTH TECHNOL-GER, V5, P179, DOI 10.1007/s12553-015-0115-1; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Cooper LAD, 2015, LAB INVEST, V95, P366, DOI 10.1038/labinvest.2014.153; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dasarathy B. V., 1991, NEAREST NEIGHBOR NN; Esgiar A N, 1998, IEEE Trans Inf Technol Biomed, V2, P197, DOI 10.1109/4233.735785; Esgiar AN, 2002, IEEE T INF TECHNOL B, V6, P54, DOI 10.1109/4233.992163; Esgiar AN, 1998, ANAL QUANT CYTOL, V20, P297; Ganeshan B, 2007, ACAD RADIOL, V14, P1058, DOI 10.1016/j.acra.2007.05.023; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hilado SDF, 2014, J ADV COMPUT INTELL, V18, P792, DOI 10.20965/jaciii.2014.p0792; HIRAOKA Y, 1987, SCIENCE, V238, P36, DOI 10.1126/science.3116667; Histace A, 2013, ANN BRIT MACHINE VIS, V2013, P1; Jiao L., 2013, IFMBE P, P1283, DOI [10.1007/978-3-642-29305-4_336, DOI 10.1007/978-3-642-29305-4_336]; Kalkan H, 2012, INT C PATT RECOG, P61; Kim TY, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/536217; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Loughrey MB, 2015, VIRCHOWS ARCH, V467, P137, DOI 10.1007/s00428-015-1780-1; Low RN, 2002, ABDOM IMAGING, V27, P418, DOI 10.1007/s00261-001-0122-8; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Matuszewski B. J., 2011, 2011 18th IEEE International Conference on Image Processing (ICIP 2011), P3081, DOI 10.1109/ICIP.2011.6116316; Miller PJ, 1995, MULTISPECTRAL IMAGIN, P354, DOI [10.1117/12.198889, DOI 10.1117/12.198889]; Ng F, 2013, RADIOLOGY, V266, P177, DOI 10.1148/radiol.12120254; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Peyreti R, 2015, IEEE ENG MED BIO, P7218, DOI 10.1109/EMBC.2015.7320057; Rao SX, 2014, UNITED EUR GASTROENT, V2, P530, DOI 10.1177/2050640614552463; Rathore S, 2013, IEEEACM T COMPUT BIO; Refaeilzadeh P., 2009, ENCY DATABASE SYSTEM, VVolume 5, P532, DOI DOI 10.1007/978-0-387-39940-9_565; Rokach L, 2007, DATA MINING DECISION; Sargent DJ, 2007, J CLIN ONCOL, V25, P4569, DOI 10.1200/JCO.2006.10.4323; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Witten I.H., 2005, DATA MINING PRACTICA; Yan Xu, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1626, DOI 10.1109/ICASSP.2014.6853873	42	28	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149893	10.1371/journal.pone.0149893	http://dx.doi.org/10.1371/journal.pone.0149893			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901134	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000371276100177
J	Wu, YX; Kang, XJ; Zheng, HY; Liu, HY; Huang, Q; Liu, JQ				Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Huang, Qing; Liu, Jianqiao			Effect of Paternal Age on Reproductive Outcomes of Intracytoplasmic Sperm Injection	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; MALE-FERTILITY; PRETERM BIRTH; PREGNANCY; FATHERS; COUPLES	The impact of paternal age on reproduction, especially using assisted reproductive technologies, has not been well studied to date. To investigate the effect of paternal age on reproductive outcomes, here we performed a retrospective analysis of 2,627 intracytoplasmic sperm injection (ICSI) cycles performed at the Reproductive Medicine Center of the Third Affiliated Hospital of Guangzhou Medical University (China) between January 2007 and May 2015. Effect of paternal age on embryo quality [number of fertilized oocytes, 2 pronucleus zygotes (2PNs), viable embryos, and high-quality embryos] was analyzed by multiple linear regression. Relationships between paternal age and pregnancy outcomes were analyzed by binary logistic regression. After adjusting for female age, no association between paternal age and the following parameters of embryo quality was observed: number of fertilized oocytes (B = -0.032; 95% CI -0.069-0.005; P = 0.088), number of 2PNs (B = -0.005; 95% CI -0.044-0.034; P = 0.806), and number of viable embryos (B = -0.025; 95% CI -0.052-0.001; P = 0.062). However, paternal age negatively influenced the number of highquality embryos (B = -0.020; 95% CI -0.040-0.000; P = 0.045). Moreover, paternal age had no effect on pregnancy outcomes (OR for a 5-year interval), including the rates of clinical pregnancy (OR 0.919; 95% CI 0.839-1.006; P = 0.067), ongoing pregnancy (OR 0.914; 95% CI 0.833-1.003; P = 0.058), early pregnancy loss (OR 1.019; 95% CI 0.823-1.263; P = 0.861), live births (OR 0.916; 95% CI 0.833-1.007; P = 0.070), and preterm births (OR 1.061; 95% CI 0.898-1.254; P = 0.485). Therefore, increased paternal age negatively influences the number of high-quality embryos, but has no effect on pregnancy outcomes in couples undergoing ICSI cycles. However, more studies including men aged over 60 years with a longer-term follow-up are needed.	[Wu, Yixuan; Kang, Xiangjin; Zheng, Haiyan; Liu, Haiying; Huang, Qing; Liu, Jianqiao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod Med Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Major Obstet Dis Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Wu, Yixuan] Key Lab Reprod & Genet Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Liu, JQ (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Reprod Med, Guangzhou, Guangdong, Peoples R China.	ljq88gz@163.com			National Natural Science Foundation of China [81401254]; Science and Technology Plan of Guangdong Province [2013B022000022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Plan of Guangdong Province	Funding provided by a grant from the National Natural Science Foundation of China, (No. 81401254) (grant recipient: XJK), URL: http://www.nsfc.gov.cn/. Role of funder: performed the experiments; data collection, decision to publish. Funding also provided by a grant from the Science and Technology Plan of Guangdong Province (No. 2013B022000022) (grant recipient: QH), URL: http://pro.gdstc.gov.cn/egrantweb/.	Aboulghar M, 2007, REPROD BIOMED ONLINE, V14, P588, DOI 10.1016/S1472-6483(10)61050-4; Astolfi P, 2006, EPIDEMIOLOGY, V17, P218, DOI 10.1097/01.ede.0000197053.61176.f4; Begueria R, 2014, HUM REPROD, V29, P2114, DOI 10.1093/humrep/deu189; Bellver J, 2008, REPROD BIOMED ONLINE, V17, P595, DOI 10.1016/S1472-6483(10)60305-7; Cocuzza M, 2008, UROLOGY, V71, P490, DOI 10.1016/j.urology.2007.11.041; de la Rochebrochard E, 2006, FERTIL STERIL, V85, P1420, DOI 10.1016/j.fertnstert.2005.11.040; Ferreira RC, 2010, FERTIL STERIL, V93, P1870, DOI 10.1016/j.fertnstert.2008.12.043; Frattarelli JL, 2008, FERTIL STERIL, V90, P97, DOI 10.1016/j.fertnstert.2007.06.009; Jenkins TG, 2013, FERTIL STERIL, V100, P945, DOI 10.1016/j.fertnstert.2013.05.039; Kazaura M, 2004, ANN EPIDEMIOL, V14, P566, DOI 10.1016/j.annepidem.2003.10.003; Klonoff-Cohen HS, 2004, AM J OBSTET GYNECOL, V191, P507, DOI 10.1016/j.ajog.2004.01.035; Kovac JR, 2014, UROL ANNALS, V6, P41, DOI 10.4103/0974-7796.127026; Luna M, 2009, FERTIL STERIL, V92, P1772, DOI 10.1016/j.fertnstert.2009.05.036; Moskovtsev SI, 2006, FERTIL STERIL, V85, P496, DOI 10.1016/j.fertnstert.2005.05.075; Paulson RJ, 2001, AM J OBSTET GYNECOL, V184, P818, DOI 10.1067/mob.2001.113852; Plas E, 2000, EXP GERONTOL, V35, P543, DOI 10.1016/S0531-5565(00)00120-0; Sartorelli EMP, 2001, FERTIL STERIL, V76, P1119, DOI 10.1016/S0015-0282(01)02894-1; Spandorfer SD, 1998, HUM REPROD, V13, P334, DOI 10.1093/humrep/13.2.334; Tsai YR, 2013, TAIWAN J OBSTET GYNE, V52, P351, DOI 10.1016/j.tjog.2013.06.001; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135734; Zhu JL, 2005, EPIDEMIOLOGY, V16, P259, DOI 10.1097/01.ede.0000152526.63279.da	22	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149867	10.1371/journal.pone.0149867	http://dx.doi.org/10.1371/journal.pone.0149867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901529	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100169
J	Dermentzaki, G; Paschalidis, N; Politis, PK; Stefanis, L				Dermentzaki, Georgia; Paschalidis, Nikolaos; Politis, Panagiotis K.; Stefanis, Leonidas			Complex Effects of the ZSCAN21 Transcription Factor on Transcriptional Regulation of -Synuclein in Primary Neuronal Cultures and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein; neuron; Parkinson disease; rat; transcription regulation; zinc finger and SCAN domain containing 21 transcription factor	CHAPERONE-MEDIATED AUTOPHAGY; MESSENGER-RNA EXPRESSION; GENOME-WIDE ASSOCIATION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; ALLELIC VARIATION; SUBSTANTIA-NIGRA; BETA-SYNUCLEIN; RISK-FACTORS; LEWY BODY	-Synuclein, a presynaptic neuronal protein encoded by the SNCA gene, is strongly implicated in Parkinson disease (PD). PD pathogenesis is linked to increased SNCA levels; however, the transcriptional elements that control SNCA expression are still elusive. Previous experiments in PC12 cells demonstrated that the transcription factor zinc finger and SCAN domain containing 21 (ZSCAN21) plays an important regulatory role in SNCA transcription. Currently, we characterized the role of ZSCAN21 in SNCA transcription in primary neuronal cultures and in vivo. We found that ZSCAN21 is developmentally expressed in neurons in different rat brain regions. We confirmed its binding in the intron 1 region of SNCA in rat cortical cultures. Lentivirus-mediated silencing of ZSCAN21 increased significantly SNCA promoter activity, mRNA, and protein levels in such cultures. In contrast, ZSCAN21 silencing reduced SNCA in neurosphere cultures. Interestingly, ZSCAN21 overexpression in cortical neurons led to robust mRNA but negligible protein expression, suggesting that ZSCAN21 protein levels are tightly regulated post-transcriptionally and/or post-translationally in primary neurons. Efficient adeno-associated virus-mediated knockdown of ZSCAN21 in the postnatal and adult hippocampus, an area linked with non-motor PD symptoms, revealed no significant alterations in SNCA levels. Overall, our study demonstrates that ZSCAN21 is involved in the transcriptional regulation of SNCA in primary neuronal cultures, but the direction of the effect is variable, likely depending on neuronal maturation. However, the unaltered SNCA levels observed following ZSCAN21 down-regulation in the rat brain, possibly due to compensatory mechanisms, imply that ZSCAN21 is not a master regulator of SNCA in vivo.	[Dermentzaki, Georgia; Paschalidis, Nikolaos; Politis, Panagiotis K.; Stefanis, Leonidas] Acad Athens, Biomed Res Fdn, Athens 11527, Greece; [Stefanis, Leonidas] Natl & Kapodistrian Univ Athens, Hosp Attikon, Sch Med, Dept Neurol 2, Athens 12462, Greece	Academy of Athens; Athens Medical School; National & Kapodistrian University of Athens; University Hospital Attikon	Stefanis, L (corresponding author), Acad Athens, Biomed Res Fdn, Athens 11527, Greece.	lstefanis@bioacademy.gr	Politis, Panagiotis/AAO-2423-2020; Stefanis, Leonidas/AAD-7192-2019	Politis, Panagiotis/0000-0002-2556-2857; Paschalidis, Nikolaos/0000-0001-6278-4144	European Union; Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund	European Union(European Commission); Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund	This work was supported in part by the European Union (European Social Fund) and Greek National Funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework-Research Funding Program: Heracleitus II, Investing in Knowledge Society through the European Social Fund. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott RD, 2001, NEUROLOGY, V57, P456, DOI 10.1212/WNL.57.3.456; Ai SX, 2014, J NEUROL SCI, V337, P123, DOI 10.1016/j.jns.2013.11.033; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Bayer TA, 1999, NEUROREPORT, V10, P2799, DOI 10.1097/00001756-199909090-00019; Brenner S, 2015, NEUROSCI LETT, V599, P140, DOI 10.1016/j.neulet.2015.05.029; Calabresi P, 2013, LANCET NEUROL, V12, P811, DOI 10.1016/S1474-4422(13)70118-2; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Clough RL, 2011, J NEUROCHEM, V117, P275, DOI 10.1111/j.1471-4159.2011.07199.x; Clough RL, 2009, J NEUROCHEM, V110, P1479, DOI 10.1111/j.1471-4159.2009.06250.x; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Dietrich P, 2003, MOL CELL NEUROSCI, V24, P430, DOI 10.1016/S1044-7431(03)00201-X; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Galvin JE, 2001, EXP NEUROL, V168, P347, DOI 10.1006/exnr.2000.7615; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Kaltezioti V, 2014, J NEUROSCI, V34, P15816, DOI 10.1523/JNEUROSCI.1865-14.2014; Kaltezioti V, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000565; Kim JY, 2013, EUR J NEUROSCI, V37, P1203, DOI 10.1111/ejn.12126; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Linnertz C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007480; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lutz M, 2015, ALZHEIMERS DEMENT, V11, P1133, DOI 10.1016/j.jalz.2015.05.011; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Mizuta I, 2013, J HUM GENET, V58, P711, DOI 10.1038/jhg.2013.90; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Nuber S, 2008, J NEUROSCI, V28, P2471, DOI 10.1523/JNEUROSCI.3040-07.2008; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Papapetropoulos S, 2007, MOVEMENT DISORD, V22, P1057, DOI 10.1002/mds.21466; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petersen K, 1999, NEUROSCIENCE, V91, P651, DOI 10.1016/S0306-4522(98)00596-X; Pihlstrom L, 2015, MOVEMENT DISORD, V30, P577, DOI 10.1002/mds.26073; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Raghavan R, 2004, PEDIATR DEVEL PATHOL, V7, P506, DOI 10.1007/s10024-003-7080-9; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Saleh H, 2015, TRANSL NEURODEGENER, V4, DOI 10.1186/s40035-015-0026-0; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stefanis L, 2001, J NEUROCHEM, V76, P1165, DOI 10.1046/j.1471-4159.2001.00114.x; Sterling Lori, 2014, F1000Res, V3, P259, DOI 10.12688/f1000research.3281.2; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tan YY, 2014, PARKINSONISM RELAT D, V20, P308, DOI 10.1016/j.parkreldis.2013.12.002; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Wang Y, 2013, CNS NEUROSCI THER, V19, P183, DOI 10.1111/cns.12059; Woods NT, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002255; Wright JA, 2013, MOL CELL NEUROSCI, V57, P33, DOI 10.1016/j.mcn.2013.09.002; Xilouri M, 2013, BRAIN, V136, P2130, DOI 10.1093/brain/awt131; Xilouri M, 2012, HUM MOL GENET, V21, P874, DOI 10.1093/hmg/ddr521; Yamamoto T, 2008, CURR GENE THER, V8, P1, DOI 10.2174/156652308783688536; Yang XW, 1999, NAT GENET, V22, P327, DOI 10.1038/11896; Yang XW, 1996, DEVELOPMENT, V122, P555; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	71	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8756	8772		10.1074/jbc.M115.704973	http://dx.doi.org/10.1074/jbc.M115.704973			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907683	Green Published, hybrid			2022-12-26	WOS:000374773200037
J	Munoz-Gonzalez, S; Perez-Simo, M; Colom-Cadena, A; Cabezon, O; Bohorquez, JA; Rosell, R; Perez, LJ; Marco, I; Lavin, S; Domingo, M; Ganges, L				Munoz-Gonzalez, Sara; Perez-Simo, Marta; Colom-Cadena, Andreu; Cabezon, Oscar; Alejandro Bohorquez, Jose; Rosell, Rosa; Josue Perez, Lester; Marco, Ignasi; Lavin, Santiago; Domingo, Mariano; Ganges, Llilianne			Classical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VESICULAR STOMATITIS-VIRUS; T-CELL RESPONSES; RT-PCR ASSAY; INTERFERON-ALPHA; N-PRO; IMMUNE-RESPONSE; VIRAL PROTEIN; STRAIN; PROTECTION	Two groups with three wild boars each were used: Group A (animals 1 to 3) served as the control, and Group B (animals 4 to 6) was postnatally persistently infected with the Cat01 strain of CSFV (primary virus). The animals, six weeks old and clinically healthy, were inoculated with the virulent strain Margarita (secondary virus). For exclusive detection of the Margarita strain, a specific qRT-PCR assay was designed, which proved not to have cross-reactivity with the Cat01 strain. The wild boars persistently infected with CSFV were protected from superinfection by the virulent CSFV Margarita strain, as evidenced by the absence of clinical signs and the absence of Margarita RNA detection in serum, swabs and tissue samples. Additionally, in PBMCs, a well-known target for CSFV viral replication, only the primary infecting virus RNA (Cat01 strain) could be detected, even after the isolation in ST cells, demonstrating SIE at the tissue level in vivo. Furthermore, the data analysis of the Margarita qRT-PCR, by means of calculated Delta Ct values, supported that PBMCs from persistently infected animals were substantially protected from superinfection after in vitro inoculation with the Margarita virus strain, while this virus was able to infect naive PBMCs efficiently. In parallel, IFN-alpha values were undetectable in the sera from animals in Group B after inoculation with the CSFV Margarita strain. Furthermore, these animals were unable to elicit adaptive humoral (no E2-specific or neutralising antibodies) or cellular immune responses (in terms of IFN-gamma-producing cells) after inoculation with the second virus. Finally, a sequence analysis could not detect CSFV Margarita RNA in the samples tested from Group B. Our results suggested that the SIE phenomenon might be involved in the evolution and phylogeny of the virus, as well as in CSFV control by vaccination. To the best of our knowledge, this study was one of the first showing efficient suppression of superinfection in animals, especially in the absence of IFN-alpha, which might be associated with the lack of innate immune mechanisms.	[Munoz-Gonzalez, Sara; Perez-Simo, Marta; Colom-Cadena, Andreu; Cabezon, Oscar; Alejandro Bohorquez, Jose; Rosell, Rosa; Domingo, Mariano; Ganges, Llilianne] IRTA UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra 08193, Spain; [Colom-Cadena, Andreu; Cabezon, Oscar; Marco, Ignasi; Lavin, Santiago] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra 08193, Spain; [Rosell, Rosa] Generalitat Catalunya, Dept Agr Ramaderia Pesca Alimentacio & Med Nat, Barcelona 08007, Spain; [Josue Perez, Lester] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim DAAM, E-08193 Barcelona, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Ganges, L (corresponding author), IRTA UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra 08193, Spain.	llilianne.ganges@irta.cat	Ganges, Llilianne/O-7342-2017; Perez, Lester J./A-1339-2016; Marco, Ignasi/E-8633-2015; Cabezón, Oscar/AAV-7876-2020; Lavín, Santiago/L-5975-2014; Cabezon, Oscar/L-3812-2014; Domingo, Mariano/A-1015-2009	Ganges, Llilianne/0000-0002-8644-3560; Perez, Lester J./0000-0002-5717-5181; Marco, Ignasi/0000-0001-7479-3419; Lavín, Santiago/0000-0001-5655-588X; Munoz-Gonzalez, Sara/0000-0002-7846-7001; Bohorquez Garzon, Jose Alejandro/0000-0002-6715-1757; Cabezon, Oscar/0000-0001-7543-8371; Rosell, Rosa/0000-0002-8294-1159; Domingo, Mariano/0000-0002-9623-4826	Spanish government [AGL2012-38343]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya [FI-DGR 2014]	Spanish government(Spanish GovernmentEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This research was supported by grant AGL2012-38343 from the Spanish government. S.M. and A.C. had a predoctoral fellowship FI-DGR 2014 from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bergua M, 2014, J VIROL, V88, P11327, DOI 10.1128/JVI.01612-14; Cabezon O, 2015, TRANSBOUND EMERG DIS; Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009; Claus C, 2007, J GEN VIROL, V88, P2769, DOI 10.1099/vir.0.83092-0; Das A, 2011, J VET DIAGN INVEST, V23, P727, DOI 10.1177/1040638711407685; de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018; de Arce HD, 1999, VIRUS RES, V64, P61, DOI 10.1016/S0168-1702(99)00077-5; DEARCE HD, 1992, VET IMMUNOL IMMUNOP, V30, P319, DOI 10.1016/0165-2427(92)90102-V; de Arce HD, 2009, VET MICROBIOL, V139, P245, DOI 10.1016/j.vetmic.2009.06.004; Drager C, 2015, VACCINE, V33, P3100, DOI 10.1016/j.vaccine.2015.04.103; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Formella S, 2000, J VIROL, V74, P7878, DOI 10.1128/JVI.74.17.7878-7883.2000; Gal-On A, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P261, DOI 10.1007/1-4020-3780-5_12; Ganges L, 2005, VACCINE, V23, P3741, DOI 10.1016/j.vaccine.2005.01.153; Ganges L, 2008, VET J, V177, P169, DOI 10.1016/j.tvjl.2007.01.030; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Greiser-Wilke I, 2007, VACCINE, V25, P5524, DOI 10.1016/j.vaccine.2006.11.043; Gutierrez S, 2015, J VIROL, V89, P9665, DOI 10.1128/JVI.00537-15; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Husser L, 2012, J INTERF CYTOK RES, V32, P221, DOI 10.1089/jir.2011.0068; Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030; Perez LJ, 2011, J VIROL METHODS, V174, P53, DOI 10.1016/j.jviromet.2011.03.022; Kaden V, 2004, J VET MED B, V51, P260, DOI 10.1111/j.1439-0450.2004.00766.x; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; KASZA L, 1972, RES VET SCI, V13, P46; Laliberte JP, 2014, J VIROL, V88, P9751, DOI 10.1128/JVI.00816-14; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Leifer I, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-33; Liu LH, 2011, J VIROL METHODS, V175, P170, DOI 10.1016/j.jviromet.2011.05.003; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Julve JM, 2013, PLANT MOL BIOL, V81, P553, DOI 10.1007/s11103-013-0028-1; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Mittelholzer C, 1998, J GEN VIROL, V79, P2981, DOI 10.1099/0022-1317-79-12-2981; Munoz-Gonzalez S, 2015, VET RES, V46, DOI 10.1186/s13567-015-0209-9; Munoz-Gonzalez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125692; NOWACKI W, 1993, RES IMMUNOL, V144, P111, DOI 10.1016/0923-2494(93)80066-8; Peterhans E, 2013, BIOLOGICALS, V41, P39, DOI 10.1016/j.biologicals.2012.07.006; Ramirez S, 2010, J GEN VIROL, V91, P1183, DOI 10.1099/vir.0.018929-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renson P, VET RES, V41, P7; Ruemenapf Till, 2008, P39; Schweizer M, 2014, ANNU REV ANIM BIOSCI, V2, P141, DOI 10.1146/annurev-animal-022513-114209; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; SOLLER A, 1965, VIROLOGY, V26, P715, DOI 10.1016/0042-6822(65)90335-1; Summerfield A, 2006, J INTERF CYTOK RES, V26, P248, DOI 10.1089/jir.2006.26.248; Summerfield A, 1998, J VIROL, V72, P1853, DOI 10.1128/JVI.72.3.1853-1861.1998; Tamura T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-47; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004; Tarradas J, 2011, VACCINE, V29, P4422, DOI 10.1016/j.vaccine.2011.03.095; TERPSTRA C, 1984, VET MICROBIOL, V9, P113, DOI 10.1016/0378-1135(84)90026-9; Thiel HJ, 2005, VIRUS TAXONOMY, P979; Thomas A. H., 1999, NUCL ACIDS S SERIES, p[41, 95]; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; Walters KA, 2004, J VIROL, V78, P7925, DOI 10.1128/JVI.78.15.7925-7937.2004; Webster B, 2013, J VIROL, V87, P13354, DOI 10.1128/JVI.02465-13; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P137, DOI 10.1016/0042-6822(83)90540-8	63	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149469	10.1371/journal.pone.0149469	http://dx.doi.org/10.1371/journal.pone.0149469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919741	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400023
J	Ossoli, A; Neufeld, EB; Thacker, SG; Vaisman, B; Pryor, M; Freeman, LA; Brantner, CA; Baranova, I; Francone, NO; Demosky, SJ; Vitali, C; Locatelli, M; Abbate, M; Zoja, C; Franceschini, G; Calabresi, L; Remaley, AT				Ossoli, Alice; Neufeld, Edward B.; Thacker, Seth G.; Vaisman, Boris; Pryor, Milton; Freeman, Lita A.; Brantner, Christine A.; Baranova, Irina; Francone, Nicolas O.; Demosky, Stephen J., Jr.; Vitali, Cecilia; Locatelli, Monica; Abbate, Mauro; Zoja, Carlamaria; Franceschini, Guido; Calabresi, Laura; Remaley, Alan T.			Lipoprotein X Causes Renal Disease in LCAT Deficiency	PLOS ONE			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; APOLIPOPROTEIN-A-I; FAMILIAL LECITHIN; GLOMERULAR ENDOTHELIUM; MESANGIAL CELLS; METABOLISM; PODOCYTES; PATIENT; BIOLOGY; MICE	Human familial lecithin: cholesterol acyltransferase (LCAT) deficiency (FLD) is characterized by low HDL, accumulation of an abnormal cholesterol-rich multilamellar particle called lipoprotein-X (LpX) in plasma, and renal disease. The aim of our study was to determine if LpX is nephrotoxic and to gain insight into the pathogenesis of FLD renal disease. We administered a synthetic LpX, nearly identical to endogenous LpX in its physical, chemical and biologic characteristics, to wild-type and Lcat(-/-) mice. Our in vitro and in vivo studies demonstrated an apoA-I and LCAT-dependent pathway for LpX conversion to HDL-like particles, which likely mediates normal plasma clearance of LpX. Plasma clearance of exogenous LpX was markedly delayed in Lcat(-/-) mice, which have low HDL, but only minimal amounts of endogenous LpX and do not spontaneously develop renal disease. Chronically administered exogenous LpX deposited in all renal glomerular cellular and matrical compartments of Lcat(-/-) mice, and induced proteinuria and nephrotoxic gene changes, as well as all of the hallmarks of FLD renal disease as assessed by histological, TEM, and SEM analyses. Extensive in vivo EM studies revealed LpX uptake by macropinocytosis into mouse glomerular endothelial cells, podocytes, and mesangial cells and delivery to lysosomes where it was degraded. Endocytosed LpX appeared to be degraded by both human podocyte and mesangial cell lysosomal PLA(2) and induced podocyte secretion of pro-inflammatory IL-6 in vitro and renal Cxl10 expression in Lcat(-/-) mice. In conclusion, LpX is a nephrotoxic particle that in the absence of Lcat induces all of the histological and functional hallmarks of FLD and hence may serve as a biomarker for monitoring recombinant LCAT therapy. In addition, our studies suggest that LpX-induced loss of endothelial barrier function and release of cytokines by renal glomerular cells likely plays a role in the initiation and progression of FLD nephrosis.	[Ossoli, Alice; Vitali, Cecilia; Franceschini, Guido; Calabresi, Laura] Univ Milan, Ctr Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Neufeld, Edward B.; Thacker, Seth G.; Vaisman, Boris; Pryor, Milton; Freeman, Lita A.; Francone, Nicolas O.; Demosky, Stephen J., Jr.; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Brantner, Christine A.] NIH, NHLBI Elect Microscopy Core Facil, Bldg 10, Bethesda, MD 20892 USA; [Baranova, Irina] NIH, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Locatelli, Monica; Abbate, Mauro] IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk Kilometro Rosso, Bergamo, Italy	University of Milan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Neufeld, EB (corresponding author), NHLBI, Lipoprot Metab Sect, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	neufelde@mail.nih.gov	zoja, carlamaria/ABF-5896-2020; Vaisman, Boris L/B-3453-2008; Ossoli, Alice/K-5917-2016; Mauro, Abbate/ABH-3533-2020; Neufeld, Edward/R-3819-2019	zoja, carlamaria/0000-0003-2507-8894; Ossoli, Alice/0000-0002-9902-252X; Mauro, Abbate/0000-0002-2092-7474; Brantner, Christine/0000-0001-8172-901X; Locatelli, Monica/0000-0002-1395-3172	Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH [GGP14125]; Telethon - Italy; MedImmune, Inc. as a CRADA-NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006092, ZIAHL002058] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH; Telethon - Italy(Fondazione Telethon); MedImmune, Inc. as a CRADA-NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research support for this study came from the Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH, grant number: GGP14125. Funding Institution: Telethon - Italy (www.Telethon.it). Additional funding to ATR was provided by MedImmune, Inc. as a CRADA-NIH Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT F, 1991, KIDNEY INT, V40, P597, DOI 10.1038/ki.1991.250; Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Ahsan L., 2014, HDL HDB BIOL FUNCTIO, P159, DOI DOI 10.1016/B978-0-12-407867-3.00007-X; Aranda P, 2008, CLIN NEPHROL, V69, P213; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Asztalos BF, 2007, J LIPID RES, V48, P592, DOI 10.1194/jlr.M600403-JLR200; BORYSIEWICZ LK, 1982, Q J MED, V51, P411; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Fornoni A, 2014, NAT REV NEPHROL, V10, P379, DOI 10.1038/nrneph.2014.87; Genot E, 2014, EUR J CELL BIOL, V93, P367, DOI 10.1016/j.ejcb.2014.10.002; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Haraldsson BS, 2014, KIDNEY INT, V85, P8, DOI 10.1038/ki.2013.317; IMBASCIATI E, 1986, AM J NEPHROL, V6, P66, DOI 10.1159/000167056; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; KANWAR YS, 1979, J CELL BIOL, V81, P137, DOI 10.1083/jcb.81.1.137; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Lambert G, 2001, J BIOL CHEM, V276, P15090, DOI 10.1074/jbc.M008466200; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lynn EG, 1997, MOL CELL BIOCHEM, V175, P187, DOI 10.1023/A:1006865420286; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00169; Miarka P, 2011, CLIN EXP NEPHROL, V15, P424, DOI 10.1007/s10157-011-0409-1; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Naito S, 2013, ATHEROSCLEROSIS, V228, P193, DOI 10.1016/j.atherosclerosis.2013.02.034; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; Nishiwaki M, 2006, ARTERIOSCL THROM VAS, V26, P1370, DOI 10.1161/01.ATV.0000217910.90210.99; Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002; O K, 1995, J LIPID RES, V36, P2344; O K, 1997, MOL CELL BIOCHEM, V173, P17, DOI 10.1023/A:1006836704042; Obeidat M, 2012, EXP CELL RES, V318, P964, DOI 10.1016/j.yexcr.2012.02.032; RITLAND S, 1975, SCAND J GASTROENTERO, V10, P785; Rousset X, 2010, J PHARMACOL EXP THER, V335, P140, DOI 10.1124/jpet.110.169540; RUBIESPRAT J, 1977, CLIN CHIM ACTA, V75, P117, DOI 10.1016/0009-8981(77)90506-X; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Santamarina-Fojo S, 2001, METABOLIC MOL BASES, P2817; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scindia YM, 2010, ADV DRUG DELIVER REV, V62, P1337, DOI 10.1016/j.addr.2010.08.011; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Sessa A, 2001, NEPHRON, V88, P268, DOI 10.1159/000046001; Shamburek RD, 2016, J CLIN LIPIDOLOGY; Shamburek RD, 2016, CIRC RES, V118, P73, DOI 10.1161/CIRCRESAHA.115.306223; Shamburek RD, 2013, CIRCULATION, V128; Shayman JA, 2013, BBA-MOL CELL BIOL L, V1831, P602, DOI 10.1016/j.bbalip.2012.08.013; Steenhard BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050745; Strom EH, 2011, ULTRASTRUCT PATHOL, V35, P139, DOI 10.3109/01913123.2010.551578; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tsuchiya Y, 2011, CLIN NEPHROL, V76, P492, DOI 10.5414/CN107007; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Weber CL, 2007, NEPHROL DIAL TRANSPL, V22, P2084, DOI 10.1093/ndt/gfm233; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286; Yee MS, 2009, ATHEROSCLEROSIS, V205, P528, DOI 10.1016/j.atherosclerosis.2008.11.033; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	59	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150083	10.1371/journal.pone.0150083	http://dx.doi.org/10.1371/journal.pone.0150083			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919698	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400084
J	Yan, YW; Fan, J; Bai, SL; Hou, WJ; Li, X; Tong, H				Yan, Ya-Wei; Fan, Jun; Bai, Shu-Ling; Hou, Wei-Jian; Li, Xiang; Tong, Hao			Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-kappa B Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY CYTOKINES; GENE-EXPRESSION; TRANSPLANT ARTERIOSCLEROSIS; KINASE-BETA; IN-VITRO; INHIBITION; A20; WALL; RAT	Chronic inflammation and degradation of elastin are the main processes in the development of abdominal aortic aneurysm (AAA). Recent studies show that zinc has an anti-inflammatory effect. Based on these, zinc may render effective therapy for the treatment of the AAA. Currently, we want to investigate the effects of zinc on AAA progression and its related molecular mechanism. Rat AAA models were induced by periaortic application of CaCl2. AAA rats were treated by daily intraperitoneal injection of ZnSO4 or vehicle alone. The aorta segments were collected at 4 weeks after surgery. The primary rat aortic vascular smooth muscle cells (VSMCs) were stimulated with TNF-alpha alone or with ZnSO4 for 3 weeks. The results showed that zinc supplementation significantly suppressed the CaCl2-induced expansion of the abdominal aortic diameter, as well as a preservation of medial elastin fibers in the aortas. Zinc supplementation also obviously attenuated infiltration of the macrophages and lymphocytes in the aortas. In addition, zinc reduced MMP-2 and MMP-9 production in the aortas. Most importantly, zinc treatment significantly induced A20 expression, along with inhibition of the NF-kappa B canonical signaling pathway in vitro in VSMCs and in vivo in rat AAA. This study demonstrated, for the first time, that zinc supplementation could prevent the development of rat experimental AAA by induction of A20-mediated inhibition of the NF-kappa B canonical signaling pathway.	[Yan, Ya-Wei; Fan, Jun; Bai, Shu-Ling; Hou, Wei-Jian; Tong, Hao] China Med Univ, Sch Fundamental Sci, Dept Tissue Engn, Shenyang 110001, Peoples R China; [Li, Xiang] China Med Univ, Coll Basic Med, Dept Cell Biol, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Bai, SL (corresponding author), China Med Univ, Sch Fundamental Sci, Dept Tissue Engn, Shenyang 110001, Peoples R China.	baishuling@hotmail.com			National Natural Science Foundation of China [81571919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Contract (No. 81571919) for FJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvelo MB, 1999, TRANSPLANT P, V31, P858, DOI 10.1016/S0041-1345(98)01804-1; Baltaci AK, 2003, BIOL TRACE ELEM RES, V96, P237, DOI 10.1385/BTER:96:1-3:237; Bao B, 2008, TRANSL RES, V152, P67, DOI 10.1016/j.trsl.2008.06.001; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Cheng WT, 2013, ASIAN PAC J TROP MED, V6, P570, DOI 10.1016/S1995-7645(13)60098-X; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Ciavarella C, 2015, CIRC J, V79, P1460, DOI 10.1253/circj.CJ-14-0857; Damrauer SM, 2010, ATHEROSCLEROSIS, V211, P404, DOI 10.1016/j.atherosclerosis.2010.03.029; Daugherty Alan, 2002, Curr Atheroscler Rep, V4, P222, DOI 10.1007/s11883-002-0023-5; Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676; Gasparini C, 2014, CELL MOL LIFE SCI, V71, P2083, DOI 10.1007/s00018-013-1545-4; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; Hurks R, 2014, ATHEROSCLEROSIS, V235, P632, DOI 10.1016/j.atherosclerosis.2014.05.928; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Jayaraman T, 2008, VASC HEALTH RISK MAN, V4, P805, DOI 10.2147/VHRM.S2700; KAHARI VM, 1992, J BIOL CHEM, V267, P26134; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kunter U, 2003, TRANSPLANTATION, V75, P3, DOI 10.1097/00007890-200301150-00002; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Livingstone C, 2015, NUTR CLIN PRACT, V30, P371, DOI 10.1177/0884533615570376; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Metz RP, 2012, METHODS MOL BIOL, V843, P169, DOI 10.1007/978-1-61779-523-7_16; Mi T, 2011, J HUAZHONG U SCI-MED, V31, P602, DOI 10.1007/s11596-011-0568-z; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Nakashima H, 2004, CIRCULATION, V109, P132, DOI 10.1161/01.CIR.0000105725.61763.A2; Ozturk A, 2003, BIOL TRACE ELEM RES, V96, P247, DOI 10.1385/BTER:96:1-3:247; Piechota-Polanczyk A, 2012, EUR J VASC ENDOVASC, V44, P133, DOI 10.1016/j.ejvs.2012.04.020; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; PRASAD AS, 1979, AM J PHYSIOL, V236, pE272, DOI 10.1152/ajpendo.1979.236.3.E272; Prasad AS, 1996, J LAB CLIN MED, V128, P51, DOI 10.1016/S0022-2143(96)90113-4; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen HY, 2008, J AM COLL NUTR, V27, P577, DOI 10.1080/07315724.2008.10719741; Shih CJ, 2013, INFLAMMATION, V36, P616, DOI 10.1007/s10753-012-9583-x; Siracuse JJ, 2012, TRANSPLANTATION, V93, P373, DOI 10.1097/TP.0b013e3182419829; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sproul EP, 2013, MATRIX BIOL, V32, P86, DOI 10.1016/j.matbio.2012.11.004; Takacs P, 2012, INT UROGYNECOL J, V23, P1775, DOI 10.1007/s00192-012-1807-y; Treska V, 2002, CYTOKINES CELL MOL T, V7, P91, DOI 10.1080/13684730310001652; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; von Bulow V, 2007, J IMMUNOL, V179, P4180, DOI 10.4049/jimmunol.179.6.4180; Wang J, 2015, J VASC SURG, V62, P1615, DOI 10.1016/j.jvs.2014.06.004; Xiong J, 2013, CHINESE MED J-PEKING, V126, P437, DOI 10.3760/cma.j.issn.0366-6999.20122151; Zhang Q, 2011, J SURG RES, V167, pE385, DOI 10.1016/j.jss.2011.01.017	49	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148536	10.1371/journal.pone.0148536	http://dx.doi.org/10.1371/journal.pone.0148536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918963	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400006
J	Adane, K; Spigt, M; Ferede, S; Asmelash, T; Abebe, M; Dinant, GJ				Adane, Kelemework; Spigt, Mark; Ferede, Semaw; Asmelash, Tsehaye; Abebe, Markos; Dinant, Geert-Jan			Half of Pulmonary Tuberculosis Cases Were Left Undiagnosed in Prisons of the Tigray Region of Ethiopia: Implications for Tuberculosis Control	PLOS ONE			English	Article							PREVALENCE; POPULATION; AFRICA	Introduction Prison settings have been often identified as important but neglected reservoirs for TB. This study was designed to determine the prevalence of undiagnosed pulmonary TB and assess the potential risk factors for such TB cases in prisons of the Tigray region. Method A cross-sectional study was conducted between August 2013 and February 2014 in nine prisons. A standardized symptom-based questionnaire was initially used to identify presumptive TB cases. From each, three consecutive sputum samples were collected for acid-fast bacilli (AFB) microscopy and culture. Blood samples were collected from consented participants for HIV testing. Result Out of 809 presumptive TB cases with culture result, 4.0% (95% CI: 2.65-5.35) were confirmed to have undiagnosed TB. The overall estimated point prevalence of undiagnosed TB was found to be 505/100,000 prisoners (95% CI: 360-640). Together with the 27 patients who were already on treatment, the overall estimated point prevalence of TB would be 793/100,000 prisoners (95% CI: 610-970), about four times higher than in the general population. The ratio of active to passive case detection was 1.18: 1. The prevalence of HIV was 4.4% (36/809) among presumptive TB cases and 6.3% (2/32) among undiagnosed TB cases. In a multivariate logistic regression analysis, chewing Khat (adjusted OR = 2.81; 95% CI: 1.02-7.75) and having had a close contact with a TB patient (adjusted OR = 2.18; 95% CI: 1.05-4.51) were found to be predictors of undiagnosed TB among presumptive TB cases. Conclusions This study revealed that at least half of symptomatic pulmonary TB cases in Northern Ethiopian prisons remain undiagnosed and hence untreated. The prevalence of undiagnosed TB in the study prisons was more than two folds higher than in the general population of Tigray. This may indicate the need for more investment and commitment to improving TB case detection in the study prisons.	[Adane, Kelemework; Asmelash, Tsehaye] Mekelle Univ, Coll Hlth Sci, Dept Med Microbiol & Immunol, Mekelle, Ethiopia; [Adane, Kelemework; Spigt, Mark; Dinant, Geert-Jan] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands; [Ferede, Semaw] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Mekelle University; Maastricht University; Mekelle University	Adane, K (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Microbiol & Immunol, Mekelle, Ethiopia.; Adane, K (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands.	ingoldmlt@gmail.com	Kempker, Russell/F-5776-2017		Maastricht University through Nuffic scholarship; Mekelle University through NORAD collaboration project; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	Maastricht University through Nuffic scholarship; Mekelle University through NORAD collaboration project; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was financially supported by Maastricht University through Nuffic scholarship and Mekelle University through NORAD collaboration project. Moreover, Armauer Hasen Research Institute (AHRI) provided us reagent and bench work supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2002, ETHIOPIAN MED J, V40, P79; Abbink JG, 1998, NE AFRICAN STUDIES, P59; Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; [Anonymous], 2009, EP FACT SHEET HIV AI; [Anonymous], 2014, HUMAN RIGHTS ANAL RE; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Berhe G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-448; Berile, 2012, STATUS HUMAN RIGHTS; Breen RAM, 2006, DRUGS, V66, P2299, DOI 10.2165/00003495-200666180-00003; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Leung CC, 2005, INT J TUBERC LUNG D, V9, P627; Masoud D, 2009, GUIDELINES CONTROL T; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; O'Grady J, 2011, SAMJ S AFR MED J, V101, P107, DOI 10.7196/SAMJ.4629; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Ormerod P, 2000, THORAX, V55, P887; RUTTA E, 1994, INT J TUBERC LUNG D, V2001, P703; Saunders DL, 2001, PUBLIC HEALTH REP, V116, P210, DOI 10.1016/S0033-3549(04)50036-5; Ssengooba W, 2012, TUBERC RES TREAT, V2012; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; Thapa B., 2013, INT J INFECT MICROBI, V2, P68; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Walmsley R, 2010, WORLD PRISON POPULAT, Veleventh, P15; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, GLOBAL TUBERCULOSIS; WHO, 2007, STAT PAP PRIS TUB; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2014, GLOB TUB REP	35	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149453	10.1371/journal.pone.0149453	http://dx.doi.org/10.1371/journal.pone.0149453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914770	Green Submitted, gold, Green Published			2022-12-26	WOS:000371175700016
J	Varrella, S; Romano, G; Costantini, S; Ruocco, N; Ianora, A; Bentley, MG; Costantini, M				Varrella, Stefano; Romano, Giovanna; Costantini, Susan; Ruocco, Nadia; Ianora, Adrianna; Bentley, Matt G.; Costantini, Maria			Toxic Diatom Aldehydes Affect Defence Gene Networks in Sea Urchins	PLOS ONE			English	Article							NF-KAPPA-B; EXPRESSION; APOPTOSIS; STRESS; P53; INHIBITION; RESPONSES; PATHWAYS; CELLS; MODEL	Marine organisms possess a series of cellular strategies to counteract the negative effects of toxic compounds, including the massive reorganization of gene expression networks. Here we report the modulated dose-dependent response of activated genes by diatom polyunsaturated aldehydes (PUAs) in the sea urchin Paracentrotus lividus. PUAs are secondary metabolites deriving from the oxidation of fatty acids, inducing deleterious effects on the reproduction and development of planktonic and benthic organisms that feed on these unicellular algae and with anti-cancer activity. Our previous results showed that PUAs target several genes, implicated in different functional processes in this sea urchin. Using interactomic Ingenuity Pathway Analysis we now show that the genes targeted by PUAs are correlated with four HUB genes, NF-kappa B, p53, delta-2-catenin and HIF1A, which have not been previously reported for P. lividus. We propose a working model describing hypothetical pathways potentially involved in toxic aldehyde stress response in sea urchins. This represents the first report on gene networks affected by PUAs, opening new perspectives in understanding the cellular mechanisms underlying the response of benthic organisms to diatom exposure.	[Varrella, Stefano; Ruocco, Nadia; Costantini, Maria] Sdn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Sdn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy; [Costantini, Susan] IRCCS, Ist Nazl Tumori Fdn G Pascale, CROM, Naples, Italy; [Bentley, Matt G.] Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole BH12 5BB, Dorset, England	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; IRCCS Fondazione Pascale; Bournemouth University	Costantini, M (corresponding author), Sdn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.	maria.costantini@szn.it	Ruocco, Nadia/HGA-2143-2022; Romano, Giovanna/F-4561-2015; Costantini, Susan/J-9914-2018; Costantini, Maria/AGH-4080-2022; Varrella, Stefano/ABI-5401-2020; Ianora, Adrianna/O-3408-2019; Varrella, Stefano/GXF-3079-2022	Romano, Giovanna/0000-0002-4898-7153; Varrella, Stefano/0000-0002-8582-3502; Costantini, Susan/0000-0002-7538-4657	Stazione Zoologica Anton Dohrn PhD fellowship	Stazione Zoologica Anton Dohrn PhD fellowship	SV has been supported by a Stazione Zoologica Anton Dohrn PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaventura R, 2005, BIOCHEM BIOPH RES CO, V328, P150, DOI 10.1016/j.bbrc.2004.12.161; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Carotenuto Y, 2005, LIMNOL OCEANOGR, V50, P449, DOI 10.4319/lo.2005.50.2.0449; Casano C, 2003, CELL STRESS CHAPERON, V8, P70, DOI 10.1379/1466-1268(2003)8<70:SUDITA>2.0.CO;2; Clarke AR, 1997, ONCOGENE, V14, P2015, DOI 10.1038/sj.onc.1201040; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; Fulda S., 2010, INT J CELL BIOL; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Griffiths SD, 1997, ONCOGENE, V14, P523, DOI 10.1038/sj.onc.1200871; Guenther J, 2009, MAR ECOL PROG SER, V385, P137, DOI 10.3354/meps08034; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Kozlowsky-Suzuki B, 2009, HARMFUL ALGAE, V8, P395, DOI 10.1016/j.hal.2008.08.025; Lesser MP, 2003, J EXP BIOL, V206, P4097, DOI 10.1242/jeb.00621; Marrone V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031750; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nayak RR, 2014, NUCLEIC ACIDS RES, V42, P1757, DOI 10.1093/nar/gkt999; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Puszynski K, 2009, IET SYST BIOL, V3, P356, DOI 10.1049/iet-syb.2008.0172; Ravi R, 2000, GENE DEV, V14, P34; Renzing J, 1996, J CELL SCI, V109, P1105; Romano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025980; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Russo R, 2014, MAR ENVIRON RES, V93, P85, DOI 10.1016/j.marenvres.2013.08.006; Sansone C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101220; Simon CA, 2010, AQUACULTURE, V310, P52, DOI 10.1016/j.aquaculture.2010.10.031; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varrella S, 2014, MAR DRUGS, V12, P2089, DOI 10.3390/md12042089; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615	50	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149734	10.1371/journal.pone.0149734	http://dx.doi.org/10.1371/journal.pone.0149734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914213	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000371175700025
J	Wright, AD; Jarrett, M; Vavasour, I; Shahinfard, E; Kolind, S; van Donkelaar, P; Taunton, J; Li, D; Rauscher, A				Wright, Alexander D.; Jarrett, Michael; Vavasour, Irene; Shahinfard, Elham; Kolind, Shannon; van Donkelaar, Paul; Taunton, Jack; Li, David; Rauscher, Alexander			Myelin Water Fraction Is Transiently Reduced after a Single Mild Traumatic Brain Injury - A Prospective Cohort Study in Collegiate Hockey Players	PLOS ONE			English	Article							SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; WHITE-MATTER INTEGRITY; DIFFUSE AXONAL INJURY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; UNMYELINATED AXONS; N-ACETYLASPARTATE; NERVOUS-SYSTEM; DAMAGE	Impact-related mild traumatic brain injuries (mTBI) are a major public health concern, and remain as one of the most poorly understood injuries in the field of neuroscience. Currently, the diagnosis and management of such injuries are based largely on patient-reported symptoms. An improved understanding of the underlying pathophysiology of mTBI is urgently needed in order to develop better diagnostic and management protocols. Specifically, dynamic post-injury changes to the myelin sheath in the human brain have not been examined, despite 'compromised white matter integrity' often being described as a consequence of mTBI. In this preliminary cohort study, myelin water imaging was used to prospectively evaluate changes in myelin water fraction, derived from the T2 decay signal, in two varsity hockey teams (45 players) over one season of athletic competition. 11 players sustained a concussion during competition, and were scanned at 72 hours, 2 weeks, and 2 months post-injury. Results demonstrated a reduction in myelin water fraction at 2 weeks post-injury in several brain areas relative to preseason scans, including the splenium of the corpus callosum, right posterior thalamic radiation, left superior corona radiata, left superior longitudinal fasciculus, and left posterior limb of the internal capsule. Myelin water fraction recovered to pre-season values by 2 months post-injury. These results may indicate transient myelin disruption following a single mTBI, with subsequent remyelination of affected neurons. Myelin disruption was not apparent in the athletes who did not experience a concussion, despite exposure to repetitive subconcussive trauma over a season of collegiate hockey. These findings may help to explain many of the metabolic and neurological deficits observed clinically following mTBI.	[Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC V5Z 1M9, Canada; [Wright, Alexander D.] Univ British Columbia Okanagan, Southern Med Program, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada; [Jarrett, Michael; Vavasour, Irene; Shahinfard, Elham; Rauscher, Alexander] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Kolind, Shannon] Univ British Columbia, Div Neurol, Fac Med, Vancouver, BC V5Z 1M9, Canada; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Taunton, Jack] Univ British Columbia, Fac Med, Div Sports Med, Vancouver, BC, Canada; [Li, David] Univ British Columbia, Fac Med, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alexander] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia; University of British Columbia	Rauscher, A (corresponding author), Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada.	rauscher@physics.ubc.ca		Jarrett, Michael/0000-0002-3702-2014; Shahinfard, Elham/0000-0002-3526-0086; Rauscher, Alexander/0000-0002-1961-8252	London Drugs Award for Research Excellence in Radiology; Canadian Institutes for Health Research (CIHR) [201109MSH-261306-183304]; Vanier Canada Graduate Scholarships program	London Drugs Award for Research Excellence in Radiology; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarships program	This research was funded by a London Drugs Award for Research Excellence in Radiology (no grant number) and by a New Investigator Award to Alexander Rauscher from the Canadian Institutes for Health Research (CIHR, grant #201109MSH-261306-183304). Alexander Rauscher is also a Canada Research Chair in Developmental Neuroimaging. Alexander D. Wright was supported by the Vanier Canada Graduate Scholarships program. No persons other than the listed authors had substantial scientific input into this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R.C., 2015, EXP NEUROL; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Faisal A.A., 2011, BMC NEUROSCI, V12, pP100, DOI [10.1186/1471-2202-12-S1-P100, DOI 10.1186/1471-2202-12-S1-P100]; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hsieh S-T, 1993, BRAIN PATHOL, V3, P307; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kozlowski P, 2008, MAGN RESON MED, V59, P796, DOI 10.1002/mrm.21527; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liang ALW, 2012, J NEUROL, V259, P1151, DOI 10.1007/s00415-011-6318-0; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Maxwell WL, 2015, J NEUROTRAUMA; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Meier TB, 2015, JAMA NEUROL; Meyers SM, 2013, J MAGN RESON IMAGING, V38, P1445, DOI 10.1002/jmri.24106; Meyers SM, 2009, MAGN RESON IMAGING, V27, P1096, DOI 10.1016/j.mri.2009.02.001; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miyamoto N, 2013, STROKE, V44, P3516, DOI 10.1161/STROKEAHA.113.002813; Narayanan S, 1997, ANN NEUROL, V41, P385, DOI 10.1002/ana.410410314; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nordengen K, 2015, BRAIN STRUCT FUNCT, V220, P899, DOI 10.1007/s00429-013-0691-7; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oh J, 2007, J NEUROIMAGING, V17, P156, DOI 10.1111/j.1552-6569.2007.00098.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sanchez I, 1996, J NEUROSCI, V16, P5095; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H., 2015, EXP NEUROL; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanisz GJ, 2004, MAGNET RESON MED, V51, P473, DOI 10.1002/mrm.20008; STEWART WA, 1993, MAGNET RESON MED, V29, P767, DOI 10.1002/mrm.1910290608; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vavasour IM, 2009, J NEUROL SCI, V276, P49, DOI 10.1016/j.jns.2008.08.022; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; WAXMAN SG, 1977, ARCH NEUROL-CHICAGO, V34, P585, DOI 10.1001/archneur.1977.00500220019003; Webb S, 2003, MAGNET RESON MED, V49, P638, DOI 10.1002/mrm.10411; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	81	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150215	10.1371/journal.pone.0150215	http://dx.doi.org/10.1371/journal.pone.0150215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26913900	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700062
J	Ko, YC; Hwang, DK; Chen, WT; Lee, CC; Liu, CJ				Ko, Yu-Chieh; Hwang, De-Kuang; Chen, Wei-Ta; Lee, Ching-Chih; Liu, Catherine J.			Impact of Socioeconomic Status on the Diagnosis of Primary Open-Angle Glaucoma and Primary Angle Closure Glaucoma: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							OPTIC-NERVE HEAD; HEALTH-INSURANCE; VISUAL-FIELD; BLINDNESS; ADULTS; PREVALENCE; DISPARITY; KNOWLEDGE; DISEASE; MYOPIA	Purpose To understand the impact of socioeconomic status (SES) on the diagnosis of primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG) in Taiwan. Methods Subjects with glaucoma were identified from the National Health Insurance Research Database of year 2006, which included one million randomly selected insurants. Individuals who had >= 4 ambulatory visits within one year which had the diagnosis code of POAG (ICD-9-CM 365.11 or 365.12) or PACG (365.23) and concurrent prescription of anti-glaucoma medication or surgery were selected. Individual SES was represented by monthly income calculated from the insurance premium. Neighborhood SES was defined based on neighborhood household income averages. Urbanization level of habitation was categorized into 3 levels. The odds ratio of having POAG or PACG in subjects with different SES was evaluated by using multiple logistic regression analysis. Results In total, 752 and 561 subjects with POAG and PACG, respectively, who were treated on a regular basis, were identified. The diagnosis of glaucoma was affected by age, gender, frequency of healthcare utilization, individual SES, and urbanization level of habitation. With the adjustment of age, gender, healthcare utilization, neighborhood SES and level of urbanization, subjects with lower income were more likely to be diagnosed as PACG, but less likely as POAG. Conclusions Subjects with more frequent healthcare utilization were more likely to be diagnosed with glaucoma. Subjects with low SES were more susceptible to PACG, but subjects with high SES were more likely to be diagnosed as POAG. This information is useful for the design and target participant setting in glaucoma education and screening campaign to maximize the efficacy of limited resources in preventing glaucoma blindness.	[Ko, Yu-Chieh; Liu, Catherine J.] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Ko, Yu-Chieh; Hwang, De-Kuang; Chen, Wei-Ta; Liu, Catherine J.] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Ko, Yu-Chieh] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Hwang, De-Kuang] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chen, Wei-Ta] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.; Lee, CC (corresponding author), Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan.; Lee, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hematcd2@hotmail.com; jlliu@vghtpe.gov.tw	Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485	Taipei Veterans General Hospital, Taipei, Taiwan [V104C-180]; Ministry of Science and Technology, Taiwan [MOST 103-2628-B-075-001-MY3]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The project was supported by grant V104C-180 from the Taipei Veterans General Hospital, Taipei, Taiwan (http://www.vghtpe.gov.tw/doce/) and grant MOST 103-2628-B-075-001-MY3 from Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J POPUL STUD; Attebo K, 1997, AUST NZ J OPHTHALMOL, V25, P283, DOI 10.1111/j.1442-9071.1997.tb01516.x; Boland MV, 2008, OPHTHALMOLOGY, V115, P239, DOI 10.1016/j.ophtha.2007.03.086; Buys YM, 2013, CAN J OPHTHALMOL, P4883; Chen PP, 2003, OPHTHALMOLOGY, V110, P726, DOI 10.1016/S0161-6420(02)01974-7; Chen YY, 2013, EYE, V27, P1070, DOI 10.1038/eye.2013.127; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Gogate P, 2011, INDIAN J OPHTHALMOL, V59, P29, DOI 10.4103/0301-4738.73720; Hennis A, 2007, OPHTHALMOLOGY, V114, P1816, DOI 10.1016/j.ophtha.2007.06.013; Hoevenaars JGMM, 2006, ACTA OPHTHALMOL SCAN, V84, P84, DOI 10.1111/j.1600-0420.2005.00587.x; Hwang DK, 2014, JAMA OPHTHALMOL, V132, P1446, DOI 10.1001/jamaophthalmol.2014.3333; Jin YP, 2011, CAN J OPHTHALMOL, V46, P133, DOI 10.3129/i10-120; Ko YC, 2015, OPHTHAL EPIDEMIOL, V22, P109, DOI 10.3109/09286586.2015.1012270; Ko YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107660; Lee S, 2014, INVEST OPHTH VIS SCI, V55, P4378, DOI 10.1167/iovs.14-14227; Lee YY, 2013, INVEST OPHTH VIS SCI, V54, P1026, DOI 10.1167/iovs.12-10480; Leung VC, 2015, J GLAUCOMA, V24, P69, DOI 10.1097/IJG.0000000000000081; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Ulldemolins AR, 2012, INDIAN J OPHTHALMOL, V60, P368, DOI 10.4103/0301-4738.100529; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topouzis F, 2008, AM J OPHTHALMOL, V145, P327, DOI 10.1016/j.ajo.2007.09.013; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WANG Y, 2013, PLOS ONE, V2013; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5; Yip JLY, 2011, OPHTHAL EPIDEMIOL, V18, P217, DOI 10.3109/09286586.2011.602507; Zhang XZ, 2013, JAMA OPHTHALMOL, V131, P1198, DOI 10.1001/jamaophthalmol.2013.4694	36	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149698	10.1371/journal.pone.0149698	http://dx.doi.org/10.1371/journal.pone.0149698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905307	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000019
J	Szabat, M; Gudanis, D; Kotkowiak, W; Gdaniec, Z; Kierzek, R; Pasternak, A				Szabat, Marta; Gudanis, Dorota; Kotkowiak, Weronika; Gdaniec, Zofia; Kierzek, Ryszard; Pasternak, Anna			Thermodynamic Features of Structural Motifs Formed by beta-L-RNA	PLOS ONE			English	Article							HETEROCHIRAL DNA; NUCLEIC-ACIDS; HYBRIDIZATION PROPERTIES; OLIGONUCLEOTIDES; STABILITY; APTAMER; BINDING; INTERFERENCE; PARAMETERS; CANCER	This is the first report to provide comprehensive thermodynamic and structural data concerning duplex, hairpin, quadruplex and i-motif structures in beta-L-RNA series. Herein we confirm that, within the limits of experimental error, the thermodynamic stability of enantiomeric structural motifs is the same as that of naturally occurring D-RNA counterparts. In addition, formation of D-RNA/L-RNA heterochiral duplexes is also observed; however, their thermodynamic stability is significantly reduced in reference to homochiral D-RNA duplexes. The presence of three locked nucleic acid (LNA) residues within the D-RNA strand diminishes the negative effect of the enantiomeric, complementary L-RNA strand in the formation of heterochiral RNA duplexes. Similar behavior is also observed for heterochiral LNA-2'-O-methyl- D-RNA/L-RNA duplexes. The formation of heterochiral duplexes was confirmed by H-1 NMR spectroscopy. The CD curves of homochiral L-RNA structural motifs are always reversed, whereas CD curves of heterochiral duplexes present individual features dependent on the composition of chiral strands.	[Szabat, Marta; Gudanis, Dorota; Kotkowiak, Weronika; Gdaniec, Zofia; Kierzek, Ryszard; Pasternak, Anna] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Kierzek, R; Pasternak, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl; apa@ibch.poznan.pl	Szabat, Marta/AAD-1372-2021; Pasternak, Anna/H-9411-2013; Gudanis, Dorota/AAY-7057-2021; Gdaniec, Zofia/D-2649-2015	Szabat, Marta/0000-0001-5772-0808; Gdaniec, Zofia/0000-0003-2955-1829; Gudanis, Dorota/0000-0001-5046-9761; Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Kotkowiak, Weronika/0000-0002-9776-0924	Polish National Science Center [UMO-2014/13/B/ST5/04144, UMO-2013/08/A/ST5/00295, UMO-2013/10/E/NZ1/00741, UMO-2012/05/D/ST5/03599]; Polish Ministry of Science and Higher Education, under the KNOW program; Institute of Bioorganic Chemistry for young researchers and PhD students	Polish National Science Center; Polish Ministry of Science and Higher Education, under the KNOW program; Institute of Bioorganic Chemistry for young researchers and PhD students	This work was supported by Polish National Science Center grants UMO-2014/13/B/ST5/04144 to ZG, UMO-2013/08/A/ST5/00295 to RK, UMO-2013/10/E/NZ1/00741 and UMO-2012/05/D/ST5/03599 to AP. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program, and a grant from the Institute of Bioorganic Chemistry for young researchers and PhD students.	ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; Baranowski DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137674; DAMHA MJ, 1994, BIOCHEMISTRY-US, V33, P7877, DOI 10.1021/bi00191a015; Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Frieden M, 2006, IDRUGS, V9, P706; Garbesi A, 1998, NUCLEOS NUCLEOT, V17, P1275, DOI 10.1080/07328319808004239; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P5286, DOI 10.1093/nar/21.22.5286; Jensen TB, 2011, BIOORGAN MED CHEM, V19, P4739, DOI 10.1016/j.bmc.2011.06.087; Kawakami J, 2005, ANAL SCI, V21, P77, DOI 10.2116/analsci.21.77; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Pasternak A, 2011, ORG BIOMOL CHEM, V9, P3591, DOI 10.1039/c0ob01085e; Pasternak A, 2011, BIOORG MED CHEM LETT, V21, P752, DOI 10.1016/j.bmcl.2010.11.106; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Szabat M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143354; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; URATA H, 1993, J AM CHEM SOC, V115, P9852, DOI 10.1021/ja00074a083; Urata H, 2003, BIOCHEM BIOPH RES CO, V309, P79, DOI 10.1016/S0006-291X(03)01531-6; Urata H, 1996, TETRAHEDRON LETT, V37, P5551, DOI 10.1016/0040-4039(96)01153-7; Vallazza M, 2004, ACTA CRYSTALLOGR D, V60, P1, DOI 10.1107/S0907444903027690; Vater A, 2013, J BIOL CHEM, V288, P21136, DOI 10.1074/jbc.M112.444414; Wyszko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086673; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	29	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149478	10.1371/journal.pone.0149478	http://dx.doi.org/10.1371/journal.pone.0149478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908023	Green Published, gold			2022-12-26	WOS:000371163000013
J	Ben Khalaf, N; Taha, S; Bakhiet, M; Fathallah, MD				Ben Khalaf, Noureddine; Taha, Safa; Bakhiet, Moiz; Fathallah, M. Dahmani			A Central Nervous System-Dependent Intron-Embedded Gene Encodes a Novel Murine Fyn Binding Protein	PLOS ONE			English	Article							TO-BRAIN COMMUNICATION; PREDICTION; PHOSPHORYLATION; SEQUENCE; IMMUNE	The interplay between the nervous and immune systems is gradually being unraveled. We previously reported in the mouse the novel soluble immune system factor ISRAA, whose activation in the spleen is central nervous system-dependent. We also showed that ISRAA plays a role in modulating anti-infection immunity. Herein, we report the genomic description of the israa locus, along with some insights into the structure-function relationship of the protein. Our findings revealed that israa is nested within intron 6 of the mouse zmiz1 gene. Protein sequence analysis revealed a typical SH2 binding motif (Y102TEV), with Fyn being the most likely binding partner. Docking simulation showed a favorable conformation for the ISRAA-Fyn complex, with a specific binding mode for the binding of the YTEV motif to the SH2 domain. Experimental studies showed that in vitro, recombinant ISRAA is phosphorylated by Fyn at tyrosine 102. Cell transfection and pull-down experiments revealed Fyn as a binding partner of ISRAA in the EL4 mouse T-cell line. Indeed, we demonstrated that ISRAA downregulates T-cell activation and the phosphorylation of an activation tyrosine (Y-416) of Src-family kinases in mouse splenocytes. Our observations highlight ISRAA as a novel Fyn binding protein that is likely to be involved in a signaling pathway driven by the nervous system.	[Ben Khalaf, Noureddine; Fathallah, M. Dahmani] Arabian Gulf Univ, Coll Postgrad Studies, Manama, Bahrain; [Ben Khalaf, Noureddine; Taha, Safa; Bakhiet, Moiz] HH Al Jawhara Ctr Mol Med & Inherited Dis, Manama, Bahrain	Arabian Gulf University	Fathallah, MD (corresponding author), Arabian Gulf Univ, Coll Postgrad Studies, Manama, Bahrain.	d.fathallahh@agu.edu.bh	Khalaf, Noureddine Ben/AAG-2650-2021	Khalaf, Noureddine Ben/0000-0001-7573-754X	Arabian Gulf University Research Division	Arabian Gulf University Research Division	This work was supported and funded by an internal grant from the Arabian Gulf University Research Division.	[Anonymous], PYMOL MOL GRAPH SYST; Bakhiet M, 2008, IMMUNOL CELL BIOL, V86, P688, DOI 10.1038/icb.2008.57; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; BLALOCK JE, 1989, PHYSIOL REV, V69, P1, DOI 10.1152/physrev.1989.69.1.1; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; COOKE M P, 1989, New Biologist, V1, P66; Dantzer R, 2004, BRAIN BEHAV IMMUN, V18, P1, DOI 10.1016/j.bbi.2003.09.008; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Goehler LE, 2000, AUTON NEUROSCI-BASIC, V85, P49, DOI 10.1016/S1566-0702(00)00219-8; GUTIERREZ EG, 1994, J NEUROIMMUNOL, V55, P153, DOI 10.1016/0165-5728(94)90005-1; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lenaerts T, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-43; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MORRISON DA, 1977, J BACTERIOL, V132, P349, DOI 10.1128/JB.132.1.349-351.1977; Nachman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011215; Neuberger G, 2003, J MOL BIOL, V328, P567, DOI 10.1016/S0022-2836(03)00318-8; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Pellicena P, 2001, J BIOL CHEM, V276, P28190, DOI 10.1074/jbc.M100055200; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Procaccini C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00143; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Saeed RW, 2005, J EXP MED, V201, P1113, DOI 10.1084/jem.20040463; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Seykora JT, 2002, J BIOL CHEM, V277, P2812, DOI 10.1074/jbc.M106813200; van Gunsteren SRB W. F., 1996, BIOMOLECULAR SIMULAT; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; WATKINS LR, 1995, LIFE SCI, V57, P1011, DOI 10.1016/0024-3205(95)02047-M; Wiederstein M., 2007, NUCL ACIDS RES, V35, pW407, DOI DOI https://doi.org/10.1093/nar/gkm290	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149612	10.1371/journal.pone.0149612	http://dx.doi.org/10.1371/journal.pone.0149612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901312	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100111
J	Gong, YF; Tao, LM; Jing, L; Liu, DS; Hu, SJ; Liu, W; Zhou, NJ; Xie, Y				Gong, Yanfeng; Tao, Liming; Jing, Lei; Liu, Dongsheng; Hu, Sijun; Liu, Wei; Zhou, Nanjin; Xie, Yong			Association of TLR4 and Treg in Helicobacter pylori Colonization and Inflammation in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; INFECTION; RESPONSES; IMMUNITY; VACCINE; DIFFERENTIATION; ADJUVANT; CHITOSAN; CANCER	The host immune response plays an important role in the pathogenesis of Helicobacter pylori infection. The aim of this study was to clarify the immune pathogenic mechanism of Helicobacter pylori infection via TLR signaling and gastric mucosal Treg cells in mice. To discover the underlying mechanism, we selectively blocked the TLR signaling pathway and subpopulations of regulatory T cells in the gastric mucosa of mice, and examined the consequences on H. pylori infection and inflammatory response as measured by MyD88, NF-kappa B p65, and Foxp3 protein expression levels and the levels of Th1, Th17 and Th2 cytokines in the gastric mucosa. We determined that blocking TLR4 signaling in H. pylori infected mice decreased the numbers of Th1 and Th17 Treg cells compared to controls (P < 0.001-0.05), depressed the immune response as measured by inflammatory grade (P < 0.05), and enhanced H. pylori colonization (P < 0.05). In contrast, blocking CD25 had the opposite effects, wherein the Th1 and Th17 cell numbers were increased (P < 0.001-0.05), immune response was enhanced (P < 0.05), and H. pylori colonization was inhibited (P < 0.05) compared to the non-blocked group. In both blocked groups, the Th2 cytokine IL-4 remained unchanged, although IL-10 in the CD25 blocked group was significantly decreased (P < 0.05). Furthermore, MyD88, NF-kappa B p65, and Foxp3 in the non-blocked group were significantly lower than those in the TLR4 blocked group (P < 0.05), but significantly higher than those of the CD25 blocked group (P < 0.05). Together, these results suggest that there might be an interaction between TLR signaling and Treg cells that is important for limiting H. pylori colonization and suppressing the inflammatory response of infected mice.	[Gong, Yanfeng; Jing, Lei; Liu, Dongsheng; Hu, Sijun; Liu, Wei; Xie, Yong] Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China; [Gong, Yanfeng] Nanchang Univ, Affiliated Hosp 1, Dept Geriatr, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China; [Zhou, Nanjin] Jiangxi Acad Med Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China; [Tao, Liming] Nanchang Univ, Affiliated Hosp 1, Dept Obstet, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Xie, Y (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Gastroenterol, 17 Yongwai Zheng St, Nanchang, Jiangxi, Peoples R China.; Zhou, NJ (corresponding author), Jiangxi Acad Med Sci, Dept Biochem & Mol Biol, Nanchang, Jiangxi, Peoples R China.	jxznj@tom.com; xieyon_med@163.com	TAO, Li/HIR-4254-2022		National Natural Science Foundation of China [30660068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (no. 30660068), and YX received the funding.	An HZ, 2010, SCI CHINA LIFE SCI, V53, P34, DOI 10.1007/s11427-010-0011-x; Banerjee A, 2014, INFECT IMMUN, V82, P356, DOI 10.1128/IAI.01344-13; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; deFoneska A, 2010, CURR OPIN GASTROEN, V26, P604, DOI 10.1097/MOG.0b013e32833f1222; Gong YF, 2015, MOL MED REP, V12, P4123, DOI 10.3892/mmr.2015.3950; Hu SJ, 2009, INDIAN J MED RES, V130, P115; Kabisch R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104804; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kawahara Tsukasa, 2001, Journal of Medical Investigation, V48, P190; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Knechtle SJ, 2010, TRANSPL P, V42, pS13, DOI 10.1016/j.transproceed.2010.07.039; Lacave-Lapalun JV, 2014, J LEUKOCYTE BIOL, V95, P931, DOI 10.1189/jlb.0413209; Lagunes-Servin H, 2013, HELICOBACTER, V18, P423, DOI 10.1111/hel.12067; Li P, 2014, GENET TEST MOL BIOMA, V18, P610, DOI 10.1089/gtmb.2014.0047; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; Menon R, 2011, GASTROENTEROL CLIN N, V40, P427, DOI 10.1016/j.gtc.2011.03.002; Munari F, 2014, J IMMUNOL, V193, P5584, DOI 10.4049/jimmunol.1302865; Murphy TJ, 2005, J IMMUNOL, V174, P2957, DOI 10.4049/jimmunol.174.5.2957; Okeke EB, 2013, SHOCK, V40, P65, DOI 10.1097/SHK.0b013e318296e65b; Piccioni M, 2014, ADV EXP MED BIOL, V841, P67, DOI 10.1007/978-94-017-9487-9_4; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Raghavan S, 2003, CLIN EXP IMMUNOL, V132, P393, DOI 10.1046/j.1365-2249.2003.02177.x; Smith SM, 2004, WORLD J GASTROINTEST, V5, P133; Sun X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074595; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Toka FN, 2004, J VIROL, V78, P13082, DOI 10.1128/JVI.78.23.13082-13089.2004; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Voo KS, 2014, J IMMUNOL, V193, P627, DOI 10.4049/jimmunol.1203334; Wang Qiang, 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V21, P469, DOI 10.7534/j.issn.1009-2137.2013.02.044; Wang RF, 2006, SEMIN CANCER BIOL, V16, P106, DOI 10.1016/j.semcancer.2005.11.004; Wang TR, 2014, INT J CLIN EXP PATHO, V7, P6950; Wang XP, 2005, PANCREAS, V31, P251, DOI 10.1097/01.mpa.0000175179.62916.17; Xie Y, 2007, WORLD J GASTROENTERO, V13, P1547, DOI 10.3748/wjg.v13.i10.1547; Xie Yong, 2007, Zhonghua Nei Ke Za Zhi, V46, P220	36	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149629	10.1371/journal.pone.0149629	http://dx.doi.org/10.1371/journal.pone.0149629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901645	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100114
J	Hong, J; Li, D; Cao, WB				Hong, Jie; Li, Dan; Cao, Weibiao			Rho Kinase ROCK2 Mediates Acid-Induced NADPH Oxidase NOX5-S Expression in Human Esophageal Adenocarcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROTON PUMP INHIBITORS; BARRETTS-ESOPHAGUS; REACTIVE OXYGEN; SMOOTH-MUSCLE; NEOPLASTIC PROGRESSION; FOCAL ADHESIONS; UP-REGULATION; IN-VITRO; BINDING	Mechanisms of the progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA) are not fully understood. We have shown that NOX5-S may be involved in this progression. However, how acid upregulates NOX5-S is not well known. We found that acid-induced increase in NOX5-S expression was significantly decreased by the Rho kinase (ROCK) inhibitor Y27632 in BE mucosal biopsies and FLO-1 EA cells. In addition, acid treatment significantly increased the Rho kinase activity in FLO-1 cells. The acid-induced increase in NOX5-S expression and H2O2 production was significantly decreased by knockdown of Rho kinase ROCK2, but not by knockdown of ROCK1. Conversely, the overexpression of the constitutively active ROCK2, but not the constitutively active ROCK1, significantly enhanced the NOX5-S expression and H2O2 production. Moreover, the acid-induced increase in Rho kinase activity and in NOX5-S mRNA expression was blocked by the removal of calcium in both FLO-1 and OE33 cells. The calcium ionophore A23187 significantly increased the Rho kinase activity and NOX5-S mRNA expression. We conclude that acid-induced increase in NOX5-S expression and H2O2 production may depend on the activation of ROCK2, but not ROCK1, in EA cells. The acid-induced activation of Rho kinase may be mediated by the intracellular calcium increase. It is possible that persistent acid reflux present in BE patients may increase the intracellular calcium, activate ROCK2 and thereby upregulate NOX5-S. High levels of reactive oxygen species derived from NOX5-S may cause DNA damage and thereby contribute to the progression from BE to EA.	[Hong, Jie; Li, Dan; Cao, Weibiao] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Hong, Jie; Li, Dan; Cao, Weibiao] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Cao, Weibiao] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA; [Hong, Jie] Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Shanghai Jiao Tong University	Cao, WB (corresponding author), Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.; Cao, WB (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Cao, WB (corresponding author), Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA.	wcao@hotmail.com			NIDDK [R01 DK080703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080703] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK R01 DK080703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; Das KM, 2011, INT J CANCER, V128, P274, DOI 10.1002/ijc.25343; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; Falk GW, 2002, GASTROENTEROLOGY, V122, P1569, DOI 10.1053/gast.2002.33427; Farhadi A, 2002, AM J GASTROENTEROL, V97, P22; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Fountoulakis A, 2004, DIGEST DIS SCI, V49, P914, DOI 10.1023/B:DDAS.0000034548.89117.d6; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hong J, 2011, AM J PHYSIOL-CELL PH, V301, pC413, DOI 10.1152/ajpcell.00027.2011; Hong J, 2010, AM J PHYSIOL-GASTR L, V299, pG697, DOI 10.1152/ajpgi.00186.2010; Hughes SJ, 1997, CANCER RES, V57, P5571; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kahrilas PJ, 2011, NEW ENGL J MED, V365, P1437, DOI 10.1056/NEJMe1108435; Kastelein F, 2013, CLIN GASTROENTEROL H, V11, P382, DOI 10.1016/j.cgh.2012.11.014; Kim JS, 2005, EXP MOL MED, V37, P575, DOI 10.1038/emm.2005.71; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Koksel O, 2005, EUR J PHARMACOL, V510, P135, DOI 10.1016/j.ejphar.2004.12.010; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li D, 2014, AM J PHYSIOL-GASTR L, V306, pG863, DOI 10.1152/ajpgi.00321.2013; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; OLYAEE M, 1995, GUT, V37, P168, DOI 10.1136/gut.37.2.168; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pohl H, 2013, AM J GASTROENTEROL, V108, P200, DOI 10.1038/ajg.2012.387; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Si J, 2007, J BIOL CHEM, V282, P16244, DOI 10.1074/jbc.M700297200; Sihvo EIT, 2003, J THORAC CARDIOV SUR, V126, P1952, DOI 10.1016/j.jtcvs.2003.08.014; Somlyo AV, 2003, FASEB J, V17, P223, DOI 10.1096/fj.02-0655com; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wetscher G J, 1997, Dis Esophagus, V10, P29; Wetscher GJ, 1997, DIS ESOPHAGUS, V10, P3; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang HY, 2009, CANCER RES, V69, P9083, DOI 10.1158/0008-5472.CAN-09-2518	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149735	10.1371/journal.pone.0149735	http://dx.doi.org/10.1371/journal.pone.0149735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901778	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100137
J	Vilanova, E; Santos, GRC; Aquino, RS; Valle-Delgado, JJ; Anselmetti, D; Fernandez-Busquets, X; Mourao, PAS				Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Valle-Delgado, Juan J.; Anselmetti, Dario; Fernandez-Busquets, Xavier; Mourao, Paulo A. S.			Carbohydrate-Carbohydrate Interactions Mediated by Sulfate Esters and Calcium Provide the Cell Adhesion Required for the Emergence of Early Metazoans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR PROTEOGLYCANS; FORCE; RECOGNITION; GLYCOSAMINOGLYCANS; POLYSACCHARIDES; GALACTAN; CHONDROITIN; RECEPTOR; PORIFERA; SPONGES	Early metazoans had to evolve the first cell adhesion mechanism addressed to maintain a distinctive multicellular morphology. As the oldest extant animals, sponges are good candidates for possessing remnants of the molecules responsible for this crucial evolutionary innovation. Cell adhesion in sponges is mediated by the calcium-dependent multivalent self-interactions of sulfated polysaccharides components of extracellular membrane-bound proteoglycans, namely aggregation factors. Here, we used atomic force microscopy to demonstrate that the aggregation factor of the sponge Desmapsamma anchorata has a circular supramolecular structure and that it thus belongs to the spongican family. Its sulfated polysaccharide units, which were characterized via nuclear magnetic resonance analysis, consist preponderantly of a central backbone composed of 3-alpha-Glc1 units partially sulfated at 2-and 4-positions and branches of Pyr(4,6)alpha-Gal1 -> 3-alpha-Fuc2(SO3)1 -> 3-alpha-Glc4(SO3) 1 -> 3-alpha-Glc -> 4-linked to the central alpha-Glc units. Single-molecule force measurements of self-binding forces of this sulfated polysaccharide and their chemically desulfated and carboxyl-reduced derivatives revealed that the sulfate epitopes and extracellular calcium are essential for providing the strength and stability necessary to sustain cell adhesion in sponges. We further discuss these findings within the framework of the role of molecular structures in the early evolution of metazoans.	[Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941913 Rio de Janeiro, Brazil; [Vilanova, Eduardo; Santos, Gustavo R. C.; Aquino, Rafael S.; Mourao, Paulo A. S.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo Meis, BR-21941913 Rio de Janeiro, Brazil; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Inst Bioengn Catalonia IBEC, Nanomalaria Grp, Barcelona 08028, Spain; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, E-08036 Barcelona, Spain; [Valle-Delgado, Juan J.; Fernandez-Busquets, Xavier] Univ Barcelona, Nanosci & Nanotechnol Inst IN2UB, E-08028 Barcelona, Spain; [Anselmetti, Dario] Univ Bielefeld, Fac Phys, Expt Biophys & Appl Nanosci, D-33615 Bielefeld, Germany; [Valle-Delgado, Juan J.] Aalto Univ, Sch Chem Technol, Dept Forest Prod Technol, Aalto 00076, Finland	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Bielefeld; Aalto University	Fernandez-Busquets, X (corresponding author), Ctr Esther Koplowitz, Barcelona Ctr Int Hlth Res ISGlobal, Planta 1,Rossello 149-153, Barcelona 08036, Spain.; Mourao, PAS (corresponding author), Hosp Univ Clementino Fraga Filho, Rua Prof Paulo Rocco 255,Sala 4a01, BR-21941913 Rio De Janeiro, Brazil.	xfernandez_busquets@ub.edu; pmourao@hucff.ufrj.br	Mourao, Paulo/AAA-5386-2020; Anselmetti, Dario/F-1664-2011; Valle-Delgado, Juan Jose/H-8857-2013	Anselmetti, Dario/0000-0002-8720-4369; Valle-Delgado, Juan Jose/0000-0002-4808-1730	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil; Fundacion Carolina, Spain; Ministerio de Economia y Competitividad [BIO2011-25039, BIO2014-52872-R]; Generalitat de Catalunya, Spain [2014-SGR-938]; FEDER funds, Spain	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacion Carolina, Spain; Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya); FEDER funds, Spain(Spanish Government)	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazil; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil; Coordenacao de Aperfeicoamento do Pessoal de Nivel Superior (CAPES), Brazil; Fundacion Carolina, Spain; BIO2011-25039 and BIO2014-52872-R from the Ministerio de Economia y Competitividad, including FEDER funds, Spain and 2014-SGR-938 from the Generalitat de Catalunya, Spain. The authors declare that they have no conflicts of interest with the contents of this article.	Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Alves AP, 1998, GLYCOBIOLOGY, V8, P939, DOI 10.1093/glycob/8.9.939; Aquino RS, 2010, THROMB HAEMOSTASIS, V103, P1005, DOI 10.1160/TH09-11-0761; Bao XF, 2001, CARBOHYD RES, V336, P127, DOI 10.1016/S0008-6215(01)00238-5; BAX A, 1985, J MAGN RESON, V63, P207, DOI 10.1016/0022-2364(85)90171-4; Bilan MI, 2007, CARBOHYD RES, V342, P586, DOI 10.1016/j.carres.2006.11.008; Blumbach B, 1998, J CELL SCI, V111, P2635; Bucior I, 2004, GLYCOCONJUGATE J, V21, P111, DOI 10.1023/B:GLYC.0000044843.72595.7d; Bucior I, 2004, CURR OPIN STRUC BIOL, V14, P631, DOI 10.1016/j.sbi.2004.08.006; Bucior I, 2004, J CELL BIOL, V165, P529, DOI 10.1083/jcb.200309005; DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599; EGGENS I, 1989, J BIOL CHEM, V264, P9476; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; Fernandez-Busquets X, 2003, CELL MOL LIFE SCI, V60, P88, DOI 10.1007/s000180300006; Fernandez-Busquets X, 1998, J BIOL CHEM, V273, P29545, DOI 10.1074/jbc.273.45.29545; Fernandez-Busquets X., 2010, ENCY LIFE SCI, P1; Fernandez-Busquets X, 2009, MOL BIOL EVOL, V26, P2551, DOI 10.1093/molbev/msp170; FernandezBusquets X, 1997, J BIOL CHEM, V272, P27839, DOI 10.1074/jbc.272.44.27839; Garcia-Manyes S, 2006, J BIOL CHEM, V281, P5992, DOI 10.1074/jbc.M507878200; Guerardel Y, 2004, J BIOL CHEM, V279, P15591, DOI 10.1074/jbc.M308928200; Haseley SR, 2001, P NATL ACAD SCI USA, V98, P9419, DOI 10.1073/pnas.151111298; HEGNER M, 1993, SURF SCI, V291, P39, DOI 10.1016/0039-6028(93)91474-4; Huang QL, 2005, BIOPOLYMERS, V79, P28, DOI 10.1002/bip.20332; Jarchow J, 2000, J STRUCT BIOL, V132, P95, DOI 10.1006/jsbi.2000.4309; Knoll AH, 2011, ANNU REV EARTH PL SC, V39, P217, DOI 10.1146/annurev.earth.031208.100209; KOJIMA N, 1991, J BIOL CHEM, V266, P17552; Koshy KM, 1996, J BIOL CHEM, V271, P3496; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Lorenz B, 2012, J AM CHEM SOC, V134, P3326, DOI 10.1021/ja210304j; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Mathews C.K., 1990, BIOCHEMISTRY-US, V3d; Medeiros GF, 2000, BBA-GEN SUBJECTS, V1475, P287, DOI 10.1016/S0304-4165(00)00079-9; Mills DB, 2014, P NATL ACAD SCI USA, V111, P4168, DOI 10.1073/pnas.1400547111; Misevic GN, 2004, J BIOL CHEM, V279, P15579, DOI 10.1074/jbc.M308927200; Morrow C, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0099-8; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Ori A, 2011, J BIOL CHEM, V286, P19892, DOI 10.1074/jbc.M111.228114; PAVAO MSG, 1990, CARBOHYD RES, V208, P153, DOI 10.1016/0008-6215(90)80095-K; Pereira MS, 2002, CARBOHYD RES, V337, P2231, DOI 10.1016/S0008-6215(02)00215-X; Peterson KJ, 2005, P NATL ACAD SCI USA, V102, P9547, DOI 10.1073/pnas.0503660102; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Popescu O, 2003, BIOCHIMIE, V85, P181, DOI 10.1016/S0300-9084(03)00063-4; Sabella C, 2007, J IMMUNOL, V179, P5927, DOI 10.4049/jimmunol.179.9.5927; Santos GRC, 2015, GLYCOBIOLOGY, V25, P1043, DOI 10.1093/glycob/cwv044; Spillmann D, 1996, J CELL BIOCHEM, V61, P562, DOI 10.1002/(SICI)1097-4644(19960616)61:4<562::AID-JCB9>3.0.CO;2-M; Spillmann D., 2000, CARBOHYDRATES CHEM B, P1061; Taylor R. L., 1976, METHODS CARBOHYDRATE, V7, P149; Nguyen TH, 2015, NANOSCALE, V7, P10130, DOI 10.1039/c5nr02132d; Vilanova E, 2010, CELL TISSUE RES, V340, P523, DOI 10.1007/s00441-010-0963-y; Vilanova E, 2009, GLYCOBIOLOGY, V19, P860, DOI 10.1093/glycob/cwp059; Vilanova Eduardo, 2007, V28, P653; Vilela-Silva ACES, 2002, J BIOL CHEM, V277, P379, DOI 10.1074/jbc.M108496200; Wang B, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4876603; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zierer MS, 2000, CARBOHYD RES, V328, P209, DOI 10.1016/S0008-6215(00)00076-8	61	19	19	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9425	9437		10.1074/jbc.M115.708958	http://dx.doi.org/10.1074/jbc.M115.708958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26917726	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000375602300004
J	Bachmann, AS; Opoku-Ansah, J; Ibarra-Rivera, TR; Yco, LP; Ambadi, S; Roberts, CC; Chang, CEA; Pirrung, MC				Bachmann, Andre S.; Opoku-Ansah, John; Ibarra-Rivera, Tannya R.; Yco, Lisette P.; Ambadi, Sudhakar; Roberts, Christopher C.; Chang, Chia-en A.; Pirrung, Michael C.			Syrbactin Structural Analog TIR-199 Blocks Proteasome Activity and Induces Tumor Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						computer modeling; multiple myeloma; natural product; neuroblastoma; proteasome; TIR-199; anti-tumor activity; chemical synthesis; hollow fiber assays; syringolin A	RELAPSED MULTIPLE-MYELOMA; BIOLOGICAL-ACTIVITY; SYRINGOLIN; BORTEZOMIB; DISEASE; LINES; NEUROBLASTOMA; INHIBITORS; IMMUNOPROTEASOME; GLIDOBACTIN	Multiple myeloma is an aggressive hematopoietic cancer of plasma cells. The recent emergence of three effective FDA-approved proteasome-inhibiting drugs, bortezomib (Velcade (R)), carfilzomib (Kyprolis (R)), and ixazomib (Ninlaro (R)), confirms that proteasome inhibitors are therapeutically useful against neoplastic disease, in particular refractory multiple myeloma and mantle cell lymphoma. This study describes the synthesis, computational affinity assessment, and preclinical evaluation of TIR-199, a natural product-derived syrbactin structural analog. Molecular modeling and simulation suggested that TIR-199 covalently binds each of the three catalytic subunits (beta 1, beta 2, and beta 5) and revealed key interaction sites. In vitro and cell culture-based proteasome activity measurements confirmed that TIR-199 inhibits the proteasome in a dose-dependent manner and induces tumor cell death in multiple myeloma and neuroblastoma cells as well as other cancer types in the NCI-60 cell panel. It is particularly effective against kidney tumor cell lines, with >250-fold higher anti-tumor activities than observed with the natural product syringolin A. In vivo studies in mice revealed a maximum tolerated dose of TIR-199 at 25 mg/kg. The anti-tumor activity of TIR-199 was confirmed in hollow fiber assays in mice. Adverse drug reaction screens in a kidney panel revealed no off-targets of concern. This is the first study to examine the efficacy of a syrbactin in animals. Taken together, the results suggest that TIR-199 is a potent new proteasome inhibitor with promise for further development into a clinical drug for the treatment of multiple myeloma and other forms of cancer.	[Bachmann, Andre S.; Yco, Lisette P.] Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 301 Michigan St,NE, Grand Rapids, MI 49503 USA; [Bachmann, Andre S.; Opoku-Ansah, John; Yco, Lisette P.] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Bachmann, Andre S.; Yco, Lisette P.] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Ibarra-Rivera, Tannya R.; Ambadi, Sudhakar; Roberts, Christopher C.; Chang, Chia-en A.; Pirrung, Michael C.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Pirrung, Michael C.] Univ Calif Irvine, Dept Pharmaceut Sci, Irvine, CA 92697 USA; [Ibarra-Rivera, Tannya R.] Univ Autonoma Nuevo Leon, Fac Med, Monterrey 64460, Nuevo Leon, Mexico	Michigan State University; Michigan State University College of Human Medicine; University of Hawaii System; University Hawaii Hilo; University of Hawaii System; University of Hawaii Manoa; University of California System; University of California Riverside; University of California System; University of California Irvine; Universidad Autonoma de Nuevo Leon	Bachmann, AS (corresponding author), Michigan State Univ, Coll Human Med, Dept Pediat & Human Dev, 301 Michigan St,NE, Grand Rapids, MI 49503 USA.; Pirrung, MC (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	andre.bachmann@hc.msu.edu; Michael.pirrung@ucr.edu			Robert C. Perry Fund of the Hawaii Community Foundation (HCF) [09ADVC-45411]; Daniel K. Inouye College of Pharmacy; University of California Cancer Research Coordinating Committee; UC-MEXUS; CONACYT	Robert C. Perry Fund of the Hawaii Community Foundation (HCF); Daniel K. Inouye College of Pharmacy; University of California Cancer Research Coordinating Committee(University of California System); UC-MEXUS; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported in part by funding from the Robert C. Perry Fund of the Hawaii Community Foundation (HCF 09ADVC-45411) (to A. S. B.) and internal funds from the Daniel K. Inouye College of Pharmacy (to A. S. B.). Further support was provided by the University of California Cancer Research Coordinating Committee (to M. C. P.) and postdoctoral fellowships from UC-MEXUS and CONACYT (to T. R. I.-R.). This work was also supported by contributions via experiment.com from Francois Souchay, Yong Rok Lee, Bruce Liu, Ann Adenbaum, Alan Schramm, and Robert Patton. A. S. B. is a named inventor of a United States patent (US 8,597,904, December 3, 2013) that relates to pharmaceutical compositions for the treatment of conditions responsive to proteasome inhibition. This patent is assigned to PONO Pharma Inc. (Honolulu, HI), for which A. S. B. currently serves as an independent agent. M. C. P. is a named inventor on a United States patent application (US 2015-0141392 A1) assigned to the University of California concerning synthetic macrocyclic compounds having proteasome inhibitory activity.	Adams J, 2004, NAT REV CANCER, V4, P349, DOI 10.1038/nrc1361; Adams J, 1998, BIOORG MED CHEM LETT, V8, P333, DOI 10.1016/S0960-894X(98)00029-8; Anshu A, 2011, BIOCHEM PHARMACOL, V82, P600, DOI 10.1016/j.bcp.2011.06.031; Archer CR, 2012, BIOCHEMISTRY-US, V51, P6880, DOI 10.1021/bi300841r; Archer CR, 2010, BIOCHEM PHARMACOL, V80, P170, DOI 10.1016/j.bcp.2010.03.031; Borissenko L, 2007, CHEM REV, V107, P687, DOI 10.1021/cr0502504; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chiba T, 2015, BIOORG MED CHEM LETT, V25, P4872, DOI 10.1016/j.bmcl.2015.06.015; Chiba T, 2014, ANGEW CHEM INT EDIT, V53, P4836, DOI 10.1002/anie.201402428; Clerc J, 2011, CHEM COMMUN, V47, P385, DOI 10.1039/c0cc02238a; Clerc J, 2010, EUR J ORG CHEM, V2010, P3991, DOI 10.1002/ejoc.201000317; Clerc J, 2009, CHEMBIOCHEM, V10, P2638, DOI 10.1002/cbic.200900411; Clerc J, 2009, P NATL ACAD SCI USA, V106, P6507, DOI 10.1073/pnas.0901982106; Coleman CS, 2006, CELL PROLIFERAT, V39, P599, DOI 10.1111/j.1365-2184.2006.00402.x; Cragg GM, 2009, CHEM REV, V109, P3012, DOI 10.1021/cr900019j; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Egerer T, 2006, ARTHRITIS RHEUM-US, V54, P1501, DOI 10.1002/art.21782; Ethen CM, 2007, FEBS LETT, V581, P885, DOI 10.1016/j.febslet.2007.01.061; Fisher RI, 2006, J CLIN ONCOL, V24, P4867, DOI 10.1200/JCO.2006.07.9665; Fitzpatrick LR, 2007, DIS COLON RECTUM, V50, P337, DOI 10.1007/s10350-006-0796-7; Greenstein S, 2003, EXP HEMATOL, V31, P271, DOI 10.1016/S0301-472X(03)00023-7; Groll M, 2008, NATURE, V452, P755, DOI 10.1038/nature06782; Herndon TM, 2013, CLIN CANCER RES, V19, P4559, DOI 10.1158/1078-0432.CCR-13-0755; HOLLINGSHEAD MG, 1995, LIFE SCI, V57, P131, DOI 10.1016/0024-3205(95)00254-4; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Ibarra-Rivera TR, 2011, TETRAHEDRON, V67, P9950, DOI 10.1016/j.tet.2011.09.048; Lu SQ, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-13; Massova I, 2000, PERSPECT DRUG DISCOV, V18, P113, DOI 10.1023/A:1008763014207; Mishto M, 2006, NEUROBIOL AGING, V27, P54, DOI 10.1016/j.neurobiolaging.2004.12.004; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; OKA M, 1988, J ANTIBIOT, V41, P1812, DOI 10.7164/antibiotics.41.1812; OKA M, 1988, J ANTIBIOT, V41, P1331, DOI 10.7164/antibiotics.41.1331; Opoku-Ansah J, 2012, PHARM BIOL, V50, P25, DOI 10.3109/13880209.2011.626784; Pirrung MC, 2010, ORG LETT, V12, P2402, DOI 10.1021/ol100761z; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Richardson PG, 2007, BLOOD, V110, P3557, DOI 10.1182/blood-2006-08-036947; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Strauss SJ, 2006, J CLIN ONCOL, V24, P2105, DOI 10.1200/JCO.2005.04.6789; Totaro KA, 2015, BIOORGAN MED CHEM, V23, P6218, DOI 10.1016/j.bmc.2015.07.041; Trivella DBB, 2014, CHEM BIOL, V21, P782, DOI 10.1016/j.chembiol.2014.04.010; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Visekruna A, 2006, J CLIN INVEST, V116, P3195, DOI 10.1172/JCI28804; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035	47	11	12	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8350	8362		10.1074/jbc.M115.710053	http://dx.doi.org/10.1074/jbc.M115.710053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907687	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000374773200004
J	Schweitzer, MH; Moyer, AE; Zheng, WX				Schweitzer, Mary Higby; Moyer, Alison E.; Zheng, Wenxia			Testing the Hypothesis of Biofilm as a Source for Soft Tissue and Cell-Like Structures Preserved in Dinosaur Bone	PLOS ONE			English	Article							ARCHAEOLOGICAL BONE; PROTEIN SEQUENCES; BLOOD-VESSELS; FUNGAL HYPHAE; ANCIENT; DECAY; EVOLUTION; MASTODON; DEGRADATION; SURVIVAL	Recovery of still-soft tissue structures, including blood vessels and osteocytes, from dinosaur bone after demineralization was reported in 2005 and in subsequent publications. Despite multiple lines of evidence supporting an endogenous source, it was proposed that these structures arose from contamination from biofilm-forming organisms. To test the hypothesis that soft tissue structures result from microbial invasion of the fossil bone, we used two different biofilm-forming microorganisms to inoculate modern bone fragments from which organic components had been removed. We show fundamental morphological, chemical and textural differences between the resultant biofilm structures and those derived from dinosaur bone. The data do not support the hypothesis that biofilm-forming microorganisms are the source of these structures.	[Schweitzer, Mary Higby; Moyer, Alison E.; Zheng, Wenxia] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary Higby] North Carolina Museum Nat Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Schweitzer, MH (corresponding author), North Carolina Museum Nat Sci, Raleigh, NC USA.	schweitzer@ncsu.edu	Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010	schweitzer, mary h/0000-0002-0427-3829	David and Lucile Packard Foundation [30533]; National Science Foundation INSPIRE program [EAR-1344198]; National Science Foundation GRFP [DGE-1252376]; Directorate For Geosciences [1344198] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation INSPIRE program; National Science Foundation GRFP(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by grants to MHS from the David and Lucile Packard Foundation (30533), to MHS and WZ from the National Science Foundation INSPIRE program (EAR-1344198), and to AEM from the National Science Foundation GRFP (DGE-1252376). The EAR-1344198 was given to only MHS as PI. WZ is funded off of this grant, but she is not a PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Boyd CA, 2011, ZOOMORPHOLOGY, V130, P305, DOI 10.1007/s00435-011-0136-x; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2003, FOSSIL AND RECENT BIOFILMS, P281; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; CHILD AM, 1995, STUD CONSERV, V40, P19, DOI 10.2307/1506608; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Cleland TP, 2015, J PROTEOME RES, V14, P5252, DOI 10.1021/acs.jproteome.5b00675; COATES M, 1980, TEX REP BIOL MED, V40, P9; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Gutierrez G, 1998, MOL BIOL EVOL, V15, P926, DOI 10.1093/oxfordjournals.molbev.a025998; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hardison R, 1998, J EXP BIOL, V201, P1099; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Iniesto M, 2015, FRONTIERS EARTH SCI, P3; Jans MME, 2002, ARCHAEOMETRY, V44, P343, DOI 10.1111/1475-4754.t01-1-00067; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0614; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Liu J, 2004, METH MOLEC MED, V95, P71; MECHAM RP, 1991, ANN NY ACAD SCI, V624, P137, DOI 10.1111/j.1749-6632.1991.tb17013.x; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Peterson JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013334; Pitre MC, 2013, J ARCHAEOL SCI, V40, P24, DOI 10.1016/j.jas.2012.06.022; RAFF EC, 2008, P NATL ACAD SCI USA, V105, P1936, DOI DOI 10.1146/ANNUREV.EARTH.31.100901.144746; Raff EC, 2013, EVOL DEV, V15, P243, DOI 10.1111/ede.12028; Rhoads D D, 2008, J Wound Care, V17, P502; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Schweitzer MH, 2015, BIOESSAYS, V37, P1174, DOI 10.1002/bies.201500061; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stoodley P, 1997, BIOFILMS COMMUNITY I, P1; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; TANAKA Y, 1976, AM J ANAT, V145, P485, DOI 10.1002/aja.1001450407; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; Vito RP, 2003, ANNU REV BIOMED ENG, V5, P413, DOI 10.1146/annurev.bioeng.5.011303.120719; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	62	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150238	10.1371/journal.pone.0150238	http://dx.doi.org/10.1371/journal.pone.0150238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926069	Green Published, gold, Green Submitted			2022-12-26	WOS:000371424200030
J	Aliuos, P; Schulze, J; Schomaker, M; Reuter, G; Stolle, SRO; Werner, D; Ripken, T; Lenarz, T; Warnecke, A				Aliuos, Pooyan; Schulze, Jennifer; Schomaker, Markus; Reuter, Guenter; Stolle, Stefan R. O.; Werner, Darja; Ripken, Tammo; Lenarz, Thomas; Warnecke, Athanasia			Magnetic Beads Enhance Adhesion of NIH 3T3 Fibroblasts: A Proof-of-Principle In Vitro Study for Implant-Mediated Long-Term Drug Delivery to the Inner Ear	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; NEUROTROPHIC FACTOR; ELECTRICAL-STIMULATION; COCHLEAR IMPLANTATION; NEURITE OUTGROWTH; CELL SURVIVAL; BDNF; NANOPARTICLES; PERCEPTION; CESSATION	Introduction Long-term drug delivery to the inner ear may be achieved by functionalizing cochlear implant (CI) electrodes with cells providing neuroprotective factors. However, effective strategies in order to coat implant surfaces with cells need to be developed. Our vision is to make benefit of electromagnetic field attracting forces generated by CI electrodes to bind BDNF-secreting cells that are labelled with magnetic beads (MB) onto the electrode surfaces. Thus, the effect of MB-labelling on cell viability and BDNF production were investigated. Materials and Methods Murine NIH 3T3 fibroblasts-genetically modified to produce BDNF-were labelled with MB. Results Atomic force and bright field microscopy illustrated the internalization of MB by fibroblasts after 24 h of cultivation. Labelling cells with MB did not expose cytotoxic effects on fibroblasts and allowed adhesion on magnetic surfaces with sufficient BDNF release. Discussion Our data demonstrate a novel approach for mediating enhanced long-term adhesion of BDNF-secreting fibroblasts on model electrode surfaces for cell-based drug delivery applications in vitro and in vivo. This therapeutic strategy, once transferred to cells suitable for clinical application, may allow the biological modifications of CI surfaces with cells releasing neurotrophic or other factors of interest.	[Aliuos, Pooyan; Schulze, Jennifer; Reuter, Guenter; Stolle, Stefan R. O.; Werner, Darja; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Aliuos, Pooyan; Schulze, Jennifer; Ripken, Tammo; Lenarz, Thomas; Warnecke, Athanasia] Cluster Excellence Hearing4All, Hannover, Germany; [Schomaker, Markus; Ripken, Tammo] Laser Zentrum Hannover eV, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany.; Warnecke, A (corresponding author), Cluster Excellence Hearing4All, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022		German Research Foundation	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation, Project Group "Medical Technology". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Budenz CL, 2012, ANAT REC, V295, P1896, DOI 10.1002/ar.22586; Burkhardt O, 2002, ANN ANAT, V184, P55, DOI 10.1016/S0940-9602(02)80036-X; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Calmels MN, 2004, INT J PEDIATR OTORHI, V68, P347, DOI 10.1016/j.ijporl.2003.11.006; Coco A, 2007, HEARING RES, V225, P60, DOI 10.1016/j.heares.2006.12.004; Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228; Gallo J, 2013, CHEM SOC REV, V42, P7816, DOI 10.1039/c3cs60149h; Gillespie LN, 2015, J CONTROL RELEASE, V198, P26, DOI 10.1016/j.jconrel.2014.11.026; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jorgensen JR, 2012, EXP NEUROL, V233, P172, DOI 10.1016/j.expneurol.2011.09.027; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; Lenarz T, 2013, CURR PHARM BIOTECHNO, V14, P112; Lynam DA, 2015, ACTA BIOMATER, V18, P128, DOI 10.1016/j.actbio.2015.02.014; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; Murphy J, 2007, LARYNGOSCOPE, V117, P1412, DOI 10.1097/MLG.0b013e318068b594; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; O'Leary SJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055002; Peng SC, 2008, EAR HEARING, V29, P336, DOI 10.1097/AUD.0b013e318168d94d; Pierzchalski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074745; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Tietze R, 2013, NANOMED-NANOTECHNOL, V9, P961, DOI 10.1016/j.nano.2013.05.001; Tjelle TE, 1998, J CELL SCI, V111, P141; UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129; Ugelstad J., 1976, RUBBER CHEM TECHNOL, V49, P536, DOI DOI 10.5254/1.3534976; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu HX, 2012, ACTA OTO-LARYNGOL, V132, P482, DOI 10.3109/00016489.2011.647361; Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; Zhao M, 2013, DRUG DELIV, V20, P95, DOI 10.3109/10717544.2013.779328	43	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150057	10.1371/journal.pone.0150057	http://dx.doi.org/10.1371/journal.pone.0150057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918945	gold, Green Submitted, Green Published			2022-12-26	WOS:000371274400078
J	Carroll, R; Metcalfe, C; Steeg, S; Davies, NM; Cooper, J; Kapur, N; Gunnell, D				Carroll, Robert; Metcalfe, Chris; Steeg, Sarah; Davies, Neil M.; Cooper, Jayne; Kapur, Nav; Gunnell, David			Psychosocial Assessment of Self-Harm Patients and Risk of Repeat Presentation: An Instrumental Variable Analysis Using Time of Hospital Presentation	PLOS ONE			English	Article							BIAS	Background Clinical guidelines have recommended psychosocial assessment of self-harm patients for years, yet estimates of its impact on the risk of repeat self-harm vary. Assessing the association of psychosocial assessment with risk of repeat self-harm is challenging due to the effects of confounding by indication. Methods We analysed data from a cohort study of 15,113 patients presenting to the emergency departments of three UK hospitals to investigate the association of psychosocial assessment with risk of repeat hospital presentation for self-harm. Time of day of hospital presentation was used as an instrument for psychosocial assessment, attempting to control for confounding by indication. Results Conventional regression analysis suggested psychosocial assessment was not associated with risk of repeat self-harm within 12 months (Risk Difference (RD) 0.00 95% confidence interval (95% CI) -0.01 to 0.02). In contrast, IV analysis suggested risk of repeat self-harm was reduced by 18% (RD -0.18, 95% CI -0.32 to -0.03) in those patients receiving a psychosocial assessment. However, the instrument of time of day did not remove all potential effects of confounding by indication, suggesting the IV effect estimate may be biased. Conclusions We found that psychosocial assessments reduce risk of repeat self-harm. This is in-line with other non-randomised studies based on populations in which allocation to assessment was less subject to confounding by indication. However, as our instrument did not fully balance important confounders across time of day, the IV effect estimate should be interpreted with caution.	[Carroll, Robert; Metcalfe, Chris; Davies, Neil M.; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Steeg, Sarah; Cooper, Jayne; Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England; [Kapur, Nav] Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England; [Davies, Neil M.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Gunnell, David] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Bristol, Avon, England	University of Bristol; University of Manchester; Open University - UK; University of Bristol; University of Bristol	Metcalfe, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Chris.Metcalfe@Bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234; Metcalfe, Chris/0000-0001-8318-8907; Davies, Neil/0000-0002-2460-0508; Steeg, Sarah/0000-0002-7935-1414	Department of Health (England) as part of the Multi-Centre Study of Self-harm; Manchester Mental Health and Social Care Trust; NIHR; Medical Research Council; University of Bristol [MC_UU_12013/9]; Economics and Social Research Council (ESRC) [ES/N000757/1]; MRC [MC_UU_12013/9, MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, MC_UU_12013/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068, DRF-2012-05-189] Funding Source: researchfish	Department of Health (England) as part of the Multi-Centre Study of Self-harm; Manchester Mental Health and Social Care Trust; NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Economics and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The MASH Project is funded by the Department of Health (England) as part of the Multi-Centre Study of Self-harm. NK is supported by Manchester Mental Health and Social Care Trust. RC was funded by a NIHR doctoral research fellowship. DG's time is supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West). The Integrative Epidemiology Unit is supported by the Medical Research Council and the University of Bristol [MC_UU_12013/9]. NMD is supported by the Economics and Social Research Council (ESRC) via a Future Research Leaders Fellowship (ES/N000757/1). The funders had no role in study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the paper for publication. The views and opinions expressed within this paper are those of the authors and do not necessarily reflect those of the NIHR, MRC, ESRC or the Department of Health.	Baum CF, 2003, STATA J, V3, P1, DOI 10.1177/1536867X0300300101; Bennewith O, 2005, J AFFECT DISORDERS, V89, P91, DOI 10.1016/j.jad.2005.08.011; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bickley H, 2013, MANCHEST SELF HARM P; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Clarke PS, 2012, J AM STAT ASSOC, V107, P1638, DOI 10.1080/01621459.2012.734171; Clarke PS, 2010, BIOSTATISTICS, V11, P756, DOI 10.1093/biostatistics/kxq024; Cooper J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003444; Davies NM, 2013, J CLIN EPIDEMIOL, V66, P1386, DOI 10.1016/j.jclinepi.2013.06.008; Greenland S, 2000, INT J EPIDEMIOL, V29, P1102, DOI 10.1093/oxfordjournals.ije.a019909; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062; Ho V, 2000, HEALTH SERV RES, V34, P1499; Kapur N, 2005, BMJ-BRIT MED J, V330, P394, DOI 10.1136/bmj.38337.584225.82; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kapur N, 2008, J AFFECT DISORDERS, V106, P285, DOI 10.1016/j.jad.2007.07.010; Larkin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084282; National Institute for Clinical Excellence, 2004, SELF HARM SHORT TERM; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; O'Donnell HC, 2014, ACAD PEDIATR, V14, P84, DOI 10.1016/j.acap.2013.09.010; Royal College of Psychiatrists, 2004, ASS FOLL SELF HARM A; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	26	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149713	10.1371/journal.pone.0149713	http://dx.doi.org/10.1371/journal.pone.0149713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918579	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400039
J	Manoukis, NC				Manoukis, Nicholas C.			To Catch a Fly: Landing and Capture of Ceratitis capitata in a Jackson Trap with and without an Insecticide	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; EFFECTIVE ATTRACTION RADIUS; BACTROCERA-DORSALIS; DIPTERA TEPHRITIDAE; METHYL EUGENOL; PLASTIC MATRIX; MALE LURES; TRIMEDLURE; ERADICATION; POPULATIONS	Attractant-based traps are a cornerstone of detection, delimitation and eradication programs for pests such as tephritid fruit flies. The ideal trap and lure combination has high attraction (it brings insects to the trap from a distance) and high capture efficiency (it has a high probability of capturing the insect once it arrives at the trap). We examined the effect of an insecticide (DDVP) in combination with a pheromone lure (trimedlure) on capture of Ceratitis capitata using 1) digital images of surfaces of a Jackson trap analyzed via computer vision, and 2) counts of the number of flies caught in the trap and in the area under the trap. Our results indicate no significant difference in trap capture without or with insecticide (means +/- SD = 324 +/- 135 and 356 +/- 108, respectively). However, significantly more dead flies were found around the trap with insecticide (92 +/- 53 with insecticide compared with 35 +/- 22 without), suggesting a possible decrease in trap efficiency due to mortality before insects enter the trap. Indeed, the average number of flies detected on all surfaces of the traps with insecticide was lower than that for lure-only (4.15 +/- 0.39 vs 8.30 +/- 1.18), and both were higher than control (no lure: 0.76 +/- 0.08). We found that the majority of fly sightings, 71% of the total, occurred on the inside panels of the lure-only traps, suggesting that increased efficiency of the Jackson trap may be obtained by adding a contact insecticide to those surfaces.	[Manoukis, Nicholas C.] USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA	United States Department of Agriculture (USDA)	Manoukis, NC (corresponding author), USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA.	nicholas.manoukis@ars.usda.gov	Manoukis, Nicholas C./V-9063-2019	Manoukis, Nicholas C./0000-0001-5062-7256	USDA-ARS; intramural research arm of USDA	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); intramural research arm of USDA	This study was funded by USDA-ARS, the intramural research arm of USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Apple J. L., 1976, INTEGRATED PEST MANA, DOI 10.1007/978-1-4615-7269-5; BAKKE A, 1985, Z ANGEW ENTOMOL, V99, P33; BYERS JA, 1989, J CHEM ECOL, V15, P749, DOI 10.1007/BF01014716; Cam N, 1990, 9010 EH CA DEP FOOD; CHENIER JVR, 1989, CAN ENTOMOL, V121, P159, DOI 10.4039/Ent121159-2; Cunningham RT, 1981, MANAGEMENT INSECT PE, P95; Denning J, 1944, MO DEP AG B, V42; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; Gilbert A., 2013, INSECT TRAPPING GUID; HENDRICHS J, 1989, INSECT SCI APPL, V10, P285, DOI 10.1017/S1742758400003519; Hiramoto Matthew K., 2006, Proceedings of the Hawaiian Entomological Society, V38, P103; Jang EB, 2011, J APPL ENTOMOL, V135, P456, DOI 10.1111/j.1439-0418.2010.01557.x; Jang EB, 2013, J ECON ENTOMOL, V106, P727, DOI 10.1603/EC12371; KATSOYANNOS BI, 1994, J APPL ENTOMOL, V118, P442, DOI 10.1111/j.1439-0418.1994.tb00823.x; Manoukis NC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07015; Manoukis NC, 2013, ANN ENTOMOL SOC AM, V106, P136, DOI 10.1603/AN12095; MCGOVERN TP, 1987, J ECON ENTOMOL, V80, P617, DOI 10.1093/jee/80.3.617; McPheron BA, 1996, FRUIT FLY PESTS WORL; Muirhead-Thompson R.C., 1991, TRAP RESPONSES FLYIN; NAKAGAWA S, 1970, J ECON ENTOMOL, V63, P227, DOI 10.1093/jee/63.1.227; NAKAGAWA S, 1975, J ECON ENTOMOL, V68, P405, DOI 10.1093/jee/68.3.405; National Oceanic and Atmospheric Administration (NOAA), 2011, NOAAS 1981 2010 CLIM; Ros JP, 2007, DEV IMPR ATTR THEIR, P27; SCHLYTER F, 1992, J APPL ENTOMOL, V114, P439, DOI 10.1111/j.1439-0418.1992.tb01150.x; Severin HHP, 1913, J ECON ENTOMOL, V6, P347, DOI 10.1093/jee/6.4.347; Shelly T., 2014, TRAPPING DETECTION C; SHELLY TE, 1993, ANN ENTOMOL SOC AM, V86, P341, DOI 10.1093/aesa/86.3.341; Shelly Todd E., 2013, Proceedings of the Hawaiian Entomological Society, V45, P119; STEINER LF, 1961, J ECON ENTOMOL, V54, P30, DOI 10.1093/jee/54.1.30; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; vanRossum G., 1995, PYTHON TUTORIAL; Vargas RI, 2015, J ECON ENTOMOL, V108, P1612, DOI 10.1093/jee/tov137; Vargas RI, 2009, J ECON ENTOMOL, V102, P552, DOI 10.1603/029.102.0212; WALL C, 1987, ENTOMOL EXP APPL, V44, P5, DOI 10.1007/BF00361302; WIJESURYA SR, 1995, J AUST ENTOMOL SOC, V34, P273	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149869	10.1371/journal.pone.0149869	http://dx.doi.org/10.1371/journal.pone.0149869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918513	Green Submitted, gold, Green Published			2022-12-26	WOS:000371274400051
J	Saleem, Z; Saeed, H; Ahmad, M; Yousaf, M; Hassan, HB; Javed, A; Anees, N; Maharjan, S				Saleem, Zikria; Saeed, Hamid; Ahmad, Mobasher; Yousaf, Mahrukh; Hassan, Hafsa Binte; Javed, Ayesha; Anees, Nida; Maharjan, Sonu			Antibiotic Self-Prescribing Trends, Experiences and Attitudes in Upper Respiratory Tract Infection among Pharmacy and Non-Pharmacy Students: A Study from Lahore	PLOS ONE			English	Article							NONMEDICAL UNIVERSITY-STUDENTS; MEDICAL-STUDENTS; PHYSICIANS; COUNTRIES; KARACHI; CARE	Pharmacists are the custodians of drugs; hence their education, training, behaviors and experiences would affect the future use of drugs at community and hospital pharmacies. Therefore, we aimed at evaluating the self-prescribing antibiotic trends, knowledge and attitudes among pharmacy and non-pharmacy students. We found that pharmacy students had higher risks of experiencing URIs related symptoms such as cough (RR; 1.7, p = 0.002), allergy (RR; 2.07, p = 0.03) and running nose (RR; 3.17, p<0.005), compared to non-pharmacy students-resulting in higher probabilities of selecting cough syrups (OR; 2.3, p<0.005), anti-histamines (OR; 1.8, p = 0.036) and anti-inflammatory/anti-pyretic (OR; 2.4, p<0.005) drugs. Likewise, bachelor's degree pupils (OR; 2, p = 0.045), urban area residents (OR; 2.44; p = 0.002) and pharmacy students (OR; 2.9, p<0.005) exhibited higher propensities of antibiotic self-use-notable classes include, b-lactams (45.9%) followed by macrolides (26.5%) and augmentin (28.94%), respectively. Surprisingly, pharmacy and non-pharmacy students had higher odds of using antibiotics in common cold (OR; 3.2, p<0.005) and pain (OR; 2.37, p = 0.015), respectively. Unlike non-pharmacy students, pharmacy students were likely to select alternative therapy, such as Joshanda (OR; 2.22, p = 0.011) and were well acquainted with antibiotic hazards, with 77% reduction in risk of antibiotics re-use. In conclusion, university students exhibited antibiotic self-prescribing trends in conditions that does not warrant their use, thus are irrational users. The pharmacy education confers very little benefit to rational self-prescribing practices among students, while non-pharmacy students are more vulnerable to repeated antibiotic usage. Thus, the educational and training modules should be designed for university students to disseminate targeted information regarding the potential hazards of antibiotic self-use and importance of consultation with qualified and registered medical doctor/pharmacist before starting with antibiotics.	[Saleem, Zikria; Saeed, Hamid; Ahmad, Mobasher; Yousaf, Mahrukh; Hassan, Hafsa Binte; Javed, Ayesha; Anees, Nida; Maharjan, Sonu] Univ Punjab, Clin Pharm Sect, Univ Coll Pharm, AllamaIqbal Campus, Lahore 54000, Pakistan	University of Punjab	Saeed, H (corresponding author), Univ Punjab, Clin Pharm Sect, Univ Coll Pharm, AllamaIqbal Campus, Lahore 54000, Pakistan.	hamid.pharmacy@pu.edu.pk	Saleem, Zikria/AAB-5786-2022	Saleem, Zikria/0000-0003-3202-6347				Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Aljinovic-Vucic V, 2005, CROAT MED J, V46, P74; Appelbaum P, 1977, LANCET, V310, P995; Ashraf S, 2010, J PAK MED ASSOC, V60, P1015; Balbisi EA, 2005, AM J HEALTH-SYST PH, V62, P2508, DOI 10.2146/ajhp050007; Barden LS, 1998, CLIN PEDIATR, V37, P665, DOI 10.1177/000992289803701104; Benson V, 1994, VITAL HLTH STAT, V189, P1; Burak LJ, 2000, J AM COLL HEALTH, V49, P118, DOI 10.1080/07448480009596293; Choudhry AJ, 1997, MOTHER CHILD, V35, P84; Dabney D A, 2001, J Am Pharm Assoc (Wash), V41, P392; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Grimsmo A, 2001, SCAND J PRIM HEALTH, V19, P76; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; James H, 2008, INT J CLIN PHARM TH, V46, P23; Jaruseviciene L, 2013, UPSALA J MED SCI, V118, P98, DOI 10.3109/03009734.2013.778925; Kafle K, 1993, SELF MEDICATION ITS; Mainous AG, 1998, ARCH FAM MED, V7, P45, DOI 10.1001/archfami.7.1.45; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Mumtaz Y, 2011, J LIAQUAT UNIV MED H, V10, P102; Nalini G. K., 2010, British Journal of Medical Practitioners, V3, P325; Napolitano F, 2013, PUBLIC KNOWLEDGE ATT; Pandya RN, 2013, INT J BASIC CLINPHAR, V2, P275; Sawalha AF, 2008, RES SOC ADMIN PHARM, V4, P164, DOI 10.1016/j.sapharm.2007.04.004; Shah SJ, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-74; Sharif SI, 2012, AM J PHARMACOLTOXICO, V7, P135, DOI DOI 10.3844/AJPTSP.2012.135.140; Tomasi Elaine, 2007, Rev. bras. epidemiol., V10, P66; TOMSON G, 1986, LANCET, V2, P620; Van der Linden MW, 2004, 2 NATL STUDY DIS ACT; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Yamada K, 2015, PHARMACOTHERAPY, V5, P4; Zafar Syed Nabeel, 2008, J Pak Med Assoc, V58, P214; Zafar SN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-162	34	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149929	10.1371/journal.pone.0149929	http://dx.doi.org/10.1371/journal.pone.0149929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919465	Green Published, gold			2022-12-26	WOS:000371274400058
J	Chiang, ER; Ma, HL; Wang, JP; Liu, CL; Chen, TH; Hung, SC				Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh			Allogeneic Mesenchymal Stem Cells in Combination with Hyaluronic Acid for the Treatment of Osteoarthritis in Rabbits	PLOS ONE			English	Article							SYNOVIAL-CELLS; KNEE; MODEL; CARTILAGE; TRANSPLANTATION; MEDICINE; THERAPY; CULTURE	Mesenchymal stem cell (MSC)-based therapies may aid in the repair of articular cartilage defects. The purpose of this study was to investigate the effects of intraarticular injection of allogeneic MSCs in an in vivo anterior cruciate ligament transection (ACLT) model of osteoarthritis in rabbits. Allogeneic bone marrow-derived MSCs were isolated and cultured under hypoxia (1% O-2). After 8 weeks following ACLT, MSCs suspended in hyaluronic acid (HA) were injected into the knees, and the contralateral knees were injected with HA alone. Additional controls consisted of a sham operation group as well as an untreated osteoarthritis group. The tissues were analyzed by macroscopic examination as well as histologic and immunohistochemical methods at 6 and 12 weeks post-transplantation. At 6 and 12 weeks, the joint surface showed less cartilage loss and surface abrasion after MSC injection as compared to the tissues receiving HA injection alone. Significantly better histological scores and cartilage content were observed with the MSC transplantation. Furthermore, engraftment of allogenic MSCs were evident in surface cartilage. Thus, injection of the allogeneic MSCs reduced the progression of osteoarthritis in vivo.	[Chiang, En-Rung; Wang, Jung-Pan; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; [Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Orthopaed & Traumatol, Taipei 112, Taiwan; [Hung, Shih-Chieh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Hung, Shih-Chieh] China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung 404, Taiwan; [Hung, Shih-Chieh] China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan; [Hung, Shih-Chieh] China Med Univ, Inst Clin Med, Taichung 404, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.; Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.; Hung, SC (corresponding author), Taipei Vet Gen Hosp, Orthopaed & Traumatol, Taipei 112, Taiwan.; Hung, SC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Hung, SC (corresponding author), China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung 404, Taiwan.; Hung, SC (corresponding author), China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan.; Hung, SC (corresponding author), China Med Univ, Inst Clin Med, Taichung 404, Taiwan.	hung3340@gmail.com			Taipei Veterans General Hospital [102DHA0100340]; National Science Council [NSC 101-2314-B-075-002]; National Yang-Ming University, Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University, Ministry of Education	This study was supported in part by grants from Taipei Veterans General Hospital (102DHA0100340), National Science Council (NSC 101-2314-B-075-002) and National Yang-Ming University, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; ARMSTRONG S, 1994, J RHEUMATOL, V21, P680; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Deng MW, 2014, CELL TRANSPLANT; Edouard P, 2013, PHYS THER SPORT, V14, P116, DOI 10.1016/j.ptsp.2013.02.001; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Gallagher B, 2014, AM J SPORTS MED; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Maniwa S, 2001, ACTA ORTHOP SCAND, V72, P299, DOI 10.1080/00016470152846664; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054; Shieh DB, 2005, BIOMATERIALS, V26, P7183, DOI 10.1016/j.biomaterials.2005.05.020; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stebulis JA, 2005, J RHEUMATOL, V32, P301; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Toghraie FS, 2011, KNEE, V18, P71, DOI 10.1016/j.knee.2010.03.001; Wei CC, 2014, CELL TRANSPLANT, V23, P505, DOI 10.3727/096368914X678328; Williams JM, 1997, OSTEOARTHR CARTILAGE, V5, P235, DOI 10.1016/S1063-4584(97)80019-2; Yoshioka M, 1997, OSTEOARTHR CARTILAGE, V5, P251, DOI 10.1016/S1063-4584(97)80021-0; Yoshioka M, 1996, OSTEOARTHR CARTILAGE, V4, P87, DOI 10.1016/S1063-4584(05)80318-8	29	69	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149835	10.1371/journal.pone.0149835	http://dx.doi.org/10.1371/journal.pone.0149835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915044	gold, Green Published, Green Submitted			2022-12-26	WOS:000371175700032
J	Haroun, D; El Saleh, O; Wood, L; Mechli, R; Al Marzouqi, N; Anouti, S				Haroun, Dalia; El Saleh, Ola; Wood, Lesley; Mechli, Rola; Al Marzouqi, Nada; Anouti, Samir			Assessing Knowledge of, and Attitudes to, HIV/AIDS among University Students in the United Arab Emirates	PLOS ONE			English	Article							COLLEGE-STUDENTS; TURKISH	Background The Middle East and North Africa (MENA) region is among the top two regions in the world with the fastest growing HIV epidemic. In this context, risks and vulnerability are high as the epidemic is on the rise with evidence indicating significantly increasing HIV prevalence, new HIV infections and AIDS-related deaths. Objective The aim of the survey was to assess HIV/AIDS knowledge and attitudes related to HIV/AIDS among a wide group of university students in the United Arab Emirates (UAE). Methods In a cross-sectional survey, a total sample of 2,294 students (406 male; 1,888 female) from four universities in three different Emirates in the UAE were approached to take part in the study. Students self-completed a questionnaire that was designed to measure their knowledge and attitudes to HIV/AIDS. Results The overall average knowledge score of HIV. AIDS was 61%. Non-Emirati and postgraduates demonstrated higher levels of knowledge compared to Emirati and undergraduate students respectively. No significant differences between males and females; and marital status were found. Eighty-five percent of students expressed negative attitudes towards people living with HIV, with Emirati and single students significantly holding more negative attitudes compared to non-Emiratis and those that are married respectively. Conclusions The findings provide strong evidence that there is a need to advocate for appropriate National HIV/AIDS awareness raising campaigns in universities to reduce the gaps in knowledge and decrease stigmatizing attitudes towards people living with HIV/AIDS.	[Haroun, Dalia; El Saleh, Ola; Wood, Lesley; Anouti, Samir] UNICEF Gulf Area Off, Programs, Dubai, U Arab Emirates; [Haroun, Dalia; Mechli, Rola] Zayed Univ, Nat Sci & Publ Hlth, Dubai, U Arab Emirates; [Al Marzouqi, Nada] Minist Hlth, Prevent Med, Dubai, U Arab Emirates	Zayed University	Haroun, D (corresponding author), UNICEF Gulf Area Off, Programs, Dubai, U Arab Emirates.; Haroun, D (corresponding author), Zayed Univ, Nat Sci & Publ Hlth, Dubai, U Arab Emirates.	Dalia.haroun@zu.ac.ae			UNICEF Regional and Gulf Area office	UNICEF Regional and Gulf Area office	The study was funded by UNICEF Regional and Gulf Area office and was carried out in partnership with UAE Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jabri AA, 2003, SAUDI MED J, V24, P273; Badahdah A. M., 2010, Eastern Mediterranean Health Journal, V16, P901; Badahdah AM, 2010, J TRANSCULT NURS, V21, P386, DOI 10.1177/1043659609360873; Barss P, 2009, JAIDS-J ACQ IMM DEF, V52, P86, DOI 10.1097/QAI.0b013e31819c153f; Bektas HA, 2007, AIDS CARE, V19, P888, DOI 10.1080/09540120701203352; Bhatta D N, 2013, Kathmandu Univ Med J (KUMJ), V11, P158; Ellepola ANB, 2011, EUR J DENT EDUC, V15, P165, DOI 10.1111/j.1600-0579.2010.00652.x; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Ibrahim N, 2012, PREV MED, V55, P505, DOI 10.1016/j.ypmed.2012.09.003; Kocken P, 2001, EUR J PUBLIC HEALTH, V11, P153, DOI 10.1093/eurpub/11.2.153; Premadasa G, 2015, J INVESTIG CLIN DENT, V6, P147, DOI 10.1111/jicd.12080; Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17; Thato R, 2013, J PEDIATR ADOL GYNEC, V26, P58, DOI 10.1016/j.jpag.2012.09.011; Turhan O, 2010, INT J OCCUP MED ENV, V23, P153, DOI 10.2478/v10001-010-0008-5; UNAIDS, 2014, 2014 FACT SHEETS; UNICEF, 2011, MULT IND CLUST COUNT; UNICEF, 2014, 2014 STAT UPD CHILDR	17	42	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149920	10.1371/journal.pone.0149920	http://dx.doi.org/10.1371/journal.pone.0149920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26913902	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700036
J	Kavet, R; Wyman, MT; Klimley, AP				Kavet, Robert; Wyman, Megan T.; Klimley, A. Peter			Modeling Magnetic Fields from a DC Power Cable Buried Beneath San Francisco Bay Based on Empirical Measurements	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; GREEN STURGEON; MOVEMENTS; ORIENTATION; SMOLTS	The Trans Bay Cable (TBC) is a +/- 200-kilovolt (kV), 400 MW 85-km long High Voltage Direct Current (DC) buried transmission line linking Pittsburg, CA with San Francisco, CA (SF) beneath the San Francisco Estuary. The TBC runs parallel to the migratory route of various marine species, including green sturgeon, Chinook salmon, and steelhead trout. In July and August 2014, an extensive series of magnetic field measurements were taken using a pair of submerged Geometrics magnetometers towed behind a survey vessel in four locations in the San Francisco estuary along profiles that cross the cable's path; these included the San Francisco-Oakland Bay Bridge (BB), the Richmond-San Rafael Bridge (RSR), the Benicia-Martinez Bridge (Ben) and an area in San Pablo Bay (SP) in which a bridge is not present. In this paper, we apply basic formulas that ideally describe the magnetic field from a DC cable summed vectorially with the background geomagnetic field (in the absence of other sources that would perturb the ambient field) to derive characteristics of the cable that are otherwise not immediately observable. Magnetic field profiles from measurements taken along 170 survey lines were inspected visually for evidence of a distinct pattern representing the presence of the cable. Many profiles were dominated by field distortions unrelated to the cable caused by bridge structures or other submerged objects, and the cable's contribution to the field was not detectable. BB, with 40 of the survey lines, did not yield usable data for these reasons. The unrelated anomalies could be up to 100 times greater than those from the cable. In total, discernible magnetic field profiles measured from 76 survey lines were regressed against the equations, representing eight days of measurement. The modeled field anomalies due to the cable (the difference between the maximum and minimum field along the survey line at the cable crossing) were virtually identical to the measured values. The modeling yielded a pooled cable depth below the bay floor of 2.06 m (+/- 1.46 std dev), and estimated the angle to the horizontal of the imaginary line connecting the cross-sectional center of the cable's two conductors (0.1143 m apart) as 178.9 degrees +/- 61.9 degrees (std dev) for Ben, 78.6 degrees +/- 37.0 degrees (std dev) for RSR, and 139.9 degrees +/- 27.4 degrees (std dev) for SP. The mean of the eight daily average currents derived from the regressions was 986 +/- 185 amperes (A) (std dev), as compared to 722 +/- 95 A (std dev) provided by Trans Bay Cable LLC. Overall, the regressions based on fundamental principles (Biot Savart law) and the vectorial summation of cable and geomagnetic fields provide estimates of cable characteristics consistent with plausible expectations.	[Kavet, Robert] Elect Power Res Inst, Environm Sector, Palo Alto, CA USA; [Wyman, Megan T.; Klimley, A. Peter] Univ Calif Davis, Biotelemetry Lab, Dept Fish Wildlife & Conservat Biol, Davis, CA 95616 USA	Electric Power Research Institute (EPRI); University of California System; University of California Davis	Kavet, R (corresponding author), Elect Power Res Inst, Environm Sector, Palo Alto, CA USA.	rkavet@epri.com			United States Department of Energy [DE-EE0006382]; Electric Power Research Institute; DOE, EPRI Project [1-105902]; U.S. Department of Energy [DE-EE0006382]; Electric Power Research Institute [1-105902]	United States Department of Energy(United States Department of Energy (DOE)); Electric Power Research Institute; DOE, EPRI Project; U.S. Department of Energy(United States Department of Energy (DOE)); Electric Power Research Institute	MTW, PK: United States Department of Energy DE-EE0006382; http://www.energy.gov/. RK: Electric Power Research Institute, costshare agreement with DOE, EPRI Project 1-105902 www.epri.com.; We would like to kindly thank Trans Bay Cable LLC for providing cable load data for our study. We also thank the boat operators and crew who helped conduct the magnetometer survey (Ryan Battleson, Tommy Agosta, Eric Chapman, Matt Pagel, Mike Thomas, Gabe Singer, and Jamilynn Poletto) and the staff at Geometrics for their training and support (especially Mikhail Tchernychev, Ross Johnson, Randl Rivera, and Naiema Jackson). This work was supported under award DE-EE0006382 from the U.S. Department of Energy with a cost share agreement with the Electric Power Research Institute (Project 1-105902).	[Anonymous], J ICHTHYOLOGY; Cada GF, 2012, ORNLTM2012119; Chapman ED, 2013, ENVIRON BIOL FISH, V96, P273, DOI 10.1007/s10641-012-0001-x; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Haugh CV, 1998, J NAVIGATION, V51, P35, DOI 10.1017/S0373463397007595; Hearn AR, 2014, ENVIRON BIOL FISH, V97, P851, DOI 10.1007/s10641-013-0184-9; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Michel CJ, 2013, ENVIRON BIOL FISH, V96, P257, DOI 10.1007/s10641-012-9990-8; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1983, CAN J FISH AQUAT SCI, V40, P1598, DOI 10.1139/f83-185; Singer GP, 2013, ENVIRON BIOL FISH, V96, P363, DOI 10.1007/s10641-012-0037-y; TAYLOR PB, 1986, J FISH BIOL, V28, P607, DOI 10.1111/j.1095-8649.1986.tb05196.x; TEETER JH, 1980, J COMP PHYSIOL, V138, P213, DOI 10.1007/BF00657039; Teo SLH, 2013, ENVIRON BIOL FISH, V96, P175, DOI 10.1007/s10641-011-9938-4; Thomas MJ, 2013, N AM J FISH MANAGE, V33, P287, DOI 10.1080/02755947.2012.758201	15	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148543	10.1371/journal.pone.0148543	http://dx.doi.org/10.1371/journal.pone.0148543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915084	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700007
J	Mueller, S; Carlsohn, A; Mueller, J; Baur, H; Mayer, F				Mueller, Steffen; Carlsohn, Anja; Mueller, Juliane; Baur, Heiner; Mayer, Frank			Influence of Obesity on Foot Loading Characteristics in Gait for Children Aged 1 to 12 Years	PLOS ONE			English	Article							PLANTAR PRESSURE DISTRIBUTION; BODY-MASS INDEX; CHILDHOOD OBESITY; SPEED; OVERWEIGHT; WALKING; FORCES; ADOLESCENTS; PREVALENCE; FOOTPRINTS	Background Overweight and obesity are increasing health problems that are not restricted to adults only. Childhood obesity is associated with metabolic, psychological and musculoskeletal comorbidities. However, knowledge about the effect of obesity on the foot function across maturation is lacking. Decreased foot function with disproportional loading characteristics is expected for obese children. The aim of this study was to examine foot loading characteristics during gait of normal-weight, overweight and obese children aged 1-12 years. Methods A total of 10382 children aged one to twelve years were enrolled in the study. Finally, 7575 children (m/f: n = 3630/3945; 7.0 +/- 2.9yr; 1.23 +/- 0.19m; 26.6 +/- 10.6kg; BMI: 17.1 +/- 2.4kg/m(2)) were included for (complete case) data analysis. Children were categorized to normalweight (>= 3rd and <90th percentile; n = 6458), overweight (>= 90rd and <97th percentile; n = 746) or obese (>97th percentile; n = 371) according to the German reference system that is based on age and gender-specific body mass indices (BMI). Plantar pressure measurements were assessed during gait on an instrumented walkway. Contact area, arch index (AI), peak pressure (PP) and force time integral (FTI) were calculated for the total, fore-, mid-and hindfoot. Data was analyzed descriptively (mean +/- SD) followed by ANOVA/Welch-test (according to homogeneity of variances: yes/no) for group differences according to BMI categorization (normal-weight, overweight, obesity) and for each age group 1 to 12yrs (post-hoc Tukey Kramer/Dunnett's C; alpha = 0.05). Results Mean walking velocity was 0.95 +/- 0.25 m/s with no differences between normal-weight, overweight or obese children (p = 0.0841). Results show higher foot contact area, arch index, peak pressure and force time integral in overweight and obese children (p< 0.001). Obese children showed the 1.48-fold (1 year-old) to 3.49-fold (10 year-old) midfoot loading (FTI) compared to normal-weight. Conclusion Additional body mass leads to higher overall load, with disproportional impact on the midfoot area and longitudinal foot arch showing characteristic foot loading patterns. Already the feet of one and two year old children are significantly affected. Childhood overweight and obesity is not compensated by the musculoskeletal system. To avoid excessive foot loading with potential risk of discomfort or pain in childhood, prevention strategies should be developed and validated for children with a high body mass index and functional changes in the midfoot area. The presented plantar pressure values could additionally serve as reference data to identify suspicious foot loading patterns in children.	[Mueller, Steffen; Mueller, Juliane; Mayer, Frank] Univ Potsdam, Univ Outpatient Clin, Sports Med & Sports Orthopaed, Potsdam, Germany; [Carlsohn, Anja] Univ Educ Schwabisch Gmund, Inst Hlth Sci, Schwabisch Gmund, Germany; [Baur, Heiner] Bern Univ Appl Sci, Hlth, Physiotherapy, Bern, Switzerland	University of Potsdam	Mueller, S (corresponding author), Univ Potsdam, Univ Outpatient Clin, Sports Med & Sports Orthopaed, Potsdam, Germany.	stefmue@uni-potsdam.de	Baur, Heiner/A-8673-2017; Müller, Juliane/P-2457-2019; Baur, Heiner/M-9995-2019	Baur, Heiner/0000-0002-4780-225X; Müller, Juliane/0000-0002-4184-5427; 	Federation of the German Footwear Industry (HDS, Offenbach, Germany); RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany); University of Potsdam (Potsdam, Germany); Deutsche Forschungsgemeinschaft; University of Potsdam	Federation of the German Footwear Industry (HDS, Offenbach, Germany); RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany); University of Potsdam (Potsdam, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Potsdam	This study was supported by the Federation of the German Footwear Industry (HDS, Offenbach, Germany; URL: www.hdsl.eu/Home-en), the RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany; URL: www.ricosta.de/en.html) and the University of Potsdam (Potsdam, Germany; URL: www.uni-potsdam.de/en/index.html). The funding was received by Prof. Frank Mayer as the head of the University Outpatient Clinic Potsdam. We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; CAVANAGH PR, 1987, FOOT ANKLE, V7, P262, DOI 10.1177/107110078700700502; Cousins SD, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-36; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dowling AM, 2004, INT J OBESITY, V28, P1514, DOI 10.1038/sj.ijo.0802729; DUFEK JS, 1990, MED SCI SPORT EXER, V22, P370; Echarri JJ, 2003, J PEDIATR ORTHOP B, V12, P141, DOI 10.1097/00009957-200303000-00012; Filippin NT, 2007, REV BRAS FISIOTER, V11, P495, DOI 10.1590/S1413-35552007000600012; Filippin NT, 2008, FOOT ANKLE INT, V29, P1141, DOI 10.3113/FAI.2008.1141; Frey C, 2007, FOOT ANKLE INT, V28, P996, DOI 10.3113/FAI.2007.0996; Glasser N, 2011, EUR J CLIN NUTR, V65, P151, DOI 10.1038/ejcn.2010.245; Gross KD, 2011, ARTHRIT CARE RES, V63, P937, DOI 10.1002/acr.20431; Gurney JK, 2008, GAIT POSTURE, V27, P706, DOI 10.1016/j.gaitpost.2007.07.002; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; HRELJAC A, 1995, J BIOMECH, V28, P669, DOI 10.1016/0021-9290(94)00120-S; Jacob HAC, 2001, CLIN BIOMECH, V16, P783, DOI 10.1016/S0268-0033(01)00070-5; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Li L, 1999, HUM MOVEMENT SCI, V18, P67, DOI 10.1016/S0167-9457(98)00034-7; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Michelson JD, 2002, FOOT ANKLE INT, V23, P629, DOI 10.1177/107110070202300708; Mickle KJ, 2006, INT J PEDIATR OBES, V1, P183, DOI 10.1080/17477160600881734; Mickle KJ, 2015, GAIT POSTURE, V42, P442, DOI 10.1016/j.gaitpost.2015.07.013; Muller J, 2013, GAIT POSTURE, V38, P631, DOI 10.1016/j.gaitpost.2013.02.011; Muller S, 2012, GAIT POSTURE, V35, P389, DOI 10.1016/j.gaitpost.2011.10.357; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Phethean J, 2012, GAIT POSTURE, V36, P287, DOI 10.1016/j.gaitpost.2012.03.012; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Riddiford-Harland DL, 2015, MED SCI SPORT EXER, V47, P357, DOI 10.1249/MSS.0000000000000403; Riddiford-Harland DL, 2000, INT J OBESITY, V24, P541, DOI 10.1038/sj.ijo.0801192; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; Villarroya MA, 2009, EUR J PEDIATR, V168, P559, DOI 10.1007/s00431-008-0789-8; Wearing SC, 2006, OBES REV, V7, P209, DOI 10.1111/j.1467-789X.2006.00216.x; Yan SH, 2013, GAIT POSTURE, V37, P37, DOI 10.1016/j.gaitpost.2012.05.018	37	27	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149924	10.1371/journal.pone.0149924	http://dx.doi.org/10.1371/journal.pone.0149924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914211	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700038
J	Hofstetter, AR; De La Cruz, JA; Cao, WP; Patel, J; Belser, JA; McCoy, J; Liepkalns, JS; Amoah, S; Cheng, GJ; Ranjan, P; Diebold, BA; Shieh, WJ; Zaki, S; Katz, JM; Sambhara, S; Lambeth, JD; Gangappa, S				Hofstetter, Amelia R.; De La Cruz, Juan A.; Cao, Weiping; Patel, Jenish; Belser, Jessica A.; McCoy, James; Liepkalns, Justine S.; Amoah, Samuel; Cheng, Guangjie; Ranjan, Priya; Diebold, Becky A.; Shieh, Wun-Ju; Zaki, Sherif; Katz, Jacqueline M.; Sambhara, Suryaprakash; Lambeth, J. David; Gangappa, Shivaprakash			NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice	PLOS ONE			English	Article							DENDRITIC CELLS; REACTIVE OXYGEN; ANTIBODY-RESPONSE; NOX ENZYMES; PATHOGENESIS; MEMORY; LUNG; DIFFERENTIATION; EXPRESSION; EFFECTOR	The role of the reactive oxygen species-producing NADPH oxidase family of enzymes in the pathology of influenza A virus infection remains enigmatic. Previous reports implicated NADPH oxidase 2 in influenza A virus-induced inflammation. In contrast, NADPH oxidase 1 (Nox1) was reported to decrease inflammation in mice within 7 days post-influenza A virus infection. However, the effect of NADPH oxidase 1 on lethality and adaptive immunity after influenza A virus challenge has not been explored. Here we report improved survival and decreased morbidity in mice with catalytically inactive NADPH oxidase 1 (Nox1(*/Y)) compared with controls after challenge with A/PR/8/34 influenza A virus. While changes in lung inflammation were not obvious between Nox1(*/Y) and control mice, we observed alterations in the T cell response to influenza A virus by day 15 post-infection, including increased interleukin-7 receptor-expressing virus-specific CD8(+) T cells in lungs and draining lymph nodes of Nox1(*/Y), and increased cytokine-producing T cells in lungs and spleen. Furthermore, a greater percentage of conventional and interstitial dendritic cells from Nox1(*/Y) draining lymph nodes expressed the co-stimulatory ligand CD40 within 6 days post-infection. Results indicate that NADPH oxidase 1 modulates the innate and adaptive cellular immune response to influenza virus infection, while also playing a role in host survival. Results suggest that NADPH oxidase 1 inhibitors may be beneficial as adjunct therapeutics during acute influenza infection.	[Hofstetter, Amelia R.; De La Cruz, Juan A.; Cao, Weiping; Patel, Jenish; Belser, Jessica A.; Liepkalns, Justine S.; Amoah, Samuel; Ranjan, Priya; Katz, Jacqueline M.; Sambhara, Suryaprakash; Gangappa, Shivaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Hofstetter, Amelia R.; McCoy, James; Cheng, Guangjie; Diebold, Becky A.; Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Shieh, Wun-Ju; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Cheng, Guangjie] UAB Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA	Centers for Disease Control & Prevention - USA; Emory University; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Gangappa, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.; Lambeth, JD (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	noxdoc@mac.com; sgangappa@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021; Hofstetter, Amelia Ruth/AAM-4896-2020	Hofstetter, Amelia Ruth/0000-0003-4113-5473; Cao, Weiping/0000-0002-5794-9685	National Institutes of Health [AI102197-01, T32 DK00771]; Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102197, R33AI102197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health Grants AI102197-01 (JDL) (http://report.nih.gov/quicklinks.aspx), T32 DK00771 (http://report.nih.gov/quicklinks.aspx), and Centers for Disease Control and Prevention intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Balish A.L., 2013, CURR PROTOC MICROBIO, V29, p15G.1.1, DOI [10.1002/9780471729259.mc15g01s29, DOI 10.1002/9780471729259.MC15G01S29]; Ballesteros-Tato A, 2013, J EXP MED, V210, P1591, DOI 10.1084/jem.20130097; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BENDER BS, 1991, IMMUNOLOGY, V72, P514; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boyden AW, 2014, IMMUNOL RES, V59, P73, DOI 10.1007/s12026-014-8541-0; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Carnesecchi S, 2012, CELL MOL LIFE SCI, V69, P2373, DOI 10.1007/s00018-012-1013-6; Ciancio BC, 2014, SURVEILLANCE FOR SEA, P41; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]; Davis AM, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-167; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; Hamilton SE, 2007, IMMUNITY, V27, P180, DOI 10.1016/j.immuni.2007.08.003; Han SN, 2000, J INFECT DIS, V182, pS74, DOI 10.1086/315915; Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P63, DOI 10.1111/irv.12045; Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jones B, 2012, B WORLD HEALTH ORGAN, V90, P252, DOI 10.2471/BLT.12.030412; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mosmann T R, 1997, Semin Immunol, V9, P87, DOI 10.1006/smim.1997.0065; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Olson MR, 2014, J IMMUNOL, V193, P5420, DOI 10.4049/jimmunol.1303359; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Selemidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060792; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977; Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001; Trocme C, 2015, J PATHOL, V235, P65, DOI 10.1002/path.4423; Vlahos R, 2014, MOL PHARMACOL, V86, P747, DOI 10.1124/mol.114.095216; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang CH, 2014, CRIT CARE MED, V42, P313, DOI 10.1097/CCM.0b013e3182a2727d; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; YAP KL, 1978, SCAND J IMMUNOL, V7, P73, DOI 10.1111/j.1365-3083.1978.tb00428.x; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	68	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149864	10.1371/journal.pone.0149864	http://dx.doi.org/10.1371/journal.pone.0149864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910342	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700051
J	Oikkonen, J; Kuusi, T; Peltonen, P; Raijas, P; Ukkola-Vuoti, L; Karma, K; Onkamo, P; Jarvela, I				Oikkonen, Jaana; Kuusi, Tuire; Peltonen, Petri; Raijas, Pirre; Ukkola-Vuoti, Liisa; Karma, Kai; Onkamo, Paivi; Jarvela, Irma			Creative Activities in Music - A Genome-Wide Linkage Analysis	PLOS ONE			English	Article							LONG-TERM DEPRESSION; BRAIN; AMPA; ASSOCIATION; IDENTIFICATION; PERFORMANCE; GENERATION; APTITUDE; GENE; FMRI	Creative activities in music represent a complex cognitive function of the human brain, whose biological basis is largely unknown. In order to elucidate the biological background of creative activities in music we performed genome-wide linkage and linkage disequilibrium (LD) scans in musically experienced individuals characterised for self-reported composing, arranging and non-music related creativity. The participants consisted of 474 individuals from 79 families, and 103 sporadic individuals. We found promising evidence for linkage at 16p12.1-q12.1 for arranging (LOD 2.75, 120 cases), 4q22.1 for composing (LOD 2.15, 103 cases) and Xp11.23 for non-music related creativity (LOD 2.50, 259 cases). Surprisingly, statistically significant evidence for linkage was found for the opposite phenotype of creative activity in music (neither composing nor arranging; NCNA) at 18q21 (LOD 3.09, 149 cases), which contains cadherin genes like CDH7 and CDH19. The locus at 4q22.1 overlaps the previously identified region of musical aptitude, music perception and performance giving further support for this region as a candidate region for broad range of music-related traits. The other regions at 18q21 and 16p12.1-q12.1 are also adjacent to the previously identified loci with musical aptitude. Pathway analysis of the genes suggestively associated with composing suggested an overrepresentation of the cerebellar long-term depression pathway (LTD), which is a cellular model for synaptic plasticity. The LTD also includes cadherins and AMPA receptors, whose component GSG1L was linked to arranging. These results suggest that molecular pathways linked to memory and learning via LTD affect music-related creative behaviour. Musical creativity is a complex phenotype where a common background with musicality and intelligence has been proposed. Here, we implicate genetic regions affecting music-related creative behaviour, which also include genes with neuropsychiatric associations. We also propose a common genetic background for music-related creative behaviour and musical abilities at chromosome 4.	[Oikkonen, Jaana; Peltonen, Petri; Ukkola-Vuoti, Liisa; Jarvela, Irma] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Kuusi, Tuire; Karma, Kai] Univ Arts Helsinki, Sibelius Acad, Helsinki, Finland; [Raijas, Pirre] Conservatory Joensuu, Joensuu, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ukkola-Vuoti, Liisa] Univ Helsinki, FIMM, Helsinki, Finland	University of Helsinki; University of the Arts Helsinki; University of Helsinki; University of Helsinki	Oikkonen, J (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	jaana.oikkonen@helsinki.fi	Ukkola-Vuoti, Liisa/E-6564-2016; Jarvela, Irma/L-5836-2013	Ukkola-Vuoti, Liisa/0000-0002-0770-361X; Kuusi, Tuire/0000-0003-2757-6328; Jarvela, Irma/0000-0002-1770-6187; Oikkonen, Jaana/0000-0002-1063-2736	Academy of Finland [137713]; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Academy of Finland (137713) and the Finnish Cultural Foundation to IJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abraham A, 2016, BRAIN IMAGING BEHAV, V10, P609, DOI 10.1007/s11682-015-9410-8; Amaducci L, 2002, EUR J NEUROL, V9, P75, DOI 10.1046/j.1468-1331.2002.00351.x; Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Baer J, 2008, J CREATIVE BEHAV, V42, P75, DOI 10.1002/j.2162-6057.2008.tb01289.x; Baer LH, 2015, NEUROIMAGE, V109, P130, DOI 10.1016/j.neuroimage.2014.12.076; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Carson S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00771; Chen N, 2014, J PROTEOME RES, V13, P5695, DOI 10.1021/pr500697b; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; De Backer J, 2014, MUSIC MUSIC THERAPY; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Fenster C, 2012, BRAIN RES BULL, V87, P21, DOI 10.1016/j.brainresbull.2011.10.011; Gertz EM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-47; Gordon E.E., 1979, PRIMARY MEASURES MUS; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Honing H, 2015, PHILOS T R SOC B, V370, P5, DOI 10.1098/rstb.2014.0088; Jerde TA, 2011, NEUROIMAGE, V57, P1572, DOI 10.1016/j.neuroimage.2011.05.061; Kanduri C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09506; Kanduri C, 2015, PEERJ, V3, DOI 10.7717/peerj.830; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Kiehn MT, 2003, J RES MUSIC EDUC, V51, P278, DOI 10.2307/3345655; Koelsch S, 2014, HUM BRAIN MAPP, V35, P3485, DOI 10.1002/hbm.22416; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0130-1; Levitin DJ, 2012, NEURON, V73, P633, DOI 10.1016/j.neuron.2012.01.017; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Liu SY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00834; Madsen P., 2013, USERS GUIDE DMU VERS; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Mayseless N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00502; Mills F, 2014, P NATL ACAD SCI USA, V111, P8631, DOI 10.1073/pnas.1404670111; Mosing MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113874; Murphy M, 2013, CREATIVITY RES J, V25, P147, DOI 10.1080/10400419.2013.752305; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oikkonen J, 2015, MOL PSYCHIATR, V20, P275, DOI 10.1038/mp.2014.8; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Parks TN, 2000, HEARING RES, V147, P77, DOI 10.1016/S0378-5955(00)00122-2; Petsche H, 1997, INT J PSYCHOPHYSIOL, V26, P77, DOI 10.1016/S0167-8760(97)00757-5; Pohjannoro U, 2014, MUSIC SCI, V18, P166, DOI 10.1177/1029864914520848; Power RA, 2013, AM J MED GENET B, V162, P521, DOI 10.1002/ajmg.b.32180; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Salimpoor VN, 2015, TRENDS COGN SCI, V19, P86, DOI 10.1016/j.tics.2014.12.001; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Seashore CE, 1960, SEASHORE MEASURES OF; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Sillivan SE, 2013, BIOL PSYCHIAT, V74, P511, DOI 10.1016/j.biopsych.2013.04.012; St Pourcain B, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-34; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Tolgyesi B, 2014, J NEUROL SCI, V343, P76, DOI 10.1016/j.jns.2014.05.036; Torrance E. P., 1981, THINKING CREATIVELY; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Ukkola-Vuoti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056356; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Vinkhuyzen AAE, 2009, BEHAV GENET, V39, P380, DOI 10.1007/s10519-009-9260-5; Wang C, 1985, MEASURES CREAT UNPUB; Webster P. R., 1983, LOYOL S CREAT NEW OR; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Wiggins GA, 2015, PHILOS T R SOC B, V370, P129, DOI 10.1098/rstb.2014.0099; Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	84	20	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148679	10.1371/journal.pone.0148679	http://dx.doi.org/10.1371/journal.pone.0148679			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF2IA	26909693	gold, Green Published			2022-12-26	WOS:000371164700013
J	Sauguet, L; Fourati, Z; Prange, T; Delarue, M; Colloc'h, N				Sauguet, Ludovic; Fourati, Zeineb; Prange, Thierry; Delarue, Marc; Colloc'h, Nathalie			Structural Basis for Xenon Inhibition in a Cationic Pentameric Ligand-Gated Ion Channel	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; ANESTHETIC-GASES XENON; X-RAY-STRUCTURE; NITROUS-OXIDE; NOBLE-GASES; COMPETITIVE-INHIBITION; HYDROPHOBIC CAVITY; BINDING-SITES; NMDA RECEPTORS; BRAIN-DAMAGE	GLIC receptor is a bacterial pentameric ligand-gated ion channel whose action is inhibited by xenon. Xenon has been used in clinical practice as a potent gaseous anaesthetic for decades, but the molecular mechanism of interactions with its integral membrane receptor targets remains poorly understood. Here we characterize by X-ray crystallography the xenon-binding sites within both the open and "locally-closed" (inactive) conformations of GLIC. Major binding sites of xenon, which differ between the two conformations, were identified in three distinct regions that all belong to the trans-membrane domain of GLIC: 1) in an intra-subunit cavity, 2) at the interface between adjacent subunits, and 3) in the pore. The pore site is unique to the locally-closed form where the binding of xenon effectively seals the channel. A putative mechanism of the inhibition of GLIC by xenon is proposed, which might be extended to other pentameric cationic ligand-gated ion channels.	[Sauguet, Ludovic; Fourati, Zeineb; Delarue, Marc] Inst Pasteur, CNRS, Unite Dynam Struct Macromol, UMR 3528, Paris, France; [Prange, Thierry] CNRS, UMR 8015, Lab Cristallog & RMN Biol, Paris, France; [Colloc'h, Nathalie] GIP Cyceron, ISTCT CERVOxy Grp, CNRS, UMR 6301, Caen, France; [Colloc'h, Nathalie] Normandie Univ, UMR ISTCT 6301, UNICAEN, Caen, France; [Colloc'h, Nathalie] CEA, DSV I2BM, UMR ISTCT 6301, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Universite de Caen Normandie; CEA	Delarue, M (corresponding author), Inst Pasteur, CNRS, Unite Dynam Struct Macromol, UMR 3528, Paris, France.	marc.delarue@pasteur.fr	Colloc'h, Nathalie/L-1570-2015; Prangé, Thierry/AAA-4009-2022	Prangé, Thierry/0000-0002-7129-7396; Fourati, Zaineb/0000-0002-2316-4142	Agence Nationale pour la Recherche (ANR) [ANR 13 BSV8 0020]	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	Zeineb Fourati-Kammoun was supported by a fellowship from Agence Nationale pour la Recherche (ANR), grant ANR 13 BSV8 0020.	Abraini JH, 2014, ANESTHESIOLOGY, V121, P1018, DOI 10.1097/ALN.0000000000000435; Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Blanc E., 2011, BUSTER VERSION 2 11; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Booker RD, 2013, BBA-BIOMEMBRANES, V1828, P1347, DOI 10.1016/j.bbamem.2013.01.016; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chen Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13833; Colloc'h N, 2011, CURRENT TRENDS IN X-RAY CRYSTALLOGRAPHY, P285; Colloc'h N, 2014, FEBS LETT, V588, P1715, DOI 10.1016/j.febslet.2014.03.017; Colloc'h N, 2007, BIOPHYS J, V92, P217, DOI 10.1529/biophysj.106.093807; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 1997, PHARMACOL REV, V49, P343; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Harris PD, 2008, ANAESTHESIA, V63, P284, DOI 10.1111/j.1365-2044.2007.05253.x; Hayakawa N, 2008, J MOL BIOL, V384, P812, DOI 10.1016/j.jmb.2008.09.075; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Howard RJ, 2014, PHARMACOL REV, V66, P396, DOI 10.1124/pr.113.007468; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Imai T, 2007, J PHYS CHEM B, V111, P11585, DOI 10.1021/jp074865b; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Johansson JS, 2005, FEBS J, V272, P573, DOI 10.1111/j.1742-4658.2004.04500.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Landon C, 2001, PROTEIN SCI, V10, P762, DOI 10.1110/ps.47001; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Liu LT, 2010, J PHYS CHEM B, V114, P9010, DOI 10.1021/jp101687j; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mann G, 2000, J MOL BIOL, V302, P979, DOI 10.1006/jmbi.2000.4064; Marassio G, 2011, FASEB J, V25, P2266, DOI 10.1096/fj.11-183046; Miller KW, 2002, BRIT J ANAESTH, V89, P17, DOI 10.1093/bja/aef167; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Petrenko AB, 2014, EUR J PHARMACOL, V723, P29, DOI 10.1016/j.ejphar.2013.11.039; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Quillin ML, 2000, J MOL BIOL, V302, P955, DOI 10.1006/jmbi.2000.4063; Rubin SM, 2002, J MOL BIOL, V322, P425, DOI 10.1016/S0022-2836(02)00739-8; Salmi E, 2008, ANESTH ANALG, V106, P129, DOI 10.1213/01.ane.0000287658.14763.13; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; Sanders RD, 2003, BRIT J ANAESTH, V91, P709, DOI 10.1093/bja/aeg232; Sanders RD, 2005, CURR OPIN ANESTHESIO, V18, P405, DOI 10.1097/01.aco.0000174957.97759.f6; Sauguet L, 2015, BBA-GEN SUBJECTS, V1850, P511, DOI 10.1016/j.bbagen.2014.05.007; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; SCHILTZ M, 1994, J APPL CRYSTALLOGR, V27, P950, DOI 10.1107/S0021889894005923; Schiltz M, 2003, METHOD ENZYMOL, V374, P83, DOI 10.1016/S0076-6879(03)74004-X; SCHOENBORN BP, 1966, MOL PHARMACOL, V2, P495; Seto T, 2008, ANESTH ANALG, V107, P1223, DOI 10.1213/ane.0b013e31817f1317; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stimson LM, 2005, CELL MOL BIOL LETT, V10, P563; TILTON RF, 1986, J MOL BIOL, V192, P443, DOI 10.1016/0022-2836(86)90374-8; TILTON RF, 1988, J MOL BIOL, V199, P195, DOI 10.1016/0022-2836(88)90389-0; Ulens C, 2014, STRUCTURE, V22, P1399, DOI 10.1016/j.str.2014.07.013; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; Yamamoto E, 2012, J PHYS CHEM B, V116, P8989, DOI 10.1021/jp303330c; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429	78	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149795	10.1371/journal.pone.0149795	http://dx.doi.org/10.1371/journal.pone.0149795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910105	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700049
J	Szczepanek, SM; Roberts, S; Rogers, K; Cotte, C; Adami, AJ; Bracken, SJ; Salmon, S; Secor, ER; Thrall, RS; Andemariam, B; Metzger, DW				Szczepanek, Steven M.; Roberts, Sean; Rogers, Kara; Cotte, Christina; Adami, Alexander J.; Bracken, Sonali J.; Salmon, Sharon; Secor, Eric R., Jr.; Thrall, Roger S.; Andemariam, Biree; Metzger, Dennis W.			Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers	PLOS ONE			English	Article							MEMORY B-CELLS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; PENICILLIN PROPHYLAXIS; CONJUGATE VACCINE; CHILDREN; INFECTIONS; EXPRESSION; MORTALITY; RESPONSES	Background One of the most common causes of morbidity and mortality in children with sickle cell disease (SCD) is infection with the pneumococcal bacterium (Streptococcus pneumoniae). Unfortunately, the polysaccharide-conjugate vaccine appears to be less effective in individuals with SCD when compared to the general population. We sought to better understand the relative efficacy of pneumococcal vaccination in a SCD mouse challenge model. Methods Transgenic control and SCD mice were monitored for mortality after intranasal pneumococcal infection or pneumococcal vaccination with Prevnar-13 and type-matched challenge. Anti-pneumococcal antibody titers were measured by ELISA and opsonophagocytosis was measured in vitro. Results Mortality after pneumococcal infection was similar between control and SCD mice. However, after three intramuscular polysaccharide-conjugate vaccinations, all control mice were protected following high-dose intranasal infection, whereas 60% of SCD mice died. Anti-pneumococcal antibody titers showed initial IgG and IgM responses in both groups, but waning titers were observed in the SCD group, even after boosting. When functionally assayed in vitro, serum from SCD mice 13 weeks after a second booster shot maintained little to no ability to opsonize pneumococci, while serum from control mice sustained a significantly higher capacity opsonization. Thus, it appears that SCD mice do not maintain antibody responses to pneumococcal polysaccharides after Prevnar-13 vaccination, thereby leaving them susceptible to mortality after type-matched infection. Conclusion Our results emphasize the need to better understand the correlates of immune protection in SCD so that pneumococcal vaccines can be improved and mortality reduced in this susceptible population.	[Szczepanek, Steven M.; Rogers, Kara; Cotte, Christina] Univ Connecticut, Dept Pathobiol & Vet Sci, Ctr Excellence Vaccine Res, Storrs, CT 06269 USA; [Roberts, Sean; Salmon, Sharon; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Adami, Alexander J.; Bracken, Sonali J.; Thrall, Roger S.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Secor, Eric R., Jr.] Hartford Hosp, Helen & Harry Gray Canc Ctr, Hartford, CT 06106 USA; [Secor, Eric R., Jr.] Hartford Hosp, Dept Med, Div Integrat Med, Hartford, CT 06106 USA; [Andemariam, Biree] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Leas Fdn Ctr Hematol Disorders, Farmington, CT 06030 USA	University of Connecticut; Albany Medical College; University of Connecticut; Hartford Hospital; Hartford Hospital; University of Connecticut	Szczepanek, SM (corresponding author), Univ Connecticut, Dept Pathobiol & Vet Sci, Ctr Excellence Vaccine Res, Storrs, CT 06269 USA.	steven.szczepanek@uconn.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907; Roberts, Sean/0000-0001-9867-1483; Adami, Alexander/0000-0002-8233-9547; , Christina/0000-0002-8385-1921	University of Connecticut	University of Connecticut	Startup funding from the University of Connecticut provided to Biree Andemariam and Steven Szczepanek was used to purchase the mice and for analysis tools. Indirect cost recoveries to Dennis Metzger and Roger Thrall were used to purchase reagents, vaccines, and cover animal care costs.	Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Amoateng-Adjepong Y, 2010, EPIDEMIOLOGY, V21, P347, DOI 10.1097/EDE.0b013e3181d7e1f4; Bjornson AB, 1996, J PEDIATR-US, V129, P828, DOI 10.1016/S0022-3476(96)70026-4; BJORNSON AB, 1987, J CLIN INVEST, V79, P388, DOI 10.1172/JCI112824; BRILES DE, 1981, NATURE, V294, P88, DOI 10.1038/294088a0; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; Cafini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012041; Carsetti Rita, 2004, Methods Mol Biol, V271, P25; Carter R, 2014, CELL HOST MICROBE, V15, P587, DOI 10.1016/j.chom.2014.04.005; De Montalembert M, 2015, PEDIATR BLOOD CANCER, V62, P1427, DOI 10.1002/pbc.25502; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kuppers R, 2008, IMMUNOL CELL BIOL, V86, P635, DOI 10.1038/icb.2008.59; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; McCavit TL, 2012, PEDIATR BLOOD CANCER, V58, P945, DOI 10.1002/pbc.23259; Miller ML, 2007, J INFECT DIS, V195, P581, DOI 10.1086/510626; Neves M, 2011, AUTOIMMUN REV, V10, P375, DOI 10.1016/j.autrev.2010.12.007; Overturf G D, 1999, Adv Pediatr Infect Dis, V14, P191; Poehling KA, 2010, EPIDEMIOLOGY, V21, P340, DOI 10.1097/EDE.0b013e3181d61af8; Ramos-Sevillano E, 2012, ANTIMICROB AGENTS CH, V56, P5534, DOI 10.1128/AAC.01470-12; Ramos-Sevillano E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044135; RAO SP, 1995, J PEDIATR-US, V127, P590, DOI 10.1016/S0022-3476(95)70119-2; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Rosado MM, 2013, EUR J IMMUNOL, V43, P2659, DOI 10.1002/eji.201343577; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Spets H, 2002, EUR J HAEMATOL, V69, P76, DOI 10.1034/j.1600-0609.2002.01549.x; Szczepanek SM, 2013, PEDIATR RES, V74, P141, DOI 10.1038/pr.2013.85; Szczepanek SM, 2012, AM J PATHOL, V181, P1725, DOI 10.1016/j.ajpath.2012.07.034; William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149261	10.1371/journal.pone.0149261	http://dx.doi.org/10.1371/journal.pone.0149261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910228	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700027
J	Tardif, KD; Pyne, MT; Malmberg, E; Lunt, TC; Schlaberg, R				Tardif, Keith D.; Pyne, Michael T.; Malmberg, Elisabeth; Lunt, Tatum C.; Schlaberg, Robert			Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; CANCER; AMERICAN; PERFORMANCE; PROGRAM; ATHENA; MEDIA; WOMEN	None of the commercial HPV tests are U.S. FDA-approved for testing of cervical cytology specimens in SurePath preservative. Still, similar to 30% of HPV testing is performed on specimens in this formalin-containing preservative. Formalin-induced DNA fragmentation and cross-linking may interfere with HPV detection. We evaluated analytical sensitivity and specimen stability of the cobas 4800 HPV (Roche) and Hybrid Capture 2 HPV (HC2, Qiagen) tests with residual cervical cytology samples in SurePath preservative available within 1 week of collection. Cobas testing was performed with and without heating samples at 120 degrees C for 20 min diluted 1: 1 in an alkaline environment (pretreatment) to revert DNA crosslinking. Stability was tested after 2 weeks of storage at ambient temperature followed by <= 10 weeks at 4 degrees C. Analytical sensitivity and positivity rates (HC2, 18%; cobas pretreated, 46%; cobas untreated, 47%) were greater for cobas than HC2 (n = 682). After 6 weeks of storage, mean HC2 ratios were lower (mean 0.9, SD 6.3) but high variability limited statistical power to detect trends. Cobas threshold cycles (Ct's) increased in untreated (mean 2.1) but not pretreated samples (mean 0.3; n = 110; p <= 0.0001). Overall, cobas had greater analytical sensitivity for samples in SurePath preservative. Although pretreatment introduced a manual sample transfer step and 30 min of incubation times, it improved stability without negatively affecting analytical sensitivity. While awaiting results of large trials to evaluate the clinical performance of cobas, the addition of the pretreatment step may improve the detection of HPV, especially after prolonged sample storage.	[Tardif, Keith D.; Pyne, Michael T.; Malmberg, Elisabeth; Lunt, Tatum C.; Schlaberg, Robert] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Schlaberg, Robert] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Schlaberg, R (corresponding author), ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA.; Schlaberg, R (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA.	robert.schlaberg@path.utah.edu			Roche Molecular Systems; Roche Diagnostics; ARUP Institute for Clinical and Experimental Pathology; Roche Diagnostics and Hologic	Roche Molecular Systems; Roche Diagnostics; ARUP Institute for Clinical and Experimental Pathology; Roche Diagnostics and Hologic	This study was funded in part by Roche Molecular Systems, which provided financial, instrumentation, and reagent support. This work was sponsored in part by Roche Diagnostics and the ARUP Institute for Clinical and Experimental Pathology. RS has received research support from Roche Diagnostics and Hologic, speaker honorarium from Roche Diagnostics, and an advisory board member for Roche Diagnostics. Study design, sample testing, data collection, data analysis, and manuscript preparation were not influenced by funders.	Agreda PM, 2013, J CLIN MICROBIOL, V51, P2702, DOI 10.1128/JCM.00759-13; Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; BD Diagnostics, 2012, BD SUMM B SUREPATH S; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Campos PF, 2012, METHODS MOL BIOL, V840, P81, DOI 10.1007/978-1-61779-516-9_11; Castle PE, 2003, CANCER CYTOPATHOL, V99, P320, DOI 10.1002/cncr.11723; Castle PE, 2003, CANCER CYTOPATHOL, V99, P89, DOI 10.1002/cncr.11058; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Cui M, 2014, J CLIN MICROBIOL, V52, P2210, DOI 10.1128/JCM.00883-14; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Duval K, 2010, FORENSIC SCI INT-GEN, V4, P80, DOI 10.1016/j.fsigen.2009.06.003; Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331; Gage JC, 2012, J CLIN MICROBIOL, V50, P61, DOI 10.1128/JCM.05989-11; Gilbert L, 2013, J CLIN MICROBIOL, V51, P3412, DOI 10.1128/JCM.01391-13; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Naryshkin S, 2012, DRUG HEALTHC PATIENT, V4, P167, DOI 10.2147/DHPS.S37273; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Negri G, 2004, AM J CLIN PATHOL, V122, P90, DOI 10.1309/RUDE6NRH2NGENYRR; Powell N, 2006, J VIROL METHODS, V137, P58, DOI 10.1016/j.jviromet.2006.05.033; Rao A, 2013, J CLIN VIROL, V58, P161, DOI 10.1016/j.jcv.2013.06.041; Research WHOaDoRHa, 2008, WHORHR0814; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rowe LR, 2002, DIAGN CYTOPATHOL, V27, P312, DOI 10.1002/dc.10193; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149611	10.1371/journal.pone.0149611	http://dx.doi.org/10.1371/journal.pone.0149611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905067	Green Submitted, gold, Green Published			2022-12-26	WOS:000371163000017
J	Aung, NY; Ohe, R; Meng, HX; Kabasawa, T; Yang, SR; Kato, T; Yamakawa, M				Aung, Naing Ye; Ohe, Rintaro; Meng, Hongxue; Kabasawa, Takanobu; Yang, Suran; Kato, Tomoya; Yamakawa, Mitsunori			Specific Neuropilins Expression in Alveolar Macrophages among Tissue-Specific Macrophages	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; MESSENGER-RNA; ENDOTHELIAL-CELLS; SEMAPHORIN 3A; GROWTH; CANCER; RECEPTORS; ATHEROSCLEROSIS; ANGIOGENESIS; POLARIZATION	In the immune system, neuropilins (NRPs), including NRP-1 and NRP-2, are expressed in thymocytes, dendritic cells, regulatory T cells and macrophages. Their functions on immune cells around the neoplastic cells vary into pro-angiogenesis, tumor progression and anti-angiogenesis according to their ligands. Even though NRPs expression on malignant tumors and immune system has studied, a PubMed-based literature query did not yield any articles describing NRPs expression on tissue-specific macrophages. The aims of this study were (i) to detect NRPs expression on tissue-specific macrophages in the brain, liver, spleen, lymph node and lung; (ii) to observe NRPs expression in classes of macrophages, including alveolar macrophages (AMs), bronchial macrophages (BMs), interstitial macrophages (IMs), intravascular macrophages (IVMs) and macrophage subsets (M1, M2 and Mox) in lung; and (iii) to detect the co-expression of NRPs and dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) in AMs. Both NRPs were specifically detected in AMs among tissue-specific macrophages by immunohistochemistry (IHC). NRPs mRNA expression levels were characterized in normal lung by reverse transcriptase polymerase chain reaction (RT-PCR) and in situ-polymerase chain reaction (in situ-PCR). The expression of both NRPs was detected in AMs, BMs and IVMs by IHC. The frequency of NRPs(+) AMs in lung tissue adjacent to the cancer margin was significantly higher than the frequencies in inflamed and normal lung tissue. Double and triple IHC demonstrated that NRPs are expressed on all macrophage subsets in lung. Double IHC showed co-expression of DC-SIGN and NRPs in AMs. This study demonstrated for the first time the specific expression of both NRPs in AMs among tissue-specific macrophages and their expression on M1, M2 and Mox macrophages. Furthermore, the possible origin of AMs from blood monocytes could be suggested from a co-expression of NRPs and DC-SIGN.	[Aung, Naing Ye; Ohe, Rintaro; Meng, Hongxue; Kabasawa, Takanobu; Yang, Suran; Kato, Tomoya; Yamakawa, Mitsunori] Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan	Yamagata University	Yamakawa, M (corresponding author), Yamagata Univ, Fac Med, Dept Pathol Diagnost, Yamagata 990, Japan.	myamakaw@med.id.yamagata-u.ac.jp	Ohe, Rintaro/AAP-1604-2020	Ohe, Rintaro/0000-0002-8035-791X; Meng, Hongxue/0000-0002-1831-2737	 [25460451]		This work was supported by 25460451, https://www.jsps.go.jp/english/e-grants/ Yamagata University Faculty of Medicine, Mitsunori Yamakawa.	Aber A, 2012, INT J EXP PATHOL, V93, P243, DOI [10.1111/j.1365-2613.2012.00833.x, DOI 10.1111/J.1365-2613.2012.00833.X]; Bagasra O, 2007, NAT PROTOC, V2, P2782, DOI 10.1038/nprot.2007.395; Balhara J, 2012, MUCOSAL IMMUNOL, V5, P605, DOI 10.1038/mi.2012.74; Ball SG, 2010, BIOCHEM J, V427, P29, DOI 10.1042/BJ20091512; Baltzell K, 2012, BREAST CANCER RES TR, V132, P267, DOI 10.1007/s10549-011-1841-3; Butcher MJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00044; Cai Y, 2010, PATHOL RES PRACT, V206, P793, DOI 10.1016/j.prp.2010.08.001; Cassol E, 2009, J IMMUNOL, V182, P6237, DOI 10.4049/jimmunol.0803447; Chistiakov DA, 2015, J CELL MOL MED, V19, P1163, DOI 10.1111/jcmm.12591; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hodge S, 2011, AM J RESP CELL MOL, V44, P673, DOI 10.1165/rcmb.2009-0459OC; Hsieh SH, 2008, ONCOGENE, V27, P3746, DOI 10.1038/sj.onc.1211029; Hu B, 2007, ONCOGENE, V26, P5577, DOI 10.1038/sj.onc.1210348; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Jubb AM, 2012, HISTOPATHOLOGY, V61, P340, DOI 10.1111/j.1365-2559.2012.04224.x; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kim WH, 2009, EXP CELL RES, V315, P2154, DOI 10.1016/j.yexcr.2009.04.018; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Matsushita A, 2007, CANCER RES, V67, P10309, DOI 10.1158/0008-5472.CAN-07-3256; Moniuszko M, 2007, FOLIA HISTOCHEM CYTO, V45, P181; Moreira AP, 2010, J ALLERGY CLIN IMMUN, V126, P712, DOI 10.1016/j.jaci.2010.06.010; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Prud'homme GJ, 2012, ONCOTARGET, V3, P921, DOI 10.18632/oncotarget.626; Raimondi C, 2013, SEMIN CELL DEV BIOL, V24, P172, DOI 10.1016/j.semcdb.2013.01.001; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Sierra-Filardi E, 2010, IMMUNOBIOLOGY, V215, P788, DOI 10.1016/j.imbio.2010.05.020; Staples KJ, 2011, IMMUNOBIOLOGY, V216, P832, DOI 10.1016/j.imbio.2010.12.005; Staton CA, 2007, J PATHOL, V212, P237, DOI 10.1002/path.2182; West DC, 2005, J BIOL CHEM, V280, P13457, DOI 10.1074/jbc.M410924200; Wild JRL, 2012, INT J EXP PATHOL, V93, P81, DOI 10.1111/j.1365-2613.2012.00810.x; Wolfs IMJ, 2011, THROMB HAEMOSTASIS, V106, P763, DOI 10.1160/TH11-05-0320	36	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147358	10.1371/journal.pone.0147358	http://dx.doi.org/10.1371/journal.pone.0147358			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900851	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100009
J	Franco-Pedroso, J; Ramos, D; Gonzalez-Rodriguez, J				Franco-Pedroso, Javier; Ramos, Daniel; Gonzalez-Rodriguez, Joaquin			Gaussian Mixture Models of Between-Source Variation for Likelihood Ratio Computation from Multivariate Data	PLOS ONE			English	Article								In forensic science, trace evidence found at a crime scene and on suspect has to be evaluated from the measurements performed on them, usually in the form of multivariate data (for example, several chemical compound or physical characteristics). In order to assess the strength of that evidence, the likelihood ratio framework is being increasingly adopted. Several methods have been derived in order to obtain likelihood ratios directly from univariate or multivariate data by modelling both the variation appearing between observations (or features) coming from the same source (within-source variation) and that appearing between observations coming from different sources (between-source variation). In the widely used multivariate kernel likelihood-ratio, the within-source distribution is assumed to be normally distributed and constant among different sources and the between-source variation is modelled through a kernel density function (KDF). In order to better fit the observed distribution of the between-source variation, this paper presents a different approach in which a Gaussian mixture model (GMM) is used instead of a KDF. As it will be shown, this approach provides better-calibrated likelihood ratios as measured by the log-likelihood ratio cost (C-llr) in experiments performed on freely available forensic datasets involving different trace evidences: inks, glass fragments and car paints.	[Franco-Pedroso, Javier; Ramos, Daniel; Gonzalez-Rodriguez, Joaquin] Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain	Autonomous University of Madrid	Franco-Pedroso, J (corresponding author), Univ Autonoma Madrid, ATVS Biometr Recognit Grp, Madrid, Spain.	javier.franco@uam.es			Ministerio de Economia y Competitividad (ES) [TEC2012-37585-C02-01]	Ministerio de Economia y Competitividad (ES)	JFP recieved funding from "Ministerio de Economia y Competitividad (ES)" (http://www.mineco.gob.es/) through the project "CMC-V2: Caracterizacion, Modelado y Compensacion de Variabilidad en la Senal de Voz", with grant number TEC2012-37585-C02-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja RK, 2001, OPER RES, V49, P784, DOI 10.1287/opre.49.5.784.10601; Aitken C., 2004, STAT EVALUATION EVID, P26; Aitken CGG, 2004, J ROY STAT SOC C-APP, V53, P109, DOI 10.1046/j.0035-9254.2003.05271.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bishop C. M, 2006, PATTERN RECOGNITION; Bolck A, 2009, FORENSIC SCI INT, V191, P42, DOI 10.1016/j.forsciint.2009.06.006; Borgstrom BJ, 2013, INT CONF ACOUST SPEE, P7693, DOI 10.1109/ICASSP.2013.6639160; Brummer N, 2006, COMPUT SPEECH LANG, V20, P230, DOI 10.1016/j.csl.2005.08.001; Cook R, 1998, SCI JUSTICE, V38, P231, DOI 10.1016/S1355-0306(98)72117-3; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EPANECHN.VA, 1969, THEOR PROBAB APPL+, V14, P153, DOI 10.1137/1114019; Gonzalez-Rodriguez J, 2007, IEEE T AUDIO SPEECH, V15, P2104, DOI 10.1109/TASL.2007.902747; Jain AK, 2006, IEEE T INF FOREN SEC, V1, P125, DOI 10.1109/TIFS.2006.873653; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Li P, 2012, IEEE T PATTERN ANAL, V34, P144, DOI 10.1109/TPAMI.2011.104; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; McLachlan Geoffrey J., 1988, APPL STAT; Ramos D, 2013, J FORENSIC SCI, V58, P1503, DOI 10.1111/1556-4029.12233; Ramos D, 2013, FORENSIC SCI INT, V230, P156, DOI 10.1016/j.forsciint.2013.04.014; Rose P, 2015, INT CONF ACOUST SPEE, P4819, DOI 10.1109/ICASSP.2015.7178886; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sizov A, 2014, LECT NOTES COMPUT SC, V8621, P464, DOI 10.1007/978-3-662-44415-3_47; Turk M. A., 1991, Proceedings 1991 IEEE Computer Society Conference on Computer Vision and Pattern Recognition (91CH2983-5), P586, DOI 10.1109/CVPR.1991.139758; van Leeuwen David A., 2007, Speaker Classification I. Fundamentals, Features, and Methods. (Lecture Notes in Artificial Intelligence vol. 4343), P330, DOI 10.1007/978-3-540-74200-5_19; Zadora G, 2014, STATISTICAL ANALYSIS IN FORENSIC SCIENCE: EVIDENTIAL VALUE OF MULTIVARIATE PHYSICOCHEMICAL DATA, P1, DOI 10.1002/9781118763155; Zadrozny B., 2002, P 8 ACM SIGKDD INT C, P694, DOI [10.1145/775047.775151, DOI 10.1145/775047.775151]	28	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149958	10.1371/journal.pone.0149958	http://dx.doi.org/10.1371/journal.pone.0149958			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901680	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100193
J	Kapelner, T; Jiang, N; Holobar, A; Vujaklija, I; Roche, AD; Farina, D; Aszmann, OC				Kapelner, Tamas; Jiang, Ning; Holobar, Ales; Vujaklija, Ivan; Roche, Aidan D.; Farina, Dario; Aszmann, Oskar C.			Motor Unit Characteristics after Targeted Muscle Reinnervation	PLOS ONE			English	Article							SURFACE ELECTROMYOGRAM; ACTION-POTENTIALS; EMG; ELECTRODES; PATTERNS; NERVE	Targeted muscle reinnervation (TMR) is a surgical procedure used to redirect nerves originally controlling muscles of the amputated limb into remaining muscles above the amputation, to treat phantom limb pain and facilitate prosthetic control. While this procedure effectively establishes robust prosthetic control, there is little knowledge on the behavior and characteristics of the reinnervated motor units. In this study we compared the m. pectoralis of five TMR patients to nine able-bodied controls with respect to motor unit action potential (MUAP) characteristics. We recorded and decomposed high-density surface EMG signals into individual spike trains of motor unit action potentials. In the TMR patients the MUAP surface area normalized to the electrode grid surface (0.25 +/- 0.17 and 0.81 +/- 0.46, p < 0.001) and the MUAP duration (10.92 +/- 3.89 ms and 14.03 +/- 3.91 ms, p < 0.01) were smaller for the TMR group than for the controls. The mean MUAP amplitude (0.19 +/- 0.11 mV and 0.14 +/- 0.06 mV, p = 0.07) was not significantly different between the two groups. Finally, we observed that MUAP surface representation in TMR generally overlapped, and the surface occupied by motor units corresponding to only one motor task was on average smaller than 12% of the electrode surface. These results suggest that smaller MUAP surface areas in TMR patients do not necessarily facilitate prosthetic control due to a high degree of overlap between these areas, and a neural information-based control could lead to improved performance. Based on the results we also infer that the size of the motor units after reinnervation is influenced by the size of the innervating motor neuron.	[Kapelner, Tamas; Vujaklija, Ivan; Farina, Dario] Univ Gottingen, Bernstein Ctr Computat Neurosci, Univ Med Ctr Gottingen, Inst Neurorehabil Syst, D-37073 Gottingen, Germany; [Jiang, Ning] Univ Waterloo, Dept Syst Design Engn, Waterloo, ON N2L 3G1, Canada; [Holobar, Ales] Univ Maribor, Fac Elect Engn & Comp Sci, SLO-2000 Maribor, Slovenia; [Roche, Aidan D.; Aszmann, Oskar C.] Med Univ Vienna, Div Plast & Reconstruct Surg, CD Lab Restorat Extrem Funct, Vienna, Austria	University of Gottingen; University of Waterloo; University of Maribor; Medical University of Vienna	Aszmann, OC (corresponding author), Med Univ Vienna, Div Plast & Reconstruct Surg, CD Lab Restorat Extrem Funct, Vienna, Austria.	oskar.aszmann@meduniwien.ac.at	Jiang, Ning/H-1844-2011; Roche, Aidan/AAC-5695-2019; Vujaklija, Ivan/AAB-9163-2021; Farina, Dario/AAB-2648-2019	Jiang, Ning/0000-0003-1579-3114; Vujaklija, Ivan/0000-0002-7394-9474; Roche, Aidan/0000-0002-8892-5053	German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists [57076385]; European Research Council Advanced Grant DEMOVE [267888]; Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research Economy	German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists; European Research Council Advanced Grant DEMOVE; Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research Economy	This work was financially supported by the German Academic Exchange Service Research Grant for Doctoral Candidates and Young Academics and Scientists (Grant #57076385, http://www.daad.de), by the European Research Council Advanced Grant DEMOVE (contract #267888, http://erc.europa.eu/), and by the Christian Doppler Research Association of the Austrian Federal Ministry of Science, Research & Economy (https://www.cdg.ac.at/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aszmann OC, 2008, HANDCHIR MIKROCHIR P, V40, P60, DOI 10.1055/s-2007-989415; BODINEFOWLER S, 1990, MUSCLE NERVE, V13, P1133, DOI 10.1002/mus.880131208; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Dumanian GA, 2009, PLAST RECONSTR SURG, V124, P863, DOI 10.1097/PRS.0b013e3181b038c9; Enoka R.M., 2008, NEUROMECHANICS HUMAN; Farid D., 2013, IEEE T NEUR SYS REH, P1; Farina D, 2001, IEEE T BIO-MED ENG, V48, P637, DOI 10.1109/10.923782; Farina D, 2008, J NEUROPHYSIOL, V100, P1223, DOI 10.1152/jn.90219.2008; FOEHRING RC, 1987, J NEUROPHYSIOL, V57, P1210, DOI 10.1152/jn.1987.57.4.1210; FUGLEVAND AJ, 1992, BIOL CYBERN, V67, P143, DOI 10.1007/BF00201021; Hargrove LJ, 2013, IEEE ENG MED BIO, P1599, DOI 10.1109/EMBC.2013.6609821; Holobar A, 2007, IEEE T SIGNAL PROCES, V55, P4487, DOI 10.1109/TSP.2007.896108; Holobar A, 2009, CLIN NEUROPHYSIOL, V120, P551, DOI 10.1016/j.clinph.2008.10.160; Kapelner T, 2015, 7 INT C NEUR ENG MON, P652; KUGELBERG E, 1970, J NEUROL NEUROSUR PS, V33, P319, DOI 10.1136/jnnp.33.3.319; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Marasco PD, 2009, BRAIN, V132, P1441, DOI 10.1093/brain/awp082; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; REDFERN MS, 1993, CLIN BIOMECH, V8, P44, DOI 10.1016/S0268-0033(05)80009-9; Roeleveld K, 1997, J ELECTROMYOGR KINES, V7, P221, DOI 10.1016/S1050-6411(97)00009-6; Smith LH, 2013, I IEEE EMBS C NEUR E, P1155, DOI 10.1109/NER.2013.6696143; SRETER FA, 1975, J GEN PHYSIOL, V66, P811, DOI 10.1085/jgp.66.6.811	22	30	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149772	10.1371/journal.pone.0149772	http://dx.doi.org/10.1371/journal.pone.0149772			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901631	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100148
J	Lengyel, S; Deri, E; Magura, T				Lengyel, Szabolcs; Deri, Eszter; Magura, Tibor			Species Richness Responses to Structural or Compositional Habitat Diversity between and within Grassland Patches: A Multi-Taxon Approach	PLOS ONE			English	Article							WESTERN-AUSTRALIAN WHEATBELT; AREA PER-SE; ISLAND AREA; PLANT PRODUCTIVITY; PREY AVAILABILITY; INSECT DIVERSITY; MANAGEMENT; BIODIVERSITY; ASSEMBLAGES; SCALE	Habitat diversity (spatial heterogeneity within and between habitat patches in a landscape, HD) is often invoked as a driver of species diversity at small spatial scales. However, the effect of HD on species richness (SR) of multiple taxa is not well understood. We quantified HD and SR in a wet-dry gradient of open grassland habitats in Hortobagy National Park (E-Hungary) and tested the effect of compositional and structural factors of HD on SR of flowering plants, orthopterans, true bugs, spiders, ground beetles and birds. Our dataset on 434 grassland species (170 plants, 264 animals) showed that the wet-dry gradient (compositional HD at the between-patch scale) was primarily related to SR in orthopterans, ground-dwelling arthropods, and all animals combined. The patchiness, or plant association richness, of the vegetation (compositional HD at the within-patch scale) was related to SR of vegetation-dwelling arthropods, whereas vegetation height (structural HD at the withinpatch scale) was related to SR of ground-dwelling arthropods and birds. Patch area was related to SR only in birds, whereas management (grazing, mowing, none) was related to SR of plants and true bugs. All relationships between HD and SR were positive, indicating increasing SR with increasing HD. However, total SR was not related to HD because different taxa showed similar positive responses to different HD variables. Our findings, therefore, show that even though HD positively influences SR in a wide range of grassland taxa, each taxon responds to different compositional or structural measures of HD, resulting in the lack of a consistent relationship between HD and SR when taxon responses are pooled. The idiosyncratic responses shown here exemplify the difficulties in detecting general HDSR relationships over multiple taxa. Our results also suggest that management and restoration aimed specifically to sustain or increase the diversity of habitats are required to conserve biodiversity in complex landscapes.	[Lengyel, Szabolcs] Hungarian Acad Sci, Danube Res Inst, Dept Tisza Res, Ctr Ecol Res, Bem Ter 18-C, H-4026 Debrecen, Hungary; [Deri, Eszter] Zool Soc London, Regents Pk, London NW1 4RY, England; [Magura, Tibor] Univ Debrecen, Dept Ecol, POB 400, H-4002 Debrecen, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Ecological Research; Zoological Society of London; University of Debrecen	Lengyel, S (corresponding author), Hungarian Acad Sci, Danube Res Inst, Dept Tisza Res, Ctr Ecol Res, Bem Ter 18-C, H-4026 Debrecen, Hungary.	lengyel.szabolcs@okologia.mta.hu	Magura, Tibor/I-4383-2019; Lengyel, Szabolcs/A-3483-2011	Magura, Tibor/0000-0002-9130-6122; Lengyel, Szabolcs/0000-0002-7049-0100	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA [K 106133]; EU LIFE-Nature programme [LIFE04NAT/HU/000119]; EU FP7 project "SCALES" [226852]	Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU LIFE-Nature programme; EU FP7 project "SCALES"	This work was supported by the Hungarian Scientific Research Fund (Orszagos Tudomanyos Kutatasi Alapprogramok), OTKA K 106133, to SL; EU LIFE-Nature programme, LIFE04NAT/HU/000119, to SL; and EU FP7 project "SCALES", Contract No. 226852, to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MAGYARORSZAG NOVENYT; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2000, MAGYARORSZAGI EDENYE; Baldi A, 1999, ACTA OECOL, V20, P125, DOI 10.1016/S1146-609X(99)80025-3; Baldi A, 2008, J BIOGEOGR, V35, P675, DOI 10.1111/j.1365-2699.2007.01825.x; Barczi A, 2006, QUATERN INT, V156, P49, DOI 10.1016/j.quaint.2006.05.024; Beever EA, 2006, DIVERS DISTRIB, V12, P229, DOI 10.1111/j.1366-9516.2006.00260.x; BLAKE JG, 1987, ECOLOGY, V68, P1724, DOI 10.2307/1939864; BohningGaese K, 1997, J BIOGEOGR, V24, P49, DOI 10.1111/j.1365-2699.1997.tb00049.x; Boloni J, 2007, ANN BOT-COENOL PLANT, V7, P55; Brose U, 2003, OECOLOGIA, V135, P407, DOI 10.1007/s00442-003-1222-7; Burbidge AA, 1997, J BIOGEOGR, V24, P703, DOI 10.1046/j.1365-2699.1997.00145.x; BURNHAM KP, 1979, ECOLOGY, V60, P927, DOI 10.2307/1936861; Cattin MF, 2003, BIOL CONSERV, V113, P179, DOI 10.1016/S0006-3207(02)00297-5; Collinge SK, 1996, LANDSCAPE URBAN PLAN, V36, P59, DOI 10.1016/S0169-2046(96)00341-6; Davidowitz G, 1998, J BIOGEOGR, V25, P553, DOI 10.1046/j.1365-2699.1998.2530553.x; Di Giulio M, 2001, J APPL ECOL, V38, P310, DOI 10.1046/j.1365-2664.2001.00605.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duelli P, 1997, AGR ECOSYST ENVIRON, V62, P81, DOI 10.1016/S0167-8809(96)01143-7; Forman R., 2014, ECOLOGICAL DESIGN PL, P217; Groom M.J., 2006, PRINCIPLES CONSERVAT; Halaj J, 2000, OIKOS, V90, P139, DOI 10.1034/j.1600-0706.2000.900114.x; Halaj J, 1998, J ARACHNOL, V26, P203; HAMILTON TH, 1963, SCIENCE, V142, P1575, DOI 10.1126/science.142.3599.1575; Hannus JJ, 2008, J BIOGEOGR, V35, P1077, DOI 10.1111/j.1365-2699.2007.01862.x; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Henle K, 2010, GAIA, V19, P187, DOI 10.14512/gaia.19.3.8; Hortal J, 2009, AM NAT, V174, pE205, DOI 10.1086/645085; Horvath R, 2005, CAN J ZOOL, V83, P324, DOI [10.1139/z05-009, 10.1139/Z05-009]; Johnson M., 1974, J BIOGEOGR, V1, P149, DOI DOI 10.2307/3037964; JOHNSON MP, 1968, AM NAT, V102, P297, DOI 10.1086/282544; Jost L, 2006, OIKOS, V113, P363, DOI 10.1111/j.2006.0030-1299.14714.x; Kallimanis AS, 2010, BIODIVERS CONSERV, V19, P1225, DOI 10.1007/s10531-009-9748-6; Kallimanis AS, 2008, GLOBAL ECOL BIOGEOGR, V17, P532, DOI 10.1111/j.1466-8238.2008.00393.x; KITCHENER DJ, 1980, BIOL CONSERV, V17, P25, DOI 10.1016/0006-3207(80)90024-5; KITCHENER DJ, 1982, BIOL CONSERV, V22, P127, DOI 10.1016/0006-3207(82)90010-6; KOHN DD, 1994, J ECOL, V82, P367, DOI 10.2307/2261304; Kruess A, 2002, BIOL CONSERV, V106, P293, DOI 10.1016/S0006-3207(01)00255-5; Langellotto GA, 2004, OECOLOGIA, V139, P1, DOI 10.1007/s00442-004-1497-3; Langsrud Y, 2003, STAT COMPUT, V13, P163, DOI 10.1023/A:1023260610025; Lassau SA, 2005, DIVERS DISTRIB, V11, P73, DOI 10.1111/j.1366-9516.2005.00124.x; Lengyel S, 2012, APPL VEG SCI, V15, P264, DOI 10.1111/j.1654-109X.2011.01179.x; Lomolino MV, 2001, J BIOGEOGR, V28, P431, DOI 10.1046/j.1365-2699.2001.00550.x; LOSOS JB, 1986, OECOLOGIA, V68, P338, DOI 10.1007/BF01036735; Lovei GL, 2006, GLOBAL ECOL BIOGEOGR, V15, P283, DOI 10.1111/j.1466-8238.2005.00221.x; Magura T, 2008, ACTA OECOL, V33, P272, DOI 10.1016/j.actao.2007.11.007; Magura T, 2007, AGR ECOSYST ENVIRON, V119, P396, DOI 10.1016/j.agee.2006.08.014; MALY EJ, 1977, AM MIDL NAT, V97, P59, DOI 10.2307/2424685; Marini L, 2010, BIOL CONSERV, V143, P2164, DOI 10.1016/j.biocon.2010.05.029; Mero TO, 2015, ANIM CONSERV, V18, P442, DOI 10.1111/acv.12191; Mero TO, 2015, J ORNITHOL, V156, P579, DOI 10.1007/s10336-015-1202-9; Mester B, 2015, BIOL CONSERV, V192, P237, DOI 10.1016/j.biocon.2015.09.030; Mester B, 2015, HERPETOL CONSERV BIO, V10, P679; NILSSON SG, 1988, J ANIM ECOL, V57, P685, DOI 10.2307/4933; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Papanikolaou AD, SCALING ECOLOGY BIOD, P156; PATTON D R, 1975, Wildlife Society Bulletin, V3, P171; Perner J, 2005, ECOGRAPHY, V28, P429, DOI 10.1111/j.0906-7590.2005.04119.x; Reid AM, 2007, AUSTRAL ECOL, V32, P708, DOI 10.1111/j.1442-9993.2007.01767.x; Ricklefs RE, 1999, J ANIM ECOL, V68, P1142, DOI 10.1046/j.1365-2656.1999.00358.x; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Schaffers AP, 2008, ECOLOGY, V89, P782, DOI 10.1890/07-0361.1; Shi JM, 2010, BIODIVERS CONSERV, V19, P1279, DOI 10.1007/s10531-009-9757-5; Siemann E, 1998, ECOLOGY, V79, P2057, DOI 10.1890/0012-9658(1998)079[2057:ETOEOP]2.0.CO;2; Szep Tibor, 2000, Ring, V22, P45; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Triantis KA, 2003, J BIOGEOGR, V30, P19, DOI 10.1046/j.1365-2699.2003.00805.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x; Woodcock BA, 2010, BIODIVERS CONSERV, V19, P81, DOI 10.1007/s10531-009-9703-6	70	30	34	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149662	10.1371/journal.pone.0149662	http://dx.doi.org/10.1371/journal.pone.0149662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901569	gold, Green Accepted, Green Published			2022-12-26	WOS:000371276100125
J	Li, L; Bonneton, F; Tohme, M; Bernard, L; Chen, XY; Laudet, V				Li, Ling; Bonneton, Francois; Tohme, Marie; Bernard, Laure; Chen, Xiao Yong; Laudet, Vincent			In Vivo Screening Using Transgenic Zebrafish Embryos Reveals New Effects of HDAC Inhibitors Trichostatin A and Valproic Acid on Organogenesis	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; HORMONE-EXPRESSING CELLS; PANCREAS DEVELOPMENT; DANIO-RERIO; GENE-EXPRESSION; BISPHENOL-A; MODEL; DICLOFENAC; TOXICITY; FISH	The effects of endocrine disrupting chemicals (EDCs) on reproduction are well known, whereas their developmental effects are much less characterized. However, exposure to endocrine disruptors during organogenesis may lead to deleterious and permanent problems later in life. Zebrafish (Danio rerio) transgenic lines expressing the green fluorescent protein (GFP) in specific organs and tissues are powerful tools to uncover developmental defects elicited by EDCs. Here, we used seven transgenic lines to visualize in vivo whether a series of EDCs and other pharmaceutical compounds can alter organogenesis in zebrafish. We used transgenic lines expressing GFP in pancreas, liver, blood vessels, inner ear, nervous system, pharyngeal tooth and pectoral fins. This screen revealed that four of the tested chemicals have detectable effects on different organs, which shows that the range of effects elicited by EDCs is wider than anticipated. The endocrine disruptor tetrabromobisphenol-A (TBBPA), as well as the three drugs diclofenac, trichostatin A (TSA) and valproic acid (VPA) induced abnormalities in the embryonic vascular system of zebrafish. Moreover, TSA and VPA induced specific alterations during the development of pancreas, an observation that was confirmed by in situ hybridization with specific markers. Developmental delays were also induced by TSA and VPA in the liver and in pharyngeal teeth, resulting in smaller organ size. Our results show that EDCs can induce a large range of developmental alterations during embryogenesis of zebrafish and establish GFP transgenic lines as powerful tools to screen for EDCs effects in vivo.	[Li, Ling; Bonneton, Francois; Tohme, Marie; Bernard, Laure; Laudet, Vincent] Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France; [Li, Ling; Chen, Xiao Yong] E China Normal Univ, Sch Ecol & Environm Sci, Shanghai 200062, Peoples R China; [Laudet, Vincent] Observ Oceanol Banyuls Sur Mer, Lab Arago, Banyuls Sur Mer, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); East China Normal University; UDICE-French Research Universities; Sorbonne Universite	Laudet, V (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, CNRS, Inst Genom Fonct Lyon,INRA, F-69365 Lyon, France.; Laudet, V (corresponding author), Observ Oceanol Banyuls Sur Mer, Lab Arago, Banyuls Sur Mer, France.	vincent.laudet@obs-banyuls.fr	Chen, Xiao-Yong/B-1467-2009	Chen, Xiao-Yong/0000-0002-4795-8940; Bonneton, Francois/0000-0002-6500-1931; Laudet, Vincent/0000-0003-4022-4175; Li, Ling/0000-0003-0882-3266	Joint Research Institute for Science and Society (JORISS); French Ministry of Foreign Affairs; China Scholarship Council (CSC); ANR TOXSYN project [ANR-13-CESA-0017]	Joint Research Institute for Science and Society (JORISS); French Ministry of Foreign Affairs; China Scholarship Council (CSC)(China Scholarship Council); ANR TOXSYN project(French National Research Agency (ANR))	The Joint Research Institute for Science and Society (JORISS), the French Ministry of Foreign Affairs (Eiffel scholarships), and the China Scholarship Council (CSC) supported Li Ling. This work was funded by the ANR TOXSYN project (ANR-13-CESA-0017).	Argenton F, 1999, MECH DEVELOP, V87, P217, DOI 10.1016/S0925-4773(99)00151-3; BERGERON JM, 1994, ENVIRON HEALTH PERSP, V102, P780, DOI 10.2307/3432139; Besse JP, 2008, TOXICOL LETT, V176, P104, DOI 10.1016/j.toxlet.2007.10.012; Biemar F, 2001, DEV BIOL, V230, P189, DOI 10.1006/dbio.2000.0103; Boverhof DR, 2011, TOXICOL SCI, V121, P207, DOI 10.1093/toxsci/kfr075; Brion F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036069; Bugel Sean M, 2014, Curr Environ Health Rep, V1, P341; Carnevali O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010201; Carson Rachel, 1994, SILENT SPRING; Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200; Cha YI, 2005, DEV BIOL, V282, P274, DOI 10.1016/j.ydbio.2005.03.014; Chan LY, 2001, HUM REPROD, V16, P2390, DOI 10.1093/humrep/16.11.2390; Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031; Christensen DP, 2011, MOL MED, V17, P378, DOI 10.2119/molmed.2011.00021; COLBORN T, 1995, ENVIRON HEALTH PERSP, V103, P81, DOI 10.2307/3432353; Colborn T., 1996, OUR STOLEN FUTURE; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Epping MT, 2007, P NATL ACAD SCI USA, V104, P17777, DOI 10.1073/pnas.0702518104; Eroschenko VP, 2002, NEUROTOXICOL TERATOL, V24, P29, DOI 10.1016/S0892-0362(01)00194-5; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Farooq M, 2008, DEV BIOL, V317, P336, DOI 10.1016/j.ydbio.2008.02.034; Folsvik N, 1999, CHEMOSPHERE, V38, P681, DOI 10.1016/S0045-6535(98)00202-1; Gibert Y, 2010, FASEB J, V24, P3298, DOI 10.1096/fj.09-147488; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Goldman D, 2001, TRANSGENIC RES, V10, P21, DOI 10.1023/A:1008998832552; Gore AC, 2006, ENDOCRINOLOGY, V147, pS1, DOI 10.1210/en.2005-1367; Green JD, 1997, ENVIRON RES, V72, P56, DOI 10.1006/enrs.1996.3692; Guillette LJ, 2005, INTEGR COMP BIOL, V45, P19, DOI 10.1093/icb/45.1.19; Gurvich N, 2005, FASEB J, V19, P1166, DOI 10.1096/fj.04-3425fje; Hallare AV, 2004, CHEMOSPHERE, V56, P659, DOI 10.1016/j.chemosphere.2004.04.007; Hayes TB, 2011, J STEROID BIOCHEM, V127, P64, DOI 10.1016/j.jsbmb.2011.03.015; Her GM, 2003, FEBS LETT, V538, P125, DOI 10.1016/S0014-5793(03)00157-1; Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110; Huang HG, 2001, MOL CELL ENDOCRINOL, V177, P117, DOI 10.1016/S0303-7207(01)00408-7; Jackman WR, 2006, P NATL ACAD SCI USA, V103, P19390, DOI 10.1073/pnas.0609575103; Khan SJ, 2002, WATER SCI TECHNOL, V46, P105, DOI 10.2166/wst.2002.0065; Kharrazian D, 2014, AUTOIMMUN DIS, V2014, DOI 10.1155/2014/743616; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kinkel MD, 2009, BIOESSAYS, V31, P139, DOI 10.1002/bies.200800123; Kudo C, 2003, BIOCHEM PHARMACOL, V66, P289, DOI 10.1016/S0006-2952(03)00235-1; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; le Maire A, 2010, NAT STRUCT MOL BIOL, V17, P801, DOI 10.1038/nsmb.1855; Lee HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090160; Lemaire G, 2006, LIFE SCI, V79, P1160, DOI 10.1016/j.lfs.2006.03.023; McCormick JM, 2010, AQUAT TOXICOL, V100, P255, DOI 10.1016/j.aquatox.2010.07.019; McGrath P, 2008, DRUG DISCOV TODAY, V13, P394, DOI 10.1016/j.drudis.2008.03.002; McLachlan JA, 2001, ENDOCR REV, V22, P319, DOI 10.1210/er.22.3.319; Miard S, 2005, INT J OBESITY, V29, pS10, DOI 10.1038/sj.ijo.0802906; Newbold RR, 2007, MOL CARCINOGEN, V46, P783, DOI 10.1002/mc.20308; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Pillai R, 2004, DEV DYNAM, V231, P647, DOI 10.1002/dvdy.20168; Poupardin R, 2008, INSECT BIOCHEM MOLEC, V38, P540, DOI 10.1016/j.ibmb.2008.01.004; Riu A, 2014, TOXICOL SCI, V139, P48, DOI 10.1093/toxsci/kfu036; Santos GM, 2011, TRENDS ENDOCRIN MET, V22, P87, DOI 10.1016/j.tem.2010.11.004; Scholz S, 2008, MOL CELL ENDOCRINOL, V293, P57, DOI 10.1016/j.mce.2008.06.008; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Suzawa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002117; Tabb MM, 2006, MOL ENDOCRINOL, V20, P475, DOI 10.1210/me.2004-0513; Tehrani Z, 2011, CELL CYCLE, V10, P3466, DOI 10.4161/cc.10.20.17764; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tiso N, 2009, MOL CELL ENDOCRINOL, V312, P24, DOI 10.1016/j.mce.2009.04.018; Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707; Udvadia AJ, 2003, DEV BIOL, V256, P1, DOI 10.1016/S0012-1606(02)00083-0; van den Brandhof EJ, 2010, ECOTOX ENVIRON SAFE, V73, P1862, DOI 10.1016/j.ecoenv.2010.08.031; Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Walker SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029916; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; WASSERMAN DH, 1995, INT J OBESITY, V19, pS22; Wiegand C, 2001, ECOTOX ENVIRON SAFE, V49, P199, DOI 10.1006/eesa.2001.2073; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055474	73	16	17	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149497	10.1371/journal.pone.0149497	http://dx.doi.org/10.1371/journal.pone.0149497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900852	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100086
J	Sticchi, E; Magi, A; Kamstrup, PR; Marcucci, R; Prisco, D; Martinelli, I; Mannucci, PM; Abbate, R; Giusti, B				Sticchi, Elena; Magi, Alberto; Kamstrup, Pia R.; Marcucci, Rossella; Prisco, Domenico; Martinelli, Ida; Mannucci, Pier Mannuccio; Abbate, Rosanna; Giusti, Betti			Apolipoprotein(a) Kringle-IV Type 2 Copy Number Variation Is Associated with Venous Thromboembolism	PLOS ONE			English	Article							EXTREME LIPOPROTEIN(A) LEVELS; PLASMA LIPOPROTEIN(A); RISK-FACTOR; MYOCARDIAL-INFARCTION; C/T POLYMORPHISM; LPA GENE; CORONARY; DISEASE; ATHEROSCLEROSIS; LP(A)	In addition to the established association between high lipoprotein(a) [Lp(a)] concentrations and coronary artery disease, an association between Lp(a) and venous thromboembolism (VTE) has also been described. Lp(a) is controlled by genetic variants in LPA gene, coding for apolipoprotein(a), including the kringle-IV type 2 (KIV-2) size polymorphism. Aim of the study was to investigate the role of LPA gene KIV-2 size polymorphism and single nucleotide polymorphisms (SNPs) (rs1853021, rs1800769, rs3798220, rs10455872) in modulating VTE susceptibility. Five hundred and sixteen patients with VTE without hereditary and acquired thrombophilia and 1117 healthy control subjects, comparable for age and sex, were investigated. LPA KIV-2 polymorphism, rs3798220 and rs10455872 SNPs were genotyped by TaqMan technology. Concerning rs1853021 and rs1800769 SNPs, PCR-RFLP assay was used. LPA KIV-2 repeat number was significantly lower in patients than in controls [median (interquartile range) 11(6-17) vs 15(9-25), p<0.0001]. A significantly higher prevalence of KIV-2 repeat number <= 7 was observed in patients than in controls (33.5% vs 15.5%, p<0.0001). KIV-2 repeat number was independently associated with VTE (p = 4.36 x10(-9)), as evidenced by the general linear model analysis adjusted for transient risk factors. No significant difference in allele frequency for all SNPs investigated was observed. Haplotype analysis showed that LPA haplotypes rather than individual SNPs influenced disease susceptibility. Receiver operating characteristic curves analysis showed that a combined risk prediction model, including KIV-2 size polymorphism and clinical variables, had a higher performance in identifying subjects at VTE risk than a clinical-only model, also separately in men and women.	[Sticchi, Elena; Magi, Alberto; Marcucci, Rossella; Abbate, Rosanna; Giusti, Betti] Univ Florence, Careggi Hosp, Atherothrombot Dis Ctr, Dept Expt & Clin Med, Florence, Italy; [Kamstrup, Pia R.] Copenhagen Univ Hosp, Dept Clin Biochem, Herlev, Denmark; [Prisco, Domenico] Univ Florence, Careggi Hosp, Ctr Autoimmune System Dis, Dept Expt & Clin Med,SOD Patol Med,Behcet Ctr & L, Florence, Italy; [Martinelli, Ida; Mannucci, Pier Mannuccio] Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Mannucci, Pier Mannuccio] Fdn Ca Granda Osped Maggiore Policlin, Sci Direct, Milan, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Copenhagen; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Giusti, B (corresponding author), Univ Florence, Careggi Hosp, Atherothrombot Dis Ctr, Dept Expt & Clin Med, Florence, Italy.	betti.giusti@unifi.it	Magi, Alberto/M-6773-2015; Sticchi, Elena/K-8237-2016; Marcucci, Rossella/K-8471-2016; Giusti, Betti/K-6978-2016; Martinelli, ida/J-2287-2015	Magi, Alberto/0000-0001-7393-4283; Sticchi, Elena/0000-0002-0990-4618; Giusti, Betti/0000-0002-8708-9444; Martinelli, ida/0000-0001-9218-3622; Marcucci, Rossella/0000-0001-9549-7176	Italian Ministry of Health; Fiorgen Foundation, Florence, Italy	Italian Ministry of Health(Ministry of Health, Italy); Fiorgen Foundation, Florence, Italy	This work was supported by grants from Italian Ministry of Health and from Fiorgen Foundation, Florence, Italy.	BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; Boonmark NW, 1997, J CLIN INVEST, V100, P558, DOI 10.1172/JCI119565; Catalano M, 2008, CLIN CHIM ACTA, V387, P109, DOI 10.1016/j.cca.2007.09.014; Clarke R, 2009, NEW ENGL J MED, V361, P2518, DOI 10.1056/NEJMoa0902604; Danik JS, 2013, J THROMB HAEMOST, V11, P205, DOI 10.1111/jth.12056; De Stefano V, 2012, BEST PRACT RES CL HA, V25, P253, DOI 10.1016/j.beha.2012.07.002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Frezzato M, 1996, AM J EPIDEMIOL, V143, P1257; GAW A, 1994, J CLIN INVEST, V93, P2526, DOI 10.1172/JCI117263; Giusti B, 2010, THROMB HAEMOSTASIS, V104, P231, DOI 10.1160/TH09-11-0748; Greif M, 2013, EUR J INTERN MED, V24, P75, DOI 10.1016/j.ejim.2012.08.014; Gurdasani D, 2012, ARTERIOSCL THROM VAS, V32, P3058, DOI 10.1161/ATVBAHA.112.255521; Helgadottir A, 2012, J AM COLL CARDIOL, V60, P722, DOI 10.1016/j.jacc.2012.01.078; Kamstrup PR, 2008, CIRCULATION, V117, P176, DOI 10.1161/CIRCULATIONAHA.107.715698; Kamstrup PR, 2013, J AM COLL CARDIOL, V61, P1146, DOI 10.1016/j.jacc.2012.12.023; Kamstrup PR, 2012, ARTERIOSCL THROM VAS, V32, P1732, DOI 10.1161/ATVBAHA.112.248765; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Koschinsky ML, 2004, CAN J CARDIOL, V20, p37B; Kraft HG, 1996, EUR J HUM GENET, V4, P74; Kraft HG, 1998, HUM MOL GENET, V7, P257, DOI 10.1093/hmg/7.2.257; Kronenberg F, 2013, J INTERN MED, V273, P6, DOI 10.1111/j.1365-2796.2012.02592.x; Langer C, 2011, SEMIN THROMB HEMOST, V37, P810, DOI 10.1055/s-0031-1297172; Lanktree MB, 2010, CIRC-CARDIOVASC GENE, V3, P39, DOI 10.1161/CIRCGENETICS.109.907642; Lanktree MB, 2009, J LIPID RES, V50, P768, DOI 10.1194/jlr.D800050-JLR200; Lippi G, 1999, HAEMATOLOGICA, V84, P726; Marcovina Santica M, 2002, Semin Vasc Med, V2, P335, DOI 10.1055/s-2002-35404; Marcucci R, 2003, AM J MED, V115, P601, DOI 10.1016/j.amjmed.2003.06.005; MARZ W, 1990, KLIN WOCHENSCHR, V68, P111; McColl MD, 2000, BLOOD COAGUL FIBRIN, V11, P225; Momiyama Y, 2012, ATHEROSCLEROSIS, V222, P241, DOI 10.1016/j.atherosclerosis.2012.02.008; Nielsen LB, 1999, ATHEROSCLEROSIS, V143, P229, DOI 10.1016/S0021-9150(99)00064-7; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Qasim AN, 2011, INT J CARDIOL, V150, P17, DOI 10.1016/j.ijcard.2010.02.021; Sofi F, 2007, ATHEROSCLEROSIS, V195, pE147, DOI 10.1016/j.atherosclerosis.2007.05.020; Sofi F, 2007, AM J MED, V120, P728, DOI 10.1016/j.amjmed.2007.01.029; Sotiriou SN, 2006, FASEB J, V20, P559, DOI 10.1096/fj.05-4857fje; Spence JD, 2012, ARTERIOSCL THROM VAS, V32, P1550, DOI 10.1161/ATVBAHA.112.251306; Sticchi E, 2007, MOL GENET METAB, V91, P79, DOI 10.1016/j.ymgme.2006.12.011; Suzuki K, 1997, J CLIN INVEST, V99, P1361, DOI 10.1172/JCI119295; Tsai AW, 2002, ARCH INTERN MED, V162, P1182, DOI 10.1001/archinte.162.10.1182; Tsimikas S, 2012, J AM COLL CARDIOL, V60, P716, DOI 10.1016/j.jacc.2012.04.038; Undas A, 2012, THROMB RES, V130, pE184, DOI 10.1016/j.thromres.2012.06.005; von Depka M, 2000, BLOOD, V96, P3364; Vormittag R, 2007, THROMB RES, V120, P15, DOI 10.1016/j.thromres.2006.03.002; ZYSOW BR, 1995, ARTERIOSCL THROM VAS, V15, P58, DOI 10.1161/01.ATV.15.1.58	46	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149427	10.1371/journal.pone.0149427	http://dx.doi.org/10.1371/journal.pone.0149427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900838	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100075
J	Xie, Y; Bowe, B; Xian, H; Balasubramanian, S; Al-Aly, Z				Xie, Yan; Bowe, Benjamin; Xian, Hong; Balasubramanian, Sumitra; Al-Aly, Ziyad			Renal Function Trajectories in Patients with Prior Improved eGFR Slopes and Risk of Death	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; KIDNEY-FUNCTION DECLINE; ALL-CAUSE MORTALITY; ADVERSE OUTCOMES; MIXTURE-MODELS; SAS PROCEDURE; DISEASE; TIME; CKD	Background Multiple prior studies demonstrated that patients with early Chronic Kidney Disease (CKD) and positive estimated Glomerular Filtration Rate (eGFR) slopes experience increased risk of death. We sought to characterize patients with positive eGFR slopes, examine the renal function trajectory that follows the time period where positive slope is observed, and examine the association between different trajectories and risk of death. Methods and Findings We built a cohort of 204,132 United States veterans with early CKD stage 3; eGFR slopes were defined based on Bayesian mixed-effects models using outpatient eGFR measurements between October 1999 and September 2004; to build renal function trajectories, patients were followed longitudinally thereafter (from October 2004) until September 2013. There were 41,410 (20.29%) patients with positive eGFR slope and they exhibited increased risk of death compared to patients with stable eGFR slope (HR = 1.33, CI: 1.31-1.35). There was an inverse graded association between severity of albuminuria and the odds of positive eGFR slope (OR = 0.94, CI: 0.90-0.98, and OR = 0.76, CI: 0.69-0.84 for microalbuminuria and albuminuria; respectively). Following the time period where positive eGFR slope is observed, we characterized 4 trajectory phenotypes: high eGFR intercept and positive trajectory (HIPT) (12.42%), intermediate intercept and mild negative trajectory (IIMNT) (60.04%), low intercept and fast negative trajectory (LIFNT)(23.33%), and high intercept and fast negative trajectory (HIFNT) (4.20%). Compared to IIMNT (reference group), HIPT is associated with younger age, dementia, HIV, chronic lung disease, peripheral artery disease, weight loss, and inversely associated with albuminuria; LIFNT and HIFNT were associated with diabetes, hypertension, cardiovascular disease, peripheral artery disease, and albuminuria. The risk of death at 9 years was lowest in IIMNT (HR = 1.12, CI: 1.09-1.14), highest in HIPT (HR = 1.71, CI: 1.63-1.79), and intermediate in LIFNT (HR = 1.36, CI: 1.32-1.40) and HIFNT (HR = 1.56, CI: 1.45-1.68). Conclusions Our results demonstrate that patients with positive eGFR slopes, when followed over longer period of time, follow 4 distinct trajectory phenotypes that have distinct demographic and clinical correlates and are differentially associated with risk of death.	[Xie, Yan; Bowe, Benjamin; Xian, Hong; Balasubramanian, Sumitra; Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, St Louis, MO USA; [Xian, Hong] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Biostat, St Louis, MO 63103 USA; [Al-Aly, Ziyad] VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO USA	Saint Louis University	Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Clin Epidemiol Ctr, St Louis, MO USA.; Al-Aly, Z (corresponding author), VA St Louis Hlth Care Syst, Dept Med, Div Nephrol, St Louis, MO USA.	zalay@gmail.com	Al-Aly, Ziyad/S-4439-2016	Al-Aly, Ziyad/0000-0002-2600-0434; Xie, Yan/0000-0002-2457-9382	United States Department of Veterans Affairs	United States Department of Veterans Affairs(US Department of Veterans Affairs)	Funding provided by T21 Grant from the United States Department of Veterans Affairs, PI: ZAA.	Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Benjamin Bowe YX, KIDNEY INT; Bhandari S, 2012, KIDNEY INT, V81, P1152, DOI 10.1038/ki.2012.49; Dodge Hiroko H, 2008, J Data Sci, V6, P247; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hu B, 2012, J AM SOC NEPHROL, V23, P706, DOI 10.1681/ASN.2011050456; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Little RJA, 1996, BIOMETRICS, V52, P98, DOI 10.2307/2533148; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Murphy Patricia A, 2002, Eff Clin Pract, V5, pE4; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Oddone Eugene Z, 2008, N C Med J, V69, P35; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Perkins RM, 2011, CLIN J AM SOC NEPHRO, V6, P1879, DOI 10.2215/CJN.00470111; Tonelli M, 2011, KIDNEY INT, V80, P1306, DOI 10.1038/ki.2011.280; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443; Turin TC, 2012, NEPHROL DIAL TRANSPL, V27, P3835, DOI 10.1093/ndt/gfs263; Turin TC, 2012, AM J NEPHROL, V36, P41, DOI 10.1159/000339289; Turin TC, 2012, J AM SOC NEPHROL, V23, P575, DOI 10.1681/ASN.2012020144; Turin TC, 2011, CLIN J AM SOC NEPHRO, V6, P1805, DOI 10.2215/CJN.05950611; US Department of Veterans Affairs, 2009, VIREC RES US GUID VE; US Department of Veterans Affairs VA Information Resource Center, 2007, VIREC RES US GUID VH; Xie Y, 2015, CLIN J AM SOC NEPHRO, V10, P1946, DOI 10.2215/CJN.04480415	27	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149283	10.1371/journal.pone.0149283	http://dx.doi.org/10.1371/journal.pone.0149283			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900691	gold, Green Published			2022-12-26	WOS:000371276100052
J	Paul, CD; Shea, DJ; Mahoney, MR; Chai, A; Laney, V; Hung, WC; Konstantopoulos, K				Paul, Colin D.; Shea, Daniel J.; Mahoney, Megan R.; Chai, Andreas; Laney, Victoria; Hung, Wei-Chien; Konstantopoulos, Konstantinos			Interplay of the physical microenvironment, contact guidance, and intracellular signaling in cell decision making	FASEB JOURNAL			English	Article						cell migration; microfluidics; confinement	MYOSIN-II; CONFINED MICROENVIRONMENTS; CANCER-CELLS; MIGRATION; INVASION; ADHESION; PLASTICITY; REORGANIZATION; ACTIVATION; COLLAGEN	The peritumoral physical microenvironment consists of complex topographies that influence cell migration. Cell decision making, upon encountering anisotropic, physiologically relevant physical cues, has yet to be elucidated. By integrating microfabrication with cell and molecular biology techniques, we provide a quantitative and mechanistic analysis of cell decision making in a variety of well-defined physical microenvironments. We used MDA-MB-231 breast carcinoma and HT1080 fibrosarcoma as cell models. Cell decision making after lateral confinement in 2-dimensional microcontact printed lines is governed by branch width at bifurcations. Cells confined in narrow feeder microchannels prefer to enter wider branches at bifurcations. In contrast, in feeder channels that are wider than the cell body, cells elongate along one side wall of the channel and are guided by contact with the wall to the contiguous branch channel independent of its width. Knockdown of 1-integrins or inhibition of cellular contractility suppresses contact guidance. Concurrent, but not individual, knockdown of nonmuscle myosin isoforms IIA and IIB also decreases contact guidance, which suggests the existence of a compensatory mechanism between myosin IIA and myosin IIB. Conversely, knockdown or inhibition of cell division control protein 42 homolog promotes contact guidance-mediated decision making. Taken together, the dimensionality, length scales of the physical microenvironment, and intrinsic cell signaling regulate cell decision making at intersections.Paul, C. D., Shea, D. J., Mahoney, M. R., Chai, A., Laney, V., Hung, W.-C., Konstantopoulos, K. Interplay of the physical microenvironment, contact guidance, and intracellular signaling in cell decision making.	[Paul, Colin D.; Shea, Daniel J.; Mahoney, Megan R.; Chai, Andreas; Laney, Victoria; Hung, Wei-Chien; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomol & Chem Engn, 3400 North Charles St,Maryland Hall Room 221, Baltimore, MD 21218 USA; [Paul, Colin D.; Konstantopoulos, Konstantinos] Johns Hopkins Univ, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Konstantopoulos, Konstantinos] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Konstantopoulos, K (corresponding author), Johns Hopkins Univ, Dept Biomol & Chem Engn, 3400 North Charles St,Maryland Hall Room 221, Baltimore, MD 21218 USA.	konstant@jhu.edu		Chai, Andreas/0000-0001-8651-0164	U.S. National Institutes of Health, National Cancer Institute [R01-CA183804, R01-CA186286]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA183804, R01CA186286] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Denis Wirtz (The Johns Hopkins University) for providing HT1080 cells. This study was supported by the U.S. National Institutes of Health, National Cancer Institute Grants R01-CA183804 and R01-CA186286 (to K. K.), and by a National Science Foundation Graduate Research Fellowship (to C. D. P.). The authors declare no conflicts of interest.	Alexander S, 2013, CURR OPIN CELL BIOL, V25, P659, DOI 10.1016/j.ceb.2013.07.001; Alexander S, 2008, HISTOCHEM CELL BIOL, V130, P1147, DOI 10.1007/s00418-008-0529-1; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Chang SS, 2013, BIOPHYS J, V104, P313, DOI 10.1016/j.bpj.2012.12.001; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Doyle AD, 2009, J CELL BIOL, V184, P481, DOI 10.1083/jcb.200810041; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2010, J CELL BIOL, V188, P11, DOI 10.1083/jcb.200909003; Grzesiak JJ, 2011, INT J CANCER, V129, P2905, DOI 10.1002/ijc.25942; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Irimia D, 2009, INTEGR BIOL, V1, P506, DOI 10.1039/b908595e; Kedrin D, 2008, NAT METHODS, V5, P1019, DOI 10.1038/nmeth.1269; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Liu YJ, 2015, CELL, V160, P659, DOI 10.1016/j.cell.2015.01.007; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Maiuri P, 2012, CURR BIOL, V22, pR673, DOI 10.1016/j.cub.2012.07.052; Mak M, 2014, LAB CHIP, V14, P964, DOI 10.1039/c3lc51173a; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Pasapera AM, 2010, J CELL BIOL, V188, P877, DOI 10.1083/jcb.200906012; Prentice-Mott HV, 2013, P NATL ACAD SCI USA, V110, P21006, DOI 10.1073/pnas.1317441110; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Raman PS, 2013, LAB CHIP, V13, P4599, DOI 10.1039/c3lc50802a; Ross TD, 2013, CURR OPIN CELL BIOL, V25, P613, DOI 10.1016/j.ceb.2013.05.006; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Scherber C, 2012, INTEGR BIOL-UK, V4, P259, DOI 10.1039/c2ib00106c; Shieh AC, 2011, CANCER RES, V71, P790, DOI 10.1158/0008-5472.CAN-10-1513; Stroka KM, 2014, CURR OPIN CELL BIOL, V30, P41, DOI 10.1016/j.ceb.2014.06.001; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Tozluoglu M, 2013, NAT CELL BIOL, V15, P751, DOI 10.1038/ncb2775; Wang P, 2015, ONCOGENE, V34, P4558, DOI 10.1038/onc.2014.397; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Wolf K, 2009, SEMIN CELL DEV BIOL, V20, P931, DOI 10.1016/j.semcdb.2009.08.005; Zuo YF, 2012, J CELL PHYSIOL, V227, P1399, DOI 10.1002/jcp.22853	45	33	34	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2161	2170		10.1096/fj.201500199R	http://dx.doi.org/10.1096/fj.201500199R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26902610	Green Published			2022-12-26	WOS:000376878300010
J	Dohmen, LCT; Navas, A; Vargas, DA; Gregory, DJ; Kip, A; Dorlo, TPC; Gomez, MA				Dohmen, Luuk C. T.; Navas, Adriana; Vargas, Deninson Alejandro; Gregory, David J.; Kip, Anke; Dorlo, Thomas P. C.; Adelaida Gomez, Maria			Functional Validation of ABCA3 as a Miltefosine Transporter in Human Macrophages IMPACT ON INTRACELLULAR SURVIVAL OF LEISHMANIA (VIANNIA) PANAMENSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-LIKE TRANSPORTER; BINDING CASSETTE TRANSPORTER; CUTANEOUS LEISHMANIASIS; DRUG-RESISTANCE; METABOLIZING-ENZYMES; MULTIDRUG-RESISTANCE; TREATMENT FAILURE; LEUKEMIA-CELLS; SUSCEPTIBILITY; PHENOTYPE	Within its mammalian host, Leishmania resides and replicates as an intracellular parasite. The direct activity of antileishmanials must therefore depend on intracellular drug transport, metabolism, and accumulation within the host cell. In this study, we explored the role of human macrophage transporters in the intracellular accumulation and antileishmanial activity of miltefosine (MLF), the only oral drug available for the treatment of visceral and cutaneous leishmaniasis (CL). Membrane transporter gene expression in primary human macrophages infected in vitro with Leishmania Viannia panamensis and exposed to MLF showed modulation of ABC and solute liquid carrier transporters gene transcripts. Among these, ABCA3, a lipid transporter, was significantly induced after exposure to MLF, and this induction was confirmed in primary macrophages from CL patients. Functional validation of MLF as a substrate for ABCA3 was performed by shRNA gene knockdown (KD) in THP-1 monocytes. Intracellular accumulation of radiolabeled MLF was significantly higher in ABCA3KD macrophages. ABCA3KD resulted in increased cytotoxicity induced by MLF exposure. ABCA3 gene expression inversely correlated with intracellular MLF content in primary macrophages from CL patients. ABCA3KD reduced parasite survival during macrophage infection with an L. V. panamensis strain exhibiting low in vitro susceptibility to MLF. Confocal microscopy showed ABCA3 to be located in the cell membrane of resting macrophages and in intracellular compartments in L. V. panamensis-infected cells. These results provide evidence of ABCA3 as an MLF efflux transporter in human macrophages and support its role in the direct antileishmanial effect of this alkylphosphocholine drug.	[Adelaida Gomez, Maria] Ctr Int Entrenamiento & Invest Med, Cra 125 19-225, Cali, Colombia; [Dohmen, Luuk C. T.; Kip, Anke; Dorlo, Thomas P. C.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, NL-3508 TB Utrecht, Netherlands; [Gregory, David J.] Harvard Univ, TH Chan Sch Publ Hlth, Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Kip, Anke] Slotervaart Hosp, Antoni van Leeuwenhoek Hosp, Dept Pharm & Pharmacol, NL-1066 CX Amsterdam, Netherlands; [Dorlo, Thomas P. C.] Uppsala Univ, Dept Pharmaceut Biosci, S-75124 Uppsala, Sweden	Utrecht University; Harvard University; Harvard T.H. Chan School of Public Health; Slotervaart Hospital; Uppsala University	Gomez, MA (corresponding author), Ctr Int Entrenamiento & Invest Med, Cra 125 19-225, Cali, Colombia.	mgomez@cideim.org.co	Dorlo, Thomas/F-1339-2011; Navas, Adriana/ABC-7647-2020; Gregory, David/P-2582-2015	Dorlo, Thomas/0000-0003-3076-8435; Gregory, David/0000-0001-6534-7150; Gomez, Maria Adelaida/0000-0001-8792-1563	COLCIENCIAS [250-2010, 2229-519-28930, 738-2009, 2229-49326161]; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant [B00032]; NIAID, National Institutes of Health [R01AI104823]; FOGARTY INTERNATIONAL CENTER [D43TW006589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104823] Funding Source: NIH RePORTER	COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in part, by COLCIENCIAS Grants 250-2010, Code 2229-519-28930, and 738-2009, Code 2229-49326161, the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Re-entry Grant B00032, and NIAID, National Institutes of Health Grant R01AI104823. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Gomez MA, 2014, J ANTIMICROB CHEMOTH, V69, P139, DOI 10.1093/jac/dkt334; Agrawal A, 2012, PEDIATR RES, V71, P633, DOI 10.1038/pr.2012.21; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Bosch Tessa M., 2008, V448, P63, DOI 10.1007/978-1-59745-205-2_5; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chapuy B, 2008, LEUKEMIA, V22, P1576, DOI 10.1038/leu.2008.103; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Cohen AL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.47; Rubiano LC, 2012, J INFECT DIS, V205, P684, DOI 10.1093/infdis/jir816; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Escobar P, 2002, ACTA TROP, V81, P151, DOI 10.1016/S0001-706X(01)00197-8; Kip AE, 2015, J CHROMATOGR B, V998, P57, DOI 10.1016/j.jchromb.2015.06.017; Fernandez OL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002871; Matsumura Y, 2007, FEBS LETT, V581, P3139, DOI 10.1016/j.febslet.2007.05.078; Menez C, 2007, LIPIDS, V42, P229, DOI 10.1007/s11745-007-3026-8; Menez C, 2007, PHARM RES-DORDR, V24, P546, DOI 10.1007/s11095-006-9170-7; Obonaga R, 2014, ANTIMICROB AGENTS CH, V58, P144, DOI 10.1128/AAC.01023-13; Overbeck TR, 2013, ONCOLOGY-BASEL, V84, P362, DOI 10.1159/000348884; Perez-Victoria JM, 2002, CURR DRUG TARGETS, V3, P311, DOI 10.2174/1389450023347588; Perez-Victoria JM, 2001, ANTIMICROB AGENTS CH, V45, P2468, DOI 10.1128/AAC.45.9.2468-2474.2001; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Roy G, 2000, MOL BIOCHEM PARASIT, V110, P195, DOI 10.1016/S0166-6851(00)00270-X; Rybczynska M, 2001, BRIT J CANCER, V84, P1405, DOI 10.1054/bjoc.2001.1776; Seifert K, 2010, J ANTIMICROB CHEMOTH, V65, P508, DOI 10.1093/jac/dkp500; Song JH, 2008, INT J ONCOL, V32, P931; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Soto J, 2008, AM J TROP MED HYG, V78, P210, DOI 10.4269/ajtmh.2008.78.210; Tarling EJ, 2013, TRENDS ENDOCRIN MET, V24, P342, DOI 10.1016/j.tem.2013.01.006; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272; Zhou HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031752	37	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9638	9647		10.1074/jbc.M115.688168	http://dx.doi.org/10.1074/jbc.M115.688168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26903515	Green Published, hybrid			2022-12-26	WOS:000375602300022
J	Patel, D; Menon, D; Bernfeld, E; Mroz, V; Kalan, S; Loayza, D; Foster, DA				Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Mroz, Victoria; Kalan, Sampada; Loayza, Diego; Foster, David A.			Aspartate Rescues S-phase Arrest Caused by Suppression of Glutamine Utilization in KRas-driven Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHESIS; REPLICATION; CHECKPOINT; PROTEIN; ATR; DNA	During G(1)-phase of the cell cycle, normal cells respond first to growth factors that indicate that it is appropriate to divide and then later in G(1) to the presence of nutrients that indicate sufficient raw material to generate two daughter cells. Dividing cells rely on the "conditionally essential" amino acid glutamine (Q) as an anaplerotic carbon source for TCA cycle intermediates and as a nitrogen source for nucleotide biosynthesis. We previously reported that while non-transformed cells arrest in the latter portion of G(1) upon Q deprivation, mutant KRas-driven cancer cells bypass the G(1) checkpoint, and instead, arrest in S-phase. In this study, we report that the arrest of KRas-driven cancer cells in S-phase upon Q deprivation is due to the lack of deoxynucleotides needed for DNA synthesis. The lack of deoxynucleotides causes replicative stress leading to activation of the ataxia telangiectasia and Rad3-related protein (ATR)-mediated DNA damage pathway, which arrests cells in S-phase. The key metabolite generated from Q utilization was aspartate, which is generated from a transaminase reaction whereby Q-derived glutamate is converted to alpha-ketoglutarate with the concomitant conversion of oxaloacetate to aspartate. Aspartate is a critical metabolite for both purine and pyrimidine nucleotide biosynthesis. This study identifies the molecular basis for the S-phase arrest caused by Q deprivation in KRas-driven cancer cells that arrest in S-phase in response to Q deprivation. Given that arresting cells in S-phase sensitizes cells to apoptotic insult, this study suggests novel therapeutic approaches to KRas-driven cancers.	[Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Mroz, Victoria; Kalan, Sampada; Loayza, Diego; Foster, David A.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10065 USA; [Patel, Deven; Menon, Deepak; Bernfeld, Elyssa; Loayza, Diego; Foster, David A.] CUNY, Grad Ctr, Biochem Program, New York, NY 10016 USA; [Kalan, Sampada; Loayza, Diego; Foster, David A.] CUNY, Grad Ctr, Biol Program, New York, NY 10016 USA; [Foster, David A.] Weill Cornell Coll Med, Dept Pharmacol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Foster, DA (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 413 East 69th St, New York, NY 10021 USA.	foster@genectr.hunter.cuny.edu	Patel, Deven/J-4886-2019; Menon, Deepak/S-7899-2019	Menon, Deepak/0000-0002-6529-7859; Lehman, Elyssa/0000-0002-9869-1588	NCI, National Institutes of Health [R01-CA046677, R01-CA179542]; National Center for Research Resources of the National Institutes of Health [RR-03039]; NATIONAL CANCER INSTITUTE [R01CA046677, R01CA179542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM094071] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grants R01-CA046677, R01-CA179542 from the NCI, National Institutes of Health. Research Centers in Minority Institutions Award RR-03039 from the National Center for Research Resources of the National Institutes of Health, which supports infrastructure and instrumentation in the Biological Sciences Dept. at Hunter College, is also acknowledged. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Boza JJ, 2000, EUR J NUTR, V39, P38, DOI 10.1007/s003940050074; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dai Y, 2013, MOL CANCER THER, V12, P878, DOI 10.1158/1535-7163.MCT-12-0902; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Foster David A, 2010, Genes Cancer, V1, P1124, DOI 10.1177/1947601910392989; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Goodarzi Aaron A, 2003, Prog Cell Cycle Res, V5, P393; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Rabinovich S, 2015, NATURE, V527, P379, DOI 10.1038/nature15529; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Saqcena M., ONCOGENE, V34, P2672; Saqcena M, 2015, CELL CYCLE, V14, P2285, DOI 10.1080/15384101.2015.1046653; Saqcena M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074157; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Van Vranken JG, 2015, CELL, V162, P471, DOI 10.1016/j.cell.2015.07.027; Wasa M, 1996, ANN SURG, V224, P189, DOI 10.1097/00000658-199608000-00012; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018	26	45	48	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9322	9329		10.1074/jbc.M115.710145	http://dx.doi.org/10.1074/jbc.M115.710145			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26921316	Green Published, hybrid			2022-12-26	WOS:000374849000040
J	Jiang, SS; Dai, L; Qin, Y; Xiong, L; Sun, QJ				Jiang, Suisui; Dai, Lei; Qin, Yang; Xiong, Liu; Sun, Qingjie			Preparation and Characterization of Octenyl Succinic Anhydride Modified Taro Starch Nanoparticles	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; NANOCRYSTALS; ESTERIFICATION; FILMS; RICE; OSA	The polar surface and hydrophilicity of starch nanoparticles (SNPs) result in their poor dispersibility in nonpolar solvent and poor compatibility with hydrophobic polymers, which limited the application in hydrophobic system. To improve their hydrophobicity, SNPs prepared through self-assembly of short chain amylose debranched from cooked taro starch, were modified by octenyl succinic anhydride (OSA). Size via dynamic light scattering of OSA-SNPs increased compared with SNPs. Fourier transform infrared spectroscopy data indicated the OSA-SNPs had a new absorption peak at 1727 cm(-1), which was the characteristic peak of carbonyl, indicating the formation of the ester bond. The dispersibility of the modified SNPs in the mixture of water with nonpolar solvent increased with increasing of degree of substitution (DS). OSA-SNPs appear to be a potential agent to stabilize the oil-water systems.	[Jiang, Suisui; Dai, Lei; Qin, Yang; Xiong, Liu; Sun, Qingjie] Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China; [Dai, Lei] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China	Qingdao Agricultural University; China Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China.	phdsun@163.com	Dai, Lei/HCH-4898-2022	Dai, Lei/0000-0002-9491-6567				Abbas S, 2014, ULTRASON SONOCHEM, V21, P1265, DOI 10.1016/j.ultsonch.2013.12.017; Bao JS, 2003, J AGR FOOD CHEM, V51, P2283, DOI 10.1021/jf020371u; Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015; Dai L, 2015, FOOD CHEM, V174, P82, DOI 10.1016/j.foodchem.2014.11.005; Duan B, 2011, STARCH-STARKE, V63, P528, DOI 10.1002/star.201000136; Garcia NL, 2012, POLYM DEGRAD STABIL, V97, P2021, DOI 10.1016/j.polymdegradstab.2012.03.032; Garcia NL, 2011, CARBOHYD POLYM, V84, P203, DOI 10.1016/j.carbpol.2010.11.024; He GQ, 2006, J AGR FOOD CHEM, V54, P2775, DOI 10.1021/jf052981a; Jeon YS, 1999, STARCH-STARKE, V51, P90, DOI 10.1002/(SICI)1521-379X(199903)51:2<90::AID-STAR90>3.3.CO;2-D; Jivan MJ, 2013, FOOD CHEM, V141, P1661, DOI 10.1016/j.foodchem.2013.04.071; Mahadevan B, 2014, FOOD CHEM TOXICOL, V72, P83, DOI 10.1016/j.fct.2014.07.009; Mayol L, 2014, CARBOHYD POLYM, V102, P110, DOI 10.1016/j.carbpol.2013.11.003; Miao M, 2014, FOOD CHEM, V151, P154, DOI 10.1016/j.foodchem.2013.11.043; Namazi H, 2010, CARBOHYD POLYM, V79, P731, DOI 10.1016/j.carbpol.2009.09.033; Payyappilly SS, 2014, SOFT MATTER, V10, P2150, DOI 10.1039/c3sm52699b; Ren LL, 2014, IND CROP PROD, V59, P115, DOI 10.1016/j.indcrop.2014.05.014; Ren LL, 2010, CARBOHYD POLYM, V82, P1010, DOI 10.1016/j.carbpol.2010.05.041; Simsek S, 2012, CARBOHYD POLYM, V90, P1204, DOI 10.1016/j.carbpol.2012.06.039; Song SW, 2008, J APPL POLYM SCI, V107, P418, DOI 10.1002/app.27076; Sweedman MC, 2013, CARBOHYD POLYM, V92, P905, DOI 10.1016/j.carbpol.2012.09.040; Tizzotti MJ, 2013, FOOD HYDROCOLLOID, V31, P365, DOI 10.1016/j.foodhyd.2012.11.023; Wang C, 2014, ARAB J SCI ENG, V39, P6703, DOI 10.1007/s13369-014-1201-9; Wang C, 2013, FOOD CHEM, V141, P3381, DOI 10.1016/j.foodchem.2013.06.029; Wang JP, 2010, J SCI FOOD AGR, V90, P424, DOI 10.1002/jsfa.3832; Xu YF, 2015, FOOD HYDROCOLLOID, V48, P55, DOI 10.1016/j.foodhyd.2015.02.010; Xu Y, 2010, CARBOHYD POLYM, V80, P1078, DOI 10.1016/j.carbpol.2010.01.027; Yusoff A, 2011, FOOD HYDROCOLLOID, V25, P42, DOI 10.1016/j.foodhyd.2010.05.004; Zare Y, 2013, WASTE MANAGE, V33, P598, DOI 10.1016/j.wasman.2012.07.031; Zhang B, 2011, CARBOHYD POLYM, V84, P1276, DOI 10.1016/j.carbpol.2011.01.020; Zheng H, 2009, POLYM COMPOSITE, V30, P474, DOI 10.1002/pc.20612; Zhu J, 2013, FOOD HYDROCOLLOID, V32, P1, DOI 10.1016/j.foodhyd.2012.11.033; Zou JW, 2011, CARBOHYD POLYM, V85, P824, DOI 10.1016/j.carbpol.2011.04.006	32	36	38	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150043	10.1371/journal.pone.0150043	http://dx.doi.org/10.1371/journal.pone.0150043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918568	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400075
J	Steinach, M; Kohlberg, E; Maggioni, MA; Mendt, S; Opatz, O; Stahn, A; Gunga, HC				Steinach, Mathias; Kohlberg, Eberhard; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Gunga, Hanns-Christian			Sleep Quality Changes during Overwintering at the German Antarctic Stations Neumayer II and III: The Gender Factor	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; RESTING ENERGY-EXPENDITURE; FAT-FREE MASS; PHYSICAL-ACTIVITY; CIRCADIAN PHASE; SENSEWEAR ARMBAND; ACTIVITY MONITORS; BODY-COMPOSITION; SEX-DIFFERENCES; NATURAL LIGHT	Purpose Antarctic residence holds many challenges to human physiology, like increased psychosocial tension and altered circadian rhythm, known to influence sleep. We assessed changes in sleep patterns during 13 months of overwintering at the German Stations Neumayer II and III from 2008 to 2014, with focus on gender, as many previous investigations were inconclusive regarding gender-based differences or had only included men. Materials & Methods Time in bed, sleep time, sleep efficiency, number of arousals, sleep latency, sleep onset, sleep offset, and physical activity level were determined twice per month during seven overwintering campaigns of n = 54 participants (37 male, 17 female) using actimetry. Data were analyzed using polynomial regression and analysis of covariance for change over time with the covariates gender, inhabited station, overwintering season and influence of physical activity and local sunshine radiation. Results We found overall longer times in bed (p = 0.004) and sleep time (p = 0.014) for women. The covariate gender had a significant influence on time in bed (p<0.001), sleep time (p<0.001), number of arousals (p = 0.04), sleep latency (p = 0.04), and sleep onset (p<0.001). Women separately (p = 0.02), but not men (p = 0.165), showed a linear increase in number of arousals. Physical activity decreased over overwintering time for men (p = 0.003), but not for women (p = 0.174). The decline in local sunshine radiation led to a 48 minutes longer time in bed (p<0.001), 3.8% lower sleep efficiency (p<0.001), a delay of 32 minutes in sleep onset (p<0.001), a delay of 54 minutes in sleep offset (p<0.001), and 11% less daily energy expenditure (p<0.001), for all participants in reaction to the Antarctic winter's darkness-phase. Conclusions Overwinterings at the Stations Neumayer II and III are associated with significant changes in sleep patterns, with dependences from overwintering time and local sunshine radiation. Gender appears to be an influence, as women showed a declining sleep quality, despite that their physical activity remained unchanged, suggesting other causes such as a higher susceptibility to psycho-social stress and changes in environmental circadian rhythm during long-term isolation in Antarctica.	[Steinach, Mathias; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Gunga, Hanns-Christian] Charite, Ctr Space Med & Extreme Environm Berlin, Inst Physiol, D-13353 Berlin, Germany; [Kohlberg, Eberhard] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Maggioni, Martina Anna] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Milan	Steinach, M (corresponding author), Charite, Ctr Space Med & Extreme Environm Berlin, Inst Physiol, D-13353 Berlin, Germany.	mathias.steinach@charite.de	Maggioni, Martina Anna/P-1351-2019; Maggioni, Martina Anna A/M-2931-2016	Maggioni, Martina Anna/0000-0002-6319-8566; Maggioni, Martina Anna A/0000-0002-6319-8566; Mendt, Stefan/0000-0001-8227-9655	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne) [AZ50WB0724, AZ50WB1030, AZ50WB1330]	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne)	All Grants received by the Federal Ministry for Economic Affairs and Energy (BMWi, Berlin, website: http://www.bmwi.de/en); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel, website: http://www.dlr.de/rd/en); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne, website: http://www.dlr.de/dlr/en) [Grant numbers: "Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724" (AZ50WB0724), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030" (AZ50WB1030), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330" (AZ50WB1330) (to HCG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert K, 2015, PSYCHONEUROENDOCRINO, V59, P14, DOI 10.1016/j.psyneuen.2015.04.022; Almeida GJM, 2011, PHYS THER, V91, P1367, DOI 10.2522/ptj.20100291; ANGUS RG, 1979, AVIAT SPACE ENVIR MD, V50, P692; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; AWI, 2012, A WEG I POL MAR RES; Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; Belavy DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060090; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; BIERSNER RJ, 1984, J RES PERS, V18, P491, DOI 10.1016/0092-6566(84)90007-2; BodyMedia Inc., 2010, SENSEWEAR ARMB DISPL; BOGOSLOV.MM, 1974, LANCET, V1, P503, DOI 10.1016/S0140-6736(74)92803-7; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; BROADWAY J, 1987, NEUROSCI LETT, V79, P185, DOI 10.1016/0304-3940(87)90694-X; BUGUET A, 1987, SLEEP, V10, P374, DOI 10.1093/sleep/10.4.374; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carvalho FG, 2014, CHRONOBIOL INT, V31, P442, DOI 10.3109/07420528.2013.846350; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; Chae KY, 2009, SLEEP MED, V10, P621, DOI 10.1016/j.sleep.2008.07.009; Conradt R, 1997, Pneumologie, V51 Suppl 3, P721; Corbett RW, 2012, NEUROSCI LETT, V525, P146, DOI 10.1016/j.neulet.2012.06.046; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; DUNCAN R, 1988, EUR J APPL PHYSIOL, V57, P514, DOI 10.1007/BF00418001; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Finan PH, 2015, SLEEP, V38, P1735, DOI 10.5665/sleep.5154; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Goel N, 2005, CHRONOBIOL INT, V22, P905, DOI 10.1080/07420520500263235; Goel N, 2014, J WOMENS HEALTH, V23, P975, DOI 10.1089/jwh.2014.4911; GUNDERSON EK, 1963, ARCH GEN PSYCHIAT, V9, P362; Gunga H. -C., 2015, HUMAN PHYSL EXTREME, P273, DOI [10.1016/B978-0-12-386947-0.00007-1, DOI 10.1016/B978-0-12-386947-0.00007-1]; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Hanninen V, 1996, SOC SCI MED, V43, P1453, DOI 10.1016/0277-9536(96)00045-7; Harb F, 2015, CHRONOBIOL INT, V32, P368, DOI 10.3109/07420528.2014.982757; Ikegawa M, 1998, AVIAT SPACE ENVIR MD, V69, P452; Illner K, 2000, AM J PHYSIOL-ENDOC M, V278, pE308, DOI 10.1152/ajpendo.2000.278.2.E308; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; JOERN AT, 1970, ARCH INTERN MED, V125, P649, DOI 10.1001/archinte.125.4.649; Jones V, 2011, INT J TELEMED APPL, V2011, DOI 10.1155/2011/671040; KAUPPILA A, 1987, J CLIN ENDOCR METAB, V65, P823, DOI 10.1210/jcem-65-5-823; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Kobayashi R, 1998, PSYCHIAT CLIN NEUROS, V52, P186, DOI 10.1111/j.1440-1819.1998.tb01021.x; KOKHANOVSKY A.A., 2006, CLOUD OPTICS; Kraft NO, 2002, AVIAT SPACE ENVIR MD, V73, P1089; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Lee HJ, 2011, J AFFECT DISORDERS, V133, P573, DOI 10.1016/j.jad.2011.04.046; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lorton D, 2006, NEUROIMMUNOMODULAT, V13, P357, DOI 10.1159/000104864; Lucht M., 1999, ARCH WOMEN MENT HLTH, V2, P83, DOI DOI 10.1007/S007370050040; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Middleton B, 2002, NEUROSCI LETT, V329, P41, DOI 10.1016/S0304-3940(02)00574-8; Mottram V, 2011, J SLEEP RES, V20, P154, DOI 10.1111/j.1365-2869.2010.00875.x; Moyer D B, 1976, US Navy Med, V67, P19; NASA Quest Website, 2015, INF LIV ANT HDB MCMU; NATANI K, 1970, ARCH INTERN MED, V125, P655, DOI 10.1001/archinte.125.4.655; Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; O'Driscoll DM, 2013, SLEEP BREATH, V17, P139, DOI 10.1007/s11325-012-0662-x; Oginska H, 2014, CHRONOBIOL INT, V31, P523, DOI 10.3109/07420528.2013.874355; Palinkas L A, 2000, Int J Circumpolar Health, V59, P63; Palinkas L A, 1989, Med Anthropol, V10, P235; PALINKAS LA, 1992, SOC SCI MED, V35, P651, DOI 10.1016/0277-9536(92)90004-A; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, pA29; Palinkas Lawrence A, 2004, Int J Circumpolar Health, V63, P157; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; PALMAI G, 1963, BRIT J PSYCHIAT, V109, P364, DOI 10.1192/bjp.109.460.364; PATERSON RA, 1975, LANCET, V1, P468, DOI 10.1016/S0140-6736(75)91552-4; POLOSATOV MV, 1973, SOVIET ANTARCTICA EX, V86, P69; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; Reitz CJ, 2015, CURR PHARM DESIGN, V21, P3505, DOI 10.2174/1381612821666150706105926; Roane BM, 2015, J SLEEP RES, V24, P714, DOI 10.1111/jsr.12317; Roosli M, 2014, NOISE HEALTH, V16, P197, DOI 10.4103/1463-1741.137036; Rosnet E, 2004, AVIAT SPACE ENVIR MD, V75, pC10; ROTHBLUM ED, 1990, J PSYCHOL, V124, P253, DOI 10.1080/00223980.1990.10543221; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Schneider S, 2010, BEHAV BRAIN RES, V211, P208, DOI 10.1016/j.bbr.2010.03.034; Serreze MC, 2005, ARCTIC CLIMATE SYSTE, P120; Shayler DJ, 2005, WOMEN SPACE FOLLOWIN; Shearer WT, 2002, J ALLERGY CLIN IMMUN, V109, P854, DOI 10.1067/mai.2002.123873; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Shin M, 2015, SLEEP SCI, V8, P9, DOI 10.1016/j.slsci.2015.02.003; Simpson A, 2010, INT J CIRCUMPOL HEAL, V69, P220, DOI 10.3402/ijch.v69i3.17625; Soric M, 2013, SLEEP MED, V14, P201, DOI 10.1016/j.sleep.2012.11.003; Stahn A, 2012, HDB ANTHROPOMETRY PH, P49; Steinach M., 2012, STRESS CHALLENGES IM, P87; Steinach M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144130; STRANGE RE, 1971, ANTARCT J US, V6, P255; Strassl H, 1951, POLARFORSCHUNG, V21, P40; STROUD MA, 1993, EUR J APPL PHYSIOL O, V67, P375, DOI 10.1007/BF00357638; Suedfeld P, 2000, ENVIRON BEHAV, V32, P7, DOI 10.1177/00139160021972405; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Weess H-G, 2009, PRAXIS SCHLAFMEDIZIN, P23; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Yoneyama S, 1999, AM J PHYSIOL-REG I, V277, pR1091, DOI 10.1152/ajpregu.1999.277.4.R1091; Zavalko I M, 2013, Fiziol Cheloveka, V39, P45	103	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150099	10.1371/journal.pone.0150099	http://dx.doi.org/10.1371/journal.pone.0150099			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918440	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400086
J	Taba, ST; Hossain, L; Heard, R; Brennan, P; Lee, W; Lewis, S				Taba, Seyedamir Tavakoli; Hossain, Liaquat; Heard, Robert; Brennan, Patrick; Lee, Warwick; Lewis, Sarah			Personal and Network Dynamics in Performance of Knowledge Workers: A Study of Australian Breast Radiologists	PLOS ONE			English	Article							SOCIAL NETWORKS; SELF-ESTEEM; DIVERSITY; FEEDBACK; TASK; JOB	Materials and Methods In this paper, we propose a theoretical model based upon previous studies about personal and social network dynamics of job performance. We provide empirical support for this model using real-world data within the context of the Australian radiology profession. An examination of radiologists' professional network topology through structural-positional and relational dimensions and radiologists' personal characteristics in terms of knowledge, experience and self-esteem is provided. Thirty one breast imaging radiologists completed a purpose designed questionnaire regarding their network characteristics and personal attributes. These radiologists also independently read a test set of 60 mammographic cases: 20 cases with cancer and 40 normal cases. A Jackknife free response operating characteristic (JAFROC) method was used to measure the performance of the radiologists' in detecting breast cancers. Results Correlational analyses showed that reader performance was positively correlated with the social network variables of degree centrality and effective size, but negatively correlated with constraint and hierarchy. For personal characteristics, the number of mammograms read per year and self-esteem (self-evaluation) positively correlated with reader performance. Hierarchical multiple regression analysis indicated that the combination of number of mammograms read per year and network's effective size, hierarchy and tie strength was the best fitting model, explaining 63.4% of the variance in reader performance. The results from this study indicate the positive relationship between reading high volumes of cases by radiologists and expertise development, but also strongly emphasise the association between effective social/professional interactions and informal knowledge sharing with high performance.	[Taba, Seyedamir Tavakoli; Hossain, Liaquat] Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW, Australia; [Hossain, Liaquat] Univ Hong Kong, Div Informat & Technol Studies, Fac Educ, Hong Kong, Hong Kong, Peoples R China; [Heard, Robert] Univ Sydney, Hlth Syst & Global Populat Res Grp, Fac Hlth Sci, Sydney, NSW, Australia; [Brennan, Patrick; Lee, Warwick; Lewis, Sarah] Univ Sydney, Med Image Optimisat & Percept Grp MIOPeG, Fac Hlth Sci, Sydney, NSW, Australia	University of Sydney; University of Hong Kong; University of Sydney; University of Sydney	Taba, ST (corresponding author), Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW, Australia.	amir.tavakoli@sydney.edu.au	Brennan, Patrick/AAC-7774-2019; /E-7946-2010	Brennan, Patrick/0000-0001-8611-7258; /0000-0002-7616-9182	BREAST Australia from National Breast Cancer Foundation; National Breast Cancer Foundation [IF-12-02] Funding Source: researchfish	BREAST Australia from National Breast Cancer Foundation; National Breast Cancer Foundation	This study was supported by the BREAST Australia Infrastructure through funding from the National Breast Cancer Foundation.	Alcantara SB, 2014, EUR J CANCER CARE, V23, P616, DOI 10.1111/ecc.12169; BALZER WK, 1989, PSYCHOL BULL, V106, P410, DOI 10.1037/0033-2909.106.3.410; Bdeir F., 2013, NETWORKS INTERORGANI; Bernardin H.J., 1984, PERFORMANCE APPRAISA; Borgatti SP., 2006, E NET SOFTWARE ANAL; Burt R. S, 1992, STRUCTURAL HOLES; Burt RS, 2012, BMJ QUAL SAF, V21, P992, DOI 10.1136/bmjqs-2011-000521; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Campbell J. P., 1993, PERSONNEL SELECTION, P35; Campbell J.P., 1996, FRONT IND ORG PSYCH, V1st, P258; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Chung KSK, 2009, PROJ MANAG J, V40, P34, DOI 10.1002/pmj.20115; Cleveland, 1983, PERFORMANCE MEASUREM, P257; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Cross R, 2004, ACAD MANAGE J, V47, P928, DOI 10.2307/20159632; Gardner DG, 1998, GROUP ORGAN MANAGE, V23, P48, DOI 10.1177/1059601198231004; Garton L, 1997, J COMPUT-MEDIAT COMM, V3; Halgin D.S., 2012, CONNECTIONS, VVol. 32, P37; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Hegarty M, 2010, J EXP PSYCHOL LEARN, V36, P37, DOI 10.1037/a0017683; Knoke D., 2008, SOCIAL NETWORK ANAL; KRACKHARDT D, 1988, SOC PSYCHOL QUART, V51, P123, DOI 10.2307/2786835; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Marsden PV, 2002, SOC NETWORKS, V24, P407, DOI 10.1016/S0378-8733(02)00016-3; McCrae R. R., 1996, 5 FACTOR MODEL PERSO, P51; Meisel MK, 2013, ADDICTION, V108, P584, DOI 10.1111/add.12014; Miglioretti DL, 2007, J NATL CANCER I, V99, P1854, DOI 10.1093/jnci/djm238; Motowidlo SJ, 1997, HUM PERFORM, V10, P71, DOI 10.1207/s15327043hup1002_1; P/L AsH, 2008, ROL RAD MULT CAR TEA; PIERCE JL, 1989, ACAD MANAGE J, V32, P622, DOI 10.2307/256437; Quinones MA, 1995, PERS PSYCHOL, V48, P887, DOI 10.1111/j.1744-6570.1995.tb01785.x; Rawashdeh M, 2013, IMPACT USING JAFROC; Rawashdeh MA, 2013, RADIOLOGY, V269, P61, DOI 10.1148/radiol.13122581; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637; Reed WM, 2010, ACAD RADIOL, V17, P1409, DOI 10.1016/j.acra.2010.06.016; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Suleiman WI, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.1.015503; TEACHMAN JD, 1980, SOCIOL METHOD RES, V8, P341, DOI 10.1177/004912418000800305; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Van Deven T, 2013, EUR J RADIOL, V82, P883, DOI 10.1016/j.ejrad.2012.12.001; Waldie KE, 1996, AM J MENT RETARD, V100, P620; WEGENER B, 1991, AM SOCIOL REV, V56, P60, DOI 10.2307/2095673; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X	45	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150186	10.1371/journal.pone.0150186	http://dx.doi.org/10.1371/journal.pone.0150186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918644	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400099
J	Wang, J; Li, X; Lu, D; Du, Y; Ma, L; Li, WJ; Chen, JH; Li, FL; Fan, Y; Hu, GR; Wang, JF				Wang, Jie; Li, Xin; Lu, Dong; Du, Yan; Ma, Liang; Li, Wenjian; Chen, Jihong; Li, Fuli; Fan, Yong; Hu, Guangrong; Wang, Jufang			Photosynthetic Effect in Selenastrum capricornutum Progeny after Carbon-Ion Irradiation	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; MUTATION-RATE; PHOTOPROTECTION; MUTANTS; COMPLEX; NANNOCHLOROPSIS; INDUCTION; SPECTRUM; STRESS	A large proportion of mutants with altered pigment features have been obtained via exposure to heavy-ion beams, a technique that is efficient for trait improvement in the breeding of plants and algae. However, little is known about the underlying mechanisms by which the photosynthetic pigments are altered by heavy-ion irradiation. In our study, the photosynthetic characteristics of progenies from carbon-ion irradiated Selenastrum capricornutum were investigated. Five progenies deficient in chlorophyll a were isolated after carbon-ion exposure. Photosynthetic characteristics, photoprotection capacity and gene expression of the light-harvesting complex in these progenies were further characterized by the measurement of chlorophyll fluorescence parameters (Fv/Fm,.PSII, NPQ, ETR), the de-epoxidation state of the xanthophyll cycle, the amount of lutein and quantitative real-time PCR. High maximum quantum yield of photosystem II at day 10 and high thermal dissipation ability were observed in progenies #23 and #37 under normal culture condition. Progenies #18, #19 and #20 showed stronger resistance against high levels of light steps than the control group (612-1077 mu mol photons m(-2) s(-1), p< 0.05). The progenies #20 and #23 exhibited strong photoprotection by thermal dissipation and quenching of (3)Chl* after 24 h of high light treatment. The mRNA levels of Lhcb5, Lhcbm5 and Lhcbm1 of the light-harvesting complex revealed markedly differential expression in the five progenies irradiated by carbon-ion beams. This work indicates that photosynthetic efficiency, photoprotection ability and the expression of light-harvesting antennae in unicellular green algae can be markedly influenced by irradiation. To our knowledge, this is the first report on changes in the photosynthetic pigments of green algae after treatment with carbon-ion beams.	[Wang, Jie; Li, Xin; Lu, Dong; Du, Yan; Ma, Liang; Li, Wenjian; Chen, Jihong; Wang, Jufang] Chinese Acad Sci, Inst Modern Phys, Gansu Key Lab Space Radiobiol & Microbial Resourc, Lanzhou, Peoples R China; [Wang, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Fuli; Fan, Yong; Hu, Guangrong] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, JF (corresponding author), Chinese Acad Sci, Inst Modern Phys, Gansu Key Lab Space Radiobiol & Microbial Resourc, Lanzhou, Peoples R China.	jufangwang@impcas.ac.cn	Li, Fu-Li/B-5894-2015; Li, Fu-Li/X-4669-2019	Li, Fu-Li/0000-0003-0381-2234; Li, Fu-Li/0000-0003-0381-2234	National Nature Science Foundation of China [U1232126]; Chinese Academy of Sciences, China [Y306010XB0]; Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences [Y506050STS]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, China(Chinese Academy of Sciences); Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences	This study was supported by the National Nature Science Foundation of China (U1232126), Western Talent Training Program of the Chinese Academy of Sciences, China (Y306010XB0), and also supported by Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences (Y506050STS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, J RADIAT RES, V43, pS157; Angelini G, 2001, PHYS MEDICA, V17, P267; Bae CH, 2001, ANN BOT-LONDON, V88, P545, DOI 10.1006/anbo.2001.1495; Bae CH, 2000, PLANT SCI, V151, P93, DOI 10.1016/S0168-9452(99)00205-8; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; De Micco V, 2011, RADIAT ENVIRON BIOPH, V50, P1, DOI 10.1007/s00411-010-0343-8; Demming-Adams B, 2014, NONPHOTOCHEMICAL QUE; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Esnault MA, 2010, ENVIRON EXP BOT, V68, P231, DOI 10.1016/j.envexpbot.2010.01.007; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; He JY, 2011, NUCL SCI TECH, V22, P77; Henriques M., 2007, COMMUNICATING CURREN, VVolume 1, P586; Hu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060700; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Liu BY, 2011, ECOTOX ENVIRON SAFE, V74, P1027, DOI 10.1016/j.ecoenv.2011.01.022; Ma YB, 2013, BIORESOURCE TECHNOL, V136, P360, DOI 10.1016/j.biortech.2013.03.020; Matuo Y, 2006, MUTAT RES-FUND MOL M, V602, P7, DOI 10.1016/j.mrfmmm.2006.07.001; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niwa K, 2009, PHYCOL RES, V57, P194, DOI 10.1111/j.1440-1835.2009.00539.x; Ocampo-Alvarez H, 2013, BBA-BIOENERGETICS, V1827, P427, DOI 10.1016/j.bbabio.2012.12.006; Ota S, 2013, BIORESOURCE TECHNOL, V149, P432, DOI 10.1016/j.biortech.2013.09.079; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Quaas T, 2015, J PLANT PHYSIOL, V172, P92, DOI 10.1016/j.jplph.2014.07.023; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ramundo S, 2013, PLANT CELL, V25, P167, DOI 10.1105/tpc.112.103051; SARTORY DP, 1984, HYDROBIOLOGIA, V114, P177, DOI 10.1007/BF00031869; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shikazono N, 2003, GENETICS, V163, P1449; Tanaka A, 2010, J RADIAT RES, V51, P223, DOI 10.1269/jrr.09143; Doan TTY, 2012, ALGAL RES, V1, P17, DOI 10.1016/j.algal.2012.03.001; Yoshihara R, 2013, J RADIAT RES, V54, P1050, DOI 10.1093/jrr/rrt074	37	4	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149381	10.1371/journal.pone.0149381	http://dx.doi.org/10.1371/journal.pone.0149381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919351	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400019
J	Wang, ZW; Qu, YF; Dong, SH; Wen, P; Li, JJ; Tan, K; Menzel, R				Wang, Zhengwei; Qu, Yufeng; Dong, Shihao; Wen, Ping; Li, Jianjun; Tan, Ken; Menzel, Randolf			Honey Bees Modulate Their Olfactory Learning in the Presence of Hornet Predators and Alarm Component	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; VESPA-VELUTINA; APIS-CERANA; DEFENSIVE BEHAVIOR; MINI-BRAIN; HYMENOPTERA; MEMORY; WASP; RECOGNITION; PHEROMONE	In Southeast Asia the native honey bee species Apis cerana is often attacked by hornets (Vespa velutina), mainly in the period from April to November. During the co-evolution of these two species honey bees have developed several strategies to defend themselves such as learning the odors of hornets and releasing alarm components to inform other mates. However, so far little is known about whether and how honey bees modulate their olfactory learning in the presence of the hornet predator and alarm components of honey bee itself. In the present study, we test for associative olfactory learning of A. cerana in the presence of predator odors, the alarm pheromone component isopentyl acetate (IPA), or a floral odor (hexanal) as a control. The results show that bees can detect live hornet odors, that there is almost no association between the innately aversive hornet odor and the appetitive stimulus sucrose, and that IPA is less well associated with an appetitive stimulus when compared with a floral odor. In order to imitate natural conditions, e.g. when bees are foraging on flowers and a predator shows up, or alarm pheromone is released by a captured mate, we tested combinations of the hornet odor and floral odor, or IPA and floral odor. Both of these combinations led to reduced learning scores. This study aims to contribute to a better understanding of the prey-predator system between A. cerana and V. velutina.	[Wang, Zhengwei; Qu, Yufeng; Wen, Ping; Li, Jianjun; Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Dong, Shihao; Tan, Ken] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Menzel, Randolf] Free Univ Berlin, Inst Biol & Neurobiol, Berlin, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; Free University of Berlin	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.; Tan, K (corresponding author), Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China.	kentan@xtbg.ac.cn			Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science, China National Research Fund [31260585]; CSC-DAAD	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science, China National Research Fund; CSC-DAAD	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBGT01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. Thanks to the support of CSC-DAAD Postdoc scholarship to Zhengwei Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BOCH R, 1962, NATURE, V195, P1018, DOI 10.1038/1951018b0; BOCH R, 1971, J INSECT PHYSIOL, V17, P2277, DOI 10.1016/0022-1910(71)90077-1; Bos N, 2010, ANIM BEHAV, V80, P839, DOI 10.1016/j.anbehav.2010.08.001; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Giurfa M, 2003, BEE WORLD, V84, P5, DOI 10.1080/0005772X.2003.11099566; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; HEINRICH B, 1979, J EXP BIOL, V80, P217; Ignell R, 2004, METHODS INSECT SENSO, P319; Kaspi R, 2013, APIDOLOGIE, V44, P100, DOI 10.1007/s13592-012-0160-y; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KOENIGER N, 1979, J INSECT PHYSIOL, V25, P467, DOI 10.1016/S0022-1910(79)80004-9; Li JJ, 2014, ANIM BEHAV, V97, P69, DOI 10.1016/j.anbehav.2014.08.015; Li JJ, 2014, J EXP BIOL, V217, P3512, DOI 10.1242/jeb.110171; Li T, 1993, EXPLOITATION UTILITY; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; Muller U, 2006, CELL MOL LIFE SCI, V63, P961, DOI 10.1007/s00018-006-6021-y; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; ONO M, 1987, EXPERIENTIA, V43, P1031, DOI 10.1007/BF01952231; Ono Masato, 1996, Honeybee Science, V17, P27; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pirk C.W.W., 2011, PHEROMONES, P207; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Roussel E, 2012, ANIM COGN, V15, P135, DOI 10.1007/s10071-011-0426-1; Salisbury E., 1984, Verhandlungen der Deutschen Zoologischen Gesellschaft, V77, P235; Sandoz JC, 2001, J COMP PHYSIOL A, V187, P559, DOI 10.1007/s003590100228; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Stabentheiner A, 2002, J EXP BIOL, V205, P2637; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066295; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Urlacher E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113630; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Wager BR, 2000, ANN ENTOMOL SOC AM, V93, P1329, DOI 10.1603/0013-8746(2000)093[1329:DHBSAP]2.0.CO;2; Wang ZW, 2014, APIDOLOGIE, V45, P45, DOI 10.1007/s13592-013-0228-3	50	20	20	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150399	10.1371/journal.pone.0150399	http://dx.doi.org/10.1371/journal.pone.0150399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919132	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400127
J	Xiao, DL; Wang, L; Huang, XH; Li, Y; Dasgupta, C; Zhang, LB				Xiao, DaLiao; Wang, Lei; Huang, Xiaohui; Li, Yong; Dasgupta, Chiranjib; Zhang, Lubo			Protective Effect of Antenatal Antioxidant on Nicotine-Induced Heart Ischemia-Sensitive Phenotype in Rat Offspring	PLOS ONE			English	Article							PKC-EPSILON GENE; GLYCOGEN-SYNTHASE KINASE-3-BETA; LOW-PROTEIN DIET; OXIDATIVE STRESS; BLOOD-PRESSURE; N-ACETYLCYSTEINE; REPERFUSION INJURY; DNA METHYLATION; EPIGENETIC REPRESSION; VASCULAR DYSFUNCTION	Fetal nicotine exposure increased risk of developing cardiovascular disease later in life. The present study tested the hypothesis that perinatal nicotine-induced programming of heart ischemia-sensitive phenotype is mediated by enhanced reactive oxygen species (ROS) in offspring. Nicotine was administered to pregnant rats via subcutaneous osmotic minipumps from day 4 of gestation to day 10 after birth, in the absence or presence of a ROS inhibitor, N-acetyl-cysteine (NAC) in drinking water. Experiments were conducted in 8 month old age male offspring. Isolated hearts were perfused in a Langendorff preparation. Perinatal nicotine treatment significantly increased ischemia and reperfusion-induced left ventricular injury, and decreased post-ischemic recovery of left ventricular function and coronary flow rate. In addition, nicotine enhanced cardiac ROS production and significantly attenuated protein kinase Ce (PKCe) protein abundance in the heart. Although nicotine had no effect on total cardiac glycogen synthase kinase-3 beta (GSK3 beta) protein expression, it significantly increased the phosphorylation of GSK3 beta at serine 9 residue in the heart. NAC inhibited nicotine-mediated increase in ROS production, recovered PKCe gene expression and abrogated increased phosphorylation of GSK3 beta. Of importance, NAC blocked perinatal nicotine-induced increase in ischemia and reperfusion injury in the heart. These findings provide novel evidence that increased oxidative stress plays a causal role in perinatal nicotine-induced developmental programming of ischemic sensitive phenotype in the heart, and suggest potential therapeutic targets of anti-oxidative stress in the treatment of ischemic heart disease.	[Xiao, DaLiao; Wang, Lei; Huang, Xiaohui; Li, Yong; Dasgupta, Chiranjib; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA USA; [Wang, Lei] Shanghai Putuo Dist Peoples Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China	Loma Linda University	Xiao, DL (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA USA.	Dxiao@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861, DA032510]; Regents of the University of California Tobacco Related Disease Research Program (TRDRP) [22XT-0022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California Tobacco Related Disease Research Program (TRDRP); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants HL118861 (LZ), DA032510 (DX), and by the Regents of the University of California Tobacco Related Disease Research Program (TRDRP) grant 22XT-0022 (DX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NP, 2001, J AM COLL CARDIOL, V37, P117, DOI 10.1016/S0735-1097(00)01093-7; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bae S, 2005, BRIT J PHARMACOL, V144, P900, DOI 10.1038/sj.bjp.0706129; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Beratis NG, 1996, J PEDIATR-US, V128, P806, DOI 10.1016/S0022-3476(96)70333-5; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Bruin JE, 2008, FREE RADICAL BIO MED, V44, P1919, DOI 10.1016/j.freeradbiomed.2008.02.010; Bruin JE, 2012, J DIABETES, V4, P297, DOI 10.1111/j.1753-0407.2012.00195.x; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Cambonie G, 2007, AM J PHYSIOL-REG I, V292, pR1236, DOI 10.1152/ajpregu.00227.2006; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Elmes MJ, 2008, LIFE SCI, V82, P149, DOI 10.1016/j.lfs.2007.10.022; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Franco MD, 2009, LIFE SCI, V85, P327, DOI 10.1016/j.lfs.2009.06.013; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gao YJ, 2008, EUR J PHARMACOL, V590, P264, DOI 10.1016/j.ejphar.2008.05.044; Garrett BE, 2013, MMWR SURVEILL SUMM S, V62, P381; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Gregory KN, 2004, J MOL CELL CARDIOL, V36, P313, DOI 10.1016/j.yjmcc.2003.12.001; Haleagrahara N, 2011, CARDIOVASC TOXICOL, V11, P373, DOI 10.1007/s12012-011-9132-0; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Kelly G S, 1998, Altern Med Rev, V3, P114; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lawrence J, 2011, CARDIOVASC RES, V89, P89, DOI 10.1093/cvr/cvq270; Li GH, 2004, AM J PHYSIOL-HEART C, V286, pH1712, DOI 10.1152/ajpheart.00898.2003; Mayhan WG, 1999, J APPL PHYSIOL, V86, P1126, DOI 10.1152/jappl.1999.86.4.1126; Meyer K, 2009, J MOL CELL CARDIOL, V47, P504, DOI 10.1016/j.yjmcc.2009.06.004; Noakes PS, 2007, THORAX, V62, P714, DOI 10.1136/thx.2006.061630; Palpant NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126259; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Roghair RD, 2011, CLIN SCI, V121, P427, DOI 10.1042/CS20110153; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Tao HH, 2013, PEPTIDES, V44, P111, DOI 10.1016/j.peptides.2013.02.019; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wang CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/189785; Wang YH, 2009, DIABETES, V58, P1391, DOI 10.2337/db08-1697; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2007, J PHARMACOL EXP THER, V320, P654, DOI 10.1124/jpet.106.113332; Xiao DL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132381; Xiao DL, 2014, CARDIOVASC RES, V101, P373, DOI 10.1093/cvr/cvt264; Xiao DL, 2013, HYPERTENSION, V61, P1246, DOI 10.1161/HYPERTENSIONAHA.113.01152; Xiao DL, 2011, BRIT J PHARMACOL, V164, P1400, DOI 10.1111/j.1476-5381.2011.01437.x; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Yzydorczyk C, 2006, AM J PHYSIOL-REG I, V291, pR1060, DOI 10.1152/ajpregu.00798.2005; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang HT, 2007, MOL PHARMACOL, V71, P1319, DOI 10.1124/mol.106.032011	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150557	10.1371/journal.pone.0150557	http://dx.doi.org/10.1371/journal.pone.0150557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918336	gold, Green Published			2022-12-26	WOS:000371274400133
J	Rietz, A; Petrov, DP; Bartolowits, M; DeSmet, M; Davisson, VJ; Androphy, EJ				Rietz, Anne; Petrov, Dino P.; Bartolowits, Matthew; DeSmet, Marsha; Davisson, V. Jo; Androphy, Elliot J.			Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; CERVICAL-CARCINOMA CELLS; MAMMARY EPITHELIAL-CELLS; STRUCTURAL BASIS; DNA-BINDING; ONCOPROTEIN; P53; APOPTOSIS; IDENTIFICATION; DEGRADATION	The human papillomavirus (HPV) HPV E6 protein has emerged as a central oncoprotein in HPV-associated cancers in which sustained expression is required for tumor progression. A majority of the E6 protein interactions within the human proteome use an alpha-helix groove interface for binding. The UBE3A/E6AP HECT domain ubiquitin ligase binds E6 at this helix-groove interface. This enables formation of a trimeric complex with p53, resulting in destruction of this tumor suppressor. While recent x-ray crystal structures are useful, examples of small molecule probes that can modulate protein interactions at this interface are limited. To develop insights useful for potential structure-based design of ligands for HPV E6, a series of 2,6-disubstituted benzopyranones were prepared and tested as competitive antagonists of E6-E6AP helix-groove interactions. These small molecule probes were used in both binding and functional assays to evaluate recognition features of the E6 protein. Evidence for an ionic functional group interaction within the helix groove was implicated by the structure-activity among the highest affinity ligands. The molecular topographies of these protein-ligand interactions were evaluated by comparing the binding and activities of single amino acid E6 mutants with the results of molecular dynamic simulations. A group of arginine residues that form a rim-cap over the E6 helix groove offer compensatory roles in binding and recognition of the small molecule probes. The flexibility and impact on the overall helix-groove shape dictated by these residues offer new insights for structure-based targeting of HPV E6.	[Rietz, Anne; DeSmet, Marsha; Androphy, Elliot J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Petrov, Dino P.; Bartolowits, Matthew; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Androphy, EJ (corresponding author), Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA.	eandro@iu.edu			National Cancer Institute [R01CA107394]; Indiana Clinical Translational Sciences Institute NIH [5UL1TR001108]; Simon Cancer Center; Purdue Center for Cancer Research (NIH/NCI) [P30 CA023168]; NATIONAL CANCER INSTITUTE [R01CA107394, R01CA119904, P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Indiana Clinical Translational Sciences Institute NIH; Simon Cancer Center; Purdue Center for Cancer Research (NIH/NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Cancer Institute R01CA107394 to EJA, Indiana Clinical Translational Sciences Institute NIH grant 5UL1TR001108 to EJA and VJD, the Simon Cancer Center to EJA, and the Purdue Center for Cancer Research (NIH/NCI P30 CA023168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; Bowers KJ, 2006, P ACM IEEE SC 2006 C; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Filippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200; Filippova M, 2002, J BIOL CHEM, V277, P21730, DOI 10.1074/jbc.M200113200; Gagnon D, 2015, METHODS MOL BIOL, V1249, P111, DOI 10.1007/978-1-4939-2013-6_8; Garnett TO, 2006, CELL DEATH DIFFER, V13, P1915, DOI 10.1038/sj.cdd.4401886; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071453; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; Hu Y, 2009, CANCER INVEST, V27, P298, DOI 10.1080/07357900802350798; Huang YJ, 2014, ACS CHEM BIOL, V9, P802, DOI 10.1021/cb400728e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMAI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1402, DOI 10.1016/0006-291X(89)91826-3; Karlsson OA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09382; Kumar S, 2015, INTERDISCIP SCI, V7, P136, DOI 10.1007/s12539-015-0008-z; Kumar Satish, 2014, Genomics & Informatics, V12, P64, DOI 10.5808/GI.2014.12.2.64; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; Malecka KA, 2014, ACS CHEM BIOL, V9, P1603, DOI 10.1021/cb500229d; Manzo-Merino J, 2013, EXPERT OPIN THER TAR, V17, P1357, DOI 10.1517/14728222.2013.832204; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Ramirez J, 2015, ANGEW CHEM INT EDIT, V54, P7958, DOI 10.1002/anie.201502646; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shamanin VA, 2008, J VIROL, V82, P3912, DOI 10.1128/JVI.02466-07; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Stutz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132339; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Xie X, 2014, ONCOGENE, V33, P1037, DOI 10.1038/onc.2013.25; Yuan CH, 2012, BIOORG MED CHEM LETT, V22, P2125, DOI 10.1016/j.bmcl.2011.12.145; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x	49	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149845	10.1371/journal.pone.0149845	http://dx.doi.org/10.1371/journal.pone.0149845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915086	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700033
J	Song, HZ; Zheng, ZH; Wu, JA; Lai, J; Chu, Q; Zheng, XD				Song, Haizhao; Zheng, Zihuan; Wu, Jianan; Lai, Jia; Chu, Qiang; Zheng, Xiaodong			White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; RED; POLYRHIZUS; MECHANISMS; INCREASES; FGF-21	Insulin resistance and hepatic steatosis are the most common complications of obesity. Pitaya is an important source of phytochemicals such as polyphenols, flavonoid and vitamin C which are related to its antioxidant activity. The present study was conducted to evaluate the influence of white pitaya juice (WPJ) on obesity-related metabolic disorders (e.g. insulin resistance and hepatic steatosis) in high-fat diet-fed mice. Forty-eight male C57BL/6J mice were assigned into four groups and fed low-fat diet with free access to water or WPJ, or fed high-fat diet with free access to water or WPJ for 14 weeks. Our results showed that administration of WPJ improved high-fat diet-induced insulin resistance, hepatic steatosis and adipose hypertrophy, but it exerted no influence on body weight gain in mice. Hepatic gene expression analysis indicated that WPJ supplement not only changed the expression profile of genes involved in lipid and cholesterol metabolism (Srebp1, HMGCoR, Cpt1b, HL, Insig1 and Insig2) but also significantly increased the expression levels of FGF21-related genes (Klb, FGFR2, Egr1 and cFos). In conclusion, WPJ protected from diet-induced hepatic steatosis and insulin resistance, which was associated with the improved FGF21 resistance and lipid metabolism.	[Song, Haizhao; Zheng, Zihuan; Wu, Jianan; Lai, Jia; Chu, Qiang; Zheng, Xiaodong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Song, Haizhao; Zheng, Xiaodong] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, XD (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Zheng, XD (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdzhengzju@yahoo.com	Wu, Jianan/I-1666-2017	Wu, Jianan/0000-0002-6513-4769; Chu, Qiang/0000-0003-3075-3444	National Key Technology R&D Program of China [2012BAD33B08]; Zhejiang Provincial Natural Science Foundation of China [Z14C200006]; Foundation of Fuli Institute of Food Science, Zhejiang University [KY201301]	National Key Technology R&D Program of China(National Key Technology R&D Program); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Fuli Institute of Food Science, Zhejiang University	This work was supported by National Key Technology R&D Program of China (Grant No. 2012BAD33B08, http://program.most.gov.cn/, received by XDZ), Zhejiang Provincial Natural Science Foundation of China (Grant No. Z14C200006, http://www.zjnsf.gov.cn/, received by XDZ) and the Foundation of Fuli Institute of Food Science, Zhejiang University (Grant No. KY201301, http://fifs.zju.edu.cn/content/detail.php?sid=3&cid=642, received by XDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BORNEO SCI; Auinger A, 2013, BRIT J NUTR, V109, P810, DOI 10.1017/S0007114512002656; Balkau B, 2005, LANCET, V366, P1921, DOI 10.1016/S0140-6736(05)67777-X; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beaton MD, 2012, CAN J GASTROENTEROL, V26, P353, DOI 10.1155/2012/725468; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Chang JJ, 2013, J AGR FOOD CHEM, V61, P6069, DOI 10.1021/jf401171k; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Esquivel P, 2007, Z NATURFORSCH C, V62, P636; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruszynska YT, 1996, J INVEST MED, V44, P413; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Omidizadeh A, 2014, RSC ADV, V4, P62978, DOI 10.1039/c4ra10789f; Ramli NS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-189; Ruzlan N, 2008, ANTIOXIDANT STUDY PU; Seymour EM, 2008, J MED FOOD, V11, P252, DOI 10.1089/jmf.2007.658; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Suh DH, 2014, J AGR FOOD CHEM, V62, P8764, DOI 10.1021/jf5020704; Timmers S, 2013, ANN NY ACAD SCI, V1290, P83, DOI 10.1111/nyas.12185; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wybraniec S, 2002, J AGR FOOD CHEM, V50, P6086, DOI 10.1021/jf020145k; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yusof RM, 2009, ANN NUTR METAB, V55, P92; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	45	35	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149670	10.1371/journal.pone.0149670	http://dx.doi.org/10.1371/journal.pone.0149670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914024	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700024
J	Zhou, X; Guo, YL; Kong, H; Zuo, J; Huang, QX; Jia, RZ; Guo, AP; Xu, L				Zhou, Xia; Guo, Yunling; Kong, Hua; Zuo, Jiao; Huang, Qixing; Jia, Ruizong; Guo, Anping; Xu, Lin			A Comprehensive Assessment of the Effects of Transgenic Cry1Ac/Cry1Ab Rice Huahui 1 on Adult Micraspis discolor (Fabricius) (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							SYNTHETIC CRY1AB GENE; BACILLUS-THURINGIENSIS; BT RICE; POLLEN; CONSUMPTION; CRY3BB1; PROTEIN; IMPACT	Micraspis discolor (Fabricius) (Coleoptera: Coccinellidae) is a widely distributed coleoptera predator in southern Asia in rice ecosystem, and adult M. discolor feed on both rice pollen and soft-bodied arthropods. Bitrophic bioassay and tritrophic bioassay were conducted to evaluate the potential impact of Cry1Ac/Cry1Ab-expressing rice Huahui 1 and its non-transgenic counterpart Minghui 63 on fitness parameters of adult M. discolor. The results showed that the survival, and fecundity of this beetle' adults were not different when they fed on Bt rice or non-Bt rice pollen or Nilaparvata lugens (Stal) reared on Bt rice or non-Bt rice. Toxicity assessment to ensure M. discolor adults were not sensitive to Cry1Ab or Cry1Ac protein independent from the pollen background, M. discolor adults were fed with an artificial diet containing Cry1Ac, Cry1Ab or both protein approximately 10 times higher concentration than in Huahui 1 rice pollen. No difference was detected for any of the lifetable parameters tested between Cry protein-containing and pure diet. Artificial diet containing E-64 (N-(trans-Epoxysuccinyl)-L-leucine 4-guanidinobutylamide) was included as a positive control. In contrast, the pre-oviposition and fecundity of M. discolor were significantly adversely affected by feeding on E-64-containing diet. In both bioassays, the uptakes of Cry protein by adult M. discolor were tested by ELISA measurements. These results indicated that adults of M. discolor are not affected by Cry1Ab-or Cry1Ac-expressing rice pollen and are not sensitive to Cry protein at concentrations exceeding the levels in rice pollen in Huahui1. This suggests that M. discolor adults would not be harmed by Cry1Ac/Cry1Ab rice if Bt rice Huahui 1 were commercialized.	[Zhou, Xia; Guo, Yunling; Kong, Hua; Zuo, Jiao; Huang, Qixing; Jia, Ruizong; Guo, Anping; Xu, Lin] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Guo, AP (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China.	gap211@126.com			National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area [2013ZX08012- 004]; Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China [201403075]	National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area; Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China	This work was supported by National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area (Grant No. 2013ZX08012- 004 awarded to Anping Guo) and the Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China (Grant No. 201403075 awarded to Anping Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2012, ENVIRON ENTOMOL, V41, P1687, DOI 10.1603/EN12032; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Ara Begum M., 2002, J BIOL SCI, V2, P630, DOI DOI 10.3923/JBS.2002.630.632; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Chen X N., 2003, BROWN PLANTHOPPER OC, P1; Cohen Michael B., 2008, V5, P223, DOI 10.1007/978-1-4020-8373-0_8; Conway G., 1997, DOUBLY GREEN REVOLUT; CONWAY GR, 1991, UNWELCOME HARVEST AG; Cui JinJie, 1999, Acta Gossypii Sinica, V11, P84; Dale D, 1994, BIOL MANAGEMENT RICE, P388; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; JEPSON PC, 1994, MOL ECOL, V3, P81, DOI 10.1111/j.1365-294X.1994.tb00049.x; JIANG YC, 1985, ACTA ENTOMOL SINICA, V28, P115; Jiang YC, 1995, ENTOMOLOGICAL KNOWLE, V32, P114; Li Y, 2011, ABSTR APPL ANAL, V22, P1, DOI DOI 10.1371/J0URNAL.P0NE.0026656; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002909; Lou YG, 2014, BIOL CONTROL, V68, P103, DOI 10.1016/j.biocontrol.2013.09.018; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Pushpendra KS, 2010, INDIAN NEW YORK SCI, V3, P112; Rattanapun W, 2012, Commun Agric Appl Biol Sci, V77, P541; Riddick EW, 1998, ANN ENTOMOL SOC AM, V91, P303, DOI 10.1093/aesa/91.3.303; Shanker C, 2013, J APPL ENTOMOL, V137, P601, DOI 10.1111/jen.12035; [盛承发 Sheng Chengfa], 2002, [自然灾害学报, Journal of Natural Disasters], V11, P103; Shu QY, 2000, MOL BREEDING, V6, P433, DOI 10.1023/A:1009658024114; Sims SR, 1995, SOUTHWEST ENTOMOL, V20, P493; Singh Manoj Kumar, 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P613, DOI 10.1007/s40011-014-0329-4; Tanaka K, 2000, APPL ENTOMOL ZOOL, V35, P177, DOI 10.1303/aez.2000.177; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Wang EH, 2014, FOOD CHEM TOXICOL, V65, P312, DOI 10.1016/j.fct.2013.11.045; Wang YM, 2010, CROP PROT, V29, P128, DOI 10.1016/j.cropro.2009.10.004; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wu Gang, 2001, Scientia Agricultura Sinica, V34, P496; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Zhang SM, 1982, NAUTRAL ENEMIES INSE, V4, P28	38	3	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0142714	10.1371/journal.pone.0142714	http://dx.doi.org/10.1371/journal.pone.0142714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914608	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700002
J	Paul-Clark, M; Elsheikh, W; Kirkby, N; Chan, M; Devchand, P; Agbor, TA; Flannigan, KL; Cheadle, C; Freydin, M; Ianaro, A; Mitchell, JA; Wallace, JL				Paul-Clark, Mark; Elsheikh, Wagdi; Kirkby, Nicholas; Chan, Melissa; Devchand, Pallavi; Agbor, Terence A.; Flannigan, Kyle L.; Cheadle, Charlotte; Freydin, Maxim; Ianaro, Angela; Mitchell, Jane A.; Wallace, John L.			Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC(Min/+) Mouse Model of Intestinal Tumorigenesis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; S-SULFHYDRATION; TUMOR-CELLS; EXPRESSION; GENE; PREVENTION; INHIBITORS; ADENOMAS; COLITIS	Nonsteroidal anti-inflammatory drugs have been shown to reduce the incidence of gastrointestinal cancers, but the propensity of these drugs to cause ulcers and bleeding limits their use. H2S has been shown to be a powerful cytoprotective and anti-inflammatory substance in the digestive system. This study explored the possibility that a H2S-releasing nonsteroidal anti-inflammatory drug (ATB-346) would be effective in a murine model of hereditary intestinal cancer (APC(Min+) mouse) and investigated potential mechanisms of action via transcriptomics analysis. Daily treatment with ATB-346 was significantly more effective at preventing intestinal polyp formation than naproxen. Significant beneficial effects were seen with a treatment period of only 3-7 days, and reversal of existing polyps was observed in the colon. ATB-346, but not naproxen, significantly decreased expression of intestinal cancerassociated signaling molecules (cMyc, beta-catenin). Transcriptomic analysis identified 20 genes that were up-regulated in APC(Min+) mice, 18 of which were reduced to wild-type levels by one week of treatment with ATB-346. ATB-346 is a novel, gastrointestinal-sparing antiinflammatory drug that potently and rapidly prevents and reverses the development of precancerous lesions in a mouse model of hereditary intestinal tumorigenesis. These effects may be related to the combined effects of suppression of cyclooxygenase and release of H2S, and correction of most of the APC(Min+)-associated alterations in the transcriptome. ATB-346 may represent a promising agent for chemoprevention of tumorigenesis in the GI tract and elsewhere.	[Paul-Clark, Mark; Kirkby, Nicholas; Cheadle, Charlotte; Freydin, Maxim; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Elsheikh, Wagdi; Agbor, Terence A.; Flannigan, Kyle L.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Chan, Melissa] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England; [Devchand, Pallavi] Mt Sinai Hosp, Icahn Med Inst, New York, NY 10029 USA; [Ianaro, Angela] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Wallace, John L.] Univ Camilo Castelo Branco, Fac Med, Sao Paulo, SP, Brazil	Imperial College London; McMaster University; University of London; Queen Mary University London; Icahn School of Medicine at Mount Sinai; University of Naples Federico II; University of Calgary; Universidade Brasil	Wallace, JL (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Wallace, JL (corresponding author), Univ Camilo Castelo Branco, Fac Med, Sao Paulo, SP, Brazil.	altapharm@hotmail.com	ianaro, angela/ABC-2713-2020; Wallace, John/AAL-3763-2021	Cheadle, Charlotte/0000-0002-0293-1840; Kirkby, Nicholas/0000-0003-3509-8549	Canadian Institutes of Health Research grant; Canadian Institutes of Health Research	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a Canadian Institutes of Health Research grant to JLW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Webb McKnight and Lu Wang for their assistance in performing these studies. This research was supported by a research grant from the Canadian Institutes of Health Research.	Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; Chattopadhyay M, 2012, BIOCHEM BIOPH RES CO, V419, P523, DOI 10.1016/j.bbrc.2012.02.051; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P715, DOI 10.1016/j.bcp.2011.12.018; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Elsheikh W, 2014, NITRIC OXIDE-BIOL CH, V41, P131, DOI 10.1016/j.niox.2014.04.006; Farrugia G, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/504230; Fijneman RJA, 2012, CANCER SCI, V103, P593, DOI 10.1111/j.1349-7006.2011.02189.x; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; Gemici B, 2015, NITRIC OXIDE-BIOL CH, V46, P25, DOI 10.1016/j.niox.2014.11.010; Iwama T, 2009, J GASTROENTEROL, V44, P72, DOI 10.1007/s00535-008-2265-7; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kashfi K, 2014, ANTIOXID REDOX SIGN, V20, P831, DOI 10.1089/ars.2013.5308; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kishimoto Y, 2002, J GASTROENTEROL, V37, P186, DOI 10.1007/s005350200019; KUDO T, 1980, GANN, V71, P260; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; Macadam RCA, 2000, BRIT J CANCER, V83, P188; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Narushima Y, 1997, GENE, V185, P159, DOI 10.1016/S0378-1119(96)00589-6; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; SEYAMA K, 1994, J CANCER RES CLIN, V120, P213, DOI 10.1007/BF01372559; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; Teicher BA, 2015, BIOCHEM PHARMACOL, V96, P1, DOI 10.1016/j.bcp.2015.04.008; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Valladares-Ayerbes M, 2008, CANCER DETECT PREV, V32, P236, DOI 10.1016/j.cdp.2008.08.002; Wallace J. L., 2008, United States Patent Application, Patent No. [WO/2008/009127, 2008009127]; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wallace JL, 2013, DIGEST DIS SCI, V58, P3088, DOI 10.1007/s10620-013-2777-8; Wallace JL, 2013, WORLD J GASTROENTERO, V19, P1861, DOI 10.3748/wjg.v19.i12.1861; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2012, J MOL CELL CARDIOL, V52, P677, DOI 10.1016/j.yjmcc.2011.12.004; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147289	10.1371/journal.pone.0147289	http://dx.doi.org/10.1371/journal.pone.0147289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910063	Green Published, gold			2022-12-26	WOS:000371164700004
J	Wang, X; Luo, Y; Masci, PP; Crawford, R; Xiao, Y				Wang, Xin; Luo, Yan; Masci, Paul P.; Crawford, Ross; Xiao, Yin			Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing	PLOS ONE			English	Article							RICH PLASMA; FRACTURE HEMATOMA; FIBRIN STRUCTURE; CROSS-LINKING; GAMMA-CHAIN; POLYMERIZATION; MECHANISMS; THROMBOSIS; IL-1-BETA; STABILITY	Objectives Hematoma quality (especially the fibrin matrix) plays an important role in the bone healing process. Here, we investigated the effect of interleukin-1 beta (IL-1 beta) on fibrin clot formation from platelet-poor plasma (PPP). Methods Five-milliliter of rat whole-blood samples were collected from the hepatic portal vein. All blood samples were firstly standardized via a thrombelastograph (TEG), blood cell count, and the measurement of fibrinogen concentration. PPP was prepared by collecting the top two-fifths of the plasma after centrifugation under 400 x g for 10 min at 20 degrees C. The effects of IL-1 beta cytokines on artificial fibrin clot formation from PPP solutions were determined by scanning electronic microscopy (SEM), confocal microscopy (CM), turbidity, and clot lysis assays. Results The lag time for protofibril formation was markedly shortened in the IL-1 beta treatment groups (243.8 +/- 76.85 in the 50 pg/mL of IL-1 beta and 97.5 +/- 19.36 in the 500 pg/mL of IL-1 beta) compared to the control group without IL-1 beta (543.8 +/- 205.8). Maximal turbidity was observed in the control group. IL-1 beta (500 pg/mL) treatment significantly decreased fiber diameters resulting in smaller pore sizes and increased density of the fibrin clot structure formed from PPP (P < 0.05). The clot lysis assay revealed that 500 pg/mL IL-1 beta induced a lower susceptibility to dissolution due to the formation of thinner and denser fibers. Conclusion IL-1 beta can significantly influence PPP fibrin clot structure, which may affect the early bone healing process.	[Wang, Xin] Zunyi Med Coll, Dept Spine, Affiliated Hosp, Zunyi, Guizhou Provinc, Peoples R China; [Wang, Xin; Luo, Yan; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Wang, Xin; Luo, Yan; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld 4001, Australia; [Wang, Xin; Masci, Paul P.] Univ Queensland, Sch Med, Translat Res Inst, Brisbane, Qld, Australia	Zunyi Medical University; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland	Xiao, Y (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.; Xiao, Y (corresponding author), Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld 4001, Australia.	yin.xiao@qut.edu.au	Xiao, Yin/AAM-4033-2020; Wang, Xin/GMW-8059-2022	Xiao, Yin/0000-0003-1785-3491; Crawford, Ross/0000-0001-6079-1316				Aggrey AA, 2013, J IMMUNOL, V190, P4685, DOI 10.4049/jimmunol.1202672; Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23; Bateman RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043660; Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Duval C, 2014, THROMB HAEMOSTASIS, V111, P842, DOI 10.1160/TH13-10-0855; Echeverri LF, 2015, B MATH BIOL, V77, P156, DOI 10.1007/s11538-014-0055-3; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gersh KC, 2009, THROMB HAEMOSTASIS, V102, P1169, DOI 10.1160/TH09-03-0199; Ghanaati Shahram, 2013, Ann Maxillofac Surg, V3, P126, DOI 10.4103/2231-0746.119221; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Hernandez-Fernandez A, 2013, INJURY, V44, P901, DOI 10.1016/j.injury.2012.10.018; Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147; Koga T, 2013, INT ORTHOP, V37, P961, DOI 10.1007/s00264-013-1813-9; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Konings J, 2011, BLOOD, V118, P3942, DOI 10.1182/blood-2011-03-339572; Lai BFL, 2010, BIOMATERIALS, V31, P5749, DOI 10.1016/j.biomaterials.2010.03.076; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Mackie IJ, 2003, BRIT J HAEMATOL, V121, P396, DOI 10.1046/j.1365-2141.2003.04256.x; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Naik Balaram, 2013, J Conserv Dent, V16, P284, DOI 10.4103/0972-0707.114344; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Perrien DS, 2004, TOXICOL SCI, V82, P656, DOI 10.1093/toxsci/kfi002; Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x; River C, 1984, CHARLES RIVER TECHNI, V3; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Sahni A, 2003, J THROMB HAEMOST, V1, P1271, DOI 10.1046/j.1538-7836.2003.00228.x; Saluja Harish, 2011, Ann Maxillofac Surg, V1, P53, DOI 10.4103/2231-0746.83158; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shiu HT, 2014, J MATER CHEM B, V2, P3009, DOI 10.1039/c4tb00009a; Soffer E, 2003, ORAL SURG ORAL MED O, V95, P521, DOI 10.1067/moe.2003.152; Stevic I, 2013, BLOOD, V122, P578; Talens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041966; Textor JA, 2014, AM J VET RES, V75, P392, DOI 10.2460/ajvr.75.4.392; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; VARADI A, 1986, BIOCHEMISTRY-US, V25, P519, DOI 10.1021/bi00351a001; Viennet C, 2014, J WOUND CARE, V23, P66, DOI 10.12968/jowc.2014.23.2.66; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Willie BM, 2010, SOFT MATTER, V6, P4976, DOI 10.1039/c0sm00262c; Wohlauer MV, 2011, SHOCK, V36, P524, DOI 10.1097/SHK.0b013e31822dc518; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	53	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149775	10.1371/journal.pone.0149775	http://dx.doi.org/10.1371/journal.pone.0149775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909757	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700047
J	Ullinger, HL; Kennedy, MJ; Schneider, WH; Miller, CM				Ullinger, Heather L.; Kennedy, Marla J.; Schneider, William H.; Miller, Christopher M.			Exploratory Disposal and Reuse Feasibility Analysis of Winter Maintenance Wash Water	PLOS ONE			English	Article							EMISSIONS; WEAR	The Ohio Department of Transportation has more than 60 facilities without sewer access generating approximately 19 million gallons of winter maintenance wash water. Off-site disposal is costly, creating the need for sustainable management strategies. The objective of this study was to conduct an exploratory feasibility analysis to assess wash water disposal and potential reuse as brine. Based on a comprehensive literature review and relevant environmental chemistry, a sampling protocol consisting of 31 water quality constituents was utilized for monthly sampling at three geographically distinct Ohio Department of Transportation garages during the winter of 2012. Results were compared to local disposal and reuse guidance limits. Three constituents, including a maximum copper concentration of 858 ppb, exceeded disposal limits, and many constituents also failed to meet reuse limits. Some concentrations were orders of magnitude higher than reuse limits and suggest pretreatment would be necessary if wash water were reused as brine. These water quality results, in conjunction with copper chemical equilibrium modeling, show pH and dissolved carbon both significantly impact the total dissolved copper concentration and should be measured to assess reuse potential. The sampling protocol and specific obstacles highlighted in this paper aid in the future development of sustainable wash water management strategies.	[Ullinger, Heather L.; Kennedy, Marla J.; Schneider, William H.; Miller, Christopher M.] Univ Akron, Dept Civil Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Miller, CM (corresponding author), Univ Akron, Dept Civil Engn, Akron, OH 44325 USA.	cmmiller@uakron.edu			Federal Highway Administration [SJN 134629]	Federal Highway Administration	This work was supported by the Federal Highway Administration, SJN 134629 (CMM WHS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman JE, 2004, PUBLICATION FHWA IN; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Benjamin M. M., 2002, WATER CHEM; Budai P, 2011, TRANSPORT RES D-TR E, V16, P244, DOI 10.1016/j.trd.2010.12.003; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Fitch GM, 2005, TRANSPORT RES REC, V1911, P124; Garg BD, 2000, ENVIRON SCI TECHNOL, V34, P4463, DOI 10.1021/es001108h; Harrison RM, 2012, ENVIRON SCI TECHNOL, V46, P6523, DOI 10.1021/es300894r; Hjortenkrans DST, 2007, ENVIRON SCI TECHNOL, V41, P5224, DOI 10.1021/es070198o; Hull & Associates Inc., 2010, PROC PLAN BEN REUS W; Jang YC, 2010, SCI TOTAL ENVIRON, V408, P1878, DOI 10.1016/j.scitotenv.2010.01.036; Jang YC, 2009, J ENVIRON MANAGE, V91, P320, DOI 10.1016/j.jenvman.2009.08.018; Johansson C, 2009, ATMOS ENVIRON, V43, P4681, DOI 10.1016/j.atmosenv.2008.10.024; Luhana L, 2004, MEASUREMENT NONEXHAU; Miller CM, 2015, PUBLIC WORKS MANAG P, V20, P80, DOI 10.1177/1087724X14522601; Snoeyink VL., 1980, WATER CHEM; USEPA, 2007, EPA822R07001 OFF WAT; Westerlund K.-G., 2001, METAL EMISSIONS STOC	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149500	10.1371/journal.pone.0149500	http://dx.doi.org/10.1371/journal.pone.0149500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908148	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000014
J	Cavaliere, G; Trinchese, G; Bergamo, P; De Filippo, C; Raso, GM; Gifuni, G; Putti, R; Moni, BH; Canani, RB; Meli, R; Mollica, MP				Cavaliere, Gina; Trinchese, Giovanna; Bergamo, Paolo; De Filippo, Chiara; Raso, Giuseppina Mattace; Gifuni, Giorgio; Putti, Rosalba; Moni, Bottu Heleena; Canani, Roberto Berni; Meli, Rosaria; Mollica, Maria Pina			Polyunsaturated Fatty Acids Attenuate Diet Induced Obesity and Insulin Resistance, Modulating Mitochondrial Respiratory Uncoupling in Rat Skeletal Muscle	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE-PHOSPHORYLATION; FISH-OIL; COACTIVATOR; ADIPONECTIN; SENSITIVITY; PGC-1-BETA; MECHANISM; RECEPTOR	Objectives Omega (omega)-3 polyunsaturated fatty acids (PUFA) are dietary compounds able to attenuate insulin resistance. Anyway, the precise actions of omega-3PUFAs in skeletal muscle are overlooked. We hypothesized that PUFAs, modulating mitochondrial function and efficiency, would ameliorate pro-inflammatory and pro-oxidant signs of nutritionally induced obesity. Study Design To this aim, rats were fed a control diet (CD) or isocaloric high fat diets containing either omega-3 PUFA (FD) or lard (LD) for 6 weeks. Results FD rats showed lower weight, lipid gain and energy efficiency compared to LD-fed animals, showing higher energy expenditure and O-2 consumption/CO2 production. Serum lipid profile and pro-inflammatory parameters in FD-fed animals were reduced compared to LD. Accordingly, FD rats exhibited a higher glucose tolerance revealed by an improved glucose and insulin tolerance tests compared to LD, accompanied by a restoration of insulin signalling in skeletal muscle. PUFAs increased lipid oxidation and reduced energy efficiency in subsarcolemmal mitochondria, and increase AMPK activation, reducing both endoplasmic reticulum and oxidative stress. Increased mitochondrial respiration was related to an increased mitochondriogenesis in FD skeletal muscle, as shown by the increase in PGC1-alpha and -beta. Conclusions our data strengthened the association of high dietary omega 3-PUFA intake with reduced mitochondrial energy efficiency in the skeletal muscle.	[Cavaliere, Gina; Trinchese, Giovanna; De Filippo, Chiara; Gifuni, Giorgio; Putti, Rosalba; Moni, Bottu Heleena; Mollica, Maria Pina] Univ Naples Federico II, Dept Biol, Naples, Italy; [Bergamo, Paolo] CNR ISA, Inst Food Sci, Avellino, Italy; [Raso, Giuseppina Mattace; Meli, Rosaria] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Canani, Roberto Berni] Univ Naples Federico II, European Lab Food Induced Dis, Dept Translat Med Sci, Naples, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); University of Naples Federico II; University of Naples Federico II	Mollica, MP (corresponding author), Univ Naples Federico II, Dept Biol, Naples, Italy.	mariapia.mollica@unina.it	Canani, Roberto Berni/AAC-4810-2022; Bergamo, Paolo/F-7835-2013; Giovanna, Trinchese/AAC-5995-2022	Canani, Roberto Berni/0000-0002-5169-9574; Bergamo, Paolo/0000-0002-1726-7911; Giovanna, Trinchese/0000-0002-4096-6876; Heleena Moni, Bottu/0000-0003-3280-5180; Mattace Raso, Giuseppina/0000-0002-5254-139X; Meli, Rosaria/0000-0002-6246-6813; Mollica, Maria Pina/0000-0003-2726-7779	University of Naples Federico II [COAN CA0440050101]	University of Naples Federico II	This work was supported by the University of Naples Federico II, grant number COAN CA0440050101. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXSON SEH, 1988, J BIOL CHEM, V263, P13564; Arany Z, 2007, CELL METAB, V5, P35, DOI 10.1016/j.cmet.2006.12.003; Barbosa MR, 2013, BBA-MOL BASIS DIS, V1832, P1591, DOI 10.1016/j.bbadis.2013.04.029; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Crescenzo R, 2006, DIABETES, V55, P2286, DOI 10.2337/db06-0312; Dominguez JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006790; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Habig W H, 1981, Methods Enzymol, V77, P398; Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x; Harper ME, 2008, ANNU REV NUTR, V28, P13, DOI 10.1146/annurev.nutr.28.061807.155357; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holloway GP, 2008, AM J PHYSIOL-ENDOC M, V294, pE1060, DOI 10.1152/ajpendo.00726.2007; Holness MJ, 2004, DIABETES, V53, pS166, DOI 10.2337/diabetes.53.2007.S166; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Iossa S, 2002, INT J OBESITY, V26, P65, DOI 10.1038/sj.ijo.0801844; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jelenik T, 2010, DIABETES, V59, P2737, DOI 10.2337/db09-1716; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Keipert S, 2014, AM J PHYSIOL-ENDOC M, V306, pE469, DOI 10.1152/ajpendo.00330.2013; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Lanza IR, 2013, AM J PHYSIOL-ENDOC M, V304, pE1391, DOI 10.1152/ajpendo.00584.2012; Lauritzen HPMM, 2013, EXERC SPORT SCI REV, V41, P77, DOI 10.1097/JES.0b013e318275574c; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li B, 2000, NAT MED, V6, P1115, DOI 10.1038/80450; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Lionetti L, 2014, INT J MOL SCI, V15, P3040, DOI 10.3390/ijms15023040; Liu Y, 2014, BEST PRACT RES CL EN, V28, P33, DOI 10.1016/j.beem.2013.08.003; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Meirhaeghe A, 2003, BIOCHEM J, V373, P155, DOI 10.1042/BJ20030200; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mollica MP, 2006, CELL MOL LIFE SCI, V63, P358, DOI 10.1007/s00018-005-5443-2; Nedergaard J, 2005, EMBO REP, V6, P917, DOI 10.1038/sj.embor.7400532; Nielsen J, 2010, AM J PHYSIOL-ENDOC M, V298, pE706, DOI 10.1152/ajpendo.00692.2009; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467, DOI 10.1056/NEJM198802253180802; Ruderman NB, 1999, AM J PHYSIOL-ENDOC M, V276, pE1, DOI 10.1152/ajpendo.1999.276.1.E1; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Si Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007000; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; Stannard SR, 2004, J PHYSIOL-LONDON, V554, P595, DOI 10.1113/jphysiol.2003.053926; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; TERADA H, 1990, ENVIRON HEALTH PERSP, V87, P213, DOI 10.2307/3431027; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; van Loon LJC, 2004, AM J PHYSIOL-ENDOC M, V287, pE558, DOI 10.1152/ajpendo.00464.2003; Wang Y, 2011, J BIOL CHEM, V286, P11119, DOI 10.1074/jbc.M110.203323; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yuzefovych LV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054059; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	63	56	58	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149033	10.1371/journal.pone.0149033	http://dx.doi.org/10.1371/journal.pone.0149033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901315	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100035
J	He, L; Pan, XH; Doug, ZH; Huang, P; Zhou, X; Peng, ZH; Zheng, JL; Zhang, JF; Yang, JZ; Xu, Y; Jiang, J; Chen, L; Jiang, JM; Wang, N				He, Lin; Pan, Xiaohong; Doug, Zhihui; Huang, Peng; Zhou, Xin; Peng, Zhihang; Zheng, Jinlei; Zhang, Jiafeng; Yang, Jiezhe; Xu, Yun; Jiang, Jun; Chen, Lin; Jiang, Jianmin; Wang, Ning			The Factors Related to CD4+T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; COTRIMOXAZOLE PROPHYLAXIS; VIROLOGICAL SUPPRESSION; IMMUNOLOGICAL RESPONSE; OBSERVATIONAL COHORT; TREATMENT OUTCOMES; TERM MORTALITY; RURAL UGANDA; INFECTION; INDIVIDUALS	Background Since China has a unique system of delivering HIV care that includes all patients' records. The factors related to CD4+ T-cell recovery and viral suppression in patients who have low CD4+ T cell counts at the initiation of HAART are understudied in the China despite subsequent virological suppression (viral load < 50 copies/mL) is unknown. Methods The authors conducted a retrospective cohort study using data from the national HIV treatment sub-database of Zhejiang province to identify records of HIV+ patients. Patient records were included if they were < 16 years of age, had an initial CD4 count < 100 cells/mu L, were on continuous HAART for at least one year by the end of December 31, 2014; and achieved and maintained continued maximum virological suppression (MVS) (< 50 copies/ml) by 9 months after starting HAART. The primary endpoint for analysis was time to first CD4+ T cell count recovery (>= 200, 350, 500 cells/mu L). Cox proportional hazard regression was used to identify the risk factors for CD4+ T cell count recovery to key thresholds (200350, 350-500, >= 00 cells/mu L) by the time of last clinical follow-up (whichever occurred first), key thresholds (follow-up date for analysis), with patients still unable to reach the end-points being censored by the end December 31, 2014 (follow-up date for analysis). Results Of the 918 patients who were included in the study, and the median CD4+ T cell count was 39 cells/mu L at the baseline. At the end of follow-up, 727 (79.2%), 363 (39.5%) and 149 (16.2%) patients had return to >= 200, 350, and 500 cells/mu L, respectively. Kaplan-Meier analysis demonstrated that the rate of patients with CD4+ count recovery to >= 200, 350, and 500 cells/mu L after 1 year on HAART was 43.6, 8.6, and 2.5%, respectively, after 3 years on treatment was 90.8, 46.3, and 17.9%, respectively, and after 5 years on HAART was 97.1, 72.2, and 36.4%, respectively. The median time to return to 200-350, 350-500, >= 500cells/mu L was 1.11, 3.33 and 6.91 years, respectively. Factors of age (aHR = 0.77, 95% CI 0.61-0.97), baseline CD4+ count (aHR = 1.60, 95% CI 1.37-1.86), initial regimens, changes in regimen (aHR = 0.58, 95% CI 0.49-0.69), and inclusion of a cotrimoxazole prophylaxis (aHR = 0.66, 95% CI 0.51-0.85) were associated with CD4+ T cell count recovery. Conclusion The proportion of patients with initially low CD4 counts after nine months of treatment and that achieved continuous virological suppression was greater than 70% for persons with CD4+ count >= 350. Conversely, only 35% of patients recovered to levels of 500 cells/mu L after 5 years of treatment, and levels continued to rise significantly with further long-term HAART. Early HAART intervention will be necessary for achieving effective CD4+ T cell responses and optimal immunological function in HIV+ patients.	[He, Lin; Pan, Xiaohong; Zhou, Xin; Zheng, Jinlei; Zhang, Jiafeng; Yang, Jiezhe; Xu, Yun; Jiang, Jun; Chen, Lin; Jiang, Jianmin] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Doug, Zhihui; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Huang, Peng; Peng, Zhihang] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Nanjing Medical University	Pan, XH (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	xhpan@cdc.zj.cn; wangnbj@163.com			National S & T Major Project Foundation of China [2012ZX10001-001]	National S & T Major Project Foundation of China	The work was supported by National S & T Major Project Foundation of China (2012ZX10001-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Amoroso A, 2012, JAIDS-J ACQ IMM DEF, V60, P314, DOI 10.1097/QAI.0b013e31824e5256; [Anonymous], 2012, CHIN FREE ART MAN; [Anonymous], 2015, CHINESE J AIDS STD, V87; Cain L, 2012, AIDS, V26, P1691, DOI 10.1097/QAD.0b013e328354f497; Carrero-Gras A, 2014, J INT AIDS SOC, V17, P199, DOI 10.7448/IAS.17.4.19819; Chadborn TR, 2006, AIDS, V20, P2371, DOI 10.1097/QAD.0b013e32801138f7; Cheng W, 2015, B WORLD HEALTH ORGAN, V93, P152, DOI 10.2471/BLT.14.142745; Chintu C, 2004, LANCET, V364, P1865, DOI 10.1016/S0140-6736(04)17442-4; Crawford KW, 2015, HIV MED, V16, P95, DOI 10.1111/hiv.12177; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Engsig FN, 2014, CLIN INFECT DIS, V58, P1312, DOI 10.1093/cid/ciu038; Forna F, 2007, JAIDS-J ACQ IMM DEF, V44, P456, DOI 10.1097/QAI.0b013e318033ffa1; Gandhi M, 2009, JAIDS-J ACQ IMM DEF, V50, P482, DOI 10.1097/QAI.0b013e31819c3376; Haering M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472869; Han Y, 2015, PLOS ONE, V10; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2002, AIDS, V16, P359, DOI 10.1097/00002030-200202150-00007; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Lee FJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097482; Ma Y, 2010, CLIN INFECT DIS, V50, P264, DOI 10.1086/649215; Mermin J, 2004, LANCET, V364, P1428, DOI 10.1016/S0140-6736(04)17225-5; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Mocroft A, 2006, AIDS, V20, P1141, DOI 10.1097/01.aids.0000226954.95094.39; Moniz P, 2014, J INT AIDS SOC, V17, P185, DOI 10.7448/IAS.17.4.19797; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Nachega JB, 2008, AIDS, V22, P2117, DOI 10.1097/QAD.0b013e328310407e; O'Connor JL, 2014, AIDS, V28, P919, DOI 10.1097/QAD.0000000000000165; Patel A K, 2006, J Assoc Physicians India, V54, P915; Sarfo FS, 2014, J ANTIMICROB CHEMOTH, V69, P254, DOI 10.1093/jac/dkt336; Smit M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076071; Tang HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096098; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002; van Oosterhout JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042029; Velen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064459; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Walker AS, 2010, LANCET, V375, P1278, DOI 10.1016/S0140-6736(10)60057-8; WHO, 2010, ANT THER HIV INF AD; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4	43	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148915	10.1371/journal.pone.0148915	http://dx.doi.org/10.1371/journal.pone.0148915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900702	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100030
J	Kleisner, KM; Fogarty, MJ; McGee, S; Barnette, A; Fratantoni, P; Greene, J; Hare, JA; Luceyl, SM; McGuire, C; Odell, J; Saba, VS; Smith, L; Weaver, KJ; Pinsky, ML				Kleisner, Kristin M.; Fogarty, Michael J.; McGee, Sally; Barnette, Analie; Fratantoni, Paula; Greene, Jennifer; Hare, Jonathan A.; Luceyl, Sean M.; McGuire, Christopher; Odell, Jay; Saba, Vincent S.; Smith, Laurel; Weaver, Katherine J.; Pinsky, Malin L.			The Effects of Sub-Regional Climate Velocity on the Distribution and Spatial Extent of Marine Species Assemblages	PLOS ONE			English	Article							RANGE SHIFTS; PHENOLOGICAL RESPONSE; CONTINENTAL-SHELF; TEMPERATURE; VALIDATION; DYNAMICS	Many studies illustrate variable patterns in individual species distribution shifts in response to changing temperature. However, an assemblage, a group of species that shares a common environmental niche, will likely exhibit similar responses to climate changes, and these community-level responses may have significant implications for ecosystem function. Therefore, we examine the relationship between observed shifts of species in assemblages and regional climate velocity (i.e., the rate and direction of change of temperature isotherms). The assemblages are defined in two sub-regions of the U.S. Northeast Shelf that have heterogeneous oceanography and bathymetry using four decades of bottom trawl survey data and we explore temporal changes in distribution, spatial range extent, thermal habitat area, and biomass, within assemblages. These sub-regional analyses allow the dissection of the relative roles of regional climate velocity and local physiography in shaping observed distribution shifts. We find that assemblages of species associated with shallower, warmer waters tend to shift west-southwest and to shallower waters over time, possibly towards cooler temperatures in the semi-enclosed Gulf of Maine, while species assemblages associated with relatively cooler and deeper waters shift deeper, but with little latitudinal change. Conversely, species assemblages associated with warmer and shallower water on the broad, shallow continental shelf from the Mid-Atlantic Bight to Georges Bank shift strongly northeast along latitudinal gradients with little change in depth. Shifts in depth among the southern species associated with deeper and cooler waters are more variable, although predominantly shifts are toward deeper waters. In addition, spatial expansion and contraction of species assemblages in each region corresponds to the area of suitable thermal habitat, but is inversely related to assemblage biomass. This suggests that assemblage distribution shifts in conjunction with expansion or contraction of thermal habitat acts to compress or stretch marine species assemblages, which may respectively amplify or dilute species interactions to an extent that is rarely considered. Overall, regional differences in climate change effects on the movement and extent of species assemblages hold important implications for management, mitigation, and adaptation on the U.S. Northeast Shelf.	[Kleisner, Kristin M.; Fogarty, Michael J.; Fratantoni, Paula; Luceyl, Sean M.; Smith, Laurel] NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA; [McGee, Sally; Barnette, Analie; Greene, Jennifer; McGuire, Christopher; Odell, Jay; Weaver, Katherine J.] Nature Conservancy, Boston, MA USA; [Hare, Jonathan A.] NOAA, Northeast Fisheries Sci Ctr, Narragansett, RI USA; [Saba, Vincent S.] NOAA, Northeast Fisheries Sci Ctr, Geophys Fluid Dynam Lab, Princeton Univ Forrestal Campus, Princeton, NJ USA; [Pinsky, Malin L.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Rutgers State University New Brunswick	Kleisner, KM (corresponding author), NOAA, Northeast Fisheries Sci Ctr, Woods Hole, MA USA.	kristin.kleisner@noaa.gov	Saba, Vincent/A-3799-2010; Pinsky, Malin L./K-2884-2015	Saba, Vincent/0000-0002-2974-4826; Pinsky, Malin L./0000-0002-8523-8952; McGuire, Christopher/0000-0001-7835-3728	National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center; Gordon and Betty Moore Foundation; Division Of Ocean Sciences [1426891] Funding Source: National Science Foundation	National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this joint partnership project between the National Oceanic and Atmospheric Administration's Northeast Fisheries Science Center and The Nature Conservancy comes from a grant from the Gordon and Betty Moore Foundation (https://www.moore.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew NR, 2013, PEERJ, V1, DOI 10.7717/peerj.11; Aschan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062748; Bell RJ, 2015, ICES J MAR SCI, V72, P1311, DOI 10.1093/icesjms/fsu217; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cheung WWL, 2013, NATURE, V497, P365, DOI 10.1038/nature12156; Cope JM, 2012, MAR ECOL PROG SER, V451, P187, DOI 10.3354/meps09595; Dell AI, 2014, J ANIM ECOL, V83, P70, DOI 10.1111/1365-2656.12081; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Dulvy NK, 2008, J APPL ECOL, V45, P1029, DOI 10.1111/j.1365-2664.2008.01488.x; Dunn J. C., 1974, Journal of Cybernetics, V4, P95, DOI 10.1080/01969727408546059; Friedland K, 2014, ECOSYSTEM ADVISORY N, V1; Friedland KD, 2007, CONT SHELF RES, V27, P2313, DOI 10.1016/j.csr.2007.06.001; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Gaston KJ, 1996, TRENDS ECOL EVOL, V11, P197, DOI 10.1016/0169-5347(96)10027-6; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Hare JA, 2010, ECOL APPL, V20, P452, DOI 10.1890/08-1863.1; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Harvey ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080955; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hodd RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095147; Hollander M., 1973, NONPARAMETRIC STAT M; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lucey SM, 2010, MAR ECOL PROG SER, V415, P23, DOI 10.3354/meps08743; Lyons SK, 2005, AM NAT, V165, pE168, DOI 10.1086/429699; MacCall AD., 1990, DYNAMIC GEOGRAPHY MA; Mahon R, 1998, CAN J FISH AQUAT SCI, V55, P1704, DOI 10.1139/cjfas-55-7-1704; MENGE BA, 1990, TRENDS ECOL EVOL, V5, P52, DOI 10.1016/0169-5347(90)90048-I; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; MOUNTAIN DG, 1987, J MAR RES, V45, P319, DOI 10.1357/002224087788401160; Northfield TD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001685; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Ovaskainen O, 2013, P NATL ACAD SCI USA, V110, P13434, DOI 10.1073/pnas.1305533110; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2007, GLOBAL CHANGE BIOL, V13, P1860, DOI 10.1111/j.1365-2486.2007.01404.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Pinsky ML, 2012, CLIMATIC CHANGE, V115, P883, DOI 10.1007/s10584-012-0599-x; R Core Team, 2021, R LANGUAGE ENV STAT; Rao JS., 2001, TOPICS CIRCULAR STAT; Robinson CLK, 2013, CAN J FISH AQUAT SCI, V70, P775, DOI 10.1139/cjfas-2012-0339; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Simpson MR, 2004, J SEA RES, V51, P199, DOI 10.1016/j.seares.2003.08.007; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Taylor MH, 2009, CONT SHELF RES, V29, P433, DOI 10.1016/j.csr.2008.11.002; Walsh HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137382; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuur Alain F., 2009, P1	53	90	91	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149220	10.1371/journal.pone.0149220	http://dx.doi.org/10.1371/journal.pone.0149220			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901435	Green Published, gold			2022-12-26	WOS:000371276100047
J	Taschereau-Dumouchel, V; Hetu, S; Bagramian, A; Labrecque, A; Racine, M; Chagnon, YC; Jackson, PL				Taschereau-Dumouchel, Vincent; Hetu, Sebastien; Bagramian, Anait; Labrecque, Alexandre; Racine, Marion; Chagnon, Yvon C.; Jackson, Philip L.			BDNF Val(66)Met Polymorphism Is Associated with Self-Reported Empathy	PLOS ONE			English	Article							OXYTOCIN RECEPTOR GENE; ACTIVITY-DEPENDENT SECRETION; VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; PAIN; OXTR; NEUROSCIENCE; MECHANISMS; EVOLUTION; OTHERS	Empathy is an important driver of human social behaviors and presents genetic roots that have been studied in neuroimaging using the intermediate phenotype approach. Notably, the Val(66)Met polymorphism of the Brain-derived neurotrophic factor (BDNF) gene has been identified as a potential target in neuroimaging studies based on its influence on emotion perception and social cognition, but its impact on self-reported empathy has never been documented. Using a neurogenetic approach, we investigated the association between the BDNF Val(66)Met polymorphism and self-reported empathy (Davis' Interpersonal Reactivity Index; IRI) in a sample of 110 young adults. Our results indicate that the BDNF genotype is significantly associated with the linear combination of the four facets of the IRI, one of the most widely used self-reported empathy questionnaire. Crucially, the effect of BDNF Val(66)Met goes beyond the variance explained by two polymorphisms of the oxytocin transporter gene previously associated with empathy and its neural underpinnings (OXTR rs53576 and rs2254298). These results represent the first evidence suggesting a link between the BDNF gene and self-reported empathy and warrant further studies of this polymorphism due to its potential clinical significance.	[Taschereau-Dumouchel, Vincent; Bagramian, Anait; Labrecque, Alexandre; Racine, Marion; Jackson, Philip L.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Taschereau-Dumouchel, Vincent; Jackson, Philip L.] CIRRIS, Quebec City, PQ, Canada; [Taschereau-Dumouchel, Vincent; Chagnon, Yvon C.; Jackson, Philip L.] CRIUSMQ, Quebec City, PQ, Canada; [Hetu, Sebastien] Virginia Tech, Human Neuroimaging Lab, Caril Res Inst, Roanoke, VA USA; [Chagnon, Yvon C.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University; Laval University; Virginia Polytechnic Institute & State University; Laval University	Taschereau-Dumouchel, V (corresponding author), Univ Laval, Ecole Psychol, Quebec City, PQ, Canada.; Taschereau-Dumouchel, V (corresponding author), CIRRIS, Quebec City, PQ, Canada.; Taschereau-Dumouchel, V (corresponding author), CRIUSMQ, Quebec City, PQ, Canada.	vincent.taschereau-dumouchel.1@ulaval.ca		Jackson, Philip/0000-0001-8991-3217	National Science and Engineering Research Council (NSERC); Quebec Bio-Imaging Network (QBIN); NSERC; Centre thematique de recherche en neurosciences; Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Canadian Institute of Health Research (CIHR); Fond de recherche Quebec-Sante (FRQS); CIHR; FRQS	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Bio-Imaging Network (QBIN); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre thematique de recherche en neurosciences; Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fond de recherche Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by grants from the National Science and Engineering Research Council (NSERC) and from the Quebec Bio-Imaging Network (QBIN). Vincent Taschereau-Dumouchel was supported by scholarships from the NSERC, the Centre thematique de recherche en neurosciences, Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS) and the Canadian Institute of Health Research (CIHR). Sebastien Hetu was supported by scholarship from the Fond de recherche Quebec-Sante (FRQS) and CIHR. Philip L. Jackson was supported by a New Investigator Award from the CIHR and a Chercheur-Boursier Senior Award from the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Carlson JM, 2014, CEREB CORTEX, V24, P2249, DOI 10.1093/cercor/bht089; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; COCHRAN WG, 1948, ANN MATH STAT, V19, P151, DOI 10.1214/aoms/1177730242; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Leung CY, 1999, J MULTIVARIATE ANAL, V71, P111, DOI 10.1006/jmva.1999.1827; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; Notaras M, 2015, NEUROSCI BIOBEHAV R, V51, P15, DOI 10.1016/j.neubiorev.2014.12.016; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith KE, 2014, SOC NEUROSCI-UK, V9, P1, DOI 10.1080/17470919.2013.863223; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; Wade M, 2014, GENES BRAIN BEHAV, V13, P603, DOI 10.1111/gbb.12148; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009	42	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149911	10.1371/journal.pone.0149911	http://dx.doi.org/10.1371/journal.pone.0149911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901829	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100183
J	Wallace, D; Cooper, NR; Paulmann, S; Fitzgerald, PB; Russo, R				Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Fitzgerald, Paul B.; Russo, Riccardo			Perceived Comfort and Blinding Efficacy in Randomised Sham-Controlled Transcranial Direct Current Stimulation (tDCS) Trials at 2 mA in Young and Older Healthy Adults	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; MINI-MENTAL-STATE; ELECTRICAL-STIMULATION; WORKING-MEMORY; DC STIMULATION; PERCEPTION; SAFETY; EXCITABILITY; ELECTRODES	Background tDCS studies typically find that: lowest levels of comfort occur at stimulation-onset; young adult participants experience less comfort than older participants; and participants' blinding seems effective at low current strengths. At 2 mA conflicting results have been reported, questioning the effectiveness of blinding in sham-controlled paradigms using higher current strengths. Investigator blinding is rarely reported. Objective Using a protocol with 30 min of 2 mA stimulation we sought to: (a) investigate the level of perceived comfort in young and older adults, ranging in age from 19 to 29 years and 63 to 76 years, respectively; (b) test investigator and participant blinding; (c) assess comfort over a longer stimulation duration; (d) add to the literature on protocols using 2 mA current strength. Methods A two-session experiment was conducted where sham and active stimulation were administered to the frontal cortex at the F8/FP1 sites in a within-subjects manner. Levels of perceived comfort were measured, using a visual analogue scale, at the start and end of stimulation in young and older adults. Post-stimulation, participants and investigators judged whether or not active stimulation was used. Results Comfort scores were lower at stimulation onset in both age groups. Older adults reported: (i) more comfort than young participants overall; (ii) comparable levels of comfort in sham and active stimulation; (iii) significantly more comfort than the young participants during active stimulation. Stimulation mode was correctly identified above chance in the second of the two sessions; 65% of all participants correctly identified the stimulation mode, resulting in a statistical trend. Similarly, the experimenter correctly identified stimulation mode significantly above chance, with 62% of all investigator judgements correct across 120 judgements. Conclusions Using 2 mA current strength over 30 minutes, tDCS stimulation comfort is lower at stimulation onset in young and older adults and, overall, lower for young participants. Investigators and participants may be able to identify active stimulation at above chance levels, although accuracy never exceeded 65% for either participants or the experimenter. Further research into blinding efficacy is recommended.	[Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Russo, Riccardo] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Wallace, Denise; Cooper, Nicholas R.; Paulmann, Silke; Russo, Riccardo] Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England; [Fitzgerald, Paul B.] Monash Univ, Cent Clin Sch, Monash Alfred Psychiat Res Ctr, Melbourne, Vic 3004, Australia; [Fitzgerald, Paul B.] Monash Univ, Alfred, Melbourne, Vic 3004, Australia	University of Essex; University of Essex; Monash University; Monash University	Wallace, D; Russo, R (corresponding author), Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England.; Wallace, D; Russo, R (corresponding author), Univ Essex, Ctr Brain Sci, Colchester CO4 3SQ, Essex, England.	dwallace@essex.ac.uk; rrusso@essex.ac.uk	Fitzgerald, Paul B/A-1225-2008	Fitzgerald, Paul B/0000-0003-4217-8096; , Riccardo Russo/0000-0002-5946-8914; Paulmann, Silke/0000-0003-4148-3806	University of Essex Ageing and Assisted Living Seedcorn fund	University of Essex Ageing and Assisted Living Seedcorn fund	A grant awarded to Silke Paulmann and Riccardo Russo by the University of Essex Ageing and Assisted Living Seedcorn fund fully supported this project. There was no additional external funding received for this study.	Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Ambrus GG, 2010, CLIN NEUROPHYSIOL, V121, P1908, DOI 10.1016/j.clinph.2010.04.020; Bashir S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00111; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Berger VW, 2012, J CLIN EPIDEMIOL, V65, P1236, DOI 10.1016/j.jclinepi.2012.04.016; Bikson M, 2009, CLIN NEUROPHYSIOL, V120, P1033, DOI 10.1016/j.clinph.2009.03.018; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Davis NJ, 2013, EUR J NEUROSCI, V38, P2973, DOI 10.1111/ejn.12307; Dundas JE, 2007, CLIN NEUROPHYSIOL, V118, P1166, DOI 10.1016/j.clinph.2007.01.010; Fertonani A, 2015, CLIN NEUROPHYSIOL, V126, P2181, DOI 10.1016/j.clinph.2015.03.015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Heft MW, 2014, AGE, V36, P1, DOI 10.1007/s11357-013-9536-9; Hoy KE, 2014, SCHIZOPHR RES, V155, P96, DOI 10.1016/j.schres.2014.03.006; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Jo JM, 2009, AM J PHYS MED REHAB, V88, P404, DOI 10.1097/PHM.0b013e3181a0e4cb; Keel JC, 2001, CLIN NEUROPHYSIOL, V112, P720, DOI 10.1016/S1388-2457(00)00518-6; Kemp J, 2014, CLIN NEUROPHYSIOL, V125, P602, DOI 10.1016/j.clinph.2013.08.020; Kessler SK, 2012, BRAIN STIMUL, V5, P155, DOI 10.1016/j.brs.2011.02.007; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Liew SL, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00378; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Meng ZQ, 2014, J PSYCHIATR RES, V54, P19, DOI 10.1016/j.jpsychires.2014.03.007; Minhas P, 2011, CLIN NEUROPHYSIOL, V122, P637, DOI 10.1016/j.clinph.2010.09.023; Monte-Silva K, 2013, BRAIN STIMUL, V6, P424, DOI 10.1016/j.brs.2012.04.011; Monti A, 2013, J NEUROL NEUROSUR PS, V84, P832, DOI 10.1136/jnnp-2012-302825; neuroConn GmbH, 2012, NEUROCONN PROGR DIR; Ngernyam N, 2015, CLIN NEUROPHYSIOL, V126, P382, DOI 10.1016/j.clinph.2014.05.034; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; O'Connell NE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047514; Ohn SH, 2008, NEUROREPORT, V19, P43, DOI 10.1097/WNR.0b013e3282f2adfd; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Peron J, 2011, PROG NEURO-PSYCHOPH, V35, P987, DOI 10.1016/j.pnpbp.2011.01.019; Poreisz C, 2007, BRAIN RES BULL, V72, P208, DOI 10.1016/j.brainresbull.2007.01.004; Richmond L, 2014, J COGNITIVE NEUROSCI, P1; Russo R, 2013, BRAIN STIMUL, V6, P946, DOI 10.1016/j.brs.2013.05.009; San-Juan D, 2015, BRAIN STIMUL, V8, P455, DOI 10.1016/j.brs.2015.01.001; Shiozawa P, 2014, INT J NEUROPSYCHOPH, V17, P1443, DOI 10.1017/S1461145714000418; SMITH L, 1989, CUTIS, V43, P414; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Turi Z, 2014, BRAIN STIMUL, V7, P460, DOI 10.1016/j.brs.2014.01.059; Ulam F, 2015, CLIN NEUROPHYSIOL, V126, P486, DOI 10.1016/j.clinph.2014.05.015; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227	47	50	50	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149703	10.1371/journal.pone.0149703	http://dx.doi.org/10.1371/journal.pone.0149703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900961	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000371276100131
J	Zhang, WX; Wang, P; Chen, SY; Zhang, Z; Liang, TM; Liu, C				Zhang, Wenxiang; Wang, Peng; Chen, Siyu; Zhang, Zhao; Liang, Tingming; Liu, Chang			Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver	FASEB JOURNAL			English	Article						circadian clock; miRNAs; restricted feeding; energy metabolism	ORPHAN NUCLEAR RECEPTOR; CIRCADIAN-CLOCK; LIPID-METABOLISM; TIME; MICRORNAS; INTERPLAY; GENOMICS; ALPHA; WEB	Circadian clocks orchestrate daily oscillations in mammalian behaviors, physiology, and gene expression. MicroRNAs (miRNAs) play a crucial role in fine-tuning of the circadian system. However, little is known about the direct regulation of the clock genes by specific miRNAs. In this study, we found that miR-27b-3p exhibits rhythmic expression in the metabolic tissues of the mice subjected to constant darkness. MiR-27b-3p's expression is induced in livers of unfed and ob/ob mice. In addition, the oscillation phases of miR-27b-3p can be reversed by restricted feeding, suggesting a role of peripheral clock in regulating its rhythmicity. Bioinformatics analysis indicated that aryl hydrocarbon receptor nuclear translocator-like (also known as Bmal1) may be a direct target of miR-27b-3p. Luciferase reporter assay showed that miR-27b-3p suppressed Bmal1 3 UTR activity in a dose-dependent manner, and mutagenesis of their binding site abolished this suppression. Furthermore, overexpression of miR-27b-3p dose-dependently reduced the protein expression levels of BMAL1 and impaired the endogenous BMAL1 and gluconeogenic protein rhythmicity. Collectively, our results suggest that miR-27b-3p plays an important role in the posttranscriptional regulation of BMAL1 protein in the liver. MiR-27b-3p may serve as a novel node to integrate the circadian clock and energy metabolism.Zhang, W., Wang, P., Chen, S., Zhang, Z., Liang, T., Liu, C. Rhythmic expression of miR-27b-3p targets the clock gene Bmal1 at the posttranscriptional level in the mouse liver.	[Zhang, Wenxiang; Wang, Peng; Chen, Siyu; Zhang, Zhao; Liang, Tingming; Liu, Chang] Nanjing Normal Univ, Jiangsu Key Lab Mol & Med Biotechnol, Coll Life Sci, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Liang, TM; Liu, C (corresponding author), 1 Wenyuan Rd, Nanjing 210023, Jiangsu, Peoples R China.	tmliang@njnu.edu.cn; changliu@njnu.edu.cn	Liang, Tingming/ACL-6141-2022	Zhang, Wenxiang/0000-0002-1077-8014; Chen, Siyu/0000-0002-3809-1062	National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; National Natural Science Foundation of China (NSF) [31422028, 31271261, 31401009]; Ten Thousand Talents Program; Jiangsu Province of China [NSF (BK20140041)]; Jiangsu Province of China [Six Talents Summit Project]; Jiangsu Province of China [333 Talents Project] [BRA2015323]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions; innovative Projects of Scientific Research for Graduate Students of Jiangsu Province [KYZZ15_0216]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China (NSF)(National Natural Science Foundation of China (NSFC)); Ten Thousand Talents Program; Jiangsu Province of China; Jiangsu Province of China [Six Talents Summit Project]; Jiangsu Province of China [333 Talents Project]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions; innovative Projects of Scientific Research for Graduate Students of Jiangsu Province	This work is supported by grants from the National Basic Research Program of China (973 Program; 2012CB947600, 2013CB911600), the National Natural Science Foundation of China (NSF; 31422028, 31271261, 31401009), Ten Thousand Talents Program, programs issued by Jiangsu Province of China [NSF (BK20140041), Six Talents Summit Project, and 333 Talents Project (BRA2015323)], the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, the innovative Projects of Scientific Research for Graduate Students of Jiangsu Province (KYZZ15_0216). The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen KD, 2014, TRANSPL P, V46, P1198, DOI 10.1016/j.transproceed.2013.12.013; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2004, LIVER INT, V24, P179, DOI 10.1111/j.1478-3231.2004.00917.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Gatfield D, 2009, GENE DEV, V23, P1313, DOI 10.1101/gad.1781009; Gnocchi Davide, 2015, Biology-Basel, V4, P104, DOI 10.3390/biology4010104; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lau P, 2008, J BIOL CHEM, V283, P18411, DOI 10.1074/jbc.M710526200; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080774; Loher P, 2012, BIOINFORMATICS, V28, P3322, DOI 10.1093/bioinformatics/bts615; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Mu WJ, 2015, CELL RES, V25, P477, DOI 10.1038/cr.2015.23; Du NH, 2014, ELIFE, V3, DOI 10.7554/eLife.02510; Paschos GK, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00112; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Santoro MM, 2013, EXP CELL RES, V319, P1324, DOI 10.1016/j.yexcr.2012.12.009; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Shende VR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022586; Singaravelu R, 2014, HEPATOLOGY, V59, P98, DOI 10.1002/hep.26634; Staiger D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-208; Sun XJ, 2015, J BIOL CHEM, V290, P2189, DOI 10.1074/jbc.M114.612358; Tan XC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-27; Tan YW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105192, 10.1371/journal.pone.0094264]; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Vickers KC, 2013, HEPATOLOGY, V57, P533, DOI 10.1002/hep.25846; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang X, 2015, CURR MED CHEM, V22, P1582, DOI 10.2174/0929867322666150227155009; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603	46	25	26	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2151	2160		10.1096/fj.201500120	http://dx.doi.org/10.1096/fj.201500120			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26919869				2022-12-26	WOS:000376878300009
J	Chiatante, G; Meriggi, A				Chiatante, Gianpasquale; Meriggi, Alberto			The Importance of Rotational Crops for Biodiversity Conservation in Mediterranean Areas	PLOS ONE			English	Article							BIRD SPECIES RICHNESS; PROTECTED AREAS; FARMLAND BIRDS; AGRICULTURAL INTENSIFICATION; LANDSCAPE HETEROGENEITY; FRUGIVOROUS BIRDS; POPULATION TRENDS; GAP ANALYSIS; HOT-SPOTS; DIVERSITY	Nowadays we are seeing the largest biodiversity loss since the extinction of the dinosaurs. To conserve biodiversity it is essential to plan protected areas using a prioritization approach, which takes into account the current biodiversity value of the sites. Considering that in the Mediterranean Basin the agro-ecosystems are one of the most important parts of the landscape, the conservation of crops is essential to biodiversity conservation. In the framework of agro-ecosystem conservation, farmland birds play an important role because of their representativeness, and because of their steady decline in the last Century in Western Europe. The main aim of this research was to define if crop dominated landscapes could be useful for biodiversity conservation in a Mediterranean area in which the landscape was modified by humans in the last thousand years and was affected by the important biogeographical phenomenon of peninsula effect. To assess this, we identify the hotspots and the coldspots of bird diversity in southern Italy both during the winter and in the breeding season. In particular we used a scoring method, defining a biodiversity value for each cell of a 1-km grid superimposed on the study area, using data collected by fieldwork following a stratified random sampling design. This value was analysed by a multiple linear regression analysis and was predicted in the whole study area. Then we defined the hotspots and the coldspots of the study area as 15% of the cells with higher and lower value of biodiversity, respectively. Finally, we used GAP analysis to compare hotspot distribution with the current network of protected areas. This study showed that the winter hotspots of bird diversity were associated with marshes and water bodies, shrublands, and irrigated crops, whilst the breeding hotspots were associated with more natural areas (e.g. transitional wood/shrubs), such as open areas (natural grasslands, pastures and not irrigated crops). Moreover, the results underlined the negative effects of permanent crops, such as vineyards, olive groves, and orchards, in particular during the winter season. This research highlights the importance of farmland areas mainly for wintering species and the importance of open areas for breeding species in the Mediterranean Basin. This may be true even when the species' spatial distribution could be affected by biogeography. An important result showed that the hotspots for breeding species cannot be used as a surrogate for the wintering species, which were often not considered in the planning of protected areas.	[Chiatante, Gianpasquale; Meriggi, Alberto] Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy	University of Pavia	Chiatante, G (corresponding author), Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy.	harrier84@libero.it	Chiatante, Gianpasquale/AAF-9928-2020	Chiatante, Gianpasquale/0000-0002-4570-9350	project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy); project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy)	project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy); project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy)	This study was funded by the project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Giovanni Ferrara of Hunting District "Bari" for his help during the project. This study was funded by the project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy). We appreciate the improvements in English usage made by Andrew Sturgeon. We thank three anonymous referees for reviewing the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Andelman SJ, 2003, ECOL LETT, V6, P818, DOI 10.1046/j.1461-0248.2003.00503.x; Araujo MB, 2001, CONSERV BIOL, V15, P1710, DOI 10.1046/j.1523-1739.2001.99450.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Bacaro G, 2011, BIODIVERS CONSERV, V20, P1677, DOI 10.1007/s10531-011-0054-8; Baccetti Nicola, 2002, Biologia e Conservazione della Fauna, V111, P1; Barabesi L, 2013, ENVIRON ECOL STAT, V20, P215, DOI 10.1007/s10651-012-0216-1; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BirdLife International, 2004, BIRDS EUR POP EST TR; Bishop JA, 2005, ECOL INDIC, V5, P33, DOI 10.1016/j.ecolind.2004.10.001; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Boucheker A, 2011, OSTRICH, V82, P167, DOI 10.2989/00306525.2011.607856; Brambilla M, 2010, BIOL CONSERV, V143, P2770, DOI 10.1016/j.biocon.2010.07.025; BROWN JW, 1990, J BIOGEOGR, V17, P615, DOI 10.2307/2845143; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Burfield I., 2005, ECOLOGY CONSERVATION, P119; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campedelli T, 2015, AGR ECOSYST ENVIRON, V213, P32, DOI 10.1016/j.agee.2015.07.012; Campedelli T, 2010, ARDEOLA, V57, P51; Castro-Caro JC, 2014, J ORNITHOL, V155, P357, DOI 10.1007/s10336-013-1010-z; Cerezo A, 2011, BIODIVERS CONSERV, V20, P2649, DOI 10.1007/s10531-011-0096-y; Chamberlain D, 2014, BIRD STUDY, V61, P121, DOI 10.1080/00063657.2013.870527; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chuman T, 2010, LANDSCAPE URBAN PLAN, V98, P200, DOI 10.1016/j.landurbplan.2010.08.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COMINS JS, 1993, LANDSCAPE URBAN PLAN, V23, P155, DOI 10.1016/0169-2046(93)90065-L; Covas R, 1998, IBIS, V140, P395, DOI 10.1111/j.1474-919X.1998.tb04600.x; Crawley M.J., 1993, GLIM ECOLOGISTS; Danielsen F, 2004, ANIM CONSERV, V7, P79, DOI 10.1017/S1367943003001215; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; de la Montana E, 2011, BIOL CONSERV, V144, P2468, DOI 10.1016/j.biocon.2011.07.001; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031; Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fornasari Lorenzo, 2010, Avocetta, V34, P5; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; FRETWELL S D, 1972, P217; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Genghini M, 2006, BIODIVERS CONSERV, V15, P3077, DOI 10.1007/s10531-005-5400-2; Gil-Tena A, 2015, AGR ECOSYST ENVIRON, V205, P79, DOI 10.1016/j.agee.2015.03.013; Gill F, 2014, IOC WORLD BIRD LIST; GOUTNER V, 1992, BIOL CONSERV, V62, P131, DOI 10.1016/0006-3207(92)90934-F; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Haslem A, 2008, ECOL APPL, V18, P185, DOI 10.1890/07-0692.1; Hoctor TS, 2000, CONSERV BIOL, V14, P984, DOI 10.1046/j.1523-1739.2000.99075.x; Huertas DL, 2001, CAN J ZOOL, V79, P279, DOI 10.1139/cjz-79-2-279; Jackson SF, 2009, BIODIVERS CONSERV, V18, P2143, DOI 10.1007/s10531-009-9578-6; Jeliazkov A, 2016, AGR ECOSYST ENVIRON, V216, P9, DOI 10.1016/j.agee.2015.09.017; Jiguet F, 2005, BIODIVERS CONSERV, V14, P3305, DOI 10.1007/s10531-004-0448-y; Kati V, 2004, BIOL CONSERV, V120, P471, DOI 10.1016/j.biocon.2004.03.020; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Krebs CJ., 1999, ECOLOGICAL METHODOLO; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWLOR TE, 1983, AM NAT, V121, P432, DOI 10.1086/284071; Legendre P., 2012, NUMERICAL ECOLOGY; Liordos V, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-12; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Magurran A.E, 2004, MEASURING BIOL DIVER; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Marfil-Daza C, 2013, ANIM CONSERV, V16, P60, DOI 10.1111/j.1469-1795.2012.00569.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mendoza AM, 2014, BIODIVERS CONSERV, V23, P909, DOI 10.1007/s10531-014-0642-5; Meynard CN, 2009, BIODIVERS CONSERV, V18, P3061, DOI 10.1007/s10531-009-9625-3; Mezquida ET, 2006, ORNIS FENNICA, V83, P11; Mihoub JB, 2010, BIOL CONSERV, V143, P839, DOI 10.1016/j.biocon.2009.12.026; Morelli F, 2013, ECOL INDIC, V34, P372, DOI 10.1016/j.ecolind.2013.05.021; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Oldfield TEE, 2004, BIOL CONSERV, V120, P303, DOI 10.1016/j.biocon.2004.03.003; Olsvig-Whittaker L, 2005, ISR J PLANT SCI, V53, P149, DOI 10.1560/A1QK-KN7P-0DUY-FL4B; Pace RM, 2000, J WILDLIFE MANAGE, V64, P933, DOI 10.2307/3803201; Peronace Valentina, 2012, Avocetta, V36, P11; PETIT DR, 1989, J FIELD ORNITHOL, V60, P241; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Reif J, 2008, IBIS, V150, P596, DOI 10.1111/j.1474-919X.2008.00829.x; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Rey PJ, 2011, J APPL ECOL, V48, P228, DOI 10.1111/j.1365-2664.2010.01902.x; REY PJ, 1993, ARDEA, V81, P151; Rippa D, 2011, IBIS, V153, P721, DOI 10.1111/j.1474-919X.2011.01156.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Santos KC, 2008, LANDSCAPE URBAN PLAN, V84, P140, DOI 10.1016/j.landurbplan.2007.07.004; SAVIN NE, 1977, ECONOMETRICA, V45, P1989, DOI 10.2307/1914122; Schouten MA, 2010, BIODIVERS CONSERV, V19, P2517, DOI 10.1007/s10531-010-9857-2; SCOTT J M, 1993, WILDLIFE MONOGR, V123, P3, DOI DOI 10.1016/0006-3207(94)90022-1; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; Shi H, 2005, CONSERV BIOL, V19, P1273, DOI 10.1111/j.1523-1739.2005.00225.x; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Solymos P, 2005, CONSERV BIOL, V19, P1084, DOI 10.1111/j.1523-1739.2005.00193.x; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Thompson BC, 2001, BIOL CONSERV, V100, P229, DOI 10.1016/S0006-3207(01)00026-X; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; Troupin D, 2014, BIOL CONSERV, V169, P158, DOI 10.1016/j.biocon.2013.11.009; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; Wiersma YF, 2009, BIOL CONSERV, V142, P1639, DOI 10.1016/j.biocon.2009.02.034; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Williams PH, 2003, BIODIVERS CONSERV, V12, P1297, DOI 10.1023/A:1023092100942; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Yip JY, 2004, BIODIVERS CONSERV, V13, P943, DOI 10.1023/B:BIOC.0000014463.32427.cf; Zenatello M, 2014, RISULTATI CENSIMENTI; Zuur Alain F., 2009, P1	118	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149323	10.1371/journal.pone.0149323	http://dx.doi.org/10.1371/journal.pone.0149323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918960	gold, Green Submitted, Green Published			2022-12-26	WOS:000371274400016
J	Curie, A; Brun, A; Cheylus, A; Reboul, A; Nazir, T; Bussy, G; Delange, K; Paulignan, Y; Mercier, S; David, A; Marignier, S; Merle, L; de Freminville, B; Prieur, F; Till, M; Mortemousque, I; Toutain, A; Bieth, E; Touraine, R; Sanlaville, D; Chelly, J; Kong, J; Ott, D; Kassai, B; Hadjikhani, N; Gollub, RL; des Portes, V				Curie, Aurore; Brun, Amandine; Cheylus, Anne; Reboul, Anne; Nazir, Tatjana; Bussy, Gerald; Delange, Karine; Paulignan, Yves; Mercier, Sandra; David, Albert; Marignier, Stephanie; Merle, Lydie; de Freminville, Benedicte; Prieur, Fabienne; Till, Michel; Mortemousque, Isabelle; Toutain, Annick; Bieth, Eric; Touraine, Renaud; Sanlaville, Damien; Chelly, Jamel; Kong, Jian; Ott, Daniel; Kassai, Behrouz; Hadjikhani, Nouchine; Gollub, Randy L.; des Portes, Vincent			A Novel Analog Reasoning Paradigm: New Insights in Intellectually Disabled Patients	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; RAVEN PROGRESSIVE MATRICES; LINKED MENTAL-RETARDATION; DOWN-SYNDROME; DEVELOPMENTAL DISORDERS; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; YOUNG MALES; TERM-MEMORY; CHILDREN	Background Intellectual Disability (ID) is characterized by deficits in intellectual functions such as reasoning, problem-solving, planning, abstract thinking, judgment, and learning. As new avenues are emerging for treatment of genetically determined ID (such as Down's syndrome or Fragile X syndrome), it is necessary to identify objective reliable and sensitive outcome measures for use in clinical trials. Objective We developed a novel visual analogical reasoning paradigm, inspired by the Progressive Raven's Matrices, but appropriate for Intellectually Disabled patients. This new paradigm assesses reasoning and inhibition abilities in ID patients. Methods We performed behavioural analyses for this task (with a reaction time and error rate analysis, Study 1) in 96 healthy controls (adults and typically developed children older than 4) and 41 genetically determined ID patients (Fragile X syndrome, Down syndrome and ARX mutated patients). In order to establish and quantify the cognitive strategies used to solve the task, we also performed an eye-tracking analysis (Study 2). Results Down syndrome, ARX and Fragile X patients were significantly slower and made significantly more errors than chronological age-matched healthy controls. The effect of inhibition on error rate was greater than the matrix complexity effect in ID patients, opposite to findings in adult healthy controls. Interestingly, ID patients were more impaired by inhibition than mental age-matched healthy controls, but not by the matrix complexity. Eye-tracking analysis made it possible to identify the strategy used by the participants to solve the task. Adult healthy controls used a matrix-based strategy, whereas ID patients used a response-based strategy. Furthermore, etiologic-specific reasoning differences were evidenced between ID patients groups. Conclusion We suggest that this paradigm, appropriate for ID patients and developmental populations as well as adult healthy controls, provides an objective and quantitative assessment of visual analogical reasoning and cognitive inhibition, enabling testing for the effect of pharmacological or behavioural intervention in these specific populations.	[Curie, Aurore; Brun, Amandine; Bussy, Gerald; Delange, Karine; Marignier, Stephanie; des Portes, Vincent] Hosp Civils Lyon, Hop Femme Mere Enfant, Deficiences Intellectuelles Causes Rares, Ctr Reference, Bron, France; [Curie, Aurore; Brun, Amandine; Cheylus, Anne; Reboul, Anne; Nazir, Tatjana; Bussy, Gerald; Delange, Karine; Paulignan, Yves; des Portes, Vincent] CNRS, UMR 5304, L2C2, Inst Cognit Sci, Bron, France; [Curie, Aurore; des Portes, Vincent] Univ Lyon, Fac Med Lyon Sud Charles Merieux, Lyon, France; [Curie, Aurore; Kong, Jian; Ott, Daniel; Hadjikhani, Nouchine; Gollub, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Curie, Aurore; Kassai, Behrouz] Univ Lyon, LBBE, UMR5558, INSERM,EPICIME CIC 1407, Lyon, France; [Mercier, Sandra; David, Albert] CHU Nantes, Genet, F-44035 Nantes 01, France; [Merle, Lydie] CH Ie Vinatier, Ctr Rech Neurosci Lyon, INSERM, U1028,CNRS,UMR5292, Lyon, France; [de Freminville, Benedicte; Prieur, Fabienne; Touraine, Renaud] Ctr Hosp Univ, Genet, St Etienne, France; [Till, Michel] Hop St Luc St Joseph, Med Interne, Lyon, France; [Mortemousque, Isabelle; Toutain, Annick] CHU Tours, Genet, Tours, France; [Bieth, Eric] Ctr Hosp Univ, Genet, Toulouse, France; [Sanlaville, Damien] Univ Lyon 1, Hop Femme Mere Enfant, Hosp Civils Lyon, Serv Genet,CRNL,CNRS,UMR5292,INSERM,U1028, F-69365 Lyon, France; [Chelly, Jamel] Univ Strasbourg, Hop Univ Strasbourg, IGBMC, Strasbourg, France; [Hadjikhani, Nouchine] Gillberg Neuropsychiatr Ctr, Gothenburg, Sweden	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National de la Sante et de la Recherche Medicale (Inserm); VetAgro Sup; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; CHU Tours; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Curie, A (corresponding author), Hosp Civils Lyon, Hop Femme Mere Enfant, Deficiences Intellectuelles Causes Rares, Ctr Reference, Bron, France.; Curie, A (corresponding author), CNRS, UMR 5304, L2C2, Inst Cognit Sci, Bron, France.; Curie, A (corresponding author), Univ Lyon, Fac Med Lyon Sud Charles Merieux, Lyon, France.; Curie, A (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.; Curie, A (corresponding author), Univ Lyon, LBBE, UMR5558, INSERM,EPICIME CIC 1407, Lyon, France.	aurorecurie@yahoo.fr	Cheylus, Anne/GSD-3809-2022; Chelly, Jamel/J-7528-2015; Sanlaville, Damien/M-4716-2014; Hadjikhani, Nouchine/C-2018-2008; Mercier, Sandra/E-8922-2018; Touraine, Renaud/AAV-1605-2020	Cheylus, Anne/0000-0002-4243-3686; Chelly, Jamel/0000-0002-0939-8719; Sanlaville, Damien/0000-0001-9939-2849; Hadjikhani, Nouchine/0000-0003-4075-3106; Paulignan, Yves/0000-0001-9474-3080; Kassai, Behrouz/0000-0002-1712-120X; Toutain, Annick/0000-0002-5999-5300; Nazir, Tatjana/0000-0002-6313-9259; Curie, Aurore/0000-0001-7823-290X; Gollub, Randy L./0000-0002-9434-4044	French Ministry of Health; CNRS / Hospice Civils de Lyon; Fondation Jerome-Lejeune; Xtraordinaire Association; Novartis Pharmaceuticals; ARRENNE association; French XLMR parents' association "Xtraordinaire"; French Fragile X parents' association "Le Goeland"; association "Xtraordinaire"	French Ministry of Health; CNRS / Hospice Civils de Lyon; Fondation Jerome-Lejeune; Xtraordinaire Association; Novartis Pharmaceuticals(Novartis); ARRENNE association; French XLMR parents' association "Xtraordinaire"; French Fragile X parents' association "Le Goeland"; association "Xtraordinaire"	Financial support was provided from the French Ministry of Health (grant PHRC 2008, VDP), the CNRS / Hospice Civils de Lyon (research fellow post-graduate grant for AC), the Fondation Jerome-Lejeune (grant for AC), the Xtraordinaire Association (grant for AC), Novartis Pharmaceuticals and the ARRENNE association (grant for AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors received funding from Novartis Pharmaceuticals. But Novartis was not involved in the study design, collection, analysis, and interpretation of data, writing of the paper nor decision to submit for publication.; Authors are indebted to patients and their families and caregivers. Special thanks for the support of the French XLMR parents' association "Xtraordinaire" and of the French Fragile X parents' association "Le Goeland". Financial support was provided from the French Ministry of Health (grant PHRC 2008, VDP), the CNRS / Hospice Civils de Lyon (research fellow postgraduate grant for AC), the Fondation Jerome-Lejeune (grant for AC), the association "Xtraordinaire" (grant for AC), Novartis Pharmaceuticals and the ARRENNE association (grant for AC).	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; BETHELLFOX CE, 1984, INTELLIGENCE, V8, P205, DOI 10.1016/0160-2896(84)90009-6; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Cornish KM, 1999, CORTEX, V35, P263, DOI 10.1016/S0010-9452(08)70799-8; Curie A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-25; Danielsson H, 2012, RES DEV DISABIL, V33, P600, DOI 10.1016/j.ridd.2011.11.004; Danielsson H, 2010, RES DEV DISABIL, V31, P1299, DOI 10.1016/j.ridd.2010.07.012; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Ellis N.R., 1982, RES PERSPECTIVES MEN, P121; Frenkel S, 2009, J INTELL DISABIL RES, V53, P152, DOI 10.1111/j.1365-2788.2008.01139.x; Gligorovic M, 2014, J INTELL DISABIL RES, V58, P233, DOI 10.1111/jir.12000; Greenspan S, 2014, CURR OPIN PSYCHIATR, V27, P110, DOI 10.1097/YCO.0000000000000037; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; Jensen, 1987, SPEED INFORMATION PR, P74; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Karmiloff-Smith A, 2009, DEV PSYCHOL, V45, P56, DOI 10.1037/a0014506; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munir F, 2000, NEUROPSYCHOLOGIA, V38, P1261, DOI 10.1016/S0028-3932(00)00036-1; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Picker JD, 2013, ANN NEUROL, V74, P382, DOI 10.1002/ana.24002; Schalock R., 2021, INTELLECTUAL DISABIL; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sullivan K, 2007, AM J MED GENET B, V144B, P517, DOI 10.1002/ajmg.b.30504; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Thomas MSC, 2009, J SPEECH LANG HEAR R, V52, P336, DOI 10.1044/1092-4388(2009/07-0144); Vakil E, 2012, RES DEV DISABIL, V33, P645, DOI 10.1016/j.ridd.2011.11.009; Van der Molen MJW, 2010, RES DEV DISABIL, V31, P426, DOI 10.1016/j.ridd.2009.10.013; Verguts T, 1999, INTELLIGENCE, V27, P329, DOI 10.1016/S0160-2896(99)00023-9; Vicari S, 2001, Downs Syndr Res Pract, V7, P35; Vicari S, 2006, BEHAV GENET, V36, P355, DOI 10.1007/s10519-006-9057-8; Vigneau F, 2006, INTELLIGENCE, V34, P261, DOI 10.1016/j.intell.2005.11.003; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; Woodcock KA, 2009, COGN NEUROPSYCHOL, V26, P172, DOI 10.1080/02643290802685921; Zigler E., 1982, MENTAL RETARDATION D	42	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149717	10.1371/journal.pone.0149717	http://dx.doi.org/10.1371/journal.pone.0149717			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918704	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400040
J	Deschamps, I; Hasson, U; Tremblay, P				Deschamps, Isabelle; Hasson, Uri; Tremblay, Pascale			The Structural Correlates of Statistical Information Processing during Speech Perception	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; BRAIN STRUCTURE; NONADJACENT DEPENDENCIES; FUNCTIONAL NEUROANATOMY; REPETITION SUPPRESSION; SUPRAMARGINAL GYRUS; STRUCTURE PREDICTS; WORD SEGMENTATION	The processing of continuous and complex auditory signals such as speech relies on the ability to use statistical cues (e.g. transitional probabilities). In this study, participants heard short auditory sequences composed either of Italian syllables or bird songs and completed a regularity-rating task. Behaviorally, participants were better at differentiating between levels of regularity in the syllable sequences than in the bird song sequences. Inter-individual differences in sensitivity to regularity for speech stimuli were correlated with variations in surface-based cortical thickness (CT). These correlations were found in several cortical areas including regions previously associated with statistical structure processing (e.g. bilateral superior temporal sulcus, left precentral sulcus and inferior frontal gyrus), as well other regions (e.g. left insula, bilateral superior frontal gyrus/sulcus and supramarginal gyrus). In all regions, this correlation was positive suggesting that thicker cortex is related to higher sensitivity to variations in the statistical structure of auditory sequences. Overall, these results suggest that inter-individual differences in CT within a distributed network of cortical regions involved in statistical structure processing, attention and memory is predictive of the ability to detect structural structure in auditory speech sequences.	[Deschamps, Isabelle; Tremblay, Pascale] Univ Laval, Dept Readaptat, Quebec City, PQ, Canada; [Deschamps, Isabelle; Tremblay, Pascale] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Hasson, Uri] Univ Trent, Ctr Mind & Brain Sci CIMeC, Mattarello, TN, Italy	Laval University; Laval University; University of Trento	Tremblay, P (corresponding author), Univ Laval, Dept Readaptat, Quebec City, PQ, Canada.; Tremblay, P (corresponding author), Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada.	pascale.tremblay@fmed.ulaval.ca		Hasson, Uri/0000-0002-8530-5051	European Research Council (ERC-STG) [263318]; Natural Sciences and Engineering Research Council of Canada (NSERC) [1958126]; Social Sciences and Humanities Research Council of Canada (SSHRC) [430-2013-1084]; "Fonds de Recherche du Quebec - Sante" (FRQS); "Fonds de Recherche du Quebec-Sante" (FRQS)	European Research Council (ERC-STG)(European Research Council (ERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); "Fonds de Recherche du Quebec - Sante" (FRQS)(Fonds de la Recherche en Sante du Quebec); "Fonds de Recherche du Quebec-Sante" (FRQS)	This study was supported by a research grant from the European Research Council under the 7th framework starting grant program (ERC-STG #263318) to U. Hasson and by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC #1958126) and Social Sciences and Humanities Research Council of Canada (SSHRC #430-2013-1084) to P. Tremblay. P. Tremblay holds a Career Award from the "Fonds de Recherche du Quebec - Sante" (FRQS).; This study was supported by a research grant from the European Research Council under the 7th framework starting grant program (ERC-STG #263318) to U. Hasson and by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC #1958126) and Social Sciences and Humanities Research Council of Canada (SSHRC #430-2013-1084) to P. Tremblay. P. Tremblay holds a Career Award from the "Fonds de Recherche du Quebec-Sante" (FRQS). We thank Margaret Moreno for her help collecting data, the MRI staff of the Functional Neuroimaging Lab at the Center for Mind & Brain Sciences (CIMeC) at the University of Trento, and all the participants. The data presented in this article can be accessed from the Research Registry of the University of Trento at http://hdl.handle.net/11572/134214	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bilodeau-Mercure M, 2015, BRAIN STRUCT FUNCT, V220, P979, DOI 10.1007/s00429-013-0695-3; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Church JA, 2011, J COGNITIVE NEUROSCI, V23, P1475, DOI 10.1162/jocn.2010.21515; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; Conway CM, 2005, J EXP PSYCHOL LEARN, V31, P24, DOI 10.1037/0278-7393.31.1.24; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crottaz-Herbette S, 2005, HIPPOCAMPUS, V15, P132, DOI 10.1002/hipo.20039; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deschamps I, 2011, NEUR LANG C WASH US; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Francois C, 2014, HEARING RES, V308, P122, DOI 10.1016/j.heares.2013.08.018; Furl N, 2011, NEUROIMAGE, V54, P2267, DOI 10.1016/j.neuroimage.2010.10.038; Gaser C, 2003, J NEUROSCI, V23, P9240; Gebhart AL, 2009, PSYCHON B REV, V16, P486, DOI 10.3758/PBR.16.3.486; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hoch L, 2013, PSYCHON B REV, V20, P142, DOI 10.3758/s13423-012-0309-8; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kadosh KC, 2013, CEREB CORTEX, V23, P1630, DOI 10.1093/cercor/bhs150; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Karuza EA, 2013, BRAIN LANG, V127, P46, DOI 10.1016/j.bandl.2012.11.007; Kim H, 2014, HUM BRAIN MAPP, V35, P2265, DOI 10.1002/hbm.22326; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; McNealy K, 2006, J NEUROSCI, V26, P7629, DOI 10.1523/JNEUROSCI.5501-05.2006; McNealy K, 2010, DEVELOPMENTAL SCI, V13, P385, DOI 10.1111/j.1467-7687.2009.00895.x; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; Mizuno K, 2012, NEUROPSYCHOLOGIA, V50, P1998, DOI 10.1016/j.neuropsychologia.2012.04.025; Nastase S, 2014, HUM BRAIN MAPP, V35, P1111, DOI 10.1002/hbm.22238; Neger TM, 2014, FRONT HUM NEUROSCI, P8; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overath T, 2007, PLOS BIOL, V5, P2723, DOI 10.1371/journal.pbio.0050288; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P943, DOI 10.1162/jocn.2009.21238; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tobia MJ, 2012, NEUROIMAGE, V63, P1730, DOI 10.1016/j.neuroimage.2012.08.017; Tobia MJ, 2012, NEUROIMAGE, V60, P991, DOI 10.1016/j.neuroimage.2012.01.041; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Tremblay P, 2013, NEUROIMAGE, V66, P318, DOI 10.1016/j.neuroimage.2012.10.055; Tremblay P, STRUCTURAL BRA UNPUB; Tremblay P, 2013, NEUROBIOL AGING, V34, P1935, DOI 10.1016/j.neurobiolaging.2013.02.004; Westlye LT, 2009, NEUROIMAGE, V47, P1545, DOI 10.1016/j.neuroimage.2009.05.084; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	87	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149375	10.1371/journal.pone.0149375	http://dx.doi.org/10.1371/journal.pone.0149375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919234	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400018
J	Marcsisin, RA; Lewis, ERG; Barbour, AG				Marcsisin, Renee A.; Lewis, Eric R. G.; Barbour, Alan G.			Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; LYME-DISEASE; ANTIGENIC VARIATION; SURFACE PROTEIN; LINEAR PLASMIDS; BINDING PROTEIN; ARRAY REVEALS; NORTH-AMERICA; MOUSE MODEL; IN-VITRO	Borrelia hermsii, a spirochete and cause of relapsing fever, is notable for its immune evasion by multiphasic antigenic variation within its vertebrate host. This is based on a diverse repertoire of surface antigen genes, only one of which is expressed at a time. Another major surface protein, the Variable Tick Protein (Vtp), is expressed in the tick vector and is invariable at its genetic locus. Given the limited immune systems of ticks, the finding of considerable diversity among the Vtp proteins of different strains of B. hermsii was unexpected. We investigated one explanation for this diversity of Vtp proteins, namely expression of the protein in mammals and a consequent elicitation of a specific immune response. Mice were infected with B. hermsii of either the HS1 or CC1 strain, which have antigenically distinctive Vtp proteins but otherwise have similar repertoires of the variable surface antigens. Subsequently collected sera were examined for antibody reactivities against Vtp and other antigens using Western blot analysis, dot blot, and protein microarray. Week-6 sera of infected mice contained antibodies that were largely specific for the Vtp of the infecting strain and were not attributable to antibody cross-reactivities. The antibody responses of the mice infected with different strains were otherwise similar. Further evidence of in vivo expression of the vtp gene was from enumeration of cDNA sequence reads that mapped to a set of selected B. hermsii genes. This measure of transcription of the infecting strain's vtp gene was similar to 10% of that for the abundantly-expressed, serotype-defining variable antigen gene but similar to that of genes known for in vivo expression. The findings of Vtp expression in a vertebrate host and elicitation of a specific anti-Vtp antibody response support the view that balancing selection by host adaptive immunity accounts in part for the observed diversity of Vtp proteins.	[Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Lewis, Eric R. G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Medical Branch Galveston	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	abarbour@uci.edu		Barbour, Alan/0000-0002-0719-5248	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R37 AI24424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024424] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AGB received funding from grant R37 AI24424 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Barbour A, 2005, TICK BORNE DIS HUMAN, P220; Barbour A.G., 2010, BORRELIA MOL BIOL HO, P333; BARBOUR AG, 1982, J EXP MED, V156, P1312, DOI 10.1084/jem.156.5.1312; BARBOUR AG, 1984, INFECT IMMUN, V45, P94, DOI 10.1128/IAI.45.1.94-100.1984; Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Baum E, 2014, CLIN VACCINE IMMUNOL, V21, P838, DOI 10.1128/CVI.00018-14; Baum E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067445; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 1996, INFECT IMMUN, V64, P5111, DOI 10.1128/IAI.64.12.5111-5116.1996; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; Casjens S., 2010, BORRELIA GENOMICS CH, P27; Dai Q., 2007, THESIS U CALIFORNIA; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Hovis KM, 2004, J BACTERIOL, V186, P2612, DOI 10.1128/JB.186.9.2612-2618.2004; Hynes WL, 2014, BIOL TICKS, V2, P129; Krajacich BJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1170-1; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; LEBECH AM, 1991, J CLIN MICROBIOL, V29, P731, DOI 10.1128/JCM.29.4.731-737.1991; Lee SH, 2003, FEMS MICROBIOL LETT, V222, P51, DOI 10.1016/S0378-1097(03)00237-4; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Lewis ERG, 2014, INFECT IMMUN, V82, P2520, DOI 10.1128/IAI.01582-14; LIVEY I, 1995, MOL MICROBIOL, V18, P257, DOI 10.1111/j.1365-2958.1995.mmi_18020257.x; Marcsisin RA, 2010, THESIS U CALIFORNIA; Marcsisin RA, 2012, INFECT IMMUN, V80, P1881, DOI 10.1128/IAI.06419-11; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Pennington PM, 1997, INFECT IMMUN, V65, P285, DOI 10.1128/IAI.65.1.285-292.1997; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; RESTREPO BI, 1992, MOL MICROBIOL, V6, P3299, DOI 10.1111/j.1365-2958.1992.tb02198.x; Sadziene A, 1996, J INFECT DIS, V173, P1184, DOI 10.1093/infdis/173.5.1184; SADZIENE A, 1994, INFECT IMMUN, V62, P2037, DOI 10.1128/IAI.62.5.2037-2045.1994; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; STOENNER HG, 1982, J EXP MED, V156, P1297, DOI 10.1084/jem.156.5.1297; THOMPSON RS, 1969, J AMER MED ASSOC, V210, P1045, DOI 10.1001/jama.210.6.1045; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Wang IN, 1999, GENETICS, V151, P15; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhong JM, 2004, MOL MICROBIOL, V51, P729, DOI 10.1046/j.1365-2958.2003.03849.x	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149889	10.1371/journal.pone.0149889	http://dx.doi.org/10.1371/journal.pone.0149889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918760	Green Published, gold			2022-12-26	WOS:000371274400053
J	Mo, JQ; Zhang, W; Zhong, DY; Xu, H; Wang, L; Yu, J; Luo, ZP				Mo, Jianqiang; Zhang, Wen; Zhong, Dongyan; Xu, Hao; Wang, Lan; Yu, Jia; Luo, Zongping			Is Preventative Long-Segment Surgery for Multi-Level Spondylolysis Necessary? A Finite Element Analysis Study	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; LEVEL ISTHMIC SPONDYLOLISTHESIS; BIOMECHANICAL ANALYSIS; DIRECT REPAIR; NATURAL-HISTORY; SPINE; ADJACENT; FIXATION; DEGENERATION; CAGE	Objective For multi-level spondylolysis patients, surgeons commonly choose to fix all the segments with pars interarticularis defect even those without slippage and not responsible for clinical symptoms. In this study, we tried to study the necessity of the preventative long-segment surgery for the defected segment without slippage in treatment of multi-level spondylolysis patients from a biomechanical perspective. Method We established a bi-level spondylolysis model with pars defects at L4 and L5 segments, and simulated posterior lumbar interbody fusion (PLIF) and pedicle screw fixation at L5-S1 level. Then we compared the biomechanical changes at L4 segment before and after surgery in neutral, flexion, extension, lateral bending and axial rotation position. Results The stress on L4 pars interarticularis was very similar before and after surgery, and reached the highest in axial rotation. The L3-L4 intradiscal pressure was almost the same, while L4-L5 intradiscal pressure changed a little in lateral bending (increase from 1.993 to 2.160 MPa) and axial rotation (decrease from 1.639 to 1.307 MPa) after surgery. The PLIF surgery caused a little increase of range of motion at adjacent L4-L5 and L3-L4 levels, but the change is very tiny (1 degree). Conclusion The PLIF surgery will not cause significant biomechanical change at adjacent segment with pars defect in multi-level spondylolysis. On the contrary, excessive long-segment surgery will damage surrounding soft tissues which are important for maintaining the stability of spine. So a preventative long-segment surgery is not necessary for multi-level spondylolysis as long as there are no soft tissue degeneration signs at adjacent level.	[Mo, Jianqiang; Zhang, Wen; Zhong, Dongyan; Xu, Hao; Wang, Lan; Yu, Jia; Luo, Zongping] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Inst Orthoped,Med Coll, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Luo, ZP (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Inst Orthoped,Med Coll, Suzhou, Jiangsu, Peoples R China.	zongping_luo@yahoo.com		Yu, Jia/0000-0002-0159-060X	National Natural Science Foundation of China [81320108018, 31270995, 61304123]; Jiangsu Provincial Special Program of Medical Science [BL2012004]; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grants of No. 81320108018 to ZL, No. 31270995 to ZL, No. 61304123 to LW; Jiangsu Provincial Special Program of Medical Science (http://jsycw.ec.js.edu.cn/) grant of No. BL2012004 to ZL; Jiangsu Provincial Clinical Orthopedic Center, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://fyy.sdfyy.cn/Main/NewsView_B255_A10003.html); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Tetsu, 2013, Case Rep Orthop, V2013, P472968, DOI 10.1155/2013/472968; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Boszczyk BM, 2006, EUR SPINE J, V15, P965, DOI 10.1007/s00586-005-0986-3; Cabello J, 2013, ARCH ORTHOP TRAUM SU, V133, P443, DOI 10.1007/s00402-013-1685-x; Cavalier R, 2006, J AM ACAD ORTHOP SUR, V14, P417, DOI 10.5435/00124635-200607000-00004; Chen CS, 2001, MED ENG PHYS, V23, P483; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Chosa E, 2004, J SPINAL DISORD TECH, V17, P134, DOI 10.1097/00024720-200404000-00010; Chosa E, 2004, J ORTHOP RES, V22, P158, DOI 10.1016/S0736-0266(03)00160-8; Chung CH, 2007, J SPINAL DISORD TECH, V20, P399, DOI 10.1097/01.bsd.0000211253.67576.90; Goto Keisuke, 2003, J Orthop Sci, V8, P577, DOI 10.1007/s00776-003-0675-1; Hersh DS, 2011, BULL HOSP JT DIS, V69, P339; Hongo M, 2009, SPINE J, V9, P846, DOI [10.1016/j.spinee.2009.06.015, 10.1016/j.spinee.2009.06.019]; Kim YT., 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31827069e4 ., DOI 10.1097/BSD.0B013E31827069E4]; Kuo CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-151; Lee GW, 2015, SPINE, V40, pE234, DOI 10.1097/BRS.0000000000000714; Lee SH, 2009, INDIAN J ORTHOP, V43, P197, DOI 10.4103/0019-5413.41870; Liu XY, 2015, J NEUROSURG-SPINE, V22, P283, DOI 10.3171/2014.10.SPINE14415; Moo IH, 2015, INT J SURG CASE REP, V8, P120, DOI 10.1016/j.ijscr.2014.10.018; Ozcan-Eksi EE, 2016, MUSCLE NERVE, V53, P422, DOI 10.1002/mus.24759; Park WM, 2014, MANUAL THER, V19, P527, DOI 10.1016/j.math.2014.05.004; RAVICHANDRAN G, 1980, SPINE, V5, P552, DOI 10.1097/00007632-198011000-00011; Rohlmann A, 2009, J BIOMECH, V42, P1520, DOI 10.1016/j.jbiomech.2009.03.048; Sairyo K, 2006, CLIN BIOMECH, V21, P1020, DOI 10.1016/j.clinbiomech.2006.06.011; Sairyo K, 2006, EUR SPINE J, V15, P930, DOI 10.1007/s00586-005-1033-0; Sairyo K, 2009, ARCH ORTHOP TRAUM SU, V129, P1433, DOI 10.1007/s00402-008-0795-3; Sakai T, 2010, J ORTHOP SCI, V15, P281, DOI 10.1007/s00776-010-1454-4; Sakai T, 2009, SPINE, V34, P2346, DOI 10.1097/BRS.0b013e3181b4abbe; SHARMA M, 1995, SPINE, V20, P887, DOI 10.1097/00007632-199504150-00003; Song DY, 2015, CLIN NEUROL NEUROSUR, V138, P111, DOI 10.1016/j.clineuro.2015.08.012; Song DY, 2014, J NEUROSURG-SPINE, V20, P396, DOI 10.3171/2013.12.SPINE13521; Standaert CJ, 2000, BRIT J SPORT MED, V34, P415, DOI 10.1136/bjsm.34.6.415; Terai T, 2011, ARCH ORTHOP TRAUM SU, V131, P1187, DOI 10.1007/s00402-010-1257-2; Wong Leong C, 2004, J Can Chiropr Assoc, V48, P142; Xiao ZT, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-31; Xu H, 2013, NEUROSURGERY, V73, P198, DOI 10.1227/01.neu.0000430320.39870.f7; [张文 Zhang Wen], 2014, [医用生物力学, Journal of Medical Biomechanics], V29, P405; Zhong ZC, 2006, MED ENG PHYS, V28, P90, DOI 10.1016/j.medengphy.2005.03.007; Zhu ZQ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-014-0142-z	39	3	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149707	10.1371/journal.pone.0149707	http://dx.doi.org/10.1371/journal.pone.0149707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918333	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400037
J	Zhang-Haagen, B; Biehl, R; Nagel-Steger, L; Radulescu, A; Richter, D; Willbold, D				Zhang-Haagen, Bo; Biehl, Ralf; Nagel-Steger, Luitgard; Radulescu, Aurel; Richter, Dieter; Willbold, Dieter			Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering	PLOS ONE			English	Article							X-RAY-SCATTERING; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; CONFORMATIONAL TRANSITION; PROTEIN; OLIGOMERS; AGGREGATION; TOXICITY; HYDRATION; DYNAMICS	Small proteins like amyloid beta (A beta) monomers are related to neurodegenerative disorders by aggregation to insoluble fibrils. Small angle neutron scattering (SANS) is a nondestructive method to observe the aggregation process in solution. We show that SANS is able to resolve monomers of small molecular weight like A beta for aggregation studies. We examine A beta monomers after prolonged storing in d-hexafluoroisopropanol (dHFIP) by using SANS and dynamic light scattering (DLS). We determined the radius of gyration from SANS as 1.0+/-0.1 nm for A beta(1-40) and 1.6+/-0.1 nm for A beta(1-42) in agreement with 3D NMR structures in similar solvents suggesting a solvent surface layer with 5% increased density. After initial dissolution in dHFIP A beta aggregates sediment with a major component of pure monomers showing a hydrodynamic radius of 1.8+/-0.3 nm for A beta(1-40) and 3.2+/-0.4 nm for A beta(1-42) including a surface layer of dHFIP solvent molecules.	[Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, Julich Ctr Neutron Sci, Julich, Germany; [Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, Inst Complex Syst, Neutron Scattering JCNS 1, Julich, Germany; [Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, ICS 1, Julich, Germany; [Zhang-Haagen, Bo; Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, Julich, Germany; [Radulescu, Aurel] Res Ctr Julich, MLZ JCNS MLZ, Outstn, Julich Ctr Neutron Sci, Garching, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Biehl, R (corresponding author), Res Ctr Julich, Julich Ctr Neutron Sci, Julich, Germany.; Biehl, R (corresponding author), Res Ctr Julich, Inst Complex Syst, Neutron Scattering JCNS 1, Julich, Germany.; Biehl, R (corresponding author), Res Ctr Julich, ICS 1, Julich, Germany.	ra.biehl@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Biehl, Ralf/J-9464-2013; Richter, Dieter/H-3701-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Biehl, Ralf/0000-0002-1999-547X; Richter, Dieter/0000-0003-0719-8470; Willbold, Dieter/0000-0002-0065-7366; Radulescu, Aurel/0000-0002-6050-0176				Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Biehl R, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/50/503103; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bolisetty S, 2011, SOFT MATTER, V7, P493, DOI 10.1039/c0sm00502a; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Calvetti D, 2004, NUMER ALGORITHMS, V35, P301, DOI 10.1023/B:NUMA.0000021764.16526.47; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Hammouda B, 2010, J APPL CRYSTALLOGR, V43, P1474, DOI 10.1107/S0021889810033856; IBEL K, 1975, J MOL BIOL, V93, P255, DOI 10.1016/0022-2836(75)90131-X; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jeng US, 2006, PHYSICA B, V385-86, P865, DOI 10.1016/j.physb.2006.05.128; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; MORRISON ID, 1985, LANGMUIR, V1, P496, DOI 10.1021/la00064a016; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Radulescu A, 2012, J PHYS CONF SER, V351, DOI 10.1088/1742-6596/351/1/012026; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinson KA, 2008, J APPL CRYSTALLOGR, V41, P456, DOI 10.1107/S0021889808004950; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Sigurdsson E. M., 2005, AMYLOID PROTEINS MET; Sommer B, 2002, CURR OPIN PHARMACOL, V2, P87, DOI 10.1016/S1471-4892(01)00126-6; SOTO C, 1994, J NEUROCHEM, V63, P1191; Stadler AM, 2014, J AM CHEM SOC, V136, P6987, DOI 10.1021/ja502343b; Stanley CB, 2011, BIOPHYS J, V100, P2504, DOI 10.1016/j.bpj.2011.04.022; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; van der Linden E, 2007, CURR OPIN COLLOID IN, V12, P158, DOI 10.1016/j.cocis.2007.07.010; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wolff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127865; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	57	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150267	10.1371/journal.pone.0150267	http://dx.doi.org/10.1371/journal.pone.0150267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919121	Green Published, gold			2022-12-26	WOS:000371274400114
J	Bergmann, EJ; Venugopal, PD; Martinson, HM; Raupp, MJ; Shrewsbury, PM				Bergmann, Erik J.; Venugopal, P. Dilip; Martinson, Holly M.; Raupp, Michael J.; Shrewsbury, Paula M.			Host Plant Use by the Invasive Halyomorpha halys (Stal) on Woody Ornamental Trees and Shrubs	PLOS ONE			English	Article							MARMORATED STINK BUG; HEMIPTERA-PENTATOMIDAE; HETEROPTERA-PENTATOMIDAE; SOYBEAN FIELDS; WILD HOSTS; ABUNDANCE; PEST; AVAILABILITY; MANAGEMENT; NURSERIES	The brown marmorated stink bug, Halyomorpha halys (Stal) (Hemiptera: Pentatomidae) is an invasive plant-feeding insect native to eastern Asia. This herbivore is highly polyphagous, feeding on and damaging diverse plants, including field crops, vegetables, tree fruits, and ornamentals. Woody ornamental plants provide early-and late-season resources for adults emerging from and returning to overwintering sites, as well as feeding and breeding sites for H. halys throughout the growing season. In this study, we quantify the use of diverse plants by H. halys in two commercial nurseries in Maryland, recording data on the abundance of egg masses, early and late instar nymphs, and adults over a three-year study period. Our specific goals were to provide a quantitative comparison of the use of diverse plant species and cultivated varieties, identify non-hosts that could be used to create landscapes refractory to H. halys, and determine whether the use of plants varied across life stages of H. halys or the taxonomic status of plants. We found broad use of diverse plants in this study, identifying 88 host plants used by all life stages of H. halys. We also highlight the 43 plant taxa that did not support any life stage of H. halys and are thus classified as nonhosts. Interestingly, some of these plants were congeners of highly-used plants, underscoring high intrageneric and intraspecific variation in the use of plants by this polyphagous herbivore. We discuss how the selective planting of non-hosts, especially gymnosperms, may aid in reducing the agricultural and nuisance pest status of this invasive insect.	[Bergmann, Erik J.; Venugopal, P. Dilip; Martinson, Holly M.; Raupp, Michael J.; Shrewsbury, Paula M.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Shrewsbury, PM (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	pshrewsbury@umd.edu		Martinson, Holly/0000-0003-1462-0051; Venugopal, Dilip/0000-0001-6339-5087	United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative [2011-51181-30937]; United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant [MD-ENTM-04168757]	United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative; United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant	This work was supported by the United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative; Award 2011-51181-30937 (http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) to HMM, MJR, and PMS, and the United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant; MD-ENTM-04168757 (http://nifa.usda.gov/program/mcintire-stennis-capacity-grant) to MJR.	Bakken AJ, 2015, ENVIRON ENTOMOL, V44, P1011, DOI 10.1093/ee/nvv092; Bernard G, 2004, TLS-TIMES LIT SUPPL, P17; Callot Henry, 2013, Entomologiste (Paris), V69, P69; Cayuela L, 2012, METHODS ECOL EVOL, V3, P1078, DOI 10.1111/j.2041-210X.2012.00232.x; Clapp J. Casey, 2014, Arboricultural Journal, V36, P161, DOI 10.1080/03071375.2014.950861; Commonwealth of Australia, 2015, BROWN MARM STINK BUG; Cooper R., 2010, BROWN MARMORATED STI, P15; Dirr MA, 2009, MANUAL WOODY LANDSCA, VIII; Fujisawa T., 2001, JPN AGR TECHNOL, V45, P42; Funayama K, 2005, JPN J APPL ENTOMOL Z, V49, P265, DOI 10.1303/jjaez.2005.265; Funayama K, 2002, JPN J APPL ENTOMOL Z, V46, P1, DOI 10.1303/jjaez.2002.1; Hamilton George C., 2009, American Entomologist, V55, P19; Haye T., 2014, Proceedings of the 8th International Conference on Urban Pests, 20-23 July 2014, Zurich, Switzerland, P309; Heckmann Ralf, 2012, Heteropteron, V36, P17; Herms DA, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P217, DOI 10.1007/0-306-47596-0_10; Hiruki C, 1999, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.1999.496.6; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; KAWADA H, 1983, JPN J APPL ENTOMOL Z, V27, P304, DOI 10.1303/jjaez.27.304; Kuhar T.P., 2012, PLANT HLTH PROG, V13, P41, DOI [10.1094/PHP-2012-0523-01-BR, DOI 10.1094/PHP-2012-0523-01-BR]; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; MacLellan R., 2013, Surveillance (Wellington), V40, P34; Marrotte EL, 2004, WHY FRUIT TREES FAIL; Martinson HM, 2015, J PEST SCI, V88, P461, DOI 10.1007/s10340-015-0677-8; Martinson HM, 2013, ANN ENTOMOL SOC AM, V106, P47, DOI 10.1603/AN12088; Maxwell F.G., 1980, BREEDING PLANTS RESI; Milonas P. G., 2014, Bulletin OEPP, V44, P183, DOI 10.1111/epp.12129; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Northeastern IPM Center, 2015, WHER IS BMBS; Oda M., 1980, B NARA AGR EXP STATI, V11, P53; Oda M., 1982, B NARA AGR EXP STN, V13, P66; Painter RH, 1951, INSECT RESISTANCE CR; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Pansa M. G., 2013, Informatore Agrario, V69, P60; Potter DA, 1986, ADV URBAN PEST MANAG, P219; Qin W., 1990, PLANT PROT, V16, P22; R Development Core Team, 2014, R LANG ENV STAT COMP; RAUPP MJ, 1992, ANNU REV ENTOMOL, V37, P561, DOI 10.1146/annurev.en.37.010192.003021; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; VELASCO LRI, 1992, ENVIRON ENTOMOL, V21, P751, DOI 10.1093/ee/21.4.751; Venugopal PD, 2015, J ECON ENTOMOL, V108, P2231, DOI 10.1093/jee/tov188; Venugopal PD, 2015, ENVIRON ENTOMOL, V44, P474, DOI 10.1093/ee/nvv061; Venugopal PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109917; Vetek G, 2014, ZOOTAXA, V 3780, P194, DOI 10.11646/zootaxa.3780.1.8; Wermelinger B, 2008, ENTOMOL GESELLSCHAFT, V81, P1, DOI DOI 10.5169/SEALS-402954; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Y., 2007, INT WORKSH BIOL CONT, P20; Yanagi T., 1980, PLANT PROTECTION, V34, P315; Zhang Jun-Ming, 2007, Chinese Bulletin of Entomology, V44, P898	52	62	67	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149975	10.1371/journal.pone.0149975	http://dx.doi.org/10.1371/journal.pone.0149975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906399	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000026
J	Dotan, I; Roche, PJR; Paliouras, M; Mitmaker, EJ; Trifiro, MA				Dotan, Idit; Roche, Philip J. R.; Paliouras, Miltiadis; Mitmaker, Elliot J.; Trifiro, Mark A.			Engineering Multi-Walled Carbon Nanotube Therapeutic Bionanofluids to Selectively Target Papillary Thyroid Cancer Cells	PLOS ONE			English	Article							STIMULATING HORMONE-RECEPTOR; EXTERNAL-BEAM RADIOTHERAPY; THYROTROPIN RECEPTOR; PHOTOTHERMAL THERAPY; THERMAL ABLATION; TSH RECEPTOR; TUMOR-CELLS; IN-VITRO; DIFFERENTIAL EXPRESSION; MONOCLONAL-ANTIBODIES	Background The incidence of papillary thyroid carcinoma (PTC) has risen steadily over the past few decades as well as the recurrence rates. It has been proposed that targeted ablative physical therapy could be a therapeutic modality in thyroid cancer. Targeted bio-affinity functionalized multi-walled carbon nanotubes (BioNanofluid) act locally, to efficiently convert external light energy to heat thereby specifically killing cancer cells. This may represent a promising new cancer therapeutic modality, advancing beyond conventional laser ablation and other nanoparticle approaches. Methods Thyroid Stimulating Hormone Receptor (TSHR) was selected as a target for PTC cells, due to its wide expression. Either TSHR antibodies or Thyrogen or purified TSH (Thyrotropin) were chemically conjugated to our functionalized Bionanofluid. A diode laser system (532 nm) was used to illuminate a PTC cell line for set exposure times. Cell death was assessed using Trypan Blue staining. Results TSHR-targeted BioNanofluids were capable of selectively ablating BCPAP, a TSHR-positive PTC cell line, while not TSHR-null NSC-34 cells. We determined that a 2:1 BCPAP cell: alpha-TSHR-BioNanofluid conjugate ratio and a 30 second laser exposure killed approximately 60% of the BCPAP cells, while 65% and >70% of cells were ablated using Thyrotropin-and Thyrogen-BioNanofluid conjugates, respectively. Furthermore, minimal non-targeted killing was observed using selective controls. Conclusion A BioNanofluid platform offering a potential therapeutic path for papillary thyroid cancer has been investigated, with our in vitro results suggesting the development of a potent and rapid method of selective cancer cell killing. Therefore, BioNanofluid treatment emphasizes the need for new technology to treat patients with local recurrence and metastatic disease who are currently undergoing either re-operative neck explorations, repeated administration of radioactive iodine and as a last resort external beam radiation or chemotherapy, with fewer side effects and improved quality of life.	[Dotan, Idit; Roche, Philip J. R.; Paliouras, Miltiadis; Mitmaker, Elliot J.; Trifiro, Mark A.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Dotan, Idit; Paliouras, Miltiadis; Trifiro, Mark A.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Paliouras, Miltiadis; Mitmaker, Elliot J.] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada; [Trifiro, Mark A.] McGill Univ, Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University	Paliouras, M; Mitmaker, EJ (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Paliouras, M (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Paliouras, M; Mitmaker, EJ (corresponding author), McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.	miltiadis.paliouras@mcgill.ca; elliot.mitmaker@mcgill.ce			Israel Cancer Research Fund (ICRF)	Israel Cancer Research Fund (ICRF)	I.D. received salary support from the Israel Cancer Research Fund (ICRF).	Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Al-Saif O, 2010, J CLIN ENDOCR METAB, V95, P2187, DOI 10.1210/jc.2010-0063; Avetisyan YA, 2012, APPL OPTICS, V51, pC88, DOI 10.1364/AO.51.000C88; Baffou G, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3116645; Baffou G, 2014, NANOSCALE, V6, P8984, DOI 10.1039/c4nr01644k; Boca SC, 2011, CANCER LETT, V311, P131, DOI 10.1016/j.canlet.2011.06.022; BRABANT G, 1991, MOL CELL ENDOCRINOL, V82, pR7, DOI 10.1016/0303-7207(91)90018-N; Brierley JD, 2011, J CLIN ENDOCR METAB, V96, P2289, DOI 10.1210/jc.2011-1109; Brioli A, 2014, BRIT J HAEMATOL, V165, P441, DOI 10.1111/bjh.12805; Burke A, 2009, P NATL ACAD SCI USA, V106, P12897, DOI 10.1073/pnas.0905195106; Burlaka A., 2010, Experimental Oncology, V32, P48; Busuttil BE, 2001, J CLIN ENDOCR METAB, V86, P2315, DOI 10.1210/jc.86.5.2315; CASHMAN NR, 1992, DEV DYNAM, V194, P209, DOI 10.1002/aja.1001940306; Chakravarty P, 2008, P NATL ACAD SCI USA, V105, P8697, DOI 10.1073/pnas.0803557105; Chang EH, 2015, BIOCHEM BIOPH RES CO, V468, P511, DOI 10.1016/j.bbrc.2015.10.136; Chen ST, 2000, J ENDOCRINOL, V165, P379, DOI 10.1677/joe.0.1650379; Chia SY, 2007, J CLIN ENDOCR METAB, V92, P468, DOI 10.1210/jc.2006-2088; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Ell C, 1998, GUT, V43, P345, DOI 10.1136/gut.43.3.345; FABIEN N, 1994, CANCER, V73, P2206, DOI 10.1002/1097-0142(19940415)73:8<2206::AID-CNCR2820730828>3.0.CO;2-M; Ford D, 2003, CLIN ONCOL-UK, V15, P337, DOI 10.1016/S0936-6555(03)00162-6; Giordano D, 2012, THYROID, V22, P911, DOI 10.1089/thy.2012.0011; Hashida Y, 2014, J CONTROL RELEASE, V173, P59, DOI 10.1016/j.jconrel.2013.10.039; Huang XH, 2008, LASER MED SCI, V23, P217, DOI 10.1007/s10103-007-0470-x; Hudson DE, 2013, PHOTOMED LASER SURG, V31, P163, DOI 10.1089/pho.2012.3284; Hundahl SA, 1998, CANCER-AM CANCER SOC, V83, P2638, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1; Jeffreys J, 2002, THYROID, V12, P1051, DOI 10.1089/105072502321085144; Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102; Kazaure HS, 2012, ANN SURG ONCOL, V19, P1874, DOI 10.1245/s10434-011-2129-x; Kloos Richard T, 2005, Curr Treat Options Oncol, V6, P323; Kumar S, 2011, J MOL ENDOCRINOL, V46, P155, DOI 10.1530/JME-11-0006; Lee N, 2006, ENDOCR-RELAT CANCER, V13, P971, DOI 10.1677/ERC-06-0039; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Malic E, 2006, PHYS REV B, V74, P1; Marches R, 2009, INT J CANCER, V125, P2970, DOI 10.1002/ijc.24659; Maestro LM, 2013, NANOSCALE, V5, P7882, DOI 10.1039/c3nr01398g; McLeod DSA, 2013, LANCET, V381, P1046, DOI 10.1016/S0140-6736(12)62205-3; Melisi D, 2013, CURR OPIN PHARMACOL, V13, P536, DOI 10.1016/j.coph.2013.06.012; Melong JC, 2015, J OTOLARYNGOL-HEAD N, V44, DOI 10.1186/s40463-015-0093-3; Mendoza-Nava H, 2013, PHOTOMED LASER SURG, V31, P17, DOI 10.1089/pho.2012.3320; Moodley K, 2011, J NEUROL SCI, V302, P114, DOI 10.1016/j.jns.2010.11.027; Oda Y, 1998, J MOL ENDOCRINOL, V20, P233, DOI 10.1677/jme.0.0200233; Oda Y, 2000, THYROID, V10, P1051, DOI 10.1089/thy.2000.10.1051; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Panchapakesan B, 2005, NANOBIOTHCHNOLOGY, V1, P7; Park A, 2013, ENDOCRINOLOGY, V154, P1373, DOI 10.1210/en.2012-2010; Pattani VP, 2012, LASER SURG MED, V44, P675, DOI 10.1002/lsm.22072; PAULIN C, 1992, CR ACAD SCI III-VIE, V315, P493; Pilli T, 2009, THYROID, V19, P1333, DOI 10.1089/thy.2009.0195; Pokrass M, 2012, OPT MATER EXPRESS, V2, P825, DOI 10.1364/OME.2.000825; RAHMAN MM, 2014, SCI WORLD J, DOI DOI 10.1155/2014/; Ritts AC, 2011, POLYMERS-BASEL, V3, P2142, DOI 10.3390/polym3042142; Schlumberger MJ, 1998, NEW ENGL J MED, V338, P297, DOI 10.1056/NEJM199801293380506; Schwartz DL, 2009, INT J RADIAT ONCOL, V74, P1083, DOI 10.1016/j.ijrobp.2008.09.023; Sellitti DF, 1997, THYROID, V7, P641, DOI 10.1089/thy.1997.7.641; Sia MA, 2010, J THROID RES, V2010, DOI 10.4061/2010/183461; Silver CE, 2011, HEAD NECK-J SCI SPEC, V33, P1052, DOI 10.1002/hed.21494; Simard EP, 2012, CA-CANCER J CLIN, V62, P118, DOI 10.3322/caac.20141; Torti SV, 2007, INT J NANOMED, V2, P707; Uchida H, 2013, SURG TODAY, V43, P848, DOI 10.1007/s00595-012-0353-z; Valyasevi RW, 1999, J CLIN ENDOCR METAB, V84, P2557, DOI 10.1210/jc.84.7.2557; VASSART G, 1992, ENDOCR REV, V13, P596, DOI 10.1210/er.13.3.596; Wang L, 2013, PHARM RES-DORDR, V30, P2757, DOI 10.1007/s11095-013-1095-3; Wang SS, 2013, ONCOL LETT, V5, P368, DOI 10.3892/ol.2012.947; Wang ZF, 2011, TUMORI, V97, P540, DOI 10.1700/950.10410; Williams GR, 2011, ANN ENDOCRINOL-PARIS, V72, P68, DOI 10.1016/j.ando.2011.03.006; Wu A, 2013, P NATL ACAD SCI USA, V110, P16103, DOI 10.1073/pnas.1314385110; Yang ST, 2012, THERANOSTICS, V2, P271, DOI 10.7150/thno.3618; Zhu LQ, 2015, GASTROENTEROLOGY RES, P1; 2007, NANOTECHNOLOGY, V18, P9	71	13	13	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149723	10.1371/journal.pone.0149723	http://dx.doi.org/10.1371/journal.pone.0149723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901566	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100135
J	Motswaledi, MS; Kasvosve, I; Oguntibeju, OO				Motswaledi, Modisa Sekhamo; Kasvosve, Ishmael; Oguntibeju, Oluwafemi Omoniyi			Blood Group Antigens C, Lub and P1 May Have a Role in HIV Infection in Africans	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTROPHIL COUNTS; PLASMODIUM-VIVAX; CHEMOKINES DARC; RECEPTOR; CELLS; SUSCEPTIBILITY; AIDS; HLA; GLYCOPROTEIN	Background Botswana is among the world's countries with the highest rates of HIV infection. It is not known whether or not this susceptibility to infection is due to genetic factors in the population. Accumulating evidence, however, points to the role of erythrocytes as potential mediators of infection. We therefore sought to establish the role, if any, of some erythrocyte antigens in HIV infection in a cross-section of the population. Methods 348 (346 HIV-negative and 2 HIV-positive) samples were obtained from the National Blood Transfusion Service as residual samples, while 194 HIV-positive samples were obtained from the Botswana-Harvard HIV Reference Laboratory. Samples were grouped for twenty three antigens. Chi-square or Fischer Exact analyses were used to compare the frequencies of the antigens in the two groups. A stepwise, binary logistic regression was used to study the interaction of the various antigens in the light of HIV-status. Results The Rh antigens C and E were associated with HIV-negative status, while blood group Jk(a), P-1 and Lu-b were associated with HIV-positive status. A stepwise binary logistic regression analysis yielded group C as the most significant protective blood group while Lu-b and P-1 were associated with significantly higher odds ratio in favor of HIV-infection. The lower-risk-associated group C was significantly lower in Africans compared to published data for Caucasians and might partially explain the difference in susceptibility to HIV-1. Conclusion The most influential antigen C, which also appears to be protective, is significantly lower in Africans than published data for Caucasians or Asians. On the other hand, there appear to be multiple antigens associated with increased risk that may override the protective role of C. A study of the distribution of these antigens in other populations may shed light on their roles in the HIV pandemic.	[Motswaledi, Modisa Sekhamo; Kasvosve, Ishmael] Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana; [Motswaledi, Modisa Sekhamo; Oguntibeju, Oluwafemi Omoniyi] Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Nutr & Chron Dis Res Grp, Oxidat Stress Res Ctr,Dept Biomed Sci, Cape Town, South Africa	University of Botswana; Cape Peninsula University of Technology	Motswaledi, MS (corresponding author), Univ Botswana, Dept Med Lab Sci, Fac Hlth Sci, Gaborone, Botswana.; Motswaledi, MS (corresponding author), Cape Peninsula Univ Technol, Fac Hlth & Wellness Sci, Nutr & Chron Dis Res Grp, Oxidat Stress Res Ctr,Dept Biomed Sci, Cape Town, South Africa.	modisa.motswaledi@mopipi.ub.bw	Motswaledi, Modisa/AAY-7597-2020; Oguntibeju, Oluwafemi/AAR-2256-2020	Motswaledi, Modisa/0000-0001-8163-7166; Kasvosve, Ishmael/0000-0002-2046-545X	University of Botswana Office of Research and Development [R0649]; Cape Peninsula University of Technology; National Research Foundation (NRF) of South Africa	University of Botswana Office of Research and Development; Cape Peninsula University of Technology; National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This work was funded by University of Botswana Office of Research and Development, Grant no. R0649, to MM (http://www.ub.bw/ord/), and Cape Peninsula University of Technology and National Research Foundation (NRF) of South Africa, to OO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulazeez AA, 2008, BIOMED RES-INDIA, V19, P41; Agency CSOaNAC, 2008, 2008 BOTSW AIDS IMP, P8; ANSTEE DJ, 1993, BAILLIERE CLIN HAEM, V6, P401, DOI 10.1016/S0950-3536(05)80152-0; ARENDRUP M, 1991, AIDS, V5, P441, DOI 10.1097/00002030-199104000-00014; Badjie K, 2015, MOL ANAL DETERMINING; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bolton MJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-523; Branch DR, 2010, CURR OPIN HEMATOL, V17, P558, DOI 10.1097/MOH.0b013e32833ece31; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; DHAWAN S, 1992, J LEUKOCYTE BIOL, V52, P62, DOI 10.1002/jlb.52.1.62; Egene J., 2004, NIGER J PHYSL SCI, V19, P7; Eyler CE, 2006, TRANSFUSION, V46, P668, DOI 10.1111/j.1537-2995.2006.00779.x; Gomez H, 2007, 2007 BOTSWANA ANC 2; Hadley TJ, 1997, BLOOD, V89, P3077, DOI 10.1182/blood.V89.9.3077; Hammache D, 1999, J VIROL, V73, P5244, DOI 10.1128/JVI.73.6.5244-5248.1999; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Hellberg A, 2013, Immunohematology, V29, P25; Hellberg A, 2007, THESIS LUND; Horakova E, 2004, J IMMUNOL, V173, P4236, DOI 10.4049/jimmunol.173.6.4236; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; *ISO, 2007, 15189 ISO; Keetile M, 2014, SAHARA J-J SOC ASP H, V11, P158, DOI 10.1080/17290376.2014.960948; Lachgar A, 1998, BIOMED PHARMACOTHER, V52, P436, DOI 10.1016/S0753-3322(99)80021-3; Lund N, 2005, AIDS, V19, P1543, DOI 10.1097/01.aids.0000183521.90878.79; Lund N, 2009, BLOOD, V113, P4980, DOI 10.1182/blood-2008-03-143396; Malhotra U, 2001, J CLIN INVEST, V107, P505, DOI 10.1172/JCI11275; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Neil SJ, 2003, A B O BLOOD GROUPS H; Nemer WE, 1998, J BIOL CHEM, V273, P16686, DOI [10.1074/jbc.273.27.16686, DOI 10.1074/JBC.273.27.16686]; Nilsson J, 2009, GLYCOCONJUGATE J, V26, P1171, DOI 10.1007/s10719-009-9237-x; Onsten Tor Gunnar Hugo, 2013, Open AIDS J, V7, P47, DOI 10.2174/1874613601307010047; PARSONS SF, 1995, P NATL ACAD SCI USA, V92, P5496, DOI 10.1073/pnas.92.12.5496; Puri A, 1998, BIOCHEM BIOPH RES CO, V242, P219, DOI 10.1006/bbrc.1997.7941; Puri A, 2004, AIDS, V18, P849, DOI 10.1097/00002030-200404090-00002; Quillent C, 1998, LANCET, V351, P14, DOI 10.1016/S0140-6736(97)09185-X; Ramsuran V, 2011, CLIN INFECT DIS, V52, P1248, DOI 10.1093/cid/cir119; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Sayal S K, 1996, Indian J Dermatol Venereol Leprol, V62, P295; Thobakgale CF, 2014, CURR OPIN HEMATOL, V21, P50, DOI 10.1097/MOH.0000000000000007; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010	43	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149883	10.1371/journal.pone.0149883	http://dx.doi.org/10.1371/journal.pone.0149883			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900853	Green Published, gold			2022-12-26	WOS:000371276100174
J	Rojo, C; Mesquita-Joanes, F; Monros, JS; Armengol, J; Sasa, M; Bonilla, F; Rueda, R; Benavent-Corail, J; Piculo, R; Segura, MM				Rojo, Carmen; Mesquita-Joanes, Francesc; Monros, Juan S.; Armengol, Javier; Sasa, Mahmood; Bonilla, Fabian; Rueda, Ricardo; Benavent-Corail, Jose; Piculo, Ruben; Matilde Segura, M.			Hydrology Affects Environmental and Spatial Structuring of Microalgal Metacommunities in Tropical Pacific Coast Wetlands	PLOS ONE			English	Article							COMMUNITY COMPOSITION; ECOLOGICAL DATA; DISPERSAL; PHYTOPLANKTON; FRAMEWORK; PATTERNS; RIVER; MICROORGANISMS; SIMILARITY; VARIABLES	The alternating climate between wet and dry periods has important effects on the hydrology and therefore on niche-based processes of water bodies in tropical areas. Additionally, assemblages of microorganism can show spatial patterns, in the form of a distance decay relationship due to their size or life form. We aimed to test spatial and environmental effects, modulated by a seasonal flooding climatic pattern, on the distribution of microalgae in 30 wetlands of a tropical dry forest region: the Pacific coast of Costa Rica and Nicaragua. Three surveys were conducted corresponding to the beginning, the highest peak, and the end of the hydrological year during the wet season, and species abundance and composition of planktonic and benthic microalgae was determined. Variation partitioning analysis (as explained by spatial distance or environmental factors) was applied to each seasonal dataset by means of partial redundancy analysis. Our results show that microalgal assemblages were structured by spatial and environmental factors depending on the hydrological period of the year. At the onset of hydroperiod and during flooding, neutral effects dominated community dynamics, but niche-based local effects resulted in more structured algal communities at the final periods of desiccating water bodies. Results suggest that climate-mediated effects on hydrology can influence the relative role of spatial and environmental factors on metacommunities of microalgae. Such variability needs to be accounted in order to describe accurately community dynamics in tropical coastal wetlands.	[Rojo, Carmen; Mesquita-Joanes, Francesc; Monros, Juan S.; Armengol, Javier; Benavent-Corail, Jose; Piculo, Ruben; Matilde Segura, M.] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain; [Rueda, Ricardo] Univ Nacl Autonoma Nicaragua, Fac Ciencia & Tecnol, Dept Biol, Leon, Nicaragua; [Sasa, Mahmood; Bonilla, Fabian] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica	University of Valencia; Universidad Costa Rica	Rojo, C (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain.	carmen.rojo@uv.es	Mesquita-Joanes, Francesc/F-3200-2011; Monros, Juan/AAA-3726-2020; Armengol, Javier/AFX-9563-2022; Rojo, Carmen/L-5358-2014; Armengol, Javier/H-2325-2015; Monros, Juan S/L-9750-2014	Mesquita-Joanes, Francesc/0000-0001-7168-1980; Monros, Juan/0000-0002-0952-2089; Armengol, Javier/0000-0002-0312-0396; Armengol, Javier/0000-0002-0312-0396; Monros, Juan S/0000-0002-0952-2089; Rojo, Carmen/0000-0003-1034-0175; Sasa, Mahmood/0000-0003-0118-5142	Agencia espanola de coperacion y desarrollo [A1024073/09, A/031019/10, C/032994/10, A3/036594/11]; Vicerrectoria de Investigacion Universidad de Costa Rica [741-B1-517]	Agencia espanola de coperacion y desarrollo; Vicerrectoria de Investigacion Universidad de Costa Rica	The authors acknowledge financial support from the Agencia espanola de coperacion y desarrollo (http://www.aecid.es/ES), grants A1024073/09, A/031019/10, C/032994/10, A3/036594/11 received by JSM, CR, JA, FMJ, MS, FB and RR. This study was also funded by the Vicerrectoria de Investigacion Universidad de Costa Rica (http://www.vinv.ucr.ac.cr/); grant 741-B1-517 received by MS and FB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahuhta J, 2013, J BIOGEOGR, V40, P1572, DOI 10.1111/jbi.12089; Anderson MJ, 1999, J STAT COMPUT SIM, V62, P271, DOI 10.1080/00949659908811936; Angeler DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077338; Angeler DG, 2010, ECOL RES, V25, P513, DOI 10.1007/s11284-009-0681-7; [Anonymous], CLIMATE CHANGE 2007; APHA American Public Health Association, 1992, STANDARD METHODS EXA; Astorga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P365, DOI 10.1111/j.1466-8238.2011.00681.x; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; Blanchet FG, 2011, OECOLOGIA, V166, P357, DOI 10.1007/s00442-010-1867-y; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bottin M, 2014, FRESHW SCI, V33, P402, DOI 10.1086/675726; Cisneros LM, 2015, J ANIM ECOL, V84, P373, DOI 10.1111/1365-2656.12299; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; de Emiliani MOG, 1997, HYDROBIOLOGIA, V357, P1; Douglas MM, 2005, MAR FRESHWATER RES, V56, P329, DOI 10.1071/MF04084; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Ellison Aaron M., 2004, Wetlands Ecology and Management, V12, P3, DOI 10.1023/B:WETL.0000016809.95746.b1; ESRI, 2006, ARCGIS 10; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fernandes IM, 2014, ECOGRAPHY, V37, P464, DOI 10.1111/j.1600-0587.2013.00527.x; Flinn KM, 2010, J ECOL, V98, P1292, DOI 10.1111/j.1365-2745.2010.01708.x; Garcia EA, 2015, HYDROBIOLOGIA, V760, P43, DOI 10.1007/s10750-015-2301-6; Gotelli NJ, 2013, ECOSIMR 1 00; Gothe E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072237; Gronroos M, 2013, ECOL EVOL, V3, P4473, DOI 10.1002/ece3.834; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jeppesen E, 2005, RESTORATION AND MANAGEMENT OF TROPICAL EUTROPHIC LAKES, P341; JIMENEZ-RAMON J. A., 1999, WWF CENTROAMERICA, V2, P4; Jones D. L., 2012, FATHOM TOOLBOX MATLA; Junk WJ, 2002, ENVIRON CONSERV, V29, P414, DOI 10.1017/S0376892902000310; Kosten S, 2012, FRESHWATER BIOL, V57, P1191, DOI 10.1111/j.1365-2427.2012.02785.x; Kruk C, 2012, HYDROBIOLOGIA, V698, P191, DOI 10.1007/s10750-012-1072-6; Kruk C, 2009, FRESHWATER BIOL, V54, P2628, DOI 10.1111/j.1365-2427.2009.02274.x; Kundzewicz ZW, 2008, HYDROLOG SCI J, V53, P3, DOI 10.1623/hysj.53.1.3; Landeiro VL, 2012, FRESHWATER BIOL, V57, P1554, DOI 10.1111/j.1365-2427.2012.02816.x; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Louette G, 2008, FRESHWATER BIOL, V53, P2309, DOI 10.1111/j.1365-2427.2008.02052.x; LUND JWG, 1958, HYDROBIOLOGIA, V11, P143, DOI DOI 10.1007/BF00007865; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Meier S, 2015, HYDROBIOLOGIA, V743, P175, DOI 10.1007/s10750-014-2034-y; MELACK JM, 1979, OECOLOGIA, V44, P1, DOI 10.1007/BF00346388; Melo-Magalhaes E.M., 2011, Brazilian Journal of Aquatic Science and Technology, V15, P95; Mitra S, 2005, CURR SCI INDIA, V88, P25; MORA G., 2012, AMBIENTALES, V43, P29; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Reynolds C. S., 1984, ECOLOGY FRESHWATER P; Rojo C, 2012, BIODIVERS CONSERV, V21, P2453, DOI 10.1007/s10531-012-0307-1; Sasa M, 2015, LIMNETICA, V34, P1; SCHEFFER M, 1993, TRENDS ECOL EVOL, V8, P275, DOI 10.1016/0169-5347(93)90254-M; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Soininen J, 2014, GLOBAL ECOL BIOGEOGR, V23, P1264, DOI 10.1111/geb.12204; Soininen J, 2011, LIMNOL OCEANOGR, V56, P508, DOI 10.4319/lo.2011.56.2.0508; Soofi ES, 2000, DECISION SCI, V31, P595, DOI 10.1111/j.1540-5915.2000.tb00936.x; Thomaz SM, 2007, HYDROBIOLOGIA, V579, P1, DOI 10.1007/s10750-006-0285-y; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanschoenwinkel B, 2010, J N AM BENTHOL SOC, V29, P1267, DOI 10.1899/09-114.1; Wang HJ, 2014, FRESHWATER BIOL, V59, P1659, DOI 10.1111/fwb.12372; Wetzel CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045071	65	18	20	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149505	10.1371/journal.pone.0149505	http://dx.doi.org/10.1371/journal.pone.0149505			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900916	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100087
J	Zhang, XY; Zhang, T; Pei, J; Liu, YY; Li, XS; Medrano-Gracia, P				Zhang, Xingyu; Zhang, Tao; Pei, Jiao; Liu, Yuanyuan; Li, Xiaosong; Medrano-Gracia, Pau			Time Series Modelling of Syphilis Incidence in China from 2005 to 2012	PLOS ONE			English	Article							NEURAL-NETWORK; EPIDEMIOLOGY; ARIMA; SEASONALITY; RISK	Background The infection rate of syphilis in China has increased dramatically in recent decades, becoming a serious public health concern. Early prediction of syphilis is therefore of great importance for heath planning and management. Methods In this paper, we analyzed surveillance time series data for primary, secondary, tertiary, congenital and latent syphilis in mainland China from 2005 to 2012. Seasonality and long-term trend were explored with decomposition methods. Autoregressive integrated moving average (ARIMA) was used to fit a univariate time series model of syphilis incidence. A separate multi-variable time series for each syphilis type was also tested using an autoregressive integrated moving average model with exogenous variables (ARIMAX). Results The syphilis incidence rates have increased three-fold from 2005 to 2012. All syphilis time series showed strong seasonality and increasing long-term trend. Both ARIMA and ARIMAX models fitted and estimated syphilis incidence well. All univariate time series showed highest goodness-of-fit results with the ARIMA(0,0,1) x(0,1,1) model. Conclusion Time series analysis was an effective tool for modelling the historical and future incidence of syphilis in China. The ARIMAX model showed superior performance than the ARIMA model for the modelling of syphilis incidence. Time series correlations existed between the models for primary, secondary, tertiary, congenital and latent syphilis.	[Zhang, Xingyu; Zhang, Tao; Liu, Yuanyuan; Li, Xiaosong] Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu 610064, Sichuan, Peoples R China; [Zhang, Xingyu; Medrano-Gracia, Pau] Univ Auckland, Dept Anat Radiol, Auckland 1, New Zealand; [Pei, Jiao] Sichuan Canc Hosp & Inst, Dept Sci & Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; University of Auckland	Li, XS (corresponding author), Sichuan Univ, West China Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Chengdu 610064, Sichuan, Peoples R China.	lixiaosong1101@126.com	liu, yuanyuan/GWZ-5838-2022	Zhang, Xingyu/0000-0001-8108-1997; Medrano-Gracia, Pau/0000-0002-6255-4864	National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen" [2012ZX10004201-006]; China Scholarship Council (CSC)	National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen"; China Scholarship Council (CSC)(China Scholarship Council)	The research is funded by National science and technology major special project "Data mining and analysis of the surveillance data of five syndrome pathogen (grant no. 2012ZX10004201-006)." Xingyu Zhang was financially supported by China Scholarship Council (CSC) for his doctoral studies.	Abeysinghe T, 1991, J Appl Stat, V18, P275, DOI 10.1080/02664769100000021; Bobak M, 2001, HUM REPROD, V16, P1512, DOI 10.1093/humrep/16.7.1512; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Douglas JM, 2009, JAMA-J AM MED ASSOC, V301, P769, DOI 10.1001/jama.2009.143; Dowell D, 2012, AM J PUBLIC HEALTH, V102, P148, DOI 10.2105/AJPH.2011.300283; Faruk DO, 2010, ENG APPL ARTIF INTEL, V23, P586, DOI 10.1016/j.engappai.2009.09.015; Fong PW, 2003, COMPUT STAT DATA AN, V43, P369, DOI 10.1016/S0167-9473(02)00298-0; Galbraith JW, 1999, J ECONOMETRICS, V93, P25, DOI 10.1016/S0304-4076(98)00097-9; Garnett GP, 1997, SEX TRANSM DIS, V24, P185, DOI 10.1097/00007435-199704000-00002; Genc M, 2000, SEX TRANSM INFECT, V76, P73, DOI 10.1136/sti.76.2.73; Guo Qing, 2010, Disease Surveillance, V25, P410; Hannan E. J., 2009, MULTIPLE TIME SERIES; Ho SL, 2002, COMPUT IND ENG, V42, P371, DOI 10.1016/S0360-8352(02)00036-0; Kass-Hout T, 2010, BIOSURVEILLANCE METH; Kent ME, 2008, ANN PHARMACOTHER, V42, P226, DOI 10.1345/aph.1K086; KOEHLER AB, 1988, J R STAT SOC C-APPL, V37, P187; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Liu A-Y, 2014, GLOBAL J HLTH SCI, V7, pp249; Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963; Pai PF, 2005, OMEGA-INT J MANAGE S, V33, P497, DOI 10.1016/j.omega.2004.07.024; Rios M, 2000, EUR J EPIDEMIOL, V16, P483, DOI 10.1023/A:1007653329972; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Stamm LV, 2010, ANTIMICROB AGENTS CH, V54, P583, DOI 10.1128/AAC.01095-09; Tan NX, 2013, J INFECT DIS; TIAO GC, 1981, J AM STAT ASSOC, V76, P802, DOI 10.2307/2287575; Tucker JD, 2011, SEX TRANSM INFECT, V87, pII16, DOI 10.1136/sti.2010.048314; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Tucker JD, 2010, B WORLD HEALTH ORGAN, V88, P452, DOI 10.2471/BLT.09.070326; Tucker JD, 2010, NEW ENGL J MED, V362, P1658, DOI 10.1056/NEJMp0911149; Ture M, 2006, EXPERT SYST APPL, V31, P41, DOI 10.1016/j.eswa.2005.09.002; Wangdi K, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-251; Williams K, INVESTIGATING RISK F; WRIGHT RA, 1978, BRIT J VENER DIS, V54, P433; ZAIDI AA, 1989, STAT MED, V8, P353, DOI 10.1002/sim.4780080316; Zhang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031076; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]; Zhang XY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063116	39	23	36	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149401	10.1371/journal.pone.0149401	http://dx.doi.org/10.1371/journal.pone.0149401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901682	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100070
J	Bianchi, V; Bulek, A; Fuller, A; Lloyd, A; Attaf, M; Rizkallah, PJ; Dolton, G; Sewell, AK; Cole, DK				Bianchi, Valentina; Bulek, Anna; Fuller, Anna; Lloyd, Angharad; Attaf, Meriem; Rizkallah, Pierre J.; Dolton, Garry; Sewell, Andrew K.; Cole, David K.			A Molecular Switch Abrogates Glycoprotein 100 (gp100) T-cell Receptor (TCR) Targeting of a Human Melanoma Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; HETEROCLITIC PEPTIDES; STRUCTURAL BASIS; ANCHOR RESIDUES; REACTIVE CTL; GENE-THERAPY; ALPHA-BETA; BINDING; RECOGNITION; EPITOPES	Human CD8(+) cytotoxic T lymphocytes can mediate tumor regression in melanoma through the specific recognition of HLA-restricted peptides. Because of the relatively weak affinity of most anti-cancer T-cell receptors (TCRs), there is growing emphasis on immunizing melanoma patients with altered peptide ligands in order to induce strong anti-tumor immunity capable of breaking tolerance toward these self-antigens. However, previous studies have shown that these immunogenic designer peptides are not always effective. The melanocyte differentiation protein, glycoprotein 100 (gp100), encodes a naturally processed epitope that is an attractive target for melanoma immunotherapies, in particular peptide-based vaccines. Previous studies have shown that substitutions at peptide residue Glu(3) have a broad negative impact on polyclonal T-cell responses. Here, we describe the first atomic structure of a natural cognate TCR in complex with this gp100 epitope and highlight the relatively high affinity of the interaction. Alanine scan mutagenesis performed across the gp100(280-288) peptide showed that Glu(3) was critically important for TCR binding. Unexpectedly, structural analysis demonstrated that the Glu(3) -> Ala substitution resulted in a molecular switch that was transmitted to adjacent residues, abrogating TCR binding and T-cell recognition. These findings help to clarify the mechanism of T-cell recognition of gp100 during melanoma responses and could direct the development of altered peptides for vaccination.	[Cole, David K.] Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; Cardiff Univ, Sch Med, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Cole, DK (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	coledk@cf.ac.uk	Rizkallah, Pierre J/A-5367-2012; Sewell, Andrew/GPT-4220-2022	Rizkallah, Pierre J/0000-0002-9290-0369; Sewell, Andrew/0000-0003-3194-3135; Fuller, Anna/0000-0002-8655-6741; Cole, David/0000-0003-0028-9396	Cancer Research Wales Ph.D. studentship; Research Council UK fellowship; Wellcome Trust [WT095767]; BBSRC [BB/H001085/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H001085/1] Funding Source: researchfish; Medical Research Council [1247762] Funding Source: researchfish; Wellcome Trust [100327/Z/12/Z] Funding Source: researchfish	Cancer Research Wales Ph.D. studentship; Research Council UK fellowship; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a Cancer Research Wales Ph.D. studentship.; Supported by a Research Council UK fellowship.; A Wellcome Trust Research Career Development Fellow (Grant WT095767).	Aleksic M, 2012, EUR J IMMUNOL, V42, P3174, DOI 10.1002/eji.201242606; Armstrong KM, 2008, J MOL RECOGNIT, V21, P275, DOI 10.1002/jmr.896; Armstrong KM, 2007, BIOPHYS J, V93, P597, DOI 10.1529/biophysj.107.104570; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Borbulevych OY, 2011, J IMMUNOL, V187, P2453, DOI 10.4049/jimmunol.1101268; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Bridgeman JS, 2012, IMMUNOLOGY, V135, P9, DOI 10.1111/j.1365-2567.2011.03515.x; Bulek AM, 2012, J IMMUNOL METHODS, V382, P203, DOI 10.1016/j.jim.2012.06.007; Chen JL, 2005, J EXP MED, V201, P1243, DOI 10.1084/jem.20042323; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Deng L, 2007, NAT IMMUNOL, V8, P398, DOI 10.1038/ni1447; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garboczi DN, 1996, J IMMUNOL, V157, P5403; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; KAWAKAMI Y, 1994, J EXP MED, V180, P347, DOI 10.1084/jem.180.1.347; KAWAKAMI Y, 1995, J IMMUNOL, V154, P3961; Kloverpris HN, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0149-5; Lesterhuis WJ, 2011, CANCER IMMUNOL IMMUN, V60, P249, DOI 10.1007/s00262-010-0942-x; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Madura F, 2015, EUR J IMMUNOL, V45, P584, DOI 10.1002/eji.201445114; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miles KM, 2011, MOL IMMUNOL, V48, P728, DOI 10.1016/j.molimm.2010.11.004; Motozono C, 2015, J BIOL CHEM, V290, P18924, DOI 10.1074/jbc.M114.622522; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PARKER KC, 1992, J IMMUNOL, V149, P3580; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Rosenberg SA, 1998, NAT MED, V4, P321, DOI 10.1038/nm0398-321; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; RUPPERT J, 1993, CELL, V74, P929, DOI 10.1016/0092-8674(93)90472-3; Salgaller ML, 1996, CANCER RES, V56, P4749; Schaft N, 2003, J IMMUNOL, V170, P2186, DOI 10.4049/jimmunol.170.4.2186; Schaft N, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00270; Skipper JCA, 1999, INT J CANCER, V82, P669, DOI 10.1002/(SICI)1097-0215(19990827)82:5<669::AID-IJC9>3.0.CO;2-#; Speiser DE, 2008, P NATL ACAD SCI USA, V105, P3849, DOI 10.1073/pnas.0800080105; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Tynan FE, 2005, NAT IMMUNOL, V6, P1114, DOI 10.1038/ni1257; Wagner SN, 1997, CANCER IMMUNOL IMMUN, V44, P239, DOI 10.1007/s002620050379; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wyer JR, 1999, IMMUNITY, V10, P219, DOI 10.1016/S1074-7613(00)80022-9	45	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8951	8959		10.1074/jbc.M115.707414	http://dx.doi.org/10.1074/jbc.M115.707414			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917722	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000374849000008
J	McLaughlin, D; Coey, CT; Yang, WC; Drohat, AC; Matunis, MJ				McLaughlin, Dylan; Coey, Christopher T.; Yang, Wei-Chih; Drohat, Alexander C.; Matunis, Michael J.			Characterizing Requirements for Small Ubiquitin-like Modifier (SUMO) Modification and Binding on Base Excision Repair Activity of Thymine-DNA Glycosylase in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBNUCLEAR LOCALIZATION; CRYSTAL-STRUCTURE; TDG; RECEPTOR; TET; 5-CARBOXYLCYTOSINE; TRANSCRIPTION; SUMOYLATION; REPRESSION; COOPERATE	Thymine-DNA glycosylase (TDG) plays critical roles in DNA base excision repair and DNA demethylation. It has been proposed, based on structural studies and in vitro biochemistry, that sumoylation is required for efficient TDG enzymatic turnover following base excision. However, whether sumoylation is required for TDG activity in vivo has not previously been tested. We have developed an in vivo assay for TDG activity that takes advantage of its recently discovered role in DNA demethylation and selective recognition and repair of 5-carboxylcytosine. Using this assay, we investigated the role of sumoylation in regulating TDG activity through the use of TDG mutants defective for sumoylation and Small Ubiquitin-like Modifier (SUMO) binding and by altering TDG sumoylation through SUMO and SUMO protease overexpression experiments. Our findings indicate that sumoylation and SUMO binding are not essential for TDG-mediated excision and repair of 5-carboxylcytosine bases. Moreover, in vitro assays revealed that apurinic/apyrimidinic nuclease 1 provides nearly maximum stimulation of TDG processing of G.caC substrates. Thus, under our assay conditions, apurinic/apyrimidinic nuclease 1-mediated stimulation or other mechanisms sufficiently alleviate TDG product inhibition and promote its enzymatic turnover in vivo.	[McLaughlin, Dylan; Yang, Wei-Chih; Matunis, Michael J.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Coey, Christopher T.; Drohat, Alexander C.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore	Matunis, MJ (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.; Drohat, AC (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	adrohat@som.umaryland.edu; mmatuni1@jhu.edu		Matunis, Michael/0000-0002-9350-6611; Drohat, Alex/0000-0002-7458-8770	National Institutes of Health [R01-GM72711, R01-GM060980]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072711, R01GM060980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01-GM72711 (to A. C. D.) and R01-GM060980 (to M. J. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Baba D, 2006, J MOL BIOL, V359, P137, DOI 10.1016/j.jmb.2006.03.036; Baldwin MR, 2010, BIOCHEMISTRY-US, V49, P7879, DOI 10.1021/bi100889r; Bellacosa A, 2015, DNA REPAIR, V32, P33, DOI 10.1016/j.dnarep.2015.04.011; Boiteux S, 2004, DNA REPAIR, V3, P1, DOI 10.1016/j.dnarep.2003.10.002; Burrage PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2564; Calini V, 2002, CELL BIOL TOXICOL, V18, P369, DOI 10.1023/A:1020811522100; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Coey CT, 2014, J BIOL CHEM, V289, P15810, DOI 10.1074/jbc.M114.572081; Cubenas-Potts C, 2013, MOL BIOL CELL, V24, P3483, DOI 10.1091/mbc.E13-05-0230; Fitzgerald ME, 2008, J BIOL CHEM, V283, P32680, DOI 10.1074/jbc.M805504200; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goeres J, 2011, MOL BIOL CELL, V22, P4868, DOI 10.1091/mbc.E10-12-0953; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hardeland U, 2001, PROG NUCLEIC ACID RE, V68, P235; Hardeland U, 2007, NUCLEIC ACIDS RES, V35, P3859, DOI 10.1093/nar/gkm337; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Jia YY, 2014, J MOL CELL BIOL, V6, P231, DOI 10.1093/jmcb/mju014; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Krokan HE, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012583; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Malik SS, 2015, NUCLEIC ACIDS RES, V43, P9541, DOI 10.1093/nar/gkv890; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Mohan RD, 2007, MOL CELL BIOL, V27, P229, DOI 10.1128/MCB.00323-06; Morgan MT, 2011, NUCLEIC ACIDS RES, V39, P2319, DOI 10.1093/nar/gkq1164; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Raman N, 2013, CHROMOSOMA, V122, P475, DOI 10.1007/s00412-013-0429-6; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shibata E, 2014, J BIOL CHEM, V289, P23056, DOI 10.1074/jbc.M114.574210; Sjolund AB, 2013, MUTAT RES-FUND MOL M, V743, P12, DOI 10.1016/j.mrfmmm.2012.11.001; Slenn TJ, 2014, J BIOL CHEM, V289, P23043, DOI 10.1074/jbc.M114.574194; Smet-Nocca C, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-4; Steinacher R, 2005, CURR BIOL, V15, P616, DOI 10.1016/j.cub.2005.02.054; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Waters TR, 1999, J BIOL CHEM, V274, P67, DOI 10.1074/jbc.274.1.67; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	45	14	14	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9014	9024		10.1074/jbc.M115.706325	http://dx.doi.org/10.1074/jbc.M115.706325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917720	Green Published, hybrid			2022-12-26	WOS:000374849000016
J	Li, HY; Wang, J; Meng, F; Jia, ZK; Su, Y; Bai, QF; Lv, LL; Ma, FR; Potempa, LA; Yan, YB; Ji, SR; Wu, Y				Li, Hai-Yun; Wang, Jing; Meng, Fan; Jia, Zhe-Kun; Su, Yang; Bai, Qi-Feng; Lv, Ling-Ling; Ma, Fu-Rong; Potempa, Lawrence A.; Yan, Yong-Bin; Ji, Shang-Rong; Wu, Yi			An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						atherosclerosis; endothelial dysfunction; extracellular matrix; inflammation; protein motif; C-reactive protein; intrinsically disordered region	AMINO-ACID-SEQUENCE; ENDOTHELIAL-CELLS; SYNTHETIC PEPTIDE; COMPLEMENT ACTIVATION; NEUTROPHIL ADHESION; MOLECULAR-DYNAMICS; INFLAMMATION; ATHEROSCLEROSIS; PLATELETS; DISEASE	Most proinflammatory actions of C-reactive protein (CRP) are only expressed following dissociation of its native pentameric assembly into monomeric form (mCRP). However, little is known about what underlies the greatly enhanced activities of mCRP. Here we show that a single sequence motif, i.e. cholesterol binding sequence (CBS; a.a. 35-47), is responsible for mediating the interactions of mCRP with diverse ligands. The binding of mCRP to lipoprotein component ApoB, to complement component C1q, to extracellular matrix components fibronectin and collagen, to blood coagulation component fibrinogen, and to membrane lipid component cholesterol, are all found to be markedly inhibited by the synthetic CBS peptide but not by other CRP sequences tested. Likewise, mutating CBS in mCRP also greatly impairs these interactions. Functional experiments further reveal that CBS peptide significantly reduces the effects of mCRP on activation of endothelial cells in vitro and on acute induction of IL-6 in mice. The potency and specificity of CBS are critically determined by the N-terminal residues Cys-36, Leu-37, and His-38; while the versatility of CBS appears to originate from its intrinsically disordered conformation polymorphism. Together, these data unexpectedly identify CBS as the major recognition site of mCRP and suggest that this motif may be exploited to tune the proinflammatory actions of mCRP.	[Li, Hai-Yun; Wu, Yi] Xi An Jiao Tong Univ, Sch Basic Med Sci, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Shaanxi, Peoples R China; [Li, Hai-Yun; Yan, Yong-Bin] Tsinghua Univ, Sch Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Wang, Jing; Meng, Fan; Jia, Zhe-Kun; Su, Yang; Lv, Ling-Ling; Ma, Fu-Rong; Ji, Shang-Rong; Wu, Yi] Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China; [Bai, Qi-Feng] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Potempa, Lawrence A.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA	Xi'an Jiaotong University; Tsinghua University; Lanzhou University; Lanzhou University	Wu, Y (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, MOE Key Lab Environm & Genes Related Dis, Xian 710061, Shaanxi, Peoples R China.; Ji, SR; Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	jsr@lzu.edu.cn; wuy@lzu.edu.cn	Bai, Qifeng/A-2950-2019; Yan, Yong-Bin/A-4282-2008	Bai, Qifeng/0000-0001-7296-6187; Yan, Yong-Bin/0000-0002-8565-3558; Wu, Yi/0000-0003-0365-5590; Li, Haiyun/0000-0002-7458-7399; Ji, Shang-Rong/0000-0001-8595-3756	National Natural Science Foundation of China [31270813, 31222015, 30930024]; China Postdoctoral Science Foundation [2014M560075]; National Natural Science Foundation of China [31270813, 31222015, 30930024]; China Postdoctoral Science Foundation [2014M560075]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (Grant Numbers, 31270813, 31222015, 30930024) and the China Postdoctoral Science Foundation (Grant Numbers 2014M560075). The authors declare that they have no conflicts of interest with the contents of this article.	BARNA BP, 1993, CANCER IMMUNOL IMMUN, V36, P171, DOI 10.1007/BF01741088; Braig D, 2014, INT IMMUNOL, V26, P467, DOI 10.1093/intimm/dxu056; De La Torre R, 2013, J THROMB HAEMOST, V11, P2048, DOI 10.1111/jth.12415; Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040; EISCHEN A, 1994, BRIT J HAEMATOL, V88, P712, DOI 10.1111/j.1365-2141.1994.tb05109.x; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; El Kebir D, 2011, J LEUKOCYTE BIOL, V90, P1167, DOI 10.1189/jlb.0111032; Fujita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093738; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Hammond DJ, 2010, J BIOL CHEM, V285, P36235, DOI 10.1074/jbc.M110.142026; Heuertz RM, 1996, J IMMUNOL, V156, P3412; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Lauer N, 2011, J IMMUNOL, V187, P4374, DOI 10.4049/jimmunol.1002488; Li HY, 2014, J BIOL CHEM, V289, P14283, DOI 10.1074/jbc.M114.555318; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POTEMPA LA, 1983, MOL IMMUNOL, V20, P1165, DOI 10.1016/0161-5890(83)90140-2; Potempa Lawrence A, 2015, Biophys Rep, V1, P18; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHEPHARD EG, 1992, IMMUNOLOGY, V76, P79; SHEPHARD EG, 1990, J IMMUNOL, V145, P1469; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Strang F, 2012, BRAIN PATHOL, V22, P337, DOI 10.1111/j.1750-3639.2011.00539.x; Su HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102418; SWANSON SJ, 1990, MOL IMMUNOL, V27, P679, DOI 10.1016/0161-5890(90)90011-N; Thiele JR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/372432; Thiele JR, 2014, CIRCULATION, V130, P35, DOI 10.1161/CIRCULATIONAHA.113.007124; THOMASSEN MJ, 1993, J IMMUNOTHER, V13, P1, DOI 10.1097/00002371-199301000-00001; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; Wang MS, 2012, SOFT MATTER, V8, P7909, DOI 10.1039/c2sm25779c; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu Y, 2015, BIOL CHEM, V396, P1181, DOI 10.1515/hsz-2015-0149; Xu PC, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0077-0; YING SC, 1989, J IMMUNOL, V143, P221; Zhang L, 2015, J IMMUNOL, V194, P5243, DOI 10.4049/jimmunol.1402909; Zhang YJ, 2012, J BIOL CHEM, V287, P748, DOI 10.1074/jbc.M111.281295; Zhao J, 2010, CELL MOL BIOL LETT, V15, P485, DOI 10.2478/s11658-010-0022-4; Zhong WJ, 1998, J IMMUNOL, V161, P2533; Zouki C, 1997, J CLIN INVEST, V100, P522, DOI 10.1172/JCI119561	53	37	41	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8795	8804		10.1074/jbc.M115.695023	http://dx.doi.org/10.1074/jbc.M115.695023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26907682	hybrid, Green Published			2022-12-26	WOS:000374773200040
J	Ma, DY; Ma, AJ; Huang, ZH; Wang, GN; Wang, T; Xia, DD; Ma, BH				Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe			Transcriptome Analysis for Identification of Genes Related to Gonad Differentiation, Growth, Immune Response and Marker Discovery in The Turbot (Scophthalmus maximus)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ACID-BINDING PROTEINS; SALMO-SALAR L.; SEX-DIFFERENTIATION; RAINBOW-TROUT; EXPRESSION PATTERNS; MOLECULAR-STRUCTURE; INNATE IMMUNITY; CANDIDATE GENES; CARCASS TRAITS	Background Turbot Scophthalmus maximus is an economically important species extensively aquacultured in China. The genetic selection program is necessary and urgent for the sustainable development of this industry, requiring more and more genome background knowledge. Transcriptome sequencing is an excellent alternative way to identify transcripts involved in specific biological processes and exploit a considerable quantity of molecular makers when no genome sequences are available. In this study, a comprehensive transcript dataset for major tissues of S. maximus was produced on basis of an Illumina platform. Results Total RNA was isolated from liver, spleen, kidney, cerebrum, gonad (testis and ovary) and muscle. Equal quantities of RNA from each type of tissues were pooled to construct two cDNA libraries (male and female). Using the Illumina paired-end sequencing technology, nearly 44.22 million clean reads in length of 100 bp were generated and then assembled into 106,643 contigs, of which 71,107 were named unigenes with an average length of 892 bp after the elimination of redundancies. Of these, 24,052 unigenes (33.83% of the total) were successfully annotated. GO, KEGG pathway mapping and COG analysis were performed to predict potential genes and their functions. Based on our sequence analysis and published documents, many candidate genes with fundamental roles in sex determination and gonad differentiation (dmrt1), growth (ghrh, myf5, prl/prlr) and immune response (TLR1/TLR21/TLR22, IL-15/IL-34), were identified for the first time in this species. In addition, a large number of credible genetic markers, including 21,192 SSRs and 8,642 SNPs, were identified in the present dataset. Conclusion This informative transcriptome provides valuable new data to increase genomic resources of Scophthalmus maximus. The future studies of corresponding gene functions will be very useful for the management of reproduction, growth and disease control in turbot aquaculture breeding programs. The molecular markers identified in this database will aid in genetic linkage analyses, mapping of quantitative trait loci, and acceleration of marker assisted selection programs.	[Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe] Chinese Acad Fishery Sci, Qingdao Key Lab Marine Fish Breeding & Biotechnol, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst,Minist Agr, Qingdao 266071, Peoples R China; [Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China; [Ma, Deyou] Dalian Ocean Univ, Dalian 116023, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Dalian Ocean University	Ma, AJ (corresponding author), Chinese Acad Fishery Sci, Qingdao Key Lab Marine Fish Breeding & Biotechnol, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst,Minist Agr, Qingdao 266071, Peoples R China.; Ma, AJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China.	maaj@ysfri.ac.cn			Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-50-G01]; National High Technology Research and Development Program of China (863 Program) [12AA10A408-8]; Qingdao Postdoctoral Science Foundation [ZQ51201415036]	Earmarked Fund for Modern Agro-Industry Technology Research System; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Qingdao Postdoctoral Science Foundation	Both the Earmarked Fund for Modern Agro-Industry Technology Research System (No. CARS-50-G01) (URL: http://119.253.58.231/) and the National High Technology Research and Development Program of China (863 Program) (No. 12AA10A408-8) (URL: http://www.most.gov.cn/bszn/new/863/bslc/) were received by AM, had roles in data collection and analysis of trancriptome. The decision to publish and preparation of the manuscript were sponsored by the 2014 Qingdao Postdoctoral Science Foundation ( No. ZQ51201415036, received by AM, URL: http://www.qdhrss.gov.cn/pages/zczs/zcfgk/bmzcfg/17589.html).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Alves E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020970; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; Carmichael SN, 2013, BIOMED RES INT, V14, P408, DOI DOI 10.1155/2014/291067; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen YH, 2001, GENESIS, V29, P22, DOI 10.1002/1526-968X(200101)29:1<22::AID-GENE1002>3.0.CO;2-Z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheong HS, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-35; Chou MY, 2002, J COMP PHYSIOL B, V172, P109, DOI 10.1007/s00360-001-0231-2; Cnaani A, 2009, SEX DEV, V3, P164, DOI 10.1159/000223080; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; De-Santis C, 2007, AQUACULTURE, V272, P22, DOI 10.1016/j.aquaculture.2007.08.036; DEVAUCHELLE N, 1988, AQUACULTURE, V69, P159, DOI 10.1016/0044-8486(88)90194-9; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fang W, 2007, FISH SHELLFISH IMMUN, V23, P119, DOI 10.1016/j.fsi.2006.09.011; Gross R, 1999, AQUACULTURE, V173, P73, DOI 10.1016/S0044-8486(98)00470-0; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Haffray P, 2009, AQUACULTURE, V294, P30, DOI 10.1016/j.aquaculture.2009.05.004; Hardie LJ, 1998, CYTOKINE, V10, P555, DOI 10.1006/cyto.1997.0334; Harms CA, 2000, FISH SHELLFISH IMMUN, V10, P61, DOI 10.1006/fsim.1999.0230; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Her GM, 2004, GENESIS, V38, P26, DOI 10.1002/gene.10248; Herpin A, 2011, FEBS J, V278, P1010, DOI 10.1111/j.1742-4658.2011.08030.x; Hickford JGH, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2009.01965.x; Ikenishi K, 1997, DEV GROWTH DIFFER, V39, P625; Imsland AK, 1997, AQUAC RES, V28, P101; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JH, 2002, FISHERIES SCI, V68, P494, DOI 10.1046/j.1444-2906.2002.00453.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kent J, 1996, DEVELOPMENT, V122, P2813; Kohli G, 2003, ENDOCRINOLOGY, V144, P1931, DOI 10.1210/en.2002-0126; Li C, 2004, J ANIM SCI, V82, P1; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li Q, 2008, BIOL CELL, V100, P453, DOI 10.1042/BC20070114; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu QY, 2012, COMP BIOCHEM PHYS B, V163, P86, DOI 10.1016/j.cbpb.2012.05.004; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; Navajas-Perez R, 2012, MOL ECOL RESOUR, V12, P706, DOI 10.1111/j.1755-0998.2012.03126.x; Navarro-Martin L, 2009, MOL CELL ENDOCRINOL, V299, P240, DOI 10.1016/j.mce.2008.11.013; Navarro-Martin L, 2012, COMP BIOCHEM PHYS B, V163, P316, DOI 10.1016/j.cbpb.2012.08.004; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Pardo BG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-37; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Piferrer F, 2004, AQUACULTURE, V238, P403, DOI 10.1016/j.aquaculture.2004.05.009; Piferrer F, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260802324644; POOMPUANG S, 1997, REV FISH SCI, V5, P253, DOI DOI 10.1080/10641269709388600; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Power DM, 2005, GEN COMP ENDOCR, V142, P25, DOI 10.1016/j.ygcen.2004.10.003; Qi ZZ, 2009, AQUACULTURE, V290, P15, DOI 10.1016/j.aquaculture.2009.02.012; Ribas L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-180; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1149; Rodriguez-Ramilo ST, 2014, MAR BIOTECHNOL, V16, P265, DOI 10.1007/s10126-013-9544-x; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sandra O, 2000, J MOL ENDOCRINOL, V24, P215, DOI 10.1677/jme.0.0240215; Sawatari E, 2010, COMP BIOCHEM PHYS A, V155, P183, DOI 10.1016/j.cbpa.2009.10.030; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Sheng Y, 2014, MOL BIOL REP, V41, P1237, DOI 10.1007/s11033-013-2968-6; Shepherd BS, 1997, P NATL ACAD SCI USA, V94, P2068, DOI 10.1073/pnas.94.5.2068; Sundaram AYM, 2012, MOL BIOL REP, V39, P8965, DOI 10.1007/s11033-012-1765-y; Tan XG, 2006, COMP BIOCHEM PHYS B, V145, P204, DOI 10.1016/j.cbpb.2006.07.008; [唐永凯 TANG Yongkai], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P44; Tao WJ, 2003, HEREDITY, V91, P60, DOI 10.1038/sj.hdy.6800281; Torstensen BE, 2009, AQUACULT NUTR, V15, P440, DOI 10.1111/j.1365-2095.2008.00609.x; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Ting, 2014, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V45, P1300; Wang XL, 2010, COMP BIOCHEM PHYS B, V155, P327, DOI 10.1016/j.cbpb.2009.12.001; Wargelius A, 2005, GEN COMP ENDOCR, V142, P163, DOI 10.1016/j.ygcen.2004.12.005; Watts M, 2001, AUST VET J, V79, P570, DOI 10.1111/j.1751-0813.2001.tb10753.x; Wei YC, 2011, VET IMMUNOL IMMUNOP, V141, P173, DOI 10.1016/j.vetimm.2011.02.016; Winkler C, 2004, MECH DEVELOP, V121, P997, DOI 10.1016/j.mod.2004.03.018; Wu Lian, 2012, Agricultural Science & Technology - Hunan, V13, P2464; Wu XY, 2008, INT J IMMUNOGENET, V35, P215, DOI 10.1111/j.1744-313X.2008.00759.x; Xia XH, 2010, J GENET, V89, P183, DOI 10.1007/s12041-010-0024-z; Yada T, 2004, GEN COMP ENDOCR, V136, P298, DOI 10.1016/j.ygcen.2004.01.003; Yada T, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730483; Yamaguchi T, 2007, BIOCHEM BIOPH RES CO, V359, P935, DOI 10.1016/j.bbrc.2007.05.208; Yang BY, 1999, MOL REPROD DEV, V53, P127, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;127::AID-MRD1&gt;3.0.CO;2-H; Yi ZA, 2014, CYTOKINE GROWTH F R, V25, P147, DOI 10.1016/j.cytogfr.2013.12.002; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	103	29	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149414	10.1371/journal.pone.0149414	http://dx.doi.org/10.1371/journal.pone.0149414			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925843	Green Published, gold, Green Submitted			2022-12-26	WOS:000371424200009
J	Laurie, LE; Kokubo, H; Nakamura, M; Saga, Y; Funato, N				Laurie, Lindsay E.; Kokubo, Hiroki; Nakamura, Masataka; Saga, Yumiko; Funato, Noriko			The Transcription Factor Hand1 Is Involved In Runx2-Ihh-Regulated Endochondral Ossification	PLOS ONE			English	Article							LIMB DEVELOPMENT; INDIAN-HEDGEHOG; BONE-FORMATION; DNA-BINDING; EXPRESSION; DIFFERENTIATION; GROWTH; RUNX2; LOOP; BUD	The developing long bone is a model of endochondral ossification that displays the morphological layers of chondrocytes toward the ossification center of the diaphysis. Indian hedgehog (Ihh), a member of the hedgehog family of secreted molecules, regulates chondrocyte proliferation and differentiation, as well as osteoblast differentiation, through the process of endochondral ossification. Here, we report that the basic helix-loop-helix transcription factor Hand1, which is expressed in the cartilage primordia, is involved in proper osteogenesis of the bone collar via its control of Ihh production. Genetic overexpression of Hand1 in the osteochondral progenitors resulted in prenatal hypoplastic or aplastic ossification in the diaphyses, mimicking an Ihh loss-of-function phenotype. Ihh expression was downregulated in femur epiphyses of Hand1-overexpressing mice. We also confirmed that Hand1 downregulated Ihh gene expression in vitro by inhibiting Runx2 transactivation of the Ihh proximal promoter. These results demonstrate that Hand1 in chondrocytes regulates endochondral ossification, at least in part through the Runx2-Ihh axis.	[Laurie, Lindsay E.; Nakamura, Masataka; Funato, Noriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Kokubo, Hiroki; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 411, Japan; [Kokubo, Hiroki; Saga, Yumiko] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka, Japan; [Kokubo, Hiroki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Minami Ku, Hiroshima, Japan	Tokyo Medical & Dental University (TMDU); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Hiroshima University	Funato, N (corresponding author), Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	noriko-funato@umin.ac.jp	Funato, Noriko/AAY-5113-2020	Funato, Noriko/0000-0002-1320-3304	Japan Society for the Promotion of Science KAKENHI [22390340, 15K11004]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) KAKENHI (22390340, 15K11004) to N.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Charite J, 2000, DEVELOPMENT, V127, P2461; Fernandez-Teran M, 2003, DEV DYNAM, V226, P690, DOI 10.1002/dvdy.10271; Funato N, 1998, LAB INVEST, V78, P477; Funato N, 2003, J BIOL CHEM, V278, P7486, DOI 10.1074/jbc.M212248200; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Osterwalder M, 2014, DEV CELL, V31, P345, DOI 10.1016/j.devcel.2014.09.018; Otsuka T, 2005, AM J MED GENET A, V134A, P330, DOI 10.1002/ajmg.a.30643; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tamura M, 2013, HUM MOL GENET, V22, P2471, DOI 10.1093/hmg/ddt099; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	22	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150263	10.1371/journal.pone.0150263	http://dx.doi.org/10.1371/journal.pone.0150263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918743	Green Published, gold			2022-12-26	WOS:000371274400112
J	Chiu, CY; Yeh, KW; Lin, G; Chiang, MH; Yang, SC; Chao, WJ; Yao, TC; Tsai, MH; Hua, MC; Liao, SL; Lai, SH; Cheng, ML; Huang, JL				Chiu, Chih-Yung; Yeh, Kuo-Wei; Lin, Gigin; Chiang, Meng-Han; Yang, Shu-Chen; Chao, Wei-Ju; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Cheng, Mei-Ling; Huang, Jing-Long			Metabolomics Reveals Dynamic Metabolic Changes Associated with Age in Early Childhood	PLOS ONE			English	Article							SKELETAL-MUSCLE; NITROGEN-METABOLISM; CROSS-VALIDATION; HEALTHY-SUBJECTS; SYSTEMS BIOLOGY; DISEASE; GENDER; DIET; RAT; METABONOMICS	Objectives A detailed understanding of the metabolic processes governing rapid growth in early life is still lacking. The aim of this study was to investigate the age-related metabolic changes in healthy children throughout early childhood. Methods Healthy children from a birth cohort were enrolled in this study from birth through 4 years of age. Urinary metabolites were assessed at 6 months, and 1, 2, 3, and 4 yr of age by using H-1-nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical analysis including principal components analysis (PCA) and partial least-squares discriminant analysis (PLS-DA). Metabolic pathway analysis was performed using the MetPA web tool. Results A total of 105 urine samples from 30 healthy children were collected and analyzed. Metabolites contributing to the discrimination between age groups were identified by using supervised PLS-DA (Q(2) = 0.60; R-2 = 0.66). A significantly higher urinary trimethylamine N-oxide (TMAO) and betaine level was found in children aged 6 months. Urinary glycine and glutamine levels declined significantly after 6 months of age and there was a concomitant compensatory increase in urinary creatine and creatinine. Metabolic pathway analysis using MetPA revealed similar nitrogen metabolism associated energy production across all ages assessed. Pathways associated with amino acid metabolism were significantly different between infants aged 6 months and 1 year, whereas pathways associated with carbohydrate metabolism were significantly different between children at ages 2 and 3 years. Conclusions Urine metabolomics ideally represents dynamic metabolic changes across age. Urinary metabolic profiles change significantly within the first year of life, which can potentially provide crucial information about infant nutrition and growth.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling] Chang Gung Mem Hosp Keelung, Dept Pediat, Taoyuan, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Lin, Gigin; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Univ, Taoyuan, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Chiang, Meng-Han; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Dept Pediat, Taoyuan, Taiwan; [Lin, Gigin] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Yang, Shu-Chen; Chao, Wei-Ju] Chang Gung Mem Hosp, Dept Nutr Therapy, Keelung, Taiwan; [Cheng, Mei-Ling] Chang Gung Univ, Grad Inst Med Biotechnol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, JL (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Huang, JL (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.; Huang, JL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Taoyuan, Taiwan.; Cheng, ML (corresponding author), Chang Gung Univ, Grad Inst Med Biotechnol, Taoyuan, Taiwan.	chengm@mail.cgu.edu.tw; long@adm.cgmh.org.tw	Chiu, CY/Q-4238-2019; Lin, Gigin/A-2676-2017; Yeh, Kuo-Wei/V-3725-2019	Lin, Gigin/0000-0001-7246-1058; Huang, Jing-Long/0000-0002-3530-7753; Huang, Jing-Long/0000-0001-9280-920X	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-53]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-53 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Shmais GA, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-4; Ali Syed Sadat, 2013, Adv Biomed Res, V2, P91, DOI 10.4103/2277-9175.122523; Ascher E, 2001, SURGERY, V129, P231, DOI 10.1067/msy.2001.112594; BALSOM PD, 1995, ACTA PHYSIOL SCAND, V154, P303, DOI 10.1111/j.1748-1716.1995.tb09914.x; BELL JD, 1991, MAGN RESON MED, V17, P414, DOI 10.1002/mrm.1910170213; Chiu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115216; Da M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110072; Fanos V, 2013, SEMIN FETAL NEONAT M, V18, P3, DOI 10.1016/j.siny.2012.10.014; Fanos V, 2013, CURR OPIN PEDIAT; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Heavner DL, 2006, J PHARMACEUT BIOMED, V40, P928, DOI 10.1016/j.jpba.2005.08.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JUNG E, 1985, AM J CLIN NUTR, V42, P182, DOI 10.1093/ajcn/42.2.182; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kristal Bruce S, 2007, Methods Mol Biol, V371, P393; Lin GG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/625095; Lunden A, 2002, J DAIRY RES, V69, P383, DOI 10.1017/S002202990200568X; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Moco S, 2013, PEDIATR RES, V73, P570, DOI 10.1038/pr.2013.1; Moltu SJ, 2014, NUTRIENTS, V6, P1913, DOI 10.3390/nu6051913; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Phipps AN, 1998, XENOBIOTICA, V28, P527, DOI 10.1080/004982598239443; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; STANKO RT, 1992, AM J CLIN NUTR, V55, P771, DOI 10.1093/ajcn/55.4.771; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743; YAYHA ZAH, 1994, CLIN SCI, V87, P213, DOI 10.1042/cs0870213; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	41	46	47	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149823	10.1371/journal.pone.0149823	http://dx.doi.org/10.1371/journal.pone.0149823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914934	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700031
J	Labonte, LE; Bourbeau, J; Daskalopoulou, SS; Zhang, M; Coulombe, P; Garland, K; Baglole, CJ				Labonte, Laura E.; Bourbeau, Jean; Daskalopoulou, Stella S.; Zhang, Michele; Coulombe, Patrick; Garland, Katie; Baglole, Carolyn J.			Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients	PLOS ONE			English	Article							NF-KAPPA-B; SURFACTANT PROTEIN-D; PULSE-WAVE VELOCITY; OBSTRUCTIVE PULMONARY-DISEASE; CARDIOVASCULAR RISK; EXPRESSION; SERUM; BIOMARKERS; CC16; MORTALITY	Background Exacerbations of chronic obstructive pulmonary disease (COPD) are acute events of worsened respiratory symptoms that may increase the risk of cardiovascular disease (CVD), a leading cause of mortality amongst COPD patients. The utility of lung-specific inflammatory mediators such as club cell protein-16 (CC-16) and surfactant protein D (SPD) and that of a novel marker of CV outcomes in COPD-RelB-in predicting adverse cardiovascular events during exacerbation is not known. Methods Thirty-eight subjects with COPD admitted to the hospital for severe exacerbation were included in this analysis. Clinical, physiological and arterial stiffness measurements were performed within 72 hours of admission; this was followed by measurements taken every 3 days until hospital discharge, then once a week until 30 days after discharge, and then again at 90 and 180 days. Plasma concentrations of inflammatory mediators were measured from peripheral venous blood taken at admission, and at days 15, 30, 90 and 180. Results CC-16 and RelB concentrations were increased at day 15 of exacerbations whereas SPD concentrations were decreased. The course of change in CC-16 and RelB levels over time was inversely associated with that of carotid-femoral pulse wave velocity, the gold-standard measure of arterial stiffness. Increases in CC-16 could predict a decreased number of subsequent exacerbations during follow-up. Conclusions Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time. CC-16 can predict subsequent exacerbations in subjects with severe COPD and may be an important biomarker of pulmonary and systemic stress in COPD.	[Labonte, Laura E.; Bourbeau, Jean; Daskalopoulou, Stella S.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Labonte, Laura E.; Bourbeau, Jean; Zhang, Michele; Coulombe, Patrick; Garland, Katie] McGill Univ, Ctr Hlth, Res Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pathol, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada.	carolyn.baglole@mcgill.ca			GlaxoSmithKline Canada Ltd.; Canadian Institute of Health Research; Fonds de Recherche du Quebec-Sante (FRQ-S)	GlaxoSmithKline Canada Ltd.; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQ-S)	This study was funded as an investigator-initiated grant by GlaxoSmithKline Canada Ltd. LL was funded by a Canadian Institute of Health Research Doctoral Award. Infrastructure for this project was supported by the Canada Foundation for Innovation (CFI) -Leaders Opportunities Fund (CJB). CJB was supported by a salary award from the Fonds de Recherche du Quebec-Sante (FRQ-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon C, 2000, BIOCHEM BIOPH RES CO, V268, P99, DOI 10.1006/bbrc.1999.2083; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Braam B, 2004, AM J PHYSIOL-HEART C, V287, pH1977, DOI 10.1152/ajpheart.00323.2004; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; de Souza AR, 2014, TOXICOL SCI, V140, P204, DOI 10.1093/toxsci/kfu068; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; Labonte L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112965; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mattsson J, 2005, TRANSPLANTATION, V79, P1411, DOI 10.1097/01.TP.0000158354.39635.AB; McMillan DH, 2011, AM J PATHOL, V179, P125, DOI 10.1016/j.ajpath.2011.03.030; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Moreno D, 2014, RECENT PATENTS ENDOC, V8, P42, DOI 10.2174/1872214808666140209142640; Park HY, 2013, AM J RESP CRIT CARE, V188, P1413, DOI 10.1164/rccm.201305-0892OC; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Rosenberg SR, 2012, TRANSL RES, V159, P228, DOI 10.1016/j.trsl.2012.01.019; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P930, DOI 10.1164/ajrccm.160.3.9803113; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2008, CHEST, V133, P1296, DOI 10.1378/chest.08-0455; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Sin Don D, 2008, Ther Adv Respir Dis, V2, P65, DOI 10.1177/1753465808088903; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; White AJ, 2003, THORAX, V58, P73, DOI 10.1136/thorax.58.1.73; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020; Zielinski J, 1997, Monaldi Arch Chest Dis, V52, P43	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149974	10.1371/journal.pone.0149974	http://dx.doi.org/10.1371/journal.pone.0149974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914709	gold, Green Published, Green Submitted			2022-12-26	WOS:000371175700042
J	Put, K; Brisse, E; Avau, A; Imbrechts, M; Mitera, T; Janssens, R; Proost, P; Fallarino, F; Wouters, CH; Matthys, P				Put, Karen; Brisse, Ellen; Avau, Anneleen; Imbrechts, Maya; Mitera, Tania; Janssens, Rik; Proost, Paul; Fallarino, Francesca; Wouters, Carine H.; Matthys, Patrick			IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis	PLOS ONE			English	Article							MACROPHAGE ACTIVATION SYNDROME; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-GAMMA; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; TOLERANCE	Objectives Indoleamine 2,3-dioxygenase-1 (IDO1) is an immune-modulatory enzyme that catalyzes the degradation of tryptophan (Trp) to kynurenine (Kyn) and is strongly induced by interferon (IFN)-gamma We previously reported highly increased levels of IFN-gamma and corresponding IDO activity in patients with hemophagocytic lymphohistiocytosis (HLH), a hyper-inflammatory syndrome. On the other hand, IFN-gamma and IDO were low in patients with systemic juvenile idiopathic arthritis (sJIA), an autoinflammatory syndrome. As HLH can occur as a complication of sJIA, the opposing levels of both IFN-gamma and IDO are remarkable. In animal models for sJIA and HLH, the role of IFN-gamma differs from being protective to pathogenic. In this study, we aimed to unravel the role of IDO1 in the pathogenesis of sJIA and HLH. Methods Wild-type and IDO1-knockout (IDO1-KO) mice were used in 3 models of sJIA or HLH: complete Freund's adjuvant (CFA)-injected mice developed an sJIA-like syndrome and secondary HLH (sHLH) was evoked by either repeated injection of unmethylated CpG oligonucleotide or by primary infection with mouse cytomegalovirus (MCMV). An anti-CD3-induced cytokine release syndrome was used as a non-sJIA/HLH control model. Results No differences were found in clinical, laboratory and hematological features of sJIA/HLH between wild-type and IDO1-KO mice. As IDO modulates the immune response via induction of regulatory T cells and inhibition of T cell proliferation, we investigated both features in a T cell-triggered cytokine release syndrome. Again, no differences were observed in serum cytokine levels, percentages of regulatory T cells, nor of proliferating or apoptotic thymocytes and lymph node cells. Conclusions Our data demonstrate that IDO1 deficiency does not affect inflammation in sJIA, sHLH and a T cell-triggered cytokine release model. We hypothesize that other tryptophan-catabolizing enzymes like IDO2 and tryptophan 2,3-dioxygenase (TDO) might compensate for the lack of IDO1.	[Put, Karen; Brisse, Ellen; Avau, Anneleen; Imbrechts, Maya; Mitera, Tania; Matthys, Patrick] KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Immunobiol Lab, Leuven, Belgium; [Janssens, Rik; Proost, Paul] KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Lab Mol Immunol, Leuven, Belgium; [Fallarino, Francesca] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Wouters, Carine H.] KU Leuven Univ Leuven, Univ Hosp Leuven, Lab Pediat Immunol, Leuven, Belgium	KU Leuven; KU Leuven; University of Perugia; KU Leuven; University Hospital Leuven	Matthys, P (corresponding author), KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Immunobiol Lab, Leuven, Belgium.	patrick.matthys@kuleuven.be	Janssens, Rik/S-7744-2017; Matthys, Patrick/B-4813-2018; Proost, Paul/V-3052-2017; Imbrechts, Maya/E-5264-2018; Fallarino, Francesca/O-3358-2013	Janssens, Rik/0000-0003-1428-3921; Matthys, Patrick/0000-0002-9685-6836; Proost, Paul/0000-0002-0133-5545; Imbrechts, Maya/0000-0002-4467-9831; Wouters, Carine/0000-0002-6426-8845; Fallarino, Francesca/0000-0002-8501-2136	Fund for Scientific Research-Flanders (FWO-Vlaanderen) [G.0515.12N, G.OD66.13]; Regional Government of Flanders (GOA program) [GOA13/014]; Interuniversity Attraction Poles (IAP) [IAP P7/39]; FWO-Vlaanderen; Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Regional Government of Flanders (GOA program); Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); FWO-Vlaanderen(FWO); Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Fund for Scientific Research-Flanders (FWO-Vlaanderen, www.fwo.be, G.0515.12N and G.OD66.13), the Regional Government of Flanders (GOA program, www.kuleuven.be, GOA13/014) and the Interuniversity Attraction Poles (IAP, www.belspo.be, IAP P7/39). AA and KP received a fellowship from the FWO-Vlaanderen. EB received a fellowship from the Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen).	Avau A, 2015, PHARMACEUTI IN PRESS, V8; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Behrens EM, 2007, J RHEUMATOL, V34, P1133; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Brisse E, 2014, J CLIN IMMUNOL, V34, P139; Brisse E, 2015, CYTOKINE GROWTH F R, V26, P263, DOI 10.1016/j.cytogfr.2014.10.001; Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; De Benedetti F, 2010, TXB PEDIAT RHEUMATOL, P236; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fatokun AA, 2013, AMINO ACIDS, V45, P1319, DOI 10.1007/s00726-013-1602-1; Grom AA., 2010, TXB PEDIAT RHEUMATOL, V6th edn, P674; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kaufman KM, 2014, ARTHRITIS RHEUMATOL, V66, P3486, DOI 10.1002/art.38793; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; MATTHYS P, 1995, J IMMUNOL, V155, P3823; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metz R, 2014, INT IMMUNOL, V26, P357, DOI 10.1093/intimm/dxt073; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; Pachlopnik SJ, 2009, EMBO MOL MED, V1, P112, DOI DOI 10.1002/EMMM.200900009; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Put K, 2015, RHEUMATOLOGY, V54, P1507, DOI 10.1093/rheumatology/keu524; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shimizu M, 2015, CLIN IMMUNOL, V160, P277, DOI 10.1016/j.clim.2015.06.005; Szanto S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2205; Takada H, 2003, CLIN EXP IMMUNOL, V133, P448, DOI 10.1046/j.1365-2249.2003.02237.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zhang MC, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0439-2	42	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150075	10.1371/journal.pone.0150075	http://dx.doi.org/10.1371/journal.pone.0150075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914138	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700050
J	Meier, V; Guscetti, F; Roos, M; Ohlerth, S; Pruschy, M; Bley, CR				Meier, Valeria; Guscetti, Franco; Roos, Malgorzata; Ohlerth, Stefanie; Pruschy, Martin; Bley, Carla Rohrer			Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia	PLOS ONE			English	Article							FRACTIONATED RADIATION-THERAPY; POWER DOPPLER ULTRASONOGRAPHY; MEASURED OXYGENATION LEVELS; SQUAMOUS-CELL CARCINOMAS; TUMOR HYPOXIA; RETROSPECTIVE ANALYSIS; GLUCOSE-TRANSPORTER; IX EXPRESSION; DOGS; GLUCOSE-TRANSPORTER-1	For various types of tumor therapy, it is suggested that co-targeting of tumor microenvironment, mainly tumor vasculature, mediates tumor response mechanisms. Immunohistochemistry for glucose transporter-1 (GLUT-1), carbonic anhydrase-IX (CAIX), Ki-67, and von Willebrand factor VIII for microvessel density (MVD) were performed on formalin-fixed paraffin-embedded samples of canine oral malignant neoplasms. Polarographic oxygen measurements (median pO2) and perfusion data via contrast-enhanced power Doppler ultrasound (median vascularity, median blood volume) provided additional information. Ninety-two samples were analyzed: sarcomas (n = 32), carcinomas (n = 30), and malignant melanomas (n = 30). Polarographic oxygen and perfusion data was available in 22.8%(sarcomas n = 9, carcinomas n = 7, melanomas n = 5), and 27.1% (sarcomas n = 10, carcinomas n = 8, melanomas n = 7) of cases, respectively. GLUT-1 expression was detected in 46.7% of all samples, and was generally weak. CAIX expression was found in 34.8% of all samples. Median Ki-67 score and MVD count was 19% and 17, respectively. The evaluation of the GLUT-1 score and continuous data showed significantly lower GLUT-1 levels in sarcomas (mean 5.1%, SD 6.2) versus carcinomas and melanomas (mean 16.5%/19.0%, SD 17.3/20.9, p = 0.001). The expression of CAIX correlated mildly positively with GLUT-1 (p = 0.018, rho = 0.250) as well as with Ki-67 (p = 0.014, rho = 0.295). MVD showed a significantly lower level in melanomas (mean 12.6, SD 7.7) versus sarcomas and carcinomas (mean 21.8/26.9, SD 13.0/20.4, p = 0.001). Median vascularity and blood volume were significantly lower in sarcomas (mean 10.4%, SD 11.0, and mean 6.3%, SD 6.5, respectively) versus carcinomas (mean 39.2%, SD 16.4 and mean 33.0%, SD 25.6, respectively) and melanomas (mean 36.0%, SD 18.3, and 31.5%, SD 24.5). Between the 3 histological groups, there was neither a significant difference in the GLUT-1 and CAIX score and continuous data, nor the Ki67 score, or polarographic oxygen measurements. GLUT-1 continuous data and Ki-67 (p<0.001, rho = 0.403), as well as Ki-67 and MVD (p = 0.029, rho = 0.228) correlated positively and a mild correlation was found between vascularity and GLUT-1 (p =	[Meier, Valeria; Bley, Carla Rohrer] Univ Zurich, Vetsuisse Fac, Div Radiat Oncol, Zurich, Switzerland; [Guscetti, Franco] Univ Zurich, Inst Vet Pathol, Zurich, Switzerland; [Roos, Malgorzata] Univ Zurich, Fac Med, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Ohlerth, Stefanie] Univ Zurich, Clin Diagnost Imaging, Vetsuisse Fac, Zurich, Switzerland; [Pruschy, Martin] Univ Zurich Hosp, Lab Mol Radiobiol, Radiat Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University of Geneva; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Meier, V (corresponding author), Univ Zurich, Vetsuisse Fac, Div Radiat Oncol, Zurich, Switzerland.	vmeier@vetclinics.uzh.ch	Rohrer Bley, Carla/G-1192-2013; Guscetti, Franco/C-2672-2018	Rohrer Bley, Carla/0000-0002-5733-2722; Roos, Malgorzata/0000-0001-9878-6969; Guscetti, Franco/0000-0002-3173-4811; Pruschy, Martin/0000-0002-3124-9015	Swiss National Science Foundation (SNSF) [320030_132441]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNSF; recipient: CRB, grant number: 320030_132441, URL: http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondati E, 2013, VET PATHOL, V50, P1063, DOI 10.1177/0300985813486810; Achermann R, 2002, IN VIVO, V16, P431; Achermann RE, 2004, STRAHLENTHER ONKOL, V180, P297, DOI 10.1007/s00066-004-1193-6; Airley R, 2001, CLIN CANCER RES, V7, P928; Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Barnes K, 2002, J CELL SCI, V115, P2433; Bergin IL, 2011, VET PATHOL, V48, P41, DOI 10.1177/0300985810388947; Bley CR, 2007, EUR J CANCER, V43, P963, DOI 10.1016/j.ejca.2006.12.007; Bley CR, 2006, STRAHLENTHER ONKOL, V182, P518, DOI 10.1007/s00066-006-1519-7; Bley CR, 2009, STRAHLENTHER ONKOL, V185, P756, DOI 10.1007/s00066-009-1988-6; Boado RJ, 2002, J NEUROCHEM, V80, P552, DOI 10.1046/j.0022-3042.2001.00756.x; Brown JM, 2008, INT J RADIAT ONCOL, V71, P324, DOI 10.1016/j.ijrobp.2008.02.003; Brown JM, 2014, INT J RADIAT ONCOL, V88, P254, DOI 10.1016/j.ijrobp.2013.07.022; Fulton AJ, 2013, JAVMA-J AM VET MED A, V243, P696, DOI 10.2460/javma.243.5.696; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gardner H, 2015, VET COMP ONCOL, V13, P40, DOI 10.1111/vco.12017; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Grosse N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-203; Hedley D, 2003, CLIN CANCER RES, V9, P5666; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Keller SM, 2007, J VET DIAGN INVEST, V19, P652, DOI 10.1177/104063870701900606; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Loncaster JA, 2001, CANCER RES, V61, P6394; Madewell BR, 2001, J VET INTERN MED, V15, P334, DOI 10.1892/0891-6640(2001)015&lt;0334:CPITAR&gt;2.3.CO;2; Mayer A, 2005, CLIN CANCER RES, V11, P2768, DOI 10.1158/1078-0432.CCR-04-2344; Mayer A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-760; Mees G, 2011, RES VET SCI, V91, pE125, DOI 10.1016/j.rvsc.2011.01.014; Ohlerth S, 2010, VET J, V186, P58, DOI 10.1016/j.tvjl.2009.07.006; Ohlerth S, 2010, VET J, V183, P58, DOI 10.1016/j.tvjl.2008.08.026; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Petty JC, 2008, VET COMP ONCOL, V6, P133, DOI 10.1111/j.1476-5829.2007.00155.x; PIRHONEN JP, 1995, CANCER-AM CANCER SOC, V76, P67, DOI 10.1002/1097-0142(19950701)76:1<67::AID-CNCR2820760109>3.0.CO;2-0; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Rademakers SE, 2008, MOL ONCOL, V2, P41, DOI 10.1016/j.molonc.2008.03.006; Ramos-Vara JA, 2010, VET PATHOL, V47, P725, DOI 10.1177/0300985810364528; Sakata KI, 2006, STRAHLENTHER ONKOL, V182, P511, DOI 10.1007/s00066-006-1532-x; Smedley RC, 2011, VET PATHOL, V48, P54, DOI 10.1177/0300985810390717; Song DY, 2004, ONCOLOGY-NY, V18, P1419; Song DY, 2004, ONCOLOGY WILLISTON P, V30, P32; Thrall DE, 2012, INT J HYPERTHER, V28, P431, DOI 10.3109/02656736.2012.689087; Tuohy JL, 2014, JAVMA-J AM VET MED A, V245, P1266, DOI 10.2460/javma.245.11.1266; Webster JD, 2007, VET PATHOL, V44, P298, DOI 10.1354/vp.44-3-298; WEIDNER N, 1993, AM J PATHOL, V143, P401; Woldemeskel M, 2010, VET RES COMMUN, V34, P153, DOI 10.1007/s11259-010-9341-1; Wolfesberger B, 2012, RES VET SCI, V92, P444, DOI 10.1016/j.rvsc.2011.04.018; Wolfesberger B, 2008, RES VET SCI, V85, P56, DOI 10.1016/j.rvsc.2007.07.008	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149993	10.1371/journal.pone.0149993	http://dx.doi.org/10.1371/journal.pone.0149993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906567	gold, Green Published, Green Accepted			2022-12-26	WOS:000371163000027
J	Pinto-Sarmento, TCD; Abreu, MH; Gomes, MC; Costa, EMMD; Martins, CC; Granville-Garcia, AF; Paiva, SM				de Almeida Pinto-Sarmento, Tassia Cristina; Abreu, Mauro Henrique; Gomes, Monalisa Cesarino; Melo de Brito Costa, Edja Maria; Martins, Carolina Castro; Granville-Garcia, Ana Flavia; Paiva, Saul Martins			Determinant Factors of Untreated Dental Caries and Lesion Activity in Preschool Children Using ICDAS	PLOS ONE			English	Article							ASSESSMENT SYSTEM ICDAS; EARLY-CHILDHOOD CARIES; QUALITY-OF-LIFE; SOCIOBEHAVIORAL FACTORS; FEEDING PRACTICES; PREVALENCE; RISK; COMPARABILITY; ASSOCIATION; EXPERIENCE	The aim of the present study was to investigate determinant factors associated with the presence of dental caries and lesion activity in preschool children. A population-based, cross-sectional study was carried out with 843 children of aged three to five years enrolled at public and private preschools in the city of Campina Grande, Brazil. A questionnaire addressing socio-demographic data and oral health care was self-administered by parents/caregivers. Three dentists previously calibrated examined the children for the diagnosis of dental caries and lesion activity using the International Caries Detection and Assessment System (ICDAS). Nutritional status was evaluated based on the body mass index. Logistic regression analysis for complex samples was performed (alpha = 5%). The prevalence of dental caries was 66.3%. Among the children with caries, 88.0% had active lesions. Dental caries was more prevalent in girls (OR = 1.53, 95% CI: 1.05-2.23), in children from families with a monthly household income <= US$312.50 (OR = 2.38, 95% CI: 1.65-3.43) and those whose mothers had up to eight years of schooling (OR = 1.55, 95% CI: 1.07-2.23). Lesion activity was significantly associated with mother's schooling <= 8 years (OR = 2.15, 95% CI: 1.154.00). The prevalence rates of dental caries and lesion activity were high and mainly associated with a lower socioeconomic status and mother's schooling.	[de Almeida Pinto-Sarmento, Tassia Cristina; Gomes, Monalisa Cesarino; Melo de Brito Costa, Edja Maria; Granville-Garcia, Ana Flavia] State Univ Paraiba, Dept Dent, Campina Grande, Paraiba, Brazil; [Abreu, Mauro Henrique] Univ Fed Minas Gerais, Dept Publ Hlth, Belo Horizonte, MG, Brazil; [Martins, Carolina Castro; Paiva, Saul Martins] Univ Fed Minas Gerais, Dept Paediat Dent & Orthodont, Belo Horizonte, MG, Brazil	Universidade Estadual da Paraiba; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Granville-Garcia, AF (corresponding author), State Univ Paraiba, Dept Dent, Campina Grande, Paraiba, Brazil.	anaflaviagg@hotmail.com	Granville-Garcia, Ana Flávia/Q-9297-2019; Martins, Carolina/AFD-8433-2022; Martins, Carolina Castro/O-2514-2014; Granville-Garcia, Ana F/L-6980-2013; Paiva, Saul Martins/H-5757-2012; Abreu, Mauro Henrique/G-6502-2012; Maria Melo de Brito Costa, Edja/GVT-9390-2022	Martins, Carolina/0000-0001-9072-3226; Martins, Carolina Castro/0000-0001-9072-3226; Granville-Garcia, Ana F/0000-0002-6054-8372; Paiva, Saul Martins/0000-0002-3968-1638; Abreu, Mauro Henrique/0000-0001-8794-5725; Maria Melo de Brito Costa, Edja/0000-0002-3166-709X	State University of Paraiba; Brazilian Coordination of Higher Education; Ministry of Education (CAPES); Research Foundation of the State of Minas Gerais (FAPEMIG); National Council for Scientific and Technological Development (CNPQ), Brazil [471-790.2011/7]	State University of Paraiba; Brazilian Coordination of Higher Education; Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Research Foundation of the State of Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPQ), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the State University of Paraiba, the Brazilian Coordination of Higher Education, Ministry of Education (CAPES), the Research Foundation of the State of Minas Gerais (FAPEMIG) and the National Council for Scientific and Technological Development (CNPQ), Brazil)-471-790.2011/7.	Agarwal V, 2011, INT J PAEDIATR DENT, V21, P382, DOI 10.1111/j.1365-263X.2011.01141.x; Agustsdottir H, 2010, COMMUNITY DENT ORAL, V38, P299, DOI 10.1111/j.1600-0528.2010.00538.x; Altman DG, 2006, PRACTICAL STAT MED R; Borges HC, 2012, BRAZ ORAL RES, V26, P564, DOI 10.1590/S1806-83242012000600013; Braga MM, 2009, CARIES RES, V43, P245, DOI 10.1159/000217855; Braga MM, 2010, COMMUNITY DENT ORAL, V38, P549, DOI 10.1111/j.1600-0528.2010.00567.x; Browner WS, 2007, DESIGNING CLIN RES, P65; Cadavid Alexandra Saldarriaga, 2010, Braz. oral res., V24, P211, DOI 10.1590/S1806-83242010000200014; Celeste RK, 2009, SOC SCI MED, V69, P1468, DOI 10.1016/j.socscimed.2009.08.005; Chankanka O, 2015, J PUBLIC HEALTH DENT, V75, P265, DOI 10.1111/j.1752-7325.2012.00376.x; Clementino MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130602; Cohen J., 1998, STAT POWER ANAL BEHA; Cook SL, 2008, INT J PAEDIATR DENT, V18, P275, DOI 10.1111/j.1365-263X.2007.00889.x; Diniz MB, 2009, COMMUNITY DENT ORAL, V37, P399, DOI 10.1111/j.1600-0528.2009.00487.x; Feldens CA, 2012, EUR ARCH PAEDIATR DE, V13, P70, DOI 10.1007/BF03262847; Feldens CA, 2010, CARIES RES, V44, P445, DOI 10.1159/000319898; Guido JA, 2011, INT J PAEDIATR DENT, V21, P432, DOI 10.1111/j.1365-263X.2011.01146.x; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Honkala E, 2011, INT J DENT, V2011, DOI 10.1155/2011/150424; Instituto Brasileiro de Geografia e Estatistic, 1 RES 2010 CENS; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Kidd E, 2011, J DENT, V39, pS3, DOI 10.1016/j.jdent.2011.11.004; Kramer PF, 2008, CAD SAUDE PUBLICA, V24, P150, DOI 10.1590/S0102-311X2008000100015; Lukacs JR, 2006, AM J HUM BIOL, V18, P540, DOI 10.1002/ajhb.20530; Mendes FM, 2010, COMMUNITY DENT ORAL, V38, P398, DOI 10.1111/j.1600-0528.2010.00557.x; Naidu R, 2013, BMC ORAL HEALTH, V13, DOI 10.1186/1472-6831-13-30; Nishimura M, 2008, J AM DENT ASSOC, V139, P63, DOI 10.14219/jada.archive.2008.0022; Nyvad B, 2003, J DENT RES, V82, P117, DOI 10.1177/154405910308200208; Piovesan C, 2010, J PUBLIC HEALTH DENT, V70, P319, DOI 10.1111/j.1752-7325.2010.00191.x; Pitts NB, 2009, MONOGR ORAL SCI, V21, P1, DOI 10.1159/000224208; Ramos-Jorge J, 2014, COMMUNITY DENT ORAL, V42, P311, DOI 10.1111/cdoe.12086; Sarumathi T, 2013, J CLIN DIAGN RES, V7, P1789, DOI 10.7860/JCDR/2013/6201.3277; Scarpelli AC, 2013, COMMUNITY DENT ORAL, V41, P336, DOI 10.1111/cdoe.12022; Stromberg U, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-9; Thitasomakul S, 2006, COMMUNITY DENT ORAL, V34, P429, DOI 10.1111/j.1600-0528.2006.00292.x; Wagner Y, 2014, COMMUNITY DENT ORAL, V42, P160, DOI 10.1111/cdoe.12072; Wellappuli N, 2012, CARIES RES, V46, P208, DOI 10.1159/000337399; World Health Organization, 2012, ANTHROPLUS PERS COMP	39	30	34	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150116	10.1371/journal.pone.0150116	http://dx.doi.org/10.1371/journal.pone.0150116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900846	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100207
J	La-Touche, S; Lemetre, C; Lambros, M; Stankiewicz, E; Ng, CKY; Weigelt, B; Rajab, R; Tinwell, B; Corbishley, C; Watkin, N; Berney, D; Reis-Filho, JS				La-Touche, Susannah; Lemetre, Christophe; Lambros, Maryou; Stankiewicz, Elzbieta; Ng, Charlotte K. Y.; Weigelt, Britta; Rajab, Ramzi; Tinwell, Brendan; Corbishley, Cathy; Watkin, Nick; Berney, Dan; Reis-Filho, Jorge S.			DNA Copy Number Aberrations, and Human Papillomavirus Status in Penile Carcinoma. Clinico-Pathological Correlations and Potential Driver Genes	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; LYMPH-NODE METASTASIS; HPV INFECTION; DUCTAL CARCINOMAS; CANCER; BREAST; P53; ACTIVATION; EXPRESSION	Penile squamous cell carcinoma is a rare disease, in which somatic genetic aberrations have yet to be characterized. We hypothesized that gene copy aberrations might correlate with human papillomavirus status and clinico-pathological features. We sought to determine the spectrum of gene copy number aberrations in a large series of PSCCs and to define their correlations with human papillomavirus, histopathological subtype, and tumor grade, stage and lymph node status. Seventy formalin-fixed, paraffin embedded penile squamous cell carcinomas were centrally reviewed by expert uropathologists. DNA was extracted from micro-dissected samples, subjected to PCR-based human papillomavirus assessment and genotyping (INNO-LiPA human papillomavirus Genotyping Extra Assay) and microarray-based comparative genomic hybridization using a 32K Bacterial Artificial Chromosome array platform. Sixty-four samples yielded interpretable results. Recurrent gains were observed in chromosomes 1p13.3-q44 (88%), 3p12.3-q29 (86%), 5p15.33-p11 (67%) and 8p12-q24.3 (84%). Amplifications of 5p15.33-p11 and 11p14.1-p12 were found in seven (11%) and four (6%) cases, respectively. Losses were observed in chromosomes 2q33-q37.3 (86%), 3p26.3-q11.1 (83%) and 11q12.2-q25 (81%). Although many losses and gains were similar throughout the cohort, there were small significant differences observed at specific loci, between human papillomavirus positive and negative tumors, between tumor types, and tumor grade and nodal status. These results demonstrate that despite the diversity of genetic aberrations in penile squamous cell carcinomas, there are significant correlations between the clinico-pathological data and the genetic changes that may play a role in disease natural history and progression and highlight potential driver genes, which may feature in molecular pathways for existing therapeutic agents.	[La-Touche, Susannah; Stankiewicz, Elzbieta; Berney, Dan] Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, John Vane Sci Ctr, Charterhouse Sq, London, England; [Lemetre, Christophe; Ng, Charlotte K. Y.; Weigelt, Britta; Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Lambros, Maryou] Inst Canc Res, Mol Pathol, London SW3 6JB, England; [Rajab, Ramzi; Tinwell, Brendan; Corbishley, Cathy; Watkin, Nick] St George Hosp, London, England; [Reis-Filho, Jorge S.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA	University of London; Queen Mary University London; Memorial Sloan Kettering Cancer Center; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; St Georges University London; Memorial Sloan Kettering Cancer Center	La-Touche, S (corresponding author), Queen Mary Univ London, Ctr Mol Oncol, Barts Canc Inst, John Vane Sci Ctr, Charterhouse Sq, London, England.	latouche81@yahoo.co.uk	Ng, Charlotte K Y/AAY-3178-2021; Ng, Charlotte K Y/AAA-1670-2020	Ng, Charlotte K Y/0000-0002-6100-0026; Berney, Daniel/0000-0001-5474-8696; Stankiewicz, Elzbieta/0000-0003-0812-4086	Orchid male cancer charity; Barts Cancer Institute (London); Queen Mary University of London; St Georges Hospital (London); Memorial Sloan Kettering Cancer Center (New York); Institute of Cancer Research (London);  [ONAG1R1R]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Orchid male cancer charity; Barts Cancer Institute (London); Queen Mary University of London; St Georges Hospital (London); Memorial Sloan Kettering Cancer Center (New York); Institute of Cancer Research (London); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was financially supported by Orchid male cancer charity [http://www.orchid-cancer.org.uk], including some equipment, supplies and reimbursement for attending the 29th Annual European Association of Urology Congress. The grant code for internal use at Queen Mary, University of London was ONAG1R1R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Collaborative support was provided by Barts Cancer Institute (London), Queen Mary University of London, St Georges Hospital (London), Memorial Sloan Kettering Cancer Center (New York) and the Institute of Cancer Research (London).	Alves G, 2001, GENE CHROMOSOME CANC, V31, P48, DOI 10.1002/gcc.1117; Anic GM, 2011, PREV MED, V53, pS36, DOI 10.1016/j.ypmed.2011.08.002; Barnholtz-Sloan JS, 2007, UROL ONCOL-SEMIN ORI, V25, P361, DOI 10.1016/j.urolonc.2006.08.029; Bleeker MCG, 2009, WORLD J UROL, V27, P141, DOI 10.1007/s00345-008-0302-z; Busso-Lopes AF, 2015, CANCER PREV RES, V8, P149, DOI 10.1158/1940-6207.CAPR-14-0284; Cai CL, 2012, CELL CYCLE, V11, P1773, DOI 10.4161/cc.20121; Chaux A, 2012, HUM PATHOL, V43, P771, DOI 10.1016/j.humpath.2012.01.014; Chaux A, 2012, SEMIN DIAGN PATHOL, V29, P67, DOI 10.1053/j.semdp.2011.09.001; Coe BP, 2007, GENOMICS, V89, P647, DOI 10.1016/j.ygeno.2006.12.012; Cubilla LC, 2004, STERNBERGS DIAGNOSTI; Curado MP, 2007, CANC INCIDENCE 5 CON, P160; De Villiers EM, 2004, INT J CANCER, V109, P253, DOI 10.1002/ijc.11685; Ding XJ, 2008, ONCOL REP, V20, P1041, DOI 10.3892/or_00000107; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Gunnarsson R, 2008, GENE CHROMOSOME CANC, V47, P697, DOI 10.1002/gcc.20575; Hernandez L, 2012, J PATHOL, V227, P42, DOI 10.1002/path.3990; Horlings HM, 2013, BREAST CANCER RES TR, V142, P257, DOI 10.1007/s10549-013-2740-6; Huang FY, 2005, CANCER GENET CYTOGEN, V157, P42, DOI 10.1016/j.cancergencyto.2004.06.002; Jung AC, 2010, INT J CANCER, V126, P1882, DOI 10.1002/ijc.24911; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Lacroix-Triki M, 2010, J PATHOL, V222, P282, DOI 10.1002/path.2763; Liang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-73; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Matsha T, 2007, VIROLOGY, V369, P182, DOI 10.1016/j.virol.2007.07.025; Misra S, 2004, LANCET ONCOL, V5, P240, DOI 10.1016/S1470-2045(04)01427-5; Moll UM, 2003, MOL CANCER RES, V1, P1001; Natrajan R, 2009, CLIN CANCER RES, V15, P2711, DOI 10.1158/1078-0432.CCR-08-1878; Nichols Anthony C, 2012, ISRN Oncol, V2012, P809370, DOI 10.5402/2012/809370; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Policht FA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-432; Purdie KJ, 2010, BRIT J CANCER, V102, P1044, DOI 10.1038/sj.bjc.6605589; Rainsbury JW, 2013, HEAD NECK-J SCI SPEC, V35, P1048, DOI 10.1002/hed.22950; Rao PH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-5; Sakai N, 2010, DIS ESOPHAGUS, V23, P415, DOI 10.1111/j.1442-2050.2009.01026.x; Schafer G, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-185; Senba M, 2010, ONCOL LETT, V1, P599, DOI 10.3892/ol_00000106; Shi ZZ, 2011, GENE CHROMOSOME CANC, V50, P518, DOI 10.1002/gcc.20875; Singh B, 2002, GENE DEV, V16, P984, DOI 10.1101/gad.973602; Sobin LHGM., 2009, TNM CLASSIFICATION M, V7th; Stankiewicz E, 2012, J CLIN PATHOL, V65, P534, DOI 10.1136/jclinpath-2011-200638; Stankiewicz E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017517; Stankiewicz E, 2011, HISTOPATHOLOGY, V58, P433, DOI 10.1111/j.1365-2559.2011.03762.x; Stankiewicz E, 2009, MODERN PATHOL, V22, P1160, DOI 10.1038/modpathol.2009.77; Syrjanen KJ, 2002, J CLIN PATHOL, V55, P721, DOI 10.1136/jcp.55.10.721; Tan DSP, 2007, LAB INVEST, V87, P737, DOI 10.1038/labinvest.3700593; Tosco P, 2011, ORAL DIS, V17, P102, DOI 10.1111/j.1601-0825.2010.01713.x; Wang XC, 2009, MOL CANCER RES, V7, P12, DOI 10.1158/1541-7786.MCR-08-0092; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; Yangling O, 2007, EUR J GYNAECOL ONCOL, V28, P442; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	50	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146740	10.1371/journal.pone.0146740	http://dx.doi.org/10.1371/journal.pone.0146740			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901676	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100006
J	Vergnaud, G; Girault, G; Thierry, S; Pourcel, C; Madani, N; Blouin, Y				Vergnaud, Gilles; Girault, Guillaume; Thierry, Simon; Pourcel, Christine; Madani, Nora; Blouin, Yann			Comparison of French and Worldwide Bacillus anthracis Strains Favors a Recent, Post-Columbian Origin of the Predominant North-American Clade	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TANDEM-REPEAT ANALYSIS; DRAFT GENOME SEQUENCE; POPULATION-STRUCTURE; EPIDEMIC ANTHRAX; DIVERSITY; EVOLUTION; DISCOVERY; OUTBREAK; FRANCE	Background Bacillus anthracis, the highly dangerous zoonotic bacterial pathogen species is currently composed of three genetic groups, called A, B and C. Group A is represented worldwide whereas group B is present essentially in Western Europe and Southern Africa. Only three strains from group C have been reported. This knowledge is derived from the genotyping of more than 2000 strains collected worldwide. Strains from both group A and group B are present in France. Previous investigations showed that the majority of sporadic French strains belong to the so-called A.Br.011/009 group A clade and define a very remarkable polytomy with six branches. Here we explore the significance of this polytomy by comparing the French B. anthracis lineages to worldwide lineages. We take advantage of whole genome sequence data previously determined for 122 French strains and 45 strains of various origins. Results A total of 6690 SNPs was identified among the available dataset and used to draw the phylogeny. The phylogeny of the French B group strains which belongs to B.Br.CNEVA indicates an expansion from the south-east part of France (the Alps) towards the south-west (Massif-Central and Pyrenees). The relatively small group A strains belonging to A.Br.001/002 results from at least two independent introductions. Strikingly, the data clearly demonstrates that the currently predominant B. anthracis lineage in North America, called WNA for Western North American, is derived from one branch of the A.Br.011/009 polytomy predominant in France. Conclusions/Significance The present work extends the range of observed substitution rate heterogeneity within B. anthracis, in agreement with its ecology and in contrast with some other pathogens. The population structure of the six branches A.Br.011/009 polytomy identified in France, diversity of branch length, and comparison with the WNA lineage, suggests that WNA is of post-Columbian and west European origin, with France as a likely source. Furthermore, it is tempting to speculate that the polytomy's most recent common ancestor -MRCA- dates back to the Hundred Years' war between France and England started in the mid-fourteenth century. These events were associated in France with deadly epidemics and major economic and social changes.	[Vergnaud, Gilles; Pourcel, Christine; Blouin, Yann] Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Girault, Guillaume; Thierry, Simon; Madani, Nora] Univ Paris Est, Anses, Hlth Anim Lab, Bacterial Zoonoses Unit, Maisons Alfort, France; [Blouin, Yann] DGA Maitrise NRBC, Dept Analyt Microbiol, Vert Le Petit, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA)	Vergnaud, G (corresponding author), Univ Paris Saclay, Univ Paris 11, CNRS, CEA,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	gilles.vergnaud@u-psud.fr	Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020; Vergnaud, Gilles/P-1304-2015	Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; Vergnaud, Gilles/0000-0003-0913-194X	Agence Nationale de la Recherche [ANR-11-ASTR-0007]; Anses grant; Direction Generale de l'Armement (DGA) grant; DGA	Agence Nationale de la Recherche(French National Research Agency (ANR)); Anses grant; Direction Generale de l'Armement (DGA) grant; DGA	This work is supported by the Agence Nationale de la Recherche grant number ANR-11-ASTR-0007 project Franthracis, http://www.agencenationale-recherche.fr. GG is a PhD student co-supported by Anses and Direction Generale de l'Armement (DGA) grants. Work by YB and GV on the description of dangerous pathogens is supported by DGA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; Antwerpen M, 2012, J BACTERIOL, V194, P6360, DOI 10.1128/JB.01676-12; Birdsell DN, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00152-13; Birdsell DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032866; Blouin Y, 2014, EMERG INFECT DIS, V20, P21, DOI 10.3201/eid2001.130652; Blouin Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052841; Calavas D, 2009, B EPIDEMIOLOGIQUE, V32, P1; Chun JH, 2012, J BACTERIOL, V194, P4116, DOI 10.1128/JB.00159-12; Cohen-Gihon I, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genorneA.00075-14e00075-14, DOI 10.1128/GENORNEA.00075-14]; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Derzelle S, 2011, J CLIN MICROBIOL, V49, P4286, DOI 10.1128/JCM.05439-11; Fouet AS, 2002, J CLIN MICROBIOL, V40, P4732, DOI 10.1128/JCM.40.12.4732-4734.2002; Girault G, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00736-14e00736-14, DOI 10.1128/GENOMEA.00736-14E00736-14]; Girault G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-288; Grissa I, 2008, BIOCHIMIE, V90, P660, DOI 10.1016/j.biochi.2007.07.014; Hang'ombe MB, 2012, TROP DOCT, V42, P136, DOI 10.1258/td.2012.110454; Harrington R, 2013, GENOME ANNOUNC, V1, DOI [10.1128/genomeA.00067-12e00067-12, DOI 10.1128/GENOMEA.00067-12E00067-12]; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Jung KH, 2012, J VET SCI, V13, P385, DOI 10.4142/jvs.2012.13.4.385; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004813; Kenefic LJ, 2010, BACTERIAL POPULATION, P169; Khmaladze E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102651; Le Fleche P, 2001, BMC Microbiol, V1, P2; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Maho A, 2006, J CLIN MICROBIOL, V44, P3422, DOI 10.1128/JCM.01269-06; Marston CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028274; Morens DM, 2003, AM J PUBLIC HEALTH, V93, P886, DOI 10.2105/AJPH.93.6.886; Morens DM, 2002, EMERG INFECT DIS, V8, P1160, DOI 10.3201/eid0810.020173; Ohnishi N, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00116-14; Okinaka RT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-477; Papazisi L, 2011, GENOMICS, V98, P26, DOI 10.1016/j.ygeno.2011.03.008; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Price EP, 2012, EMERG INFECT DIS, V18, P1307, DOI 10.3201/eid1808.111343; Price EP, 2010, ELECTROPHORESIS, V31, P3881, DOI 10.1002/elps.201000379; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Revich BA, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8482; Rouli L, 2014, New Microbes New Infect, V2, P161, DOI 10.1002/nmi2.62; Ruckert C, 2012, J BACTERIOL, V194, P5997, DOI 10.1128/JB.01410-12; Simonson TS, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-71; Thierry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095131; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461	42	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146216	10.1371/journal.pone.0146216	http://dx.doi.org/10.1371/journal.pone.0146216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901621	Green Published, gold			2022-12-26	WOS:000371276100005
J	Yang, LL; Sui, WJ; Li, YQ; Qi, X; Wang, Y; Zhou, QJ; Gao, H				Yang, Lingling; Sui, Wenjie; Li, Yunqiu; Qi, Xia; Wang, Yao; Zhou, Qingjun; Gao, Hua			Substance P Inhibits Hyperosmotic Stress-Induced Apoptosis in Corneal Epithelial Cells through the Mechanism of Akt Activation and Reactive Oxygen Species Scavenging via the Neurokinin-1 Receptor	PLOS ONE			English	Article							DRY EYE; DIABETES-MELLITUS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; HUMAN TENOCYTES; OSMOLARITY; PATHWAYS; MITOCHONDRIA; DEATH; ROS	Hyperosmolarity has been recognized as an important pathological factor in dry eye leading to ocular discomfort and damage. As one of the major neuropeptides of corneal innervation, substance P (SP) has been shown to possess anti-apoptotic effects in various cells. The aim of this study was to determine the capacity and mechanism of SP against hyperosmotic stress-induced apoptosis in cultured corneal epithelial cells. The cells were exposed to hyperosmotic stress by the addition of high glucose in the presence or absence of SP. The results showed that SP inhibited hyperosmotic stress-induced apoptosis of mouse corneal epithelial cells. Moreover, SP promoted the recovery of phosphorylated Akt level, mitochondrial membrane potential, Ca2+ contents, intracellular reactive oxygen species (ROS) and glutathione levels that impaired by hyperosmotic stress. However, the antiapoptotic capacity of SP was partially suppressed by Akt inhibitor or glutathione depleting agent, while the neurokinin-1 (NK-1) receptor antagonist impaired Akt activation and ROS scavenging that promoted by SP addition. In conclusion, SP protects corneal epithelial cells from hyperosmotic stress-induced apoptosis through the mechanism of Akt activation and ROS scavenging via the NK-1 receptor.	[Yang, Lingling; Li, Yunqiu; Qi, Xia; Wang, Yao; Zhou, Qingjun; Gao, Hua] Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China; [Sui, Wenjie; Gao, Hua] Shandong Eye Hosp, Shandong Acad Med Sci, Shandong Eye Inst, Qingdao, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhou, QJ; Gao, H (corresponding author), Shandong Acad Med Sci, Shandong Eye Inst, State Key Lab Cultivat Base, Shandong Prov Key Lab Ophthalmol, Qingdao, Peoples R China.; Gao, H (corresponding author), Shandong Eye Hosp, Shandong Acad Med Sci, Shandong Eye Inst, Qingdao, Peoples R China.	qjzhou2000@hotmail.com; gaohua100@126.com	yang, lingling/AAP-9608-2020		Shandong Provincial Nature Science Fund for Distinguished Young Scholars [JQ201518]; National Natural Science Foundation of China [81470610, 81170816, 81200665]; Taishan Scholar Program [20150215]; Innovation Project of Shandong Academy of Medical Sciences	Shandong Provincial Nature Science Fund for Distinguished Young Scholars; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program; Innovation Project of Shandong Academy of Medical Sciences	This work was partially supported by the Shandong Provincial Nature Science Fund for Distinguished Young Scholars (JQ201518) and the National Natural Science Foundation of China (81470610, 81170816, and 81200665). Qingjun Zhou and Hua Gao are partially supported by the Taishan Scholar Program (20150215) and the Innovation Project of Shandong Academy of Medical Sciences.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Backman LJ, 2014, BRIT J SPORT MED, V48, P1414, DOI 10.1136/bjsports-2013-092438; Backman LJ, 2013, J CELL MOL MED, V17, P723, DOI 10.1111/jcmm.12059; Bejarano I, 2008, FERTIL STERIL, V90, P1340, DOI 10.1016/j.fertnstert.2007.08.069; Bron AJ, 2002, ADV EXP MED BIOL, V506, P1087; CHANG MM, 1970, J BIOL CHEM, V245, P4784; Clouzeau C, 2012, MOL VIS, V18, P851; Daugas E, 2000, FEBS LETT, V476, P118, DOI 10.1016/S0014-5793(00)01731-2; DeFea KA, 2000, P NATL ACAD SCI USA, V97, P11086, DOI 10.1073/pnas.190276697; Dehlin HM, 2013, INT J CARDIOL, V168, P4643, DOI 10.1016/j.ijcard.2013.07.190; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Euler USv, 1931, J PHYSL, V72, P74; FARRIS RL, 1994, ADV EXP MED BIOL, V350, P495; Fortes MB, 2011, MED SCI SPORT EXER, V43, P1590, DOI 10.1249/MSS.0b013e31820e7cb6; Fuerst N, 2014, CLIN OPHTHALMOL, V8, P507, DOI 10.2147/OPTH.S51514; Garrett Q, 2013, EXP EYE RES, V108, P33, DOI 10.1016/j.exer.2012.12.001; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Herrera B, 2001, FASEB J, V15, P741, DOI 10.1096/fj.00-0267com; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; Iskeleli Guzin, 2002, CLAO Journal, V28, P174; Janelsins BM, 2009, BLOOD, V113, P3017, DOI 10.1182/blood-2008-06-163121; Jiang LB, 2015, CELL CYCLE, V14, P867, DOI 10.1080/15384101.2015.1004946; Kawakita T, 2008, J CELL MOL MED, V12, P1303, DOI 10.1111/j.1582-4934.2008.00297.x; Khandekar N, 2013, MOL VIS, V19, P1945; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Lee JH, 2014, YONSEI MED J, V55, P203, DOI 10.3349/ymj.2014.55.1.203; Lim CB, 2014, ONCOTARGET; Liu HX, 2009, INVEST OPHTH VIS SCI, V50, P3671, DOI 10.1167/iovs.08-2689; Lozano GM, 2009, J REPROD DEVELOP, V55, P615, DOI 10.1262/jrd.20250; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Luo LH, 2007, CORNEA, V26, P452, DOI 10.1097/ICO.0b013e318030d259; Luo WH, 1996, CANCER RES, V56, P4983; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Munoz M, 2008, INVEST NEW DRUG, V26, P111, DOI 10.1007/s10637-007-9087-y; Najafi L, 2013, J DIABETES COMPLICAT, V27, P459, DOI 10.1016/j.jdiacomp.2013.04.006; Park WH, 2014, ONCOL REP, V31, P2413, DOI 10.3892/or.2014.3084; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; Png E, 2011, J CELL PHYSIOL, V226, P693, DOI 10.1002/jcp.22389; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sagdik HM, 2013, OPHTHALMIC RES, V50, P1, DOI 10.1159/000345770; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P3200, DOI 10.1167/iovs.10-6485; Wang WL, 2015, CANCER LETT, V358, P47, DOI 10.1016/j.canlet.2014.12.025; Yang LL, 2014, DIABETES, V63, P4262, DOI 10.2337/db14-0163; Yen CC, 2014, ONCOTARGET, V5, P716, DOI 10.18632/oncotarget.1704; Zhang YY, 2015, BIOCHEM BIOPH RES CO, V456, P926, DOI 10.1016/j.bbrc.2014.12.036	49	8	11	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149865	10.1371/journal.pone.0149865	http://dx.doi.org/10.1371/journal.pone.0149865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901348	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100167
J	Coleman, SK; Hou, Y; Willibald, M; Semenov, A; Moykkynen, T; Keinanen, K				Coleman, Sarah K.; Hou, Ying; Willibald, Marina; Semenov, Artur; Moykkynen, Tommi; Keinanen, Kari			Aggregation Limits Surface Expression of Homomeric GluA3 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPA receptor; AMPAR); ionotropic glutamate receptor; protein aggregation; protein assembly; protein folding; protein trafficking; surface expression	N-TERMINAL DOMAIN; AMPA RECEPTOR; LIGAND-BINDING; ENDOPLASMIC-RETICULUM; ACID AMPA; SYNAPTIC PLASTICITY; GLUTAMATE-RECEPTOR; SUBUNIT; TRAFFICKING; BIOGENESIS	AMPA receptors are glutamate-gated cation channels assembled from GluA1-4 subunits and have properties that are strongly dependent on the subunit composition. The subunits have different propensities to form homomeric or various heteromeric receptors expressed on cell surface, but the underlying mechanisms are still poorly understood. Here, we examined the biochemical basis for the poor ability of GluA3 subunits to form homomeric receptors, linked previously to two amino acid residues, Tyr-454 and Arg-461, in its ligand binding domain (LBD). Surface expression of GluA3 was improved by co-assembly with GluA2 but not with stargazin, a trafficking chaperone and modulator of AMPA receptors. The secretion efficiency of GluA2 and GluA3 LBDs paralleled the transport difference between the respective full-length receptors and was similarly dependent on Tyr-454/Arg-461 but not on LBD stability. In comparison to GluA2, GluA3 homomeric receptors showed a strong and Tyr-454/Arg-461-dependent tendency to aggregate both in the macroscopic scale measured as lower solubility in nonionic detergent and in the microscopic scale evident as the preponderance of hydrodynamically large structures in density gradient centrifugation and native gel electrophoresis. We conclude that the impaired surface expression of homomeric GluA3 receptors is caused by nonproductive assembly and aggregation to which LBD residues Tyr-454 and Arg-461 strongly contribute. This aggregation inhibits the entry of newly synthesized GluA3 receptors to the secretory pathway.	[Coleman, Sarah K.; Hou, Ying; Willibald, Marina; Semenov, Artur; Moykkynen, Tommi; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, POB 56,Viikinkaari 9, FI-00014 Helsinki, Finland; [Coleman, Sarah K.] Univ Westminster, Dept Life Sci, London W1W 6UW, England; [Hou, Ying] Rm 11-1-602, Beijing 100176, Peoples R China; [Willibald, Marina] Forschungslabore Frauenklin Univ Klinikum, Life Sci Ctr, D-40225 Dusseldorf, Germany	University of Helsinki; University of Westminster	Keinanen, K (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, POB 56,Viikinkaari 9, FI-00014 Helsinki, Finland.	kari.keinanen@helsinki.fi		Coleman, Sarah/0000-0002-1066-8296	Academy of Finland [137596]; Magnus Ehrnrooth Foundation	Academy of Finland(Academy of Finland); Magnus Ehrnrooth Foundation	This work was supported by grants from the Academy of Finland (137596; to K. K.) and from the Magnus Ehrnrooth Foundation (to S. K. C, A. S., and T. M). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Balasuriya D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.469205; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Coleman SK, 2003, J NEUROSCI, V23, P798; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Gan Q, 2015, J PHYSIOL-LONDON, V593, P39, DOI 10.1113/jphysiol.2014.273755; Gill MB, 2011, J NEUROSCI, V31, P6928, DOI 10.1523/JNEUROSCI.6271-10.2011; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Kim KS, 2010, J NEUROSCI, V30, P1064, DOI 10.1523/JNEUROSCI.3909-09.2010; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Mayer ML, 2011, CURR OPIN NEUROBIOL, V21, P283, DOI 10.1016/j.conb.2011.02.001; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; Nakagawa T, 2010, MOL NEUROBIOL, V42, P161, DOI 10.1007/s12035-010-8149-x; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sukumaran M, 2012, ADV EXP MED BIOL, V970, P241, DOI 10.1007/978-3-7091-0932-8_11; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	39	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8784	8794		10.1074/jbc.M115.689125	http://dx.doi.org/10.1074/jbc.M115.689125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912664	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000374773200039
J	Tang, XQ; Li, W; Xing, J; Sheng, XZ; Zhan, WB				Tang, Xiaoqian; Li, Wei; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin			SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis	PLOS ONE			English	Article							BETA-INTEGRIN; PROTEIN; SUMOYLATION; EXPRESSION; SHRIMP; WSSV; INTERACTS; FEATURES; GENES; CRAB	In previous work, small ubiquitin-like modifier (SUMO) in hemocytes of Chinese shrimp Fenneropenaeus chinensis was found to be up-regulated post-white spot syndrome virus (WSSV) infection using proteomic approach. However, the role of SUMO in viral infection is still unclear. In the present work, full length cDNAs of SUMO (FcSUMO) and SUMO-conjugating enzyme E2 UBC9 (FcUBC9) were cloned from F. chinensis using rapid amplification of cDNA ends approach. The open reading frame (ORF) of FcSUMO encoded a 93 amino acids peptide with the predicted molecular weight (M. W) of 10.55 kDa, and the UBC9 ORF encoded a 160 amino acids peptide with the predicted M. W of 18.35 kDa. By quantitative real-time RT-PCR, higher mRNA transcription levels of FcSUMO and FcUBC9 were detected in hemocytes and ovary of F. chinensis, and the two genes were significantly upregulated post WSSV infection. Subsequently, the recombinant proteins of FcSUMO and FcUBC9 were expressed in Escherichia coli BL21 (DE3), and employed as immunogens for the production of polyclonal antibody (PAb). Indirect immunofluorescence assay revealed that the FcSUMO and UBC9 proteins were mainly located in the hemocytes nuclei. By western blotting, a 13.5 kDa protein and a 18.7 kDa protein in hemocytes were recognized by the PAb against SUMO or UBC9 respectively. Furthermore, gene silencing of FcSUMO and FcUBC9 were performed using RNA interference, and the results showed that the number of WSSV copies and the viral gene expressions were inhibited by knockdown of either SUMO or UBC9, and the mortalities of shrimp were also reduced. These results indicated that FcSUMO and FcUBC9 played important roles in WSSV infection.	[Tang, Xiaoqian; Li, Wei; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Yushan Rd 5, Qingdao 266003, Peoples R China; [Zhan, Wenbin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, 1 Wenhai Rd, Qingdao 266071, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Zhan, WB (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Yushan Rd 5, Qingdao 266003, Peoples R China.; Zhan, WB (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, 1 Wenhai Rd, Qingdao 266071, Peoples R China.	wbzhan@ouc.edu.cn			National Basic Research Program of China [2012CB114405]; Key Technology R&D Program of China [2012BAD17B01]; Taishan Scholar Program of Shandong Province; Special Fund for Agro-scientific Research in the Public Interest [201103034]	National Basic Research Program of China(National Basic Research Program of China); Key Technology R&D Program of China(National Key Technology R&D Program); Taishan Scholar Program of Shandong Province; Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the National Basic Research Program of China ( grant 2012CB114405), Key Technology R&D Program of China ( grant 2012BAD17B01), Taishan Scholar Program of Shandong Province, and Special Fund for Agro-scientific Research in the Public Interest ( grant 201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chen AJ, 2013, J VIROL, V87, P636, DOI 10.1128/JVI.01671-12; Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9; Dai YB, 2012, GENE, V503, P260, DOI 10.1016/j.gene.2012.04.056; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hayashi T, 2002, EXP CELL RES, V280, P212, DOI 10.1006/excr.2002.5634; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Kuwata T, 2008, GENES CELLS, V13, P931, DOI 10.1111/j.1365-2443.2008.01216.x; Laoong-U-Thai Y, 2009, INT J BIOL SCI, V5, P205; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li Q, 2007, FISH SHELLFISH IMMUN, V23, P982, DOI 10.1016/j.fsi.2007.03.008; Li W, 2013, PLOS ONE, V9; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Ongvarrasopone C, 2008, MAR BIOTECHNOL, V10, P374, DOI 10.1007/s10126-007-9073-6; Rout N, 2005, AQUACULTURE, V245, P31, DOI 10.1016/j.aquaculture.2004.11.040; Sanchez-Martinez JG, 2007, AQUAC RES, V38, P1339, DOI 10.1111/j.1365-2109.2007.01827.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XQ, 2012, AQUACULTURE, V368, P1, DOI 10.1016/j.aquaculture.2012.08.004; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang Q, 2012, GENE, V501, P135, DOI 10.1016/j.gene.2012.04.016; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Zhong RJ, 2013, FISH SHELLFISH IMMUN, V35, P539, DOI 10.1016/j.fsi.2013.05.004	33	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150324	10.1371/journal.pone.0150324	http://dx.doi.org/10.1371/journal.pone.0150324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927328	Green Published, gold			2022-12-26	WOS:000371424200036
J	Troup, LJ; Bastidas, S; Nguyen, MT; Andrzejewski, JA; Bowers, M; Nomi, JS				Troup, Lucy J.; Bastidas, Stephanie; Nguyen, Maia T.; Andrzejewski, Jeremy A.; Bowers, Matthew; Nomi, Jason S.			An Event-Related Potential Study on the Effects of Cannabis on Emotion Processing	PLOS ONE			English	Article							VISUAL SELECTIVE ATTENTION; ENDOCANNABINOID SYSTEM; FACIAL EXPRESSIONS; P300; STIMULI; USERS; P3A; DELTA(9)-THC; PERCEPTION; VALENCE	The effect of cannabis on emotional processing was investigated using event-related potential paradigms (ERPs). ERPs associated with emotional processing of cannabis users, and non-using controls, were recorded and compared during an implicit and explicit emotional expression recognition and empathy task. Comparisons in P3 component mean amplitudes were made between cannabis users and controls. Results showed a significant decrease in the P3 amplitude in cannabis users compared to controls. Specifically, cannabis users showed reduced P3 amplitudes for implicit compared to explicit processing over centro-parietal sites which reversed, and was enhanced, at fronto-central sites. Cannabis users also showed a decreased P3 to happy faces, with an increase to angry faces, compared to controls. These effects appear to increase with those participants that self-reported the highest levels of cannabis consumption. Those cannabis users with the greatest consumption rates showed the largest P3 deficits for explicit processing and negative emotions. These data suggest that there is a complex relationship between cannabis consumption and emotion processing that appears to be modulated by attention.	[Troup, Lucy J.; Bastidas, Stephanie; Nguyen, Maia T.; Andrzejewski, Jeremy A.; Bowers, Matthew] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Nomi, Jason S.] Univ Miami, Dept Psychol, Miami, FL USA	Colorado State University; University of Miami	Troup, LJ (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	Lucy.Troup@colostate.edu	Troup, Lucy J/AAD-9747-2019	Troup, Lucy/0000-0001-6992-498X	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund	The authors would like to acknowledge the Colorado State University Libraries Open Access Research and Scholarship Fund in providing funding for the publication of this article.	Ballard ME, 2012, J PSYCHOPHARMACOL, V26, P1289, DOI 10.1177/0269881112446530; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bocker KBE, 2010, PHARMACOL BIOCHEM BE, V96, P67, DOI 10.1016/j.pbb.2010.04.008; Bossong MG, 2013, EUR NEUROPSYCHOPHARM, V23, P1687, DOI 10.1016/j.euroneuro.2013.06.009; Campos-Outcalt D, 2014, ADHS12017291 COL DEP; CHAPMAN RM, 1964, NATURE, V203, P1155, DOI 10.1038/2031155a0; Compumedics Neuroscan, 2003, OFFL AN ACQ DAT SCAN, VII; Conroy MA, 2007, COGNITION EMOTION, V21, P891, DOI 10.1080/02699930600926752; Crean AD, 2011, J ADDICT MED, V5, P1, DOI [10.1097/ADM.0b013e31820c23fa, DOI 10.1097/ADM.0B013E31820C23FA]; D'Souza DC, 2012, NEUROPSYCHOPHARMACOL, V37, P1632, DOI 10.1038/npp.2012.8; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Delplanque S, 2006, INT J PSYCHOPHYSIOL, V60, P315, DOI 10.1016/j.ijpsycho.2005.06.006; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hindocha CN, 2014, EUR NEUROPSYCHOPHARM; JOHNSTON VS, 1986, PSYCHOPHYSIOLOGY, V23, P684, DOI 10.1111/j.1469-8986.1986.tb00694.x; Kempel P, 2003, NEUROPSYCHOBIOLOGY, V48, P95, DOI 10.1159/000072884; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LAURIAN S, 1991, INT J PSYCHOPHYSIOL, V10, P231, DOI 10.1016/0167-8760(91)90033-T; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Morgan CJA, 2012, PSYCHOL MED, V42, P391, DOI 10.1017/S0033291711001322; Nicholls C, 2015, BIOL PSYCHOL, V110, P115, DOI 10.1016/j.biopsycho.2015.07.013; Nomi JS, 2013, NEUROREPORT, V24, P813, DOI 10.1097/WNR.0b013e3283647682; Platt B, 2010, DRUG ALCOHOL DEPEN, V112, P27, DOI 10.1016/j.drugalcdep.2010.05.004; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J., 2003, DETECTION CHANGE EVE, P83, DOI DOI 10.1007/978-1-4615-0294-4_; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Roschke J, 2003, NEUROPSYCHOPHARMACOL, V28, pS9, DOI 10.1038/sj.npp.1300139; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SOLOWIJ N, 1995, LIFE SCI, V56, P2119, DOI 10.1016/0024-3205(95)00197-E; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Theunissen EL, 2012, PSYCHOPHARMACOLOGY, V220, P341, DOI 10.1007/s00213-011-2479-x; Troup LJ, EDORIUM J PSYCHOL, V1, P9, DOI [10.5348/P13-2015-2-OA-2, DOI 10.5348/P13-2015-2-0A-2]; Weiland BJ, 2015, J NEUROSCI, V35, P1505, DOI 10.1523/JNEUROSCI.2946-14.2015; Weiser M., 2015, PSYCHIAT RES	45	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149764	10.1371/journal.pone.0149764	http://dx.doi.org/10.1371/journal.pone.0149764			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926868	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200015
J	Padayachee, T; Khamiakova, T; Shkedy, Z; Perola, M; Salo, P; Burzykowski, T				Padayachee, Trishanta; Khamiakova, Tatsiana; Shkedy, Ziv; Perola, Markus; Salo, Perttu; Burzykowski, Tomasz			The Detection of Metabolite-Mediated Gene Module Co-Expression Using Multivariate Linear Models	PLOS ONE			English	Article							LIKELIHOOD RATIO; EXPRESSION DATA; EQUALITY	Investigating whether metabolites regulate the co-expression of a predefined gene module is one of the relevant questions posed in the integrative analysis of metabolomic and transcriptomic data. This article concerns the integrative analysis of the two high-dimensional datasets by means of multivariate models and statistical tests for the dependence between metabolites and the co-expression of a gene module. The general linear model (GLM) for correlated data that we propose models the dependence between adjusted gene expression values through a block-diagonal variance-covariance structure formed by metabolic-subset specific general variance-covariance blocks. Performance of statistical tests for the inference of conditional co-expression are evaluated through a simulation study. The proposed methodology is applied to the gene expression data of the previously characterized lipid-leukocyte module. Our results show that the GLM approach improves on a previous approach by being less prone to the detection of spurious conditional co-expression.	[Padayachee, Trishanta; Khamiakova, Tatsiana; Shkedy, Ziv; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat Biostat, Diepenbeek, Belgium; [Perola, Markus; Salo, Perttu] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki, Finland	Hasselt University; Finland National Institute for Health & Welfare	Padayachee, T (corresponding author), Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat Biostat, Diepenbeek, Belgium.	trishanta.padayachee@uhasselt.be	Shkedy, Ziv/AAQ-3096-2020; Burzykowski, Tomasz/T-2222-2018	Shkedy, Ziv/0000-0002-6306-0823; Burzykowski, Tomasz/0000-0003-3378-975X	European Union [305280]; IAP Research Network of the Belgian state (Belgian Science Policy) [P7/06]	European Union(European Commission); IAP Research Network of the Belgian state (Belgian Science Policy)(Belgian Federal Science Policy Office)	This research was funded by the MIMOmics grant of the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under the grant agreement number 305280. The support of the IAP Research Network of the Belgian state (Belgian Science Policy) P7/06 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen J, 2011, BIOMETRICS, V67, P299, DOI 10.1111/j.1541-0420.2010.01413.x; Cole N, 1968, 66 U N CAR; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Gill PS, 2004, BIOMETRICS, V60, P525, DOI 10.1111/j.0006-341X.2004.00199.x; Gillis J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-306; Haldermans P, 2007, STAT APPL GENET MOL, V6; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Kayano M, 2014, IEEE ACM T COMPUT BI, V11, P154, DOI 10.1109/TCBB.2013.2297921; Larntz K., 1985, RAPPORT TECHNIQUE, P141; Lewis J, 2000, ESTIMATING REG UNPUB; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin D., 2012, MODELING DOSE RESPON; MODARRES R, 1992, COMMUN STAT-THEOR M, V21, P2107, DOI 10.1080/03610929208830901; Molenberghs G, 2011, LINEAR MIXED MODELS; Pooi AH, 2003, COMMUN STAT-SIMUL C, V32, P411, DOI 10.1081/SAC-120017498; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	25	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150257	10.1371/journal.pone.0150257	http://dx.doi.org/10.1371/journal.pone.0150257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918614	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400111
J	Pesonen, AK; Lahti, M; Kuusinen, T; Tuovinen, S; Villa, P; Hamalainen, E; Laivuori, H; Kajantie, E; Raikkonen, K				Pesonen, Anu-Katriina; Lahti, Marius; Kuusinen, Tiina; Tuovinen, Soile; Villa, Pia; Hamalainen, Esa; Laivuori, Hannele; Kajantie, Eero; Raikkonen, Katri			Maternal Prenatal Positive Affect, Depressive and Anxiety Symptoms and Birth Outcomes: The PREDO Study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PRETERM BIRTH; PSYCHOLOGICAL DISTRESS; PREGNANCY; STRESS; RISK; METAANALYSIS; POSTPARTUM; GESTATION; IMPACT	Background We investigated whether maternal prenatal emotions are associated with gestational length and birth weight in the large PREDO Study with multiple measurement points of emotions during gestation. Methods Altogether 3376 pregnant women self-assessed their positive affect (PA, Positive and Negative Affect Schedule) and depressive (Center for Epidemiologic Studies Depression Scale, CES-D) and anxiety (Spielberger State Anxiety Scale, STAI) symptoms up to 14 times during gestation. Birth characteristics were derived from the National Birth Register and from medical records. Results One standard deviation (SD) unit higher PA during the third pregnancy trimester was associated with a 0.05 SD unit longer gestational length, whereas one SD unit higher CES-D and STAI scores during the third trimester were associated with 0.04-0.05 SD unit shorter gestational lengths (P-values <= 0.02), corresponding to only 0.1-0.2% of the variation in gestational length. Higher PA during the third trimester was associated with a significantly decreased risk for preterm (< 37 weeks) delivery (for each SD unit higher positive affect, odds ratio was 0.8-fold (P = 0.02). Mothers with preterm delivery showed a decline in PA and an increase in CES-D and STAI during eight weeks prior to delivery. Post-term birth (>= 42 weeks), birth weight and fetal growth were not associated with maternal prenatal emotions. Conclusions This study with 14 measurements of maternal emotions during pregnancy show modest effects of prenatal emotions during the third pregnancy trimester, particularly in the weeks close to delivery, on gestational length. From the clinical perspective, the effects were negligible. No associations were detected between prenatal emotions and birth weight.	[Pesonen, Anu-Katriina; Lahti, Marius; Kuusinen, Tiina; Tuovinen, Soile; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Villa, Pia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Med Genet, Helsinki, Finland; [Laivuori, Hannele] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu	Pesonen, AK; Raikkonen, K (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	anukatriina.pesonen@helsinki.fi; katri.raikkonen@helsinki.fi	Laivuori, Hannele/F-2953-2011	Laivuori, Hannele/0000-0003-3212-7826	Academy of Finland; Emil Aaltonen Foundation, EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Novo Nordisk Fonden [NNF15OC0016362, NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation, EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Academy of Finland, the Emil Aaltonen Foundation, EVO (a special state subsidy for health, science research), the Finnish Medical Foundation, the Jane and Aatos Erkko Foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, AM J EPIDEMIOL, V159, P872, DOI 10.1093/aje/kwh122; Bussieres EL, 2015, DEV REV, V36, P179, DOI 10.1016/j.dr.2015.04.001; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Field T, 2008, INT J NEUROSCI, V118, P1181, DOI 10.1080/00207450701820944; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Huizink AC, 2014, J PSYCHOSOM OBST GYN, V35, P92, DOI 10.3109/0167482X.2014.944498; Kertes DA, 2016, CHILD DEV, V87, P61, DOI 10.1111/cdev.12487; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lobel M, 2000, HEALTH PSYCHOL, V19, P544, DOI 10.1037/0278-6133.19.6.544; Lockwood CJ, 1999, AM J OBSTET GYNECOL, V180, pS264, DOI 10.1016/S0002-9378(99)70713-1; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; O'Keane V, 2011, J AFFECT DISORDERS, V130, P300, DOI 10.1016/j.jad.2010.10.004; Orr ST, 2012, MATERN CHILD HLTH J, V16, P973, DOI 10.1007/s10995-011-0822-9; Palma-Gudiel H, 2015, EPIGENETICS-US, V10, P893, DOI 10.1080/15592294.2015.1088630; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Pihkala J, 1989, Duodecim, V105, P1540; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2015, PSYCHOL MED, V45, P3217, DOI 10.1017/S003329171500121X; Raikkonen K, 2014, CLIN ENDOCRINOL, V81, P175, DOI 10.1111/cen.12412; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Reynolds R. M., 2015, PSYCHOL MED, P1; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rich-Edwards JW, 2008, J CLIN ENDOCR METAB, V93, P1946, DOI 10.1210/jc.2007-2535; Rini CK, 1999, HEALTH PSYCHOL, V18, P333, DOI 10.1037/0278-6133.18.4.333; Sandman CA, 1997, ANN NY ACAD SCI, V814, P266, DOI 10.1111/j.1749-6632.1997.tb46162.x; Spielberger CD, 1983, MANUAL FOR THE STATE; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Villa PM, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/j.1471-0528.2012.03493.x; Voellmin A, 2013, J PSYCHOSOM RES, V75, P336, DOI 10.1016/j.jpsychores.2013.06.031; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	42	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150058	10.1371/journal.pone.0150058	http://dx.doi.org/10.1371/journal.pone.0150058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919119	Green Published, gold			2022-12-26	WOS:000371274400079
J	Yokota, S; Oshio, S; Moriya, N; Takeda, K				Yokota, Satoshi; Oshio, Shigeru; Moriya, Nozomu; Takeda, Ken			Social Isolation-Induced Territorial Aggression in Male Offspring Is Enhanced by Exposure to Diesel Exhaust during Pregnancy	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BRAIN MONOAMINE TURNOVER; PRENATAL EXPOSURE; PARTICULATE MATTER; OXIDATIVE STRESS; GENE DISRUPTION; BEHAVIOR; PARTICLES; ULTRAFINE; SEROTONIN	Diesel exhaust particles are a major component of ambient particulate matter, and concern about the health effects of exposure to ambient particulate matter is growing. Previously, we found that in utero exposure to diesel exhaust affected locomotor activity and motor coordination, but there are also indications that such exposure may contribute to increased aggression in offspring. Therefore, the aim of the present study was to test the effects of prenatal diesel exhaust exposure on social isolation-induced territorial aggression. Pregnant mice were exposed to low concentrations of diesel exhaust (DE; mass concentration of 90 mu g/m(3): DE group: n = 15) or clean air (control group: n = 15) for 8 h/day during gestation. Basal locomotion of male offspring was measured at 10 weeks of age. Thereafter, male offspring were individually housed for 2 weeks and subsequently assessed for aggression using the resident-intruder test at 12 weeks of age, and blood and brain tissue were collected from the male offspring on the following day for measuring serum testosterone levels and neurochemical analysis. There were no significant differences in locomotion between control and DE-exposed mice. However, DE-exposed mice showed significantly greater social isolation-induced territorial aggressive behavior than control mice. Additionally, socially-isolated DE-exposed mice expressed significantly higher concentrations of serum testosterone levels than control mice. Neurochemical analysis revealed that dopamine levels in the prefrontal cortex and nucleus accumbens were higher in socially isolated DE-exposed mice. Serotonin levels in the nucleus accumbens, amygdala, and hypothalamus were also lower in the socially isolated DE-exposed mice than in control mice. Thus, even at low doses, prenatal exposure to DE increased aggression and serum testosterone levels, and caused neurochemical changes in male socially isolated mice. These results may have serious implications for pregnant women living in regions with high levels of traffic-related air pollution.	[Yokota, Satoshi; Takeda, Ken] Tokyo Univ Sci, Ctr Environm Hlth Sci Next Generat, Res Inst Sci & Technol, Noda, Chiba 278, Japan; [Yokota, Satoshi; Oshio, Shigeru] Ohu Univ, Dept Hyg Chem, Sch Pharmaceut Sci, Koriyama, Fukushima, Japan; [Moriya, Nozomu] Hyogo Univ Hlth Sci, Dept Biopharmaceut, Kobe, Hyogo, Japan	Tokyo University of Science	Yokota, S (corresponding author), Tokyo Univ Sci, Ctr Environm Hlth Sci Next Generat, Res Inst Sci & Technol, Noda, Chiba 278, Japan.	satoshi_yokota1008@yahoo.co.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare;  [22. 5895]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); 	This work was supported by a Grant-in-Aid for JSPS Fellows (Satoshi Yokota, 22. 5895) and in part by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by a Grant-in Aid for the Private University Science Research Upgrade Promotion Business "Academic Frontier Project, a Grant-in Aid for Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, from the Ministry of Health, Labor, and Welfare" and a Grant-in Aid for MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Antonini JM, 2009, NEUROTOXICOLOGY, V30, P915, DOI 10.1016/j.neuro.2009.09.006; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Bannai M, 2007, PSYCHOPHARMACOLOGY, V193, P295, DOI 10.1007/s00213-007-0780-5; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Brunner D, 1997, ANN NY ACAD SCI, V836, P81, DOI 10.1111/j.1749-6632.1997.tb52356.x; BUTTE JC, 1976, J ENDOCRINOL, V68, P235, DOI 10.1677/joe.0.0680235; Claxton LD, 2015, MUTAT RES-REV MUTAT, V763, P30, DOI 10.1016/j.mrrev.2014.09.002; Cologer-Clifford A, 1999, PHYSIOL BEHAV, V65, P823; CologerClifford A, 1997, PHARMACOL BIOCHEM BE, V58, P425, DOI 10.1016/S0091-3057(97)00295-5; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; HADFIELD MG, 1988, BEHAV BRAIN RES, V31, P93, DOI 10.1016/0166-4328(88)90163-5; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HILAKIVI LA, 1989, PHARMACOL BIOCHEM BE, V33, P371, DOI 10.1016/0091-3057(89)90516-9; Hougaard KS, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-3; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001; JONES GH, 1992, PHARMACOL BIOCHEM BE, V43, P17, DOI 10.1016/0091-3057(92)90635-S; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Krivoshto IN, 2008, J AM BOARD FAM MED, V21, P55, DOI 10.3122/jabfm.2008.01.070139; Kumamoto T, 2013, J TOXICOL SCI, V38, P245, DOI 10.2131/jts.38.245; LASLEY SM, 1985, PSYCHOPHARMACOLOGY, V87, P313, DOI 10.1007/BF00432714; Leng A, 2004, PHARMACOL BIOCHEM BE, V77, P371, DOI 10.1016/j.pbb.2003.11.011; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Matsui Y, 2009, SPECTROCHIM ACTA B, V64, P796, DOI 10.1016/j.sab.2009.06.017; MIACHON S, 1993, BRAIN RES BULL, V32, P611, DOI 10.1016/0361-9230(93)90162-5; MILLER BL, 1979, NEUROPSYCHOBIOLOGY, V5, P11, DOI 10.1159/000117658; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Ogawa S, 1997, P NATL ACAD SCI USA, V94, P1476, DOI 10.1073/pnas.94.4.1476; Ono N, 2007, INHAL TOXICOL, V19, P275, DOI 10.1080/08958370601069257; Pagani JH, 2015, GENES BRAIN BEHAV, V14, P167, DOI 10.1111/gbb.12202; Palanza P, 1999, PHARMACOL BIOCHEM BE, V64, P665, DOI 10.1016/S0091-3057(99)00151-3; Paxinos G, 2001, MOUSE BRAIN STEREOTA; SAYEGH J F, 1990, Steroids, V55, P79, DOI 10.1016/0039-128X(90)90029-B; SCHLINGER BA, 1990, GEN COMP ENDOCR, V79, P39, DOI 10.1016/0016-6480(90)90086-2; SCHNEIDER R, 1992, BEHAV NEURAL BIOL, V57, P198, DOI 10.1016/0163-1047(92)90150-3; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; Simon NG, 1998, NEUROSCI BIOBEHAV R, V23, P325, DOI 10.1016/S0149-7634(98)00034-7; Sugamata M, 2006, J HEALTH SCI, V52, P82, DOI 10.1248/jhs.52.82; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; Takeda Ken, 2004, Environ Sci, V11, P33; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Wallace LA, 2004, ENVIRON SCI TECHNOL, V38, P2304, DOI 10.1021/es0306260; Win-Shwe TT, 2012, NANOTOXICOLOGY, V6, P543, DOI 10.3109/17435390.2011.590904; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7; Yokota S, 2015, NEUROTOXICOLOGY, V50, P108, DOI 10.1016/j.neuro.2015.08.009; Yokota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070145; Yokota S, 2013, J TOXICOL SCI, V38, P13, DOI 10.2131/jts.38.13; Yokota S, 2009, NEUROSCI LETT, V449, P38, DOI 10.1016/j.neulet.2008.09.085; Yoshida Seiichi, 2006, Environmental Sciences, V13, P139	59	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149737	10.1371/journal.pone.0149737	http://dx.doi.org/10.1371/journal.pone.0149737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919122	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400043
J	Fong, SW; Lin, HC; Wu, MF; Chen, CC; Huang, YS				Fong, Sitt Wai; Lin, Hsiu-Chen; Wu, Meng-Fang; Chen, Chih-Cheng; Huang, Yi-Shuian			CPEB3 Deficiency Elevates TRPV1 Expression in Dorsal Root Ganglia Neurons to Potentiate Thermosensation	PLOS ONE			English	Article							INFLAMMATORY THERMAL HYPERALGESIA; COMPLETE FREUNDS-ADJUVANT; VANILLOID RECEPTOR TRPV1; PROTEIN-KINASE-C; CAPSAICIN-RECEPTOR; MESSENGER-RNA; TRANSLATIONAL CONTROL; SYNAPTIC PLASTICITY; SENSORY NEURONS; NMDA RECEPTORS	Cytoplasmic polyadenylation element binding protein 3 (CPEB3) is a sequence-specific RNA-binding protein that downregulates translation of multiple plasticity-related proteins (PRPs) at the glutamatergic synapses. Activity-induced synthesis of PRPs maintains long-lasting synaptic changes that are critical for memory consolidation and chronic pain manifestation. CPEB3-knockout (KO) mice show aberrant hippocampus-related plasticity and memory, so we investigated whether CPEB3 might have a role in nociception-associated plasticity. CPEB3 is widely expressed in the brain and peripheral afferent sensory neurons. CPEB3-KO mice with normal mechanosensation showed hypersensitivity to noxious heat. In the complete Freund's adjuvant (CFA)-induced inflammatory pain model, CPEB3-KO animals showed normal thermal hyperalgesia and transiently enhanced mechanical hyperalgesia. Translation of transient receptor potential vanilloid 1 (TRPV1) RNA was suppressed by CPEB3 in dorsal root ganglia (DRG), whereas CFA-induced inflammation reversed this inhibition. Moreover, CPEB3/TRPV1 double-KO mice behaved like TRPV1-KO mice, with severely impaired thermosensation and thermal hyperalgesia. An enhanced thermal response was recapitulated in non-inflamed but not inflamed conditional-KO mice, with cpeb3 gene ablated mostly but not completely, in small-diameter nociceptive DRG neurons. CPEB3-regulated translation of TRPV1 RNA may play a role in fine-tuning thermal sensitivity of nociceptors.	[Fong, Sitt Wai; Lin, Hsiu-Chen; Wu, Meng-Fang; Chen, Chih-Cheng; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Huang, YS (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	yishuian@ibms.sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018; Chen, Chih-Cheng/S-7015-2018; Chen, Chih-Cheng/AAT-1062-2021	Huang, Yi-Shuian/0000-0001-9000-7748; Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660	Ministry of Science and Technology [MOST 102-2628-B-001-007-MY3, MOST102-2321-B-001-058]; Academia Sinica in Taiwan [AS-103-TP-B05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology [MOST 102-2628-B-001-007-MY3 and MOST102-2321-B-001-058 to YSH] and Academia Sinica [AS-103-TP-B05 to YSH] in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Baker KB, 2010, GENES BRAIN BEHAV, V9, P562, DOI 10.1111/j.1601-183X.2010.00585.x; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bogen O, 2012, J NEUROSCI, V32, P2018, DOI 10.1523/JNEUROSCI.5138-11.2012; Bonin RP, 2014, NAT NEUROSCI, V17, P1043, DOI 10.1038/nn.3758; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Cohen MR, 2014, CURR TOP MEMBR, V74, P181, DOI 10.1016/B978-0-12-800181-3.00007-5; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Moura JC, 2014, BRIT J PHARMACOL, V171, P4289, DOI 10.1111/bph.12786; Ferrari LF, 2014, P NATL ACAD SCI USA, V111, P18363, DOI 10.1073/pnas.1420601111; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kidd BL, 2001, BRIT J ANAESTH, V87, P3, DOI 10.1093/bja/87.1.3; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Lutz BM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0030-5; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Obara I, 2012, CURR OPIN PHARMACOL, V12, P42, DOI 10.1016/j.coph.2011.10.005; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sandkuhler J, 2013, TRENDS NEUROSCI, V36, P343, DOI 10.1016/j.tins.2013.03.004; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084978; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	57	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148491	10.1371/journal.pone.0148491	http://dx.doi.org/10.1371/journal.pone.0148491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915043	gold, Green Published			2022-12-26	WOS:000371175700006
J	Mielgo-Ayuso, J; Aparicio-Ugarriza, R; Castillo, A; Ruiz, E; Avila, JM; Aranceta-Batrina, J; Gil, A; Ortega, RM; Serra-Majem, L; Varela-Moreiras, G; Gonzalez-Gross, M				Mielgo-Ayuso, Juan; Aparicio-Ugarriza, Raquel; Castillo, Adrian; Ruiz, Emma; Manuel Avila, Jose; Aranceta-Batrina, Javier; Gil, Angel; Ortega, Rosa M.; Serra-Majem, Lluis; Varela-Moreiras, Gregorio; Gonzalez-Gross, Marcela			Physical Activity Patterns of the Spanish Population Are Mostly Determined by Sex and Age: Findings in the ANIBES Study	PLOS ONE			English	Article							LEISURE-TIME; ACTIVITY RECOMMENDATIONS; ACTIVITY INTERVENTION; ENERGY-BALANCE; OLDER-ADULTS; FOLLOW-UP; HEALTH; FITNESS; OBESITY; TRENDS	Background Representative data for the Spanish population regarding physical activity (PA) behaviors are scarce and seldom comparable due to methodological inconsistencies. Aim Our objectives were to describe the PA behavior by means of the standardized self-reported International Physical Activity Questionnaire (IPAQ) and to know the proportion of the Spanish population meeting and not meeting international PA recommendations. Material and Methods PA was assessed using the IPAQ in a representative sample of 2285 individuals (males, 50.4%) aged 9-75 years and living in municipalities of at least 2,000 inhabitants. Data were analyzed according to: age groups 9-12, 13-17, 18-64, and 65-75 years; sex; geographical distribution; locality size and educational levels. Results Mean total PA was 868.8+/-660.9 min/wk, mean vigorous PA 146.4+/-254.1 min/wk, and mean moderate PA 398.1+/-408.0 min/wk, showing significant differences between sexes (p<0.05). Children performed higher moderate-vigorous PA than adolescents and seniors (p<0.05), and adults than adolescents and seniors (p<0.05). Compared to recommendations, 36.2% of adults performed <150 min/week of moderate PA, 65.4% <75 min/week of vigorous PA and 27.0% did not perform any PA at all, presenting significant differences between sexes (p<0.05). A total of 55.4% of children and adolescents performed less than 420 min/week of MVPA, being higher in the later (62.6%) than in the former (48.4%). Highest non-compliance was observed in adolescent females (86.5%). Conclusion Sex and age are the main influencing factors on PA in the Spanish population. Males engage in more vigorous and light PA overall, whereas females perform more moderate PA. PA behavior differs between age groups and no clear lineal increase with age could be observed. Twenty-seven percent of adults and 55.4% of children and adolescents do not meet international PA recommendations. Identified target groups should be addressed to increase PA in the Spanish population.	[Mielgo-Ayuso, Juan; Aparicio-Ugarriza, Raquel; Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Castillo, Adrian; Ruiz, Emma; Manuel Avila, Jose; Varela-Moreiras, Gregorio] Spanish Nutr Fdn FEN, Madrid, Spain; [Aranceta-Batrina, Javier] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Aranceta-Batrina, Javier; Gil, Angel; Serra-Majem, Lluis; Gonzalez-Gross, Marcela] Inst Salud Carlos III ISCIII, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain; [Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Gil, Angel] Univ Granada, Inst Nutr & Food Sci, Granada, Spain; [Ortega, Rosa M.] Univ Complutense Madrid, Fac Pharm, Dept Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain; [Varela-Moreiras, Gregorio] CEU San Pablo Univ, Dept Pharmaceut & Hlth Sci, Fac Pharm, Madrid, Spain	Universidad Politecnica de Madrid; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Granada; University of Granada; Complutense University of Madrid; Universidad de Las Palmas de Gran Canaria; San Pablo CEU University	Gonzalez-Gross, M (corresponding author), Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain.; Gonzalez-Gross, M (corresponding author), Inst Salud Carlos III ISCIII, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.	marcela.gonzalez.gross@upm.es	Gil, Angel/ABA-7621-2020; Serra-Majem, Lluis/I-6708-2019; Aparicio-Ugarriza, Raquel/AAE-8946-2020; Gil, Angel/L-2275-2014; Ortega, Rosa M/S-5760-2016; Moreno, Emma Ruiz/S-7210-2018; Mielgo-Ayuso, Juan/E-7525-2019; Gonzalez-Gross, Marcela/W-8000-2018	Gil, Angel/0000-0001-7663-0939; Serra-Majem, Lluis/0000-0002-9658-9061; Gil, Angel/0000-0001-7663-0939; Ortega, Rosa M/0000-0003-3837-9450; Moreno, Emma Ruiz/0000-0003-3662-4440; Mielgo-Ayuso, Juan/0000-0002-6554-4602; Gonzalez-Gross, Marcela/0000-0001-7757-3235; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Coca-Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	Coca-Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	The ANIBES study was financially supported by a grant from Coca-Cola Iberia through an agreement with the Spanish Nutrition Foundation (FEN). The funding sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Coca-Cola Iberia for its support, particularly Dr. Rafael Urrialde and Isabel de Julian.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Aparicio-Ugarriza R, 2015, NUTR HOSP, V31, P219, DOI 10.3305/nh.2015.31.sup3.8769; Balboa-Castillo T, 2011, AM J PREV MED, V40, P39, DOI 10.1016/j.amepre.2010.10.005; Carlson S. A., 2008, Morbidity and Mortality Weekly Report, V57, P1297; Casado-Perez C, 2015, MATURITAS, V80, P391, DOI 10.1016/j.maturitas.2014.12.014; Celis-Morales C, 2015, J PUBLIC HLTH OXF, P1; Chillon P, 2013, INT J BEHAV MED, V20, P529, DOI 10.1007/s12529-012-9267-9; Chodzko-Zajko WJ, 2012, GAC SANIT, V26, P525, DOI [10.1016/j.gaceta.2012.10.019, 10.1016/j.gaceta.2011.10.019]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Currie C., 2012, SOCIAL DETERMINANTS; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; European Commission, 2010, EUR 72 3 SPORT PHYS; European Commission, 2014, SPEC EUR 412 SPORT P; Ferrus M.A., 2015, REV COMCIENT FICO AE, V21, P45; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gerovasili V, 2015, PREV MED, V81, P87, DOI 10.1016/j.ypmed.2015.08.005; Guallar-Castillon P, 2004, MED CLIN-BARCELONA, V123, P606, DOI 10.1157/13068435; Gutin B, 2008, INT J PEDIATR OBES, V3, P3, DOI 10.1080/17477160801896457; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P1209; Lakka TA, 2005, HANDB EXP PHARM, V170, P137; Lamonte MJ, 2001, MED SCI SPORT EXER, V33, pS370, DOI 10.1097/00005768-200106001-00006; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Martinez-Gomez D, 2009, NUTR HOSP, V24, P226; Martinez-Gomez D, 2009, REV ESP SALUD PUBLIC, V83, P427, DOI 10.1590/s1135-57272009000300008; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Ministerio de Sanidad Consumo Igualdad y Servicios Sociales, 2012, ENC NAC SAL 2011 201; Owen N, 2012, PHYSIOL MEAS, V33, P1801, DOI 10.1088/0967-3334/33/11/1801; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Pardo A, 2014, J SCI MED SPORT, V17, P188, DOI 10.1016/j.jsams.2013.04.002; Pedrero-Chamizo R, 2012, ARCH GERONTOL GERIAT, V55, P406, DOI 10.1016/j.archger.2012.02.004; Perez-Rios M, 2015, GAC SANIT, V29, P127, DOI 10.1016/j.gaceta.2014.09.007; Roman B, 2009, NUTR REV, V67, pS94, DOI 10.1111/j.1753-4887.2009.00168.x; Roman-Vinas B, 2010, EUR J SPORT SCI, V10, P297, DOI 10.1080/17461390903426667; Ruiz E, 2015, NUTRIENTS, V7, P970, DOI 10.3390/nu7020970; Salanave B, 2012, PUBLIC HEALTH NUTR, V15, P2054, DOI 10.1017/S1368980012003278; Schnohr C, 2004, SCAND J PUBLIC HEALT, V32, P250, DOI 10.1177/140349480403200403; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Smith LP, 2014, SOC SCI MED, V120, P126, DOI 10.1016/j.socscimed.2014.09.010; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Moreiras GV, 2015, NUTR HOSP, V31, P101, DOI 10.3305/nh.2015.31.sup3.8758; Varela-Moreiras G, 2013, NUTR HOSP, V28, P1, DOI 10.3305/nh.2013.28.sup5.6913; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; World Health Organization, 2010, SOC DET HLTH IN CHIL	49	74	78	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149969	10.1371/journal.pone.0149969	http://dx.doi.org/10.1371/journal.pone.0149969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914609	gold, Green Published, Green Submitted			2022-12-26	WOS:000371175700041
J	van der Kroef, S; Noordam, R; Deelen, J; Akintola, AA; Jansen, SWM; Postmus, I; Wijsman, CA; Beekman, M; Mooijaart, SP; Slagboom, PE; van Heemst, D				van der Kroef, Sabrina; Noordam, Raymond; Deelen, Joris; Akintola, Abimbola A.; Jansen, Steffy W. M.; Postmus, Iris; Wijsman, Carolien A.; Beekman, Marian; Mooijaart, Simon P.; Slagboom, P. Eline; van Heemst, Diana			Association between the rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; NONDIABETIC INDIVIDUALS; GLYCEMIC VARIABILITY; BODY-COMPOSITION; FASTING GLUCOSE; WEIGHT-LOSS; RISK LOCI; TYPE-2; VARIANTS	Background The rs7903146-T allele in the transcription factor 7-like 2 (TCF7L2) gene has been associated with impaired pancreatic insulin secretion, enhanced liver glucose production, and an increased risk of type 2 diabetes. Nevertheless, the impact of rs7903146 on daily glucose trajectories remains unclear. Continuous glucose monitoring (CGM) can estimate glycemia and glycemic variability based on consecutive glucose measurements collected over several days. The purpose of the present study was to investigate the associations of rs7903146 with glycemia and glycemic variability in middle-aged participants without diabetes. Methods Complete data from 235 participants without diabetes from the Leiden Longevity Study were available. Participants were divided into two groups based on rs7903146 genotype; rs7903146-CC genotype carriers (N = 123) and rs7903146-CT/TT genotype carriers (N = 112). Validated parameters of glycemia (e.g., mean 24h glucose level) and glycemic variability (e.g., 24h standard deviation) were derived from data collected with a CGM system for a 72-hour period. Results The study population was on average 64.7 years old (standard deviation = 5.9) and composed of 49.8% of women. Compared with rs7903146-CC carriers, rs7903146-CT/TT carriers exhibited a trend towards a higher mean 24-hour glucose level (5.21 versus 5.32 mmol/L; p-value = 0.15) and a significantly higher mean nocturnal glucose (3: 00 am-6: 00am; 4.48 versus 4.67 mmol/L; p-value = 0.03) that was explained for 34.6% by body weight and percentage body fat. No differences in measures of glycemic variability between the genotype groups were observed. Conclusion Despite limited sample size, our study indicates that the rs7903146-T allele in TCF7L2 was associated with a higher mean nocturnal glucose dependent on body composition, which might suggest that rs7902146 affects liver-specific aspects of glucose metabolism.	[van der Kroef, Sabrina; Noordam, Raymond; Akintola, Abimbola A.; Jansen, Steffy W. M.; Postmus, Iris; Wijsman, Carolien A.; Mooijaart, Simon P.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Deelen, Joris; Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Heemst, D (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	D.van_Heemst@lumc.nl	Akintola, Abi/T-5361-2019; Deelen, Joris/H-3201-2019; Slagboom, P. Eline/R-4790-2016; Mooijaart, Simon P./A-5306-2008; Beekman, Marian/L-3004-2019	Deelen, Joris/0000-0003-4483-3701; Slagboom, P. Eline/0000-0002-2875-4723; Mooijaart, Simon P./0000-0003-3106-3568; Beekman, Marian/0000-0003-0585-6206; Noordam, Raymond/0000-0001-7801-809X	European Commission [Health-2013-INNOVATION-1-602757, Health-F2-2010-259772]; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [050-060-810. NCHA]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by the European Commission funded projects Health and the Understanding of Metabolism, Aging and Nutrition (HUMAN, FP7, Health-2013-INNOVATION-1-602757) and Switchbox (FP7, Health-F2-2010-259772) and the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; 050-060-810. NCHA). The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintola AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139973; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Borg R, 2010, DIABETOLOGIA, V53, P1608, DOI 10.1007/s00125-010-1741-9; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haupt A, 2010, DIABETES, V59, P747, DOI 10.2337/db09-1050; Le Bacquer O, 2012, DIABETOLOGIA, V55, P2677, DOI 10.1007/s00125-012-2660-8; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mastrototaro J J, 2000, Diabetes Technol Ther, V2 Suppl 1, pS13, DOI 10.1089/15209150050214078; Mattei J, 2012, AM J CLIN NUTR, V96, P1129, DOI 10.3945/ajcn.112.038125; McCarthy MI, 2013, CELL METAB, V17, P157, DOI 10.1016/j.cmet.2013.01.011; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith-Palmer J, 2014, DIABETES RES CLIN PR, V105, P273, DOI 10.1016/j.diabres.2014.06.007; Takamoto I, 2014, DIABETOLOGIA, V57, P542, DOI 10.1007/s00125-013-3131-6; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wijsman CA, 2013, AGING CELL, V12, P207, DOI 10.1111/acel.12042; Yan Y, 2010, DIABETES-METAB RES, V26, P371, DOI 10.1002/dmrr.1087; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149992	10.1371/journal.pone.0149992	http://dx.doi.org/10.1371/journal.pone.0149992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914832	Green Published, gold			2022-12-26	WOS:000371175700043
J	Guha, TK; Hausner, G				Guha, Tuhin Kumar; Hausner, Georg			Using Group II Introns for Attenuating the In Vitro and In Vivo Expression of a Homing Endonuclease	PLOS ONE			English	Article							DNA-POLYMERASE GENE; ESCHERICHIA-COLI; RNA; IDENTIFICATION; MAGNESIUM; INTEIN; CRISPR-CAS9; DISRUPTION; INHIBITION; TRANSPORT	In Chaetomium thermophilum (DSM 1495) within the mitochondrial DNA (mtDNA) small ribosomal subunit (rns) gene a group IIA1 intron interrupts an open reading frame (ORF) encoded within a group I intron (mS1247). This arrangement offers the opportunity to examine if the nested group II intron could be utilized as a regulatory element for the expression of the homing endonuclease (HEase). Constructs were generated where the codon-optimized ORF was interrupted with either the native group IIA1 intron or a group IIB type intron. This study showed that the expression of the HEase (in vivo) in Escherichia coli can be regulated by manipulating the splicing efficiency of the HEase ORF-embedded group II introns. Exogenous magnesium chloride (MgCl2) stimulated the expression of a functional HEase but the addition of cobalt chloride (CoCl2) to growth media antagonized the expression of HEase activity. Ultimately the ability to attenuate HEase activity might be useful in precision genome engineering, minimizing off target activities, or where pathways have to be altered during a specific growth phase.	[Guha, Tuhin Kumar; Hausner, Georg] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Hausner, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	hausnerg@cc.umanitoba.ca	Hausner, Georg/X-5517-2019	Guha, Tuhin/0000-0003-0683-3751	Natural Sciences and Engineering Research Council of Canada; University of Manitoba Faculty of Science Graduate Award; University of Manitoba Faculty of Graduate Studies GETS program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Manitoba Faculty of Science Graduate Award; University of Manitoba Faculty of Graduate Studies GETS program	This research is supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to GH. The authors also gratefully acknowledge support for TKG from a University of Manitoba Faculty of Science Graduate Award and the University of Manitoba Faculty of Graduate Studies GETS program.	Bae H, 2009, FEMS MICROBIOL LETT, V297, P180, DOI 10.1111/j.1574-6968.2009.01671.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Choudhary PK, 2014, RNA, V20, P36, DOI 10.1261/rna.039909.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Donghi D, 2013, NUCLEIC ACIDS RES, V41, P2489, DOI 10.1093/nar/gks1179; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; Edgell DR, 2000, J BACTERIOL, V182, P5281, DOI 10.1128/JB.182.19.5281-5289.2000; Enyeart PJ, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-2; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gimble FS, 2000, FEMS MICROBIOL LETT, V185, P99; Gordon PM, 2007, CHEM BIOL, V14, P607, DOI 10.1016/j.chembiol.2007.05.008; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; Grizot S, 2010, NUCLEIC ACIDS RES, V38, P2006, DOI 10.1093/nar/gkp1171; Guha TK, 2014, FUNGAL GENET BIOL, V65, P57, DOI 10.1016/j.fgb.2014.01.004; Hafez M, 2013, FUNGAL GENET BIOL, V53, P71, DOI 10.1016/j.fgb.2013.01.005; Hafez M, 2012, GENOME, V55, P553, DOI [10.1139/G2012-049, 10.1139/g2012-049]; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Hoefel T, 2012, BIOTECHNOL J, V7, P1277, DOI 10.1002/biot.201200046; Hollander V, 1999, NUCLEIC ACIDS RES, V27, P2339, DOI 10.1093/nar/27.11.2339; Ishijima S, 2015, BBA-BIOMEMBRANES, V1848, P1376, DOI 10.1016/j.bbamem.2015.03.005; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KUCK U, 1990, NUCLEIC ACIDS RES, V18, P2691, DOI 10.1093/nar/18.9.2691; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lamech LT, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002028; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110852; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merendino L, 2006, NUCLEIC ACIDS RES, V34, P262, DOI 10.1093/nar/gkj429; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Mueller JE, 1996, GENE DEV, V10, P2158, DOI 10.1101/gad.10.17.2158; Muir RS, 1997, J MOL BIOL, V274, P722, DOI 10.1006/jmbi.1997.1419; NELSON DL, 1972, P NATL ACAD SCI USA, V69, P1091, DOI 10.1073/pnas.69.5.1091; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishioka M, 1998, NUCLEIC ACIDS RES, V26, P4409, DOI 10.1093/nar/26.19.4409; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Olga F, 2007, BIOL CHEM, V388, P665; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Posey KL, 2002, BIOCHEMISTRY-US, V41, P2184, DOI 10.1021/bi015944v; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyne ME, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0163-1; Quiroga C, 2011, RNA, V17, P2212, DOI 10.1261/rna.028886.111; Sigel RKO, 2005, EUR J INORG CHEM, P2281, DOI 10.1002/ejic.200401007; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stoddard BL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-7; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Thakker C, 2016, BIOTECHNOL J, V11, P80, DOI 10.1002/biot.201500205; Toor N, 2002, RNA, V8, P1373, DOI 10.1017/S1355838202023087; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Truong DM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005422; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang L, 2002, SCIENCE, V295, P2084, DOI 10.1126/science.1069268; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5	73	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150097	10.1371/journal.pone.0150097	http://dx.doi.org/10.1371/journal.pone.0150097			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909494	gold, Green Submitted, Green Published			2022-12-26	WOS:000371164700067
J	Herens, M; Bakker, EJ; van Ophem, J; Wagemakers, A; Koelen, M				Herens, Marion; Bakker, Evert Jan; van Ophem, Johan; Wagemakers, Annemarie; Koelen, Maria			Health-Related Quality of Life, Self-Efficacy and Enjoyment Keep the Socially Vulnerable Physically Active in Community-Based Physical Activity Programs: A Sequential Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; OLDER-ADULTS; ACTIVITY BEHAVIOR; GROUP-DYNAMICS; VALIDITY; MAINTENANCE; EXERCISE; MODEL; INTERVENTION; PROMOTION	Physical inactivity is most commonly found in socially vulnerable groups. Dutch policies target these groups through community-based health-enhancing physical activity (CBHEPA) programs. As robust evidence on the effectiveness of this approach is limited, this study investigated whether CBHEPA programs contribute to an increase in and the maintenance of physical activity in socially vulnerable groups. In four successive cohorts, starting at a six-month interval, 268 participants from 19 groups were monitored for twelve months in seven CBHEPA programs. Data collection was based on repeated questionnaires. Socio-economic indicators, program participation and coping ability were measured at baseline. Physical activity, health-related quality of life and on-going program participation were measured three times. Self-efficacy and enjoyment were measured at baseline and at twelve months. Statistical analyses were based on a quasi-RCT design (independent t-tests), a comparison of participants and dropouts (Mann-Whitney test), and multilevel modelling to assess change in individual physical activity, including group level characteristics. Participants of CBHEPA programs are socially vulnerable in terms of low education (48.6%), low income (52.4%), non-Dutch origin (64.6%) and health-related quality of life outcomes. Physical activity levels were not below the Dutch average. No increase in physical activity levels over time was observed. The multilevel models showed significant positive associations between health-related quality of life, self-efficacy and enjoyment, and leisure-time physical activity over time. Short CBHEPA programs (10-13 weeks) with multiple trainers and gender- homogeneous groups were associated with lower physical activity levels over time. At twelve months, dropouts' leisure-time physical activity levels were significantly lower compared to continuing participants, as were health-related quality of life, self-efficacy and enjoyment outcomes. BMI and care consumption scored significantly higher among dropouts. In conclusion, Dutch CBHEPA programs reach socially vulnerable, but not necessarily inactive, groups in terms of socio-economic and health-related quality of life outcomes. Our findings suggest that CBHEPA programs particularly contribute to physical activity maintenance in socially vulnerable groups, rather than to an increase in physical activity behaviour over time.	[Herens, Marion; Wagemakers, Annemarie; Koelen, Maria] Wageningen Univ, Social Sci Grp, Hlth & Soc, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands; [Bakker, Evert Jan] Wageningen Univ, Plant Sci Grp, Math & Stat Methods, Droevendaalsesteeg 1, NL-6700 AA Wageningen, Netherlands; [van Ophem, Johan] Wageningen Univ, Social Sci Grp, Econ Consumers & Households, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Herens, M (corresponding author), Wageningen Univ, Social Sci Grp, Hlth & Soc, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands.	marion.herens@wur.nl			ZonMw, the Netherlands Organisation for Health Research and Development [50-51505-98-103]	ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The study is funded by ZonMw, the Netherlands Organisation for Health Research and Development (project number: 50-51505-98-103), www.zonmw.nl. NISB developed the Communities on the Move program and is the collaborating agency, www.nisb.nl.	Antonovsky A, 1996, ISRAEL J MED SCI, V32, P170; Antonovsky A, 1996, HEALTH PROMOT INT, V11, P11, DOI 10.1093/heapro/11.1.11; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bauman AE, 2014, HEALTH PROMOT INT, V29, P143, DOI 10.1093/heapro/dau049; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Blokstra A, 2011, MEASURING NETHERLAND; Bonevski B, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-42; Bowling A, 2005, HDB HLTH RES METHODS; Boynton PM, 2004, BMJ-BRIT MED J, V328, P1433, DOI 10.1136/bmj.328.7453.1433; Burke SM, 2006, PSYCHOL SPORT EXERC, V7, P1, DOI 10.1016/j.psychsport.2005.03.002; Cawley J, 2004, AM J PREV MED, V27, P117, DOI 10.1016/j.amepre.2004.06.012; Cerin E, 2010, J PHYS ACT HEALTH, V7, P451, DOI 10.1123/jpah.7.4.451; Chen YM, 2006, INT J OBESITY, V30, P918, DOI 10.1038/sj.ijo.0803220; Claes C, 2015, EVAL PROGRAM PLANN, V48, P132, DOI 10.1016/j.evalprogplan.2014.08.002; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Crawford R, 2006, HEALTH, V10, P401, DOI 10.1177/1363459306067310; Creswell JohnW., 2006, RES SCH, V13, P1; de Hollander EL, 2012, J CLIN EPIDEMIOL, V65, P73, DOI 10.1016/j.jclinepi.2011.05.005; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dholakia UM, 2010, REV MARKET RES, V7, P145, DOI 10.1108/S1548-6435(2010)0000007009; Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Estabrooks PA, 2004, J AGING PHYS ACTIV, V12, P232, DOI 10.1123/japa.12.3.232; Estabrooks PA, 2011, INT J SPORT EXERC PS, V9, P4, DOI 10.1080/1612197X.2011.563123; Estabrooks PA, 2012, SOC PERSONAL PSYCHOL, V6, P18, DOI 10.1111/j.1751-9004.2011.00409.x; Feskens R, 2006, FIELD METHOD, V18, P284, DOI 10.1177/1525822X06288756; Fisher KJ, 2004, J AGING PHYS ACTIV, V12, P45, DOI 10.1123/japa.12.1.45; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Hagberg LA, 2009, SCAND J MED SCI SPOR, V19, P740, DOI 10.1111/j.1600-0838.2008.00844.x; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Heck RH, 2014, QUANT METH SER, P1; Herens M, 2015, TSG, V93, P93, DOI DOI 10.1007/S12508-015-0040-8; Herens M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2515-6; Herens M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2327; Hildebrandt V, 2013, TREND REPORT PHYS AC; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Kassavou A, 2014, HEALTH PSYCHOL, V33, P752, DOI 10.1037/hea0000015; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; Koelen MA, 2001, J EPIDEMIOL COMMUN H, V55, P257, DOI 10.1136/jech.55.4.257; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Konerding U, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0181-5; Kuroda Y, 2012, GLOB HEALTH PROMOT, V19, P14, DOI 10.1177/1757975911423073; Lehnert K, 2012, EUR REV AGING PHYS A, V9, P87, DOI 10.1007/s11556-012-0095-3; LEVIE WH, 1982, ECTJ-EDUC COMMUN TEC, V30, P195; Lewis BA, 2002, AM J PREV MED, V23, P26, DOI 10.1016/S0749-3797(02)00471-3; Li FZ, 2005, J AGING PHYS ACTIV, V13, P145, DOI 10.1123/japa.13.2.145; Lundberg O., 1995, EUR J PUBLIC HEALTH, V5, P56, DOI DOI 10.1093/EURPUB/5.1.56; Maas CJM, 2003, QUAL QUANT, V37, P71, DOI 10.1023/A:1022545930672; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Mason P, 2013, MENT HEALTH PHYS ACT, V6, P111, DOI 10.1016/j.mhpa.2013.06.005; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Ministry of Health Welfare and Sports, 2012, SPORT BEW BUURT; Ministry of Health Welfare and Sports: Samen voor sport [Together for sport], 2006, IMPL PROGR 2006 2010; Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; National Institute for Public Health and the Environment (RIVM), LOC NAT HLTH MON; Nigg CR, 2008, APPL PSYCHOL-INT REV, V57, P544, DOI 10.1111/j.1464-0597.2008.00343.x; Nusselder A., 2012, TIJDSCHR PRAKTIJKOND, V7, P66; Olsson M, 2009, J EPIDEMIOL COMMUN H, V63, P166, DOI 10.1136/jech.2007.063420; Pawlowski T, 2011, EUR REV AGING PHYS A, V8, P93, DOI 10.1007/s11556-011-0085-x; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Pratt M, 2004, AM J PREV MED, V27, P136, DOI 10.1016/j.amepre.2004.06.015; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rabin R., 2011, EQ 5D 5L USER GUIDE, P22; Raedeke TD, 2007, J APPL SPORT PSYCHOL, V19, P105, DOI 10.1080/10413200601113638; Rhodes RE, 2006, PSYCHOL SPORT EXERC, V7, P15, DOI 10.1016/j.psychsport.2005.08.011; Rimer B, 2005, THEORY GLANCE GUIDE; Rodrigues AM, 2015, HEALTH PSYCHOL, V34, P61, DOI 10.1037/hea0000104; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rutten A, 2010, HEALTH ASSETS IN A GLOBAL CONTEXT: THEORY, METHODS, ACTION, P197, DOI 10.1007/978-1-4419-5921-8_11; Sallis JF, 2013, ANN BEHAV MED, V45, pS14, DOI 10.1007/s12160-012-9415-0; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; SHERMAN SJ, 1980, J PERS SOC PSYCHOL, V39, P211, DOI 10.1037/0022-3514.39.2.211; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; StatWeb, AV INC PERS PRIV HOU; StatWeb, AV INC PRIV HOUS VAR; StatWeb, LAB FORC LEV ED ETHN; Stiggelbout M, 2006, HEALTH EDUC RES, V21, P1, DOI 10.1093/her/cyh037; Stiggelbout M, 2005, J AGING PHYS ACTIV, V13, P409, DOI 10.1123/japa.13.4.409; Subramanian S. V., 2003, Neighborhoods and health, P65; Super S, 2014, J EPIDEMIOL COMMUN H, V68, P411, DOI 10.1136/jech-2013-203085; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Twisk JW, 2013, APPL LONGITUDINAL DA; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van den Brink C, 2011, TIJDSCHRIFT GEZONDHE, V89, P83, DOI [10.1007/s12508-011-0030-4, DOI 10.1007/S12508-011-0030-4]; van Stralen MM, 2009, HEALTH PSYCHOL REV, V3, P147, DOI 10.1080/17437190903229462; Wagemakers A, 2010, EVAL PROGRAM PLANN, V33, P428, DOI 10.1016/j.evalprogplan.2009.12.008; Wendel-Vos GCW, 2009, AM J PREV MED, V37, P50, DOI 10.1016/j.amepre.2009.03.015; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; White JL, 2005, WOMEN HEALTH, V41, P123, DOI 10.1300/J013v41n04_07; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams DM, 2006, J SPORT EXERCISE PSY, V28, P300, DOI 10.1123/jsep.28.3.300; World Health Organization, 2012, WHO DISC PAP	98	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150025	10.1371/journal.pone.0150025	http://dx.doi.org/10.1371/journal.pone.0150025			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26909696	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700057
J	Lv, N; Wang, C; Karmonik, C; Fang, YB; Xu, JY; Yu, Y; Cao, W; Liu, JM; Huang, QH				Lv, Nan; Wang, Chi; Karmonik, Christof; Fang, Yibin; Xu, Jinyu; Yu, Ying; Cao, Wei; Liu, Jianmin; Huang, Qinghai			Morphological and Hemodynamic Discriminators for Rupture Status in Posterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CLINICAL RISK-FACTORS; CEREBRAL ANEURYSMS; SACCULAR ANEURYSM; SHEAR-STRESS; ENVIRONMENT; COHORT; RATIO; FLOW	Background and Purpose The conflicting findings of previous morphological and hemodynamic studies on intracranial aneurysm rupture may be caused by the relatively small sample sizes and the variation in location of the patient-specific aneurysm models. We aimed to determine the discriminators for aneurysm rupture status by focusing on only posterior communicating artery (PCoA) aneurysms. Materials and Methods In 129 PCoA aneurysms (85 ruptured, 44 unruptured), clinical, morphological and hemodynamic characteristics were compared between the ruptured and unruptured cases. Multivariate logistic regression analysis was performed to determine the discriminators for rupture status of PCoA aneurysms. Results While univariate analyses showed that the size of aneurysm dome, aspect ratio (AR), size ratio (SR), dome-to-neck ratio (DN), inflow angle (IA), normalized wall shear stress (NWSS) and percentage of low wall shear stress area (LSA) were significantly associated with PCoA aneurysm rupture status. With multivariate analyses, significance was only retained for higher IA (OR = 1.539, p < 0.001) and LSA (OR = 1.393, p = 0.041). Conclusions Hemodynamics and morphology were related to rupture status of intracranial aneurysms. Higher IA and LSA were identified as discriminators for rupture status of PCoA aneurysms.	[Lv, Nan; Wang, Chi; Fang, Yibin; Xu, Jinyu; Yu, Ying; Cao, Wei; Liu, Jianmin; Huang, Qinghai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Karmonik, Christof] Houston Methodist, Dept Neurosurg, Cerebrovasc Ctr, Houston, TX USA	Naval Medical University; The Methodist Hospital System; The Methodist Hospital - Houston	Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	ocinhqh@163.com			National Natural Science Foundation of China [81301004, 81571118]; National Science-technology Support Plan Projects [2011BAI08B06]; Key Project of Shanghai Science and Technology Committee [13411950300]; Key Project of Shanghai Municipal Health Bureau [2013ZYJB007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects; Key Project of Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Key Project of Shanghai Municipal Health Bureau	This work was supported by the National Natural Science Foundation of China (No. 81301004) received by YF and by (No. 81571118) received by QH, the National Science-technology Support Plan Projects (No. 2011BAI08B06) received by JL, the Key Project of Shanghai Science and Technology Committee (No. 13411950300) received by JL, and the Key Project of Shanghai Municipal Health Bureau (No. 2013ZYJB007) received by JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Bor ASE, 2015, STROKE, V46, P42, DOI 10.1161/STROKEAHA.114.005963; Can A, 2016, NEUROSURGERY, V78, P510, DOI 10.1227/NEU.0000000000001083; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Duan GL, 2016, J NEUROINTERV SURG, V8, P47, DOI 10.1136/neurintsurg-2014-011450; Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006; Golshani Kiarash, 2010, Surg Neurol Int, V1, P88, DOI 10.4103/2152-7806.74147; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Ho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094837; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Matsukawa H, 2014, J NEUROSURG, V120, P104, DOI 10.3171/2013.9.JNS13921; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Ruiz DS, 2006, AM J NEURORADIOL, V27, P504; San MRD, 2006, AM J NEURORADIOL, V27, P504; Sato K, 2008, MED ENG PHYS, V30, P774, DOI 10.1016/j.medengphy.2007.09.006; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Turjman AS, 2014, CIRCULATION, V129, P373, DOI 10.1161/CIRCULATIONAHA.113.001444; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055413, 10.1371/journal.pone.0059050]; Zhang Y, 2016, J NEUROINTERV SURG, V8, P808, DOI 10.1136/neurintsurg-2015-011865	27	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149906	10.1371/journal.pone.0149906	http://dx.doi.org/10.1371/journal.pone.0149906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910518	Green Published, gold			2022-12-26	WOS:000371164700053
J	Taskesen, E; Reinders, MJT				Taskesen, Erdogan; Reinders, Marcel J. T.			2D Representation of Transcriptomes by t-SNE Exposes Relatedness between Human Tissues	PLOS ONE			English	Article								The GTEx Consortium reported that hierarchical clustering of RNA profiles from 25 unique tissue types among 1641 individuals accurately distinguished the tissue types, but a multidimensional scaling failed to generate a 2D projection of the data that separates tissue-subtypes. In this study we show that a projection by t-Distributed Stochastic Neighbor Embedding is in line with the cluster analysis which allows a more detailed examination and visualization of human tissue relationships.	[Taskesen, Erdogan; Reinders, Marcel J. T.] Delft Univ Technol, DBL, NL-2628 CD Delft, Netherlands	Delft University of Technology	Reinders, MJT (corresponding author), Delft Univ Technol, DBL, NL-2628 CD Delft, Netherlands.	M.J.T.Reinders@tudelft.nl	Taskesen, Erdogan/N-4983-2015	Taskesen, Erdogan/0000-0002-3430-9618	Netherlands Genomics Initiative (NGI) [BIOPATH BR 2.5]	Netherlands Genomics Initiative (NGI)	Publication costs for this article were sourced from the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by the Netherlands Genomics Initiative (NGI, Project: BIOPATH BR 2.5).	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	8	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149853	10.1371/journal.pone.0149853	http://dx.doi.org/10.1371/journal.pone.0149853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906061	Green Submitted, gold, Green Published			2022-12-26	WOS:000371163000024
J	Wang, ZX; Feng, TJ; Lau, JTF; Kim, Y				Wang, Zixin; Feng, Tiejian; Lau, Joseph T. F.; Kim, Yoona			Acceptability of Voluntary Medical Male Circumcision (VMMC) among Male Sexually Transmitted Diseases Patients (MSTDP) in China	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RISK HUMAN-PAPILLOMAVIRUS; HONG-KONG; HIV INTERVENTION; WESTERN CHINA; GENITAL WARTS; SOUTH-AFRICA; YOUNG MEN; HEALTH; SEX	Voluntary Medical Male circumcision (VMMC) is an evidence-based, yet under-utilized biomedical HIV intervention in China. No study has investigated acceptability of VMMC among male sexually transmitted diseases patients (MSTDP) who are at high risk of HIV transmission. A cross-sectional survey interviewed 350 HIV negative heterosexual MSTDP in Shenzhen, China; 12.0% (n = 42) of them were circumcised at the time of survey. When the uncircumcised participants (n = 308) were informed that VMMC could reduce the risk of HIV infection via heterosexual intercourse by 50%, the prevalence of acceptability of VMMC in the next six months was 46.1%. Adjusted for significant background variables, significant factors of acceptability of VMMC included: 1) emotional variables: the Emotional Representation Subscale (adjusted odds ratios, AOR = 1.13, 95%CI: 1.06-1.18), 2) cognitive variables derived from Health Belief Model (HBM): perceived some chance of having sex with HIV positive women in the next 12 months (AOR = 2.48, 95%CI: 1.15-5.33) (perceived susceptibility), perceived severity of STD infection (AOR = 1.06, 95%CI: 1.02-1.10), perceived benefit of VMMC in risk reduction (AOR = 1.29, 95%CI: 1.16-1.42) and sexual performance (AOR = 1.45, 95% CI: 1.26-1.71), perceived barriers against taking up VMMC (AOR = 0.88, 95% CI: 0.81-0.95), and perceived cue to action (AOR = 1.41, 95%CI: 1.23-1.61) and self-efficacy (AOR = 1.38, 95%CI: 1.26-1.35) related to taking up VMMC. The association between perceived severity of STD infection and acceptability was fully mediated by emotional representation of STD infection. The relatively low prevalence of circumcision and high acceptability suggested that the situation was favorable for implementing VMMC as a means of HIV intervention among MSTDP in China. HBM is a potential suitable framework to guide the design of future VMMC promotion. Future implementation programs should be conducted in STD clinic settings, taking the important findings of this study into account.	[Wang, Zixin; Lau, Joseph T. F.; Kim, Yoona] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behaviours Res, Hong Kong, Hong Kong, Peoples R China; [Wang, Zixin; Lau, Joseph T. F.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Feng, Tiejian] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China; [Lau, Joseph T. F.] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behaviours Res, Hong Kong, Hong Kong, Peoples R China.; Lau, JTF (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.; Lau, JTF (corresponding author), Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022; Kim, Yoona/AAB-8207-2020	Kim, Yoona/0000-0003-3473-8516	National Natural Science Foundation of China [81373054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (Ref# 81373054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, UNAIDS MAL CIRC GLOB; [Anonymous], 2013, 2013 SHENZH STAT YB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Ben Kun-Long, 2009, Zhonghua Nan Ke Xue, V15, P395; Ben Kun-Long, 2008, Zhonghua Nan Ke Xue, V14, P291; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Cai Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-205; Chen WT, 2007, ADV NURS SCI, V30, P329, DOI 10.1097/01.ANS.0000300182.48854.65; Feng Nan, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P281; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gittelsohn J, 2006, HEALTH EDUC BEHAV, V33, P25, DOI 10.1177/1090198105282412; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Goswami P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002183; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; Hao C, 2012, AIDS BEHAV, V16, P1138, DOI 10.1007/s10461-012-0141-1; Huang J, 2013, INT J STD AIDS, V24, P541, DOI 10.1177/0956462412473893; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jiang JJ, 2013, AIDS RES HUM RETROV, V29, P1582, DOI [10.1089/aid.2013.0156, 10.1089/AID.2013.0156]; Lau JTF, 2014, ARCH SEX BEHAV, V43, P789, DOI 10.1007/s10508-013-0172-3; Lau JTF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057204; Lau JTF, 2012, J SEX MED, V9, P1904, DOI 10.1111/j.1743-6109.2010.02050.x; Araujo MAL, 2009, AIDS PATIENT CARE ST, V23, P663, DOI 10.1089/apc.2008.0123; Luo Hao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P313, DOI 10.3881/j.issn.1000-503X.2011.03.020; Madhivanan P, 2011, SEX TRANSM DIS, V38, P571, DOI 10.1097/OLQ.0b013e318219c930; McAninch JW, 2013, SMITH TANAGHOS GEN U; Mehta P, 2014, INT Q COMMUNITY HEAL, V34, P101, DOI 10.2190/IQ.34.1.h; MILLER WR, 1983, BEHAV PSYCHOTHER, V11, P147, DOI 10.1017/S0141347300006583; Ministry of Health of China, 2012, EST HIV AIDS EP CHIN; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nilsson D, 2007, EUR J MARKETING, V41, P367, DOI 10.1108/03090560710728381; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Reback Cathy J, 2010, Open AIDS J, V4, P116, DOI 10.2174/1874613601004030116; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Scott BE, 2005, AIDS CARE, V17, P304, DOI 10.1080/09540120412331299744; Serwadda D, 2010, J INFECT DIS, V201, P1463, DOI 10.1086/652185; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Valente TW, 2006, SEX TRANSM DIS, V33, pS23, DOI 10.1097/01.olq.0000221018.32533.6d; Wang B, 2009, EPIDEMIC SEXUALLY TR; Wang QQ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-955; Wang Z, 2015, AIDS BEHAV; Wang ZX, 2013, VACCINE, V31, P4675, DOI 10.1016/j.vaccine.2013.06.090; Wang ZX, 2012, AIDS BEHAV, V16, P1836, DOI 10.1007/s10461-011-0088-7; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wiysonge CS, 2011, COCHRANE DB SYST REV, V15; Wu XiaoBing, 2009, China Tropical Medicine, V9, P1856; Xu Yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P987; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	61	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149801	10.1371/journal.pone.0149801	http://dx.doi.org/10.1371/journal.pone.0149801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2HK	26905739	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000022
J	Banish, NP; Burdick, SM; Moyer, KR				Banish, Nolan P.; Burdick, Summer M.; Moyer, Katherine R.			Efficiency of Portable Antennas for Detecting Passive Integrated Transponder Tags in Stream-Dwelling Salmonids	PLOS ONE			English	Article							PIT; TRACKING; ABUNDANCE; FISH; MOVEMENT; SURVIVAL	Portable antennas have become an increasingly common technique for tracking fish marked with passive integrated transponder (PIT) tags. We used logistic regression to evaluate how species, fish length, and physical habitat characteristics influence portable antenna detection efficiency in stream-dwelling brown trout (Salmo trutta), bull trout (Salvelinus confluentus), and redband trout (Oncorhynchus mykiss newberrii) marked with 12-mm PIT tags. We redetected 56% (20/36) of brown trout, 34% (68/202) of bull trout, and 33% (20/61) of redband trout after a recovery period of 21 to 46 hours. Models indicate support for length and species and minor support for percent boulder, large woody debris, and percent cobble as parameters important for describing variation in detection efficiency, although 95% confidence intervals for estimates were large. The odds of detecting brown trout (1.5 +/- 2.2 [mean +/- SE]) are approximately four times as high as bull trout (0.4 +/- 1.6) or redband trout (0.3 +/- 1.8) and species-specific differences may be related to length. Our reported detection efficiency for brown trout falls within the range of other studies, but is the first reported for bull trout and redband trout. Portable antennas may be a relatively unbiased way of redetecting varying sizes of all three salmonid species.	[Banish, Nolan P.] US Fish & Wildlife Serv, Klamath Falls Fish & Wildlife Off, Klamath Falls, OR USA; [Burdick, Summer M.] US Geol Survey, Western Fisheries Res Ctr, Klamath Falls Field Stn, Klamath Falls, OR USA; [Moyer, Katherine R.] Chicago Bot Garden, Conservat & Land Management Internship Program, Glencoe, IL USA; [Moyer, Katherine R.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	United States Department of the Interior; US Fish & Wildlife Service; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle	Banish, NP (corresponding author), US Fish & Wildlife Serv, Klamath Falls Fish & Wildlife Off, Klamath Falls, OR USA.	nolan_banish@fws.gov						Anderson D. R., 2008, MODEL BASED INFERENC; Bonneau Joseph L., 1995, North American Journal of Fisheries Management, V15, P563, DOI 10.1577/1548-8675(1995)015<0563:CMAEOJ>2.3.CO;2; Bowerman T, 2012, N AM J FISH MANAGE, V32, P1123, DOI 10.1080/02755947.2012.720644; Breen MJ, 2009, CAN J FISH AQUAT SCI, V66, P31, DOI 10.1139/F08-189; Brignon WR, 2011, J FISH WILDL MANAG, V2, P90, DOI 10.3996/052010-JFWM-012; Buchanan T.J., 1969, TECHNIQUES WATER RES; Burnett NJ, 2013, N AM J FISH MANAGE, V33, P7, DOI 10.1080/02755947.2012.734895; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cooke SJ, 2012, FISHERIES TECHNIQUES, THIRD EDITION, P819; Cucherousset J, 2005, N AM J FISH MANAGE, V25, P270, DOI 10.1577/M04-053.1; Cucherousset J, 2010, J FISH BIOL, V76, P1039, DOI 10.1111/j.1095-8649.2010.02543.x; Drasgow F., 1986, ENCY STAT SCI, VVol. 7, P68, DOI DOI 10.1002/0471667196.ESS2014.PUB2.ACCESSED; Ellis TR, 2013, T AM FISH SOC, V142, P660, DOI 10.1080/00028487.2012.754789; Hewitt DA, 2010, FISHERIES, V35, P217, DOI 10.1577/1548-8446-35.5.217; Hill MS, 2006, FISH RES, V77, P102, DOI 10.1016/j.fishres.2005.08.001; Keeler RA, 2007, T AM FISH SOC, V136, P281, DOI 10.1577/T05-131.1; Linnansaari T, 2013, CAN J FISH AQUAT SCI, V70, P1488, DOI 10.1139/cjfas-2012-0236; McKenzie J., 2012, ADV FISH TAGGING MAR; Moyle P.B., 2002, INLAND FISHES CALIFO; O'Donnell MJ, 2010, N AM J FISH MANAGE, V30, P323, DOI 10.1577/M09-008.1; Peterson JI, 2005, N AM J FISH MANAGE, V25, P732, DOI 10.1577/M04-051.1; Peterson JT, 2004, T AM FISH SOC, V133, P462, DOI 10.1577/03-044; Pine WE, 2003, FISHERIES, V28, P10, DOI 10.1577/1548-8446(2003)28[10:AROTMF]2.0.CO;2; R Core Team, 2012, R LANG ENV STAT COMP; Roussel JM, 2000, CAN J FISH AQUAT SCI, V57, P1326, DOI 10.1139/cjfas-57-7-1326; Sloat MR, 2011, N AM J FISH MANAGE, V31, P986, DOI 10.1080/02755947.2011.635486; Thurow RF, 2006, N AM J FISH MANAGE, V26, P217, DOI 10.1577/M05-054.1; Venables WN., 2002, MODERN APPL STAT S 4; Vetterling W.T., 1988, NUMERICAL RECIPES C; White G. C., 2001, WILDLIFE LAND PEOPLE, P368; Zaroban DW, 2010, WEST N AM NATURALIST, V70, P218, DOI 10.3398/064.070.0208	31	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149898	10.1371/journal.pone.0149898	http://dx.doi.org/10.1371/journal.pone.0149898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901317	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100178
J	Li, NC; Fan, JJ; Papadopoulos, V				Li, Nancy C.; Fan, Jinjiang; Papadopoulos, Vassilios			Sterol Carrier Protein-2, a Nonspecific Lipid-Transfer Protein, in Intracellular Cholesterol Trafficking in Testicular Leydig Cells	PLOS ONE			English	Article							FATTY ACYL-COENZYME; ACID-BINDING SITE; LUTEINIZING-HORMONE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; RAT-LIVER; EXPRESSION; PEROXISOMES; SEQUENCE; LOCALIZATION	Sterol carrier protein-2 (SCP2), also called nonspecific lipid-transfer protein, is thought to play a major role in intracellular lipid transport and metabolism, and it has been associated with diseases involving abnormalities in lipid trafficking, such as Zellweger syndrome. The Scp2 gene encodes the 58 kDa sterol carrier protein-x (SCPX) and 15 kDa pro-SCP2 proteins, both of which contain a 13 kDa SCP2 domain in their C-termini. We found that 22-NBD-cholesterol, a fluorescent analog of cholesterol and a preferred SCP2 ligands, was not localized in the peroxisomes. This raises questions about previous reports on the localization of the SCPX and SCP2 proteins and their relationship to peroxisomes and mitochondria in intracellular cholesterol transport. Immunofluorescent staining of cryosections of mouse testis and of MA-10 mouse tumor Leydig cells showed that SCPX and SCP2 are present in both mouse testicular interstitial tissue and in MA-10 cells. Fluorescent fusion proteins of SCPX and SCP2, as well as confocal live-cell imaging, were used to investigate the subcellular targeting of these proteins and the function of the putative mitochondrial targeting sequence. The results showed that SCPX and SCP2 are targeted to the peroxisomes by the C-terminal PTS1 domain, but the putative N-terminal mitochondrial targeting sequence alone is not potent enough to localize SCPX and SCP2 to the mitochondria. Homology modeling and molecular docking studies indicated that the SCP2 domain binds cholesterol, but lacks specificity of the binding and/or transport. These findings further our understanding of the role of SCPX and SCP2 in intracellular cholesterol transport, and present a new point of view on the role of these proteins in cholesterol trafficking.	[Li, Nancy C.; Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Ctr Hlth, Res Inst, Ctr Translat Biol, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada; [Li, Nancy C.; Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada; [Fan, Jinjiang; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Ctr Translat Biol, 1001 Blvd Decarie, Montreal, PQ H4A 3J1, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada.; Papadopoulos, V (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019; Fan, Jinjiang/C-2010-2009	Papadopoulos, Vassilios/0000-0002-1183-8568; Fan, Jinjiang/0000-0003-3102-4833	Canadian Institutes of Health Research [MOP125983]; Canada Research Chair in Biochemical Pharmacology; Les Fonds de la Recherche du Quebec Sante	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Les Fonds de la Recherche du Quebec Sante	This work was supported by a grant from the Canadian Institutes of Health Research (MOP125983) and a Canada Research Chair in Biochemical Pharmacology. The Research Institute of the McGill University Health Centre was supported by a center grant from Les Fonds de la Recherche du Quebec Sante.	Aghazadeh Y, 2014, J BIOL CHEM, V289, P26542, DOI 10.1074/jbc.M114.569079; ASCOLI M, 1981, ENDOCRINOLOGY, V108, P88, DOI 10.1210/endo-108-1-88; Atshaves BP, 1999, J LIPID RES, V40, P610; Baum CL, 1997, J BIOL CHEM, V272, P6490, DOI 10.1074/jbc.272.10.6490; Chao H, 1999, BBA-MOL CELL BIOL L, V1439, P371, DOI 10.1016/S1388-1981(99)00109-2; Faletrov YV, 2013, J STEROID BIOCHEM, V134, P59, DOI 10.1016/j.jsbmb.2012.09.035; Fan JJ, 2015, P NATL ACAD SCI USA, V112, P7261, DOI 10.1073/pnas.1502670112; Fan JJ, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097535; Castillo AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022822; Filipp FV, 2007, BIOCHEMISTRY-US, V46, P7980, DOI 10.1021/bi6025616; Frolov A, 1997, LIPIDS, V32, P1201, DOI 10.1007/s11745-997-0154-5; Frolov A, 1996, J BIOL CHEM, V271, P31878, DOI 10.1074/jbc.271.50.31878; GADELLA TWJ, 1991, BIOCHIM BIOPHYS ACTA, V1070, P237, DOI 10.1016/0005-2736(91)90170-D; Gallegos AM, 2001, PROG LIPID RES, V40, P498, DOI 10.1016/S0163-7827(01)00015-7; Gallegos AM, 2001, BIOCHEMISTRY-US, V40, P6493, DOI 10.1021/bi010217l; Gallegos AM, 2000, CHEM PHYS LIPIDS, V105, P9, DOI 10.1016/S0009-3084(99)00128-0; Issop L, 2015, ENDOCRINOLOGY, V156, P334, DOI 10.1210/en.2014-1503; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; KELLER GA, 1989, J CELL BIOL, V108, P1353, DOI 10.1083/jcb.108.4.1353; KILGORE MW, 1990, MOL CELL ENDOCRINOL, V69, P9, DOI 10.1016/0303-7207(90)90083-K; Klipsic D, 2015, AM J PHYSIOL-GASTR L, V309, pG387, DOI 10.1152/ajpgi.00460.2014; KRISANS SK, 1992, AM J RESP CELL MOL, V7, P358, DOI 10.1165/ajrcmb/7.4.358; Martin GG, 2015, ARCH BIOCHEM BIOPHYS, V580, P41, DOI 10.1016/j.abb.2015.06.009; Mendis-Handagama SMLC, 2000, TISSUE CELL, V32, P102, DOI 10.1054/tice.1999.0092; Mendis-Handagama SMLC, 1998, TISSUE CELL, V30, P64, DOI 10.1016/S0040-8166(98)80007-4; MENDISHANDAGAMA SMLC, 1992, ENDOCRINOLOGY, V131, P2839, DOI 10.1210/en.131.6.2839; MendisHandagama SMLC, 1997, HISTOL HISTOPATHOL, V12, P869; Moncecchi D, 1996, BBA-LIPID LIPID MET, V1302, P110, DOI 10.1016/0005-2760(96)00044-6; MONCECCHI D, 1991, J BIOL CHEM, V266, P9885; MORI T, 1991, P NATL ACAD SCI USA, V88, P4338, DOI 10.1073/pnas.88.10.4338; Nenicu A, 2007, BIOL REPROD, V77, P1060, DOI 10.1095/biolreprod.107.061242; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; PAYNE AH, 1995, BIOL REPROD, V52, P217, DOI 10.1095/biolreprod52.2.217; PFEIFER SM, 1993, J STEROID BIOCHEM, V47, P167, DOI 10.1016/0960-0760(93)90071-4; PUGLIELLI L, 1995, J BIOL CHEM, V270, P18723, DOI 10.1074/jbc.270.32.18723; Rone Malena B, 2014, Biol Reprod, V91, P96, DOI 10.1095/biolreprod.114.121434; SCHROEDER F, 1995, BIOCHEMISTRY-US, V34, P11919, DOI 10.1021/bi00037a033; Schroeder F, 2000, J BIOL CHEM, V275, P25547, DOI 10.1074/jbc.M000431200; SEEDORF U, 1991, J BIOL CHEM, V266, P630; Seedorf U, 1998, GENE DEV, V12, P1189, DOI 10.1101/gad.12.8.1189; Starodub O, 2000, AM J PHYSIOL-CELL PH, V279, pC1259, DOI 10.1152/ajpcell.2000.279.4.C1259; STOCCO DM, 1990, J ENDOCRINOL, V126, P367, DOI 10.1677/joe.0.1260367; Stolowich N, 1999, J BIOL CHEM, V274, P35425, DOI 10.1074/jbc.274.50.35425; Stolowich NJ, 1997, BIOCHEMISTRY-US, V36, P1719, DOI 10.1021/bi962317a; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANHAREN L, 1992, BIOCHIM BIOPHYS ACTA, V1124, P288; VANHEUSDEN GPH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P315, DOI 10.1016/0005-2760(90)90247-U; WESTERMAN J, 1985, BIOCHEM BIOPH RES CO, V127, P333, DOI 10.1016/S0006-291X(85)80163-7; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; WIRTZ KWA, 1990, EXPERIENTIA, V46, P592, DOI 10.1007/BF01939698; YAMAMOTO R, 1991, P NATL ACAD SCI USA, V88, P463, DOI 10.1073/pnas.88.2.463	51	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149728	10.1371/journal.pone.0149728	http://dx.doi.org/10.1371/journal.pone.0149728			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901662	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100136
J	Murrison, LB; Ananthakrishnan, R; Sukumar, S; Augustine, S; Krishnan, N; Pai, M; Dowdy, DW				Murrison, Liza Bronner; Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini; Pai, Madhukar; Dowdy, David W.			How Do Urban Indian Private Practitioners Diagnose and Treat Tuberculosis? A Cross-Sectional Study in Chennai	PLOS ONE			English	Article							MANAGEMENT; QUALITY	Setting Private practitioners are frequently the first point of healthcare contact for patients with tuberculosis (TB) in India. Inappropriate TB management practices among private practitioners may contribute to delayed TB diagnosis and generate drug resistance. However, these practices are not well understood. We evaluated diagnostic and treatment practices for active TB and benchmarked practices against International Standards for TB Care (ISTC) among private medical practitioners in Chennai. Design A cross-sectional survey of 228 practitioners practicing in the private sector from January 2014 to February 2015 in Chennai city who saw at least one TB patient in the previous year. Practitioners were randomly selected from both the general community and a list of practitioners who referred patients to a public-private mix program for TB treatment in Chennai. Practitioners were interviewed using standardized questionnaires. Results Among 228 private practitioners, a median of 12 (IQR 4-28) patients with TB were seen per year. Of 10 ISTC standards evaluated, the median of standards adhered to was 4.0 (IQR 3.0-6.0). Chest physicians reported greater median ISTC adherence than other MD and MS practitioners (score 7.0 vs. 4.0, P<0.001), or MBBS practitioners (score 7.0 vs. 4.0, P< 0.001). Only 52% of all practitioners sent >5% of patients with cough for TB testing, 83% used smear microscopy for diagnosis, 33% monitored treatment response, and 22% notified TB cases to authorities. Of 228 practitioners, 68 reported referring all patients with new pulmonary TB for treatment, while 160 listed 27 different regimens; 78% (125/160) prescribed a regimen classified as consistent with ISTC. Appropriate treatment practices differed significantly between chest physicians and other MD and MS practitioners (54% vs. 87%, P<0.001). Conclusion TB management practices in India's urban private sector are heterogeneous and often suboptimal. Private providers must be better engaged to improve diagnostic capacity and decrease TB transmission in the community.	[Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Murrison, Liza Bronner; Dowdy, David W.] Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA; [Ananthakrishnan, Ramya; Sukumar, Sumanya; Augustine, Sheela; Krishnan, Nalini] REACH, Madras, Tamil Nadu, India; [Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Pai, Madhukar] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; McGill University; McGill University	Dowdy, DW (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.; Dowdy, DW (corresponding author), Johns Hopkins Univ, Ctr TB Res, Baltimore, MD USA.	ddowdy1@jhmi.edu	Murrison, Liza/AAE-7682-2019; Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X; Bronner Murrison, Liza/0000-0002-8668-3898	Bill & Melinda Gates Foundation [OPP1061487]; Global Health Field Research Award by the Johns Hopkins Center for Global Health; Canadian Institutes of Health Research	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Health Field Research Award by the Johns Hopkins Center for Global Health; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was supported by a grant by the Bill & Melinda Gates Foundation (grant OPP1061487) and by a Global Health Field Research Award grant by the Johns Hopkins Center for Global Health. Madhukar Pai was a recipient of a Tier 1 Canada Research Chair from the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Achanta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071119; Bharaswadkar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097993; Bronner Murrison L, 2016, INT J TUBERC LUNG DI; Central TB Division Directorate General of Health Services Ministry of Health and Family Welfare Government of India, 2014, TB IND 2014 REV NAT; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Das J, 2015, LANCET INFECT DIS; Engel N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135112; Government of India Ministry of Home Affairs Office of the Registrar General and Census Commissioner, 2011, PRIM CENS ABSTRACT C; Jaroslawski S, 2012, J EPIDEMIOL GLOB HEA, V2, P39, DOI 10.1016/j.jegh.2011.12.001; Kapoor SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042458; Krishnan N, 2009, INT J TUBERC LUNG D, V13, P112; Miller R, 2012, INT J HEALTH PLAN M, V27, P180, DOI 10.1002/hpm.2105; Nagaraja SB, 2014, INT J TUBERC LUNG D, V18, P1353, DOI 10.5588/ijtld.13.0836; Pai M, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001805; Pai M, 2014, LANCET GLOB HEALTH, V2, pE189, DOI 10.1016/S2214-109X(14)70198-6; Pai M, 2013, NATL MED J INDIA, V26, P65; Paramasivan CN, 2010, INT J TUBERC LUNG D, V14, P243; Philip S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123286; Sachdeva KS, 2012, INDIAN J MED RES, V135, P690; Salje H, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001674; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; TBCARE I, 2014, INT STAND TUB CAR; Thomas A, 2011, INT J TUBERC LUNG D, V15, P1323, DOI 10.5588/ijtld.10.0530; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; World Health Organization, 2014, STAND TB CAR IND; World Health Organization, 2014, WHOHTMTB201408	29	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149862	10.1371/journal.pone.0149862	http://dx.doi.org/10.1371/journal.pone.0149862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901165	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100166
J	Pagin, A; Devos, A; Figeac, M; Truant, M; Willoquaux, C; Broly, F; Lalau, G				Pagin, Adrien; Devos, Aurore; Figeac, Martin; Truant, Maryse; Willoquaux, Christelle; Broly, Franck; Lalau, Guy			Applicability and Efficiency of NGS in Routine Diagnosis: In-Depth Performance Analysis of a Complete Workflow for CFTR Mutation Analysis	PLOS ONE			English	Article							CYSTIC-FIBROSIS; DISORDERS; RECOMMENDATIONS; DELETION; GENE	Background Actually, about 2000 sequence variations have been documented in the CFTR gene requiring extensive and multi-step genetic testing in the diagnosis of cystic fibrosis and CFTR-related disorders. We present a two phases study, with validation and performance monitoring, of a single experiment methodology based on multiplex PCR and high throughput sequencing that allows detection of all variants, including large rearrangements, affecting the coding regions plus three deep intronic loci. Methods A total of 340 samples, including 257 patients and 83 previously characterized control samples, were sequenced in 17 MiSeq runs and analyzed with two bioinformatic pipelines in routine diagnostic conditions. We obtained 100% coverage for all the target regions in every tested sample. Results We correctly identified all the 87 known variants in the control samples and successfully confirmed the 62 variants identified among the patients without observing false positive results. Large rearrangements were identified in 18/18 control samples. Only 17 patient samples showed false positive signals (6.6%), 12 of which showed a borderline result for a single amplicon. We also demonstrated the ability of the assay to detect allele specific dropout of amplicons when a sequence variation occurs at a primer binding site thus limiting the risk for false negative results. Conclusions We described here the first NGS workflow for CFTR routine analysis that demonstrated equivalent diagnostic performances compared to Sanger sequencing and multiplex ligation-dependent probe amplification. This study illustrates the advantages of NGS in term of scalability, workload reduction and cost-effectiveness in combination with an improvement of the overall data quality due to the simultaneous detection of SNVs and large rearrangements.	[Pagin, Adrien; Devos, Aurore; Truant, Maryse; Willoquaux, Christelle; Broly, Franck; Lalau, Guy] Lille Univ Hosp, Biol Pathol Ctr, Dept Toxicol & Genopathy, Lille, France; [Figeac, Martin] Funct & Struct Genom Platform, Lille, France; [Broly, Franck] Univ Lille 2, Lille, France	Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; Universite de Lille	Pagin, A (corresponding author), Lille Univ Hosp, Biol Pathol Ctr, Dept Toxicol & Genopathy, Lille, France.	adrien.pagin@chru-lille.fr		Figeac, Martin/0000-0001-8523-3708				Abou Tayoun AN, 2013, CLIN CHEM, V59, P1481, DOI 10.1373/clinchem.2013.206466; Biesecker LG, 2014, NEW ENGL J MED, V371, P1170, DOI 10.1056/NEJMc1408914; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bonini J, 2015, GENET MED, V17, P796, DOI 10.1038/gim.2014.194; Buermans HPJ, 2014, BBA-MOL BASIS DIS, V1842, P1932, DOI 10.1016/j.bbadis.2014.06.015; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; Claustres M, 2000, HUM MUTAT, V16, P143, DOI 10.1002/1098-1004(200008)16:2<143::AID-HUMU7>3.0.CO;2-J; Costes B, 2000, CLIN CHEM, V46, P1417; Dequeker E, 2009, EUR J HUM GENET, V17, P51, DOI 10.1038/ejhg.2008.136; El-Seedy A, 2009, J MOL DIAGN, V11, P488, DOI 10.2353/jmoldx.2009.090005; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magnani C, 1996, HUM GENET, V98, P102, DOI 10.1007/s004390050167; Masson E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073522; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Nakano E, 2015, DIGEST DIS SCI, V60, P1297, DOI 10.1007/s10620-014-3476-9; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Tomaiuolo R, 2008, J CYST FIBROS, V7, P347, DOI 10.1016/j.jcf.2007.12.004; Trujillano D, 2013, J MED GENET, V50, P455, DOI 10.1136/jmedgenet-2013-101602; Trujillano D, 2015, MOL GENET GENOM MED, V3, P396, DOI 10.1002/mgg3.149	24	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149426	10.1371/journal.pone.0149426	http://dx.doi.org/10.1371/journal.pone.0149426			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900683	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100074
J	Mukherjee, S; Manna, A; Bhattacharjee, P; Mazumdar, M; Saha, S; Chakraborty, S; Guha, D; Adhikary, A; Jana, D; Gorain, M; Mukherjee, SA; Kundu, GC; Sarkar, DK; Das, T				Mukherjee, S.; Manna, A.; Bhattacharjee, P.; Mazumdar, M.; Saha, S.; Chakraborty, S.; Guha, D.; Adhikary, A.; Jana, D.; Gorain, M.; Mukherjee, S. A.; Kundu, G. C.; Sarkar, D. K.; Das, T.			Non-migratory tumorigenic intrinsic cancer stem cells ensure breast cancer metastasis by generation of CXCR4(+) migrating cancer stem cells	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CHEMOKINE RECEPTOR CXCR4; TUMOR-CELLS; CARCINOMA-CELLS; GROWTH; MICROENVIRONMENT; PERSPECTIVE; PROGRESSION; RESISTANCE; INHIBITION	Although the role of metastatic cancer stem cells (mCSCs) in tumor progression has been well documented, our study reveals a hitherto unidentified role of tumorigenic intrinsic CSCs (iCSCs) in breast cancer metastasis. We show that unlike highly migratory mCSCs residing in the breast tumor disseminating/peripheral regions, iCSCs populate the inner mass of the tumor and are nonmigratory. However iCSCs, via paracrine signaling, induce conversion of non-stem cancer cells to CSCs that (i) are identical to the previously reported mCSCs, and (ii) in contrast to iCSCs, express chemokine receptor, chemokine (C-X-C motif) receptor 4 (CXCR4), which is crucial for their metastatic potential. These mCSCs also demonstrate high in vivo tumorigenicity. Physical non-participation of iCSCs in metastasis is further validated in vivo, where only mCSCs are found to exist in the metastatic sites, lymph nodes and bone marrow, whereas the primary tumor retains both iCSCs and mCSCs. However, iCSCs ensure metastasis since their presence is crucial for deliverance of highly metastatic CXCR4(+) mCSCs to the migrating fraction of cells. Cumulatively, these results unveil a novel role of iCSCs in breast cancer metastasis as parental regulators of CXCR4(+) mCSCs, and highlight the therapeutic requisite of targeting iCSCs, but not CXCR4(+) mCSCs, to restrain breast cancer metastasis from the root by inhibiting the generation of mCSCs from iCSCs. Considering the pivotal role of iCSCs in tumor metastasis, the possibility of metastasis to be a 'stem cell phenomena' is suggested.	[Mukherjee, S.; Manna, A.; Bhattacharjee, P.; Mazumdar, M.; Saha, S.; Chakraborty, S.; Guha, D.; Adhikary, A.; Das, T.] Calcutta Improvement Trust Scheme VII M, Bose Inst, Div Mol Med, P-1-12, Kolkata, W Bengal, India; [Jana, D.; Sarkar, D. K.] SSKM Hosp, Dept Surg, Kolkata, India; [Gorain, M.; Kundu, G. C.] NCCS, Lab Tumor Biol Angiogenesis & Nanomed Res, NCCS Complex, Pune, Maharashtra, India; [Mukherjee, S. A.] Bankura Sammilani Med Coll, Dept Physiol, Kenduadihi, Bankura, India	Department of Science & Technology (India); Bose Institute; Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Das, T (corresponding author), P 1 12 CIT Scheme VII M, Bose Inst, Div Mol Med, Kolkata 700054, India.	tanya@jcbose.ac.in	Gorain, Mahadeo/AED-4445-2022; Bhattacharjee, Pushpak/AFV-4590-2022; Kundu, Gopal C./ABA-9897-2020; Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	Council of Scientific and Industrial Research (CSIR), Government of India; Department of Science and Technology (DST), Government of India; Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	We thank Gaurisankar Sa for his helpful discussions. Authors also acknowledge Uttam K. Ghosh and Ranjan Dutta for technical assistance. This work was supported by research grants from Council of Scientific and Industrial Research (CSIR), Department of Science and Technology (DST) and Department of Biotechnology (DBT), Government of India.	Ablett MP, 2014, ONCOTARGET, V5, P599, DOI 10.18632/oncotarget.1169; Adhikary A, 2014, J BIOL CHEM, V289, P25431, DOI 10.1074/jbc.M113.527267; Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chaffer CL, 2011, P NATL ACAD SCI USA, V108, P7950, DOI 10.1073/pnas.1102454108; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chimal-Ramirez GK, 2013, J ONCOL, V2013, DOI 10.1155/2013/835956; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Currier N, 2005, TOXICOL PATHOL, V33, P726, DOI 10.1080/01926230500352226; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fehm T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2349; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Hallab N, 2000, BIOMATERIALS, V21, P1301, DOI 10.1016/S0142-9612(99)00235-5; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jinushi M, 2012, AM J CANCER RES, V2, P529; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mukherjee D, 2013, AM J CANCER RES, V3, P46; Mukherjee S, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt506; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Park BH, 2013, J BIOL CHEM, V288, P28656, DOI 10.1074/jbc.M113.509505; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Rasanen K, 2012, CANCER DISCOV, V2, P775, DOI 10.1158/2159-8290.CD-12-0312; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; Tamamura H, 2003, FEBS LETT, V550, P79, DOI 10.1016/S0014-5793(03)00824-X; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang XF, 2013, CANCER EPIDEMIOL, V37, P60, DOI 10.1016/j.canep.2012.07.007; Wei W, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S6; Wiedswang G, 2004, CLIN CANCER RES, V10, P5342, DOI 10.1158/1078-0432.CCR-04-0245; Yao XH, 2008, J PATHOL, V215, P369, DOI 10.1002/path.2356	45	36	36	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4937	4948		10.1038/onc.2016.26	http://dx.doi.org/10.1038/onc.2016.26			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26923331				2022-12-26	WOS:000383330700011
J	Ha, SD; Reid, C; Meshkibaf, S; Kim, SO				Ha, Soon-Duck; Reid, Chantelle; Meshkibaf, Shahab; Kim, Sung Ouk			Inhibition of Interleukin 1 (IL-1) Expression by Anthrax Lethal Toxin (LeTx) Is Reversed by Histone Deacetylase 8 (HDAC8) Inhibition in Murine Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anthrax toxin; histone deacetylase (HDAC); interleukin 1 (IL-1); lipopolysaccharide (LPS); transcription enhancer	LONG NONCODING RNAS; NF-KAPPA-B; GENE-EXPRESSION; SIGNALING PATHWAYS; ENHANCER RNAS; PROINFLAMMATORY CYTOKINES; INFLAMMATORY RESPONSE; INHALATION ANTHRAX; PROTECTIVE ANTIGEN; ADAPTIVE IMMUNITY	Many pathogenic microbes often release toxins that subvert the host's immune responses to render the environment suitable for their survival and proliferation. LeTx is one of the toxins causing immune paralysis by cleaving and inactivating the mitogen-activated protein kinase (MAPK) kinases (MEKs). Here, we show that inhibition of the histone deacetylase 8 (HDAC8) by either the HDAC8-specific inhibitor PCI-34051 or small interference (si)RNAs rendered LeTx-exposed murine macrophages responsive to LPS in pro-IL-1 production. HDAC8 selectively targeted acetylated histone H3 lysine 27 (H3K27Ac), which is known to associate with active enhancers. LeTx induced HDAC8 expression, in part through inhibiting p38 MAPK, which resulted in a decrease of H3K27Ac levels. Inhibition of HDAC8 increased H3K27Ac levels and enhanced NF-B-mediated pro-IL-1 enhancer and messenger RNA production in LeTx-exposed macrophages. Collectively, this study demonstrates a novel role of HDAC8 in LeTx immunotoxicity and regulation of pro-IL-1 production likely through eRNAs. Targeting HDAC8 could be a strategy for enhancing immune responses in macrophages exposed to LeTx or other toxins that inhibit MAPKs.	Univ Western Ontario, Siebens Drake Res Inst, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada; Univ Western Ontario, Siebens Drake Res Inst, Infect Dis Res Grp, London, ON N6G 2V4, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6G 2V4, Canada.	skim283@uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020	Kim, Sung Ouk/0000-0002-0282-6661	Natural Sciences and Engineering Research of Canada [RGPIN 312482-2013]	Natural Sciences and Engineering Research of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research of Canada Grant RGPIN 312482-2013 (to S. O. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal A, 2003, NATURE, V424, P329, DOI 10.1038/nature01794; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ascenzi P, 2002, FEBS LETT, V531, P384, DOI 10.1016/S0014-5793(02)03609-8; Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; Baldari CT, 2006, TRENDS IMMUNOL, V27, P434, DOI 10.1016/j.it.2006.07.002; Bjerling P, 2002, MOL CELL BIOL, V22, P2170, DOI 10.1128/MCB.22.7.2170-2181.2002; Boyer AE, 2009, INFECT IMMUN, V77, P3432, DOI 10.1128/IAI.00346-09; Buggy JJ, 2000, BIOCHEM J, V350, P199, DOI 10.1042/0264-6021:3500199; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Coggeshall KM, 2013, J CELL MOL MED, V17, P914, DOI 10.1111/jcmm.12075; Cote CK, 2015, TOXINS, V7, P3167, DOI 10.3390/toxins7083167; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Durst KL, 2003, MOL CELL BIOL, V23, P607, DOI 10.1128/MCB.23.2.607-619.2003; Erwin JL, 2001, INFECT IMMUN, V69, P1175, DOI 10.1128/IAI.69.2.1175-1177.2001; Fortier A, 2005, TRENDS MICROBIOL, V13, P328, DOI 10.1016/j.tim.2005.05.007; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Fukao T, 2004, LANCET INFECT DIS, V4, P166, DOI 10.1016/S1473-3099(04)00940-5; Gao JX, 2009, BIOCHEM BIOPH RES CO, V379, P1, DOI 10.1016/j.bbrc.2008.11.135; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Ha SD, 2007, J BIOL CHEM, V282, P36230, DOI 10.1074/jbc.M707622200; Ha SD, 2007, J BIOL CHEM, V282, P26275, DOI 10.1074/jbc.M703668200; Ha SD, 2014, J IMMUNOL, V193, P1333, DOI 10.4049/jimmunol.1400420; Ha SD, 2012, MOL CELL BIOL, V32, P4846, DOI 10.1128/MCB.00494-12; Hamon MA, 2007, P NATL ACAD SCI USA, V104, P13467, DOI 10.1073/pnas.0702729104; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Heward JA, 2015, FEBS LETT, V589, P396, DOI 10.1016/j.febslet.2014.12.026; Hicks CW, 2011, TOXINS, V3, P1185, DOI 10.3390/toxins3091185; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Karolczak-Bayatti M, 2011, J BIOL CHEM, V286, P34346, DOI 10.1074/jbc.M111.278549; Kassam A, 2005, CELL MICROBIOL, V7, P281, DOI 10.1111/j.1462-5822.2004.00458.x; Kim TK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018622; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; KLIMPEL KR, 1994, MOL MICROBIOL, V13, P1093, DOI 10.1111/j.1365-2958.1994.tb00500.x; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; Lee H, 2006, MOL CELL BIOL, V26, P5259, DOI 10.1128/MCB.01971-05; Li S, 2015, J BIOL CHEM, V290, P2368, DOI 10.1074/jbc.M114.618454; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu TF, 2011, J BIOL CHEM, V286, P9856, DOI 10.1074/jbc.M110.196790; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; Murko C, 2010, INT J DEV BIOL, V54, P1527, DOI 10.1387/ijdb.092971cm; Murray PJ, 2012, NAT IMMUNOL, V13, P916, DOI 10.1038/ni.2391; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Nusinzon I, 2006, MOL CELL BIOL, V26, P3106, DOI 10.1128/MCB.26.8.3106-3113.2006; Olson DE, 2014, ACS CHEM BIOL, V9, P2210, DOI 10.1021/cb500492r; Orom UA, 2013, CELL, V154, P1190, DOI 10.1016/j.cell.2013.08.028; Park S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057138; Pedra JHF, 2007, J IMMUNOL, V179, P4783, DOI 10.4049/jimmunol.179.7.4783; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Raymond B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000359; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Saccani S, 2002, NAT IMMUNOL, V3, P69, DOI 10.1038/ni748; Saha A, 2013, BIOORGAN MED CHEM, V21, P4201, DOI 10.1016/j.bmc.2013.05.002; Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Scarpa M, 2012, INFLAMM BOWEL DIS, V18, P1982, DOI 10.1002/ibd.22934; Smith E, 2014, NAT STRUCT MOL BIOL, V21, P210, DOI 10.1038/nsmb.2784; Terra JK, 2010, J IMMUNOL, V184, P17, DOI 10.4049/jimmunol.0903114; Tonello F, 2003, J BIOL CHEM, V278, P40075, DOI 10.1074/jbc.M306466200; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Turk BE, 2007, BIOCHEM J, V402, P405, DOI 10.1042/BJ20061891; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Wang SA, 2014, BBA-MOL CELL RES, V1843, P1135, DOI 10.1016/j.bbamcr.2014.02.001; WARREN MK, 1985, J IMMUNOL, V134, P982; Wilson BJ, 2010, MOL ENDOCRINOL, V24, P1349, DOI 10.1210/me.2009-0441; Wolfson NA, 2013, BIOPOLYMERS, V99, P112, DOI 10.1002/bip.22135; Xu LX, 2008, J IMMUNOL, V180, P4139, DOI 10.4049/jimmunol.180.6.4139; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yasui T, 2011, J BONE MINER RES, V26, P2665, DOI 10.1002/jbmr.464; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhao BW, 2006, VIROLOGY, V352, P338, DOI 10.1016/j.virol.2006.04.036	89	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8745	8755		10.1074/jbc.M115.695809	http://dx.doi.org/10.1074/jbc.M115.695809			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912657	Green Published, hybrid			2022-12-26	WOS:000374773200036
J	Abou Rajab, Y; Leuschner, C; Barus, H; Tjoa, A; Hertel, D				Abou Rajab, Yasmin; Leuschner, Christoph; Barus, Henry; Tjoa, Aiyen; Hertel, Dietrich			Cacao Cultivation under Diverse Shade Tree Cover Allows High Carbon Storage and Sequestration without Yield Losses	PLOS ONE			English	Article							THEOBROMA-CACAO; BIODIVERSITY CONSERVATION; AGROFORESTRY SYSTEMS; ROOT BIOMASS; CENTRAL SULAWESI; COCOA; FOREST; DEFORESTATION; COFFEE; STOCKS	One of the main drivers of tropical forest loss is their conversion to oil palm, soy or cacao plantations with low biodiversity and greatly reduced carbon storage. Southeast Asian cacao plantations are often established under shade tree cover, but are later converted to non-shaded monocultures to avoid resource competition. We compared three co-occurring cacao cultivation systems (3 replicate stands each) with different shade intensity (non-shaded monoculture, cacao with the legume Gliricidia sepium shade trees, and cacao with several shade tree species) in Sulawesi (Indonesia) with respect to above-and belowground biomass and productivity, and cacao bean yield. Total biomass C stocks (aboveand belowground) increased fivefold from the monoculture to the multi-shade tree system (from 11 to 57 Mg ha(-1)), total net primary production rose twofold (from 9 to 18 Mg C ha(-1) yr(-1)). This increase was associated with a 6fold increase in aboveground biomass, but only a 3.5fold increase in root biomass, indicating a clear shift in C allocation to aboveground tree organs with increasing shade for both cacao and shade trees. Despite a canopy cover increase from 50 to 93%, cacao bean yield remained invariant across the systems (variation: 1.1-1.2 Mg C ha(-1) yr(-1)). The monocultures had a twice as rapid leaf turnover suggesting that shading reduces the exposure of cacao to atmospheric drought, probably resulting in greater leaf longevity. Thus, contrary to general belief, cacao bean yield does not necessarily decrease under shading which seems to reduce physical stress. If planned properly, cacao plantations under a shade tree cover allow combining high yield with benefits for carbon sequestration and storage, production system stability under stress, and higher levels of animal and plant diversity.	[Abou Rajab, Yasmin; Leuschner, Christoph; Hertel, Dietrich] Univ Gottingen, Plant Ecol & Ecosyst Res, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Barus, Henry; Tjoa, Aiyen] Tadulako Univ, Fac Agr Sci, Dept Agrotechnol, Palu, Sulawesi Tengah, Indonesia	University of Gottingen; Universitas Tadulako	Abou Rajab, Y (corresponding author), Univ Gottingen, Plant Ecol & Ecosyst Res, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany.	abourajab@yahoo.de		Barus, Henry/0000-0003-2351-2132	German Research Foundation (DFG); collaborative research center CRC990	German Research Foundation (DFG)(German Research Foundation (DFG)); collaborative research center CRC990	This study was financed by the German Research Foundation (DFG) in the framework of the interdisciplinary German-Indonesian research project ELUC ('Environmental and land-use change in Sulawesi, Indonesia') and the collaborative research center CRC990 'Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)', subproject B04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; BALASIMHA D, 1991, AGR FOREST METEOROL, V55, P15, DOI 10.1016/0168-1923(91)90019-M; Baligar VC, 2008, PHOTOSYNTHETICA, V46, P216, DOI 10.1007/s11099-008-0035-7; BEER J, 1987, AGROFOREST SYST, V5, P3, DOI 10.1007/BF00046410; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; BEER J, 1990, AGROFOREST SYST, V12, P229, DOI 10.1007/BF00137286; Belsky JM, 2003, AGR HUM VALUES, V20, P277, DOI 10.1023/A:1026100714149; Bisseleua DHB, 2009, CONSERV BIOL, V23, P1176, DOI 10.1111/j.1523-1739.2009.01220.x; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Bos MM, 2007, AGR ECOSYST ENVIRON, V120, P201, DOI 10.1016/j.agee.2006.09.004; Bowers J.H., 2001, PLANT HLTH PROG, V2, P12, DOI DOI 10.1094/PHP-2001-0709-01-RV; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Duguma B, 2001, AGROFOREST SYST, V51, P177, DOI 10.1023/A:1010747224249; Ewel JJ, 2008, P NATL ACAD SCI USA, V105, P18836, DOI 10.1073/pnas.0807216105; Frimpong Eric A., 2011, Journal of Pollination Ecology, V5, P74; Fuentes-Talavera FJ, 2011, MADERA BOSQUES, V17, P37; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Groeneveld JH, 2010, PERSPECT PLANT ECOL, V12, P183, DOI 10.1016/j.ppees.2010.02.005; Hairiah K, 2001, ASB LECT NOTE, P32; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hertel D, 2002, PLANT SOIL, V239, P237, DOI 10.1023/A:1015030320845; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Isaac ME, 2007, PLANT SOIL, V298, P243, DOI 10.1007/s11104-007-9362-x; Johns ND, 1999, ENVIRON MANAGE, V23, P31, DOI 10.1007/s002679900166; Kessler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047192; Klein AM, 2002, BIODIVERS CONSERV, V11, P683, DOI 10.1023/A:1015548426672; Kohler M, 2014, AGROFOREST SYST, V88, P63, DOI 10.1007/s10457-013-9656-3; Kohler M, 2009, ECOHYDROLOGY, V2, P520, DOI 10.1002/eco.67; Kotowska MM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00191; Lehmann J, 2003, PLANT SOIL, V255, P319, DOI 10.1023/A:1026195527076; Leuschner C, 2001, OECOLOGIA, V126, P276, DOI 10.1007/s004420000507; Leuschner C, 2013, AGROFOREST SYST, V87, P1173, DOI 10.1007/s10457-013-9628-7; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Miyaji KI, 1997, NEW PHYTOL, V135, P445, DOI 10.1046/j.1469-8137.1997.00667.x; Montagnini F, 2004, AGROFOREST SYST, V61-2, P281, DOI 10.1023/B:AGFO.0000029005.92691.79; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; Nair PKR, 2010, ADV AGRONOMY, P237; Obiri BD, 2007, AGROFOREST SYST, V71, P139, DOI 10.1007/s10457-007-9058-5; ONG CK, 1991, FOREST ECOL MANAG, V45, P45, DOI 10.1016/0378-1127(91)90205-A; Ong CK, 2004, ECOLOGICAL INTERACTI, P1; Perfecto I, 2007, ENVIRON SCI ENG, P227; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; PERSSON H, 1980, Acta Phytogeographica Suecica, V68, P101; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Ruf F., 1995, Cocoa cycles: the economics of cocoa supply., P339; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saj S, 2013, AGROFOREST SYST, V87, P1309, DOI 10.1007/s10457-013-9639-4; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Schroth G, 2007, BIODIVERS CONSERV, V16, P2237, DOI 10.1007/s10531-007-9195-1; Schwendenmann L, 2010, GLOBAL CHANGE BIOL, V16, P1515, DOI 10.1111/j.1365-2486.2009.02034.x; Siebert SF, 2002, BIODIVERS CONSERV, V11, P1889, DOI 10.1023/A:1020804611740; Smiley GL, 2010, AGROFOREST SYST, V78, P97, DOI 10.1007/s10457-009-9259-1; Somarriba E, 2013, AGR ECOSYST ENVIRON, V173, P46, DOI 10.1016/j.agee.2013.04.013; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; van Noordwijk M, 2002, ECOL MODEL, V149, P41, DOI 10.1016/S0304-3800(01)00513-0; VANPRAAG HJ, 1988, PLANT SOIL, V105, P87, DOI 10.1007/BF02371146; Vogt KA, 1998, DEV PLANT SOIL SCI, V82, P687; Wade ASI, 2010, AGR ECOSYST ENVIRON, V138, P324, DOI 10.1016/j.agee.2010.06.007; Wielgoss A, 2012, J APPL ECOL, V49, P465, DOI 10.1111/j.1365-2664.2012.02122.x; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; YOUNG AM, 1982, J APPL ECOL, V19, P47, DOI 10.2307/2402990	76	48	48	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149949	10.1371/journal.pone.0149949	http://dx.doi.org/10.1371/journal.pone.0149949			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927428	Green Published, gold, Green Submitted			2022-12-26	WOS:000371424200017
J	Alldred, M; Baines, SB; Findlay, S				Alldred, Mary; Baines, Stephen B.; Findlay, Stuart			Effects of Invasive-Plant Management on Nitrogen-Removal Services in Freshwater Tidal Marshes	PLOS ONE			English	Article							PHRAGMITES-AUSTRALIS; ECOSYSTEM SERVICES; COMMON REED; WETLANDS; DENITRIFICATION; CONSEQUENCES; BIODIVERSITY; IMPACT	Establishing relationships between biodiversity and ecosystem function is an ongoing endeavor in contemporary ecosystem and community ecology, with important practical implications for conservation and the maintenance of ecosystem services. Removal of invasive plant species to conserve native diversity is a common management objective in many ecosystems, including wetlands. However, substantial changes in plant community composition have the potential to alter sediment characteristics and ecosystem services, including permanent removal of nitrogen from these systems via microbial denitrification. A balanced assessment of costs associated with keeping and removing invasive plants is needed to manage simultaneously for biodiversity and pollution targets. We monitored small-scale removals of Phragmites australis over four years to determine their effects on potential denitrification rates relative to three untreated Phragmites sites and adjacent sites dominated by native Typha angustifolia. Sediment ammonium increased following the removal of vegetation from treated sites, likely as a result of decreases in both plant uptake and nitrification. Denitrification potentials were lower in removal sites relative to untreated Phragmites sites, a pattern that persisted at least two years following removal as native plant species began to re-colonize treated sites. These results suggest the potential for a trade-off between invasive-plant management and nitrogen-removal services. A balanced assessment of costs associated with keeping versus removing invasive plants is needed to adequately manage simultaneously for biodiversity and pollution targets.	[Alldred, Mary; Baines, Stephen B.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Findlay, Stuart] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Alldred, Mary] CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cary Institute of Ecosystem Studies; City University of New York (CUNY) System; Baruch College (CUNY)	Alldred, M (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.; Alldred, M (corresponding author), CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA.	malldred1@gmail.com			ENY Chapter of the Nature Conservancy; Hudson River Foundation; New York Sea Grant [R/CMC-10]; Robert R. Sokal Award for Research in Statistical Biology; Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University; Direct For Biological Sciences [1119739] Funding Source: National Science Foundation	ENY Chapter of the Nature Conservancy; Hudson River Foundation; New York Sea Grant; Robert R. Sokal Award for Research in Statistical Biology; Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the ENY Chapter of the Nature Conservancy (www.nature.org), a Tibor T. Polgar Fellowship and Graduate Research Fellowship from the Hudson River Foundation (www.hudsonriver.org), New York Sea Grant (R/CMC-10, seagrant.sunysb.edu), a Robert R. Sokal Award for Research in Statistical Biology, and a Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University (life.bio.sunysb.edu/ee). The ENY Chapter of the Nature Conservancy selected sites for initial invasive-plant management. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldred M, 2015, ECOLOGICAL APPL; Alldred M, 2011, INVASIVE SPECIES REM; [Anonymous], 2002, METHODS DETERMINATIO; [Anonymous], 1989, JMP R JMP R VERS 11; ARMSTRONG J, 1990, NEW PHYTOL, V114, P121, DOI 10.1111/j.1469-8137.1990.tb00382.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Corp P-E, 1991, 2400 SER 2 CHNS O AN; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Fell PE, 2003, ESTUARIES, V26, P534, DOI 10.1007/BF02823729; Findlay SEG, 2002, AQUAT SCI, V64, P107, DOI 10.1007/s00027-002-8059-8; Findlay S, 2003, WETL ECOL MANAG, V11, P157, DOI 10.1023/A:1024255827418; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Hazelton ELG, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu001; HESSLEIN RH, 1976, LIMNOL OCEANOGR, V21, P912, DOI 10.4319/lo.1976.21.6.0912; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Keller Barbara E. M., 2000, Wetlands Ecology and Management, V8, P391, DOI 10.1023/A:1026505817409; Kettenring KM, 2011, J APPL ECOL, V48, P970, DOI 10.1111/j.1365-2664.2011.01979.x; Kettenring KM, 2012, AOB PLANTS, V2012, P1, DOI DOI 10.1093/A0BPLA/PLS040; Kiviat E, 2006, 01200A HUDS RIV FDN; Kiviat E, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt008; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lalli C.M., 1984, MANUAL CHEM BIOL MET, P7; Lombard KB, 2012, NORTHEAST NAT, V19, P181, DOI 10.1656/045.019.s614; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; Meyerson L. A., 1999, Biological Invasions, V1, P129, DOI 10.1023/A:1010005724468; Meyerson LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P827; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Orson R. A., 1999, Biological Invasions, V1, P149, DOI 10.1023/A:1010047731369; Otto S, 1999, J ENVIRON QUAL, V28, P1252, DOI 10.2134/jeq1999.00472425002800040028x; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Simberloff D, 2015, F1000PRIME REPORTS, V7, DOI 10.12703/P7-47; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Solomon KR, 2003, J TOXICOL ENV HEAL B, V6, P289, DOI 10.1080/10937400306468; Stein C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0075396; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Truitt AM, 2015, ENVIRON MANAGE, V55, P1217, DOI 10.1007/s00267-015-0465-5; Wainger LA, 2010, ECOL ECON, V69, P978, DOI 10.1016/j.ecolecon.2009.12.011; Wickham H., 2015, GGPLOT2 ELEGANT GRAP; Windham L, 2003, ESTUARIES, V26, P452, DOI 10.1007/BF02823722; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005; Windham L, 2001, MAR POLLUT BULL, V42, P811, DOI 10.1016/S0025-326X(00)00224-1; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zimmerman C, 2009, HUDSON RIVER INVASIV; Zimmerman C, 2013, TRAJECTORY VEGETATIO	55	20	20	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149813	10.1371/journal.pone.0149813	http://dx.doi.org/10.1371/journal.pone.0149813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914688	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700029
J	He, YY; Yu, SJ; Hu, JW; Cui, Y; Liu, PG				He, Yanyu; Yu, Sijiu; Hu, Junwei; Cui, Yan; Liu, Penggang			Changes in the Anatomic and Microscopic Structure and the Expression of HIF-1 alpha and VEGF of the Yak Heart with Aging and Hypoxia	PLOS ONE			English	Article							MAMMALIAN CARDIAC MUSCLE; HUMAN CORONARY-ARTERIES; ONE-LUNG VENTILATION; POLARIZATION MICROSCOPY; AREA-COMPOSITA; HIGH ALTITUDES; COLLAGEN; FAILURE; CELLS; MYOCARDIUM	The study aimed to identify the changes of anatomic and microscopic structure and the expression and localization of hypoxia-inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF) in the myocardium and coronary artery of the yak heart adapted to chronic hypoxia with aging. Thirty-two yaks (1 day, 6 months, 1 year, 2 years, and 5 year old) were included, and immunoelectronmicroscopy, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA) were used. Right ventricular hypertrophy was not present in yaks with aging. There was no intima thickening phenomenon in the coronary artery. The ultrastructure of myofibrils, mitochondria, and collagen fibers and the diameter and quantity of collagen changed significantly with aging. The enzymatic activity of complexes I, II, and V increased with age. Immunogold labeling showed the localization of HIF-1 alpha protein in the cytoplasm and nuclei of endothelial cells and cytoplasm of cardiac muscle cells, and VEGF protein in the nuclei and perinuclei areas of smooth muscle cells of coronary artery, and in the cytoplasm and nuclei of endothelial cells. ELISA results showed that HIF-1 alpha secretion significantly increased in the myocardium and coronary artery from an age of 1 day to 2 years of yaks and decreased in old yaks. However, VEGF protein always increased with aging. The findings of this study suggest that 6 months is a key age of yak before which there are some adaptive changes to deal with low-oxygen environment, and there is a maturation of the yak heart from the age of 6 months to 2 years.	[He, Yanyu; Yu, Sijiu; Hu, Junwei; Cui, Yan; Liu, Penggang] Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China	Gansu Agricultural University	Cui, Y (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China.	Cuiyan369@sina.com			Nature Science Foundation of China [30960270, 31360594]; Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University	This study was supported by Nature Science Foundation of China (grant No. 30960270, 31360594) and by the Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER AF, 1959, AM J VET RES, V20, P680; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; BROOK WH, 1983, J ANAT, V137, P729; Chantler PD, 2006, HEART, V92, P686, DOI 10.1136/hrt.2005.063578; Collier P, 2012, J MOL CELL CARDIOL, V52, P148, DOI 10.1016/j.yjmcc.2011.10.002; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Debessa CRG, 2001, MECH AGEING DEV, V122, P1049; Duan DY, 2012, ANAT REC, V295, P2045, DOI 10.1002/ar.22591; EGHBALI M, 1989, CARDIOVASC RES, V23, P723, DOI 10.1093/cvr/23.8.723; Eleftheriadis SG, 2010, ANTICANCER RES, V30, P1143; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; HE J-f, 2008, CHINESE VET SCI, V12; He YY, 2010, ANAT REC, V293, P1519, DOI 10.1002/ar.21201; HEATH D, 1984, CARDIOVASC RES, V18, P133, DOI 10.1093/cvr/18.3.133; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Li LY, 1966, ANATOMY DOMESTIC ANI; Lin F, 2015, LIFE SCI, V124, P50, DOI 10.1016/j.lfs.2014.12.020; Salazar BL, 2006, REV ESP CARDIOL, V59, P1047, DOI 10.1157/13093982; Lubkemeier I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0348-y; MacDonald AA, 2007, J ANAT, V211, P64, DOI 10.1111/j.1469-7580.2007.00743.x; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; MEDUGORAC I, 1980, CARDIOVASC RES, V14, P551, DOI 10.1093/cvr/14.9.551; MOORE DH, 1957, J BIOPHYS BIOCHEM CY, V3, P261, DOI 10.1083/jcb.3.2.261; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Pieperhoff S, 2008, EUR J CELL BIOL, V87, P413, DOI 10.1016/j.ejcb.2008.02.005; Poynter JA, 2011, SURGERY, V150, P278, DOI 10.1016/j.surg.2011.06.006; RECAVARREN S, 1964, BRIT HEART J, V26, P806; Sakabe Masahide, 2006, Acta Anatomica Nipponica, V81, P117; Shao SX, 2001, PROGR ANATOMICAL SCI, V1, P30; Shimada T, 1994, MED ELECT MICROSCOPY, V27, P227; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SIMS FH, 1990, CORONARY ARTERY DIS, V1, P205, DOI 10.1097/00019501-199003000-00009; SIMS FH, 1989, AM HEART J, V118, P32, DOI 10.1016/0002-8703(89)90068-9; STENGER RJ, 1961, J BIOPHYS BIOCHEM CY, V9, P325, DOI 10.1083/jcb.9.2.325; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Tipoe GL, 2003, RESP PHYSIOL NEUROBI, V138, P143, DOI 10.1016/S1569-9048(03)00188-5; Serrano FV, 2007, EUR HEART J, V28, P653; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; VERZAR F, 1964, GERONTOLOGY, V9, P209, DOI 10.1159/000211257; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; [周金星 Zhou Jinxing], 2015, [中国兽医学报, Chinese Journal of Veterinary Science], V35, P1840; Zhou JX, 2013, ANAT REC, V296, P1775, DOI 10.1002/ar.22790	48	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149947	10.1371/journal.pone.0149947	http://dx.doi.org/10.1371/journal.pone.0149947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914488	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700040
J	Devarajan, N; Laffite, A; Mulaji, CK; Otamonga, JP; Mpiana, PT; Mubedi, JI; Prabakar, K; Ibelings, BW; Pote, J				Devarajan, Naresh; Laffite, Amandine; Mulaji, Crispin Kyela; Otamonga, Jean-Paul; Mpiana, Pius Tshimankinda; Mubedi, Josue Ilunga; Prabakar, Kandasamy; Ibelings, Bastiaan Willem; Pote, John			Occurrence of Antibiotic Resistance Genes and Bacterial Markers in a Tropical River Receiving Hospital and Urban Wastewaters	PLOS ONE			English	Article							LAKE GENEVA; WASTE-WATER; CLASS-1 INTEGRONS; BETA-LACTAMASE; TOXIC METALS; SEDIMENTS; ACCUMULATION; CAUVERY; DISSEMINATION; EFFLUENTS	The occurrence of emerging biological contaminants including antibiotic resistance genes (ARGs) and Faecal Indicator Bacteria (FIB) is still little investigated in developing countries under tropical conditions. In this study, the total bacterial load, the abundance of FIB (E. coli and Enterococcus spp. (ENT)), Pseudomonas spp. and ARGs (bla(TEM), bla(CTX-M), bla(SHV), bla(NDM) and aadA) were quantified using quantitative PCR in the total DNA extracted from the sediments recovered from hospital outlet pipes (HOP) and the Cauvery River Basin (CRB), Tiruchirappalli, Tamil Nadu, India. The abundance of bacterial marker genes were 120, 104 and 89 fold higher for the E. coli, Enterococcus spp. and Pseudomonas spp., respectively at HOP when compared with CRB. The ARGs aadA and blaTEM were most frequently detected in higher concentration than other ARGs at all the sampling sites. The ARGs blaSHV and blaNDM were identified in CRB sediments contaminated by hospital and urban wastewaters. The ARGs abundance strongly correlated (r >= 0.36, p < 0.05, n = 45) with total bacterial load and E. coli in the sediments, indicating a common origin and extant source of contamination. Tropical aquatic ecosystems receiving wastewaters can act as reservoir of ARGs, which could potentially be transferred to susceptible bacterial pathogens at these sites.	[Devarajan, Naresh; Laffite, Amandine; Ibelings, Bastiaan Willem; Pote, John] Univ Geneva, Inst FA Forel, Geneva, Switzerland; [Devarajan, Naresh; Laffite, Amandine; Ibelings, Bastiaan Willem; Pote, John] Univ Geneva, Inst Environm Sci, Geneva, Switzerland; [Mulaji, Crispin Kyela; Mpiana, Pius Tshimankinda; Pote, John] Univ Kinshasa UNIKIN, Fac Sci, Dept Chem, Kinshasa XI, DEM REP CONGO; [Otamonga, Jean-Paul; Mubedi, Josue Ilunga; Pote, John] UPN, Croisement Route Matadi & Ave Liberat, Kinshasa, DEM REP CONGO; [Prabakar, Kandasamy] Jamal Mohamed Coll, Postgrad & Res Dept Zool, Tiruchirappalli 620020, Tamil Nadu, India	University of Geneva; University of Geneva; Universite de Kinshasa; Jamal Mohamed College	Pote, J (corresponding author), Univ Geneva, Inst FA Forel, Geneva, Switzerland.; Pote, J (corresponding author), Univ Geneva, Inst Environm Sci, Geneva, Switzerland.; Pote, J (corresponding author), Univ Kinshasa UNIKIN, Fac Sci, Dept Chem, Kinshasa XI, DEM REP CONGO.; Pote, J (corresponding author), UPN, Croisement Route Matadi & Ave Liberat, Kinshasa, DEM REP CONGO.	john.pote@unige.ch	Devarajan, Naresh/L-5718-2019; Ha, Dat Thinh/D-4995-2015; Devarajan, Naresh/W-4594-2018	Devarajan, Naresh/0000-0002-2823-3952; Ha, Dat Thinh/0000-0003-4260-4876; Devarajan, Naresh/0000-0002-2823-3952; prabakar, kandasamy/0000-0003-4498-2328; Mulaji, Crispin/0000-0002-9406-3277; PRABAKAR, KANDASAMY/0000-0002-7055-7299	Swiss National Science Foundation [31003A_150163/1]; Ernst and Lucie Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst and Lucie Schmidheiny Foundation	The authors are grateful to financial sources: the Swiss National Science Foundation (grant no. 31003A_150163/1); Bourse Augustin Lombard 2013 for field sampling. Naresh Devarajan is a Ph.D. student supported by Ernst and Lucie Schmidheiny Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahammad ZS, 2014, ENVIRON SCI TECHNOL, V48, P3014, DOI 10.1021/es405348h; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Berglund B, 2015, ENVIRON TOXICOL CHEM, V34, P192, DOI 10.1002/etc.2784; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; CCME, 1999, 98E CCME EPC; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chen BW, 2013, WATER RES, V47, P2811, DOI 10.1016/j.watres.2013.02.042; Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8; Dekov VM, 1998, SCI TOTAL ENVIRON, V212, P89, DOI 10.1016/S0048-9697(97)00132-0; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Devarajan N, 2015, ENVIRON SCI POLLUT R, V22, P12941, DOI 10.1007/s11356-015-4457-z; Devarajan N, 2015, ENVIRON SCI TECHNOL, V49, P6528, DOI 10.1021/acs.est.5b01031; Dhanakumar S, 2015, ECOTOX ENVIRON SAFE, V113, P145, DOI 10.1016/j.ecoenv.2014.11.032; GELDREICH EE, 1976, CRIT REV ENV CONTR, V6, P349, DOI 10.1080/10643387609381645; Haller L, 2009, WATER AIR SOIL POLL, V203, P217, DOI 10.1007/s11270-009-0005-0; Haller L, 2009, ECOL INDIC, V9, P540, DOI 10.1016/j.ecolind.2008.08.001; Keil RG, 2014, TREATISE GEOCHEMISTR, P337, DOI DOI 10.1016/B978-0-08-095975-7.01024-X; Khan GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062712; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Laht M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103705; Mubedi JI, 2013, CHEMOSPHERE, V93, P1070, DOI 10.1016/j.chemosphere.2013.05.080; Mwanamoki PM, 2014, ENVIRON MONIT ASSESS, V186, P6821, DOI 10.1007/s10661-014-3891-6; Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223; Ouattara NK, 2011, ENVIRON MONIT ASSESS, V183, P243, DOI 10.1007/s10661-011-1918-9; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pote J, 2008, BIORESOURCE TECHNOL, V99, P7122, DOI 10.1016/j.biortech.2007.12.075; Pote J, 2007, ECOTOX ENVIRON SAFE, V68, P293, DOI 10.1016/j.ecoenv.2006.11.004; Pote J, 2010, ECOL INDIC, V10, P234, DOI 10.1016/j.ecolind.2009.05.002; Poza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044105; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Quinteira S, 2005, ANTIMICROB AGENTS CH, V49, P2140, DOI 10.1128/AAC.49.5.2140-2141.2005; Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Skariyachan S, 2015, ENV MONITORING ASSES, V187; Spindler A, 2012, ANTON LEEUW INT J G, V102, P73, DOI 10.1007/s10482-012-9714-2; Srinivasan V, 2008, MICROB ECOL, V55, P184, DOI 10.1007/s00248-007-9266-6; Srinivasan V, 2007, INT J ANTIMICROB AG, V29, P254, DOI 10.1016/j.ijantimicag.2006.08.040; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f; Thevenon F, 2012, CHEMOSPHERE, V86, P468, DOI 10.1016/j.chemosphere.2011.09.048; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization (WHO), ANTIMICROBIAL RESIST; Zhang ST, 2013, J ENVIRON BIOL, V34, P345; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	50	71	75	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149211	10.1371/journal.pone.0149211	http://dx.doi.org/10.1371/journal.pone.0149211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910062	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700026
J	Ihara, Y; Tomonoh, Y; Deshimaru, M; Zhang, B; Uchida, T; Ishii, A; Hirose, S				Ihara, Yukiko; Tomonoh, Yuko; Deshimaru, Masanobu; Zhang, Bo; Uchida, Taku; Ishii, Atsushi; Hirose, Shinichi			Retigabine, a K(v)7.2/K(v)7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations	PLOS ONE			English	Article							FAMILIAL NEONATAL CONVULSIONS; KCNQ2/KCNQ3 K+ CHANNELS; ANTICONVULSANT RETIGABINE; EPILEPTIC ENCEPHALOPATHY; POTASSIUM CHANNELS; NEURONAL EXCITABILITY; RAT HIPPOCAMPUS; MOUSE MODELS; EZOGABINE; CURRENTS	The hetero-tetrameric voltage-gated potassium channel K(v)7.2/K(v)7.3, which is encoded by KCNQ2 and KCNQ3, plays an important role in limiting network excitability in the neonatal brain. K(v)7.2/K(v)7.3 dysfunction resulting from KCNQ2 mutations predominantly causes self-limited or benign epilepsy in neonates, but also causes early onset epileptic encephalopathy. Retigabine (RTG), a K(v)7.2/K(v)7.3-channel opener, seems to be a rational antiepileptic drug for epilepsies caused by KCNQ2 mutations. We therefore evaluated the effects of RTG on seizures in two strains of knock-in mice harboring different Kcnq2 mutations, in comparison to the effects of phenobarbital (PB), which is the first-line antiepileptic drug for seizures in neonates. The subjects were heterozygous knock-in mice (Kcnq2(Y284C/+) and Kcnq2(A306T/+)) bearing the Y284C or A306T Kcnq2 mutation, respectively, and their wildtype (WT) littermates, at 63-100 days of age. Seizures induced by intraperitoneal injection of kainic acid (KA, 12mg/kg) were recorded using a video-electroencephalography (EEG) monitoring system. Effects of RTG on KA-induced seizures of both strains of knock-in mice were assessed using seizure scores from a modified Racine's scale and compared with those of PB. The number and total duration of spike bursts on EEG and behaviors monitored by video recording were also used to evaluate the effects of RTG and PB. Both Kcnq2(Y284C/+) and Kcnq2(A306T/+) mice showed significantly more KA-induced seizures than WT mice. RTG significantly attenuated KA-induced seizure activities in both Kcnq2(Y284C/+) and Kcnq2(A306T/+) mice, and more markedly than PB. This is the first reported evidence of RTG ameliorating KA-induced seizures in knock-in mice bearing mutations of Kcnq2, with more marked effects than those observed with PB. RTG or other K(v)7.2-channel openers may be considered as first-line antiepileptic treatments for epilepsies resulting from KCNQ2 mutations.	[Ihara, Yukiko; Tomonoh, Yuko; Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Deshimaru, Masanobu] Fukuoka Univ, Fac Sci, Dept Chem, Fukuoka 81401, Japan; [Zhang, Bo] Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 81401, Japan; [Uchida, Taku; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Fukuoka University; Fukuoka University	Hirose, S (corresponding author), Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan.; Hirose, S (corresponding author), Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp		HIROSE, Shinichi/0000-0001-6796-3790	Japan Society for the Promotion of Science Foundation [23791201, 24249060, 25670481]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor, and Welfare, an Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [H26-Nanji-Ippan-051, 049, 24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Kobayashi Magobei Foundation; Kurozumi medical foundation; Japan Epilepsy Research Foundation Grant; Kaibara Medical Foundation; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN	Japan Society for the Promotion of Science Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, an Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Kobayashi Magobei Foundation; Kurozumi medical foundation(Kurozumi Medical Foundation); Japan Epilepsy Research Foundation Grant; Kaibara Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aids for Young Scientists (B) (23791201; A. I, and 26870781; T.U.), a Grant-in-Aid for Scientific Research (A) (24249060; S.H.), a Grant-in-Aid for Challenging Exploratory Research (25670481; S.H.) from the Japan Society for the Promotion of Science Foundation, and Grants for Scientific Research on Innovative Areas (221S0002 and 25129708; A. I and S.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (H26-Nanji-Ippan-051 and 049; S.H.) from the Ministry of Health, Labor, and Welfare, an Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.), the Takeda Scientific Foundation (S.H.), the Kobayashi Magobei Foundation (A.I.), the Kurozumi medical foundation (A.I.), the Japan Epilepsy Research Foundation Grant (T.U. and A.I.) and the Kaibara Medical Foundation (T.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Grant-in-Aid for Young Scientists (B) (23791201; A. I, and 26870781; T.U.), a Grant-in-Aid for Scientific Research (A) (24249060; S.H.), a Grant-in-Aid for Challenging Exploratory Research (25670481; S.H.) from the Japan Society for the Promotion of Science Foundation, and Grants for Scientific Research on Innovative Areas (221S0002 and 25129708; A. I and S.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (H26-Nanji-Ippan-051 and 049; S.H.) from the Ministry of Health, Labor, and Welfare, an Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.), the Takeda Scientific Foundation (S.H.), the Kobayashi Magobei Foundation (A. I.), the Kurozumi medical foundation (A.I.), the Japan Epilepsy Research Foundation Grant (T.U. and A.I.) and the Kaibara Medical Foundation (T.U.).	Abidi A, 2015, NEUROBIOL DIS, V80, P80, DOI 10.1016/j.nbd.2015.04.017; [Anonymous], 2013, Prescrire Int, V22, P269; [Anonymous], 2015, COUNTREG PROC SAS ST; [Anonymous], 2015, LOGISTIC PROC SAS ST; Bassi MT, 2005, NEUROGENETICS, V6, P185, DOI 10.1007/s10048-005-0012-2; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Fukuda A, 2005, NAT MED, V11, P1153, DOI 10.1038/nm1105-1153; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Harris JA, 2011, THER ADV CHRONIC DIS, V2, P371, DOI 10.1177/2040622311421542; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Hirose S, 2014, PROG BRAIN RES, V213, P55, DOI 10.1016/B978-0-444-63326-2.00003-X; Ishii A, 2012, EPILEPSY RES, V102, P122, DOI 10.1016/j.eplepsyres.2012.07.011; Ishii A, 2009, BRAIN DEV-JPN, V31, P27, DOI 10.1016/j.braindev.2008.05.010; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalappa BI, 2015, J NEUROSCI, V35, P8829, DOI 10.1523/JNEUROSCI.5176-14.2015; Kanaumi T, 2008, BRAIN DEV-JPN, V30, P362, DOI 10.1016/j.braindev.2007.11.003; Kaneko S, 2002, EPILEPSIA, V43, P16, DOI 10.1046/j.1528-1157.43.s.9.5.x; Kapur J, 1999, MOL PHARMACOL, V55, P444; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; Kurahashi H, 2009, NEUROLOGY, V73, P1214, DOI 10.1212/WNL.0b013e3181bc0158; Kurahashi H., 1993, GENEREVIEWS R; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Maljevic S, 2011, HUM MUTAT, V32, pE2283, DOI 10.1002/humu.21554; Milh M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-80; Morel JG, 2012, OEVERDISPERSION MODE; Nardou R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00016; Okada M, 2003, EPILEPSY RES, V53, P81, DOI 10.1016/S0920-1211(02)00249-8; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Otto JF, 2009, EPILEPSIA, V50, P1752, DOI 10.1111/j.1528-1167.2009.02100.x; Otto JE, 2004, EPILEPSIA, V45, P1009, DOI 10.1111/j.0013-9580.2004.65703.x; Otto JF, 2006, J NEUROSCI, V26, P2053, DOI 10.1523/JNEUROSCI.1575-05.2006; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Raol YH, 2009, ANN NEUROL, V65, P326, DOI 10.1002/ana.21593; Robbins J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071809; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shkolnik TG, 2014, JAMA DERMATOL, V150, P984, DOI 10.1001/jamadermatol.2013.8895; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; Stokes M.E., 2012, CATEGORICAL DATA ANA; Swann J, 1997, EPILEPSY COMPREHENSI, P467; Talos DM, 2006, J COMP NEUROL, V497, P61, DOI 10.1002/cne.20978; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tomonoh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088549; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118; Zhu G, 2000, NEUROSCI LETT, V294, P53, DOI 10.1016/S0304-3940(00)01522-6	74	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150095	10.1371/journal.pone.0150095	http://dx.doi.org/10.1371/journal.pone.0150095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910900	gold, Green Published			2022-12-26	WOS:000371164700066
J	Sun, LH; Perakyla, J; Kovalainen, A; Ogawa, KH; Karhunen, PJ; Hartikainen, KM				Sun, Lihua; Perakyla, Jari; Kovalainen, Anselmi; Ogawa, Keith H.; Karhunen, Pekka J.; Hartikainen, Kaisa M.			Human Brain Reacts to Transcranial Extraocular Light	PLOS ONE			English	Article							STIMULI COMPETE; BRIGHT LIGHT; ATTENTION; TISSUE; PHOTORECEPTORS; P300; ENCEPHALOPSIN; PERFORMANCE; RESPONSES; SYMPTOMS	Transcranial extraocular light affects the brains of birds and modulates their seasonal changes in physiology and behavior. However, whether the human brain is sensitive to extraocular light is unknown. To test whether extraocular light has any effect on human brain functioning, we measured brain electrophysiology of 18 young healthy subjects using event-related potentials while they performed a visual attention task embedded with emotional distractors. Extraocular light delivered via ear canals abolished normal emotional modulation of attention related brain responses. With no extraocular light delivered, emotional distractors reduced centro-parietal P300 amplitude compared to neutral distractors. This phenomenon disappeared with extraocular light delivery. Extraocular light delivered through the ear canals was shown to penetrate at the base of the scull of a cadaver. Thus, we have shown that extraocular light impacts human brain functioning calling for further research on the mechanisms of action of light on the human brain.	[Sun, Lihua; Perakyla, Jari; Kovalainen, Anselmi; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland; [Ogawa, Keith H.] St Marys Coll Calif, John Magaddino Neurosci Lab, Moraga, CA USA; [Karhunen, Pekka J.] Tampere Univ, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.] Fimlab Labs, Tampere, Finland; [Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland	Tampere University; Tampere University Hospital; Saint Mary's College of California; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital	Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland.; Hartikainen, KM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland.	kaisa.hartikainen@uta.fi	Kovalainen, Anselmi/GQZ-4190-2022	Kovalainen, Anselmi/0000-0002-5461-8338; Hartikainen, Kaisa/0000-0001-7278-9635; Sun, Lihua/0000-0002-9931-9497	Pirkanmaa Hospital District Competitive Research Fund [32 500, 13 665]	Pirkanmaa Hospital District Competitive Research Fund	The work was supported by the following: Pirkanmaa Hospital District Competitive Research Fund (32 500 and 13 665), http://www.pshp.fi/default.aspx?contentid=22524, http://www.pshp.fi/default.aspx?contentid=43373; Academy of Finland.	Asaumi Y, 2014, PSYCHIAT CLIN NEUROS, V68, P558, DOI 10.1111/pcn.12162; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Benoit J, 1935, CR SOC BIOL, V118, P669; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bromundt V, 2014, CHRONOBIOL INT, V31, P343, DOI 10.3109/07420528.2013.854250; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Consortium CAD, 2015, NATURE GENETICS; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Flyktman A, 2015, J EXP BIOL, V218, P1521, DOI 10.1242/jeb.111864; FOSTER RG, 1985, NATURE, V313, P50, DOI 10.1038/313050a0; FOSTER RG, 1994, NEUROSCI BIOBEHAV R, V18, P541, DOI 10.1016/0149-7634(94)90009-4; Hanifin John P., 2007, Journal of Physiological Anthropology, V26, P87, DOI 10.2114/jpa2.26.87; Hansenne M, 2003, NEUROPSYCHOBIOLOGY, V48, P77, DOI 10.1159/000072881; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Ilveskoski E, 1999, CIRCULATION, V100, P608, DOI 10.1161/01.CIR.100.6.608; Isotalo K, 2012, BRAIN PATHOL, V22, P765, DOI 10.1111/j.1750-3639.2012.00586.x; Jurvelin H, 2015, AEROSP MED HUM PERF, V86, P344, DOI 10.3357/AMHP.4139.2015; Jurvelin H, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0288-6; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Kouider S, 2013, SCIENCE, V340, P376, DOI 10.1126/science.1232509; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Lawrence MA, 2013, EZ EASY ANAL VISUALI; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Luck S.J., 2005, INTRO EVENT RELATED; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; SIOPES TD, 1974, POULTRY SCI, V53, P2035, DOI 10.3382/ps.0532035; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Van Brunt EE, PENETRATION LIGHT BR; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2013, J COGNITIVE NEUROSCI, V25, P2072, DOI 10.1162/jocn_a_00450; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; WADE PD, 1988, P NATL ACAD SCI USA, V85, P9322, DOI 10.1073/pnas.85.23.9322	47	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149525	10.1371/journal.pone.0149525	http://dx.doi.org/10.1371/journal.pone.0149525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910350	gold, Green Published			2022-12-26	WOS:000371164700039
J	Guttikonda, SK; Marri, P; Mammadov, J; Ye, L; Soe, K; Richey, K; Cruse, J; Zhuang, MB; Gao, ZF; Evans, C; Rounsley, S; Kumpatla, SP				Guttikonda, Satish K.; Marri, Pradeep; Mammadov, Jafar; Ye, Liang; Soe, Khaing; Richey, Kimberly; Cruse, James; Zhuang, Meibao; Gao, Zhifang; Evans, Clive; Rounsley, Steve; Kumpatla, Siva P.			Molecular Characterization of Transgenic Events Using Next Generation Sequencing Approach	PLOS ONE			English	Article							DISCOVERY	Demand for the commercial use of genetically modified (GM) crops has been increasing in light of the projected growth of world population to nine billion by 2050. A prerequisite of paramount importance for regulatory submissions is the rigorous safety assessment of GM crops. One of the components of safety assessment is molecular characterization at DNA level which helps to determine the copy number, integrity and stability of a transgene; characterize the integration site within a host genome; and confirm the absence of vector DNA. Historically, molecular characterization has been carried out using Southern blot analysis coupled with Sanger sequencing. While this is a robust approach to characterize the transgenic crops, it is both time- and resource-consuming. The emergence of next-generation sequencing (NGS) technologies has provided highly sensitive and cost- and labor-effective alternative for molecular characterization compared to traditional Southern blot analysis. Herein, we have demonstrated the successful application of both whole genome sequencing and target capture sequencing approaches for the characterization of single and stacked transgenic events and compared the results and inferences with traditional method with respect to key criteria required for regulatory submissions.	[Guttikonda, Satish K.; Marri, Pradeep; Mammadov, Jafar; Ye, Liang; Soe, Khaing; Richey, Kimberly; Cruse, James; Zhuang, Meibao; Gao, Zhifang; Evans, Clive; Rounsley, Steve; Kumpatla, Siva P.] Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA	Dow Chemical Company	Guttikonda, SK (corresponding author), Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	SKGuttikonda@dow.com						Abel HJ, 2013, CANCER GENET-NY, V206, P432, DOI 10.1016/j.cancergen.2013.11.002; BHAT S, 2012, PLANT SCI, V163, P673; Claros Manuel Gonzalo, 2012, Biology (Basel), V1, P439, DOI 10.3390/biology1020439; Fritsch L, 2015, TRANSGENIC RES, V24, P615, DOI 10.1007/s11248-015-9864-x; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Kovalic D, 2012, PLANT GENOME-US, V5, P149, DOI 10.3835/plantgenome2012.10.0026; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latham JR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/25376; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Memelink J., 1994, PLANT MOL BIOL M SPR, P273, DOI [10.1007/978-94-011-0511-8_19, DOI 10.1007/978-94-011-0511-8_19]; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nekrutenko A, 2012, NAT REV GENET, V13, P667, DOI 10.1038/nrg3305; Pauwels K, 2015, TRENDS FOOD SCI TECH, V45, P319, DOI 10.1016/j.tifs.2015.07.009; Privalle LS, 2012, J AGR FOOD CHEM, V60, P10179, DOI 10.1021/jf302706e; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards E, 1994, CURR PROTOC MOL BIOL, V27, P2, DOI [10.1002/0471142727.mb0203-27, DOI 10.1002/0471142727.MB0203-27, 10.1002/0471142727.mb0203s27, DOI 10.1002/0471142727.MB0203S27]; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Srivastava A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-367; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Yang L, 2013, SCI REP, V3, P2389; Zastrow-Hayes GM, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.08.0037; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050348	25	36	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149515	10.1371/journal.pone.0149515	http://dx.doi.org/10.1371/journal.pone.0149515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908260	Green Published, gold			2022-12-26	WOS:000371163000015
J	Choueiry, N; Salamoun, T; Jabbour, H; El Osta, N; Hajj, A; Khabbaz, LR				Choueiry, Nour; Salamoun, Tracy; Jabbour, Hicham; El Osta, Nada; Hajj, Aline; Khabbaz, Lydia Rabbaa			Insomnia and Relationship with Anxiety in University Students: A Cross-Sectional Designed Study	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; QUALITY INDEX; SEVERITY INDEX; MENTAL-HEALTH; PRIMARY-CARE; EPIDEMIOLOGY; DISORDERS; PREVALENCE; ASSOCIATION; VALIDATION	Purpose Sleep disorders (SDs) are now recognized as a public health concern with considerable psychiatric and societal consequences specifically on the academic life of students. The aims of this study were to assess SDs in a group of university students in Lebanon and to examine the relationship between SDs and anxiety. Methods An observational cross-sectional study was conducted at Saint-Joseph University, Lebanon, during the academic year 2013-2014. Four questionnaires were face-to-face administered to 462 students after obtaining their written consent: Insomnia Severity Index (ISI), Pittsburgh Sleep Quality Index (PSQI), Epworth Sleepiness Scale (ESS), and Generalized Anxiety Disorder 7-item scale (GAD-7). Results The prevalence of clinically significant insomnia was 10.6% (95% CI: 7.8-13.4%), more frequent in first year students. ISI mean score was 10.06 (SD = 3.76). 37.1% of the participants were poor sleepers. Excessive daytime sleepiness (EDS) and poor sleep were significantly more frequent among participants with clinical insomnia (p = 0.031 and 0.001 respectively). Clinically significant anxiety was more frequent in students suffering from clinical insomnia (p = 0.006) and in poor sleepers (p = 0.003). 50.8% of the participants with clinically significant anxiety presented EDS versus 30.9% of those with no clinically significant anxiety (p<0.0001). Conclusions The magnitude of SDs in this sample of Lebanese university students demonstrate the importance of examining sleep health in this population. Moreover, the link between SD and anxiety reminds us of the importance of treating anxiety as soon as detected and not simply targeting the reduction of sleep problems.	[Choueiry, Nour; Salamoun, Tracy; Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Dept Anesthesia & Crit Care, Hotel Dieu France Hosp, Beirut, Lebanon; [Jabbour, Hicham] St Joseph Univ Beirut, Fac Med, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Fac Med, Dept Publ Hlth, Beirut, Lebanon; [El Osta, Nada] St Joseph Univ, Fac Med Dent, Dept Prosthodont, Beirut, Lebanon; [Hajj, Aline; Khabbaz, Lydia Rabbaa] St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon		Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Beirut, Lebanon.; Khabbaz, LR (corresponding author), St Joseph Univ Beirut, Fac Pharm, Lab Pharmacol Pharm Clin & Controle Qualite Medic, Beirut, Lebanon.	lydia.khabbaz@usj.edu.lb	EL OSTA, Nada/GRS-4789-2022	Jabbour, Hicham/0000-0003-1033-850X				Alfano CA, 2010, CHILD PSYCHIAT HUM D, V41, P156, DOI 10.1007/s10578-009-0158-5; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Armstrong D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101368; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Belleville G, 2011, CLIN PSYCHOL REV, V31, P638, DOI 10.1016/j.cpr.2011.02.004; Blais FC, 2001, CAN FAM PHYSICIAN, V47, P759; Buysse D J, 1989, Psychiatry Res, V28, P193; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; Carroll JE, 2015, PSYCHONEUROENDOCRINO, V55, P184, DOI 10.1016/j.psyneuen.2015.02.010; Cho YW, 2014, J CLIN NEUROL, V10, P210, DOI 10.3988/jcn.2014.10.3.210; Chung KF, 2015, SLEEP MED, V16, P477, DOI 10.1016/j.sleep.2014.10.018; Forbes EE, 2008, J AM ACAD CHILD PSY, V47, P148, DOI 10.1097/chi.0b013e31815cd9bc; Gagnon C, 2013, J AM BOARD FAM MED, V26, P701, DOI 10.3122/jabfm.2013.06.130064; Gellis LA, 2014, BEHAV THER, V45, P806, DOI 10.1016/j.beth.2014.05.002; Goldman-Mellor S, 2014, SLEEP, V37, P1767, DOI 10.5665/sleep.4168; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; HABTEGABR E, 1991, J CLIN EPIDEMIOL, V44, P5, DOI 10.1016/0895-4356(91)90195-F; Hasler G, 2005, J CLIN PSYCHIAT, V66, P521, DOI 10.4088/JCP.v66n0416; Hayley AC, 2015, METABOLISM, V64, P244, DOI 10.1016/j.metabol.2014.09.011; Hayley AC, 2013, AUST NZ J PSYCHIAT, V47, P772, DOI 10.1177/0004867413490036; Jansson M, 2006, BRIT J HEALTH PSYCH, V11, P501, DOI 10.1348/135910705X57412; Jansson-Frojmark M, 2008, J PSYCHOSOM RES, V64, P443, DOI 10.1016/j.jpsychores.2007.10.016; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson EO, 2006, PEDIATRICS, V117, pE247, DOI 10.1542/peds.2004-2629; Johnson EO, 2006, J PSYCHIATR RES, V40, P700, DOI 10.1016/j.jpsychires.2006.07.008; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Leger D, 2010, SLEEP MED, V11, P987, DOI 10.1016/j.sleep.2010.04.019; Leistner SM, 2015, EUR J ENDOCRINOL; Mason EC, 2014, J AFFECT DISORDERS, V168, P415, DOI 10.1016/j.jad.2014.07.020; Mondal P, 2013, NAT SCI SLEEP, V5, P15, DOI 10.2147/NSS.S40608; Monti JM, 2004, SLEEP MED REV, V8, P133, DOI 10.1016/S1087-0792(02)00158-2; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morphy H, 2007, SLEEP, V30, P274; Murthy Vasantmeghna Srinivasa, 2014, Ind Psychiatry J, V23, P23, DOI 10.4103/0972-6748.144952; National Center On Sleep Disorders Research, 2011, NAT I HLTH SLEEP DIS; Ohayon MM, 2012, SLEEP MED, V13, P52, DOI 10.1016/j.sleep.2011.06.010; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Roth T, 2007, J CLIN SLEEP MED, V3, pS7, DOI [10.5664/jcsm.26929, DOI 10.5664/JCSM.26929]; Royal College of Psychiatrists, 2011, MENT HLTH STUD HIGH; Sekercioglu N, 2015, REN FAIL, P1; Shamsuddin K, 2013, ASIAN J PSYCHIATR, V6, P318, DOI 10.1016/j.ajp.2013.01.014; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Storch EA, 2008, J ANXIETY DISORD, V22, P877, DOI 10.1016/j.janxdis.2007.09.003; Taylor DJ, 2013, BEHAV THER, V44, P339, DOI 10.1016/j.beth.2012.12.001; Thomas SJ, 2014, BEHAV SLEEP MED, V12, P169, DOI 10.1080/15402002.2013.778202	45	66	71	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149643	10.1371/journal.pone.0149643	http://dx.doi.org/10.1371/journal.pone.0149643			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900686	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100118
J	Hwang, SM; Jeon, TY; Yoo, SY; Kim, JH; Kang, B; Choe, YH; Choi, H; Kim, JS				Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye; Kang, Ben; Choe, Yon Ho; Choi, Haeyon; Kim, Jung Sun			Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT	PLOS ONE			English	Article							PORTAL VENOUS SYSTEM; HEPATOCELLULAR-CARCINOMA; ARTERIOHEPATIC DYSPLASIA; HUMAN JAGGED1; CHILDREN; PORTOENTEROSTOMY; HEPATOCARCINOMA; MUTATIONS; CIRRHOSIS; FEATURES	Purpose To compare preoperative CT findings before liver transplantation between patients with Alagille syndrome (AGS) and those with end-stage biliary atresia (BA). Materials and Methods The institutional review board approved this retrospective study. Eleven children with AGS (median age, 19.0 +/- 13.0 months; male to female ratio, 3:8) and 109 children with end-stage BA (median age, 17.9 +/- 25.8 months; male to female ratio, 37:72) who underwent abdomen CT as candidates for liver transplant were included. CT images were reviewed focusing on hepatic parenchymal changes, vascular changes, presence of focal lesions, and signs of portal hypertension. Results Hepatic parenchymal changes were present in 27% (3/11) of AGS patients and 100% (109/109) of end-stage BA patients (P < .001). The hepatic artery diameter was significantly smaller (1.9 mm versus 3.6 mm, P = 008), whereas portal vein diameter was larger (6.8 mm versus 5.0 mm, P < .001) in patients with AGS compared with patients with end-stage BA. No focal lesion was seen in patients with AGS, whereas 44% (48/109) of patients with endstage BA had intrahepatic biliary cysts (39%, 43/109) and hepatic tumors (8%, 9/109) (P = .008). Splenomegaly was commonly seen in both groups (P = .082), and ascites (9% [1/11] versus 50% [54/109], P = .010) and gastroesophageal varix (0% [0/11] versus 80% [87/ 109], P < .001) were less common in patients with AGS than in patients with end-stage BA. Conclusion Fibrotic or cirrhotic changes of the liver, presence of focal lesions, and relevant portal hypertension were less common in patients with AGS than in patients with end-stage BA.	[Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea; [Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea; [Kang, Ben; Choe, Yon Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 135710, South Korea; [Choi, Haeyon; Kim, Jung Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea.; Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea.	hathor97.jeon@samsung.com		Hwang, Sook Min/0000-0003-1755-4846; Kang, Ben/0000-0002-8516-9803				ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; BEKASSY AN, 1992, MED PEDIATR ONCOL, V20, P78, DOI 10.1002/mpo.2950200118; Berrocal T, 1997, EUR RADIOL, V7, P115, DOI 10.1007/s003300050122; Bhadri VA, 2005, J PEDIATR GASTR NUTR, V41, P676, DOI 10.1097/01.mpg.0000179759.60048.c4; Carpino G, 2015, J HEPATOL, V63, P1220, DOI 10.1016/j.jhep.2015.06.018; Caruso S, 2010, EUR RADIOL, V20, P1468, DOI 10.1007/s00330-009-1681-2; Castaneda C, 1992, G E N, V46, P341; CHIARETTI A, 1992, ACTA PAEDIATR, V81, P937, DOI 10.1111/j.1651-2227.1992.tb12141.x; Cho JM, 2015, PEDIATR INT, V57, P552, DOI 10.1111/ped.12602; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073; HALVORSEN RA, 1995, ABDOM IMAGING, V20, P191, DOI 10.1007/BF00200391; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; HERNANDEZCANO AM, 1987, J PEDIATR SURG, V22, P519, DOI 10.1016/S0022-3468(87)80211-7; HOFFENBERG EJ, 1995, J PEDIATR-US, V127, P220, DOI 10.1016/S0022-3476(95)70298-9; Inoue Y, 2008, J PEDIATR SURG, V43, P2165, DOI 10.1016/j.jpedsurg.2008.08.039; Jeon TY, 2013, CLIN RADIOL, V68, P588, DOI 10.1016/j.crad.2012.12.004; KAUFMAN SS, 1987, AM J DIS CHILD, V141, P698, DOI 10.1001/archpedi.1987.04460060114050; Kim B, 2005, PATHOL RES PRACT, V201, P55, DOI 10.1016/j.prp.2004.11.007; Kim WS, 2007, RADIOLOGY, V245, P549, DOI 10.1148/radiol.2452061093; LAFORTUNE M, 1984, RADIOLOGY, V151, P27, DOI 10.1148/radiology.151.1.6701328; Lanzoni G, 2015, HEPATOLOGY; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lykavieris P, 2001, GUT, V49, P431, DOI 10.1136/gut.49.3.431; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Piccoli DA, 2001, SEMIN LIVER DIS, V21, P525, DOI 10.1055/s-2001-19036; PRASSOPOULOS P, 1994, ACTA RADIOL, V35, P152; RABINOVITZ M, 1989, J PEDIATR GASTR NUTR, V8, P26, DOI 10.1097/00005176-198901000-00006; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Tainaka T, 2008, PEDIATR SURG INT, V24, P265, DOI 10.1007/s00383-007-2099-z; Uflacker R, 2004, CARDIOVASC INTER RAD, V27, P486, DOI 10.1007/s00270-004-2636-2; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wetli SC, 2010, PEDIATR RADIOL, V40, P1696, DOI 10.1007/s00247-010-1784-6; Yoon HJ, 2014, CLIN RADIOL, V69, pE113, DOI 10.1016/j.crad.2013.10.017; Yu CY, 2009, PEDIATR TRANSPLANT, V13, P984, DOI 10.1111/j.1399-3046.2008.01100.x; Zen Y, 2014, HISTOPATHOLOGY, V64, P671, DOI 10.1111/his.12312; Zhou HY, 2015, CLIN RES HEPATOL GAS, V39, P351, DOI 10.1016/j.clinre.2014.09.012	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149681	10.1371/journal.pone.0149681	http://dx.doi.org/10.1371/journal.pone.0149681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901874	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100128
J	Joubert, M; Bellevre, D; Legallois, D; Elie, N; Coulbault, L; Allouche, S; Manrique, A				Joubert, Michael; Bellevre, Dimitri; Legallois, Damien; Elie, Nicolas; Coulbault, Laurent; Allouche, Stephane; Manrique, Alain			Hyperglycemia-Induced Hypovolemia Is Involved in Early Cardiac Magnetic Resonance Alterations in Streptozotocin-Induced Diabetic Mice: A Comparison with Furosemide-Induced Hypovolemia	PLOS ONE			English	Article							IN-VIVO; MYOCARDIAL FIBROSIS; HEART-FAILURE; CARDIOMYOPATHY; DYSFUNCTION; RAT; OVEREXPRESSION; INSULIN; TYPE-1; METABOLISM	Aims The aim of the study was to assess the early features of diabetic cardiomyopathy using cardiac magnetic resonance within the first week after streptozotocin injection in mice. We focused on the relationship between left ventricular function and hypovolemia markers in diabetic animals compared to a hypovolemic rodent model. Methods and Results Swiss mice were randomized into control (group C), streptozotocin(induced diabetes (group D) and furosemide(induced hypovolemia (group F) groups. Cardiac magnetic resonance, non(invasive blood pressure, urine volume, plasma markers of dehydration and cardiac histology were assessed in all groups. Mean blood glucose was higher in diabetic animals than in groups C and F (30.5 +/- 5.8 compared to 10.4 +/- 2.1 and 11.1 +/- 2.8 mmol/L, respectively; p < 0.01). Diuresis was increased in animals from group D and F compared to C (14650 +/- 11499 and 1533 +/- 540 compared to 192 +/- 111 mu L/24 h; p < 0.05). End diastolic and end systolic volumes were lower in group D than in group C at week 1 (1.52 +/- 0.36 vs. 1.93 +/- 0.35 and 0.54 +/- 0.22 vs. 0.75 +/- 0.18 mL/kg, p < 0.05). These left ventricular volume values in group D were comparable to those observed in the acute hypovolemia model (group F). Increased dehydration plasma markers and an absence of obvious intrinsic myocardial damage (evaluated by cardiac magnetic resonance and histology) suggest that a hemodynamic mechanism underlies the very early drop in left ventricular volumes in group D and provides a potential link to hyperglycemic osmotic diuresis. Conclusions Researchers using cardiac magnetic resonance in hyperglycemic rodent models should be aware of this hemodynamic mechanism, which may partially explain modifications in cardiac parameters in addition to diabetic myocardial damage.	[Joubert, Michael] Caen Univ Hosp, Diabet Care Unit, Caen, France; [Bellevre, Dimitri; Manrique, Alain] Caen Univ Hosp, Dept Nucl Med, Caen, France; [Legallois, Damien] Caen Univ Hosp, Cardiol Unit, Caen, France; [Elie, Nicolas] Univ Caen Normandie, IBFA, CMABIO HIQ Facil, ICORE SF4206, Caen, France; [Coulbault, Laurent; Allouche, Stephane] Caen Univ Hosp, Biochem Unit, Caen, France; [Joubert, Michael; Bellevre, Dimitri; Legallois, Damien; Coulbault, Laurent; Allouche, Stephane; Manrique, Alain] Univ Caen Normandie, EA4650, GIP Cyceron, Caen, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie	Joubert, M (corresponding author), Caen Univ Hosp, Diabet Care Unit, Caen, France.; Joubert, M (corresponding author), Univ Caen Normandie, EA4650, GIP Cyceron, Caen, France.	joubert-m@chu-caen.fr	Elie, Nicolas/ABC-4069-2020	Elie, Nicolas/0000-0001-5772-8252; Allouche, stephane/0000-0003-3134-7501	AIR Association; ANABIM Association	AIR Association; ANABIM Association	MJ received a research grant form AIR Association. DB received a research grant from ANABIM Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors received no specific funding for this work.	Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Aronson D, 1997, ANN INTERN MED, V126, P296, DOI 10.7326/0003-4819-126-4-199702150-00006; Becher PM, 2013, INT J MOL MED, V32, P158, DOI 10.3892/ijmm.2013.1368; Bonito P, 2005, DIABETIC MED, V22, P1720, DOI 10.1111/j.1464-5491.2005.01685.x; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Brands MW, 2012, AM J PHYSIOL-REG I, V303, pR1101, DOI 10.1152/ajpregu.00390.2012; Bugger H, 2009, DIS MODEL MECH, V2, P454, DOI 10.1242/dmm.001941; Bun SS, 2012, INVEST RADIOL, V47, P319, DOI 10.1097/RLI.0b013e318243e062; Bupha-Intr T, 2011, AM J PHYSIOL-HEART C, V300, pH1661, DOI 10.1152/ajpheart.00411.2010; Carrabba N, 2004, CIRCULATION, V110, P1974, DOI 10.1161/01.CIR.0000143376.64970.4A; de Jong S, 2011, J MOL CELL CARDIOL, V51, P974, DOI 10.1016/j.yjmcc.2011.08.024; Frustaci A, 2000, CIRC RES, V87, P1123, DOI 10.1161/01.RES.87.12.1123; Gaede P, 2004, DIABETES, V53, pS39, DOI 10.2337/diabetes.53.suppl_3.S39; Goode Adam, 2013, J Pathol Inform, V4, P27, DOI 10.4103/2153-3539.119005; HILSTED J, 1993, CLIN PHYSIOL, V13, P1, DOI 10.1111/j.1475-097X.1993.tb00312.x; Joffe II, 1999, J AM COLL CARDIOL, V34, P2111, DOI 10.1016/S0735-1097(99)00436-2; Kajstura J, 2001, DIABETES, V50, P1414, DOI 10.2337/diabetes.50.6.1414; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kruger M, 2010, J MOL CELL CARDIOL, V48, P910, DOI 10.1016/j.yjmcc.2010.02.012; Labombarda F, 2014, DIABETES METAB, V40, P292, DOI 10.1016/j.diabet.2014.03.007; Loganathan R, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-7; Luik PT, 2003, EUR J CLIN INVEST, V33, P787, DOI 10.1046/j.1365-2362.2003.01215.x; Maliha G, 2015, J AM SOC HYPERTENS, V9, P48, DOI 10.1016/j.jash.2014.11.001; Malone MA, 2007, METABOLISM, V56, P1118, DOI 10.1016/j.metabol.2007.04.005; Miki T, 2013, HEART FAIL REV, V18, P149, DOI 10.1007/s10741-012-9313-3; Muniyappa R, 2007, ENDOCR REV, V28, P463, DOI 10.1210/er.2007-0006; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Oh Se Won, 2015, Electrolyte Blood Press, V13, P17, DOI 10.5049/EBP.2015.13.1.17; Palm F, 2004, DIABETES-METAB RES, V20, P452, DOI 10.1002/dmrr.472; Radovits T, 2009, AM J PHYSIOL-HEART C, V297, pH125, DOI 10.1152/ajpheart.00165.2009; Rijzewijk LJ, 2008, J AM COLL CARDIOL, V52, P1793, DOI 10.1016/j.jacc.2008.07.062; Rijzewijk LJ, 2009, J AM COLL CARDIOL, V54, P1524, DOI 10.1016/j.jacc.2009.04.074; Setser RM, 2000, J MAGN RESON IMAGING, V12, P430, DOI 10.1002/1522-2586(200009)12:3<430::AID-JMRI8>3.0.CO;2-V; Shah AM, 2010, EUR J HEART FAIL, V12, P1229, DOI 10.1093/eurjhf/hfq179; Taylor AC, 2008, AM J PHYSIOL-REG I, V294, pR1285, DOI 10.1152/ajpregu.00003.2008; Tocci G, 2008, J HYPERTENS, V26, P1477, DOI 10.1097/HJH.0b013e3282fe1d3d; Trost SU, 2002, DIABETES, V51, P1166, DOI 10.2337/diabetes.51.4.1166; Vallee JP, 2004, MAGN RESON MATER PHY, V17, P149, DOI 10.1007/s10334-004-0066-4; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yu XC, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-6; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	41	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149808	10.1371/journal.pone.0149808	http://dx.doi.org/10.1371/journal.pone.0149808			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901278	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100155
J	Kim, EJ; Kyeong, S; Cho, SW; Chun, JW; Park, HJ; Kim, J; Kim, J; Dolan, RJ; Kim, JJ				Kim, Eun Joo; Kyeong, Sunghyon; Cho, Sang Woo; Chun, Ji-Won; Park, Hae-Jeong; Kim, Jihye; Kim, Joohan; Dolan, Raymond J.; Kim, Jae-Jin			Happier People Show Greater Neural Connectivity during Negative Self-Referential Processing	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; LIFE SATISFACTION; SOCIAL COGNITION; ESTEEM; METAANALYSIS; PERSONALITY; BRAIN; FMRI; RESPONSES; HAPPINESS	Life satisfaction is an essential component of subjective well-being and provides a fundamental resource for optimal everyday functioning. The goal of the present study was to examine how life satisfaction influences self-referential processing of emotionally valenced stimuli. Nineteen individuals with high life satisfaction (HLS) and 21 individuals with low life satisfaction (LLS) were scanned using functional MRI while performing a face-word relevance rating task, which consisted of 3 types of face stimuli (self, public other, and unfamiliar other) and 3 types of word stimuli (positive, negative, and neutral). We found a significant group x word valence interaction effect, most strikingly in the dorsal medial prefrontal cortex. In the positive word condition dorsal medial prefrontal cortex activity was significantly higher in the LLS group, whereas in the negative word condition it was significantly higher in the HLS group. The two groups showed distinct functional connectivity of the dorsal medial prefrontal cortex with emotional processing-related regions. The findings suggest that, in response to emotional stimuli, individuals with HLS may successfully recruit emotion regulation-related regions in contrast to individuals with LLS. The difference in functional connectivity during self-referential processing may lead to an influence of life satisfaction on responses to emotion-eliciting stimuli.	[Kim, Eun Joo] Yonsei Univ, Grad Sch Educ, Seoul 120749, South Korea; [Kyeong, Sunghyon; Cho, Sang Woo; Chun, Ji-Won; Kim, Jae-Jin] Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med, Seoul, South Korea; [Kim, Jihye] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Kim, Joohan] Yonsei Univ, Dept Commun, Seoul 120749, South Korea; [Dolan, Raymond J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Kim, Jae-Jin] Yonsei Univ, Dept Psychiat, Gangnam Severance Hosp, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; University of London; University College London; Yonsei University; Yonsei University Health System	Kim, JJ (corresponding author), Yonsei Univ, Coll Med, Inst Behav Sci Med, Seoul, South Korea.; Kim, JJ (corresponding author), Yonsei Univ, Dept Psychiat, Gangnam Severance Hosp, Seoul 120749, South Korea.	jaejkim@yonsei.ac.kr		Park, Hae-Jeong/0000-0002-4633-0756; Chun, Ji-Won/0000-0002-0629-0358; Kyeong, Sunghyon/0000-0002-9095-5219; Kim, Jae-Jin/0000-0002-1395-4562	National Research Foundation of Korea (NRF) - Korean government (MEST) [NRF-2013R1A2A2A03068342]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. NRF-2013R1A2A2A03068342).	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Ayduk O, 2008, PSYCHOL SCI, V19, P229, DOI 10.1111/j.1467-9280.2008.02073.x; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Baumeister RF, 2003, PSYCHOL SCI, P1, DOI 10.1111/1529-1006.01431; Blair KS, 2013, NEUROIMAGE, V78, P103, DOI 10.1016/j.neuroimage.2013.03.063; Caprara GV, 2009, BEHAV GENET, V39, P277, DOI 10.1007/s10519-009-9267-y; Collins AL, 2009, PSYCHOL AGING, V24, P696, DOI 10.1037/a0016777; Cummins RA., 2002, J HAPPINESS STUD, V3, P37, DOI [10.1023/A:1015678915305, DOI 10.1023/A:1015678915305, 10.1023/a:1015678915305]; D'Argembeau A, 2012, CEREB CORTEX, V22, P659, DOI 10.1093/cercor/bhr144; DeCoster J, 2009, PSYCHOL METHODS, V14, P349, DOI 10.1037/a0016956; DeNeve KM, 1998, PSYCHOL BULL, V124, P197, DOI 10.1037/0033-2909.124.2.197; Denny BT, 2012, J COGNITIVE NEUROSCI, V24, P1742, DOI 10.1162/jocn_a_00233; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Frewen PA, 2008, CLIN PSYCHOL REV, V28, P228, DOI 10.1016/j.cpr.2007.05.002; Frewen PA, 2013, SOC COGN AFFECT NEUR, V8, P546, DOI 10.1093/scan/nss032; Frewen PA, 2011, SOC COGN AFFECT NEUR, V6, P375, DOI 10.1093/scan/nsq047; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gannon N, 2005, PERS INDIV DIFFER, V38, P1353, DOI 10.1016/j.paid.2004.09.001; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Grecucci A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00523; Gyurak A, 2012, SOC COGN AFFECT NEUR, V7, P322, DOI 10.1093/scan/nsr014; Hampton AN, 2007, NEURON, V55, P545, DOI 10.1016/j.neuron.2007.07.022; ISEN AM, 1978, J PERS SOC PSYCHOL, V36, P1, DOI 10.1037/0022-3514.36.1.1; Kim SH, 2007, J COGNITIVE NEUROSCI, V19, P776, DOI 10.1162/jocn.2007.19.5.776; Koenigsberg HW, 2010, NEUROPSYCHOLOGIA, V48, P1813, DOI 10.1016/j.neuropsychologia.2010.03.002; Larson MJ, 2010, BIOL PSYCHOL, V83, P222, DOI 10.1016/j.biopsycho.2010.01.003; Legrand D, 2009, PSYCHOL REV, V116, P252, DOI 10.1037/a0014172; Leiberg S, 2012, HUM BRAIN MAPP, V33, P2464, DOI 10.1002/hbm.21376; Lyubomirsky S, 1998, MOTIV EMOTION, V22, P155, DOI 10.1023/A:1021396422190; Lyubomirsky S, 2006, SOC INDIC RES, V78, P363, DOI 10.1007/s11205-005-0213-y; Murray RJ, 2012, NEUROSCI BIOBEHAV R, V36, P1043, DOI 10.1016/j.neubiorev.2011.12.013; Nicolle A, 2012, NEURON, V75, P1114, DOI 10.1016/j.neuron.2012.07.023; Nohlen HU, 2014, SOC COGN AFFECT NEUR, V9, P924, DOI 10.1093/scan/nst074; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Oikawa H, 2012, NEUROIMAGE, V59, P3668, DOI 10.1016/j.neuroimage.2011.10.098; Olsson A, 2008, TRENDS COGN SCI, V12, P65, DOI 10.1016/j.tics.2007.11.010; Onoda K, 2010, SOC COGN AFFECT NEUR, V5, P385, DOI 10.1093/scan/nsq002; Park J.Y., 2011, KOREAN FACIAL EXPRES; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Perlman G, 2012, J AFFECT DISORDERS, V139, P75, DOI 10.1016/j.jad.2012.01.044; Pfeifer JH, 2007, J COGNITIVE NEUROSCI, V19, P1323, DOI 10.1162/jocn.2007.19.8.1323; Platek SM, 2009, NEUROPSYCHOLOGIA, V47, P849, DOI 10.1016/j.neuropsychologia.2008.12.027; Pruessner JC, 2005, NEUROIMAGE, V28, P815, DOI 10.1016/j.neuroimage.2005.06.014; Rasmussen HN, 2006, J PERS, V74, P1721, DOI 10.1111/j.1467-6494.2006.00426.x; Reich WA, 2013, J HAPPINESS STUD, V14, P293, DOI 10.1007/s10902-012-9332-8; Schimmack U, 2002, J PERS SOC PSYCHOL, V82, P582, DOI 10.1037//0022-3514.82.4.582; Schimmack U, 2004, PERS SOC PSYCHOL B, V30, P1062, DOI 10.1177/0146167204264292; Sokol-Hessner P, 2013, SOC COGN AFFECT NEUR, V8, P341, DOI 10.1093/scan/nss002; Somerville LH, 2010, CEREB CORTEX, V20, P3005, DOI 10.1093/cercor/bhq049; Tucker KL, 2007, J SOC CLIN PSYCHOL, V26, P791, DOI 10.1521/jscp.2007.26.7.791; Uddin LQ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003526; Urry HL, 2009, NEUROIMAGE, V47, P852, DOI 10.1016/j.neuroimage.2009.05.069; van Buuren M, 2010, HUM BRAIN MAPP, V31, P1117, DOI 10.1002/hbm.20920; van der Meer L, 2010, NEUROSCI BIOBEHAV R, V34, P935, DOI 10.1016/j.neubiorev.2009.12.004; van Duijvenvoorde ACK, 2008, J NEUROSCI, V28, P9495, DOI 10.1523/JNEUROSCI.1485-08.2008; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Waldinger RJ, 2011, COGN AFFECT BEHAV NE, V11, P426, DOI 10.3758/s13415-011-0039-9; Yang J, 2012, NEUROPSYCHOLOGIA, V50, P1267, DOI 10.1016/j.neuropsychologia.2012.02.010; Zotev V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024522	62	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149554	10.1371/journal.pone.0149554	http://dx.doi.org/10.1371/journal.pone.0149554			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900857	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100097
J	Nuss, A; Carlos, CJ; Moreno, IB; Fagundes, NJR				Nuss, Andressa; Carlos, Caio J.; Moreno, Ignacio B.; Fagundes, Nelson J. R.			Population Genetic Structure of the Magnificent Frigatebird Fregata magnificens (Aves, Suliformes) Breeding Colonies in the Western Atlantic Ocean	PLOS ONE			English	Article							DIFFERENTIATION; CONSERVATION; LOCI; INDIVIDUALS; MOVEMENTS; INFERENCE; SOFTWARE; PRIMERS; RATES	The Magnificent Frigatebird Fregata magnificens has a pantropical distribution, nesting on islands along the Atlantic and Pacific coasts. In the Caribbean, there is little genetic structure among colonies; however, the genetic structure among the colonies off Brazil and its relationship with those in the Caribbean are unknown. In this study, we used mtDNA and microsatellite markers to infer population structure and evolutionary history in a sample of F. magnificens individuals collected in Brazil, Grand Connetable (French Guyana), and Barbuda. Virtually all Brazilian individuals had the same mtDNA haplotype. There was no haplotype sharing between Brazil and the Caribbean, though Grand Connetable shared haplotypes with both regions. A Bayesian clustering analysis using microsatellite data found two genetic clusters: one associated with Barbuda and the other with the Brazilian populations. Grand Connetable was more similar to Barbuda but had ancestry from both clusters, corroborating its "intermediate" position. The Caribbean and Grand Connetable populations showed higher genetic diversity and effective population size compared to the Brazilian population. Overall, our results are in good agreement with an effect of marine winds in isolating the Brazilian meta-population.	[Nuss, Andressa; Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil; [Carlos, Caio J.; Moreno, Ignacio B.] Univ Fed Rio Grande do Sul, Inst Biosci, Dept Zool, Lab Sistemat & Ecol Aves & Mamiferos Marinhos LAB, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil.	nelson.fagundes@ufrgs.br	Carlos, Caio J/G-4345-2010; Moreno, Ignacio b/I-3235-2012; Fagundes, Nelson/F-7490-2014	Carlos, Caio J/0000-0001-9071-1444; Moreno, Ignacio b/0000-0001-9854-6033; Fagundes, Nelson/0000-0003-0456-0323	Petrobras; CNPq; PPGBM/UFRGS	Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPGBM/UFRGS	The authors thank Petrobras, CNPq and PPGBM/UFRGS for financial support. Part of the results of this study will be included in the project "Projeto Ilhas do Rio", performed by "Instituto Mar Adentro" and sponsored by Petrobras, through the grant "Programa Petrobras Ambiental". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2003, MOL ECOL, V12, P2953, DOI 10.1046/j.1365-294X.2003.01980.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; BirdLife International, 2012, IUCN RED LIST THREAT, V2012; BirdLife International, 2014, SPEC FACTSH FREG MAG; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Brohede J, 2004, MUTAT RES-FUND MOL M, V545, P73, DOI 10.1016/j.mrfmmm.2003.09.012; CARLOS C.J., 2009, SEA SWALLOW, V58, P17; Dearborn DC, 2003, MOL ECOL, V12, P2835, DOI 10.1046/j.1365-294X.2003.01931.x; Dearborn DC, 2008, MOL ECOL RESOUR, V8, P1399, DOI 10.1111/j.1755-0998.2008.02351.x; Diamond A.W., 2002, BIRDS N AM ONLINE; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond A., 2011, GENEIOUS V5 5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Faria PJ, 2010, J AVIAN BIOL, V41, P378, DOI 10.1111/j.1600-048X.2009.04902.x; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gonzalez-Jaramillo M, 2011, BIOCHEM SYST ECOL, V39, P392, DOI 10.1016/j.bse.2011.05.014; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hailer F, 2011, P ROY SOC B-BIOL SCI, V278, P817, DOI 10.1098/rspb.2010.1342; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kushlan J.A., 2002, WATERBIRD CONSERVATI; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; Masters BS, 2011, BIOL LETTERS, V7, P127, DOI 10.1098/rsbl.2010.0643; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Ortego J, 2008, MUTAT RES-FUND MOL M, V648, P82, DOI 10.1016/j.mrfmmm.2008.09.012; PALACIO F J, 1982, Boletim do Instituto Oceanografico, V31, P69; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Rocha-Olivares A, 2014, REV MEX BIODIVERS, V85, P532, DOI 10.7550/rmb.40246; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; TAJIMA F, 1989, GENETICS, V123, P585; Tomczak M, 1993, REGIONAL OCEANOGRAPH; Van Oosterhout C, 2004, MICROCHECKER MICROCH; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Wilson GA, 2003, GENETICS, V163, P1177	46	7	7	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149834	10.1371/journal.pone.0149834	http://dx.doi.org/10.1371/journal.pone.0149834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901878	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100161
J	Qiu, Y; Wang, SW; Chen, Z; Guo, YJ; Song, Y				Qiu, Yi; Wang, Shiwei; Chen, Zhi; Guo, Yajie; Song, Yuan			An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA; ADAPTATION; SEQUENCE; IMMUNITY; TRANSCRIPTION; INFECTIONS; RESISTANCE; EFFICIENCY; MEMORY	CRISPR-Cas systems, the small RNA-dependent immune systems, are widely distributed in prokaryotes. However, only a small proportion of CRISPR-Cas systems have been identified to be active in bacteria. In this work, a naturally active type I-E CRISPR-Cas system was found in Streptomyces avermitilis. The system shares many common genetic features with the type I-E system of Escherichia coli, and meanwhile shows unique characteristics. It not only degrades plasmid DNA with target protospacers, but also acquires new spacers from the target plasmid DNA. The naive features of spacer acquisition in the type I-E system of S. avermitilis were investigated and a completely conserved PAM 5'-AAG-3' was identified. Spacer acquisition displayed differential strand bias upstream and downstream of the priming spacer, and irregular integrations of new spacers were observed. In addition, introduction of this system into host conferred phage resistance to some extent. This study will give new insights into adaptation mechanism of the type I-E systems in vivo, and meanwhile provide theoretical foundation for applying this system on the genetic modification of S. avermitilis.	[Qiu, Yi; Wang, Shiwei; Chen, Zhi; Guo, Yajie; Song, Yuan] China Agr Univ, Coll Biol Sci, Dept Microbiol, Beijing 100094, Peoples R China; [Wang, Shiwei] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Song, Y (corresponding author), China Agr Univ, Coll Biol Sci, Dept Microbiol, Beijing 100094, Peoples R China.	syuan@cau.edu.cn			National Natural Science Foundation of China [31570084]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by a grant from the National Natural Science Foundation of China (www.nsfc.gov.cn) to YS (31570084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Barrangou R, 2012, ANNU REV FOOD SCI T, V3, P143, DOI 10.1146/annurev-food-022811-101134; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; BURG RW, 1979, ANTIMICROB AGENTS CH, V15, P361, DOI 10.1128/AAC.15.3.361; Chen W, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-198; Cobb RE, 2015, ACS SYNTH BIOL, V4, P723, DOI 10.1021/sb500351f; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Demain AL, 1999, APPL MICROBIOL BIOT, V52, P455, DOI 10.1007/s002530051546; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Guo P, 2011, ACTA BIOCH BIOPH SIN, V43, P630, DOI 10.1093/abbs/gmr052; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; ISHINO Y, 1987, J BACTERIOL, V169, P5429, DOI 10.1128/jb.169.12.5429-5433.1987; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2015, ANNU REV MICROBIOL, V69, P209, DOI 10.1146/annurev-micro-091014-104441; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Li Y., 2012, ARCH ANIM NUTR, V1, P1, DOI DOI 10.1099/VIR.0.039289-0; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pougach K, 2010, MOL MICROBIOL, V77, P1367, DOI 10.1111/j.1365-2958.2010.07265.x; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shmakov S, 2014, NUCLEIC ACIDS RES, V42, P5907, DOI 10.1093/nar/gku226; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Wang SW, 2010, VIROLOGY, V403, P78, DOI 10.1016/j.virol.2010.03.044; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Yosef I, 2013, P NATL ACAD SCI USA, V110, P14396, DOI 10.1073/pnas.1300108110; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zeng H, 2015, APPL MICROBIOL BIOT, V99, P10575, DOI 10.1007/s00253-015-6931-4; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	37	13	15	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149533	10.1371/journal.pone.0149533	http://dx.doi.org/10.1371/journal.pone.0149533			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901661	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100093
J	Vasques, ER; Cunha, JEM; Coelho, AMM; Sampietre, SN; Patzina, RA; Abdo, EE; Nader, HB; Tersariol, ILS; Lima, MA; Godoy, CMG; Rodrigues, T; Chaib, E; D'Albuquerque, LAC				Vasques, Enio Rodrigues; Monteiro Cunha, Jose Eduardo; Mendonca Coelho, Ana Maria; Sampietre, Sandra N.; Patzina, Rosely Antunes; Abdo, Emilio Elias; Nader, Helena B.; Tersariol, Ivarne L. S.; Lima, Marcelo Andrade; Godoy, Carlos M. G.; Rodrigues, Tiago; Chaib, Eleazar; D'Albuquerque, Luiz A. C.			Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MOLECULAR-WEIGHT HEPARIN; HEPATIC ISCHEMIA; RAT-LIVER; LIPID-PEROXIDATION; CYTOSOLIC CALCIUM; EXCHANGER; APOPTOSIS; PEPTIDE; DAMAGE	Background Ischemia and reperfusion (I/R) causes tissue damage and intracellular calcium levels are a factor of cell death. Sodium calcium exchanger (NCX) regulates calcium extrusion and Trisulfated Disaccharide (TD) acts on NCX decreasing intracellular calcium through the inhibition of the exchange inhibitory peptide (XIP). Objectives The aims of this research are to evaluate TD effects in liver injury secondary to I/R in animals and in vitro action on cytosolic calcium of hepatocytes cultures under calcium overload. Methods Wistar rats submitted to partial liver ischemia were divided in groups: Control: (n = 10): surgical manipulation with no liver ischemia; Saline: (n = 15): rats receiving IV saline before reperfusion; and TD: (n = 15): rats receiving IV TD before reperfusion. Four hours after reperfusion, serum levels of AST, ALT, TNF-alpha, IL-6, and IL-10 were measured. Liver tissue samples were collected for mitochondrial function and malondialdehyde (MDA) content. Pulmonary vascular permeability and histologic parameters of liver were determined. TD effect on cytosolic calcium was evaluated in BRL3A hepatic rat cell cultures stimulated by thapsigargin pre and after treatment with TD. Results AST, ALT, cytokines, liver MDA, mitochondrial dysfunction and hepatic histologic injury scores were less in TD group when compared to Saline Group (p<0.05) with no differences in pulmonary vascular permeability. In culture cells, TD diminished the intracellular calcium raise and prevented the calcium increase pre and after treatment with thapsigargin, respectively. Conclusion TD decreases liver cell damage, preserves mitochondrial function and increases hepatic tolerance to I/R injury by calcium extrusion in Ca2+ overload situations.	[Vasques, Enio Rodrigues; Monteiro Cunha, Jose Eduardo; Mendonca Coelho, Ana Maria; Sampietre, Sandra N.; Patzina, Rosely Antunes; Abdo, Emilio Elias; Chaib, Eleazar; D'Albuquerque, Luiz A. C.] Univ Sao Paulo, Sch Med, Dept Gastroenterol LIM 37, Sao Paulo, Brazil; [Nader, Helena B.; Tersariol, Ivarne L. S.; Lima, Marcelo Andrade] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Sao Paulo, Brazil; [Godoy, Carlos M. G.] Fed Univ Sao Paulo UNIFESP, Dept Sci & Technol, Sao Paulo, Brazil; [Rodrigues, Tiago] Fed Univ ABC, Ctr Nat & Human Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC)	Vasques, ER (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol LIM 37, Sao Paulo, Brazil.	evasques@globo.com	D'Albuquerque, Luiz A Carneiro/I-4011-2012; Rodrigues, Tiago/AAG-1121-2020; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; de Godoy, Carlos Marcelo Gurjão/P-4538-2019; Chaib, Eleazar/G-3446-2012; de Godoy, Carlos Marcelo MG Gurjão/A-2563-2013; Rodrigues, Tiago/B-8459-2012; Nader, Helena Bonciani/D-9253-2012; VASQUES, ENIO/E-2285-2013	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Rodrigues, Tiago/0000-0003-1277-0224; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; de Godoy, Carlos Marcelo Gurjão/0000-0001-8846-3242; de Godoy, Carlos Marcelo MG Gurjão/0000-0001-8846-3242; Rodrigues, Tiago/0000-0003-1277-0224; NADER, HELENA/0000-0002-7569-2166; VASQUES, ENIO/0000-0002-8424-2669				Abdel-Salam OME, 2005, PHARMACOL RES, V51, P59, DOI 10.1016/j.phrs.2004.04.009; Amberger A, 2001, TRANSPLANTATION, V71, P1821, DOI 10.1097/00007890-200106270-00019; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Canedo Leonardo Fernandes, 2012, Rev. Col. Bras. Cir., V39, P216; CARINI R, 1995, BIOCHEM BIOPH RES CO, V208, P813, DOI 10.1006/bbrc.1995.1409; Chan CC, 2014, J GASTROEN HEPATOL, V29, P603, DOI 10.1111/jgh.12366; CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0; Chang WJ, 2010, J INVEST SURG, V23, P228, DOI 10.3109/08941939.2010.496036; Chattopadhyay P, 2010, APPL BIOCHEM BIOTECH, V160, P1968, DOI 10.1007/s12010-009-8761-2; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clavien PA, 2004, J GASTROINTEST SURG, V8, P313, DOI 10.1016/j.gassur.2003.12.006; Coelho AMM, 1997, BRAZ J MED BIOL RES, V30, P947, DOI 10.1590/S0100-879X1997000800006; Crisostomo PR, 2006, J AM COLL SURGEONS, V202, P797, DOI 10.1016/j.jamcollsurg.2005.12.002; DIETRICH CP, 1968, BIOCHEM J, V108, P647, DOI 10.1042/bj1080647; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Teixeira ARF, 2009, ACTA CIR BRAS, V24, P52, DOI 10.1590/S0102-86502009000100011; Harada N, 2006, CRIT CARE MED, V34, P1883, DOI 10.1097/01.CCM.0000220764.10155.03; JANCAR S, 1988, PROSTAGLANDINS, V35, P757, DOI 10.1016/0090-6980(88)90148-7; Kim JA, 2000, FREE RADICAL RES, V33, P267, DOI 10.1080/10715760000301431; Kukner A, 2010, ANN HEPATOL, V9, P445, DOI 10.1016/S1665-2681(19)31621-7; Kupiec-Weglinski JW, TRANSPLANT P, V37, P1653; Li J, 2015, EUR REV MED PHARMACO, V19, P2036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Coelho AMM, 2011, J GASTROINTEST SURG, V15, P1679, DOI 10.1007/s11605-011-1648-x; Moussa M E, 1996, Liver Transpl Surg, V2, P461, DOI 10.1002/lt.500020609; Nicoud IB, 2007, AM J PHYSIOL-GASTR L, V293, pG623, DOI 10.1152/ajpgi.00521.2006; Nogueira MA, 2014, WORLD J GASTROENTERO, V20, P15319, DOI 10.3748/wjg.v20.i41.15319; Quireze C, 2006, J INVEST SURG, V19, P229, DOI 10.1080/08941930600778206; Seabra ALR, 2012, ABCD-ARQ BRAS CIR DI, V25, P105, DOI 10.1590/S0102-67202012000200009; Figueira ERR, 2010, SURGERY, V147, P415, DOI 10.1016/j.surg.2009.10.018; Camara-Lemarroy CR, 2014, ARCH MED RES, V45, P210, DOI 10.1016/j.arcmed.2014.02.001; Sakamoto K, 2009, J PHYSIOL-LONDON, V587, P5345, DOI 10.1113/jphysiol.2009.172080; Schwartz J, 2013, TOXICOL APPL PHARM, V273, P172, DOI 10.1016/j.taap.2013.08.027; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shinjo SK, 2002, J BIOL CHEM, V277, P48227, DOI 10.1074/jbc.M205867200; Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008; Taha MO, 2009, TRANSPL P, V41, P812, DOI 10.1016/j.transproceed.2009.02.042; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; van Golen RF, 2015, J HEPATOL, V62, P975, DOI 10.1016/j.jhep.2014.12.014; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Xing WJ, 2011, CLIN EXP PHARMACOL P, V38, P605, DOI 10.1111/j.1440-1681.2011.05559.x; Yamanaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122214; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Yener AU, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-35; Zhang WX, 2011, HEPATOB PANCREAT DIS, V10, P78, DOI 10.1016/S1499-3872(11)60011-8; Zhou T, 2002, WORLD J GASTROENTERO, V8, P897, DOI 10.3748/wjg.v8.i5.897	49	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149630	10.1371/journal.pone.0149630	http://dx.doi.org/10.1371/journal.pone.0149630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901764	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000371276100115
J	Wang, J; Dupuis, C; Tyring, SK; Underbrink, MP				Wang, Jia; Dupuis, Crystal; Tyring, Stephen K.; Underbrink, Michael P.			Sterile a Motif Domain Containing 9 Is a Novel Cellular Interacting Partner to Low-Risk Type Human Papillomavirus E6 Proteins	PLOS ONE			English	Article							RECURRENT RESPIRATORY PAPILLOMATOSIS; ONCOPROTEIN E6; ALPHA MOTIF; DEGRADATION; P53; ASSOCIATION; INTERFERON; BINDING; SAMD9; UBIQUITINATION	Low-risk type human papillomavirus (HPV) 6 and 11 infection causes recurrent respiratory papillomatosis (RRP) and genital warts. RRP is the most common benign tumor of the larynx in children with frequent relapses. Repeated surgeries are often needed to improve vocal function and prevent life-threatening respiratory obstruction. Currently, there are no effective treatments available to completely eliminate these diseases, largely due to limited knowledge regarding their viral molecular pathogenesis. HPV E6 proteins contribute to cell immortalization by interacting with a variety of cellular proteins, which have been well studied for the high-risk type HPVs related to cancer progression. However, the functions of low-risk HPV E6 proteins are largely unknown. In this study, we report GST-pulldown coupled mass spectrometry analysis with low-risk HPV E6 proteins that identified sterile alpha motif domain containing 9 (SAMD9) as a novel interacting partner. We then confirmed the interaction between HPV-E6 and SAMD9 using co-immunoprecipitation, proximity ligation assay, and confocal immunofluorescence staining. The SAMD9 gene is down-regulated in a variety of neoplasms and deleteriously mutated in normophosphatemic familial tumoral calcinosis. Interestingly, SAMD9 also has antiviral functions against poxvirus. Our study adds to the limited knowledge of the molecular properties of low-risk HPVs and describes new potential functions for the low-risk HPV E6 protein.	[Wang, Jia; Underbrink, Michael P.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Dupuis, Crystal; Underbrink, Michael P.] Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston	Underbrink, MP (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.; Underbrink, MP (corresponding author), Univ Texas Med Branch, Dept Otolaryngol, Galveston, TX 77555 USA.	mpunderb@utmb.edu			National Institute on Deafness and Other Communication Disorders [K08DC010337]; McLaughlin Endowment at University of Texas Medical Branch; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC010337] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); McLaughlin Endowment at University of Texas Medical Branch; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by a National Institute on Deafness and Other Communication Disorders grant to MU: K08DC010337, http://www.nidcd.nih.gov/Pages/default.aspx. JW was supported by a Predoctoral fellowship from McLaughlin Endowment at University of Texas Medical Branch, http://www.utmb.edu/mclaughlin/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brimer N, 2007, VIROLOGY, V358, P303, DOI 10.1016/j.virol.2006.08.038; Chefetz I, 2008, J INVEST DERMATOL, V128, P1423, DOI 10.1038/sj.jid.5701203; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8; Degenhardt YY, 2001, J VIROL, V75, P151, DOI 10.1128/JVI.75.1.151-160.2001; Degenhardt YY, 2001, J VIROL, V75, P11791, DOI 10.1128/JVI.75.23.11791-11802.2001; FOSTER SA, 1994, J VIROL, V68, P5698, DOI 10.1128/JVI.68.9.5698-5705.1994; Gerein V, 2005, ANN OTO RHINOL LARYN, V114, P463, DOI 10.1177/000348940511400608; Glaunsinger BA, 2000, ONCOGENE, V19, P5270, DOI 10.1038/sj.onc.1203906; Gupta S, 2003, VIROLOGY, V317, P155, DOI 10.1016/j.virol.2003.08.008; HALBERT CL, 1992, J VIROL, V66, P2125, DOI 10.1128/JVI.66.4.2125-2134.1992; HALBERT CL, 1991, J VIROL, V65, P473, DOI 10.1128/JVI.65.1.473-478.1991; HEALY GB, 1988, NEW ENGL J MED, V319, P401, DOI 10.1056/NEJM198808183190704; Howie HL, 2009, VIROLOGY, V384, P324, DOI 10.1016/j.virol.2008.11.017; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jha S, 2010, MOL CELL, V38, P700, DOI 10.1016/j.molcel.2010.05.020; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Kehmeier E, 2002, VIROLOGY, V299, P72, DOI 10.1006/viro.2002.1502; Kiyono T, 1997, P NATL ACAD SCI USA, V94, P11612, DOI 10.1073/pnas.94.21.11612; Kuhne C, 1998, J BIOL CHEM, V273, P34302, DOI 10.1074/jbc.273.51.34302; Kukimoto I, 1998, BIOCHEM BIOPH RES CO, V249, P258, DOI 10.1006/bbrc.1998.9066; Lacey CJN, 2006, VACCINE, V24, P35, DOI 10.1016/j.vaccine.2006.06.015; LEVENTHAL BG, 1991, NEW ENGL J MED, V325, P613, DOI 10.1056/NEJM199108293250904; Li CF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-92; Liu J, 2015, J VIROL, V89, P1925, DOI 10.1128/JVI.02262-14; Liu J, 2011, J VIROL, V85, P3270, DOI 10.1128/JVI.02243-10; Nakagawa S, 2000, MOL CELL BIOL, V20, P8244, DOI 10.1128/MCB.20.21.8244-8253.2000; Neveu G, 2012, METHODS, V58, P349, DOI 10.1016/j.ymeth.2012.07.029; Nomine Y, 2006, MOL CELL, V21, P665, DOI 10.1016/j.molcel.2006.01.024; Oh ST, 2004, J VIROL, V78, P2620, DOI 10.1128/JVI.78.5.2620-2626.2004; Park JS, 2001, INT J CANCER, V91, P822, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1130>3.0.CO;2-0; Park KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038990; Rozenblatt-Rosen O, 2012, NATURE, V487, P491, DOI 10.1038/nature11288; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sivan G, 2015, MBIO, V6, DOI 10.1128/mBio.01122-15; Spangle JM, 2010, J VIROL, V84, P9398, DOI 10.1128/JVI.00974-10; Tanaka M, 2010, INT J CANCER, V126, P1982, DOI 10.1002/ijc.24965; Tao MF, 2003, J VIROL, V77, P13232, DOI 10.1128/JVI.77.24.13232-13247.2003; Thomas M, 1999, J GEN VIROL, V80, P1513, DOI 10.1099/0022-1317-80-6-1513; Thomas M, 2013, VIROLOGY, V435, P357, DOI 10.1016/j.virol.2012.11.004; Topaz O, 2006, AM J HUM GENET, V79, P759, DOI 10.1086/508069; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; White EA, 2013, VIROLOGY, V435, P57, DOI 10.1016/j.virol.2012.09.046; White EA, 2012, J VIROL, V86, P13174, DOI 10.1128/JVI.02172-12; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zhang GF, 2010, MOL ENDOCRINOL, V24, P1737, DOI 10.1210/me.2010-0125; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x	48	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149859	10.1371/journal.pone.0149859	http://dx.doi.org/10.1371/journal.pone.0149859			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901061	Green Published, gold			2022-12-26	WOS:000371276100165
J	Yadava, RS; Foff, EP; Yu, Q; Gladman, JT; Zheng, TS; Mahadevan, MS				Yadava, Ramesh S.; Foff, Erin P.; Yu, Qing; Gladman, Jordan T.; Zheng, Timothy S.; Mahadevan, Mani S.			TWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity	PLOS ONE			English	Article							SKELETAL-MUSCLE; MYOTONIC-DYSTROPHY; WEAK INDUCER; APOPTOSIS TWEAK; KAPPA-B; SIGNALING PATHWAYS; CYTOKINE; ATROPHY; REPEAT; CELLS	Myotonic dystrophy type 1 (DM1), the most common form of muscular dystrophy in adults, is caused by toxic RNAs produced from the mutant DM protein kinase (DMPK) gene. DM1 is characterized by progressive muscle wasting and weakness. Therapeutic strategies have mainly focused on targeting the toxic RNA. Previously, we found that fibroblast growth factor-inducible 14 (Fn14), the receptor for TWEAK, is induced in skeletal muscles and hearts of mouse models of RNA toxicity and that blocking TWEAK/Fn14 signaling improves muscle function and histology. Here, we studied the effect of Tweak deficiency in a RNA toxicity mouse model. The genetic deletion of Tweak in these mice significantly reduced muscle damage and improved muscle function. In contrast, administration of TWEAK in the RNA toxicity mice impaired functional outcomes and worsened muscle histopathology. These studies show that signaling via TWEAK is deleterious to muscle in RNA toxicity and support the demonstrated utility of anti-TWEAK therapeutics.	[Yadava, Ramesh S.; Yu, Qing; Gladman, Jordan T.; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Foff, Erin P.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Zheng, Timothy S.] Biogen Idec Inc, Dept Immunol, Cambridge, MA USA	University of Virginia; University of Virginia; Biogen	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021	Yadava, Ramesh S/0000-0002-0092-5033	Biogen; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045992, R01AR062189, R01AR052771] Funding Source: NIH RePORTER	Biogen(Biogen); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Biogen provided salary support for Dr. Timothy S. Zheng. The funder provided support in the form of salaries for author TSZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bossen C, 2006, J BIOL CHEM, V281, P13964, DOI 10.1074/jbc.M601553200; Bowerman M, 2015, HUM MOL GENET, V24, P3440, DOI 10.1093/hmg/ddv094; Brown SAN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065248; Burkly LC, 2011, IMMUNOL REV, V244, P99, DOI 10.1111/j.1600-065X.2011.01054.x; Campbell S, 2006, J IMMUNOL, V176, P1889, DOI 10.4049/jimmunol.176.3.1889; Chicheportiche Y, 1997, J BIOL CHEM, V272, P32401, DOI 10.1074/jbc.272.51.32401; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fugier C, 2011, NAT MED, V17, P720, DOI 10.1038/nm.2374; Girgenrath M, 2006, EMBO J, V25, P5826, DOI 10.1038/sj.emboj.7601441; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Kumar M, 2009, J IMMUNOL, V182, P2439, DOI 10.4049/jimmunol.0803357; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Morosetti R, 2012, AM J PATHOL, V180, P1603, DOI 10.1016/j.ajpath.2011.12.027; Ogura Y, 2013, J BIOL CHEM, V288, P35159, DOI 10.1074/jbc.M113.517300; Peterson JM, 2011, CURR TOP DEV BIOL, V96, P85, DOI 10.1016/B978-0-12-385940-2.00004-8; Sato S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00018; Tajrishi MM, 2014, BIOCHEM BIOPH RES CO, V446, P1219, DOI 10.1016/j.bbrc.2014.03.084; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tang ZZ, 2012, HUM MOL GENET, V21, P1312, DOI 10.1093/hmg/ddr568; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Yadava RS, 2008, NAT GENET, V40, P61, DOI 10.1038/ng.2007.28; Yadava RS, 2015, HUM MOL GENET, V24, P2035, DOI 10.1093/hmg/ddu617	34	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150192	10.1371/journal.pone.0150192	http://dx.doi.org/10.1371/journal.pone.0150192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901467	Green Published, gold			2022-12-26	WOS:000371276100211
J	Rice, MA; Ishteiwy, RA; Magani, F; Udayakumar, T; Reiner, T; Yates, TJ; Miller, P; Perez-Stable, C; Rai, P; Verdun, R; Dykxhoorn, DM; Burnstein, KL				Rice, M. A.; Ishteiwy, R. A.; Magani, F.; Udayakumar, T.; Reiner, T.; Yates, T. J.; Miller, P.; Perez-Stable, C.; Rai, P.; Verdun, R.; Dykxhoorn, D. M.; Burnstein, K. L.			The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related	ONCOGENE			English	Article							MICRORNA EXPRESSION; MOLECULAR PATHWAYS; HIP1R; FAMILY; GROWTH; MODEL	Deregulation of microRNAs (miRs) contributes to progression and metastasis of prostate and other cancers. miR-23b and -27b, encoded in the same miR cluster (miR-23b/-27b), are downregulated in human metastatic prostate cancer compared with primary tumors and benign tissue. Expression of miR-23b/-27b decreases prostate cancer cell migration, invasion and results in anoikis resistance. Conversely, antagomiR-mediated miR-23b and -27b silencing produces the opposite result in a more indolent prostate cancer cell line. However, neither miR-23b/-27b expression or inhibition impacts prostate cancer cell proliferation suggesting that miR-23b/-27b selectively suppresses metastasis. To examine the effects of miR-23b/-27b on prostate cancer metastasis in vivo, orthotopic prostate xenografts were established using aggressive prostate cancer cells transduced with miR-23b/-27b or non-targeting control miRNA. Although primary tumor formation was similar between miR-23b/-27b-transduced cells and controls, miR-23b/-27b expression in prostate cancer cells decreased seminal vesicle invasion and distant metastases. Gene-expression profiling identified the endocytic adaptor, Huntingtin-interacting protein 1-related (HIP1R) as being downregulated by miR-23b/-27b. Increased HIP1R expression in prostate cancer cells inversely phenocopied the effects of miR-23b/-27b overexpression on migration, invasion and anchorage-independent growth. HIP1R rescued miR-23b/-27b-mediated repression of migration in prostate cancer cells. HIP1R mRNA levels were decreased in seminal vesicle tissue from mice bearing miR-23b/-27b-transduced prostate cancer cell xenografts compared with scrambled controls, suggesting HIP1R is a key functional target of miR-23b/-27b. In addition, depletion of HIP1R led to a more rounded, less mesenchymal-like cell morphology, consistent with decreased metastatic properties. Together, these data demonstrate that the miR-23b/-27b cluster functions as a metastasis-suppressor by decreasing HIP1R levels in pre-clinical models of prostate cancer.	[Rice, M. A.; Magani, F.; Yates, T. J.] Univ Miami, Miller Sch Med, Sheila & David Fuente Grad Program Canc Biol, Miami, FL 33136 USA; [Ishteiwy, R. A.; Burnstein, K. L.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6155,R-189, Miami, FL 33136 USA; [Udayakumar, T.] Univ Miami, Miller Sch Med, Dept Radiat Oncol, Miami, FL 33136 USA; [Reiner, T.; Perez-Stable, C.; Verdun, R.] Univ Miami, Miller Sch Med, Div Geriatr, Dept Med, Miami, FL 33136 USA; [Miller, P.; Perez-Stable, C.; Rai, P.; Verdun, R.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA; [Dykxhoorn, D. M.] Univ Miami, Miller Sch Med, Dept Human Genet, John T Macdonald Fdn, Miami, FL 33136 USA; [Dykxhoorn, D. M.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Dykxhoorn, D. M.] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Burnstein, KL (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, 1600 NW 10th Ave,RMSB 6155,R-189, Miami, FL 33136 USA.	KBurnstein@med.miami.edu	Rice, Meghan/AAH-3098-2019	Rai, Priyamvada/0000-0001-7822-7553; Rice, Meghan/0000-0003-4578-0461	DOD [W81XWH-11-1-0314]; NIH [R01CA132200]; Women's Cancer Association of the University of Miami; NATIONAL CANCER INSTITUTE [R01CA132200] Funding Source: NIH RePORTER	DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Women's Cancer Association of the University of Miami; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding provided by DOD pre-doctoral fellowship W81XWH-11-1-0314 (RAI/MAR), NIH R01CA132200 and Women's Cancer Association of the University of Miami (KLB). We thank UM investigators Drs Cale Fahrenholtz, Stephanie Peacock and Ning Zhao, as well as Annie Greene and Govindi Samaranayake for helpful technical assistance and guidance. Dr Michael Henry at the University of Iowa and Dr David Drubin at University of California at Berkeley generously provided the PQCXIN-luciferase and HIP1R-6myc constructs respectively.	Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Boettner DR, 2012, NAT CELL BIOL, V14, P2, DOI 10.1038/ncb2403; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; D'Ambrosio J, 2009, CLIN EXP METASTAS, V26, P955, DOI 10.1007/s10585-009-9286-3; Dalmay T, 2006, ONCOGENE, V25, P6170, DOI 10.1038/sj.onc.1209911; DAMICO AV, 1995, J UROLOGY, V154, P131, DOI 10.1016/S0022-5347(01)67248-3; Dykxhoorn DM, 2010, CANCER RES, V70, P6401, DOI 10.1158/0008-5472.CAN-10-1346; Engqvist-Goldstein AEY, 2004, MOL BIOL CELL, V15, P1666, DOI 10.1091/mbc.E03-09-0639; Engqvist-Goldstein AEY, 1999, J CELL BIOL, V147, P1503, DOI 10.1083/jcb.147.7.1503; Fuse M, 2012, J HUM GENET, V57, P691, DOI 10.1038/jhg.2012.95; Gandellini P, 2009, TRENDS MOL MED, V15, P381, DOI 10.1016/j.molmed.2009.07.004; Gottfried I, 2010, BIOCHEM SOC T, V38, P187, DOI 10.1042/BST0380187; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Howe EN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2867; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Hyun TS, 2004, MOL CELL BIOL, V24, P4329, DOI 10.1128/MCB.24.10.4329-4340.2004; Hyun TS, 2004, J BIOL CHEM, V279, P14294, DOI 10.1074/jbc.M312645200; Ishteiwy RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052106; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Liu W, 2014, CANCER MICROENVIRON, V7, P117, DOI 10.1007/s12307-014-0148-4; LOOP SM, 1993, PROSTATE, V22, P93, DOI 10.1002/pros.2990220202; Lyons LS, 2008, MOL ENDOCRINOL, V22, P597, DOI 10.1210/me.2007-0158; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Peacock SO, 2012, MOL ENDOCRINOL, V26, P1967, DOI 10.1210/me.2012-1165; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rao DS, 2002, J CLIN INVEST, V110, P351, DOI 10.1172/JCI200215529; Seki N, 1998, J HUM GENET, V43, P268, DOI 10.1007/s100380050087; Shi XB, 2008, J CELL MOL MED, V12, P1456, DOI 10.1111/j.1582-4934.2008.00420.x; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Sun T, 2012, PROSTATE, V72, P1093, DOI 10.1002/pros.22456; Sun T, 2009, CANCER RES, V69, P3356, DOI 10.1158/0008-5472.CAN-08-4112; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Wang JH, 2008, NEOPLASIA, V10, P847, DOI 10.1593/neo.08450; WANG M, 1991, DIFFERENTIATION, V48, P115, DOI 10.1111/j.1432-0436.1991.tb00250.x; Wang YL, 2015, CLIN GENITOURIN CANC, V13, P261, DOI 10.1016/j.clgc.2015.01.003; Yates TJ, 2015, JNCI-J NATL CANCER I, V107, P7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158	45	34	38	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 8	2016	35	36					4752	4761		10.1038/onc.2016.6	http://dx.doi.org/10.1038/onc.2016.6			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0IS	26898757	Green Accepted			2022-12-26	WOS:000383324700008
J	Hodge, CD; Ismail, IH; Edwards, RA; Hura, GL; Xiao, AT; Tainer, JA; Hendzel, MJ; Glover, JNM				Hodge, Curtis D.; Ismail, Ismail H.; Edwards, Ross A.; Hura, Greg L.; Xiao, Andrew T.; Tainer, John A.; Hendzel, Michael J.; Glover, J. N. Mark			RNF8 E3 Ubiquitin Ligase Stimulates Ubc13 E2 Conjugating Activity That Is Essential for DNA Double Strand Break Signaling and BRCA1 Tumor Suppressor Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY SOLUTION; DAMAGE RESPONSE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; COMPLEX; MDC1; PROTEINS; REVEALS; SAXS; UBIQUITYLATION	DNA double strand break (DSB) responses depend on the sequential actions of the E3 ubiquitin ligases RNF8 and RNF168 plus E2 ubiquitin-conjugating enzyme Ubc13 to specifically generate histone Lys-63-linked ubiquitin chains in DSB signaling. Here, we defined the activated RNF8-Ubc13 similar to ubiquitin complex by x-ray crystallography and its functional solution conformations by x-ray scattering, as tested by separation-offunction mutations imaged in cells by immunofluorescence. The collective results show that the RING E3 RNF8 targets E2 Ubc13 to DSB sites and plays a critical role in damage signaling by stimulating polyubiquitination through modulating conformations of ubiquitin covalently linked to the Ubc13 active site. Structure-guided separation-of-function mutations show that the RNF8 E2 stimulating activity is essential for DSB signaling in mammalian cells and is necessary for down stream recruitment of 53BP1 and BRCA1. Chromatin-targeted RNF168 rescues 53BP1 recruitment involved in non-homologous end joining but not BRCA1 recruitment for homologous recombination. These findings suggest an allosteric approach to targeting the ubiquitin-docking cleft at the E2-E3 interface for possible interventions in cancer and chronic inflammation, and moreover, they establish an independent RNF8 role in BRCA1 recruitment.	[Hodge, Curtis D.; Edwards, Ross A.; Xiao, Andrew T.; Glover, J. N. Mark] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Ismail, Ismail H.; Hendzel, Michael J.] Univ Alberta, Dept Oncol, Edmonton, AB T6G 1Z2, Canada; [Hura, Greg L.; Tainer, John A.] Lawrence Berkeley Natl Lab, Berkeley, CA 94704 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Ismail, Ismail H.] Cairo Univ, Fac Sci, Dept Biophys, Giza 12613, Egypt	University of Alberta; University of Alberta; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; UTMD Anderson Cancer Center; Egyptian Knowledge Bank (EKB); Cairo University	Glover, JNM (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	mark.glover@ualberta.ca	Hendzel, Michael/C-3391-2009; Classen, Scott/AAY-8176-2020; Tainer, John/GWQ-4878-2022	Hendzel, Michael/0000-0002-9603-7945; Tainer, John/0000-0003-1659-2429; Hura, Greg/0000-0003-0501-8464; Hodge, Curtis/0000-0002-7528-4058; Ismail, Ismail Hassan/0000-0002-5526-6063	Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research); National Institutes of Health MINOS Grant [GM105404]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105404] Funding Source: NIH RePORTER	Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research); National Institutes of Health MINOS Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Classen at the Advanced Light Source (SIBYLS) for crystallographic data collections and support. We also thank the Cellular Imaging Facility at the Cross Cancer Institute for the use of microscopes. We thank X. Yu, Division of Molecular Medicine and Genetics, University of Michigan Medical School, Ann Arbor, MI, for the gift of the RNF8 knock-out MEFs. SAXS data collection and analysis at SIBYLS BL12.3.1 at the Advanced Light Source were supported by the Integrated Diffraction Analysis Technologies Program (Department of Energy/Biological and Environmental Research) and by National Institutes of Health MINOS Grant GM105404.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berndsen CE, 2014, NAT STRUCT MOL BIOL, V21, P301, DOI 10.1038/nsmb.2780; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Branigan E, 2015, NAT STRUCT MOL BIOL, V22, P597, DOI 10.1038/nsmb.3052; Campbell SJ, 2012, J BIOL CHEM, V287, P23900, DOI 10.1074/jbc.M112.359653; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Carvalho AF, 2012, MOL BIOTECHNOL, V51, P254, DOI 10.1007/s12033-011-9463-x; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Deshpande RA, 2014, EMBO J, V33, P482, DOI 10.1002/embj.201386100; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Haas AL, 1997, FASEB J, V11, P1257; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hodge CD, 2015, ACS CHEM BIOL, V10, P1718, DOI 10.1021/acschembio.5b00222; Huen MSY, 2008, MOL CELL BIOL, V28, P6104, DOI 10.1128/MCB.00987-08; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Minter-Dykhouse K, 2008, J CELL BIOL, V181, P727, DOI 10.1083/jcb.200801083; Moraes TF, 2001, NAT STRUCT BIOL, V8, P669, DOI 10.1038/90373; Nordquist KA, 2010, BIOCHEMISTRY-US, V49, P347, DOI 10.1021/bi901620v; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Plans V, 2006, J CELL BIOCHEM, V97, P572, DOI 10.1002/jcb.20587; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Polo SE, 2011, GENE DEV, V25, P409, DOI 10.1101/gad.2021311; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Saito T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012239; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shibata A, 2014, MOL CELL, V53, P7, DOI 10.1016/j.molcel.2013.11.003; Soss SE, 2013, BIOCHEMISTRY-US, V52, P2991, DOI 10.1021/bi3015949; Soss SE, 2011, J BIOL CHEM, V286, P21277, DOI 10.1074/jbc.M111.224006; Spycher C, 2008, J CELL BIOL, V181, P227, DOI 10.1083/jcb.200709008; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Williams RS, 2007, BIOCHEM CELL BIOL, V85, P509, DOI 10.1139/O07-069; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005; Yin Q, 2009, NAT STRUCT MOL BIOL, V16, P658, DOI 10.1038/nsmb.1605; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	64	22	22	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9396	9410		10.1074/jbc.M116.715698	http://dx.doi.org/10.1074/jbc.M116.715698			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26903517	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000375602300002
J	Yao, LL; Shen, M; Lu, ZK; Ikebe, M; Li, XD				Yao, Lin-Lin; Shen, Mei; Lu, Zekuan; Ikebe, Mitsuo; Li, Xiang-dong			Identification of the Isoform-specific Interactions between the Tail and the Head of Class V Myosin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; ATPase; intracellular trafficking; molecular motor; myosin; unconventional myosin	CARGO-BINDING DOMAIN; LOW DUTY RATIO; STRUCTURAL BASIS; GLOBULAR TAIL; UNCONVENTIONAL MYOSIN; CONFORMATIONAL-CHANGE; CRYSTAL-STRUCTURE; MESSENGER-RNA; MOTOR; CALMODULIN	Vertebrates have three isoforms of class V myosin (Myo5), Myo5a, Myo5b, and Myo5c, which are involved in transport of multiple cargoes. It is well established that the motor functions of Myo5a and Myo5b are regulated by a tail inhibition mechanism. Here we found that the motor function of Myo5c was also inhibited by its globular tail domain (GTD), and this inhibition was abolished by high Ca2+, indicating that the tail inhibition mechanism is conserved in vertebrate Myo5. Interestingly, we found that Myo5a-GTD and Myo5c-GTD were not interchangeable in terms of inhibition of motor function, indicating isoform-specific interactions between the GTD and the head of Myo5. To identify the isoform-specific interactions, we produced a number of Myo5 chimeras by swapping the corresponding regions of Myo5a and Myo5c. We found that Myo5a-GTD, with its H11-H12 loop being substituted with that of Myo5c, was able to inhibit the ATPase activity of Myo5c and that Myo5a-GTD was able to inhibit the ATPase activity of Myo5c-S1 and Myo5c-HMM only when their IQ1 motif was substituted with that of Myo5a. Those results indicate that the H11-H12 loop in the GTD and the IQ1 motif in the head dictate the isoform-specific interactions between the GTD and head of Myo5. Because the IQ1 motif is wrapped by calmodulin, whose conformation is influenced by the sequence of the IQ1 motif, we proposed that the calmodulin bound to the IQ1 motif interacts with the H11-H12 loop of the GTD in the inhibited state of Myo5.	[Yao, Lin-Lin; Shen, Mei; Lu, Zekuan; Li, Xiang-dong] Chinese Acad Sci, Inst Zool, Grp Cell Motil & Muscle Contract, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Ikebe, Mitsuo] Univ Texas Tyler, Hlth Sci Ctr, Dept Cellular & Mol Biol, Tyler, TX 75708 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Li, XD (corresponding author), Chinese Acad Sci, Inst Zool, Beijing 100101, Peoples R China.	lixd@ioz.ac.cn			National Basic Research Program of China [2013CB932802, 2012CB114102]; National Natural Science Foundation of China [31171367, 31470791]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2013CB932802 and 2012CB114102 and National Natural Science Foundation of China Grants 31171367 and 31470791. The authors declare that they have no conflicts of interest with the contents of this article.	Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Dominguez R, 1998, CELL, V94, P559, DOI 10.1016/S0092-8674(00)81598-6; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Gunther LK, 2014, SCI REP-UK, V4, DOI 10.1038/srep04907; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Houdusse A, 2000, P NATL ACAD SCI USA, V97, P11238, DOI 10.1073/pnas.200376897; Houdusse A, 2006, P NATL ACAD SCI USA, V103, P19326, DOI 10.1073/pnas.0609436103; Ikebe M, 2008, BIOCHEM BIOPH RES CO, V369, P157, DOI 10.1016/j.bbrc.2008.01.057; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Ji HH, 2015, BIOCHEM J, V469, P135, DOI 10.1042/BJ20141330; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lu Q, 2015, NAT STRUCT MOL BIOL, V22, P81, DOI 10.1038/nsmb.2923; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; Nascimento AFZ, 2013, J BIOL CHEM, V288, P34131, DOI 10.1074/jbc.M113.507202; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, EUKARYOT CELL, V4, P787, DOI 10.1128/EC.4.4.787-798.2005; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Rodriguez OC, 2002, J CELL SCI, V115, P991; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takagi Y, 2008, J BIOL CHEM, V283, P8527, DOI 10.1074/jbc.M709150200; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Velvarska H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082065; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Wang ZP, 2008, CELL, V135, P535, DOI 10.1016/j.cell.2008.09.057; Watanabe S, 2008, J BIOL CHEM, V283, P10581, DOI 10.1074/jbc.M707657200; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Wu XF, 1997, J CELL SCI, V110, P847; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Yao LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep10874; Zhao LP, 1996, P NATL ACAD SCI USA, V93, P10826, DOI 10.1073/pnas.93.20.10826	40	5	5	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8241	8250		10.1074/jbc.M115.693762	http://dx.doi.org/10.1074/jbc.M115.693762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26912658	Green Published, hybrid			2022-12-26	WOS:000374056700039
J	Chowdhury, MQ; De Ridder, M; Beeckman, H				Chowdhury, Md. Qumruzzaman; De Ridder, Maaike; Beeckman, Hans			Climatic Signals in Tree Rings of Heritiera fomes Buch.-Ham. in the Sundarbans, Bangladesh	PLOS ONE			English	Article							GROWTH RINGS; TROPICAL TREES; MANGROVES; VARIABILITY; FOREST; DENDROCHRONOLOGY; PERIODICITY; DYNAMICS; BIOMASS; IMPACT	Mangroves occur along the coastlines throughout the tropics and sub-tropics, supporting a wide variety of resources and services. In order to understand the responses of future climate change on this ecosystem, we need to know how mangrove species have responded to climate changes in the recent past. This study aims at exploring the climatic influences on the radial growth of Heritiera fomes from a local to global scale. A total of 40 stem discs were collected at breast height position from two different zones with contrasting salinity in the Sundarbans, Bangladesh. All specimens showed distinct tree rings and most of the trees (70%) could be visually and statistically crossdated. Successful crossdating enabled the development of two zone-specific chronologies. The mean radial increment was significantly higher at low salinity (eastern) zone compared to higher salinity (western) zone. The two zone-specific chronologies synchronized significantly, allowing for the construction of a regional chronology. The annual and monsoon precipitation mainly influence the tree growth of H. fomes. The growth response to local precipitation is similar in both zones except June and November in the western zone, while the significant influence is lacking. The large-scale climatic drivers such as sea surface temperature (SST) of equatorial Pacific and Indian Ocean as well as the El Nio-Southern Oscillation (ENSO) revealed no teleconnection with tree growth. The tree rings of this species are thus an indicator for monsoon precipitation variations in Bangladesh. The wider distribution of this species from the South to South East Asian coast presents an outstanding opportunity for developing a large-scale tree-ring network of mangroves.	[Chowdhury, Md. Qumruzzaman; De Ridder, Maaike; Beeckman, Hans] RMCA, Wood Biol Serv, Leuvensesteenweg 13, B-3080 Tervuren, Belgium; [Chowdhury, Md. Qumruzzaman] Shahjalal Univ Sci & Technol, Dept Forestry & Environm Sci, Sylhet 3114, Bangladesh	Royal Museum for Central Africa; Shahjalal University of Science & Technology (SUST)	Chowdhury, MQ (corresponding author), RMCA, Wood Biol Serv, Leuvensesteenweg 13, B-3080 Tervuren, Belgium.; Chowdhury, MQ (corresponding author), Shahjalal Univ Sci & Technol, Dept Forestry & Environm Sci, Sylhet 3114, Bangladesh.	qumrul-for@sust.edu	Beeckman, Hans/I-7653-2019; Chowdhury, Qumruzzaman/H-5118-2019	Beeckman, Hans/0000-0001-8954-6277; Chowdhury, Qumruzzaman/0000-0002-1766-1185	Belgian Federal Science Policy office - Marie Curie Actions from the European Commission	Belgian Federal Science Policy office - Marie Curie Actions from the European Commission	MQC was supported by a mobility grant from the Belgian Federal Science Policy office co-funded by the Marie Curie Actions from the European Commission. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Agrawala S, 2003, DEVELOPMENT; Ahasan MN, 2010, J HYDRO, P7, DOI 10.3126/jhm.v7i1.5612; AMOBI CC, 1974, ANN BOT-LONDON, V38, P931, DOI 10.1093/oxfordjournals.aob.a084887; BAILLIE M G L, 1973, Tree-Ring Bulletin, V33, P7; Bhattacharyya A, 2009, IAWA J, V30, P361, DOI 10.1163/22941932-90000224; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biswas SR, 2007, FOREST ECOL MANAG, V245, P1, DOI 10.1016/j.foreco.2007.02.011; Biswas SR, 2012, J PLANT ECOL, V5, P157, DOI 10.1093/jpe/rtr050; Brienen RJW, 2010, GLOBAL CHANGE BIOL, V16, P2001, DOI 10.1111/j.1365-2486.2009.02059.x; Briffa K.R., 1990, METHODS DENDROCHRONO, P137, DOI DOI 10.1007/978-94-015-7879-0; Briffa KR, 1998, PHILOS T ROY SOC B, V353, P65, DOI 10.1098/rstb.1998.0191; Buckley BM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023745; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Chaudhuri A. B., 1994, MANGROVES SUNDARBANS, V1, P1; Chowdhury MQ, 2008, IAWA J, V29, P265; Chowdhury MQ, 2015, TREES, DOI 10.1007/s00468-015-1292-2; Chowdhury MR, 2003, THEOR APPL CLIMATOL, V76, P105, DOI 10.1007/s00704-003-0001-z; Cook E.R., 2013, METHODS DENDROCHRONO; D'Arrigo R, 2011, GEOPHYS RES LETT, P38, DOI 10.1029/2011GL049927; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Day P.R., 1965, METHODS SOIL ANAL 1, P545, DOI DOI 10.2134/AGRONMONOGR9.1.C43; De Ridder M, 2013, FOREST ECOL MANAG, V304, P417, DOI 10.1016/j.foreco.2013.05.007; De Ridder M, 2013, TREES-STRUCT FUNCT, V27, P1225, DOI 10.1007/s00468-013-0871-3; Devoe NN, 1998, FOREST ECOL MANAG, V103, P33, DOI 10.1016/S0378-1127(97)00176-X; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; DOUGLASS A. E., 1941, JOUR FOREST, V39, P825; Estrada GCD, 2008, TREES-STRUCT FUNCT, V22, P663, DOI 10.1007/s00468-008-0224-9; Eckstein D, 1969, FORSTWISSENSCHAFTLIC, V88, P230, DOI DOI 10.1007/BF02741777; Ellison AM, 2000, J ECOL, V88, P813, DOI 10.1046/j.1365-2745.2000.00500.x; Fritts H. C., 1976, TREE RINGS CLIMATE; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; Iftekhar M. S., 2008, Wetlands Ecology and Management, V16, P119, DOI 10.1007/s11273-007-9060-8; Islam MS, 2005, HYDROBIOLOGIA, V542, P165, DOI 10.1007/s10750-004-0756-y; Islam Shafi Noor, 2008, Frontiers of Earth Science in China, V2, P439, DOI 10.1007/s11707-008-0049-2; IUCN, 2003, STATUS; IUCN, 2001, BANGL SUND PHOT REAL; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kennedy JJ, 2011, J GEOPHYS RES, P116; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Krauss KW, 2006, HYDROBIOLOGIA, V569, P311, DOI 10.1007/s10750-006-0139-7; Kripalani RH, 1996, INT J CLIMATOL, V16, P689, DOI 10.1002/(SICI)1097-0088(199606)16:6&lt;689::AID-JOC36&gt;3.0.CO;2-K; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Mbow C, 2013, DENDROCHRONOLOGIA, V31, P41, DOI 10.1016/j.dendro.2012.06.001; Mirza MMQ, 1998, ENVIRON MANAGE, V22, P711, DOI 10.1007/s002679900141; Misra V, 2012, CLIM DYNAM, V39, P1149, DOI 10.1007/s00382-012-1319-y; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; MWANGI T, 1999, J ECOL, V37, P180; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Pumijumnong N, 2013, TREES-STRUCT FUNCT, V27, P343, DOI 10.1007/s00468-012-0775-7; Rahman MA, 2003, TOP; RAO RV, 1987, IAWA BULL, V8, P337; Rinn F., 2003, TSAP WINTM USER REFE; Robert EMR, 2011, TREES-STRUCT FUNCT, V25, P49, DOI 10.1007/s00468-010-0487-9; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Santini NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080116; Sarker SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21234; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz Nele, 2007, Dendrochronologia, V25, P87, DOI 10.1016/j.dendro.2006.08.001; Schongart J, 2004, GLOBAL CHANGE BIOL, V10, P683, DOI 10.1111/j.1529-8817.2003.00754.x; Schweingruber FH, 1988, TREE; Schweingruber FH, 1996, FOREST SNOW LANDSCAP; Shahid S.A., 2013, DEV SOIL SALINITY AS, P3; Siddiqi NA, 2001, ENV SCI; Solomon S, 2007, CLIMATE CHANGE 2007, V4; Srivastava R, 2001, IAWA J, V22, P85, DOI 10.1163/22941932-90000271; Sun Qiang, 2000, Acta Phytotaxonomica et Geobotanica, V51, P37; Tomlinson PB, 1994, BOT MANGROVES; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Trouet V, 2013, TREE-RING RES, V69, P3, DOI 10.3959/1536-1098-69.1.3; Trouet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047364; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; Ummenhofer CC, 2013, CLIM DYNAM, V40, P1319, DOI 10.1007/s00382-012-1458-1; van Oldenborgh GJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023110; Verheyden A, 2005, NEW PHYTOL, V167, P425, DOI 10.1111/j.1469-8137.2005.01415.x; Verheyden A, 2004, ANN BOT-LONDON, V94, P59, DOI 10.1093/aob/mch115; Vliet G. J. C. M. van, 1976, Wood structure in biological and technological research (Leiden Botanical Series No. 3)., P20; Wang B, 1999, B AM METEOROL SOC, V80, P629, DOI 10.1175/1520-0477(1999)080<0629:COSASM>2.0.CO;2; Wils THG, 2011, TREES-STRUCT FUNCT, V25, P71, DOI 10.1007/s00468-010-0475-0; Worbes M, 1995, IAWA J, V16, P337, DOI 10.1163/22941932-90001424; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Yu KF, 2007, NUCL INSTRUM METH B, V255, P399, DOI 10.1016/j.nimb.2006.11.127	85	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149788	10.1371/journal.pone.0149788	http://dx.doi.org/10.1371/journal.pone.0149788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927229	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200016
J	Beiki, F; Busquets, A; Gomila, M; Rahimian, H; Lalucat, J; Garcia-Valdes, E				Beiki, Farid; Busquets, Antonio; Gomila, Margarita; Rahimian, Heshmat; Lalucat, Jorge; Garcia-Valdes, Elena			New Pseudomonas spp. Are Pathogenic to Citrus	PLOS ONE			English	Article							SP NOV.; BACTERIA; IDENTIFICATION; PHYLOGENY; NAMES; LIST	Five putative novel Pseudomonas species shown to be pathogenic to citrus have been characterized in a screening of 126 Pseudomonas strains isolated from diseased citrus leaves and stems in northern Iran. The 126 strains were studied using a polyphasic approach that included phenotypic characterizations and phylogenetic multilocus sequence analysis. The pathogenicity of these strains against 3 cultivars of citrus is demonstrated in greenhouse and field studies. The strains were initially grouped phenotypically and by their partial rpoD gene sequences into 11 coherent groups in the Pseudomonas fluorescens phylogenetic lineage. Fifty-three strains that are representatives of the 11 groups were selected and analyzed by partial sequencing of their 16S rRNA and gyrB genes. The individual and concatenated partial sequences of the three genes were used to construct the corresponding phylogenetic trees. The majority of the strains were identified at the species level: P. lurida (5 strains), P. monteilii (2 strains), P. moraviensis (1 strain), P. orientalis (16 strains), P. simiae (7 strains), P. syringae (46 strains, distributed phylogenetically in at least 5 pathovars), and P. viridiflava (2 strains). This is the first report of pathogenicity on citrus of P. orientalis, P. simiae, P. lurida, P. moraviensis and P. monteilii strains. The remaining 47 strains that could not be identified at the species level are considered representatives of at least 5 putative novel Pseudomonas species that are not yet described.	[Beiki, Farid] Agr Res Educ & Extens Org AREEO, Iranian Res Inst Plant Protect, Tehran, Iran; [Busquets, Antonio; Gomila, Margarita; Lalucat, Jorge; Garcia-Valdes, Elena] Univ Illes Balears, Dept Biol Microbiol, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain; [Rahimian, Heshmat] Univ Sari, Agr Sci & Nat Resources, Mazandaran, Iran; [Rahimian, Heshmat] Sari Agr Sci & Nat Resources Univ, Dept Plant Protect, POB 578, Mazandaran, SaSari, Iran; [Lalucat, Jorge; Garcia-Valdes, Elena] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain	Universitat de les Illes Balears; Sari Agricultural Sciences & Natural Resources University (SANRU); Sari Agricultural Sciences & Natural Resources University (SANRU); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Garcia-Valdes, E (corresponding author), Univ Illes Balears, Dept Biol Microbiol, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.; Garcia-Valdes, E (corresponding author), CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.	elena.garciavaldes@uib.es	Gomila, Margarita/H-3314-2015; Lalucat, Jorge/K-1127-2014; Garcia-Valdes, Elena/K-1143-2014; Busquets Bisbal, Antonio/K-9206-2014	Gomila, Margarita/0000-0001-8725-190X; Lalucat, Jorge/0000-0002-8350-6087; Garcia-Valdes, Elena/0000-0001-5829-0002; Busquets Bisbal, Antonio/0000-0002-2793-1388	Spanish Ministry of Economy and Competitiveness MINECO [BOS2011 CGL24318, CSD2009-00006]	Spanish Ministry of Economy and Competitiveness MINECO(Spanish Government)	The work was supported by BOS2011 CGL24318 and Consolider CSD2009-00006 from Spanish Ministry of Economy and Competitiveness MINECO.	Behrendt U, 2007, INT J SYST EVOL MICR, V57, P979, DOI 10.1099/ijs.0.64793-0; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; Brent K. J., 1998, FUNGICIDE RESISTANCE; Bull CT, 2012, J PLANT PATHOL, V94, P21; Bull CT, 2010, J PLANT PATHOL, V92, P551; Cladera AM, 2004, J BACTERIOL, V186, P5239, DOI 10.1128/JB.186.16.5239-5248.2004; Dabboussi F, 1999, RES MICROBIOL, V150, P303, DOI 10.1016/S0923-2508(99)80056-4; Edwards C. A., 1993, The pesticide question: environment, economics and ethics., P13, DOI 10.1007/978-0-585-36973-0_2; Elomari M, 1997, INT J SYST BACTERIOL, V47, P846, DOI 10.1099/00207713-47-3-846; Ewing JH, 1960, SYST EVOL MICROBIOL, V10, P223; Hojo H, 2008, MICROBIOL-SGM, V154, P2920, DOI 10.1099/mic.0.2008/021097-0; KING EO, 1954, J LAB CLIN MED, V44, P301; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Martinez-Rosales C, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.7123; Masuda M, 2007, EXTREMOPHILES, V11, P355, DOI 10.1007/s00792-006-0047-9; Mishra PK, 2009, BIOL RES, V42, P305, DOI [/S0716-97602009000300005, 10.4067/S0716-97602009000300005]; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Mulet M, 2008, INT J SYST EVOL MICR, V58, P2309, DOI 10.1099/ijs.0.65797-0; Mulet M, 2012, SYST APPL MICROBIOL, V35, P455, DOI 10.1016/j.syapm.2012.08.007; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Mulet M, 2009, MOL CELL PROBE, V23, P140, DOI 10.1016/j.mcp.2009.02.001; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Razinataj M, 2004, IRAN J AGR SCI, V35, P253; Schaad NW, 2001, LAB GUIDE IDENTIFICA, P373; Scotta C, 2012, EUR J CLIN MICROBIOL, V31, P2133, DOI 10.1007/s10096-012-1547-4; Selvakumar G, 2011, WORLD J MICROB BIOT, V27, P1129, DOI 10.1007/s11274-010-0559-4; Shams-Bakhsh M, 1997, IRANIAN J PLANT PATH, V33, P132; STEAD DE, 1992, INT J SYST BACTERIOL, V42, P281, DOI 10.1099/00207713-42-2-281; Taghavi S. M., 2003, Journal of Science and Technology of Agriculture and Natural Resources, V7, P199; Timmer L.W., 2000, COMPENDIUM CITRUS DI, V2nd; Vela AI, 2006, INT J SYST EVOL MICR, V56, P2671, DOI 10.1099/ijs.0.64378-0; Whiteside JO, 1989, COMPENDIUM CITRUS DI; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Young JM, 2010, J PLANT PATHOL, V92, pS5	37	19	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148796	10.1371/journal.pone.0148796	http://dx.doi.org/10.1371/journal.pone.0148796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919540	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400010
J	Louis, S; Tappu, RM; Damms-Machado, A; Huson, DH; Bischoff, SC				Louis, Sandrine; Tappu, Rewati-Mukund; Damms-Machado, Antje; Huson, Daniel H.; Bischoff, Stephan C.			Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing	PLOS ONE			English	Article							DIET; INFLAMMATION; IMPACT; MICE; NOV.; TOOL	Background/Objectives Cross-sectional studies suggested that obesity is promoted by the gut microbiota. However, longitudinal data on taxonomic and functional changes in the gut microbiota of obese patients are scarce. The aim of this work is to study microbiota changes in the course of weight loss therapy and the following year in obese individuals with or without co-morbidities, and to asses a possible predictive value of the gut microbiota with regard to weight loss maintenance. Subjects/Methods Sixteen adult patients, who followed a 52-week weight-loss program comprising low calorie diet, exercise and behavioral therapy, were selected according to their weight-loss course. Over two years, anthropometric and metabolic parameters were assessed and microbiota from stool samples was functionally and taxonomically analyzed using DNA shotgun sequencing. Results Overall the microbiota responded to the dietetic and lifestyle intervention but tended to return to the initial situation both at the taxonomical and functional level at the end of the intervention after one year, except for an increase in Akkermansia abundance which remained stable over two years (12.7x10(3) counts, 95% CI: 322-25100 at month 0; 141x10(3) counts, 95% CI: 49-233x10(3) at month 24; p = 0.005). The Firmicutes/Bacteroidetes ratio was higher in obese subjects with metabolic syndrome (0.64, 95% CI: 0.34-0.95) than in the "healthy obese" (0.27, 95% CI: 0.08-0.45, p = 0.04). Participants, who succeeded in losing their weight consistently over the two years, had at baseline a microbiota enriched in Alistipes, Pseudoflavonifractor and enzymes of the oxidative phosphorylation pathway compared to patients who were less successful in weight reduction. Conclusions Successful weight reduction in the obese is accompanied with increased Akkermansia numbers in feces. Metabolic co-morbidities are associated with a higher Firmicutes/Bacteroidetes ratio. Most interestingly, microbiota differences might allow discrimination between successful and unsuccessful weight loss prior to intervention.	[Louis, Sandrine; Damms-Machado, Antje; Bischoff, Stephan C.] Univ Hohenheim, Inst Clin Nutr, Stuttgart, Germany; [Tappu, Rewati-Mukund; Huson, Daniel H.] Univ Tubingen, Algorithms Bioinformat, Tubingen, Germany; [Damms-Machado, Antje] German Canc Res Ctr, Heidelberg, Germany	University Hohenheim; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Bischoff, SC (corresponding author), Univ Hohenheim, Inst Clin Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Huson, Daniel H./AAC-5494-2019		Federal Ministry of Education and Research (Germany) from the "Competence Network Obesity" project [01GI1122H]	Federal Ministry of Education and Research (Germany) from the "Competence Network Obesity" project	This work was supported by the Federal Ministry of Education and Research (Germany): Funding number 01GI1122H from the "Competence Network Obesity" project, obtained by SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kim HW, 2014, ENVIRON RES, V135, P354, DOI 10.1016/j.envres.2014.08.032; Landig J, 1998, CLIN NUTR, V17, P113, DOI 10.1016/S0261-5614(98)80004-6; Leifer CA, 2014, IMMUNOL LETT, V162, P3, DOI 10.1016/j.imlet.2014.07.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-26; Mishra P, 2007, AM J GASTROENTEROL, V102, P2716, DOI 10.1111/j.1572-0241.2007.01520.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rautio M, 2003, SYST APPL MICROBIOL, V26, P182, DOI 10.1078/072320203322346029; Roberts DW, 2015, LABDSV ORDINATION MU; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simoes CD, 2014, EUR J NUTR, V53, P1421, DOI 10.1007/s00394-013-0645-0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Xu J, 2015, ISME J, V9, P552, DOI 10.1038/ismej.2014.177; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	48	152	160	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149564	10.1371/journal.pone.0149564	http://dx.doi.org/10.1371/journal.pone.0149564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919743	Green Submitted, gold, Green Published			2022-12-26	WOS:000371274400024
J	Mishra, S; Bansal, S; Mishra, B; Sangwan, RS; Jadaun, AJS; Sangwan, NS				Mishra, Smrati; Bansal, Shilpi; Mishra, Bhawana; Sangwan, Rajender Singh; Jadaun, Asha Jyoti Singh; Sangwan, Neelam S.			RNAi and Homologous Over-Expression Based Functional Approaches Reveal Triterpenoid Synthase Gene-Cycloartenol Synthase Is Involved in Downstream Withanolide Biosynthesis in Withania somnifera	PLOS ONE			English	Article							MOLECULAR-CLONING; OXIDOSQUALENE CYCLASES; STEROIDAL LACTONES; PROMOTER ANALYSIS; PLANT; REDUCTION; ROOTS; CDNA	Withania somnifera Dunal, is one of the most commonly used medicinal plant in Ayurvedic and indigenous medicine traditionally owing to its therapeutic potential, because of major chemical constituents, withanolides. Withanolide biosynthesis requires the activities of several enzymes in vivo. Cycloartenol synthase (CAS) is an important enzyme in the withanolide biosynthetic pathway, catalyzing cyclization of 2, 3 oxidosqualene into cycloartenol. In the present study, we have cloned full-length WsCAS from Withania somnifera by homology-based PCR method. For gene function investigation, we constructed three RNAi gene-silencing constructs in backbone of RNAi vector pGSA and a full-length over-expression construct. These constructs were transformed in Agrobacterium strain GV3101 for plant transformation in W. somnifera. Molecular and metabolite analysis was performed in putative Withania transformants. The PCR and Southern blot results showed the genomic integration of these RNAi and overexpression construct(s) in Withania genome. The qRT-PCR analysis showed that the expression of WsCAS gene was considerably downregulated in stable transgenic silenced Withania lines compared with the non-transformed control and HPLC analysis showed that withanolide content was greatly reduced in silenced lines. Transgenic plants over expressing CAS gene displayed enhanced level of CAS transcript and withanolide content compared to non-transformed controls. This work is the first full proof report of functional validation of any metabolic pathway gene inW. somnifera at whole plant level as per our knowledge and it will be further useful to understand the regulatory role of different genes involved in the biosynthesis of withanolides.	[Mishra, Smrati; Bansal, Shilpi; Mishra, Bhawana; Sangwan, Rajender Singh; Jadaun, Asha Jyoti Singh; Sangwan, Neelam S.] CSIR Cent Inst Med & Aromat Plants CSIR CIMAP, Dept Metab & Struct Biol, PO CIMAP, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] Ctr Innovat & Appl Bioproc CIAB, Ind Area, C-127,Phase 8, Mohali, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Department of Biotechnology (DBT) India; Center of Innovative & Applied Bioprocessing (CIAB)	Sangwan, NS (corresponding author), CSIR Cent Inst Med & Aromat Plants CSIR CIMAP, Dept Metab & Struct Biol, PO CIMAP, Lucknow, Uttar Pradesh, India.	nss.cimap@gmail.com	Jadaun, Dr Jyoti/GQA-8219-2022	Jadaun, Dr Jyoti/0000-0001-9276-4865; Mishra, Bhawana/0000-0002-0777-8830; sangwan, Neelam singh/0000-0003-2761-702X	Department of Biotechnology, New Delhi, NMITLI, Government of India [BT/PR10715/AGR/36/602/2008]; CSIR, New Delhi;  [BSC 203]	Department of Biotechnology, New Delhi, NMITLI, Government of India; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); 	This work was supported by grant No. BT/PR10715/AGR/36/602/2008 from the Department of Biotechnology, New Delhi, NMITLI, Government of India to NSS and RSS. The authors are also thankful to BSC 203 grant for supporting completion of work. SB is thankful to CSIR, New Delhi for Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeeva I, TRANSGENIC PLANTS AD; Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Basyuni M, 2007, BIOSCI BIOTECH BIOCH, V71, P1788, DOI 10.1271/bbb.70113; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; D'Ambrosio C, 2011, TRANSGENIC RES, V20, P47, DOI 10.1007/s11248-010-9387-4; Dhar N, 2013, MOL BIOL REP, V40, P7007, DOI 10.1007/s11033-013-2820-z; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Gas-Pascual E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109156; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Han JY, 2006, PLANT CELL PHYSIOL, V47, P1653, DOI 10.1093/pcp/pcl032; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Hayashi H, 2000, BIOL PHARM BULL, V23, P231, DOI 10.1248/bpb.23.231; Hayashi H, 2001, BIOL PHARM BULL, V24, P912, DOI 10.1248/bpb.24.912; Hoffmann T, 2006, PLANT J, V48, P818, DOI 10.1111/j.1365-313X.2006.02913.x; Hoque M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068390; Jiang F, 2013, J PLANT GROWTH REGUL, V32, P182, DOI 10.1007/s00344-012-9289-1; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Kushwaha AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074777; Ma C, 2011, PLANT MOL BIOL REP, V29, P117, DOI 10.1007/s11105-010-0211-3; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra S, 2016, J PLANT BIOCHEM BIOT, V25, P191, DOI 10.1007/s13562-015-0324-8; Mohanpuria P, 2011, MOL BIOTECHNOL, V48, P235, DOI 10.1007/s12033-010-9364-4; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Morita M, 1997, BIOL PHARM BULL, V20, P770, DOI 10.1248/bpb.20.770; Moses T, 2015, PLANT CELL, V27, P286, DOI 10.1105/tpc.114.134486; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Sabir F, 2013, PROTOPLASMA, V250, P539, DOI 10.1007/s00709-012-0438-y; Sambrook J., 2001, MOL CLONING LAB MANU; Sangwan N.S., 2013, RECENT PATENT BIOTEC, V8, P25; Sangwan NS, 2014, PLANT CELL MONOGR, V22, P325, DOI 10.1007/978-3-642-41787-0_11; Sangwan NS, 2013, CROP SCI; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sawai S, 2011, FEBS LETT, V585, P1031, DOI 10.1016/j.febslet.2011.02.037; Senthil K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1214-0; Shinozaki J, 2008, FEBS LETT, V582, P310, DOI 10.1016/j.febslet.2007.12.023; Sil B, 2015, PROTOPLASMA, V252, P1097, DOI 10.1007/s00709-014-0743-8; Singh R, 2007, CHEM PHARM BULL, V55, P1371, DOI 10.1248/cpb.55.1371; Srivastava S, 2015, PROTOPLASMA, V252, P1421, DOI 10.1007/s00709-015-0766-9; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Takagi K, 2011, PLANT CELL REP, V30, P1835, DOI 10.1007/s00299-011-1091-1; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Wang P, 2008, J BIOSCIENCES, V33, P177, DOI 10.1007/s12038-008-0035-6; Wang ZH, 2010, J BIOL CHEM, V285, P29703, DOI 10.1074/jbc.M109.098871; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Zarate R, 2013, BIOTECHNOLOGY MED PL, P359	56	21	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149691	10.1371/journal.pone.0149691	http://dx.doi.org/10.1371/journal.pone.0149691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919744	gold, Green Published			2022-12-26	WOS:000371274400035
J	Toia, F; Buccheri, S; Anfosso, A; Moschella, F; Dieli, F; Meraviglia, S; Cordova, A				Toia, Francesca; Buccheri, Simona; Anfosso, Ampelio; Moschella, Francesco; Dieli, Francesco; Meraviglia, Serena; Cordova, Adriana			Skewed Differentiation of Circulating V gamma 9V delta 2 T Lymphocytes in Melanoma and Impact on Clinical Outcome	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; RECEPTOR GAMMA-DELTA; METASTATIC MELANOMA; IMPAIRED FUNCTION; CELLS; CANCER; IMMUNOTHERAPY; INTERLEUKIN-2; ZOLEDRONATE; ACTIVATION	Objective The aim of this study was to evaluate over time circulating gamma delta T lymphocytes in melanoma patients in terms of frequency, effector functions, and relationship with clinical stage and evolution, by comparing preoperative values to those obtained at a mean follow-up of 36 months or in the event of recurrence or disease progression, and to those of healthy controls. Also, we correlated the presence of tumor-infiltrating gamma delta T lymphocytes with clinical evolution of melanoma. Results Mean frequencies of circulating gamma delta T cells before and after melanoma removal were very similar and comparable to healthy subjects, but patients who progressed to stage III or IV showed a significantly decreased frequency of circulating V gamma 9V delta 2 T cells. The distribution of V gamma 9V delta 2 memory and effector subsets was similar in healthy subjects and melanoma patients at diagnosis, but circulating gamma delta T cells of patients after melanoma removal had a skewed terminally-differentiated effector memory phenotype. Highly suggestive of progressive differentiation toward a cytotoxic phenotype, V gamma 9V delta 2T cells from patients at follow up had increased cytotoxic potential and limited cytokine production capability, while the opposite pattern was detected in V gamma 9V delta 2T cells from patients before melanoma removal. Conclusions Follow-up data also showed that tumor infiltrating gamma delta T cells were significantly associated with lower mortality and relapse rates, suggesting that they may serve as a prognostic biomarker, for human melanoma.	[Toia, Francesca; Anfosso, Ampelio; Moschella, Francesco] Univ Palermo, Dept Surg Oncol & Oral Sci DICHIRONS, Palermo, Italy; [Buccheri, Simona; Dieli, Francesco; Meraviglia, Serena] Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Palermo, Italy; [Buccheri, Simona; Dieli, Francesco; Meraviglia, Serena] Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy; [Buccheri, Simona] Mediterranean Inst Transplantat & Adv Specialized, Dept Treatment & Study Abdominal Dis & Transplant, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Dieli, F (corresponding author), Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Palermo, Italy.; Dieli, F (corresponding author), Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy.	francesco.dieli@unipa.it	Meraviglia, Serena/K-5164-2016; Toia, Francesca/AAH-4246-2021	Dieli, Francesco/0000-0002-6685-352X				Argentati K, 2003, J INVEST DERMATOL, V120, P829, DOI 10.1046/j.1523-1747.2003.12141.x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Becker JC, 2000, CLIN EXP DERMATOL, V25, P503, DOI 10.1046/j.1365-2230.2000.00690.x; Bedane C, 2013, CURR MED RES OPIN, V29, P1297, DOI 10.1185/03007995.2013.820693; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boring C C, 1991, Bol Asoc Med P R, V83, P225; Buccheri S, 2014, J BIOL REG HOMEOS AG, V28, P81; Caccamo N, 2006, J LEUKOCYTE BIOL, V79, P663, DOI 10.1189/jlb.1105640; Campillo JA, 2007, DERMATOLOGY, V214, P283, DOI 10.1159/000100878; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; Cordova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049878; Coscia M, 2012, BLOOD, V120, P3271, DOI 10.1182/blood-2012-03-417519; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; ITOH K, 1986, CANCER RES, V46, P3011; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Khammari A, 2007, CANCER IMMUNOL IMMUN, V56, P1853, DOI 10.1007/s00262-007-0340-1; Mandala M, 2014, VIRCHOWS ARCH, V464, P265, DOI 10.1007/s00428-013-1526-x; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P199; MUUL LM, 1987, J IMMUNOL, V138, P989; Nunes C, 2012, CLIN CANCER RES, V18, P678, DOI 10.1158/1078-0432.CCR-11-2630; Oberg HH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00643; Oberg HH, 2014, CANCER RES, V74, P1349, DOI 10.1158/0008-5472.CAN-13-0675; Oelke M, 2005, DRUG TODAY, V41, P13, DOI 10.1358/dot.2005.41.1.875775; Petrini I, 2011, EUR J CLIN INVEST, V41, P1186, DOI 10.1111/j.1365-2362.2011.02524.x; Poccia F, 1997, J LEUKOCYTE BIOL, V62, P287, DOI 10.1002/jlb.62.3.287; Provinciali M, 2010, SCAND J IMMUNOL, V72, P142, DOI 10.1111/j.1365-3083.2010.02413.x; Saleh FH, 2001, INT J CANCER, V94, P551, DOI 10.1002/ijc.1491; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; Sireci G, 1997, HUM IMMUNOL, V58, P70, DOI 10.1016/S0198-8859(97)00211-5; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TEFANY FJ, 1991, J INVEST DERMATOL, V97, P197, DOI 10.1111/1523-1747.ep12479662; Tinhofer I, 2009, J IMMUNOTHER, V32, P302, DOI 10.1097/CJI.0b013e318197b5e4; Varela-Rohena A, 2008, IMMUNOL RES, V42, P166, DOI 10.1007/s12026-008-8057-6; Welton JL, 2013, ONCOLOGIST, V18, pE22, DOI 10.1634/theoncologist.2013-0097	48	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149570	10.1371/journal.pone.0149570	http://dx.doi.org/10.1371/journal.pone.0149570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915072	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700019
J	Foy, SP; Sennino, B; dela Cruz, T; Cote, JJ; Gordon, EJ; Kemp, F; Xavier, V; Franzusoff, A; Rountree, RB; Mandl, SJ				Foy, Susan P.; Sennino, Barbara; dela Cruz, Tracy; Cote, Joseph J.; Gordon, Evan J.; Kemp, Felicia; Xavier, Veronica; Franzusoff, Alex; Rountree, Ryan B.; Mandl, Stefanie J.			Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PHASE-II; T-CELLS; EXPRESSION; VACCINE; RESPONSES; ANTIGEN; PSA; IMMUNORESISTANCE; IMMUNIZATION	Poxvirus-based active immunotherapies mediate anti-tumor efficacy by triggering broad and durable Th1 dominated T cell responses against the tumor. While monotherapy significantly delays tumor growth, it often does not lead to complete tumor regression. It was hypothesized that the induced robust infiltration of IFN gamma-producing T cells into the tumor could provoke an adaptive immune evasive response by the tumor through the upregulation of PD-L1 expression. In therapeutic CT26-HER-2 tumor models, MVA-BN-HER2 poxvirus immunotherapy resulted in significant tumor growth delay accompanied by a robust, tumor-infiltrating T cell response that was characterized by low to mid-levels of PD-1 expression on T cells. As hypothesized, this response was countered by significantly increased PD-L1 expression on the tumor and, unexpectedly, also on infiltrating T cells. Synergistic benefit of anti-tumor therapy was observed when MVA-BN-HER2 immunotherapy was combined with PD-1 immune checkpoint blockade. Interestingly, PD-1 blockade stimulated a second immune checkpoint molecule, LAG-3, to be expressed on T cells. Combining MVA-BN-HER2 immunotherapy with dual PD-1 plus LAG-3 blockade resulted in comprehensive tumor regression in all mice treated with the triple combination therapy. Subsequent rejection of tumors lacking the HER-2 antigen by treatment-responsive mice without further therapy six months after the original challenge demonstrated long lasting memory and suggested that effective T cell immunity to novel, non-targeted tumor antigens (antigen spread) had occurred. These data support the clinical investigation of this triple therapy regimen, especially in cancer patients harboring PD-L1(neg/low) tumors unlikely to benefit from immune checkpoint blockade alone.	[Foy, Susan P.; Sennino, Barbara; dela Cruz, Tracy; Cote, Joseph J.; Gordon, Evan J.; Kemp, Felicia; Xavier, Veronica; Franzusoff, Alex; Rountree, Ryan B.; Mandl, Stefanie J.] Bavarian Nord Inc, Redwood City, CA USA	Bavarian Nordic	Foy, SP (corresponding author), Bavarian Nord Inc, Redwood City, CA USA.	SusanPFoy@gmail.com		Kemp, Felicia/0000-0001-8400-3089	Bavarian Nordic, Inc.	Bavarian Nordic, Inc.	The authors received no specific funding for this work. Bavarian Nordic, Inc. provided support in the form of salaries for authors [SPF, BS, TC, JC, EJG, FK, VX, AF, RBR, SJM] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akagi J, 1997, J IMMUNOTHER, V20, P38, DOI 10.1097/00002371-199701000-00004; Baitsch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030852; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Durham NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109080; Fleury S G, 1991, Semin Immunol, V3, P177; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; Foy SP, 2014, J CLIN ONCOL S, V32; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Gulley JL, 2014, CANCER IMMUNOL RES, V2, P133, DOI 10.1158/2326-6066.CIR-13-0108; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodge JW, 1999, CANCER RES, V59, P5800; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jochems C, 2014, CANCER IMMUNOL IMMUN, V63, P407, DOI 10.1007/s00262-014-1524-0; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Kudo-Saito C, 2005, CLIN CANCER RES, V11, P2416, DOI 10.1158/1078-0432.CCR-04-1380; Li ZJ, 2010, J VIROL METHODS, V169, P87, DOI 10.1016/j.jviromet.2010.07.003; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Madan RA, 2012, LANCET ONCOL, V13, P501, DOI 10.1016/S1470-2045(12)70006-2; Madan RA, 2009, EXPERT OPIN INV DRUG, V18, P1001, DOI 10.1517/13543780902997928; Mandl SJ, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0034-0; Mandl SJ, 2012, CANCER IMMUNOL IMMUN, V61, P19, DOI 10.1007/s00262-011-1077-4; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; Morse MA, 2013, ANN SURG, V258, P879, DOI 10.1097/SLA.0b013e318292919e; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Renard V, 2003, J IMMUNOL, V171, P1588, DOI 10.4049/jimmunol.171.3.1588; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Singh H, 2015, J CLIN ONCOL, V33; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Villaruz LC, 2014, TRANSL LUNG CANCER R, V3, P2, DOI 10.3978/j.issn.2218-6751.2013.10.13; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185	49	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150084	10.1371/journal.pone.0150084	http://dx.doi.org/10.1371/journal.pone.0150084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910562	gold, Green Submitted, Green Published			2022-12-26	WOS:000371164700063
J	Hwang, M; Song, JS; Lee, YS; Li, C; Shim, EB; Pak, HN				Hwang, Minki; Song, Jun-Seop; Lee, Young-Seon; Li, Changyong; Shim, Eun Bo; Pak, Hui-Nam			Electrophysiological Rotor Ablation in In-Silico Modeling of Atrial Fibrillation: Comparisons with Dominant Frequency, Shannon Entropy, and Phase Singularity	PLOS ONE			English	Article							COMPLEX FRACTIONATED ELECTROGRAMS; RADIOFREQUENCY CATHETER ABLATION; PULMONARY VEIN ISOLATION; OPEN-CHEST DOGS; VENTRICULAR-FIBRILLATION; CARDIAC FIBRILLATION; IONIC DETERMINANTS; MOTHER ROTORS; MECHANISMS; REENTRY	Background Although rotors have been considered among the drivers of atrial fibrillation (AF), the rotor definition is inconsistent. We evaluated the nature of rotors in 2D and 3D in- silico models of persistent AF (PeAF) by analyzing phase singularity (PS), dominant frequency (DF), Shannon entropy (ShEn), and complex fractionated atrial electrogram cycle length (CFAE-CL) and their ablation. Methods Mother rotor was spatiotemporally defined as stationary reentries with a meandering tip remaining within half the wavelength and lasting longer than 5 s. We generated 2D- and 3D-maps of the PS, DF, ShEn, and CFAE-CL during AF. The spatial correlations and ablation outcomes targeting each parameter were analyzed. Results 1. In the 2D PeAF model, we observed a mother rotor that matched relatively well with DF (>9 Hz, 71.0%, p<0.001), ShEn (upper 2.5%, 33.2%, p<0.001), and CFAE-CL (lower 2.5%, 23.7%, p<0.001). 2. The 3D-PeAF model also showed mother rotors that had spatial correlations with DF (>5.5 Hz, 39.7%, p<0.001), ShEn (upper 8.5%, 15.1%, p <0.001), and CFAE (lower 8.5%, 8.0%, p = 0.002). 3. In both the 2D and 3D models, virtual ablation targeting the upper 5% of the DF terminated AF within 20 s, but not the ablations based on long-lasting PS, high ShEn area, or lower CFAE-CL area. Conclusion Mother rotors were observed in both 2D and 3D human AF models. Rotor locations were well represented by DF, and their virtual ablation altered wave dynamics and terminated AF.	[Hwang, Minki; Song, Jun-Seop; Lee, Young-Seon; Li, Changyong; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea; [Shim, Eun Bo] Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea	Yonsei University; Yonsei University Health System; Kangwon National University	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea.; Shim, EB (corresponding author), Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea.	ebshim@kangwon.ac.kr; hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Pak, Hui-Nam/0000-0002-3256-3620; Song, Jun-Seop/0000-0002-5886-4210	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; Basic Science Research Program run by the National Research Foundation of Korea (NRF), Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059391]	Korea Health 21 R&D Project, Ministry of Health and Welfare; Basic Science Research Program run by the National Research Foundation of Korea (NRF), Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], the Basic Science Research Program run by the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/nrf_eng_cms/) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza F, 2014, J AM COLL CARDIOL, V64, P2455, DOI 10.1016/j.jacc.2014.09.053; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Buch Eric, 2016, Heart Rhythm, V13, P636, DOI 10.1016/j.hrthm.2015.10.031; Calvo CJ, 2014, BIOPHYS J, V106, P1811, DOI 10.1016/j.bpj.2014.02.030; Chou CC, 2011, J AM COLL CARDIOL, V58, P158, DOI 10.1016/j.jacc.2011.02.045; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dewire J, 2013, NAT REV CARDIOL, V10, P599, DOI 10.1038/nrcardio.2013.121; Ganesan AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110662; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Haissaguerre M, 2014, CIRCULATION, V130, P530, DOI 10.1161/CIRCULATIONAHA.113.005421; Hwang M, 2015, IEEE T BIO-MED ENG, V62, P673, DOI 10.1109/TBME.2014.2363669; Hwang M, 2014, PROG BIOPHYS MOL BIO, V116, P40, DOI 10.1016/j.pbiomolbio.2014.09.006; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Konings K., 1994, CIRCULATION, V1994, P1665; Kuklik P, 2015, IEEE T BIO-MED ENG, V62, P296, DOI 10.1109/TBME.2014.2350029; Labarthe S, 2014, EUROPACE, V16, P21, DOI 10.1093/europace/euu256; McDowell KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117110; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Pak HN, 2003, CIRCULATION, V108, P3149, DOI 10.1161/01.CIR.0000104563.12408.12; Pak HN, 2008, CIRC J, V72, P1185, DOI 10.1253/circj.72.1185; Pak HN, 2006, J CARDIOVASC ELECTR, V17, P777, DOI 10.1111/j.1540-8167.2006.00511.x; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Rappel WJ, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1325, DOI 10.1161/CIRCEP.115.002956; Sommer P, 2016, J CARDIOVASC ELECTR, V27, P274, DOI 10.1111/jce.12874; Spector P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P655, DOI 10.1161/CIRCEP.113.000311; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Verma A, 2011, J CARDIOVASC ELECTR, V22, P1309, DOI 10.1111/j.1540-8167.2011.02128.x; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Wynn GJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P841, DOI 10.1161/CIRCEP.114.001759; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Yun Y, 2014, J KOREAN MED SCI, V29, P370, DOI 10.3346/jkms.2014.29.3.370; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	43	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149695	10.1371/journal.pone.0149695	http://dx.doi.org/10.1371/journal.pone.0149695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909492	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700045
J	Modebadze, T; Morgan, NH; Peres, IAA; Hadid, RD; Amada, N; Hill, C; Williams, C; Stanford, IM; Morris, CM; Jones, RSG; Whalley, BJ; Woodhall, GL				Modebadze, Tamara; Morgan, Nicola H.; Peres, Isabelle A. A.; Hadid, Rebecca D.; Amada, Naoki; Hill, Charlotte; Williams, Claire; Stanford, Ian M.; Morris, Christopher M.; Jones, Roland S. G.; Whalley, Benjamin J.; Woodhall, Gavin L.			A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PILOCARPINE-INDUCED EPILEPSY; ELECTRICAL STIMULATION; ENTORHINAL CORTEX; SPATIAL MEMORY; SEIZURES; RECEPTORS; GLUTAMATE; KETAMINE; DEFICITS	Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and establishment of the disorder. Typically, following a systemic or local insult, vulnerable brain regions undergo a process leading to the development, over time, of spontaneous recurrent seizures. Many such models make use of a period of intense seizure activity or status epilepticus, and this may be associated with high mortality and/or global damage to large areas of the brain. These undesirable elements have driven improvements in the design of chronic epilepsy models, for example the lithium-pilocarpine epileptogenesis model. Here, we present an optimised model of chronic epilepsy that reduces mortality to 1% whilst retaining features of high epileptogenicity and development of spontaneous seizures. Using local field potential recordings from hippocampus in vitro as a probe, we show that the model does not result in significant loss of neuronal network function in area CA3 and, instead, subtle alterations in network dynamics appear during a process of epileptogenesis, which eventually leads to a chronic seizure state. The model's features of very low mortality and high morbidity in the absence of global neuronal damage offer the chance to explore the processes underlying epileptogenesis in detail, in a population of animals not defined by their resistance to seizures, whilst acknowledging and being driven by the 3Rs (Replacement, Refinement and Reduction of animal use in scientific procedures) principles.	[Modebadze, Tamara; Morgan, Nicola H.; Stanford, Ian M.; Woodhall, Gavin L.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Peres, Isabelle A. A.; Hadid, Rebecca D.; Amada, Naoki; Hill, Charlotte; Williams, Claire; Whalley, Benjamin J.] Univ Reading, Sch Pharm, Hopkins Life Sci Bldg, Reading, Berks, England; [Jones, Roland S. G.] Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England; [Morris, Christopher M.] Newcastle Univ, Med Toxicol Ctr, Claremont Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Aston University; University of Reading; University of Bath; Newcastle University - UK	Woodhall, GL (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	g.l.woodhall@aston.ac.uk	Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; Morris, Christopher/0000-0002-3749-0993; Stanford, Ian M/0000-0002-5677-8538; Hadid, Rebecca/0000-0002-4995-8493; woodhall, gavin/0000-0003-1281-9008	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK) [G0700639/1]; NC3Rs [G0700639/1]	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was supported by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK; grant number G0700639/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NC3Rs grant number G0700639/1	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Bajorat R, 2011, EPILEPSIA, V52, pE118, DOI 10.1111/j.1528-1167.2011.03200.x; Cook LL, 1998, PERCEPT MOTOR SKILL, V86, P1288, DOI 10.2466/pms.1998.86.3c.1288; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Farrimond JA, 2009, BEHAV RES METHODS, V41, P446, DOI 10.3758/BRM.41.2.446; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; FUJIKAWA DG, 1995, EPILEPSIA, V36, P186, DOI 10.1111/j.1528-1157.1995.tb00979.x; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Huang X, 2012, NEUROSCIENCE, V215, P90, DOI 10.1016/j.neuroscience.2012.04.011; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; JOPE RS, 1986, EXP NEUROL, V91, P471, DOI 10.1016/0014-4886(86)90045-2; JOY RM, 1983, PHARMACOL BIOCHEM BE, V19, P345, DOI 10.1016/0091-3057(83)90063-1; Karbowski LM, 2013, EPILEPSY BEHAV, V27, P18, DOI 10.1016/j.yebeh.2012.12.021; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LOUIS ED, 1990, ELECTROEN CLIN NEURO, V75, P548, DOI 10.1016/0013-4694(90)90141-6; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; MOSER VC, 1988, FUND APPL TOXICOL, V11, P189, DOI 10.1016/0272-0590(88)90144-3; Polascheck N, 2010, EXP NEUROL, V224, P219, DOI 10.1016/j.expneurol.2010.03.014; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rice AC, 1998, EPILEPSIA, V39, P1148, DOI 10.1111/j.1528-1157.1998.tb01305.x; Samoriski GM, 1997, J NEUROSCI, V17, P5581; Santi SA, 2001, INT J NEUROSCI, V107, P63, DOI 10.3109/00207450109149757; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; STARZL TE, 1953, J NEUROPATH EXP NEUR, V12, P262, DOI 10.1097/00005072-195307000-00006; Tang FR, 2007, NEUROPHARMACOLOGY, V53, P821, DOI 10.1016/j.neuropharm.2007.08.012; Tatum WO, 2013, NEUROLOGY, V80, pS12, DOI 10.1212/WNL.0b013e3182797325; Thompson SE, 2006, NEUROSIGNALS, V15, P202, DOI 10.1159/000098515; Tremblay E, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P241, DOI 10.1016/S0370-4475(84)80011-8; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147265	10.1371/journal.pone.0147265	http://dx.doi.org/10.1371/journal.pone.0147265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909803	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371164700003
J	Fukui, N; Oshima, T; Ueda, T; Ogasawara, N; Tobe, T				Fukui, Naoki; Oshima, Taku; Ueda, Takeshi; Ogasawara, Naotake; Tobe, Toru			Gene Activation through the Modulation of Nucleoid Structures by a Horizontally Transferred Regulator, Pch, in Enterohemorrhagic Escherichia coli	PLOS ONE			English	Article							H-NS; TRANSCRIPTIONAL REGULATION; PATHOGENICITY ISLAND; EXPRESSION; VIRULENCE; LER; DNA; PROMOTERS; ADHERENCE; PROTEINS	The horizontally transferred chromosomal segments, which are the main source of genetic diversity among bacterial pathogens, are bound by the nucleoid protein H-NS, resulting in the formation of a nucleoprotein complex and the silencing of gene expression. The desilencing or activation of virulence genes necessary for the colonization of enterohemorrhagic Escherichia coli is achieved mainly by the action of two regulators, Pch and Ler, which are encoded by horizontally transferred elements. Although Ler has been shown to activate transcription by counteracting H-NS silencing, the mechanism for Pch is poorly understood. We show here that Pch activates the LEE1 promoter and also enhances the Ler-mediated activation of other LEE promoters. Transcriptional activation was completely dependent on repression by the H-NS/StpA/Hha/YdgT complex, indicating that Pch-derived activation was achieved by alleviating H-NS-mediated silencing. Expression of pch reduced the binding of H-NS at LEE1 promoter and altered the nucleoprotein complex. Furthermore, in vitro reconstruction of the protein-DNA complex on LEE1 promoter DNA confirmed the exclusive effect of Pch on H-NS binding. These results demonstrated that Pch is another anti-silencing regulator and a modulator of H-NS-containing nucleoprotein complexes. Thus, the anti-silencing mechanism plays a key role in the coordinated regulation of virulence genes in EHEC.	[Fukui, Naoki; Tobe, Toru] Osaka Univ, Dept Biomed Informat, Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan; [Oshima, Taku; Ueda, Takeshi; Ogasawara, Naotake] Nara Inst Sci & Technol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300101, Japan	Osaka University; Nara Institute of Science & Technology	Tobe, T (corresponding author), Osaka Univ, Dept Biomed Informat, Grad Sch Med, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	torutobe@sahs.med.osaka-u.ac.jp			Ministry of Education, Science, and Technology of Japan	Ministry of Education, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Technology of Japan.	Abe H, 2008, DNA RES, V15, P25, DOI 10.1093/dnares/dsm033; Ali SS, 2013, J BIOL CHEM, V288, P13356, DOI 10.1074/jbc.M113.455378; Bhat A, 2014, P NATL ACAD SCI USA, V111, pE2586, DOI 10.1073/pnas.1322033111; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Brown Nat F., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020042; Bustamante VH, 2001, MOL MICROBIOL, V39, P664, DOI 10.1046/j.1365-2958.2001.02209.x; Bustamante VH, 2011, MOL MICROBIOL, V82, P398, DOI 10.1111/j.1365-2958.2011.07819.x; Castang S, 2008, P NATL ACAD SCI USA, V105, P18947, DOI 10.1073/pnas.0808215105; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884; Fass E, 2009, CURR OPIN MICROBIOL, V12, P199, DOI 10.1016/j.mib.2009.01.004; Gal-Mor O, 2006, CELL MICROBIOL, V8, P1707, DOI 10.1111/j.1462-5822.2006.00794.x; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hurme R, 1998, MOL MICROBIOL, V30, P1, DOI 10.1046/j.1365-2958.1998.01049.x; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Knutton S, 1997, INFECT IMMUN, V65, P1644, DOI 10.1128/IAI.65.5.1644-1652.1997; KNUTTON S, 1987, INFECT IMMUN, V55, P69, DOI 10.1128/IAI.55.1.69-77.1987; Lucchini S, 2006, PLOS PATHOG, V2, P746, DOI 10.1371/journal.ppat.0020081; McDaniel TK, 1997, MOL MICROBIOL, V23, P399, DOI 10.1046/j.1365-2958.1997.2311591.x; Mellies JL, 2008, MICROBIOL-SGM, V154, P3624, DOI 10.1099/mic.0.2008/023382-0; Miyahara A, 2009, CELL MICROBIOL, V11, P337, DOI 10.1111/j.1462-5822.2008.01256.x; Nakanishi N, 2006, MOL MICROBIOL, V61, P194, DOI 10.1111/j.1365-2958.2006.05217.x; Nakanishi N, 2009, MICROBIOL-SGM, V155, P521, DOI 10.1099/mic.0.023499-0; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; Porter ME, 2005, J BACTERIOL, V187, P458, DOI 10.1128/JB.187.2.458-472.2005; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Rojas-Lopez M, 2011, J BACTERIOL, V193, P1622, DOI 10.1128/JB.01082-10; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Takao M, 2014, MOL MICROBIOL, V93, P1302, DOI 10.1111/mmi.12737; Tobe T, 2005, MOL MICROBIOL, V58, P320, DOI 10.1111/j.1365-2958.2005.04828.x; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; Torres AG, 2007, J BACTERIOL, V189, P5916, DOI 10.1128/JB.00245-07; Ueda T, 2013, DNA RES, V20, P263, DOI 10.1093/dnares/dst008; Umanski T, 2002, MICROBIOL-SGM, V148, P2735, DOI 10.1099/00221287-148-9-2735	38	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149718	10.1371/journal.pone.0149718	http://dx.doi.org/10.1371/journal.pone.0149718			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901318	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100133
J	Hadi, SIIA; Santana, H; Brunale, PPM; Gomes, TG; Oliveira, MD; Matthiensen, A; Oliveira, MEC; Silva, FCP; Brasil, BSAF				Hadi, Samed I. I. A.; Santana, Hugo; Brunale, Patricia P. M.; Gomes, Taisa G.; Oliveira, Marcia D.; Matthiensen, Alexandre; Oliveira, Marcos E. C.; Silva, Flavia C. P.; Brasil, Bruno S. A. F.			DNA Barcoding Green Microalgae Isolated from Neotropical Inland Waters	PLOS ONE			English	Article							CHLORELLA TREBOUXIOPHYCEAE; CHLOROPHYTA; SEQUENCE; ALGAE; ULVOPHYCEAE; BRAZIL; CONSERVATION; BIODIVERSITY; COLLECTION; MORPHOLOGY	This study evaluated the feasibility of using the Ribulose Bisphosphate Carboxylase Large subunit gene (rbcL) and the Internal Transcribed Spacers 1 and 2 of the nuclear rDNA (nuITS1 and nuITS2) markers for identifying a very diverse, albeit poorly known group, of green microalgae from neotropical inland waters. Fifty-one freshwater green microalgae strains isolated from Brazil, the largest biodiversity reservoir in the neotropics, were submitted to DNA barcoding. Currently available universal primers for ITS1-5.8S-ITS2 region amplification were sufficient to successfully amplify and sequence 47 (92%) of the samples. On the other hand, new sets of primers had to be designed for rbcL, which allowed 96% of the samples to be sequenced. Thirty-five percent of the strains could be unambiguously identified to the species level based either on nuITS1 or nuITS2 sequences' using barcode gap calculations. nuITS2 Compensatory Base Change (CBC) and ITS1-5.8S-ITS2 region phylogenetic analysis, together with morphological inspection, confirmed the identification accuracy. In contrast, only 6% of the strains could be assigned to the correct species based solely on rbcL sequences. In conclusion, the data presented here indicates that either nuITS1 or nuITS2 are useful markers for DNA barcoding of freshwater green microalgae, with advantage for nuITS2 due to the larger availability of analytical tools and reference barcodes deposited at databases for this marker.	[Hadi, Samed I. I. A.; Santana, Hugo; Brunale, Patricia P. M.; Silva, Flavia C. P.; Brasil, Bruno S. A. F.] Embrapa Agroenergy, Brasilia, DF, Brazil; [Hadi, Samed I. I. A.; Gomes, Taisa G.] Univ Fed Tocantins, Gurupi, TO, Brazil; [Hadi, Samed I. I. A.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Santana, Hugo] Univ Fed Bahia, Vitoria De Conquista, BA, Brazil; [Oliveira, Marcia D.] Embrapa Pantanal, Corumba, MS, Brazil; [Matthiensen, Alexandre] Embrapa Swine & Poultry, Concordia, SC, Brazil; [Oliveira, Marcos E. C.] Embrapa Amazonia Oriental, Belem, PA, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Tocantins (UFT); Universidade Federal de Minas Gerais; Universidade Federal da Bahia; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brasil, BSAF (corresponding author), Embrapa Agroenergy, Brasilia, DF, Brazil.	bruno.brasil@embrapa.br	Santana, Hugo/AAH-9127-2020; Brasil, Bruno S. A. F./E-8817-2012	Santana, Hugo/0000-0002-2259-4239; Brasil, Bruno S. A. F./0000-0002-8690-2157	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Financiadora de Estudos e Projetos (FINEP); Conselho Nacional de Pesquisa (CNPq)	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful to the Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Financiadora de Estudos e Projetos (FINEP) and Conselho Nacional de Pesquisa (CNPq) for supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho AA, 2005, CONSERV BIOL, V19, P646, DOI 10.1111/j.1523-1739.2005.00701.x; Amengual-Morro C, 2012, J ENVIRON MANAGE, V95, pS71, DOI 10.1016/j.jenvman.2011.07.008; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Becker B, 2009, ANN BOT-LONDON, V103, P999, DOI 10.1093/aob/mcp044; Bellinger EG, 2015, FRESHWATER ALGAE: IDENTIFICATION, ENUMERATION AND USE AS BIOINDICATORS, 2ND EDITION, P1, DOI 10.1002/9781118917152; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Bock C, 2010, EUR J PHYCOL, V45, P267, DOI 10.1080/09670262.2010.487920; Bonato ALV, 2002, EXTRACAO DNA GENOMIC; Buchheim MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016931; Caisova L, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-262; Carvalho DC, 2011, MITOCHONDR DNA, V22, P97, DOI 10.3109/19401736.2011.588219; Carvalho DC, 2015, FOOD CONTROL, V50, P784, DOI 10.1016/j.foodcont.2014.10.025; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Collins RA, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028381, 10.1371/journal.pone.0030581]; Costa ES, 2012, J APPL PHYCOL, V24, P1643, DOI 10.1007/s10811-012-9828-y; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; De Clerck O, 2013, J PHYCOL, V49, P215, DOI 10.1111/jpy.12020; Drummond MG, 2013, FOOD CONTROL, V29, P131, DOI 10.1016/j.foodcont.2012.05.051; Du GY, 2014, J OCEAN U CHINA, V13, P97, DOI 10.1007/s11802-014-2197-1; Fawley MW, 2011, PHYCOLOGIA, V50, P23, DOI 10.2216/10-16.1; Francis RA, 2011, PROG PHYS GEOG, V35, P43, DOI 10.1177/0309133310385166; Freitas Lilian Cristina, 2013, Check List, V9, P1471; Gorelova OA, 2015, PROTOPLASMA, V252, P489, DOI 10.1007/s00709-014-0694-0; Guiry MD, 2012, J PHYCOL, V48, P1057, DOI 10.1111/j.1529-8817.2012.01222.x; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hegewald E, 2013, FOTTEA, V13, P149, DOI 10.5507/fot.2013.013; Hoef-Emden K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043652; Hoshina Ryo, 2014, BMC Res Notes, V7, P592, DOI 10.1186/1756-0500-7-592; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koetschan C, 2012, MOL PHYLOGENET EVOL, V63, P585, DOI 10.1016/j.ympev.2012.01.026; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2015, TRENDS PLANT SCI, V20, P67, DOI 10.1016/j.tplants.2014.11.005; Krienitz L, 2012, HYDROBIOLOGIA, V698, P295, DOI 10.1007/s10750-012-1079-z; Leliaert F, 2014, EUR J PHYCOL, V49, P179, DOI 10.1080/09670262.2014.904524; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Loughnane CJ, 2008, PHYCOLOGIA, V47, P416, DOI 10.2216/PH07-61.1; Luo W, 2010, PLANT BIOLOGY, V12, P545, DOI 10.1111/j.1438-8677.2009.00221.x; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; Nascimento IA, 2013, BIOENERG RES, V6, P1, DOI 10.1007/s12155-012-9222-2; Nozaki H, 2001, EUR J PHYCOL, V36, P23, DOI 10.1080/09670260110001735158; Palhares RM, 2014, J ETHNOPHARMACOL, V155, P815, DOI 10.1016/j.jep.2014.06.040; Palhares RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127866; Pawlowski J, 2014, J FORAMIN RES, V44, P62, DOI 10.2113/gsjfr.44.1.62; Pawlowski J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001419; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Proschold T, 2010, PHYCOL RES, V58, P1, DOI 10.1111/j.1440-1835.2009.00552.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Schlosser UG, 1997, BOT ACTA, V110, P424, DOI 10.1111/j.1438-8677.1997.tb00659.x; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Seibel Philipp N, 2008, BMC Res Notes, V1, P91, DOI 10.1186/1756-0500-1-91; Skaloud P, 2006, NOVA HEDWIGIA, V83, P533, DOI 10.1127/0029-5035/2006/0083-0533; Subhadra B, 2011, J SCI FOOD AGR, V91, P2, DOI 10.1002/jsfa.4207; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmins M, 2009, J EXP BOT, V60, P1691, DOI 10.1093/jxb/erp052; Torres MA, 2008, ECOTOX ENVIRON SAFE, V71, P1, DOI 10.1016/j.ecoenv.2008.05.009; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726	65	43	44	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149284	10.1371/journal.pone.0149284	http://dx.doi.org/10.1371/journal.pone.0149284			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900844	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100053
J	Monteiro, RLS; Carneiro, TKG; Fontoura, JRA; da Silva, VL; Moret, MA; Pereira, HBD				Monteiro, Roberto L. S.; Carneiro, Tereza Kelly G.; Fontoura, Jose Roberto A.; da Silva, Valeria L.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges			A Model for Improving the Learning Curves of Artificial Neural Networks	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; CHEMOTAXIS; DYNAMICS	In this article, the performance of a hybrid artificial neural network (i.e. scale-free and small-world) was analyzed and its learning curve compared to three other topologies: random, scale-free and small-world, as well as to the chemotaxis neural network of the nematode Caenorhabditis Elegans. One hundred equivalent networks (same number of vertices and average degree) for each topology were generated and each was trained for one thousand epochs. After comparing the mean learning curves of each network topology with the C. elegans neural network, we found that the networks that exhibited preferential attachment exhibited the best learning curves.	[Monteiro, Roberto L. S.; da Silva, Valeria L.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges] SENAI CIMATEC, Programa Modelagem Computat, Ave Orlando Gomes 1845, BR-41650010 Salvador, BA, Brazil; [Monteiro, Roberto L. S.; Fontoura, Jose Roberto A.; Moret, Marcelo A.; de Barros Pereira, Hernane Borges] Univ Estado Bahia, Salvador, BA, Brazil; [Carneiro, Tereza Kelly G.] Univ Estadual Ciencias Saude Alagoas, Maceio, Brazil	Faculdade de Tecnologia Senai Cimatec; Universidade do Estado Bahia; Universidade Estadual de Ciencias da Saude de Alagoas	Monteiro, RLS (corresponding author), SENAI CIMATEC, Programa Modelagem Computat, Ave Orlando Gomes 1845, BR-41650010 Salvador, BA, Brazil.; Monteiro, RLS (corresponding author), Univ Estado Bahia, Salvador, BA, Brazil.	roberto@souzamonteiro.com	de Barros Pereira, Hernane Borges/AAG-2785-2019; Moret, Marcelo A./O-3485-2018; Pereira, Hernane B B/D-6693-2012	de Barros Pereira, Hernane Borges/0000-0001-7476-9267; Moret, Marcelo A./0000-0003-0051-6309; Pereira, Hernane B B/0000-0001-7476-9267; Loureiro da Silva, Valeria/0000-0001-5466-7933	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency [304454/2014-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, a Federal Brazilian funding agency, grant no. 304454/2014-1 MAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Batagelj V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036113; Bohland JW, 2001, NEUROCOMPUTING, V38, P489, DOI 10.1016/S0925-2312(01)00378-2; Chatterjee N, 2008, PROG BRAIN RES, V168, P145, DOI 10.1016/S0079-6123(07)68012-1; Chen BL, 2006, P NATL ACAD SCI USA, V103, P4723, DOI 10.1073/pnas.0506806103; Dunn NA, 2004, J COMPUT NEUROSCI, V17, P137, DOI 10.1023/B:JCNS.0000037679.42570.d5; Emmert-Streib F, 2006, NEUROCOMPUTING, V69, P1179, DOI 10.1016/j.neucom.2005.12.070; ERDOS P, 1960, B INT STATIST INST, V38, P343; HORN D, 1993, NEURAL COMPUT, V5, P736, DOI 10.1162/neco.1993.5.5.736; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lublin A L, 2013, Drug Discov Today Technol, V10, pe115, DOI 10.1016/j.ddtec.2012.02.002; Monteiro RLS, 2014, PHYSICA A, V403, P276, DOI 10.1016/j.physa.2014.02.019; Morita S, 2001, PHYSICA A, V298, P553, DOI 10.1016/S0378-4371(01)00266-7; Nazzal JM., 2008, WORLD APPL SCI J, V5, P546; Pereira HBB, 2011, PHYSICA A, V390, P1192, DOI 10.1016/j.physa.2010.12.001; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Puri IK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015176; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Segev R, 2000, NEURAL NETWORKS, V13, P185, DOI 10.1016/S0893-6080(99)00084-2; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; Watts DJ, 1999, AM J SOCIOL, V105, P493, DOI 10.1086/210318; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056	24	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149874	10.1371/journal.pone.0149874	http://dx.doi.org/10.1371/journal.pone.0149874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901646	gold, Green Submitted, Green Published			2022-12-26	WOS:000371276100170
J	Druso, JE; Endo, M; Lin, MCJ; Peng, X; Antonyak, MA; Meller, S; Cerione, RA				Druso, Joseph E.; Endo, Makoto; Lin, Miao-chong Joy; Peng, Xu; Antonyak, Marc A.; Meller, Stephanie; Cerione, Richard A.			An Essential Role for Cdc42 in the Functioning of the Adult Mammary Gland	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; CELL-POLARITY; DIFFERENTIATION; MORPHOGENESIS; EXPRESSION; CADHERIN; ENDOCYTOSIS; TISSUE; STAT5; METASTASIS	The Rho family small GTPase Cdc42 has been implicated in a wide range of cellular functions including the establishment of cell polarity and the remodeling of the actin cytoskeletal architecture, resulting in the tight regulation of cell growth and survival during developmental processes. The complete knock-out of Cdc42 in the mouse is embryonic-lethal, and its targeted deletion in various tissues has been shown to disrupt tissue homeostasis. Thus far, in most studies, the targeted deletion of Cdc42 occurred during embryogenesis. Here, we have used a conditional gene deletion strategy in mice to probe the specific role of Cdc42 during adult mammary gland function. Cdc42 conditional-knock-out females were unable to adequately nourish their pups, due to a disorganized epithelial compartment within their mammary glands. A closer examination showed that their mammary epithelial cells were not able to maintain functional alveolar lumens, due to an inability to establish normal apical/basal epithelial polarity, as well as proper cell-cell contacts. Loss of these essential epithelial characteristics led to a premature sloughing off of the Cdc42-null epithelial cells. Overall our findings demonstrate that Cdc42 plays essential roles in mammary gland function post pregnancy, where it helps to establish proper epithelial cell polarity and tissue homeostasis during lactation.	[Druso, Joseph E.; Endo, Makoto; Lin, Miao-chong Joy; Peng, Xu; Antonyak, Marc A.; Meller, Stephanie; Cerione, Richard A.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Cerione, Richard A.] Cornell Univ, Dept Chem & Biol Chem, Baker Lab, Ithaca, NY 14853 USA; [Peng, Xu] Texas A&M Univ, Hlth Sci Ctr, Coll Med, Dept Med Physiol, Temple, TX 76504 USA	Cornell University; Cornell University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Cerione, RA (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	rac1@cornell.edu		Endo, Makoto/0000-0002-2055-5471	National Institutes of Health [GM047458, GM040654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047458, P41GM103485, R01GM040654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM047458 and GM040654 (to R. A. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhtar N, 2006, J CELL BIOL, V173, P781, DOI 10.1083/jcb.200601059; Bray K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3487; Bray Kristi, 2011, Small GTPases, V2, P247; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Izumi G, 2004, J CELL BIOL, V166, P237, DOI 10.1083/jcb.200401078; Jaffe AB, 2008, J CELL BIOL, V183, P625, DOI 10.1083/jcb.200807121; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LIU XW, 1995, P NATL ACAD SCI USA, V92, P8831, DOI 10.1073/pnas.92.19.8831; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lo AT, 2012, J MAMMARY GLAND BIOL, V17, P103, DOI 10.1007/s10911-012-9251-7; Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McHenry PR, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2643; Melendez J, 2011, J BIOL CHEM, V286, P2375, DOI 10.1074/jbc.R110.200329; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Pedersen E, 2012, EXP CELL RES, V318, P1779, DOI 10.1016/j.yexcr.2012.05.004; Peng X, 2013, PROTEIN CELL, V4, P231, DOI 10.1007/s13238-012-2098-2; Rojas R, 2001, MOL BIOL CELL, V12, P2257, DOI 10.1091/mbc.12.8.2257; TAYLORPAPADIMITRIOU J, 1989, J CELL SCI, V94, P403; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wu XW, 2007, DEV DYNAM, V236, P2767, DOI 10.1002/dvdy.21309; Wu XW, 2006, MATRIX BIOL, V25, P466, DOI 10.1016/j.matbio.2006.09.001; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Yuan HX, 2009, HEPATOLOGY, V49, P240, DOI 10.1002/hep.22610	35	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8886	8895		10.1074/jbc.M115.694349	http://dx.doi.org/10.1074/jbc.M115.694349			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912661	Green Published, hybrid			2022-12-26	WOS:000374849000003
J	Larmonier, CB; Shehab, KW; Laubitz, D; Jamwal, DR; Ghishan, FK; Kiela, PR				Larmonier, Claire B.; Shehab, Kareem W.; Laubitz, Daniel; Jamwal, Deepa R.; Ghishan, Fayez K.; Kiela, Pawel R.			Transcriptional Reprogramming and Resistance to Colonic Mucosal Injury in Poly(ADP-ribose) Polymerase 1 (PARP1)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; NF-KAPPA-B; FECAL MICROBIOTA; PARP-1; BINDING; INHIBITION; APOPTOSIS; INFLAMMATION; MODULATION; SYNTHETASE	Poly(ADP-ribose) polymerases (PARPs) synthesize and bind branched polymers of ADP-ribose to acceptor proteins using NAD as a substrate and participate in the control of gene transcription and DNA repair. PARP1, the most abundant isoform, regulates the expression of proinflammatory mediator cytokines, chemokines, and adhesion molecules, and inhibition of PARP1 enzymatic activity reduced or ameliorated autoimmune diseases in several experimental models, including colitis. However, the mechanism(s) underlying the protective effects of PARP1 inhibition in colitis and the cell types in which Parp1 deletion has the most significant impact are unknown. The objective of the current study was to determine the impact of Parp1 deletion on the innate immune response to mucosal injury and on the gut microbiome composition. Parp1 deficiency was evaluated in DSS-induced colitis in WT, Parp1(-/-), Rag2(-/-), and Rag2(-/-)xParp1(-/-) double knock-out mice. Genome-wide analysis of the colonic transcriptome and fecal 16S amplicon profiling was performed. Compared with WT, we demonstrated that Parp1(-/-) were protected from dextran-sulfate sodium-induced colitis and that this protection was associated with a dramatic transcriptional reprogramming in the colon. PARP1 deficiency was also associated with a modulation of the colonic microbiota (increases relative abundance of Clostridia clusters IV and XIVa) and a concomitant increase in the frequency of mucosal CD4(+)CD25(+)Foxp3(+) regulatory T cells. The protective effects conferred by Parp1 deletion were lost in Rag2(-/-) x Parp1(-/-) mice, highlighting the role of the adaptive immune system for full protection.	[Larmonier, Claire B.; Shehab, Kareem W.; Laubitz, Daniel; Jamwal, Deepa R.; Ghishan, Fayez K.; Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Kiela, Pawel R.] Univ Arizona, Hlth Sci Ctr, Dept Immunobiol, 1501 N Campbell Ave, Tucson, AZ 85724 USA; [Larmonier, Claire B.] Ctr Hosp Univ Pellegrin, GRIC, Pole Biol & Pathol, Lab Immunol & Immunogenet, F-33000 Bordeaux, France	University of Arizona; University of Arizona Health Sciences; University of Arizona; University of Arizona Health Sciences; CHU Bordeaux	Kiela, PR (corresponding author), Univ Arizona, Hlth Sci Ctr, Steele Childrens Res Ctr, Dept Pediat, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	pkiela@peds.arizona.edu	Jamwal, Deepa/L-8955-2016; Kiela, Pawel/AAF-5320-2020	Kiela, Pawel/0000-0002-0014-3517; Laubitz, Daniel/0000-0002-7482-8500	National Institutes of Health through the NIDDK [R37DK033209, 1K01DK099268]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099268, R37DK033209] Funding Source: NIH RePORTER	National Institutes of Health through the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R37DK033209 (to F. K. G.) and 1K01DK099268 (to C. B. L.) through the NIDDK. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Boehm F, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-97; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cuzzocrea S, 2000, MOL MED, V6, P766, DOI 10.1007/BF03402192; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Di Paola R, 2005, EUR J PHARMACOL, V527, P163, DOI 10.1016/j.ejphar.2005.09.055; Forsythe RM, 2002, SHOCK, V17, P180, DOI 10.1097/00024382-200203000-00004; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang FC, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/103890; Jijon HB, 2000, AM J PHYSIOL-GASTR L, V279, pG641, DOI 10.1152/ajpgi.2000.279.3.G641; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kim TW, 2006, WORLD J GASTROENTERO, V12, P302, DOI 10.3748/wjg.v12.i2.302; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Lopetuso LR, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-23; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Majewski PM, 2010, J BIOL CHEM, V285, P34828, DOI 10.1074/jbc.M110.152868; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Matsuki T, 2002, APPL ENVIRON MICROB, V68, P5445, DOI 10.1128/AEM.68.11.5445-5451.2002; Mazzon E, 2002, BIOCHEM PHARMACOL, V64, P327, DOI 10.1016/S0006-2952(02)01075-4; Nakajima H, 2004, J BIOL CHEM, V279, P42774, DOI 10.1074/jbc.M407923200; Nasta F, 2010, J IMMUNOL, V184, P3470, DOI 10.4049/jimmunol.0901568; Paone G, 2006, J BIOL CHEM, V281, P17054, DOI 10.1074/jbc.M603042200; Peralta-Leal A, 2009, FREE RADICAL BIO MED, V47, P13, DOI 10.1016/j.freeradbiomed.2009.04.008; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Qiu W, 2011, J CLIN INVEST, V121, P1722, DOI 10.1172/JCI42917; Rosado MM, 2013, IMMUNOLOGY, V139, P428, DOI 10.1111/imm.12099; Sanchez-Fidalgo S, 2007, EUR J PHARMACOL, V563, P216, DOI 10.1016/j.ejphar.2007.01.070; Seman M, 2003, IMMUNITY, V19, P571, DOI 10.1016/S1074-7613(03)00266-8; Sodhi RK, 2010, VASC PHARMACOL, V53, P77, DOI 10.1016/j.vph.2010.06.003; SUZUKI H, 1986, J BIOL CHEM, V261, P6048; Szabo C, 2006, TRENDS PHARMACOL SCI, V27, P626, DOI 10.1016/j.tips.2006.10.003; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Welsby I, 2012, BIOCHEM PHARMACOL, V84, P11, DOI 10.1016/j.bcp.2012.02.016; Zhang P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071590; Zingarelli B, 1999, GASTROENTEROLOGY, V116, P335, DOI 10.1016/S0016-5085(99)70130-7; Zingarelli B, 2004, IMMUNOLOGY, V113, P509, DOI 10.1111/j.1365-2567.2004.01991.x; Zingarelli B, 2003, EUR J PHARMACOL, V469, P183, DOI 10.1016/S0014-2999(03)01726-6	43	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8918	8930		10.1074/jbc.M116.714386	http://dx.doi.org/10.1074/jbc.M116.714386			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26912654	Green Published, hybrid			2022-12-26	WOS:000374849000006
J	Hai, J; Serradji, N; Mouton, L; Redeker, V; Cornu, D; Chahine, JME; Verbeke, P; Hemadi, M				Hai, Jun; Serradji, Nawal; Mouton, Ludovic; Redeker, Virginie; Cornu, David; Chahine, Jean-Michel El Hage; Verbeke, Philippe; Hemadi, Miryana			Targeted Delivery of Amoxicillin to C. trachomatis by the Transferrin Iron Acquisition Pathway	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; DRUG-DELIVERY; INTRACELLULAR PATHOGEN; DEVELOPMENTAL CYCLE; SERUM-TRANSFERRIN; ENDOCYTIC PATHWAY; EPITHELIAL-CELLS; IN-VITRO; RECEPTOR; MECHANISM	Weak intracellular penetration of antibiotics makes some infections difficult to treat. The Trojan horse strategy for targeted drug delivery is among the interesting routes being explored to overcome this therapeutic difficulty. Chlamydia trachomatis, as an obligate intracellular human pathogen, is responsible for both trachoma and sexually transmitted diseases. Chlamydia develops in a vacuole and is therefore protected by four membranes (plasma membrane, bacterial inclusion membrane, and bacterial membranes). In this work, the irontransport protein, human serum-transferrin, was used as a Trojan horse for antibiotic delivery into the bacterial vacuole. Amoxicillin was grafted onto transferrin. The transferrin-amoxicillin construct was characterized by mass spectrometry and absorption spectroscopy. Its affinity for transferrin receptor 1, determined by fluorescence emission titration [KaffTf-amox = (1.3 +/- 1.0) x 10(8)], is very close to that of transferrin [4.3 x 10(8)]. Transmission electron and confocal microscopies showed a co-localization of transferrin with the bacteria in the vacuole and were also used to evaluate the antibiotic capability of the construct. It is significantly more effective than amoxicillin alone. These promising results demonstrate targeted delivery of amoxicillin to suppress Chlamydia and are of interest for Chlamydiaceae and maybe other intracellular bacteria therapies.	[Hai, Jun; Serradji, Nawal; Mouton, Ludovic; Chahine, Jean-Michel El Hage; Hemadi, Miryana] Univ Paris Diderot, ITODYS Interfaces Traitements Org & Dynam Syst, Sorbonne Paris Cite, CNRS UMR 7086, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France; [Redeker, Virginie] CNRS, Paris Saclay Inst Neurosci, UMR 9197, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Cornu, David] CNRS, Serv Identificat & Caracterisat Prot, UMR 9198, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Verbeke, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, Fac Med, UMR 1149,Inserm,CNRS,ERL 8252,Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chahine, JME; Hemadi, M (corresponding author), Univ Paris Diderot, ITODYS Interfaces Traitements Org & Dynam Syst, Sorbonne Paris Cite, CNRS UMR 7086, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France.; Verbeke, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Fac Med, UMR 1149,Inserm,CNRS,ERL 8252,Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France.	chahine@univ-paris-diderot.fr; philippe.verbeke@inserm.fr; hemadi@univ-paris-diderot.fr	Redeker, Virginie/L-8929-2018; Hai, Jun/F-9392-2018; Serradji, Nawal/AAJ-9599-2020; Hémadi, Miryana/R-9308-2018	Redeker, Virginie/0000-0003-2694-8388; Hai, Jun/0000-0002-7466-4649; Hémadi, Miryana/0000-0002-2658-859X				AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Brizzolara S S, 1990, Hawaii Med J, V49, P335; Brizzolara SS, 1990, HAWAII MED J, V49, P335; Brizzolara SS, 1990, HAWAII MED J, V49, P339; Chahine JME, 2012, BBA-GEN SUBJECTS, V1820, P334, DOI 10.1016/j.bbagen.2011.07.008; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Dumoux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083511; el-Shourbagy M, 1996, J Obstet Gynaecol Res, V22, P467; Hemadi M, 2004, BIOCHEMISTRY-US, V43, P1736, DOI 10.1021/bi030142g; Hemadi M, 2003, BIOCHEMISTRY-US, V42, P3120, DOI 10.1021/bi020627p; Hemadi M, 2006, J MOL BIOL, V358, P1125, DOI 10.1016/j.jmb.2006.02.055; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Ibrahim HR, 2015, EUR J PHARM SCI, V66, P59, DOI 10.1016/j.ejps.2014.10.005; Jacquier N, 2015, FEMS MICROBIOL REV, V39, P262, DOI 10.1093/femsre/fuv001; Kakuta K, 1997, COMP BIOCHEM PHYS A, V118, P165, DOI 10.1016/S0300-9629(96)00403-3; Klockner A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5201; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; MAKEY DG, 1976, BIOCHIM BIOPHYS ACTA, V453, P250, DOI 10.1016/0005-2795(76)90270-1; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Ojcius DM, 1997, INFECT IMMUN, V65, P2437, DOI 10.1128/IAI.65.6.2437-2442.1997; Ouellette SP, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00112; Pakdaman R, 1999, J MOL BIOL, V293, P1273, DOI 10.1006/jmbi.1999.3238; Pakdaman R, 1996, EUR J BIOCHEM, V236, P922, DOI 10.1111/j.1432-1033.1996.00922.x; Piraux H, 2013, BBA-GEN SUBJECTS, V1830, P4254, DOI 10.1016/j.bbagen.2013.04.035; PUNGETTI D, 1988, Acta Europaea Fertilitatis, V19, P93; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schachter J, 1991, MANUAL CLIN MICROBIO, P1045; Schuler J, 1999, BIOPHYS J, V77, P1117, DOI 10.1016/S0006-3495(99)76962-6; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Taraska T, 1996, INFECT IMMUN, V64, P3713, DOI 10.1128/IAI.64.9.3713-3727.1996; TURKEWITZ AP, 1988, J BIOL CHEM, V263, P8318; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yewale C, 2013, EXPERT OPIN DRUG DEL, V10, P1429, DOI 10.1517/17425247.2013.805200	53	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150031	10.1371/journal.pone.0150031	http://dx.doi.org/10.1371/journal.pone.0150031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919720	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400072
J	Hu, MG; Li, W; Li, LF; Houston, D; Wu, J				Hu, Maogui; Li, Wei; Li, Lianfa; Houston, Douglas; Wu, Jun			Refining Time-Activity Classification of Human Subjects Using the Global Positioning System	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AIR-POLLUTION; ACCELEROMETER DATA; RANDOM FORESTS; ULTRAFINE PARTICLES; GPS TRACKING; EXPOSURE; TRAVEL; LOCATION; DISEASE	Background Detailed spatial location information is important in accurately estimating personal exposure to air pollution. Global Position System (GPS) has been widely used in tracking personal paths and activities. Previous researchers have developed time-activity classification models based on GPS data, most of them were developed for specific regions. An adaptive model for time-location classification can be widely applied to air pollution studies that use GPS to track individual level time-activity patterns. Methods Time-activity data were collected for seven days using GPS loggers and accelerometers from thirteen adult participants from Southern California under free living conditions. We developed an automated model based on random forests to classify major time-activity patterns (i.e. indoor, outdoor-static, outdoor-walking, and in-vehicle travel). Sensitivity analysis was conducted to examine the contribution of the accelerometer data and the supplemental spatial data (i.e. roadway and tax parcel data) to the accuracy of time-activity classification. Our model was evaluated using both leave-one-fold-out and leave-one-subject-out methods. Results Maximum speeds in averaging time intervals of 7 and 5 minutes, and distance to primary highways with limited access were found to be the three most important variables in the classification model. Leave-one-fold-out cross-validation showed an overall accuracy of 99.71%. Sensitivities varied from 84.62% (outdoor walking) to 99.90% (indoor). Specificities varied from 96.33% (indoor) to 99.98% (outdoor static). The exclusion of accelerometer and ambient light sensor variables caused a slight loss in sensitivity for outdoor walking, but little loss in overall accuracy. However, leave-one-subject-out cross-validation showed considerable loss in sensitivity for outdoor static and outdoor walking conditions. Conclusions The random forests classification model can achieve high accuracy for the four major time-activity categories. The model also performed well with just GPS, road and tax parcel data. However, caution is warranted when generalizing the model developed from a small number of subjects to other populations.	[Hu, Maogui; Li, Lianfa; Wu, Jun] Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA; [Li, Wei] Texas A&M Univ, Dept Landscape Architecture & Urban Planning, College Stn, TX USA; [Houston, Douglas] Univ Calif Irvine, Sch Social Ecol, Dept Planning Policy & Design, Irvine, CA USA; [Hu, Maogui; Li, Lianfa] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Hu, Maogui] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China	University of California System; University of California Irvine; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wu, J (corresponding author), Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA.	junwu@uci.edu	Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863	UCI Academic Senate Council on Research, Computing and Libraries (CORCL); Active Living Accelerometer Loan Program	UCI Academic Senate Council on Research, Computing and Libraries (CORCL); Active Living Accelerometer Loan Program	The research was supported by the UCI Academic Senate Council on Research, Computing and Libraries (CORCL) Faculty Research and Travel Grant, and the research was supported by the Active Living Accelerometer Loan Program. Staff support was provided by the California Department of Transportation. It would not have been possible without the study participants who generously allowed us to track their activities for multiple days.	Ali Z, 2013, REC ADV SPAC TECHN R; Audrey S, 2013, EUR J PUBLIC HEALTH, V23, P475, DOI 10.1093/eurpub/cks081; Barrett J, 2009, 50 AIAA ASME ASCE AH, P1; Bohte W, 2009, TRANSPORT RES C-EMER, V17, P285, DOI 10.1016/j.trc.2008.11.004; Breen MS, 2014, J EXPO SCI ENV EPID, V24, P412, DOI 10.1038/jes.2014.13; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs DJ, 2008, ENVIRON INT, V34, P12, DOI 10.1016/j.envint.2007.06.011; Brondeel R, 2015, MED SCI SPORTS EXERC; Brook Robert D., 2007, Reviews on Environmental Health, V22, P115; CHAN CC, 1991, ENVIRON SCI TECHNOL, V25, P964, DOI 10.1021/es00017a021; Chen Hong, 2008, Reviews on Environmental Health, V23, P243; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Chung EH, 2005, TRANSPORT PLAN TECHN, V28, P381, DOI 10.1080/03081060500322599; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Du J, 2007, TRANSPORT RES A-POL, V41, P220, DOI 10.1016/j.tra.2006.05.001; Duncan JS, 2009, J SCI MED SPORT, V12, P583, DOI 10.1016/j.jsams.2008.09.010; Duncan MJ, 2007, MED SCI SPORT EXER, V39, P1851, DOI 10.1249/mss.0b013e31811ff31e; Duncan MJ, 2007, AM J PREV MED, V33, P51, DOI 10.1016/j.amepre.2007.02.042; Elgethun K, 2007, J EXPO SCI ENV EPID, V17, P196, DOI 10.1038/sj.jes.7500496; Ellis K., 2013, P 4 INT SENSECAM PER, P88, DOI [10.1145/2526667.2526685, DOI 10.1145/2526667.2526685]; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Ellis K, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00036; eMarketer, 2014, WORLDW SMARTPH US GR; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Evenson KR, 2013, MED SCI SPORT EXER, V45, P1981, DOI 10.1249/MSS.0b013e318293330e; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gong L, 2014, PROCD SOC BEHV, V138, P557, DOI 10.1016/j.sbspro.2014.07.239; Gonzalez PA, 2010, IET INTELL TRANSP SY, V4, P37, DOI 10.1049/iet-its.2009.0029; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Houston D, 2013, ATMOS ENVIRON, V71, P148, DOI 10.1016/j.atmosenv.2013.02.002; Hurvitz PM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00002; Kang B, 2013, MED SCI SPORT EXER, V45, P1419, DOI 10.1249/MSS.0b013e318285f202; Kohla B, 2014, ADV DATA MIN DATABAS, P134, DOI 10.4018/978-1-4666-6170-7.ch009; Kuhnlein M, 2014, REMOTE SENS ENVIRON, V141, P129, DOI 10.1016/j.rse.2013.10.026; Larsson P, 2001, MED SCI SPORT EXER, V33, P1919, DOI 10.1097/00005768-200111000-00018; Lee J, 2015, J APPL STAT, V42, P676, DOI 10.1080/02664763.2014.978270; Nethery E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-33; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Oreskovic NM, 2012, GEOSPATIAL HEALTH, V6, P263, DOI 10.4081/gh.2012.144; Park YS, 2013, ECOL INFORM, V13, P40, DOI 10.1016/j.ecoinf.2012.10.008; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; Phillips ML, 2001, J EXPO ANAL ENV EPID, V11, P207, DOI 10.1038/sj.jea.7500161; Rainham D, 2010, SOC SCI MED, V70, P668, DOI 10.1016/j.socscimed.2009.10.035; RCore Team, 2020, R LANG ENV STAT COMP; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Rodriguez DA, 2012, J PHYS ACT HEALTH, V9, P421, DOI 10.1123/jpah.9.3.421; Schantz P, 2009, MED SCI SPORT EXER, V41, P472, DOI 10.1249/MSS.0b013e3181877aaf; Schuessler N, 2009, TRANSPORT RES REC, P28, DOI 10.3141/2105-04; Sreenivas K, 2014, J INDIAN SOC REMOTE, V42, P577, DOI 10.1007/s12524-013-0332-x; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Stopher P, 2008, TRANSPORT RES C-EMER, V16, P350, DOI 10.1016/j.trc.2007.10.002; Stumpf A, 2011, REMOTE SENS ENVIRON, V115, P2564, DOI 10.1016/j.rse.2011.05.013; Suh HH, 2000, ENVIRON HEALTH PERSP, V108, P625, DOI 10.2307/3454398; Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052; Thierry B, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-14; Van Dierendonck A. J., 1992, Navigation. Journal of the Institute of Navigation, V39, P265; Vitale M, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1992-z; Westerdahl D, 2005, ATMOS ENVIRON, V39, P3597, DOI 10.1016/j.atmosenv.2005.02.034; Wu J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-47; Wu J, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-101; Wu J, 2010, ENVIRON HEALTH INSIG, V4, P93, DOI 10.4137/EHI.S6246; Xu X, 2005, J EXPO ANAL ENV EPID, V15, P6, DOI 10.1038/sj.jea.7500374; Zheng Y, 2008, 11 INT C WORLD WID W; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797	65	10	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148875	10.1371/journal.pone.0148875	http://dx.doi.org/10.1371/journal.pone.0148875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919723	Green Published, gold			2022-12-26	WOS:000371274400012
J	Kim, K; Bang, SY; Yoo, DH; Cho, SK; Choi, CB; Sung, YK; Kim, TH; Jun, JB; Kang, YM; Suh, CH; Shim, SC; Lee, SS; Lee, J; Chung, WT; Kim, SK; Choe, JY; Nath, SK; Lee, HS; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Yoo, Dae Hyun; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Kang, Young Mo; Suh, Chang-Hee; Shim, Seung-Cheol; Lee, Shin-Seok; Lee, Jisoo; Chung, Won Tae; Kim, Seong-Kyu; Choe, Jung-Yoon; Nath, Swapan K.; Lee, Hye-Soon; Bae, Sang-Cheol			Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus	PLOS ONE			English	Article							EXPRESSION; MHC; HLA-DR-BETA-1; INDIVIDUALS; HAPLOTYPE; MOLECULES; EXPLAIN	The genetic association of HLA-DRB1 with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) is well documented, but association with other HLA-DR beta genes (HLA-DRB3, HLA-DRB4 and HLA-DRB5) has not been thoroughly studied, despite their similar functions and chromosomal positions. We examined variants in all functional HLA-DR beta genes in RA and SLE patients and controls, down to the amino-acid level, to better understand disease association with the HLA-DR locus. To this end, we improved an existing HLA reference panel to impute variants in all protein-coding HLA-DR beta genes. Using the reference panel, HLA variants were inferred from high-density SNP data of 9,271 RA-control subjects and 5,342 SLE-control subjects. Disease association tests were performed by logistic regression and log-likelihood ratio tests. After imputation using the newly constructed HLA reference panel and statistical analysis, we observed that HLA-DRB1 variants better accounted for the association between MHC and susceptibility to RA and SLE than did the other three HLA-DRB variants. Moreover, there were no secondary effects in HLA-DRB3, HLA-DRB4, or HLA-DRB5 in RA or SLE. Of all the HLA-DR beta chain paralogs, those encoded by HLA-DRB1 solely or dominantly influence susceptibility to RA and SLE.	[Kim, Kwangwoo; Bang, So-Young; Yoo, Dae Hyun; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, Suwon 441749, South Korea; [Shim, Seung-Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Div Rheumatol, Daejeon, South Korea; [Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea; [Lee, Jisoo] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Chung, Won Tae] Dong A Univ, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Kim, Seong-Kyu; Choe, Jung-Yoon] Catholic Univ, Daegu Sch Med, Arthrit & Autoimmun Res Ctr, Div Rheumatol,Dept Internal Med, Daegu, South Korea; [Nath, Swapan K.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Hanyang University; Kyungpook National University; Ajou University; Chungnam National University; Chungnam National University Hospital; Chonnam National University; Ewha Womans University; Dong A University; Catholic University of Daegu; Oklahoma Medical Research Foundation	Bae, SC (corresponding author), Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea.	scbae@hanyang.ac.kr	Suh, Chang-Hee/H-9723-2019; Yoo, Dae Hyun/M-3924-2017; Choi, Chan-Bum/M-4110-2017; Lee, Shin-Seok/AAC-6779-2021	Suh, Chang-Hee/0000-0001-6156-393X; Choi, Chan-Bum/0000-0002-4691-5455; Shim, Seung cheol/0000-0002-3199-359X; Bae, Sang-Cheol/0000-0003-4658-1093; Kim, Kwangwoo/0000-0001-8926-6216	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1C1A1A02036527]; US National Institutes of Health [R01MD007909, R01AR060366]; Korea Healthcare Technology R&D Project of the Ministry for Health Welfare [HI13C2124]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060366] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007909] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Healthcare Technology R&D Project of the Ministry for Health Welfare; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1C1A1A02036527 to Dr. Kwangwoo Kim), the US National Institutes of Health (R01MD007909 and R01AR060366 to Dr. Swapan K. Nath), and the Korea Healthcare Technology R&D Project of the Ministry for Health & Welfare (HI13C2124 to Dr. Sang-Cheol Bae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1994, IMMUNOL TODAY, V15, P58, DOI 10.1016/0167-5699(94)90134-1; Andersson Goran, 1998, Frontiers in Bioscience, V3, pD739; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; COTNER T, 1989, J BIOL CHEM, V264, P11107; Czerwony G, 1999, HUM IMMUNOL, V60, P1, DOI 10.1016/S0198-8859(98)00096-2; Hohjoh H, 2003, IMMUNOGENETICS, V54, P856, DOI 10.1007/s00251-003-0539-z; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6902; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112546; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Prat E, 2005, J NEUROIMMUNOL, V167, P108, DOI 10.1016/j.jneuroim.2005.04.027; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Satta Y, 1996, HUM IMMUNOL, V51, P1, DOI 10.1016/S0198-8859(96)00155-3	16	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150283	10.1371/journal.pone.0150283	http://dx.doi.org/10.1371/journal.pone.0150283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919467	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400117
J	Li, XY; Chen, YQ; Gao, WG; Ouyang, WW; Wei, J; Wen, ZH				Li, Xiaoyan; Chen, Yunqin; Gao, Weiguo; Ouyang, Wenwei; Wei, Jia; Wen, Zehuai			Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MANAGEMENT; PATHOGENS; EFFICACY; SAFETY; EUROPE; TIGECYCLINE; DAPTOMYCIN; VANCOMYCIN	Complicated skin and soft tissue infections (cSSTI) are some of the most commonly treated infections in hospitals, and place heavy economic burdens on patients and society. Here we report the findings from an analysis of cSSTI based on a retrospective study which was conducted within the Chinese inpatient population. We focused our research on the analysis of the patient population, antibiotic treatment, clinical outcome and economic burden. The study population comprised 527 selected patients hospitalized between 2008 and 2013. Among the hospitalizations with microbiological diagnoses, 61.41%(n = 113) were diagnosed as infected with Gram-positive bacteria, while 46.20%(n = 85) were infected with Gram-negative bacteria. The most commonly found Gram-positive bacteria was Staphylococcus aureus (40.76%, n = 75), and the most common Gram-negative bacteria was Escherichia coli (14.13%, n = 26). About 20% of the Staphylococcus aureus were methicillin-resistant. The resistance rate of isolated Staphylococcus aureus or Escherichia coli to penicillin was around 90%; in contrast, the resistance rate to vancomycin, linezolid or imipenem was low (<20%). A large percentage of patients were treated with cephalosporins and fluoroquinolones, while vancomycin and imipenem were also included to treat drug-resistant pathogens. Over half of the hospitalizations (58.43%, n = 336) experienced treatment modifications. The cost to patients with antibiotic modifications was relatively higher than to those without. In conclusion, our study offers an analysis of the disease characteristics, microbiological diagnoses, treatment patterns and clinical outcomes of cSSTI in four hospitals in Guangdong Province, and sheds lights on the current clinical management of cSSTI in China.	[Li, Xiaoyan; Ouyang, Wenwei; Wen, Zehuai] Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China; [Chen, Yunqin; Gao, Weiguo; Wei, Jia] AstraZeneca, R&D Informat China, 199 Liangjing Rd, Shanghai 201203, Peoples R China	Guangzhou University of Chinese Medicine; AstraZeneca	Wen, ZH (corresponding author), Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China.; Wei, J (corresponding author), AstraZeneca, R&D Informat China, 199 Liangjing Rd, Shanghai 201203, Peoples R China.	jenny.wei@astrazeneca.com; wenzh@gzucm.edu.cn	Wen, Zehuai/A-5103-2015	Wen, Zehuai/0000-0002-1797-2047				Bassetti M, 2014, CLIN MICROBIOL INFEC, V20, P3, DOI 10.1111/1469-0691.12463; Chuang YC, 2011, J MICROBIOL IMMUNOL, V44, P116, DOI 10.1016/j.jmii.2010.04.002; Cornia PB, 2008, EXPERT OPIN PHARMACO, V9, P717, DOI 10.1517/14656566.9.5.717; Fritz SA, 2013, ANTIMICROB AGENTS CH, V57, P559, DOI 10.1128/AAC.01633-12; Garau J, 2013, CLIN MICROBIOL INFEC, V19, pE377, DOI 10.1111/1469-0691.12235; Gonzalez-Ruiz A, 2013, INT J ANTIMICROB AG, V41, P372, DOI 10.1016/j.ijantimicag.2012.12.017; Heizmann WR, 2013, J ANTIMICROB CHEMOTH, V68, pii45, DOI 10.1093/jac/dkt144; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Lai CC, 2012, J MICROBIOL IMMUNOL, V45, P52, DOI 10.1016/j.jmii.2011.09.018; Lee Su Young, 2005, Surg Infect (Larchmt), V6, P283, DOI 10.1089/sur.2005.6.283; Lin DF, 2008, INT J ANTIMICROB AG, V32, P241, DOI 10.1016/j.ijantimicag.2008.04.004; Lipsky BA, 2014, DIAGN MICR INFEC DIS, V79, P273, DOI 10.1016/j.diagmicrobio.2014.02.011; May AK, 2009, SURG INFECT, V10, P467, DOI 10.1089/sur.2009.012; Merlino James I, 2007, Cleve Clin J Med, V74 Suppl 4, pS21; Nathwani D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-476; Nichols RL, 1999, J ANTIMICROB CHEMOTH, V44, P19, DOI 10.1093/jac/44.suppl_1.19; Ostermann Helmut, 2014, J Med Econ, V17, P719, DOI 10.3111/13696998.2014.940423; Puzniak LA, 2014, DIAGN MICR INFEC DIS, V78, P295, DOI 10.1016/j.diagmicrobio.2013.11.001; Rajan S, 2012, CLEV CLIN J MED, V79, P57, DOI 10.3949/ccjm.79a.11044; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Szczypinska E, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-696; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Zervos MJ, 2012, J CLIN MICROBIOL, V50, P238, DOI 10.1128/JCM.05817-11; Zilberberg MD, 2009, INFECT CONT HOSP EP, V30, P1203, DOI 10.1086/648083	24	15	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149960	10.1371/journal.pone.0149960	http://dx.doi.org/10.1371/journal.pone.0149960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918456	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400062
J	Stone, HR; McGreevy, PD; Starling, MJ; Forkman, B				Stone, Holly R.; McGreevy, Paul D.; Starling, Melissa J.; Forkman, Bjorn			Associations between Domestic-Dog Morphology and Behaviour Scores in the Dog Mentality Assessment	PLOS ONE			English	Article							PERSONALITY-TRAITS; SKULL SHAPE; SEX; AGE	The domestic dog shows a wide range of morphologies, that humans have selected for in the process of creating unique breeds. Recent studies have revealed correlations between changes in morphology and behaviour as reported by owners. For example, as height and weight decrease, many undesirable behaviours (non-social fear, hyperactivity and attention seeking) become more apparent. The current study aimed to explore more of these correlations, but this time used reports from trained observers. Phenotypic measurements were recorded from a range of common dog breeds (n = 45) and included cephalic index (CI: the ratio of skull width to skull length), bodyweight, height and sex. These data were then correlated with results from the Dog Mentality Assessment (DMA), which involves trained observers scoring a dog's reaction to stimuli presented over 10 standardised subtests. Each subtest is designed to evoke a behavioural response. Backward elimination and weighted step-wise regression revealed that shorter dogs demonstrated more aggressive tendencies, reacting defensively toward both assistants dressed as ghosts (p = 0.045), and to a dummy (p = 0.008). Taller dogs were more affectionate when greeting and being handled by humans (p = 0.007, p = < 0.001, respectively). Taller dogs were also more cooperative (p = < 0.001), and playful (p = 0.001) with humans than shorter dogs. Heavier dogs were more inquisitive toward a dummy (p = 0.011), to the source of a metallic noise (p = 0.010) and to an assistant (p = 0.003). Heavier dogs were also more attentive to the ghosts (p = 0.013). In comparison, lighter dogs were cautious of a dummy (p = < 0.001) and fearful of the sound of a gunshot (p = < 0.001). Lighter dogs were also cautious of, and demonstrated prolonged fearfulness toward, the source of metallic noise (p = < 0.001, p = < 0.034, respectively). With a far larger sample and the advantage of third-party reporting (which overcomes potential owner bias), the current findings build on previous studies in this field, further supporting covariance between morphology and behaviour.	[Stone, Holly R.; McGreevy, Paul D.; Starling, Melissa J.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Forkman, Bjorn] Univ Copenhagen, Copenhagen, Denmark	University of Sydney; University of Copenhagen	Stone, HR (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	hsto8847@uni.sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378; Forkman, Bjorn/0000-0002-0153-6240	University of Sydney	University of Sydney(University of Sydney)	$200 funding from the University of Sydney was used to support statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Evans H.E., 1993, MILLERS ANATOMY DOG; Fogle B, 1995, ENCY DOG; Franco Fernanda Catharino Menezes, 2013, Dental Press J Orthod, V18, P159; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Georgevsky D, 2014, J VET BEHAV, V9, P228, DOI 10.1016/j.jveb.2014.04.007; Martinez AG, 2011, J VET BEHAV, V6, P225, DOI 10.1016/j.jveb.2011.01.006; Goodloe L P, 1998, J Appl Anim Welf Sci, V1, P303, DOI 10.1207/s15327604jaws0104_1; Hecht J, 2015, ANTHROZOOS, V28, P153, DOI 10.2752/089279315X14129350722217; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; LOMBER SG, 2005, J VISION, V5, P49; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; McGreevy PD, 2012, J VET BEHAV, V7, P103, DOI 10.1016/j.jveb.2011.06.001; McGreevy PD, 2009, A MODERN DOGS LIFE; Overall KL, 2014, J VET BEHAV, V9, P1, DOI 10.1016/j.jveb.2013.12.001; Payne E, 2015, PSYCHOL RES BEHAV MA, V8, P71, DOI 10.2147/PRBM.S74972; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Rooney NJ, 2002, APPL ANIM BEHAV SCI, V75, P161, DOI 10.1016/S0168-1591(01)00192-7; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Scott JP., 1965, GENETICS SOCIAL BEHA; Serpell J.A., 2014, DOMESTIC DOG COGNITI, DOI [10.1007/978-3-642-53994-7_2, DOI 10.1007/978-3-642-53994-7_2]; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svartberg K, 2007, BEHAV BIOL DOGS, P190; The Kennel Club, 2014, HIST KENN CLUB; van Rooy Diane, 2014, Canine Genet Epidemiol, V1, P7, DOI 10.1186/2052-6687-1-7	32	32	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149403	10.1371/journal.pone.0149403	http://dx.doi.org/10.1371/journal.pone.0149403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919495	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400020
J	Garrido-Sanz, D; Meier-Kolthoff, JP; Goker, M; Martin, M; Rivilla, R; Redondo-Nieto, M				Garrido-Sanz, Daniel; Meier-Kolthoff, Jan P.; Goeker, Markus; Martin, Marta; Rivilla, Rafael; Redondo-Nieto, Miguel			Genomic and Genetic Diversity within the Pseudomonas fluorescens Complex	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; ESCHERICHIA-COLI; SYSTEMIC RESISTANCE; PHENAZINE COMPOUNDS; SPECIES DEFINITION; GENUS PSEUDOMONAS; PHENYLACETIC ACID; CHLORORAPHIS O6; INSECT TOXIN; PLANT	The Pseudomonas fluorescens complex includes Pseudomonas strains that have been taxonomically assigned to more than fifty different species, many of which have been described as plant growth-promoting rhizobacteria (PGPR) with potential applications in biocontrol and biofertilization. So far the phylogeny of this complex has been analyzed according to phenotypic traits, 16S rDNA, MLSA and inferred by whole-genome analysis. However, since most of the type strains have not been fully sequenced and new species are frequently described, correlation between taxonomy and phylogenomic analysis is missing. In recent years, the genomes of a large number of strains have been sequenced, showing important genomic heterogeneity and providing information suitable for genomic studies that are important to understand the genomic and genetic diversity shown by strains of this complex. Based on MLSA and several whole-genome sequence-based analyses of 93 sequenced strains, we have divided the P. fluorescens complex into eight phylogenomic groups that agree with previous works based on type strains. Digital DDH (dDDH) identified 69 species and 75 subspecies within the 93 genomes. The eight groups corresponded to clustering with a threshold of 31.8% dDDH, in full agreement with our MLSA. The Average Nucleotide Identity (ANI) approach showed inconsistencies regarding the assignment to species and to the eight groups. The small core genome of 1,334 CDSs and the large pangenome of 30,848 CDSs, show the large diversity and genetic heterogeneity of the P. fluorescens complex. However, a low number of strains were enough to explain most of the CDSs diversity at core and strain-specific genomic fractions. Finally, the identification and analysis of group-specific genome and the screening for distinctive characters revealed a phylogenomic distribution of traits among the groups that provided insights into biocontrol and bioremediation applications as well as their role as PGPR.	[Garrido-Sanz, Daniel; Martin, Marta; Rivilla, Rafael; Redondo-Nieto, Miguel] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, C Darwin 2, E-28049 Madrid, Spain; [Meier-Kolthoff, Jan P.; Goeker, Markus] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany	Autonomous University of Madrid; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Redondo-Nieto, M (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol, C Darwin 2, E-28049 Madrid, Spain.	miguel.redondo@uam.es	Meier-Kolthoff, Jan P./GOP-1205-2022; martin, marta/H-2169-2015; Redondo-Nieto, Miguel/A-6169-2011; Rivilla, Rafael/A-1659-2008; Meier-Kolthoff, Jan Philipp/AAX-6799-2021; Garrido-Sanz, Daniel/W-7473-2019; Göker, Markus/AAX-6258-2021; Basanta, Marta Martin/AAI-5459-2020	martin, marta/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X; Rivilla, Rafael/0000-0003-0701-2939; Meier-Kolthoff, Jan Philipp/0000-0001-9105-9814; Göker, Markus/0000-0002-5144-6200; Basanta, Marta Martin/0000-0003-2498-9768; Garrido-Sanz, Daniel/0000-0003-3279-6421	Ministerio de Economia y Competitividad [BIO2012-31634]; Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain; FPU fellowship program from Ministerio de Educacion, Cultura y Deporte, Spain [FPU14/03965]; MINECO [BIO2012-31634]	Ministerio de Economia y Competitividad(Spanish Government); Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain; FPU fellowship program from Ministerio de Educacion, Cultura y Deporte, Spain; MINECO(Spanish Government)	Research was funded by: 1) Grant BIO2012-31634 from Ministerio de Economia y Competitividad to MM; 2) Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain to RR; 3) DGS was granted by FPU fellowship program (FPU14/03965) from Ministerio de Educacion, Cultura y Deporte, Spain.; We thank Dr. Jacob Malone for the critical reading of the manuscript. Research was funded by Grant BIO2012-31634 from MINECO and the research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain. DGS was granted by FPU fellowship program (FPU14/03965) from Ministerio de Educacion, Cultura y Deporte, Spain. We thank Centro de Computacion Cientifica from UAM for giving us access to their computational facilities.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Brodhagen M, 2005, APPL ENVIRON MICROB, V71, P6900, DOI 10.1128/AEM.71.11.6900-6909.2005; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; Calderon CE, 2013, MOL PLANT MICROBE IN, V26, P554, DOI 10.1094/MPMI-01-13-0012-R; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao L, 2013, J HAZARD MATER, V261, P246, DOI 10.1016/j.jhazmat.2013.07.019; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; COOK AM, 1984, J AGR FOOD CHEM, V32, P581, DOI 10.1021/jf00123a040; Cowan D, 1998, EXTREMOPHILES, V2, P207, DOI 10.1007/s007920050062; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Daubner SC, 2002, P NATL ACAD SCI USA, V99, P2702, DOI 10.1073/pnas.052527799; De Maayer P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-404; Dean CR, 1996, J BACTERIOL, V178, P5361, DOI 10.1128/jb.178.18.5361-5369.1996; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Devi KK, 2009, FEMS MICROBIOL LETT, V300, P195, DOI 10.1111/j.1574-6968.2009.01782.x; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Ellis RJ, 2000, ENVIRON MICROBIOL, V2, P274, DOI 10.1046/j.1462-2920.2000.00102.x; Expert D, 1996, TRENDS MICROBIOL, V4, P232, DOI 10.1016/0966-842X(96)10038-X; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Ghiglione JF, 2002, FEMS MICROBIOL ECOL, V39, P121, DOI 10.1111/j.1574-6941.2002.tb00913.x; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Han SH, 2006, MOL PLANT MICROBE IN, V19, P924, DOI 10.1094/MPMI-19-0924; Henz SR, 2005, BIOINFORMATICS, V21, P2329, DOI 10.1093/bioinformatics/bth324; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Ivanova EP, 2009, INT J SYST EVOL MICR, V59, P2476, DOI 10.1099/ijs.0.009654-0; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Jousset A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00322-14; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kampfer P, 2012, ENVIRON MICROBIOL, V14, P291, DOI 10.1111/j.1462-2920.2011.02615.x; KANDA N, 1975, J ANTIBIOT, V28, P935, DOI 10.7164/antibiotics.28.935; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Kim YO, 2004, CURR MICROBIOL, V48, P312, DOI 10.1007/s00284-003-4193-3; KITAHARA T, 1975, J ANTIBIOT, V28, P943, DOI 10.7164/antibiotics.28.943; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuiper I, 2001, MOL PLANT MICROBE IN, V14, P1096, DOI 10.1094/MPMI.2001.14.9.1096; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Li A, 2012, J BACTERIOL, V194, P5720, DOI 10.1128/JB.01376-12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li QA, 2010, J BIOTECHNOL, V149, P115, DOI 10.1016/j.jbiotec.2009.12.015; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Marchi M, 2013, ENV MICROBIOL REP, V5, P393, DOI 10.1111/1758-2229.12048; MAURHOFER M, 1992, PHYTOPATHOLOGY, V82, P190, DOI 10.1094/Phyto-82-190; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mazurier S, 2009, ISME J, V3, P977, DOI 10.1038/ismej.2009.33; Mehnaz S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01108-13; Meier-Kolthoff JP, 2014, CONCURR COMP-PRACT E, V26, P1715, DOI 10.1002/cpe.3112; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mirleau P, 2001, APPL ENVIRON MICROB, V67, P2627, DOI 10.1128/AEM.67.6.2627-2635.2001; Mulet M, 2012, SYST APPL MICROBIOL, V35, P455, DOI 10.1016/j.syapm.2012.08.007; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Muriel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132242; Nandi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123184; Nayyar H, 2005, BOT B ACAD SINICA, V46, P6; Nowak-Thompson B, 2003, J BACTERIOL, V185, P860, DOI 10.1128/JB.185.3.860-869.2003; Nowak-Thompson B, 1999, J BACTERIOL, V181, P2166, DOI 10.1128/JB.181.7.2166-2174.1999; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Palleroni NJ, 1984, BERGEYS MANUAL SYSTE, V2, P279; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Patil Kaustubh R, 2013, Genome Biol Evol, V5, P1470, DOI 10.1093/gbe/evt105; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Pechy-Tarr M, 2013, ENVIRON MICROBIOL, V15, P736, DOI 10.1111/1462-2920.12050; PHILIPPOT L, 1995, APPL ENVIRON MICROB, V61, P1426, DOI 10.1128/AEM.61.4.1426-1430.1995; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Prosen H, 2005, ENVIRON POLLUT, V133, P517, DOI 10.1016/j.envpol.2004.06.015; R Core Team, 2021, R LANGUAGE ENV STAT; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Roy P, 2005, PLANT SCI, V168, P583, DOI 10.1016/j.plantsci.2004.08.014; Sagarkar S, 2014, J ENVIRON MANAGE, V139, P208, DOI 10.1016/j.jenvman.2014.02.016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samolski I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-217; Seaton S. C., 2014, GENOMICS PLANT ASS B, P99; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Sheets TJ, 1963, WEED SCI SOC AM, V11, P6; Shen WY, 2000, PLANT PHYSIOL, V124, P431, DOI 10.1104/pp.124.1.431; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TAKEDA R, 1958, J AM CHEM SOC, V80, P4749, DOI 10.1021/ja01550a093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wasi S, 2013, ENVIRON MONIT ASSESS, V185, P8147, DOI 10.1007/s10661-013-3163-x; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Weller DM, 2007, PLANT BIOLOGY, V9, P4, DOI 10.1055/s-2006-924473; Wong BT, 2014, J BIOSCI BIOENG, V117, P71, DOI 10.1016/j.jbiosc.2013.06.006; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yi Huiguang, 2013, Nucleic Acids Res, V41, pe75, DOI 10.1093/nar/gkt003; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Zhang Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00110; Zhao LF, 2013, BRAZ J MICROBIOL, V44, P629, DOI 10.1590/S1517-83822013000200043; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	136	132	133	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150183	10.1371/journal.pone.0150183	http://dx.doi.org/10.1371/journal.pone.0150183			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915094	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700059
J	Shimoni, S; Bar, I; Meledin, V; Derazne, E; Gandelman, G; George, J				Shimoni, Sara; Bar, Iris; Meledin, Valery; Derazne, Estela; Gandelman, Gera; George, Jacob			Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; STANDARDS COMMITTEE; VALVE STENOSIS; EARLY LESION; TASK-FORCE; RECOMMENDATIONS; NUMBER; ECHOCARDIOGRAPHY; QUANTIFICATION	Background Aortic stenosis (AS) is the most common valvular disease. Endothelial progenitor cells (EPCs) have a role in the repair of endothelial surfaces after injury. Reduced numbers of EPCs are associated with endothelial dysfunction and adverse clinical events, suggesting that endothelial injury in the absence of sufficient repair by circulating EPCs promotes the progression of vascular and possibly valvular disorders. The aim of this study was to assess EPC number in patients with AS and to study the predictive value of their circulating levels on prognosis. Methods The number of EPCs was determined by flow cytometry in 241 patients with AS and a control group of 73 pts. Thirty-eight, 52 and 151 patients had mild, moderate and severe AS, respectively. We evaluated the association between baseline levels of EPCs and death from cardiovascular causes during follow up. Results EPC level was significantly higher in patients with AS compared to the control group (p = 0.017). Two hundred and three patients with moderate and severe AS were followed for a median of 20 months. One hundred and twenty patients underwent an intervention. Thirty four patients died during follow up, 20 patients died due to cardiac causes. Advanced age, the presence of coronary artery disease, AS severity index (combination of high NYHA class, smaller aortic valve area and elevated pulmonary artery pressure) and a low EPC number were predictors of cardiac death in the univariate analysis. Multivariate logistic regression model identified low EPCs number and AS severity index as associated with cardiac death during follow up (p = 0.026 and p = 0.037, respectively). Conclusions EPC number is increased in patients with AS. However, in patients with moderate or severe AS a relatively low number of EPCs is associated with cardiac death at follow up. These results may help to identify AS patients at increased cardiovascular risk.	[Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Kaplan Med Ctr, Inst Heart, Rehovot, Israel; [Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Hebrew Univ Jerusalem, Jerusalem, Israel; [Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Derazne, Estela] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine	Shimoni, S (corresponding author), Kaplan Med Ctr, Inst Heart, Rehovot, Israel.; Shimoni, S (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.; Shimoni, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel.	Sara_s@clalit.org.il			Clalit Research Institute of Clalit Health Services, Israel	Clalit Research Institute of Clalit Health Services, Israel	The study was supported by the Clalit Research Institute of Clalit Health Services, Israel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Bhattacharyya S, 2012, EUR HEART J, V33, P2377, DOI 10.1093/eurheartj/ehs190; Davies PF, 2004, ARTERIOSCL THROM VAS, V24, P1331, DOI 10.1161/01.ATV.0000130659.89433.c1; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331; Gossl M, 2012, J AM COLL CARDIOL, V60, P1945, DOI 10.1016/j.jacc.2012.07.042; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Lamirault G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt382; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Matsumoto Y, 2009, EUR HEART J, V30, P346, DOI 10.1093/eurheartj/ehn501; Mazzone A, 2004, J AM COLL CARDIOL, V43, P1670, DOI 10.1016/j.jacc.2003.12.041; Michowitz Y, 2007, HEART, V93, P1046, DOI 10.1136/hrt.2006.102657; Mirzaie Masoud, 2002, Ann Thorac Cardiovasc Surg, V8, P24; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Redondo S, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-2; Skowasch D, 2005, EUR HEART J, V26, P2576, DOI 10.1093/eurheartj/ehi458; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Thomas HE, 2008, ARTERIOSCL THROM VAS, V28, pE21, DOI 10.1161/ATVBAHA.107.160317; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915	31	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148766	10.1371/journal.pone.0148766	http://dx.doi.org/10.1371/journal.pone.0148766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913741	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700009
J	Ambrosio, LJ; Baeza, JA				Ambrosio, Louis J.; Antonio Baeza, J.			Territoriality and Conflict Avoidance Explain Asociality (Solitariness) of the Endosymbiotic Pea Crab Tunicotheres moseri	PLOS ONE			English	Article							PAGURUS-POLLICARIS SAY; IN-HOUSE CRICKETS; SEA-ANEMONE; LARVAL SETTLEMENT; HERMIT-CRAB; COMPETITION; BEHAVIOR; CRUSTACEA; SHRIMP; BRACHYURA	Host monopolization theory predicts symbiotic organisms inhabiting morphologically simple, relatively small and scarce hosts to live solitarily as a result of territorial behaviors. We tested this prediction with Tunicotheres moseri, an endosymbiotic crab dwelling in the atrial chamber of the morphologically simple, small, and relatively scarce ascidian Styela plicata. As predicted, natural populations of T. moseri inhabit ascidian hosts solitarily with greater frequency than expected by chance alone. Furthermore, laboratory experiments demonstrated that intruder crabs take significantly longer to colonize previously infected compared to uninfected hosts, indicating as expected, that resident crabs exhibit monopolization behaviors. While territoriality does occur, agonistic behaviors employed by T. moseri do not mirror the overt behaviors commonly reported for other territorial crustaceans. Documented double and triple cohabitations in the field coupled with laboratory observations demonstrating the almost invariable success of intruder crabs colonizing occupied hosts, suggest that territoriality is ineffective in completely explaining the solitary social habit of this species. Additional experiments showed that T. moseri juveniles and adults, when searching for ascidians use chemical cues to avoid hosts occupied by conspecifics. This conspecific avoidance behavior reported herein is a novel strategy most likely employed to preemptively resolve costly territorial conflicts. In general, this study supports predictions central to host monopolization theory, but also implies that alternative behavioral strategies (i.e., conflict avoidance) may be more important than originally thought in explaining the host use pattern of symbiotic organisms.	[Ambrosio, Louis J.; Antonio Baeza, J.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Antonio Baeza, J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL USA; [Antonio Baeza, J.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile	Clemson University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Catolica del Norte	Ambrosio, LJ (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ljambro@g.clemson.edu		Baeza, Juan Antonio/0000-0002-2573-6773				ABELE LG, 1976, SCIENCE, V192, P461, DOI 10.1126/science.192.4238.461; ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Allison P. D., 1995, SURVIVAL ANAL USING; Ambrosio LJ, 2011, SYMBIOSIS, V53, P53, DOI 10.1007/s13199-011-0112-8; Anderson JA, 2010, J EXP MAR BIOL ECOL, V384, P87, DOI 10.1016/j.jembe.2009.12.014; Baeza JA, 2011, INVERTEBR BIOL, V130, P351, DOI 10.1111/j.1744-7410.2011.00244.x; Arnott G, 2008, ANIM BEHAV, V76, P529, DOI 10.1016/j.anbehav.2008.04.019; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; BACH CE, 1980, CRUSTACEANA, V38, P104, DOI 10.1163/156854080X00508; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza JA, 2012, BIOL J LINN SOC, V105, P548, DOI 10.1111/j.1095-8312.2011.01803.x; Baeza JA, 2003, MAR BIOL, V142, P93, DOI 10.1007/s00227-002-0927-1; Baeza JA, 2002, MAR FRESHW BEHAV PHY, V35, P189, DOI 10.1080/1023624021000003817; Bolanos J, 2004, SCI MAR, V68, P373, DOI 10.3989/scimar.2004.68n3373; Both C, 2003, AM NAT, V161, P326, DOI 10.1086/346098; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; BROOKS WR, 1989, J EXP MAR BIOL ECOL, V132, P109, DOI 10.1016/0022-0981(89)90218-9; BROOKS WR, 1985, J EXP MAR BIOL ECOL, V87, P111, DOI 10.1016/0022-0981(85)90084-X; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Calado R, 2007, SCI MAR, V71, P287, DOI 10.3989/scimar.2007.71n2287; CALDWELL RL, 1979, BEHAVIOUR, V69, P254, DOI 10.1163/156853979X00502; Chapman MR, 1996, ANIM BEHAV, V52, P83, DOI 10.1006/anbe.1996.0154; CROWL TA, 1994, J N AM BENTHOL SOC, V13, P291, DOI 10.2307/1467247; CROWLEY PH, 1988, ANIM BEHAV, V36, P1496, DOI 10.1016/S0003-3472(88)80220-3; De Bruyn C, 2009, MAR ECOL PROG SER, V375, P173, DOI 10.3354/meps07733; DIESEL R, 1988, J CRUSTACEAN BIOL, V8, P63, DOI 10.2307/1548431; DUFFY JE, 1992, MAR ECOL PROG SER, V90, P127, DOI 10.3354/meps090127; Duffy JE, 1996, J CRUSTACEAN BIOL, V16, P564, DOI 10.2307/1548748; Elbourne PD, 2010, J EXP MAR BIOL ECOL, V392, P99, DOI 10.1016/j.jembe.2010.04.013; Elliot JM, 1971, SCI PUBLICATIONS, V25; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Figler MH, 2005, MAR FRESHW BEHAV PHY, V38, P237, DOI 10.1080/10236240500376477; Franke HD, 1998, J EXP MAR BIOL ECOL, V227, P1, DOI 10.1016/S0022-0981(97)00253-0; Gandy R, 2015, DIS AQUAT ORGAN, V113, P235, DOI 10.3354/dao02841; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; GRAND TC, 1994, ANIM BEHAV, V47, P91, DOI 10.1006/anbe.1994.1010; GRANT JWA, 1993, MAR BEHAV PHYSIOL, V23, P137, DOI 10.1080/10236249309378862; GRANT JWA, 1993, BEHAV ECOL, V4, P293, DOI 10.1093/beheco/4.4.293; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; Hack MA, 1997, BEHAV ECOL, V8, P28, DOI 10.1093/beheco/8.1.28; HARRIGAN P, 1989, B MAR SCI, V44, P65; Henkel TP, 2005, MAR BIOL, V146, P301, DOI 10.1007/s00227-004-1448-x; Hernandez JE, 2012, BIOL BULL-US, V223, P278, DOI 10.1086/BBLv223n3p278; HUBER ME, 1986, MAR ECOL PROG SER, V30, P21, DOI 10.3354/meps030021; HUBER ME, 1987, J CRUSTACEAN BIOL, V7, P238, DOI 10.2307/1548604; JANSSEN A, 1995, BEHAV ECOL SOCIOBIOL, V36, P229, DOI 10.1007/s002650050144; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Kobak J, 2015, J ZOOL, V297, P66, DOI 10.1111/jzo.12252; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Martinez, 1976, AN MUS HIST NAT VALP, V9, P45; McDonald J.H., 2014, HDB BIOL STAT; Ocampo EH, 2012, J EXP MAR BIOL ECOL, V429, P36, DOI 10.1016/j.jembe.2012.06.009; PALOMBIT RA, 1993, AM J PRIMATOL, V31, P311, DOI 10.1002/ajp.1350310407; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; RANTA E, 1992, ETHOLOGY, V92, P217; Rathbun MJ, 1918, B US NATN MUS, V97, p[1, 1], DOI DOI 10.5479/SI.03629236.97.I; SAS Institute Inc, 2015, JMP 12, V12; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; STEBBINS TD, 1989, MAR BIOL, V101, P329, DOI 10.1007/BF00428129; STONER AW, 1984, COPEIA, P174, DOI 10.2307/1445050; SWEATMAN H, 1988, J EXP MAR BIOL ECOL, V124, P163, DOI 10.1016/0022-0981(88)90170-0; TELFORD M, 1982, B MAR SCI, V32, P584; Thiel M, 2003, J ZOOL, V261, P353, DOI 10.1017/S0952836903004333; Thiel M, 2003, B MAR SCI, V72, P89; Thiel M, 2001, SYMBIOSIS, V30, P163; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; Weiss I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3767; WELLS HARRY W., 1961, BULL MAR SCI GULF AND CARIBBEAN, V11, P267; WRIGHT HO, 1968, AM ZOOL, V8, P655; YOUNG CM, 1981, INT J INVER REP DEV, V3, P221; Zamzow JP, 2010, MAR ECOL PROG SER, V400, P155, DOI 10.3354/meps08399; Zar J.H., 2009, BIOSTATISTICAL ANAL	75	21	22	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148285	10.1371/journal.pone.0148285	http://dx.doi.org/10.1371/journal.pone.0148285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910474	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700007
J	Singh, P; Irwin, DM				Singh, Parmveer; Irwin, David M.			Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; ELEMENT-BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; GLUCOSE-METABOLISM; ENERGY-METABOLISM; WEB SERVER; CHREBP; GLUCOKINASE; ALIGNMENTS; WBSCR14	ChREBP and MondoA are glucose-sensitive transcription factors that regulate aspects of energy metabolism. Here we performed a phylogenomic analysis of Mlxip (encoding MondoA) and Mlxipl (encoding ChREBP) genes across vertebrates. Analysis of extant Mlxip and Mlxipl genes suggests that the most recent common ancestor of these genes was composed of 17 coding exons. Single copy genes encoding both ChREBP and MondoA, along with their interacting partner Mlx, were found in diverse vertebrate genomes, including fish that have experienced a genome duplication. This observation suggests that a single Mlx gene has been retained to maintain coordinate regulation of ChREBP and MondoA. The ChREBP-beta isoform, the more potent and constitutively active isoform, appeared with the evolution of tetrapods and is absent from the Mlxipl genes of fish. Evaluation of the conservation of ChREBP and MondoA sequences demonstrate that MondoA is better conserved and potentially mediates more ancient function in glucose metabolism.	[Singh, Parmveer; Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 1L5, Canada	University of Toronto; University of Toronto	Irwin, DM (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Irwin, DM (corresponding author), Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 1L5, Canada.	david.irwin@utoronto.ca		Irwin, David/0000-0001-6131-4933	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research [CCI - 109605]; Banting and Best Diabetes Summer Studentship	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research; Banting and Best Diabetes Summer Studentship	This work was funded by a National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number CCI - 109605 to DMI. Parmveer Singh was supported by a Banting and Best Diabetes Summer Studentship (www.bbdc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hirota K, 2010, J RECEPT SIG TRANSD, V30, P403, DOI 10.3109/10799893.2010.509730; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kahn A, 1997, BIOCHIMIE, V79, P113, DOI 10.1016/S0300-9084(97)81501-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; McFerrin LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034803; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z; Panserat S, 2014, NUTR RES REV, V27, P21, DOI 10.1017/S0954422414000018; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rojas JM, 2014, DIABETES OBES METAB, V16, P33, DOI 10.1111/dom.12332; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smit A, 1996, REPEATMASKER OPEN 30; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174	44	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149682	10.1371/journal.pone.0149682	http://dx.doi.org/10.1371/journal.pone.0149682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910886	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700044
J	Erjavec, I; Bordukalo-Niksic, T; Brkljacic, J; Grcevic, D; Mokrovic, G; Kesic, M; Rogic, D; Zavadoski, W; Paralkar, VM; Grgurevic, L; Trkulja, V; Cicin-Sain, L; Vukicevic, S				Erjavec, Igor; Bordukalo-Niksic, Tatjana; Brkljacic, Jelena; Grcevic, Danka; Mokrovic, Gordana; Kesic, Maja; Rogic, Dunja; Zavadoski, William; Paralkar, Vishwas M.; Grgurevic, Lovorka; Trkulja, Vladimir; Cicin-Sain, Lipa; Vukicevic, Slobodan			Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats	PLOS ONE			English	Article							TRYPTOPHAN-HYDROXYLASE; PLATELET SEROTONIN; SKELETAL PHENOTYPES; MASS; TRANSPORTER; LRP5; OSTEOPOROSIS; MUTATIONS; DENSITY; GROWTH	Reduced peripheral serotonin (5HT) in mice lacking tryptophan hydroxylase (TPH1), the rate limiting enzyme for 5HT synthesis, was reported to be anabolic to the skeleton. However, in other studies TPH1 deletion either had no bone effect or an age dependent inhibition of osteoclastic bone resorption. The role of 5HT in bone therefore remains poorly understood. To address this issue, we used selective breeding to create rat sublines with constitutively high (high-5HT) and low (low-5HT) platelet 5HT level (PSL) and platelet 5HT uptake (PSU). High-5HT rats had decreased bone volume due to increased bone turnover characterized by increased bone formation and mineral apposition rate, increased osteoclast number and serum C-telopeptide level. Daily oral administration of the TPH1 inhibitor (LX1032) for 6 weeks reduced PSL and increased the trabecular bone volume and trabecular number of the spine and femur in high-5HT rats. High-5HT animals also developed a type 2 diabetes (T2D) phenotype with increased: plasma insulin, glucose, hemoglobin A1c, body weight, visceral fat, beta-cell pancreatic islets size, serum cholesterol, and decreased muscle strength. Serum calcium accretion mediated by parathyroid hormone slightly increased, whereas treatment with 1,25(OH)(2)D-3 decreased PSL. Insulin reduction was paralleled by a drop in PSL in high-5HT rats. In vitro, insulin and 5HT synergistically up-regulated osteoblast differentiation isolated from high-5HT rats, whereas TPH1 inhibition decreased the number of bone marrow-derived osteoclasts. These results suggest that constitutively elevated PSL is associated with bone loss and T2D via a homeostatic interplay between the peripheral 5HT, bone and insulin.	[Erjavec, Igor; Bordukalo-Niksic, Tatjana; Brkljacic, Jelena; Grgurevic, Lovorka; Vukicevic, Slobodan] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Lab Mineralized Tissues, Zagreb 41001, Croatia; [Grcevic, Danka] Univ Zagreb, Sch Med, Dept Physiol & Immunol, Zagreb 41001, Croatia; [Mokrovic, Gordana; Kesic, Maja; Cicin-Sain, Lipa] Rudjer Boskovic Inst, Dept Mol Biol, Lab Neurochem & Mol Neurobiol, Zagreb, Croatia; [Rogic, Dunja] Clin Hosp Ctr Zagreb, Zagreb, Croatia; [Zavadoski, William; Paralkar, Vishwas M.] Karos Pharmaceut, New Haven, CT USA; [Trkulja, Vladimir] Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia	University of Zagreb; University of Zagreb; Rudjer Boskovic Institute; University of Zagreb; University of Zagreb	Vukicevic, S (corresponding author), Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Lab Mineralized Tissues, Zagreb 41001, Croatia.	vukicev@mef.hr	Vukicevic, Slobodan/AEG-2646-2022; Erjavec, Igor/AAU-8987-2020; Grcevic, Danka/AAS-1666-2021	Vukicevic, Slobodan/0000-0003-4076-0285; Erjavec, Igor/0000-0002-3038-9665; Grcevic, Danka/0000-0002-2365-8249; Bordukalo Niksic, Tatjana/0000-0003-2306-6152; Cicin-Sain, Lipa/0000-0002-0222-3174	Croatian National Foundation for Science [08/5]; Karos Pharmaceuticals	Croatian National Foundation for Science; Karos Pharmaceuticals	The study was supported from the Croatian National Foundation for Science to SV (project 08/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Karos Pharmaceuticals provided support in the form of salaries for authors (WZ and VMP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Djurdjica Car, Mirjana Marija Renic, Katarina Karlo and Vladimir Vranesa for their technical support in rat experiments and biochemical assays. The study was supported from the Croatian National Foundation for Science to SV (project 08/5).	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Barbosa R, 2008, LIFE SCI, V82, P529, DOI 10.1016/j.lfs.2007.12.011; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Brommage R, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.87; Brommage R, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.34; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chang MK, 2014, J BONE MINER RES, V29, P29, DOI 10.1002/jbmr.2059; Cicin-Sain L, 2005, LIFE SCI, V77, P452, DOI 10.1016/j.lfs.2005.01.007; Cui YJ, 2014, NAT MED, V20, P1229, DOI 10.1038/nm.3697; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P4524, DOI 10.1210/jc.2013-2472; EHRET M, 1989, J NEUROCHEM, V52, P1886, DOI 10.1111/j.1471-4159.1989.tb07272.x; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Foong JPP, 2010, AM J PHYSIOL-GASTR L, V298, pG384, DOI 10.1152/ajpgi.00438.2009; Frost M, 2011, J BONE MINER RES, V26, P1721, DOI 10.1002/jbmr.376; Frost M, 2010, J BONE MINER RES, V25, P673, DOI 10.1002/jbmr.44; Guo J, 2011, WORLD J GASTROENTERO, V17, P4479, DOI 10.3748/wjg.v17.i40.4479; Gupta PS, 2014, CLIN ENDOCRINOL, V80, P246, DOI 10.1111/cen.12270; Haden ST, 2000, CLIN ENDOCRINOL, V52, P329, DOI 10.1046/j.1365-2265.2000.00912.x; JERNEJ B, 1990, PSYCHIAT RES, V32, P167, DOI 10.1016/0165-1781(90)90083-H; Jernej B, 1998, NEUROCHEM INT, V33, P519, DOI 10.1016/S0197-0186(98)00059-X; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kode A, 2014, NAT MED, V20, P1228, DOI 10.1038/nm.3698; Kode A, 2012, J CLIN INVEST, V122, P3490, DOI 10.1172/JCI64906; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; KREMPIEN B, 1988, J BONE MINER RES, V3, P573; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolis KG, 2014, GUT, V63, P928, DOI 10.1136/gutjnl-2013-304901; MAZESS RB, 1988, J BONE MINER RES, V3, P13; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Milne M, 1998, ENDOCRINOLOGY, V139, P2527, DOI 10.1210/en.139.5.2527; Modder UI, 2010, J BONE MINER RES, V25, P415, DOI 10.1359/jbmr.090721; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peric M, 2015, BONE, V70, P73, DOI 10.1016/j.bone.2014.07.010; Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; SMYTHE GA, 1973, NATURE, V244, P230, DOI 10.1038/244230a0; Suwanwalaikorn S, 1996, EUR J ENDOCRINOL, V134, P655, DOI 10.1530/eje.0.1340655; VUKICEVIC S, 1987, J BONE MINER RES, V2, P533; Walsh JS, 2013, J CLIN ENDOCR METAB, V98, P2902, DOI 10.1210/jc.2012-4174; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109028; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372	48	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150102	10.1371/journal.pone.0150102	http://dx.doi.org/10.1371/journal.pone.0150102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907598	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371163000031
J	Lyukmanova, EN; Shulepko, MA; Kudryavtsev, D; Bychkov, ML; Kulbatskii, DS; Kasheverov, IE; Astapova, MV; Feofanov, AV; Thomsen, MS; Mikkelsen, JD; Shenkarev, ZO; Tsetlin, VI; Dolgikh, DA; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Kudryavtsev, Denis; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Kasheverov, Igor E.; Astapova, Maria V.; Feofanov, Alexey V.; Thomsen, Morten S.; Mikkelsen, Jens D.; Shenkarev, Zakhar O.; Tsetlin, Victor I.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.			Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of alpha 7 Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							BACTERIAL EXPRESSION; VENOM INTERACTS; NEUROMODULATOR; IDENTIFICATION; LYNX1; TOXIN; SYSTEM; MEMBER	SLURP-1 is a secreted toxin-like Ly-6/uPAR protein found in epithelium, sensory neurons and immune cells. Point mutations in the slurp-1 gene cause the autosomal inflammation skin disease Mal de Meleda. SLURP-1 is considered an autocrine/paracrine hormone that regulates growth and differentiation of keratinocytes and controls inflammation and malignant cell transformation. The majority of previous studies of SLURP-1 have been made using fusion constructs containing, in addition to the native protein, extra polypeptide sequences. Here we describe the activity and pharmacological profile of a recombinant analogue of human SLURP-1 (rSLURP-1) differing from the native protein only by one additional N-terminal Met residue. rSLURP-1 significantly inhibited proliferation (up to similar to 40%, EC50 similar to 4 nM) of human oral keratinocytes (Het-1A cells). Application of mecamylamine and atropine,-non-selective inhibitors of nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors, respectively, and anti-alpha 7-nAChRs antibodies revealed alpha 7 type nAChRs as an rSLURP-1 target in keratinocytes. Using affinity purification from human cortical extracts, we confirmed that rSLURP-1 binds selectively to the alpha 7-nAChRs. Exposure of Xenopus oocytes expressing alpha 7-nAChRs to rSLURP-1 caused a significant noncompetitive inhibition of the response to acetylcholine (up to similar to 70%, IC50 similar to 1 mu M). It was shown that rSLURP-1 binds to alpha 7-nAChRs overexpressed in GH(4)C(l) cells, but does not compete with I-125-alpha-bungarotoxin for binding to the receptor. These findings imply an allosteric antagonist-like mode of SLURP-1 interaction with alpha 7-nAChRs outside the classical ligand-binding site. Contrary to rSLURP-1, other inhibitors of alpha 7-nAChRs (mecamylamine, alpha-bungarotoxin and Lynx1) did not suppress the proliferation of keratinocytes. Moreover, the co-application of alpha-bungarotoxin with rSLURP-1 did not influence antiproliferative activity of the latter. This supports the hypothesis that the antiproliferative activity of SLURP-1 is related to 'metabotropic' signaling pathway through alpha 7-nAChR, that activates intracellular signaling cascades without opening the receptor channel.	[Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Feofanov, Alexey V.; Shenkarev, Zakhar O.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia; [Kudryavtsev, Denis; Kasheverov, Igor E.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Mol Basics Neurosignalling, Moscow, Russia; [Astapova, Maria V.; Feofanov, Alexey V.; Shenkarev, Zakhar O.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Biol Struct, Moscow, Russia; [Thomsen, Morten S.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Shenkarev, Zakhar O.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Copenhagen; Moscow Institute of Physics & Technology	Lyukmanova, EN (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.; Lyukmanova, EN (corresponding author), Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia.	ekaterina-lyukmanova@yandex.ru	Feofanov, Alexey V/K-3082-2012; Shulepko, Mikhail/N-9124-2016; Lyukmanova, Ekaterina/F-2340-2014; Tsetlin, Victor/X-2491-2018; Kudryavtsev, Denis S/O-4811-2015; Dolgikh, Dmitry A/F-2369-2014; Kulbatskiy, Dmitry/S-7845-2016; Shenkarev, Zakhar/P-1808-2015	Feofanov, Alexey V/0000-0002-1596-9506; Lyukmanova, Ekaterina/0000-0002-9728-9407; Kudryavtsev, Denis S/0000-0002-0313-9193; Kulbatskiii, Dmitrii/0000-0001-7212-1360; Shulepko, Mikhail/0000-0002-0436-2127; Dolgikh, Dmitry/0000-0002-9880-7202; Shenkarev, Zakhar/0000-0003-1383-3522; Kirpichnikov, Mikhail/0000-0001-8170-1607	Russian Academy of Sciences; Russian Foundation of Basic Researches [14-04-00885, 16-04-01697]; Russian Science Foundation [14-14-00255]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was partially supported by the Russian Academy of Sciences (Program of Molecular and Cellular Biology), and Russian Foundation of Basic Researches (project No 14-04-00885 issued to VIT, IEK, and DK, and No 16-04-01697 issued to ENL and MAS). The work on affinity purification from cortical extracts and test of antiproliferative activity of rSLURP-1 was done with the support from the Russian Science Foundation (project 14-14-00255 issued to ENL, MAS, MLB, DSK, ZOS, and DAD).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2007, LIFE SCI, V80, P2243, DOI 10.1016/j.lfs.2007.01.003; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Chernyavsky A.I., 2008, J STOMATOL INVEST, V2, P5; Chernyavsky AI, 2015, INT IMMUNOPHARMACOL, V29, P36, DOI 10.1016/j.intimp.2015.05.033; Chernyavsky AI, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/609086; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; COLQUHOUN D, 1979, J PHYSIOL-LONDON, V293, P247, DOI 10.1113/jphysiol.1979.sp012888; Efremenko AV, 2012, PHOTOCH PHOTOBIO SCI, V11, P645, DOI 10.1039/c2pp05237g; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Jensen MM, 2015, NEUROBIOL AGING, V36, P1629, DOI 10.1016/j.neurobiolaging.2015.01.001; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006; Lyukmanova EN, 2014, ACTA NATURAE, V6, P60, DOI 10.32607/20758251-2014-6-4-60-66; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Narumoto O, 2013, BIOCHEM BIOPH RES CO, V438, P175, DOI 10.1016/j.bbrc.2013.07.048; Pettersson A, 2009, AUTON NEUROSCI-BASIC, V148, P97, DOI 10.1016/j.autneu.2009.03.002; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2014, 2014 NEUR M PLANN WA; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7; Zhao LS, 2014, ACTA DERM-VENEREOL, V94, P707, DOI 10.2340/00015555-1840	38	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149733	10.1371/journal.pone.0149733	http://dx.doi.org/10.1371/journal.pone.0149733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905431	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000020
J	Bollaerts, K; Shinde, V; Dos Santos, G; Ferreira, G; Bauchau, V; Cohet, C; Verstraeten, T				Bollaerts, Kaatje; Shinde, Vivek; Dos Santos, Gael; Ferreira, Germano; Bauchau, Vincent; Cohet, Catherine; Verstraeten, Thomas			Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix (TM) and Narcolepsy	PLOS ONE			English	Article							SENSITIVITY-ANALYSIS; INFLUENZA VACCINE; H1N1; RISK; CHILDREN; POPULATION; DIAGNOSIS; CATAPLEXY; FRANCE	Background An increase in narcolepsy cases was observed in Finland and Sweden towards the end of the 2009 H1N1 influenza pandemic. Preliminary observational studies suggested a temporal link with the pandemic influenza vaccine Pandemrix (TM), leading to a number of additional studies across Europe. Given the public health urgency, these studies used readily available retrospective data from various sources. The potential for bias in such settings was generally acknowledged. Although generally advocated by key opinion leaders and international health authorities, no systematic quantitative assessment of the potential joint impact of biases was undertaken in any of these studies. Methods We applied bias-level multiple-bias analyses to two of the published narcolepsy studies: a pediatric cohort study from Finland and a case-control study from France. In particular, we developed Monte Carlo simulation models to evaluate a potential cascade of biases, including confounding by age, by indication and by natural H1N1 infection, selection bias, disease-and exposure misclassification. All bias parameters were evidence-based to the extent possible. Results Given the assumptions used for confounding, selection bias and misclassification, the Finnish rate ratio of 13.78 (95% CI: 5.72-28.11) reduced to a median value of 6.06 (2.5th-97.5th percentile: 2.49-15.1) and the French odds ratio of 5.43 (95% CI: 2.6-10.08) to 1.85 (2.5th-97.5th percentile: 0.85-4.08). Conclusion We illustrate multiple-bias analyses using two studies on the Pandemrix (TM)-narcolepsy association and advocate their use to better understand the robustness of study findings. Based on our multiple-bias models, the observed Pandemrix (TM)-narcolepsy association consistently persists in the Finnish study. For the French study, the results of our multiple-bias models were inconclusive.	[Bollaerts, Kaatje; Verstraeten, Thomas] P95 Pharmacovigilance & Epidemiol Serv, Koning Leopold III Laan 1, B-3001 Leuven, Belgium; [Shinde, Vivek] GSK Vaccines, 2301 Renaissance Blvd, King Of Prussia, PA 19406 USA; [Dos Santos, Gael] Business & Decis Life Sci, Rue St Lambert 141, B-1200 Brussels, Belgium; [Ferreira, Germano; Bauchau, Vincent; Cohet, Catherine] GSK Vaccines, Ave Fleming 20, B-1300 Wavre, Belgium	GlaxoSmithKline; GlaxoSmithKline	Bollaerts, K (corresponding author), P95 Pharmacovigilance & Epidemiol Serv, Koning Leopold III Laan 1, B-3001 Leuven, Belgium.	Kaatje.Bollaerts@p-95.com	bauchau, vincent g/H-3710-2012	Cohet, Catherine/0000-0002-0022-7251	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	This work was supported by GlaxoSmithKline Biologicals SA. GlaxoSmithKline was involved in the design of the study analysis. GlaxoSmithKline paid for all costs associated with the development and the publishing of the present manuscript.	Ahmed I, 2010, CLIN CHEST MED, V31, P371, DOI 10.1016/j.ccm.2010.02.014; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; Bardage C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5956; Bone A, 2010, VACCINE, V28, P8157, DOI 10.1016/j.vaccine.2010.09.096; Caille-Brillet AL, 2013, EUROSURVEILLANCE, V18, P13, DOI 10.2807/1560-7917.ES2013.18.45.20628; Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187; ECDC, 2012, NARC ASS PAND INFL V; Greenland S, 1996, INT J EPIDEMIOL, V25, P1107, DOI 10.1093/ije/25.6.1107-a; Greenland S, 2005, J R STAT SOC A STAT, V168, P267, DOI 10.1111/j.1467-985X.2004.00349.x; Greenland S, 2008, MODERN EPIDEMIOLOGY, V3rd; Groenwold RHH, 2010, INT J EPIDEMIOL, V39, P107, DOI 10.1093/ije/dyp332; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Heier MS, 2013, SLEEP MED, V14, P867, DOI 10.1016/j.sleep.2013.03.020; INSERM, 2012, ET NARCOFLU VF NARCO; Lakemedelsverket (Medical Products Agency), 2010, MPA INV REP NARC PAT; Lash TL, 2014, INT J EPIDEMIOL, V43, P1969, DOI 10.1093/ije/dyu149; Lash TL, 2009, APPL QUANTITATIVE BI; Llupia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039496; Lyytikainen O, 2011, EURO SURVEILL, V16; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; MPA, 2011, REP EP STUD SWED VAC; MPA, 2011, 1 MPA, P1; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; O'Flanagan D, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.17.20789; Partinen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033723; Persson I, 2014, J INTERN MED, V275, P172, DOI 10.1111/joim.12150; Phillips CV, 2003, EPIDEMIOLOGY, V14, P459, DOI 10.1097/01.ede.0000072106.65262.ae; Pizza F, 2014, SLEEP MED, V15, P262, DOI 10.1016/j.sleep.2013.09.021; Poli F, 2013, VACCINE, V31, P994, DOI 10.1016/j.vaccine.2012.12.014; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Shubin M, 2014, EPIDEMIOL INFECT, V142, P964, DOI 10.1017/S0950268813002537; Steenland K, 2004, AM J EPIDEMIOL, V160, P384, DOI 10.1093/aje/kwh211; Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026; Szakacs A, 2013, NEUROLOGY, V80, P1315, DOI 10.1212/WNL.0b013e31828ab26f; Tafti M, 2014, SLEEP, V37, P19, DOI 10.5665/sleep.3300; The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP), 2010, GUID METH STAND PHAR; THL, 2010, NAT I HLTH WELF REC; Thorpy MJ, 2014, SLEEP MED, V15, P502, DOI 10.1016/j.sleep.2014.01.015; U.S. FDA: Guide for Industry and FDA Staff, 2013, BEST PRACTICES CONDU; Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI 10.1111/irv.12074; Verstraeten T, 2015, HUMAN VACCI IN PRESS; Vose D., 2008, RISK ANAL QUANTITATI; WHO, 2009, REC STRAT ADV GROUP; WHO, 2010, EV PAND A H1N1 2009; Wijnans L, 2013, VACCINE, V31, P1246, DOI 10.1016/j.vaccine.2012.12.015; Xu CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017919	48	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149289	10.1371/journal.pone.0149289	http://dx.doi.org/10.1371/journal.pone.0149289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901063	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100055
J	Dentico, D; Ferrarelli, F; Riedner, BA; Smith, R; Zennig, C; Lutz, A; Tononi, G; Davidson, RJ				Dentico, Daniela; Ferrarelli, Fabio; Riedner, Brady A.; Smith, Richard; Zennig, Corinna; Lutz, Antoine; Tononi, Giulio; Davidson, Richard J.			Short Meditation Trainings Enhance Non-REM Sleep Low-Frequency Oscillations	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; PSYCHOMETRIC EVALUATION; EEG; BRAIN; VALIDATION; ATTENTION; SCALE; NIGHT; PRACTITIONERS; CONSCIOUSNESS	Study Objectives We have recently shown higher parietal-occipital EEG gamma activity during sleep in long-term meditators compared to meditation-naive individuals. This gamma increase was specific for NREM sleep, was present throughout the entire night and correlated with meditation expertise, thus suggesting underlying long-lasting neuroplastic changes induced through prolonged training. The aim of this study was to explore the neuroplastic changes acutely induced by 2 intensive days of different meditation practices in the same group of practitioners. We also repeated baseline recordings in a meditation-naive cohort to account for time effects on sleep EEG activity. Design High-density EEG recordings of human brain activity were acquired over the course of whole sleep nights following intervention. Setting Sound-attenuated sleep research room. Patients or Participants Twenty-four long-term meditators and twenty-four meditation-naive controls. Interventions Two 8-h sessions of either a mindfulness-based meditation or a form of meditation designed to cultivate compassion and loving kindness, hereafter referred to as compassion meditation. Measurements and Results We found an increase in EEG low-frequency oscillatory activities (1-12 Hz, centered around 7-8 Hz) over prefrontal and left parietal electrodes across whole night NREM cycles. This power increase peaked early in the night and extended during the third cycle to high-frequencies up to the gamma range (25-40 Hz). There was no difference in sleep EEG activity between meditation styles in long-term meditators nor in the meditation naive group across different time points. Furthermore, the prefrontal-parietal changes were dependent on meditation life experience. Conclusions This low-frequency prefrontal-parietal activation likely reflects acute, meditation-related plastic changes occurring during wakefulness, and may underlie a top-down regulation from frontal and anterior parietal areas to the posterior parietal and occipital regions showing chronic, long-lasting plastic changes in long-term meditators.	[Dentico, Daniela; Ferrarelli, Fabio; Riedner, Brady A.; Smith, Richard; Zennig, Corinna; Tononi, Giulio] Univ Wisconsin, Dept Psychiat, 6001 Res Pk Blvd, Madison, WI 53719 USA; [Dentico, Daniela; Davidson, Richard J.] Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53705 USA; [Dentico, Daniela; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53705 USA; [Lutz, Antoine] Univ Lyon 1, Lyon Neurosci Res Ctr, CNRS UMR5292, INSERM U1028, F-69500 Bron, France; [Lutz, Antoine; Davidson, Richard J.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Wisconsin System; University of Wisconsin Madison	Davidson, RJ (corresponding author), Univ Wisconsin, Waisman Ctr Brain Imaging & Behav, Madison, WI 53705 USA.; Davidson, RJ (corresponding author), Univ Wisconsin, Ctr Hlth Minds, Madison, WI 53705 USA.; Davidson, RJ (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	rjdavids@wisc.edu	Ferrarelli, Fabio/D-3219-2019; LUTZ, Antoine/AAE-5114-2020; Dentico, Daniela/AAP-6736-2020	Ferrarelli, Fabio/0000-0003-0560-0227; LUTZ, Antoine/0000-0002-0258-3233; Dentico, Daniela/0000-0003-1050-0327; Davidson, Richard/0000-0002-8506-4964	National Center for Complementary and Alternative Medicine (NCCAM) [P01AT004952]; National Institute of Mental Health (NIMH) [R01-MH43454, P50-MH084051]; Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development [P30 HD003352-449015]; International Re-integration Grants (IRG) [FP7-PEOPLE-2009-RG]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [P01AT004952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043454, P50MH084051] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fetzer Institute; John Templeton Foundation; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); International Re-integration Grants (IRG); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Center for Complementary and Alternative Medicine (NCCAM) P01AT004952 to GT, RJD and AL, grants from the National Institute of Mental Health (NIMH) R01-MH43454, P50-MH084051 to RJD, grants from the Fetzer Institute and the John Templeton Foundation to RJD, a core grant to the Waisman Center from the National Institute of Child Health and Human Development [P30 HD003352-449015], and an International Re-integration Grants (IRG), FP7-PEOPLE-2009-RG for AL.	AESCHBACH D, 1993, J SLEEP RES, V2, P70, DOI 10.1111/j.1365-2869.1993.tb00065.x; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Berkovich-Ohana A, 2012, CLIN NEUROPHYSIOL, V123, P700, DOI 10.1016/j.clinph.2011.07.048; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Cahn BR, 2010, COGN PROCESS, V11, P39, DOI 10.1007/s10339-009-0352-1; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Corsi-Cabrera M, 2008, BRAIN RES, V1235, P82, DOI 10.1016/j.brainres.2008.06.052; Dentico D, 2015, 21 ANN MEEET ORG HUM; Dentico D, 2014, P 17 WORLD C PSYCH I, P94; DEROGATIS LR, 1977, BRIT J SOC CLIN PSYC, V16, P347, DOI 10.1111/j.2044-8260.1977.tb00241.x; Ermis U, 2010, J SLEEP RES, V19, P400, DOI 10.1111/j.1365-2869.2010.00831.x; FEINBERG I, 1979, PSYCHOPHYSIOLOGY, V16, P283, DOI 10.1111/j.1469-8986.1979.tb02991.x; Ferrarelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073417; Halasz P, 2004, J SLEEP RES, V13, P1, DOI 10.1111/j.1365-2869.2004.00388.x; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hollingshead AB., 1957, 2 FACTOR INDEX SOCIA; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hung CS, 2013, SLEEP, V36, P59, DOI 10.5665/sleep.2302; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Johnson LA, 2012, P NATL ACAD SCI USA, V109, P18583, DOI 10.1073/pnas.1207532109; Jung TP, 2001, P IEEE, V89, P1107, DOI 10.1109/5.939827; Landsness E, 2011, BRAIN, V134, P2222, DOI 10.1093/brain/awr152; Lee TMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040054; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MacLean, 1992, J Sleep Res, V1, P35; Maatta S, 2010, BRAIN RES BULL, V82, P118, DOI 10.1016/j.brainresbull.2010.01.006; Martinez D, 2010, CLIN NEUROPHYSIOL, V121, P704, DOI 10.1016/j.clinph.2010.01.005; Marzano C, 2011, J NEUROSCI, V31, P6674, DOI 10.1523/JNEUROSCI.0412-11.2011; Mason LI, 1997, SLEEP, V20, P102, DOI 10.1093/sleep/20.2.102; McKinney SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017351; Murphy M, 2011, SLEEP, V34, P283, DOI 10.1093/sleep/34.3.283; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Slagter HA, 2007, PLOS BIOL, V5, P1228, DOI 10.1371/journal.pbio.0050138; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Takahara M, 2002, PSYCHIAT CLIN NEUROS, V56, P257, DOI 10.1046/j.1440-1819.2002.00999.x; Travis F, 2010, CONSCIOUS COGN, V19, P1110, DOI 10.1016/j.concog.2010.01.007; Valko PO, 2008, SLEEP, V31, P1601, DOI 10.1093/sleep/31.11.1601; Voss U, 2009, SLEEP, V32, P1191, DOI 10.1093/sleep/32.9.1191; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	45	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148961	10.1371/journal.pone.0148961	http://dx.doi.org/10.1371/journal.pone.0148961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900914	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100032
J	Hsiao, KL; Wang, LY; Lin, CL; Liu, HF				Hsiao, Kuang-Liang; Wang, Li-Yu; Lin, Chiung-Ling; Liu, Hsin-Fu			New Phylogenetic Groups of Torque Teno Virus Identified in Eastern Taiwan Indigenes	PLOS ONE			English	Article							TT VIRUS; MOLECULAR EPIDEMIOLOGY; HIGH PREVALENCE; MESSENGER-RNAS; DNA; INFECTION; GENOTYPES; GENOME; PCR; CLASSIFICATION	Torque teno virus (TTV) is a single-stranded DNA virus highly prevalent in the world. It has been detected in eastern Taiwan indigenes with a low prevalence of 11% by using N22 region of which known to underestimate TTV prevalence excessively. In order to clarify their realistic epidemiology, we re-analyzed TTV prevalence with UTR region. One hundred and forty serum samples from eastern Taiwanese indigenous population were collected and TTV DNA was detected in 133 (95%) samples. Direct sequencing revealed an extensive mix-infection of different TTV strains within the infected individual. Entire TTV open reading frame 1 was amplified and cloned from a TTV positive individual to distinguish mix-infected strains. Phylogenetic analysis showed eleven isolates were clustered into a monophyletic group that is distinct from all known groups. In addition, another our isolate was clustered with recently described Hebei-1 strain and formed an independent clade. Based on the distribution pattern of pairwise distances, both new clusters were placed at phylogenetic group level, designed as the 6th and 7th phylogenetic group. In present study, we showed a very high prevalence of TTV infection in eastern Taiwan indigenes and indentified new phylogenetic groups from the infected individual. Both intra-and inter-phylogenetic group mix-infections can be found from one healthy person. Our study has further broadened the field of human TTVs and proposed a robust criterion for classification of the major TTV phylogenetic groups.	[Hsiao, Kuang-Liang; Liu, Hsin-Fu] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan; [Hsiao, Kuang-Liang; Lin, Chiung-Ling; Liu, Hsin-Fu] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Wang, Li-Yu] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Liu, Hsin-Fu] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan	National Taiwan Ocean University; Mackay Memorial Hospital; Mackay Medical College; National Taipei University of Nursing & Health Science (NTUNHS)	Liu, HF (corresponding author), Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung, Taiwan.; Liu, HF (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.; Liu, HF (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan.	hsinfu@mmh.org.tw	Liu, Hsin-Fu/AAR-5960-2020	Liu, Hsin-Fu/0000-0003-0082-2269; Hsiao, Kuang-Liang/0000-0003-4397-7762	Ministry of Science and Technology, Taiwan [NSC 96-2314-B-195-010, NSC 102-2314-B-195-013-MY2]; Mackay Memorial Hospital, Taiwan [MMH-104-48]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Mackay Memorial Hospital, Taiwan	This study was supported in part by the Ministry of Science and Technology, Taiwan (grant NSC 96-2314-B-195-010, NSC 102-2314-B-195-013-MY2, https://www.most.gov.tw/en/public) and Mackay Memorial Hospital, Taiwan (grant MMH-104-48, http://eng.mmh.org.tw/dnn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biagini P, 2009, CURR TOP MICROBIOL, V331, P21; Biagini P, 2005, VIRUS TAXONOMY, P335; Dai CY, 2001, TRANSFUS APHER SCI, V24, P9, DOI 10.1016/S0955-3886(00)00121-1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Huang LY, 2001, J MED VIROL, V64, P381, DOI 10.1002/jmv.1062; Jelcic I, 2004, J VIROL, V78, P7498, DOI 10.1128/JVI.78.14.7498-7507.2004; Kamahora T, 2000, J VIROL, V74, P9980, DOI 10.1128/JVI.74.21.9980-9986.2000; Lee HH, 2004, GENOMICS, V83, P944, DOI 10.1016/j.ygeno.2003.11.006; Lemey P, 2002, VIRUS RES, V85, P47, DOI 10.1016/S0168-1702(02)00017-5; Lo SY, 1999, J MED VIROL, V59, P198, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;198::AID-JMV12&gt;3.0.CO;2-2; Miyata H, 1999, J VIROL, V73, P3582, DOI 10.1128/JVI.73.5.3582-3586.1999; Muljono DH, 2001, ARCH VIROL, V146, P1249, DOI 10.1007/s007050170089; Nishizawa T, 1999, J VIROL, V73, P9604, DOI 10.1128/JVI.73.11.9604-9608.1999; Nishizawa T, 1997, BIOCHEM BIOPH RES CO, V241, P92, DOI 10.1006/bbrc.1997.7765; Okamoto H, 2009, CURR TOP MICROBIOL, V331, P1, DOI 10.1007/978-3-540-70972-5_1; Okamoto H, 1999, VIROLOGY, V259, P428, DOI 10.1006/viro.1999.9770; Okamoto H, 2000, BIOCHEM BIOPH RES CO, V279, P700, DOI 10.1006/bbrc.2000.4012; Peng YH, 2002, ARCH VIROL, V147, P21, DOI 10.1007/s705-002-8301-7; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Takahashi K, 1998, HEPATOL RES, V12, P233, DOI 10.1016/S1386-6346(98)00068-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vasilyev EV, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-134; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036	23	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149901	10.1371/journal.pone.0149901	http://dx.doi.org/10.1371/journal.pone.0149901			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901643	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100181
J	Lin, YW; Huang, HC; Lin, MF; Shyu, ML; Tsai, PL; Chang, HJ				Lin, Yu-Wen; Huang, Hui-Chuan; Lin, Mei-Feng; Shyu, Meei-Ling; Tsai, Po-Li; Chang, Hsiu-Ju			Influential Factors for and Outcomes of Hospitalized Patients with Suicide-Related Behaviors: A National Record Study in Taiwan from 1997-2010	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; PHYSICAL ILLNESS; PRIMARY-CARE; ALCOHOL; INDIVIDUALS; DEPRESSION; MORTALITY; DISORDER; COHORT	Background Investigating the factors related to suicide is crucial for suicide prevention. Psychiatric disorders, gender, socioeconomic status, and catastrophic illnesses are associated with increased risk of suicide. Most studies have typically focused on the separate influences of physiological or psychological factors on suicide-related behaviors, and have rarely used national data records to examine and compare the effects of major physical illnesses, psychiatric disorders, and socioeconomic status on the risk of suicide-related behaviors. Objectives To identify the characteristics of people who exhibited suicide-related behaviors and the multiple factors associated with repeated suicide-related behaviors and deaths by suicide by examining national data records. Design This is a cohort study of Taiwan's national data records of hospitalized patients with suicide-related behaviors from January 1, 1997, to December 31, 2010. Participants The study population included all people in Taiwan who were hospitalized with a code indicating suicide or self-inflicted injury (E950-E959) according to the International Classification of Disease, Ninth Revision, Clinical Modification. Results Self-poisoning was the most common method of self-inflicted injury among hospitalized patients with suicide-related behaviors who used a single method. Those who were female, had been hospitalized for suicide-related behaviors at a younger age, had a low income, had a psychiatric disorder (i.e., personality disorder, major depressive disorder, bipolar disorder, schizophrenia, alcohol-related disorder, or adjustment disorder), had a catastrophic illness, or had been hospitalized for suicide-related behaviors that involved two methods of self-inflicted injury had a higher risk of hospitalization for repeated suicide-related behaviors. Those who were male, had been hospitalized for suicide-related behaviors at an older age, had low income, had schizophrenia, showed repeated suicide-related behaviors, had a catastrophic illness, or had adopted a single lethal method had an increased risk of death by suicide. Conclusions High-risk factors should be considered when devising suicide-prevention strategies.	[Lin, Yu-Wen; Huang, Hui-Chuan; Shyu, Meei-Ling; Chang, Hsiu-Ju] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Lin, Mei-Feng] Natl Cheng Kung Univ, Dept Nursing, Tainan 701, Taiwan; [Tsai, Po-Li] Mackay Mem Hosp, Dept Surg, Div Colon & Rectal Surg, Taipei, Taiwan	Taipei Medical University; National Cheng Kung University; Mackay Memorial Hospital	Chang, HJ (corresponding author), Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan.	hsiuju@tmu.edu.tw		Chang, Hsiu-Ju/0000-0002-8544-0712				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Blasco-Fontecilla H, 2009, ACTA PSYCHIAT SCAND, V119, P149, DOI 10.1111/j.1600-0447.2008.01284.x; Boisseau CL, 2013, COMPR PSYCHIAT, V54, P238, DOI 10.1016/j.comppsych.2012.07.062; Bolton JM, 2008, J CLIN PSYCHIAT, V69, P1139, DOI 10.4088/JCP.v69n0714; Cibis A, 2012, J AFFECT DISORDERS, V136, P9, DOI 10.1016/j.jad.2011.08.032; Goodwin RD, 2003, PSYCHOSOM MED, V65, P501, DOI 10.1097/01.PSY.0000041544.14277.EC; Gradus Jaimie L, 2010, Clin Epidemiol, V2, P23; Haukka J, 2008, AM J EPIDEMIOL, V167, P1155; Hawton K, 2005, BRIT J PSYCHIAT, V187, P9, DOI 10.1192/bjp.187.1.9; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Hawton K, 2011, J AFFECT DISORDERS, V134, P320, DOI 10.1016/j.jad.2011.05.044; Holikatti P, 2010, BRIT J PSYCHIAT, V196, P415, DOI 10.1192/bjp.196.5.415; Kapur N, 2013, BRIT J PSYCHIAT, V202, P326, DOI 10.1192/bjp.bp.112.116111; Kuo CJ, 2012, BRIT J PSYCHIAT, V200, P405, DOI 10.1192/bjp.bp.111.099366; Landberg J, 2008, DRUG ALCOHOL REV, V27, P361, DOI 10.1080/09595230802093778; Logan J, 2011, ARCH GEN PSYCHIAT, V68, P935, DOI 10.1001/archgenpsychiatry.2011.85; Ministry of Health and Welfare Taiwan (R. O. C.), 2013, 10 LEAD CAUS DEATH T; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Pompili M, 2011, PSYCHIAT RES, V186, P300, DOI 10.1016/j.psychres.2010.09.003; Qin P, 2013, J INTERN MED, V273, P48, DOI 10.1111/j.1365-2796.2012.02572.x; Rudd MD, 2006, J CLIN PSYCHOL, V62, P157, DOI 10.1002/jclp.20219; Runeson B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3222; Sher L, 2006, QJM-INT J MED, V99, P57, DOI 10.1093/qjmed/hci146; Silverman AB, 1996, CHILD ABUSE NEGLECT, V20, P709, DOI 10.1016/0145-2134(96)00059-2; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Taiwanese Society of Suicidology, 2013, SURV AND RES; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Uribe IP, 2013, J AFFECT DISORDERS, V150, P840, DOI 10.1016/j.jad.2013.03.013; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561; World Health Organization, 2013, HLTH TOP SUIC; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149559	10.1371/journal.pone.0149559	http://dx.doi.org/10.1371/journal.pone.0149559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900930	Green Published, gold			2022-12-26	WOS:000371276100098
J	Mechai, S; Margos, G; Feil, EJ; Barairo, N; Lindsay, LR; Michel, P; Ogden, NH				Mechai, Samir; Margos, Gabriele; Feil, Edward J.; Barairo, Nicole; Lindsay, L. Robbin; Michel, Pascal; Ogden, Nicholas H.			Evidence for Host-Genotype Associations of Borrelia burgdorferi Sensu Stricto	PLOS ONE			English	Article							VECTOR IXODES-SCAPULARIS; CHIPMUNK TAMIAS-STRIATUS; WHITE-FOOTED MICE; LYME-DISEASE; POPULATION-STRUCTURE; EASTERN CHIPMUNK; HEMATOGENOUS DISSEMINATION; RANGE EXPANSION; CLIMATE-CHANGE; NORTH-AMERICA	Different genotypes of the agent of Lyme disease in North America, Borrelia burgdorferi sensu stricto, show varying degrees of pathogenicity in humans. This variation in pathogenicity correlates with phylogeny and we have hypothesized that the different phylogenetic lineages in North America reflect adaptation to different host species. In this study, evidence for host species associations of B. burgdorferi genotypes was investigated using 41 B. burgdorferi-positive samples from five mammal species and 50 samples from host-seeking ticks collected during the course of field studies in four regions of Canada: Manitoba, northwestern Ontario, Quebec, and the Maritimes. The B. burgdorferi genotypes in the samples were characterized using three established molecular markers (multi-locus sequence typing [MLST], 16S-23S rrs-rrlA intergenic spacer, and outer surface protein C sequence [ospC] major groups). Correspondence analysis and generalized linear mixed effect models revealed significant associations between B. burgdorferi genotypes and host species (in particular chipmunks, and white-footed mice and deer mice), supporting the hypotheses that host adaptation contributes to the phylogenetic structure and possibly the observed variation in pathogenicity in humans.	[Mechai, Samir; Michel, Pascal; Ogden, Nicholas H.] Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada; [Margos, Gabriele] Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Margos, Gabriele] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England; [Barairo, Nicole; Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Michel, Pascal; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada	Universite de Montreal; Bavarian Health & Food Safety Authority; University of Bath; Public Health Agency of Canada; Public Health Agency of Canada	Ogden, NH (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada.	nicholas.ogden@phac-aspc.gc.ca		Mechai, Sam/0000-0001-9979-5525; MARGOS, Gabriele/0000-0001-5304-9615; Lindsay, Robbin/0000-0001-7236-2930	Public Health Agency of Canada	Public Health Agency of Canada	The study was funded by the Public Health Agency of Canada.	ANDERSON JF, 1985, J CLIN MICROBIOL, V22, P36, DOI 10.1128/JCM.22.1.36-38.1985; Barbour AG, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0903-5; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Bush SE, 2006, EVOLUTION, V60, P2158, DOI 10.1111/j.0014-3820.2006.tb01853.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0381-0; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Dsouli N, 2006, J MED ENTOMOL, V43, P737, DOI 10.1603/0022-2585(2006)43[737:RROLPA]2.0.CO;2; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gern Lise, 2002, P149, DOI 10.1079/9780851996325.0149; Ginsberg HS, 2004, ENVIRON ENTOMOL, V33, P1266, DOI 10.1603/0046-225X-33.5.1266; Giorgi MS, 2004, OECOLOGIA, V138, P648, DOI 10.1007/s00442-003-1475-1; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Jungnick S, 2015, INT J MED MICROBIOL, V305, P673, DOI 10.1016/j.ijmm.2015.08.017; Kalkvik HM, 2012, ECOGRAPHY, V35, P54, DOI 10.1111/j.1600-0587.2011.06994.x; Korenberg Edward I., 2002, P175, DOI 10.1079/9780851996325.0175; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LIVERIS D, 1995, J CLIN MICROBIOL, V33, P589, DOI 10.1128/JCM.33.3.589-595.1995; MANNELLI A, 1993, J MED ENTOMOL, V30, P87, DOI 10.1093/jmedent/30.1.87; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margos G, 2013, INT J SYST EVOL MICR, V63, P4284, DOI 10.1099/ijs.0.052001-0; Margos G, 2012, PARASITOLOGY, V139, P1952, DOI 10.1017/S0031182012000741; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Margos G, 2010, TICKS TICK-BORNE DIS, V1, P151, DOI 10.1016/j.ttbdis.2010.09.002; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; MCLEAN RG, 1993, J WILDLIFE DIS, V29, P527, DOI 10.7589/0090-3558-29.4.527; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Mendlova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-69; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 2015, APPL ENVIRON MICROB, V81, P7350, DOI 10.1128/AEM.01671-15; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; PRICE PK, 1980, AM MIDL NAT, V103, P73, DOI 10.2307/2425040; Qiu WG, 2002, GENETICS, V160, P833; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Rowe KC, 2006, MOL ECOL, V15, P4003, DOI 10.1111/j.1365-294X.2006.03063.x; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sasal P, 1999, PARASITOLOGY, V119, P635, DOI 10.1017/S0031182099005077; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Slajchert T, 1997, J WILDLIFE DIS, V33, P40, DOI 10.7589/0090-3558-33.1.40; Strandh M, 2015, PHILOS T R SOC LON B, V370, P1675; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Teixeira AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119315; TRYON CA, 1973, J MAMMAL, V54, P145, DOI 10.2307/1378877; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Voordouw MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118265; Wang IN, 1999, GENETICS, V151, P15; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x; Zhu M, SAS0262014 INT INC	82	33	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149345	10.1371/journal.pone.0149345	http://dx.doi.org/10.1371/journal.pone.0149345			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901761	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100061
J	Prendergast, ME; Rouby, H; Punnwong, P; Marchant, R; Crowther, A; Kourampas, N; Shipton, C; Walsh, M; Lambeck, K; Boivin, NL				Prendergast, Mary E.; Rouby, Helene; Punnwong, Paramita; Marchant, Robert; Crowther, Alison; Kourampas, Nikos; Shipton, Ceri; Walsh, Martin; Lambeck, Kurt; Boivin, Nicole L.			Continental Island Formation and the Archaeology of Defaunation on Zanzibar, Eastern Africa	PLOS ONE			English	Article							HOLOCENE MANGROVE DYNAMICS; SEA-LEVEL CHANGES; CAPRA-HIRCUS; VERTEBRATES; BAY; ARCHIPELAGO; RETHINKING; EVOLUTION; IMPACTS; HISTORY	With rising sea levels at the end of the Pleistocene, land-bridge or continental islands were formed around the world. Many of these islands have been extensively studied from a biogeographical perspective, particularly in terms of impacts of island creation on terrestrial vertebrates. However, a majority of studies rely on contemporary faunal distributions rather than fossil data. Here, we present archaeological findings from the island of Zanzibar (also known as Unguja) off the eastern African coast, to provide a temporal perspective on island biogeography. The site of Kuumbi Cave, excavated by multiple teams since 2005, has revealed the longest cultural and faunal record for any eastern African island. This record extends to the Late Pleistocene, when Zanzibar was part of the mainland, and attests to the extirpation of large mainland mammals in the millennia after the island became separated. We draw on modeling and sedimentary data to examine the process by which Zanzibar was most recently separated from the mainland, providing the first systematic insights into the nature and chronology of this process. We subsequently investigate the cultural and faunal record from Kuumbi Cave, which provides at least five key temporal windows into human activities and faunal presence: two at the end of the Last Glacial Maximum (LGM), one during the period of post-LGM rapid sea level rise and island formation, and two in the late Holocene (Middle Iron Age and Late Iron Age). This record demonstrates the presence of large mammals during the period of island formation, and their severe reduction or disappearance in the Kuumbi Cave sequence by the late Holocene. While various limitations, including discontinuity in the sequence, problematize attempts to clearly attribute defaunation to anthropogenic or island biogeographic processes, Kuumbi Cave offers an unprecedented opportunity to examine post-Pleistocene island formation and its long-term consequences for human and animal communities.	[Prendergast, Mary E.] St Louis Univ, Dept Sociol & Anthropol, Madrid, Spain; [Rouby, Helene] Ecole Normale Super, CNRS, UMR 8538, Geol Lab, F-75231 Paris, France; [Rouby, Helene; Lambeck, Kurt] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Punnwong, Paramita] Mahidol Univ, Fac Environm & Resource Studies, Salaya 73170, Nakhon Pathom, Thailand; [Marchant, Robert] York Inst Trop Ecosyst, Dept Environm, York, N Yorkshire, England; [Crowther, Alison] Univ Queensland, Sch Social Sci, Brisbane, Qld, Australia; [Kourampas, Nikos] Univ Edinburgh, Off Lifelong Learning, Edinburgh, Midlothian, Scotland; [Kourampas, Nikos] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Shipton, Ceri] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge, England; [Shipton, Ceri] British Acad, British Inst Eastern Africa, Nairobi, Kenya; [Walsh, Martin] Univ Cambridge Wolfson Coll, Cambridge CB3 9BB, England; [Boivin, Nicole L.] Univ Oxford, Res Lab Archaeol & Hist Art, Sch Archaeol, Oxford, England; [Boivin, Nicole L.] Max Planck Inst Sci Human Hist, Jena, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Australian National University; Mahidol University; University of Queensland; University of Edinburgh; University of Stirling; University of Cambridge; University of Cambridge; University of Oxford	Prendergast, ME (corresponding author), St Louis Univ, Dept Sociol & Anthropol, Madrid, Spain.	mprendergast@post.harvard.edu	Crowther, Alison/B-7854-2016; Crowther, Alison/AAR-9872-2021	Crowther, Alison/0000-0002-2394-1917; Walsh, Martin/0000-0003-1662-286X; Marchant, Robert/0000-0001-5013-4056; BOIVIN, NICOLE/0000-0002-7783-4199	European Research Council [206148]; Natural Environmental Research Council Radiocarbon Facility [NF/2012/2/4]; European Research Council grant (ERC) [295719]; British Institute in Eastern Africa; McDonald Institute for Archaeological Research, University of Cambridge; British Academy Postdoctoral Research Fellowship; University of Queensland	European Research Council(European Research Council (ERC)European Commission); Natural Environmental Research Council Radiocarbon Facility; European Research Council grant (ERC)(European Research Council (ERC)); British Institute in Eastern Africa; McDonald Institute for Archaeological Research, University of Cambridge(University of Cambridge); British Academy Postdoctoral Research Fellowship; University of Queensland(University of Queensland)	The Sealinks Project is funded by a European Research Council grant to NB (Starter Grant 206148, 'SEALINKS'), under the 'Ideas' specific Programme of the 7th Framework Programme (FP7; http://ec.europa.eu/research/fp7/). Additional funding for analyses was contributed by a Natural Environmental Research Council Radiocarbon Facility grant to NB (NF/2012/2/4; http://www.c14.org.uk/) and a European Research Council grant (ERC no. 295719; https://erc.europa.eu/funding-and-grants). CS is funded by the British Institute in Eastern Africa (http://www.biea.ac.uk/) and the McDonald Institute for Archaeological Research, University of Cambridge (http://www.mcdonald.cam.ac.uk/). AC was funded by a British Academy Postdoctoral Research Fellowship (2010-2013; http://www.britac.ac.uk/funding/), and a University of Queensland Postdoctoral Fellowship (2015-2017; http://www.uq.edu.au/research/research-management/uq-postdoctoral-research-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agenbroad LD, 2012, QUATERN INT, V255, P2, DOI 10.1016/j.quaint.2011.03.044; Alcover Josep Antonia, 1999, P165; [Anonymous], 2016, CONSTITUTION UNION C, P15; Arthurton RS, 1999, J COASTAL RES, V15, P635; Arthurton Russell, 2003, Western Indian Ocean Journal of Marine Science, V2, P1; Athens J. S., 2002, ARCHAEOL OCEAN, V37, P57, DOI DOI 10.1002/j.1834-4453.2002.tb00507.x; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; BROWN JH, 1971, AM NAT, V105, P467, DOI 10.1086/282738; Burgess N. D., 2000, Coastal forests of eastern Africa; Burney DA, 2003, P NATL ACAD SCI USA, V100, P10800, DOI 10.1073/pnas.1534700100; Camoin GF, 1997, CORAL REEFS, V16, P247, DOI 10.1007/s003380050080; Camoin GF, 2004, MAR GEOL, V206, P119, DOI 10.1016/j.margeo.2004.02.003; Castaneda IS, 2009, PALAEOGEOGR PALAEOCL, V275, P100, DOI 10.1016/j.palaeo.2009.02.008; Chami F., 2009, ZANZIBAR SWAHILI COA; Chami F., 2001, PEOPLE CONTACTS ENV; Chami F., 2006, UNITY AFRICAN ANCIEN; Cheke A., 2008, LOST LAND DODO ECOLO; Cheke A.S., 1987, P5, DOI 10.1017/CBO9780511735769.003; Cheke Anthony, 2010, Phelsuma, V18, P38; Chynoweth MW, 2013, PAC SCI, V67, P141, DOI 10.2984/67.2.1; COBLENTZ BE, 1978, BIOL CONSERV, V13, P279, DOI 10.1016/0006-3207(78)90038-1; Compton JS, 2001, HOLOCENE, V11, P395, DOI 10.1191/095968301678302832; Crowther A, 2014, AZANIA, V49, P21, DOI 10.1080/0067270X.2013.878104; Davies AM, 1927, REPORT PALAEONTOLOGY; Dewar R.E., 1984, P574; DEWAR RE, 1993, J WORLD PREHIST, V7, P417, DOI 10.1007/BF00997802; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Ellis Erle C., 2013, Elementa-Science of the Anthropocene, V1, P000018, DOI 10.12952/journal.elementa.000018; Erlandson JM, 2013, ANTHROPOCENE, V4, P1, DOI 10.1016/j.ancene.2014.05.003; Erlandson JM, 2011, SCIENCE, V331, P1181, DOI 10.1126/science.1201477; Erlandson JM, 2010, ANNU REV MAR SCI, V2, P231, DOI 10.1146/annurev.marine.010908.163749; Goldman Helle V., 2002, Journal of East African Natural History, V91, P15, DOI 10.2982/0012-8317(2002)91[15:ITZLPP]2.0.CO;2; Goldman HV, 2003, J E AFR NAT HIST, V92, P4; GOODMAN SM, 1997, NATURAL CHANGE HUMAN; Greenway J. C. Jr, 1958, EXTINCT VANISHING BI; Groucutt HS, 2015, EVOL ANTHROPOL, V24, P149, DOI 10.1002/evan.21455; Grove R. H., 1995, GREEN IMPERIALISM CO; Helm R. M., 2000, AZANIA, V35, P183, DOI DOI 10.1080/00672700009511601; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; HOPE J H, 1973, Proceedings of the Royal Society of Victoria, V85, P163; Horton MC, ZANZIBAR PE IN PRESS; Hunt TL, 2007, J ARCHAEOL SCI, V34, P485, DOI 10.1016/j.jas.2006.10.003; JARITZ W, 1977, GEOLOGISCHES JB, V26, P3; Juma A, 2004, THESIS UPPSALA U; Kent P.E., 1971, GEOLOGY GEOPHYS COAS, P6; Kiage LM, 2006, PROG PHYS GEOG, V30, P633, DOI 10.1177/0309133306071146; Kourampas N, 2015, INT J SPELEOL, V44, P293, DOI 10.5038/1827-806X.44.3.7; Lambeck K, 2003, QUATERNARY SCI REV, V22, P309, DOI 10.1016/S0277-3791(02)00142-7; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Langley MC, AZANIA IN PRESS; LAWLOR TE, 1986, BIOL J LINN SOC, V28, P99, DOI 10.1111/j.1095-8312.1986.tb01751.x; Lomolino MV, 2000, GLOBAL ECOL BIOGEOGR, V9, P1, DOI 10.1046/j.1365-2699.2000.00185.x; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Louette M, 1988, OISEAUX COMORES; Louette M, 1999, FAUNE TERRESTRE MAYO; MAC ARTHUR ROBERT H., 1967; Marchant R, 2004, EARTH-SCI REV, V66, P217, DOI 10.1016/j.earscirev.2004.01.003; Marean Curtis W., 2004, Journal of Taphonomy, V2, P69; Marti R, 2012, REV ARQUEOLOGIA, V21, P14; Martin del Molino A, 1989, AFRICA 2000, V4, P4; Masoud TS, 2004, MANGROVE MANAGEMENT AND CONSERVATION: PRESENT AND FUTURE, P280; Moreau RE, 1941, P ZOOL SOC LOND A-GE, V110, P97; Moreau RE, 1940, NATURE, V146, P462, DOI 10.1038/146462a0; Morner N., 1992, URBAN ORIGINS E AFRI, P256; Muzuka AN, 2004, B DIR GEOL MOZAMB, V43, P8; NAKADA M, 1987, GEOPHYS J INT, V90, P171, DOI 10.1111/j.1365-246X.1987.tb00680.x; Norstrom E, 2012, QUATERN INT, V260, P153, DOI 10.1016/j.quaint.2011.11.032; Pakenham R. H. W., 1983, J E AFR NAT HIST SOC, V177, P1; Patterson B.D., 1984, P247; Pluet J, 1991, WORLD ATLAS HOLOCENE; Prendergast M.E., 2009, DOCUMENTA ARCHAEOBIO, V7, P203; Punwong P, 2013, THESIS U YORK; Punwong P, 2013, VEG HIST ARCHAEOBOT, V22, P381, DOI 10.1007/s00334-012-0383-x; Punwong P, 2013, PALAEOGEOGR PALAEOCL, V379, P54, DOI 10.1016/j.palaeo.2013.04.004; Punwong P, 2013, QUATERN INT, V298, P4, DOI 10.1016/j.quaint.2013.02.007; Quintana Morales, 2013, THESIS U BRISTOL; Ramsay PJ, 2002, QUATERNARY RES, V57, P82, DOI 10.1006/qres.2001.2290; Ramsay PJ, 1996, QUATERN INT, V31, P71, DOI 10.1016/1040-6182(95)00040-P; Rick TC, 2014, BIOSCIENCE, V64, P680, DOI 10.1093/biosci/biu094; Rijsdijk KF, 2011, HOLOCENE, V21, P1179, DOI 10.1177/0959683611405236; Robertshaw P, 2009, POLITICS POWER ARCHA, P208; Rowson B, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.70.762; Rucina SM, 2010, HOLOCENE, V20, P667, DOI 10.1177/0959683609358910; Salum LA, 2009, AFR J ECOL, V47, P166, DOI 10.1111/j.1365-2028.2008.01065.x; Saunders F, 2011, CONSERV SOC, V9, P961; Sheriff Abdul, 1987, SLAVES SPICES IVORY; Sheriff Abdul, 1995, HIST CONSERVATION ZA; Shipton C, AZANIA IN PRESS; Sinclair P, 2006, STUD AFR PAST, V5, P95; Smith BD, 2013, ANTHROPOCENE, V4, P8, DOI 10.1016/j.ancene.2013.05.001; Steadman DW, 2002, HUM ECOL, V30, P339, DOI 10.1023/A:1016520602698; Stockley G. M., 1942, Geological Magazine London, V79, P233; Stockley GM, 1928, REPORT GEOLOGY ZANZI; Sutton JEG, 2002, J AFR HIST, V43, P503, DOI 10.1017/S0021853702218411; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; Terborgh John, 1997, P256; Vigne JD, 1988, MAMMIFERES POSTGLACI; Walker R., 1985, GUIDE POSTCRANIAL BO; Walsh M.T., 2007, AZANIA, V42, P83, DOI [DOI 10.1080/00672700709480452, 10.1080/00672700709480452]; Williams A, 1996, POPULATION SURVEY MI; Woodroffe SA, 2005, J ASIAN EARTH SCI, V25, P29, DOI 10.1016/j.jseaes.2004.01.009; Woodroffe SA, 2015, HOLOCENE, V25, P820, DOI 10.1177/0959683615571422; Zinke J, 2003, MAR GEOL, V194, P181, DOI 10.1016/S0025-3227(02)00705-3	105	43	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149565	10.1371/journal.pone.0149565	http://dx.doi.org/10.1371/journal.pone.0149565			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF3VL	26901050	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100099
J	Tamayo, E; Benabdellah, K; Ferrol, N				Tamayo, Elisabeth; Benabdellah, Karim; Ferrol, Nuria			Characterization of Three New Glutaredoxin Genes in the Arbuscular Mycorrhizal Fungus Rhizophagus irregularis: Putative Role of RiGRX4 and RiGRX5 in Iron Homeostasis	PLOS ONE			English	Article							MONOTHIOL GLUTAREDOXINS; GLOMUS-INTRARADICES; CALCIUM HOMEOSTASIS; YEAST; LOCALIZATION; PERCEPTION; SYSTEM; CELLS; ACCUMULATION; PROTEINS	Glutaredoxins (GRXs) are small ubiquitous oxidoreductases involved in the regulation of the redox state in living cells. In an attempt to identify the full complement of GRXs in the arbuscular mycorrhizal (AM) fungus Rhizophagus irregularis, three additional GRX homologs, besides the formerly characterized GintGRX1 (renamed here as RiGRX1), were identified. The three new GRXs (RiGRX4, RiGRX5 and RiGRX6) contain the CXXS domain of monothiol GRXs, but whereas RiGRX4 and RiGRX5 belong to class II GRXs, RiGRX6 belongs to class I together with RiGRX1. By using a yeast expression system, we observed that the newly identified homologs partially reverted sensitivity of the GRX deletion yeast strains to external oxidants. Furthermore, our results indicated that RiGRX4 and RiGRX5 play a role in iron homeostasis in yeast. Gene expression analyses revealed that RiGRX1 and RiGRX6 were more highly expressed in the intraradical (IRM) than in the extraradical mycelium (ERM). Exposure of the ERM to hydrogen peroxide induced up-regulation of RiGRX1, RiGRX4 and RiGRX5 gene expression. RiGRX4 expression was also up-regulated in the ERM when the fungus was grown in media supplemented with a high iron concentration. These data indicate the two monothiol class II GRXs, RiGRX4 and RiGRX5, might be involved in oxidative stress protection and in the regulation of fungal iron homeostasis. Increased expression of RiGRX1 and RiGRX6 in the IRM suggests that these GRXs should play a key role in oxidative stress protection of R. irregularis during its in planta phase.	[Tamayo, Elisabeth; Ferrol, Nuria] CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain; [Benabdellah, Karim] Pfizer Univ Granada Andalusian Reg Govt, Ctr Genom & Oncol Res, GENYO, Genom Med Dept, Parque Tecnol Ciencias Salud, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ); Pfizer; University of Granada	Ferrol, N (corresponding author), CSIC, Dept Microbiol Suelo & Sistemas Simbiot, Estn Expt Zaidin, Granada, Spain.	nuria.ferrol@eez.csic.es	Tamayo, Elisabeth/GPP-0978-2022; Benabdellah, karim/F-4209-2016; Benabdellah, karim/L-4569-2014; Ferrol, Nuria/H-5330-2015	Tamayo, Elisabeth/0000-0001-8617-1940; Benabdellah, karim/0000-0003-2790-562X; Benabdellah, karim/0000-0003-4673-2111; Ferrol, Nuria/0000-0001-7963-3537	Spanish Ministry of Economy and Competitivity [AGL2012-35611, AGL2015-67098-R]; Spanish National Research Council (CSIC) [JAEPre_2010_00977]; Pfizer	Spanish Ministry of Economy and Competitivity(Spanish Government); Spanish National Research Council (CSIC); Pfizer(Pfizer)	This research was supported by the Spanish Ministry of Economy and Competitivity (Projects AGL2012-35611 and AGL2015-67098-R). Elisabeth Tamayo was supported by a PhD contract (I3P) from the Spanish National Research Council (CSIC) (JAEPre_2010_00977). Karim Benabdellah is employed by Genomic Medicine Department, GENYO, Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government. GENYO is a public center co-financed by Pfizer, but Pfizer did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arthikala MK, 2014, NEW PHYTOL, V202, P886, DOI 10.1111/nph.12714; Arthikala MK, 2013, PLANT CELL PHYSIOL, V54, P1391, DOI 10.1093/pcp/pct089; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barea JM, 2014, BENEFICIAL PLANT-MICROBIAL INTERACTIONS: ECOLOGY AND APPLICATIONS, P353; Belmondo S, 2016, PLANTA, V243, P251, DOI 10.1007/s00425-015-2407-0; Benabdellah K, 2009, FUNGAL GENET BIOL, V46, P94, DOI 10.1016/j.fgb.2008.09.013; Benabdellah K, 2009, NEW PHYTOL, V184, P682, DOI 10.1111/j.1469-8137.2009.02978.x; Benyamina SM, 2013, ENVIRON MICROBIOL, V15, P795, DOI 10.1111/j.1462-2920.2012.02835.x; Bonfante P, 2015, TRENDS PLANT SCI, V20, P150, DOI 10.1016/j.tplants.2014.12.002; Bucher M, 2014, NEW PHYTOL, V204, P833, DOI 10.1111/nph.12862; CHABOT S, 1992, MYCOLOGIA, V84, P315, DOI 10.2307/3760183; Chung WH, 2005, BIOCHEM BIOPH RES CO, V330, P604, DOI 10.1016/j.bbrc.2005.02.183; Couturier J, 2015, BBA-MOL CELL RES, V1853, P1513, DOI 10.1016/j.bbamcr.2014.09.018; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Demaegd D, 2013, P NATL ACAD SCI USA, V110, P6859, DOI 10.1073/pnas.1219871110; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Ellerbeck M, 2013, EUKARYOT CELL, V12, P1554, DOI 10.1128/EC.00139-13; Farah ME, 2007, MOL BIOL CELL, V18, P1359, DOI 10.1091/mbc.E06-08-0718; Fester T, 2005, MYCORRHIZA, V15, P373, DOI 10.1007/s00572-005-0363-4; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gallego C, 1997, EMBO J, V16, P7196, DOI 10.1093/emboj/16.23.7196; Garcia-Rodriguez S, 2007, PHYSIOL PLANTARUM, V129, P737, DOI 10.1111/j.1399-3054.2007.00873.x; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Gonzalez-Guerrero M, 2010, CURR GENET, V56, P265, DOI 10.1007/s00294-010-0298-y; Gutjahr C, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00204; Haunhorst P, 2010, BIOCHEM BIOPH RES CO, V394, P372, DOI 10.1016/j.bbrc.2010.03.016; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; Herrero E, 2010, CURR PROTEIN PEPT SC, V11, P659, DOI 10.2174/138920310794557637; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Izquierdo A, 2008, EUKARYOT CELL, V7, P1415, DOI 10.1128/EC.00133-08; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Kiirika LM, 2012, PLANT PHYSIOL, V159, P501, DOI 10.1104/pp.112.193706; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Labbe S, 2013, CURR OPIN MICROBIOL, V16, P669, DOI 10.1016/j.mib.2013.07.007; Lanfranco L, 2005, PLANT PHYSIOL, V137, P1319, DOI 10.1104/pp.104.050435; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; Lin K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004078; Liu Y, 2013, FUNGAL BIOL-UK, V117, P22, DOI 10.1016/j.funbio.2012.11.002; Luo M, 2010, J MOL BIOL, V398, P614, DOI 10.1016/j.jmb.2010.03.029; Mapolelo DT, 2013, DALTON T, V42, P3107, DOI 10.1039/c2dt32263c; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; MINET M, 1992, PLANT J, V2, P417; Moon JS, 2005, MOL CELLS, V20, P74; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Perez-Tienda Jacob, 2014, Plant Physiol Biochem, V75, P1, DOI 10.1016/j.plaphy.2013.11.029; Puigpinos J, 2015, MOL BIOL CELL, V26, P104, DOI 10.1091/mbc.E14-06-1137; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Pujol-Carrion N, 2010, APPL ENVIRON MICROB, V76, P7826, DOI 10.1128/AEM.01755-10; Requena N, 2007, PHYTOCHEMISTRY, V68, P33, DOI 10.1016/j.phytochem.2006.09.036; Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517; Rouhier N, 2010, TRENDS BIOCHEM SCI, V35, P43, DOI 10.1016/j.tibs.2009.08.005; Salzer P, 1999, PLANTA, V208, P319, DOI 10.1007/s004250050565; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shenton D, 2002, J BIOL CHEM, V277, P16853, DOI 10.1074/jbc.M200559200; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; StArnaud M, 1996, MYCOL RES, V100, P328, DOI 10.1016/S0953-7562(96)80164-X; Stroher E, 2012, BIOCHEM J, V446, P333, DOI 10.1042/BJ20112131; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tisserant E, 2013, P NATL ACAD SCI USA, V110, P20117, DOI 10.1073/pnas.1313452110; WALLIS JW, 1989, CELL, V58, P409, DOI 10.1016/0092-8674(89)90855-6	71	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149606	10.1371/journal.pone.0149606	http://dx.doi.org/10.1371/journal.pone.0149606			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900849	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100108
J	Wang, XF; Cheng, G; Lug, Y; Zhang, CL; Wu, XB; Han, HT; Zhao, YF; Ren, LM				Wang, Xifeng; Cheng, Gang; Lug, Yan; Zhang, Chenglin; Wu, Xiaobing; Han, Haitang; Zhao, Yaofeng; Ren, Liming			A Comprehensive Analysis of the Phylogeny, Genomic Organization and Expression of Immunoglobulin Light Chain Genes in Alligator sinensis, an Endangered Reptile Species	PLOS ONE			English	Article							ANTIBODY REPERTOIRE DEVELOPMENT; XENOPUS-LAEVIS IG; V(D)J RECOMBINATION; EVOLUTIONARY IMPLICATIONS; AMERICAN ALLIGATOR; EXTENSIVE DIVERSIFICATION; ANOLIS-CAROLINENSIS; CHANNEL CATFISH; RAINBOW-TROUT; LAMBDA-GENES	Crocodilians are evolutionarily distinct reptiles that are distantly related to lizards and are thought to be the closest relatives of birds. Compared with birds and mammals, few studies have investigated the Ig light chain of crocodilians. Here, employing an Alligator sinensis genomic bacterial artificial chromosome (BAC) library and available genome data, we characterized the genomic organization of the Alligator sinensis IgL gene loci. The Alligator sinensis has two IgL isotypes, lambda and kappa, the same as Anolis carolinensis. The Ig(lambda) locus contains 6 C-lambda genes, each preceded by a J(lambda) gene, and 86 potentially functional V-lambda genes upstream of (J(lambda)-C-lambda)(n). The Ig kappa locus contains a single C-kappa gene, 6 J(kappa)s and 62 functional V(kappa)s. All V-L genes are classified into a total of 31 families: 19 V-lambda families and 12 V-kappa families. Based on an analysis of the chromosomal location of the light chain genes among mammals, birds, lizards and frogs, the data further confirm that there are two IgL isotypes in the Alligator sinensis: Ig lambda and Ig kappa. By analyzing the cloned Ig lambda/kappa cDNA, we identified a biased usage pattern of V families in the expressed V-lambda and V-kappa. An analysis of the junctions of the recombined VJ revealed the presence of N and P nucleotides in both expressed. and. sequences. Phylogenetic analysis of the V genes revealed V families shared by mammals, birds, reptiles and Xenopus, suggesting that these conserved V families are orthologous and have been retained during the evolution of IgL. Our data suggest that the Alligator sinensis IgL gene repertoire is highly diverse and complex and provide insight into immunoglobulin gene evolution in vertebrates.	[Wang, Xifeng; Cheng, Gang; Han, Haitang; Zhao, Yaofeng; Ren, Liming] China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Lug, Yan; Zhang, Chenglin] Beijing Zoo, Beijing 100044, Peoples R China; [Wu, Xiaobing] Anhui Normal Univ, Coll Life Sci, Anhui Prov Key Lab Conservat & Exploitat Biol Res, Wuhu 241000, Peoples R China	China Agricultural University; Anhui Normal University	Ren, LM (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	renlm@cau.edu.cn	Zhang, Cheng/GRS-8698-2022		National Natural Science Foundation of China [31472085, 31272433]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/, grant number: 31472085 and 31272433). The author Yaofeng Zhao received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; Almagro JC, 1998, IMMUNOGENETICS, V47, P355, DOI 10.1007/s002510050370; Bao YH, 2010, FISH SHELLFISH IMMUN, V28, P40, DOI 10.1016/j.fsi.2009.09.014; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bengten E, 2000, CURR TOP MICROBIOL, V248, P189; Butler JE, 2006, DEV COMP IMMUNOL, V30, P199, DOI 10.1016/j.dci.2005.06.025; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Cheng G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2317; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Criscitiello MF, 2007, EUR J IMMUNOL, V37, P2683, DOI 10.1002/eji.200737263; DAGGFELDT A, 1993, IMMUNOGENETICS, V38, P199; Darville LNF, 2010, COMP BIOCHEM PHYS D, V5, P308, DOI 10.1016/j.cbd.2010.09.001; Das S, 2008, P NATL ACAD SCI USA, V105, P16647, DOI 10.1073/pnas.0808800105; Das S, 2010, MOL BIOL EVOL, V27, P113, DOI 10.1093/molbev/msp212; Dooley H, 2006, DEV COMP IMMUNOL, V30, P43, DOI 10.1016/j.dci.2005.06.022; Edholm ES, 2011, DEV COMP IMMUNOL, V35, P906, DOI 10.1016/j.dci.2011.01.012; Edholm ES, 2009, IMMUNOGENETICS, V61, P353, DOI 10.1007/s00251-009-0365-z; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Deza FG, 2009, MOL IMMUNOL, V46, P1679, DOI 10.1016/j.molimm.2009.02.019; Gambon-Deza F, 2008, MOL IMMUNOL, V45, P3470, DOI 10.1016/j.molimm.2008.02.027; Gambon-Deza F, 2012, DEV COMP IMMUNOL, V38, P1, DOI 10.1016/j.dci.2012.03.001; Gerdes T, 2002, IMMUNOGENETICS, V54, P62, DOI 10.1007/s00251-002-0435-y; GHAFFARI SH, 1993, J IMMUNOL, V151, P6900; Ghaffari SH, 1997, J IMMUNOL, V159, P250; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; Haire RN, 1996, J IMMUNOL, V157, P1544; Haire RN, 2000, IMMUNOGENETICS, V51, P915, DOI 10.1007/s002510000229; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hikima JI, 2011, DEV COMP IMMUNOL, V35, P924, DOI 10.1016/j.dci.2010.10.011; Huang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034346; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kawasaki K, 2001, EUR J IMMUNOL, V31, P1017, DOI 10.1002/1521-4141(200104)31:4<1017::AID-IMMU1017>3.3.CO;2-V; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lee SS, 2002, IMMUNITY, V16, P571, DOI 10.1016/S1074-7613(02)00300-X; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Lefranc Marie-Paule, 2005, Immunome Res, V1, P3, DOI 10.1186/1745-7580-1-3; Lefranc MP, 1998, EXP CLIN IMMUNOGENET, V15, P1, DOI 10.1159/000019049; Li LX, 2012, J IMMUNOL, V189, P3995, DOI 10.4049/jimmunol.1200188; Litman GF, 1999, ANNU REV IMMUNOL, V17, P109, DOI 10.1146/annurev.immunol.17.1.109; Lundqvist M, 1996, J IMMUNOL, V157, P2031; Magadan-Mompo S, 2013, IMMUNOGENETICS, V65, P531, DOI 10.1007/s00251-013-0692-y; Magadan-Mompo S, 2013, IMMUNOGENETICS, V65, P227, DOI 10.1007/s00251-012-0672-7; MAGOR KE, 1994, DEV COMP IMMUNOL, V18, P523, DOI 10.1016/S0145-305X(06)80006-6; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; Merchant ME, 2006, VET IMMUNOL IMMUNOP, V110, P221, DOI 10.1016/j.vetimm.2005.10.001; Modesto SP, 2004, SYST BIOL, V53, P815, DOI 10.1080/10635150490503026; Olivieri DN, 2014, IMMUNOGENETICS, V66, P479, DOI 10.1007/s00251-014-0784-3; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Partula S, 1996, IMMUNOGENETICS, V45, P44, DOI 10.1007/s002510050165; PARVARI R, 1987, EMBO J, V6, P97, DOI 10.1002/j.1460-2075.1987.tb04724.x; Pilstrom L, 2002, DEV COMP IMMUNOL, V26, P207, DOI 10.1016/S0145-305X(01)00066-0; Qin T, 2008, DEV COMP IMMUNOL, V32, P156, DOI 10.1016/j.dci.2007.05.007; Retief J D, 2000, Methods Mol Biol, V132, P243; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SALUK PH, 1970, P SOC EXP BIOL MED, V133, P365; SANDERS BG, 1975, BIOCHEM GENET, V13, P779, DOI 10.1007/BF00484409; SCHWAGER J, 1991, EMBO J, V10, P505, DOI 10.1002/j.1460-2075.1991.tb07976.x; Shedlock AM, 2007, P NATL ACAD SCI USA, V104, P2767, DOI 10.1073/pnas.0606204104; Sun Y, 2011, DEV COMP IMMUNOL, V35, P975, DOI 10.1016/j.dci.2010.12.010; Wang T, 2012, J IMMUNOL, V189, P3557, DOI 10.4049/jimmunol.1200212; Wei ZG, 2009, J IMMUNOL, V183, P3858, DOI 10.4049/jimmunol.0803251; Wu Q, 2010, DEV COMP IMMUNOL, V34, P579, DOI 10.1016/j.dci.2009.12.019; Xu Z, 2009, MOL IMMUNOL, V46, P2124, DOI 10.1016/j.molimm.2009.03.028; ZEZZA DJ, 1992, J IMMUNOL, V149, P3968; ZEZZA DJ, 1991, J IMMUNOL, V146, P4041	68	4	4	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147704	10.1371/journal.pone.0147704	http://dx.doi.org/10.1371/journal.pone.0147704			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901135	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100012
J	Williams, AM; Maman, Y; Alinikula, J; Schatz, DG				Williams, Alan M.; Maman, Yaakov; Alinikula, Jukka; Schatz, David G.			Bcl6 Is Required for Somatic Hypermutation and Gene Conversion in Chicken DT40 Cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; CENTER B-CELLS; TRANSCRIPTION ELONGATION-FACTOR; LYMPHOCYTE DIFFERENTIATION; AID; DNA; EXPRESSION; MECHANISMS; REPRESSION; DEAMINASE	The activation induced cytosine deaminase (AID) mediates diversification of B cell immunoglobulin genes by the three distinct yet related processes of somatic hypermutation (SHM), class switch recombination (CSR), and gene conversion (GCV). SHM occurs in germinal center B cells, and the transcription factor Bcl6 is a key regulator of the germinal center B cell gene expression program, including expression of AID. To test the hypothesis that Bcl6 function is important for the process of SHM, we compared WT chicken DT40 B cells, which constitutively perform SHM/GCV, to their Bcl6-deficient counterparts. We found that Bcl6-deficient DT40 cells were unable to perform SHM and GCV despite enforced high level expression of AID and substantial levels of AID in the nucleus of the cells. To gain mechanistic insight into the GCV/SHM dependency on Bcl6, transcriptional features of a highly expressed SHM target gene were analyzed in Bcl6-sufficient and -deficient DT40 cells. No defect was observed in the accumulation of single stranded DNA in the target gene as a result of Bcl6 deficiency. In contrast, association of Spt5, an RNA polymerase II (Pol II) and AID binding factor, was strongly reduced at the target gene body relative to the transcription start site in Bcl6-deficient cells as compared to WT cells. However, partial reconstitution of Bcl6 function substantially reconstituted Spt5 association with the target gene body but did not restore detectable SHM. Our observations suggest that in the absence of Bcl6, Spt5 fails to associate efficiently with Pol II at SHM targets, perhaps precluding robust AID action on the SHM target DNA. Our data also suggest, however, that Spt5 binding is not sufficient for SHM of a target gene even in DT40 cells with strong expression of AID.	[Williams, Alan M.; Maman, Yaakov; Alinikula, Jukka; Schatz, David G.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA; [Schatz, David G.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Alinikula, Jukka] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	Yale University; Howard Hughes Medical Institute; University of Turku	Schatz, DG (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT USA.; Schatz, DG (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	david.schatz@yale.edu	Alinikula, Jukka/AAD-1594-2020	Alinikula, Jukka/0000-0001-9926-6439; Schatz, David/0000-0002-5669-1176	Howard Hughes Medical Institute; National Science Foundation; National Institutes of Health [T32AI007019]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources were Howard Hughes Medical Institute (http://www.hhmi.org/) (YM, JA, DGS), National Science Foundation (predoctoral fellowship to AMW) (http://www.nsf.gov/), and National Institutes of Health T32AI007019 (AMW) (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinikula J, 2011, EUR J IMMUNOL, V41, P2404, DOI 10.1002/eji.201141553; Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051; Basso K, 2012, IMMUNOL REV, V247, P172, DOI 10.1111/j.1600-065X.2012.01112.x; Blagodatski A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000332; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Brookes E, 2012, CELL STEM CELL, V10, P157, DOI 10.1016/j.stem.2011.12.017; Buerstedde JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001831; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Cimmino L, 2008, J IMMUNOL, V181, P2338, DOI 10.4049/jimmunol.181.4.2338; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Di Noia JM, 2004, EUR J IMMUNOL, V34, P504, DOI 10.1002/eji.200324631; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Fukita Y, 1998, IMMUNITY, V9, P105, DOI 10.1016/S1074-7613(00)80592-0; Geisberger R, 2009, P NATL ACAD SCI USA, V106, P6736, DOI 10.1073/pnas.0810808106; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Klein U, 2003, P NATL ACAD SCI USA, V100, P2639, DOI 10.1073/pnas.0437996100; Kohler KM, 2012, J IMMUNOL, V189, P5314, DOI 10.4049/jimmunol.1202082; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Longerich S, 2005, J EXP MED, V202, P1443, DOI 10.1084/jem.20051604; Lozano G, 2015, CURR OPIN VIROL, V12, P113, DOI 10.1016/j.coviro.2015.04.008; Maul RW, 2014, J EXP MED, V211, P2297, DOI 10.1084/jem.20131512; McDonald JJ, 2013, J IMMUNOL, V191, P1556, DOI 10.4049/jimmunol.1300969; Methot SP, 2015, J EXP MED, V212, P581, DOI 10.1084/jem.20141157; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Patenaude AM, 2009, NAT STRUCT MOL BIOL, V16, P517, DOI 10.1038/nsmb.1598; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Phan RT, 2007, NAT IMMUNOL, V8, P1132, DOI 10.1038/ni1508; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; Ronai D, 2007, J EXP MED, V204, P181, DOI 10.1084/jem.20062032; Saribasak H, 2006, J IMMUNOL, V176, P365, DOI 10.4049/jimmunol.176.1.365; Selth LA, 2010, ANNU REV BIOCHEM, V79, P271, DOI 10.1146/annurev.biochem.78.062807.091425; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Tunyaplin C, 2004, J IMMUNOL, V173, P1158, DOI 10.4049/jimmunol.173.2.1158; Vasanwala FH, 2002, J IMMUNOL, V169, P1922, DOI 10.4049/jimmunol.169.4.1922; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Yamaguchi Y, 1999, J BIOL CHEM, V274, P8085, DOI 10.1074/jbc.274.12.8085; Yang SY, 2006, J EXP MED, V203, P2919, DOI 10.1084/jem.20061835; Yeap LS, 2015, CELL, V163, P1124, DOI 10.1016/j.cell.2015.10.042; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	48	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149146	10.1371/journal.pone.0149146	http://dx.doi.org/10.1371/journal.pone.0149146			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900682	Green Published, gold			2022-12-26	WOS:000371276100041
J	Xiao, FZ; Peng, GW; Nie, CM; Yu, LM				Xiao, Fangzhu; Peng, Guowen; Nie, Changming; Yu, Limei			Predicting Thermodynamic Properties of PBXTHs with New Quantum Topological Indexes	PLOS ONE			English	Article							QUANTITATIVE STRUCTURE; MOLECULAR DESCRIPTORS; INHIBITORS; QSPR; QSAR	Novel group quantitative structure-property relationship (QSPR) models on the thermodynamic properties of PBXTHs were presented, by the multiple linear regression (MLR) analysis method. Four thermodynamic properties were studied: the entropy (S-theta), the standard enthalpy of formation (Delta H-f(theta)), the standard Gibbs energy of formation (Delta(f)G(theta)), and the relative standard Gibbs energy of formation (Delta(R)G(theta)). The results by the formula indicate that the calculated and predicted data in this study are in good agreement with those in literature and the deviation is within the experimental errors. To validate the estimation reliability for internal samples and the predictive ability for other samples, leave-one-out (LOO) cross validation (CV) and external validation were performed, and the results show that the models are satisfactory.	[Xiao, Fangzhu] Univ South China, Sch Publ Hlth, Hengyang 421001, Peoples R China; [Peng, Guowen; Nie, Changming; Yu, Limei] Univ South China, Sch Chem & Chem Engn, Hengyang 421001, Peoples R China	University of South China; University of South China	Peng, GW (corresponding author), Univ South China, Sch Chem & Chem Engn, Hengyang 421001, Peoples R China.	pgwnh@sohu.com	NIE, Changming/X-5351-2019; Nie, Changming/ABB-8899-2021	NIE, Changming/0000-0003-2744-8924; 	National Natural Science Foundation of China [51574152, 11205084]; Foundation of Hunan Province Science and Technology Department [2014GK3079]; social development and science & technology support of Hengyang city [2014KS26]; Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation, Changsha University of Science & Technology, P. R. China [2016CL03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Hunan Province Science and Technology Department; social development and science & technology support of Hengyang city; Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation, Changsha University of Science & Technology, P. R. China	This paper was financially supported by the National Natural Science Foundation of China (No. 51574152,11205084), the Foundation of Hunan Province Science and Technology Department (2014GK3079), the social development and science & technology support of Hengyang city (No. 2014KS26), and the Hunan Provincial Key Laboratory of Materials Protection for Electric Power and Transportation (No. 2016CL03), Changsha University of Science & Technology, P. R. China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal VK, 2003, BIOORGAN MED CHEM, V11, P5519, DOI 10.1016/j.bmc.2003.09.025; Bajaj S, 2006, QSAR COMB SCI, V25, P813, DOI 10.1002/qsar.200430918; Dai YM, 2012, J CENT SOUTH UNIV, V19, P93, DOI 10.1007/s11771-012-0977-6; Dai YM, 2011, J CENT S U, V18, P324; Duchowicz P R, 2005, CHEM PHYS LETT, V412, P377; Gharagheizi F, 2012, CHEM ENG SCI, V76, P99, DOI 10.1016/j.ces.2012.03.033; Hu L H, 2002, J SYN CHEM, V4, P285; Kiralj R, 2003, J MOL GRAPH MODEL, V21, P435, DOI 10.1016/S1093-3263(02)00201-2; Liu FP, 2011, INT J MOL SCI, V12, P2448, DOI 10.3390/ijms12042448; Lu CH, 2006, CHEM PHYS LETT, V417, P11, DOI 10.1016/j.cplett.2005.09.051; Lucic B, 1999, J CHEM INF COMP SCI, V39, P610, DOI 10.1021/ci980161a; Netzeva TI, 2005, CHEMOSPHERE, V61, P1632, DOI 10.1016/j.chemosphere.2005.04.040; Nie C.M., 2000, J WUHAN U NAT SCI ED, V46, P176; Nie CM, 2006, CHINESE J ANAL CHEM, V34, P1560; Nie CM, 2009, J THEOR COMPUT CHEM, V8, P19, DOI 10.1142/S0219633609004447; [彭国文 Peng Guowen], 2011, [化工学报, Journal of Chemical Industry and Engineering (China)], V62, P604; [彭国文 Peng Guowen], 2010, [化学研究与应用, Chemical Research and Application], V22, P1498; Peng GW, 2011, ACTA CHIM SINICA, V69, P305; Rose K, 2002, J CHEM INF COMP SCI, V42, P651, DOI 10.1021/ci010127n; Shang G, 2010, J STRUCT CHEM, V29, P227; Xiao FZ, 2014, J MOL STRUCT, V1074, P679, DOI 10.1016/j.molstruc.2014.04.072; [肖方竹 XIAO Fangzhu], 2011, [化工学报, Journal of Chemical Industry and Engineering (China)], V62, P1808; Yang F, 2003, J CHEM INF COMP SCI, V43, P753, DOI 10.1021/ci025663+; Yang Y. B., 1995, Acta Pharmaceutica Sinica, V30, P440; Zhou CY, 2007, J COMPUT CHEM, V28, P2413, DOI 10.1002/jcc.20540; Zhou CY, 2007, B CHEM SOC JPN, V80, P1504, DOI 10.1246/bcsj.80.1504	26	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147126	10.1371/journal.pone.0147126	http://dx.doi.org/10.1371/journal.pone.0147126			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900689	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100008
J	Zhang, Y; Lu, T; Wong, M; Wang, XY; Stodieck, L; Karouia, F; Story, M; Wu, HL				Zhang, Ye; Lu, Tao; Wong, Michael; Wang, Xiaoyu; Stodieck, Louis; Karouia, Fathi; Story, Michael; Wu, Honglu			Transient gene and microRNA expression profile changes of confluent human fibroblast cells in spaceflight	FASEB JOURNAL			English	Article						microgravity; omics; cell growth condition	NF-KAPPA-B; HEPATOCYTE GROWTH-FACTOR; SIMULATED MICROGRAVITY; SIGNALING PATHWAY; PROLIFERATION; CYTOSKELETON; ACTIVATION; HYPERGRAVITY; GRAVITY; DIFFERENTIATION	Microgravity, or an altered gravity environment different from the 1 g of the Earth, has been shown to influence global gene expression patterns and protein levels in cultured cells. However, most of the reported studies that have been conducted in space or by using simulated microgravity on the ground have focused on the growth or differentiation of these cells. It has not been specifically addressed whether nonproliferating cultured cells will sense the presence of microgravity in space. In an experiment conducted onboard the International Space Station, confluent human fibroblast cells were fixed after being cultured in space for 3 and 14 d, respectively, to investigate changes in gene and microRNA (miRNA) expression profiles in these cells. Results of the experiment showed that on d 3, both the flown and ground cells were still proliferating slowly, as measured by the percentage of Ki-67(+) cells. Gene and miRNA expression data indicated activation of NF-B and other growth-related pathways that involve hepatocyte growth factor and VEGF as well as the down-regulation of the Let-7 miRNA family. On d 14, when the cells were mostly nonproliferating, the gene and miRNA expression profile of the flight sample was indistinguishable from that of the ground sample. Comparison of gene and miRNA expressions in the d 3 samples, with respect to d 14, revealed that most of the changes observed on d 3 were related to cell growth for both the flown and ground cells. Analysis of cytoskeletal changes via immunohistochemistry staining of the cells with antibodies for -tubulin and fibronectin showed no difference between the flown and ground samples. Taken together, our study suggests that in true nondividing human fibroblast cells in culture, microgravity experienced in space has little effect on gene and miRNA expression profiles.Zhang, Y., Lu, T., Wong, M., Wang, X., Stodieck, L., Karouia, F., Story, M., Wu, H. Transient gene and microRNA expression profile changes of confluent human fibroblast cells in spaceflight.	[Zhang, Ye; Lu, Tao; Wong, Michael; Wu, Honglu] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Zhang, Ye] Wyle Labs, Houston, TX USA; [Zhang, Ye] NASA, Kennedy Space Ctr, Cape Canaveral, FL USA; [Lu, Tao] Univ Houston Clear Lake, Houston, TX USA; [Wang, Xiaoyu; Story, Michael] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Stodieck, Louis] BioServe Space Technol, Boulder, CO USA; [Karouia, Fathi] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Karouia, Fathi] Univ Calif San Francisco, San Francisco, CA 94143 USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); University of Houston System; University of Houston; University of Houston Clear Lake; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California San Francisco	Wu, HL (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	honglu.wu-1@nasa.gov	Story, Michael/AAX-2864-2021	Story, Michael/0000-0001-6522-4169; Wong, Michael/0000-0002-0949-4102; Karouia, Fathi/0000-0002-1142-9684	NASA Fundamental Space Biology Program	NASA Fundamental Space Biology Program	The authors thank Stefanie Countryman, Jon Beno, Mark Rupert, and Shankini Doraisingam (BioServe Space Technologies), with whom this work was done in collaboration. The authors thank Ashleigh Ruggles and Satyanand Narayan [Kennedy Space Center, National Aeronautics and Space Administration (NASA)], and Kevin Sato (NASA Ames Research Center) for support during various phases of the project. The authors also thank Astronaut Thomas Mashburn for performing experiments onboard the ISS. This work was supported by the NASA Fundamental Space Biology Program.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Allen Jeffrey D, 2009, J Cancer Sci Ther, V1, P25; Boonstra J, 1999, FASEB J, V13, pS35, DOI 10.1096/fasebj.13.9001.s35; Buravkova LB, 2001, ACTA ASTRONAUT, V48, P647, DOI 10.1016/S0094-5765(01)00023-6; Chang TT, 2012, J LEUKOCYTE BIOL, V92, P1133, DOI 10.1189/jlb.0312157; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Clement JQ., 2007, J GRAVIT PHYSL, V14, P121; Cooper D, 2001, IN VITRO CELL DEV-AN, V37, P63; Dai ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063661; Di Fiore R, 2014, INT J ONCOL, V45, P2013, DOI 10.3892/ijo.2014.2618; Ding LH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-372; Gao Y, 2015, J RADIAT RES, V56, P872, DOI 10.1093/jrr/rrv050; Gasparri F, 2004, J BIOMOL SCREEN, V9, P232, DOI 10.1177/1087057103262836; Genchi GG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/748121; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Grimm D, 2014, EXPERT REV PROTEOMIC, V11, P465, DOI 10.1586/14789450.2014.926221; Grimm D, 2011, EXPERT REV PROTEOMIC, V8, P13, DOI 10.1586/EPR.10.105; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Hammond TG, 1999, NAT MED, V5, P359, DOI 10.1038/7331; Hao NB, 2015, CANCER LETT, V361, P57, DOI 10.1016/j.canlet.2015.02.043; Hargens AR, 2013, EUR J APPL PHYSIOL, V113, P2183, DOI 10.1007/s00421-012-2523-5; Horneck G, 2010, MICROBIOL MOL BIOL R, V74, P121, DOI 10.1128/MMBR.00016-09; Hughes-Fulford M, 2003, ADV SPACE RES-SERIES, V32, P1585, DOI 10.1016/S0273-1177(03)90399-1; Hughes-Fulford M, 1998, Gravit Space Biol Bull, V11, P51; Hughes-Fulford M, 2015, FASEB J, V29, P4893, DOI 10.1096/fj.15-277392; Iwasaki T, 2015, INT J ONCOL, V46, P1543, DOI 10.3892/ijo.2015.2867; Jia LF, 2014, ORAL ONCOL, V50, P1062, DOI 10.1016/j.oraloncology.2014.07.010; Kwon O, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3128718; Lee KH, 2012, CLIN EXP METASTAS, V29, P263, DOI 10.1007/s10585-011-9449-x; Liu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083083; Luna C, 2009, MOL VIS, V15, P2488; Luu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070604; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Mangala LS, 2011, J BIOL CHEM, V286, P32483, DOI 10.1074/jbc.M111.267765; Marcu O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015361; Martin TA, 2010, ANTI-CANCER AGENT ME, V10, P2, DOI 10.2174/1871520611009010002; Matsui T, 2015, OR SURG OR MED OR PA, V120, P436, DOI 10.1016/j.oooo.2015.06.002; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; MIWA M, 1991, BONE MINER, V14, P15, DOI 10.1016/0169-6009(91)90099-L; Muller M, 2002, MOL CELL BIOL, V22, P1060, DOI 10.1128/MCB.22.4.1060-1072.2002; Nichols HL, 2006, PHYSIOL GENOMICS, V26, P163, DOI 10.1152/physiolgenomics.00323.2005; Ohnishi Ken, 2004, Biol Sci Space, V18, P201, DOI 10.2187/bss.18.201; Paul AL, 2012, ASTROBIOLOGY, V12, P40, DOI 10.1089/ast.2011.0696; Phan LM, 2015, CANCER RES, V75, P4131, DOI 10.1158/0008-5472.CAN-14-3707; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Santi S., 2002, J GRAVIT PHYSL, V9, P283; Sciola L, 1999, ADV SPACE RES, V24, P801, DOI 10.1016/S0273-1177(99)00078-2; Semov A, 2002, FASEB J, V16, P899, DOI 10.1096/fj.01-1002fje; Sharma CS, 2008, MOL CELL BIOCHEM, V313, P71, DOI 10.1007/s11010-008-9743-3; Sonnenfeld Gerald, 2003, Rev Environ Health, V18, P1; Stowe RP, 2011, AVIAT SPACE ENVIR MD, V82, P627, DOI 10.3357/ASEM.2980.2011; TSCHOPP A, 1983, EXPERIENTIA, V39, P1323, DOI 10.1007/BF01990088; Uva BM, 2002, BRAIN RES, V934, P132, DOI 10.1016/S0006-8993(02)02415-0; Vassy J., 2001, FASEB Journal, V15, P1104; Vidyasekar P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135958; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Ward NE, 2006, J CELL BIOCHEM, V99, P1187, DOI 10.1002/jcb.20988; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Wilson JW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003923; Wilson JW, 2002, P NATL ACAD SCI USA, V99, P13807, DOI 10.1073/pnas.212387899; Wu H, 2006, RADIAT RES, V166, P583, DOI 10.1667/RR0535.1; Xie HX, 2015, ORAL ONCOL, V51, P991, DOI 10.1016/j.oraloncology.2015.08.007; Xie Y, 2009, BIOINFORMATICS, V25, P751, DOI 10.1093/bioinformatics/btp040; Yao P, 2004, J HEPATOL, V40, P391, DOI 10.1016/j.jhep.2003.11.001; Zhang CC, 2012, ARCH ORAL BIOL, V57, P1395, DOI 10.1016/j.archoralbio.2012.04.010; Zhang KX, 2014, INT J CLIN EXP PATHO, V7, P5701	68	23	26	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2211	2224		10.1096/fj.201500121	http://dx.doi.org/10.1096/fj.201500121			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26917741				2022-12-26	WOS:000376878300014
J	Sankaran, SM; Wilkinson, AW; Elias, JE; Gozani, O				Sankaran, Saumya M.; Wilkinson, Alex W.; Elias, Joshua E.; Gozani, Or			A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA; 36 TRIMETHYLATION; CELL-CYCLE; GENE; DNA; RECOGNITION; MMSET; METHYLATION; PROTEINS; ADHESION	The readout of histone modifications plays a critical role in chromatin-regulated processes. Dimethylation at Lys-36 on histone H3 (H3K36me2) is associated with actively transcribed genes, and global up-regulation of this modification is associated with several cancers. However, the molecular mechanism by which H3K36me2 is sensed and transduced to downstream biological outcomes remains unclear. Here we identify a PWWP domain within the histone lysine methyltransferase and oncoprotein NSD2 that preferentially binds to nucleosomes containing H3K36me2. In cells, the NSD2 PWWP domain interaction with H3K36me2 plays a role in stabilizing NSD2 at chromatin. Furthermore, NSD2's ability to induce global increases in H3K36me2 via its enzymatic activity, and consequently promote cellular proliferation, is compromised by mutations within the PWWP domain that specifically abrogate H3K36me2-recognition. Together, our results identify a pivotal role for NSD2 binding to its catalytic product in regulating its cellular functions, and suggest a model for how this interaction may facilitate epigenetic spreading and propagation of H3K36me2.	[Sankaran, Saumya M.; Wilkinson, Alex W.; Gozani, Or] Stanford Univ, Sch Med, Dept Biol, Stanford, CA 94305 USA; [Elias, Joshua E.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Gozani, O (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA USA.	ogozani@stanford.edu		Gozani, Or/0000-0002-1365-4463	National Institutes of Health [R01 GM079641, T32 GM007276]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grant R01 GM079641 (to O. G.). O. G. is a co-founder of EpiCypher, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Training Grant T32 GM007276.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bartke T, 2010, CELL, V143, P470, DOI 10.1016/j.cell.2010.10.012; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Bua DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006789; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Collins RE, 2008, NAT STRUCT MOL BIOL, V15, P245, DOI 10.1038/nsmb.1384; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Grosso AR, 2015, ELIFE, V4, DOI 10.7554/eLife.09214; Guo R, 2014, MOL CELL, V56, P298, DOI 10.1016/j.molcel.2014.08.022; Jaffe JD, 2013, NAT GENET, V45, P1386, DOI 10.1038/ng.2777; Jha D. K., 2014, NAT COMMUN, V5, P1; Jha DK, 2014, NAT STRUCT MOL BIOL, V21, P655, DOI 10.1038/nsmb.2866; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Moore KE, 2013, MOL CELL, V50, P444, DOI 10.1016/j.molcel.2013.03.005; Morishita M, 2011, BBA-REV CANCER, V1816, P158, DOI 10.1016/j.bbcan.2011.05.004; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Oyer JA, 2014, LEUKEMIA, V28, P198, DOI 10.1038/leu.2013.204; Pai C. -C., 2014, NAT COMMUN, V5, P1; Qin S, 2014, TRENDS BIOCHEM SCI, V39, P536, DOI 10.1016/j.tibs.2014.09.001; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wen H, 2014, NATURE, V508, P263, DOI 10.1038/nature13045	45	43	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8465	8474		10.1074/jbc.M116.720748	http://dx.doi.org/10.1074/jbc.M116.720748			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912663	Green Published, hybrid			2022-12-26	WOS:000374773200013
J	Reuter, KE; Randell, H; Wills, AR; Janvier, TE; Belalahy, TR; Sewall, BJ				Reuter, Kim E.; Randell, Haley; Wills, Abigail R.; Janvier, Totozafy Eric; Belalahy, Tertius Rodriguez; Sewall, Brent J.			Capture, Movement, Trade, and Consumption of Mammals in Madagascar	PLOS ONE			English	Article							BUSHMEAT COMMODITY CHAIN; FOOD SECURITY; WILDLIFE CONSUMPTION; WEST-AFRICA; CONGO BASIN; CONSERVATION; LIVELIHOODS; EDUCATION; IMPACTS; ECOLOGY	Wild meat trade constitutes a threat to many animal species. Understanding the commodity chain of wild animals (hunting, transportation, trade, consumption) can help target conservation initiatives. Wild meat commodity chain research has focused on the formal trade and less on informal enterprises, although informal enterprises contribute to a large portion of the wild meat trade in sub-Saharan Africa. We aimed to provide a more comprehensive understanding of the formal and informal components of these commodity chains by focusing on the mammalian wild meat trade in Madagascar. Our objectives were to: (1) identify hunting strategies used to capture different wild mammals; (2) analyze patterns of movement of wild meat from the capture location to the final consumer; (3) examine wild meat prices, volumes, and venues of sale; and (4) estimate the volume of wild meat consumption. Data were collected in May-August 2013 using semi-structured interviews with consumers (n = 1343 households, 21 towns), meat-sellers (n = 520 restaurants, open-air markets stalls, and supermarkets, 9 towns), and drivers of inter-city transit vehicles (n = 61, 5 towns). We found that: (1) a wide range of hunting methods were used, though prevalence of use differed by animal group; (2) wild meat was transported distances of up to 166 km to consumers, though some animal groups were hunted locally (< 10 km) in rural areas; (3) most wild meat was procured from free sources (hunting, gifts), though urban respondents who consumed bats and wild pigs were more likely to purchase those meats; and (4) wild meat was consumed at lower rates than domestic meat, though urban respondents consumed wild meat twice as much per year compared to rural respondents. Apart from the hunting stage, the consumption and trade of wild meat in Madagascar is also likely more formalized than previously thought.	[Reuter, Kim E.; Randell, Haley; Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Wills, Abigail R.] Mpingo Conservat & Dev Initiat, Kilwa Masoko, Tanzania; [Janvier, Totozafy Eric; Belalahy, Tertius Rodriguez] Univ Antsiranana, Dept Sci Nat & Environm, Antsiranana, Madagascar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Reuter, KE (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	kimeleanorreuter@gmail.com			National Science Foundation [DGE-1144462, DEB-1257916]; Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology [1257916] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. (DGE-1144462) to KER (https://www.nsfgrfp.org), a National Science Foundation grant (DEB-1257916) to BJS (http://www.nsf.gov/funding/), an Explorers Club Grant to KER (https://explorers.org/expeditions/funding/expedition_grants), and a Temple University Faculty Senate grant to BJS (https://www.temple.edu/research/facinitiatives/facini_int_funding.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Benjamin N, 2014, INFORM GROWTH DEV AF; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bowen-Jones E, 2003, AREA, V35, P390, DOI 10.1111/j.0004-0894.2003.00189.x; Breuer T, 2010, AM J PRIMATOL, V72, P454, DOI 10.1002/ajp.20774; Bulte E, 2007, J ENVIRON ECON MANAG, V54, P311, DOI 10.1016/j.jeem.2007.02.003; Campbell BM, 2010, ECOL SOC, V15; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Crookes DJ, 2005, ENVIRON CONSERV, V32, P333, DOI 10.1017/S037689290500250X; DUCKWORTH JW, 1995, INT J PRIMATOL, V16, P545, DOI 10.1007/BF02735803; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Gardner CJ, 2014, HUM ECOL, V42, P21, DOI 10.1007/s10745-013-9629-1; Golden CD, 2013, ANIM CONSERV, V16, P597, DOI 10.1111/acv.12047; Golden CD, 2014, CONSERV BIOL, V28, P234, DOI 10.1111/cobi.12174; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Goodman Steven M., 2003, Lemur News, V8, P4; Guerbois C, 2013, CONSERV BIOL, V27, P844, DOI 10.1111/cobi.12108; HAWKINS AFA, 1990, BIOL CONSERV, V54, P83, DOI 10.1016/0006-3207(90)90136-D; Irwin Mitchell T., 2000, Lemur News, V5, P20; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; Kumpel NF, 2010, HUM ECOL, V38, P251, DOI 10.1007/s10745-010-9316-4; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Martinez Barbara, 2008, Lemur News, V13, P11; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Peres C.A., 2001, CONSERVATION EXPLOIT, P203; Rakotoarivelo Andrinajoro R., 2011, Madagascar Conservation & Development, V6, P37; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; Razafimanahaka JH, 2012, ORYX, V46, P584, DOI 10.1017/S0030605312000579; Reuter KE, ENV CONSERV IN PRESS; Reuter KE, 2016, ORYX, V50, P344, DOI 10.1017/S003060531400074X; Rietbergen-McCracken J., 1998, PARTICIPATION SOCIAL; Rigamonti MM, 1996, LEMUR NEWS, V2, P9; Rist J, 2010, CONSERV BIOL, V24, P489, DOI 10.1111/j.1523-1739.2010.01470.x; Sarter S, 2010, FOOD CONTROL, V21, P253, DOI 10.1016/j.foodcont.2009.05.015; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Tucker B, 2007, HUM NATURE-INT BIOS, V18, P190, DOI 10.1007/s12110-007-9017-x; United Nations, 2013, OP RAT EXCH; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; Vasey N, 1996, LEMUR NEWS, V2, P7; Westerman Kame, 2013, Conservation Evidence, V10, P4; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871	47	10	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150305	10.1371/journal.pone.0150305	http://dx.doi.org/10.1371/journal.pone.0150305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926987	Green Published, gold			2022-12-26	WOS:000371424200035
J	Rincon, JA; Poza-Lujan, JL; Julian, V; Posadas-Yague, JL; Carrascosa, C				Rincon, J. A.; Poza-Lujan, Jose-Luis; Julian, V.; Posadas-Yaguee, Juan-Luis; Carrascosa, C.			Extending MAM5 Meta-Model and JaCalIV E Framework to Integrate Smart Devices from Real Environments	PLOS ONE			English	Article							SENSOR NETWORK	This paper presents the extension of a meta-model (MAM5) and a framework based on the model (JaCalIVE) for developing intelligent virtual environments. The goal of this extension is to develop augmented mirror worlds that represent a real and virtual world coupled, so that the virtual world not only reflects the real one, but also complements it. A new component called a smart resource artifact, that enables modelling and developing devices to access the real physical world, and a human in the loop agent to place a human in the system have been included in the meta-model and framework. The proposed extension of MAM5 has been tested by simulating a light control system where agents can access both virtual and real sensor/actuators through the smart resources developed. The results show that the use of real environment interactive elements (smart resource artifacts) in agent-based simulations allows to minimize the error between simulated and real system.	[Rincon, J. A.; Julian, V.; Carrascosa, C.] Univ Politecn Valencia, DSIC, Camino Vera S-N, E-46022 Valencia, Spain; [Poza-Lujan, Jose-Luis; Posadas-Yaguee, Juan-Luis] Univ Politecn Valencia, Inst Control Syst & Ind Comp Ai2, Camino Vera S-N, E-46022 Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Poza-Lujan, JL (corresponding author), Univ Politecn Valencia, Inst Control Syst & Ind Comp Ai2, Camino Vera S-N, E-46022 Valencia, Spain.	jopolu@disca.upv.es	Poza-Lujan, Jose-Luis/ACY-9738-2022; Corchado Rodríguez, Juan/D-3229-2013; Arango, Jaime Andres Rincon/P-7179-2019; Carrascosa, Carlos/L-5463-2013; Poza-Lujan, Jose-Luis/AAU-8915-2021; Julian, Vicente/K-6029-2013; Posadas-Yague, Juan-Luis/P-2871-2014	Corchado Rodríguez, Juan/0000-0002-2829-1829; Arango, Jaime Andres Rincon/0000-0003-1153-0616; Carrascosa, Carlos/0000-0003-3649-6530; Poza-Lujan, Jose-Luis/0000-0003-2450-9920; Julian, Vicente/0000-0002-2743-6037; Posadas-Yague, Juan-Luis/0000-0002-5017-8689	COST Action [IC0801]; FPI grant [AP2013-01276 548];  [TIN2009-13839-C03-01];  [TIN2011-27652-C03-01];  [547CSD2007-00022];  [FP7-294931]	COST Action(European Cooperation in Science and Technology (COST)); FPI grant; ; ; ; 	This work is partially supported by the TIN2009-13839-C03-01, TIN2011-27652-C03-01, 547CSD2007-00022, COST Action IC0801, FP7-294931 and the FPI grant AP2013-01276 548 awarded to Jaime-Andres Rincon.	Anastassakis G., 2001, KI 2001: Advances in Artificial Intelligence. Joint German/ Austrian Conference on AI. Proceedings (Lecture Notes in Artificial Intelligence Vol.2174), P381; Andreoli R, 2005, Ninth International Conference on Information Visualisation, Proceedings, P515, DOI 10.1109/IV.2005.64; [Anonymous], AGENTS GAMES SIMULAT, DOI DOI 10.1007/978-3-642-18181-8_; Barbero A, 2007, EUROPEAN SIMULATION; Barella A, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY (IAT 2007), P532, DOI 10.1109/IAT.2007.10; Barella A, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P237; Barella A., 2012, 10 EUROPEAN WORKSHOP, P16; Barella A, 2009, IEEE T EDUC, V52, P228, DOI 10.1109/TE.2008.925764; Behrens TM, 2011, ANN MATH ARTIF INTEL, V61, P261, DOI 10.1007/s10472-010-9215-9; Bordini R., 2007, PROGRAMMING MULTIAGE; Castrillon-Santana M, 2014, REV IBEROAM AUTOM IN, V11, P348, DOI 10.1016/j.riai.2014.05.006; Chong CY, 2003, P IEEE, V91, P1247, DOI 10.1109/JPROC.2003.814918; Compton M, 2012, J WEB SEMANT, V17, P25, DOI 10.1016/j.websem.2012.05.003; Cook DJ, 2007, PERVASIVE MOB COMPUT, V3, P53, DOI 10.1016/j.pmcj.2006.12.001; Corchado E, 2014, NEUROCOMPUTING, V126, P1, DOI 10.1016/j.neucom.2013.07.001; Dignum F, 2012, AUTON AGENT MULTI-AG, V24, P217, DOI 10.1007/s10458-011-9169-2; Dimuro GP, 2008, INTERVAL VALUED HIDD; dos Santos C. T., 2004, Proceedings of the 28th Annual International Computer Software and Applications Conference. COMPSAC 2004, P468; Edle MJS, 2011, INT J ENTERPRISE COM, V1, P1; Fenfen Cheng, 2013, Advanced Materials Research, V722, P397, DOI 10.4028/www.scientific.net/AMR.722.397; Garca-Pardo JA, 2011, LECT NOTES ARTIF INT, V6973, P29, DOI 10.1007/978-3-642-24603-6_5; Gelernter D., 1993, MIRROR WORLDS DAY SO; Go CAL, 2007, ADV SOFT COMP, V41, P677, DOI 10.1007/978-3-540-72432-2_68; Gonzalez-Jorge H, 2013, MEASUREMENT, V46, P1800, DOI 10.1016/j.measurement.2013.01.011; Guinard D, 2011, ARCHITECTING THE INTERNET OF THINGS, P97; Jia L., 2007, IEEE INT WORKSH HAPT, P90, DOI [DOI 10.1109/HAVE.2007.4371594, 10.1109/HAVE.2007.4371594]; Kavitha R, INT J SCI RES IJSR, P2319; Kazemi A, 2009, INT J ADV MANUF TECH, V44, P180, DOI 10.1007/s00170-008-1826-5; Kushner D., 2011, IEEE SPECTRUM, V26; Leccese F, 2014, SENSORS-BASEL, V14, P24408, DOI 10.3390/s141224408; Lidoris G, 2006, SPRINGER TRAC ADV RO, V22, P15; Luck M, 2000, APPL ARTIF INTELL, V14, P3, DOI 10.1080/088395100117142; Mago VK, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1396; Mateevitsi V., 2013, P 4 AUGMENTED HUMAN, P51, DOI DOI 10.1145/2459236.2459246; Munera Eduardo, 2015, International Journal of Imaging and Robotics, V15, P117; Munera E, 2015, SENSORS-BASEL, V15, P18080, DOI 10.3390/s150818080; Omicini A, 2008, AUTON AGENT MULTI-AG, V17, P432, DOI 10.1007/s10458-008-9053-x; Pan MS, 2008, IEEE SENS J, V8, P1710, DOI 10.1109/JSEN.2008.2004294; Papoutsidakis Michail, 2014, WSEAS Transactions on Systems, V13, P242; Ranathunga S., 2011, AAMAS, P1181; Rehman SU, 2011, COMM COM INF SC, V257, P11; Ricci A., 2007, 5 INT WORKSH PROGR M, P54; Ricci A., 2007, P 6 INT JOINT C AUT, P150; Ricci A, 2008, LECT NOTES ARTIF INT, V4908, P89; Richardson L., 2013, RESTFUL WEB APIS; Rincon JA, 2015, ADV INTELL SYST, V368, P203, DOI 10.1007/978-3-319-19719-7_18; Rincon JA, 2015, COMM COM INF SC, V524, P377, DOI 10.1007/978-3-319-19033-4_33; Roncancio C, 2010, ADV INTELL SOFT COMP, V71, P623; Salzmann C., 2013, 4 IEEE GLOB ENG ED C; Sanchis A, 2014, WIHAS 14 INTELLIGENT, P1; Schmidt A, 2001, IEEE PERS COMMUN, V8, P66, DOI 10.1109/98.944006; Surakul K, 2015, INFORM TECHNOLOGY J, V11; Tian J, 2003, LECT NOTES ARTIF INT, V2831, P85; Upton Eben, 2014, RASPBERRY PI USER GU; Van Oijen J., 2011, AGENTS GAMES SIMULAT, P38; Villarrubia G, 2014, SENSORS-BASEL, V14, P13955, DOI 10.3390/s140813955; Wozniak M, 2014, INFORM FUSION, V16, P3, DOI 10.1016/j.inffus.2013.04.006; Yoder M. A., 2015, BEAGLEBONE COOKBOOK; Yu C.-H., 2008, IROS 2008 WORKSH SEL; Yu CH, 2011, INT J ROBOT RES, V30, P1015, DOI 10.1177/0278364910384753	60	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149665	10.1371/journal.pone.0149665	http://dx.doi.org/10.1371/journal.pone.0149665			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926691	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200014
J	Ball, MS; Shipman, EP; Kim, H; Liby, KT; Pioli, PA				Ball, Michael S.; Shipman, Emilie P.; Kim, Hyunjung; Liby, Karen T.; Pioli, Patricia A.			CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages	PLOS ONE			English	Article							HUMAN MONOCYTES; METHYL ESTER; CANCER; RECEPTOR; POLARIZATION; PROGRESSION; EXPRESSION; PLASTICITY; BLOCKS; CELLS	Tumor-associated macrophages can account for up to 50% of the tumor mass in breast cancer patients and high TAM density is associated with poor clinical prognosis. Because TAMs enhance tumor growth, development, and metastatic potential, redirection of TAM activation may have significant therapeutic benefit. Our studies in primary human macrophages and murine breast TAMs suggest that the synthetic oleanane triterpenoid CDDO-methyl ester (CDDO-Me) reprograms the activation profile of TAMs from tumor-promoting to tumor-inhibiting. We show that CDDO-Me treatment inhibits expression of IL-10 and VEGF in stimulated human M2 macrophages and TAMs but increases expression of TNF-alpha and IL-6. Surface expression of CD206 and CD163, which are characteristic of M2 activation, is significantly attenuated by CDDO-Me. In contrast, CDDO-Me up-regulates surface expression of HLA-DR and CD80, which are markers of M1 activation, and importantly potentiates macrophage activation of autologous T cells but inhibits endothelial cell vascularization. These results show for the first time that CDDO-Me redirects activation of M2 macrophages and TAMs from immune-suppressive to immune-stimulatory, and implicate a role for CDDO-Me as an immunotherapeutic in the treatment of breast and potentially other types of cancer.	[Ball, Michael S.; Shipman, Emilie P.; Kim, Hyunjung; Pioli, Patricia A.] Geisel Sch Med, Dept Obstet & Gynecol, Lebanon, NH USA; [Liby, Karen T.] Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA	Dartmouth College; Dartmouth College	Pioli, PA (corresponding author), Geisel Sch Med, Dept Obstet & Gynecol, Lebanon, NH USA.	Pioli@Dartmouth.edu		Liby, Karen/0000-0003-3317-3437	Centers of Biomedical Research Excellence (COBRE) from the Dartmouth Clinical and Translational Science Institute [P20 RR 016437]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR001086]; Reata Pharmaceuticals, Inc.; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence (COBRE) from the Dartmouth Clinical and Translational Science Institute; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Reata Pharmaceuticals, Inc.; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Centers of Biomedical Research Excellence (COBRE) P20 RR 016437 Pilot Project Grant (to KTL and PAP), Pilot Project funding (to KTL and PAP) from the Dartmouth Clinical and Translational Science Institute, under award number UL1TR001086 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), Reata Pharmaceuticals, Inc. (to KTL) and the Breast Cancer Research Foundation (to KTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bynum JA, 2015, PHARMACOLOGY, V95, P181, DOI 10.1159/000381188; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Chen WC, 2013, INTERLEUKIN 17 PRODU, DOI [10.1111/his.12156, DOI 10.1111/HIS.12156]; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Duluc D, 2007, BLOOD; Espey MG, 2006, FREE RADICAL BIO MED, V41, P1621, DOI 10.1016/j.freeradbiomed.2006.08.026; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110378; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He ZS, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-86; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin EY, 2003, PROGR MALIGNANCY POL; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2013, ARTERIOSCL THROM VAS, V33, P1478, DOI 10.1161/ATVBAHA.113.300168; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Meyer T, 2008, EXPERT OPIN INV DRUG, V17, P1051, DOI [10.1517/13543784.17.7.1051, 10.1517/13543784.17.7.1051 ]; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rego SL, 2014, ANGIOGENESIS, V17, P573, DOI 10.1007/s10456-013-9405-2; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Schmittel A, 1995, SCAND J IMMUNOL, V42, P701, DOI 10.1111/j.1365-3083.1995.tb03714.x; Scotton C, 2001, BRIT J CANCER, V85, P891, DOI 10.1054/bjoc.2001.2020; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2000, AUTOCRINE PRODUCTION, DOI [10.4049/jimmunol.164.2.762, DOI 10.4049/JIMMUNOL.164.2.762]; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Solinas G, 2009, TUMOR ASS MACROPHAGE; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110; Tsutsui S, 2005, ONCOL REP, V14, P425; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096; Weiss M, 2013, IRF5 IS SPECIFIC MAR; Yang C, 2010, SPINE, V35, P1668, DOI 10.1097/BRS.0b013e3181c2d2b4; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	66	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149600	10.1371/journal.pone.0149600	http://dx.doi.org/10.1371/journal.pone.0149600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918785	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400027
J	de Leng, WWJ; Gadellaa-van Hooijdonk, CG; Barendregt-Smouter, FAS; Koudijs, MJ; Nijman, I; Hinrichs, JWJ; Cuppen, E; van Lieshout, S; Loberg, RD; de Jonge, M; Voest, EE; de Weger, RA; Steeghs, N; Langenberg, MHG; Sleijfer, S; Willems, SM; Lolkema, MP				de Leng, Wendy W. J.; Gadellaa-van Hooijdonk, Christa G.; Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Hinrichs, John W. J.; Cuppen, Edwin; van Lieshout, Stef; Loberg, Robert D.; de Jonge, Maja; Voest, Emile E.; de Weger, Roel A.; Steeghs, Neeltje; Langenberg, Marlies H. G.; Sleijfer, Stefan; Willems, Stefan M.; Lolkema, Martijn P.			Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material	PLOS ONE			English	Article							CLINICALLY RELEVANT MUTATIONS; BURROWS-WHEELER TRANSFORM; CELL LUNG-CANCER; ION TORRENT; COLORECTAL-CANCER; READ ALIGNMENT; VALIDATION; PLATFORMS; ACCURATE; EGFR	Background Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple genetic aberrations in diagnostic pathology practice, which is necessary for personalized cancer treatment. However, no standards regarding input material have been defined. This study therefore aimed to determine the effect of the type of input material (e.g. formalin fixed paraffin embedded (FFPE) versus fresh frozen (FF) tissue) on NGS derived results. Moreover, this study aimed to explore a standardized analysis pipeline to support consistent clinical decision-making. Method We used the Ion Torrent PGM sequencing platform in combination with the Ion AmpliSeq Cancer Hotspot Panel v2 to sequence frequently mutated regions in 50 cancer related genes, and validated the NGS detected variants in 250 FFPE samples using standard diagnostic assays. Next, 386 tumour samples were sequenced to explore the effect of input material on variant detection variables. For variant calling, Ion Torrent analysis software was supplemented with additional variant annotation and filtering. Results Both FFPE and FF tissue could be sequenced reliably with a sensitivity of 99.1%. Validation showed a 98.5% concordance between NGS and conventional sequencing techniques, where NGS provided both the advantage of low input DNA concentration and the detection of low-frequency variants. The reliability of mutation analysis could be further improved with manual inspection of sequence data. Conclusion Targeted NGS can be reliably implemented in cancer diagnostics using both FFPE and FF tissue when using appropriate analysis settings, even with low input DNA.	[de Leng, Wendy W. J.; Hinrichs, John W. J.; de Weger, Roel A.; Willems, Stefan M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Gadellaa-van Hooijdonk, Christa G.; Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Cuppen, Edwin; van Lieshout, Stef; de Jonge, Maja; Steeghs, Neeltje; Langenberg, Marlies H. G.; Sleijfer, Stefan; Willems, Stefan M.; Lolkema, Martijn P.] Netherlands Ctr Personalized Canc Treatment, Utrecht, Netherlands; [Gadellaa-van Hooijdonk, Christa G.; Langenberg, Marlies H. G.; Lolkema, Martijn P.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands; [Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Cuppen, Edwin; van Lieshout, Stef] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Voest, Emile E.; Steeghs, Neeltje] Netherlands Canc Inst, Dept Med Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Loberg, Robert D.] Amgen Inc, Med Sci, Thousand Oaks, CA 91320 USA; [de Jonge, Maja; Sleijfer, Stefan; Lolkema, Martijn P.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; [de Jonge, Maja; Sleijfer, Stefan; Lolkema, Martijn P.] Canc Genom Netherlands, NL-3075 EA Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Amgen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Lolkema, MP (corresponding author), Netherlands Ctr Personalized Canc Treatment, Utrecht, Netherlands.; Lolkema, MP (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands.; Lolkema, MP (corresponding author), Erasmus MC Canc Inst, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands.; Lolkema, MP (corresponding author), Canc Genom Netherlands, NL-3075 EA Rotterdam, Netherlands.	m.lolkema@erasmusmc.nl	Steeghs, Neeltje/GQH-3468-2022; Cuppen, Edwin/F-5696-2011; Lolkema, M.P./AAE-2906-2019; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Lolkema, M.P./0000-0003-0466-2928; Cuppen, Edwin/0000-0002-0400-9542	Barcode for Life; Stichting NutsOhra; Amgen	Barcode for Life; Stichting NutsOhra; Amgen(Amgen)	Funded by Barcode for Life (www.barcodeforlife.nl) and Stichting NutsOhra (www.fondsnutsohra.nl). These funders only contributed financially for benchfee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amgen provided support in the form of salaries for RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belardinilli F, 2015, CLIN BIOCHEM, V48, P908, DOI 10.1016/j.clinbiochem.2015.04.003; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gleeson FC, 2015, CLIN GASTROENTEROL H, V13, P202, DOI 10.1016/j.cgh.2014.06.024; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hinrichs JWJ, 2015, AM J CLIN PATHOL, V143, P573, DOI 10.1309/AJCP40XETVYAMJPY; Hoogstraat M, 2015, J MOL DIAGN, V17, P10, DOI 10.1016/j.jmoldx.2014.09.004; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Johnson DB, 2014, ONCOLOGIST, V19, P616, DOI 10.1634/theoncologist.2014-0011; Latham GJ, 2013, EXPERT REV MOL DIAGN, V13, P769, DOI 10.1586/14737159.2013.845090; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mafficini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104979; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Malapelle U, 2015, J CLIN PATHOL, V68, P64, DOI 10.1136/jclinpath-2014-202691; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Portier BP, 2014, AM J CLIN PATHOL, V141, P559, DOI 10.1309/AJCP1JUGQMW7ZNTL; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Smits AJJ, 2014, MODERN PATHOL, V27, P168, DOI 10.1038/modpathol.2013.134; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025	40	66	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149405	10.1371/journal.pone.0149405	http://dx.doi.org/10.1371/journal.pone.0149405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919633	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400021
J	Fan, YJ; Li, XS; Zhang, Y; Fan, XF; Zhang, N; Zheng, H; Song, YP; Shen, CF; Shen, JY; Ren, FD; Yang, JL				Fan, Yujuan; Li, Xuesong; Zhang, Yu; Fan, Xiaofang; Zhang, Ning; Zheng, Hui; Song, Yuping; Shen, Chunfang; Shen, Jiayi; Ren, Fengdong; Yang, Jialin			Genetic Variants of TPCN2 Associated with Type 2 Diabetes Risk in the Chinese Population	PLOS ONE			English	Article							DINUCLEOTIDE PHOSPHATE NAADP; PANCREATIC BETA-CELLS; ION CHANNELS; 2-PORE; INVOLVEMENT; CALCIUM; LINKAGE; MICE	Objective The aim of this study was to determine whether TPCN2 genetic variants are associated with type 2 diabetes and to elucidate which variants in TPCN2 confer diabetes susceptibility in the Chinese population. Research Design and Methods The sample population included 384 patients with type 2 diabetes and 1468 controls. Anthropometric parameters, glycemic and lipid profiles and insulin resistance were measured. We selected 6 TPCN2 tag single nucleotide polymorphisms (rs35264875, rs267603153, rs267603154, rs3829241, rs1551305, and rs3750965). Genotypes were determined using a Sequenom MassARRAY SNP genotyping system. Results Ultimately, we genotyped 3 single nucleotide polymorphisms (rs3750965, rs3829241, and rs1551305) in all individuals. There was a 5.1% higher prevalence of the rs1551305 variant allele in type 2 diabetes individuals (A) compared with wild-type homozygous individuals (G). The AA genotype of rs1551305 was associated with a higher diabetes risk (p<0.05). The distributions of rs3829241 and rs3750965 polymorphisms were not significantly different between the two groups. HOMA-%B of subjects harboring the AA genotype of rs1551305 decreased by 14.87% relative to the GG genotype. Conclusions TPCN2 plays a role in metabolic regulation, and the rs1551305 single nucleotide polymorphism is associated with type 2 diabetes risk. Future work will begin to unravel the underlying mechanisms.	[Fan, Yujuan; Li, Xuesong; Zhang, Yu; Fan, Xiaofang; Zhang, Ning; Zheng, Hui; Song, Yuping; Shen, Chunfang; Shen, Jiayi; Ren, Fengdong; Yang, Jialin] Fudan Univ, Dept Endocrinol, Cent Hosp Minhang Dist, Minhang Hosp, Shanghai 200433, Peoples R China	Fudan University	Yang, JL (corresponding author), Fudan Univ, Dept Endocrinol, Cent Hosp Minhang Dist, Minhang Hosp, Shanghai 200433, Peoples R China.	jialinyang2002@163.com			Shanghai Science and Technology Development Fund [114119b0400, 15411970700]; Natural Science Research Project of Minhang District, Shanghai [2015MHZ074]; Shanghai Science and Technology Development [114119b0400, 15411970700]	Shanghai Science and Technology Development Fund; Natural Science Research Project of Minhang District, Shanghai; Shanghai Science and Technology Development	Funded by Shanghai Science and Technology Development Fund (114119b0400,15411970700) (Jialin Yang) and Natural Science Research Project of Minhang District, Shanghai(2015MHZ074)(Yujuan Fan).; This study was funded by the grant from Shanghai Science and Technology Development (114119b0400,15411970700) and Natural Science Research Project of Minhang District, Shanghai(2015MHZ074).	Arredouani A, 2015, J BIOL CHEM, V290, P21376, DOI 10.1074/jbc.M115.671248; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Lear PV, 2015, ENDOCRINOLOGY, V156, P975, DOI 10.1210/en.2014-1766; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Shawl AI, 2012, ISLETS, V4, P145, DOI 10.4161/isl.19490; Shawl AI, 2009, ISLETS, V1, P216, DOI 10.4161/isl.1.3.9646; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tsaih SW, 2014, GENETICS, V198, P17, DOI 10.1534/genetics.114.162982; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036	21	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149614	10.1371/journal.pone.0149614	http://dx.doi.org/10.1371/journal.pone.0149614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918892	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400028
J	Moinfar, Z; Dambach, H; Schoenebeck, B; Forster, E; Prochnow, N; Faustmann, PM				Moinfar, Zahra; Dambach, Hannes; Schoenebeck, Bodo; Foerster, Eckart; Prochnow, Nora; Faustmann, Pedro Michael			Estradiol Receptors Regulate Differential Connexin 43 Expression in F98 and C6 Glioma Cell Lines	PLOS ONE			English	Article							GAP-JUNCTION GENES; REPRODUCTIVE FACTORS; ESTROGEN; GROWTH; TUMORS; BETA; ASTROCYTES; APOPTOSIS; PROTEINS; ROLES	Introduction Glioma is the most common malignant primary brain tumour with male preponderance and poor prognosis. Glioma cells express variable amounts of connexin 43 (Cx43) and estrogen receptors (ERs). Both, Cx43 and ERs, play important roles in cell proliferation and migration. Therefore, we investigated the effects of 17-beta estradiol (E2) on Cx43 expression in two glioma cell lines with variable native expression of Cx43. Materials and Methods F98 and C6 rat glioma cells were cultured for 24 h in the presence of 10 nM or 100 nM E2, and the E2-antagonist, Fulvestrant. An MTT assay was performed to evaluate cell viability. ER alpha, ER beta and Cx43 protein expressions were analysed by western blotting and Cx43 mRNA expression was analysed by real-time polymerase chain reaction. To quantify cell migration, an exclusive zone migration assay was used. Functional coupling of cells via gap junctions was examined using whole-cell patch-clamp technique. Results E2 reduced Cx43 expression in C6 cells, but increased Cx43 expression in F98 cultures. These effects were mediated via ERs. Moreover, E2 promoted C6 cell migration, but it did not affect F98 cell migration. The expression level of ER alpha was found to be high in C6, but low in F98 cells. ER beta was exclusively expressed in C6 cells. In addition, E2 treatment induced a significant decrease of ER beta in C6 cultures, while it decreased ER alpha expression in F98 glioma cells. Discussion These findings show that E2 differentially modulates Cx43 expression in F98 and C6 glioma cells, likely due to the differential expression of ERs in each of these cell lines. Our findings point to the molecular mechanisms that might contribute to the gender-specific differences in the malignancy of glioma and could have implications for therapeutic strategies against glioma.	[Moinfar, Zahra; Dambach, Hannes; Schoenebeck, Bodo; Foerster, Eckart; Prochnow, Nora; Faustmann, Pedro Michael] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany; [Moinfar, Zahra; Faustmann, Pedro Michael] Ruhr Univ Bochum, IGSN, D-44801 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Faustmann, PM (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany.; Faustmann, PM (corresponding author), Ruhr Univ Bochum, IGSN, D-44801 Bochum, Germany.	Pedro.m.Faustmann@ruhr-uni-bochum.de	Moinfar, Zahra/AAE-7118-2020		International Graduate School of Neuroscience at Ruhr University Bochum	International Graduate School of Neuroscience at Ruhr University Bochum	This work was performed with funding from International Graduate School of Neuroscience at Ruhr University Bochum.	Anic GM, 2014, J NEURO-ONCOL, V118, P297, DOI 10.1007/s11060-014-1427-0; Barone TA, 2009, J NEURO-ONCOL, V95, P37, DOI 10.1007/s11060-009-9904-6; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruzzone R, 2006, CELL TISSUE RES, V326, P239, DOI 10.1007/s00441-006-0287-0; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; DAHL G, 1981, NATURE, V289, P683, DOI 10.1038/289683a0; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Gilmore W, 1997, J IMMUNOL, V158, P446; Gonzalez-Arenas A, 2012, BBA-MOL CELL RES, V1823, P379, DOI 10.1016/j.bbamcr.2011.11.004; Hinkerohe D, 2011, J NEURO-ONCOL, V103, P479, DOI 10.1007/s11060-010-0456-6; Huang K, 2004, CANCER EPIDEM BIOMAR, V13, P1583; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li WJ, 2013, BRAIN RES, V1503, P97, DOI 10.1016/j.brainres.2013.02.004; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; McKinley BP, 2000, J NEUROSURG, V93, P932, DOI 10.3171/jns.2000.93.6.0932; NAUS CCG, 1991, NEUROSCI LETT, V126, P33, DOI 10.1016/0304-3940(91)90364-Y; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Ul-Hussain M, 2014, J BIOL CHEM, V289, P20979, DOI 10.1074/jbc.M113.540187; Yamasaki H, 1999, CR ACAD SCI III-VIE, V322, P151, DOI 10.1016/S0764-4469(99)80038-9; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200	37	7	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150007	10.1371/journal.pone.0150007	http://dx.doi.org/10.1371/journal.pone.0150007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919293	Green Published, gold			2022-12-26	WOS:000371274400068
J	Sharma, M; Mukhopadhyay, A; Gupta, V; Pental, D; Pradhan, AK				Sharma, Manisha; Mukhopadhyay, Arundhati; Gupta, Vibha; Pental, Deepak; Pradhan, Akshay K.			BjuB.CYP79F1 Regulates Synthesis of Propyl Fraction of Aliphatic Glucosinolates in Oilseed Mustard Brassica juncea: Functional Validation through Genetic and Transgenic Approaches	PLOS ONE			English	Article							SEQ BASED SNPS; CHAIN ELONGATION; BIOSYNTHESIS; EVOLUTION; IDENTIFICATION; OLERACEA; GENOMES; LINES; REVEALS; CYP79F1	Among the different types of methionine-derived aliphatic glucosinolates (GS), sinigrin (2-propenyl), the final product in 3C GS biosynthetic pathway is considered very important as it has many pharmacological and therapeutic properties. In Brassica species, the candidate gene regulating synthesis of 3C GS remains ambiguous. Earlier reports of GSL-PRO, an ortholog of Arabidopsis thaliana gene At1g18500 as a probable candidate gene responsible for 3C GS biosynthesis in B. napus and B. oleracea could not be validated in B. juncea through genetic analysis. In this communication, we report the isolation and characterization of the gene CYP79F1, an ortholog of A. thaliana gene At1g16410 that is involved in the first step of core GS biosynthesis. The gene CYP79F1 in B. juncea showed presence-absence polymorphism between lines Varuna that synthesizes sinigrin and Heera virtually free from sinigrin. Using this presence-absence polymorphism, CYP79F1 was mapped to the previously mapped 3C GS QTL region (J16Gsl4) in the LG B4 of B. juncea. In Heera, the gene was observed to be truncated due to an insertion of a similar to 4.7 kb TE like element leading to the loss of function of the gene. Functional validation of the gene was carried out through both genetic and transgenic approaches. An F-2 population segregating only for the gene CYP79F1 and the sinigrin phenotype showed perfect co-segregation. Finally, genetic transformation of a B. juncea line (QTL-NIL J16Gsl4) having high seed GS but lacking sinigrin with the wild type CYP79F1 showed the synthesis of sinigrin validating the role of CYP79F1 in regulating the synthesis of 3C GS in B. juncea.	[Sharma, Manisha; Pental, Deepak; Pradhan, Akshay K.] Univ Delhi South Campus, Dept Genet, New Delhi, India; [Mukhopadhyay, Arundhati; Gupta, Vibha; Pental, Deepak; Pradhan, Akshay K.] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India	University of Delhi; University of Delhi	Pradhan, AK (corresponding author), Univ Delhi South Campus, Dept Genet, New Delhi, India.; Pradhan, AK (corresponding author), Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India.	pradhancgmcp@gmail.com			National Dairy Development Board (NDDB) [PFA:DU:882]; Department of Biotechnology, Government of India through Centre of Excellence on Brassica breeding [BT/01/COE/08/06-II]; University Grants Commission (UGC), India	National Dairy Development Board (NDDB); Department of Biotechnology, Government of India through Centre of Excellence on Brassica breeding; University Grants Commission (UGC), India(University Grants Commission, India)	The study was funded by the National Dairy Development Board (NDDB) (http://www.nddb.org/) (PF&A:DU:882) and also partly supported by the Department of Biotechnology (http://www.dbtindia.nic.in/), Government of India, through the award of a Centre of Excellence on Brassica breeding (BT/01/COE/08/06-II). MS acknowledges the receipt of research fellowship from the University Grants Commission (UGC) (http://www.ugc.ac.in/), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine R, 2013, PLANT BIOTECHNOL J, V11, P855, DOI 10.1111/pbi.12078; Bhattacharya A, 2010, CARCINOGENESIS, V31, P2105, DOI 10.1093/carcin/bgq202; Bisht NC, 2009, THEOR APPL GENET, V118, P413, DOI 10.1007/s00122-008-0907-z; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Gao MQ, 2006, PLANT CELL REP, V25, P592, DOI 10.1007/s00299-005-0078-1; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gland A, 1981, Z PFLANZENZUECHTUNG, P87; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jagannath A., 2003, PLANT GENETIC ENG, V2, P349; Jie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110145; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P1900, DOI 10.1111/j.1365-3040.2011.02385.x; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Li G, 2003, THEOR APPL GENET, V107, P168, DOI 10.1007/s00122-003-1236-x; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; MAGRATH R, 1994, HEREDITY, V72, P290, DOI 10.1038/hdy.1994.39; Okulicz M, 2010, PLANT FOOD HUM NUTR, V65, P217, DOI 10.1007/s11130-010-0183-3; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Paritosh K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-396; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS446; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Rout K, 2015, THEOR APPL GENET, V128, P657, DOI 10.1007/s00122-015-2461-9; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093260; Sodhi YS, 2002, PLANT BREEDING, V121, P508, DOI 10.1046/j.1439-0523.2002.00747.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2010, PLANT PHYSIOL, V153, P348, DOI 10.1104/pp.109.149286; Sotelo T, 2015, APPL ENVIRON MICROB, V81, P432, DOI 10.1128/AEM.03142-14; Srivastava A, 2001, THEOR APPL GENET, V102, P193, DOI 10.1007/s001220051635; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Van Ooijen JW, 2006, JOINMAP 4 SOFTWARE C, P33; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang TX, 2012, KOREAN J CHEM ENG, V29, P396, DOI 10.1007/s11814-011-0175-5; Yang JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-107	44	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150060	10.1371/journal.pone.0150060	http://dx.doi.org/10.1371/journal.pone.0150060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919200	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400080
J	Zhang, XR; Kluz, T; Gesumaria, L; Matsui, MS; Costa, M; Sun, H				Zhang, Xiaoru; Kluz, Thomas; Gesumaria, Lisa; Matsui, Mary S.; Costa, Max; Sun, Hong			Solar Simulated Ultraviolet Radiation Induces Global Histone Hypoacetylation in Human Keratinocytes	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; UV-IRRADIATION; H2AX PHOSPHORYLATION; CHROMATIN-STRUCTURE; HUMAN-CELLS; LYSINE 56; REPAIR; ACETYLATION; PROTEIN	Ultraviolet radiation (UVR) from sunlight is the primary effector of skin DNA damage. Chromatin remodeling and histone post-translational modification (PTM) are critical factors in repairing DNA damage and maintaining genomic integrity, however, the dynamic changes of histone marks in response to solar UVR are not well characterized. Here we report global changes in histone PTMs induced by solar simulated UVR (ssUVR). A decrease in lysine acetylation of histones H3 and H4, particularly at positions of H3 lysine 9, lysine 56, H4 lysine 5, and lysine 16, was found in human keratinocytes exposed to ssUVR. These acetylation changes were highly associated with ssUVR in a dose-dependent and time-specific manner. Interestingly, H4K16ac, a mark that is crucial for higher order chromatin structure, exhibited a persistent reduction by ssUVR that was transmitted through multiple cell divisions. In addition, the enzymatic activities of histone acetyltransferases were significantly reduced in irradiated cells, which may account for decreased global acetylation. Moreover, depletion of histone deacetylase SIRT1 in keratinocytes rescued ssUVR-induced H4K16 hypoacetylation. These results indicate that ssUVR affects both HDAC and HAT activities, leading to reduced histone acetylation.	[Zhang, Xiaoru; Kluz, Thomas; Gesumaria, Lisa; Costa, Max; Sun, Hong] New York Univ, Dept Environm Med, Tuxedo Pk, NY USA; [Matsui, Mary S.] Estee Lauder Co Inc, Melville, NY USA	New York University; Estee Lauder Companies	Costa, M; Sun, H (corresponding author), New York Univ, Dept Environm Med, Tuxedo Pk, NY USA.	Max.Costa@nyumc.org; Hong.Sun@nyumc.org			NIH [R03 ES023028, P30 ES000260]; Estee Lauder Companies, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES023028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estee Lauder Companies, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant number R03 ES023028, to HS, XZ; NIH grant number P30 ES000260, to MC. This work was partially funded by Estee Lauder Companies, Inc., which provided the solar simulated UV radiation instrument. Author Mary S. Matsui is employed by Estee Lauder Companies, Inc. Estee Lauder Companies, Inc. provided support in the form of salary for author MSM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Athar M, 2000, BIOCHEM BIOPH RES CO, V277, P107, DOI 10.1006/bbrc.2000.3436; Bartova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027281; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Farrell AW, 2011, INT J MOL SCI, V12, P8063, DOI 10.3390/ijms12118063; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Fullgrabe J, 2014, AUTOPHAGY, V10, P556, DOI 10.4161/auto.27280; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gesumaria L, 2015, EXP DERMATOL, V24, P384, DOI 10.1111/exd.12675; Gospodinov A, 2013, MUTAT RES-REV MUTAT, V752, P45, DOI 10.1016/j.mrrev.2012.10.001; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hiraoka N, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.66; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Luijsterburg MS, 2011, MOL ONCOL, V5, P349, DOI 10.1016/j.molonc.2011.06.001; Maroschik B, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-15; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sustackova G, 2012, J CELL PHYSIOL, V227, P1838, DOI 10.1002/jcp.22912; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Yang W, 2011, PROTEIN SCI, V20, P1781, DOI 10.1002/pro.723; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150175	10.1371/journal.pone.0150175	http://dx.doi.org/10.1371/journal.pone.0150175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918332	Green Published, gold			2022-12-26	WOS:000371274400097
J	Zhao, Y; Zhang, XL; Chen, JZ; Lin, C; Shao, RF; Yan, CX; Chen, C				Zhao, Yan; Zhang, Xinli; Chen, Jiezhong; Lin, Chao; Shao, Renfu; Yan, Chunxia; Chen, Chen			Hexarelin Protects Rodent Pancreatic B-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling Pathways In Vivo and In Vitro	PLOS ONE			English	Article							BETA-CELLS; INSULIN-SECRETION; GLUCOSE-HOMEOSTASIS; GHRELIN RECEPTOR; APOPTOSIS; DYSFUNCTION; RAT; METABOLISM; ABLATION; MODEL	Mitochondrial functions are crucial for pancreatic beta-cell survival and glucose-induced insulin secretion. Hexarelin (Hex) is a synthetic small peptide ghrelin analogue, which has been shown to protect cardiomyocytes from the ischemia-reperfusion process. In this study, we used in vitro and in vivo models of streptozotocin (STZ)-induced beta-cell damage to study the protective effect of Hex and the associated mechanisms. We found that STZ produced a cytotoxic effect in a dose-and time-dependent manner in MIN6 cells (a mouse beta-cell line). Hex (1.0 mu M) decreased the STZ-induced damage in beta-cells. Rhodamine 123 assay and superoxide DHE production assay revealed that Hex ameliorated STZ-induced mitochondrial damage and excessive superoxide activity in beta-cells. In addition, Hex significantly reduced STZ-induced expression of cleaved Caspases-3, Caspases-9 and the ratio of proapoptotic protein Bax to anti-apoptotic protein Bcl-2 in MIN6 cells. We further examined the in vivo effect of Hex in a rat model of type 1 diabetes induced by STZ injection. Hex ameliorated STZ-induced decrease in plasma insulin and protected the structure of islets from STZ-induced disruption. Hex also ameliorated STZ-induced expression of cleaved Caspase-9 and the Bax in beta-cells. In conclusion, our data indicate that Hex is able to protects beta-cell mass from STZ-caused cytotoxic effects involving mitochondrial pathways in vitro and in vivo. Hex may serve as a potential protective agent for the management of diabetes.	[Zhao, Yan] Xian Med Univ, Inst Basic Med Sci, Xian, Peoples R China; [Zhao, Yan; Yan, Chunxia] Xi An Jiao Tong Univ, Dept Forens Sci, Sch Med, Xian 710049, Peoples R China; [Zhao, Yan; Zhang, Xinli; Chen, Jiezhong; Lin, Chao; Chen, Chen] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Shao, Renfu] Univ Sunshine Coast, Gene Cology Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Xi'an Medical University; Xi'an Jiaotong University; University of Queensland; University of the Sunshine Coast	Chen, C (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	chen.chen@uq.edu.au	CHEN, CHEN/HDM-6657-2022; Chen, Chen/B-4284-2010; chen, chen/GRY-7085-2022	Chen, Chen/0000-0003-2104-534X; Chen, Jiezhong/0000-0003-1977-6143; Shao, Renfu/0000-0002-1686-4968	NHMRC; University of Queensland; National Nature Science Foundation of China (NSFC) [81501175]; Leading Disciplines Development Government Foundation of Shaanxi, China; overseas postgraduate research scholarship from the China Scholarship Council (CSC)	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Leading Disciplines Development Government Foundation of Shaanxi, China; overseas postgraduate research scholarship from the China Scholarship Council (CSC)	Research work was supported by NHMRC, the University of Queensland, the National Nature Science Foundation of China (NSFC grant no. 81501175) and the Leading Disciplines Development Government Foundation of Shaanxi, China. YZ is a recipient of overseas postgraduate research scholarship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunachalam K, 2013, J ETHNOPHARMACOL, V147, P302, DOI 10.1016/j.jep.2013.03.004; Bando M, 2013, AM J PHYSIOL-ENDOC M, V305, pE140, DOI 10.1152/ajpendo.00112.2013; Chabot F, 2014, WORLD J DIABETES, V5, P328, DOI 10.4239/wjd.v5.i3.328; Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054374; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Ortiz MD, 2013, NEUROCHEM RES, V38, P2570, DOI 10.1007/s11064-013-1172-3; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; Egro FM, 2013, J MOL ENDOCRINOL, V51, pR1, DOI 10.1530/JME-13-0067; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Ghasemi A, 2014, ACTA PHYSIOL HUNG, V101, P408, DOI 10.1556/APhysiol.101.2014.4.2; Gimenez-Cassina A, 2015, TRENDS ENDOCRIN MET, V26, P165, DOI 10.1016/j.tem.2015.02.004; Ginter E, 2013, ADV EXP MED BIOL, V771, P35; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Hosoda H, 2006, J PHARMACOL SCI, V100, P398, DOI 10.1254/jphs.CRJ06002X; Jian L, 2013, HORM METAB RES, V45, P561, DOI 10.1055/s-0033-1341500; Jimenez-Gonzalez M, 2013, DIABETOLOGIA, V56, P838, DOI 10.1007/s00125-012-2822-8; JOHANSSON EB, 1978, ACTA ENDOCRINOL-COP, V89, P339, DOI 10.1530/acta.0.0890339; Kumar S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-95; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lightfoot YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020617; Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802; Lin CY, 2012, CYTOKINE, V59, P65, DOI 10.1016/j.cyto.2012.04.011; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Liu L, 2010, GROWTH FACTORS, V28, P370, DOI 10.3109/08977194.2010.504721; Ma XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE422, DOI 10.1152/ajpendo.00576.2011; Ma Y, 2012, ENDOCRINOLOGY, V153, P5480, DOI 10.1210/en.2012-1404; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035265; Mao YJ, 2014, J GERIATR CARDIOL, V11, P253, DOI 10.11909/j.issn.1671-5411.2014.03.007; Maric G, 2014, ACTA PHYSIOL HUNG, V101, P395, DOI 10.1556/APhysiol.101.2014.4.1; McGill JB, 2012, CURR DIABETES REV, V8, P257, DOI 10.2174/157339912800840541; Mohan V, 2004, J Assoc Physicians India, V52, P468; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Scully Tony, 2012, Nature, V485, pS2; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Wierup N, 2013, J MOL ENDOCRINOLOGY; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhang ZF, 2011, EUR J PHARMACOL, V670, P311, DOI 10.1016/j.ejphar.2011.08.033; Zhao YF, 2010, ENDOCRINE, V37, P76, DOI 10.1007/s12020-009-9275-y	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149730	10.1371/journal.pone.0149730	http://dx.doi.org/10.1371/journal.pone.0149730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918825	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400041
J	Guedes, RNC; Yack, JE				Guedes, Raul Narciso C.; Yack, Jayne E.			Shaking Youngsters and Shaken Adults: Female Beetles Eavesdrop on Larval Seed Vibrations to Make Egg-Laying Decisions	PLOS ONE			English	Article							CALLOSOBRUCHUS-MACULATUS COLEOPTERA; AZUKI-BEAN WEEVIL; COWPEA WEEVIL; OVIPOSITION DECISIONS; F COLEOPTERA; BEHAVIOR; COMPETITION; BRUCHIDAE; DISCRIMINATION; CHINENSIS	Egg-laying decisions are critical for insects, and particularly those competing for limited resources. Sensory information used by females to mediate egg-laying decisions has been reported to be primarily chemical, but the role of vibration has received little attention. We tested the hypothesis that vibrational cues produced by feeding larvae occupying a seed influences egg-laying decisions amongst female cowpea beetles. This hypothesis is supported by three lines of evidence using two strains of the cowpea beetle (Callosobruchus maculatus), an Indian strain with choosy females and aggressively competing larvae and a Brazilian strain with less choosy females and larvae exhibiting an "accommodating" type of competition. First, in free-choice bioassays of seed selection, choosy Indian females selected control seeds (free of eggs, larvae, or egg-laying marker) over seeds with live larvae (free of eggs and egg-laying marker), but did not discriminate between control seeds and those with dead larvae. In contrast, less choosy Brazilian females showed no preference for seeds containing live or dead larvae over controls. Second, laser-doppler vibrometer recordings confirmed that larvae feeding inside seeds generate vibrations that are available to the female during egg-laying decisions. Third, during dichotomous choice experiments where artificial vibrations approximating those produced by feeding larvae were played back during seed selection, Indian females preferred immobile control seeds over vibrating seeds, but Brazilian females showed no preference. These results support the hypothesis that females use larval vibrations in their egg-laying decisions; whether these vibrations are passive cues exploited by the female, or active signals that 'steer' the behaviour of the female is unknown. We propose that vibration cues and signals could be important for host selection in insects, particularly those laying on substrates where visual or chemical cues may be unreliable. This seems to be the case with females of the cowpea beetle since visual cues are not important and chemical egg-marking does not last more than two weeks, allowing vibration cues to improve discrimination of egg-laying substrate particularly by choosy females.	[Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Guedes, Raul Narciso C.; Yack, Jayne E.] Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada	Universidade Federal de Vicosa; Carleton University	Yack, JE (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	jayneyack@cunet.carleton.ca	Guedes, Raul Narciso Carvalho/L-3924-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549	Natural Sciences and Engineering Research Council of Canada (NSERC) [261847-2007]; Canadian Foundation for Innovation (CFI) [9555]; National Council of Scientific and Technological Development (CNPq) [PDE016 301847-2015]; Minas Gerais State Foundation of Research Aid (FAPEMIG) [CAG-201234]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC), grant no: 261847-2007 (URL: http://www.nserc-crsng.gc.ca/index_eng.asp); Canadian Foundation for Innovation (CFI), grant no: 9555 (URL: http://www.innovation.ca/); National Council of Scientific and Technological Development (CNPq), grant no: PDE016 301847-2015 (URL: www.cnpq.br); and Minas Gerais State Foundation of Research Aid (FAPEMIG), grant no: CAG-201234 (URL: www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STUDYING VIBRATIONAL; BELLOWS TS, 1982, J ANIM ECOL, V51, P263, DOI 10.2307/4324; Clotuche G, 2013, BEHAV PROCESS, V92, P24, DOI 10.1016/j.beproc.2012.09.014; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cope JM, 2003, J STORED PROD RES, V39, P355, DOI 10.1016/S0022-474X(02)00028-0; Crediland PF, 1986, J ECON ENTOMOL, V11, P41; CREDLAND PF, 1987, J STORED PROD RES, V23, P31, DOI 10.1016/0022-474X(87)90033-6; CREDLAND PF, 1990, PHYSIOL ENTOMOL, V15, P285, DOI 10.1111/j.1365-3032.1990.tb00517.x; Devereau AD, 2003, J STORED PROD RES, V39, P117, DOI 10.1016/S0022-474X(02)00025-5; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; Fricke C, 2004, J EVOLUTION BIOL, V17, P1345, DOI 10.1111/j.1420-9101.2004.00757.x; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Guedes RNC, 2007, AUSTRAL ECOL, V32, P697, DOI 10.1111/j.1442-9993.2007.01769.x; Guedes RNC, 2008, PHYSIOL ENTOMOL, V33, P372, DOI 10.1111/j.1365-3032.2008.00643.x; Guedes RNC, 2003, PHYSIOL ENTOMOL, V28, P298, DOI 10.1111/j.1365-3032.2003.00347.x; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Horng SB, 1999, RES POPUL ECOL, V41, P283, DOI 10.1007/s101440050033; Horng SB, 1997, ANIM BEHAV, V53, P1, DOI 10.1006/anbe.1996.9999; Ignacimuthu S, 2000, ENTOMOL EXP APPL, V96, P213, DOI 10.1023/A:1004016127866; Jeram S, 1996, TISSUE CELL, V28, P227, DOI 10.1016/S0040-8166(96)80011-5; Messina FJ, 2004, ECOL ENTOMOL, V29, P318, DOI 10.1111/j.1365-2311.2004.0599.x; MESSINA FJ, 1991, ECOL ENTOMOL, V16, P509, DOI 10.1111/j.1365-2311.1991.tb00243.x; MESSINA FJ, 1989, J INSECT BEHAV, V2, P727, DOI 10.1007/BF01049397; MESSINA FJ, 1985, ECOL ENTOMOL, V10, P225, DOI 10.1111/j.1365-2311.1985.tb00552.x; MESSINA FJ, 1985, ENTOMOL EXP APPL, V37, P241, DOI 10.1007/BF00191655; MESSINA FJ, 1987, ENTOMOL EXP APPL, V43, P169, DOI 10.1007/BF00301748; MESSINA FJ, 1993, ANN ENTOMOL SOC AM, V86, P207, DOI 10.1093/aesa/86.2.207; MESSINA FJ, 1987, J CHEM ECOL, V13, P219, DOI 10.1007/BF01020364; Messina FJ, 2014, ENTOMOL EXP APPL, V153, P231, DOI 10.1111/eea.12244; Messina FJ, 2013, ANN ENTOMOL SOC AM, V106, P128, DOI 10.1603/AN12103; Messina FJ, 2009, ANN ENTOMOL SOC AM, V102, P181, DOI 10.1603/008.102.0121; Meyhofer R, 1999, J INSECT PHYSIOL, V45, P967, DOI 10.1016/S0022-1910(99)00060-8; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MITCHELL R, 1975, ECOLOGY, V56, P696, DOI 10.2307/1935504; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; OFUYA T, 1989, ECOL ENTOMOL, V14, P243, DOI 10.1111/j.1365-2311.1989.tb00776.x; OSHIMA K, 1973, AGR BIOL CHEM TOKYO, V37, P2679, DOI 10.1080/00021369.1973.10861061; Polajnar J, 2015, PEST MANAG SCI, V71, P15, DOI 10.1002/ps.3848; RYOO MI, 1993, ENVIRON ENTOMOL, V22, P1009, DOI 10.1093/ee/22.5.1009; SAS Institute, 2008, SAS STAT US MAN VER; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; Smith R.H., 1985, P423; SMITH RH, 1991, ADV ECOL RES, V21, P63, DOI 10.1016/S0065-2504(08)60097-5; SMITH RH, 1990, SERIES ENTOM, V46, P351; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SOUTHGATE BJ, 1979, ANNU REV ENTOMOL, V24, P449, DOI 10.1146/annurev.en.24.010179.002313; Tanaka Y, 2000, ENTOMOL EXP APPL, V96, P239, DOI 10.1023/A:1004059726050; THANTHIANGA C, 1987, ENTOMOL EXP APPL, V44, P15, DOI 10.1007/BF00361303; Tran BMD, 1995, BIOL J LINN SOC, V56, P483, DOI 10.1111/j.1095-8312.1995.tb01106.x; Tuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106268; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Wang Xiaoyi, 2008, Acta Ecologica Sinica, V28, P1257; WASSERMAN SS, 1985, J ECON ENTOMOL, V78, P89, DOI 10.1093/jee/78.1.89; WILSON K, 1988, ECOL ENTOMOL, V13, P107, DOI 10.1111/j.1365-2311.1988.tb00338.x; Yack J.E., 2016, SPRINGER HDB AUDITOR, V44; Yang RL, 2006, ECOL ENTOMOL, V31, P285, DOI 10.1111/j.1365-2311.2006.00696.x	56	11	11	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150034	10.1371/journal.pone.0150034	http://dx.doi.org/10.1371/journal.pone.0150034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913508	Green Submitted, gold, Green Published			2022-12-26	WOS:000371175700047
J	Jee, YH; Sadowski, SM; Celi, FS; Xi, LQ; Raffeld, M; Sacks, DB; Remaley, AT; Wellstein, A; Kebebew, E; Baron, J				Jee, Youn Hee; Sadowski, Samira M.; Celi, Francesco S.; Xi, Liqiang; Raffeld, Mark; Sacks, David B.; Remaley, Alan T.; Wellstein, Anton; Kebebew, Electron; Baron, Jeffrey			Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer	PLOS ONE			English	Article							FOLLICULAR LESIONS; CELL-GROWTH; MIDKINE MK; EXPRESSION; NODULES; MANAGEMENT; DIAGNOSIS; BENIGN; FAMILY; MOUSE	Background Thyroid nodules are common, and approximately 5% of these nodules are malignant. Pleiotrophin (PTN) is a heparin-binding growth factor which is overexpressed in many cancers. The expression of PTN in papillary thyroid cancer (PTC) is unknown. Method and Findings 74 subjects (age 47 +/- 12 y, 15 males) who had thyroidectomy with a histological diagnosis: 79 benign nodules and 23 PTCs (10 classic, 6 tall cell, 6 follicular variant and 1 undetermined). Fine-needle aspiration (FNA) samples were obtained ex vivo from surgically excised tissue and assayed for PTN and thyroglobulin (Tg). Immunohistochemistry (IHC) was performed on tissue sections. In FNA samples, PTN concentration normalized to Tg was significantly higher in PTC than in benign nodules (16 +/- 6 vs 0.3 +/- 0.1 ng/mg, p < 0.001). In follicular variant of PTC (n = 6), the PTN/Tg ratio was also higher than in benign nodules (1.3 +/- 0.6 vs 0.3 +/- 0.1 ng/mg, P < 0.001, respectively). IHC showed cytoplasmic localization of PTN in PTC cells. Conclusion In ex vivo FNA samples, the PTN to thyroglobulin ratio was higher in PTCs, including follicular variant PTC, than in benign thyroid nodules. The findings raise the possibility that measurement of the PTN to Tg ratio may provide useful diagnostic and/or prognostic information in the evaluation of thyroid nodules.	[Jee, Youn Hee; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Sadowski, Samira M.; Kebebew, Electron] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA; [Celi, Francesco S.] Virginia Commonwealth Univ, Div Endocrinol & Metab, Richmond, VA USA; [Xi, Liqiang; Raffeld, Mark] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sacks, David B.; Remaley, Alan T.] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Wellstein, Anton] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Wellstein, Anton] Lombardi Comprehens Canc Ctr, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Georgetown University	Baron, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA.	jeffrey.baron@nih.gov		Sacks, David/0000-0003-3100-0735	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Center for Cancer Research, National Cancer Institute (NCI); Clinical Center of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICBC011079] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Cancer Research, National Cancer Institute (NCI); Clinical Center of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Center for Cancer Research, National Cancer Institute (NCI), and the Clinical Center of the National Institutes of Health.	Adthapanyawanich K, 2013, ARCH ORAL BIOL, V58, P181, DOI 10.1016/j.archoralbio.2012.09.005; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Ameur N, 2009, ENDOCR-RELAT CANCER, V16, P1261, DOI 10.1677/ERC-08-0289; BELFIORE A, 1989, ACTA ENDOCRINOL-COP, V121, P197, DOI 10.1530/acta.0.1210197; Castro MR, 2005, ANN INTERN MED, V142, P926, DOI 10.7326/0003-4819-142-11-200506070-00011; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Erlandsen H, 2012, J HISTOCHEM CYTOCHEM, V60, P366, DOI 10.1369/0022155412439316; Fuhrer D, 2005, EUR J ENDOCRINOL, V152, P785, DOI 10.1530/eje.1.01912; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Jee YH, 2014, CLIN ENDOCR IN PRESS; Kitano M, 2012, THYROID, V22, P285, DOI 10.1089/thy.2011.0313; Koyama-Nasu R, 2014, ONCOGENE, V33, P2236, DOI 10.1038/onc.2013.168; Mathur A, 2014, SURG CLIN N AM, V94, P499, DOI 10.1016/j.suc.2014.02.005; NAKAMOTO M, 1992, J BIOCHEM-TOKYO, V112, P346, DOI 10.1093/oxfordjournals.jbchem.a123903; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Rossi M, 2015, THYROID, V25, P221, DOI 10.1089/thy.2014.0338; Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x; Sethi G, 2014, MOL CARCINOG IN PRES; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tsirmoula S, 2012, CANCER SCI, V103, P1826, DOI 10.1111/j.1349-7006.2012.02383.x; TSUTSUI J, 1991, BIOCHEM BIOPH RES CO, V176, P792, DOI 10.1016/S0006-291X(05)80255-4; Weber D, 2000, CANCER RES, V60, P5284; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Wu SJ, 2012, DIAGN CYTOPATHOL, V40, pE8, DOI 10.1002/dc.21477	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149383	10.1371/journal.pone.0149383	http://dx.doi.org/10.1371/journal.pone.0149383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914549	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700014
J	Zhu, WY; Hu, FC; Liu, XG; Guo, SC; Tao, Q				Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Guo, Songcan; Tao, Qian			Role of the Accessory Parotid Gland in the Etiology of Parotitis: Statistical Analysis of Sialographic Features	PLOS ONE			English	Article							SALIVARY-GLANDS; RECURRENT PAROTITIS; SIALOLITHIASIS; SIALADENITIS; DIAGNOSIS; FLOW	This retrospective study aimed to identify if the existence of the accessory parotid gland correlated with the etiology of parotitis. This may aid the development of better treatment strategies in the future. Sialographic features of cases with parotitis and healthy subjects were reviewed. The chi-square test was used to compare the incidence of accessory parotid gland between the groups. The Student's t test was used to compare the length of Stensen's duct, the length from the orifice to the confluence of the accessory duct, and the angle between the accessory duct and Stensen's duct between the groups. The incidence of accessory parotid gland in patients with parotitis was 71.8%(28/39), which was significantly higher than that in healthy subjects (P = 0.005). Patients with parotitis had a longer Stensen's duct than healthy subjects (P = 0.003). There was no significant difference in the length from the orifice to the confluence of the accessory duct or the angle between the accessory duct and Stensen's duct (P = 0.136 and 0.511, respectively) between the groups. The accessory parotid gland might play a role in the pathogenesis of parotitis. The existence of an accessory parotid gland is likely to interfere with salivary flow. Computational fluid dynamics analysis of salivary flow in the ductal system would be useful in future etiologic studies on parotitis.	[Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Tao, Qian] Sun Yat Sen Univ, Affiliated Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou 510055, Guangdong, Peoples R China; [Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Tao, Qian] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Guo, Songcan] Sun Yat Sen Univ, Sch Engneering, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tao, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou 510055, Guangdong, Peoples R China.; Tao, Q (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China.	taoqian@mail.sysu.edu.cn	刘, 刘兴光/GPW-6396-2022	zhu, wangyong/0000-0002-4422-5258				Bahadir O, 2004, ANN OTO RHINOL LARYN, V113, P52, DOI 10.1177/000348940411300112; Bodner L, 1993, Compendium, V14, P574; Chitre VV, 1997, ARCH DIS CHILD, V77, P359, DOI 10.1136/adc.77.4.359; Debnath SC, 2015, BRIT J ORAL MAX SURG, V53, P658, DOI 10.1016/j.bjoms.2015.04.009; FERGUSON MM, 1978, ORAL SURG ORAL MED O, V45, P696, DOI 10.1016/0030-4220(78)90143-3; FROMMER J, 1977, ORAL SURG ORAL MED O, V43, P671, DOI 10.1016/0030-4220(77)90049-4; HOLTERMAN HJ, 1990, COLLOID POLYM SCI, V268, P1036, DOI 10.1007/BF01410592; Horsburgh A, 2013, INT J ORAL MAX SURG, V42, P124, DOI 10.1016/j.ijom.2012.10.006; KATZ P, 1991, ANN RADIOL, V34, P110; Koch M, 2005, OTOLARYNG HEAD NECK, V133, P863, DOI 10.1016/j.otohns.2005.08.005; McGurk M, 2005, BRIT J SURG, V92, P107, DOI 10.1002/bjs.4789; Nahlieli O, 2000, LARYNGOSCOPE, V110, P988, DOI 10.1097/00005537-200006000-00020; NICHOLS RD, 1977, LARYNGOSCOPE, V87, P2066; Park MS, 2007, ORAL DIS, V13, P181, DOI 10.1111/j.1601-0825.2006.01263.x; SAUNDERS JR, 1986, SURG CLIN N AM, V66, P59; Stenner M, 2008, EUR ARCH OTO-RHINO-L, V265, P1135, DOI 10.1007/s00405-008-0580-5; Sun GW, 2009, J ORAL MAXIL SURG, V67, P1520, DOI 10.1016/j.joms.2008.12.029; TOH H, 1993, ANAT REC, V236, P586, DOI 10.1002/ar.1092360319; WATKIN GT, 1986, BRIT J SURG, V73, P745, DOI 10.1002/bjs.1800730922; Zhu P, 2014, ORAL DIS, V20, P624, DOI 10.1111/odi.12182	20	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150212	10.1371/journal.pone.0150212	http://dx.doi.org/10.1371/journal.pone.0150212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913509	Green Published, gold			2022-12-26	WOS:000371175700060
J	Hu, J; Yang, ZY; Wang, JB; Yu, J; Guo, J; Liu, SY; Qian, CM; Song, LW; Wu, Y; Cheng, JJ				Hu, Jing; Yang, Zhiyong; Wang, Jinbo; Yu, Jia; Guo, Jing; Liu, Shiying; Qian, Chunmei; Song, Liwen; Wu, Yi; Cheng, Jiajing			Zinc Chloride Transiently Maintains Mouse Embryonic Stem Cell Pluripotency by Activating Stat3 Signaling	PLOS ONE			English	Article							SELF-RENEWAL; DIFFERENTIATION; PHOSPHORYLATION; INVOLVEMENT; EXPRESSION; BIOLOGY; DISEASE; GENOME; MICE; KLF4	An improved understanding of the pluripotency maintenance of embryonic stem (ES) cells is important for investigations of early embryo development and for cell replacement therapy, but the mechanism behind pluripotency is still incompletely understood. Recent findings show that zinc, an essential trace element in humans, is critically involved in regulating various signaling pathways and genes expression. However, its role in ES cell fate determination remains to be further explored. Here we showed that 2 mu M zinc chloride (ZnCl2) transiently maintained mouse ES cell pluripotency in vitro. The cultured mouse ES cells remained undifferentiated under 2 mu M ZnCl2 treatment in leukemia inhibitory factor (LIF) withdrawal, retinoic acid (RA) or embryoid bodies (EBs) differentiation assays. In addition, ZnCl2 increased pluripotency genes expression and inhibited differentiation genes expression. Further mechanistic studies revealed that ZnCl2 transiently activated signal transducers and activators of transcription 3 (Stat3) signaling through promoting Stat3 phosphorylation. Inhibition of Stat3 signaling abrogated the effects of ZnCl2 on mouse ES cell pluripotency. Taken together, this study demonstrated a critical role of zinc in the pluripotency maintenance of mouse ES cells, as well as an important regulator of Stat3 signaling.	[Hu, Jing; Yang, Zhiyong; Wang, Jinbo; Yu, Jia; Guo, Jing; Liu, Shiying; Qian, Chunmei; Song, Liwen; Wu, Yi; Cheng, Jiajing] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [Wang, Jinbo; Cheng, Jiajing] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Tongji University; Nanjing Medical University	Wu, Y; Cheng, JJ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China.; Cheng, JJ (corresponding author), Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China.	wuyi_sh@163.com; chengjiajing0911@163.com			Shanghai Committee of Science and Technology, China [15ZR1432600, 15695841100]; National Natural Science Foundation of China [81202045]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Shanghai Committee of Science and Technology, China; Grant No. 15ZR1432600; funding recipient: Liwen Song; URL: http://www.stcsm.gov.cn/. Shanghai Committee of Science and Technology, China; Grant No. 15695841100; funding recipient: Jiajing Cheng; URL: http://www.stcsm.gov.cn/. National Natural Science Foundation of China; Grant No. 81202045; URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by two grants from the Shanghai Committee of Science and Technology, China (Grant No. 15ZR1432600 and Grant No. 15695841100), partly by a grant from the National Natural Science Foundation of China (Grant No. 81202045). We are grateful to Bo Zhang for his foundation financial support (the National Natural Science Foundation of China, Grant No. 81202045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corradi S, 2015, TOXICOL IN VITRO, V29, P1587, DOI 10.1016/j.tiv.2015.06.015; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Gruber K, 2013, J BIOL REG HOMEOS AG, V27, P661; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hawkins K, 2012, STEM CELLS, V30, P1842, DOI 10.1002/stem.1148; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang GY, 2014, STEM CELLS, V32, P1149, DOI 10.1002/stem.1609; Jeon Y, 2015, THERIOGENOLOGY, V84, P531, DOI 10.1016/j.theriogenology.2015.04.006; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094934; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mulvey CM, 2015, STEM CELLS IN PRESS; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang FX, 2008, BIODRUGS, V22, P361, DOI 10.2165/0063030-200822060-00003; Zhang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132566; Zhao MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130791	42	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148994	10.1371/journal.pone.0148994	http://dx.doi.org/10.1371/journal.pone.0148994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910359	Green Published, gold, Green Submitted			2022-12-26	WOS:000371164700018
J	Chen, HF; Yi, ZF; Schmidt-Vogt, D; Ahrends, A; Beckschafer, P; Kleinn, C; Ranjitkar, S; Xu, JC				Chen, Huafang; Yi, Zhuang-Fang; Schmidt-Vogt, Dietrich; Ahrends, Antje; Beckschaefer, Philip; Kleinn, Christoph; Ranjitkar, Sailesh; Xu, Jianchu			Pushing the Limits: The Pattern and Dynamics of Rubber Monoculture Expansion in Xishuangbanna, SW China	PLOS ONE			English	Article							LAND-COVER CHANGE; SOUTHWEST CHINA; RAIN-FOREST; PLANTATIONS; BIODIVERSITY; DIVERSITY; MENGLUN; TRANSFORMATION; INDICATORS; LANDSCAPE	The rapidly growing car industry in China has led to an equally rapid expansion of monoculture rubber in many regions of South East Asia. Xishuangbanna, the second largest rubber planting area in China, located in the Indo-Burma biodiversity hotspot, supplies about 37% of the domestic natural rubber production. There, high income possibilities from rubber drive a dramatic expansion of monoculture plantations which poses a threat to natural forests. For the first time we mapped rubber plantations in and outside protected areas and their net present value for the years 1988, 2002 (Landsat, 30 m resolution) and 2010 (RapidEye, 5 m resolution). The purpose of our study was to better understand the pattern and dynamics of the expansion of rubber plantations in Xishuangbanna, as well as its economic prospects and conservation impacts. We found that 1) the area of rubber plantations was 4.5% of the total area of Xishuangbanna in 1988, 9.9% in 2002, and 22.2% in 2010; 2) rubber monoculture expanded to higher elevations and onto steeper slopes between 1988 and 2010; 3) the proportion of rubber plantations with medium economic potential dropped from 57% between 1988 and 2002 to 47% in 2010, while the proportion of plantations with lower economic potential had increased from 30% to 40%; and 4) nearly 10% of the total area of nature reserves within Xishuangbanna has been converted to rubber monoculture by 2010. On the basis of our findings, we conclude that the rapid expansion of rubber plantations into higher elevations, steeper terrain, and into nature reserves (where most of the remaining forests of Xishuangbanna are located) poses a serious threat to biodiversity and environmental services while not producing the expected economic returns. Therefore, it is essential that local governments develop long-term land use strategies for balancing economic benefits with environmental sustainability, as well as for assisting farmers with the selection of land suitable for rubber production.	[Chen, Huafang; Yi, Zhuang-Fang; Ranjitkar, Sailesh; Xu, Jianchu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Chen, Huafang; Yi, Zhuang-Fang; Schmidt-Vogt, Dietrich; Ranjitkar, Sailesh; Xu, Jianchu] World Agroforestry Ctr ICRAF East & Cent Asia, Kunming, Peoples R China; [Schmidt-Vogt, Dietrich] Univ Cent Asia, Mt Soc Res Inst, Bishkek, Kyrgyzstan; [Ahrends, Antje] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Beckschaefer, Philip; Kleinn, Christoph] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; American University of Central Asia; University of Gottingen	Xu, JC (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.; Schmidt-Vogt, D; Xu, JC (corresponding author), World Agroforestry Ctr ICRAF East & Cent Asia, Kunming, Peoples R China.; Schmidt-Vogt, D (corresponding author), Univ Cent Asia, Mt Soc Res Inst, Bishkek, Kyrgyzstan.	dietrich.schmidt-vogt@ucentralasia.org; jxu@mail.kib.ac.cn	Xu, Jianchu/Y-2890-2019; Ranjitkar, Sailesh/I-9307-2014; Kleinn, Christoph/AAG-1768-2020	Ranjitkar, Sailesh/0000-0002-4741-3975; Beckschafer, Philip/0000-0003-1728-724X	Project "Making the Mekong Connected" - Federal Ministry for Economic Cooperation and Development (BMZ) [08.7860.3-001.00]; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); Project "Green Rubber" - Federal Ministry for Economic Cooperation and Development (BMZ) [13.1432.7-00100]; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	Project "Making the Mekong Connected" - Federal Ministry for Economic Cooperation and Development (BMZ); Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); Project "Green Rubber" - Federal Ministry for Economic Cooperation and Development (BMZ); Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The work was supported by the following: Project "Making the Mekong Connected" (project No. 08.7860.3-001.00), sponsored by Federal Ministry for Economic Cooperation and Development (BMZ) and Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); and Project "Green Rubber" (Project No. 13.1432.7-00100), sponsored by Federal Ministry for Economic Cooperation and Development (BMZ) and Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ). This research is also part of the CGIAR (Consultative Group for International Agricultural Research) Research Program 6: Forests, Trees and Agroforestry. URL: http://www.giz.de/de/html/index.html, http://www.bmz.de/en.	Ahrends A, 2015, GLOBAL ENVIRON CHANG, V34, P48, DOI 10.1016/j.gloenvcha.2015.06.002; [Anonymous], RUBBER BOOM LU UNPUB; Association of Natural Rubber Producing Countries, 2010, NAT RUBB TRENDS STAT; Chen Li, 2013, Shengwu Duoyangxing, V21, P359, DOI 10.3724/SP.J.1003.2013.05162; Dong JW, 2013, REMOTE SENS ENVIRON, V134, P392, DOI 10.1016/j.rse.2013.03.014; Food and Agriculture Organization of the United Nations, FAO STAT YB; Fox, 2011, INT J GEOSCI, V2, P573, DOI [10.4236/ijg.2011.24060, DOI 10.4236/IJG.2011.24060]; Fox J, 2005, ENVIRON MANAGE, V36, P394, DOI 10.1007/s00267-003-0288-7; Fox J, 2014, SOCIAL LIVES FORESTS, P249; Hammond J., 2014, WORKING PAPER; Hu HB, 2008, ENVIRON MONIT ASSESS, V146, P147, DOI 10.1007/s10661-007-0067-7; Hurni K, 2008, DETECTION ACTUAL ASS; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Li HM, 2009, BIODIVERS CONSERV, V18, P3421, DOI 10.1007/s10531-009-9651-1; Li Zeng-Jia, 2008, Zhiwu Shengtai Xuebao, V32, P1091, DOI 10.3773/j.issn.1005-264x.2008.05.014; Li Z, 2012, APPL GEOGR, V32, P420, DOI 10.1016/j.apgeog.2011.06.018; Li Z, 2011, REMOTE SENS LETT, V2, P157, DOI 10.1080/01431161.2010.505589; Liu JJ, 2014, BIOL CONSERV, V171, P99, DOI 10.1016/j.biocon.2014.01.004; Liu WJ, 2006, MT RES DEV, V26, P245, DOI 10.1659/0276-4741(2006)26[245:EASIOI]2.0.CO;2; Liu XN, 2013, J GEOGR SCI, V23, P1019, DOI 10.1007/s11442-013-1060-4; Mann CC, 2009, SCIENCE, V325, P564, DOI 10.1126/science.325_564; Ministry of Environmental Protection of China, 2011 2030 CHIN BIOD; National Bureau of Statistics of China, 2011, CHIN STAT YB; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Priyadarshan P.M., 2005, J CROP IMPROVEMENT, V14, P221, DOI [DOI 10.1300/J411V14N01., DOI 10.1300/J411V14N01_]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rao PS, 1998, AGR FOREST METEOROL, V90, P235, DOI 10.1016/S0168-1923(98)00051-3; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; Shi, 2008, RUBBER BOOM LUANG NA; Statistics Bureau of Yunnan Province, 2011, YUNN STAT YB 2011; Suratman MN, 2004, INT FOREST REV, V6, P1, DOI 10.1505/ifor.6.1.1.32055; Wang F, 2008, TROP AGR SCI TECHNOL, V31, P15; Wu ZL, 2001, INT J SUST DEV WORLD, V8, P337, DOI 10.1080/13504500109470091; Xiao G, 2007, TROPICAL AGR SCI TEC, V30, P1; Xishuangbanna Bureau of Statistics, 2008, STAT REP SOC DEV XIS; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2006, MT RES DEV, V26, P254, DOI 10.1659/0276-4741(2006)26[254:TPSAET]2.0.CO;2; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; Yi Z, 2012, NATURAL FORESTS RUBB; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Yu Y, 2006, TROPICAL AGR SCI TEC, V29, P42; Zhai DL, 2012, J ENVIRON MANAGE, V96, P64, DOI 10.1016/j.jenvman.2011.10.011; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhu H, 2004, BIODIVERS CONSERV, V13, P1355, DOI 10.1023/B:BIOC.0000019397.98407.c3; Zhuang J., 2007, THEORY PRACTICE CHOI; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028; [No title captured]	50	58	59	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150062	10.1371/journal.pone.0150062	http://dx.doi.org/10.1371/journal.pone.0150062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907479	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000030
J	Bruinvels, G; Burden, R; Brown, N; Richards, T; Pedlar, C				Bruinvels, Georgie; Burden, Richard; Brown, Nicola; Richards, Toby; Pedlar, Charles			The Prevalence and Impact of Heavy Menstrual Bleeding (Menorrhagia) in Elite and Non-Elite Athletes	PLOS ONE			English	Article							IRON-DEFICIENCY; EXERCISE	To identify the prevalence and impact of heavy menstrual bleeding (HMB) in exercising females where anemia may have a significant effect on training and performance a 'Female Health Questionnaire' was designed incorporating a validated diagnostic HMB series, demographics, exercise ability data, training status, anemia, iron supplementation and whether the menstrual cycle had affected training and performance. The survey was conducted in two stages; initially online, advertised via social media, and then repeated via face-to-face interviews with runners registered for the 2015 London Marathon. 789 participants responded to the online survey, and 1073 completed the survey at the marathon. HMB was reported by half of those online (54%), and by more than a third of the marathon runners (36%). Surprisingly, HMB was also prevalent amongst elite athletes (37%). Overall, 32% of exercising females reported a history of anemia, and 50% had previously supplemented with iron. Only a minority (22%) had sought medical advice. HMB is highly prevalent in exercising females, associated with self-reported anemia, increased use of iron supplementation and a perceived negative impact on performance. Further research is needed to investigate the impact of HMB, iron deficiency and anemia in exercising females.	[Bruinvels, Georgie; Richards, Toby] UCL, Div Surg & Intervent Sci, London, England; [Bruinvels, Georgie; Burden, Richard; Brown, Nicola; Pedlar, Charles] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England; [Bruinvels, Georgie; Burden, Richard; Pedlar, Charles] Orreco Ltd, Inst Technol, Sligo, Ireland; [Burden, Richard] English Inst Sport, Loughborough, Leics, England	University of London; University College London; St Mary's University Twickenham London; Institute of Technology Tralee	Bruinvels, G (corresponding author), UCL, Div Surg & Intervent Sci, London, England.; Bruinvels, G (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England.; Bruinvels, G (corresponding author), Orreco Ltd, Inst Technol, Sligo, Ireland.	georgie.bruinvels.14@ucl.ac.uk	Richards, Toby/K-6547-2013; Pedlar, Charles/I-4351-2019	Pedlar, Charles/0000-0002-3075-9101; Brown, Nicola/0000-0001-5538-2171	Department of Health [10/104/06] Funding Source: Medline; National Institute for Health Research [10/104/06] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Barrack MT, 2013, CURR REV MUSCULOSKE, V6, P195, DOI 10.1007/s12178-013-9168-9; Beard J, 2000, AM J CLIN NUTR, V72, p594S, DOI 10.1093/ajcn/72.2.594S; Beglinger C, 2010, TREATMENT IRON DEFIC; Bruinvels G, 2016, BRIT J SPORT MED, V50, P566, DOI 10.1136/bjsports-2015-095505; Burden RJ, 2015, MED SCI SPORT EXER, V47, P1399, DOI 10.1249/MSS.0000000000000568; Copher R, 2013, CURR MED RES OPIN, V29, P127, DOI 10.1185/03007995.2012.759096; de Oliveira EP, 2009, CURR OPIN CLIN NUTR, V12, P533, DOI 10.1097/MCO.0b013e32832e6776; Deli C. K., 2013, CURRENT ISSUES SPORT; DeRuisseau KC, 2002, INT J SPORT NUTR EXE, V12, P428, DOI 10.1123/ijsnem.12.4.428; Fraser IS, 2015, INT J GYNECOL OBSTET, V128, P196, DOI 10.1016/j.ijgo.2014.09.027; Garvican LA, 2011, INT J SPORT PHYSIOL, V6, P137, DOI 10.1123/ijspp.6.1.137; HALLBERG L, 1964, SCAND J CLIN LAB INV, V16, P244, DOI 10.3109/00365516409060511; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Kaplowitz MD, 2004, PUBLIC OPIN QUART, V68, P94, DOI 10.1093/poq/nfh006; Karlsson TS, 2014, ACTA OBSTET GYN SCAN, V93, P52, DOI 10.1111/aogs.12292; Liu ZM, 2007, VALUE HEALTH, V10, P183, DOI 10.1111/j.1524-4733.2007.00168.x; Marret H, 2010, EUR J OBSTET GYN R B, V152, P133, DOI 10.1016/j.ejogrb.2010.07.016; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; National Institute for Health Care and Excellence, 2007, HEAV MENSTR BLEED; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Nazem TG, 2012, SPORTS HEALTH, V4, P302, DOI 10.1177/1941738112439685; ROWLAND TW, 1989, AM J DIS CHILD, V143, P197, DOI 10.1001/archpedi.1989.02150140087026; Royal College of Obstetricians and Gynaecologists, 2013, 3 ROYAL COLL OBST GY; SIEGEL AJ, 1979, JAMA-J AM MED ASSOC, V241, P391, DOI 10.1001/jama.241.4.391; Taylor S, 2015, POL ARCH MED WEWN, V125, P452, DOI 10.20452/pamw.2888; Telford RD, 2003, J APPL PHYSIOL, V94, P38, DOI 10.1152/japplphysiol.00631.2001	27	75	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149881	10.1371/journal.pone.0149881	http://dx.doi.org/10.1371/journal.pone.0149881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901873	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000371276100172
J	Chapman, PA; Owen, H; Flint, M; Traub, RJ; Cribb, TH; Mills, PC				Chapman, Phoebe A.; Owen, Helen; Flint, Mark; Traub, Rebecca J.; Cribb, Thomas H.; Mills, Paul C.			Molecular Characterization of Coccidia Associated with an Epizootic in Green Sea Turtles (Chelonia mydas) in South East Queensland, Australia	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PHYLOGENETIC TREES; APICOMPLEXA; CARYOSPORA; EIMERIA; MODELS; DIAGNOSIS; INFERENCE; MRBAYES	In the spring of 2014, mass mortalities among wild green sea turtles occurred off the coast of south-east Queensland, Australia. The suspected causative agent was Caryospora cheloniae, an eimeriid coccidian implicated in previous epizootics. Necropsies were undertaken on a subset of 11 dead turtles, with subsequent histopathology and molecular analyses. All turtles returned positive PCR results for coccidial infection in various tissues; these included the brain, gastrointestinal tract, lung, kidney and thyroid. Granulomatous encephalitis was consistently observed, as well as enteritis and, less frequently, thyroiditis and nephritis. Sequencing and phylogenetic analyses indicated the presence of two distinct coccidian genotypes, presumably separate species-one associated with the brain, gastrointestinal tract and lung, and the second with the thyroid and kidney. Maximum likelihood and Bayesian inference analyses placed the first genotype closest to the lankesterellid genus Schellackia, rather than in the Eimeriidae, while the second was paraphyletic to the eimeriids. Presence of coccidial stages in extra-intestinal tissues of the primary host raises questions about the potential presence of intermediate or paratenic hosts within the life cycles, as well as their current placement relative to the genus Caryospora. This study represents the first genetic characterization of this emerging disease agent in green sea turtles, an endangered species, and has relevance for life-cycle elucidation and future development of diagnostics.	[Chapman, Phoebe A.; Owen, Helen; Flint, Mark; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton, Qld, Australia; [Flint, Mark] Univ Florida, Florida Aquariums Ctr Conservat, Sch Forest Resources & Conservat, Apollo Beach, FL USA; [Traub, Rebecca J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Cribb, Thomas H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland; State University System of Florida; University of Florida; University of Melbourne; University of Queensland	Chapman, PA (corresponding author), Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton, Qld, Australia.	p.chapman3@uq.edu.au	Traub, Rebecca/A-4273-2013; Cribb, Thomas/C-4449-2008; Chapman, Phoebe/E-5044-2016	Traub, Rebecca/0000-0002-7484-7592; Cribb, Thomas/0000-0003-1092-9705; Chapman, Phoebe/0000-0002-3303-9134	Australian Research Council [LP110100569]	Australian Research Council(Australian Research Council)	This project was funded by Australian Research Council Linkage Project Grant LP110100569 (URL http://www.arc.gov.au/default.htm) awarded to PCM as first investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; [Anonymous], 2009, GEOSP FINCHTV 1 4 0; Austen JM, 2014, EXP PARASITOL, V138, P48, DOI 10.1016/j.exppara.2014.01.007; Ball S, 1989, ADV PARASITOL, V28, P1; Barta JR, 2001, J PARASITOL, V87, P121, DOI 10.1645/0022-3395(2001)087[0121:MPOTOT]2.0.CO;2; Chapman PA, 2015, SYST PARASITOL, V90, P67, DOI 10.1007/s11230-014-9535-y; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Duszynski D.W., 2014, BIOL IDENTIFICATION; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Flint M, 2009, J VET DIAGN INVEST, V21, P733, DOI 10.1177/104063870902100601; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; GORDON AN, 1993, J WILDLIFE DIS, V29, P490, DOI 10.7589/0090-3558-29.3.490; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T., 2005, BIOEDIT BIOL SEQUENC; Heckeroth AR, 1999, INT J PARASITOL, V29, P1331, DOI 10.1016/S0020-7519(99)00111-3; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LEIBOVITZ L, 1978, J WILDLIFE DIS, V14, P269, DOI 10.7589/0090-3558-14.2.269; Levine ND, 1988, PROTOZOAN PHYLUM API, V2; LIMPUS C.J., 1994, MEMOIRS QUEENSLAND M, V35, P139; Lindsay D.S., 1989, Journal of Veterinary Parasitology, V3, P1; Liu Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0902-6; Merino S, 2008, J EUKARYOT MICROBIOL, V55, P536, DOI 10.1111/j.1550-7408.2008.00358.x; Merino S, 2010, PARASITOLOGY, V137, P37, DOI 10.1017/S0031182009990710; NOVILLA MN, 1981, J PROTOZOOL, V28, P248, DOI 10.1111/j.1550-7408.1981.tb02844.x; O'Callaghan MG, 2001, T ROY SOC SOUTH AUST, V125, P129; OVERSTREET RM, 1981, J PROTOZOOL, V28, P258, DOI 10.1111/j.1550-7408.1981.tb02846.x; Pellerdy L. P., 1974, COCCIDIA COCCIDIOSIS, V2nd; Perkins F.O., 2000, ILLUSTRATED GUIDE PR, Vsecond; Power ML, 2009, EXP PARASITOL, V122, P165, DOI 10.1016/j.exppara.2009.02.008; Rambaut A., 2014, TRACER V1 6; Rebell G., 1974, Proceedings a Wkshop Wld Maricult Soc, V5, P197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saffo MB, 2010, P NATL ACAD SCI USA, V107, P16190, DOI 10.1073/pnas.1002335107; TELFORD SR, 1993, SYST PARASITOL, V25, P109, DOI 10.1007/BF00009980; Yang RC, 2014, EXP PARASITOL, V145, P68, DOI 10.1016/j.exppara.2014.07.008; Zhu BY, 2009, VET PARASITOL, V159, P105, DOI 10.1016/j.vetpar.2008.10.031	38	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149962	10.1371/journal.pone.0149962	http://dx.doi.org/10.1371/journal.pone.0149962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901786	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100194
J	Egan, AM; O'Doherty, JV; Vigors, S; Sweeney, T				Egan, Aine M.; O'Doherty, John V.; Vigors, Stafford; Sweeney, Torres			Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo	PLOS ONE			English	Article							NEUROPEPTIDE-Y; BODY-WEIGHT; FOOD-INTAKE; MEAL SIZE; BRAIN; LEPTIN; OLIGOSACCHARIDES; EXPRESSION; DIETARY; GAMMA	The crustacean shells-derived polysaccharide chitosan has received much attention for its anti-obesity potential. Dietary supplementation of chitosan has been linked with reductions in feed intake, suggesting a potential link between chitosan and appetite control. Hence the objective of this experiment was to investigate the appetite suppressing potential of prawn shell derived chitosan in a pig model. Pigs (70 +/- 0.90 kg, 125 days of age, SD 2.0) were fed either T1) basal diet or T2) basal diet plus 1000 ppm chitosan (n = 20 gilts per group) for 63 days. The parameter categories which were assessed included performance, feeding behaviour, serum leptin concentrations and expression of genes influencing feeding behaviour in the small intestine, hypothalamus and adipose tissue. Pigs offered chitosan visited the feeder less times per day (P < 0.001), had lower intake per visit (P < 0.001), spent less time eating per day (P < 0.001), had a lower eating rate (P < 0.01) and had reduced feed intake and final body weight (P < 0.001) compared to animals offered the basal diet. There was a treatment (P < 0.05) and time effect (P < 0.05) on serum leptin concentrations in animals offered the chitosan diet compared to animals offered the basal diet. Pigs receiving dietary chitosan had an up-regulation in gene expression of growth hormone receptor (P < 0.05), Peroxisome proliferator activated receptor gamma (P < 0.01), neuromedin B (P < 0.05), neuropeptide Y receptor 5 (P < 0.05) in hypothalamic nuclei and neuropeptide Y (P < 0.05) in the jejunum. Animals consuming chitosan had increased leptin expression in adipose tissue compared to pigs offered the basal diet (P < 0.05). In conclusion, these data support the hypothesis that dietary prawn shell chitosan exhibits anti-obesogenic potential through alterations to appetite, and feeding behaviour affecting satiety signals in vivo.	[Egan, Aine M.; O'Doherty, John V.; Vigors, Stafford] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Sweeney, Torres] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland	University College Dublin; University College Dublin	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; Vigors, Stafford/0000-0002-9304-2925	Marine Institute [MFFRI/07/01]; Department of Agriculture, Food and the Marine; National Development Plan	Marine Institute; Department of Agriculture, Food and the Marine; National Development Plan	This study was supported financially (Grant-Aid Agreement No. MFFRI/07/01) under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013.	Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; CAMPBELL RG, 1988, J ANIM SCI, V66, P676; Chaudhri OB, 2008, DIABETES CARE, V31, pS284, DOI 10.2337/dc08-s269; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; Dyer CJ, 1999, DOMEST ANIM ENDOCRIN, V16, P145, DOI 10.1016/S0739-7240(99)00011-9; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97; Geerling JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055217; Hajji S, 2015, APPL BIOCHEM BIOTECH, V177, P18, DOI 10.1007/s12010-015-1724-x; Heim G, 2014, THE BRITISH JOURNAL, P1; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; HIRANO S, 1990, J AGR FOOD CHEM, V38, P1214, DOI 10.1021/jf00095a012; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Houseknecht KL, 2003, NUTR RES REV, V16, P83, DOI 10.1079/NRR200256; Huang LL, 2015, MAR DRUGS, V13, P2732, DOI 10.3390/md13052732; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Lee HW, 2003, BIOL PHARM BULL, V26, P1100; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; LITTELL RC, 1996, SAS SYSTEM FOR MIXED; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; McMahon CD, 1999, J ENDOCRINOL, V161, P333, DOI 10.1677/joe.0.1610333; Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x; Morley JE, 1987, NEUROPEPTIDE Y INCRE; Munro CA, 2001, MED MYCOL, V39, P41, DOI 10.1080/744118878; Muurahainen NE, 1993, INTRAVENOUS INFUSION; MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0; NRC, 2012, NUTRIENT REQUIREMENT; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PENG C, 1993, ENDOCRINOLOGY, V132, P1820, DOI 10.1210/en.132.4.1820; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; SAS, 2004, SAS USERS GUIDE; Sauvant D, 2004, TABLE OF COMPOSITION; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simpson KA, 2009, ARQ BRAS ENDOCRINOL, V53, P120, DOI 10.1590/S0004-27302009000200002; SKORUPSKI P, 1994, J EXP BIOL, V187, P305; Soumian S, 2005, J CLIN PATHOL, V58, P1255, DOI 10.1136/jcp.2005.026161; STEIN LJ, 1982, PEPTIDES, V3, P833, DOI 10.1016/0196-9781(82)90023-7; Stoving RK, 1999, J PSYCHIATR RES, V33, P139, DOI 10.1016/S0022-3956(98)00049-1; STUCKEY JA, 1985, PEPTIDES, V6, P1249, DOI 10.1016/0196-9781(85)90458-9; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Suzuki K, 2012, EXP DIABETES RES, DOI 10.1155/2012/824305; Sweeney T, 2012, BRIT J NUTR, V108, P1226, DOI 10.1017/S0007114511006751; Swiatkiewicz S, 2015, J ANIM PHYSIOL AN N, V99, P1, DOI 10.1111/jpn.12222; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Vernarelli JA, 2011, J NUTR, V141, P2204, DOI 10.3945/jn.111.146092; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Washington MC, 2014, PEPTIDES, V51, P145, DOI 10.1016/j.peptides.2013.11.016; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27	63	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149820	10.1371/journal.pone.0149820	http://dx.doi.org/10.1371/journal.pone.0149820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901760	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100159
J	Erra, RG; Gervain, J				Erra, Ramon Guevara; Gervain, Judit			The Efficient Coding of Speech: Cross-Linguistic Differences	PLOS ONE			English	Article							LANGUAGE DISCRIMINATION; INFORMATION; STATISTICS; TIME; PERCEPTION; NEWBORNS; RHYTHM	Neural coding in the auditory system has been shown to obey the principle of efficient neural coding. The statistical properties of speech appear to be particularly well matched to the auditory neural code. However, only English has so far been analyzed from an efficient coding perspective. It thus remains unknown whether such an approach is able to capture differences between the sound patterns of different languages. Here, we use independent component analysis to derive information theoretically optimal, non-redundant codes (filter populations) for seven typologically distinct languages (Dutch, English, Japanese, Marathi, Polish, Spanish and Turkish) and relate the statistical properties of these filter populations to documented differences in the speech rhythms (Analysis 1) and consonant inventories (Analysis 2) of these languages. We show that consonant class membership plays a particularly important role in shaping the statistical structure of speech in different languages, suggesting that acoustic transience, a property that discriminates consonant classes from one another, is highly relevant for efficient coding.	[Gervain, Judit] CNRS, Lab Psychol Percept, Paris, France; Univ Paris 05, Sorbonne Paris Cite, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Gervain, J (corresponding author), CNRS, Lab Psychol Percept, Paris, France.	judit.gervain@parisdescartes.fr		Gervain, Judit/0000-0002-2125-6369	City of Paris, Emergence program; Human Frontiers Science Program [RGY-073/2014]	City of Paris, Emergence program(Region Ile-de-France); Human Frontiers Science Program(Human Frontier Science Program)	This work was supported by (1) City of Paris, Emergence program (http://next.paris.fr/pro/chercheurs/2d3es-appels-a-projets/programme-emergence-s/rub_9587_stand_79582_port_23607) and (2) Human Frontiers Science Program grant nr. RGY-073/2014 (http://www.hfsp.org/funding/research-grants). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amari S, 1996, ADV NEUR IN, V8, P757; [Anonymous], 2013, WORLD ATLAS LANGUAGE; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Baayen R Harald, 1993, CELEX LEXICAL DATA B; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bosch L, 1997, COGNITION, V65, P33, DOI 10.1016/S0010-0277(97)00040-1; Byers-Heinlein K, 2010, PSYCHOL SCI; Catford J. C., 1988, PRACTICAL INTRO PHON; CUTLER A, 1983, NATURE, V304, P159, DOI 10.1038/304159a0; DEBOER E, 1978, J ACOUST SOC AM, V63, P115, DOI 10.1121/1.381704; Dellwo V., 2006, LANGUAGE LANGUAGE PR, P231, DOI DOI 10.5167/UZH-111789; Eddington David, 2004, SPANISH PHONOLOGY MO; Evans E.F., 1975, HDB SENSORY PHYSL, P1; Fenk-Oczlon G., 2005, SPRACHE NATURLICHKEI; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Galves A, 2002, SPEECH PROS 2002 INT; Geffen MN, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00015; Gervain J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096278; Grabe E, 2002, PHONOL PHONET, V4-1, P515; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Lee JH, 2002, NEURAL PROCESS LETT, V15, P235, DOI 10.1023/A:1015777200976; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; Lindblom B., 1988, LANGUAGE SPEECH MIND; Loukina A, 2011, J ACOUST SOC AM, V129, P3258, DOI 10.1121/1.3559709; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; MEHLER J, 1988, COGNITION, V29, P143, DOI 10.1016/0010-0277(88)90035-2; Mehler J, 2004, NEW COGNITIVE NEUROS, P825; MINES MA, 1978, LANG SPEECH, V21, P221, DOI 10.1177/002383097802100302; Ming VL, 2009, J ACOUST SOC AM, V126, P1312, DOI 10.1121/1.3158939; Molnar M, NONLINGUIST IN PRESS; Molnar M, 2013, INFANCY; MOON C, 1993, INFANT BEHAV DEV, V16, P495, DOI 10.1016/0163-6383(93)80007-U; Nazzi T, 1998, J EXP PSYCHOL HUMAN, V24, P756, DOI 10.1037/0096-1523.24.3.756; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Ordin M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00316; Pallier C, 1998, MEM COGNITION, V26, P844, DOI 10.3758/BF03211403; Pallier C, 1997, TRENDS COGN SCI, V1, P129, DOI 10.1016/S1364-6613(97)01044-9; Ramus F, 1999, COGNITION, V73, P265, DOI 10.1016/S0010-0277(99)00058-X; Ramus F, 1999, J ACOUST SOC AM, V105, P512, DOI 10.1121/1.424522; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Ruggero M. A., 1992, MAMMALIAN AUDITORY P, DOI [10.1007/978-1-4612-2838-7_2, DOI 10.1007/978-1-4612-2838-7_2]; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Smits R, 2003, J ACOUST SOC AM, V113, P563, DOI 10.1121/1.1525287; Stilp CE, 2014, P M AC AC SOC AM; Stilp CE, 2010, P NATL ACAD SCI USA, V107, P12387, DOI 10.1073/pnas.0913625107; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wiget L, 2010, J ACOUST SOC AM, V127, P1559, DOI 10.1121/1.3293004	52	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148861	10.1371/journal.pone.0148861	http://dx.doi.org/10.1371/journal.pone.0148861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901527	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100026
J	Sakamoto, Y; Kanatsu, J; Toh, M; Naka, A; Kondo, K; Iida, K				Sakamoto, Yuri; Kanatsu, Junko; Toh, Mariko; Naka, Ayano; Kondo, Kazuo; Iida, Kaoruko			The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPAR alpha/gamma and JNK Pathways in Adipocyte and Macrophage Co-Cultures	PLOS ONE			English	Article							OBESITY-RELATED INFLAMMATION; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CIRCULATING INTERLEUKIN-6; KAPPA-B; C-JUN; ACTIVATION; GAMMA	Obesity-induced inflammation caused by adipocyte-macrophage interactions plays a critical role in developing insulin resistance, and peroxisome proliferator-activated receptors (PPARs) regulate inflammatory gene expression in these cells. Recently, the soy isoflavone daidzein was reported to act as a PPAR activator. We examined whether daidzein affected adipocyte-macrophage crosstalk via the regulation of PPARs. Co-cultures of 3T3-L1 adipocytes and RAW264 macrophages, or palmitate-stimulated RAW264 macrophages were treated with daidzein in the presence or absence of specific inhibitors for PPARs: GW6471 (a PPAR alpha antagonist), and GW9662 (a PPAR gamma antagonist). Inflammatory gene expression was then determined. Daidzein significantly decreased chemokine (C-C motif) ligand 2 (Ccl2, known in humans as monocyte chemo-attractant protein 1 (MCP1)) and interleukin 6 (Il6) mRNA levels induced by co-culture. In 3T3-L1 adipocytes, daidzein inversed the attenuation of adiponectin gene expression by co-culture, and these effects were inhibited by the PPAR-gamma specific inhibitor. Daidzein also decreased Ccl2 and Il6 mRNA levels in RAW264 macrophages stimulated with palmitate or conditioned medium (CM) from hypertrophied 3T3-L1 adipocytes. This inhibitory effect on Il6 expression was abrogated by a PPAR-alpha inhibitor. Additionally, we examined the activation of nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) pathways and found that daidzein significantly inhibited palmitate- induced phosphorylation of JNK. Our data suggest that daidzein regulates pro-inflammatory gene expression by activating PPAR-alpha and -gamma and inhibiting the JNK pathway in adipocyte and macrophage co-cultures. These effects might be favorable in improving adipose inflammation, thus, treatment of daidzein may be a therapeutic strategy for chronic inflammation in obese adipose tissue.	[Sakamoto, Yuri; Kanatsu, Junko; Toh, Mariko; Iida, Kaoruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 112, Japan; [Naka, Ayano] Ochanomizu Univ, Fac Human Life & Environm Sci, Lab Appl Nutr, Tokyo 112, Japan; [Kondo, Kazuo] Ochanomizu Univ, Endowed Res Dept Food Hlth, Tokyo 112, Japan	Ochanomizu University; Ochanomizu University; Ochanomizu University	Iida, K (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 112, Japan.	iida.kaoruko@ocha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24300254, 26750037, 15J11645, 15H02895]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants-in-aid for Scientific Research (grant nos. 24300254, 26750037, 15J11645 and 15H02895) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hirai S, 2007, LIFE SCI, V81, P1272, DOI 10.1016/j.lfs.2007.09.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Ma ZQ, 2013, INFLAMMATION, V36, P1560, DOI 10.1007/s10753-013-9700-5; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Park OJ, 2015, IMMUNOBIOLOGY, V220, P1067, DOI 10.1016/j.imbio.2015.05.008; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Qiu LX, 2012, MOL MED REP, V5, P217, DOI 10.3892/mmr.2011.599; Reyes-Farias M, 2015, J MED FOOD, V18, P601, DOI 10.1089/jmf.2014.0031; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sakamoto Y, 2014, MOL NUTR FOOD RES, V58, P718, DOI 10.1002/mnfr.201300482; Sakurai T, 2010, J NUTR BIOCHEM, V21, P47, DOI 10.1016/j.jnutbio.2008.10.003; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Shen P, 2006, J NUTR, V136, P899, DOI 10.1093/jn/136.4.899; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van der Velpen V, 2014, AM J CLIN NUTR, V100, P1269, DOI 10.3945/ajcn.114.088484; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	45	56	59	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149676	10.1371/journal.pone.0149676	http://dx.doi.org/10.1371/journal.pone.0149676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901838	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100127
J	Wang, SY; Blachley, TS; Andrews, CA; Ayanian, JZ; Lee, PP; Stein, JD				Wang, Sophia Y.; Blachley, Taylor S.; Andrews, Chris A.; Ayanian, John Z.; Lee, Paul P.; Stein, Joshua D.			Hospitalization after Cataract Surgery in a Nationwide Managed-Care Population	PLOS ONE			English	Article							ADVERSE EVENTS; ACCURACY; PATIENT	Purpose Little is known regarding the extent by which patients undergoing outpatient cataract surgery are at risk for postoperative hospitalization. We sought to determine the percentage of patients undergoing cataract surgery who were subsequently hospitalized, the patient characteristics associated with postoperative hospitalization, and the reasons for hospitalization. Methods We identified all beneficiaries of a large U.S. managed care network age >= 40 years old who underwent >= 1 cataract surgery from 2001-2011. All enrollees who required inpatient hospitalization within 7, 14, 30, and 90 days following initial cataract surgery and the reasons for hospitalization were determined. Logistic regression was performed to assess factors that significantly impacted the odds of requiring postoperative hospitalization. Results Among the 64,981 patients who underwent cataract surgery, rates of hospitalization within 7, 14, 30, and 90 days were 0.3%, 0.5%, 1.3% and 4.2%, respectively. Among the 10,674 patients who had no major preexisting medical comorbidities, 0.1% were hospitalized within 7 days. The odds of hospitalization increased by 35% (OR = 1.35 [CI, 1.23-1.48]) with the presence of each additional comorbidity and by 14% with each additional hospitalization in the 3 years prior to cataract surgery (OR = 1.14 [CI, 1.10-1,18]). Those who were hospitalized in the 30 days prior to cataract surgery had 524% increased odds of being hospitalized within 7 days after cataract surgery (OR = 6.24, [CI, 3.37-11.57]) compared to those with no record of preoperative hospitalization. Postoperative hospitalizations were most commonly due to cardiovascular conditions, comprising over 25% of primary diagnoses associated with hospitalization. Conclusions The risk of hospitalization after cataract surgery is low, and is very low among those with no major preexisting medical comorbidities. Opportunities may exist to limit comprehensive preoperative evaluation and testing to those who have serious pre-existing medical comorbidities.	[Wang, Sophia Y.; Blachley, Taylor S.; Andrews, Chris A.; Lee, Paul P.; Stein, Joshua D.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA; [Ayanian, John Z.; Lee, Paul P.; Stein, Joshua D.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA; [Ayanian, John Z.] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Stein, Joshua D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Stein, JD (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI USA.; Stein, JD (corresponding author), Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA.; Stein, JD (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA.	jastein@med.umich.edu		Andrews, Chris/0000-0001-5130-6374; Wang, Sophia/0000-0003-0916-9403; Stein, Joshua/0000-0003-2937-6987	National Eye Institute [1K23EY019511]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [K23EY019511] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute (https://nei.nih.gov/) (1K23EY019511, JDS) and Research to Prevent Blindness (http://www.rpbusa.org/rpb/?) (Physician Scientist Award, JDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Medical Association, 2006, CPT 2006 CURR PROC T; BASS EB, 1995, ARCH OPHTHALMOL-CHIC, V113, P1248, DOI 10.1001/archopht.1995.01100100036025; Cavallini GM, 2004, EUR J OPHTHALMOL, V14, P369, DOI 10.1177/112067210401400502; Danielson D, 2012, PREOPERATIVE EVALUAT; De Hert S, 2011, EUR J ANAESTH, V28, P684, DOI 10.1097/EJA.0b013e3283499e3b; Fleisher LA, 2004, ARCH SURG-CHICAGO, V139, P67, DOI 10.1001/archsurg.139.1.67; Fleisher LA, 2007, J AM COLL CARDIOL, V50, P1707, DOI 10.1016/j.jacc.2007.09.001; Greenberg PB, 2010, OPHTHALMOLOGY, V117, P1894, DOI 10.1016/j.ophtha.2010.02.009; HCUP CCS, 2014, HEALTHC COST UT PROJ; Hepner David L, 2009, Cleve Clin J Med, V76 Suppl 4, pS22, DOI 10.3949/ccjm.76.s4.04; ICD-9-CM for Physicians, 2006, ICD 9 CM PHYS INT CL; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P605, DOI 10.1001/archopht.1993.01090050039024; Katz J, 2001, OPHTHALMOLOGY, V108, P1721, DOI 10.1016/S0161-6420(01)00704-7; Keay L, 2012, COCHRANE COLLABORATI; Kosanke J, 2004, GMATCH; Lira R P, 2001, Rev Panam Salud Publica, V10, P13, DOI 10.1590/S1020-49892001000700003; Muir KW, 2013, JAMA OPHTHALMOL, V131, P119, DOI 10.1001/jamaophthalmol.2013.577; Newman-Casey PA, 2011, OPHTHALMOLOGY, V118, P1318, DOI 10.1016/j.ophtha.2010.11.022; Rutkow IM, 1997, ARCH SURG-CHICAGO, V132, P983; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Stein JD, 2012, CURR OPIN OPHTHALMOL, V23, P219, DOI 10.1097/ICU.0b013e3283524068; Stein JD, 2011, OPHTHALMOLOGY, V118, P1716, DOI 10.1016/j.ophtha.2011.02.024; Stein JD, 2011, OPHTHALMOLOGY, V118, P1031, DOI 10.1016/j.ophtha.2010.10.024; Thilen SR, 2014, JAMA INTERN MED, V174, P380, DOI 10.1001/jamainternmed.2013.13426; VanderBeek BL, 2011, AM J OPHTHALMOL, V152, P273, DOI 10.1016/j.ajo.2011.02.004	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149819	10.1371/journal.pone.0149819	http://dx.doi.org/10.1371/journal.pone.0149819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901594	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100158
J	Kumar, A; Singhal, M; Chopra, C; Srinivasan, S; Surabhi, RP; Kanumuri, R; Tentu, S; Jagadeeshan, S; Sundaram, S; Ramanathan, K; Pitani, RS; Muthuswamy, B; Abhijit, S; Nair, AS; Venkatraman, G; Rayala, SK				Kumar, A.; Singhal, M.; Chopra, C.; Srinivasan, S.; Surabhi, R. P.; Kanumuri, R.; Tentu, S.; Jagadeeshan, S.; Sundaram, S.; Ramanathan, K.; Pitani, R. Shankar; Muthuswamy, B.; Abhijit, S.; Nair, A. S.; Venkatraman, G.; Rayala, S. K.			Threonine 209 phosphorylation on RUNX3 by Pak1 is a molecular switch for its dualistic functions	ONCOGENE			English	Article							TUMOR-SUPPRESSOR; PROMOTER HYPERMETHYLATION; PROTEIN MISLOCALIZATION; GASTRIC-CANCER; EXPRESSION; FAMILY	P21 Activated Kinase 1 (Pak1), an oncogenic serine/threonine kinase, is known to have a significant role in the regulation of cytoskeleton and cellular morphology. Runx3 was initially known for its role in tumor suppressor function, but recent studies have reported the oncogenic role of Runx3 in various cancers. However, the mechanism that controls the paradoxical functions of Runx3 still remains unclear. In this study, we show that Runx3 is a physiologically interacting substrate of Pak1. We identified the site of phosphorylation in Runx3 as Threonine 209 by mass spectrometry analysis and site-directed mutagenesis, and further confirmed the same with a site-specific antibody. Results from our functional studies showed that Threonine 209 phosphorylation in Runx3 alters its subcellular localization by protein mislocalization from the nucleus to the cytoplasm and subsequently converses its biological functions. This was further supported by in vivo tumor xenograft studies in nude mouse models which clearly demonstrated that PANC-28 cells transfected with the Runx3-T209E clone showed high tumorigenic potential as compared with other clones. Our results from clinical samples also suggest that Threonine 209 phosphorylation by Pak1 could be a potential therapeutic target and of great clinical relevance with implications for Runx3 inactivation in cancer cells where Runx3 is known to be oncogenic. The findings presented in this study provide evidence of Runx3-Threonine 209 phosphorylation as a molecular switch in dictating the tissue-specific dualistic functions of Runx3 for the first time.	[Kumar, A.; Singhal, M.; Chopra, C.; Srinivasan, S.; Surabhi, R. P.; Kanumuri, R.; Tentu, S.; Jagadeeshan, S.; Rayala, S. K.] IITM, Dept Biotechnol, Madras 600036, Tamil Nadu, India; [Sundaram, S.; Ramanathan, K.] Sri Ramachandra Univ, Dept Pathol, Madras, Tamil Nadu, India; [Pitani, R. Shankar] Sri Ramachandra Univ, Dept Community Med, Madras, Tamil Nadu, India; [Muthuswamy, B.; Abhijit, S.] MDRF, Madras, Tamil Nadu, India; [Nair, A. S.] RGCB, Thiruvananthapuram, Kerala, India; [Venkatraman, G.] Sri Ramachandra Univ, Dept Human Genet, Madras, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Sri Ramachandra Institute of Higher Education & Research; Sri Ramachandra Institute of Higher Education & Research; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Sri Ramachandra Institute of Higher Education & Research	Rayala, SK (corresponding author), IITM, Dept Biotechnol, Madras 600036, Tamil Nadu, India.; Venkatraman, G (corresponding author), Sri Ramachandra Univ, Dept Human Genet, Madras, Tamil Nadu, India.	ganeshv@sriramachandra.edu.in; rayala@iitm.ac.in	Venkatraman, Ganesh/AAB-1467-2020; Singhal, Mahak/V-4017-2019; CHELLUBOYINA, ARUNA KUMAR/GZL-7536-2022; GAMPALA, SILPA/A-1541-2019; Gampala, Silpa/AAL-7982-2020; CHELLUBOYINA, ARUNA KUMAR/GXG-8165-2022; JAGADEESHAN, SANKAR/S-8384-2019; Kanumuri, Rahul Sankrityayan/AGF-8012-2022	Venkatraman, Ganesh/0000-0003-0179-9785; Singhal, Mahak/0000-0002-7303-9585; CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; Gampala, Silpa/0000-0001-9928-3941; CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; JAGADEESHAN, SANKAR/0000-0002-3778-8757; Kanumuri, Rahul Sankrityayan/0000-0001-6039-461X; Chopra, Chirag/0000-0002-7239-709X; Rayala, Suresh/0000-0003-4394-4450	DAE-BRNS Government of India [35/14/41/2014-BRNS-RTAC]; DBT Government of India [BT/PR14340/NNT/28/860/2015]	DAE-BRNS Government of India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS)); DBT Government of India(Department of Biotechnology (DBT) India)	We thank Prof Yoshiaki Ito, Cancer Science Institute of Singapore, Singapore, for providing us the Runx3 constructs. We profusely thank Prof Susanne M Gollin, University of Pittsburgh, for providing us with SCC-131 cells. We thank Dr Marsha Fraizer (University of Texas, M. D. Anderson Cancer Center, USA); for providing MDA Panc 28 cells. We thank Dr Rajeshwari, Bioklone, Chennai, for generating polyclonal Runx3-Threonine 209 phospho antibody. We thank DAE-BRNS (Grant # 35/14/41/2014-BRNS-RTAC), DBT (BT/PR14340/NNT/28/860/2015) Government of India for financial support to SKR and the Department of Biotechnology, Indian Institute of Technology Madras (IITM) for infrastructural facilities. We thank Mr Balabhaskara Rao and Ms Lakshmi Arivazhagan for the initial help with protein expression studies and Runx3 clones. We thank Professor SP Thyagarajan, Dean Research and Management of SRU for Support and encouragement.	Bae SC, 2006, GENE, V366, P58, DOI 10.1016/j.gene.2005.10.017; Bae SC, 2004, ONCOGENE, V23, P4336, DOI 10.1038/sj.onc.1207286; Baross JA, 2015, CELL, V162, P13, DOI 10.1016/j.cell.2015.06.038; Chauang LS, 2013, INT J CANCER, V15, P1260; Chi XZ, 2005, MOL CELL BIOL, V25, P8097, DOI 10.1128/MCB.25.18.8097-8107.2005; Chuang LSH, 2010, ONCOGENE, V29, P2605, DOI 10.1038/onc.2010.88; Chuang LSH, 2013, INT J CANCER, V132, P1260, DOI 10.1002/ijc.27964; Goh YM, 2010, J BIOL CHEM, V285, P10122, DOI 10.1074/jbc.M109.071381; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito Y, 2004, ONCOGENE, V23, P4198, DOI 10.1038/sj.onc.1207755; Kim WJ, 2005, CANCER RES, V65, P9347, DOI 10.1158/0008-5472.CAN-05-1647; Kudo Y, 2011, J CELL BIOCHEM, V112, P387, DOI 10.1002/jcb.22967; Kumar R, 2006, NAT REV CANCER, V6, P459, DOI 10.1038/nrc1892; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee CWL, 2011, GYNECOL ONCOL, V122, P410, DOI 10.1016/j.ygyno.2011.04.044; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Tsang YHN, 2013, ONCOGENE, V32, P1488, DOI 10.1038/onc.2012.178; Tsunematsu T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005892; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x	19	6	6	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4857	4865		10.1038/onc.2016.18	http://dx.doi.org/10.1038/onc.2016.18			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26898755				2022-12-26	WOS:000383330700004
J	Bernal-Ulloa, SM; Heinzmann, J; Herrmann, D; Hadeler, KG; Aldag, P; Winkler, S; Pache, D; Baulain, U; Lucas-Hahn, A; Niemann, H				Bernal-Ulloa, Sandra Milena; Heinzmann, Julia; Herrmann, Doris; Hadeler, Klaus-Gerd; Aldag, Patrick; Winkler, Sylke; Pache, Dorit; Baulain, Ulrich; Lucas-Hahn, Andrea; Niemann, Heiner			Cyclic AMP Affects Oocyte Maturation and Embryo Development in Prepubertal and Adult Cattle	PLOS ONE			English	Article							IN-VITRO MATURATION; DNA METHYLATION; GENE-EXPRESSION; CALF OOCYTES; GONADOTROPIN STIMULATION; PHYSIOLOGICAL FUNCTIONS; PRIMORDIAL FOLLICLES; MEIOTIC PROGRESSION; BOVINE EMBRYOS; MOUSE OVARY	High cAMP levels during in vitro maturation (IVM) have been related to improved blastocyst yields. Here, we employed the cAMP/cGMP modulators, forskolin, IBMX, and cilostamide, during IVM to unravel the role of high cAMP in early embryonic development produced from prepubertal and adult bovine oocytes. Oocytes were collected via transvaginal aspiration and randomly assigned to three experimental groups: TCM24 (24h IVM/control), cAMP30 (2h pre-IVM (forskolin-IBMX), 30h IVM-cilostamide), and DMSO30 (Dimethyl Sulfoxide/vehicle control). After IVM, oocytes were fertilized in vitro and zygotes were cultured in vitro to blastocysts. Meiotic progression, cAMP levels, mRNA abundance of selected genes and DNA methylation were evaluated in oocytes. Blastocysts were used for gene expression or DNA methylation analyses. Blastocysts from the cAMP30 groups were transferred to recipients. The cAMP elevation delayed meiotic progression, but developmental rates were not increased. In immature oocytes, mRNA abundance of PRKACA was higher for cAMP30 protocol and no differences were found for PDE3A, SMAD2, ZAR1, PRDX1 and SLC2A8. EGR1 gene was up-regulated in prepubertal cAMP30 immature oocytes and down-regulated in blastocysts from all in vitro treatments. A similar gene expression profile was observed for DNMT3b, BCL2L1, PRDX1 and SLC2A8 in blastocysts. Satellite DNA methylation profiles were different between prepubertal and adult oocytes and blastocysts derived from the TCM24 and DMSO30 groups. Blastocysts obtained from prepubertal and adult oocytes in the cAMP30 treatment displayed normal methylation profiles and produced offspring. These data indicate that cAMP regulates IVM in prepubertal and adult oocytes in a similar manner, with impact on the establishment of epigenetic marks and acquisition of full developmental competency.	[Bernal-Ulloa, Sandra Milena; Heinzmann, Julia; Herrmann, Doris; Hadeler, Klaus-Gerd; Aldag, Patrick; Baulain, Ulrich; Lucas-Hahn, Andrea; Niemann, Heiner] Friedrich Loeffler Inst, Inst Farm Anim Genet, Biotechnol, Mariensee, Germany; [Bernal-Ulloa, Sandra Milena] Univ Ciencias Aplicadas & Ambientales, Fac Ciencias Agr, Bogota, Colombia; [Winkler, Sylke; Pache, Dorit] Max Planck Inst Mol Cell Biol & Genet, DNA Sequencing Facil, Dresden, Germany	Friedrich Loeffler Institute; Max Planck Society	Niemann, H (corresponding author), Friedrich Loeffler Inst, Inst Farm Anim Genet, Biotechnol, Mariensee, Germany.	heiner.niemann@fli.bund.de			DFG Research Group "Germ Cell potential" [FOR 1041, Ni 256/ 30-2, Ni 256/ 30-3]; German Academic Exchange service (DAAD)	DFG Research Group "Germ Cell potential"; German Academic Exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported in part by the DFG Research Group "Germ Cell potential" (FOR 1041; Ni 256/ 30-2 and 3). Sandra Milena Bernal-Ulloa was supported by the German Academic Exchange service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; ARMSTRONG DT, 1994, THERIOGENOLOGY, V42, P1227, DOI 10.1016/0093-691X(94)90871-0; Avery B, 2000, MOL REPROD DEV, V55, P438, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;438::AID-MRD12&gt;3.0.CO;2-Y; Bagg MA, 2006, MOL REPROD DEV, V73, P1326, DOI 10.1002/mrd.20555; Bernal SM, 2014, ZYGOTE, P1, DOI [10.1017/S0967199413000658, DOI 10.1017/S0967199413000658]; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019464; BRUOT BC, 1986, J ENDOCRINOL INVEST, V9, P171, DOI 10.1007/BF03348091; BUNGARTZ L, 1994, J REPROD FERTIL, V101, P583, DOI 10.1530/jrf.0.1010583; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Diederich M, 2012, REPRODUCTION, V144, P319, DOI 10.1530/REP-12-0134; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Enukashvily NI, 2013, ADV PROTEIN CHEM STR, V90, P31, DOI 10.1016/B978-0-12-410523-2.00002-X; Estes SJ, 2015, ENDOCRIN METAB CLIN, V44, P799, DOI 10.1016/j.ecl.2015.07.005; Fry RC, 1998, THERIOGENOLOGY, V49, P1077, DOI 10.1016/S0093-691X(98)00057-0; Gilchrist RB, 2015, THERIOGENOLOGY, V84, P656, DOI 10.1016/j.theriogenology.2015.03.032; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Grupen CG, 2006, REPROD FERT DEVELOP, V18, P309, DOI 10.1071/RD05125; Guimaraes ALS, 2015, THERIOGENOLOGY, V83, P52, DOI 10.1016/j.theriogenology.2014.07.042; Han D, 2010, REPRODUCTION, V139, P959, DOI 10.1530/REP-09-0485; Heinzmann J, 2015, MOL HUM REPROD, V21, P770, DOI 10.1093/molehr/gav040; Kang YK, 2005, MOL REPROD DEV, V71, P29, DOI 10.1002/mrd.20249; Kauffold J, 2005, J REPROD DEVELOP, V51, P325, DOI 10.1262/jrd.17002; Khatir H, 1998, THERIOGENOLOGY, V50, P1201, DOI 10.1016/S0093-691X(98)00220-9; Ledda S, 2001, BIOL REPROD, V65, P247, DOI 10.1095/biolreprod65.1.247; Li BL, 2006, BIOCHEM BIOPH RES CO, V350, P179, DOI 10.1016/j.bbrc.2006.09.016; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Oktay K, 2016, J PEDIATR ADOL GYNEC, V29, P409, DOI 10.1016/j.jpag.2015.10.011; Oropeza A, 2004, BIOL REPROD, V70, P1634, DOI 10.1095/biolreprod.103.025494; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; R Development Core Team, 2014, R LANG ENV STAT COMP; REVEL F, 1995, J REPROD FERTIL, V103, P115, DOI 10.1530/jrf.0.1030115; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; SAS Institute, 2008, SAS SYST WIND REL 9; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Stinshoff H, 2014, REPROD FERT DEVELOP, V26, P502, DOI 10.1071/RD12372; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; Taneja M, 2000, BIOL REPROD, V62, P206, DOI 10.1095/biolreprod62.1.206; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; Urrego R, 2014, EPIGENETICS-US, V9, P803, DOI 10.4161/epi.28711; Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Zaraza J, 2010, THERIOGENOLOGY, V74, P75, DOI 10.1016/j.theriogenology.2009.11.033; Zeng HT, 2013, HUM REPROD, V28, P1536, DOI 10.1093/humrep/det086; Zhang GM, 2013, THERIOGENOLOGY, V80, P328, DOI 10.1016/j.theriogenology.2013.04.019; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	53	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150264	10.1371/journal.pone.0150264	http://dx.doi.org/10.1371/journal.pone.0150264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926596	Green Published, Green Submitted, gold			2022-12-26	WOS:000371424200033
J	Yang, YL; Qian, MY; Yi, SQ; Liu, SL; Li, B; Yu, R; Guo, Q; Zhang, XP; Yu, CM; Li, JM; Xu, JJ; Chen, W				Yang, Yilong; Qian, Mengying; Yi, Shaoqiong; Liu, Shuling; Li, Bing; Yu, Rui; Guo, Qiang; Zhang, Xiaopeng; Yu, Changming; Li, Jianmin; Xu, Junjie; Chen, Wei			Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice	PLOS ONE			English	Article							INFECTIONS; DIALYSIS; SEQUENCE; PREVENTION; THERAPY; DISEASE; BINDING; ISAA	Epidemic methicillin-resistant Staphylococcus aureus (MRSA) imposes an increasing impact on public health. Due to multi-antibiotics resistance in MRSA strains, there is an urgent need to develop novel therapeutics such as effective monoclonal antibodies (mAbs) against MRSA infections. Staphylococcus aureus surface protein A (SasA), a large surface-located protein (similar to 240 kDa), is one of MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) and a potential target for immunotherapeutic approaches against S. aureus infections. In the present study, we analyzed the sequence of SasA with bioinformatics tools and generated a protective monoclonal antibody (2H7) targeting the conserved domain of SasA. 2H7 was shown to recognize wild-type S. aureus and promote opsonophagocytic killing of S. aureus. In both sepsis and peritoneal infection models, prophylactic administration of 2H7 improved the survival of BALB/c mice challenged by S. aureus strain USA300 and ST239 (prevalent MRSA clones in North America and Asian countries, respectively) and enhanced bacterial clearance in kidneys. Additionally, 2H7 prophylaxis prevented the formation of intraperitoneal abscess in a murine model of peritoneal infection and therapeutic administration of 2H7 showed protective efficacy in a murine sepsis model. Our results presented here provide supporting evidences that an anti-SasA mAb might be a potential component in an antibody-based immunotherapeutic treatment of MRSA infections.	[Yang, Yilong; Qian, Mengying; Yi, Shaoqiong; Liu, Shuling; Yu, Rui; Guo, Qiang; Zhang, Xiaopeng; Yu, Changming; Li, Jianmin; Xu, Junjie; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China; [Li, Bing] Peoples Liberat Army, Hosp 306, Dept Clin Lab, Beijing, Peoples R China		Chen, W (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China.	cw0226@foxmail.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Major Scientific and Technological Special Project for prevention and control of infectious disease [2013ZX1004001]	National Major Scientific and Technological Special Project for prevention and control of infectious disease	This study was supported by grants from the National Major Scientific and Technological Special Project for prevention and control of infectious disease ( grant no. 2013ZX1004001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Govindarajulu S, 2010, PERITON DIALYSIS INT, V30, P311, DOI 10.3747/pdi.2008.00258; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Hilliard JJ, 2015, ANTIMICROB AGENTS CH, V59, P299, DOI 10.1128/AAC.03918-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lorenz U, 2011, ANTIMICROB AGENTS CH, V55, P165, DOI 10.1128/AAC.01144-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nguyen DB, 2013, CLIN INFECT DIS, V57, P1393, DOI 10.1093/cid/cit546; Pancari G, 2012, FRONTIERS CELLULAR I; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Park S, 2014, INFECT IMMUN, V82, P5049, DOI 10.1128/IAI.02373-14; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Provenza G, 2010, FEBS J, V277, P4490, DOI 10.1111/j.1742-4658.2010.07835.x; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Saylor C, 2009, VACCINE, V27, pG38, DOI 10.1016/j.vaccine.2009.09.105; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; van den Berg S, 2015, INT J MED MICROBIOL, V305, P55, DOI 10.1016/j.ijmm.2014.11.002; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Weisman LE, 2009, ANTIMICROB AGENTS CH, V53, P2879, DOI 10.1128/AAC.01565-08; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Yi SQ, 2012, MICROBIOL IMMUNOL, V56, P406, DOI 10.1111/j.1348-0421.2012.00451.x; Zacharioudakis IM, 2014, J AM SOC NEPHROL, V25, P2131, DOI 10.1681/ASN.2013091028	37	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149460	10.1371/journal.pone.0149460	http://dx.doi.org/10.1371/journal.pone.0149460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926145	Green Submitted, Green Published, gold			2022-12-26	WOS:000371424200011
J	Alabi, OJ; Casassa, F; Gutha, LR; Larsen, RC; Henick-Kling, T; Harbertson, JF; Naidu, RA				Alabi, Olufemi J.; Casassa, Federico; Gutha, Linga R.; Larsen, Richard C.; Henick-Kling, Thomas; Harbertson, James F.; Naidu, Rayapati A.			Impacts of Grapevine Leafroll Disease on Fruit Yield and Grape and Wine Chemistry in a Wine Grape (Vitis vinifera L.) Cultivar	PLOS ONE			English	Article							VIRUSES GLRAV-2 AND-3; SUGAR ACCUMULATION; QUALITY; PERFORMANCE; TRANSMISSION; PHYSIOLOGY; INFECTION; FAMILY; GENUS	Grapevine leafroll disease (GLD) is an economically important virus disease affecting wine grapes (Vitis vinifera L.), but little is known about its effect on wine chemistry and sensory composition of wines. In this study, impacts of GLD on fruit yield, berry quality and wine chemistry and sensory features were investigated in a red wine grape cultivar planted in a commercial vineyard. Own-rooted Merlot vines showing GLD symptoms and tested positive for Grapevine leafroll-associated virus 3 and adjacent non-symptomatic vines that tested negative for the virus were compared during three consecutive seasons. Number and total weight of clusters per vine were significantly less in symptomatic relative to non-symptomatic vines. In contrast to previous studies, a time-course analysis of juice from grapes harvested at different stages of berry development from symptomatic and non-symptomatic vines indicated more prominent negative impacts of GLD on total soluble solids (TSS) and berry skin anthocyanins than in juice pH and titratable acidity. Differences in TSS between grapes of symptomatic and non-symptomatic vines were more pronounced after the onset of veraison, with significantly lower concentrations of TSS in grapes from symptomatic vines throughout berry ripening until harvest. Wines made from grapes of GLD-affected vines had significantly lower alcohol, polymeric pigments, and anthocyanins compared to corresponding wines from grapes of non-symptomatic vines. Sensory descriptive analysis of 2010 wines indicated significant differences in color, aroma and astringency between wines made from grapes harvested from GLD-affected and unaffected vines. The impacts of GLD on yield and fruit and wine quality traits were variable between the seasons, with greater impacts observed during a cooler season, suggesting the influence of host plant x environment interactions on overall impacts of the disease.	[Alabi, Olufemi J.; Gutha, Linga R.; Naidu, Rayapati A.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA; [Casassa, Federico; Larsen, Richard C.; Henick-Kling, Thomas; Harbertson, James F.] Washington State Univ, Viticulture & Enol Program, Wine Sci Ctr, 2710 Crimson Way, Richland, WA USA; [Alabi, Olufemi J.] Texas A&M AgriLife Res & Extens Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Casassa, Federico] Calif Polytech State Univ San Luis Obispo, Wine & Viticulture Dept, San Luis Obispo, CA 93407 USA; [Gutha, Linga R.] EI DuPont India Pvt Ltd, DuPont Knowledge Ctr Hyderabad, Hyderabad, Andhra Pradesh, India	Washington State University; Washington State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; California State University System; California Polytechnic State University San Luis Obispo	Naidu, RA (corresponding author), Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA.	naidu.rayapati@wsu.edu	Alabi, Olufemi J./ABD-9930-2020	Alabi, Olufemi J./0000-0002-2471-7052; Rayapati, Naidu/0000-0002-7273-5116	Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences; Wine Advisory Committee; Washington Wine Commission; Washington State Grape & Wine Research Program; USDA-NIFA-Specialty Crop Research Initiative [2009-51181-06027]; USDA Northwest Center for Small Fruits Research; USDA-NIFA -Specialty Crop Research Initiative [2009-51181- 06027]; Hatch Project [WNPO 0616]	Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences; Wine Advisory Committee; Washington Wine Commission; Washington State Grape & Wine Research Program; USDA-NIFA-Specialty Crop Research Initiative; USDA Northwest Center for Small Fruits Research; USDA-NIFA -Specialty Crop Research Initiative; Hatch Project(United States Department of Agriculture (USDA))	This study was funded, in part, by the Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences, the Wine Advisory Committee, the Washington Wine Commission, and Washington State Grape & Wine Research Program, USDA-NIFA-Specialty Crop Research Initiative (Award No. 2009-51181-06027) and USDA Northwest Center for Small Fruits Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded, in part, by the Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences, the Wine Advisory Committee, the Washington Wine Commission, and Washington State Grape & Wine Research Program, USDA-NIFA -Specialty Crop Research Initiative (Award No. 2009-51181- 06027) and USDA Northwest Center for Small Fruits Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Maria Mireles and Christopher W. Beaver for their technical assistance and an anonymous commercial grower for providing the vineyard site for conducting our study. PPNS# 0711, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences Agricultural Research Center, Hatch Project No. WNPO 0616, Washington State University, Pullman 99164.	Al Rwahnih M, 2012, VIRUS RES, V163, P302, DOI 10.1016/j.virusres.2011.10.018; Alabi OJ, 2012, P 17 C INT COUNC STU, P170; Alabi OJ, 2012, MOL PLANT PATHOL, V13, P1060, DOI 10.1111/j.1364-3703.2012.00815.x; Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Basso MF, 2010, TROP PLANT PATHOL, V35, P351, DOI 10.1590/S1982-56762010000600003; BOWER JA, 1995, NUTR FOOD SCI, V6, P35, DOI DOI 10.1108/00346659510103647; Casassa LF, 2013, AUST J GRAPE WINE R, V19, P25, DOI 10.1111/ajgw.12009; Castellano M. A., 2000, Journal of Plant Pathology, V82, P9; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; Chloupek O, 2004, FIELD CROP RES, V85, P167, DOI 10.1016/S0378-4290(03)00162-X; Cookson SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-147; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Dai ZW, 2011, AM J ENOL VITICULT, V62, P413, DOI 10.5344/ajev.2011.10116; Dal Santo S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r54; Giribaldi M, 2011, J PROTEOMICS, V75, P306, DOI 10.1016/j.jprot.2011.08.006; Golino D. A., 2009, 16 M ICVG DIJ FRANC, P243; Guidoni S, 2008, AM J ENOL VITICULT, V59, P22; Harbertson JF, 2003, AM J ENOL VITICULT, V54, P301; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hayasaka Y, 2003, AUST J GRAPE WINE R, V9, P210, DOI 10.1111/j.1755-0238.2003.tb00272.x; HOLM S, 1979, SCAND J STAT, V6, P65; HUNTER J J, 1988, South African Journal for Enology and Viticulture, V9, P3; Illand P., 2000, TECHNIQUES CHEM ANAL, P111; Jones GV, 2000, AM J ENOL VITICULT, V51, P249; Komar V, 2010, AM J ENOL VITICULT, V61, P68; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Le Maguet J, 2012, PHYTOPATHOLOGY, V102, P717, DOI 10.1094/PHYTO-10-11-0289; Lee JM, 2009, FOOD CHEM, V112, P889, DOI 10.1016/j.foodchem.2008.06.065; Lee J, 2009, FOOD CHEM, V117, P99, DOI 10.1016/j.foodchem.2009.03.082; Legrand H, 1945, J OPT SOC AM, V35, P268; Mannini F, 2012, AM J ENOL VITICULT, V63, P144, DOI 10.5344/ajev.2011.11020; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Martelli GP, 2012, J PLANT PATHOL, V94, P7; Martelli GP, 2014, J PLANT PATHOL, V96, P1; Meilgaard MC, 2006, SENS EV TECHN 5 ED, V4th, DOI DOI 10.1201/B16452; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; MOTOMURA Y, 1993, AM J ENOL VITICULT, V44, P1; Naidu R. A., 2011, WSU VITICULTURE ENOL, P6; Naidu R, 2014, PLANT DIS, V98, P1172, DOI 10.1094/PDIS-08-13-0880-FE; Naidu RA, 2015, ANNU REV PHYTOPATHOL, V53, P613, DOI 10.1146/annurev-phyto-102313-045946; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Poojari S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-324; Rayapati A. N., 2008, WSU EXTENSION B; SPAYD SE, 2002, AM J ENOL VITICULT, V53, P3; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Wallis CM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00502; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207	49	39	39	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149666	10.1371/journal.pone.0149666	http://dx.doi.org/10.1371/journal.pone.0149666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919614	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400033
J	Holt, LM; Olsen, ML				Holt, Leanne Melissa; Olsen, Michelle Lynne			Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System	PLOS ONE			English	Article							ADULT-RAT-BRAIN; RETT-SYNDROME; MOUSE-BRAIN; VASCULAR CELLS; IN-VITRO; ASTROCYTES; MICROGLIA; NEURONS; TRANSCRIPTOME; MECP2	The isolation and study of cell-specific populations in the central nervous system (CNS) has gained significant interest in the neuroscience community. The ability to examine cell-specific gene and protein expression patterns in healthy and pathological tissue is critical for our understanding of CNS function. Several techniques currently exist to isolate cell-specific populations, each having their own inherent advantages and shortcomings. Isolation of distinct cell populations using magnetic sorting is a technique which has been available for nearly 3 decades, although rarely used in adult whole CNS tissue homogenate. In the current study we demonstrate that distinct cell populations can be isolated in rodents from early postnatal development through adulthood. We found this technique to be amendable to customization using commercially available membrane-targeted antibodies, allowing for cell-specific isolation across development and animal species. This technique yields RNA which can be utilized for downstream applications-including quantitative PCR and RNA sequencing-at relatively low cost and without the need for specialized equipment or fluorescently labeled cells. Adding to its utility, we demonstrate that cells can be isolated largely intact, retaining their processes, enabling analysis of extrasomatic proteins. We propose that magnetic cell sorting will prove to be a highly useful technique for the examination of cell specific CNS populations.	[Holt, Leanne Melissa; Olsen, Michelle Lynne] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Olsen, Michelle Lynne] Univ Alabama Birmingham, Ctr Glial Biol Med, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Olsen, ML (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.; Olsen, ML (corresponding author), Univ Alabama Birmingham, Ctr Glial Biol Med, Birmingham, AL USA.	molsen@uab.edu		Olsen, Michelle/0000-0003-1394-664X; Holt, Leanne/0000-0003-0954-2298	National Institutes of Health [R01 NS075062];  [P30AR48311];  [CA13148];  [AI027767]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01 NS075062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank E. Keyser from the UAB Flow Cytometry Facility (core supported by P30AR48311) who performed FAC sorting of eGFP+ astrocytes and the Heflin Center for Genomic Science Genomics Core facility (supported by CA13148 and AI027767) who analyzed RNA quality.	Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadi G, 2009, J MOL HISTOL, V40, P241, DOI 10.1007/s10735-009-9235-0; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dincman TA, 2012, J NEUROSCI METH, V209, P219, DOI 10.1016/j.jneumeth.2012.06.017; Dong WJ, 2009, J LIPID RES, V50, P2095, DOI 10.1194/jlr.M900236-JLR200; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Feldmann M, 2014, J BIOL METHODS, V1; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Foo Lynette C, 2013, Cold Spring Harb Protoc, V2013, P421, DOI 10.1101/pdb.prot074211; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Gilliam D, 2014, JVETINTERNMED; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Harms Ashley S, 2013, Methods Mol Biol, V1041, P33, DOI 10.1007/978-1-62703-520-0_5; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Jacob AL, 2015, HIPPOCAMPUS, V25, P798, DOI 10.1002/hipo.22404; Jungblut M, 2012, GLIA, V60, P894, DOI 10.1002/glia.22322; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Losciuto S, 2012, J NEUROSCI METH, V207, P59, DOI 10.1016/j.jneumeth.2012.03.010; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Matsutani S, 1997, GLIA, V20, P1, DOI 10.1002/(SICI)1098-1136(199705)20:1<1::AID-GLIA1>3.0.CO;2-E; McCullumsmith RE, 2011, BIOL PSYCHIAT, V69, P127, DOI 10.1016/j.biopsych.2010.09.035; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagy JI, 2003, CELL COMMUN ADHES, V10, P401, DOI 10.1080/15419060390263191; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nwaobi S, 2013, DNA METHYLATION IS C; Nwaobi SE, 2014, GLIA, V62, P411, DOI 10.1002/glia.22613; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Smith SMC, 2014, ASN NEURO, V6, DOI 10.1042/AN20130050; Standaert DG, 2005, ARCH NEUROL-CHICAGO, V62, P203, DOI 10.1001/archneur.62.2.203; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	44	47	48	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150290	10.1371/journal.pone.0150290	http://dx.doi.org/10.1371/journal.pone.0150290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919701	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400119
J	Zhu, QZ; Zhang, YF; Liu, YL; Cheng, H; Wang, J; Zhang, Y; Rui, YC; Li, TJ				Zhu, Qiuzhen; Zhang, Yuefan; Liu, Yulan; Cheng, Hao; Wang, Jing; Zhang, Yue; Rui, Yaocheng; Li, Tiejun			MLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; APOPTOSIS; PROTEIN; EXPRESSION; EEF1A2; CELLS; RAT; FACTOR-1-ALPHA; PROLIFERATION	Monocyte locomotion inhibitory factor (MLIF), a heat-stable pentapeptide, has been shown to exert potent anti-inflammatory effects in ischemic brain injury. In this study, we investigated the neuroprotective action of MLIF against oxygen-glucose deprivation (OGD)-induced injury in human neuroblastoma SH-SY5Y cells. MTT assay was used to assess cell viability, and flow cytometry assay and Hoechst staining were used to evaluate apoptosis. LDH assay was used to exam necrosis. The release of inflammatory cytokines was detected by ELISA. Levels of the apoptosis associated proteins were measured by western blot analysis. To identify the protein target of MLIF, pull-down assay and mass spectrometry were performed. We observed that MLIF enhanced cell survival and inhibited apoptosis and necrosis by inhibiting p-JNK, p53, c-caspase9 and c-caspase3 expression. In the microglia, OGD-induced secretion of inflammatory cytokines was markedly reduced in the presence of MLIF. Furthermore, we found that eukaryotic translation elongation factor 1A2 (eEF1A2) is a downstream target of MLIF. Knockdown eEF1A2 using short interfering RNA (siRNA) almost completely abrogated the anti-apoptotic effect of MLIF in SH-SY5Y cells subjected to OGD, with an associated decrease in cell survival and an increase in expression of pJNK and p53. These results indicate that MLIF ameliorates OGD-induced SH-SY5Y neuroblastoma injury by inhibiting the p-JNK/p53 apoptotic signaling pathway via eEF1A2. Our findings suggest that eEF1A2 may be a new therapeutic target for ischemic brain injury.	[Zhu, Qiuzhen; Zhang, Yuefan; Liu, Yulan; Rui, Yaocheng; Li, Tiejun] Second Mil Med Univ, Dept Pharmacol, Coll Pharm, Shanghai, Peoples R China; [Cheng, Hao; Wang, Jing; Zhang, Yue] Anhui Univ Chinese Med, Coll Pharm, Hefei, Anhui, Peoples R China	Naval Medical University; Anhui University of Chinese Medicine	Rui, YC; Li, TJ (corresponding author), Second Mil Med Univ, Dept Pharmacol, Coll Pharm, Shanghai, Peoples R China.	ruiyc163@163.com; ltj204@163.com	zhang, yuefan/AEE-5392-2022		Shanghai Natural Science Foundation [12ZR1437600]; Shanghai Science and Technology Committee; Shanghai Science and Technology Transformation and Industrialization [15431908500]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013ZX09103001-005]; Ministry of Science and Technology of China	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Science and Technology Transformation and Industrialization; National Science and Technology Major Project of the Ministry of Science and Technology of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported by 3 funds. 1. Shanghai Natural Science Foundation, Grant No. 12ZR1437600, funding institution: Shanghai Science and Technology Committee, website: http://www.stcsm.gov.cn/. 2. The Project of Shanghai Science and Technology Transformation and Industrialization, Grant No. 15431908500, funding institution: Shanghai Science and Technology Committee, website: http://www.stcsm.gov.cn/. 3. National Science and Technology Major Project of the Ministry of Science and Technology of China, Grant No. 2013ZX09103001-005, funding institution: the Ministry of Science and Technology of China, website: http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; ANN DK, 1992, J BIOL CHEM, V267, P699; Antonelli MC, 2012, NEUROTOX RES, V21, P49, DOI 10.1007/s12640-011-9265-8; Bermeo G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340727; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Chong ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045456; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Doig J, 2013, FEBS J, V280, P6528, DOI 10.1111/febs.12554; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Faheem M, 2015, CNS NEUROL DISORD-DR, V14, P468, DOI 10.2174/1871527314666150429111737; Gandin V, 2013, MOL CELL BIOL, V33, P2510, DOI 10.1128/MCB.01362-12; Gehringer M, 2015, EXPERT OPIN THER PAT, V25, P849, DOI 10.1517/13543776.2015.1039984; Gimenez Scherer JA, 1997, ARCH MED RES, V28, P237; Godina-Gonzalez S, 2010, INFLAMM RES, V59, P1041, DOI 10.1007/s00011-010-0224-2; Han QD, 2014, BRAIN RES, V1542, P176, DOI 10.1016/j.brainres.2013.10.026; Henderson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139273; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Li Y, 1994, STROKE, V25, P855; Li ZB, 2010, NATIONAL TEACHING SEMINAR ON CRYPTOGRAPHY AND INFORMATION SECURITY (2010NTS-CIS), PROCEEDINGS, P1; Lin LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136959; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Mori T, 2006, BIOORGAN MED CHEM, V14, P5549, DOI 10.1016/j.bmc.2006.04.028; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nakajima J, 2015, CLIN GENET, V87, P356, DOI 10.1111/cge.12394; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; Pan J, 2004, DEV BRAIN RES, V149, P1, DOI 10.1016/j.devbrainres.2003.10.011; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Schulz I, 2014, BBA-MOL CELL RES, V1843, P965, DOI 10.1016/j.bbamcr.2014.01.022; Silva-Garcia R, 2011, INFLAMM RES, V60, P111, DOI 10.1007/s00011-010-0261-x; Sun Y, 2014, BIOCHEM BIOPH RES CO, V450, P1, DOI 10.1016/j.bbrc.2014.05.045; Tendler DS, 2001, CANCER RES, V61, P3682; Tong XX, 2012, PEPTIDES, V38, P217, DOI 10.1016/j.peptides.2012.06.020; Topisirovic I, 2009, P NATL ACAD SCI USA, V106, P12676, DOI 10.1073/pnas.0900596106; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vlasenko DO, 2015, FEBS LETT, V589, P1187, DOI 10.1016/j.febslet.2015.03.030; Wang XL, 2012, PEPTIDES, V33, P298, DOI 10.1016/j.peptides.2011.12.015; Welser JV, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-89; Wen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062942; Yao J, 2011, PEPTIDES, V32, P1047, DOI 10.1016/j.peptides.2011.03.005; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3; Zhang HT, 2015, BRAIN RES, V1622, P474, DOI 10.1016/j.brainres.2015.07.004; Zhang YF, 2012, STROKE, V43, P2764, DOI 10.1161/STROKEAHA.112.657908; Zhang ZQ, 2015, ARCH VIROL, V160, P1449, DOI 10.1007/s00705-015-2403-5	54	18	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149965	10.1371/journal.pone.0149965	http://dx.doi.org/10.1371/journal.pone.0149965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918757	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400064
J	Turdalieva, A; Solandt, J; Shambetova, N; Xu, H; Blom, H; Brismar, H; Zelenina, M; Fu, Y				Turdalieva, Aizat; Solandt, Johan; Shambetova, Nestan; Xu, Hao; Blom, Hans; Brismar, Hjalmar; Zelenina, Marina; Fu, Ying			Bioelectric and Morphological Response of Liquid-Covered Human Airway Epithelial Calu-3 Cell Monolayer to Periodic Deposition of Colloidal 3-Mercaptopropionic-Acid Coated CdSe-CdS/ZnS Core-Multishell Quantum Dots	PLOS ONE			English	Article							PRIMARY CILIA; IN-VITRO; NANOPARTICLES; JUNCTIONS; TOXICITY; PROMOTES; MUCUS; LINE	Lung epithelial cells are extensively exposed to nanoparticles present in the modern urban environment. Nanoparticles, including colloidal quantum dots (QDs), are also considered to be potentially useful carriers for the delivery of drugs into the body. It is therefore important to understand the ways of distribution and the effects of the various types of nanoparticles in the lung epithelium. We use a model system of liquid-covered human airway epithelial Calu-3 cell cultures to study the immediate and long-term effects of repeated deposition of colloidal 3-mercaptopropionic-acid coated CdSe-CdS/ZnS core-multishell QDs on the lung epithelial cell surface. By live confocal microscope imaging and by QD fluorescence measurements we show that the QD permeation through the mature epithelial monolayers is very limited. At the time of QD deposition, the transepithelial electrical resistance (TEER) of the epithelial monolayers transiently decreased, with the decrement being proportional to the QD dose. Repeated QD deposition, once every six days for two months, lead to accumulation of only small amounts of the QDs in the cell monolayer. However, it did not induce any noticeable changes in the long-term TEER and the molecular morphology of the cells. The colloidal 3-mercaptopropionic-acid coated CdSe-CdS/ZnS core-multishell QDs could therefore be potentially used for the delivery of drugs intended for the surface of the lung epithelia during limited treatment periods.	[Turdalieva, Aizat; Shambetova, Nestan; Xu, Hao; Brismar, Hjalmar; Zelenina, Marina; Fu, Ying] Royal Inst Technol, Dept Appl Phys, Sci Life Lab, SE-10691 Stockholm, Sweden; [Solandt, Johan] AstraZeneca R&D, SE-43183 Molndal, Sweden; [Blom, Hans] Sci Life Lab, Adv Light Microscopy facil, Solna, Sweden	Royal Institute of Technology; AstraZeneca	Fu, Y (corresponding author), Royal Inst Technol, Dept Appl Phys, Sci Life Lab, SE-10691 Stockholm, Sweden.	fu@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003	Swedish Research Council [621-2011-4381]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was partially supported by Swedish Research Council (621-2011-4381). The funder provided support in the form of salaries for author Y. Fu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Babu Polani B Ramesh, 2005, Pediatr Crit Care Med, V6, P188; Balda MS, 1998, J CELL SCI, V111, P541; Banga A, 2012, CELL PHYSIOL BIOCHEM, V29, P197, DOI 10.1159/000337601; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chang YN, 2012, MATERIALS, V5, P2850, DOI 10.3390/ma5122850; Cohen JM, 2014, NANOTOXICOLOGY, V8, P216, DOI 10.3109/17435390.2013.879612; Florea BI, 2003, J CONTROL RELEASE, V87, P131, DOI 10.1016/S0168-3659(02)00356-5; Foster KA, 2000, INT J PHARMACEUT, V208, P1, DOI 10.1016/S0378-5173(00)00452-X; Fu Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/37003; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Haghi M, 2010, DRUG DEV IND PHARM, V36, P1207, DOI 10.3109/03639041003695113; Harcourt JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50157; Hoet Peter Hm, 2004, J Nanobiotechnology, V2, P12, DOI 10.1186/1477-3155-2-12; Hu QL, 2014, BIOCHEM CELL BIOL, V92, P547, DOI 10.1139/bcb-2014-0062; Jiang XE, 2010, ACS NANO, V4, P6787, DOI 10.1021/nn101277w; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Li L, 2013, J PHYS CHEM C, V117, P4844, DOI 10.1021/jp311975h; Liu SL, 2011, BIOMATERIALS, V32, P7616, DOI 10.1016/j.biomaterials.2011.06.046; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Mathias NR, 2002, J DRUG TARGET, V10, P31, DOI 10.1080/10611860290007504; McCarthy J, 2011, INT J NANOMED, V6, P1343, DOI 10.2147/IJN.S21145; Molnar M, 2010, CELL MED, V1, P105, DOI 10.3727/215517910X451603; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Morris-Cohen AJ, 2013, CHEM MATER, V25, P1155, DOI 10.1021/cm302108j; Nagy A, 2012, ACS NANO, V6, P4748, DOI 10.1021/nn204886b; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Rajan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066600; Ram S, 2012, BIOPHYS J, V103, P1594, DOI 10.1016/j.bpj.2012.08.054; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; Rotoli BM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1069-0; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Tan RS, 2015, ACS CHEM BIOL, V10, P2073, DOI 10.1021/acschembio.5b00434; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Zhu Y, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/394578	39	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149915	10.1371/journal.pone.0149915	http://dx.doi.org/10.1371/journal.pone.0149915			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913754	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700035
J	Sekar, K; Gentile, AM; Bostick, JW; Tyo, KEJ				Sekar, Karthik; Gentile, Andrew M.; Bostick, John W.; Tyo, Keith E. J.			N-Terminal-Based Targeted, Inducible Protein Degradation in Escherichia coli	PLOS ONE			English	Article							END RULE SUBSTRATE; SYNTHETIC BIOLOGY; CLPS; RECOGNITION; METABOLISM; MECHANISM; DEGRADOME; PROMOTER	Dynamically altering protein concentration is a central activity in synthetic biology. While many tools are available to modulate protein concentration by altering protein synthesis rate, methods for decreasing protein concentration by inactivation or degradation rate are just being realized. Altering protein synthesis rates can quickly increase the concentration of a protein but not decrease, as residual protein will remain for a while. Inducible, targeted protein degradation is an attractive option and some tools have been introduced for higher organisms and bacteria. Current bacterial tools rely on C-terminal fusions, so we have developed an N-terminal fusion (Ntag) strategy to increase the possible proteins that can be targeted. We demonstrate Ntag dependent degradation of mCherry and beta-galactosidase and reconfigure the Ntag system to perform dynamic, exogenously inducible degradation of a targeted protein and complement protein depletion by traditional synthesis repression. Model driven analysis that focused on rates, rather than concentrations, was critical to understanding and engineering the system. We expect this tool and our model to enable inducible protein degradation use particularly in metabolic engineering, biological study of essential proteins, and protein circuits.	[Sekar, Karthik; Bostick, John W.; Tyo, Keith E. J.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Gentile, Andrew M.] Northwestern Univ, Master Biotechnol Program, Evanston, IL USA; [Bostick, John W.] Northwestern Univ, Dept Pathol, Chicago, IL 60611 USA; [Bostick, John W.] Northwestern Univ, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University	Tyo, KEJ (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.	k-tyo@northwestern.edu	Tyo, Keith/H-6227-2012; Tyo, Keith/AAM-4543-2020	Tyo, Keith/0000-0002-2342-0687; Bostick, John/0000-0001-8925-2447; Sekar, Karthik/0000-0003-2045-9364	National Science Foundation Graduate Research Fellowship Program [DGE-0824162]; National Science Foundation Early Career Award [CBET 1452549]; Achievement Rewards for College Students - Chicago Chapter Scholar Award; McCormick School of Engineering Terminal Year Fellowship; Institute for Sustainability and Energy at Northwestern Early Career Investigator award; McCormick School of Engineering; Searle Leadership Fund; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Science Foundation Early Career Award(National Science Foundation (NSF)); Achievement Rewards for College Students - Chicago Chapter Scholar Award; McCormick School of Engineering Terminal Year Fellowship; Institute for Sustainability and Energy at Northwestern Early Career Investigator award; McCormick School of Engineering; Searle Leadership Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge funding from the National Science Foundation (http://www.nsf.gov/) Graduate Research Fellowship Program (K.S.) (Grant no. DGE-0824162), the National Science Foundation Early Career Award (Grant no. CBET 1452549), the Achievement Rewards for College Students (https://www.arcsfoundation.org/) - Chicago Chapter Scholar Award (K.S.), a McCormick School of Engineering (https://www.mccormick.northwestern.edu/) Terminal Year Fellowship (K.S.), the Institute for Sustainability and Energy at Northwestern (http://isen.northwestern.edu/) Early Career Investigator award, the McCormick School of Engineering, and Searle Leadership Fund (http://www.research.northwestern.edu/policies/searle.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bayer TS, 2005, NAT BIOTECHNOL, V23, P337, DOI 10.1038/nbt1069; Brockman IM, 2015, BIOTECHNOL J, V10, P1360, DOI 10.1002/biot.201400422; Brockman IM, 2015, METAB ENG, V28, P104, DOI 10.1016/j.ymben.2014.12.005; Cameron DE, 2014, NAT BIOTECHNOL, V32, P1276, DOI 10.1038/nbt.3053; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Cookson NA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.94; Daringer NM, 2014, ACS SYNTH BIOL, V3, P892, DOI 10.1021/sb400128g; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Daum G, 2014, P NATL ACAD SCI USA, V111, P14619, DOI 10.1073/pnas.1406446111; Davis JH, 2011, ACS CHEM BIOL, V6, P1205, DOI 10.1021/cb2001389; De Donatis GM, 2010, J BIOL CHEM, V285, P8771, DOI 10.1074/jbc.M109.053736; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; DENNIS PP, 1974, J MOL BIOL, V84, P407, DOI 10.1016/0022-2836(74)90449-5; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; Flynn JM, 2001, P NATL ACAD SCI USA, V98, P10584, DOI 10.1073/pnas.191375298; Gerosa L, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.14; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hintsche M, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-22; Humbard MA, 2013, J BIOL CHEM, V288, P28913, DOI 10.1074/jbc.M113.492108; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Klumpp S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020403; Knight J, 2014, E COMMUNICATION; LARRABEE KL, 1980, J BIOL CHEM, V255, P4125; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; McGinness KE, 2006, MOL CELL, V22, P701, DOI 10.1016/j.molcel.2006.04.027; MOSTELLER RD, 1980, J BIOL CHEM, V255, P2524; NATH K, 1971, J BIOL CHEM, V246, P6956; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; Prindle A, 2014, NATURE, V508, P387, DOI 10.1038/nature13238; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rodriguez-Limas WA, 2015, BIOTECHNOL BIOENG, V112, P376, DOI 10.1002/bit.25360; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; Sezonov G, 2007, J BACTERIOL, V189, P8746, DOI 10.1128/JB.01368-07; SKERRA A, 1994, GENE, V151, P131, DOI 10.1016/0378-1119(94)90643-2; Taxis C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.25; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; Torella JP, 2013, P NATL ACAD SCI USA, V110, P11290, DOI 10.1073/pnas.1307129110; Tyo KEJ, 2010, CURR OPIN MICROBIOL, V13, P255, DOI 10.1016/j.mib.2010.02.001; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Yu T, 2014, CELL RES, V24, P1214, DOI 10.1038/cr.2014.122; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	52	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149746	10.1371/journal.pone.0149746	http://dx.doi.org/10.1371/journal.pone.0149746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900850	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100141
J	Zhang, WP; Tian, FJ; Zheng, JP; Li, SL; Qiang, M				Zhang, Wenping; Tian, Fengjie; Zheng, Jinping; Li, Senlin; Qiang, Mei			Chronic Administration of Benzo(a)pyrene Induces Memory Impairment and Anxiety-Like Behavior and Increases of NR2B DNA Methylation	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RECEPTOR 2B SUBUNIT; NMDA RECEPTORS; BIPOLAR DISORDER; GENE-EXPRESSION; GRIN2B GENE; FEMALE MICE; F344 RATS; EXPOSURE; ASSOCIATION	Background Recently, an increasing number of human and animal studies have reported that exposure to benzo(a) pyrene (BaP) induces neurological abnormalities and is also associated with adverse effects, such as tumor formation, immunosuppression, teratogenicity, and hormonal disorders. However, the exact mechanisms underlying BaP-induced impairment of neurological function remain unclear. The aim of this study was to examine the regulating mechanisms underlying the impact of chronic BaP exposure on neurobehavioral performance. Methods C57BL mice received either BaP in different doses (1.0, 2.5, 6.25 mg/kg) or olive oil twice a week for 90 days. Memory and emotional behaviors were evaluated using Y-maze and open-field tests, respectively. Furthermore, levels of mRNA expression were measured by using qPCR, and DNA methylation of NMDA receptor 2B subunit (NR2B) was examined using bisulfate pyrosequencing in the prefrontal cortex and hippocampus. Results Compared to controls, mice that received BaP (2.5, 6.25 mg/kg) showed deficits in short-term memory and an anxiety-like behavior. These behavioral alterations were associated with a down-regulation of the NR2B gene and a concomitant increase in the level of DNA methylation in the NR2B promoter in the two brain regions. Conclusions Chronic BaP exposure induces an increase in DNA methylation in the NR2B gene promoter and down-regulates NR2B expression, which may contribute to its neurotoxic effects on behavioral performance. The results suggest that NR2B vulnerability represents a target for environmental toxicants in the brain.	[Zhang, Wenping; Tian, Fengjie; Zheng, Jinping] Shanxi Med Univ, Sch Publ Hlth, Dept Neurotoxicol, Taiyuan 030001, Shanxi, Peoples R China; [Qiang, Mei] Shanxi Med Univ, Sch Publ Hlth, Dept Children & Adolescences, Taiyuan 030001, Shanxi, Peoples R China; [Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA	Shanxi Medical University; Shanxi Medical University; University of Texas System; University of Texas Health San Antonio	Qiang, M (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Dept Children & Adolescences, Taiyuan 030001, Shanxi, Peoples R China.	qiang@uthscsa.edu			Science and Technology Innovation Fund of Shanxi Medical University [2010-01201006]; Shanxi Scholar Exchange Fund [2010-40]; Shanxi Scholarship Council of China [2015-051]	Science and Technology Innovation Fund of Shanxi Medical University; Shanxi Scholar Exchange Fund; Shanxi Scholarship Council of China	This work was supported by the Science and Technology Innovation Fund of Shanxi Medical University (Grant #2010-01201006 for Wenping Zhang) and the Shanxi Scholar Exchange Fund (Grant #2010-40 for Wenping Zhang) and Shanxi Scholarship Council of China (Grant #2015-051 For Mei Qiang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso P, 2012, J PSYCHIATR NEUROSCI, V37, P273, DOI 10.1503/jpn.110109; Altmann L, 2001, TOXICOL SCI, V61, P321, DOI 10.1093/toxsci/61.2.321; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Baraldi M, 2002, ENVIRON HEALTH PERSP, V110, P855, DOI 10.1289/ehp.02110s5855; Bouayed J, 2009, TOXICOLOGY, V259, P97, DOI 10.1016/j.tox.2009.02.010; Boyce-Rustay JM, 2006, PSYCHOPHARMACOLOGY, V187, P455, DOI 10.1007/s00213-006-0448-6; Brigman JL, 2010, J NEUROSCI, V30, P4590, DOI 10.1523/JNEUROSCI.0640-10.2010; Brown LA, 2007, NEUROTOXICOLOGY, V28, P965, DOI 10.1016/j.neuro.2007.05.005; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; Chen HH, 2004, ANN NY ACAD SCI, V1025, P552, DOI 10.1196/annals.1316.067; Cimino F, 2014, DRUG CHEM TOXICOL, V37, P32, DOI 10.3109/01480545.2013.806529; Cui YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020312; DAS M, 1985, B ENVIRON CONTAM TOX, V35, P500, DOI 10.1007/BF01636545; David R, 2016, ENVIRON HEALTH PERSP, V124, P88, DOI 10.1289/ehp.1409557; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fontan-Lozano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024915; Grova N, 2008, CHEMOSPHERE, V73, pS295, DOI 10.1016/j.chemosphere.2007.12.037; Grova N, 2007, NEUROTOXICOLOGY, V28, P630, DOI 10.1016/j.neuro.2007.01.010; IARC Monogr, 2011, IARC MONOGR EVAL CAR, P219; JAYASEKARA S, 1992, ECOTOX ENVIRON SAFE, V24, P1, DOI 10.1016/0147-6513(92)90029-3; Jiang HQ, 2009, NEUROSCI LETT, V450, P356, DOI 10.1016/j.neulet.2008.10.075; Kim SY, 2005, EXP MOL MED, V37, P58, DOI 10.1038/emm.2005.8; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Lett TA, 2014, BIOL PSYCHIAT, V75, P361, DOI 10.1016/j.biopsych.2013.07.026; Ma JH, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-33; Maciel ES, 2014, NEUROCHEM RES, V39, P731, DOI 10.1007/s11064-014-1261-y; Maddox SA, 2011, LEARN MEMORY, V18, P579, DOI 10.1101/lm.2243411; Martucci L, 2006, SCHIZOPHR RES, V84, P214, DOI 10.1016/j.schres.2006.02.001; McCallister MM, 2008, NEUROTOXICOLOGY, V29, P846, DOI 10.1016/j.neuro.2008.07.008; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Palaszewska-Tkacz A, 2015, MED PR, V66, P29; Patri M, 2013, J NEUROSCI RES, V91, P1450, DOI 10.1002/jnr.23265; Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742; Qiang M, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu072; Qiang M, 2011, EPIGENETICS-US, V6, P1095, DOI 10.4161/epi.6.9.16924; Qiang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008798; Qiu CY, 2013, AM J IND MED, V56, P347, DOI 10.1002/ajim.22119; Ramesh A, 2001, EXP TOXICOL PATHOL, V53, P275, DOI 10.1078/0940-2993-00192; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Saunders CR, 2002, TOXICOL LETT, V129, P33, DOI 10.1016/S0378-4274(01)00467-2; Schellenberger MT, 2013, TOXICOL APPL PHARM, V271, P175, DOI 10.1016/j.taap.2013.05.007; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Seripa D, 2008, DEMENT GERIATR COGN, V25, P287, DOI 10.1159/000118634; Stephanou P, 1998, EUR J DRUG METAB PH, V23, P475, DOI 10.1007/BF03189998; Sze CI, 2001, J NEUROL SCI, V182, P151, DOI 10.1016/S0022-510X(00)00467-6; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Verma N, 2012, PROTEOMICS, V12, P1731, DOI 10.1002/pmic.201100466; Wormley DD, 2004, CELL MOL BIOL, V50, P715; Wormley DD, 2004, TOXICOL APPL PHARM, V197, P49, DOI 10.1016/j.taap.2004.01.016; Xia YY, 2011, NEUROTOXICOLOGY, V32, P188, DOI 10.1016/j.neuro.2010.12.015; Yin XL, 2011, NEURON, V70, P310, DOI 10.1016/j.neuron.2011.02.049; Zhang XH, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-9; Zhao QA, 2011, PSYCHIAT RES, V185, P290, DOI 10.1016/j.psychres.2009.11.026	54	20	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149574	10.1371/journal.pone.0149574	http://dx.doi.org/10.1371/journal.pone.0149574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901155	gold, Green Submitted, Green Published			2022-12-26	WOS:000371276100100
J	Zhou, HH; Lv, K; Yang, RT; Li, Z; Li, ZB				Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing			Mechanics in the Production of Mandibular Fractures: A Clinical, Retrospective Case-Control Study	PLOS ONE			English	Article							CONDYLAR FRACTURES; 3RD MOLARS; MAXILLOFACIAL FRACTURES; DENTAL INJURIES; ANGLE FRACTURE; TRAUMA; ETIOLOGY; BODY; ASSOCIATION; SYMPHYSIS	As the mandible is susceptible to fracture, the aim of this study was to use multivariate logistic regression analysis to identify and distinguish various internal factors that may influence the location of mandibular fractures. The study included 1131 patients with maxillofacial fractures during the period from January 2000 to December 2009 to evaluate the association of mandibular fracture location (unilateral symphysis, body, angle, condylar, or bilateral condylar fractures) with various internal factors. Among the 1131 patients, 869 had mandibular fractures. Data on age, sex, soft tissue injuries, dental trauma, and maxillofacial fracture type were collected and analyzed using multivariate logistic regression. In total, 387, 210, 139, 319, and 172 patients were diagnosed with unilateral symphysis, body, angle, unilateral, or bilateral condylar fractures, respectively. The dental trauma in patients with bilateral condylar fractures differed from that in patients with unilateral condylar fractures. Patients with mandibular fracture (unilateral symphysis, body, unilateral or bilateral condylar) possessed an approximately equal risk of soft tissue injuries in the mandible. Patients with either unilateral or bilateral condylar fractures were associated with a low risk of mandibular angle fracture (OR < 1). Similarly, patients with mandibular angle fracture were associated with a low risk of unilateral or bilateral condylar fractures (OR < 1). Moreover, patients with symphysis fracture were associated with a low risk of bilateral condylar fractures (90 of 387 [23.3%], OR 0.899). By contrast, patients with bilateral condylar fractures were associated with a high risk of symphysis fracture (90 of 172 [52.3%], OR 17.38). Patients with condylar fractures, particularly those with bilateral condylar fractures, were infrequently associated with secondary mandibular fractures. Mandibular fractures tended to have less of an association with midfacial fractures. The occurrence of mandibular fractures is strongly correlated with age, sex, soft tissue injuries, dental trauma, and the pattern and position of the maxillofacial fractures in patients.	[Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China; [Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Hubei, Peoples R China; [Zhou, Haihua; Lv, Kun; Yang, Rongtao; Li, Zhi; Li, Zubing] Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Li, ZB (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Hubei, Peoples R China.; Li, ZB (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Key Lab Oral Biomed, Minist Educ, Wuhan 430072, Hubei, Peoples R China.; Li, ZB (corresponding author), Wuhan Univ, Coll & Hosp Stomatol, Dept Oral & Maxillofacial Surg, Wuhan 430072, Hubei, Peoples R China.	lizubing0827@163.com	Lv, Kun/S-1265-2019	Lv, Kun/0000-0002-1329-4381	Fundamental Research Funds for the Central Universities [2042014kf0137]; National Natural Science Foundation of China [81300854, 81470718, 81271107]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Funds for the Central Universities (grant no. 2042014kf0137); National Natural Science Foundation of China (grant no. 81300854; grant no. 81470718; grant no. 81271107).	COPE MR, 1985, BRIT J ORAL MAX SURG, V23, P112, DOI 10.1016/0266-4356(85)90060-9; DAFONSECA GD, 1974, INT J ORAL MAXILLOF, V3, P89, DOI 10.1016/S0300-9785(74)80040-2; Duan DH, 2008, INT J ORAL MAX SURG, V37, P25, DOI 10.1016/j.ijom.2007.07.010; Erol BE, 2004, J CRANIO MAXILL SURG, V32, P308, DOI 10.1016/j.jcms.2004.04.006; Flynn Thomas R, 2004, PETERSONS PRINCIPLE, V2nd, P277; Fuselier JC, 2002, J ORAL MAXIL SURG, V60, P514, DOI 10.1053/joms.2002.31847; Gassner R, 2003, J CRANIO MAXILL SURG, V31, P51, DOI 10.1016/S1010-5182(02)00168-3; Goodday RHB, 2013, ORAL MAXIL SURG CLIN, V25, P601, DOI 10.1016/j.coms.2013.07.002; Halazonetis J A, 1968, Br J Oral Surg, V6, P37, DOI 10.1016/S0007-117X(68)80025-3; He D, 2008, J ORAL MAXIL SURG, V66, P77, DOI 10.1016/j.joms.2007.08.013; HUELKE D F, 1964, J Oral Surg Anesth Hosp Dent Serv, V22, P396; HUELKE D F, 1962, J Oral Surg Anesth Hosp Dent Serv, V20, P478; HUELKE DF, 1961, J DENT RES, V40, P1042, DOI 10.1177/00220345610400050601; HUELKE DF, 1961, J DENT RES, V40, P1262, DOI 10.1177/00220345610400062001; IGNATIUS ET, 1992, ENDOD DENT TRAUMATOL, V8, P235; Krimmel M, 2000, J ORAL MAXIL SURG, V58, P1110, DOI 10.1053/joms.2000.9566; Lieger O, 2009, J ORAL MAXIL SURG, V67, P1680, DOI 10.1016/j.joms.2009.03.052; LINDAHL L, 1977, INT J ORAL MAXILLOF, V6, P12, DOI 10.1016/S0300-9785(77)80067-7; Mitsukawa N, 2004, J CRANIOFAC SURG, V15, P229, DOI 10.1097/00001665-200403000-00011; PETZEL JR, 1981, J MAXILLOFAC SURG, V9, P211, DOI 10.1016/S0301-0503(81)80046-X; REITZIK M, 1978, INT J ORAL MAXILLOF, V7, P100, DOI 10.1016/S0300-9785(78)80054-4; RUDDERMAN RH, 1992, CLIN PLAST SURG, V19, P11; SILVENNOINEN U, 1993, ENDOD DENT TRAUMATOL, V9, P254; Subhashraj K, 2009, J ORAL MAXIL SURG, V67, P968, DOI 10.1016/j.joms.2008.09.005; Thangavelu A, 2010, INT J ORAL MAX SURG, V39, P136, DOI 10.1016/j.ijom.2009.12.005; Zhou HH, 2013, DENT TRAUMATOL, V29, P291, DOI 10.1111/j.1600-9657.2012.01173.x; Zhou HH, 2013, DENT TRAUMATOL, V29, P285, DOI 10.1111/j.1600-9657.2012.01169.x; Zhou HH, 2013, J CRANIO MAXILL SURG, V41, P34, DOI 10.1016/j.jcms.2012.05.007; Zhou HH, 2012, J CRANIOFAC SURG, V23, pE494, DOI 10.1097/SCS.0b013e3182646525	29	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149553	10.1371/journal.pone.0149553	http://dx.doi.org/10.1371/journal.pone.0149553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900699	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100096
J	Zhu, ZF; Wang, HR; Yu, JS; Doug, J				Zhu, Zhongfan; Wang, Hongrui; Yu, Jingshan; Doug, Jie			On the Kaolinite Floc Size at the Steady State of Flocculation in a Turbulent Flow	PLOS ONE			English	Article							ACTIVATED-SLUDGE FLOCCULATION; VARIABLE FRACTAL DIMENSION; SHEAR-INDUCED FLOCCULATION; COHESIVE SEDIMENT; PARTICLE-SIZE; SETTLING VELOCITY; AGGREGATE SIZE; BREAKUP; DEPENDENCE; STRENGTH	The flocculation of cohesive fine-grained sediment plays an important role in the transport characteristics of pollutants and nutrients absorbed on the surface of sediment in estuarine and coastal waters through the complex processes of sediment transport, deposition, resuspension and consolidation. Many laboratory experiments have been carried out to investigate the influence of different flow shear conditions on the floc size at the steady state of flocculation in the shear flow. Most of these experiments reported that the floc size decreases with increasing shear stresses and used a power law to express this dependence. In this study, we performed a Couette-flow experiment to measure the size of the kaolinite floc through sampling observation and an image analysis system at the steady state of flocculation under six flow shear conditions. The results show that the negative correlation of the floc size on the flow shear occurs only at high shear conditions, whereas at low shear conditions, the floc size increases with increasing turbulent shear stresses regardless of electrolyte conditions. Increasing electrolyte conditions and the initial particle concentration could lead to a larger steady-state floc size.	[Zhu, Zhongfan; Wang, Hongrui; Yu, Jingshan] Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China; [Doug, Jie] Univ Tokyo, Dept Nat Environm Studies, Kashiwa, Chiba, Japan	Beijing Normal University; University of Tokyo	Yu, JS (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing 100875, Peoples R China.	jingshanyubnu@163.com	Dou, Jie/K-2809-2013	Dou, Jie/0000-0001-5930-199X; Zhu, Zhongfan/0000-0003-0579-608X	National Natural Science Foundation of China [51279006, 51479003]; Fundamental Research Funds for the Central Universities in China [2013NT50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities in China	This work received support from the National Natural Science Foundation of China (51279006, 51479003), URL: http://isisn.nsfc.gov.cn/egrantweb/. The funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Fundamental Research Funds for the Central Universities in China (Number: 2013NT50), URL: http://kejichu.bnu.edu.cn/. This funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biggs CA, 2000, WATER RES, V34, P2542, DOI 10.1016/S0043-1354(99)00431-5; Bower C, 1997, COLLOID SURFACE A, V127, P105, DOI 10.1016/S0927-7757(96)03945-3; Bubakova P, 2013, POWDER TECHNOL, V235, P540, DOI 10.1016/j.powtec.2012.11.014; Camp T.R., 1943, J BOSTON SOC CIVIL E, V30, P219; Colomer J, 2005, WATER RES, V39, P2994, DOI 10.1016/j.watres.2005.04.076; Cuthbertson AJS, 2010, COAST ENG, V57, P447, DOI 10.1016/j.coastaleng.2009.11.011; Ding A, 2006, CHEM ENG SCI, V61, P63, DOI 10.1016/j.ces.2005.02.074; DYER KR, 1989, J GEOPHYS RES-OCEANS, V94, P14327, DOI 10.1029/JC094iC10p14327; Ehrl L, 2008, LANGMUIR, V24, P3070, DOI 10.1021/la7032302; Ehrl L, 2010, AICHE J, V56, P2573, DOI 10.1002/aic.12179; Ehrl L, 2009, AICHE J, V55, P3076, DOI 10.1002/aic.11923; Flesch JC, 1999, AICHE J, V45, P1114, DOI 10.1002/aic.690450518; FRANCOIS RJ, 1988, J AM WATER WORKS ASS, V80, P92; Hinze J. O., 1975, TURBULENCE; Hopkins DC, 2003, J COLLOID INTERF SCI, V264, P184, DOI 10.1016/S0021-9797(03)00446-6; Jarvis P, 2005, WATER RES, V39, P3121, DOI 10.1016/j.watres.2005.05.022; Liang C., 2004, THESIS TSINGHUA U BE; Lu SC, 1998, ADV COLLOID INTERFAC, V78, P197, DOI 10.1016/S0001-8686(98)00062-1; Maerz J, 2011, CONT SHELF RES, V31, pS84, DOI 10.1016/j.csr.2010.05.011; Maggi F, 2007, J HYDROL, V343, P43, DOI 10.1016/j.jhydrol.2007.05.035; Maggi F, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003951; Manning AJ, 1999, MAR GEOL, V160, P147, DOI 10.1016/S0025-3227(99)00013-4; Markussen TN, 2014, J SEA RES, V89, P1, DOI 10.1016/j.seares.2014.02.001; OLES V, 1992, J COLLOID INTERF SCI, V154, P351, DOI 10.1016/0021-9797(92)90149-G; PARKER DS, 1972, J SANIT ENG DIV ASCE, V98, P79; Pejrup M, 2010, ESTUAR COAST SHELF S, V87, P177, DOI 10.1016/j.ecss.2009.09.028; Rahmani NHG, 2003, AICHE J, V49, P1645, DOI 10.1002/aic.690490705; Rudraiah N., 1986, ENCY FLUID MECH SLUR, P567; Safak I, 2013, CONT SHELF RES, V53, P1, DOI 10.1016/j.csr.2012.11.015; Selomulya C, 2003, CHEM ENG SCI, V58, P327, DOI 10.1016/S0009-2509(02)00523-7; Selomulya C, 2001, J COLLOID INTERF SCI, V236, P67, DOI 10.1006/jcis.2000.7372; Serra T, 1997, J COLLOID INTERF SCI, V187, P466, DOI 10.1006/jcis.1996.4710; Serra T, 1998, J COLLOID INTERF SCI, V206, P505, DOI 10.1006/jcis.1998.5714; Serra T, 2008, WATER RES, V42, P1113, DOI 10.1016/j.watres.2007.08.027; Smoluchowski M, 1917, Z PHYS CHEM, V92; Son M, 2009, WATER RES, V43, P3582, DOI 10.1016/j.watres.2009.05.016; Son MW, 2008, ENVIRON FLUID MECH, V8, P55, DOI 10.1007/s10652-007-9050-7; Soos M, 2007, J COLLOID INTERF SCI, V307, P433, DOI 10.1016/j.jcis.2006.12.016; Spicer PT, 1996, J COLLOID INTERF SCI, V184, P112, DOI 10.1006/jcis.1996.0601; Spicer PT, 1996, AICHE J, V42, P1612, DOI 10.1002/aic.690420612; Spicer PT, 1996, WATER RES, V30, P1049, DOI 10.1016/0043-1354(95)00253-7; Stone M, 2003, WATER RES, V37, P2739, DOI 10.1016/S0043-1354(03)00082-4; TAMBO N, 1979, WATER RES, V13, P429, DOI 10.1016/0043-1354(79)90035-6; Tang S, 2001, COLLOID SURFACE A, V180, P7, DOI 10.1016/S0927-7757(00)00743-3; Thomas DN, 1999, WATER RES, V33, P1579, DOI 10.1016/S0043-1354(98)00392-3; van Leussen W, 2011, OCEAN DYNAM, V61, P387, DOI 10.1007/s10236-011-0384-9; WILLIAMS RA, 1992, POWDER TECHNOL, V73, P75, DOI 10.1016/0032-5910(92)87009-Y; Winterwerp JC, 2006, ESTUAR COAST SHELF S, V68, P195, DOI 10.1016/j.ecss.2006.02.003; Winterwerp JC, 2002, CONT SHELF RES, V22, P1339, DOI 10.1016/S0278-4343(02)00010-9; Winterwerp JC, 1998, J HYDRAUL RES, V36, P309, DOI 10.1080/00221689809498621; [杨铁笙 Yang Tiesheng], 2002, [水利学报, Journal of Hydraulic Engineering], V0, P20; Zhang JJ, 2003, AICHE J, V49, P1870, DOI 10.1002/aic.690490723; Zhang X., 1996, ADV WATER SCI, V7, P54; Zhao M., 2010, THESIS TSINGHUA U BE; Zhu Z., 2009, THESIS TSINGHUA U BE; Zhu Z., 2014, J GEOSCIENCE ENV PRO, V2, P13; Zhu ZF, 2015, WATER-SUI, V7, P4385, DOI 10.3390/w7084385	57	10	10	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148895	10.1371/journal.pone.0148895	http://dx.doi.org/10.1371/journal.pone.0148895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901652	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100027
J	Xie, JS; Dai, CY; Hu, X				Xie, Jiansheng; Dai, Chunyan; Hu, Xun			Evidence That Does Not Support Pyruvate Kinase M2 (PKM2)-catalyzed Reaction as a Rate-limiting Step in Cancer Cell Glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BREAST-CANCER; ENZYME-ACTIVITIES; LACTATE-DEHYDROGENASE; GLUCOSE-METABOLISM; PHOSPHOFRUCTOKINASE; HEXOKINASE; PHOSPHORYLATION; DIPHOSPHATE; INHIBITION; ISOMERASE	It has been recognized that the rate-limiting function of pyruvate kinase M2 (PKM2) in glycolysis plays an important role in distributing glycolytic intermediates for anabolic and catabolic purposes in cancer cells. However, after analysis of the catalytic capacity of PKM2 relative to other glycolytic enzymes, the regulation range of PKM2 activity, metabolic flux control, and thermodynamics, we suggest that the PKM2-catalyzed reaction is not a rate-limiting step in cancer cell glycolysis. Hexokinase and phosphofructokinase 1 (PFK1), the first and third enzyme along the pathway, are rate-limiting enzymes that limit the overall glycolytic rate, whereas PKM2 and lactate dehydrogenase, the last two enzymes in the pathway, are for the fast removal of upstream intermediates to prevent the obstruction of the pathway. The argument is in accordance with the catalytic capacity of glycolytic enzymes, regulation range of enzyme activities, metabolic flux control, and thermodynamics.	[Xie, Jiansheng; Dai, Chunyan; Hu, Xun] Second Affiliated Hosp, Inst Canc, Key Lab Canc Prevent & Intervent, China Natl Minist Educ, Hangzhou 310009, Zhejiang, Peoples R China; [Xie, Jiansheng] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Biomed Res Ctr, 88 Jiefang Rd, Hangzhou 310016, Zhejiang, Peoples R China	Zhejiang University	Hu, X (corresponding author), Zhejiang Univ, Sch Med, Inst Canc, 88 Jiefang Rd, Hangzhou 310016, Zhejiang, Peoples R China.	huxun@zju.edu.cn			China National 973 Project [2013CB911303]; China Natural Sciences Foundation [81272456, 81470126, 81502398]; Fundamental Research Funds for the Central Universities, National Ministry of Education, China	China National 973 Project(National Basic Research Program of China); China Natural Sciences Foundation(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities, National Ministry of Education, China	This work was supported in part by China National 973 Project 2013CB911303, China Natural Sciences Foundation Projects 81272456 and 81470126, and the Fundamental Research Funds for the Central Universities, National Ministry of Education, China (to X. H.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by China Natural Sciences Foundation Project 81502398.	Alberty Robert A, 2006, Methods Biochem Anal, V48, P1; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; BALINSKY D, 1973, CANCER RES, V33, P249; BALINSKY D, 1984, J NATL CANCER I, V72, P217; BALINSKY D, 1984, CANCER RES, V44, P1058; BEEMER FA, 1982, CANCER RES, V42, P4228; BEEMER FA, 1984, EUR J CANCER CLIN ON, V20, P253, DOI 10.1016/0277-5379(84)90192-5; Bergmeyer H.U., 1974, METHOD ENZYMAT AN, VVol. 3., P1196; BUEDING E, 1955, J BIOL CHEM, V215, P507; BURNS JA, 1985, TRENDS BIOCHEM SCI, V10, P16, DOI 10.1016/0968-0004(85)90008-8; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaneton B, 2012, NATURE, V491, P458, DOI 10.1038/nature11540; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; COWGILL RW, 1956, J BIOL CHEM, V223, P885; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; FERDINAND W, 1964, BIOCHEM J, V92, P578, DOI 10.1042/bj0920578; GRACY RW, 1969, J BIOL CHEM, V244, P3913; GREGORIOU M, 1986, EUR J BIOCHEM, V161, P171, DOI 10.1111/j.1432-1033.1986.tb10138.x; HENNIPMAN A, 1987, TUMOR BIOL, V8, P251, DOI 10.1159/000217529; HENNIPMAN A, 1988, TUMOR BIOL, V9, P241, DOI 10.1159/000217568; HILF R, 1973, CANCER RES, V33, P2054; HILF R, 1970, CANCER RES, V30, P1874; Hitosugi T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000431; Ikeda Y, 1998, J BIOL CHEM, V273, P12227, DOI 10.1074/jbc.273.20.12227; Keller KE, 2012, SCIENCE, V338, P1069, DOI 10.1126/science.1224409; KRAAIJENHAGEN RJ, 1982, CLIN CHIM ACTA, V124, P91, DOI 10.1016/0009-8981(82)90323-0; LARNER EH, 1978, CANCER-AM CANCER SOC, V41, P1863, DOI 10.1002/1097-0142(197805)41:5<1863::AID-CNCR2820410530>3.0.CO;2-T; Li X., 2011, DATABASE, V2011; MARSHALL MJ, 1978, BRIT J CANCER, V37, P990, DOI 10.1038/bjc.1978.144; Mazurek S, 2008, ERNST SCHERING FOUND, V4, P99, DOI 10.1007/2789_2008_091; Mazurek S, 2011, INT J BIOCHEM CELL B, V43, P969, DOI 10.1016/j.biocel.2010.02.005; MELLATI AA, 1992, CANCER BIOCHEM BIOPH, V13, P33; Mendez E, 2008, BIOCHEM MOL BIOL EDU, V36, P116, DOI 10.1002/bmb.20157; Nelson D.L., 2005, LEHNINGER PRINCIPLES, DOI DOI 10.1002/BMB.2005.494033010419; OLAVARRIA JS, 1986, ENZYME, V35, P34, DOI 10.1159/000469316; PAGLIARO L, 1989, J CELL SCI, V94, P333; PEDERSEN SN, 1975, CANCER-AM CANCER SOC, V35, P469, DOI 10.1002/1097-0142(197502)35:2<469::AID-CNCR2820350226>3.0.CO;2-R; PLAUT B, 1972, BIOCHEM J, V129, P311, DOI 10.1042/bj1290311; SCOPES RK, 1969, BIOCHEM J, V113, P551, DOI 10.1042/bj1130551; SEKINE N, 1994, J BIOL CHEM, V269, P4895; TORNHEIM K, 1976, J BIOL CHEM, V251, P7322; TORRES NV, 1990, MOL CELL BIOCHEM, V93, P21; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; WILSON JE, 1968, J BIOL CHEM, V243, P3640; Wong CCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115036; Xie JS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04927; Zhao D, 2013, CANCER CELL, V23, P464, DOI 10.1016/j.ccr.2013.02.005	50	25	25	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					8987	8999		10.1074/jbc.M115.704825	http://dx.doi.org/10.1074/jbc.M115.704825			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917721	Green Published, hybrid			2022-12-26	WOS:000374849000014
J	Baskoy, K; Ay, SA; Altundag, A; Kurt, O; Salihoglu, M; Deniz, F; Tekeli, H; Yonem, A; Hummel, T				Baskoy, Kamil; Ay, Seyid Ahmet; Altundag, Aytug; Kurt, Onuralp; Salihoglu, Murat; Deniz, Ferhat; Tekeli, Hakan; Yonem, Arif; Hummel, Thomas			Is There Any Effect on Smell and Taste Functions with Levothyroxine Treatment in Subclinical Hypothyroidism?	PLOS ONE			English	Article							TURKISH POPULATION; OLFACTORY FUNCTION; THYROID-DISEASE; PERFORMANCE; RATS	Subclinical hypothyroidism has been accused for coronary heart disease, lipid metabolism disorders, neuropsychiatric disorders, infertility or pregnancy related problems with various strength of evidence. Currently there is insufficient knowledge about olfaction and taste functions in subclinical hypothyroidism. Aim of the present study is to investigate the degree of smell and taste dysfunction in patients with subclinical hypothyroidism. 28 subclinical hypothyroid patients, and 31 controls enrolled in the prospective study in Istanbul, Turkey. Subclinical hypothyroid patients were treated with L-thyroxine for 3 months. Psychophysiological olfactory testing was performed using odor dispensers similar to felt-tip pens ("Sniffin' Sticks", Burghart, Wedel, Germany). Taste function tests were made using " Taste Strips" (Burghart, Wedel, Germany) which are basically tastant adsorbed filter paper strip. Patients scored lower on psychophysical olfactory tests than controls (odor thresholds: 8.1 +/- 1.0 vs 8.9 +/- 1.1, p = 0.007; odor discrimination: 12.4 +/- 1.3 vs 13.1 +/- 0.9, p = 0.016; odor identification: 13.1 +/- 0.9 vs 14.0 +/- 1.1, p = 0.001; TDI score: 33.8 +/- 2.4 vs 36.9 +/- 2.1, p = 0.001). In contrast, results from psychophysical gustatory tests showed only a decreased score for "bitter" in patients, but not for other tastes (5.9 +/- 1.8 vs 6.6 +/- 1.0, p = 0.045). Three month after onset of treatment olfactory test scores already indicated improvement (odor thresholds: 8.1 +/- 1.0 vs 8.6 +/- 0.6, p< 0.001; odor discrimination: 12.4 +/- 1.31 vs 12.9 +/- 0.8, p = 0.011; odor identification: 13.1 +/- 0.9 vs 13.9 +/- 0.8, p< 0.001; TDI scores: 33.8 +/- 2.4 vs 35.5 +/- 1.7, p< 0.001) respectively. Taste functions did not differ between groups for sweet, salty and, sour tastes but bitter taste was improved after 3 months of thyroxin substitution (patients: 5.9 +/- 1.8 vs 6.6 +/- 1.2, p = 0.045). Correlation of changes in smell and taste, with thyroid function test were also evaluated. TSH, fT4 were found have no correlation with smell and taste changes with treatment. However bitter taste found positively correlated with T3 with treatment(r: 0.445, p: 0.018). Subclinical hypothyroid patients exhibited a significantly decreased olfactory sensitivity; in addition, bitter taste was significantly affected. Most importantly, these deficits can be remedied on average within 3 months with adequate treatment.	[Baskoy, Kamil; Ay, Seyid Ahmet; Deniz, Ferhat; Yonem, Arif] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Endocrinol & Metab, Istanbul, Turkey; [Altundag, Aytug] Istanbul Surg Hosp, Dept Otorhinolaryngol, Istanbul, Turkey; [Kurt, Onuralp] Erzincan Mil Hosp, Dept Otorhinolaryngol, Erzincan, Turkey; [Salihoglu, Murat] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Otorhinolaryngol, Istanbul, Turkey; [Tekeli, Hakan] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Neurol, Istanbul, Turkey; [Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell Taste, Dresden, Germany	Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Istanbul Cerrahi Hospital; Erzincan Military Hospital; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Technische Universitat Dresden	Altundag, A (corresponding author), Istanbul Surg Hosp, Dept Otorhinolaryngol, Istanbul, Turkey.	aaltundagkbb@yahoo.com	Altundag, Aytug/AAP-5557-2020; TEKELİ, HAKAN/B-6117-2016	Yonem, Arif/0000-0003-1517-9376				Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P811, DOI 10.4103/2230-8210.141355; Baumgartner C, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14058; Brosvic Gary M., 1996, Physiology and Behavior, V59, P117, DOI 10.1016/0031-9384(95)00145-X; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Clark AA, 2015, FASEB J, V29, P164, DOI 10.1096/fj.14-262246; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Dhong HJ, 2003, OTOLARYNG HEAD NECK, V129, P24, DOI 10.1016/S0194-5998(03)00530-8; Gunbey E, 2015, INT FORUM ALLERGY RH, V5, P919, DOI 10.1002/alr.21565; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; MCCONNELL RJ, 1975, AM J MED, V59, P354, DOI 10.1016/0002-9343(75)90394-0; Mueller C, 2003, RHINOLOGY, V41, P2; PATERNOSTRO MA, 1991, INT J DEV NEUROSCI, V9, P439, DOI 10.1016/0736-5748(91)90030-P; Salihoglu M, 2014, MED SCI MONITOR, V20, P569, DOI 10.12659/MSM.890071; Smith CD, 2015, THYROID, V25, P28, DOI 10.1089/thy.2014.0371; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tekeli H, 2013, MED SCI MONITOR, V19, P1221, DOI 10.12659/MSM.889838; Zhang LQ, 2009, NEUROBIOL DIS, V34, P366, DOI 10.1016/j.nbd.2009.02.006	19	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149979	10.1371/journal.pone.0149979	http://dx.doi.org/10.1371/journal.pone.0149979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927632	Green Published, gold, Green Submitted			2022-12-26	WOS:000371424200018
J	De Cicco, V; Barresi, M; Fantozzi, MPT; Cataldo, E; Parisi, V; Manzoni, D				De Cicco, Vincenzo; Barresi, Massimo; Fantozzi, Maria Paola Tramonti; Cataldo, Enrico; Parisi, Vincenzo; Manzoni, Diego			Oral Implant-Prostheses: New Teeth for a Brighter Brain	PLOS ONE			English	Article							TRIGEMINAL NERVE-STIMULATION; AGED SAMP8 MICE; LOCUS-COERULEUS; CHEWING GUM; RETICULAR-FORMATION; SPATIAL MEMORY; PUPIL SIZE; PERIODONTAL MECHANORECEPTORS; ASTROGLIAL RESPONSIVENESS; MOLARLESS CONDITION	Several studies have demonstrated that chewing can be regarded as a preventive measure for cognitive impairment, whereas masticatory deficiency, associated with soft-diet feeding, is a risk factor for the development of dementia. At present the link between orofacial sensorimotor activity and cognitive functions is unknown. In subjects with unilateral molar loss we have shown asymmetries in both pupil size and masticatory muscles electromyographic (EMG) activity during clenching: the molar less side was characterized by a lower EMG activity and a smaller pupil. Since implant-prostheses, greatly reduced both the asymmetry in EMG activity and in pupil's size, trigeminal unbalance, leading to unbalance in the activity of the Locus Coeruleus (LC), may be responsible for the pupil's asymmetry. According to the findings obtained in animal models, we propose that the different activity of the right and left LC may induce an asymmetry in brain activity, thus leading to cognitive impairment. According to this hypothesis, prostheses improved the performance in a complex sensorimotor task and increased the mydriasis associated with haptic tasks. In conclusion, the present study indicates that the implant-prosthesis therapy, which reduces the unbalance of trigeminal proprioceptive afferents and the asymmetry in pupil's size, may improve arousal, boosting performance in a complex sensorimotor task.	[De Cicco, Vincenzo; Fantozzi, Maria Paola Tramonti; Manzoni, Diego] Univ Pisa, Dept Translat Res, Pisa, Italy; [Barresi, Massimo] Univ Catania, Dept Drug Sci, Catania, Italy; [Cataldo, Enrico] Univ Pisa, Dept Phys, I-56100 Pisa, Italy; [Parisi, Vincenzo] GB Bietti Fdn, IRCCS, Rome, Italy	University of Pisa; University of Catania; University of Pisa; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Barresi, M (corresponding author), Univ Catania, Dept Drug Sci, Catania, Italy.	mbarresi@unict.it	Parisi, Vincenzo/J-6137-2018; Tramonti Fantozzi, Maria Paola/AAB-5912-2022	Tramonti Fantozzi, Maria Paola/0000-0001-5146-4997; barresi, massimo/0000-0001-9610-1890; De Cicco, Vincenzo/0000-0003-3048-1194	University of Pisa; Iacer Company; Implafavourite Company; Italian Ministry of Health; Fondazione Roma	University of Pisa; Iacer Company; Implafavourite Company; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	The research was supported by grants of the University of Pisa, Iacer Company and Implafavourite Company. The contribution of the GB Bietti Foundation, IRCCS, was supported by Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2012, NUTR NEUROSCI, V15, P176, DOI 10.1179/1476830512Y.0000000009; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Aoki H, 2010, NEUROSCI LETT, V469, P44, DOI 10.1016/j.neulet.2009.11.041; Areso MP, 1999, J DENT RES, V78, P1204, DOI 10.1177/00220345990780060301; Bartsch T, 2000, AUTON NEUROSCI-BASIC, V83, P66, DOI 10.1016/S0165-1838(00)00158-2; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bourque MJ, 2001, J NEUROPHYSIOL, V86, P2583, DOI 10.1152/jn.2001.86.5.2583; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BREEN LA, 1983, BRAIN RES, V261, P303, DOI 10.1016/0006-8993(83)90633-9; BRODIN P, 1993, J PHYSIOL-LONDON, V464, P711, DOI 10.1113/jphysiol.1993.sp019659; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; Cook IA, 2013, EPILEPSY BEHAV, V28, P221, DOI 10.1016/j.yebeh.2013.05.008; de Cicco V, 2014, ARCH ITAL BIOL, V152, P1; DeGiorgio Christopher M, 2013, Continuum (Minneap Minn), V19, P743, DOI 10.1212/01.CON.0000431397.61970.2b; DeGiorgio CM, 2013, NEUROLOGY, V80, P786, DOI 10.1212/WNL.0b013e318285c11a; Diagne M, 2006, J COMP NEUROL, V496, P759, DOI 10.1002/cne.20964; Edelmann E, 2015, NEURON, V86, P1041, DOI 10.1016/j.neuron.2015.04.007; Esser MJ, 1998, J COMP NEUROL, V391, P526, DOI 10.1002/(SICI)1096-9861(19980222)391:4<526::AID-CNE8>3.0.CO;2-2; Fan GP, 2000, DEV DYNAM, V218, P359, DOI 10.1002/(SICI)1097-0177(200006)218:2<359::AID-DVDY9>3.3.CO;2-C; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fujita K, 2012, J PLAST SURG HAND SU, V46, P383, DOI 10.3109/2000656X.2012.722094; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hirano Yoshiyuki, 2014, Brain Nerve, V66, P25; Hirano Y, 2013, BRAIN COGNITION, V81, P376, DOI 10.1016/j.bandc.2012.12.002; Hoffing RC, 2015, J COGNITIVE NEUROSCI, V27, P765, DOI 10.1162/jocn_a_00749; Howells FM, 2012, METAB BRAIN DIS, V27, P267, DOI 10.1007/s11011-012-9287-9; Johnson AJ, 2012, PHYSIOL BEHAV, V105, P815, DOI 10.1016/j.physbeh.2011.10.020; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; Kihara K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00827; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kubo K, 2005, BRAIN RES, V1057, P191, DOI 10.1016/j.brainres.2005.07.038; Lomber SG, 1996, VISUAL NEUROSCI, V13, P1143, DOI 10.1017/S0952523800007781; LUND JP, 1983, TRENDS NEUROSCI, V6, P458, DOI 10.1016/0166-2236(83)90219-9; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Notsu K, 2008, BRAIN RES, V1244, P71, DOI 10.1016/j.brainres.2008.09.076; Ohkubo C, 2013, J ORAL REHABIL, V40, P119, DOI 10.1111/j.1365-2842.2012.02316.x; Okamoto N, 2011, J PROSTHODONT RES, V55, P206, DOI 10.1016/j.jpor.2011.01.003; Okamoto N, 2015, J ALZHEIMERS DIS, V44, P777, DOI 10.3233/JAD-141665; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Onozuka M, 2000, BEHAV BRAIN RES, V108, P145, DOI 10.1016/S0166-4328(99)00145-X; Oue H, 2013, BEHAV BRAIN RES, V252, P318, DOI 10.1016/j.bbr.2013.06.015; Ozawa T, 2014, BEHAV BRAIN RES, V263, P210, DOI 10.1016/j.bbr.2014.01.034; Panneton WM, 2000, BRAIN RES, V874, P48, DOI 10.1016/S0006-8993(00)02549-X; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; RAJKOWSKI J, 1994, BRAIN RES BULL, V35, P607, DOI 10.1016/0361-9230(94)90175-9; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; Sakamoto K, 2009, CLIN NEUROPHYSIOL, V120, P41, DOI 10.1016/j.clinph.2008.10.001; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schrader LM, 2011, EPILEPSY BEHAV, V22, P475, DOI 10.1016/j.yebeh.2011.06.026; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; Silvetti M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00160; Smith A, 2009, NUTR NEUROSCI, V12, P81, DOI 10.1179/147683009X423247; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P1; Szabadi E, 1996, J PSYCHOPHARMACOL, V10, P6; TENTUSSCHER MPM, 1989, BRAIN RES, V494, P95, DOI 10.1016/0006-8993(89)90147-9; Trulsson M, 2006, J ORAL REHABIL, V33, P262, DOI 10.1111/j.1365-2842.2006.01629.x; Tsutsui K, 2007, BIOMED RES-TOKYO, V28, P1, DOI 10.2220/biomedres.28.1; Tucha O, 2004, APPETITE, V42, P327, DOI 10.1016/j.appet.2004.01.003; Turker KS, 2007, ARCH ORAL BIOL, V52, P361, DOI 10.1016/j.archoralbio.2006.11.014; Watanabe K, 2002, BEHAV BRAIN RES, V128, P19, DOI 10.1016/S0166-4328(01)00268-6; Watanabe K, 2001, EXP GERONTOL, V36, P283, DOI 10.1016/S0531-5565(00)00216-3; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Yamamoto Tetsu, 2009, Bull Tokyo Dent Coll, V50, P117; Yamamoto Tetsu, 2008, Bull Tokyo Dent Coll, V49, P185; Yoshihara T, 2011, NEUROSCI LETT, V503, P43, DOI 10.1016/j.neulet.2011.08.004; Zare Mohammad, 2014, Adv Biomed Res, V3, P81, DOI 10.4103/2277-9175.127994; Zhang JS, 2007, BRAIN RES, V1184, P121, DOI 10.1016/j.brainres.2007.09.061	77	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148715	10.1371/journal.pone.0148715	http://dx.doi.org/10.1371/journal.pone.0148715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919258	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400008
J	Wallis, LA; Fleming, J; Hasselberg, M; Laflamme, L; Lundin, J				Wallis, Lee A.; Fleming, Julian; Hasselberg, Marie; Laflamme, Lucie; Lundin, Johan			A Smartphone App and Cloud-Based Consultation System for Burn Injury Emergency Care	PLOS ONE			English	Article							TELEMEDICINE; DIAGNOSIS	Background Each year more than 10 million people worldwide are burned severely enough to require medical attention, with clinical outcomes noticeably worse in resource poor settings. Expert clinical advice on acute injuries can play a determinant role and there is a need for novel approaches that allow for timely access to advice. We developed an interactive mobile phone application that enables transfer of both patient data and pictures of a wound from the point-of-care to a remote burns expert who, in turn, provides advice back. Methods and Results The application is an integrated clinical decision support system that includes a mobile phone application and server software running in a cloud environment. The client application is installed on a smartphone and structured patient data and photographs can be captured in a protocol driven manner. The user can indicate the specific injured body surface(s) through a touchscreen interface and an integrated calculator estimates the total body surface area that the burn injury affects. Predefined standardised care advice including total fluid requirement is provided immediately by the software and the case data are relayed to a cloud server. A text message is automatically sent to a burn expert on call who then can access the cloud server with the smartphone app or a web browser, review the case and pictures, and respond with both structured and personalized advice to the health care professional at the point-of-care. Conclusions In this article, we present the design of the smartphone and the server application alongside the type of structured patient data collected together with the pictures taken at point-of-care. We report on how the application will be introduced at point-of-care and how its clinical impact will be evaluated prior to roll out. Challenges, strengths and limitations of the system are identified that may help materialising or hinder the expected outcome to provide a solution for remote consultation on burns that can be integrated into routine acute clinical care and thereby promote equity in injury emergency care, a growing public health burden.	[Wallis, Lee A.; Fleming, Julian] Univ Stellenbosch, Div Emergency Med, ZA-7600 Stellenbosch, South Africa; [Hasselberg, Marie; Laflamme, Lucie; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Hasselberg, Marie; Laflamme, Lucie] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Marais St, ZA-7600 Stellenbosch, South Africa; [Laflamme, Lucie] Univ S Africa, Preller St, ZA-0002 Pretoria, South Africa; [Lundin, Johan] Univ Helsinki, Inst Mol Med Finland FIMM, Tukholmankatu 8, FI-00290 Helsinki, Finland	Stellenbosch University; Karolinska Institutet; Stellenbosch University; University of South Africa; University of Helsinki	Lundin, J (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Lundin, J (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Tukholmankatu 8, FI-00290 Helsinki, Finland.	johan.lundin@ki.se	Lundin, Johan/I-1843-2018; Laflamme, Lucie/T-2953-2019; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Laflamme, Lucie/0000-0002-6443-1307; Lundin, Johan/0000-0002-2681-4139; Wallis, Lee/0000-0003-2711-3139	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA) http://www.sida.se/English/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha B, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921227; Barnes J, 2015, EMERG MED J, V32, P637, DOI 10.1136/emermed-2013-203416; BAXTER CR, 1968, ANN NY ACAD SCI, V150, P874, DOI 10.1111/j.1749-6632.1968.tb14738.x; Boccara D, 2011, BURNS, V37, P69, DOI 10.1016/j.burns.2010.05.017; Boissin C, 2015, BURNS, V41, P1253, DOI 10.1016/j.burns.2014.12.014; Boissin C, 2015, TELEMED E-HEALTH, V21, P887, DOI 10.1089/tmj.2014.0221; Boulanger B, 2001, J AM COLL SURGEONS, V192, P447, DOI 10.1016/S1072-7515(01)00796-7; Giretzlehner M, 2013, RAP BURN ASS 15 EPA; Godwin ZR, 2013, BURNS, V39, P1395, DOI 10.1016/j.burns.2013.03.021; Hasselberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098539; Karpelowsky JS, 2007, SAMJ S AFR MED J, V97, P574; Keane MG, 2009, J TELEMED TELECARE, V15, P132, DOI 10.1258/jtt.2009.003008; Kiser M, 2013, BURNS, V39, P155, DOI 10.1016/j.burns.2012.04.003; Morris R, 2014, BURNS, V40, P826, DOI 10.1016/j.burns.2013.10.015; Parvizi D, 2014, Ann Burns Fire Disasters, V27, P94; Rao B, 2009, J DRUGS DERMATOL, V8, P371; Saffle JR, 2009, J TRAUMA, V67, P358, DOI 10.1097/TA.0b013e3181ae9b02; Serrano C, 2005, BURNS, V31, P275, DOI 10.1016/j.burns.2004.11.019; Shokrollahi K, 2007, EMERG MED J, V24, P753, DOI 10.1136/emj.2007.046730; Wallace DL, 2012, BURNS, V38, P465, DOI 10.1016/j.burns.2011.09.024; Wantanajittikul K, 2011, BIOMEDICAL ENG INT C, V2011; WHO, 2015, WHO PLAN BURN PREV C; Wurzer P, 2015, BURNS, V41, P977, DOI 10.1016/j.burns.2014.11.010	23	40	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0147253	10.1371/journal.pone.0147253	http://dx.doi.org/10.1371/journal.pone.0147253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918631	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400003
J	Luef, EM; Breuer, T; Pika, S				Luef, Eva Maria; Breuer, Thomas; Pika, Simone			Food-Associated Calling in Gorillas (Gorilla g. gorilla) in the Wild	PLOS ONE			English	Article							WHITE-FACED CAPUCHINS; WESTERN GORILLAS; CLOSE CALLS; COMMUNICATION; VOCALIZATIONS; BEHAVIOR; MOUNTAIN; MONKEYS; DIET	Many nonhuman primates produce food-associated vocalizations upon encountering or ingesting particular food. Concerning the great apes, only food-associated vocalizations of chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) have been studied in detail, providing evidence that these vocalizations can be produced flexibly in relation to a variety of factors, such as the quantity and quality of food and/or the type of audience. Only anecdotal evidence exists of eastern (Gorilla beringei) and western gorillas (Gorilla gorilla) producing food-associated vocalizations, termed SINGING or HUMMING. To enable a better understanding of the context in which these calls are produced, we investigated and compared the vocal behavior of two free-ranging groups of western lowland gorillas (Gorilla g. gorilla) at Mondika, Republic of Congo. Our results show that (a) food-associated call production occurs only during feeding and not in other contexts; (b) calling is not uniformly distributed across age and sex classes; (c) calls are only produced during feeding on specific foods; and (d) normally just one individual gives calls during group feeding sessions, however, certain food types elicit simultaneous calling of two or more individuals. Our findings provide new insight into the vocal abilities of gorillas but also carry larger implications for questions concerning vocal variability among the great apes. Food-associated calls of nonhuman primates have been shown to be flexible in terms of when they are used and who they are directed at, making them interesting vocalizations from the viewpoint of language evolution. Food-associated vocalizations in great apes can offer new opportunities to investigate the phylogenetic development of vocal communication within the primate lineage and can possibly contribute novel insights into the origins of human language.	[Luef, Eva Maria; Pika, Simone] Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Eberhard Gwinner Str, D-82319 Seewiesen, Germany; [Breuer, Thomas] Wildlife Conservat Soc, Global Conservat Program, 2300 Southern Blvd, Bronx, NY 10460 USA	Max Planck Society; Wildlife Conservation Society	Pika, S (corresponding author), Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Eberhard Gwinner Str, D-82319 Seewiesen, Germany.	spika@orn.mpg.de	Luef, Eva/AAN-6158-2020	Pika, Simone/0000-0002-4398-2337	Alexander von Humboldt Stiftung (Germany) [Sofja-Kovalevskaja]; Fritz-Thyssen Stiftung (Germany); Fritz-Thyssen Foundation (Germany); Alexander-von-Humboldt-Foundation (Germany)	Alexander von Humboldt Stiftung (Germany)(Alexander von Humboldt Foundation); Fritz-Thyssen Stiftung (Germany); Fritz-Thyssen Foundation (Germany); Alexander-von-Humboldt-Foundation (Germany)(Alexander von Humboldt Foundation)	This work was supported by Alexander von Humboldt Stiftung (Germany), Simone Pika, Grant Number: Sofja-Kovalevskaja-Award 2010-2015, https://www.humboldt-foundation.de/web/start.html; and Fritz-Thyssen Stiftung (Germany), Eva Maria Luef, 2012, http://www.fritz-thyssen-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Fellowship of the Fritz-Thyssen Foundation (Germany) awarded to EML and a Sofja-Kovalevskaja-Award of the Alexander-von-Humboldt-Foundation (Germany) awarded to SP. We are grateful to the Ministere de la Recherche Scientifique of the Republic of Congo for authorizing us to work at Mondika. We thank the Wildlife Conservation Society and the Ministere de l'Economie Forestiere et Developpement Durable for logistic support of our work in Mondika. We are grateful to R. Mundry and R. Schmitz for their statistical advice and P. Kuchenbuch for reliability coding and stimulating discussions about gorilla vocalizations. We furthermore thank Katie Slocombe for helpful comments on our manuscript and J. Ahern-Seronde for her help with editing. We are particularly indebted to L. Hall for her help in the field and our Congolese assistant S. Pebou as well as the Ba'aka trackers of Central Africa who were of great help with daily tracking of the gorilla groups. The data underlying the findings of this study are available from the institutional server of the Max-Planck Institute for Ornithology, Seewiesen (Germany) following the link: http://edmond.mpdl.mpg.de/imeji/collection/s1PVeZMnznMV2m0.	Altmann D, 1991, PRACTICAL STAT MED R; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D, 2012, LME4 LINEAR MIXED EF; BENZ JJ, 1992, J COMP PSYCHOL, V106, P142, DOI 10.1037/0735-7036.106.2.142; Boinski S, 1996, ETHOLOGY, V102, P826; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brosnan SF, 2002, EVOL COMMUN, V4, P211; Bugnyar T, 2001, ANIM BEHAV, V61, P949, DOI 10.1006/anbe.2000.1668; CAINE NG, 1995, ANIM BEHAV, V50, P53, DOI 10.1006/anbe.1995.0220; Clay Z, 2009, PLOS ONE, V6; Clay Z, 2012, ANIM BEHAV, V83, P323, DOI 10.1016/j.anbehav.2011.12.008; Clay Z, 2009, ANIM BEHAV, V77, P1387, DOI 10.1016/j.anbehav.2009.02.016; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheehy DM, 2007, AM J PRIMATOL, V69, P1354, DOI 10.1002/ajp.20442; ELOWSON AM, 1991, ANIM BEHAV, V42, P931, DOI 10.1016/S0003-3472(05)80145-9; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Ey E, 2009, ETHOLOGY, V115, P493, DOI 10.1111/j.1439-0310.2009.01638.x; Fedurek P, 2013, AM J PRIMATOL, V75, P726, DOI 10.1002/ajp.22122; Fedurek P, 2011, HUM BIOL, V83, P153, DOI 10.3378/027.083.0202; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Fossey Diane, 1983, GORILLAS IN THE MIST; Gros-Louis J, 2006, INT J PRIMATOL, V27, P273, DOI 10.1007/s10764-005-9012-1; Gros-Louis J, 2004, J COMP PSYCHOL, V118, P396, DOI 10.1037/0735-7036.118.4.396; GROSLOUIS J, 2003, ANIM BEHAV, V140, P565; HARCOURT AH, 1993, BEHAVIOUR, V124, P89, DOI 10.1163/156853993X00524; HAUSER MD, 1987, FOLIA PRIMATOL, V48, P207, DOI 10.1159/000156298; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; Kalan AK, 2015, ANIM BEHAV, V101, P1, DOI 10.1016/j.anbehav.2014.12.011; Manser MB, 2013, ANIM BEHAV, V86, P491, DOI 10.1016/j.anbehav.2013.07.006; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; NISHIHARA T, 1991, FOLIA PRIMATOL, V57, P48, DOI 10.1159/000156564; R Development Core Team, 2012, R LANG ENV STAT COMP; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Roush RS, 1999, ANIM BEHAV, V58, P1299, DOI 10.1006/anbe.1999.1262; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Schaefer SA., 2011, PERSONALITY SUBJECTI; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Schel AM, 2013, ANIM BEHAV, V86, P955, DOI 10.1016/j.anbehav.2013.08.013; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Watson SK, 2015, CURR BIOL, V25, P495, DOI 10.1016/j.cub.2014.12.032	46	10	10	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0144197	10.1371/journal.pone.0144197	http://dx.doi.org/10.1371/journal.pone.0144197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909518	Green Submitted, Green Published, gold			2022-12-26	WOS:000371164700001
J	Garea-Rodriguez, E; Eesmaa, A; Lindholm, P; Schlumbohm, C; Konig, J; Meller, B; Krieglstein, K; Helms, G; Saarma, M; Fuchs, E				Garea-Rodriguez, Enrique; Eesmaa, Ave; Lindholm, Paeivi; Schlumbohm, Christina; Koenig, Jessica; Meller, Birgit; Krieglstein, Kerstin; Helms, Gunther; Saarma, Mart; Fuchs, Eberhard			Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; COMMON MARMOSET MONKEY; MIDBRAIN DOPAMINE NEURONS; HUMAN ALPHA-SYNUCLEIN; IN-VIVO; RAT MODEL; FUNCTIONAL RECOVERY; SUBSTANTIA-NIGRA; RHESUS-MONKEYS; KDEL RECEPTORS	Cerebral dopamine neurotrophic factor (CDNF) belongs to a newly discovered family of evolutionarily conserved neurotrophic factors. We demonstrate for the first time a therapeutic effect of CDNF in a unilateral 6-hydroxydopamine (6-OHDA) lesion model of Parkinson's disease in marmoset monkeys. Furthermore, we tested the impact of high chronic doses of human recombinant CDNF on unlesionedmonkeys and analyzed the amino acid sequence ofmarmoset CDNF. The severity of 6-OHDA lesions and treatment effects weremonitored in vivo using 123I-FP-CIT (DaTSCAN) SPECT. Quantitative analysis of 123I-FP-CIT SPECT showed a significant increase of dopamine transporter binding activity in lesioned animals treated with CDNF. Glial cell line-derived neurotrophic factor (GDNF), a well-characterized and potent neurotrophic factor for dopamine neurons, served as a control in a parallel comparison with CDNF. By contrast with CDNF, only single animals responded to the treatment with GDNF, but no statistical difference was observed in the GDNF group. However, increased numbers of tyrosine hydroxylase immunoreactive neurons, observed within the lesioned caudate nucleus of GDNF-treated animals, indicate a strong bioactive potential of GDNF.	[Garea-Rodriguez, Enrique; Schlumbohm, Christina; Koenig, Jessica; Fuchs, Eberhard] German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany; [Garea-Rodriguez, Enrique] Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Garea-Rodriguez, Enrique; Fuchs, Eberhard] Univ Gottingen, CMPB, D-37073 Gottingen, Germany; [Eesmaa, Ave; Lindholm, Paeivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Schlumbohm, Christina; Koenig, Jessica] Encepharm, Gottingen, Germany; [Meller, Birgit] Univ Gottingen, Dept Nucl Med, Univ Med Ctr, Gottingen, Germany; [Krieglstein, Kerstin] Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Helms, Gunther] Univ Gottingen, Dept Cognit Neurol, Univ Med Ctr, D-37073 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Freiburg; University of Gottingen; University of Helsinki; University of Gottingen; University of Freiburg; University of Gottingen	Garea-Rodriguez, E (corresponding author), German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany.; Garea-Rodriguez, E (corresponding author), Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.; Garea-Rodriguez, E (corresponding author), Univ Gottingen, CMPB, D-37073 Gottingen, Germany.	enrique.garea.rodriguez@anat.uni-freiburg.de	Helms, Gunther/A-9114-2010	Helms, Gunther/0000-0002-1371-5123; Eesmaa, Ave/0000-0002-3397-3330; Pulkkila, Paivi/0000-0003-3022-5035	EU ERA-Net NEURON (PARKCDNF); DFG Research Center Molecular Physiology of the Brain (CMPB); S. Juselius Foundation	EU ERA-Net NEURON (PARKCDNF); DFG Research Center Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG)); S. Juselius Foundation	EGR was funded by EU ERA-Net NEURON (PARKCDNF) (http://www.neuron-eranet.eu/). The study was partially supported by the DFG Research Center Molecular Physiology of the Brain (CMPB) (http://www.cmpb.uni-goettingen.de/) and by a S. Juselius Foundation (http://www.sigridjuselius.fi/foundation) grant to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Alvarez-Fischer D, 2007, NEUROIMAGE, V38, P5, DOI 10.1016/j.neuroimage.2007.05.056; Andringa G, 2005, NEUROIMAGE, V26, P1150, DOI 10.1016/j.neuroimage.2005.03.034; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Back S, 2013, BRAIN BEHAV, V3, P75, DOI 10.1002/brb3.117; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Blanchard V, 1996, BRAIN RES, V709, P319, DOI 10.1016/0006-8993(95)01391-1; Booij J, 2002, EUR J NUCL MED MOL I, V29, P1221, DOI 10.1007/s00259-002-0845-y; DayLollini PA, 1997, EXP NEUROL, V145, P24, DOI 10.1006/exnr.1997.6448; de la Fuente-Fernandez R, 2012, NEUROLOGY, V78, P696, DOI 10.1212/WNL.0b013e318248e520; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; Eslamboli A, 2005, J NEUROSCI, V25, P769, DOI 10.1523/JNEUROSCI.4421-04.2005; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Franke SK, 2016, NEUROSCIENCE, V312, P247, DOI 10.1016/j.neuroscience.2015.09.065; Garea-Rodriguez E, 2012, J NEUROSCI METH, V210, P195, DOI 10.1016/j.jneumeth.2012.07.009; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gimenez F, 2011, NEUROIMAGE, V54, pS189, DOI 10.1016/j.neuroimage.2010.01.023; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Helms G, 2013, J NEUROSCI METH, V215, P121, DOI 10.1016/j.jneumeth.2013.02.011; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Latge C, 2015, J BIOL CHEM, V290, P20527, DOI 10.1074/jbc.M115.662254; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Lo Bianco C, 2004, NEUROBIOL DIS, V17, P283, DOI 10.1016/j.nbd.2004.06.008; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Olanow CW, 2014, NAT REV NEUROL, V10, P186, DOI 10.1038/nrneurol.2014.45; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; Palfi S, 2002, J NEUROSCI, V22, P4942, DOI 10.1523/JNEUROSCI.22-12-04942.2002; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Ramaswamy S, 2009, PROG BRAIN RES, V175, P201, DOI 10.1016/S0079-6123(09)17514-3; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Saji H, 2003, ANAL SCI, V19, P67, DOI 10.2116/analsci.19.67; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Seibyl JP, 1998, J NUCL MED, V39, P1500; Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stephan H, 1980, THE BRAIN OF THE COM; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Yin D, 2010, J NEUROSCI METH, V187, P46, DOI 10.1016/j.jneumeth.2009.12.008; Yuasa S, 2009, STEREOTAXIC ATLAS MA; Zhang ZM, 1997, J PHARMACOL EXP THER, V282, P1396	76	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149776	10.1371/journal.pone.0149776	http://dx.doi.org/10.1371/journal.pone.0149776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901822	Green Published, gold			2022-12-26	WOS:000371276100150
J	Oros, J; Montesdeoca, N; Camacho, M; Arencibia, A; Calabuig, P				Oros, Jorge; Montesdeoca, Natalia; Camacho, Maria; Arencibia, Alberto; Calabuig, Pascual			Causes of Stranding and Mortality, and Final Disposition of Loggerhead Sea Turtles (Caretta caretta) Admitted to a Wildlife Rehabilitation Center in Gran Canaria Island, Spain (1998-2014): A Long-Term Retrospective Study	PLOS ONE			English	Article							CHELONIA-MYDAS; GREEN TURTLES; MARINE TURTLES; HAWAIIAN-ISLANDS; FIBROPAPILLOMATOSIS; PATHOLOGY; FLORIDA; SPIRORCHIDIASIS; JUVENILE; ATLANTIC	Aims The aims of this study were to analyze the causes of stranding of 1,860 loggerhead turtles (Caretta caretta) admitted at the Tafira Wildlife Rehabilitation Center in Gran Canaria Island, Spain, from 1998 to 2014, and to analyze the outcomes of the rehabilitation process to allow meaningful auditing of its quality. Methods Primary causes of morbidity were classified into seven categories: entanglement in fishing gear and/or plastics, ingestion of hooks and monofilament lines, trauma, infectious disease, crude oil, other causes, and unknown/undetermined. Final dispositions were calculated as euthanasia (Er), unassisted mortality (Mr), and release (Rr) rates. Time to death (Td) for euthanized and dead turtles, and length of stay for released (Tr) turtles were evaluated. Results The most frequent causes of morbidity were entanglement in fishing gear and/or plastics (50.81%), unknown/undetermined (20.37%), and ingestion of hooks (11.88%). The final disposition of the 1,634 loggerhead turtles admitted alive were: Er = 3.37%, Mr = 10.34%, and Rr = 86.29%. Er was significantly higher in the trauma category (18.67%) compared to the other causes of admission. The highest Mr was observed for turtles admitted due to trauma (30.67%). The highest R-r was observed in the crude oil (93.87%) and entanglement (92.38%) categories. The median T-r ranged from 12 days (unknown) to 70 days (trauma). Conclusions This survey is the first large-scale epidemiological study on causes of stranding and mortality of Eastern Atlantic loggerheads and demonstrates that at least 71.72% of turtles stranded due to anthropogenic causes. The high R-r (86.29%) emphasizes the importance of marine rehabilitation centers for conservation purposes. The stratified analysis by causes of admission of the three final disposition rates, and the parameters T-d and T-r should be included in the outcome research of the rehabilitation process of sea turtles in order to allow comparative studies between marine rehabilitation centers around the world.	[Oros, Jorge; Arencibia, Alberto] Univ Las Palmas Gran Canaria, Fac Vet, Dept Morphol, Arucas, Las Palmas, Spain; [Montesdeoca, Natalia] Univ Las Palmas Gran Canaria, Fac Vet, Dept Anim Pathol, Arucas, Las Palmas, Spain; [Camacho, Maria] Univ Las Palmas Gran Canaria, Fac Vet, Dept Clin Sci, Arucas, Las Palmas, Spain; [Calabuig, Pascual] Tafira Wildlife Rehabil Ctr, Tafira Baja, Las Palmas De G, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Oros, J (corresponding author), Univ Las Palmas Gran Canaria, Fac Vet, Dept Morphol, Arucas, Las Palmas, Spain.	jorge.oros@ulpgc.es	Orós, Jorge/G-8824-2015; CAMACHO, MARIA/H-5085-2015; Calabuig, Pascual/AAB-1723-2019; Arencibia, Alberto/H-5218-2015	Orós, Jorge/0000-0002-8346-5393; CAMACHO, MARIA/0000-0003-2891-1474; Arencibia, Alberto/0000-0001-6797-8220				Aguirre AA, 1998, J WILDLIFE DIS, V34, P91, DOI 10.7589/0090-3558-34.1.91; Bas C., 1995, PESCA CANARIAS AREAS; Bjorndal KA, 2000, MAR ECOL PROG SER, V202, P265, DOI 10.3354/meps202265; Bjorndal KA, 2003, ECOLOGY, V84, P1237, DOI 10.1890/0012-9658(2003)084[1237:CGIOLS]2.0.CO;2; Blanco J. C., 1992, LIBRO ROJO VERTEBRAD; Bolten Alan F., 1993, Arquipelago Boletim da Universidade dos Acores Ciencias Biologicas e Marinhas, V11A, P49; Camacho M, 2013, J WILDLIFE DIS, V49, P637, DOI 10.7589/2012-03-093; Casal AB, 2009, VET CLIN PATH, V38, P213, DOI 10.1111/j.1939-165X.2008.00106.x; Casale P, 2010, AQUAT CONSERV, V20, P611, DOI 10.1002/aqc.1133; Castro JJ, 1995, PESCA CANARIAS AREAS, P153; Chaloupka M, 2008, MAR BIOL, V154, P887, DOI 10.1007/s00227-008-0981-4; Conant TA., 2009, LOGGERHEAD SEA TURTL; Cooper JE, 2006, IN PRACTICE, V28, P2, DOI 10.1136/inpract.28.1.2; Santos MRD, 2015, DIS AQUAT ORGAN, V115, P193, DOI 10.3354/dao02883; Dellinger T, 2007, MARINE TURTLES RECOV, P97; Duguy R, 1998, OCEANOL ACTA, V21, P383, DOI 10.1016/S0399-1784(98)80025-X; Epperly SP, 1996, B MAR SCI, V59, P289; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Foley Allen M., 2007, Gulf of Mexico Science, V25, P131; Foley AM, 2005, J WILDLIFE DIS, V41, P29, DOI 10.7589/0090-3558-41.1.29; George Robert H., 1997, P363; GLAZEBROOK JS, 1989, J COMP PATHOL, V101, P231, DOI 10.1016/0021-9975(89)90033-9; GLAZEBROOK JS, 1990, DIS AQUAT ORGAN, V9, P97, DOI 10.3354/dao009097; GORDON AN, 1993, J WILDLIFE DIS, V29, P490, DOI 10.7589/0090-3558-29.3.490; Gordon AN, 1998, VET PATHOL, V35, P21, DOI 10.1177/030098589803500102; GRACZYK TK, 1995, J PARASITOL, V81, P416, DOI 10.2307/3283824; Greenblatt RJ, 2005, J ZOO WILDLIFE MED, V36, P527, DOI 10.1638/04-051.1; Gutierrez C, 1998, 2 JORN INT SEOC VIT, P349; Herbst LH, 1998, J WILDLIFE DIS, V34, P496, DOI 10.7589/0090-3558-34.3.496; HERNANDEZGARCIA V, 1995, FISH B-NOAA, V93, P403; IMO, 2007, PSSA PART SENS SEA A, V2007th; INTERNATIONAL UNION FOR CONSERVATION OF NATURE SPECIES SURVIVAL COMMISSION [IUCN SSC] AMPHIBIAN SPECIALIST GROUP, 2015, IUCN RED LIST THREAT; Jacobson ER, 2006, DIS AQUAT ORGAN, V70, P139, DOI 10.3354/dao070139; JACOBSON ER, 1989, J COMP PATHOL, V101, P39, DOI 10.1016/0021-9975(89)90075-3; Lizana M., 1997, DISTRIBUCION BIOGEOG, P477; Llinas O, 2007, MARINE TURTLES RECOV, P35; Lutcavage Molly E., 1997, P387; Miller E.A., 2012, MINIMUM STANDARDS WI, V4th ed.; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Oros J, 2005, DIS AQUAT ORGAN, V63, P13, DOI 10.3354/dao063013; Oros J, 2004, VET REC, V155, P169, DOI 10.1136/vr.155.6.169; Pritchard P.C.H.P., 1997, BIOL SEA TURTLES, VI, P1; Raidal SR, 1998, AUST VET J, V76, P415, DOI 10.1111/j.1751-0813.1998.tb12392.x; Seminoff Jeffrey A., 2004, Herpetological Review, V35, P24; Sleeman Jonathan M., 2008, P97; SMITH G. M., 1938, ZOOLOGICA [NEW YORK], V23, P93; Smith J. W., 1997, Helminthological Abstracts, V66, P255; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; Stacy BA, 2010, J PARASITOL, V96, P752, DOI 10.1645/GE-2382.1; Stacy BA, 2010, DIS AQUAT ORGAN, V89, P237, DOI 10.3354/dao02195; TEWG [Turtle Expert Working Group], 2009, ASS LOGG TURTL POP W; WITHERINGTON BE, 1989, COPEIA, P696; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; WOLKE RE, 1982, J WILDLIFE DIS, V18, P175, DOI 10.7589/0090-3558-18.2.175; Woodford M.H., 2000, QUARANTINE HLTH SCRE; Work TM, 2015, DIS AQUAT ORGAN, V115, P103, DOI 10.3354/dao02890; Work TM, 2010, J WILDLIFE DIS, V46, P422, DOI 10.7589/0090-3558-46.2.422; Work TM, 2005, J PARASITOL, V91, P871, DOI 10.1645/GE-454R.1; Work TM, 2004, DIS AQUAT ORGAN, V62, P163, DOI 10.3354/dao062163; Work TM, 2003, DIS AQUAT ORGAN, V53, P41, DOI 10.3354/dao053041; Wyneken JE., 2006, REPTILE MED SURG, P972	62	34	35	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149398	10.1371/journal.pone.0149398	http://dx.doi.org/10.1371/journal.pone.0149398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901623	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100069
J	Zhou, Y; Yang, QY; Xu, H; Zhang, JM; Deng, H; Gao, HY; Yang, J; Zhao, DY; Liu, F				Zhou, Yao; Yang, Qianyuan; Xu, Hong; Zhang, Jiamin; Deng, Huan; Gao, Haiyan; Yang, Jin; Zhao, Deyu; Liu, Feng			miRNA-221-3p Enhances the Secretion of Interleukin-4 in Mast Cells through the Phosphatase and Tensin Homolog/p38/Nuclear Factor-kappaB Pathway	PLOS ONE			English	Article							ASTHMA; LYMPHOCYTES; AKT	Mast cells play a central role in asthma. Moreover, serum miRNA-221-3p (miR-221) has been shown to be markedly increased in children with asthma. In the current study, we aimed to examine miR-221 expression in an asthma model and elucidate the mechanisms regulating interleukin (IL)-4 secretion in mast cells. Using polymerase chain reaction, we found that miR-221 was upregulated in a murine asthma model and in P815 mast cells after lipopolysaccharide (LPS) stimulation. Moreover, miR-221 upregulated IL-4 secretion from P815 cells, as shown by enzyme-linked immunosorbent assays. Bioinformatics analysis, luciferase reporter gene assays, and western blotting showed that phosphatase and tensin homolog (PTEN) was a target of miR-221 and could block IL-4 secretion stimulated by miR-221. The phosphorylation of p38 (protein) and activity of nuclear factor-kappaB (NF-kappa B) were increased after overexpression of miR-221, as shown by electrophoretic mobility shift assays. Finally, treatment with specific inhibitors could block IL-4 secretion. In conclusion, miR-221, which was overexpressed in a murine asthma model, stimulated IL-4 secretion in mast cells through a pathway involving PTEN, p38, and NF-kappa B.	[Zhou, Yao; Yang, Qianyuan; Xu, Hong; Zhang, Jiamin; Deng, Huan; Gao, Haiyan; Yang, Jin; Zhao, Deyu; Liu, Feng] Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Jin] Jiangsu Huaian Matern & Childrens Hosp, Dept Pediat, Huaian 223002, Jiangsu, Peoples R China	Nanjing Medical University	Zhao, DY; Liu, F (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China.	zhaodeyu98@126.com; axsliu@163.com			National Natural Science Foundation of China [81200012, 81370132]; Nanjing Medical Science and Technique Development Foundation; Nanjing Public Health Bureau [ZKX11012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical Science and Technique Development Foundation; Nanjing Public Health Bureau	The current research was supported by the National Natural Science Foundation of China (81200012, Feng Liu; 81370132, Deyu Zhao; http://www.nsfc.gov.cn/), by Nanjing Medical Science and Technique Development Foundation (http://se.njh.gov.cn/index/index.do) and by Nanjing Public Health Bureau (ZKX11012, Deyu Zhao; http://www.njh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2007, J IMMUNOL, V179, P8105, DOI 10.4049/jimmunol.179.12.8105; Bijani FM, 2012, INT REV IMMUNOL, V31, P379, DOI 10.3109/08830185.2012.706761; Bradding P, 2006, J ALLERGY CLIN IMMUN, V117, P1277, DOI 10.1016/j.jaci.2006.02.039; Braman SS, 2006, CHEST, V130, p4S, DOI 10.1378/chest.130.1_suppl.4S; Bredeloux P, 2007, BRIT J PHARMACOL, V150, P711, DOI 10.1038/sj.bjp.0707151; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Corominas M, 1998, CLIN EXP IMMUNOL, V112, P276; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; IRANI AMA, 1989, CLIN EXP ALLERGY, V19, P143, DOI 10.1111/j.1365-2222.1989.tb02357.x; Lin CF, 2013, IMMUNOPHARM IMMUNOT, V35, P669, DOI 10.3109/08923973.2013.837059; Liu F, 2012, MOL MED REP, V6, P1178, DOI 10.3892/mmr.2012.1030; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Medvedev AE, 2013, J INTERF CYTOK RES, V33, P467, DOI 10.1089/jir.2012.0140; OGARRA A, 1986, P NATL ACAD SCI USA, V83, P5228, DOI 10.1073/pnas.83.14.5228; Panganiban RPL, 2012, AM J CLIN EXP IMMUNO, V1, P154; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Rodriguez D, 2003, J IMMUNOL, V171, P1001, DOI 10.4049/jimmunol.171.2.1001; Saluja R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043547; Sundaramurthy P, 2009, BIOINFORMATION, V3, P250, DOI 10.6026/97320630003250; Takenaka H, 2010, BIOCHEM BIOPH RES CO, V391, P471, DOI 10.1016/j.bbrc.2009.11.082; Zheng C, 2012, MED ONCOL, V29, P815, DOI 10.1007/s12032-011-9934-8; Zhou Y, 2014, TUMOR BIOL, V35, P9269, DOI 10.1007/s13277-014-1901-5	24	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148821	10.1371/journal.pone.0148821	http://dx.doi.org/10.1371/journal.pone.0148821			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901347	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100024
J	Cai, J; Zuo, Y; Wang, T; Cao, Y; Cai, R; Chen, FL; Cheng, J; Mu, J				Cai, J.; Zuo, Y.; Wang, T.; Cao, Y.; Cai, R.; Chen, F-L; Cheng, J.; Mu, J.			A crucial role of SUMOylation in modulating Sirt6 deacetylation of H3 at lysine 56 and its tumor suppressive activity	ONCOGENE			English	Article							CANCER METABOLISM; LIFE-SPAN; DRIVERS SEAT; DNA-REPAIR; CHROMATIN; SIRTUINS; PROTEIN; IDENTIFICATION; STABILIZATION; LOCALIZATION	Sirt6 is a histone deacetylase with NAD(+)-dependent activity. Sirt6 has been shown as a tumor suppressor partially via inhibiting the expression of c-Myc target genes and ribosome biogenesis. However, how to regulate Sirt6 activity is largely unknown. In this study, we identify that Sirt6 can be modified by small ubiquitin-like modifier. Sirt6 SUMOylation deficiency specifically decreases its deacetylation of H3K56 but not H3K9 in vivo. Mechanistically, we find that SUMOylation deficiency decreases Sirt6 binding with c-Myc, decreasing Sirt6 occupancy on the locus of c-Myc target genes. Therefore, Sirt6 SUMOylation deficiency reduces its deacetylation of H3k56 and its repression of c-Myc target genes. Moreover, Sirt6 SUMOylation deficiency reduces its suppression of cell proliferation and tumorigenesis. Thus, these results reveal that SUMOylation has an important role in regulation of Sirt6 deacetylation on H3K56, as well as its tumor suppressive activity.	[Cai, J.; Zuo, Y.; Wang, T.; Cao, Y.; Cai, R.; Cheng, J.] Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, 280 Chongqing S Rd,Bldg 7 Rm 405, Shanghai 200025, Peoples R China; [Chen, F-L] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 3, Shanghai, Peoples R China; [Mu, J.] Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100021, Peoples R China; [Mu, J.] Peking Union Med Coll, Beijing 100021, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cheng, J (corresponding author), Shanghai Jiao Tong Univ, Dept Biochem & Mol Cell Biol, Shanghai Key Lab Tumor Microenvironm & Inflammat, Sch Med, 280 Chongqing S Rd,Bldg 7 Rm 405, Shanghai 200025, Peoples R China.; Mu, J (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Thorac Surg, Beijing 100021, Peoples R China.; Mu, J (corresponding author), Peking Union Med Coll, Beijing 100021, Peoples R China.	jkcheng@shsmu.edu.cn; mujuwei@cicams.ac.cn			National Basic Research Program of China (973 Program) [2013CB910902]; National Natural Science Foundation of China [91229202, 81430069]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Dr Chuxia Deng (NIH, Bethesda, MD, USA) for kindly providing for Sirt6-/- MEF cells. This work was supported by National Basic Research Program of China (973 Program; no. 2013CB910902 to JC), National Natural Science Foundation of China (91229202 and 81430069 to JC).	Ardestani PM, 2012, NUCLEUS-PHILA, V3, P442, DOI 10.4161/nucl.21134; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bosch-Presegue Laia, 2011, Genes Cancer, V2, P648, DOI 10.1177/1947601911417862; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Cheng J, 2007, CELL, V131, P584, DOI 10.1016/j.cell.2007.08.045; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Dutnall RN, 2001, CELL, V105, P161, DOI 10.1016/S0092-8674(01)00305-1; Escobar-Cabrera E, 2011, J BIOL CHEM, V286, P19816, DOI 10.1074/jbc.M111.231647; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991, DOI 10.2174/15680266113136660213; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; KLAR AJS, 1981, NATURE, V289, P239, DOI 10.1038/289239a0; Kolesar P, 2012, NUCLEIC ACIDS RES, V40, P7831, DOI 10.1093/nar/gks484; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Lefort K, 2013, EMBO J, V32, P2248, DOI 10.1038/emboj.2013.156; Lin ZH, 2013, CELL REP, V5, P1639, DOI 10.1016/j.celrep.2013.11.029; Lombard DB, 2008, J INTERN MED, V263, P128, DOI 10.1111/j.1365-2796.2007.01902.x; Lyssiotis CA, 2012, CELL, V151, P1155, DOI 10.1016/j.cell.2012.11.020; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Sebastian C, 2012, CELL, V151, P1185, DOI 10.1016/j.cell.2012.10.047; Sharma A, 2013, J BIOL CHEM, V288, P18439, DOI 10.1074/jbc.M112.405928; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Sundaresan NR, 2012, NAT MED, V18, P1643, DOI 10.1038/nm.2961; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Tasselli L, 2012, NATURE, V492, P362, DOI 10.1038/492362a; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhang ZG, 2014, MOL MED REP, V9, P882, DOI 10.3892/mmr.2013.1879; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	40	18	19	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 15	2016	35	37					4949	4956		10.1038/onc.2016.24	http://dx.doi.org/10.1038/onc.2016.24			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW0LA	26898756				2022-12-26	WOS:000383330700012
J	Maes, E; Krzewinski, F; Garenaux, E; Lequette, Y; Coddeville, B; Trivelli, X; Ronse, A; Faille, C; Guerardel, Y				Maes, Emmanuel; Krzewinski, Frederic; Garenaux, Estelle; Lequette, Yannick; Coddeville, Bernadette; Trivelli, Xavier; Ronse, Annette; Faille, Christine; Guerardel, Yann			Glycosylation of BclA Glycoprotein from Bacillus cereus and Bacillus anthracis Exosporium Is Domain-specific	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-LIKE REGION; O-POLYSACCHARIDE; MAJOR GLYCOPROTEIN; SURFACE-PROPERTIES; STAINLESS-STEEL; SPORE; TETRASACCHARIDE; ANTHROSE; OLIGOSACCHARIDE; IDENTIFICATION	The spores of the Bacillus cereus group (B. cereus, Bacillus anthracis, and Bacillus thuringiensis) are surrounded by a paracrystalline flexible yet resistant layer called exosporium that plays a major role in spore adhesion and virulence. The major constituent of its hairlike surface, the trimerized glycoprotein BclA, is attached to the basal layer through an N-terminal domain. It is then followed by a repetitive collagen-like neck bearing a globular head (C-terminal domain) that promotes glycoprotein trimerization. The collagen-like region of B. anthracis is known to be densely substituted by unusual O-glycans that may be used for developing species-specific diagnostics of B. anthracis spores and thus targeted therapeutic interventions. In the present study, we have explored the species and domain specificity of BclA glycosylation within the B. cereus group. First, we have established that the collagen-like regions of both B. anthracis and B. cereus are similarly substituted by short O-glycans that bear the species-specific deoxyhexose residues anthrose and the newly observed cereose, respectively. Second we have discovered that the C-terminal globular domains of BclA from both species are substituted by polysaccharide-like O-linked glycans whose structures are also species-specific. The presence of large carbohydrate polymers covering the surface of Bacillus spores may have a profound impact on the way that spores regulate their interactions with biotic and abiotic surfaces and represents potential new diagnostic targets.	[Maes, Emmanuel; Krzewinski, Frederic; Garenaux, Estelle; Coddeville, Bernadette; Trivelli, Xavier; Guerardel, Yann] Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France; [Lequette, Yannick; Ronse, Annette; Faille, Christine] INRA, UMR8207, F-59650 Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); INRAE; Universite de Lille - ISITE; Universite de Lille	Guerardel, Y (corresponding author), Univ Lille, CNRS, UMR 8576, UGSF, F-59000 Lille, France.	yann.guerardel@univ-lille1.fr		Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650; Krzewinski, Frederic/0000-0003-1491-6899	Region Nord-Pas de Calais; European Union (Fonds Europeen de Developpement Economique et Regional); Ministere Francais de la Recherche; Universite Lille 1; CNRS	Region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); European Union (Fonds Europeen de Developpement Economique et Regional); Ministere Francais de la Recherche(Ministry of Research, France); Universite Lille 1; CNRS(Centre National de la Recherche Scientifique (CNRS))	The 900-MHz NMR spectrometer was funded by Region Nord-Pas de Calais, European Union (Fonds Europeen de Developpement Economique et Regional), Ministere Francais de la Recherche, Universite Lille 1, and CNRS.	Boydston JA, 2005, J BACTERIOL, V187, P5310, DOI 10.1128/JB.187.15.5310-5317.2005; Bozue JA, 2005, MICROB PATHOGENESIS, V38, P1, DOI 10.1016/j.micpath.2004.10.001; Chen G, 2010, COLLOID SURFACE B, V76, P512, DOI 10.1016/j.colsurfb.2009.12.012; Coddeville B, 2011, BIOMACROMOLECULES, V12, P2064, DOI 10.1021/bm101557v; Crich D, 2007, J ORG CHEM, V72, P6513, DOI 10.1021/jo070750s; Daubenspeck JM, 2004, J BIOL CHEM, V279, P30945, DOI 10.1074/jbc.M401613200; Dhenin SGY, 2008, CARBOHYD RES, V343, P2101, DOI 10.1016/j.carres.2007.11.030; Dong SL, 2008, J BACTERIOL, V190, P2350, DOI 10.1128/JB.01899-07; Dong SL, 2009, J BACTERIOL, V191, P7094, DOI 10.1128/JB.01050-09; Faille C, 2007, J FOOD PROTECT, V70, P2346, DOI 10.4315/0362-028X-70.10.2346; Faille C, 2010, INT J FOOD MICROBIOL, V143, P125, DOI 10.1016/j.ijfoodmicro.2010.07.038; Fox A, 2003, J MICROBIOL METH, V54, P143, DOI 10.1016/S0167-7012(03)00095-2; GERHARDT P, 1964, J BACTERIOL, V88, P1774, DOI 10.1128/JB.88.6.1774-1789.1964; GILLERON M, 1990, EUR J BIOCHEM, V193, P449, DOI 10.1111/j.1432-1033.1990.tb19359.x; Giorno R, 2007, J BACTERIOL, V189, P691, DOI 10.1128/JB.00921-06; GIULIANO RM, 1988, CARBOHYD RES, V183, P277, DOI 10.1016/0008-6215(88)84080-1; Guo HB, 2007, ANGEW CHEM INT EDIT, V46, P5206, DOI 10.1002/anie.200701354; Henriques AO, 2007, ANNU REV MICROBIOL, V61, P555, DOI 10.1146/annurev.micro.61.080706.093224; Kailas L, 2011, P NATL ACAD SCI USA, V108, P16014, DOI 10.1073/pnas.1109419108; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; KOERNER TAW, 1987, METHOD ENZYMOL, V138, P38; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kubler-Kielb J, 2008, P NATL ACAD SCI USA, V105, P8709, DOI 10.1073/pnas.0803897105; Kuehn A, 2009, CLIN VACCINE IMMUNOL, V16, P1728, DOI 10.1128/CVI.00235-09; Lequette Y, 2011, BIOFOULING, V27, P751, DOI 10.1080/08927014.2011.599842; Lequette Y, 2011, APPL ENVIRON MICROB, V77, P4905, DOI 10.1128/AEM.02872-10; Liu HB, 2004, J BACTERIOL, V186, P164, DOI 10.1128/JB.186.1.164-178.2004; Mehta AS, 2006, CHEM-EUR J, V12, P9136, DOI 10.1002/chem.200601245; Milhomme O, 2012, ORG BIOMOL CHEM, V10, P8524, DOI 10.1039/c2ob26131f; Milhomme O, 2012, CARBOHYD RES, V356, P115, DOI 10.1016/j.carres.2012.01.007; Oberli MA, 2010, J AM CHEM SOC, V132, P10239, DOI 10.1021/ja104027w; Oliva CR, 2008, P NATL ACAD SCI USA, V105, P1261, DOI 10.1073/pnas.0709321105; PEZARD C, 1993, J GEN MICROBIOL, V139, P2459, DOI 10.1099/00221287-139-10-2459; Pieters RJ, 2011, ADV EXP MED BIOL, V715, P227, DOI 10.1007/978-94-007-0940-9_14; Plomp M, 2005, LANGMUIR, V21, P7892, DOI 10.1021/la050412r; Redmond C, 2004, MICROBIOL-SGM, V150, P355, DOI 10.1099/mic.0.26681-0; Rodenburg CM, 2014, J STRUCT BIOL, V186, P181, DOI 10.1016/j.jsb.2014.02.018; Senchenkova SN, 2002, CARBOHYD RES, V337, P1723, DOI 10.1016/S0008-6215(02)00268-9; Steichen CT, 2005, J BACTERIOL, V187, P5868, DOI 10.1128/JB.187.17.5868-5876.2005; Sylvestre P, 2003, J BACTERIOL, V185, P1555, DOI 10.1128/JB.185.5.1555-1563.2003; Tamborrini M, 2009, J APPL MICROBIOL, V106, P1618, DOI 10.1111/j.1365-2672.2008.04129.x; Tamborrini M, 2006, ANGEW CHEM INT EDIT, V45, P6581, DOI 10.1002/anie.200602048; Tamborrini M, 2011, J BACTERIOL, V193, P3506, DOI 10.1128/JB.00078-11; Tamborrini M, 2010, CLIN VACCINE IMMUNOL, V17, P1446, DOI 10.1128/CVI.00205-10; Toth A, 2003, ARKIVOC, P28, DOI 10.3998/ark.5550190.0004.504; Wang DN, 2007, PROTEOMICS, V7, P180, DOI 10.1002/pmic.200600478; Weaver J, 2007, INFECT IMMUN, V75, P3894, DOI 10.1128/IAI.00283-07; Zdorovenko EL, 2001, CARBOHYD RES, V330, P505, DOI 10.1016/S0008-6215(01)00005-2; Zdorovenko EL, 2012, CARBOHYD RES, V358, P106, DOI 10.1016/j.carres.2012.06.012; Zdorovenko EL, 2009, CARBOHYD RES, V344, P2519, DOI 10.1016/j.carres.2009.08.040	50	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9666	9677		10.1074/jbc.M116.718171	http://dx.doi.org/10.1074/jbc.M116.718171			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921321	Green Published, hybrid			2022-12-26	WOS:000375602300025
J	Civitelli, L; Sandin, L; Nelson, E; Khattak, SI; Brorsson, AC; Kagedal, K				Civitelli, Livia; Sandin, Linnea; Nelson, Erin; Khattak, Sikander Iqbal; Brorsson, Ann-Christin; Kagedal, Katarina			The Luminescent Oligothiophene p-FTAA Converts Toxic A beta(1-42) Species into Nontoxic Amyloid Fibers with Altered Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE OPTICAL PROBES; ALZHEIMERS-DISEASE; A-BETA; IN-VIVO; CONJUGATED POLYELECTROLYTES; OLIGOMER LEVELS; FIBRILS; CONFORMATION; BINDING; DEPOSITS	Aggregation of the amyloid-(beta) peptide (A beta) in the brain leads to the formation of extracellular amyloid plaques, which is one of the pathological hallmarks of Alzheimer disease (AD). It is a general hypothesis that soluble prefibrillar assemblies of the A beta peptide, rather than mature amyloid fibrils, cause neuronal dysfunction and memory impairment in AD. Thus, reducing the level of these prefibrillar species by using molecules that can interfere with the A beta fibrillation pathway may be a valid approach to reduce A beta cytotoxicity. Luminescent-conjugated oligothiophenes (LCOs) have amyloid binding properties and spectral properties that differ when they bind to protein aggregates with different morphologies and can therefore be used to visualize protein aggregates. In this study, cell toxicity experiments and biophysical studies demonstrated that the LCO p-FTAA was able to reduce the pool of soluble toxic A beta species in favor of the formation of larger insoluble nontoxic amyloid fibrils, there by counteracting A beta-mediated cytotoxicity. Moreover, p-FTAA bound to early formed A beta species and induced a rapid formation of beta-sheet structures. These p-FTAA generated amyloid fibrils were less hydrophobic and more resistant to proteolysis by proteinase K. In summary, our data show that p-FTAA promoted the formation of insoluble and stable A beta species that were nontoxic which indicates that p-FTAA might have therapeutic potential.	[Civitelli, Livia; Sandin, Linnea; Nelson, Erin; Khattak, Sikander Iqbal; Kagedal, Katarina] Linkoping Univ, Dept Clin & Expt Med, Expt Pathol, Linkoping, Sweden; [Brorsson, Ann-Christin] Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, Linkoping, Sweden	Linkoping University; Linkoping University	Civitelli, L; Kagedal, K (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Expt Pathol, Linkoping, Sweden.; Brorsson, AC (corresponding author), Linkoping Univ, Div Mol Biotechnol, Dept Phys Chem & Biol, Linkoping, Sweden.	livia.civitelli@liu.se; ann-christin.brorsson@liu.se; katarina.kagedal@liu.se		Civitelli, Livia/0000-0003-2399-1436; Brorsson, Ann-Christin/0000-0001-7651-3556	Swedish Research Council; Torsten Soderberg Foundation; Alzheimer Foundation; Dementia Foundation; Linkoping University Neurobiology Center	Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Alzheimer Foundation; Dementia Foundation; Linkoping University Neurobiology Center	This work was supported by the Swedish Research Council, Torsten Soderberg Foundation (to A.-C. B.), the Alzheimer Foundation (to A.-C. B. and K. K.), the Dementia Foundation (to K. K.), and by the Linkoping University Neurobiology Center (to L. C., A.-C. B., and K. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Alavez S, 2011, NATURE, V472, P226, DOI 10.1038/nature09873; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Bennett DA, 2004, ARCH NEUROL-CHICAGO, V61, P378, DOI 10.1001/archneur.61.3.378; Bieschke J, 2012, NAT CHEM BIOL, V8, P93, DOI 10.1038/nchembio.719; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bothra A, 1998, J BIOMOL STRUCT DYN, V15, P959, DOI 10.1080/07391102.1998.10508216; Caesar I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031424; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Gervais F, 2007, NEUROBIOL AGING, V28, P537, DOI 10.1016/j.neurobiolaging.2006.02.015; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Goransson AL, 2012, BIOCHEM BIOPH RES CO, V420, P895, DOI 10.1016/j.bbrc.2012.03.097; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Klingstedt T, 2011, ORG BIOMOL CHEM, V9, P8356, DOI 10.1039/c1ob05637a; Klingstedt T, 2011, BBA-GEN SUBJECTS, V1810, P286, DOI 10.1016/j.bbagen.2010.05.003; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Magnusson K, 2014, PRION, V8, P319, DOI 10.4161/pri.29239; Margalith I, 2012, J BIOL CHEM, V287, P18872, DOI 10.1074/jbc.M112.355958; Masters CL, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006262; Necula M, 2007, BIOCHEMISTRY-US, V46, P8850, DOI 10.1021/bi700411k; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nilsson KPR, 2006, CHEMBIOCHEM, V7, P1096, DOI 10.1002/cbic.200500550; Nilsson KPR, 2005, BIOCHEMISTRY-US, V44, P3718, DOI 10.1021/bi047402u; Nystrom S, 2013, ACS CHEM BIOL, V8, P1128, DOI 10.1021/cb4000376; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Ries J, 2013, ACS CHEM NEUROSCI, V4, P1057, DOI 10.1021/cn400091m; Seilheimer B, 1997, J STRUCT BIOL, V119, P59, DOI 10.1006/jsbi.1997.3859; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tomic JL, 2009, NEUROBIOL DIS, V35, P352, DOI 10.1016/j.nbd.2009.05.024; Townsend M, 2006, ANN NEUROL, V60, P668, DOI 10.1002/ana.21051; Vernaglia BA, 2004, BIOMACROMOLECULES, V5, P1362, DOI 10.1021/bm0498979; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	46	16	17	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9233	9243		10.1074/jbc.M115.696229	http://dx.doi.org/10.1074/jbc.M115.696229			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26907684	hybrid, Green Published			2022-12-26	WOS:000374849000033
J	Ferrando, PM; Balmativola, D; Cambieri, I; Scalzo, MS; Bergallo, M; Annaratone, L; Casarin, S; Fumagalli, M; Stella, M; Sapino, A; Castagnoli, C				Ferrando, Pietro Maria; Balmativola, Davide; Cambieri, Irene; Scalzo, Maria Stella; Bergallo, Massimiliano; Annaratone, Laura; Casarin, Stefania; Fumagalli, Mara; Stella, Maurizio; Sapino, Anna; Castagnoli, Carlotta			Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory Study	PLOS ONE			English	Article							COLLAGEN/ELASTIN-MEMBRANE; EXTRACELLULAR-MATRIX; RECONSTRUCTION; SKIN; EXPERIENCE; SCAFFOLDS; ALLODERM; TISSUES	Human Acellular Dermal Matrices (HADM) are employed in various reconstructive surgery procedures as scaffolds for autologous tissue regeneration. The aim of this project was to develop a new type of HADM for clinical use, composed of glycerolized reticular dermis decellularized through incubation and tilting in Dulbecco's Modified Eagle's Medium (DMEM). This manufacturing method was compared with a decellularization procedure already described in the literature, based on the use of sodium hydroxide (NaOH), on samples from 28 donors. Cell viability was assessed using an MTT assay and microbiological monitoring was performed on all samples processed after each step. Two surgeons evaluated the biomechanical characteristics of grafts of increasing thickness. The effects of the different decellularization protocols were assessed by means of histological examination and immunohistochemistry, and residual DNA after decellularization was quantified using a real-time TaqMan MGB probe. Finally, we compared the results of DMEM based decellularization protocol on reticular dermis derived samples with the results of the same protocol applied on papillary dermis derived grafts. Our experimental results indicated that the use of glycerolized reticular dermis after 5 weeks of treatment with DMEM results in an HADM with good handling and biocompatibility properties.	[Ferrando, Pietro Maria] Citta Salute & Sci, Dept Gen & Specialized Surg, Div Breast Surg, Turin, Italy; [Balmativola, Davide; Scalzo, Maria Stella; Annaratone, Laura; Sapino, Anna] Univ Turin, Dept Med Sci, Div Pathol, Turin, Italy; [Cambieri, Irene; Casarin, Stefania; Fumagalli, Mara; Stella, Maurizio; Castagnoli, Carlotta] Citta Salute & Sci, Dept Gen & Specialized Surg, Skin Bank, Turin, Italy; [Bergallo, Massimiliano] Univ Turin, Dept Publ Hlth & Pediat, Cytoimmunodiagnost Lab, Turin, Italy; [Sapino, Anna] Fdn Piemonte Oncol FPO, Candiolo Canc Inst IRCCs, Candiolo, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Ferrando, PM (corresponding author), Citta Salute & Sci, Dept Gen & Specialized Surg, Div Breast Surg, Turin, Italy.	pmferrando@hotmail.it	Sapino, Anna/AGY-9901-2022; Annaratone, Laura/J-9261-2016; Sapino, Anna/J-4113-2018; Balmativola, Davide/AAB-7662-2019; Bergallo, Massimiliano/AHD-2214-2022	Sapino, Anna/0000-0003-3542-9571; Annaratone, Laura/0000-0001-5750-1445; Sapino, Anna/0000-0003-3542-9571; Balmativola, Davide/0000-0002-3583-1846; Bergallo, Massimiliano/0000-0002-9291-1332	Compagnia di San Paolo, Turin, Italy; Fondazione CRT, Turin, Italy; Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia; Ministry of Health, Ricerca Sanitaria Finalizzata [RF-2010-2310674]; LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch)	Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); Fondazione CRT, Turin, Italy; Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia; Ministry of Health, Ricerca Sanitaria Finalizzata; LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch)	CC was supported by funds from the Compagnia di San Paolo, Turin, Italy, from Fondazione CRT, Turin, Italy, and from Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia. AS was supported by the Ministry of Health, Ricerca Sanitaria Finalizzata (RF-2010-2310674) and by LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch2014). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Bernabei P, 1999, BURNS, V25, P43, DOI 10.1016/S0305-4179(98)00128-4; Bondioli E, 2014, J TISSUE ENG REGEN M, V8, P325, DOI 10.1002/term.1530; Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519; CASTAGNOLI C, 1990, CLIN EXP IMMUNOL, V82, P350; Castagnoli C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840363; Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972; Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4; KREUZ FP, 1951, J BONE JOINT SURG AM, V33-A, P863, DOI 10.2106/00004623-195133040-00005; LAMKE L-O, 1971, Scandinavian Journal of Plastic and Reconstructive Surgery, V5, P82; Lin HJ, 2009, AM J SURG, V197, P599, DOI 10.1016/j.amjsurg.2008.12.022; LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001; Livesey SA., 2006, Pub, Patent No. [US 2006/0210960, 20060210960]; Mackie David, 2002, Burns, V28 Suppl 1, pS40; MELLONIG J T, 1991, Dental Clinics of North America, V35, P505; Moore MA, 2015, CELL TISSUE BANK, V16, P249, DOI 10.1007/s10561-014-9467-4; Nicklas JA, 2003, ANAL BIOANAL CHEM, V376, P1160, DOI 10.1007/s00216-003-1924-z; Richters CD, 2008, CELL TISSUE BANK, V9, P309, DOI 10.1007/s10561-008-9073-4; Richters CD, 1996, BURNS, V22, P113, DOI 10.1016/0305-4179(95)00103-4; Salzberg CA, 2011, PLAST RECONSTR SURG, V127, P514, DOI 10.1097/PRS.0b013e318200a961; SEDMAK DD, 1991, ARCH PATHOL LAB MED, V115, P260; Sun WQ, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413505305; Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2; vanBaare J, 1944, BURNS, V20, pS77; WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I; YUKNA RA, 1977, J PERIODONTAL RES, V12, P197, DOI 10.1111/j.1600-0765.1977.tb00122.x	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149124	10.1371/journal.pone.0149124	http://dx.doi.org/10.1371/journal.pone.0149124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918526	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400013
J	Liu, JH; Liu, M; Zheng, B; Yao, ZP; Xia, J				Liu, Jiahui; Liu, Miao; Zheng, Bo; Yao, Zhongping; Xia, Jiang			Affinity Enhancement by Ligand Clustering Effect Inspired by Peptide Dendrimers-Shank PDZ Proteins Interactions	PLOS ONE			English	Article							MASS-SPECTROMETRY; POSTSYNAPTIC DENSITY; STRUCTURAL BASIS; COMPLEXES; DOMAINS; ORGANIZATION; BINDING	High-affinity binders are desirable tools to probe the function that specific protein-protein interactions play in cell. In the process of seeking a general strategy to design high-affinity binders, we found a clue from the beta PIX (p21-activated kinase interacting exchange factor)-Shank PDZ interaction in synaptic assembly:three PDZ-binding sites are clustered by a parallel coiled-coil trimer but bind to Shank PDZ protein with 1:1 stoichiometry (1 trimer/1 PDZ). Inspired by this architecture, we proposed that peptide dendrimer, mimicking the ligand clustering in beta PIX, will also show enhanced binding affinity, yet with 1:1 stoichiometry. This postulation has been proven here, as we synthesized a set of monomeric, dimeric and trimeric peptides and measured their binding affinity and stoichiometry with Shank PDZ domains by isothermal titration calorimetry, native mass spectrometry and surface plasmon resonance. This affinity enhancement, best explained by proximity effect, will be useful to guide the design of high-affinity blockers for protein-protein interactions.	[Liu, Jiahui; Liu, Miao; Xia, Jiang] Chinese Univ Hong Kong, Dept Chem, Ctr Novel Biomat, Shatin, Hong Kong, Peoples R China; [Zheng, Bo; Yao, Zhongping] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University	Xia, J (corresponding author), Chinese Univ Hong Kong, Dept Chem, Ctr Novel Biomat, Shatin, Hong Kong, Peoples R China.	jiangxia@cuhk.edu.hk	Yao, Zhongping/K-2117-2014; CHEN, Huanwen/B-1794-2008; Xia, Jiang/AAT-2366-2020	Yao, Zhongping/0000-0003-3555-9632; Xia, Jiang/0000-0001-8112-7625	Research Grants Council [CUHK 404812, 403711, 404413, AoE/M-09/12]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council, Early Career Scheme grant CUHK 404812 (website: http://www.ugc.edu.hk/eng/rgc/fund/grants.htm#a), the Research Grants Council, General Research Fund grants 403711 and 404413 (website: http://www.ugc.edu.hk/eng/rgc/fund/grants.htm#b), and the Research Grants Council, Areas of Excellence Scheme, AoE/M-09/12 (website: http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm). Prof. Xia received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; HERMANOWSKIVOSATKA A, 1988, J BIOL CHEM, V263, P17822; Im YJ, 2010, J MOL BIOL, V397, P457, DOI 10.1016/j.jmb.2010.01.048; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen Kristina, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1712s62; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Pieters RJ, 2009, ORG BIOMOL CHEM, V7, P2013, DOI 10.1039/b901828j; RAO C, 1994, J AM CHEM SOC, V116, P6975, DOI 10.1021/ja00094a078; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Saupe J, 2011, CHEMMEDCHEM, V6, P1411, DOI 10.1002/cmdc.201100094; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Tomas S, 2010, NAT CHEM, V2, P1077, DOI 10.1038/NCHEM.892; van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	25	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149580	10.1371/journal.pone.0149580	http://dx.doi.org/10.1371/journal.pone.0149580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918521	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400025
J	Werth, AJ; Potvin, J				Werth, Alexander J.; Potvin, Jean			Baleen Hydrodynamics and Morphology of Cross-Flow Filtration in Balaenid Whale Suspension Feeding	PLOS ONE			English	Article							BOWHEAD WHALE; MECHANISMS; BEHAVIOR; PERFORMANCE; KINEMATICS	The traditional view of mysticete feeding involves static baleen directly sieving particles from seawater using a simple, dead-end flow-through filtration mechanism. Flow tank experiments on bowhead (Balaena mysticetus) baleen indicate the long-standing model of dead-end filtration, at least in balaenid (bowhead and right) whales, is not merely simplistic but wrong. To recreate continuous intraoral flow, sections of baleen were tested in a flume through which water and buoyant particles circulated with variable flow velocity. Kinematic sequences were analyzed to investigate movement and capture of particles by baleen plates and fringes. Results indicate that very few particles flow directly through the baleen rack; instead much water flows anteroposteriorly along the interior (lingual) side of the rack, allowing items to be carried posteriorly and accumulate at the posterior of the mouth where they might readily be swallowed. Since water flows mainly parallel to rather than directly through the filter, the cross-flow mechanism significantly reduces entrapment and tangling of minute items in baleen fringes, obviating the need to clean the filter. The absence of copepods or other prey found trapped in the baleen of necropsied right and bowhead whales supports this hypothesis. Reduced through-baleen flow was observed with and without boundaries modeling the tongue and lips, indicating that baleen itself is the main if not sole agent of crossflow. Preliminary investigation of baleen from balaenopterid whales that use intermittent filter feeding suggests that although the biomechanics and hydrodynamics of oral flow differ, cross-flow filtration may occur to some degree in all mysticetes.	[Werth, Alexander J.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA; [Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA	Saint Louis University	Werth, AJ (corresponding author), Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA.	awerth@hsc.edu		Werth, Alexander/0000-0002-7777-478X	Hampden-Sydney College; Virginia Foundation for Independent Colleges; University of British Columbia	Hampden-Sydney College; Virginia Foundation for Independent Colleges; University of British Columbia	Funding for AJW was provided by faculty grants from Hampden-Sydney College, and Mednick and Harris Awards from the Virginia Foundation for Independent Colleges.; Samples of baleen are from animals harvested by Inupiat hunters of the Alaska Eskimo Whaling Commission in accordance with their exemption to the U.S. Marine Mammal Protection Act and other national and international restrictions. We are grateful to hunters for allowing examination and sampling of their whales. Tissues were collected under Permit #519 issued by the National Marine Fisheries Service to T.F. Albert of the North Slope Borough (Alaska) Department of Wildlife Management. We are indebted to I. Robertson for flow tank construction and S. Vogel for design advice, and to numerous students for assistance with data collection and logistics. D.E. Lowry provided valuable assistance with statistical analysis. Our dataset is available at http://dx.doi.org/10.6084/m9.figshare.2056602. We thank R.E. Shadwick for his hospitality and financial support during our stay at the University of British Columbia. For ideas and discussion of whale feeding and experimental methods we thank J. Goldbogen, R. Shadwick, S. Pinto, M. Lillie, M. Piscitelli, N. Pyenson, F. Fish, H. Ito, J. Reidenberg, J.C. George, T. Sformo, R. Suydam, B. Kot, C. Marshall, P. van de Graaf, M. Simon, P. Madsen, T. Ford, R. Payne, A. Friedlaender, M. Baumgartner, D. Wiley, C. Mayo, S. Kraus, and S.L. Sanderson.	Aristotle, 2009, PARTIBUS ANIMALIUM; Aristotle, 2002, HIST ANIMALIUM; BAKER RJ, 1985, DESALINATION, V53, P81, DOI 10.1016/0011-9164(85)85053-0; Bannister J.L., 2008, ENCY MARINE MAMMALS, V2nd, P80; Baumgartner Mark F., 2007, P138; BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; Blatt W.F., 1970, MEMBRANE SCI TECHNOL; Brainerd EL, 2001, NATURE, V412, P387, DOI 10.1038/35086666; CARROLL GM, 1987, ARCTIC, V40, P105; Cheer AY, 2001, J THEOR BIOL, V210, P463, DOI 10.1006/jtbi.2001.2325; Croll DA, 2008, ENCY MARINE MAMMALS, P429; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Geraci J.R., 1990, P167; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2013, BIOSCIENCE, V63, P90, DOI 10.1525/bio.2013.63.2.5; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; Kot BW, 2009, THESIS U CALIFORNIA; Kundu P.K, 2011, VORTICITY DYNAMICS F; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; Lowry Lloyd F., 1993, Society for Marine Mammalogy Special Publication, V2, P201; LU WM, 1993, CHEM ENG SCI, V48, P863, DOI 10.1016/0009-2509(93)80325-K; LU WM, 1989, SEPAR SCI TECHNOL, V24, P517, DOI 10.1080/01496398908049789; Marshall CM, 2008, ENCY MARINE MAMMALS, V2e, P406; Mayo C. A., 2001, Journal of Cetacean Research and Management Special Issue, P225; Moore Michael J., 2012, Journal of Marine Biology, P1; Murkes J, 1988, CROSSFLOW FILTRATION; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Paig-Tran EWM, 2013, J MORPHOL, V274, P1026, DOI 10.1002/jmor.20160; Paig-Tran EWM, 2013, ANAT REC, P701; Pinto SJD, 2011, THESIS U BRIT COLUMB; PIVORUNAS A, 1979, AM SCI, V67, P432; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Ripperger S, 2002, SEP PURIF TECHNOL, V26, P19, DOI 10.1016/S1383-5866(01)00113-7; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; Ryerson WG, 2012, J EXP ZOOL PART A, V317A, P127, DOI 10.1002/jez.725; Sanderson S. Laurie, 1993, P37; Sanderson SL, 2001, NATURE, V412, P439, DOI 10.1038/35086574; SANDERSON SL, 1990, SCI AM, V262, P96, DOI 10.1038/scientificamerican0390-96; Sears R, 2008, ENCY MARINE MAMMALS, P120; Simon M, 2009, P ROY SOC B-BIOL SCI, V276, P3819, DOI 10.1098/rspb.2009.1135; SONG LF, 1995, J CHEM SOC FARADAY T, V91, P3389, DOI 10.1039/ft9959103389; STAUBIN DJ, 1984, CAN J ZOOL, V62, P193, DOI 10.1139/z84-032; Vogel S, 2013, COMP BIOMECHANICS E; Vogel S, 1996, LIFE MOVING FLUIDS; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Werth Alexander J., 2012, International Journal of Ecology, P1; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; Williamson G.R., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P279; Yochem P.K., 1985, HDB MARINE MAMMALS, V3, P305; Zeman L. J., 1996, MICROFILTRATION ULTR	59	41	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150106	10.1371/journal.pone.0150106	http://dx.doi.org/10.1371/journal.pone.0150106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918630	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400087
J	Wong, JD; Bobbert, MF; van Soest, AJ; Gribble, PL; Kistemaker, DA				Wong, Jeremy D.; Bobbert, Maarten F.; van Soest, Arthur J.; Gribble, Paul L.; Kistemaker, Dinant A.			Optimizing the Distribution of Leg Muscles for Vertical Jumping	PLOS ONE			English	Article							EXPLOSIVE MOVEMENTS	A goal of biomechanics and motor control is to understand the design of the human musculoskeletal system. Here we investigated human functional morphology by making predictions about the muscle volume distribution that is optimal for a specific motor task. We examined a well-studied and relatively simple human movement, vertical jumping. We investigated how high a human could jump if muscle volume were optimized for jumping, and determined how the optimal parameters improve performance. We used a four-link inverted pendulum model of human vertical jumping actuated by Hill-type muscles, that well-approximates skilled human performance. We optimized muscle volume by allowing the cross-sectional area and muscle fiber optimum length to be changed for each muscle, while maintaining constant total muscle volume. We observed, perhaps surprisingly, that the reference model, based on human anthropometric data, is relatively good for vertical jumping; it achieves 90% of the jump height predicted by a model with muscles designed specifically for jumping. Alteration of cross-sectional areas-which determine the maximum force deliverable by the muscles-constitutes the majority of improvement to jump height. The optimal distribution results in large vastus, gastrocnemius and hamstrings muscles that deliver more work, while producing a kinematic pattern essentially identical to the reference model. Work output is increased by removing muscle from rectus femoris, which cannot do work on the skeleton given its moment arm at the hip and the joint excursions during push-off. The gluteus composes a disproportionate amount of muscle volume and jump height is improved by moving it to other muscles. This approach represents a way to test hypotheses about optimal human functional morphology. Future studies may extend this approach to address other morphological questions in ethological tasks such as locomotion, and feature other sets of parameters such as properties of the skeletal segments.	[Wong, Jeremy D.; Gribble, Paul L.; Kistemaker, Dinant A.] Univ Western Ontario, Brain & Mind Inst, London, ON N6A 3K7, Canada; [Wong, Jeremy D.; Bobbert, Maarten F.; van Soest, Arthur J.; Kistemaker, Dinant A.] Vrije Univ Amsterdam, MOVE Res Inst, Nord Holland, Netherlands; [Wong, Jeremy D.] Simon Fraser Univ, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	Western University (University of Western Ontario); Vrije Universiteit Amsterdam; Simon Fraser University	Wong, JD (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON N6A 3K7, Canada.; Wong, JD (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Nord Holland, Netherlands.; Wong, JD (corresponding author), Simon Fraser Univ, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada.	jeremy_wong_4@sfu.ca		Wong, Jeremy/0000-0001-5564-1794	Michael Smith Foundation for Health Research [5552]; European Union [CORDIS FP7-PEOPLE-2011-CIG-303849]; Natural Sciences and Engineering Research Council of Canada [RGPIN-238338]; Canadian Institutes of Health Research [MOP-53296]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); European Union(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Michael Smith Foundation for Health Research #5552 (JDW), European Union Seventh Framework Programme for Research #CORDIS FP7-PEOPLE-2011-CIG-303849(DAK), Natural Sciences and Engineering Research Council of Canada #RGPIN-238338 (PLG), and Canadian Institutes of Health Research #MOP-53296 (PLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobbert MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071209; Bobbert MF, 2013, NEUROSCIENCE, V237, P232, DOI 10.1016/j.neuroscience.2013.01.055; Bobbert MF, 2001, J EXP BIOL, V204, P533; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Johnson S. G., 2015, NLOPT NONLINEAR OPTI; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; KRAFT D, 1994, ACM T MATH SOFTWARE, V20, P262, DOI 10.1145/192115.192124; MENDEZ J, 1960, METABOLISM, V9, P184; Pai DK, 2010, J BIOMECH, V43, P2093, DOI 10.1016/j.jbiomech.2010.04.004; Powell M.J.D., 2009, BOBYQA ALGORITHM BOU; POWELL M. J. D., 1994, MATH APPL, V275, P51, DOI DOI 10.1007/978-94-015-8330-5_; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Seth A, 2007, J BIOMECH, V40, P356, DOI 10.1016/j.jbiomech.2005.12.017; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; van Soest AJK, 2003, J BIOMECH ENG-T ASME, V125, P141, DOI 10.1115/1.1537735; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; VANSOEST AJ, 1994, J NEUROPHYSIOL, V71, P1390, DOI 10.1152/jn.1994.71.4.1390	18	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150019	10.1371/journal.pone.0150019	http://dx.doi.org/10.1371/journal.pone.0150019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919645	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400071
J	Choi, BH; Ro, H; Jung, ES; Kim, AJ; Chang, JH; Lee, HH; Chung, W; Jung, JY				Choi, Byoung Ho; Ro, Han; Jung, Eul Sik; Kim, Ae Jin; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Circulating S100A12 Levels Are Associated with Progression of Abdominal Aortic Calcification in Hemodialysis Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCT; SOLUBLE RECEPTOR; VASCULAR CALCIFICATION; PLASMA S100A12; SERUM S100A12; ALL-CAUSE; RAGE; MORTALITY; DISEASE; SRAGE	Vascular calcification is an important factor associated with mortality in dialysis patients. Recently, soluble receptor for advanced glycation end product (sRAGE) and extracellular RAGE binding protein S100A12 (EN-RAGE) have been reported to be involved in the process of vascular calcification. Therefore, we investigated whether sRAGE and S100A12 are useful indicators of progression of abdominal aortic calcification in hemodialysis (HD) patients. We analyzed annual changes in vascular calcification score (VCS) for up to 4 years, compared to clinical and biological parameters in 149 HD patients. VCS was assessed annually using plain X-ray images of the lateral lumbar spine. The progression group was defined as patients with an increase in VCS more than 1 point each year on average during the observation period. Time-averaged concentrations were also evaluated to examine the association between biological parameters and changes in VCS. The patients had a mean age of 58.59 +/- 12.93 years; 53.7% were male, and 45% were diabetic. The VCS increased in 55 patients; the mean increase was 1.60 +/- 2.91 points. In a stepwise multivariate logistic analysis, we found that higher levels of S100A12 were significantly associated with progression of VCS (odds ratio [OR], 2.622; 95% confidence interval [CI], 1.371-5.016; P = 0.004). The relationship between sRAGE and VCS was not statistically significant (OR, 0.644; 95% CI, 0.302-1.374; P = 0.255). Our findings suggest that serum levels of S100A12 are associated with progression of abdominal aortic calcification in HD patients, independent of sRAGE level.	[Choi, Byoung Ho; Ro, Han; Jung, Eul Sik; Kim, Ae Jin; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Incheon, South Korea; [Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Incheon, South Korea	Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Incheon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Sch Med, Incheon, South Korea.	jyjung@gachon.ac.kr		Jung, Eul Sik/0000-0003-3898-4693				Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Foley RN, 1998, J NEPHROL, V11, P239; Gawdzik J, 2011, AM J NEPHROL, V33, P250, DOI 10.1159/000324693; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Humpert PM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-9; Isoyama N, 2015, NEPHROL DIAL TRANSPL, V30, P84, DOI 10.1093/ndt/gfu259; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147255; Kim HS, 2013, NEPHROLOGY, V18, P777, DOI 10.1111/nep.12166; Kim JK, 2012, ATHEROSCLEROSIS, V220, P208, DOI 10.1016/j.atherosclerosis.2011.07.115; Kimura K, 1999, KIDNEY INT, V56, pS238, DOI 10.1046/j.1523-1755.1999.07163.x; Lindholm B, 2015, AM J NEPHROL, V42, P1, DOI 10.1159/000438873; Lindsey JB, 2009, DIABETES VASC DIS RE, V6, P7, DOI 10.3132/dvdr.2009.002; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; Nakashima A, 2010, CLIN J AM SOC NEPHRO, V5, P2213, DOI 10.2215/CJN.03360410; NasrAllah MM, 2012, INT UROL NEPHROL, V44, P1201, DOI 10.1007/s11255-011-0067-y; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Oesterle A, 2015, ARTERIOSCL THROM VAS, V35, P2496, DOI 10.1161/ATVBAHA.115.302072; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schlieper G, 2016, NEPHROL DIAL TRANSPL, V31, P31, DOI 10.1093/ndt/gfv111; Shiotsu Y, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-16; Shiotsu Y, 2011, NEPHRON EXTRA, V1, P242, DOI 10.1159/000335198; Shiotsu Y, 2011, CLIN J AM SOC NEPHRO, V6, P718, DOI 10.2215/CJN.08310910; Towler DA, 2011, ARTERIOSCL THROM VAS, V31, P237, DOI 10.1161/ATVBAHA.110.220038; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang YN, 2015, AM J NEPHROL, V42, P4, DOI 10.1159/000438869; Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529; Yan L, 2013, ATHEROSCLEROSIS, V228, P69, DOI 10.1016/j.atherosclerosis.2013.02.023	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150145	10.1371/journal.pone.0150145	http://dx.doi.org/10.1371/journal.pone.0150145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914918	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700056
J	Lind, AL; Wu, D; Freyhult, E; Bodolea, C; Ekegren, T; Larsson, A; Gustafsson, MG; Katila, L; Bergquist, J; Gordh, T; Landegren, U; Kamali-Moghaddam, M				Lind, Anne-Li; Wu, Di; Freyhult, Eva; Bodolea, Constantin; Ekegren, Titti; Larsson, Anders; Gustafsson, Mats G.; Katila, Lenka; Bergquist, Jonas; Gordh, Torsten; Landegren, Ulf; Kamali-Moghaddam, Masood			A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD STIMULATION; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR; PROXIMITY LIGATION; PLASMA BIOMARKERS; GLIAL ACTIVATION; BINDING-PROTEIN	The objective of this study was to develop and apply a novel multiplex panel of solid-phase proximity ligation assays (SP-PLA) requiring only 20 mu L of samples, as a tool for discovering protein biomarkers for neurological disease and treatment thereof in cerebrospinal fluid (CSF). We applied the SP-PLA to samples from two sets of patients with poorly understood nervous system pathologies amyotrophic lateral sclerosis (ALS) and neuropathic pain, where patients were treated with spinal cord stimulation (SCS). Forty-seven inflammatory and neurotrophic proteins were measured in samples from 20 ALS patients and 15 neuropathic pain patients, and compared to normal concentrations in CSF from control individuals. Nineteen of the 47 proteins were detectable in more than 95% of the 72 controls. None of the 21 proteins detectable in CSF from neuropathic pain patients were significantly altered by SCS. The levels of the three proteins, follistatin, interleukin-1 alpha, and kallikrein-5 were all significantly reduced in the ALS group compared to age-matched controls. These results demonstrate the utility of purpose designed multiplex SP-PLA panels in CSF biomarker research for understanding neuropathological and neurotherapeutic mechanisms. The protein changes found in the CSF of ALS patients may be of diagnostic interest.	[Lind, Anne-Li; Katila, Lenka; Gordh, Torsten] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, Uppsala, Sweden; [Lind, Anne-Li; Katila, Lenka; Gordh, Torsten] Uppsala Univ, Uppsala Berzelii Technol Ctr Neurodiagnost, Uppsala, Sweden; [Wu, Di; Landegren, Ulf; Kamali-Moghaddam, Masood] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Freyhult, Eva] Uppsala Univ, Bioinformat Infrastruct Life Sci, Sci Life Lab, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden; [Bodolea, Constantin] Univ Med & Pharm, Dept Anaesthesia & Intens Care, Cluj Napoca, Napoca, Romania; [Ekegren, Titti] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci Biochem Struct & Funct, Uppsala, Sweden; [Gustafsson, Mats G.] Uppsala Univ, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden; [Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, Analyt Chem & Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Iuliu Hatieganu University of Medicine & Pharmacy; Uppsala University; Uppsala University; Uppsala University; Uppsala University	Kamali-Moghaddam, M (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	masood.kamali@igp.uu.se	Bodolea, Constantin/AAB-4279-2020; Landegren, Ulf D/A-8197-2019	Katila, Lenka/0000-0001-7621-963X; Freyhult, Eva/0000-0003-0226-1047; Bergquist, Jonas/0000-0002-4597-041X	Swedish Governmental Agency for Innovation Systems; Swedish Research Council (Vetenskapsradet); Uppsala University; Inga-Britt och Arne Lundbergs Forskningsstiftelse; Knut and Alice Wallenberg Foundation; European Research Council under the European Union [316929]; ERC [294409]; SRC [621-2011-4423]	Swedish Governmental Agency for Innovation Systems(Vinnova); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Uppsala University; Inga-Britt och Arne Lundbergs Forskningsstiftelse; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); SRC	This work was performed at Uppsala Berzelii Technology Centre for Neurodiagnostics, financed by the Swedish Governmental Agency for Innovation Systems, the Swedish Research Council (Vetenskapsradet), and Uppsala University. Additional funding was provided by Inga-Britt och Arne Lundbergs Forskningsstiftelse, Knut and Alice Wallenberg Foundation, the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/GastricGlycoExplorer grant agreement No. 316929, ERC grant agreement No. 294409 and SRC (621-2011-4423).	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BAN EM, 1993, NEUROSCIENCE, V52, P725, DOI 10.1016/0306-4522(93)90421-B; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Berjaoui S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/573784; Blasi F, 1999, BIOL CHEM, V380, P259, DOI 10.1515/BC.1999.034; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171; Darmanis S, 2009, MOL CELL PROTEOMICS; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Devon HA, 2014, NURS RES, V63, P51, DOI 10.1097/NNR.0000000000000013; Elf K, 2014, J PROTEOMICS, V108, P55, DOI 10.1016/j.jprot.2014.05.004; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; French RA, 1999, J NEUROIMMUNOL, V93, P194, DOI 10.1016/S0165-5728(98)00224-0; Friedman WJ, 2001, EXP NEUROL, V168, P23, DOI 10.1006/exnr.2000.7595; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hammond EA, 1999, BRAIN, V122, P1697, DOI 10.1093/brain/122.9.1697; He Y, 2015, GLIA, V63, P1568, DOI 10.1002/glia.22828; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kiguchi N, 2014, J NEUROCHEM, V129, P169, DOI 10.1111/jnc.12614; Kim SJ, 2011, SPINE, V36, P2139, DOI 10.1097/BRS.0b013e31821945a3; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; Lewin GR, 2014, EUR J NEUROSCI, V39, P363, DOI 10.1111/ejn.12466; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Liou JT, 2013, PAIN, V154, P2150, DOI 10.1016/j.pain.2013.06.042; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; Mann CLA, 2002, J NEUROIMMUNOL, V129, P197, DOI 10.1016/S0165-5728(02)00181-9; McCarthy KF, 2013, NEUROMODULATION, V16, P519, DOI 10.1111/j.1525-1403.2012.00527.x; McCombe PA, 2011, CURR MOL MED, V11, P246; McMahon SB, 2004, J NEUROBIOL, V61, P72, DOI 10.1002/neu.20093; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Michel W, 2000, EUR J ENDOCRINOL, V143, P809, DOI 10.1530/eje.0.1430809; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mirowska-Guzel D, 2011, J NEUROIMMUNOL, V236, P87, DOI 10.1016/j.jneuroim.2011.04.014; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nie FC, 2013, INT J MOL MED, V31, P1333, DOI 10.3892/ijmm.2013.1344; Nijs J, 2015, EXPERT OPIN THER TAR, V19, P565, DOI 10.1517/14728222.2014.994506; Nikodemova M, 2014, NEUROBIOL DIS, V69, P43, DOI 10.1016/j.nbd.2013.11.009; Noh MY, 2014, NEUROSCI LETT, V574, P53, DOI 10.1016/j.neulet.2014.05.001; Ohnmeiss DD, 1996, SPINE, V21, P1344, DOI 10.1097/00007632-199606010-00013; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pluijms WA, 2012, BRIT J ANAESTH, V109, P623, DOI 10.1093/bja/aes251; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Ramstrom M, 2004, PROTEOMICS, V4, P4010, DOI 10.1002/pmic.200400871; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rose FF, 2009, HUM MOL GENET, V18, P997, DOI 10.1093/hmg/ddn426; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Shtilbans A, 2011, AMYOTROPH LATERAL SC, V12, P250, DOI 10.3109/17482968.2011.560946; SPIEGELMANN R, 1991, NEUROSURGERY, V28, P65, DOI 10.1227/00006123-199101000-00011; Staniland AA, 2010, J NEUROCHEM, V114, P1143, DOI 10.1111/j.1471-4159.2010.06837.x; Sussmuth SD, 2010, NEUROLOGY, V74, P982, DOI 10.1212/WNL.0b013e3181d5dc3b; Sweitzer SM, 2002, J NEUROIMMUNOL, V125, P82, DOI 10.1016/S0165-5728(02)00036-X; TAKAO T, 1990, ENDOCRINOLOGY, V127, P3070, DOI 10.1210/endo-127-6-3070; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; TOMOZAWA Y, 1995, NEUROSCI LETT, V195, P57, DOI 10.1016/0304-3940(95)11781-Q; Truin M, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.04.004; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Tsuda M, 2016, NEUROPHARMACOLOGY, V104, P76, DOI 10.1016/j.neuropharm.2015.08.042; Tsuda M, 2013, GLIA, V61, P55, DOI 10.1002/glia.22379; Tufan K, 2012, J SPINAL DISORD TECH, V25, P443, DOI 10.1097/BSD.0b013e318238e2db; Urshansky N, 2011, J NEUROIMMUNOL, V238, P96, DOI 10.1016/j.jneuroim.2011.08.003; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Wang XF, 2006, J MOL NEUROSCI, V29, P45, DOI 10.1385/JMN:29:1:45; Watt JA, 2000, J NEUROSCI RES, V60, P478, DOI 10.1002/(SICI)1097-4547(20000515)60:4<478::AID-JNR6>3.0.CO;2-R; WERDELIN L, 1990, ACTA NEUROL SCAND, V82, P132; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Wong Ma-Li, 1994, Neuroimmunomodulation, V1, P110, DOI 10.1159/000097143; Wu DD, 1999, BRAIN RES, V835, P369, DOI 10.1016/S0006-8993(99)01638-8; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E; Yousef GM, 2003, CLIN CHIM ACTA, V329, P1, DOI 10.1016/S0009-8981(03)00004-4; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhu X, 2014, J PAIN, V15, P516, DOI 10.1016/j.jpain.2014.01.492	109	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149821	10.1371/journal.pone.0149821	http://dx.doi.org/10.1371/journal.pone.0149821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914813	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700030
J	Rodriguez-Jorquera, IA; Silva-Sanchez, C; Strynar, M; Denslow, ND; Toor, GS				Rodriguez-Jorquera, Ignacio A.; Silva-Sanchez, Cecilia; Strynar, Mark; Denslow, Nancy D.; Toor, Gurpal S.			Footprints of Urban Micro-Pollution in Protected Areas: Investigating the Longitudinal Distribution of Perfluoroalkyl Acids in Wildlife Preserves	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PERFLUOROOCTANE SULFONATE PFOS; PERFLUORINATED COMPOUNDS; TREATMENT PLANTS; QUANTITATIVE-DETERMINATION; RIVER-BASIN; TOKYO BAY; SURFACTANTS; SEDIMENTS; FATE	Current approaches to protect biodiversity by establishing protected areas usually gloss over water pollution as a threat. Our objective was to determine the longitudinal and seasonal distribution of perfluoroalkyl acids (PFAAs) in water column and sediments from a wastewater dominated stream that enters preservation areas. Water samples were collected along the longitudinal section (six sites, 1000 m away from each other) of the stream during the dry and wet seasons. Sediments were collected from three sites along the stream from three depths. Water and sediments were analyzed for PFAAs using high performance liquid chromatography-tandem mass spectrometry. Eleven PFAAs with 5 to 14 carbon atoms were detected in the water column at all sampling points, with a minor reduction at the last point suggesting a dilution effect. The most detected PFAAs was PFOS, followed by perfluorooctanoic acid (PFOA), and perfluorohexanoic acid (PFHxA). Seasonal differences in PFAAs concentrations suggested contribution of stormwater runoff during the wet season. All analyzed PFAAs in sediments were under the limit of quantification, likely due to the high proportion of sand and low organic matter. However, high concentrations of PFAAs were detected in the water column inside the protected areas, which includes PFOS in concentrations considered not safe for avian wildlife. Water samples appear to be more relevant than sediments to determine PFAAs micro-pollution in water bodies with sandy sediments. Inclusion of a management plans on micro-pollution research, monitoring, and mitigation is recommended for protected areas.	[Rodriguez-Jorquera, Ignacio A.] Univ Florida, Sch Nat Resources & Environm, Soil & Water Sci Dept, Interdisciplinary Ecol Program, Gainesville, FL USA; [Rodriguez-Jorquera, Ignacio A.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Rodriguez-Jorquera, Ignacio A.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Silva-Sanchez, Cecilia] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Prote & Mass Spectrometry, Gainesville, FL USA; [Strynar, Mark] US EPA, Natl Exposure Res Lab, Durham, NC USA; [Toor, Gurpal S.] Univ Florida, Inst Food & Agr Sci, Gulf Coast Res & Educ Ctr, Soil & Water Qual Lab, Wimauma, FL USA; [Rodriguez-Jorquera, Ignacio A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Environmental Protection Agency; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Sch Nat Resources & Environm, Soil & Water Sci Dept, Interdisciplinary Ecol Program, Gainesville, FL USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA.; Toor, GS (corresponding author), Univ Florida, Inst Food & Agr Sci, Gulf Coast Res & Educ Ctr, Soil & Water Qual Lab, Wimauma, FL USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA.	irodriguezj@ufl.edu; gstoor@ufl.edu		Strynar, Mark/0000-0003-3472-7921	Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida; BecasChile Conicyt; CONCIYT-Chile; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida; BecasChile Conicyt; CONCIYT-Chile; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this research was provided by the Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida. BecasChile Conicyt provided a graduate research fellowship to IARJ.; We acknowledge the help of Kevin Kroll, Viet Dang, Cristina Colli-Dulla, Sixue Chen, Todd Osborne, and Claudio Verdugo during various phases of this research. The first author thank CONCIYT-Chile for providing a graduate student fellowship for PhD study at University of Florida. Funding for this research was provided by Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; ACEPD. Alachua County Environmental Protection Department, 2010, RES SCREEN AN ORG WA, V15; Ahrens L, 2010, DETERMINATION PERFLU; Ahrens L, 2011, CHEMOSPHERE, V85, P731, DOI 10.1016/j.chemosphere.2011.06.046; Ahrens L, 2011, J ENVIRON MONITOR, V13, P20, DOI 10.1039/c0em00373e; Ahrens L, 2010, CHEMOSPHERE, V79, P266, DOI 10.1016/j.chemosphere.2010.01.045; Ahrens L, 2009, ENVIRON SCI TECHNOL, V43, P6969, DOI 10.1021/es901213s; Ahrens L, 2009, MAR POLLUT BULL, V58, P1326, DOI 10.1016/j.marpolbul.2009.04.028; [Anonymous], 2014, AGRICOLAE STAT PROCE; [Anonymous], 2019, STATE WORLDS PARKS I; [Anonymous], 2015, R LANG ENV STAT COMP; Becker AM, 2008, ENVIRON POLLUT, V156, P818, DOI 10.1016/j.envpol.2008.05.024; Bossi R, 2008, ENVIRON INT, V34, P443, DOI 10.1016/j.envint.2007.10.002; Boulanger B, 2005, ENVIRON SCI TECHNOL, V39, P5524, DOI 10.1021/es050213u; Clara M, 2004, WATER RES, V38, P947, DOI 10.1016/j.watres.2003.10.058; Deguignet M, 2014, UN LIST PROTECTED AR, P44; Department ACEP, 2007, STAT REP BAS WAT QUA, P185; Froese KL, 1998, ENVIRON TOXICOL CHEM, V17, P484, DOI 10.1002/etc.5620170320; Giesy J P, 2001, ScientificWorldJournal, V1, P627; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Gremillion P, 2000, HYDROL PROCESS, V14, P1465, DOI [10.1002/1099-1085(20000615)14:8<1465::AID-HYP987>3.0.CO;2-6, 10.1002/1099-1085(20000615)14:8&lt;1465::AID-HYP987&gt;3.0.CO;2-6]; Guo R, 2010, WATER RES, V44, P3476, DOI 10.1016/j.watres.2010.03.028; Heidler J, 2008, ENVIRON SCI TECHNOL, V42, P6324, DOI 10.1021/es703008y; Herbert J, 2013, DROPLET, V5; Higgins CP, 2006, ENVIRON SCI TECHNOL, V40, P7251, DOI 10.1021/es061000n; Higgins CP, 2005, ENVIRON SCI TECHNOL, V39, P3946, DOI 10.1021/es048245p; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Jacobs JM, 2002, WETLANDS, V22, P374, DOI 10.1672/0277-5212(2002)022[0374:EFAWPW]2.0.CO;2; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kim SK, 2007, ENVIRON SCI TECHNOL, V41, P8328, DOI 10.1021/es072107t; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lin AYC, 2010, CHEMOSPHERE, V80, P1167, DOI 10.1016/j.chemosphere.2010.06.018; Liu CH, 2013, ENVIRON TOXICOL CHEM, V32, P2226, DOI 10.1002/etc.2306; Loganathan BG, 2007, WATER RES, V41, P4611, DOI 10.1016/j.watres.2007.06.045; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P5379, DOI 10.1021/es049331s; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, p248A, DOI 10.1021/es0405528; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Murakami M, 2009, CHEMOSPHERE, V74, P487, DOI 10.1016/j.chemosphere.2008.10.018; Nakayama SF, 2010, ENVIRON SCI TECHNOL, V44, P4103, DOI 10.1021/es100382z; Newsted JL, 2005, ENVIRON SCI TECHNOL, V39, P9357, DOI 10.1021/es050989v; Nishikoori H, 2011, CHEMOSPHERE, V84, P1125, DOI 10.1016/j.chemosphere.2011.04.036; Pan YY, 2011, SCI CHINA CHEM, V54, P552, DOI 10.1007/s11426-010-4093-x; Pistocchi A, 2009, ENVIRON SCI TECHNOL, V43, P9237, DOI 10.1021/es901246d; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Ratola N, 2012, J HAZARD MATER, V15, P1; Rodriguez-Jorquera IA, 2015, ENVIRON POLLUT, V199, P155, DOI 10.1016/j.envpol.2015.01.021; Sakurai T, 2010, ENVIRON SCI TECHNOL, V44, P4110, DOI 10.1021/es1007609; Schultz MM, 2006, ENVIRON SCI TECHNOL, V40, P289, DOI 10.1021/es051381p; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Shoemaker J.A. GPE, 2009, DETERMINATION SELECT, V1, P5; Simcik MF, 2005, ENVIRON SCI TECHNOL, V39, P8678, DOI 10.1021/es0511218; Sinclair E, 2006, ENVIRON SCI TECHNOL, V40, P1408, DOI 10.1021/es051798v; So MK, 2004, ENVIRON SCI TECHNOL, V38, P4056, DOI 10.1021/es049441z; Strynar MJ, 2012, CHEMOSPHERE, V86, P252, DOI 10.1016/j.chemosphere.2011.09.036; Sumpter JP, 2009, PHILOS T R SOC A, V367, P3877, DOI 10.1098/rsta.2009.0106; Theobald N, 2012, ENVIRON SCI POLLUT R, V19, P313, DOI 10.1007/s11356-011-0559-4; Tsuda T, 2010, B ENVIRON CONTAM TOX, V85, P593, DOI 10.1007/s00128-010-0116-8; Usenko S, 2010, ENVIRON SCI TECHNOL, V44, P4512, DOI 10.1021/es903844n; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Xiao F, 2012, WATER RES, V46, P6601, DOI 10.1016/j.watres.2011.11.029; Yang Y., 2015, J SOIL SEDIMENT, P1; Yu J, 2009, WATER RES, V43, P2399, DOI 10.1016/j.watres.2009.03.009; Zareitalabad P, 2013, PERFLUOROOCTANOIC AC; Zushi Y, 2009, CHEMOSPHERE, V76, P833, DOI 10.1016/j.chemosphere.2009.04.004	65	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148654	10.1371/journal.pone.0148654	http://dx.doi.org/10.1371/journal.pone.0148654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909512	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700012
J	Tapper, EB; Hunink, MGM; Afdhal, NH; Lai, M; Sengupta, N				Tapper, Elliot B.; Hunink, M. G. Myriam; Afdhal, Nezam H.; Lai, Michelle; Sengupta, Neil			Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score	PLOS ONE			English	Article							CONTROLLED TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; UNITED-STATES; NONINVASIVE ASSESSMENT; XL PROBE; DIAGNOSIS; METAANALYSIS; MANAGEMENT; STEATOSIS; ACCURACY	Background The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by gastroenterologists. Methods We compared the cost-effectiveness of fibrosis risk-assessment strategies in a cohort of 10,000 simulated American patients with NAFLD performed in either PCP or referral clinics using a decision analytical microsimulation state-transition model. The strategies included use of vibration-controlled transient elastography (VCTE), the NAFLD fibrosis score (NFS), combination testing with NFS and VCTE, and liver biopsy (usual care by a specialist only). NFS and VCTE performance was obtained from a prospective cohort of 164 patients with NAFLD. Outcomes included cost per quality adjusted life year (QALY) and correct classification of fibrosis. Results Risk-stratification by the PCP using the NFS alone costs $5,985 per QALY while usual care costs $7,229/QALY. In the microsimulation, at a willingness-to-pay threshold of $100,000, the NFS alone in PCP clinic was the most cost-effective strategy in 94.2% of samples, followed by combination NFS/VCTE in the PCP clinic (5.6%) and usual care in 0.2%. The NFS based strategies yield the best biopsy-correct classification ratios (3.5) while the NFS/VCTE and usual care strategies yield more correct-classifications of advanced fibrosis at the cost of 3 and 37 additional biopsies per classification. Conclusion Risk-stratification of patients with NAFLD primary care clinic is a cost-effective strategy that should be formally explored in clinical practice.	[Tapper, Elliot B.; Afdhal, Nezam H.; Lai, Michelle] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol Hepatol,Dept Med, Boston, MA 02215 USA; [Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Epidemiol, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Sengupta, Neil] Univ Chicago, Dept Med, Div Gastroenterol Hepatol Nutr, 5841 S Maryland Ave, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Chicago	Tapper, EB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol Hepatol,Dept Med, Boston, MA 02215 USA.	etapper@bidmc.harvard.edu		Afdhal, Nezam/0000-0002-7342-6593	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Afdhal NH, 2012, JAMA-J AM MED ASSOC, V308, P608, DOI 10.1001/jama.2012.8402; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Doycheva I, 2015, ALIMENTARY PHARM THE; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Festi D, 2013, ALIMENT PHARM THER, V37, P392, DOI 10.1111/apt.12186; Forrest CB, 2007, ANN FAM MED, V5, P361, DOI 10.1370/afm.703; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Kwok R, 2015, GUT; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Mehrotra A, 2011, MILBANK Q, V89, P39, DOI 10.1111/j.1468-0009.2011.00619.x; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petrou S, 2011, BMJ, V342; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; Petta S, 2015, LIVER INT, V35, P1566, DOI 10.1111/liv.12584; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Tapper EB, 2014, DIGEST DIS SCI, P1; Tapper EB, 2014, GASTROENTEROL REP OX; Tapper EB, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.07.019; Tapper EB, 2015, AM J GASTROENTEROL, V110, P1298, DOI 10.1038/ajg.2015.241; Tapper EB, 2015, CURR OPIN GASTROEN, V31, P192, DOI 10.1097/MOG.0000000000000169; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P27, DOI 10.1016/j.cgh.2014.04.039; Tapper EB, 2013, AM J MED, V126, P926, DOI 10.1016/j.amjmed.2013.01.039; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; World Health Organisation, 2003, ADHERENCE LONG TERM; Younossi ZM, 2015, J CLIN GASTROENTEROL, V49, P222, DOI 10.1097/MCG.0000000000000071	41	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0147237	10.1371/journal.pone.0147237	http://dx.doi.org/10.1371/journal.pone.0147237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905872	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000002
J	Wang, CH; Shi, CX; Rou, KM; Zhao, Y; Cao, XB; Luo, W; Liu, EW; Wu, ZY				Wang, Changhe; Shi, Cynthia X.; Rou, Keming; Zhao, Yan; Cao, Xiaobin; Luo, Wei; Liu, Enwu; Wu, Zunyou			Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GLOBAL EPIDEMIOLOGY; TREATMENT CLINICS; INJECT DRUGS; INFECTION; HIV; PEOPLE; IMPACT; KNOWLEDGE; SHANGHAI	Background Hepatitis C virus (HCV) is the most common viral infection among injecting drug users worldwide. We aimed to assess HCV antibody prevalence and associated risk factors among clients in the Chinese national methadone maintenance treatment (MMT) program. Methods Data from 296,209 clients who enrolled in the national MMT program between March 2004 and December 2012 were analyzed to assess HCV antibody prevalence, associated risk factors, and geographical distribution. Results Anti-HCV screening was positive for 54.6% of clients upon MMT entry between 2004 and 2012. HCV antibody prevalence at entry declined from 66.8% in 2005 to 45.9% in 2012. The most significant predictors of HCV seropositivity were injecting drug use (adjusted odds ratio [AOR]: 8.34, 95% confidence interval [CI]: 8.17-8.52, p<0.0001) and a history of drug use >= 9 years (AOR: 2.01, 95% CI: 1.96-2.06, p<0.0001). Being female, of Uyghur or Zhuang ethnicity, and unmarried were identified as demographic risk factors (all p-values<0.0001). Of the 28 provincial-level divisions included in the study, we found that 5 divisions had HCV antibody prevalence above 70% and 20 divisions above 50%. The HCV screening rate within 6 months after MMT entry greatly increased from 30.4% in 2004 to 93.1% in 2012. Conclusions The current HCV antibody prevalence remains alarmingly high among MMT clients throughout most provincial-level divisions in China, particularly among injecting drug users and females. A comprehensive prevention strategy is needed to control the HCV epidemic among MMT clients in China.	[Wang, Changhe; Shi, Cynthia X.; Rou, Keming; Zhao, Yan; Cao, Xiaobin; Luo, Wei; Liu, Enwu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	Liu, Enwu/AGC-4748-2022	Liu, Enwu/0000-0003-2580-3523	China National Health and Family Planning Commission [131-14-000-105-01]; US NIH Fogarty International Center and National Institute on Drug Abuse [U2RTW06918]	China National Health and Family Planning Commission; US NIH Fogarty International Center and National Institute on Drug Abuse	This work was supported by funding from China National Health and Family Planning Commission (Grant # 131-14-000-105-01), and by US NIH Fogarty International Center and National Institute on Drug Abuse (Grant# U2RTW06918). Funding organizations had no role in the design of this study, in the collection, analysis, or interpretation of data, or in the final decision to submit the manuscript for publication.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2012, AM J DRUG ALCOHOL AB, V38, P140, DOI 10.3109/00952990.2011.643984; Broers B, 1998, AIDS, V12, P2059, DOI 10.1097/00002030-199815000-00018; Chen Ang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1230; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Crofts N, 2001, AUSTR PERSPECTIVE; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Du J, 2012, AM J DRUG ALCOHOL AB, V38, P228, DOI 10.3109/00952990.2011.643974; Fuller CM, 2001, PUBLIC HEALTH REP, V116, P136, DOI 10.1093/phr/116.S1.136; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Hser Y, 2012, J PUBLIC HEALTH-UK, V34, P24, DOI 10.1093/pubmed/fdr098; Kulsudjarit K, 2004, ANN NY ACAD SCI, V1025, P446, DOI 10.1196/annals.1316.055; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Maxwell S, 2002, HEROIN ADDICT REL CL, V4, P5; McCarthy JJ, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n01_03; Metzger David S, 2010, Curr HIV/AIDS Rep, V7, P220, DOI 10.1007/s11904-010-0059-z; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Murray JM, 2003, INT J EPIDEMIOL, V32, P708, DOI 10.1093/ije/dyg102; National Center for AIDS/STD Control and Prevention/China CDC, 2013, ANN REP IMPL NAT HIV; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Novick DM, 2000, MT SINAI J MED, V67, P437; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Scheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014; Shah DP, 2012, J MED VIROL, V84, P235, DOI 10.1002/jmv.22271; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sun Y, 2007, OCCUPATION HLTH, V23, P881; Treloar C, 2012, DRUG ALCOHOL REV, V31, P918, DOI 10.1111/j.1465-3362.2012.00468.x; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Vlahov D, 2004, J URBAN HEALTH, V81, P14, DOI 10.1093/jurban/jth083; Wiessing L, 2011, EURO SURVEILL, V16; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066787; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	46	9	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0147922	10.1371/journal.pone.0147922	http://dx.doi.org/10.1371/journal.pone.0147922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2HK	26906025	Green Published, Green Submitted, gold			2022-12-26	WOS:000371163000003
J	Chan, EC; Kuo, SM; Kong, AM; Morrison, WA; Dusting, GJ; Mitchell, GM; Lim, SY; Liu, GS				Chan, Elsa C.; Kuo, Shyh-Ming; Kong, Anne M.; Morrison, Wayne A.; Dusting, Gregory J.; Mitchell, Geraldine M.; Lim, Shiang Y.; Liu, Guei-Sheung			Three Dimensional Collagen Scaffold Promotes Intrinsic Vascularisation for Tissue Engineering Applications	PLOS ONE			English	Article							STEM-CELLS; IN-VITRO; ENHANCES SURVIVAL; ENDOTHELIAL-CELLS; CARDIAC TISSUE; ANGIOGENESIS; VIVO; MATRIX; DIFFERENTIATION; POPULATION	Here, we describe a porous 3-dimensional collagen scaffold material that supports capillary formation in vitro, and promotes vascularization when implanted in vivo. Collagen scaffolds were synthesized from type I bovine collagen and have a uniform pore size of 80 mu m. In vitro, scaffolds seeded with primary human microvascular endothelial cells suspended in human fibrin gel formed CD31 positive capillary-like structures with clear lumens. In vivo, after subcutaneous implantation in mice, cell-free collagen scaffolds were vascularized by host neovessels, whilst a gradual degradation of the scaffold material occurred over 8 weeks. Collagen scaffolds, impregnated with human fibrinogen gel, were implanted subcutaneously inside a chamber enclosing the femoral vessels in rats. Angiogenic sprouts from the femoral vessels invaded throughout the scaffolds and these degraded completely after 4 weeks. Vascular volume of the resulting constructs was greater than the vascular volume of constructs from chambers implanted with fibrinogen gel alone (42.7 +/- 5.0 mu L in collagen scaffold vs 22.5 +/- 2.3 mu L in fibrinogen gel alone; p < 0.05, n = 7). In the same model, collagen scaffolds seeded with human adipose-derived stem cells (ASCs) produced greater increases in vascular volume than did cell-free collagen scaffolds (42.9 +/- 4.0 mu L in collagen scaffold with human ASCs vs 25.7 +/- 1.9 mu L in collagen scaffold alone; p < 0.05, n = 4). In summary, these collagen scaffolds are biocompatible and could be used to grow more robust vascularized tissue engineering grafts with improved the survival of implanted cells. Such scaffolds could also be used as an assay model for studies on angiogenesis, 3-dimensional cell culture, and delivery of growth factors and cells in vivo.	[Chan, Elsa C.; Dusting, Gregory J.; Liu, Guei-Sheung] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Chan, Elsa C.; Dusting, Gregory J.; Liu, Guei-Sheung] Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia; [Kuo, Shyh-Ming] I Shou Univ, Dept Biomed Engn, Kaohsiung, Taiwan; [Kong, Anne M.; Morrison, Wayne A.; Dusting, Gregory J.; Mitchell, Geraldine M.; Lim, Shiang Y.] St Vincents Inst Med Res, OBrien Inst Dept, 41 Victoria Parade, Fitzroy, Vic 3065, Australia; [Morrison, Wayne A.; Mitchell, Geraldine M.; Lim, Shiang Y.] Univ Melbourne, St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic 3065, Australia; [Morrison, Wayne A.; Mitchell, Geraldine M.] Australian Catholic Univ, Fac Hlth Sci, Fitzroy, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; I Shou University; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; Australian Catholic University	Liu, GS (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia.; Liu, GS (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, East Melbourne, Vic, Australia.; Lim, SY (corresponding author), St Vincents Inst Med Res, OBrien Inst Dept, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.; Lim, SY (corresponding author), Univ Melbourne, St Vincents Hosp Melbourne, Dept Surg, Fitzroy, Vic 3065, Australia.	mlim@svi.edu.au; guei-sheung@unimelb.edu.au	Lim, Shiang Y/AAG-5161-2020; Liu, Guei-Sheung/Q-6472-2018	Lim, Shiang Y/0000-0002-0442-3655; Liu, Guei-Sheung/0000-0003-3379-724X	National Health and Medical Research Council of Australia [1061912, 1003113]; Research Endowment Fund- St Vincent's Hospital Melbourne; Jack Brockhoff Foundation	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Research Endowment Fund- St Vincent's Hospital Melbourne; Jack Brockhoff Foundation	This work was supported by grants from the National Health and Medical Research Council of Australia (#1061912-GJD, GSL; and #1003113-GJD), the Research Endowment Fund- St Vincent's Hospital Melbourne (SYL, GMM) and the Jack Brockhoff Foundation (GMM). The Centre for Eye Research Australia and the O'Brien Institute Department of St Vincent's Institute of Medical Research receive Operational Infrastructure Support from the Victorian Government.	Abou Neel EA, 2013, ADV DRUG DELIVER REV, V65, P429, DOI 10.1016/j.addr.2012.08.010; Birla RK, 2005, TISSUE ENG, V11, P803, DOI 10.1089/ten.2005.11.803; Bitto FF, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/935046; Brougham CM, 2015, ACTA BIOMATER; Chan BP, 2008, EUR SPINE J, V17, pS467, DOI 10.1007/s00586-008-0745-3; Chan EC, 2013, BIOCHEM BIOPH RES CO, V430, P918, DOI 10.1016/j.bbrc.2012.11.138; Chen CH, 2012, BIOCHEM BIOPH RES CO, V428, P68, DOI 10.1016/j.bbrc.2012.10.007; Chiu LLY, 2012, P NATL ACAD SCI USA, V109, pE3414, DOI 10.1073/pnas.1210580109; Conconi MT, 2010, J PEPT SCI, V16, P349, DOI 10.1002/psc.1251; Dietrich M, 2013, TISSUE ENG PART C-ME, V19, P216, DOI [10.1089/ten.tec.2011.0473, 10.1089/ten.TEC.2011.0473]; Glowacki J, 2008, BIOPOLYMERS, V89, P338, DOI 10.1002/bip.20871; Haase T, 2015, J TISSUE ENG REGEN M; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Jiang B, 2014, ACTA BIOMATER, V10, P1177, DOI 10.1016/j.actbio.2013.11.029; Kannan RY, 2005, BIOMATERIALS, V26, P1857, DOI 10.1016/j.biomaterials.2004.07.006; Kofidis T, 2003, BIOMATERIALS, V24, P5009, DOI 10.1016/S0142-9612(03)00429-0; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lim SY, 2013, STEM CELL TRANSL MED, V2, P715, DOI 10.5966/sctm.2012-0161; Lim SY, 2012, TISSUE ENG PT A, V18, P2210, DOI [10.1089/ten.TEA.2011.0719, 10.1089/ten.tea.2011.0719]; Montano I, 2010, TISSUE ENG PT A, V16, P269, DOI [10.1089/ten.tea.2008.0550, 10.1089/ten.TEA.2008.0550]; Morin KT, 2013, EXP CELL RES, V319, P2409, DOI 10.1016/j.yexcr.2013.06.006; Nomi Masashi, 2006, Curr Stem Cell Res Ther, V1, P333; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Roelofs LAJ, 2008, FETAL DIAGN THER, V24, P7, DOI 10.1159/000132399; Roelofs LAJ, 2014, BJU INT, V114, P447, DOI 10.1111/bju.12591; SCHERLE W, 1970, Mikroskopie, V26, P57; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shiose S, 2004, GRAEF ARCH CLIN EXP, V242, P777, DOI 10.1007/s00417-004-0910-2; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Sukmana I, 2012, J ARTIF ORGANS, V15, P215, DOI 10.1007/s10047-012-0644-6; Tian L, 2011, J CARDIOVASC TRANSL, V4, P685, DOI 10.1007/s12265-011-9301-3; Wan Y, 2009, J MATER SCI-MATER M, V20, P719, DOI 10.1007/s10856-008-3622-z; Wang K, 2015, ACTA BIOMATER, V15, P65, DOI 10.1016/j.actbio.2014.12.025; Xiao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09409; Yannas IV, 2010, PHILOS T R SOC A, V368, P2123, DOI 10.1098/rsta.2010.0015; Zhang Y, 2015, STEM CELLS, V33, P3100, DOI 10.1002/stem.2101	37	93	94	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149799	10.1371/journal.pone.0149799	http://dx.doi.org/10.1371/journal.pone.0149799			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900837	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100152
J	Huang, CY; Hsu, CW; Chuang, CR; Lee, CC				Huang, Chih-Yuan; Hsu, Chia-Wen; Chuang, Chi-Rou; Lee, Ching-Chih			Pre-Dialysis Visits to a Nephrology Department and Major Cardiovascular Events in Patients Undergoing Dialysis	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; CHRONIC KIDNEY-DISEASE; PRE-ESRD CARE; INITIATION; MORTALITY; SURVIVAL; TAIWAN; HEMODIALYSIS; VALIDATION; COHORT	Background and Objectives Pre-dialysis care by a nephrology out-patient department (OPD) may affect the outcomes of patients who ultimately undergo maintenance dialysis. This study examined the effect of pre-dialysis care by a nephrology OPD on the incidence of one-year major cardiovascular events after initiation of dialysis. Design, Setting Participants, & Measurements The study consisted of Taiwanese patients with chronic kidney disease (CKD) who commenced dialysis from 2006 to 2008. The number of nephrology OPD visits during the critical care period (within 6 months of initiation of dialysis) and the early care period (6-36 months before initiation of dialysis) were analyzed. The primary outcome measure was one-year major cardiovascular events. Results A total of 1191 CKD patients who initiated dialysis from 2006 to 2008 were included. Binary logistic regression showed that patients with. 3 visits during the critical care period and those with. 11 visits during the early care period had fewer composite major cardiovascular events than those with 0 visits. Patients with early referral are less likely to experience composite major cardiovascular events than those with late referral, with aOR 0.574 (95% CI = 0.43-0.77, P<0.001). Patients with both. 3 visits during critical care period and. 11 visits during early care period were less likely to experience composite major cardiovascular events (aOR = 0.25, 95% CI = 0.16-0.39, P < 0.001). Conclusions Patients with adequate pre-dialysis nephrology OPD visits, not just early referral, may had fewer one-year composite major cardiovascular events after initiation of dialysis. This information may be important to medical care providers and public health policy makers in their efforts to improve the well-being of CKD patients.	[Huang, Chih-Yuan] Ditmanson Med Fdn, Chia Yi Christian Hosp, Dept Internal Med, Div Nephrol, Chiayi, Taiwan; [Hsu, Chia-Wen] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi, Taiwan; [Chuang, Chi-Rou] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan; [Lee, Ching-Chih] Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan; [Lee, Ching-Chih] Natl Def Med Ctr, Sch Med, Taipei, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Kaohsiung Veterans General Hospital; National Defense Medical Center	Chuang, CR (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Obstet & Gynecol, Chiayi, Taiwan.; Lee, CC (corresponding author), Kaohsiung Vet Gen Hosp, Dept Otorhinolaryngol Head & Neck Surg, Kaohsiung, Taiwan.; Lee, CC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.	alexleelab@hotmail.com; hematcd@hotmail.com	Huang, Chih Yuan/G-5328-2015	Huang, Chih Yuan/0000-0002-7253-6301				Agrawal V, 2009, CLIN J AM SOC NEPHRO, V4, P323, DOI 10.2215/CJN.03510708; Avron J, 2002, ARCH INTERN MED, V162, P2002; Boulware LE, 2006, AM J KIDNEY DIS, V48, P192, DOI 10.1053/j.ajkd.2006.04.073; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; de Jager DJ, 2011, NEPHROL DIAL TRANSPL, V26, P652, DOI 10.1093/ndt/gfq438; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hasegawa T, 2009, CLIN J AM SOC NEPHRO, V4, P595, DOI 10.2215/CJN.03540708; Heatley SA, 2009, PERITON DIALYSIS INT, V29, pS128; Hommel K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-108; Inaguma D, 2011, CLIN EXP NEPHROL, V15, P738, DOI 10.1007/s10157-011-0472-7; Jungers P, 2001, NEPHROL DIAL TRANSPL, V16, P2357, DOI 10.1093/ndt/16.12.2357; KDIGO-group, 2013, KIDNEY INT S, V3, P112; Khan SS, 2005, KIDNEY INT, V67, P1038, DOI 10.1111/j.1523-1755.2005.00168.x; Kip KE, 2008, J AM COLL CARDIOL, V51, P701, DOI 10.1016/j.jacc.2007.10.034; McClellan WM, 2009, J AM SOC NEPHROL, V20, P1078, DOI 10.1681/ASN.2008060624; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Singhal R, 2014, KIDNEY INT, V86, P399, DOI 10.1038/ki.2014.16; Smart NA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007333.pub2; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6	23	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147508	10.1371/journal.pone.0147508	http://dx.doi.org/10.1371/journal.pone.0147508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900915	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100010
J	Koenig, SP; Bernard, D; Devieux, JG; Atwood, S; McNairy, ML; Severe, P; Marcelin, A; Julma, P; Apollon, A; Pape, JW				Koenig, Serena P.; Bernard, Daphne; Devieux, Jessy G.; Atwood, Sidney; McNairy, Margaret L.; Severe, Patrice; Marcelin, Adias; Julma, Pierrot; Apollon, Alexandra; Pape, Jean W.			Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; FOLLOW-UP; SCALE-UP; TREATMENT PROGRAM; INFECTED ADULTS; RISK-FACTORS; MORTALITY; OUTCOMES	Background High attrition during the period from HIV testing to antiretroviral therapy (ART) initiation is widely reported. Though treatment guidelines have changed to broaden ART eligibility and services have been widely expanded over the past decade, data on the temporal trends in pre-ART outcomes are limited; such data would be useful to guide future policy decisions. Methods We evaluated temporal trends and predictors of retention for each step from HIV testing to ART initiation over the past decade at the GHESKIO clinic in Port-au-Prince Haiti. The 24,925 patients >17 years of age who received a positive HIV test at GHESKIO from March 1, 2003 to February 28, 2013 were included. Patients were followed until they remained in pre-ART care for one year or initiated ART. Results 24,925 patients (61% female, median age 35 years) were included, and 15,008 (60%) had blood drawn for CD4 count within 12 months of HIV testing; the trend increased over time from 36% in Year 1 to 78% in Year 10 (p<0.0001). Excluding transfers, the proportion of patients who were retained in pre-ART care or initiated ART within the first year after HIV testing was 84%, 82%, 64%, and 64%, for CD4 count strata <= 200, 201 to 350, 351 to 500, and >500 cells/mm(3), respectively. The trend increased over time for each CD4 strata, and in Year 10, 94%, 95%, 79%, and 74% were retained in pre-ART care or initiated ART for each CD4 strata. Predictors of pre-ART attrition included male gender, low income, and low educational status. Older age and tuberculosis (TB) at HIV testing were associated with retention in care. Conclusions The proportion of patients completing assessments for ART eligibility, remaining in pre-ART care, and initiating ART have increased over the last decade across all CD4 count strata, particularly among patients with CD4 count <= 350 cells/mm(3). However, additional retention efforts are needed for patients with higher CD4 counts.	[Koenig, Serena P.; Bernard, Daphne; Severe, Patrice; Marcelin, Adias; Julma, Pierrot; Apollon, Alexandra; Pape, Jean W.] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.; Atwood, Sidney] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Global Hlth Equ, Boston, MA 02115 USA; [Devieux, Jessy G.] Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA; [McNairy, Margaret L.; Pape, Jean W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; Florida International University; Cornell University	Koenig, SP (corresponding author), Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti.; Koenig, SP (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Global Hlth Equ, Boston, MA 02115 USA.	skoenig@partners.org			National Institute of Allergy and Infectious Diseases (NIAID) [R01AI104344]; Haiti Research Training Program in the Prevention of AIDS Cervical Cancer [1D43TW009606]; Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor) [5R25TW009337]; United States President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund to Fight AIDS, Tuberculosis and Malaria; FOGARTY INTERNATIONAL CENTER [D43TW009606, R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104344] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Haiti Research Training Program in the Prevention of AIDS Cervical Cancer; Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor); United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund to Fight AIDS, Tuberculosis and Malaria; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) Grant Number R01AI104344, Haiti Research Training Program in the Prevention of AIDS Cervical Cancer 1D43TW009606, and the Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor) 5R25TW009337. The United States President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria provided funding for medications and patient care. No funder was involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2014, UNAIDS COUNTRY REPOR; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Govindasamy D, 2014, T ROY SOC TROP MED H, V108, P1, DOI 10.1093/trstmh/trt105; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Kumarasamy N, 2008, J WOMENS HEALTH, V17, P1471, DOI 10.1089/jwh.2007.0670; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; MSPP, 2013, MAN NORM PRIS CHARG; MSPP, 2008, MAN NORM PRIS CHARG; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Noel E, 2012, J ACQUIR IMMUNE DEFI; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P690, DOI 10.1016/j.trstmh.2010.07.006; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146903	10.1371/journal.pone.0146903	http://dx.doi.org/10.1371/journal.pone.0146903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901795	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100007
J	Suh, E; Choe, DH; Saveer, AM; Zwiebel, LJ				Suh, Eunho; Choe, Dong-Hwan; Saveer, Ahmed M.; Zwiebel, Laurence J.			Suboptimal Larval Habitats Modulate Oviposition of the Malaria Vector Mosquito Anopheles coluzzii	PLOS ONE			English	Article							AEDES-AEGYPTI; GAMBIAE-S.S.; DENSITY-DEPENDENCE; SITE SELECTION; CHEMICAL CUES; CULICIDAE; RESPONSES; DIPTERA; IDENTIFICATION; ATTRACTANTS	Selection of oviposition sites by gravid females is a critical behavioral step in the reproductive cycle of Anopheles coluzzii, which is one of the principal Afrotropical malaria vector mosquitoes. Several studies suggest this decision is mediated by semiochemicals associated with potential oviposition sites. To better understand the chemosensory basis of this behavior and identify compounds that can modulate oviposition, we examined the generally held hypothesis that suboptimal larval habitats give rise to semiochemicals that negatively influence the oviposition preference of gravid females. Dual-choice bioassays indicated that oviposition sites conditioned in this manner do indeed foster significant and concentration dependent aversive effects on the oviposition site selection of gravid females. Headspace analyses derived from aversive habitats consistently noted the presence of dimethyl disulfide (DMDS), dimethyl trisulfide (DMTS) and 6-methyl-5-hepten-2-one (sulcatone) each of which unitarily affected An. coluzzii oviposition preference. Electrophysiological assays across the antennae, maxillary palp, and labellum of gravid An. coluzzii revealed differential responses to these semiochemicals. Taken together, these findings validate the hypothesis in question and suggest that suboptimal environments for An. coluzzii larval development results in the release of DMDS, DMTS and sulcatone that impact the response valence of gravid females.	[Suh, Eunho; Saveer, Ahmed M.; Zwiebel, Laurence J.] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Choe, Dong-Hwan] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst,Program Dev Biol, Nashville, TN 37232 USA; [Zwiebel, Laurence J.] Vanderbilt Univ, Med Ctr, Inst Chem Biol & Global Hlth, Nashville, TN USA	Vanderbilt University; University of California System; University of California Riverside; Vanderbilt University; Vanderbilt University	Zwiebel, LJ (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.; Zwiebel, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pharmacol, Vanderbilt Brain Inst,Program Dev Biol, Nashville, TN 37232 USA.; Zwiebel, LJ (corresponding author), Vanderbilt Univ, Med Ctr, Inst Chem Biol & Global Hlth, Nashville, TN USA.	l.zwiebel@vanderbilt.edu	Ahmed, Mohamed Saveer/H-6589-2016	Ahmed, Mohamed Saveer/0000-0002-4587-5578; Zwiebel, Laurence/0000-0001-6686-7289	Vanderbilt University; National Institutes of Health (NIAID) [AI056402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056402] Funding Source: NIH RePORTER	Vanderbilt University; National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was conducted with the support of Vanderbilt University and a grant from the National Institutes of Health (NIAID, AI056402) to LJZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afify A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-315; Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; Albeny-Simoes D, 2014, OECOLOGIA, V175, P481, DOI 10.1007/s00442-014-2910-1; Artis ML, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-163; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Birkett MA, 2004, MED VET ENTOMOL, V18, P313, DOI 10.1111/j.0269-283X.2004.00528.x; Blackwell A, 2000, ANN TROP MED PARASIT, V94, P389, DOI 10.1080/00034983.2000.11813554; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chobu M, 2015, ACTA TROP, V142, P131, DOI 10.1016/j.actatropica.2014.11.012; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Eilers EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041357; El-Moamly AA, 2013, J INFECT DEV COUNTR, V7, P769, DOI 10.3855/jidc.3079; Ellis AM, 2008, J ANIM ECOL, V77, P247, DOI 10.1111/j.1365-2656.2007.01345.x; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Fillinger U, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-62; Fritz Megan L, 2008, J Circadian Rhythms, V6, P2, DOI 10.1186/1740-3391-6-2; Harraca V, 2012, J EXP BIOL, V215, P623, DOI 10.1242/jeb.065748; Huang J, 2005, MED VET ENTOMOL, V19, P442, DOI 10.1111/j.1365-2915.2005.00588.x; Huang J, 2006, J MED ENTOMOL, V43, P498, DOI 10.1603/0022-2585(2006)43[498:AGDCOI]2.0.CO;2; Huang J, 2007, PHYSIOL ENTOMOL, V32, P34, DOI 10.1111/j.1365-3032.2006.00538.x; Kershenbaum A, 2012, EVOL ECOL, V26, P955, DOI 10.1007/s10682-011-9548-9; Koenraadt CJM, 2004, ENTOMOL EXP APPL, V112, P125, DOI 10.1111/j.0013-8703.2004.00186.x; Koenraadt CJM, 2003, MED VET ENTOMOL, V17, P61, DOI 10.1046/j.1365-2915.2003.00409.x; Koffi AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082387; KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111; Kugimiya S, 2010, J CHEM ECOL, V36, P620, DOI 10.1007/s10886-010-9802-6; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Lindh JM, 2008, J MED ENTOMOL, V45, P1039, DOI 10.1603/0022-2585(2008)45[1039:OROAGS]2.0.CO;2; Lindh JM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0636-0; Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0; Logan JG, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-239; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; MAYER MS, 1984, J INSECT PHYSIOL, V30, P757, DOI 10.1016/0022-1910(84)90041-6; McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964; MCCRAE AWR, 1984, ANN TROP MED PARASIT, V78, P307, DOI 10.1080/00034983.1984.11811821; Menger DJ, 2014, MED VET ENTOMOL, V28, P407, DOI 10.1111/mve.12061; Miller JR, 2007, NATURWISSENSCHAFTEN, V94, P195, DOI 10.1007/s00114-006-0178-y; Minakawa N, 2004, MED VET ENTOMOL, V18, P301, DOI 10.1111/j.0269-283X.2004.00503.x; Munga S, 2006, J MED ENTOMOL, V43, P221, DOI 10.1603/0022-2585(2006)043[0221:EOLCAP]2.0.CO;2; Munga S, 2005, J MED ENTOMOL, V42, P993, DOI 10.1603/0022-2585(2005)042[0993:OSPAEH]2.0.CO;2; Muriu SM, 2013, J ANIM ECOL, V82, P166, DOI 10.1111/1365-2656.12002; Okal MN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-365; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pickett JA, 1996, CIBA F SYMP, V200, P109; Pitts RJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-271; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Seenivasagan T, 2009, PARASITOL RES, V104, P827, DOI 10.1007/s00436-008-1263-2; Stensmyr MC, 2002, NATURE, V420, P625, DOI 10.1038/420625a; Su CY, 2012, NATURE, V492, P66, DOI 10.1038/nature11712; Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006; Sumba LA, 2008, J CHEM ECOL, V34, P1430, DOI 10.1007/s10886-008-9549-5; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Warburg A, 2011, J VECTOR ECOL, V36, P421, DOI 10.1111/j.1948-7134.2011.00183.x; Wasserberg G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092658; Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015; Yoshioka M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-225; Zahiri N, 1998, J MED ENTOMOL, V35, P782, DOI 10.1093/jmedent/35.5.782	64	25	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149800	10.1371/journal.pone.0149800	http://dx.doi.org/10.1371/journal.pone.0149800			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900947	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100153
J	Wu, ML; Lu, L; Zhang, Q; Guo, Q; Zhao, FX; Li, TW; Zhang, XN				Wu, Menglin; Lu, Li; Zhang, Qi; Guo, Qi; Zhao, Feixiang; Li, Tongwei; Zhang, Xuening			Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model	PLOS ONE			English	Article							ENHANCED MRI; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; EARLY PREDICTION; CANCER; CELLULARITY; MULTICENTER; CARCINOMA; ACCURACY; SURVIVAL	Objective To explore the changes in the time-signal intensity curve(TIC) type and semi-quantitative parameters of dynamic contrast-enhanced(DCE)imaging in relation to variations in the contrast agent(CA) dosage in the Walker 256 murine breast tumor model, and to determine the appropriate parameters for the evaluation of neoadjuvantchemotherapy(NAC) response. Materials and Methods Walker 256 breast tumor models were established in 21 rats, which were randomly divided into three groups of7rats each. Routine scanning and DCE-magnetic resonance imaging (MRI) of the rats were performed using a 7T MR scanner. The three groups of rats were administered different dosages of the CA0.2mmol/kg, 0.3mmol/kg, and 0.5mmol/kg, respectively; and the corresponding TICs the semi-quantitative parameters were calculated and compared among the three groups. Results The TICs were not influenced by the CA dosage and presented a washout pattern in all of the tumors evaluated and weren't influenced by the CA dose. The values of the initial enhancement percentage(E-first), initial enhancement velocity(V-first), maximum signal(S-max), maximum enhancement percentage(E-max), washout percentage(E-wash), and signal enhancement ratio(SER) showed statistically significant differences among the three groups (F = 16.952, p = 0.001; F = 69.483, p<0.001; F = 54.838, p<0.001; F = 12.510, p = 0.003; F = 5.248, p = 0.031; F = 9.733, p = 0.006, respectively). However, the values of the time to peak(T-peak), maximum enhancement velocity(V-max), and washout velocity(V-wash) did not differ significantly among the three dosage groups (F = 0.065, p = 0.937; F = 1.505, p = 0.273; chi(2) = 1.423, p = 0.319, respectively); the washout slope(Slope(wash)), too, was uninfluenced by the dosage(F = 1.654, p = 0.244). Conclusion The CA dosage didn't affect the TIC type, T-peak, V-max, V-wash or Slopewash. These dose-independent parameters as well as the TIC type might be more useful for monitoring the NAC response because they allow the comparisons of the DCE data obtained using different CA dosages.	[Wu, Menglin; Zhang, Qi; Guo, Qi; Zhao, Feixiang; Li, Tongwei; Zhang, Xuening] Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China; [Lu, Li] Tianjin Med Univ, Gen Hosp, Dept Gen Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhang, XN (corresponding author), Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China.	luckyxn_tianjin@163.com						Abramson RG, 2013, MAGN RESON IMAGING, V31, P1457, DOI 10.1016/j.mri.2013.07.002; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Atuegwu NC, 2013, TRANSL ONCOL, V6, P256, DOI 10.1593/tlo.13130; Bernardin L, 2012, EUR RADIOL, V22, P880, DOI 10.1007/s00330-011-2331-z; Bottcher J, 2014, ACTA ONCOL, V53, P759, DOI 10.3109/0284186X.2013.852688; Cho N, 2014, RADIOLOGY, V272, P385, DOI 10.1148/radiol.14131332; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051712; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; El Khouli RH, 2014, RADIOLOGY, V272, P79, DOI 10.1148/radiol.14131384; El Khouli RH, 2011, AM J ROENTGENOL, V197, P1498, DOI 10.2214/AJR.10.4665; Fedorov A, 2015, ACAD RADIOL, V22, P548, DOI 10.1016/j.acra.2014.12.022; Galie M, 2009, MICROVASC RES, V78, P370, DOI 10.1016/j.mvr.2009.09.004; Gutierrez RL, 2012, AM J ROENTGENOL, V199, P703, DOI 10.2214/AJR.11.7836; He DF, 2012, CLIN BREAST CANCER, V12, P94, DOI 10.1016/j.clbc.2011.11.002; Heywang-Korunner SH, 2001, EUR RADIOL, V11, P531, DOI 10.1007/s003300000745; HEYWANGKOBRUNNER SH, 1994, RADIOLOGY, V191, P639, DOI 10.1148/radiology.191.3.8184040; Jansen SA, 2010, ACAD RADIOL, V17, P24, DOI 10.1016/j.acra.2009.06.015; Jansen SA, 2009, AM J ROENTGENOL, V193, P832, DOI 10.2214/AJR.08.2025; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; Kanal E, 2007, AM J ROENTGENOL, V188, P1447, DOI 10.2214/AJR.06.1616; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Knopp MV, 2003, AM J ROENTGENOL, V181, P663, DOI 10.2214/ajr.181.3.1810663; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Levman J, 2014, J DIGIT IMAGING, V27, P670, DOI 10.1007/s10278-014-9723-y; Li X, 2014, MAGN RESON MED, V71, P1592, DOI 10.1002/mrm.24782; Lim I, 2014, EUR J NUCL MED MOL I, V41, P1852, DOI 10.1007/s00259-014-2797-4; Marinovich ML, 2012, BREAST, V21, P669, DOI 10.1016/j.breast.2012.07.006; Murakami Koichiro, 2008, Magn Reson Med Sci, V7, P105, DOI 10.2463/mrms.7.105; Nadrljanski MM, 2013, DIAGN INTERV RADIOL, V19, P463, DOI 10.5152/dir.2013.13201; Padhani AR, 2010, TARGET ONCOL, V5, P39, DOI 10.1007/s11523-010-0135-8; Partridge SC, 2014, ACAD RADIOL, V21, P1195, DOI 10.1016/j.acra.2014.04.013; Pickles MD, 2015, EUR RADIOL, V25, P1097, DOI 10.1007/s00330-014-3502-5; Popiel M, 2012, POL J RADIOL, V77, P35, DOI 10.12659/PJR.883627; Rahbar H, 2015, EUR J RADIOL, V84, P611, DOI 10.1016/j.ejrad.2014.12.029; Schmitz AMT, 2014, BREAST CANCER RES TR, V148, P541, DOI 10.1007/s10549-014-3170-9; Tateishi U, 2012, RADIOLOGY, V263, P53, DOI 10.1148/radiol.12111177; Woolf DK, 2014, BREAST CANCER RES TR, V147, P335, DOI 10.1007/s10549-014-3072-x; Yankeelov TE, 2006, J MAGN RESON IMAGING, V24, P1140, DOI 10.1002/jmri.20729; Yi B, 2014, EUR RADIOL, V24, P1089, DOI 10.1007/s00330-014-3100-6	40	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149279	10.1371/journal.pone.0149279	http://dx.doi.org/10.1371/journal.pone.0149279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901876	gold, Green Published			2022-12-26	WOS:000371276100051
J	Zhu, BC; Wang, JC; Zhao, LH; Sun, ZX; Brauth, SE; Tang, YZ; Cui, JG				Zhu, Bicheng; Wang, Jichao; Zhao, Longhui; Sun, Zhixin; Brauth, Steven E.; Tang, Yezhong; Cui, Jianguo			Bigger Is Not Always Better: Females Prefer Males of Mean Body Size in Philautus odontotarsus	PLOS ONE			English	Article							MALE-MATING ADVANTAGE; SEXUAL SELECTION; WATER STRIDER; EVOLUTION; DIMORPHISM; TREEFROG; COMPETITION; MECHANISMS; SUCCESS; QUALITY	Most species are believed to evolve larger body sizes over evolutionary time. Previous studies have suggested that sexual selection, through male-male competition and female choice, favors larger males. However, there is little evidence of selection against large size. The female serrate-legged small treefrogs (Philautus odontotarsus) must carry passive males from leks to breeding grounds over relatively long distances after amplexus to find a suitable place to lay eggs. The costs of large male size may therefore decrease mating success due to reduced agility and/or higher energy requirements. Thus, we hypothesized that selection would not favor larger males in P. odontotarsus. Females can assess male body size on the basis of the dominant frequency of male calls in frogs. To assess female P. odontotarsus preferences for a potential mate's body size, male calls of high, average and low dominant frequency were played back to the females in phonotaxis experiments. Results showed that most females prefer the advertisement call with average dominant frequency. In addition, we compared the body mass distribution of amplectant males with that of single males in nature. The body masses of amplectant males are more narrowly distributed in the intermediate range than that of single males. The phonotaxis results and the data of actual female preferences in the field show that females strongly prefer potential mates of mean body sizes, consistent with the view that, in this species at least, larger males are not always perceived as better by females. In the present study, P. odontotarsus provides an example of an amphibian species in which large size does not have an advantage in mating success for males. Instead, our results provide evidences that stabilizing selection favors the optimal intermediate size of males.	[Zhu, Bicheng; Zhao, Longhui; Tang, Yezhong; Cui, Jianguo] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Wang, Jichao; Sun, Zhixin] Hainan Normal Univ, Dept Biol, Haikou, Hainan, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Hainan Normal University; University System of Maryland; University of Maryland College Park	Cui, JG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	cuijgcn@gmail.com	Zhu, Bicheng/AAU-3425-2020		National Natural Science Foundation of China [31270042, 31260518, 31372217]; Youth Professor Project of CIB; Guangdong Province [2012B091100260]; Chinese Academy of Sciences [2012B091100260]; Youth Innovation Promotion Association of CAS; Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Professor Project of CIB; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of CAS; Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University)	This work was supported by the National Natural Science Foundation of China grant 31270042 (JC), 31260518 (JW), 31372217 (GF), Youth Professor Project of CIB (JC), the Project of Comprehensive Strategic Cooperation between Guangdong Province and Chinese Academy of Sciences grant 2012B091100260 (JC), Youth Innovation Promotion Association of CAS and Open Fund of the Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University) (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; Andersson Malte, 1994; ARAK A, 1983, NATURE, V306, P261, DOI 10.1038/306261a0; ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Blanckenhorn WU, 1998, J EVOLUTION BIOL, V11, P735, DOI 10.1007/s000360050116; Bonner JT., 1988, EVOLUTION COMPLEXITY; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Endler J.A., 1986, Monographs in Population Biology, pviii; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; FOX CW, 1995, ANIM BEHAV, V50, P281, DOI 10.1006/anbe.1995.0242; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GIVEN MF, 1987, HERPETOLOGICA, V43, P467; Gress BE, 2014, P ROY SOC B, V281, P2013; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; LaBarbera M., 1986, Life Sciences Research Report, P69; Liao WB, 2011, BEHAVIOUR, V148, P1087, DOI 10.1163/000579511X589848; Maynard Smith J., 1982, pi; MCLAIN DK, 1993, OIKOS, V68, P490, DOI 10.2307/3544917; MORRIS MR, 1989, BEHAV ECOL SOCIOBIOL, V25, P65, DOI 10.1007/BF00299712; Nali RC, 2014, AM NAT, V184, P727, DOI 10.1086/678455; Narins P.M., 2006, HEARING SOUND COMMUN, DOI DOI 10.1007/978-0-387-47796-1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rausch AM, 2014, BEHAVIOUR, V151, P1869, DOI 10.1163/1568539X-00003220; Reichert MS, 2011, ANIM BEHAV, V82, P1357, DOI 10.1016/j.anbehav.2011.09.019; Richardson C, 2008, ANIM BEHAV, V76, P1487, DOI 10.1016/j.anbehav.2008.06.019; Richardson C, 2010, BEHAVIOUR, V147, P1737, DOI 10.1163/000579510X530221; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P763, DOI 10.1016/S0003-3472(86)80060-4; Rowe C, 2011, SCIENCE, V333, P708, DOI 10.1126/science.1210723; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; Taylor BW, 1998, OECOLOGIA, V114, P494, DOI 10.1007/s004420050473; TEJEDO M, 1992, ANIM BEHAV, V44, P557, DOI 10.1016/0003-3472(92)90065-H; TRAVIS J, 1989, ANNU REV ECOL SYST, V20, P279, DOI 10.1146/annurev.es.20.110189.001431; Wang JC, 2012, ASIAN HERPETOL RES, V3, P205, DOI 10.3724/SP.J.1245.2012.00205; WARNER RR, 1984, AM SCI, V72, P128; William E, 1989, BEHAV ECOL SOCIOBIOL, V25, P429; WOOLBRIGHT LL, 1983, AM NAT, V121, P110, DOI 10.1086/284042	44	17	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149879	10.1371/journal.pone.0149879	http://dx.doi.org/10.1371/journal.pone.0149879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901766	gold, Green Published			2022-12-26	WOS:000371276100171
J	Kuo, TY; Kim-Muller, JY; McGraw, TE; Accili, D				Kuo, Taiyi; Kim-Muller, Ja Young; McGraw, Timothy E.; Accili, Domenico			Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic beta Cell Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN LEVELS; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; DJ-1; SECRETION; GLUCOSE; BLOOD; MICE; QUANTITATION; EXPRESSION	Insulin resistance and beta cell dysfunction contribute to the pathogenesis of type 2 diabetes. Unlike insulin resistance, beta cell dysfunction remains difficult to predict and monitor, because of the inaccessibility of the endocrine pancreas, the integrated relationship with insulin sensitivity, and the paracrine effects of incretins. The goal of our study was to survey the plasma response to a metabolic challenge in order to identify factors predictive of beta cell dysfunction. To this end, we combined (i) the power of unbiased iTRAQ (isobaric tag for relative and absolute quantification) mass spectrometry with (ii) direct sampling of the portal vein following an intravenous glucose/arginine challenge (IVGATT) in (iii) mice with a genetic beta cell defect. By so doing, we excluded the effects of peripheral insulin sensitivity as well as those of incretins on beta cells, and focused on the first phase of insulin secretion to capture the early pathophysiology of beta cell dysfunction. We compared plasma protein profiles with ex vivo islet secretome and transcriptome analyses. We detected changes to 418 plasma proteins in vivo, and detected changes to 262 proteins ex vivo. The impairment of insulin secretion was associated with greater overall changes in the plasma response to IVGATT, possibly reflecting metabolic instability. Reduced levels of proteins regulating redox state and neuronal stress markers, as well as increased levels of coagulation factors, antedated the loss of insulin secretion in diabetic mice. These results suggest that a reduced complement of antioxidants in response to a mixed secretagogue challenge is an early correlate of future beta cell failure.	[Kuo, Taiyi; Kim-Muller, Ja Young; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Kuo, Taiyi; Kim-Muller, Ja Young; Accili, Domenico] Columbia Univ, Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA; [McGraw, Timothy E.] Weill Cornell Med Coll, Dept Biochem, New York, NY 10065 USA	Columbia University; Columbia University; Cornell University	Accili, D (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY 10032 USA.; Accili, D (corresponding author), Columbia Univ, Coll Phys & Surg, Berrie Diabet Ctr, New York, NY 10032 USA.	da230@columbia.edu		Kuo, Taiyi/0000-0001-6167-0284	National Institutes of Health [DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026687, P30DK063608, P30DK020541, T32DK007328, R01DK064819] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020056] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Sheng Zhang (Cornell University) for iTRAQ and MS analysis, Thomas Kolar and Ana Flete-Castro (Columbia University) for excellent technical support, and members of the Accili laboratory for discussions. The Columbia University Diabetes Research Center was supported by National Institutes of Health Grant DK63608.	Abraham TM, 2015, DIABETES CARE, V38, P482, DOI 10.2337/dc14-1432; Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Arntfield ME, 2011, BIOESSAYS, V33, P582, DOI 10.1002/bies.201100015; Atalay M, 1997, ACTA PHYSIOL SCAND, V161, P195, DOI 10.1046/j.1365-201X.1997.00200.x; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Eberhard D, 2013, BIOESSAYS, V35, P584, DOI 10.1002/bies.201300035; Farrah T, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006353; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Geng XH, 2011, AM J PHYSIOL-ENDOC M, V300, pE276, DOI 10.1152/ajpendo.00262.2010; Gerich JE, 2002, DIABETES, V51, pS117, DOI 10.2337/diabetes.51.2007.S117; Goth L, 2001, DIABETES CARE, V24, P1839, DOI 10.2337/diacare.24.10.1839; Grimmond SM, 2003, GENOME RES, V13, P1350, DOI 10.1101/gr.983703; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jain D, 2012, J MOL CELL BIOL, V4, P221, DOI 10.1093/jmcb/mjs025; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kido Y, 2000, J CLIN INVEST, V105, P199, DOI 10.1172/JCI7917; Kikumoto Y, 2010, BBA-MOL BASIS DIS, V1802, P240, DOI 10.1016/j.bbadis.2009.10.009; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kim-Muller JY, 2014, CELL METAB, V20, P593, DOI 10.1016/j.cmet.2014.08.012; Kitamura T, 2009, MOL CELL BIOL, V29, P4417, DOI 10.1128/MCB.01622-08; Levy J, 1998, DIABETIC MED, V15, P290, DOI 10.1002/(SICI)1096-9136(199804)15:4<290::AID-DIA570>3.0.CO;2-M; Lin XM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00954; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Luber CA, 2010, IMMUNITY, V32, P279, DOI 10.1016/j.immuni.2010.01.013; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P160, DOI 10.1158/1055-9965.EPI-10-0397; Mukherjee P, 2013, BBA-PROTEINS PROTEOM, V1834, P2226, DOI 10.1016/j.bbapap.2013.01.022; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; Pomero F, 2015, ACTA DIABETOL, V52, P1007, DOI 10.1007/s00592-015-0746-8; Rodriguez-Araujo G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12081; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Steneberg P, 2013, DIABETES, V62, P2004, DOI 10.2337/db12-1045; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stojanovic I, 2012, IMMUNOL RES, V52, P81, DOI 10.1007/s12026-012-8281-y; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Talchai SC, 2015, DIABETES, V64, P2868, DOI 10.2337/db14-1696; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; TRUS M, 1980, DIABETES, V29, P1, DOI 10.2337/diabetes.29.1.1; Tsuboi Y, 2008, FEBS LETT, V582, P2643, DOI 10.1016/j.febslet.2008.06.043; Tsuchiya K, 2013, CIRC RES, V112, P992, DOI 10.1161/CIRCRESAHA.112.300749; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; Vujicic M, 2014, CYTOKINE, V69, P39, DOI 10.1016/j.cyto.2014.05.013; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Wajchenberg BL, 2007, ENDOCR REV, V28, P187, DOI 10.1210/er.2006-0038; Wang XD, 2011, ANTIOXID REDOX SIGN, V14, P391, DOI 10.1089/ars.2010.3302; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yang Y, 2007, ELECTROPHORESIS, V28, P2080, DOI 10.1002/elps.200600524; Yang Y, 2011, J PROTEOME RES, V10, P4647, DOI 10.1021/pr200455s; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970	56	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9648	9656		10.1074/jbc.M115.702183	http://dx.doi.org/10.1074/jbc.M115.702183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26917725	Green Published, hybrid			2022-12-26	WOS:000375602300023
J	Boehm, EM; Powers, KT; Kondratick, CM; Spies, M; Houtman, JCD; Washington, MT				Boehm, Elizabeth M.; Powers, Kyle T.; Kondratick, Christine M.; Spies, Maria; Houtman, Jon C. D.; Washington, M. Todd			The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase Mediates Its Interaction with the C-terminal Domain of Rev1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA polymerase; DNA repair; DNA replication; mutagenesis; translesion synthesis	YEAST REV1; SWISS-MODEL; Y-FAMILY; FUNCTIONAL INTERACTIONS; STRUCTURAL BASIS; REPAIR PROTEINS; MUTL-ALPHA; REPLICATION; BINDING; PCNA	Y-family DNA polymerases, such as polymerase , polymerase , and polymerase , catalyze the bypass of DNA damage during translesion synthesis. These enzymes are recruited to sites of DNA damage by interacting with the essential replication accessory protein proliferating cell nuclear antigen (PCNA) and the scaffold protein Rev1. In most Y-family polymerases, these interactions are mediated by one or more conserved PCNA-interacting protein (PIP) motifs that bind in a hydrophobic pocket on the front side of PCNA as well as by conserved Rev1-interacting region (RIR) motifs that bind in a hydrophobic pocket on the C-terminal domain of Rev1. Yeast polymerase , a prototypical translesion synthesis polymerase, binds both PCNA and Rev1. It possesses a single PIP motif but not an RIR motif. Here we show that the PIP motif of yeast polymerase mediates its interactions both with PCNA and with Rev1. Moreover, the PIP motif of polymerase binds in the hydrophobic pocket on the Rev1 C-terminal domain. We also show that the RIR motif of human polymerase and the PIP motif of yeast Msh6 bind both PCNA and Rev1. Overall, these findings demonstrate that PIP motifs and RIR motifs have overlapping specificities and can interact with both PCNA and Rev1 in structurally similar ways. These findings also suggest that PIP motifs are a more versatile protein interaction motif than previously believed.	[Boehm, Elizabeth M.; Powers, Kyle T.; Kondratick, Christine M.; Spies, Maria; Washington, M. Todd] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Houtman, Jon C. D.] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Washington, MT (corresponding author), Univ Iowa, Dept Biochem, 4-403 Bowen Sci Bldg, Iowa City, IA 52242 USA.	todd-washington@uiowa.edu		Spies, Maria/0000-0002-7375-8037; Houtman, Jon/0000-0002-5307-9854; Washington, Todd/0000-0001-8680-2992; Powers, Kyle/0000-0003-3240-6534	National Institutes of Health [R01 GM108027, R01 GM081433, T32 GM067795]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108617, R01GM081433, R01GM108027, T32GM067795, R01GM101167] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in whole or part by National Institutes of Health Grants R01 GM108027, R01 GM081433, and T32 GM067795. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2008, P NATL ACAD SCI USA, V105, P17724, DOI 10.1073/pnas.0809844105; Acharya N, 2007, MOL CELL BIOL, V27, P8401, DOI 10.1128/MCB.01478-07; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baldeck N, 2015, NUCLEIC ACIDS RES, V43, P2116, DOI 10.1093/nar/gkv076; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Biesiadecki BJ, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/421701; Cordes T, 2009, J AM CHEM SOC, V131, P5018, DOI 10.1021/ja809117z; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Dieckman LM, 2013, BIOCHEMISTRY-US, V52, P5611, DOI 10.1021/bi400378e; Dieckman Lynne M, 2012, Subcell Biochem, V62, P281, DOI 10.1007/978-94-007-4572-8_15; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gabel SA, 2013, DNA REPAIR, V12, P1105, DOI 10.1016/j.dnarep.2013.08.015; Gellon L, 2002, J BIOL CHEM, V277, P29963, DOI 10.1074/jbc.M202963200; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Haracska L, 2000, NAT GENET, V25, P458, DOI 10.1038/78169; Haracska L, 2002, J BIOL CHEM, V277, P15546, DOI 10.1074/jbc.M112146200; Haracska L, 2002, MOL CELL BIOL, V22, P784, DOI 10.1128/MCB.22.3.784-791.2002; Haracska L, 2001, P NATL ACAD SCI USA, V98, P14256, DOI 10.1073/pnas.261560798; Haracska L, 2001, MOL CELL BIOL, V21, P7199, DOI 10.1128/MCB.21.21.7199-7206.2001; Haracska L, 2001, MOL CELL, V8, P407, DOI 10.1016/S1097-2765(01)00319-7; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Honda M, 2009, MOL CELL, V35, P694, DOI 10.1016/j.molcel.2009.07.003; Iyer RR, 2010, J BIOL CHEM, V285, P11730, DOI 10.1074/jbc.M110.104125; Jahromi AH, 2013, NUCLEIC ACIDS RES, V41, P6687, DOI 10.1093/nar/gkt330; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Masuda-Ozawa T, 2013, NUCLEIC ACIDS RES, V41, P3576, DOI 10.1093/nar/gkt056; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Milescu LS, 2002, BIOPHYS J, V82, p267A; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohashi E, 2009, GENES CELLS, V14, P101, DOI 10.1111/j.1365-2443.2008.01255.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pozhidaeva A, 2012, BIOCHEMISTRY-US, V51, P5506, DOI 10.1021/bi300566z; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Pryor JM, 2014, NUCLEIC ACIDS MOL BI, V30, P85, DOI 10.1007/978-3-642-39796-7_4; Pryor JM, 2011, DNA REPAIR, V10, P1138, DOI 10.1016/j.dnarep.2011.08.011; Sale JE, 2012, NAT REV MOL CELL BIO, V13, P141, DOI 10.1038/nrm3289; Vijayakumar S, 2007, NUCLEIC ACIDS RES, V35, P1624, DOI 10.1093/nar/gkm006; Warbrick E, 2000, BIOESSAYS, V22, P997, DOI 10.1002/1521-1878(200011)22:11<997::AID-BIES6>3.3.CO;2-R; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Wojtaszek J, 2012, J BIOL CHEM, V287, P33836, DOI 10.1074/jbc.M112.394841; Wojtaszek J, 2012, J BIOL CHEM, V287, P26400, DOI 10.1074/jbc.M112.380998; Zhou RB, 2011, NANO LETT, V11, P5482, DOI 10.1021/nl2032876	57	37	38	6	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8735	8744		10.1074/jbc.M115.697938	http://dx.doi.org/10.1074/jbc.M115.697938			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903512	Green Published, hybrid			2022-12-26	WOS:000374773200035
J	Jang, SI; Ong, HL; Liu, X; Alevizos, I; Ambudkar, IS				Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.			Up-regulation of Store-operated Ca2+ Entry and Nuclear Factor of Activated T Cells Promote the Acinar Phenotype of the Primary Human Salivary Gland Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium release-activated calcium channel protein 1 (ORAI1); gene expression; NFAT transcription factor; stromal interaction molecule 1 (STIM1); water channel	NEURAL STEM-CELLS; EPITHELIAL-CELLS; TRANSCRIPTION FACTOR; CALCIUM SIGNALS; GROWTH-FACTOR; NFAT; SECRETION; DIFFERENTIATION; EXPRESSION; FLUID	The signaling pathways involved in the generation and maintenance of exocrine gland acinar cells have not yet been established. Primary human salivary gland epithelial cells, derived from salivary gland biopsies, acquired an acinar-like phenotype when the [Ca2+] in the serum-free medium (keratinocyte growth medium, KGM) was increased from 0.05 mm (KGM-L) to 1.2 mm (KGM-H). Here we examined the mechanism underlying this Ca2+-dependent generation of the acinar cell phenotype. Compared with cells in KGM-L, those in KGM-H display enhancement of Orai1, STIM1, STIM2, and nuclear factor of activated T cells 1 (NFAT1) expression together with an increase in store-operated Ca2+ entry (SOCE), SOCE-dependent nuclear translocation of pGFP-NFAT1, and NFAT-dependent but not NFB-dependent gene expression. Importantly, AQP5, an acinar-specific protein critical for function, is up-regulated in KGM-H via SOCE/NFAT-dependent gene expression. We identified critical NFAT binding motifs in the AQP5 promoter that are involved in Ca2+-dependent up-regulation of AQP5. These important findings reveal that the Ca2+-induced switch of salivary epithelial cells to an acinar-like phenotype involves remodeling of SOCE and NFAT signaling, which together control the expression of proteins critically relevant for acinar cell function. Our data provide a novel strategy for generating and maintaining acinar cells in culture.	[Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.] NIDCR, Secretory & Physiol Sect, NIH, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA; [Jang, Shyh-Ing; Ong, Hwei Ling; Liu, Xibao; Alevizos, Ilias; Ambudkar, Indu S.] NIDCR, Sjogrens Syndrome & Salivary Gland Dysfunct Unit, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Alevizos, I; Ambudkar, IS (corresponding author), NIDCR, Secretory & Physiol Sect, NIH, Mol Physiol & Therapeut Branch, Bethesda, MD 20892 USA.; Alevizos, I; Ambudkar, IS (corresponding author), NIDCR, Sjogrens Syndrome & Salivary Gland Dysfunct Unit, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD 20892 USA.	alevizosi@nidcr.nih.gov; indu.ambudkar@nih.gov		Ong, Hwei Ling/0000-0002-7551-6883; Alevizos, Ilias/0000-0001-5331-1652	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000733, ZIADE000438, ZIADE000704] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ambudkar IS, 2014, CELL CALCIUM, V55, P297, DOI 10.1016/j.ceca.2014.02.009; Ambudkar IS, 2000, CRIT REV ORAL BIOL M, V11, P4, DOI 10.1177/10454411000110010301; Berkefeld H, 2010, PHYSIOL REV, V90, P1437, DOI 10.1152/physrev.00049.2009; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Crist SA, 2008, BLOOD, V111, P3553, DOI 10.1182/blood-2007-05-088161; Dimitriou ID, 2002, EUR J ORAL SCI, V110, P21, DOI 10.1034/j.1600-0722.2002.00152.x; Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jang SI, 2015, J DENT RES, V94, P304, DOI 10.1177/0022034514559251; Kar P, 2015, MOL CELL, V58, P232, DOI 10.1016/j.molcel.2015.02.027; Kiselyov K, 2006, CELL CALCIUM, V40, P451, DOI 10.1016/j.ceca.2006.08.009; Kudryavtseva O, 2013, FEBS J, V280, P5488, DOI 10.1111/febs.12414; Lee MG, 2012, PHYSIOL REV, V92, P39, DOI 10.1152/physrev.00011.2011; Lewis RS, 2003, BIOCHEM SOC T, V31, P925; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071; Maric D, 2003, J NEUROSCI, V23, P240; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Mishra SK, 2006, DEVELOPMENT, V133, P675, DOI 10.1242/dev.02233; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; OKURA M, 1993, DIFFERENTIATION, V54, P143; Ong HL, 2007, J BIOL CHEM, V282, P9105, DOI 10.1074/jbc.M608942200; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Platel JC, 2008, J PHYSIOL-LONDON, V586, P3739, DOI 10.1113/jphysiol.2008.155325; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Redman R. S., 1993, BIOL SALIVARY GLANDS, P285; SABATINI LM, 1991, IN VITRO CELL DEV B, V27, P939; SENS DA, 1985, LAB INVEST, V52, P559; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shukla U, 2009, J BIOL CHEM, V284, P33719, DOI 10.1074/jbc.M109.049999; STAUFFER PL, 1993, J BIOL CHEM, V268, P19769; Yule DI, 2001, J GEN PHYSIOL, V117, P431, DOI 10.1085/jgp.117.5.431; YUSPA SH, 1989, J CELL BIOL, V109, P1207, DOI 10.1083/jcb.109.3.1207; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	37	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8709	8720		10.1074/jbc.M115.701607	http://dx.doi.org/10.1074/jbc.M115.701607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903518	hybrid, Green Published			2022-12-26	WOS:000374773200033
J	Zadeh-Tahmasebi, M; Duca, FA; Rasmussen, BA; Bauer, PV; Cote, CD; Filippi, BM; Lam, TKT				Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.			Activation of Short and Long Chain Fatty Acid Sensing Machinery in the Ileum Lowers Glucose Production in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid; glucose; glucose metabolism; intestine; lipid signaling	GLUCAGON-LIKE PEPTIDE-1; ENTEROENDOCRINE CELLS; RECEPTOR; PROPIONATE; SECRETION; INTESTINE; RESPONSES; CHOLECYSTOKININ; MICROBIOTA; DIVERSITY	Evidence continues to emerge detailing the myriad of ways the gut microbiota influences host energy homeostasis. Among the potential mechanisms, short chain fatty acids (SCFAs), the byproducts of microbial fermentation of dietary fibers, exhibit correlative beneficial metabolic effects in humans and rodents, including improvements in glucose homeostasis. The underlying mechanisms, however, remain elusive. We here report that one of the main bacterially produced SCFAs, propionate, activates ileal mucosal free fatty acid receptor 2 to trigger a negative feedback pathway to lower hepatic glucose production in healthy rats in vivo. We further demonstrate that an ileal glucagon-like peptide-1 receptor-dependent neuronal network is necessary for ileal propionate and long chain fatty acid sensing to regulate glucose homeostasis. These findings highlight the potential to manipulate fatty acid sensing machinery in the ileum to regulate glucose homeostasis.	[Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.] UHN, Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Zadeh-Tahmasebi, Melika; Duca, Frank A.; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Filippi, Beatrice M.; Lam, Tony K. T.] UHN, Dept Med, Toronto, ON M5G 1L7, Canada; [Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Lam, Tony K. T.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Zadeh-Tahmasebi, Melika; Rasmussen, Brittany A.; Bauer, Paige V.; Cote, Clemence D.; Lam, Tony K. T.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Lam, Tony K. T.] Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Lam, TKT (corresponding author), MaRS Ctr, Toronto Med Discovery Tower Rm 10-705,101 Coll St, Toronto, ON M5G 1L7, Canada.	tony.lam@uhnres.utoronto.ca			Canadian Institutes of Health Research Foundation [FDN-143204]; Banting and Best Diabetes Centre graduate studentship; Vanier Canada scholarship; Ontario Graduate Scholarship	Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Banting and Best Diabetes Centre graduate studentship; Vanier Canada scholarship; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by Canadian Institutes of Health Research Foundation Grant FDN-143204 (to T. K. T. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Banting and Best Diabetes Centre graduate studentship.; Supported by a Vanier Canada scholarship.; Supported by a Ontario Graduate Scholarship and a Banting and Best Diabetes Centre graduate studentship.	Booijink CCGM, 2007, FUTURE MICROBIOL, V2, P285, DOI 10.2217/17460913.2.3.285; BOOTH CC, 1961, GUT, V2, P23, DOI 10.1136/gut.2.1.23; Breen DM, 2012, NAT MED, V18, P950, DOI 10.1038/nm.2745; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Cani PD, 2005, J ENDOCRINOL, V185, P457, DOI 10.1677/joe.1.06100; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Cheung GWC, 2009, CELL METAB, V10, P99, DOI 10.1016/j.cmet.2009.07.005; Cote CD, 2015, NAT MED, V21, P498, DOI 10.1038/nm.3821; Cote CD, 2014, J BIOL CHEM, V289, P11642, DOI 10.1074/jbc.O114.556068; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Dumoulin V, 1998, ENDOCRINOLOGY, V139, P3780, DOI 10.1210/en.139.9.3780; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Gaisano GG, 2010, NEUROGASTROENT MOTIL, V22, P470, DOI 10.1111/j.1365-2982.2009.01430.x; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Hayes MR, 2011, AM J PHYSIOL-REG I, V301, pR1479, DOI 10.1152/ajpregu.00356.2011; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Iakoubov R, 2011, ENDOCRINOLOGY, V152, P1244, DOI 10.1210/en.2010-1352; Kaji I, 2011, J MOL HISTOL, V42, P27, DOI 10.1007/s10735-010-9304-4; Karaki S, 2006, CELL TISSUE RES, V324, P353, DOI 10.1007/s00441-005-0140-x; Kokorovic A, 2011, GASTROENTEROLOGY, V141, P1720, DOI 10.1053/j.gastro.2011.06.042; Lal S, 2001, AM J PHYSIOL-GASTR L, V281, pG907, DOI 10.1152/ajpgi.2001.281.4.G907; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Li GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097342; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687; Nakagawa A, 2004, AUTON NEUROSCI-BASIC, V110, P36, DOI 10.1016/j.autneu.2003.11.001; Nohr MK, 2013, ENDOCRINOLOGY, V154, P3552, DOI 10.1210/en.2013-1142; Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261; Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153; Randich A, 2000, AM J PHYSIOL-REG I, V278, pR34, DOI 10.1152/ajpregu.2000.278.1.R34; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Richards P, 2014, DIABETES, V63, P1224, DOI 10.2337/db13-1440; Rodriguez MD, 1997, AM J PHYSIOL-REG I, V272, pR1170, DOI 10.1152/ajpregu.1997.272.4.R1170; Schwartz A, 2010, PHYSIOL MEAS, V31, P1147, DOI 10.1088/0967-3334/31/9/006; Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; van Avesaat M, 2015, INT J OBESITY, V39, P235, DOI 10.1038/ijo.2014.112; Trung VN, 2014, J INVEST SURG, V27, P332, DOI 10.3109/08941939.2014.929764; Wang M, 2005, FEMS MICROBIOL ECOL, V54, P219, DOI 10.1016/j.femsec.2005.03.012; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Woltman T, 1995, AM J PHYSIOL-REG I, V269, pR1420, DOI 10.1152/ajpregu.1995.269.6.R1420; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	43	28	30	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8816	8824		10.1074/jbc.M116.718460	http://dx.doi.org/10.1074/jbc.M116.718460			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26896795	Green Published, hybrid			2022-12-26	WOS:000374773200042
J	Robertson, DJ; Noyes, E; Dowsett, AJ; Jenkins, R; Burton, AM				Robertson, David J.; Noyes, Eilidh; Dowsett, Andrew J.; Jenkins, Rob; Burton, A. Mike			Face Recognition by Metropolitan Police Super-Recognisers	PLOS ONE			English	Article							UNFAMILIAR FACES; QUALITY; PHOTOGRAPHS; IDENTITIES; IMAGES; MEMORY; VIDEO; CCTV	Face recognition is used to prove identity across a wide variety of settings. Despite this, research consistently shows that people are typically rather poor at matching faces to photos. Some professional groups, such as police and passport officers, have been shown to perform just as poorly as the general public on standard tests of face recognition. However, face recognition skills are subject to wide individual variation, with some people showing exceptional ability-a group that has come to be known as 'super-recognisers'. The Metropolitan Police Force (London) recruits 'super-recognisers' from within its ranks, for deployment on various identification tasks. Here we test four working super-recognisers from within this police force, and ask whether they are really able to perform at levels above control groups. We consistently find that the police 'super-recognisers' perform at well above normal levels on tests of unfamiliar and familiar face matching, with degraded as well as high quality images. Recruiting employees with high levels of skill in these areas, and allocating them to relevant tasks, is an efficient way to overcome some of the known difficulties associated with unfamiliar face recognition.	[Robertson, David J.; Noyes, Eilidh; Dowsett, Andrew J.; Jenkins, Rob; Burton, A. Mike] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	Burton, AM (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	mike.burton@york.ac.uk	Burton, Mike/A-9491-2008; Jenkins, Rob/C-5289-2008; Robertson, David/H-6515-2017	Burton, Mike/0000-0002-2035-2084; Robertson, David/0000-0002-8393-951X; Noyes, Eilidh/0000-0001-8709-879X	European Research Council under European Union / ERC [323262]; Economic and Social Research Council, UK [ES/J022950/1]; Economic and Social Research Council [ES/J022950/1, ES/J022950/2, 1215797] Funding Source: researchfish; ESRC [ES/J022950/1, ES/J022950/2] Funding Source: UKRI	European Research Council under European Union / ERC(European Research Council (ERC)); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n.323262, and from the Economic and Social Research Council, UK (ES/J022950/1). http://erc.europa.eu/; http://www.esrc.ac.uk/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenezi HM, 2013, APPL COGNITIVE PSYCH, V27, P735, DOI 10.1002/acp.2968; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Bobak AK, 2016, APPL COGNITIVE PSYCH, V30, P81, DOI 10.1002/acp.3170; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Burton A.M., 2011, OXFORD HDB FACE PERC, P287; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Clutterbuck R, 2004, VIS COGN, V11, P857, DOI 10.1080/13506280444000021; Clutterbuck R, 2002, PERCEPTION, V31, P985, DOI 10.1068/p3335; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Dowsett AJ, 2015, BRIT J PSYCHOL, V106, P433, DOI 10.1111/bjop.12103; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Edmond G, 2010, INT J EVID PROOF, V14, P146, DOI 10.1350/ijep.2010.14.2.349; Hussain Z, 2009, VISION RES, V49, P2624, DOI 10.1016/j.visres.2009.08.022; Keane, 2011, HDB FACE PERCEPTION, P307; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Kleinberg KF, 2007, J FORENSIC SCI, V52, P779, DOI 10.1111/j.1556-4029.2007.00458.x; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; Norell K, 2015, J FORENSIC SCI, V60, P331, DOI 10.1111/1556-4029.12660; Potts L., BBC NEWS; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; White D, 2015, P R SOC B, V282; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Yovel G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00562	28	93	93	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150036	10.1371/journal.pone.0150036	http://dx.doi.org/10.1371/journal.pone.0150036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918457	Green Accepted, Green Published, gold			2022-12-26	WOS:000371274400074
J	Simon, UK; Gesslbauer, L; Fink, A				Simon, Uwe K.; Gesslbauer, Lisa; Fink, Andreas			A Three-Lesson Teaching Unit Significantly Increases High School Students' Knowledge about Epilepsy and Positively Influences Their Attitude towards This Disease	PLOS ONE			English	Article							PUBLIC-ATTITUDES; CHILDREN; PERCEPTION; TEACHERS; GERMANY; STIGMA	Epilepsy is not a regular topic in many countries' schools. Thus many people harbor misconceptions about people suffering from this disease. It was our aim to a) examine what grade ten students know and believe about epilepsy, and b) to develop and test a teaching unit to improve their knowledge and attitude. The test group comprised eight grade ten classes from six different Austrian high schools (54 girls and 51 boys aged 14-17), the control group (no intervention) five grade ten classes from the same schools (26 girls and 37 boys aged 14-17). The teaching unit consisted of three 45-min lessons using different methods and material. Changes in knowledge about and attitude towards epilepsy as a result of the intervention were psychometrically assessed in a pre-test intervention post-test design (along with a follow-up assessment two months after the intervention) by means of a questionnaire capturing different facets of epilepsy-related knowledge and attitude. Across all knowledge/attitude domains, students of the test group had a significantly improved knowledge about and a more positive attitude towards epilepsy and people suffering from it after the teaching unit. However, starting levels were different between the five knowledge/attitude domains tested. Medical background knowledge was lowest and consequently associated with the highest increase after the intervention. This study shows that epilepsy-related knowledge of many grade ten high school students is fragmentary and that some harbor beliefs and attitudes which require improvement. Our comprehensive but concise teaching unit significantly increased knowledge about epilepsy and positively influenced attitude towards individuals with epilepsy. Thus we recommend implementing this unit into regular school curricula.	[Simon, Uwe K.; Gesslbauer, Lisa] Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr 51, A-8010 Graz, Austria; [Fink, Andreas] Karl Franzens Univ Graz, Inst Psychol, Univ Pl 2-DG, A-8010 Graz, Austria	University of Graz; University of Graz	Simon, UK (corresponding author), Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr 51, A-8010 Graz, Austria.	uwe.simon@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Fink, Andreas/0000-0001-7316-3140				Aldenkamp AP, 1999, EPILEPSIA, V40, P94; [Anonymous], 2009, EP SCHUL UNT; Baumgartner C, 2012, LEBEN EPILEPSIE INFO; Bautista RED, 2014, EPILEPSY BEHAV, V35, P42, DOI 10.1016/j.yebeh.2014.04.006; Bhalla D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046296; Bishop M, 2006, EPILEPSY BEHAV, V8, P397, DOI 10.1016/j.yebeh.2005.11.008; Bishop M, 2004, EPILEPSY BEHAV, V5, P308, DOI 10.1016/j.yebeh.2004.01.011; BMUKK, 2008, LEHRPL BIOL UMW; Bozkaya IO, 2010, EPILEPSY BEHAV, V17, P56, DOI 10.1016/j.yebeh.2009.10.011; Brabcova D, 2013, SEIZURE-EUR J EPILEP, V22, P179, DOI 10.1016/j.seizure.2012.11.017; Diamantopoulos N, 2006, EPILEPSIA, V47, P2154, DOI 10.1111/j.1528-1167.2006.00891.x; DIEHL LW, 1975, NERVENARZT, V46, P519; Etschenberg K, 2001, CHRONISCHE ERKRANKUN; Feger JM, 2012, PSYCHIAT PSYCHOTHERA; Feucht M, 2005, MITTEILUNGEN OSTERRE, V5, P1; FINKE M, 1981, NERVENARZT, V52, P581; Gesslbauer L, MNU IN PRESS; Goel D, 2011, ANN INDIAN ACAD NEUR, V14, P116, DOI 10.4103/0972-2327.82799; GUTTELING JM, 1986, EPILEPSIA, V27, P739, DOI 10.1111/j.1528-1157.1986.tb03604.x; Jacoby A, 2008, CURR NEUROL NEUROSCI, V8, P339, DOI 10.1007/s11910-008-0052-8; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; Joshi HS, 2012, ANN INDIAN ACAD NEUR, V15, P125, DOI 10.4103/0972-2327.94996; Kosters W, 2001, CHRONISCHE ERKRANKUN, P17; Kramer G, 2012, EPILEPTOLOGIE, V29, P1; Lee RA, 2011, NEUROL ASIA, V16, P143; Lerche H, 2011, LEHRBUCH NEUROLOGIE, P75; May TW, 2004, Z EPILEPTOL, V17, P287, DOI [10.1007/s10309, DOI 10.1007/S10309]; Mecarelli O, 2011, EPILEPSY BEHAV, V22, P285, DOI 10.1016/j.yebeh.2011.06.019; Prpic I, 2003, EPILEPSY BEHAV, V4, P142, DOI 10.1016/S1525-5050(03)00025-8; Schneble H, 2009, GRUNDSCHULE WEITERFU; Spatt J, 2005, EPILEPSIA, V46, P736, DOI 10.1111/j.1528-1167.2005.52404.x; Thorbecke R, 2010, Z EPILEPTOL, V23, P82, DOI 10.1007/s10309-009-0088-z; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Windisch R, 2009, EPILEPSIEN PADAGOGIS	34	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150014	10.1371/journal.pone.0150014	http://dx.doi.org/10.1371/journal.pone.0150014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919557	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400070
J	Tajkarimi, M; Harrison, SH; Hung, AM; Graves, JL				Tajkarimi, Mehrdad; Harrison, Scott H.; Hung, Albert M.; Graves, Joseph L., Jr.			Mechanobiology of Antimicrobial Resistant Escherichia coli and Listeria innocua	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BACTERIAL ADHESION; BIOFILM FORMATION; IN-VITRO; CELLS; ACID; QUANTIFICATION; PREVENTION; SURFACE; SILVER	A majority of antibiotic-resistant bacterial infections in the United States are associated with biofilms. Nanoscale biophysical measures are increasingly revealing that adhesive and viscoelastic properties of bacteria play essential roles across multiple stages of biofilm development. Atomic Force Microscopy (AFM) applied to strains with variation in antimicrobial resistance enables new opportunities for investigating the function of adhesive forces (stickiness) in biofilm formation. AFM force spectroscopy analysis of a field strain of Listeria innocua and the strain Escherichia coli K-12 MG1655 revealed differing adhesive forces between antimicrobial resistant and nonresistant strains. Significant increases in stickiness were found at the nanonewton level for strains of Listeria innocua and Escherichia coli in association with benzalkonium chloride and silver nanoparticle resistance respectively. This advancement in the usage of AFM provides for a fast and reliable avenue for analyzing antimicrobial resistant cells and the molecular dynamics of biofilm formation as a protective mechanism.	[Tajkarimi, Mehrdad] Joint Sch Nanosci & Nanoengn, Dept Nanosci, Greensboro, NC USA; [Harrison, Scott H.; Graves, Joseph L., Jr.] N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC 27411 USA; [Hung, Albert M.] N Carolina Agr & Tech State Univ, Joint Sch Nanosci & Nanoengn, Dept Nanoengn, Greensboro, NC 27411 USA; [Hung, Albert M.] UNC Greensboro, Greensboro, NC USA	University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University; University of North Carolina; University of North Carolina Greensboro	Tajkarimi, M (corresponding author), Joint Sch Nanosci & Nanoengn, Dept Nanosci, Greensboro, NC USA.	m_tajkar@uncg.edu			Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro	Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro	The work was sponsored by Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AC, 2014, INT BIODETER BIODEGR, V86, P34, DOI 10.1016/j.ibiod.2013.03.024; Allison DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2880; Alsteens D, 2012, METHOD ENZYMOL, V506, P3, DOI 10.1016/B978-0-12-391856-7.00025-1; An RS, 2011, MICROBIOL-SGM, V157, P2595, DOI 10.1099/mic.0.048959-0; [Anonymous], 2015, R PROJECT STAT COMPU; Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x; Chao YQ, 2011, APPL MICROBIOL BIOT, V92, P381, DOI 10.1007/s00253-011-3551-5; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7; Dorobantu LS, 2012, MICRON, V43, P1312, DOI 10.1016/j.micron.2012.05.005; Dubrovin EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047348; Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002; Dufrene YF, 2014, MBIO, V5, DOI 10.1128/mBio.01363-14; Dufrene YF, 2013, NANOSCALE, V5, P4094, DOI 10.1039/c3nr00340j; Dutta V, 2014, APPL ENVIRON MICROB, V80, P5379, DOI 10.1128/AEM.01398-14; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2; Fazlara A., 2012, AM EURASIAN J AGR EN, V12, P23, DOI DOI 10.1186/1471-2334-14-292; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Graves JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00042; Hamadi F, 2008, COLLOID SURFACE B, V65, P134, DOI 10.1016/j.colsurfb.2008.03.010; Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003; Katharios-Lanwermeyer S, 2012, APPL ENVIRON MICROB, V78, P7549, DOI 10.1128/AEM.02245-12; Kawamura-Sato K, 2008, J ANTIMICROB CHEMOTH, V61, P568, DOI 10.1093/jac/dkm498; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Longo G, 2013, J MICROBIOL METH, V93, P80, DOI 10.1016/j.mimet.2013.01.022; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1; Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]; Roos WH, 2010, BIOPHYS J, V99, P1175, DOI 10.1016/j.bpj.2010.05.033; Silagyi K. S., 2007, BIOFILM FORMATION ES; Simoes LC, 2010, APPL ENVIRON MICROB, V76, P6673, DOI 10.1128/AEM.00872-10; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Simojoki H, 2012, VET MICROBIOL, V158, P344, DOI 10.1016/j.vetmic.2012.02.031; Soumet C, 2012, VET MICROBIOL, V158, P147, DOI 10.1016/j.vetmic.2012.01.030; Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001; Tajkarimi M, 2015, BIOPHYSICAL J BIOPHY, P402; Tajkarimi M, 2015, BIOPHYS J, V108, P402; Thio BJR, 2008, COLLOID SURFACE B, V65, P308, DOI 10.1016/j.colsurfb.2008.05.005; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004; Vadillo-Rodriguez V, 2011, SOFT MATTER, V7, P4101, DOI 10.1039/c0sm01054e; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Weimer PJ, 2006, APPL ENVIRON MICROB, V72, P7559, DOI 10.1128/AEM.01632-06; Wen M, 2008, MOL VIS, V14, P114; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1; Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s	55	7	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149769	10.1371/journal.pone.0149769	http://dx.doi.org/10.1371/journal.pone.0149769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914334	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700026
J	Blanco-Kelly, F; Hoyos, MG; Martinez, MAL; Lopez-Molina, I; Riveiro-Alvarez, R; Fernandez-San Jose, P; Avila-Fernandez, A; Corton, M; Millan, JM; Sandoval, BG; Ayuso, C				Blanco-Kelly, Fiona; Garcia Hoyos, Maria; Lopez Martinez, Miguel Angel; Lopez-Molina, Isabel; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Millan, Jose M.; Garcia Sandoval, Blanca; Ayuso, Carmen			Dominant Retinitis Pigmentosa, p.Gly56Arg Mutation in NR2E3: Phenotype in a Large Cohort of 24 Cases	PLOS ONE			English	Article							S-CONE SYNDROME; RETINAL DEGENERATION; MACULOPATHY	Importance This research is the single largest NR2E3 genotype-phenotype correlation study performed to date in autosomal dominant Retinitis Pigmentosa. Objective The aim of this study is to analyse the frequency of the p.Gly56Arg mutation in NR2E3 for the largest cohort of autosomal dominant Retinitis Pigmentosa patients to date and its associated phenotype. Patients and Methods A cohort of 201 unrelated Spanish families affected by autosomal dominant Retinitis Pigmentosa. The p.Gly56Arg mutation in the NR2E3 (NM_014249.2) gene was analysed in 201 families. In the 24 cases where the mutation had been detected, a haplotype analysis linked to the p.Gly56Arg families was performed, using four extragenic polymorphic markers D15S967, D15S1050, D15S204 and D15S188. Phenotype study included presence and age of onset of night blindness, visual field loss and cataracts; and an ophthalmoscopic examination after pupillary dilation and electroretinogram for the 24 cases. Results Seven of the 201 analyzed families were positive for the p.Gly56Arg, leading to a prevalence of 3.5%. Clinical data were available for 24 subjects. Night blindness was the first noticeable symptom (mean 15.9 years). Visual field loss onset was variable (23.3 +/- 11.9 years). Loss of visual acuity appeared late in the disease's evolution. Most of the patients with cataracts (50%) presented it from the third decade of life. Fundus changes showed inter and intrafamiliar variability, but most of the patients showed typical RP changes and it was common to find macular affectation (47.4%). Electroretinogram was impaired from the beginning of the disease. Two families shared a common haplotype. Additionally, all patients shared a 104Kb region between D15S1050 and the NR2E3 gene. Conclusions This study highlights the importance of p.Gly56Arg in the NR2E3 gene as a common mutation associated with adRP, and provides new clues to its phenotype, which can allow for a better clinical management and genetic counselling of patients and their families.	[Blanco-Kelly, Fiona; Lopez Martinez, Miguel Angel; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Ayuso, Carmen] UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Genet, Madrid, Spain; [Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Millan, Jose M.; Ayuso, Carmen] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Garcia Hoyos, Maria] Inst Med Genom IMEGEN, Valencia, Spain; [Lopez-Molina, Isabel; Garcia Sandoval, Blanca] UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Ophthalmol, Madrid, Spain; [Millan, Jose M.] IIS La Fe, Grp Invest Biomed Mol Celular & Genom, Valencia, Spain; [Millan, Jose M.] Hosp Univ & Politecn La Fe, Unidad Genet Diagnost Prenatal, Valencia, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitari i Politecnic La Fe	Ayuso, C (corresponding author), UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Genet, Madrid, Spain.; Ayuso, C (corresponding author), ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.	cayuso@fjd.es		Blanco-Kelly, Fiona/0000-0003-0052-5651; Ayuso, Carmen/0000-0002-9242-7065; Corton, Marta/0000-0003-0087-1626	FIS [PI: 13/00226]; Centre for Biomedical Network Research on Rare Diseases-CIBERER [06/07/0036]; Biobank of Fundacion Jimenez Diaz University Hospital [RD09/0076/00101]; ONCE; Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce [4019-002]; Rio Hortega grant [CM12/00013]; Marta Corton by a Miguel Servet grant [CP/03256]	FIS(Instituto de Salud Carlos III); Centre for Biomedical Network Research on Rare Diseases-CIBERER; Biobank of Fundacion Jimenez Diaz University Hospital; ONCE; Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce; Rio Hortega grant; Marta Corton by a Miguel Servet grant	Support was provided by FIS (PI: 13/00226), the Centre for Biomedical Network Research on Rare Diseases-CIBERER (06/07/0036), the Biobank of Fundacion Jimenez Diaz University Hospital (RD09/0076/00101), ONCE 2014, Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce (4019-002). Patricia Fernandez-San Jose's work is supported by a Rio Hortega grant (CM12/00013), Marta Corton by a Miguel Servet grant (CP/03256) all from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo I, 2008, INVEST OPHTH VIS SCI, V49, P2082, DOI 10.1167/iovs.05-1629; AYUSO C, 1995, CLIN GENET, V48, P120; Ayuso C, 2001, ESTUDIO RETINOSIS PI; Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Drake JW, 1998, GENETICS, V148, P1667; Escher P, 2012, INVEST OPHTH VIS SCI, V53, P4754, DOI 10.1167/iovs.11-8693; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Jose PFS, 2015, ACTA OPHTHALMOL, V93, pE38, DOI 10.1111/aos.12486; Ganesh A, 2011, CURR OPIN OPHTHALMOL, V22, P332, DOI 10.1097/ICU.0b013e328349229e; GAWANDE AA, 1989, BRIT J OPHTHALMOL, V73, P115, DOI 10.1136/bjo.73.2.115; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HAIM M, 1993, CLIN GENET, V44, P62; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Ikeda Y, 2013, BRIT J OPHTHALMOL, V97, P1187, DOI 10.1136/bjophthalmol-2012-303005; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; MARMOR MF, 1991, ARCH OPHTHALMOL-CHIC, V109, P13, DOI 10.1001/archopht.1991.01080010015006; MARMOR MF, 1990, AM J OPHTHALMOL, V110, P124, DOI 10.1016/S0002-9394(14)76980-6; MARMOR MF, 1980, AM J OPHTHALMOL, V89, P692, DOI 10.1016/0002-9394(80)90289-5; MARMOR MF, 1979, ARCH OPHTHALMOL-CHIC, V97, P1300; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NASR YG, 1990, RETINA-J RET VIT DIS, V10, P178, DOI 10.1097/00006982-199001030-00004; Roduit R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007379; Schorderet DF, 2009, HUM MUTAT, V30, P1475, DOI 10.1002/humu.21096; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Sullivan LS, 2013, INVEST OPHTH VIS SCI, V54, P6255, DOI 10.1167/iovs.13-12605; Tonisson N, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P247; Yang YP, 2010, INVEST OPHTH VIS SCI, V51, P2229, DOI 10.1167/iovs.09-4299; Yzer S, 2013, JAMA OPHTHALMOL, V131, P1324, DOI 10.1001/jamaophthalmol.2013.4349	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149473	10.1371/journal.pone.0149473	http://dx.doi.org/10.1371/journal.pone.0149473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910043	Green Submitted, Green Published, gold			2022-12-26	WOS:000371164700036
J	Cain, SM; Ashton-Miller, JA; Perkins, NC				Cain, Stephen M.; Ashton-Miller, James A.; Perkins, Noel C.			On the Skill of Balancing While Riding a Bicycle	PLOS ONE			English	Article							CENTER-OF-MASS; RIDER MOTION; BODY CENTER; GRAVITY; STABILITY; DYNAMICS	Humans have ridden bicycles for over 200 years, yet there are no continuous measures of how skill differs between novice and expert. To address this knowledge gap, we measured the dynamics of human bicycle riding in 14 subjects, half of whom were skilled and half were novice. Each subject rode an instrumented bicycle on training rollers at speeds ranging from 1 to 7 m/s. Steer angle and rate, steer torque, bicycle speed, and bicycle roll angle and rate were measured and steering power calculated. A force platform beneath the roller assembly measured the net force and moment that the bicycle, rider and rollers exerted on the floor, enabling calculations of the lateral positions of the system centers of mass and pressure. Balance performance was quantified by cross-correlating the lateral positions of the centers of mass and pressure. The results show that all riders exhibited similar balance performance at the slowest speed. However at higher speeds, the skilled riders achieved superior balance performance by employing more rider lean control (quantified by crosscorrelating rider lean angle and bicycle roll angle) and less steer control (quantified by cross-correlating steer rate and bicycle roll rate) than did novice riders. Skilled riders also used smaller steering control input with less variation (measured by average positive steering power and standard deviations of steer angle and rate) and less rider lean angle variation (measured by the standard deviation of the rider lean angle) independent of speed. We conclude that the reduction in balance control input by skilled riders is not due to reduced balance demands but rather to more effective use of lean control to guide the center of mass via center of pressure movements.	[Cain, Stephen M.; Ashton-Miller, James A.; Perkins, Noel C.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cain, SM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	smcain@umich.edu			NIA NIH HHS [P30 AG024824] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cain S.M., 2012, ASME 2012 5 ANN DYN; Cain SM, 2011, 35 ANN M AM SOC BIOM; Cain SM, 2012, VEHICLE SYST DYN, V50, P1341, DOI 10.1080/00423114.2011.650181; Dempster WT, 1955, REPORT NO WADC TECHN; Doyle AJR, 1987, THESIS U SHEFFIELD; Dressel A, 2012, EUR J PHYS, V33, pL21, DOI 10.1088/0143-0807/33/4/L21; DRURY CG, 1980, J SAFETY RES, V12, P86; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Hof AL, 2005, J BIOMECH, V38, P2134, DOI 10.1016/j.jbiomech.2005.03.029; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lenzi D, 2003, J BIOMECH, V36, P1335, DOI 10.1016/S0021-9290(03)00151-9; Lunteren Av, 1969, S ERG MACH DES OCT 2, P349; Meijaard JP, 2007, P ROY SOC A-MATH PHY, V463, P1955, DOI 10.1098/rspa.2007.1857; Moore J, 2008, ENGINEERING OF SPORT 7, VOL 2, P311, DOI 10.1007/978-2-287-09413-2_39; Moore JK, 2011, MULTIBODY SYST DYN, V25, P225, DOI 10.1007/s11044-010-9225-8; Moore JK, 2010, PROCEDIA ENGINEER, V2, P2937, DOI 10.1016/j.proeng.2010.04.091; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Prem H, 1983, THESIS U MELBOURNE; Rice RS, 1978, SAE, P79; Schewe G, 1984, Blutalkohol, V21, P97; Schwab AL, 2013, VEHICLE SYST DYN, V51, P1059, DOI 10.1080/00423114.2013.793365; Schwab AL, 2012, ASME 2012 5 ANN DYN; Sheridan T. B., 1974, MAN MACHINE SYSTEMS; SHIMBA T, 1984, J BIOMECH, V17, P53, DOI 10.1016/0021-9290(84)90080-0; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Whipple F., 1899, Q J PURE APPL MATH, V30, P312; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079; Zatsiorsky VM, 1998, J BIOMECH, V31, P161, DOI 10.1016/S0021-9290(97)00116-4; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185; Zok M, 2004, MED ENG PHYS, V26, P791, DOI 10.1016/j.medengphy.2004.07.005	34	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149340	10.1371/journal.pone.0149340	http://dx.doi.org/10.1371/journal.pone.0149340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910774	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700031
J	Ma, YF; Hu, J; Zhang, N; Dong, XR; Li, Y; Yang, B; Tian, WD; Wang, XQ				Ma, Yanfen; Hu, Jian; Zhang, Ning; Dong, Xinran; Li, Ying; Yang, Bo; Tian, Weidong; Wang, Xiaoqin			Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach	PLOS ONE			English	Article							EXPRESSION SIGNATURES; CONNECTIVITY MAP; CELL-LINES; DISCOVERY; GENE; INHIBITOR; CHEMOTHERAPY; DATABASE; TARGETS; BIOLOGY	Pancreatic cancer is the leading cause of death from solid malignancies worldwide. Currently, gemcitabine is the only drug approved for treating pancreatic cancer. Developing new therapeutic drugs for this disease is, therefore, an urgent need. The C-Map project has provided a wealth of gene expression data that can be mined for repositioning drugs, a promising approach to new drug discovery. Typically, a drug is considered potentially useful for treating a disease if the drug-induced differential gene expression profile is negatively correlated with the differentially expressed genes in the target disease. However, many of the potentially useful drugs (PUDs) identified by gene expression profile correlation are likely false positives because, in C-Map, the cultured cell lines to which the drug is applied are not derived from diseased tissues. To solve this problem, we developed a combined approach for predicting candidate drugs for treating pancreatic cancer. We first identified PUDs for pancreatic cancer by using C-Map-based gene expression correlation analyses. We then applied an algorithm (Met-express) to predict key pancreatic cancer (KPC) enzymes involved in pancreatic cancer metabolism. Finally, we selected candidates from the PUDs by requiring that their targets be KPC enzymes or the substrates/products of KPC enzymes. Using this combined approach, we predicted seven candidate drugs for treating pancreatic cancer, three of which are supported by literature evidence, and three were experimentally validated to be inhibitory to pancreatic cancer celllines.	[Ma, Yanfen; Hu, Jian; Zhang, Ning; Yang, Bo; Wang, Xiaoqin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian 710049, Shaanxi, Peoples R China; [Ma, Yanfen; Zhang, Ning; Li, Ying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China; [Dong, Xinran; Tian, Weidong] Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200433, Peoples R China; [Li, Ying] SHAANXI Kang Fu Hosp, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Fudan University	Wang, XQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian 710049, Shaanxi, Peoples R China.; Tian, WD (corresponding author), Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn; 1493722680@qq.com	Dong, Xinran/AAF-7799-2019		International Science and Technology Cooperation and Exchange Program of Shaanxi Province [2015KW-045]; Science and Technology Research Program of Shaanxi Province [2013K-12-20-10]; National Natural Science Foundation of China [91231116, 31471245, 31071113]	International Science and Technology Cooperation and Exchange Program of Shaanxi Province; Science and Technology Research Program of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the International Science and Technology Cooperation and Exchange Program of Shaanxi Province (Grant No. 2015KW-045, XW), the Science and Technology Research Program of Shaanxi Province (2013K-12-20-10, JH), and the National Natural Science Foundation of China [91231116, 31471245, 31071113, WT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen B, 2015, CPT-PHARMACOMET SYST, V4, P576, DOI 10.1002/psp4.12009; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Fiorino S, 2013, PANCREATOLOGY, V13, P147, DOI 10.1016/j.pan.2013.01.005; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gansauge S, 1998, CELL GROWTH DIFFER, V9, P611; Greeshma N, 2015, CHEM-BIOL INTERACT, V238, P118, DOI 10.1016/j.cbi.2015.06.025; Gungor C, 2014, BRIT J PHARMACOL, V171, P849, DOI 10.1111/bph.12401; Guo JM, 2006, J GASTROEN HEPATOL, V21, P443, DOI 10.1111/j.1440-1746.2006.04180.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hempen PM, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9120; Henderson MC, 2009, MOL CANCER THER, V8, P36, DOI 10.1158/1535-7163.MCT-08-0789; Herreros-Villanueva M, 2013, WORLD J GASTROENTERO, V19, P638, DOI 10.3748/wjg.v19.i5.638; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kempen EC, 2001, ANAL BIOCHEM, V297, P183, DOI 10.1006/abio.2001.5325; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qu XYA, 2012, DRUG DISCOV TODAY, V17, P1289, DOI 10.1016/j.drudis.2012.07.017; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; ROSS J, 1987, GUT, V28, P197, DOI 10.1136/gut.28.Suppl.197; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Sakai R, 2014, TOXICOLOGY, V315, P8, DOI 10.1016/j.tox.2013.10.009; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Shore S, 2003, ALIMENT PHARM THER, V18, P1049, DOI 10.1111/j.1365-2036.2003.01781.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tanimoto K, 2010, NUCL MED COMMUN, V31, P604, DOI 10.1097/MNM.0b013e328339350c; Verovski VN, 1996, BRIT J CANCER, V73, P596, DOI 10.1038/bjc.1996.103; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149896	10.1371/journal.pone.0149896	http://dx.doi.org/10.1371/journal.pone.0149896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910401	Green Submitted, Green Published, gold			2022-12-26	WOS:000371164700052
J	Axenov-Gibanov, DV; Voytsekhovskaya, IV; Tokovenko, BT; Protasov, ES; Gamaiunov, SV; Rebets, YV; Luzhetskyy, AN; Timofeyev, MA				Axenov-Gibanov, Denis V.; Voytsekhovskaya, Irina V.; Tokovenko, Bogdan T.; Protasov, Eugeniy S.; Gamaiunov, Stanislav V.; Rebets, Yuriy V.; Luzhetskyy, Andriy N.; Timofeyev, Maxim A.			Actinobacteria Isolated from an Underground Lake and Moonmilk Speleothem from the Biggest Conglomeratic Karstic Cave in Siberia as Sources of Novel Biologically Active Compounds	PLOS ONE			English	Article							NATURAL-PRODUCTS; SP NOV.; DIVERSITY; ALTAMIRA; CHAXAMYCINS; DESERT	Actinobacteria isolated from unstudied ecosystems are one of the most interesting and promising sources of novel biologically active compounds. Cave ecosystems are unusual and rarely studied. Here, we report the isolation and characterization of ten new actinobacteria strains isolated from an ancient underground lake and moonmilk speleothem from the biggest conglomeratic karstic cave in Siberia with a focus on the biological activity of the obtained strains and the metabolite dereplication of one active strain. Streptomyces genera isolates from moonmilk speleothem demonstrated antibacterial and antifungal activities. Some of the strains were able to inhibit the growth of pathogenic Candida albicans.	[Axenov-Gibanov, Denis V.; Voytsekhovskaya, Irina V.; Protasov, Eugeniy S.; Gamaiunov, Stanislav V.; Timofeyev, Maxim A.] Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia; [Tokovenko, Bogdan T.; Rebets, Yuriy V.; Luzhetskyy, Andriy N.] Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany; [Luzhetskyy, Andriy N.] Univ Saarland, Pharmazeut Biotechnol, D-81310 Saarbrucken, Germany	Irkutsk State University; Helmholtz Association; Saarland University	Axenov-Gibanov, DV (corresponding author), Irkutsk State Univ, Inst Biol, Irkutsk 664003, Russia.	Denis.axengri@gmail.com	Axenov-Gribanov, Denis/J-5204-2019; Timofeyev, Maxim/F-2071-2010; Axenov-Gribanov, Denis V./F-7360-2017	Axenov-Gribanov, Denis/0000-0003-2020-6084; Timofeyev, Maxim/0000-0002-5250-6818; Axenov-Gribanov, Denis V./0000-0003-2020-6084; Protasov, Evgenii/0000-0003-1402-0224; Rebets, Yuriy/0000-0001-5071-8430	Ministry of education and science of Russian Federation as a part of Goszadanie projects [6.382.2014/K]; Russian science foundation [N 14-14-00400]; Russian foundation for basic research [N 14-04-00501, 15-54-04062, 16-34-60060, 16-34-00686]; Grants of Irkutsk State University; Deutscher Akademischer Austauschdienst	Ministry of education and science of Russian Federation as a part of Goszadanie projects; Russian science foundation(Russian Science Foundation (RSF)); Russian foundation for basic research(Russian Foundation for Basic Research (RFBR)); Grants of Irkutsk State University; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by the Ministry of education and science of Russian Federation as a part of Goszadanie projects (no. 6.382.2014/K), Russian science foundation (project N 14-14-00400), Russian foundation for basic research (projects N 14-04-00501, 15-54-04062, 16-34-60060, 16-34-00686), Grants of Irkutsk State University for young researchers and Deutscher Akademischer Austauschdienst.	Abdelmohsen UR, 2014, NAT PROD REP, V31, P381, DOI 10.1039/c3np70111e; Alvin A, 2014, MICROBIOL RES, V169, P483, DOI 10.1016/j.micres.2013.12.009; [Anonymous], 2000, PRACTICAL STREPTOMYC; Barton H.A., 2007, MICROBE, V2, P132; Barton HA, 2005, J CAVE KARST STUD, V67, P28; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Barton HA, 2007, J CAVE KARST STUD, V69, P163; Busarakam K, 2014, ANTON LEEUW INT J G, V105, P849, DOI 10.1007/s10482-014-0139-y; Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3; Culver David C., 2000, Journal of Caves and Karst Studies, V62, P11; Engel AS, 2001, GEOMICROBIOL J, V18, P259, DOI 10.1080/01490450152467787; Gonzalez JM, 2006, NATURWISSENSCHAFTEN, V93, P42, DOI 10.1007/s00114-005-0060-3; Grady F, 2005, VERTEBRATE PALEONTOL; Groth I, 1999, J MICROBIOL METH, V36, P115, DOI 10.1016/S0167-7012(99)00016-0; Groth I, 1999, INT J SYST BACTERIOL, V49, P1733, DOI 10.1099/00207713-49-4-1733; Holsinger JR, 2000, ECOSYSTEMS WORLD; Hopwood DA, 2007, MOL MICROBIOL, V63, P937, DOI 10.1111/j.1365-2958.2006.05584.x; Jurado V, 2005, INT J SYST EVOL MICR, V55, P1897, DOI 10.1099/ijs.0.63637-0; Katoh S, 2007, MOL BIOL EVOL, V30, P772; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khizhnyak SV, 2003, RUSS J ECOL+, V34, P231, DOI 10.1023/A:1024537513439; Klimchouk A.B., 2007, HYPOGENE SPELEOGENES; Laiz L, 1999, J MICROBIOL METH, V36, P129, DOI 10.1016/S0167-7012(99)00018-4; Maciejewska M, 2015, ANTON LEEUW INT J G, V107, P519, DOI 10.1007/s10482-014-0348-4; MAZINA SE, 2010, CAVES, V33, P34; Meisinger DB, 2007, ENVIRON MICROBIOL, V9, P1523, DOI 10.1111/j.1462-2920.2007.01271.x; Micheletti AC, 2011, QUIM NOVA, V34, P1014, DOI 10.1590/S0100-40422011000600019; Monciardini P, 2014, MICROB BIOTECHNOL, V7, P209, DOI 10.1111/1751-7915.12123; Nikapitiya C, 2012, ADV FOOD NUTR RES, V65, P363, DOI 10.1016/B978-0-12-416003-3.00024-X; Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750; Okoro CK, 2009, ANTON LEEUW INT J G, V95, P121, DOI 10.1007/s10482-008-9295-2; Patel K, 2010, EXTRACTION METABOLIT; Prajapati AK, 2011, QUIM NOVA, V34, P771, DOI 10.1590/S0100-40422011000500008; Rateb ME, 2011, J NAT PROD, V74, P1491, DOI 10.1021/np200320u; Rebets Y, 2015, ANGEW CHEM INT EDIT, V54, P2280, DOI 10.1002/anie.201408901; Reinbacher W.R., 1994, NSS B, V56, P1; Reitner J., 2011, ENCY GEOBIOLOGY; Ruangpan L., 2004, LAB MANUAL STANDARDI; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STROHL WR, 1997, BIOTECHNOLOGY ANTIBI; Tomoda H, 2001, SCREENING INHIBITORS; Whittle M, 2003, J CHEM INF COMP SCI, V43, P449, DOI 10.1021/ci025591m	42	35	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149216	10.1371/journal.pone.0149216	http://dx.doi.org/10.1371/journal.pone.0149216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901168	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100045
J	da Silva, TA; Mariano, VS; Sardinha-Silva, A; de Souza, MA; Mineo, TWP; Roque-Barreira, MC				da Silva, Thiago Aparecido; Mariano, Vania Sammartino; Sardinha-Silva, Aline; de Souza, Maria Aparecida; Patriarca Mineo, Tiago Wilson; Roque-Barreira, Maria Cristina			IL-17 Induction by ArtinM is Due to Stimulation of IL-23 and IL-1 Release and/or Interaction with CD3 in CD4(+) T Cells	PLOS ONE			English	Article							PARACOCCIDIOIDES-BRASILIENSIS INFECTION; ARTOCARPUS-INTEGRIFOLIA; CANDIDA-ALBICANS; C57BL/6 MICE; BALB/C MICE; KM PLUS; LECTIN; TH17; LINEAGE; BINDING	ArtinM is a D-mannose-binding lectin extracted from the seeds of Artocarpus heterophyllus that interacts with TLR2 N-glycans and activates antigen-presenting cells (APCs), as manifested by IL-12 production. In vivo ArtinM administration induces Th1 immunity and confers protection against infection with several intracellular pathogens. In the murine model of Candida albicans infection, it was verified that, in addition to Th1, ArtinM induces Th17 immunity manifested by high IL-17 levels in the treated animals. Herein, we investigated the mechanisms accounting for the ArtinM-induced IL-17 production. We found that ArtinM stimulates the IL-17 production by spleen cells in BALB/c or C57BL/6 mice, a response that was significantly reduced in the absence of IL-23, MyD88, or IL-1R. Furthermore, we showed that ArtinM directly induced the IL-23 mRNA expression and the IL-1 production by macrophages. Consistently, in cell suspensions depleted of macrophages, the IL-17 production stimulated by ArtinM was reduced by 53% and the exogenous IL-23 acted synergistically with ArtinM in promoting IL-17 production by spleen cell suspensions. We verified that the absence of IL-23, IL-1R, or MyD88 inhibited, but did not block, the IL-17 production by ArtinM-stimulated spleen cells. Therefore, we investigated whether ArtinM exerts a direct effect on CD4(+) T cells in promoting IL-17 production. Indeed, spleen cell suspensions depleted of CD4(+) T cells responded to ArtinM with very low levels of IL-17 release. Likewise, isolated CD4(+) T cells under ArtinM stimulus augmented the expression of TGF-beta mRNA and released high levels of IL-17. Considering the observed synergism between IL-23 and ArtinM, we used cells from IL-23 KO mice to assess the direct effect of lectin on CD4(+) T cells. We verified that ArtinM increased the IL-17 production significantly, a response that was inhibited when the CD4(+) T cells were pre-incubated with anti-CD3 antibody. In conclusion, ArtinM stimulates the production of IL-17 by CD4(+) T cells in two major ways: (I) through the induction of IL-23 and IL-1 by APCs and (II) through the direct interaction with CD3 on the CD4(+) T cells. This study contributes to elucidation of mechanisms accounting for the property of ArtinM in inducing Th17 immunity and opens new perspectives in designing strategies for modulating immunity by using carbohydrate recognition agents.	[da Silva, Thiago Aparecido; Mariano, Vania Sammartino; Sardinha-Silva, Aline; de Souza, Maria Aparecida; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil; [Patriarca Mineo, Tiago Wilson] Univ Fed Uberlandia, Inst Ciencias Biomed, Av Engenheiro Dinz 1178,CP 593, BR-38400 Uberlandia, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049 Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	da Silva, Thiago Aparecido/I-2315-2015; Roque-Barreira, Maria-Cristina/A-4552-2008; Mariano, Vânia Sammartino/AAV-1851-2020; Mariano, Vania/O-1133-2016; Mineo, Tiago W. P./B-4153-2009	da Silva, Thiago Aparecido/0000-0001-5017-6539; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Mariano, Vânia Sammartino/0000-0002-5399-5676; Mineo, Tiago W. P./0000-0002-2339-2743	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2006/60642-2, 2007/558879-7, 2010/51763-6, 2012/12950-0, 2012/09611-0, 2013/04088-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [475357/2013-2]; Financiadora de Estudos e Projetos [0110045900]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto	This research was financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant numbers 2006/60642-2, 2007/558879-7, 2010/51763-6, 2012/12950-0, 2012/09611-0 and 2013/04088-0), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (475357/2013-2), Financiadora de Estudos e Projetos (0110045900), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade deMedicina de Ribeirao Preto.	Cardoso MRD, 2011, VACCINE, V29, P9183, DOI 10.1016/j.vaccine.2011.09.136; Chang J, 2013, P NATL ACAD SCI USA, V110, P2270, DOI 10.1073/pnas.1206048110; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Chien YH, 2006, CELL MOL LIFE SCI, V63, P2089, DOI 10.1007/s00018-006-6020-z; Coltri KC, 2008, AM J PATHOL, V173, P423, DOI 10.2353/ajpath.2008.080126; Coltri KC, 2010, MED MYCOL, V48, P792, DOI 10.3109/13693780903501671; Corfield AP, 2015, TRENDS BIOCHEM SCI, V40, P351, DOI 10.1016/j.tibs.2015.04.004; Custodio LA, 2011, INT IMMUNOPHARMACOL, V11, P1510, DOI 10.1016/j.intimp.2011.05.005; da Silva TA, 2014, CELL TISSUE RES, V357, P719, DOI 10.1007/s00441-014-1879-8; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Ganiko L, 1998, GLYCOCONJUGATE J, V15, P527; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariano VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098512; Mechref Y, 2000, GLYCOBIOLOGY, V10, P231, DOI 10.1093/glycob/10.3.231; Moreno AN, 2003, INT ARCH ALLERGY IMM, V132, P221, DOI 10.1159/000074303; Panunto-Castelo A, 2001, GLYCOBIOLOGY, V11, P1035, DOI 10.1093/glycob/11.12.1035; Pereira-Da-Silva G, 2006, BBA-GEN SUBJECTS, V1760, P86, DOI 10.1016/j.bbagen.2005.09.011; Reynolds JM, 2010, CYTOKINE GROWTH F R, V21, P413, DOI 10.1016/j.cytogfr.2010.10.002; Ruddy MJ, 2004, J BIOL CHEM, V279, P2559, DOI 10.1074/jbc.M308809200; de Oliveira PSS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/263968; SANTOSDEOLIVEIRA R, 1994, J IMMUNOL, V153, P1798; Teixeira CR, 2006, VACCINE, V24, P3001, DOI 10.1016/j.vaccine.2005.11.067; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149721	10.1371/journal.pone.0149721	http://dx.doi.org/10.1371/journal.pone.0149721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901413	Green Published, gold			2022-12-26	WOS:000371276100134
J	de Lima, DS; Ogusku, MM; dos Santos, MP; Silva, CMD; de Almeida, VA; Antunes, IA; Boechat, AL; Ramasawmy, R; Sadahiro, A				de Lima, Dhemerson Souza; Ogusku, Mauricio Morishi; dos Santos, Maisa Porto; de Melo Silva, Claudia Maria; de Almeida, Vanessa Alves; Antunes, Irineide Assumpcao; Boechat, Antonio Luiz; Ramasawmy, Rajendranath; Sadahiro, Aya			Alleles of HLA-DRB1*04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population	PLOS ONE			English	Article							HLA-CLASS-II; HUMAN-LEUKOCYTE ANTIGEN; GENETIC SUSCEPTIBILITY; RHEUMATOID-ARTHRITIS; MOLECULAR ANALYSIS; RISK-FACTOR; POLYMORPHISMS; DISEASE; DRB; FREQUENCIES	Immunogenetic host factors are associated with susceptibility or protection to tuberculosis (TB). Strong associations of HLA class II genes with TB are reported. We analyzed the HLA-DRB1*04 alleles to identify subtypes associated with pulmonary TB and their interaction with risk factors such as alcohol, smoking, and gender in 316 pulmonary TB patients and 306 healthy individuals from the Brazilian Amazon. The HLA-DRB1*04 was prevalent in patients with pulmonary TB (p<0.0001; OR = 2.94; 95% CI = 2.12 to 4.08). Direct nucleotide sequencing of DRB1 exon 2 identified nine subtypes of HLA-DRB1*04. The subtype HLA-DRB1*04: 11: 01 (p = 0.0019; OR = 2.23; 95% CI = 1.34 to 3.70) was associated with susceptibility to pulmonary TB while DRB1*04: 07: 01 (p<0.0001; OR = 0.02; 95% CI = 0.001 to 0.33) to protection. Notably, the interaction between alcohol and HLA-DRB1*04: 11: 01 increased the risk for developing pulmonary TB (p = 0.0001; OR = 51.3; 95% CI = 6.81 to 386). Multibacillary pulmonary TB, the clinical presentation of disease transmission, was strongly associated with interaction to alcohol (p = 0.0026; OR = 11.1; 95% CI = 3.99 to 30.9), HLA-DRB1*04: 11: 01 (p = 0.0442; OR = 2.01; 95% CI = 1.03 to 3.93) and DRB1*04: 92 (p = 0.0112; OR = 8.62; 95% CI = 1.63 to 45.5). These results show that HLA-DRB1*04 are associated with pulmonary TB. Interestingly, three subtypes, DRB1*04: 07: 01, DRB1*04: 11: 01 and DRB1*04: 92 of the HLA-DRB1*04 could be potential immunogenetic markers that may help to explain mechanisms involved in disease development.	[de Lima, Dhemerson Souza; de Almeida, Vanessa Alves; Boechat, Antonio Luiz; Ramasawmy, Rajendranath; Sadahiro, Aya] Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil; [Ogusku, Mauricio Morishi; dos Santos, Maisa Porto] INPA, Lab Micobacteriol, Manaus, Amazonas, Brazil; [de Melo Silva, Claudia Maria] FCF, Programa Posgrad Ciencias Farmaceut, Manaus, Amazonas, Brazil; [Antunes, Irineide Assumpcao] Policlin Cardoso Fontes, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Fundacao Med Trop Doutor Heitor Vieira Dourado FM, Manaus, Amazonas, Brazil; [Ramasawmy, Rajendranath] Univ Nilton Lins, Manaus, Amazonas, Brazil	Universidade Federal de Amazonas; Institute Nacional de Pesquisas da Amazonia; Centro Universitario Nilton Lins	de Lima, DS (corresponding author), Univ Fed Amazonas UFAM, Inst Ciencias Biol, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.	dhemersonsouzalima@gmail.com	souza, Dhemerson/K-2907-2015; Ramasawmy, Rajendranath/V-4926-2019; Boechat, A.L./H-8484-2019	Boechat, A.L./0000-0001-5597-7343; Souza de Lima, Dhemerson/0000-0002-1040-627X; Ogusku, Mauricio Morishi/0000-0003-0173-6266	PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude; FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas [Edital 007/2009, Edital 009/2007]; PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica; MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal [473484/2007-2, MCT/CNPq 15/2007]	PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude; FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas; PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica; MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal	The work was supported by the PPSUS - Programa de Pesquisa para o SUS: Gestao compartilhada em Saude, FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas (Edital 007/2009), PIPT-Programa Integrado de Pesquisa Cientifica e Tecnologica, FAPEAM - Fundacao de Amparo a Pesquisa do Estado do Amazonas (Edital 009/2007) and MCT - Ministerio da Ciencia e Tecnologia/CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Universal, Processo No. 473484/2007-2 (Edital MCT/CNPq 15/2007).	Amirzargar AA, 2004, INT J TUBERC LUNG D, V8, P1017; Bekker LG, 2010, CLIN INFECT DIS, V50, pS208, DOI 10.1086/651493; Bellamy R, 1998, THORAX, V53, P588, DOI 10.1136/thx.53.7.588; Bhargava A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077979; Boechat ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041588; BRASIL, 2014, PESQ NAC SAUD 2013 P; BRASIL, 2015, B EP MIN SAUD, V46; BRASIL, 2008, MAN NAC VIG LAB TUB, V1, P434; Cardoso MS, 1990, J PNEUMOL, V16, P133; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Cois A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-871; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Dobler CC, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000666; Duarte R, 2011, REV PORT PNEUMOL, V17, P15; Dubaniewicz A, 2005, TUBERCULOSIS, V85, P259, DOI 10.1016/j.tube.2004.12.003; El Baghdadi J, 2013, PATHOL BIOL, V61, P11, DOI 10.1016/j.patbio.2013.01.004; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Gambhir HS, 2010, INT HEALTH, V2, P216, DOI 10.1016/j.inhe.2010.07.001; Garcia-Ortiz JE, 2006, TISSUE ANTIGENS, V68, P135, DOI 10.1111/j.1399-0039.2006.00636.x; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Goldfeld AE, 2004, TUBERCULOSIS, V84, P76, DOI 10.1016/j.tube.2003.08.007; Goldhaber-Fiebert JD, 2011, INT J EPIDEMIOL, V40, P417, DOI 10.1093/ije/dyq238; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Guha Pokhraj, 2013, Frontiers in Genetics, V4, P155, DOI 10.3389/fgene.2013.00155; GUSTINCICH S, 1991, BIOTECHNIQUES, V11, P298; IEDB, 2015, IMM EP DAT AN RES; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Jones EY, 2006, NAT REV IMMUNOL, V6, P271, DOI 10.1038/nri1805; Kim HS, 2005, HUM IMMUNOL, V66, P1074, DOI 10.1016/j.humimm.2005.08.242; Kuranov AB, 2014, TISSUE ANTIGENS, V83, P106, DOI 10.1111/tan.12279; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lin L, 2007, BIOCHEM CELL BIOL, V85, P227, DOI 10.1139/O06-204; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lombard Z, 2006, HUM IMMUNOL, V67, P643, DOI 10.1016/j.humimm.2006.04.008; Lu JQ, 2014, GENE, V543, P140, DOI 10.1016/j.gene.2014.03.042; Lucena-Silva N, 2010, J EPIDEMIOL COMMUN H, V64, P513, DOI 10.1136/jech.2008.086801; Ma MJ, 2010, HUM IMMUNOL, V71, P1005, DOI 10.1016/j.humimm.2010.07.009; Magira EE, 2012, HUM IMMUNOL, V73, P641, DOI 10.1016/j.humimm.2012.03.008; Mason CM, 2004, INFECT IMMUN, V72, P2556, DOI 10.1128/IAI.72.5.2556-2563.2004; Mishra G, 2014, INFECT GENET EVOL, V22, P175, DOI 10.1016/j.meegid.2013.08.019; Mourad J, 2013, REV BRAS REUMATOL, V53, P47, DOI 10.1016/S2255-5021(13)70005-1; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Patra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096433; PETZLERLER ML, 1994, HUM IMMUNOL, V41, P180, DOI 10.1016/0198-8859(94)90034-5; Qu HQ, 2011, J HUM GENET, V56, P177, DOI 10.1038/jhg.2010.164; Ravikumar M., 1999, Tubercle and Lung Disease, V79, P309, DOI 10.1054/tuld.1999.0213; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Rojas-Villarraga A, 2010, AUTOIMMUN REV, V9, P666, DOI 10.1016/j.autrev.2010.05.016; Ruggiero G, 2004, IMMUNOLOGY, V111, P318, DOI 10.1111/j.1365-2567.2004.01811.x; Sahiratmadja E, 2007, TUBERCULOSIS, V87, P303, DOI 10.1016/j.tube.2007.02.001; Salem Julia Ignez, 2007, Acta Amaz., V37, P419, DOI 10.1590/S0044-59672007000300013; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011; Shi GL, 2011, GENET MOL RES, V10, P1331, DOI 10.4238/vol10-3gmr1132; Teran-Escandon D, 1999, CHEST, V115, P428, DOI 10.1378/chest.115.2.428; Tong X, 2015, LUNG, V193, P309, DOI 10.1007/s00408-015-9692-z; Tsuneto LT, 2003, TISSUE ANTIGENS, V62, P512, DOI 10.1046/j.1399-0039.2003.00139.x; Vandiedonck Claire, 2009, Briefings in Functional Genomics & Proteomics, V8, P379, DOI 10.1093/bfgp/elp010; Vargas-Alarcon G, 2000, HUM IMMUNOL, V61, P341, DOI 10.1016/S0198-8859(99)00180-9; Wang LX, 2010, VACCINE, V28, P2026, DOI 10.1016/j.vaccine.2009.10.063; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zanelli E, 2000, HUM IMMUNOL, V61, P1254, DOI 10.1016/S0198-8859(00)00185-3; Zhang ZJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-328	67	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0147543	10.1371/journal.pone.0147543	http://dx.doi.org/10.1371/journal.pone.0147543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901036	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100011
J	Shearrer, GE; House, BT; Gallas, MC; Luci, JJ; Davis, JN				Shearrer, Grace E.; House, Benjamin T.; Gallas, Michelle C.; Luci, Jeffrey J.; Davis, Jaimie N.			Fat Imaging via Magnetic Resonance Imaging (MRI) in Young Children (Ages 1-4 Years) without Sedation	PLOS ONE			English	Article							ABDOMINAL FAT; WHITE-MATTER; ADIPOSE-TISSUE; VISCERAL FAT; ADOLESCENTS; RISK; INFANTS; DISEASE	Introduction This pilot study developed techniques to perform Magnetic Resonance Imaging (MRI) of specific fat deposition in 18 children (age 18 months to 4 years). Methods The children engaged in a series of practice tests to become acclimated to the scanner noises, reduce claustrophobia, and rehearse holding still for a set time. The practice tests assessed if the child could remain still for two minutes while watching a video, first while lying on a blanket, second, on the blanket with headphones, and third, in the mock scanner. The children who passed the three practice tests were then scanned with a 3T Siemens Skyra magnet. Abdominal fat distribution (region of interest (ROI) from the top of the ileac crest to the bottom of the ribcage) volume was measured using 2-point DIXON technique. This region was chosen to give an indication of the body composition around the liver. Results Twelve out of eighteen participants successfully completed the actual MRI scan. Chisquared test showed no significant difference between male and female pass-fail rates. The median age of completed scans was 36 months, whereas the median age for children unable to complete a scan was 28 months. The average total trunk fat was 240.9 +/- 85.2mL and the average total VAT was 37.7 +/- 25.9mLand liver fat was not quantifiable due to physiological motion. Several strategies (modeling, videos, and incentives) were identified to improve pediatric imaging in different age ranges. Conclusion Using an age-specific and tailored protocol, we were able to successfully use MRI for fat imaging in a majority of young children. Development of such protocols enables researchers to better understand the etiology of fat deposition in young children, which can be used to aid in the prevention and treatment of adiposity.	[Shearrer, Grace E.; House, Benjamin T.; Davis, Jaimie N.] Univ Texas Austin, Nutr Sci, Austin, TX 78712 USA; [Gallas, Michelle C.] Univ Texas Southwestern, Dept Pediat, Austin, TX USA; [Luci, Jeffrey J.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Austin	Shearrer, GE (corresponding author), Univ Texas Austin, Nutr Sci, Austin, TX 78712 USA.	grace.shearrer@gmail.com	Davis, Jaimie/AAU-7800-2021	Davis, Jaimie/0000-0002-9103-696X	University of Texas	University of Texas	This study was funded through the University of Texas' start up funding for Dr. Davis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2007, NEUROIMAGE, V35, P308, DOI 10.1016/j.neuroimage.2006.08.058; Armpilia CI, 2002, BRIT J RADIOL, V75, P590, DOI 10.1259/bjr.75.895.750590; Brambilla P, 1999, INT J OBESITY, V23, P299, DOI 10.1038/sj.ijo.0800815; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; de Amorim e Silva C J T, 2006, Australas Radiol, V50, P319; Dean DC, 2014, PEDIATR RADIOL, V44, P64, DOI 10.1007/s00247-013-2752-8; Dean DC, 2014, NEUROIMAGE, V84, P742, DOI 10.1016/j.neuroimage.2013.09.058; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Fox KR, 2000, INT J OBESITY, V24, P1653, DOI 10.1038/sj.ijo.0801464; Gastaldelli A, 2008, AM J CLIN NUTR, V87, P1118, DOI 10.1093/ajcn/87.5.1118; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515; Hallowell LM, 2008, PEDIATR RADIOL, V38, P271, DOI 10.1007/s00247-007-0704-x; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Kim SH, 2006, RADIOLOGY, V240, P116, DOI 10.1148/radiol.2393042218; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Owens S, 2000, OBES RES, V8, P287, DOI 10.1038/oby.2000.34; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Serafini G, 2008, CURR OPIN ANESTHESIO, V21, P499, DOI 10.1097/ACO.0b013e328304115b; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Valentiner DP, 1996, COGNITIVE THER RES, V20, P593, DOI 10.1007/BF02227963; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149744	10.1371/journal.pone.0149744	http://dx.doi.org/10.1371/journal.pone.0149744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901881	gold, Green Published			2022-12-26	WOS:000371276100139
J	Sreekanth, GP; Chuncharunee, A; Sirimontaporn, A; Panaampon, J; Noisakran, S; Yenchitsomanus, PT; Limjindaporn, T				Sreekanth, Gopinathan Pillai; Chuncharunee, Aporn; Sirimontaporn, Aunchalee; Panaampon, Jutatip; Noisakran, Sansanee; Yenchitsomanus, Pa-thai; Limjindaporn, Thawornchai			SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation	PLOS ONE			English	Article							GAMMA-GLUTAMYL-TRANSFERASE; PRO-INFLAMMATORY CYTOKINES; PROTEIN-KINASE INHIBITOR; HEMORRHAGIC-FEVER; CELL-DEATH; TNF-ALPHA; INDUCED APOPTOSIS; VASCULAR LEAKAGE; AG129 MICE; HEAT-SHOCK	Dengue virus (DENV) infection causes organ injuries, and the liver is one of the most important sites of DENV infection, where viral replication generates a high viral load. The molecular mechanism of DENV-induced liver injury is still under investigation. The mitogen activated protein kinases (MAPKs), including p38 MAPK, have roles in the hepatic cell apoptosis induced by DENV. However, the in vivo role of p38 MAPK in DENV-induced liver injury is not fully understood. In this study, we investigated the role of SB203580, a p38 MAPK inhibitor, in a mouse model of DENV infection. Both the hematological parameters, leucopenia and thrombocytopenia, were improved by SB203580 treatment and liver transaminases and histopathology were also improved. We used a real-time PCR microarray to profile the expression of apoptosis-related genes. Tumor necrosis factor a, caspase 9, caspase 8, and caspase 3 proteins were significantly lower in the SB203580-treated DENV-infected mice than that in the infected control mice. Increased expressions of cytokines including TNF-alpha, IL-6 and IL-10, and chemokines including RANTES and IP-10 in DENV infection were reduced by SB203580 treatment. DENV infection induced the phosphorylation of p38MAPK, and its downstream signals including MAPKAPK2, HSP27 and ATF-2. SB203580 treatment did not decrease the phosphorylation of p38 MAPK, but it significantly reduced the phosphorylation of MAPKAPK2, HSP27, and ATF2. Therefore, SB203580 modulates the downstream signals to p38 MAPK and reduces DENV-induced liver injury.	[Sreekanth, Gopinathan Pillai; Chuncharunee, Aporn; Sirimontaporn, Aunchalee; Panaampon, Jutatip; Limjindaporn, Thawornchai] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Anat, Bangkok 10700, Thailand; [Noisakran, Sansanee] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Med Biotechnol Unit, Bangkok, Thailand; [Yenchitsomanus, Pa-thai] Mahidol Univ, Fac Med, Siriraj Hosp, Div Mol Med,Dept Res & Dev, Bangkok 10700, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Limjindaporn, T (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Anat, Bangkok 10700, Thailand.	thawornchai.lim@mahidol.ac.th	Noisakran, Sansanee/H-5186-2011; Sreekanth, Gopinathan Pillai/F-3715-2010	Noisakran, Sansanee/0000-0002-9336-3331; Sreekanth, Gopinathan Pillai/0000-0002-0278-8642	Mahidol University, Mahidol University, Thailand [R015810002]	Mahidol University, Mahidol University, Thailand	This study was supported by Mahidol University Grant No. R015810002, Mahidol University, Thailand. TL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebayo D, 2015, LIVER INT, V35, P2564, DOI 10.1111/liv.12850; Alagarasu K, 2013, HUM IMMUNOL, V74, P610, DOI 10.1016/j.humimm.2013.01.027; Albarnaz JD, 2014, ANTIVIR RES, V111, P82, DOI 10.1016/j.antiviral.2014.09.004; Villar LA, 2013, BIOMEDICA, V33, P108, DOI 10.7705/biomedica.v33i0.733; Arias J, 2014, VIROLOGY, V452, P42, DOI 10.1016/j.virol.2013.12.027; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; Barreto D. F., 2004, Journal of Submicroscopic Cytology and Pathology, V36, P121; Barth OM, 2006, MEM I OSWALDO CRUZ, V101, P905, DOI 10.1590/S0074-02762006000800014; Butt N, 2008, JCPSP-J COLL PHYSICI, V18, P282, DOI 05.2008/JCPSP.282285; Cabello-Guterrez C, 2009, THROMB HAEMOSTASIS, V101, P916, DOI 10.1160/TH08-04-0271; Cardier JE, 2005, CYTOKINE, V30, P359, DOI 10.1016/j.cyto.2005.01.021; Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019; Chen HC, 2004, J MED VIROL, V73, P419, DOI 10.1002/jmv.20108; Chongsrisawat V, 2009, SE ASIAN J TROP MED, V40, P47; Chuturgoon AA, 2015, TOXICOL LETT, V235, P67, DOI 10.1016/j.toxlet.2015.03.006; Cross TG, 2000, EXP CELL RES, V256, P34, DOI 10.1006/excr.2000.4836; De Castro RAC, 2007, AM J TROP MED HYG, V76, P737, DOI 10.4269/ajtmh.2007.76.737; de Miranda AS, 2012, BEHAV BRAIN RES, V230, P237, DOI 10.1016/j.bbr.2012.02.020; Franca RFD, 2010, EXP MOL PATHOL, V89, P321, DOI 10.1016/j.yexmp.2010.07.007; Dinh TT, 2010, AM J TROP MED HYG, V83, P774, DOI 10.4269/ajtmh.2010.10-0090; Enslen H, 1998, J BIOL CHEM, V273, P1741, DOI 10.1074/jbc.273.3.1741; Fernandez-Mestre MT, 2004, TISSUE ANTIGENS, V64, P469, DOI 10.1111/j.1399-0039.2004.00304.x; French SW, 2011, EXP MOL PATHOL, V91, P653, DOI 10.1016/j.yexmp.2011.07.004; Fu YL, 2014, ANTIVIR RES, V110, P151, DOI 10.1016/j.antiviral.2014.08.004; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guabiraba R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015680; Gusev NB, 2002, BIOCHEMISTRY-MOSCOW+, V67, P511, DOI 10.1023/A:1015549725819; Halstead SB, 2013, CLIN INFECT DIS, V56, P900, DOI 10.1093/cid/cis1047; Han JH, 1996, J BIOL CHEM, V271, P2886, DOI 10.1074/jbc.271.6.2886; Hashem AM, 2014, J IMMUNOL, V193, P722, DOI 10.4049/jimmunol.1300093; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518; Huerta-Zepeda A, 2008, THROMB HAEMOSTASIS, V99, P936, DOI [10.1160/TH07-08-0483, 10.1160/TH07-08-0438]; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Jirakanjanakit N, 1997, T ROY SOC TROP MED H, V91, P614, DOI 10.1016/S0035-9203(97)90050-X; Johnson JC, 2014, ANTIVIR RES, V107, P102, DOI 10.1016/j.antiviral.2014.04.014; Juffrie M, 2001, AM J TROP MED HYG, V65, P70, DOI 10.4269/ajtmh.2001.65.70; Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673; Kan H, 2004, AM J PHYSIOL-CELL PH, V286, pC1, DOI 10.1152/ajpcell.00059.2003; Kharya G, 2011, PEDIATR HEMAT ONCOL, V28, P727, DOI 10.3109/08880018.2011.609581; Khunchai S, 2015, VIRUS RES, V197, P92, DOI 10.1016/j.virusres.2014.12.007; Kim E, 2014, TRANSPL P, V46, P1180, DOI 10.1016/j.transproceed.2013.11.028; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Kumar PR, 2005, J BIOL CHEM, V280, P8553, DOI 10.1074/jbc.M407863200; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; Lahti A, 2002, EUR J PHARMACOL, V454, P115, DOI 10.1016/S0014-2999(02)02490-1; Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005; Lee YR, 2007, VIRUS RES, V126, P216, DOI 10.1016/j.virusres.2007.03.003; Li R, 2014, J SURG RES, V192, P195, DOI 10.1016/j.jss.2014.05.042; Liao HW, 2010, J MED VIROL, V82, P1392, DOI 10.1002/jmv.21815; Liew KJL, 2006, J VIROL METHODS, V131, P47, DOI 10.1016/j.jviromet.2005.07.003; Lim EJ, 2014, J GEN VIROL, V95, P2204, DOI 10.1099/vir.0.065862-0; Limjindaporn T, 2007, BIOCHEM BIOPH RES CO, V362, P334, DOI 10.1016/j.bbrc.2007.07.194; Limonta D, 2007, J CLIN VIROL, V40, P50, DOI 10.1016/j.jcv.2007.04.024; Limonta D, 2008, DIABETES VASC DIS RE, V5, P213, DOI 10.3132/dvdr.2008.034; Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70; Ling LM, 2007, J CLIN VIROL, V38, P265, DOI 10.1016/j.jcv.2006.12.011; Liu XW, 2014, MOL MED REP, V10, P1942, DOI 10.3892/mmr.2014.2402; Malavige GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050387; Matsuda T, 2005, J GEN VIROL, V86, P1055, DOI 10.1099/vir.0.80531-0; Mohan B, 2000, J TROP PEDIATRICS, V46, P40, DOI 10.1093/tropej/46.1.40; Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012; Morley SJ, 2003, CELL SIGNAL, V15, P741, DOI 10.1016/S0898-6568(03)00008-1; Nagila A, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-105; Nasirudeen AMA, 2008, MICROBES INFECT, V10, P1124, DOI 10.1016/j.micinf.2008.06.005; Nasirudeen AMA, 2009, J MED VIROL, V81, P1069, DOI 10.1002/jmv.21486; Nguyen TL, 1997, RES VIROLOGY, V148, P273, DOI 10.1016/S0923-2516(97)88364-1; Oliveira ERA, 2016, VIROLOGY, V489, P95, DOI 10.1016/j.virol.2015.12.006; Otahal P, 2007, J IMMUNOL, V179, P6686, DOI 10.4049/jimmunol.179.10.6686; Paes MV, 2009, LAB INVEST, V89, P1140, DOI 10.1038/labinvest.2009.83; Paes MV, 2005, VIROLOGY, V338, P236, DOI 10.1016/j.virol.2005.04.042; Pham TB, 2009, J CLIN VIROL, V45, P276, DOI 10.1016/j.jcv.2009.04.004; Pinto LMO, 1999, MEM I OSWALDO CRUZ, V94, P387, DOI 10.1590/S0074-02761999000300019; Povoa TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083386; Qi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132743; Rahaus M, 2004, J GEN VIROL, V85, P3529, DOI 10.1099/vir.0.80347-0; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rajmane Y, 2013, VIRUS RES, V173, P386, DOI 10.1016/j.virusres.2013.01.002; Ramzan Mohammed, 2013, Hematol Oncol Stem Cell Ther, V6, P65, DOI 10.1016/j.hemonc.2013.05.005; Rattanaburee T, 2015, ANTIVIR RES, V124, P83, DOI 10.1016/j.antiviral.2015.10.005; Regan AD, 2009, VIROLOGY, V384, P135, DOI 10.1016/j.virol.2008.11.006; Reimold AM, 2001, INT IMMUNOL, V13, P241, DOI 10.1093/intimm/13.2.241; Robles-Diaz M, 2015, LIVER INT, V35, P2474, DOI 10.1111/liv.12834; ROUSE J, 1994, CELL, V78, P1027, DOI 10.1016/0092-8674(94)90277-1; Sarathy VV, 2015, J VIROL, V89, P1254, DOI 10.1128/JVI.01320-14; Sheng M, 2015, TRANSPL P, V47, P275, DOI 10.1016/j.transproceed.2015.01.010; Singh D, 2007, AM J PHYSIOL-LUNG C, V293, pL436, DOI 10.1152/ajplung.00097.2007; Sitati E, 2007, J VIROL, V81, P9801, DOI 10.1128/JVI.00941-07; Souza Luiz José de, 2004, Braz J Infect Dis, V8, P156, DOI 10.1590/S1413-86702004000200006; Sreekanth GP, 2014, VIRUS RES, V188, P15, DOI 10.1016/j.virusres.2014.03.025; Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13; Srikiatkhachorn A, 2014, CELL TISSUE RES, V355, P621, DOI 10.1007/s00441-014-1841-9; Stein B, 1996, J BIOL CHEM, V271, P11427, DOI 10.1074/jbc.271.19.11427; Stirling DP, 2008, NEUROSCIENCE, V155, P128, DOI 10.1016/j.neuroscience.2008.05.007; Suksanpaisan L, 2007, J MED VIROL, V79, P300, DOI 10.1002/jmv.20798; Sun PF, 2006, J IMMUNOL, V177, P6497, DOI 10.4049/jimmunol.177.9.6497; Thepparit Chutima, 2013, BMC Res Notes, V6, P372, DOI 10.1186/1756-0500-6-372; Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004; Tian ZQ, 2012, EXP THER MED, V4, P255, DOI 10.3892/etm.2012.575; Torrentes-Carvalho A, 2009, MEM I OSWALDO CRUZ, V104, P1091, DOI 10.1590/S0074-02762009000800005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ochoa MV, 2009, ARCH VIROL, V154, P919, DOI 10.1007/s00705-009-0396-7; Viprakasit V, 2014, ACTA HAEMATOL-BASEL, V131, P88, DOI 10.1159/000353119; Visuthranukul J, 2009, INFECT DIS REP, V1, DOI 10.4081/idr.2009.e3; Wati S, 2011, J GEN VIROL, V92, P807, DOI 10.1099/vir.0.028159-0; Wiwanitkit V, 2004, CLIN APPL THROMB-HEM, V10, P65, DOI 10.1177/107602960401000111; WU A, 1976, AM J GASTROENTEROL, V65, P318; Yu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139015; Zhang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113107; Zickovich JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106060	113	53	59	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149486	10.1371/journal.pone.0149486	http://dx.doi.org/10.1371/journal.pone.0149486			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901653	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100082
J	Fogelmark, K; Peterson, C; Troein, C				Fogelmark, Karl; Peterson, Carsten; Troein, Carl			Selection Shapes Transcriptional Logic and Regulatory Specialization in Genetic Networks	PLOS ONE			English	Article							EVOLUTION; DUPLICATION; EXPRESSION; DESIGN	Background Living organisms need to regulate their gene expression in response to environmental signals and internal cues. This is a computational task where genes act as logic gates that connect to form transcriptional networks, which are shaped at all scales by evolution. Large-scale mutations such as gene duplications and deletions add and remove network components, whereas smaller mutations alter the connections between them. Selection determines what mutations are accepted, but its importance for shaping the resulting networks has been debated. Methodology To investigate the effects of selection in the shaping of transcriptional networks, we derive transcriptional logic from a combinatorially powerful yet tractable model of the binding between DNA and transcription factors. By evolving the resulting networks based on their ability to function as either a simple decision system or a circadian clock, we obtain information on the regulation and logic rules encoded in functional transcriptional networks. Comparisons are made between networks evolved for different functions, as well as with structurally equivalent but non-functional (neutrally evolved) networks, and predictions are validated against the transcriptional network of E. coli. Principal Findings We find that the logic rules governing gene expression depend on the function performed by the network. Unlike the decision systems, the circadian clocks show strong cooperative binding and negative regulation, which achieves tight temporal control of gene expression. Furthermore, we find that transcription factors act preferentially as either activators or repressors, both when binding multiple sites for a single target gene and globally in the transcriptional networks. This separation into positive and negative regulators requires gene duplications, which highlights the interplay between mutation and selection in shaping the transcriptional networks.	[Fogelmark, Karl; Peterson, Carsten; Troein, Carl] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, S-22362 Lund, Sweden	Lund University	Troein, C (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, S-22362 Lund, Sweden.	carl@thep.lu.se			Swedish Research Council [621-2010-5219, 621-2013-4547]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	CT and KF were supported by grant 621-2010-5219 and CP by grant 621-2013-4547 from the Swedish Research Council (http://vr.se/).	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Banzhaf W, 2003, LECT NOTES ARTIF INT, V2801, P217; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Carre I, 2013, SEMIN CELL DEV BIOL, V24, P393, DOI 10.1016/j.semcdb.2013.03.011; De Smet R, 2012, CURR OPIN PLANT BIOL, V15, P168, DOI 10.1016/j.pbi.2012.01.003; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fogelmark K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003705; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kuo PD, 2006, BIOSYSTEMS, V85, P177, DOI 10.1016/j.biosystems.2006.01.004; Layne L, 2012, B MATH BIOL, V74, P422, DOI 10.1007/s11538-011-9692-y; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Pokhilko A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-23; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sorrells TR, 2015, CELL, V161, P714, DOI 10.1016/j.cell.2015.04.014; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Troein C, 2009, CURR BIOL, V19, P1961, DOI 10.1016/j.cub.2009.09.024	26	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150340	10.1371/journal.pone.0150340	http://dx.doi.org/10.1371/journal.pone.0150340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927540	gold, Green Published, Green Submitted			2022-12-26	WOS:000371424200037
J	Tosoni, K; Cassidy, D; Kerr, B; Land, SC; Mehta, A				Tosoni, Kendra; Cassidy, Diane; Kerr, Barry; Land, Stephen C.; Mehta, Anil			Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; IN-VITRO; PERSONALIZED THERAPY; CELL MONOLAYERS; LUNG-DISEASE; CULTURES; SODIUM; CFTR	Background Precision medicine aims to combat the variability of the therapeutic response to a given medicine by delivering the right medicine to the right patient. However, the application of precision medicine is predicated on a prior quantitation of the variance of the reference range of normality. Airway pathophysiology provides a good example due to a very variable first line of defence against airborne assault. Humans differ in their susceptibility to inhaled pollutants and pathogens in part due to the magnitude of trans-epithelial resistance that determines the degree of epithelial penetration to the submucosal space. This initial 'set-point' may drive a sentinel event in airway disease pathogenesis. Epithelia differentiated in vitro from airway biopsies are commonly used to model trans-epithelial resistance but the 'reference range of normality' remains problematic. We investigated the range of electrophysiological characteristics of human airway epithelia grown at air-liquid interface in vitro from healthy volunteers focusing on the inter-and intra-subject variability both at baseline and after sequential exposure to drugs modulating ion transport. Methodology/Principal Findings Brushed nasal airway epithelial cells were differentiated at air-liquid interface generating 137 pseudostratified ciliated epithelia from 18 donors. A positively-skewed baseline range exists for trans-epithelial resistance (Min/Max: 309/2963 Omega. cm(2)), trans-epithelial voltage (-62.3/-1.8 mV) and calculated equivalent current (-125.0/-3.2 mu A/cm(2); all non-normal, P< 0.001). A minority of healthy humans manifest a dramatic amiloride sensitivity to voltage and trans-epithelial resistance that is further discriminated by prior modulation of cAMP-stimulated chloride transport. Conclusions/Significance Healthy epithelia show log-order differences in their ion transport characteristics, likely reflective of their initial set-points of basal trans-epithelial resistance and sodium transport. Our data may guide the choice of the background set point in subjects with airway diseases and frame the reference range for the future delivery of precision airway medicine.	[Tosoni, Kendra; Cassidy, Diane; Land, Stephen C.; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland; [Kerr, Barry] Univ Dundee, Sch Med, Dundee, Scotland	University of Dundee; University of Dundee	Tosoni, K; Mehta, A (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.	k.tosoni@dundee.ac.uk; a.mehta@dundee.ac.uk			Myrovlytis Trust [804824]; Russell Trust	Myrovlytis Trust; Russell Trust	This work was funded by the Myrovlytis Trust (#804824) awarded to AM and SCL (www.myrovlytistrust.org) and the early work was funded by the Russell Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesi-Maesano I, 2012, EUR RESPIR J, V40, P12, DOI 10.1183/09031936.00072712; Awatade NT, 2015, EBIOMEDICINE, V2, P147, DOI 10.1016/j.ebiom.2014.12.005; Bachhuber T, 2008, J BIOL CHEM, V283, P13225, DOI 10.1074/jbc.M704532200; Beekman JM, 2014, J CYST FIBROS, V13, P363, DOI 10.1016/j.jcf.2014.05.007; Borthwick LA, 2016, PLOS ONE IN PRESS; Bukowy Z, 2011, J APPL GENET, V52, P39, DOI 10.1007/s13353-010-0005-1; Chen ZX, 2014, AM J PHYSIOL-LUNG C, V307, pL609, DOI 10.1152/ajplung.00126.2014; Chow CY, 2016, NAT REV GENET, V17, P63, DOI 10.1038/nrg.2015.9; Collaco JM, 2010, J PEDIATR-US, V157, P802, DOI 10.1016/j.jpeds.2010.05.018; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Crespin S, 2014, INT J BIOCHEM CELL B, V52, P152, DOI 10.1016/j.biocel.2014.02.010; de Courcey F, 2012, AM J PHYSIOL-CELL PH, V303, pC1173, DOI 10.1152/ajpcell.00384.2011; Deng XF, 2014, J VIROL METHODS, V195, P112, DOI 10.1016/j.jviromet.2013.10.012; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Hilfinger A, 2015, NATURE, V519, P422, DOI 10.1038/nature14210; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Jepsen M, 2000, AM J RHINOL, V14, P405, DOI 10.2500/105065800779954365; Keenan K, 2015, J CYST FIBROS, V14, P310, DOI 10.1016/j.jcf.2014.09.006; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Kunzelmann K, 2013, FEBS J, V280, P4417, DOI 10.1111/febs.12457; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Maiuri L, 2016, CELL DEATH IN PRESS; Mansley MK, 2010, BRIT J PHARMACOL, V161, P571, DOI 10.1111/j.1476-5381.2010.00898.x; Martel G, 2014, INT J BIOCHEM CELL B, V52, P146, DOI 10.1016/j.biocel.2014.02.002; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Molenda N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100621; Mwimbi XKMS, 2003, CELL SIGNAL, V15, P395, DOI 10.1016/S0898-6568(02)00143-2; Mwimbi XKMS, 2000, J AEROSOL MED, V13, P273, DOI 10.1089/jam.2000.13.273; Nasreen N, 2014, AM J PHYSIOL-CELL PH, V306, pC1154, DOI 10.1152/ajpcell.00415.2012; Parker JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061023; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pier GB, 2006, INFECT IMMUN, V74, P7043, DOI 10.1128/IAI.01233-06; Portelli M, 2012, EXPERT REV RESP MED, V6, P223, DOI [10.1586/ERS.12.9, 10.1586/ers.12.9]; Prytherch Z, 2011, MACROMOL BIOSCI, V11, P1467, DOI 10.1002/mabi.201100181; Sartori C, 2004, EUR RESPIR J, V23, P916, DOI 10.1183/09031936.04.00115304; Smith RP, 1996, J PHYSIOL-LONDON, V496, P883, DOI 10.1113/jphysiol.1996.sp021735; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Taouil K, 2003, J BIOL CHEM, V278, P17320, DOI 10.1074/jbc.M212227200; Thavagnanam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085802; Vermeulen F, 2015, J CYST FIBROS, V14, P317, DOI 10.1016/j.jcf.2014.08.006; Weiser N, 2011, CELL PHYSIOL BIOCHEM, V28, P289, DOI 10.1159/000331742; Xu R, 2013, BIOSCIENCE REP, V33, P847, DOI 10.1042/BSR20130087	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149550	10.1371/journal.pone.0149550	http://dx.doi.org/10.1371/journal.pone.0149550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926476	gold, Green Published, Green Submitted			2022-12-26	WOS:000371424200013
J	Gomes, CS; Matozinhos, FP; Mendes, LL; Pessoa, MC; Velasquez-Melendez, G				Gomes, Crizian Saar; Matozinhos, Fernanda Penido; Mendes, Larissa Loures; Pessoa, Milene Cristine; Velasquez-Melendez, Gustavo			Physical and Social Environment Are Associated to Leisure Time Physical Activity in Adults of a Brazilian City: A Cross-Sectional Study	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; BUILT ENVIRONMENT; PERCEIVED ENVIRONMENT; NEIGHBORHOOD ENVIRONMENTS; MULTILEVEL ANALYSIS; CURITIBA; EPIDEMIOLOGY; INDICATORS; TELEPHONE; VALIDITY	The physical activity practice is highlighted as a strategy to health promotion and to avoid chronic diseases. In addition to individual factors, environmental characteristics in which people live, may offer opportunities or barriers in adopting healthy habits and this is related to the physical activity (PA) practice among individuals. The aim of this study is to investigate the associations between neighborhood environment and leisure-time physical activity in adults. This is a cross-sectional study, developed using the database of Surveillance System for Risk and Protective Factors for Chronic Diseases by Telephone Survey (VIGITEL 2008/2010) of Belo Horizonte, Brazil. Individuals with the habit of practicing PA for at least 150 minutes of moderate-intensity PA or at least 75 minutes of vigorous-intensity PA throughout the week in leisure time were classified as active in leisure time. To characterize the built and social environment we used georeferenced data of public and private places for physical activity, population density, residential density, homicide rate and total income of the coverage area of the basic health units. The covered area of the basic health units was used as context unit. For data analysis, we used multilevel logistic regression. The study included 5779 adults, 58.77% female. There was variability of physical activity in leisure time between area covered by the basic health units (Median Odds ratio = 1.30). After adjusting for individual characteristics, the increase of density of private places for physical activity (Odds ratios-OR = 1.31; 95% confidence interval-95% CI: 1.15 to 1.48) and the smaller homicide rate (OR = 0.82; IC95%: 0.70 to 0.96) in the neighborhood increased physical activity in leisure time. The evidence of this study shows that neighborhood environment may influence the physical activity practice in leisure time and should be considered in future interventions and health promotion strategies.	[Gomes, Crizian Saar; Matozinhos, Fernanda Penido; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; [Mendes, Larissa Loures] Univ Fed Minas Gerais, Dept Nutr, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; [Pessoa, Milene Cristine] Univ Fed Ouro Preto, Dept Clin & Social Nutr, R Diogo de Vasconcelos 122, BR-35400000 Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto	Velasquez-Melendez, G (corresponding author), Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.	jguveme@gmail.com	Mendes, Larissa/Q-4817-2017; Mendes, Larissa/AAL-6662-2020; Matozinhos, Fernanda/AAW-5799-2020	Mendes, Larissa/0000-0003-0776-6845; Matozinhos, Fernanda/0000-0003-1368-4248	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CSG and FPM received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). MCP received grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ). GVM is researcher from the Fundacao de Amparo a Pesquisa do estado de Minas Gerais- PPM 00114 -13 (FAPEMIG).	Amesty SC, 2003, J PUBLIC HEALTH POL, V24, P41, DOI 10.2307/3343176; Amorim TC, 2010, J PHYS ACT HEALTH, V7, pS204, DOI 10.1123/jpah.7.s2.s204; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2013, GLOB BURD DIS GEN EV; Arango CM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-122; Bennett GG, 2007, PLOS MED, V4, P1599, DOI 10.1371/journal.pmed.0040306; Bernal Regina, 2009, Rev. Saúde Pública, V43, P421, DOI 10.1590/S0034-89102009005000024; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Corseuil MW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/641010; Del Duca GF, 2013, CAD SAUDE PUBLICA, V29, P2119, DOI 10.1590/0102-311X00130412; Evenson KR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-146; Florindo Alex Antonio, 2013, Rev. bras. cineantropom. desempenho hum., V15, P243, DOI 10.5007/1980-0037.2013v15n2p243; Florindo AA, 2013, J PHYS ACT HEALTH, V10, P563, DOI 10.1123/jpah.10.4.563; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020; Gomes GAO, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-111; Gomez LF, 2010, J PHYS ACT HEALTH, V7, pS196, DOI 10.1123/jpah.7.s2.s196; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Hanibuchi T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-657; Hino AAF, 2011, PREV MED, V52, P419, DOI 10.1016/j.ypmed.2011.03.019; Instituto Brasileiro de Geografia e Estatistica, 2012, CENS 2010; Jesus Gilmar Mercês de, 2012, Rev. Bras. Ciênc. Esporte, V34, P433; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mendes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108136; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Monteiro CA, 2008, REV SAUDE PUBL, V42, P575, DOI 10.1590/S0034-89102008000400002; Moura Erly Catarina, 2008, Rev. bras. epidemiol., V11, P20; Nakamura PM, 2013, REV BRAS ATIV FIS SA, V18, P424; Parra DC, 2011, PREV MED, V52, P234, DOI 10.1016/j.ypmed.2010.12.008; Parra DC, 2010, AM J PUBLIC HEALTH, V100, P1420, DOI 10.2105/AJPH.2009.181230; Rech CR, 2014, PREV MED, V58, P53, DOI 10.1016/j.ypmed.2013.10.023; Rech CR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-72; Reis RS, 2013, AM J PREV MED, V45, P269, DOI 10.1016/j.amepre.2013.04.020; Saelens BE, 2012, MED SCI SPORT EXER, V44, P637, DOI 10.1249/MSS.0b013e318237fe18; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; SALLIS JF, 1990, PUBLIC HEALTH REP, V105, P179; Salvador EP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-67; Salvador Emanuel Péricles, 2009, Rev. Saúde Pública, V43, P972, DOI 10.1590/S0034-89102009005000082; Boclin KDS, 2014, REV SAUDE PUBL, V48, P249, DOI 10.1590/S0034-8910.2014048004935; Van Dyck D, 2013, HEALTH PLACE, V19, P59, DOI 10.1016/j.healthplace.2012.09.017; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wong F, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5276	49	21	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150017	10.1371/journal.pone.0150017	http://dx.doi.org/10.1371/journal.pone.0150017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26915091	gold, Green Published			2022-12-26	WOS:000371175700046
J	Overdyk, FJ; Dowling, O; Marino, J; Qiu, JJ; Chien, HL; Erslon, M; Morrison, N; Harrison, B; Dahan, A; Gan, TJ				Overdyk, Frank J.; Dowling, Oonagh; Marino, Joseph; Qiu, Jiejing; Chien, Hung-Lun; Erslon, Mary; Morrison, Neil; Harrison, Brooke; Dahan, Albert; Gan, Tong J.			Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database	PLOS ONE			English	Article							CARDIAC-ARREST; ADVERSE EVENTS; RESUSCITATION; SURVIVAL; SYSTEM; TRENDS; IMPACT; GUIDELINES; HYPOXEMIA; MORTALITY	Background While opioid use confers a known risk for respiratory depression, the incremental risk of in-hospital cardiopulmonary arrest, respiratory arrest, or cardiopulmonary resuscitation (CPRA) has not been studied. Our aim was to investigate the prevalence, outcomes, and risk profile of in-hospital CPRA for patients receiving opioids and medications with central nervous system sedating side effects (sedatives). Methods A retrospective analysis of adult inpatient discharges from 2008-2012 reported in the Premier Database. Patients were grouped into four mutually exclusive categories: (1) opioids and sedatives, (2) opioids only, (3) sedatives only, and (4) neither opioids nor sedatives. Results Among 21,276,691 inpatient discharges, 53% received opioids with or without sedatives. A total of 96,554 patients suffered CPRA (0.92 per 1000 hospital bed-days). Patients who received opioids and sedatives had an adjusted odds ratio for CPRA of 3.47 (95% CI: 3.40-3.54; p<0.0001) compared with patients not receiving opioids or sedatives. Opioids alone and sedatives alone were associated with a 1.81-fold and a 1.82-fold (p<0.0001 for both) increase in the odds of CPRA, respectively. In opioid patients, locations of CPRA were intensive care (54%), general care floor (25%), and stepdown units (15%). Only 42% of patients survived CPRA and only 22% were discharged home. Opioid patients with CPRA had mean increased hospital lengths of stay of 7.57 days and mean increased total hospital costs of $27,569. Conclusions Opioids and sedatives are independent and additive risk factors for in-hospital CPRA. The impact of opioid sparing analgesia, reduced sedative use, and better monitoring on CPRA incidence deserves further study.	[Overdyk, Frank J.; Marino, Joseph] Hofstra North Shore LIJ Sch Med, Dept Anesthesiol, New Hyde Pk, NY USA; [Overdyk, Frank J.; Marino, Joseph] North Amer Partners Anesthesia, Melville, NY USA; [Dowling, Oonagh] Hofstra North Shore LIJ Sch Med, Dept Med, Hempstead, NY USA; [Qiu, Jiejing; Chien, Hung-Lun] Covidien Healthcare Econ & Outcomes Res, Mansfield, MA USA; [Erslon, Mary] Covidien Resp & Monitoring Solut, Boulder, CO USA; [Morrison, Neil] Harrier Consultancy, Lancaster, England; [Harrison, Brooke] Boulder Med Writing, Boulder, CO USA; [Dahan, Albert] Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Gan, Tong J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	Hofstra University; Northwell Health; Hofstra University; Northwell Health; Covidien; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Overdyk, FJ (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Anesthesiol, New Hyde Pk, NY USA.; Overdyk, FJ (corresponding author), North Amer Partners Anesthesia, Melville, NY USA.	overdykf@icloud.com	Dahan, Albert/B-8845-2008	Dahan, Albert/0000-0003-3161-3945	Covidien Healthcare Economics and Outcome Research; Covidien; Boulder Medical Writing	Covidien Healthcare Economics and Outcome Research; Covidien; Boulder Medical Writing	This analysis was supported by Covidien Healthcare Economics and Outcome Research. JQ, HLC, and ME are Covidien employees. The funder, Covidien, provided support in the form of salaries for authors JQ, HLC, and ME, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. FJO and JM are employed by North American Partners in Anesthesia. NM is employed by Harrier Consultancy. BH is employed by Boulder Medical Writing. North American Partners in Anesthesia, Harrier Consultancy, and Boulder Medical Writing provided support in the form of salaries for authors FJO, JM, NM, and BH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAILEY PL, 1990, ANESTHESIOLOGY, V73, P826, DOI 10.1097/00000542-199011000-00005; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Chen J, 2009, RESUSCITATION, V80, P35, DOI 10.1016/j.resuscitation.2008.10.009; Dahan A, 2010, ANESTHESIOLOGY, V112, P226, DOI 10.1097/ALN.0b013e3181c38c25; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Ebell MH, 2013, JAMA INTERN MED, V173, P1872, DOI 10.1001/jamainternmed.2013.10037; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Galhotra S, 2007, QUAL SAF HEALTH CARE, V16, P260, DOI 10.1136/qshc.2007.022210; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Giummarra MJ, 2014, PAIN MED; Herzig SJ, 2014, J HOSP MED, V9, P73, DOI 10.1002/jhm.2102; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Howington JA, 2012, CHEST, V141, P429, DOI 10.1378/chest.10-3013; Jarzyna D, 2011, PAIN MANAG NURS, V12, P118, DOI 10.1016/j.pmn.2011.06.008; Kelly JP, 2008, PAIN, V138, P507, DOI 10.1016/j.pain.2008.01.027; KOHN LT, 1999, TO ERR IS HUMAN BUIL; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; Lee LA, 2015, ANESTHESIOLOGY, V122, P659, DOI 10.1097/ALN.0000000000000564; Lindenauer PK, 2014, JAMA INTERN MED, V174, P1982, DOI 10.1001/jamainternmed.2014.5430; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Morrison LJ, 2013, CIRCULATION, V127, P1538, DOI 10.1161/CIR.0b013e31828b2770; Oderda GM, 2007, ANN PHARMACOTHER, V41, P400, DOI 10.1345/aph.1H386; Oderda Gary M, 2013, J Pain Palliat Care Pharmacother, V27, P62, DOI 10.3109/15360288.2012.751956; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Reed K, 2011, HEALTHGRADES PATIENT; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Sun Z, 2015, ANESTH ANALG, V121, P709, DOI 10.1213/ANE.0000000000000836; Taenzer AH, 2010, ANESTHESIOLOGY, V112, P282, DOI 10.1097/ALN.0b013e3181ca7a9b; The Joint Commission, 2012, SENTINEL EVENT ALERT; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25	37	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150214	10.1371/journal.pone.0150214	http://dx.doi.org/10.1371/journal.pone.0150214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913753	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700061
J	Sholzberg, M; Gomes, T; Juurlink, DN; Yao, Z; Mamdani, MM; Laupacis, A				Sholzberg, Michelle; Gomes, Tara; Juurlink, David N.; Yao, Zhan; Mamdani, Muhammad M.; Laupacis, Andreas			The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation	PLOS ONE			English	Article							COST-EFFECTIVENESS; STROKE PREVENTION; WARFARIN; DABIGATRAN; CANADA; IMPACT; DRUGS; CARE; PHARMACARE; PHYSICIANS	Importance Without third-party insurance, access to marketed drugs is limited to those who can afford to pay. We examined this phenomenon in the context of anticoagulation for patients with nonvalvular atrial fibrillation (NVAF). Objective To determine whether, among older Ontarians receiving anticoagulation for NVAF, patients of higher socioeconomic status (SES) were more likely to switch from warfarin to dabigatran prior to its addition to the provincial formulary. Design, Setting and Participants Population-based retrospective cohort study of Ontarians aged 66 years and older, between 2008 and 2012. Exposure Socioeconomic status, as approximated by median neighborhood income. Main Outcomes and Measure We identified two groups of older adults with nonvalvular atrial fibrillation: those who appeared to switch from warfarin to dabigatran after its market approval but prior to its inclusion on the provincial formulary ("switchers"), and those with ongoing warfarin use during the same interval ("non-switchers"). Results We studied 34,797 patients, including 3183 "switchers" and 31,614 "non-switchers". We found that higher SES was associated with switching to dabigatran prior to its coverage on the provincial formulary (p<0.0001). In multivariable analysis, subjects in the highest quintile were 50% more likely to switch to dabigatran than those in the lowest income quintile (11.3% vs. 7.3%; adjusted odds ratio 1.50; 95% CI 1.32 to 1.68). Following dabigatran's addition to the formulary, the income gradient disappeared. Conclusions and Relevance We documented socioeconomic inequality in access to dabigatran among patients receiving warfarin for NVAF. This disparity was eliminated following the drug's addition to the provincial formulary, highlighting the importance of timely reimbursement decisions.	[Sholzberg, Michelle; Laupacis, Andreas] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Sholzberg, Michelle; Juurlink, David N.; Laupacis, Andreas] Univ Toronto, Fac Med, Toronto, ON, Canada; [Sholzberg, Michelle] St Michaels Hosp, Dept Lab Med & Pathobiol, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Mamdani, Muhammad M.; Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Juurlink, David N.; Yao, Zhan; Mamdani, Muhammad M.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Gomes, Tara; Juurlink, David N.; Mamdani, Muhammad M.; Laupacis, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Clin Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sholzberg, M (corresponding author), St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.; Sholzberg, M (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Sholzberg, M (corresponding author), St Michaels Hosp, Dept Lab Med & Pathobiol, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sholzbergm@smh.ca		Sholzberg, Michelle/0000-0003-1220-0301; Gomes, Tara/0000-0002-1468-1965	Ontario Drug Policy Research Network (ODPRN) - Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canada Research Chair; Boehringer-Ingelheim	Ontario Drug Policy Research Network (ODPRN) - Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Boehringer-Ingelheim(Boehringer Ingelheim)	This study was supported by the Ontario Drug Policy Research Network (ODPRN) which is funded by grants from the Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Dr. Laupacis is partially funded through a Canada Research Chair. Dr. Sholzberg has previously taken part in a paid advisory board for Boehringer-Ingelheim. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	AbuDagga A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-310; Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; Antoniou Tony, 2012, Open Med, V6, pe146; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Choudhry NK, 2006, AM J MED, V119, P607, DOI 10.1016/j.amjmed.2005.09.052; Davidson T, 2013, EUR HEART J, V34, P177, DOI 10.1093/eurheartj/ehs157; Daw JR, 2012, HEALTH POLICY, V104, P19, DOI 10.1016/j.healthpol.2011.08.015; Dunlop S, 2000, SOC SCI MED, V51, P123, DOI 10.1016/S0277-9536(99)00424-4; Evans William K, 2002, Chronic Dis Can, V23, P152; Ezekowitz MD, 2011, J INTERV CARD ELECTR, V32, P173, DOI 10.1007/s10840-011-9593-x; Fletcher RH, 2012, CLIN EPIDEMIOLOGY ES, P187; Florentinus SR, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-6; Fugh-Berman A, 2007, PLOS MED, V4, P621, DOI 10.1371/journal.pmed.0040150; Gage BF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6980; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Gonzalez-Juanatey JR, 2012, REV ESP CARDIOL, V65, P901, DOI [10.1016/j.recesp.2012.06.006, 10.1016/j.rec.2012.06.003]; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Huskamp HA, 2005, ARCH GEN PSYCHIAT, V62, P435, DOI 10.1001/archpsyc.62.4.435; Garjon FJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-56; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Krieger C, 2015, ANN CARDIOLOGIE ANGE; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Laupacis A, 2006, PHARMACOECONOMICS, V24, P1157, DOI 10.2165/00019053-200624110-00011; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Morgan SG, 2003, HEALTH AFFAIR, V22, P49, DOI 10.1377/hlthaff.22.3.49; Naylor CD, 1999, HEALTH AFFAIR, V18, P9, DOI 10.1377/hlthaff.18.3.9; Pink J, 2011, BMJ-BRIT MED J, P343; Pletscher M, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13732; Rawson NSB, 2002, PHARMACOEPIDEM DR S, V11, P335, DOI 10.1002/pds.740; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Shapiro S, 2008, J FAM PLAN REPROD H, V34, P83, DOI 10.1783/147118908783972113; Steinberg BA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000535; Tamblyn R, 2001, Can J Clin Pharmacol, V8 Suppl A, p39A; Wilkins R, 2010, PCCF VERSION 5F USER; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741	39	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149142	10.1371/journal.pone.0149142	http://dx.doi.org/10.1371/journal.pone.0149142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26914450	Green Submitted, gold, Green Published			2022-12-26	WOS:000371175700013
J	MacKellar, DA; Williams, D; Storer, N; Okello, V; Azih, C; Drummond, J; Nuwagaba-Biribonwoha, H; Preko, P; Morgan, RL; Dlamini, M; Byrd, J; Agolory, S; Baughman, AL; McNairy, ML; Sahabo, R; Ehrenkranz, P				MacKellar, Duncan A.; Williams, Daniel; Storer, Nosipho; Okello, Velephi; Azih, Charles; Drummond, Jennifer; Nuwagaba-Biribonwoha, Harriet; Preko, Peter; Morgan, Rebecca L.; Dlamini, Makhosazana; Byrd, Johnita; Agolory, Simon; Baughman, Andrew L.; McNairy, Margaret L.; Sahabo, Ruben; Ehrenkranz, Peter			Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage Procedures	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RETENTION; INITIATION; INFECTION; PERCEPTIONS; ADHERENCE; COMMUNITY; BARRIERS	To improve early enrollment in HIV care, the Swaziland Ministry of Health implemented new linkage procedures for persons HIV diagnosed during the Soka Uncobe male circumcision campaign (SOKA, 2011-2012) and the Swaziland HIV Incidence Measurement Survey (SHIMS, 2011). Abstraction of clinical records and telephone interviews of a retrospective cohort of HIV-diagnosed SOKA and SHIMS clients were conducted in 2013-2014 to evaluate compliance with new linkage procedures and enrollment in HIV care at 92 facilities throughout Swaziland. Of 1,105 clients evaluated, within 3, 12, and 24 months of diagnosis, an estimated 14.0%, 24.3%, and 37.0% enrolled in HIV care, respectively, after adjusting for lost to follow-up and non-response. Kaplan-Meier functions indicated lower enrollment probability among clients 14-24 (P = 0.0001) and 25-29 (P = 0.001) years of age compared with clients > 35 years of age. At 69 facilities to which clients were referred for HIV care, compliance with new linkage procedures was low: referral forms were located for less than half (46.8%) of the clients, and few (9.6%) were recorded in the appointment register or called either before (0.3%) or after (4.9%) their appointment. Of over one thousand clients newly HIV diagnosed in Swaziland in 2011 and 2012, few received linkage services in accordance with national procedures and most had not enrolled in HIV care two years after their diagnosis. Our findings are a call to action to improve linkage services and early enrollment in HIV care in Swaziland.	[MacKellar, Duncan A.; Williams, Daniel; Drummond, Jennifer; Agolory, Simon; Baughman, Andrew L.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Natl Ctr Global Hlth, Atlanta, GA USA; [Storer, Nosipho; Nuwagaba-Biribonwoha, Harriet; Sahabo, Ruben] Columbia Univ, ICAP, Columbia, Swaziland; [Okello, Velephi; Azih, Charles] Swaziland Minist Hlth, Swaziland Natl AIDS Programme, Mbabane, Swaziland; [Nuwagaba-Biribonwoha, Harriet; McNairy, Margaret L.] Columbia Univ, ICAP, New York, NY USA; [Preko, Peter] Ctr Dis Control & Prevent Country Off, CTS Global assigned, Mbabane, Swaziland; [Morgan, Rebecca L.] McMaster Univ, Hamilton, ON, Canada; [Dlamini, Makhosazana] Populat Serv Int Country Program, Mbabane, Swaziland; [Byrd, Johnita] ICF Int, Atlanta, GA USA; [Byrd, Johnita] Bill & Melinda Gates Fdn, Seattle, WA USA	Centers for Disease Control & Prevention - USA; Columbia University; McMaster University; Bill & Melinda Gates Foundation	MacKellar, DA (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Natl Ctr Global Hlth, Atlanta, GA USA.	dym4@cdc.gov	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Morgan, Rebecca/0000-0002-1012-4897	ICF International; Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention [U2GPS002005]	ICF International; Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	This work was funded through the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (cooperative agreement U2GPS002005). ICF International was contracted by the U.S. Centers for Disease Control and Prevention to provide data-management services only. Author Johnita Byrd is employed by ICF International. ICF International provided support in the form of salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fagan JL, 2012, AIDS CARE, V24, P737, DOI 10.1080/09540121.2011.630360; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; John Snow Inc, 2012, PROC EV SOK UNC SWAZ; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Labhardt ND, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001768; Liau A, 2013, AIDS BEHAV, V17, P1941, DOI 10.1007/s10461-013-0435-y; McNairy ML, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0291-4; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Swaziland National AIDS Programme, 2004, SWAZ NAT ART PROGR E; Swaziland National AIDS Programme, 2010, NAT COMPR HIV PACK C; Swaziland National AIDS Programme, 2012, PAT LINK RET FOLL UP; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; World Health Organization (WHO), 2013, CONSOLIDATED GUIDELI	35	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150086	10.1371/journal.pone.0150086	http://dx.doi.org/10.1371/journal.pone.0150086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910847	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700065
J	Merola, I; Mills, DS				Merola, Isabella; Mills, Daniel S.			Behavioural Signs of Pain in Cats: An Expert Consensus	PLOS ONE			English	Article							POSTOPERATIVE PAIN	Objectives To identify where a consensus can be reached between veterinary experts in feline medicine on the core signs sufficient for pain (sufficient to indicate pain when they occur, but not necessarily present in all painful conditions) and necessary for pain (necessary in the presence of pain, but not always indicative of pain). Methods A modified Delphi technique was used, consisting of four rounds of questions and evaluation using nineteen participants during the period December 2014 and May 2015. Agreement was considered to be established when 80% of the experts concurred with the same opinion. Results Twenty-five signs were considered sufficient to indicate pain, but no single sign was considered necessary for it. Discussion Further studies are needed to evaluate the validity of these 25 behavioural signs if a specific pain assessment tool is to be developed that is capable of assessing pain in cats based on observational methods alone. The signs reported here may nonetheless help both vets and owners form an initial evaluation of the pain status of cats in their care.	[Merola, Isabella; Mills, Daniel S.] Lincoln Univ, Sch Life Sci, Joseph Banks Labs Green Lane, Lincoln LN6 7DL, England	University of Lincoln	Mills, DS (corresponding author), Lincoln Univ, Sch Life Sci, Joseph Banks Labs Green Lane, Lincoln LN6 7DL, England.	dmills@lincoln.ac.uk			Feline Friends Derbyshire	Feline Friends Derbyshire	This work was supported by Feline Friends Derbyshire (http://www.feline-friends.org.uk).	[Anonymous], 2014, J SMALL ANIM PRACT, V55; Benito J, 2013, VET J, V196, P368, DOI 10.1016/j.tvjl.2012.12.015; Brondani JT, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-143; Calvo G, 2014, J SMALL ANIM PRACT, V55, P622, DOI 10.1111/jsap.12280; Cambridge AJ, 2000, J AM VET MED ASSOC, V217, P685, DOI 10.2460/javma.2000.217.685; Cloutier S, 2005, APPL ANIM BEHAV SCI, V92, P325, DOI 10.1016/j.applanim.2004.11.009; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Egger Christine M., 2013, PAIN MANAGEMENT VET; Foster D, PRIV SEC RISK TRUST, P712; Gruen ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131839; Hansen GR, 2005, EMERG MED CLIN N AM, V23, P339, DOI 10.1016/j.emc.2004.12.005; Holden E, 2014, J SMALL ANIM PRACT, V55, P615, DOI 10.1111/jsap.12283; Hsu CC, 2007, PARE, V12, P1; Klinck MP, 2012, CAN VET J, V53, P1181; Kranenburg HC, 2012, VET COMP ORTHOPAED, V25, P217, DOI 10.3415/VCOT-11-06-0092; Lascelles BDX, 1999, VET REC, V145, P601, DOI 10.1136/vr.145.21.601; Merola I, 2015, J FELINE MED SURG, P1; Mills DS., 2010, ENCY APPL ANIMAL BEH, P685; Prunier A, 2013, ANIMAL, V7, P998, DOI 10.1017/S1751731112002406; Robertson SA, 2008, VET CLIN N AM-SMALL, V38, P1267, DOI 10.1016/j.cvsm.2008.06.008; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Steagall PVM, 2007, VET ANAESTH ANALG, V34, P344, DOI 10.1111/j.1467-2995.2006.00331.x; Vaisanen MAM, 2007, JAVMA-J AM VET MED A, V231, P236, DOI 10.2460/javma.231.2.236; Waran N, 2007, ANIM WELFARE, V16, P105; Yousuf M.I., 2007, PRACT ASSESS RES EVA, V12, P8, DOI [10.7275/rrph-t210, DOI 10.7275/RRPH-T210]; Zamprogno H, 2010, AM J VET RES, V71, P1417, DOI 10.2460/ajvr.71.12.1417	26	34	34	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150040	10.1371/journal.pone.0150040	http://dx.doi.org/10.1371/journal.pone.0150040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909809	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000371164700058
J	Amin, MN; Zaheer, S; Alazba, AA; Saleem, MU; Niazi, MUK; Khurram, N; Amin, MT				Amin, Muhammad Nasir; Zaheer, Selman; Alazba, Abdulrahman Ali; Saleem, Muhammad Umair; Niazi, Muhammad Umar Khan; Khurram, Nauman; Amin, Muhammad Tahir			A Component-Based Study of the Effect of Diameter on Bond and Anchorage Characteristics of Blind-Bolted Connections	PLOS ONE			English	Article							BEHAVIOR; JOINTS	Structural hollow sections are gaining worldwide importance due to their structural and architectural advantages over open steel sections. The only obstacle to their use is their connection with other structural members. To overcome the obstacle of tightening the bolt from one side has given birth to the concept of blind bolts. Blind bolts, being the practical solution to the connection hindrance for the use of hollow and concrete filled hollow sections play a vital role. Flowdrill, the Huck High Strength Blind Bolt and the Lindapter Hollobolt are the well-known commercially available blind bolts. Although the development of blind bolts has largely resolved this issue, the use of structural hollow sections remains limited to shear resistance. Therefore, a new modified version of the blind bolt, known as the "Extended Hollo-Bolt" (EHB) due to its enhanced capacity for bonding with concrete, can overcome the issue of low moment resistance capacity associated with blind-bolted connections. The load transfer mechanism of this recently developed blind bolt remains unclear, however. This study uses a parametric approach to characterising the EHB, using diameter as the variable parameter. Stiffness and load-carrying capacity were evaluated at two different bolt sizes. To investigate the load transfer mechanism, a component-based study of the bond and anchorage characteristics was performed by breaking down the EHB into its components. The results of the study provide insight into the load transfer mechanism of the blind bolt in question. The proposed component-based model was validated by a spring model, through which the stiffness of the EHB was compared to that of its components combined. The combined stiffness of the components was found to be roughly equivalent to that of the EHB as a whole, validating the use of this component-based approach.	[Amin, Muhammad Nasir; Saleem, Muhammad Umair; Niazi, Muhammad Umar Khan; Khurram, Nauman] King Faisal Univ, Coll Engn, Dept Civil & Environm Engn, POB 380, Al Hufuf 31982, Al Ahsa, Saudi Arabia; [Zaheer, Selman] Univ Nottingham, Dept Civil Engn, Nottingham NG7 2RD, England; [Alazba, Abdulrahman Ali; Amin, Muhammad Tahir] King Saud Univ, Alamoudi Water Res Chair, POB 2460, Riyadh 11451, Saudi Arabia; [Amin, Muhammad Tahir] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad 22060, Pakistan	King Faisal University; University of Nottingham; King Saud University; COMSATS University Islamabad (CUI)	Amin, MT (corresponding author), King Saud Univ, Alamoudi Water Res Chair, POB 2460, Riyadh 11451, Saudi Arabia.; Amin, MT (corresponding author), COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad 22060, Pakistan.	mtamin@ksu.edu.sa	Amin, Muhammad Nasir/D-2089-2014; Saleem, Muhammad Umair UMR/K-6245-2018; Niazi, M. Umar B./ABA-6117-2021; Amin, Muhammad Tahir/G-1525-2011	Amin, Muhammad Nasir/0000-0001-6524-4389; Saleem, Muhammad Umair UMR/0000-0002-0617-9975; Amin, Muhammad Tahir/0000-0001-8283-9958; Khurram, Nauman/0000-0002-0694-9554	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11-WAT1875-02]	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (11-WAT1875-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataei A, 2015, ENG STRUCT, V99, P616, DOI 10.1016/j.engstruct.2015.05.012; Barnett T., 2000, P CONN STEEL STRUCT, P340; Ellison S., 2004, STRUCT ENG, V82, P16; Lindapter Type HB, 2009, TYP HB HOLL BOLT CAV, P41; MacGregor JG., 1997, REINFORCED CONCRETE; MAYER KH, 1973, WIRE, V23, P1; Mesquita AM, 2008, NORD STEEL CONSTR C, P230; Mirza O, 2011, ENG STRUCT, V33, P647, DOI 10.1016/j.engstruct.2010.11.024; Pitrakkos T, 2011, 6 EUR C STEEL COMP S, P513; Pitrakkos T., 2012, TENSILE STIFFNESS NO; Swanson JA, 2001, J STRUCT ENG-ASCE, V127, P498, DOI 10.1061/(ASCE)0733-9445(2001)127:5(498); Wang JF, 2009, J CONSTR STEEL RES, V65, P925, DOI 10.1016/j.jcsr.2008.10.010; Wang JF, 2013, J CONSTR STEEL RES, V82, P33, DOI 10.1016/j.jcsr.2012.12.002; Wang JF, 2012, J CONSTR STEEL RES, V79, P56, DOI 10.1016/j.jcsr.2012.07.016	14	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149490	10.1371/journal.pone.0149490	http://dx.doi.org/10.1371/journal.pone.0149490			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901866	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100084
J	Gordo-Gilart, R; Andueza, S; Hierro, L; Jara, P; Alvarez, L				Gordo-Gilart, Raquel; Andueza, Sara; Hierro, Loreto; Jara, Paloma; Alvarez, Luis			Functional Rescue of Trafficking-Impaired ABCB4 Mutants by Chemical Chaperones	PLOS ONE			English	Article							INTRAHEPATIC CHOLESTASIS TYPE-2; CANALICULAR TRANSPORT DEFECTS; DISEASE-CAUSING MUTATIONS; ER-ASSOCIATED DEGRADATION; PLASMA-MEMBRANE; 4-PHENYLBUTYRATE THERAPY; SODIUM 4-PHENYLBUTYRATE; MISSENSE MUTATION; FOLDING DEFECTS; P-GLYCOPROTEIN	Multidrug resistance protein 3 (MDR3, ABCB4) is a hepatocellular membrane protein that mediates biliary secretion of phosphatidylcholine. Null mutations in ABCB4 gene give rise to severe early-onset cholestatic liver disease. We have previously shown that the disease-associated mutations p.G68R, p.G228R, p.D459H, and p.A934T resulted in retention of ABCB4 in the endoplasmic reticulum, thus failing to target the plasma membrane. In the present study, we tested the ability of two compounds with chaperone-like activity, 4-phenylbutyrate and curcumin, to rescue these ABCB4 mutants by assessing their effects on subcellular localization, protein maturation, and phospholipid efflux capability. Incubation of transfected cells at a reduced temperature (30 degrees C) or exposure to pharmacological doses of either 4-PBA or curcumin restored cell surface expression of mutants G228R and A934T. The delivery of these mutants to the plasma membrane was accompanied by a switch in the ratio of mature to inmature protein forms, leading to a predominant expression of the mature protein. This effect was due to an improvement in the maturation rate and not to the stabilization of the mature forms. Both mutants were also functionally rescued, displaying bile salt-dependent phospholipid efflux activity after addition of 4-PBA or curcumin. Drug-induced rescue was mutant specific, given neither 4-PBA nor curcumin had an effect on the ABCB4 mutants G68R and A934T. Collectively, these data indicate that the functionality of selected trafficking-defective ABCB4 mutants can be recovered by chemical chaperones through restoration of membrane localization, suggesting a potential treatment for patients carrying such mutations.	[Gordo-Gilart, Raquel; Andueza, Sara; Hierro, Loreto; Jara, Paloma; Alvarez, Luis] La Paz Univ Hosp Hlth Res Inst IdiPAZ, Madrid, Spain; [Hierro, Loreto; Jara, Paloma] La Paz Childrens Univ Hosp, Pediat Liver Serv, Madrid, Spain		Alvarez, L (corresponding author), La Paz Univ Hosp Hlth Res Inst IdiPAZ, Madrid, Spain.	luis.alvarez@salud.madrid.org		Jara Vega, Paloma/0000-0002-4669-7929; Hierro, Loreto/0000-0002-6173-4716	Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER) [FIS PI12/01196]; Fundacion ACS	Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER); Fundacion ACS	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII)-Fondo Europeo de Desarrollo Regional (FEDER) (FIS PI12/01196) and from Fundacion ACS.	Andress EJ, 2014, HEPATOLOGY, V59, P1921, DOI 10.1002/hep.26970; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Cheong N, 2006, J BIOL CHEM, V281, P9791, DOI 10.1074/jbc.M507515200; Davit-Spraul A, 2010, SEMIN LIVER DIS, V30, P134, DOI 10.1055/s-0030-1253223; Degiorgio D, 2014, EUR J HUM GENET, V22, P633, DOI 10.1038/ejhg.2013.214; Delaunay JL, 2016, HEPATOLOGY, V63, P1620, DOI 10.1002/hep.28300; Delaunay JL, 2009, HEPATOLOGY, V49, P1218, DOI 10.1002/hep.22775; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; Frider B, 2015, ANN HEPATOL, V14, P745, DOI 10.1016/S1665-2681(19)30771-9; Gautherot J, 2014, HEPATOLOGY, V60, P610, DOI 10.1002/hep.27170; Gautherot J, 2012, J BIOL CHEM, V287, P5070, DOI 10.1074/jbc.M111.275438; Gondcaille C, 2005, J CELL BIOL, V169, P93, DOI 10.1083/jcb.200501036; Gonzales E, 2015, HEPATOLOGY, V62, P558, DOI 10.1002/hep.27767; Gonzales E, 2012, J HEPATOL, V57, P695, DOI 10.1016/j.jhep.2012.04.017; Gonzales E, 2010, J HEPATOL, V53, P385, DOI 10.1016/j.jhep.2010.03.012; Gordo-Gilart R, 2016, LIVER INT, V36, P258, DOI 10.1111/liv.12910; Gordo-Gilart R, 2015, GUT, V64, P147, DOI 10.1136/gutjnl-2014-306896; Groen A, 2011, GASTROENTEROLOGY, V141, P1927, DOI 10.1053/j.gastro.2011.07.042; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hasegawa Y, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-89; Hayashi H, 2007, HEPATOLOGY, V45, P1506, DOI 10.1002/hep.21630; Hayashi H, 2016, HEPATOL RES, V46, P192, DOI 10.1111/hepr.12561; Iannitti T, 2011, DRUGS R&D, V11, P227, DOI 10.2165/11591280-000000000-00000; Kim TH, 2013, KOREAN J PHYSIOL PHA, V17, P525, DOI 10.4196/kjpp.2013.17.6.525; Kluth M, 2015, J BIOL CHEM, V290, P4896, DOI 10.1074/jbc.M114.588566; Kolb PS, 2015, INT J BIOCHEM CELL B, V61, P45, DOI 10.1016/j.biocel.2015.01.015; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Le Saux O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024738; Marin JJG, 2015, GUT, V64, P6, DOI 10.1136/gutjnl-2014-307014; Naoi S, 2014, J PEDIATR-US, V164, P1219, DOI 10.1016/j.jpeds.2013.12.032; OUDE ERP, 2006, PFLUGERS ARCH, V453, P601; Robben JH, 2006, MOL BIOL CELL, V17, P379, DOI 10.1091/mbc.E05-06-0579; Rubenstein RC, 1997, J CLIN INVEST, V100, P2457, DOI 10.1172/JCI119788; Rudashevskaya Elena L, 2014, Drug Discov Today Technol, V12, pe87, DOI 10.1016/j.ddtec.2014.03.009; RUETZ S, 1994, CELL, V77, P1071, DOI 10.1016/0092-8674(94)90446-4; SMITH AJ, 1994, FEBS LETT, V354, P263, DOI 10.1016/0014-5793(94)01135-4; Sorrenson B, 2013, J LIPID RES, V54, P55, DOI 10.1194/jlr.M027193; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stapelbroek JM, 2010, J HEPATOL, V52, P258, DOI 10.1016/j.jhep.2009.11.012; Thompson RJ, 2015, HEPATOLOGY, V62, P349, DOI 10.1002/hep.27817; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; van der Velden LM, 2010, HEPATOLOGY, V51, P286, DOI 10.1002/hep.23268; vanHelvoort A, 1996, CELL, V87, P507, DOI 10.1016/S0092-8674(00)81370-7; Varela-Nieto I, 1993, HDB ENDOCRINE RES TE, P391; Zhang SQ, 2011, HUM MOL GENET, V20, P3176, DOI 10.1093/hmg/ddr223	47	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150098	10.1371/journal.pone.0150098	http://dx.doi.org/10.1371/journal.pone.0150098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900700	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100206
J	Rogal, SS; Arnold, RM; Chapko, M; Hanusa, BV; Youk, A; Switzer, GE; Sevick, MA; Bayliss, NK; Zook, CL; Chidi, A; Obrosky, DS; Zickmund, SL				Rogal, Shari S.; Arnold, Robert M.; Chapko, Michael; Hanusa, Barbara V.; Youk, Ada; Switzer, Galen E.; Sevick, Mary Ann; Bayliss, Nichole K.; Zook, Carolyn L.; Chidi, Alexis; Obrosky, David S.; Zickmund, Susan L.			The Patient-Provider Relationship Is Associated with Hepatitis C Treatment Eligibility: A Prospective Mixed-Methods Cohort Study	PLOS ONE			English	Article							DRUG-USE DISORDERS; QUALITY-OF-LIFE; ANTIVIRAL THERAPY; US VETERANS; CARE; STIGMATIZATION; ADHERENCE; OUTCOMES; PREFERENCES; MANAGEMENT	Hepatitis C virus (HCV) treatment has the potential to cure the leading cause of cirrhosis and hepatocellular carcinoma. However, only those deemed eligible for treatment have the possibility of this cure. Therefore, understanding the determinants of HCV treatment eligibility is critical. Given that effective communication with and trust in healthcare providers significantly influences treatment eligibility decisions in other diseases, we aimed to understand patient-provider interactions in the HCV treatment eligibility process. This prospective cohort study was conducted in the VA Pittsburgh Healthcare System. Patients were recruited after referral for gastroenterology consultation for HCV treatment with interferon and ribavirin. Consented patients completed semi-structured interviews and validated measures of depression, substance and alcohol use, and HCV knowledge. Two coders analyzed the semi-structured interviews. Factors associated with patient eligibility for interferon-based therapy were assessed using multivariate logistic regression. Of 339 subjects included in this analysis, only 56 (16.5%) were deemed eligible for HCV therapy by gastroenterology (GI) providers. In the multivariate logistic regression, patients who were older (OR = 0.96, 95% CI = 0.92-0.99, p = .049), reported concerns about the GI provider (OR = 0.40, 95% CI = 0.10-0.87, p = 0.02) and had depression symptoms (OR = 0.32, 95% CI = 0.17-0.63, p = 0.001) were less likely to be eligible. Patients described barriers that included feeling stigmatized and poor provider interpersonal or communication skills. In conclusion, we found that patients' perceptions of the relationship with their GI providers were associated with treatment eligibility. Establishing trust and effective communication channels between patients and providers may lower barriers to potential HCV cure.	[Rogal, Shari S.; Hanusa, Barbara V.; Youk, Ada; Switzer, Galen E.; Bayliss, Nichole K.; Obrosky, David S.; Zickmund, Susan L.] Pittsburgh Healthcare Serv, Ctr Hlth Equ Res & Promot, Vet Adm, Pittsburgh, PA USA; [Rogal, Shari S.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA; [Arnold, Robert M.; Switzer, Galen E.; Chidi, Alexis; Obrosky, David S.; Zickmund, Susan L.] Univ Pittsburgh, Div Gen Internal Med, Pittsburgh, PA USA; [Chapko, Michael] Vet Adm Healthcare Serv, Seattle Ctr Innovat Veteran Ctr & Value Driven Ca, Seattle, WA USA; [Youk, Ada] Univ Pittsburgh, Dept Biostat, Pittsburgh, PA 15261 USA; [Sevick, Mary Ann] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Zook, Carolyn L.] Oregon Hlth & Sci Univ, Sch Med, Portland, OR USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; New York University; Oregon Health & Science University	Rogal, SS (corresponding author), Pittsburgh Healthcare Serv, Ctr Hlth Equ Res & Promot, Vet Adm, Pittsburgh, PA USA.; Rogal, SS (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA.	rogalss@upmc.edu	Sevick, Mary/V-6503-2019	Youk, Ada/0000-0001-6912-9759	VA HSR&D Merit Review Award [IIR 05-281]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000145] Funding Source: NIH RePORTER	VA HSR&D Merit Review Award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by VA HSR&D Merit Review Award #IIR 05-281.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Bakken S, 2000, AIDS PATIENT CARE ST, V14, P189, DOI 10.1089/108729100317795; Batki SL, 2011, AM J ADDICTION, V20, P312, DOI 10.1111/j.1521-0391.2011.00139.x; Beach MC, 2006, J GEN INTERN MED, V21, P661, DOI 10.1111/j.1525-1497.2006.00399.x; Beste LA, 2009, ALIMENT PHARM THER, V30, P275, DOI 10.1111/j.1365-2036.2009.04036.x; Bini EJ, 2007, AM J GASTROENTEROL, V102, P2434, DOI 10.1111/j.1572-0241.2007.01418.x; Bini EJ, 2005, AM J GASTROENTEROL, V100, P1772, DOI 10.1111/j.1572-0241.2005.41860.x; Bonner JE, 2012, DIGEST DIS SCI, V57, P1469, DOI 10.1007/s10620-012-2141-4; Butt AA, 2007, GUT, V56, P385, DOI 10.1136/gut.2006.099150; Cartwright Emily J, 2014, BMC Res Notes, V7, P449, DOI 10.1186/1756-0500-7-449; Cawthorne CH, 2002, AM J GASTROENTEROL, V97, P149, DOI 10.1111/j.1572-0241.2002.05439.x; Clark CH, 2002, J ADV NURS, V40, P361, DOI 10.1046/j.1365-2648.2002.02378.x; Conti F, 2014, EXPERT OPIN PHARMACO, V15, P2019, DOI 10.1517/14656566.2014.945422; Dominitz JA S-TK, 2003, IMPACT GROUP ED KNOW; Evren C, 2014, J PSYCHOACTIVE DRUGS, V46, P140, DOI 10.1080/02791072.2014.887162; Fraenkel L, 2010, MED DECIS MAKING, V30, P45, DOI 10.1177/0272989X09341588; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Giannini EG, 2012, LIVER INT, V32, P1113, DOI 10.1111/j.1478-3231.2012.02798.x; Hare CB, 2006, PHARMACOEPIDEM DR S, V15, P71, DOI 10.1002/pds.1146; Hauber AB, 2011, J VIRAL HEPATITIS, V18, P619, DOI 10.1111/j.1365-2893.2010.01343.x; Ho SB, 2008, AM J GASTROENTEROL, V103, P1810, DOI 10.1111/j.1572-0241.2008.01877.x; Kelley JM, 2009, PSYCHOSOM MED, V71, P789, DOI 10.1097/PSY.0b013e3181acee12; Kramer JR, 2011, AM J GASTROENTEROL, V106, P483, DOI 10.1038/ajg.2010.430; Livingston SE, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.18445; Lotrich Francis, 2010, Curr Hepat Rep, V9, P113, DOI 10.1007/s11901-010-0035-5; Maisto SA, 2000, PSYCHOL ASSESSMENT, V12, P186, DOI 10.1037/1040-3590.12.2.186; Markowitz JS, 2005, J VIRAL HEPATITIS, V12, P176, DOI 10.1111/j.1365-2893.2005.00607.x; Miller WaC B. F., 1992, PRIMARY CARE RES MUL; Rifai MA, 2006, PSYCHIAT SERV, V57, P570, DOI 10.1176/appi.ps.57.4.570; Schafer A, 2005, EUR J GASTROEN HEPAT, V17, P1387, DOI 10.1097/00042737-200512000-00019; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Straits-Troster K KD, 2003, HEPATITIS C VIRUS HC; Treloar C, 2013, CLIN INFECT DIS, V57, pS51, DOI 10.1093/cid/cit263; Tsui JI, 2008, DIGEST DIS SCI, V53, P809, DOI 10.1007/s10620-007-9926-x; Ward John W, 2012, Hepatology, V55, P307, DOI 10.1002/hep.24797; Ware JE, 1999, HEPATOLOGY, V30, P550, DOI 10.1002/hep.510300203; Zacks S, 2006, J CLIN GASTROENTEROL, V40, P220, DOI 10.1097/00004836-200603000-00009; Zickmund S, 2004, HEPATOLOGY, V39, P999, DOI 10.1002/hep.20132; Zickmund S, 2003, J GEN INTERN MED, V18, P835, DOI 10.1046/j.1525-1497.2003.20826.x	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148596	10.1371/journal.pone.0148596	http://dx.doi.org/10.1371/journal.pone.0148596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900932	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000371276100021
J	Nguyen, TH; Than, VT; Thanh, HD; Hung, VK; Nguyen, DT; Kim, W				Tinh Huu Nguyen; Van Thai Than; Hien Dang Thanh; Vu-Khac Hung; Duc Tan Nguyen; Kim, Wonyong			Intersubtype Reassortments of H5N1 Highly Pathogenic Avian Influenza Viruses Isolated from Quail	PLOS ONE			English	Article							A H5N1; HONG-KONG; MOLECULAR CHARACTERIZATION; INTERSPECIES TRANSMISSION; UPDATED NOMENCLATURE; MULTIPLE SUBLINEAGES; DOMESTIC POULTRY; SOUTHERN CHINA; EVOLUTION; VIETNAM	H5N1 highly pathogenic avian influenza (HPAI) viruses are considered a threat to national animal industries, causing production losses and high mortality in domestic poultry. In recent years, quail has become a popular terrestrial poultry species raised for production of meat and eggs in Asia. In this study, to better understand the roles of quail in H5N1 viral evolution, two H5N1-positive samples, designated A/quail/Vietnam/CVVI-49/2010 (CVVI-49/2010) and A/quail/Vietnam/CVVI-50/2014 (CVVI-50/2014), were isolated from quail during H5N1 outbreaks in Vietnam, and their whole genome were analyzed. The phylogenetic analysis reveals new evolutionary variation in the worldwide H5N1 viruses. The quail HA genes were clustered into clades 1.1.1 (CVVI-49/2010) and clade 2.3.2.1c (CVVI-50/2014), which may have evolved from viruses circulating from chickens and/or ducks in Cambodia, mainland of China, Taiwan, Indonesia, and South Korea in recent years. Interestingly, the M2 gene of the CVVI-49/2010 strain contained amino acid substitutions at position 26(L-I) and 31(S-N) that are related to amantadine-resistance. In particular, the CVVI-50/2014 strain revealed evidence of multiple intersubtype reassortment events between virus clades 2.3.2.1c, 2.3.2.1b, and 2.3.2.1a. Data from this study supports the possible role of quail as an important intermediate host in avian influenza virus evolution. Therefore, additional surveillance is needed to monitor these HPAI viruses both serologically and virologically in quail.	[Tinh Huu Nguyen; Van Thai Than; Hien Dang Thanh; Kim, Wonyong] Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea; [Tinh Huu Nguyen; Hien Dang Thanh; Vu-Khac Hung; Duc Tan Nguyen] Cent Vietnam Vet Inst, Nha Trang, Vietnam	Chung Ang University; Chung Ang University Hospital	Kim, W (corresponding author), Chung Ang Univ, Coll Med, Dept Microbiol, Seoul 156756, South Korea.	kimwy@cau.ac.kr	Than, Van-Thai/GPX-9664-2022; Than, Van Thai/AAX-2106-2021	Dang Thanh, Hien/0000-0002-1007-4041	National Research Foundation of Korea (NRF); Ministry of Education [2013R1A1A2A10012148]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2013R1A1A2A10012148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2000, VET MICROBIOL, V74, P3, DOI 10.1016/S0378-1135(00)00160-7; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Creanga A, 2013, VIROLOGY, V444, P12, DOI 10.1016/j.virol.2013.06.005; de Jong MD, 2006, J CLIN VIROL, V35, P2, DOI 10.1016/j.jcv.2005.09.002; Dong GY, 2014, VIRUS GENES, V49, P223, DOI 10.1007/s11262-014-1084-6; Felsenstein J., 1993, PHYLIP PHYLOGENETIC; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Hurt Aeron C, 2006, Expert Rev Anti Infect Ther, V4, P795, DOI 10.1586/14787210.4.5.795; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; JUKES T H, 1969, P21; Kim HR, 2012, EMERG INFECT DIS, V18, P480, DOI [10.3201/eid1803.111490, 10.3201/1803.111490]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Le QM, 2005, NATURE, V437, P1108, DOI 10.1038/4371108a; Le TH, 2014, CLIN EXP VACCINE RES, V3, P117, DOI 10.7774/cevr.2014.3.2.117; Leang SK, 2014, INFLUENZA OTHER RESP, V8, P135, DOI 10.1111/irv.12187; Lee EK, 2015, POULTRY SCI, V94, P650, DOI 10.3382/ps/pev036; Lee YJ, 2008, EMERG INFECT DIS, V14, P487, DOI 10.3201/eid1403.070767; Li OTW, 2007, J VIROL METHODS, V142, P218, DOI 10.1016/j.jviromet.2007.01.015; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Long JX, 2008, VIRUS GENES, V36, P471, DOI 10.1007/s11262-007-0187-8; Long NT, 2011, TRANSBOUND EMERG DIS, V58, P537, DOI 10.1111/j.1865-1682.2011.01229.x; Makarova NV, 2003, VIROLOGY, V310, P8, DOI 10.1016/S0042-6822(03)00094-1; Muramoto Y, 2006, J VET MED SCI, V68, P527, DOI 10.1292/jvms.68.527; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; Nguyen TD, 2008, EMERG INFECT DIS, V14, P632, DOI 10.3201/eid1404.071343; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Okamatsu M, 2010, VIRUS GENES, V41, P351, DOI 10.1007/s11262-010-0530-3; Perez DR, 2003, J VIROL, V77, P3148, DOI 10.1128/JVI.77.5.3148-3156.2003; Saito T, 2009, VET MICROBIOL, V133, P65, DOI 10.1016/j.vetmic.2008.06.020; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith GJD, 2006, VIROLOGY, V350, P258, DOI 10.1016/j.virol.2006.03.048; Smith GJD, 2014, INFLUENZA OTHER RESP, V8, P384, DOI 10.1111/irv.12230; Smith GJD, 2012, INFLUENZA OTHER RESP, V6, P1, DOI 10.1111/j.1750-2659.2011.00298.x; Sonnberg S, 2013, VIRUS RES, V178, P63, DOI 10.1016/j.virusres.2013.05.009; Thontiravong A, 2012, J VET SCI, V13, P395, DOI 10.4142/jvs.2012.13.4.395; Thontiravong A, 2012, VET MICROBIOL, V160, P305, DOI 10.1016/j.vetmic.2012.05.043; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Nguyen T, 2012, VIROLOGY, V432, P405, DOI 10.1016/j.virol.2012.06.021; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Uno Y, 2013, J VET MED SCI, V75, P451, DOI 10.1292/jvms.12-0433; Wan HQ, 2006, VIROLOGY, V346, P278, DOI 10.1016/j.virol.2005.10.035; Wan XF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003462; Wang J, 2008, J VIROL, V82, P3405, DOI 10.1128/JVI.02468-07; WEBSTER RG, 1995, AM J RESP CRIT CARE, V152, pS25, DOI 10.1164/ajrccm/152.4_Pt_2.S25; Wei KF, 2013, VET MICROBIOL, V167, P383, DOI 10.1016/j.vetmic.2013.09.030; WHO, RECOMMENDATIONS AND; WHO, 2014, CAND VACC VIR POT TE; WHO, H5N1 AV INFL TIM MAJ; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, AV INFL FACT SHEET; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization (WHO), INFL HUM AN INT; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhou HB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006277; Zhou NN, 1999, J VIROL, V73, P3366, DOI 10.1128/JVI.73.4.3366-3374.1999	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149608	10.1371/journal.pone.0149608	http://dx.doi.org/10.1371/journal.pone.0149608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900963	Green Published, gold			2022-12-26	WOS:000371276100109
J	Ren, C; Zhang, J; Yan, WS; Zhang, YH; Chen, XB				Ren, Cong; Zhang, Jin; Yan, Wensheng; Zhang, Yanhong; Chen, Xinbin			RNA-binding Protein PCBP2 Regulates p73 Expression and p73-dependent Antioxidant Defense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON CHAPERONES PCBP1; P53 FAMILY; IN-VIVO; POLY(C)-BINDING PROTEINS; CELL-PROLIFERATION; TARGET; TAP73; DELTA-NP73; SENESCENCE; STABILITY	TAp73, a member of the p53 family tumor suppressors, plays a critical rule in tumor suppression and neuronal development. However, how p73 activity is controlled at the posttranscriptional level is not well understood. Here, we showed that TAp73 activity is regulated by RNA-binding protein PCBP2. Specifically, we found that knockdown or knock-out of PCBP2 reduces, whereas ectopic expression of PCBP2 increases, TAp73 expression. We also showed that PCBP2 is necessary for p73 mRNA stability via the CU-rich elements in p73 3'-UTR. To uncover the biological relevance of PCBP2-regulated TAp73 expression, we showed that ectopic expression of PCBP2 inhibits, whereas knockdown or knock-out of PCBP2 increases, the production of reactive oxygen species (ROS) in a TAp73-dependent manner. Additionally, we found that glutaminase 2 (GLS2), a modulator of p73-dependent antioxidant defense, is also involved in PCBP2-regulated ROS production. Moreover, we generated PCBP2-deficient mice and primary mouse embryonic fibroblasts (MEFs) and showed that loss of PCBP2 leads to decreased p73 expression and, subsequently, increased ROS production and accelerated cellular senescence. Together, our data suggest that PCBP2 regulates p73 expression via mRNA stability and p73-dependent biological function in ROS production and cellular senescence.	[Zhang, Jin; Chen, Xinbin] Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA; Univ Calif Davis, Comparat Oncol Lab, Sch Vet Med, Davis, CA 95616 USA; [Ren, Cong] Jiangnan Univ, Sch Biotechnol, Wuxi 214122, Jiangsu, Peoples R China	University of California System; University of California Davis; University of California System; University of California Davis; Jiangnan University	Zhang, J; Chen, XB (corresponding author), Univ Calif Davis, Comparat Oncol Lab, Sch Med, Davis, CA 95616 USA.	jinzhang@ucdavis.edu; xbchen@ucdavis.edu			National Institutes of Health [CA081237, CA123227, CA121137]; NATIONAL CANCER INSTITUTE [R01CA121137, R01CA123227, R01CA081237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA081237, CA123227, and CA121137.	Afanas'ev I, 2011, AGING DIS, V2, P219; Agostini M, 2011, P NATL ACAD SCI USA, V108, P21093, DOI 10.1073/pnas.1112061109; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Cho SJ, 2012, J BIOL CHEM, V287, P14535, DOI 10.1074/jbc.M111.326827; Du WJ, 2013, NAT CELL BIOL, V15, P991, DOI 10.1038/ncb2789; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Frey AG, 2014, P NATL ACAD SCI USA, V111, P8031, DOI 10.1073/pnas.1402732111; Ghosh D, 2008, P NATL ACAD SCI USA, V105, P11673, DOI 10.1073/pnas.0803182105; Han W, 2013, J CLIN INVEST, V123, P2103, DOI 10.1172/JCI61820; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Kartasheva NN, 2002, ONCOGENE, V21, P4715, DOI 10.1038/sj.onc.1205584; Killilea DW, 2003, ANTIOXID REDOX SIGN, V5, P507, DOI 10.1089/152308603770310158; Lei Yu, 2013, Methods Mol Biol, V1031, P59, DOI 10.1007/978-1-62703-481-4_7; Leidgens S, 2013, J BIOL CHEM, V288, P17791, DOI 10.1074/jbc.M113.460253; Liu G, 2005, J BIOL CHEM, V280, P20111, DOI 10.1074/jbc.M413889200; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Murray-Zmijewski F, 2006, CELL DEATH DIFFER, V13, P962, DOI 10.1038/sj.cdd.4401914; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Nandal A, 2011, CELL METAB, V14, P647, DOI 10.1016/j.cmet.2011.08.015; Ory B, 2011, J CLIN INVEST, V121, P809, DOI 10.1172/JCI43897; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; Perrotti D, 2002, ONCOGENE, V21, P8577, DOI 10.1038/sj.onc.1206085; Petrenko O, 2003, MOL CELL BIOL, V23, P5540, DOI 10.1128/MCB.23.16.5540-5555.2003; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ren C, 2014, BIOCHEM J, V464, P377, DOI 10.1042/BJ20141164; Rieder E, 2003, J GEN VIROL, V84, P2203, DOI 10.1099/vir.0.19013-0; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Roychoudhury P, 2007, MOL CARCINOGEN, V46, P198, DOI 10.1002/mc.20265; Rufini A, 2012, GENE DEV, V26, P2009, DOI 10.1101/gad.197640.112; Sean P, 2008, VIROLOGY, V378, P243, DOI 10.1016/j.virol.2008.05.007; Sean P, 2009, VIROLOGY, V389, P45, DOI 10.1016/j.virol.2009.03.012; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Tissir F, 2009, P NATL ACAD SCI USA, V106, P16871, DOI 10.1073/pnas.0903191106; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Velletri T, 2015, CELL CYCLE, V14, P1611, DOI 10.1080/15384101.2015.1035968; Waggoner SA, 2009, J BIOL CHEM, V284, P9039, DOI 10.1074/jbc.M806986200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yan WS, 2012, MOL CELL BIOL, V32, P2336, DOI 10.1128/MCB.00215-12; Zhang J, 2013, ONCOTARGET, V4, P1121, DOI 10.18632/oncotarget.1185	41	13	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9629	9637		10.1074/jbc.M115.712125	http://dx.doi.org/10.1074/jbc.M115.712125			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26907686	hybrid, Green Published			2022-12-26	WOS:000375602300021
J	Salim, M; Knowles, TJ; Hart, R; Mohammed, F; Woodward, MJ; Willcox, CR; Overduin, M; Hayday, AC; Willcox, BE				Salim, Mahboob; Knowles, Timothy J.; Hart, Rosie; Mohammed, Fiyaz; Woodward, Martin J.; Willcox, Carrie R.; Overduin, Michael; Hayday, Adrian C.; Willcox, Benjamin E.			Characterization of a Putative Receptor Binding Surface on Skint-1, a Critical Determinant of Dendritic Epidermal T Cell Selection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN RESONANCE ASSIGNMENT; ANTIGEN RECEPTOR; REPERTOIRE; EXPRESSION; NMR; CONSERVATION; SURVEILLANCE; MODULATION; EPITHELIUM; HOMOLOGY	Dendritic epidermal T cells (DETC) form a skin-resident gamma delta T cell population that makes key contributions to cutaneous immune stress surveillance, including non-redundant contributions to protection from cutaneous carcinogens. How DETC become uniquely associated with the epidermis was in large part solved by the identification of Skint-1, the prototypic member of a novel B7-related multigene family. Expressed only by thymic epithelial cells and epidermal keratinocytes, Skint-1 drives specifically the development of DETC progenitors, making it the first clear candidate for a selecting ligand for non-MHC/CD1-restricted T cells. However, the molecular mechanisms underpinning Skint-1 activity are unresolved. Here, we provide evidence that DETC selection requires Skint-1 expression on the surface of thymic epithelial cells, and depends upon specific residues on the CDR3-like loop within the membrane-distal variable domain of Skint-1 (Skint-1 DV). Nuclear magnetic resonance of Skint-1 DV revealed a core tertiary structure conserved across the Skint family, but a highly distinct surface charge distribution, possibly explaining its unique function. Crucially, the CDR3-like loop formed an electrostatically distinct surface, featuring key charged and hydrophobic solvent-exposed residues, at the membrane-distal tip of DV. These results provide the first structural insights into the Skint family, identifying a putative receptor binding surface that directly implicates Skint-1 in receptor-ligand interactions crucial for DETC selection.	[Salim, Mahboob; Mohammed, Fiyaz; Willcox, Carrie R.; Willcox, Benjamin E.] Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England; [Knowles, Timothy J.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Hart, Rosie; Woodward, Martin J.; Hayday, Adrian C.] Lincolns Inn Fields Res Labs, Francis Crick Inst, London WC2A 3LY, England; [Overduin, Michael] Univ Birmingham, Sch Canc Sci, Henry Wellcome Bldg Biomol NMR, Birmingham B15 2TT, W Midlands, England; [Hart, Rosie; Woodward, Martin J.; Hayday, Adrian C.] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Overduin, Michael] Univ Alberta, Fac Med & Dent, Dept Biochem, 356A Med Sci Bldg, Edmonton, AB T6G 2H7, Canada	University of Birmingham; University of Birmingham; Francis Crick Institute; University of Birmingham; University of London; King's College London; University of Alberta	Willcox, BE (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Birmingham B15 2TT, W Midlands, England.	b.willcox@bham.ac.uk	Overduin, Michael/AAG-3632-2020	Overduin, Michael/0000-0002-3114-6585; Knowles, Tim/0000-0002-6632-0985	Wellcome Trust; BBSRC [BB/I013865/1, BB/H024697/1, BB/H019383/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H019383/1, BB/H024697/1, BB/I013865/1] Funding Source: researchfish; Wellcome Trust [106292/Z/14/Z] Funding Source: researchfish; The Francis Crick Institute [10093] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	This work was supported by the Wellcome Trust (to B. E. W.). The authors declare that they have no conflicts of interest with the contents of this article.	ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Boismenu R, 1996, J IMMUNOL, V157, P985; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Chen Y, 2010, PROTEIN CELL, V1, P153, DOI 10.1007/s13238-010-0022-1; Chodaczek G, 2012, NAT IMMUNOL, V13, P272, DOI 10.1038/ni.2240; Clements CS, 2003, P NATL ACAD SCI USA, V100, P11059, DOI 10.1073/pnas.1833158100; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Goddard T. D., 2001, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; HAVRAN WL, 1991, SCIENCE, V252, P1430, DOI 10.1126/science.1828619; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KYES S, 1991, P NATL ACAD SCI USA, V88, P7830, DOI 10.1073/pnas.88.17.7830; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Mallick-Wood CA, 1998, SCIENCE, V279, P1729, DOI 10.1126/science.279.5357.1729; Mohamed RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123258; Moseley HNB, 2004, J BIOMOL NMR, V28, P341, DOI 10.1023/B:JNMR.0000015420.44364.06; O'Callaghan CA, 1999, ANAL BIOCHEM, V266, P9, DOI 10.1006/abio.1998.2930; Palakodeti A, 2012, J BIOL CHEM, V287, P32780, DOI 10.1074/jbc.M112.384354; Roberts NA, 2012, IMMUNITY, V36, P427, DOI 10.1016/j.immuni.2012.01.016; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vavassori S, 2013, NAT IMMUNOL, V14, P908, DOI 10.1038/ni.2665; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394; ZHANG Y, 1995, IMMUNITY, V3, P439, DOI 10.1016/1074-7613(95)90173-6	42	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9310	9321		10.1074/jbc.M116.722066	http://dx.doi.org/10.1074/jbc.M116.722066			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26917727	Green Published, hybrid			2022-12-26	WOS:000374849000039
J	Sorokina, EM; Dodia, C; Zhou, SP; Tao, JQ; Gao, L; Raabe, T; Feinstein, SI; Fisher, AB				Sorokina, Elena M.; Dodia, Chandra; Zhou, Suiping; Tao, Jian-Qin; Gao, Ling; Raabe, Tobias; Feinstein, Sheldon I.; Fisher, Aron B.			Mutation of Serine 32 to Threonine in Peroxiredoxin 6 Preserves Its Structure and Enzymatic Function but Abolishes Its Trafficking to Lamellar Bodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LUNG PHOSPHOLIPID-METABOLISM; MICE OVEREXPRESSING PEROXIREDOXIN-6; 1-CYS PEROXIREDOXIN; GLUTATHIONE-PEROXIDASE; PULMONARY SURFACTANT; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; ANTIOXIDANT ENZYME; PROTEIN-A; RAT LUNG	Peroxiredoxin 6 (Prdx6), a bifunctional protein with phospholipase A(2) (aiPLA(2)) and GSH peroxidase activities, protects lungs from oxidative stress and participates in lung surfactant phospholipid turnover. Prdx6 has been localized to both cytosol and lamellar bodies (LB) in lung epithelium, and its organellar targeting sequence has been identified. We propose that Prdx6 LB targeting facilitates its role in the metabolism of lung surfactant phosphatidylcholine (PC). Ser-32 has been identified as the active site in Prdx6 for aiPLA(2) activity, and this activity was abolished by the mutation of serine 32 to alanine (S32A). However, aiPLA(2) activity was unaffected by mutation of serine 32 in Prdx6 to threonine (S32T). Prdx6 protein expression and aiPLA(2) activity were normal in the whole lung of a "knock-in" mouse model carrying an S32T mutation in the Prdx6 gene but were absent from isolated LB. Analyses by proximity ligation assay in lung sections demonstrated the inability of S32T Prdx6 to bind to the chaperone protein, 14-3-3 epsilon, that is required for LB targeting. The content of total phospholipid, PC, and disaturated PC in lung tissue homogenate, bronchoalveolar lavage fluid, and lung LB was increased significantly in Prdx6-S32T mutant lungs, whereas degradation of internalized [H-3]dipalmitoyl-PC was significantly decreased. Thus, Thr can substitute for Ser for the enzymatic activities of Prdx6 but not for its targeting to LB. These results confirm an important role for LB Prdx6 in the degradation and remodeling of lung surfactant phosphatidylcholine.	[Sorokina, Elena M.; Dodia, Chandra; Zhou, Suiping; Tao, Jian-Qin; Gao, Ling; Feinstein, Sheldon I.; Fisher, Aron B.] Univ Penn, Perelman Sch Med, Dept Physiol, Inst Environm Med, Philadelphia, PA 19104 USA; [Raabe, Tobias] Univ Penn, Perelman Sch Med, Penn Gene Targeting Core & Lab, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Fisher, AB (corresponding author), Univ Penn, Inst Environm Med, 3620 Hamilton Walk,1 John Morgan Bldg, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	Raabe, Tobias D/V-5606-2018		National Institutes of Health [HL102016, HL105509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105509, R01HL102016] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants HL102016 and HL105509. This work was presented in part at the Experimental Biology Annual Meeting in Boston, MA (April 20-24, 2013), San Diego, CA (April 26-30, 2014), and Boston, MA (March 28 to April 1, 2015). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akiba S, 1998, COMP BIOCHEM PHYS B, V120, P393, DOI 10.1016/S0305-0491(98)10046-9; Benipal B, 2015, REDOX BIOL, V4, P321, DOI 10.1016/j.redox.2015.01.011; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Buccoliero R, 2007, J INHERIT METAB DIS, V30, P983, DOI 10.1007/s10545-007-0597-8; Buccoliero R, 2004, J INHERIT METAB DIS, V27, P641, DOI 10.1023/B:BOLI.0000042958.22066.6c; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chen JW, 2000, J BIOL CHEM, V275, P28421, DOI 10.1074/jbc.M005073200; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Feng LJ, 1999, HUM MOL GENET, V8, P323, DOI 10.1093/hmg/8.2.323; Fisher A. B., 1985, HDB EXPT PHARM, P109; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; FISHER AB, 1985, ANNU REV PHYSIOL, V47, P789; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; Fisher AB, 1997, AM J PHYSIOL-LUNG C, V272, pL238, DOI 10.1152/ajplung.1997.272.2.L238; Fisher AB, 1996, J LIPID RES, V37, P1057; Fisher AB, 1999, J BIOL CHEM, V274, P21326, DOI 10.1074/jbc.274.30.21326; FISHER AB, 1991, AM J PHYSIOL, V260, pL226, DOI 10.1152/ajplung.1991.260.4.L226; Fisher AB, 2006, BBA-MOL CELL BIOL L, V1761, P785, DOI 10.1016/j.bbalip.2006.05.009; Fisher AB, 2011, ANTIOXID REDOX SIGN, V15, P831, DOI 10.1089/ars.2010.3412; Fisher AB, 2010, AM J PHYSIOL-LUNG C, V299, pL51, DOI 10.1152/ajplung.00066.2010; Foster KA, 1998, EXP CELL RES, V243, P359, DOI 10.1006/excr.1998.4172; Goerke J, 1998, BBA-MOL BASIS DIS, V1408, P79, DOI 10.1016/S0925-4439(98)00060-X; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Guttentag S. H., 2012, AM J RESP CRIT CARE, V185, pA1984; Kim TS, 1998, AM J PHYSIOL-LUNG C, V274, pL750, DOI 10.1152/ajplung.1998.274.5.L750; Kisselev AF, 2000, J BIOL CHEM, V275, P14831, DOI 10.1074/jbc.275.20.14831; Li H, 2015, FREE RADICAL BIO MED, V87, P356, DOI 10.1016/j.freeradbiomed.2015.06.009; Lien YC, 2012, ANTIOXID REDOX SIGN, V16, P440, DOI 10.1089/ars.2011.3950; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Manevich Y, 2004, P NATL ACAD SCI USA, V101, P3780, DOI 10.1073/pnas.0400181101; Manevich Y, 2002, P NATL ACAD SCI USA, V99, P11599, DOI 10.1073/pnas.182384499; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Marks MS, 2013, CURR OPIN CELL BIOL, V25, P495, DOI 10.1016/j.ceb.2013.04.008; Milovanova T, 2006, AM J PHYSIOL-CELL PH, V290, pC66, DOI 10.1152/ajpcell.00094.2005; Orndorff RL, 2014, AM J PHYSIOL-LUNG C, V306, pL260, DOI 10.1152/ajplung.00278.2013; Ralat LA, 2008, ARCH BIOCHEM BIOPHYS, V474, P109, DOI 10.1016/j.abb.2008.02.043; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Rivera-Santiago RF, 2015, BIOCHEM J, V468, P87, DOI 10.1042/BJ20141463; Schmidt R, 2002, AM J PHYSIOL-LUNG C, V283, pL1079, DOI 10.1152/ajplung.00484.2001; SCHMITZ G, 1991, J LIPID RES, V32, P1539; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Sorokina EM, 2009, AM J PHYSIOL-LUNG C, V297, pL871, DOI 10.1152/ajplung.00052.2009; Tolomeo AM, 2016, J COMP PHYSIOL B, V186, P59, DOI 10.1007/s00360-015-0935-3; Tripp AE, 1998, J AM CHEM SOC, V120, P5137, DOI 10.1021/ja974129t; Tsien RY, 2010, INTEGR BIOL-UK, V2, P77, DOI 10.1039/b926500g; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; Wang Y, 2006, AM J RESP CELL MOL, V34, P481, DOI 10.1165/rcmb.2005-0333OC; Wang Y, 2008, J CELL BIOCHEM, V104, P1274, DOI 10.1002/jcb.21703; Wei ZH, 2001, AM J PHYSIOL-HEART C, V281, pH2226, DOI 10.1152/ajpheart.2001.281.5.H2226; Whitsett JA, 2015, ANNU REV PATHOL-MECH, V10, P371, DOI 10.1146/annurev-pathol-012513-104644; WIDDICOMBE J G, 1987, European Journal of Respiratory Diseases Supplement, V71, P197	54	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9268	9280		10.1074/jbc.M115.698894	http://dx.doi.org/10.1074/jbc.M115.698894			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26921317	Green Published, hybrid			2022-12-26	WOS:000374849000036
J	de Graav, GN; Hesselink, DA; Dieterich, M; Kraaijeveld, R; Weimar, W; Baan, CC				de Graav, Gretchen N.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.			Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells	PLOS ONE			English	Article							ALLOGRAFT SURVIVAL; MEMORY; TACROLIMUS; PHENOTYPE; BLOCKADE	Background The co-stimulatory inhibitor of the CD28-CD80/86-pathway, belatacept, allows calcineurin-inhibitor-free immunosuppression in kidney transplantation. However, aggressive T-cell mediated allogeneic responses have been observed in belatacept-treated patients, which could be explained by effector-memory T-cells that lack membrane expression of CD28, i.e. CD28-negative (CD28(NULL)) T-cells. CD28-positive (CD28(POS)) T-cells that down regulate their surface CD28 after allogeneic stimulation could also pose a threat against the renal graft. The aim of this study was to investigate this potential escape mechanism for CD28(POS) T-cells under belatacept treatment. Materials & Methods PBMCs, isolated T-cell memory subsets and isolated CD28(POS) T-cells were obtained from end-stage renal disease (ESRD) patients and co-cultured with allo-antigen in the presence of belatacept to mimic allogeneic reactions in kidney-transplant patients under belatacept treatment. As a control, IgG was used in the absence of belatacept. Results Despite high in vitro belatacept concentrations, a residual T-cell growth of +/- 30% was observed compared to the IgG control after allogeneic stimulation. Of the alloreactive T-cells, the majority expressed an effector-memory phenotype. This predominance for effector-memory T-cells within the proliferated cells was even larger when a higher dose of belatacept was added. Contrary to isolated naive and central-memory T cells, isolated effector-memory T cells could not be inhibited by belatacept in differentiation or allogeneic IFN gamma production. The proportion of CD28-positive T cells was lower within the proliferated T cell population, but was still substantial. A fair number of the isolated initially CD28(POS) T-cells differentiated into CD28(NULL) T-cells, which made them not targetable by belatacept. These induced CD28(NULL) T-cells were not anergic as they produced high amounts of IFN gamma upon allogeneic stimulation. The majority of the proliferated isolated originally CD28(POS) T-cells, however, still expressed CD28 and also expressed IFN gamma. Conclusion This study provides evidence that, apart from CD28(NULL) T-cells, also CD28(POS), mostly effector-memory T-cells can mediate allogeneic responses despite belatacept treatment.	[de Graav, Gretchen N.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.] Univ Med Ctr, Erasmus MC, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Graav, GN (corresponding author), Univ Med Ctr, Erasmus MC, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands.	g.degraav@erasmusmc.nl		Baan, Carla/0000-0003-2274-2788	Bristol-Myers Squibb; Astellas Pharma; Chiesi Pharmaceuticals	Bristol-Myers Squibb(Bristol-Myers Squibb); Astellas Pharma(Astellas Pharmaceuticals); Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc)	D.A. Hesselink has received grant support from Bristol-Myers Squibb and Astellas Pharma. D.A. Hesselink has received lecture and consulting fees from Astellas Pharma and Chiesi Pharmaceuticals. W. Weimar and C.C. Baan received a research grant from Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Orsogna LJA, 2011, TRANSPLANTATION, V91, P494, DOI 10.1097/TP.0b013e318207944c; de Graav GN, 2016, TRANSPLANTATION, V100, P1111, DOI 10.1097/TP.0000000000001004; de Graav GN, 2015, THER DRUG MONIT, V37, P560, DOI 10.1097/FTD.0000000000000179; Demmers MWHJ, 2014, TRANSPLANTATION, V97, P47, DOI 10.1097/01.TP.0000435697.31148.b2; Espinosa J, 2016, AM J TRANSPLANT, V16, P1102, DOI 10.1111/ajt.13613; Grimbert P, 2011, NEPHROL DIAL TRANSPL, V26, P1087, DOI 10.1093/ndt/gfq453; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shen JS, 2014, CLIN DRUG INVEST, V34, P117, DOI 10.1007/s40261-013-0153-2; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Trzonkowski P, 2006, TRANSPLANTATION, V82, P1342, DOI 10.1097/01.tp.0000239268.64408.84; Vallejo AN, 1998, J BIOL CHEM, V273, P8119, DOI 10.1074/jbc.273.14.8119; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2010, J AM SOC NEPHROL, V21, P1587, DOI 10.1681/ASN.2009111109; Vu MD, 2006, J IMMUNOL, V176, P1394, DOI 10.4049/jimmunol.176.3.1394; Weaver TA, 2009, NAT MED, V15, P746, DOI 10.1038/nm.1993; Xu H, 2014, AM J TRANSPLANT, V14, P319, DOI 10.1111/ajt.12574	24	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148604	10.1371/journal.pone.0148604	http://dx.doi.org/10.1371/journal.pone.0148604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919152	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400007
J	Hettne, KM; Thompson, M; van Haagen, HHHBM; van der Horst, E; Kaliyaperumal, R; Mina, E; Tatum, Z; Laros, JFJ; van Mulligen, EM; Schuemie, M; Aten, E; Li, TS; Bruskiewich, R; Good, BM; Su, AI; Kors, JA; den Dunnen, J; van Ommen, GJB; Roos, M; 't Hoen, PA; Mons, B; Schultes, EA				Hettne, Kristina M.; Thompson, Mark; van Haagen, Herman H. H. B. M.; van der Horst, Eelke; Kaliyaperumal, Rajaram; Mina, Eleni; Tatum, Zuotian; Laros, Jeroen F. J.; van Mulligen, Erik M.; Schuemie, Martijn; Aten, Emmelien; Li, Tong Shu; Bruskiewich, Richard; Good, Benjamin M.; Su, Andrew I.; Kors, Jan A.; den Dunnen, Johan; van Ommen, Gert-Jan B.; Roos, Marco; 't Hoen, Peter A. C.; Mons, Barend; Schultes, Erik A.			The Implicitome: A Resource for Rationalizing Gene-Disease Associations	PLOS ONE			English	Article							CONCEPT PROFILES; BIOMEDICAL TEXT; MICROARRAY DATA; MUTATIONS; PROTEIN; EXPRESSION; KNOWLEDGE; UMLS; RECOGNITION; DICTIONARY	High-throughput experimental methods such as medical sequencing and genome-wide association studies (GWAS) identify increasingly large numbers of potential relations between genetic variants and diseases. Both biological complexity (millions of potential gene-disease associations) and the accelerating rate of data production necessitate computational approaches to prioritize and rationalize potential gene-disease relations. Here, we use concept profile technology to expose from the biomedical literature both explicitly stated gene-disease relations (the explicitome) and a much larger set of implied gene-disease associations (the implicitome). Implicit relations are largely unknown to, or are even unintended by the original authors, but they vastly extend the reach of existing biomedical knowledge for identification and interpretation of gene-disease associations. The implicitome can be used in conjunction with experimental data resources to rationalize both known and novel associations. We demonstrate the usefulness of the implicitome by rationalizing known and novel gene-disease associations, including those from GWAS. To facilitate the re-use of implicit gene-disease associations, we publish our data in compliance with FAIR Data Publishing recommendations [https://www.force11.org/group/fairgroup] using nanopublications. An online tool (http://knowledge.bio) is available to explore established and potential gene-disease associations in the context of other biomedical relations.	[Hettne, Kristina M.; Thompson, Mark; van Haagen, Herman H. H. B. M.; van der Horst, Eelke; Kaliyaperumal, Rajaram; Mina, Eleni; Tatum, Zuotian; Laros, Jeroen F. J.; van Mulligen, Erik M.; Aten, Emmelien; den Dunnen, Johan; van Ommen, Gert-Jan B.; Roos, Marco; 't Hoen, Peter A. C.; Mons, Barend; Schultes, Erik A.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [van Mulligen, Erik M.; Schuemie, Martijn; Kors, Jan A.] Erasmus Univ, Dept Med Informat, Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands; [Mons, Barend] Dutch Techctr Life Sci, Utrecht, Netherlands; [Schultes, Erik A.] Leiden Inst Adv Comp Sci, Leiden, Netherlands; [Li, Tong Shu; Good, Benjamin M.; Su, Andrew I.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Bruskiewich, Richard] STAR Informat Delphinai Corp, Port Moody, BC, Canada	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Scripps Research Institute	Hettne, KM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	k.m.hettne@lumc.nl	Schultes, Erik/B-6035-2012; Hoen, Peter A 't/D-3950-2018; dunnen, johan den/ABH-4228-2020; Hettne, Kristina/J-6252-2014; Mina, Eleni/J-7846-2013	Schultes, Erik/0000-0001-8888-635X; Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; Laros, Jeroen F.J./0000-0002-8715-7371; Mons, Barend/0000-0003-3934-0072; Su, Andrew I./0000-0002-9859-4104; Roos, Marco/0000-0002-8691-772X; Hettne, Kristina/0000-0002-4182-7560; Mina, Eleni/0000-0002-8972-9206; van Mulligen, Erik/0000-0003-1377-9386	Dutch Center of Medical Systems Biology (CMSB); ODEX4all [NWO 650.002.002]; Melton Foundation; John Templeton Foundation; European Commission [305444]; Innovative Medicines Initiative Joint Undertaking [115191]; European Union; National Institutes of Health [U54GM114833, GM089820]; Scripps Institute; Delphinai Corporation; SURF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833, R01GM089820] Funding Source: NIH RePORTER	Dutch Center of Medical Systems Biology (CMSB); ODEX4all; Melton Foundation; John Templeton Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scripps Institute; Delphinai Corporation; SURF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was sponsored by the Dutch Center of Medical Systems Biology (CMSB), ODEX4all (NWO 650.002.002), Melton Foundation, and a grant from the John Templeton Foundation. Funding from the European Commission (FP-7 project RD-Connect, grant agreement No. 305444), and the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115191 (Open PHACTS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and in-kind contribution of EFPIA companies are gratefully acknowledged. This work was also supported by the National Institutes of Health (U54GM114833 and GM089820). Delphinai Corporation has an open ended "payasyougo" subcontract with the Scripps Institute to develop the Knowledge.bio system, which is MIT opensourced, with joint copyright attribution. Scripps Institute has USA NIH approval to fund the collaboration with Delphinai Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was sponsored by the Dutch Center of Medical Systems Biology (CMSB), ODEX4all (NWO 650.002.002), Melton Foundation, and a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. Funding from the European Commission (FP-7 project RD-Connect, grant agreement No. 305444), and the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115191 (Open PHACTS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and in-kind contribution of EFPIA companies are gratefully acknowledged. This work was also supported by the National Institutes of Health (U54GM114833 and GM089820). This work was carried out on the Dutch national e-infrastructure with the support of SURF Foundation. We would like to thank Tobias Messemaker and Yu Sun for their expert advice on the Seckel Syndrome case study, and Jaap van den Herik of the Leiden Center for Data Science for carefully reading the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Ayvaz S, 2015, J BIOMED INFORM, V55, P206, DOI 10.1016/j.jbi.2015.04.006; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bravo A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0472-9; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Coulet Adrien, 2011, J Biomed Semantics, V2 Suppl 2, pS10, DOI 10.1186/2041-1480-2-S2-S10; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Funk C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-59; Ganapathiraju MK, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-11; Good BM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0438-7; Goodman LA, 1979, MEASURES ASS CROSS C, DOI [10.1007/978-1-4612-9995-0, DOI 10.1007/978-1-4612-9995-0]; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hettne KM, 2014, F1000RESEARCH, V3, DOI 10.12688/f1000research.4830; Hettne KM, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-2; Hettne KM, 2010, J BIOMED SEMANT, V1, DOI 10.1186/2041-1480-1-5; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Hussain MS, 2013, CLIN GENET, V83, P446, DOI 10.1111/j.1399-0004.2012.01932.x; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Jelier R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-14; Jelier R, 2011, BRIEF BIOINFORM, V12, P518, DOI 10.1093/bib/bbq082; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Machado CM, 2015, BRIEF BIOINFORM, V16, P89, DOI 10.1093/bib/bbt079; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; MCCRAY AT, 1994, J AM MED INFORM ASSN, P235; McInnes BT, 2014, J BIOMED INFORM, V47, P83, DOI 10.1016/j.jbi.2013.09.009; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Schuemie M, 2007, PROTEOMICS, V7, P921, DOI 10.1002/pmic.200600693; Schuemie MJ, 2007, J BIOMED INFORM, V40, P316, DOI 10.1016/j.jbi.2006.09.002; Schuemie MJ, P 2 BIOCREACTIVE CHA, P131; Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113; Swanson D. R., 1991, SIGIR Forum, P280; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; van Haagen HHHBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078665; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016; Yepes AJ, 2015, J BIOMED INFORM, V53, P300, DOI 10.1016/j.jbi.2014.11.015; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	58	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149621	10.1371/journal.pone.0149621	http://dx.doi.org/10.1371/journal.pone.0149621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919047	Green Published, gold			2022-12-26	WOS:000371274400029
J	Mastitskaya, S; Basalay, M; Hosford, PS; Ramage, AG; Gourine, A; Gourine, AV				Mastitskaya, Svetlana; Basalay, Marina; Hosford, Patrick S.; Ramage, Andrew G.; Gourine, Andrey; Gourine, Alexander V.			Identifying the Source of a Humoral Factor of Remote (Pre)Conditioning Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; BYPASS-SURGERY; NERVOUS-SYSTEM; LIMB ISCHEMIA; MECHANISMS; PROTECTION; INFARCTION; HEART; PATHWAYS	Signalling pathways underlying the phenomenon of remote ischaemic preconditioning (RPc) cardioprotection are not completely understood. The existing evidence agrees that intact sensory innervation of the remote tissue/organ is required for the release into the systemic circulation of preconditioning factor(s) capable of protecting a transplanted or isolated heart. However, the source and molecular identities of these factors remain unknown. Since the efficacy of RPc cardioprotection is critically dependent upon vagal activity and muscarinic mechanisms, we hypothesized that the humoral RPc factor is produced by the internal organ(s), which receive rich parasympathetic innervation. In a rat model of myocardial ischaemia/reperfusion injury we determined the efficacy of limb RPc in establishing cardioprotection after denervation of various visceral organs by sectioning celiac, hepatic, anterior and posterior gastric branches of the vagus nerve. Electrical stimulation was applied to individually sectioned branches to determine whether enhanced vagal input to a particular target area is sufficient to establish cardioprotection. It was found that RPc cardioprotection is abolished in conditions of either total subdiaphragmatic vagotomy, gastric vagotomy or sectioning of the posterior gastric branch. The efficacy of RPc cardioprotection was preserved when hepatic, celiac or anterior gastric vagal branches were cut. In the absence of remote ischaemia/reperfusion, electrical stimulation of the posterior gastric branch reduced infarct size, mimicking the effect of RPc. These data suggest that the circulating factor (or factors) of RPc are produced and released into the systemic circulation by the visceral organ(s) innervated by the posterior gastric branch of the vagus nerve.	[Mastitskaya, Svetlana; Basalay, Marina; Hosford, Patrick S.; Ramage, Andrew G.; Gourine, Alexander V.] UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England; [Gourine, Andrey] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	University of London; University College London; Karolinska Institutet; Karolinska University Hospital	Gourine, AV (corresponding author), UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England.; Gourine, A (corresponding author), Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.	agourine@hotmail.com; a.gourine@ucl.ac.uk	Basalay, Maryna/AAQ-8824-2020; Hosford, Patrick/GWQ-4408-2022; Ramage, Andrew G/A-4458-2009; Mastitskaya, Svetlana/ABF-4358-2021	Basalay, Maryna/0000-0001-5608-3878; Mastitskaya, Svetlana/0000-0002-4819-2908; Hosford, Patrick/0000-0002-3252-4832	British Heart Foundation [RG/14/4/30736, PG/13/79/30429]; Wellcome Trust [095064]; Marie Sklodowska-Curie Individual Fellowship [654691]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Sklodowska-Curie Individual Fellowship	Experimental work described in this paper was funded by the British Heart Foundation (project grants RG/14/4/30736 and PG/13/79/30429, https://www.bhf.org.uk/) and The Wellcome Trust (http://www.wellcome.ac.uk/). SM is supported by Marie Sklodowska-Curie Individual Fellowship (ref. 654691, http://ec.europa.eu/). AVG is a Wellcome Trust Senior Research Fellow (ref. 095064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Candilio L, 2015, HEART, V101, P185, DOI 10.1136/heartjnl-2014-306178; Coote JH, 2013, J PHYSIOL-LONDON, V591, P4073, DOI 10.1113/jphysiol.2013.257758; Davidson SM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0377-6; Donato M, 2013, EXP PHYSIOL, V98, P425, DOI 10.1113/expphysiol.2012.066217; Dong Jing-Hui, 2004, Shengli Xuebao, V56, P41; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gourine A, 2010, EUR HEART J, V31, P319; Gourine A, 2014, PHYSIOLOGY, V29, P133, DOI 10.1152/physiol.00037.2013; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Jensen RV, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0285-1; Jones WK, 2009, CIRCULATION, V120, pS1, DOI 10.1161/CIRCULATIONAHA.108.843938; Kingma JG, 2011, CARDIOVASC RES, V89, P384, DOI 10.1093/cvr/cvq306; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Li J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0423-z; Liem DA, 2002, AM J PHYSIOL-HEART C, V283, pH29, DOI 10.1152/ajpheart.01031.2001; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Mastitskaya S, 2013, EUR HEART J, V34, P929; Mastitskaya S, 2012, CARDIOVASC RES, V95, P487, DOI 10.1093/cvr/cvs212; McDougall SJ, 2008, NEUROPHARMACOLOGY, V54, P552, DOI 10.1016/j.neuropharm.2007.11.001; Merlocco AC, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0406-0; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Pauza DH, 2013, AUTON NEUROSCI-BASIC, V176, P32, DOI 10.1016/j.autneu.2013.01.006; Pickard JMJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0453-6; Prasad A, 2013, CATHETER CARDIO INTE, V81, P930, DOI 10.1002/ccd.24443; PRECHTL JC, 1985, J COMP NEUROL, V235, P182, DOI 10.1002/cne.902350204; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Redington KL, 2013, J PHYSIOL SCI, V63, P219, DOI 10.1007/s12576-013-0259-6; Redington KL, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0241-5; Rysevaite K, 2011, HEART RHYTHM, V8, P731, DOI 10.1016/j.hrthm.2011.01.013; Shahid M, 2008, EXP PHYSIOL, V93, P954, DOI 10.1113/expphysiol.2007.041442; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Siddiqi N, 2014, EUR HEART J, V35, P1255, DOI 10.1093/eurheartj/ehu096; Steensrud T, 2010, AM J PHYSIOL-HEART C, V299, pH1598, DOI 10.1152/ajpheart.00396.2010; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Wang X, 2004, ANESTHESIOLOGY, V100, P1198, DOI 10.1097/00000542-200405000-00023; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Yasuhara O, 2007, J HISTOCHEM CYTOCHEM, V55, P287, DOI 10.1369/jhc.6A7092.2006	47	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150108	10.1371/journal.pone.0150108	http://dx.doi.org/10.1371/journal.pone.0150108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918777	gold, Green Submitted, Green Published			2022-12-26	WOS:000371274400088
J	Tanaka, H; Mori, Y; Noro, A; Kogure, A; Kamimura, M; Yamada, N; Hanada, S; Masahashi, N; Itoi, E				Tanaka, Hidetatsu; Mori, Yu; Noro, Atsushi; Kogure, Atsushi; Kamimura, Masayuki; Yamada, Norikazu; Hanada, Shuji; Masahashi, Naoya; Itoi, Eiji			Apatite Formation and Biocompatibility of a Low Young's Modulus Ti-Nb-Sn Alloy Treated with Anodic Oxidation and Hot Water	PLOS ONE			English	Article							BETA TINBSN ALLOYS; MO-ZR-FE; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; HEAT-TREATMENT; FORMING ABILITY; THIN-FILMS; METAL; SURFACE; BEHAVIOR	Ti-6Al-4V alloy is widely prevalent as a material for orthopaedic implants because of its good corrosion resistance and biocompatibility. However, the discrepancy in Young's modulus between metal prosthesis and human cortical bone sometimes induces clinical problems, thigh pain and bone atrophy due to stress shielding. We designed a Ti-Nb-Sn alloy with a low Young's modulus to address problems of stress disproportion. In this study, we assessed effects of anodic oxidation with or without hot water treatment on the bone-bonding characteristics of a Ti-Nb-Sn alloy. We examined surface analyses and apatite formation by SEM micrographs, XPS and XRD analyses. We also evaluated biocompatibility in experimental animal models by measuring failure loads with a pull-out test and by quantitative histomorphometric analyses. By SEM, abundant apatite formation was observed on the surface of Ti-Nb-Sn alloy discs treated with anodic oxidation and hot water after incubation in Hank's solution. A strong peak of apatite formation was detected on the surface using XRD analyses. XPS analysis revealed an increase of the H2O fraction in O 1s XPS. Results of the pull-out test showed that the failure loads of Ti-Nb-Sn alloy rods treated with anodic oxidation and hot water was greater than those of untreated rods. Quantitative histomorphometric analyses indicated that anodic oxidation and hot water treatment induced higher new bone formation around the rods. Our findings indicate that Ti-Nb-Sn alloy treated with anodic oxidation and hot water showed greater capacity for apatite formation, stronger bone bonding and higher biocompatibility for osteosynthesis. Ti-Nb-Sn alloy treated with anodic oxidation and hot water treatment is a promising material for orthopaedic implants enabling higher osteosynthesis and lower stress disproportion.	[Tanaka, Hidetatsu; Mori, Yu; Noro, Atsushi; Kogure, Atsushi; Kamimura, Masayuki; Yamada, Norikazu; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan; [Hanada, Shuji; Masahashi, Naoya] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Mori, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan.	yu-mori@med.tohoku.ac.jp	Hanada, Shuji/AAU-1523-2021; Tanaka, Hidetatsu/ABB-9533-2021; Masahashi, Naoya/A-8131-2011; Mori, Yu/AAX-5874-2021	Hanada, Shuji/0000-0001-6005-0163; Masahashi, Naoya/0000-0001-6373-5926; Tanaka, Hidetatsu/0000-0001-8679-9121; Mori, Yu/0000-0002-8225-4690	Japan Society for the Promotion of Science [15K10428, 15H04138]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (No. 15K10428 to Yu Mori; No. 15H04138 to Naoya Masahashi). URL of Japan Society for the Promotion of Science is as follows: https://www.jsps.go.jp/english./index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1995, BIOCOMPATIBLE TITANI, P1760; Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041; Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012; Cui XY, 2008, J MATER SCI-MATER M, V19, P1767, DOI 10.1007/s10856-007-3314-0; DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; FROST HM, 1958, STAIN TECHNOL, V33, P273, DOI 10.3109/10520295809111862; Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077; Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20; Hanada S, 2003, MATER SCI FORUM, P426; Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051; HEAD WC, 1995, CLIN ORTHOP RELAT R, P85; Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083; Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q; Jung TK, 2010, MATER SCI FORUM, V631-632, P205, DOI 10.4028/www.scientific.net/MSF.631-632.205; Jung TK, 2013, MAT SCI ENG C-MATER, V33, P1629, DOI 10.1016/j.msec.2012.12.072; Jung TK, 2009, MATER SCI FORUM, V620-622, P591, DOI 10.4028/www.scientific.net/MSF.620-622.591; Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009; Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443; King R.C., 1992, PERKIN ELMER CORPORA, V40, P221; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3; LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070; Matsumoto H, 2007, J ALLOY COMPD, V439, P146, DOI 10.1016/j.jallcom.2006.08.267; McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H; Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008; Nag S, 2005, J MATER SCI-MATER M, V16, P679, DOI 10.1007/s10856-005-2540-6; Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540; Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; Nourbash PS, 1998, CLIN ORTHOP RELAT R, P189; Nozoe F, 2007, MATER TRANS, V48, P3007, DOI 10.2320/matertrans.MER2007182; Ozaki T, 2004, MATER TRANS, V45, P2776, DOI 10.2320/matertrans.45.2776; Seo DS, 2001, J CRYST GROWTH, V233, P298, DOI 10.1016/S0022-0248(01)01494-4; Shimizu K, 1999, THIN SOLID FILMS, V351, P220, DOI 10.1016/S0040-6090(99)00084-X; Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978; Uchida M, 2002, J BIOMED MATER RES, V63, P522, DOI 10.1002/jbm.10304; Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x; Xie L, 2011, J BIOMED MATER RES A, V98A, P312, DOI 10.1002/jbm.a.33120; Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4; Yoneyama Y, 2013, DENT MATER J, V32, P115, DOI 10.4012/dmj.2012-087	45	15	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150081	10.1371/journal.pone.0150081	http://dx.doi.org/10.1371/journal.pone.0150081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914329	Green Published, gold			2022-12-26	WOS:000371175700051
J	van Hoek, AJ; Miller, E				van Hoek, Albert Jan; Miller, Elizabeth			Cost-Effectiveness of Vaccinating Immunocompetent >= 65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England	PLOS ONE			English	Article							PNEUMONIA; DISEASE; ADULTS	Background Recently a large clinical trial showed that the use of 13-valent pneumococcal conjugate vaccine (PCV13) among immunocompetent individuals aged 65 years and over was safe and efficacious. The aim of this study was to assess the cost-effectiveness of vaccinating immunocompetent 65 year olds with PCV13 vaccine in England. England is a country with universal childhood pneumococcal conjugate vaccination programme in place (7-valent (PCV7) since 2006 and PCV13 since 2010), as well as a 23-valent pneumococcal polysaccharide (PPV23) vaccination programme targeting clinical risk-groups and those >= 65 years. Method A static cohort cost-effectiveness model was developed to follow a cohort of 65 year olds until death, which will be vaccinated in the autumn of 2016 with PCV13. Sensitivity analysis was performed to test the robustness of the results. Results The childhood vaccination programme with PCV7 has induced herd protection among older unvaccinated age groups, with a resultant low residual disease burden caused by PCV7 vaccine types. We show similar herd protection effects for the 6 additional serotypes included in PCV13, and project a new low post-introduction equilibrium of vaccine-type disease in 2018/19. Applying these incidence projections for both invasive disease and community-acquired pneumonia (CAP), and using recent measures of vaccine efficacy against these endpoints for >= 65 year olds, we estimate that vaccination of a cohort of immunocompetent 65 year olds with PCV13 would directly prevent 26 cases of IPD, 69 cases of CAP and 15 deaths. The associated cost-effectiveness ratio is 257,771 pound per QALY gained (using list price of 49.10 pound per dose and 7.51 pound administration costs) and is therefore considered not cost-effective. To obtain a cost-effective programme the price per dose would need to be negative. The results were sensitive to disease incidence, waning vaccine protection and case fatality rate; despite this, the overall conclusion was robust. Conclusions Vaccinating immunocompetent individuals aged >= 65 years with PCV13 is efficacious. However the absolute incidence of vaccine-type disease will likely become very low due to wider benefits of the childhood PCV13 vaccination programme, such that a specific PCV13 vaccination programme targeting the immunocompetent elderly would not be cost-effective.	[van Hoek, Albert Jan] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England; [van Hoek, Albert Jan; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 5EQ, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	van Hoek, AJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	albert.vanhoek@lshtm.ac.uk			National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England	AJVH was part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; BMJ Publishing Group, 2015, BRIT NATL FORMULARY; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Dirmesropian S, 2015, HUM VACC IMMUNOTHER, V11, P818, DOI 10.1080/21645515.2015.1011954; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gutierrez Rodriguez M A, 2014, Euro Surveill, V19, P20922, DOI 10.2807/1560-7917.ES2014.19.40.20922; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; Office for National Statistics, 2014, MID 2013 POP EST ENG; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Petrou S, 2005, HEALTH ECON, V14, P1169, DOI 10.1002/hec.1006; Public Health England, 2014, PNEUM POL VACC PPV C; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Roysted W, 2016, CLIN RESPIR J, V10, P756, DOI 10.1111/crj.12283; Rozenbaum Mark H, 2012, BMJ, V345, pe6879, DOI 10.1136/bmj.e6879; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63; Torres A, 2015, EUR RESPIR J, V45, P1353, DOI 10.1183/09031936.00152514; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7	23	43	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149540	10.1371/journal.pone.0149540	http://dx.doi.org/10.1371/journal.pone.0149540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914907	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000371175700017
J	Koch, C; Neumann, P; Valerius, O; Feussner, I; Ficner, R				Koch, Christian; Neumann, Piotr; Valerius, Oliver; Feussner, Ivo; Ficner, Ralf			Crystal Structure of Alcohol Oxidase from Pichia pastoris	PLOS ONE			English	Article							FLAVIN ADENINE-DINUCLEOTIDE; HANSENULA-POLYMORPHA; CATALYTIC MECHANISM; ELECTRON-MICROSCOPY; METHANOL OXIDASE; YEAST; REPRESSION; CRYSTALLOGRAPHY; CRYSTALLIZATION; IDENTIFICATION	FAD-dependent alcohol oxidases (AOX) are key enzymes of methylotrophic organisms that can utilize lower primary alcohols as sole source of carbon and energy. Here we report the crystal structure analysis of the methanol oxidase AOX1 from Pichia pastoris. The crystallographic phase problem was solved by means of Molecular Replacement in combination with initial structure rebuilding using Rosetta model completion and relaxation against an averaged electron density map. The subunit arrangement of the homo-octameric AOX1 differs from that of octameric vanillyl alcohol oxidase and other dimeric or tetrameric alcohol oxidases, due to the insertion of two large protruding loop regions and an additional C-terminal extension in AOX1. In comparison to other alcohol oxidases, the active site cavity of AOX1 is significantly reduced in size, which could explain the observed preference for methanol as substrate. All AOX1 subunits of the structure reported here harbor a modified flavin adenine dinucleotide, which contains an arabityl chain instead of a ribityl chain attached to the isoalloxazine ring.	[Koch, Christian; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Valerius, Oliver] Univ Gottingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Koch, Christian; Neumann, Piotr; Valerius, Oliver; Feussner, Ivo; Ficner, Ralf] Univ Gottingen, Goettingen Ctr Mol Biosciences GZMB, Justus von Liebig Weg 11, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Neumann, P (corresponding author), Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.; Neumann, P (corresponding author), Univ Gottingen, Goettingen Ctr Mol Biosciences GZMB, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	pneuman2@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	Open Access Publication Funds of the Goettingen University; DFG [IRTG 1422]; Biomolecules PhD program of the DFG; Kathrin Schroder-Tittmann	Open Access Publication Funds of the Goettingen University; DFG(German Research Foundation (DFG)); Biomolecules PhD program of the DFG; Kathrin Schroder-Tittmann	Synchrotron data collection was supported by the Helmholtz-Zentrum Berlin. The authors acknowledge support by the Open Access Publication Funds of the Goettingen University. The authors are grateful for financial support from the DFG (IRTG 1422) to C.K. and I.F., and C.K. was additionally supported by the Biomolecules PhD program of the DFG-funded Goettingen Graduate School of Neurosciences and Molecular Biology (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Pichia pastoris fermentation was greatly supported by Kathrin Schroder-Tittmann. We thank the Helmholtz Zentrum Berlin (HZB, Germany) for the allocation of synchrotron radiation beamtime.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashin VV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1407; BOYS CWG, 1989, J MOL BIOL, V208, P211, DOI 10.1016/0022-2836(89)90099-5; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BYSTRYKH LV, 1991, J GEN MICROBIOL, V137, P2381, DOI 10.1099/00221287-137-10-2381; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Finnegan S, 2010, ARCH BIOCHEM BIOPHYS, V501, P207, DOI 10.1016/j.abb.2010.06.014; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; GEISSLER J, 1986, EUR J BIOCHEM, V160, P93, DOI 10.1111/j.1432-1033.1986.tb09944.x; Ghanem M, 2006, BIOCHEMISTRY-US, V45, P3437, DOI 10.1021/bi052514m; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIUSEPPIN MLF, 1988, BIOTECHNOL BIOENG, V32, P577, DOI 10.1002/bit.260320502; Gvozdev AR, 2010, BIOCHEMISTRY-MOSCOW+, V75, P242, DOI 10.1134/S000629791002015X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO N, 1976, EUR J BIOCHEM, V64, P341, DOI 10.1111/j.1432-1033.1976.tb10307.x; KELLOGG RM, 1992, TETRAHEDRON, V48, P4147, DOI 10.1016/S0040-4020(01)92193-3; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, J APPL CRYSTALLOGR 4, V40, P658, DOI 10.1107/S0021889807021206; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Ozimek P, 2005, FEMS YEAST RES, V5, P975, DOI 10.1016/j.femsyr.2005.06.005; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; ROGGENKAMP R, 1984, MOL GEN GENET, V194, P489, DOI 10.1007/BF00425563; Salvi F, 2014, ACTA CRYSTALLOGR D, V70, P405, DOI 10.1107/S1399004713029283; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shleev SV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P245, DOI 10.1134/S0006297906030035; SIBIRNY AA, 1987, YEAST, V3, P233, DOI 10.1002/yea.320030404; Smitherman C, 2015, BIOCHEMISTRY-US, V54, P413, DOI 10.1021/bi500982y; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stasyk OV, 2004, J BIOL CHEM, V279, P8116, DOI 10.1074/jbc.M310960200; TYKARSKA E, 1990, J PROTEIN CHEM, V9, P83, DOI 10.1007/BF01024988; VANDERKLEI IJ, 1989, FEBS LETT, V244, P213, DOI 10.1016/0014-5793(89)81195-0; VONCK J, 1992, J STRUCT BIOL, V109, P78, DOI 10.1016/1047-8477(92)90070-Q; Waterham HR, 1997, J CELL BIOL, V139, P1419, DOI 10.1083/jcb.139.6.1419; Yurimoto Hiroya, 2011, Int J Microbiol, V2011, P101298, DOI 10.1155/2011/101298; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x	53	25	26	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149846	10.1371/journal.pone.0149846	http://dx.doi.org/10.1371/journal.pone.0149846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905908	Green Published, Green Submitted, gold			2022-12-26	WOS:000371163000023
J	Eikrem, O; Beisland, C; Hjeiie, K; Flatberg, A; Scherer, A; Landolt, L; Skogstrand, T; Leh, S; Beisvag, V; Marti, HP				Eikrem, Oystein; Beisland, Christian; Hjeiie, Karin; Flatberg, Arnar; Scherer, Andreas; Landolt, Lea; Skogstrand, Trude; Leh, Sabine; Beisvag, Vidar; Marti, Hans-Peter			Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development	PLOS ONE			English	Article							CARBONIC-ANHYDRASE IX; TARGETED THERAPY; GENE FUSION; TISSUE; CANCER; EPIGENOMICS; PROGNOSIS; DIAGNOSIS; GENOMICS; CAPTURE	Formalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater (R) (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to investigate feasibility of RNAseq in archival tissue. From each of 16 patients undergoing partial or full nephrectomy, four core biopsies, such as two specimens with ccRCC and two specimens of adjacent normal tissue, were obtained with a 16g needle. One normal and one ccRCC tissue specimen per patient was stored either in FFPE or RNAlater (R). RNA sequencing libraries were generated applying the new Illumina TruSeq (R) Access library preparation protocol. Comparative analysis was done using voom/Limma R-package. The analysis of the FFPE and RNAlater (R) datasets yielded similar numbers of detected genes, differentially expressed transcripts and affected pathways. The FFPE and RNAlater datasets shared 80% (n = 1106) differentially expressed genes. The average expression and the log2 fold changes of these transcripts correlated with R-2 = 0.97, and R-2 = 0.96, respectively. Among transcripts with the highest fold changes in both datasets were carbonic anhydrase 9 (CA9), neuronal pentraxin-2 (NPTX2) and uromodulin (UMOD) that were confirmed by immunohistochemistry. IPA revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response. To simulate the feasibility of clinical biomarker studies with FFPE samples, a classifier model was developed for the FFPE dataset: expression data for CA9 alone had an accuracy, specificity and sensitivity of 94%, respectively, and achieved similar performance in the RNAlater dataset. Transforming growth factor-beta 1 (TGFB1)-regulated genes, epithelial to mesenchymal transition (EMT) and NOTCH signaling cascade may support novel therapeutic strategies. In conclusion, in this proof of concept study, RNAseq data obtained from FFPE kidney biopsies are comparable to data obtained from fresh stored material, thereby expanding the utility of archival tissue specimens.	[Eikrem, Oystein; Landolt, Lea; Skogstrand, Trude; Leh, Sabine; Marti, Hans-Peter] Univ Bergen, Dept Clin Med, Nephrol, Bergen, Norway; [Beisland, Christian; Hjeiie, Karin] Univ Bergen, Dept Clin Med, Urol, Bergen, Norway; [Flatberg, Arnar; Beisvag, Vidar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Scherer, Andreas] Spheromics, Kontiolahti, Finland; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Marti, Hans-Peter] Haukeland Hosp, Dept Med, Nephrol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Marti, HP (corresponding author), Univ Bergen, Dept Clin Med, Nephrol, Bergen, Norway.; Marti, HP (corresponding author), Haukeland Hosp, Dept Med, Nephrol, N-5021 Bergen, Norway.	hans-peter.marti@uib.no	Leh, Sabine/E-6053-2011; Scherer, Andreas/ABD-8660-2020; Beisland, Christian/R-6046-2019	Leh, Sabine/0000-0002-0764-2941; Beisland, Christian/0000-0002-3216-4937; Scherer, Andreas/0000-0002-4254-7122; Landolt, Lea/0000-0002-9176-8933; Marti, Hans-Peter/0000-0002-6331-5902	University of Bergen; Faculty of Medicine at NTNU; Central Norway Regional Health Authority	University of Bergen; Faculty of Medicine at NTNU; Central Norway Regional Health Authority	The funder, namely the University of Bergen, provided support in the form of the salary for author Oystein Eikrem (O.E.) as PhD student scholarship but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The library preparation, sequencing and partly the bioinformatics analysis were provided by the Genomics Core Facility (GCF), which is funded by the Faculty of Medicine at NTNU and Central Norway Regional Health Authority. The specific roles of this author is articulated in the 'author contributions' section." Note, O.E. was an essential part in performing experiments and manuscript writing. Andreas Scherer (A.S.) is the sole owner/employee of Spheromics (http://spheromics.com/) and provided help in RNA sequencing data analysis and preparation of respective manuscript parts. Illumina Inc. was not involved in the present study at all; accordingly, no funding was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom AK, 2013, BIOCHEM BIOPH RES CO, V435, P126, DOI 10.1016/j.bbrc.2013.04.054; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Eisengart LJ, 2012, ARCH PATHOL LAB MED, V136, P490, DOI 10.5858/arpa.2010-0308-RA; Erdmann R, 2015, J PATHOL, V236, P403, DOI 10.1002/path.4544; Feng JY, 2013, EUR REV MED PHARMACO, V17, P2994; Funakoshi T, 2014, CANCER TREAT REV, V40, P533, DOI 10.1016/j.ctrv.2013.11.008; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gimenez-Bachs JM, 2012, SCAND J UROL NEPHROL, V46, P358, DOI 10.3109/00365599.2012.685493; Halvardson J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks816; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Huang QB, 2014, ONCOTARGET, V5, P3066, DOI 10.18632/oncotarget.1827; Huang WH, 2015, GENE CHROMOSOME CANC, V54, P500, DOI 10.1002/gcc.22261; Iacovelli R, 2015, CURR DRUG TARGETS, V16, P164, DOI 10.2174/1389450115666141120120145; Idzenga T, 2008, NEUROUROL URODYNAM, V27, P802, DOI 10.1002/nau.20594; Li P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1087; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Maher ER, 2013, SEMIN CANCER BIOL, V23, P10, DOI 10.1016/j.semcancer.2012.06.003; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oosterwijk E, 2014, SUBCELL BIOCHEM, V75, P181, DOI 10.1007/978-94-007-7359-2_10; Puls F, 2016, J PATHOL, V238, P502, DOI 10.1002/path.4683; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Stewart GD, 2014, EUR UROL, V66, P956, DOI 10.1016/j.eururo.2014.04.007; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Takacova M, 2013, ONCOL LETT, V5, P191, DOI 10.3892/ol.2012.1001; Tostain J, 2010, EUR J CANCER, V46, P3141, DOI 10.1016/j.ejca.2010.07.020; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; von Roemeling CA, 2014, CANCER RES, V74, P4796, DOI 10.1158/0008-5472.CAN-14-0210; Walther C, 2015, LAB INVEST, V95, P1071, DOI 10.1038/labinvest.2015.83; Wang W, 2014, ONCOL LETT, V8, P2627, DOI 10.3892/ol.2014.2554; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Webster AF, 2015, TOXICOL SCI, V148, P460, DOI 10.1093/toxsci/kfv195; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xiao YL, 2013, J PATHOL, V229, P535, DOI 10.1002/path.4145; Zaravinos Apostolos, 2014, Oncoscience, V1, P117; Zhang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118659; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419; Zwiener I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085150	44	40	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149743	10.1371/journal.pone.0149743	http://dx.doi.org/10.1371/journal.pone.0149743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901863	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100138
J	Foster, J; Luo, B; Nakata, PA				Foster, Justin; Luo, Bin; Nakata, Paul A.			An Oxalyl-CoA Dependent Pathway of Oxalate Catabolism Plays a Role in Regulating Calcium Oxalate Crystal Accumulation and Defending against Oxalate-Secreting Phytopathogens in Medicago truncatula	PLOS ONE			English	Article							SCLEROTINIA-SCLEROTIORUM; TRANSIENT EXPRESSION; ACID; MUTANTS; PLANTS; GERMIN; TRANSFORMATION; SYNTHETASE; COENZYME; ENZYMES	Considering the widespread occurrence of oxalate in nature and its broad impact on a host of organisms, it is surprising that so little is known about the turnover of this important acid. In plants, oxalate oxidase is the most well studied enzyme capable of degrading oxalate, but not all plants possess this activity. Recently, an Acyl Activating Enzyme 3 (AAE3), encoding an oxalyl-CoA synthetase, was identified in Arabidopsis. AAE3 has been proposed to catalyze the first step in an alternative pathway of oxalate degradation. Whether this enzyme and proposed pathway is important to other plants is unknown. Here, we identify the Medicago truncatula AAE3 (MtAAE3) and show that it encodes an oxalyl-CoA synthetase activity exhibiting high activity against oxalate with a Km = 81 +/- 9 mu M and Vmax = 19 +/- 0.9 mu moles min(-1)mg protein(-1). GFP-MtAAE3 localization suggested that this enzyme functions within the cytosol of the cell. Mtaae3 knock-down line showed a reduction in its ability to degrade oxalate into CO2. This reduction in the capacity to degrade oxalate resulted in the accumulation of druse crystals of calcium oxalate in the Mtaae3 knock-down line and an increased susceptibility to oxalate-secreting phytopathogens such as Sclerotinia sclerotiorum. Taken together, these results suggest that AAE3 dependent turnover of oxalate is important to different plants and functions in the regulation of tissue calcium oxalate crystal accumulation and in defense against oxalate-secreting phytopathogens.	[Foster, Justin; Luo, Bin; Nakata, Paul A.] Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Agriculture (USDA)	Nakata, PA (corresponding author), Baylor Coll Med, USDA ARS, Childrens Nutr Res Ctr, Dept Pediat, Houston, TX 77030 USA.	paul.nakata@ars.usda.gov		Nakata, Paul/0000-0002-6331-9700	U.S. Department of Agriculture, Agricultural Research Service [58-3092-5-001]; ARS [ARS-0426342] Funding Source: Federal RePORTER	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the U.S. Department of Agriculture, Agricultural Research Service, under Cooperative agreement number 58-3092-5-001.	BATEMAN DF, 1965, PHYTOPATHOLOGY, V55, P204; Blobel F, 1996, EUR J BIOCHEM, V240, P468, DOI 10.1111/j.1432-1033.1996.0468h.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosson V, 2006, METH MOL B, V343, P115; Dong XB, 2008, PLANTA, V228, P331, DOI 10.1007/s00425-008-0740-2; Druka A, 2002, P NATL ACAD SCI USA, V99, P850, DOI 10.1073/pnas.022627999; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; Foster J, 2014, FEBS LETT, V588, P160, DOI 10.1016/j.febslet.2013.11.026; Foster J, 2012, PLANT CELL, V24, P1217, DOI 10.1105/tpc.112.096032; Franceschi VR, 2005, ANNU REV PLANT BIOL, V56, P41, DOI 10.1146/annurev.arplant.56.032604.144106; Franceschi VR, 1995, CALCIUM OXALATE BIOL, P113; GIOVANELLI J, 1966, BIOCHIM BIOPHYS ACTA, V118, P124, DOI 10.1016/S0926-6593(66)80151-0; GIOVANELLI J, 1961, NATURE, V190, P1006, DOI 10.1038/1901006a0; Girish V, 2004, AFFORDABLE IMAGE ANA; GODOY G, 1990, PHYSIOL MOL PLANT P, V37, P179, DOI 10.1016/0885-5765(90)90010-U; Guimaraes RL, 2004, PLANT PHYSIOL, V136, P3703, DOI 10.1104/pp.104.049650; Hegedus DD, 2005, FEMS MICROBIOL LETT, V251, P177, DOI 10.1016/j.femsle.2005.07.040; Hoffmann B, 1997, MOL PLANT MICROBE IN, V10, P307, DOI 10.1094/MPMI.1997.10.3.307; Johansen LK, 2001, PLANT PHYSIOL, V126, P930, DOI 10.1104/pp.126.3.930; Kakar K, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-18; Kim KS, 2008, MOL PLANT MICROBE IN, V21, P605, DOI 10.1094/MPMI-21-5-0605; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; LANE BG, 1993, J BIOL CHEM, V268, P12239; Lane BG, 2002, IUBMB LIFE, V53, P67, DOI 10.1080/15216540211474; LUMSDEN RD, 1976, CAN J BOT, V54, P2630, DOI 10.1139/b76-283; Luo B, 2012, PLANT SCI, V188, P19, DOI 10.1016/j.plantsci.2012.02.006; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Membre N, 1997, PLANT MOL BIOL, V35, P459, DOI 10.1023/A:1005833028582; Membre N, 2000, PLANTA, V211, P345, DOI 10.1007/s004250000277; Morris J, 2007, PLANT MOL BIOL, V64, P613, DOI 10.1007/s11103-007-9180-9; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakata P. A., 2012, FRONT BIOL, V7, P254, DOI DOI 10.1007/S11515-012-1224-0; Nakata PA, 2000, PLANT PHYSIOL, V124, P1097, DOI 10.1104/pp.124.3.1097; Nakata PA, 2003, PLANT SCI, V164, P901, DOI 10.1016/S0168-9452(03)00120-1; Nakata PA, 2003, PLANT PHYSIOL BIOCH, V41, P325, DOI 10.1016/S0981-9428(03)00026-3; Nakata PA, 2007, PLANT PHYSIOL BIOCH, V45, P216, DOI 10.1016/j.plaphy.2007.01.013; Nakata PA, 2007, PLANT SCI, V172, P958, DOI 10.1016/j.plantsci.2007.01.005; Nakata PA, 2006, FUNCT PLANT BIOL, V33, P703, DOI 10.1071/FP06068; Park SH, 2009, ENTOMOL EXP APPL, V131, P208, DOI 10.1111/j.1570-7458.2009.00846.x; Scheid C, 1996, KIDNEY INT, V49, P413, DOI 10.1038/ki.1996.60; Shen JB, 2013, MOL PLANT, V6, P1419, DOI 10.1093/mp/sst079; Shockey J, 2011, PLANT J, V66, P143, DOI 10.1111/j.1365-313X.2011.04512.x; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; SMITH FW, 1972, AUST J AGR RES, V23, P969, DOI 10.1071/AR9720969; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Svedruzic D, 2005, ARCH BIOCHEM BIOPHYS, V433, P176, DOI 10.1016/j.abb.2004.08.032; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEAVER CM, 1987, J NUTR, V117, P1903, DOI 10.1093/jn/117.11.1903; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; YOSHIHARA T, 1980, ENTOMOL EXP APPL, V27, P149, DOI 10.1007/BF00573889; ZIEGLER K, 1987, ARCH MICROBIOL, V149, P62, DOI 10.1007/BF00423138	53	21	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149850	10.1371/journal.pone.0149850	http://dx.doi.org/10.1371/journal.pone.0149850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900946	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100164
J	Glat, MJ; Ben-Zur, T; Barhum, Y; Offen, D				Glat, Micaela Johanna; Ben-Zur, Tali; Barhum, Yael; Offen, Daniel			Neuroprotective Effect of a DJ-1 Based Peptide in a Toxin Induced Mouse Model of Multiple System Atrophy	PLOS ONE			English	Article							PARKINSONS-DISEASE; OXIDATIVE STRESS; 3-NITROPROPIONIC ACID; MITOCHONDRIAL-FUNCTION; ENVIRONMENTAL TOXINS; CONSENSUS STATEMENT; DOPAMINE TOXICITY; ALPHA-SYNUCLEIN; PROTEIN DJ-1; PATHWAY	Multiple System Atrophy (MSA) is a sporadic neurodegenerative disorder characterized by parkinsonism, cerebellar ataxia and dysautonomia, in various combinations. In MSA with parkinsonism (MSA-P), the degeneration is mainly restricted to the substantia nigra pars compacta and putamen. Studies have identified alterations in DJ-1 (PARK7), a key component of the anti-oxidative stress response, in Parkinson's disease (PD) and MSA patients. Previously we have shown that a short DJ-1-based peptide named ND-13, protected cultured cells against neurotoxic insults and improved behavioral outcome in animal models of Parkinson's disease (PD). In this study, we used the 3-Nitropropionic acid (3-NP)-induced mouse model of MSA and treated the animals with ND-13 in order to evaluate its therapeutic effects. Our results show that ND-13 protects cultured cells against oxidative stress generated by the mitochondrial inhibitor, 3-NP. Moreover, we show that ND-13 attenuates nigrostriatal degeneration and improves performance in motor-related behavioral tasks in 3-NP-treated mice. Our findings suggest a rationale for using ND-13 as a promising therapeutic approach for treatment of MSA.	[Glat, Micaela Johanna; Offen, Daniel] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Ben-Zur, Tali; Barhum, Yael; Offen, Daniel] Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Offen, D (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel.; Offen, D (corresponding author), Tel Aviv Univ, Sackler Sch Med, Felsenstein Med Res Ctr, Petah Tiqwa, Israel.	danioffen@gmail.com		Glat, Micaela Johanna/0000-0001-8332-1667	UGH Pharma, Inc.	UGH Pharma, Inc.	UGH Pharma, Inc. supplied the peptide (ND-13) used in the studies. This study also received funds as a scholarship from Mr. Martin Davis, a private donor. Other than the peptide (ND-13) which was supplied by UGH Pharma, Inc., and these scholarship funds, the authors received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja M, 2008, TOXICOL MECH METHODS; Aleyasin H, 2010, P NATL ACAD SCI USA, V107, P3186, DOI 10.1073/pnas.0914876107; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; BEAL MF, 1993, J NEUROSCI, V13, P4181; Bjornsdottir A, 2013, J NEUROL NEUROSUR PS, V84, P136, DOI 10.1136/jnnp-2012-302500; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen XL, 2006, AM J PHYSIOL-HEART C, V290, pH1862, DOI 10.1152/ajpheart.00651.2005; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Doeppner TR, 2010, EXP NEUROL, V223, P548, DOI 10.1016/j.expneurol.2010.02.001; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Hanna PA, 1999, ARCH NEUROL-CHICAGO, V56, P90, DOI 10.1001/archneur.56.1.90; Hao LY, 2010, P NATL ACAD SCI USA, V107, P9747, DOI 10.1073/pnas.0911175107; Irrcher I, 2010, HUM MOL GENET, V19, P3734, DOI 10.1093/hmg/ddq288; Kikuchi A, 2002, NEUROBIOL DIS, V9, P244, DOI 10.1006/nbdi.2002.0466; Kim GW, 2000, J CEREBR BLOOD F MET, V20, P119, DOI 10.1097/00004647-200001000-00016; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Lev N, 2008, NEUROTOXICOLOGY, V29, P397, DOI 10.1016/j.neuro.2008.01.007; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127549; Lev N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117190; Lev N, 2013, J GERONTOL A-BIOL, V68, P215, DOI 10.1093/gerona/gls147; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Lin DJ, 2016, CEREBELLUM, V15, P663, DOI 10.1007/s12311-015-0728-y; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mccoy MK, 2011, AUTOPHAGY, V7, P531, DOI 10.4161/auto.7.5.14684; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Rannikko EH, 2013, J NEUROCHEM, V125, P314, DOI 10.1111/jnc.12126; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Stefanova N, 2005, AM J PATHOL, V166, P869, DOI 10.1016/S0002-9440(10)62307-3; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Tao F, 2008, MOL THER, V16, P1776, DOI 10.1038/mt.2008.192; Thomas KJ, 2011, HUM MOL GENET, V20, P40, DOI 10.1093/hmg/ddq430; Ubhi K, 2009, J NEUROSCI RES, V87, P2728, DOI 10.1002/jnr.22089; Vanacore N, 2005, J NEURAL TRANSM, V112, P1605, DOI 10.1007/s00702-005-0380-7; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Waldner R, 2001, NEUROSCIENCE, V102, P581, DOI 10.1016/S0306-4522(00)00500-5; Wenning GK, 2004, LANCET NEUROL, V3, P93, DOI 10.1016/S1474-4422(03)00662-8; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211	41	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148170	10.1371/journal.pone.0148170	http://dx.doi.org/10.1371/journal.pone.0148170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901405	Green Published, gold			2022-12-26	WOS:000371276100014
J	Hung, IFN; Wong, DKH; Poon, RTP; Fong, DYT; Chui, AHW; Seto, WK; Fung, JYY; Chan, ACY; Yuen, JCH; Tiu, R; Choi, O; Lai, CL; Yuen, MF				Hung, Ivan Fan-Ngai; Wong, Danny Ka-Ho; Poon, Ronnie Tung-Ping; Fong, Daniel Yee-Tak; Chui, Ada Hang-Wai; Seto, Wai-Kay; Fung, James Yan-Yue; Chan, Albert Chi-Yan; Yuen, John Chi-Hang; Tiu, Randal; Choi, Olivia; Lai, Ching-Lung; Yuen, Man-Fung			Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							HIGH VIRAL LOAD; LIVER RESECTION; RADIOFREQUENCY ABLATION; TUMOR RECURRENCE; VIRUS; SURVIVAL; MUTATIONS; IMPACT; ASSOCIATION; PROGNOSIS	Background Independent risk factors associated with hepatitis B (HBV)-related hepatocellular carcinoma (HCC) after resection remains unknown. An accurate risk score for HCC recurrence is lacking. Methods We prospectively followed up 200 patients who underwent liver resection for HBV-related HCC for at least 2 years. Demographic, biochemical, tumor, virological and anti-viral treatment factors were analyzed to identify independent risk factors associated with recurrence after resection and a risk score for HCC recurrence formulated. Results Two hundred patients (80% male) who underwent liver resection for HBV-related HCC were recruited. The median time of recurrence was 184 weeks (IQR 52-207 weeks) for the entire cohort and 100 patients (50%) developed HCC recurrence. Stepwise Cox regression analysis identified that one-month post resection HBV DNA >20,000 IU/mL (p = 0.019; relative risk (RR) 1.67; 95% confidence interval (C.I.): 1.09-2.57), the presence of lymphovascular permeation (p<0.001; RR 2.69; 95% C.I.: 1.75-4.12), microsatellite lesions (p<0.001; RR 2.86; 95% C.I.: 1.82-4.51), and AFP >100ng/mL before resection (p = 0.021; RR 1.63; 95% C.I.: 1.08-2.47) were independently associated with HCC recurrence. Antiviral treatment before resection (p = 0.024; RR 0.1; 95% C.I.: 0.01-0.74) was independently associated with reduced risk of HCC recurrence. A post-resection independent predictive score (PRIPS) was derived and validated with sensitivity of 75.3% and 60.6% and specificity of 55.7% and 79.2%, to predict the 1- and 3-year risks for the HCC recurrence respectively with the hazard ratio of 2.71 (95% C.I.: 2.12-3.48; p<0.001). The AUC for the 1-and 3-year prediction were 0.675 (95% C.I.: 0.6-0.78) and 0.746 (95% C.I.: 0.69-0.82) respectively. Conclusion Several tumor, virological and biochemical factors were associated with a higher cumulative risk of HCC recurrence after resection. PRIPS was derived for more accurate risk assessment. Regardless of the HBV DNA level, antiviral treatment should be given to patients before resection to reduce the risk of recurrence.	[Hung, Ivan Fan-Ngai; Wong, Danny Ka-Ho; Seto, Wai-Kay; Fung, James Yan-Yue; Yuen, John Chi-Hang; Choi, Olivia; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie Tung-Ping; Chan, Albert Chi-Yan] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Queen Mary Hosp, Sch Nursing Studies, Hong Kong, Hong Kong, Peoples R China; [Chui, Ada Hang-Wai] Hosp Author, New Territories West Cluster, Qual & Safety Div, Hong Kong, Hong Kong, Peoples R China; [Tiu, Randal] Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Wong, Danny/H-6819-2016; Chan, Albert/AAC-1642-2022; Fung, James/AAG-4832-2020; Hung, Ivan FN/ABD-5916-2021; Fong, Daniel YT/C-4269-2009; SETO, Wai-Kay/H-4452-2012; Wong, Danny/S-6230-2019	Chan, Albert/0000-0002-1383-2952; Hung, Ivan FN/0000-0002-1556-2538; Fong, Daniel YT/0000-0001-7365-9146; SETO, Wai-Kay/0000-0002-9012-313X; Fung, James/0000-0002-1286-8902; /0000-0001-9078-5005; Lai, Ching-Lung/0000-0002-5927-2436	Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong [09080862]	Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong	The study was fully supported by the Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong (reference number: 09080862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LANG ENV STAT COMP; Beard RE, 2013, SURGERY, V154, P545, DOI 10.1016/j.surg.2013.02.019; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Cha C, 2003, J AM COLL SURGEONS, V197, P753, DOI 10.1016/j.jamcollsurg.2003.07.003; Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Cheung TK, 2006, ALIMENT PHARM THERAP, V24, P573, DOI 10.1111/j.1365-2036.2006.03029.x; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; ElAssal ON, 1997, SURGERY, V122, P571, DOI 10.1016/S0039-6060(97)90130-6; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Hastie T, 2003, NEURAL COMPUT, V15, P1477, DOI 10.1162/089976603321891765; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Jang JW, 2007, CANCER, V110, P1760, DOI 10.1002/cncr.22984; Jeng KS, 2004, AM J GASTROENTEROL, V99, P1503, DOI 10.1111/j.1572-0241.2004.30227.x; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kumar AMS, 2015, HEPATOB PANCREAT DIS, V14, P269, DOI 10.1016/S1499-3872(15)60382-4; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lee SY, 2014, HPB, V16, P943, DOI 10.1111/hpb.12311; Leung C. M., 2010, Hong Kong Medical Journal, V16, P463; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lyu H, 2013, J VIRAL HEPATITIS, V20, P219, DOI 10.1111/j.1365-2893.2012.01654.x; Mathews P, 2013, ANN SURG ONCOL, V20, P1216, DOI 10.1245/s10434-012-2706-7; Ohata K, 2004, J GASTROEN HEPATOL, V19, P670, DOI 10.1111/j.1440-1746.2004.03360.x; Pan JB, 2004, J GEN VIROL, V85, P275, DOI 10.1099/vir.0.19650-0; Pan QX, 2014, ONCOL RES TREAT, V37, P192, DOI 10.1159/000361082; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Pompili M, 2013, J HEPATOL, V59, P89, DOI 10.1016/j.jhep.2013.03.009; Poon RTP, 2000, J CLIN ONCOL, V18, P1094, DOI 10.1200/JCO.2000.18.5.1094; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Schaffer C., 1994, MACHINE LEARNING P, P259, DOI DOI 10.1016/B978-1-55860-335-6.50039-8; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Sinn DH, 2015, HEPATOLOGY, V62, P694, DOI 10.1002/hep.27889; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Taura K, 2007, SURGERY, V142, P685, DOI 10.1016/j.surg.2007.05.009; Wang Q, 2013, BRIT J CANCER, V109, P573, DOI 10.1038/bjc.2013.352; Wolpert DH, 1994, TECHNICAL REPORT; World Health Organization, GLOB STAT REP NONC D; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Xia F, 2012, ANN SURG ONCOL, V19, P1284, DOI 10.1245/s10434-011-2042-3; Yamamura K, 2014, J HEPATO-BIL-PAN SCI, V21, P682, DOI 10.1002/jhbp.114; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023; Zhao WH, 2002, WORLD J GASTROENTERO, V8, P237	53	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148493	10.1371/journal.pone.0148493	http://dx.doi.org/10.1371/journal.pone.0148493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901762	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100017
J	Jung, B; Padula, D; Burtscher, I; Landerer, C; Lutter, D; Theis, F; Messias, AC; Geerlof, A; Sattler, M; Kremmer, E; Boldt, K; Ueffing, M; Lickert, H				Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Landerer, Cedric; Lutter, Dominik; Theis, Fabian; Messias, Ana C.; Geerlof, Arie; Sattler, Michael; Kremmer, Elisabeth; Boldt, Karsten; Ueffing, Marius; Lickert, Heiko			Pitchfork and Gprasp2 Target Smoothened to the Primary Cilium for Hedgehog Pathway Activation	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; INTRAFLAGELLAR TRANSPORT PROTEINS; EMBRYONIC STEM-CELLS; NEURONAL CILIA; LOCALIZATION; MICE; IDENTIFICATION; CILIOPATHIES; CILIOGENESIS; TRAFFICKING	The seven-transmembrane receptor Smoothened (Smo) activates all Hedgehog (Hh) signaling by translocation into the primary cilia (PC), but how this is regulated is not well understood. Here we show that Pitchfork (Pifo) and the G protein-coupled receptor associated sorting protein 2 (Gprasp2) are essential components of an Hh induced ciliary targeting complex able to regulate Smo translocation to the PC. Depletion of Pifo or Gprasp2 leads to failure of Smo translocation to the PC and lack of Hh target gene activation. Together, our results identify a novel protein complex that is regulated by Hh signaling and required for Smo ciliary trafficking and Hh pathway activation.	[Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Munich, Germany; [Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany; [Landerer, Cedric; Lutter, Dominik; Theis, Fabian] Helmholtz Zentrum Munchen, Inst Computat Biol, Munich, Germany; [Lutter, Dominik] Helmholtz Zentrum Munchen, Inst Diabet & Adipositas, Munich, Germany; [Messias, Ana C.; Geerlof, Arie; Sattler, Michael] Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany; [Kremmer, Elisabeth] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany; [Boldt, Karsten; Ueffing, Marius] Helmholtz Zentrum Munchen, Dept Prot Sci, Munich, Germany; [Jung, Bomi; Padula, Daniela; Burtscher, Ingo; Lickert, Heiko] German Ctr Diabet Res DZD, D-85764 Munich, Germany; [Messias, Ana C.; Sattler, Michael] Tech Univ Munich, Biomol NMR Spect, Ctr Integrated Prot Sci Munich, Dept Chem, D-85747 Garching, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Inst Ophthalmol Res, Ctr Ophthalmol, D-72076 Tubingen, Germany; [Landerer, Cedric] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Tennessee System; University of Tennessee Knoxville	Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Diabet & Regenerat Res, Munich, Germany.; Lickert, H (corresponding author), Helmholtz Zentrum Munchen, Inst Stem Cell Res, Munich, Germany.; Lickert, H (corresponding author), German Ctr Diabet Res DZD, D-85764 Munich, Germany.	heiko.lickert@helmholtz-muenchen.de	Lutter, Dominik RL/B-7790-2013; Theis, Fabian J/ABD-5212-2021; Sattler, Michael/A-2407-2012	Lutter, Dominik RL/0000-0002-8800-0683; Theis, Fabian J/0000-0002-2419-1943; Sattler, Michael/0000-0002-1594-0527; Messias, Ana/0000-0002-5449-9922	German Center for Diabetes Research (DZD e.V.); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Emmy-Noether fellowship from the German Research Foundation; ERC	German Center for Diabetes Research (DZD e.V.); Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Emmy-Noether fellowship from the German Research Foundation; ERC(European Research Council (ERC)European Commission)	This work was funded in part by the German Center for Diabetes Research (DZD e.V.) and the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases. Financial support was additionally provided by an Emmy-Noether fellowship from the German Research Foundation and an ERC starting grant awarded to HL.	Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bendall SC, 2008, MOL CELL PROTEOMICS, V7, P1587, DOI 10.1074/mcp.M800113-MCP200; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Boldt K, 2011, J CLIN INVEST, V121, P2169, DOI 10.1172/JCI45627; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Butterfield NC, 2010, CURR TOP DEV BIOL, V90, P319, DOI 10.1016/S0070-2153(10)90009-4; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Chen Y, 2011, AESTIMATIO, P2; Conner DA, 1997, CIRC RES, V81, P1021; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dessaud E, 2008, DEVELOPMENT, V135, P2489, DOI 10.1242/dev.009324; Dorn KV, 2012, DEV CELL, V23, P823, DOI 10.1016/j.devcel.2012.07.004; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Gaertig J, 2008, CURR TOP DEV BIOL, V85, P83, DOI 10.1016/S0070-2153(08)00804-1; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner Christian Johannes, 2009, Curr Protoc Protein Sci, VChapter 19, DOI 10.1002/0471140864.ps1920s57; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Horn SC, 2006, J NEURAL TRANSM, V113, P1081, DOI 10.1007/s00702-006-0514-6; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Kim J, 2009, P NATL ACAD SCI USA, V106, P21666, DOI 10.1073/pnas.0912180106; Kinzel D, 2010, DEV CELL, V19, P66, DOI 10.1016/j.devcel.2010.06.005; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Mazelova J, 2009, J CELL SCI, V122, P2003, DOI 10.1242/jcs.039982; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moser E, 2010, PHARMACOLOGY, V86, P22, DOI 10.1159/000314161; Ocbina PJR, 2008, DEV DYNAM, V237, P2030, DOI 10.1002/dvdy.21551; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pan JM, 2007, CELL, V129, P1255, DOI 10.1016/j.cell.2007.06.018; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Parathath SR, 2010, CELL CYCLE, V9, P4013, DOI 10.4161/cc.9.19.13325; Pazour GJ, 2002, TRENDS CELL BIOL, V12, P551, DOI 10.1016/S0962-8924(02)02410-8; Pazour GJ, 2008, CURR TOP DEV BIOL, V85, P115, DOI 10.1016/S0070-2153(08)00805-3; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ryan KE, 2012, J BIOL CHEM, V287, P17905, DOI 10.1074/jbc.R112.356006; Santos N, 2008, DEV DYNAM, V237, P1972, DOI 10.1002/dvdy.21540; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Seeley ES, 2010, J CELL SCI, V123, P511, DOI 10.1242/jcs.061093; Simonin F, 2004, J NEUROCHEM, V89, P766, DOI 10.1111/j.1471-4159.2004.02411.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tamplin OJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-511; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Toriello HV, 2009, AM J MED GENET C, V151C, P261, DOI 10.1002/ajmg.c.30230; Uetzmann L, 2008, GENESIS, V46, P515, DOI 10.1002/dvg.20410; Vaegter CB, 2011, NAT NEUROSCI, V14, P54, DOI 10.1038/nn.2689; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; Wu VM, 2012, P NATL ACAD SCI USA, V109, P13644, DOI 10.1073/pnas.1207170109; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3	65	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149477	10.1371/journal.pone.0149477	http://dx.doi.org/10.1371/journal.pone.0149477			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901434	Green Published, gold			2022-12-26	WOS:000371276100080
J	Nooshabadi, F; Yang, HJ; Bixler, JN; Kong, Y; Cirillo, JD; Maitland, KC				Nooshabadi, Fatemeh; Yang, Hee-Jeong; Bixler, Joel N.; Kong, Ying; Cirillo, Jeffrey D.; Maitland, Kristen C.			Intravital Fluorescence Excitation in Whole-Animal Optical Imaging	PLOS ONE			English	Article							BACTERIAL-INFECTION; TUBERCULOSIS; AUTOFLUORESCENCE; TOMOGRAPHY; PROTEIN; MICE	Whole-animal fluorescence imaging with recombinant or fluorescently-tagged pathogens or cells enables real-time analysis of disease progression and treatment response in live animals. Tissue absorption limits penetration of fluorescence excitation light, particularly in the visible wavelength range, resulting in reduced sensitivity to deep targets. Here, we demonstrate the use of an optical fiber bundle to deliver light into the mouse lung to excite fluorescent bacteria, circumventing tissue absorption of excitation light in whole-animal imaging. We present the use of this technology to improve detection of recombinant reporter strains of tdTomato-expressing Mycobacterium bovis BCG (Bacillus Calmette Guerin) bacteria in the mouse lung. A microendoscope was integrated into a whole-animal fluorescence imager to enable intravital excitation in the mouse lung with whole-animal detection. Using this technique, the threshold of detection was measured as 10(3) colony forming units (CFU) during pulmonary infection. In comparison, the threshold of detection for whole-animal fluorescence imaging using standard epi-illumination was greater than 10(6) CFU.	[Nooshabadi, Fatemeh; Bixler, Joel N.; Maitland, Kristen C.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Yang, Hee-Jeong; Kong, Ying; Cirillo, Jeffrey D.] Texas A&M Univ, Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Bryan, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Maitland, KC (corresponding author), Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA.	kmaitland@tamu.edu	Maitland, Kristen/D-6961-2011; Maitland, Kristen/N-9171-2019; Cirillo, Jeffrey D./L-4286-2019	Maitland, Kristen/0000-0003-0931-0622; Maitland, Kristen/0000-0003-0931-0622; Cirillo, Jeffrey D./0000-0003-3058-2702; Nooshabadi, Fatemeh/0000-0001-6351-5229; Yang, Hee-Jeong/0000-0002-7351-8404	Bill and Melinda Gates Foundation [48523]; National Science Foundation [CBET-1254767]; National Institute of Allergy and Infectious Diseases [1R01 AI104960]; Div Of Chem, Bioeng, Env, & Transp Sys [1254767] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104960] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Science Foundation(National Science Foundation (NSF)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the Bill and Melinda Gates Foundation grant no. 48523 to JDC, http://www.gatesfoundation.org/; the National Science Foundation grant no. CBET-1254767 to KCM, http://www.nsf.gov; and the National Institute of Allergy and Infectious Diseases grant no. 1R01 AI104960 to JDC, https://www.niaid.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Baker M, 2010, NATURE, V463, P977, DOI 10.1038/463977a; Bao HC, 2010, OPT EXPRESS, V18, P1255, DOI 10.1364/OE.18.001255; Bernaerts A, 2003, EUR RADIOL, V13, P1876, DOI 10.1007/s00330-002-1608-7; Bhaumik S, 2007, LAB ANIMAL, V36, P40, DOI 10.1038/laban0907-40; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; Bird-Lieberman EL, 2012, NAT MED, V18, P315, DOI 10.1038/nm.2616; Brown CM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.4.040505; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547; Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23; Cheng SN, 2013, OPT LETT, V38, P1515, DOI 10.1364/OL.38.001515; Choi Y, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.203901; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Dedecker P, 2012, P NATL ACAD SCI USA, V109, P10909, DOI 10.1073/pnas.1204917109; Demsar J, 2006, J MACH LEARN RES, V7, P1; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Garcia S, 2010, INFORM SCIENCES, V180, P2044, DOI 10.1016/j.ins.2009.12.010; Gee JM, 2014, NEURON, V83, P1058, DOI 10.1016/j.neuron.2014.07.024; Goldgeier M, 2003, DERMATOL SURG, V29, P205, DOI 10.1046/j.1524-4725.2003.29050.x; GORDON S, 1994, IMMUNOBIOLOGY, V191, P369, DOI 10.1016/S0171-2985(11)80442-0; GUPTA PK, 1989, NEUROSURGERY, V25, P830, DOI 10.1227/00006123-198911000-00025; Iftimia N, 2012, BIOMED OPT EXPRESS, V3, P178, DOI 10.1364/BOE.3.000178; Inoue Y, 2008, MOL IMAGING, V7, P21, DOI 10.2310/7290.2008.0003; Jabbour JM, 2012, ANN BIOMED ENG, V40, P378, DOI 10.1007/s10439-011-0426-y; Keahey PA, 2015, BIOMED OPT EXPRESS, V6, P870, DOI 10.1364/BOE.6.000870; Kong Y, 2011, WHOLE BODY IMAGING I; Kong Y, 2011, CURRENT PROTOCOLS MI; Kong Y, 2010, P NATL ACAD SCI USA, V107, P12239, DOI 10.1073/pnas.1000643107; Kong Y, 2009, TUBERCULOSIS, V89, pS15, DOI 10.1016/S1472-9792(09)70006-X; Leblond F, 2010, J PHOTOCH PHOTOBIO B, V98, P77, DOI 10.1016/j.jphotobiol.2009.11.007; Lee CM, 2010, J BIOPHOTONICS, V3, P385, DOI 10.1002/jbio.200900087; Lorenser D, 2013, OPT LETT, V38, P266, DOI 10.1364/OL.38.000266; MacLaurin SA, 2006, SOC MOL IM ANN M HAW; Miller SJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021103; Mufti N, 2011, BIOMED OPT EXPRESS, V2, P1121, DOI 10.1364/BOE.2.001121; Muldoon TJ, 2008, GASTROINTEST ENDOSC, V68, P737, DOI 10.1016/j.gie.2008.05.018; Muldoon TJ, 2007, OPT EXPRESS, V15, P16413, DOI 10.1364/OE.15.016413; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Nuiachristos V, 2006, ANNU REV BIOMED ENG, V8, P1, DOI 10.1146/annurev.bioeng.8.061505.095831; Oh G, 2013, OPT FIBER TECHNOL, V19, P760, DOI 10.1016/j.yofte.2013.07.008; Pierce M, 2011, JOVE-J VIS EXP, DOI 10.3791/2306; Sevick-Muraca EM, 2012, ANNU REV MED, V63, P217, DOI 10.1146/annurev-med-070910-083323; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sosnovik DE, 2007, CIRCULATION, V115, P1384, DOI 10.1161/CIRCULATIONAHA.106.663351; Tamguney G, 2009, P NATL ACAD SCI USA, V106, P15002, DOI 10.1073/pnas.0907339106; Torres RM, 2004, AM J OPHTHALMOL, V138, P1048, DOI 10.1016/j.ajo.2004.06.020; TRAVIS LW, 1976, LARYNGOSCOPE, V86, P549, DOI 10.1288/00005537-197604000-00011; Troy Tamara, 2004, Mol Imaging, V3, P9, DOI 10.1162/153535004773861688; Wagnieres GA, 1998, PHOTOCHEM PHOTOBIOL, V68, P603; White AG, 2010, BIOCONJUGATE CHEM, V21, P1297, DOI 10.1021/bc1000998; World Health Organization, 2014, GLOB TUB REP; Yuste R, 2005, NAT METHODS, V2, P902, DOI 10.1038/nmeth1205-902; Zhang YY, 2012, P NATL ACAD SCI USA, V109, P12878, DOI 10.1073/pnas.1121495109	56	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149932	10.1371/journal.pone.0149932	http://dx.doi.org/10.1371/journal.pone.0149932			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901051	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100187
J	Sardinha, LB; Santos, DA; Silva, AM; Grontved, A; Andersen, LB; Ekelund, U				Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.; Grontved, Anders; Andersen, Lars B.; Ekelund, Ulf			A Comparison between BMI, Waist Circumference, and Waist-To-Height Ratio for Identifying Cardio-Metabolic Risk in Children and Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; TYPE-2 DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; BOGALUSA HEART; PHYSICAL-ACTIVITY; OVERWEIGHT; ADIPOSITY; HEALTH; DEFINITION	Background There is controversial evidence on the associations between anthropometric measures with clustering of cardiovascular disease risk factors in pediatric ages. We aimed to examine the associations between body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) with clustered cardiometabolic risk factors and to determine whether these anthropometric variables can be used to discriminate individuals with increased cardiometabolic risk (increased clustered triglycerides, HDL-cholesterol, systolic and diastolic blood pressure, and HOMA-IR). Methods The study sample of 4255 (2191 girls and 2064 boys) participants (8-17 years) was derived from pooled cross-sectional data comprising five studies. Outcomes included a continuous cardiometabolic risk factor z-score [corresponding to the sum of z-scores for triglycerides, HDL-cholesterol, systolic and diastolic blood pressure (mean arterial pressure), and HOMA-IR] and children with >= 1.0 SD in this score were defined as being at risk for clustering cardiometabolic risk factors.. Exposure variables were BMI, WC, WHtR. Statistics included mixed-effect regression and ROC analysis. Results All anthropometric variables were associated with clustered risk and the magnitudes of associations were similar for BMI, WC, and WHtR. Models including anthropometric variables were similar in discriminating children and adolescents at increased risk with areas under the ROC curve between 0.70 and 0.74. The sensitivity (boys: 80.5-86.4%; girls: 76.6-82.3%) was markedly higher than specificity (boys: 51.85-59.4%; girls: 60.8%). Conclusions The magnitude of associations for BMI, WC, and WHtR are similar in relation to clustered cardiometabolic risk factors, and perform better at higher levels of BMI. However, the precision of these anthropometric variables to classify increased risk is low.	[Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.] Univ Lisbon, Fac Motricidade Humana, Exercise & Hlth Lab, CIPER, Cruz Quebrada, Portugal; [Grontved, Anders; Andersen, Lars B.] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Ekelund, Ulf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Epidemiol Unit, Hills Rd, Cambridge CB2 2QQ, England; [Andersen, Lars B.; Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	Universidade de Lisboa; University of Southern Denmark; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Norwegian School of Sport Sciences	Sardinha, LB (corresponding author), Univ Lisbon, Fac Motricidade Humana, Exercise & Hlth Lab, CIPER, Cruz Quebrada, Portugal.	lsardinha@fmh.ulisboa.pt	Ekelund, Ulf/AAE-8471-2019; Sardinha, Luís B./ABG-5389-2020; Silva, Analiza M/C-9858-2010; Santos, Vanessa/AAP-4130-2020; Sardinha, Luís Bettencourt/F-2641-2013; Grøntved, Anders/AAA-8025-2022; Santos, Diana A/H-9086-2013	Ekelund, Ulf/0000-0003-2115-9267; Sardinha, Luís B./0000-0002-6230-6027; Silva, Analiza M/0000-0002-8984-8600; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Santos, Diana A/0000-0003-0429-3093; Grontved, Anders/0000-0003-1584-679X	Portuguese Foundation for Science and Technology [SFRH/BPD/92462/2013]; Medical Research Council [MC_U106179473, MC_UU_12015/3] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U106179473] Funding Source: UKRI	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DAS is supported by a scholarship from the Portuguese Foundation for Science and Technology (SFRH/BPD/92462/2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2010, INT J PEDIATR OBES, V5, P130, DOI 10.3109/17477160903111730; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; [Anonymous], 2007, GROWTH REF DAT 5 19; [Anonymous], 2009, NAT HLTH NUTR EX SUR; Bell L, 2013, J PAEDIATR CHILD H, V49, P955, DOI 10.1111/jpc.12298; Bugge A, 2012, MED SCI SPORT EXER, V44, P1310, DOI 10.1249/MSS.0b013e31824bd579; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Giorgis T, 2014, EUR J ENDOCRINOL, V170, P173, DOI 10.1530/EJE-13-0452; de Onis M, 2013, PUBLIC HEALTH NUTR, V16, P625, DOI 10.1017/S1368980012004776; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 2010, AM J CLIN NUTR, V92, P1298, DOI 10.3945/ajcn.2010.29758; Friend A, 2013, METAB SYNDR RELAT D, V11, P71, DOI 10.1089/met.2012.0122; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; IDF, 2007, IDF CONS DEF MET SYN; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kahn HS, 2014, J OBES, V2014, DOI 10.1155/2014/421658; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; Katzmarzyk PT, 2013, INT J OBES LOND; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Magnussen CG, 2012, J AM COLL CARDIOL, V60, P1631, DOI 10.1016/j.jacc.2012.05.056; Magnussen CG, 2010, CIRCULATION, V122, P1604, DOI 10.1161/CIRCULATIONAHA.110.940809; Mark AE, 2008, MED SCI SPORT EXER, V40, P1007, DOI 10.1249/MSS.0b013e318169032d; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Radziuk J, 2000, J CLIN ENDOCR METAB, V85, P4426, DOI 10.1210/jc.85.12.4426; Reinehr T, 2013, J PEDIATR-US, V163, P327, DOI 10.1016/j.jpeds.2013.01.032; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; World Health Organization, 2005, WHO STEPS SURV MAN W; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	35	96	99	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149351	10.1371/journal.pone.0149351	http://dx.doi.org/10.1371/journal.pone.0149351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901828	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100062
J	Yao, LY; Abe, M; Kawasaki, K; Akbar, SMF; Matsuura, B; Onji, M; Hiasa, Y				Yao, Liying; Abe, Masanori; Kawasaki, Keitarou; Akbar, Sheikh Mohammad Fazle; Matsuura, Bunzo; Onji, Morikazu; Hiasa, Yoichi			Characterization of Liver Monocytic Myeloid-Derived Suppressor Cells and Their Role in a Murine Model of Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							REGULATORY T-CELLS; HEPATIC STEATOSIS; NITRIC-OXIDE; IMMUNE-RESPONSE; DOWN-REGULATION; INFLAMMATION; DIET; GAMMA; IDENTIFICATION; ACCUMULATION	Myeloid-Myeloid-derived suppressor cells (MDSCs) are potent suppressors of T cell immunity in tumors and inflammatory diseases. They are identified by surface expression of CD11b(+)Gr1(+) in mice, and CD11b(+)Gr1(+) cells accumulate in the livers of obese mice. However, many myeloid cells share these CD11b(+)Gr1(+) markers. Accordingly, the aim of this study was to identify the authentic phenotype of MDSCs and investigate their functions in non-alcoholic fatty liver disease (NAFLD). C57BL/6J mice were divided into 2 diet groups: a normal control group and high-fat group to induce NAFLD. We demonstrated that monocytic CD11b(+)Gr1(dim) cells could be further divided into 2 populations based on side scatter (SSC) during flow cytometry. We found that SSC(low)CD11b(+)Gr1(dim) cells accumulated in the livers of NAFLD mice over time, and that these cells were recruited by the chemokine CCL2 and its receptor CCR2 and might expand in the liver via macrophage colony-stimulating factor stimulation. Furthermore, SSC(low)CD11b(+)Gr1(dim) cells had a strong suppressive ability on T cells; this effect was not observed for SSC(high)CD11b(+)Gr1(dim) cells, and was dependent on nitric oxide production by inducible nitric oxide synthase. Our findings demonstrate that SSC(low)CD11b(+)Gr1(dim) cells represent authentic MDSCs in NAFLD livers, and might serve an important negative feedback function in liver inflammation.	[Yao, Liying; Abe, Masanori; Kawasaki, Keitarou; Matsuura, Bunzo; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Akbar, Sheikh Mohammad Fazle] Toshiba Gen Hosp, Dept Med Sci, Shinagawa Ku, Tokyo, Japan; [Onji, Morikazu] Imabari Saiseikai Med Welfare Ctr, Dept Internal Med, Imabari, Ehime, Japan	Ehime University; Toshiba Corporation	Abe, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	masaben@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japanese Ministry of Education, Culture, Sports, Science and Technology [15K09007, 15K09006]; Japanese Ministry of Health, Labor and Welfare	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Grants-in-Aid for Scientific Research (JSPS KAKENHI 15K09007 to MA and 15K09006 to YH) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, as well as a Grant-in-Aid for Scientific Research and Development from the Japanese Ministry of Health, Labor and Welfare (to MA and YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Boelte KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018534; Bronte V, 2000, BLOOD, V96, P3838, DOI 10.1182/blood.V96.12.3838.h8003838_3838_3846; Brunt EM, 2010, NAT REV GASTRO HEPAT, V7, P195, DOI 10.1038/nrgastro.2010.21; Chalasani N, 2012, GASTROENTEROLOGY, V142, P1592, DOI 10.1053/j.gastro.2012.04.001; Chen S, 2011, CLIN EXP IMMUNOL, V166, P134, DOI 10.1111/j.1365-2249.2011.04445.x; Chen S, 2015, OBES RES CLIN PRACT, V9, P35, DOI 10.1016/j.orcp.2013.12.006; Cripps JG, 2010, HEPATOLOGY, V52, P1350, DOI 10.1002/hep.23841; Deng ZB, 2009, HEPATOLOGY, V50, P1412, DOI 10.1002/hep.23148; Feldstein AE, 2003, J HEPATOL, V39, P978, DOI 10.1016/S0168-8278(03)00460-4; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Hale M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118784; Harari O, 2004, CURR PHARM DESIGN, V10, P893, DOI 10.2174/1381612043452893; Hassan MM, 2015, GASTROENTEROLOGY, V149, P119, DOI 10.1053/j.gastro.2015.03.044; Hegde VL, 2015, J IMMUNOL, V194, P5211, DOI 10.4049/jimmunol.1401844; Hochst B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119662; Huang B, 2007, CANCER LETT, V252, P86, DOI 10.1016/j.canlet.2006.12.012; Kapanadze T, 2013, J HEPATOL, V59, P1007, DOI 10.1016/j.jhep.2013.06.010; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawasaki K, 2013, LAB INVEST, V93, P311, DOI 10.1038/labinvest.2012.176; Kong XH, 2014, J IMMUNOL, V193, P1645, DOI 10.4049/jimmunol.1303432; Ma SB, 2014, CANCER RES, V74, P1969, DOI 10.1158/0008-5472.CAN-13-2534; Ma X, 2007, HEPATOLOGY, V46, P1519, DOI 10.1002/hep.21823; Mazzoni A, 2002, J IMMUNOL, V168, P689, DOI 10.4049/jimmunol.168.2.689; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Morosawa T, 2015, HEPATOLOGY, V62, p1264A; Movahedi K, 2008, BLOOD, V111, P4233, DOI 10.1182/blood-2007-07-099226; Pollard JW, 1997, MOL REPROD DEV, V46, P54, DOI 10.1002/(SICI)1098-2795(199701)46:1&lt;54::AID-MRD9&gt;3.0.CO;2-Q; Rivoltini L, 2002, IMMUNOL REV, V188, P97, DOI 10.1034/j.1600-065X.2002.18809.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Shen P, 2014, HEPATOL RES, V44, P639, DOI 10.1111/hepr.12167; Sosroseno W, 2009, ANAEROBE, V15, P95, DOI 10.1016/j.anaerobe.2009.01.002; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tam JW, 2014, INFECT IMMUN, V82, P2606, DOI 10.1128/IAI.01590-13; Tang Y, 2011, CLIN EXP IMMUNOL, V166, P281, DOI 10.1111/j.1365-2249.2011.04471.x; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xiong XL, 2014, J HEPATOL, V60, P847, DOI 10.1016/j.jhep.2013.12.003; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zeng QL, 2014, MOL CELLS, V37, P66, DOI 10.14348/molcells.2014.2282	43	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149948	10.1371/journal.pone.0149948	http://dx.doi.org/10.1371/journal.pone.0149948			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901500	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100191
J	Li, YH; Choi, DH; Lee, EH; Seo, SR; Lee, S; Cho, EH				Li, Ying Hui; Choi, Dae Hee; Lee, Eun Hye; Seo, Su Ryeon; Lee, Seungkoo; Cho, Eun-Hee			Sirtuin 3 (SIRT3) Regulates alpha-Smooth Muscle Actin (alpha-SMA) Production through the Succinate Dehydrogenase-G Protein-coupled Receptor 91 (GPR91) Pathway in Hepatic Stellate Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY LIVER-DISEASE; RENIN RELEASE; NONALCOHOLIC STEATOHEPATITIS; DEPENDENT DEACETYLASE; INSULIN-RESISTANCE; HIGH GLUCOSE; RESVERATROL; METABOLISM; ACTIVATION; EXPRESSION	Sirtuin 3 (SIRT3) is an NAD(+)-dependent protein deacetylase. Recent studies have shown that SIRT3 expression is decreased in nonalcoholic fatty liver disease (NAFLD). Moreover, SIRT3 is a key regulator of succinate dehydrogenase (SDH), which catalyzes the oxidation of succinate to fumarate. Increased succinate concentrations and the specific G protein-coupled receptor 91 (GPR91) are involved in the activation of hepatic stellate cells (HSCs). In this study, we aimed to establish whether SIRT3 regulated the SDH activity, succinate, and GPR91 expression in HSCs and an animal model of NAFLD. Our goal was also to determine whether succinate released from hepatocytes regulated HSC activation. Inhibiting SIRT3 using SIRT3 siRNA exacerbated HSC activation via the SDH-succinate-GPR91 pathway, and SIRT3 overexpression or honokiol treatment attenuated HSC activation in vitro. In isolated liver and HSCs from methionine-and choline-deficient (MCD) diet-induced NAFLD, the expression of SIRT3 and SDH activity was decreased, and the succinate concentrations and GPR91 expression were increased. Moreover, we found that GPR91 knockdown or resveratrol treatment improved the steatosis in MCD diet-fed mice. This investigation revealed a novel mechanism of the SIRT3-SDH-GPR91 cascade in MCD diet-induced HSC activation in NAFLD. These findings highlight the biological significance of novel strategies aimed at targeting SIRT3 and GPR91 in HSCs with the goal of improving NAFLD treatment.	[Li, Ying Hui; Choi, Dae Hee; Cho, Eun-Hee] Kangwon Natl Univ, Dept Internal Med, Chunchon 200701, South Korea; [Lee, Seungkoo] Kangwon Natl Univ, Dept Anat Pathol, Sch Med, Chunchon 200701, South Korea; [Lee, Eun Hye; Seo, Su Ryeon] Kangwon Natl Univ, Coll Biomed Sci, Dept Mol Biosci, Chunchon 200701, South Korea; [Lee, Eun Hye; Seo, Su Ryeon] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea	Kangwon National University; Kangwon National University; Kangwon National University; Kangwon National University	Cho, EH (corresponding author), Kangwon Natl Univ, Sch Med, Dept Internal Med, 26 Kangwondaehak Gil, Chuncheon Si 200701, Gangwon Do, South Korea.	ehcho@kangwon.ac.kr		CHO, EUN-HEE/0000-0002-1349-8894	 [NRF-2013R1A1A1058962]		This work was supported by Grant NRF-2013R1A1A1058962. The authors declare that they have no conflicts of interest with the contents of this article.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ariza Ana Carolina, 2012, Front Endocrinol (Lausanne), V3, P22, DOI 10.3389/fendo.2012.00022; Bao JJ, 2010, FREE RADICAL BIO MED, V49, P1230, DOI 10.1016/j.freeradbiomed.2010.07.009; Barbero-Becerra VJ, 2015, TOXICOL IN VITRO, V29, P1753, DOI 10.1016/j.tiv.2015.07.010; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Caldwell SH, 1999, HEPATOLOGY, V29, P664, DOI 10.1002/hep.510290347; Cho Eun-Hee, 2014, J Lifestyle Med, V4, P80, DOI 10.15280/jlm.2014.4.2.80; Cimen H, 2010, BIOCHEMISTRY-US, V49, P304, DOI 10.1021/bi901627u; COBB MH, 1994, SEMIN CANCER BIOL, V5, P261; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; Deen PMT, 2011, J AM SOC NEPHROL, V22, P1416, DOI 10.1681/ASN.2010050481; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Gnana-Prakasam JP, 2011, INVEST OPHTH VIS SCI, V52, P3751, DOI 10.1167/iovs.10-6722; He JH, 2013, MOL CELL BIOL, V33, P2047, DOI 10.1128/MCB.01658-12; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hirschey MD, 2011, COLD SH Q B, V76, P267, DOI 10.1101/sqb.2011.76.010850; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Ismail MH, 2011, HEPATIC MED-EVID RES, V3, P69, DOI 10.2147/HMER.S9051; Jing EX, 2011, P NATL ACAD SCI USA, V108, P14608, DOI 10.1073/pnas.1111308108; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Knittel T, 1996, HEPATOLOGY, V24, P352; Krebs H A, 1970, Adv Enzyme Regul, V8, P335, DOI 10.1016/0065-2571(70)90028-2; Kulkarni SS, 2015, BBA-MOL BASIS DIS, V1852, P1114, DOI 10.1016/j.bbadis.2014.10.005; Lantier L, 2015, DIABETES, V64, P3081, DOI 10.2337/db14-1810; Li YH, 2015, BIOCHEM BIOPH RES CO, V463, P853, DOI 10.1016/j.bbrc.2015.06.023; Lim S, 2014, ENDOCRINOL METAB, V29, P1, DOI 10.3803/EnM.2014.29.1.1; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lukyanova LD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00320; Masuoka HC, 2013, ANN NY ACAD SCI, V1281, P106, DOI 10.1111/nyas.12016; McCullough AJ, 2006, J CLIN GASTROENTEROL, V40, pS17; Nogueiras R, 2012, PHYSIOL REV, V92, P1479, DOI 10.1152/physrev.00022.2011; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Pan QR, 2015, NUTR RES, V35, P576, DOI 10.1016/j.nutres.2015.05.006; Peti-Peterdi J, 2010, KIDNEY INT, V78, P1214, DOI 10.1038/ki.2010.333; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Qian H, 2015, CELL RES, V25, P930, DOI 10.1038/cr.2015.84; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Robben JH, 2009, KIDNEY INT, V76, P1258, DOI 10.1038/ki.2009.360; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sapieha P, 2008, NAT MED, V14, P1067, DOI 10.1038/nm.1873; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Vargas SL, 2009, J AM SOC NEPHROL, V20, P1002, DOI 10.1681/ASN.2008070740; Wu T, 2014, ANN CLIN LAB SCI, V44, P410; Yoo HJ, 2015, DIABETES METAB J, V39, P10, DOI 10.4093/dmj.2015.39.1.10	55	39	42	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10277	10292		10.1074/jbc.M115.692244	http://dx.doi.org/10.1074/jbc.M115.692244			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26912655	Green Published, hybrid			2022-12-26	WOS:000375602800035
J	Vangansewinkel, T; Geurts, N; Quanten, K; Nelissen, S; Lemmens, S; Geboes, L; Dooley, D; Vidal, PM; Pejler, G; Hendrix, S				Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Pejler, Gunnar; Hendrix, Sven			Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6	FASEB JOURNAL			English	Article						CNS trauma; mMCP6; ECM remodeling; gene expression; improved outcome	CENTRAL-NERVOUS-SYSTEM; CHONDROITIN SULFATE PROTEOGLYCANS; AXONAL REGENERATION; GLIAL SCAR; BETA-TRYPTASE; ABC PROMOTES; MATRIX; INFLAMMATION; BRAIN; MICE	An important barrier for axon regeneration and recovery after traumatic spinal cord injury (SCI) is attributed to the scar that is formed at the lesion site. Here, we investigated the effect of mouse mast cell protease (mMCP) 6, a mast cell (MC)-specific tryptase, on scarring and functional recovery after a spinal cord hemisection injury. Functional recovery was significantly impaired in both MC-deficient and mMCP6-knockout (mMCP6(-/-)) mice after SCI compared with wild-type control mice. This decrease in locomotor performance was associated with an increased lesion size and excessive scarring at the injury site. Axon growth-inhibitory chondroitin sulfate proteoglycans and the extracellular matrix components fibronectin, laminin, and collagen IV were significantly up-regulated in MC-deficient and mMCP6(-/-) mice, with an increase in scar volume between 23 and 32%. A degradation assay revealed that mMCP6 directly cleaves fibronectin and collagen IV in vitro. In addition, gene expression levels of the scar components fibronectin, aggrecan, and collagen IV were increased up to 6.8-fold in mMCP6(-/-) mice in the subacute phase after injury. These data indicate that endogenous mMCP6 has scar-suppressing properties after SCI via indirect cleavage of axon growth-inhibitory scar components and alteration of the gene expression profile of these factors.-Vangansewinkel, T., Geurts, N., Quanten, K., Nelissen, S., Lemmens, S., Geboes, L., Dooley, D., Vidal, P. M., Pejler, G., Hendrix, S. Mast cells promote scar remodeling and functional recovery after spinal cord injury via mouse mast cell protease 6. www.fasebj.org	[Vangansewinkel, Tim; Geurts, Nathalie; Quanten, Kirsten; Nelissen, Sofie; Lemmens, Stefanie; Geboes, Lies; Dooley, Dearbhaile; Vidal, Pia M.; Hendrix, Sven] Hasselt Univ, Biomed Res Inst, Dept Morphol, Diepenbeek, Belgium; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Pejler, Gunnar] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Vidal, Pia M.] Univ Hlth Network, Div Genet & Dev, Krembil Neurosci Ctr, Toronto, ON, Canada	Hasselt University; Swedish University of Agricultural Sciences; Uppsala University; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Hendrix, S (corresponding author), Martelarenlaan 42, B-3500 Hasselt, Belgium.	sven.hendrix@uhasselt.be	Vidal, Pia M./U-8401-2019; Hendrix, Sven/F-4059-2010; Vangansewinkel, Tim/N-4308-2017	Vidal, Pia M./0000-0001-9885-3076; Hendrix, Sven/0000-0003-2344-7369; Dooley, Dearbhaile/0000-0001-5337-1831	Deutsche Forschungsgemeinschaft [SPP1394]; Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO) [G.0389.12, G0A5813, G.0834.11N, G0A58113, 1.2.917.14N]; Agentschap voor Innovatie door Wetenschap en Technologie [101517]; COST Action Mast Cells and Basophils-Targets for Innovative Therapies [BM1007]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO)(FWO); Agentschap voor Innovatie door Wetenschap en Technologie; COST Action Mast Cells and Basophils-Targets for Innovative Therapies	The authors thank Dr. David Lee (Novartis Pharma, Basel, Switzerland) and Dr. Peter Nigrovic (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for providing the mMCP6<SUP>-/-</SUP> mice, and Dr. Leen Timmermans (Hasselt University) for her help with the qPCR analysis and immunohistochemistry. This study was supported in part by grants from Deutsche Forschungsgemeinschaft (SPP1394), Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (FWO; G.0389.12, G0A5813, G.0834.11N, and G0A58113 to S.H., and 1.2.917.14N to N.G.), and from Agentschap voor Innovatie door Wetenschap en Technologie (101517 to T.V.). This work has also benefited from the support of the COST Action BM1007 Mast Cells and Basophils-Targets for Innovative Therapies.	Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brazda N, 2009, PROG BRAIN RES, V175, P269, DOI 10.1016/S0079-6123(09)17518-0; Caughey GH, 2011, ADV EXP MED BIOL, V716, P212, DOI 10.1007/978-1-4419-9533-9_12; Clair JMS, 2004, J CLIN INVEST, V113, P628, DOI 10.1172/JCI200419062; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Didangelos A, 2014, J NEUROSCI, V34, P16424, DOI 10.1523/JNEUROSCI.2927-14.2014; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Douaiher J, 2014, ADV IMMUNOL, V122, P211, DOI 10.1016/B978-0-12-800267-4.00006-7; Drube S, 2010, BLOOD, V115, P3899, DOI 10.1182/blood-2009-10-247411; Fajardo I, 2003, J IMMUNOL, V171, P1493, DOI 10.4049/jimmunol.171.3.1493; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Galli SJ, 2008, J DERMATOL SCI, V49, P7, DOI 10.1016/j.jdermsci.2007.09.009; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165; Grimbaldeston MA, 2005, AM J PATHOL, V167, P835, DOI 10.1016/S0002-9440(10)62055-X; Hallgren J, 2000, BIOCHEMISTRY-US, V39, P13068, DOI 10.1021/bi000973b; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2001, J BIOL CHEM, V276, P42774, DOI 10.1074/jbc.M105531200; Hendrix S, 2013, FASEB J, V27, P920, DOI 10.1096/fj.12-204800; Hermanns S, 2006, ADV EXP MED BIOL, V557, P177; Hermanns S, 2001, RESTOR NEUROL NEUROS, V19, P139; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Jones LL, 2003, J NEUROSCI, V23, P9276; Jones LL, 2003, EXP NEUROL, V182, P399, DOI 10.1016/S0014-4886(03)00087-6; Jones TB, 2005, CURR PHARM DESIGN, V11, P1223, DOI 10.2174/1381612053507468; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Klapka N, 2005, EUR J NEUROSCI, V22, P3047, DOI 10.1111/j.1460-9568.2005.04495.x; Lindsberg PJ, 2010, J CEREBR BLOOD F MET, V30, P689, DOI 10.1038/jcbfm.2009.282; Liu XB, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/627831; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Loske P, 2012, J NEUROCHEM, V120, P1084, DOI 10.1111/j.1471-4159.2012.07657.x; Lundequist A, 2006, BIOL CHEM, V387, P1513, DOI 10.1515/BC.2006.189; Lundequist A, 2011, CELL MOL LIFE SCI, V68, P965, DOI 10.1007/s00018-010-0587-0; Magarinos NJ, 2013, J IMMUNOL, V191, P1404, DOI 10.4049/jimmunol.1300856; Massey JM, 2006, J NEUROSCI, V26, P4406, DOI 10.1523/JNEUROSCI.5467-05.2006; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mullan CS, 2008, AM J RESP CELL MOL, V38, P600, DOI 10.1165/rcmb.2007-0082OC; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; Nelissen S, 2014, NEUROBIOL DIS, V62, P260, DOI 10.1016/j.nbd.2013.09.012; Nelissen S, 2013, ACTA NEUROPATHOL, V125, P637, DOI 10.1007/s00401-013-1092-y; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Pejler G, 2007, ADV IMMUNOL, V95, P167, DOI 10.1016/S0065-2776(07)95006-3; Pejler G, 2010, BLOOD, V115, P4981, DOI 10.1182/blood-2010-01-257287; Polajeva J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025222; Raposo C, 2014, GLIA, V62, P1895, DOI 10.1002/glia.22676; Ribatti D, 2015, EXP CELL RES, V332, P157, DOI 10.1016/j.yexcr.2014.11.014; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Shearer MC, 2001, CELL TISSUE RES, V305, P267, DOI 10.1007/s004410100384; Shechter R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027969; Shin K, 2008, J IMMUNOL, V180, P4885, DOI 10.4049/jimmunol.180.7.4885; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Soderblom C, 2013, J NEUROSCI, V33, P13882, DOI 10.1523/JNEUROSCI.2524-13.2013; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanzola MB, 2003, J IMMUNOL, V171, P4385, DOI 10.4049/jimmunol.171.8.4385; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Tsai M, 2005, CHEM IMMUNOL ALLERGY, V87, P179, DOI 10.1159/000087644; Tuszynski MH, 2012, NEURON, V74, P777, DOI 10.1016/j.neuron.2012.05.006; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vidal PM, 2013, CYTOKINE GROWTH F R, V24, P1, DOI 10.1016/j.cytogfr.2012.08.008; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woldacki K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.214; Yang XP, 2010, LEUKEMIA LYMPHOMA, V51, P1550, DOI 10.3109/10428194.2010.496013; Yasuda S, 2005, BLOOD, V105, P3893, DOI 10.1182/blood-2003-10-3501; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Zhu YJ, 2015, J NEUROTRAUM, V32, P1158, DOI 10.1089/neu.2014.3703	74	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2016	30	5					2040	2057		10.1096/fj.201500114R	http://dx.doi.org/10.1096/fj.201500114R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DK4HW	26917739				2022-12-26	WOS:000374879400030
J	Wojcik, J; Lamontanara, AJ; Grabe, G; Koide, A; Akin, L; Gerig, B; Hantschel, O; Koide, S				Wojcik, John; Lamontanara, Allan Joaquim; Grabe, Grzegorz; Koide, Akiko; Akin, Louesa; Gerig, Barbara; Hantschel, Oliver; Koide, Shohei			Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABL tyrosine kinase; enzyme inhibitor; protein engineering; protein-protein interaction; Src homology 2 domain (SH2 domain); x-ray crystallography; FN3; PPI inhibitor	BINDING-PROTEINS; C-ABL; III DOMAIN; RESISTANCE; SCAFFOLD; STI571	Bcr-Abl is a constitutively active kinase that causes chronic myelogenous leukemia. We have shown that a tandem fusion of two designed binding proteins, termed monobodies, directed to the interaction interface between the Src homology 2 (SH2) and kinase domains and to the phosphotyrosine-binding site of the SH2 domain, respectively, inhibits the Bcr-Abl kinase activity. Because the latter monobody inhibits processive phosphorylation by Bcr-Abl and the SH2-kinase interface is occluded in the active kinase, it remained undetermined whether targeting the SH2-kinase interface alone was sufficient for Bcr-Abl inhibition. To address this question, we generated new, higher affinity monobodies with single nanomolar K-D values targeting the kinase-binding surface of SH2. Structural and mutagenesis studies revealed the molecular underpinnings of the monobody-SH2 interactions. Importantly, the new monobodies inhibited Bcr-Abl kinase activity in vitro and in cells, and they potently induced cell death in chronic myelogenous leukemia cell lines. This work provides strong evidence for the SH2-kinase interface as a pharmacologically tractable site for allosteric inhibition of Bcr-Abl.	[Wojcik, John; Grabe, Grzegorz; Koide, Akiko; Akin, Louesa; Koide, Shohei] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Lamontanara, Allan Joaquim; Gerig, Barbara; Hantschel, Oliver] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Grabe, Grzegorz] Univ Gdansk, Intercollegiate Fac Biotechnol, Gdansk, Poland; [Grabe, Grzegorz; Hantschel, Oliver] Med Univ Gdansk, Gdansk, Poland	University of Chicago; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Hantschel, O (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland.; Koide, S (corresponding author), NYU, Langone Med Ctr, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA.	oliver.hantschel@epfl.ch; Shohei.Koide@nyumc.org	Hantschel, Oliver/M-7016-2019; Hantschel, Oliver D/H-4705-2013; Grabe, Grzegorz/CAG-9633-2022	Hantschel, Oliver/0000-0001-8569-8169; Hantschel, Oliver D/0000-0001-8569-8169; Grabe, Grzegorz/0000-0002-0419-491X; Koide, Shohei/0000-0001-5473-4358	National Institutes of Health [P41 GM103403]; National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090324, T32GM007281, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Georgeon for the gel filtration data and technical support throughout the project. We acknowledge the use of the Northeastern Collaborative Access Team beamlines, which are funded by National Institutes of Health Grant P41 GM103403. The Pilatus 6M detector on the 24-ID-C beamline is funded by National Institutes of Health Office of Research Infrastructure Programs High-End Instrumentation Grant S10 RR029205. The Advanced Photon Source is a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357.	Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; BRUNGER AT, 1992, XPLOR SYSTEM XRAY CR; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlanson DA, 2004, ANNU REV BIOPH BIOM, V33, P199, DOI 10.1146/annurev.biophys.33.110502.140409; Filippakopoulos P, 2008, CELL, V134, P793, DOI 10.1016/j.cell.2008.07.047; Gilbreth RN, 2012, CURR OPIN STRUC BIOL, V22, P413, DOI 10.1016/j.sbi.2012.06.001; Grebien F, 2011, CELL, V147, P306, DOI 10.1016/j.cell.2011.08.046; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hantschel O, 2012, CANCER RES, V72, P4890, DOI 10.1158/0008-5472.CAN-12-1276; Hantschel O, 2008, MOL ONCOL, V2, P272, DOI 10.1016/j.molonc.2008.07.003; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Huang XL, 1998, J MOL BIOL, V281, P61, DOI 10.1006/jmbi.1998.1930; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide A, 2009, PROTEIN ENG DES SEL, V22, P685, DOI 10.1093/protein/gzp053; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lamontanara AJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6470; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2003, ONCOGENE, V22, P7389, DOI 10.1038/sj.onc.1206942; Sherbenou DW, 2010, BLOOD, V116, P3278, DOI 10.1182/blood-2008-10-183665; Wojcik J, 2010, NAT STRUCT MOL BIOL, V17, P519, DOI 10.1038/nsmb.1793; Wylie A, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.398.398	35	23	24	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8836	8847		10.1074/jbc.M115.707901	http://dx.doi.org/10.1074/jbc.M115.707901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912659	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000374773200044
J	Chang, TS; Chen, CL; Wu, YC; Liu, JJ; Kuo, YC; Lee, KF; Lin, SY; Lin, SE; Tung, SY; Kuo, LM; Tsai, YH; Huang, YH				Chang, Te-Sheng; Chen, Chi-Long; Wu, Yu-Chih; Liu, Jun-Jen; Kuo, Yung Che; Lee, Kam-Fai; Lin, Sin-Yi; Lin, Sey-En; Tung, Shui-Yi; Kuo, Liang-Mou; Tsai, Ying-Huang; Huang, Yen-Hua			Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							FACTOR-I RECEPTOR; LIVER INFLAMMATION; HEPATITIS-C; CANCER; CELLS; INFECTION; PATHWAY; HCC; RECURRENCE; ACTIVATION	The expression of cancer stemness is believed to reduce the efficacy of current therapies against hepatocellular carcinoma (HCC). Understanding of the stemness-regulating signaling pathways incurred by a specific etiology can facilitate the development of novel targets for individualized therapy against HCC. Niche environments, such as virus-induced inflammation, may play a crucial role. However, the mechanisms linking inflammation and stemness expression in HCC remain unclear. Here we demonstrated the distinct role of inflammatory mediators in expressions of stemness-related properties involving the pluripotent octamer-binding transcription factor 4 (OCT4) in cell migration and drug resistance of hepatitis B virus-related HCC (HBV-HCC). We observed positive immunorecognition for macrophage chemoattractant protein 1 (MCP-1)/CD68 and OCT4/NANOG in HBV-HCC tissues. The inflammation-conditioned medium (inflamed-CM) generated by lipopolysaccharide-stimulated U937 human leukemia cells significantly increased the mRNA and protein levels of OCT4/NANOG preferentially in HBV-active (HBV(+)HBsAg(+)) HCC cells. The inflamed-CM also increased the side population (SP) cell percentage, green fluorescent protein (GFP)-positive cell population, and luciferase activity of OCT4 promoter-GFP/luciferase in HBV-active HCC cells. Furthermore, the inflamed-CM upregulated the expressions of insulin-like growth factor-I (IGF-I)/IGF-I receptor (IGF-IR) and activated IGF-IR/Akt signaling in HBV-HCC. The IGF-IR phosphorylation inhibitor picropodophyllin (PPP) suppressed inflamed-CM-induced OCT4 and NANOG levels in HBV(+)HBsAg(+) Hep3B cells. Forced expression of OCT4 significantly increased the secondary sphere formation and cell migration, and reduced susceptibility of HBV-HCC cells to cisplatin, bleomycin, and doxorubicin. Taking together, our results show that niche inflammatory mediators play critical roles in inducing the expression of stemness-related properties involving IGF-IR activation, and the upregulation of OCT4 contributes to cancer migration and drug resistance of HBV-HCC cells. Findings in this paper would provide potential targets for a therapeutic strategy targeting on inflammatory environment for HBV-HCC.	[Chang, Te-Sheng; Wu, Yu-Chih; Kuo, Yung Che; Lin, Sin-Yi; Huang, Yen-Hua] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan; [Chang, Te-Sheng; Tung, Shui-Yi] Chang Gung Mem Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Chiayi, Taiwan; [Chen, Chi-Long; Lin, Sey-En] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long; Lin, Sey-En] Taipei Med Univ, Sch Med, Dept Pathol, Coll Med, Taipei, Taiwan; [Wu, Yu-Chih; Kuo, Yung Che; Huang, Yen-Hua] Taipei Med Univ, TMU Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Liu, Jun-Jen] Taipei Med Univ, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Kuo, Liang-Mou] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Chiayi, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Huang, YH (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, TMU Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan.	rita1204@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021	Lin, Sey-En/0000-0002-8994-9452; Huang, Yen-Hua/0000-0001-6020-9998; Kuo, Yung-Che/0000-0002-9425-7389; Wu, Yu-Chih/0000-0001-5781-2665	National Science Council, Taiwan [NSC(100-102)-2321-B-038-003, NSC101-2314-B-182A-028, NSC102-2628-B-038-008-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2321-B-038-011, MOST104-2321-B-038-003, MOST 104-2314-B-182A-020-MY2]; Health and Welfare Surcharge of Tobacco Products [MOHW104-TDU-B-212-124-001, MOHW105-TDU-B-212-134001]; Taipei Medical University [TMUTOP103002-9, TMU-T104-06]; Wan-Fang Hospital [103TMU-WFH-01-2]; Chang Gung Memorial Hospital [CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382, CMRPG6F0161]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Health and Welfare Surcharge of Tobacco Products; Taipei Medical University; Wan-Fang Hospital; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC(100-102)-2321-B-038-003, NSC101-2314-B-182A-028, and NSC102-2628-B-038-008-MY3) (http://www.most.gov.tw/), Ministry of Science and Technology, Taiwan (MOST 103-2321-B-038-011, MOST104-2321-B-038-003, MOST 104-2314-B-182A-020-MY2) (http://www.most.gov.tw/), Health and Welfare Surcharge of Tobacco Products (MOHW104-TDU-B-212-124-001) and (MOHW105-TDU-B-212-134001) (http://www.mohw.gov.tw/EN/Ministry/Index.aspx), Taipei Medical University (TMUTOP103002-9) and (TMU-T104-06) (http://www.tmu.edu.tw/english/main.php), Wan-Fang Hospital (103TMU-WFH-01-2) (http://www.taiwanhealthcare.com/english/index.aspx), and Chang Gung Memorial Hospital (CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382 and CMRPG6F0161) (https://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2015, SEMIN ONCOL, V42, pS3, DOI 10.1053/j.seminoncol.2015.01.001; Arndt W, 2014, J CLIN GASTROENTEROL, V48, P279, DOI [10.1097/MCG.0b013e3182a8a793, DOI 10.1097/MCG.0B013E3182A8A793]; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Berasain G, 2009, ANN NY ACAD SCI, V1155, P206, DOI [10.1111/j.1749-6632.2009.03704.x, DOI 10.1111/J.1749-6632.2009.03704.X]; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P906, DOI 10.1001/archsurg.2009.99; Chang TS, 2015, CLIN CANCER RES, V21, P201, DOI 10.1158/1078-0432.CCR-13-3274; Chiao H, 1996, J CLIN INVEST, V97, P2038, DOI 10.1172/JCI118639; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Csermely P, 2015, SEMIN CANCER BIOL, V30, P42, DOI 10.1016/j.semcancer.2013.12.004; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Fransvea E, 2009, CELL ONCOL, V31, P227, DOI 10.3233/CLO-2009-0473; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Knight B, 2005, IMMUNOL CELL BIOL, V83, P364, DOI 10.1111/j.1440-1711.2005.01346.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma N, 2011, BIOCHEM BIOPH RES CO, V414, P344, DOI 10.1016/j.bbrc.2011.09.073; Matsumoto K, 2002, HEPATOL RES, V23, P196, DOI 10.1016/S1386-6346(01)00180-2; Ramanan V, 2014, ANNU REV VIROL, V1, P475, DOI 10.1146/annurev-virology-031413-085437; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Shigdar S, 2014, CANCER LETT, V345, P271, DOI 10.1016/j.canlet.2013.07.031; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanno T, 2011, J NIPPON MED SCH, V78, P138, DOI 10.1272/jnms.78.138; Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wu HC, 2014, HUM PATHOL, V45, P1294, DOI 10.1016/j.humpath.2013.10.039; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007	33	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149897	10.1371/journal.pone.0149897	http://dx.doi.org/10.1371/journal.pone.0149897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919045	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400055
J	Duncan, DT; Kapadia, F; Regan, SD; Goedel, WC; Levy, MD; Barton, SC; Friedman, SR; Halkitis, PN				Duncan, Dustin T.; Kapadia, Farzana; Regan, Seann D.; Goedel, William C.; Levy, Michael D.; Barton, Staci C.; Friedman, Samuel R.; Halkitis, Perry N.			Feasibility and Acceptability of Global Positioning System (GPS) Methods to Study the Spatial Contexts of Substance Use and Sexual Risk Behaviors among Young Men Who Have Sex with Men in New York City: A P18 Cohort Sub-Study	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; PHYSICAL-ACTIVITY BEHAVIORS; LGBT HATE CRIMES; HIV-INFECTION; DRUG-USERS; NEIGHBORHOOD; GAY; ADOLESCENTS; MOBILITY; HEALTH	Background No global positioning system (GPS) technology study has been conducted among a sample of young gay, bisexual, and other men who have sex with men (YMSM). As such, the purpose of this study was to evaluate the feasibility and acceptability of using GPS methods to understand the spatial context of substance use and sexual risk behaviors among a sample of YMSM in New York City, a high-risk population. Methods Data came from a subsample of the ongoing P18 Cohort Study (n = 75). GPS feasibility and acceptability among participants was measured with: 1) a pre- and post-survey and 2) adherence to the GPS protocol which included returning the GPS device, self-report of charging and carrying the GPS device as well as objective data analyzed from the GPS devices. Analyses of the feasibility surveys were treated as repeated measures as each participant had a pre-and post-feasibility survey. When comparing the similar GPS survey items asked at baseline and at follow-up, we present percentages and associated p-values based on chi-square statistics. Results Participants reported high ratings of pre-GPS acceptability, ease of use, and low levels of wear-related concerns in addition to few concerns related to safety, loss, or appearance, which were maintained after baseline GPS feasibility data collection. The GPS return rate was 100%. Most participants charged and carried the GPS device on most days. Of the total of 75 participants with GPS data, 75 (100%) have at least one hour of GPS data for one day and 63 (84%) had at least one hour on all 7 days. Conclusions Results from this pilot study demonstrate that utilizing GPS methods among YMSM is feasible and acceptable. GPS devices may be used in spatial epidemiology research in YMSM populations to understand place-based determinants of health such as substance use and sexual risk behaviors.	[Duncan, Dustin T.; Kapadia, Farzana; Regan, Seann D.; Goedel, William C.; Halkitis, Perry N.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Goedel, William C.; Halkitis, Perry N.] NYU, Coll Global Publ Hlth, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Halkitis, Perry N.] NYU, Populat Ctr, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Levy, Michael D.; Barton, Staci C.; Halkitis, Perry N.] NYU, Ctr Hlth Ident Behav & Prevent Studies, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Friedman, Samuel R.; Halkitis, Perry N.] NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA; [Duncan, Dustin T.] NYU, Ctr Data Sci, New York, NY USA; [Friedman, Samuel R.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University; National Development & Research Institutes, Inc	Duncan, DT (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY USA.; Duncan, DT (corresponding author), NYU, Coll Global Publ Hlth, New York, NY USA.; Duncan, DT (corresponding author), NYU, Populat Ctr, New York, NY USA.; Duncan, DT (corresponding author), NYU, Ctr Hlth Ident Behav & Prevent Studies, New York, NY USA.; Duncan, DT (corresponding author), NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA.; Duncan, DT (corresponding author), NYU, Ctr Data Sci, New York, NY USA.	Dustin.Duncan@nyumc.org	Kapadia, farzana/AAI-8304-2020; Regan, Seann/AAL-3863-2021	Regan, Seann/0000-0002-1034-0282; Goedel, William/0000-0002-2869-1048; Kapadia, Farzana/0000-0003-3459-767X; Friedman, Sam/0000-0003-2083-1226	NYU Center for Drug Use and HIV Research Pilot Project Awards Program; National Institute on Drug Abuse [5P30DA011041-17, 18, 1R01DA025537, 2R01DA025537-06A1]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, R01DA025537] Funding Source: NIH RePORTER	NYU Center for Drug Use and HIV Research Pilot Project Awards Program; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NYU Center for Drug Use and HIV Research Pilot Project Awards Program (Drs. Dustin Duncan and Farzana Kapadia, co-Principal Investigators). The NYU Center for Drug Use and HIV Research is funded by the National Institute on Drug Abuse (Grant# 5P30DA011041-17). The parent study, Project 18, was also funded by the National Institute on Drug Abuse (Grant # 1R01DA025537; 2R01DA025537-06A1, Dr. Perry Halkitis, Principal Investigator).	[Anonymous], HIV SURVEILLANCE SUP; Brewster KL, 2012, AM J PUBLIC HEALTH, V102, P1168, DOI 10.2105/AJPH.2011.300261; Brouwer KC, 2008, INTEGRATING GIS STUD, P27; Buttram ME, 2013, AM J MENS HEALTH, V7, P110, DOI 10.1177/1557988312458793; Byrnes HF, 2015, J ADOLESCENT HEALTH, V57, P245, DOI 10.1016/j.jadohealth.2015.04.013; Carpiano RM, 2011, J HEALTH SOC BEHAV, V52, P74, DOI 10.1177/0022146510395026; CDC, 2015, HIV SURV REP, V25, P1; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Chum A, 2013, HEALTH PLACE, V24, P73, DOI 10.1016/j.healthplace.2013.07.007; Clark RA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-37; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Dasgupta S, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.2946; Dessing D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-227; Duncan DT, 2015, J MAPS IN PRESS; Duncan DT, 2014, GEOSPATIAL HEALTH, V9, P57, DOI 10.4081/gh.2014.6; Duncan DT, 2014, INT J ENV RES PUB HE, V11, P8962, DOI 10.3390/ijerph110908962; Duncan DT, 2014, AM J PUBLIC HEALTH, V104, P272, DOI 10.2105/AJPH.2013.301424; Duncan DT, 2014, DRUG ALCOHOL DEPEN, V135, P65, DOI 10.1016/j.drugalcdep.2013.11.001; Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251; Duncan JS, 2009, J SCI MED SPORT, V12, P583, DOI 10.1016/j.jsams.2008.09.010; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Epstein DH, 2014, DRUG ALCOHOL DEPEN, V134, P22, DOI [10.1016/j.drugalcdep.2013.09.007, 10.1016/j.d]; Evenson KR, 2013, MED SCI SPORT EXER, V45, P1981, DOI 10.1249/MSS.0b013e318293330e; Frye V, 2010, AIDS BEHAV, V14, P974, DOI 10.1007/s10461-008-9438-5; Georgiadou Y., 1988, Manuscripta Geodaetica, V13, P172; Goedel William C, 2015, JMIR Public Health Surveill, V1, pe4, DOI 10.2196/publichealth.4353; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Halkitis P, 2015, J ACQUIR IMMUNE DEFI; Halkitis PN, 2015, AIDS BEHAV, V19, P970, DOI 10.1007/s10461-014-0892-y; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Halkitis PN, 2013, AIDS PATIENT CARE ST, V27, P181, DOI 10.1089/apc.2012.0415; Harrison F, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-5; Hatzenbuehler ML, 2015, VIOLENCE VICTIMS, V30, P663, DOI 10.1891/0886-6708.VV-D-13-00166; Hoyt MA, 2012, HEALTH PSYCHOL, V31, P269, DOI 10.1037/a0025953; Hurvitz PM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00002; Hurvitz PM, 2012, AM J PREV MED, V42, P411, DOI 10.1016/j.amepre.2011.11.015; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kelly BC, 2012, SOCIOL HEALTH ILL, V34, P1085, DOI 10.1111/j.1467-9566.2011.01446.x; Kirchner TR, 2014, 3 INT WORKSH URB COM; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Martinez AN, 2014, INT J DRUG POLICY, V25, P516, DOI 10.1016/j.drugpo.2013.11.008; Matthews SA, 2011, SOC DISPAR H H CARE, P35, DOI 10.1007/978-1-4419-7482-2_3; McCluskey A, 2012, ISRN REHAB, V2012; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mirzazadeh A, 2014, TECHNOL HEALTH CARE, V22, P689, DOI 10.3233/THC-140838; Mustanski B, 2015, AIDS BEHAV, V19, P1037, DOI 10.1007/s10461-014-0955-0; Neaigus A, 2012, AIDS BEHAV, V16, P516, DOI 10.1007/s10461-011-0050-8; O'Connor TM, 2013, GEOSPATIAL HEALTH, V7, P375, DOI 10.4081/gh.2013.94; Oliver M, 2010, J PHYS ACT HEALTH, V7, P102, DOI 10.1123/jpah.7.1.102; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Perchoux C, 2015, PREV MED, V81, P142, DOI 10.1016/j.ypmed.2015.08.010; Phillips G, 2015, ARCH SEX BEHAV, V44, P1773, DOI 10.1007/s10508-014-0459-z; Raymond HF, 2014, AIDS BEHAV, V18, P346, DOI 10.1007/s10461-013-0508-y; Reif S, 2006, AM J PUBLIC HEALTH, V96, P970, DOI 10.2105/AJPH.2005.063149; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Rendina HJ, 2014, AIDS BEHAV, V18, P41, DOI 10.1007/s10461-013-0573-2; Rice E, 2012, J AIDS CLIN RES S, VS4, DOI DOI 10.4172/2155-6113.S4-005; Robinson AI, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-57; Sobell L.C., 1996, TIMELINE FOLLOW BACK; Spielman SE, 2013, ENVIRON PLANN B, V40, P489, DOI 10.1068/b38007; Spielman SE, 2009, SOC SCI MED, V68, P1098, DOI 10.1016/j.socscimed.2008.12.048; Stewart T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0176-6; Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI [10.1037/1524-9220.8.1.15, DOI 10.1037/1524-9220.8.1.15]; Vaughan AS, 2014, AIDS RES HUM RETROV, V30, P740, DOI [10.1089/aid.2014.0144, 10.1089/AID.2014.0144]; Webber SC, 2009, J AGING PHYS ACTIV, V17, P455, DOI 10.1123/japa.17.4.455; Wiehe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077667; Winetrobe H, 2014, AIDS CARE, V26, P1303, DOI 10.1080/09540121.2014.911811; Yan K, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/328076; Yen IH, 2015, J APPL GERONTOL, V34, pNP190, DOI 10.1177/0733464813479024; Zenk SN, 2012, J PHYS ACT HEALTH, V9, P924, DOI 10.1123/jpah.9.7.924; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	77	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0147520	10.1371/journal.pone.0147520	http://dx.doi.org/10.1371/journal.pone.0147520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918766	Green Submitted, Green Published, gold			2022-12-26	WOS:000371274400004
J	Gebrezgabiher, G; Romha, G; Ejeta, E; Asebe, G; Zemene, E; Ameni, G				Gebrezgabiher, Gebremedhin; Romha, Gebremedhin; Ejeta, Eyasu; Asebe, Getahun; Zemene, Endalew; Ameni, Gobena			Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; CONTROL PROGRAM; DOTS; REGION; CHINA	Tuberculosis (TB) is one of the major public health and socio-economic issues in the 21st century globally. Assessment of TB treatment outcomes, and monitoring and evaluation of its risk factors in Directly Observed Treatment Short Course (DOTS) are among the major indicators of the performance of a national TB control program. Hence, this institution-based retrospective study was conducted to determine the treatment outcome of TB patients and investigate factors associated with unsuccessful outcome at Dilla University Referral Hospital, southern Ethiopia. Five years (2008 to 2013) TB record of TB clinic of the hospital was reviewed. A total 1537 registered TB patients with complete information were included. Of these, 942 (61.3%) were male, 1015 (66%) were from rural areas, 544 (35.4%) were smear positive pulmonary TB (PTB+), 816 (53.1%) were smear negative pulmonary TB (PTB-) and 177(11.5%) were extra pulmonary TB (EPTB) patients. Records of the 1537 TB patients showed that 181 (11.8%) were cured, 1129(73.5%) completed treatment, 171 (11.1%) defaulted, 52 (3.4%) died and 4 (0.3%) had treatment failure. The overall mean treatment success rate of the TB patients was 85.2%. The treatment success rate of the TB patients increased from 80.5% in September 2008-August 2009 to 84.8% in September 2012-May 2013. Tuberculosis type, age, residence and year of treatment were significantly associated with unsuccessful treatment outcome. The risk of unsuccessful outcome was significantly higher among TB patients from rural areas (AOR = 1.63, 95% CI: 1.21-2.20) compared to their urban counterparts. Unsuccessful treatment outcome was also observed in PTB-patients (AOR = 1.77, 95% CI: 1.26-2.50) and EPTB (AOR = 2.07, 95% CI: 1.28-3.37) compared to the PTB+ patients. In conclusion, it appears that DOTS have improved treatment success in the hospital during five years. Regular follow-up of patients with poor treatment outcome and provision of health information on TB treatment to patients from rural area is recommended.	[Gebrezgabiher, Gebremedhin; Zemene, Endalew] Jimma Univ, Coll Hlth Sci, POB 378, Jimma, Ethiopia; [Romha, Gebremedhin] Dilla Univ, Coll Agr & Nat Resource, POB 419, Dilla, Ethiopia; [Gebrezgabiher, Gebremedhin] Samara Univ, Coll Vet Med, POB 132, Samara, Ethiopia; [Ejeta, Eyasu] Wollega Univ, Coll Hlth Sci, POB 395, Nekemte, Ethiopia; [Asebe, Getahun] Gambella Univ, Coll Agr & Nat Resource, POB 126, Gambella, Ethiopia; [Ameni, Gobena] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, POB 1176, Addis Ababa, Ethiopia	Jimma University; Dilla University; Samara University; Addis Ababa University	Gebrezgabiher, G (corresponding author), Jimma Univ, Coll Hlth Sci, POB 378, Jimma, Ethiopia.; Gebrezgabiher, G (corresponding author), Samara Univ, Coll Vet Med, POB 132, Samara, Ethiopia.	gebruska2012@yahoo.com	Ameni, Gobena/AAR-4201-2020; Zemene, Endalew/HHS-0999-2022; Asebe, Getahun/AAV-7235-2021; Gebrezgabiher, Gebremedhin/GLV-3693-2022	Ameni, Gobena/0000-0003-3987-0671; Zemene, Endalew/0000-0001-6810-5800; Asebe, Getahun/0000-0002-1123-4545	Dilla University [CAN/09/2012]; Graduate Study of Addis Ababa University; graduate school of Addis Ababa University	Dilla University; Graduate Study of Addis Ababa University; graduate school of Addis Ababa University	The research was funded by Dilla University (Grant No. CAN/09/2012) and Graduate Study of Addis Ababa University. The funding agents had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been part of the research project of Epidemiology and Public Health Importance of Bovine TB in Gedeo Zone, Southern Ethiopia. It has partly received financial support from both graduate school of Addis Ababa University and Dilla University (Grant No. CAN/09/2012). We are grateful to the TB Unit experts in the hospital who facilitated the data collection.	Ahlburg DA, 2000, EC IMPACTS TUBERCULO; Ayeno HD, 2014, IJPBS, V2, P2347; Bao QS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-344; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Diel R, 2003, INT J TUBERC LUNG D, V7, P124; Esmael A, 2014, INT J PHARM SCI RES, V5, P1500, DOI 10.13040/IJPSR.0975-8232.5(4).1500-05; Farah MG, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-14; Federal Democratic Republic of Ethiopia Ministry of Health (FMoH), 2014, Q HLTH B, V6; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; MOH, 2019, TUB LEPR CAS MAN DES; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Parry E, 2004, PRINCIPLES MED AFRIC, V3rd; Ramos Jose Manuel, 2008, Ethiop Med J, V46, P173; Rodger AJ, 2002, B WORLD HEALTH ORGAN, V80, P451; Romanus V, 2000, Lakartidningen, V97, P5613; Santos L. C., 2012, OPEN J MED MICROBIOL, V2, P24, DOI DOI 10.4236/ojmm.2012.21004; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Sisay Solomon, 2014, BMC Res Notes, V7, P44, DOI 10.1186/1756-0500-7-44; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tadesse S., 2014, Health, V6, P306, DOI 10.4236/health.2014.65044; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; TRAC/FMOH TRAC, 2013, ROADM TUB OP RES ETH; Woldeyohannes Desalegn, 2011, Ethiop Med J, V49, P221; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2009, WHOHTMTB200940; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	33	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150560	10.1371/journal.pone.0150560	http://dx.doi.org/10.1371/journal.pone.0150560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918458	gold, Green Submitted, Green Published			2022-12-26	WOS:000371274400134
J	Isasi, CR; Jung, M; Parrinello, CM; Kaplan, RC; Kim, R; Crespo, NC; Gonzalez, P; Gouskova, NA; Penedo, FJ; Perreira, KM; Perrino, T; Sotres-Alvarez, D; Van Horn, L; Gallo, LC				Isasi, Carmen R.; Jung, Molly; Parrinello, Christina M.; Kaplan, Robert C.; Kim, Ryung; Crespo, Noe C.; Gonzalez, Patricia; Gouskova, Natalia A.; Penedo, Frank J.; Perreira, Krista M.; Perrino, Tatiana; Sotres-Alvarez, Daniela; Van Horn, Linda; Gallo, Linda C.			Association of Childhood Economic Hardship with Adult Height and Adult Adiposity among Hispanics/Latinos. The HCHS/SOL Socio-Cultural Ancillary Study	PLOS ONE			English	Article							BODY-MASS INDEX; ANTHROPOMETRIC INDICATORS; SOCIOECONOMIC POSITION; PSYCHOSOCIAL STRESS; BIRTH COHORT; DIET QUALITY; LATER LIFE; OBESITY; HEALTH; OVERWEIGHT	The study examined the association of childhood and current economic hardship with anthropometric indices in Hispanic/Latino adults, using data from the HCHS/SOL Socio-cultural ancillary study (N = 5,084), a community-based study of Hispanic/Latinos living in four urban areas (Bronx, NY, Chicago, IL, Miami, FL, and San Diego, CA). Childhood economic hardship was defined as having experienced a period of time when one's family had trouble paying for basic needs (e.g., food, housing), and when this economic hardship occurred: between 0-12, 13-18 years old, or throughout both of those times. Current economic hardship was defined as experiencing trouble paying for basic needs during the past 12 months. Anthropometry included height, body mass index (BMI), waist circumference (WC), and percentage body fat (%BF). Complex survey linear regression models were used to test the associations of childhood economic hardship with adult anthropometric indices, adjusting for potential confounders (e.g., age, sex, Hispanic background). Childhood economic hardship varied by Hispanic background, place of birth, and adult socio-economic status. Childhood economic hardship during both periods, childhood and adolescence, was associated with shorter height. Childhood economic hardship was associated with greater adiposity among US born individuals only. Current economic hardship was significantly associated with all three measures of adiposity (BMI, WC, %BF). These findings suggest that previous periods of childhood economic hardship appear to influence adult height more than adiposity, whereas current economic hardship may be a better determinant of adult adiposity in Hispanics.	[Isasi, Carmen R.; Jung, Molly; Parrinello, Christina M.; Kaplan, Robert C.; Kim, Ryung] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Crespo, Noe C.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Gonzalez, Patricia] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Gouskova, Natalia A.; Sotres-Alvarez, Daniela] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Penedo, Frank J.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Perreira, Krista M.] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC USA; [Perrino, Tatiana] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Van Horn, Linda] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Gallo, Linda C.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	Yeshiva University; Albert Einstein College of Medicine; Arizona State University; Arizona State University-Downtown Phoenix; California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University	Isasi, CR (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	carmen.isasi@einstein.yu.edu	DeMarcus, Forrest/O-9190-2016; Sotres-Alvarez, Daniela/O-9085-2016	Sotres-Alvarez, Daniela/0000-0002-3226-6140; Gallo, Linda C./0000-0002-3678-5888	NHLBI [RC2HL101649]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HCHS/SOL Socio-Cultural Ancillary Study was supported by grant number RC2HL101649 from NHLBI (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; Casey PH, 2012, J PERINATOL, V32, P91, DOI 10.1038/jp.2011.75; Coly AN, 2006, J NUTR, V136, P2412, DOI 10.1093/jn/136.9.2412; Crimmins EM, 2005, SOC BIOL, V52, P164; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gallo LC, 2014, ETHNIC DIS, V24, P77; Gigante DP, 2009, EUR J CLIN NUTR, V63, P375, DOI 10.1038/sj.ejcn.1602949; Gonzalez D, 2009, CAD SAUDE PUBLICA, V25, pS427, DOI 10.1590/S0102-311X2009001500008; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Hernandez DC, 2014, J EPIDEMIOL COMMUN H, V68, P478, DOI 10.1136/jech-2013-203062; Howel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079027; Isasi CR, 2015, ANN EPIDEMIOL, V25, P84, DOI 10.1016/j.annepidem.2014.11.002; Kauhanen L, 2006, INT J EPIDEMIOL, V35, P962, DOI 10.1093/ije/dyl046; Kestila L, 2009, SCAND J PUBLIC HEALT, V37, P206, DOI 10.1177/1403494808100827; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Kivimaki M, 2006, HEART, V92, P474, DOI 10.1136/hrt.2005.067108; Klohe-Lehman DM, 2006, J AM DIET ASSOC, V106, P65, DOI 10.1016/j.jada.2005.09.047; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Leung CW, 2014, J ACAD NUTR DIET, V114, P1943, DOI 10.1016/j.jand.2014.06.353; Levine ME, 2015, SOC SCI MED, V130, P16, DOI 10.1016/j.socscimed.2015.01.030; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Nelson CP, 2015, N ENGL J MED; Nguyen BT, 2014, MAYO CLIN PROC, V89, P1211, DOI 10.1016/j.mayocp.2014.05.010; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Sarlio-Lahteenkorva S, 2007, ACTA PAEDIATR, V96, P26, DOI 10.1111/j.1651-2227.2007.00166.x; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086	33	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149923	10.1371/journal.pone.0149923	http://dx.doi.org/10.1371/journal.pone.0149923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919283	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400057
J	Low, SK; Fukunaga, K; Takahashi, A; Matsuda, K; Hongo, F; Nakanishi, H; Kitamura, H; Inoue, T; Kato, Y; Tomita, Y; Fukasawa, S; Tanaka, T; Nishimura, K; Uemura, H; Hara, I; Fujisawa, M; Matsuyama, H; Hashine, K; Tatsugami, K; Enokida, H; Kubo, M; Miki, T; Mushiroda, T				Low, Siew-Kee; Fukunaga, Koya; Takahashi, Atsushi; Matsuda, Koichi; Hongo, Fumiya; Nakanishi, Hiroyuki; Kitamura, Hiroshi; Inoue, Takamitsu; Kato, Yoichiro; Tomita, Yoshihiko; Fukasawa, Satoshi; Tanaka, Tomoaki; Nishimura, Kazuo; Uemura, Hirotsugu; Hara, Isao; Fujisawa, Masato; Matsuyama, Hideyasu; Hashine, Katsuyoshi; Tatsugami, Katsunori; Enokida, Hideki; Kubo, Michiaki; Miki, Tsuneharu; Mushiroda, Taisei			Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; TYROSINE KINASE INHIBITORS; ENDOTHELIAL GROWTH-FACTOR; ANTITUMOR-ACTIVITY; INTERFERON-ALPHA; LUNG-CANCER; MUTATIONS; GEFITINIB; EFFICACY	Sunitinib is a tyrosine kinase inhibitor and used as the first-line treatment for advanced renal cell carcinoma (RCC). Nevertheless, inter-individual variability of drug's toxicity was often observed among patients who received sunitinib treatment. This study is to investigate the association of a functional germline variant on ABCG2 that affects the pharmacokinetics of sunitinib with sunitinib-induced toxicity of RCC patients in the Japanese population. A total of 219 RCC patients were recruited to this pharmacogenetic study. ABCG2 421C> A (Q141K) was genotyped by using PCR-Invader assay. The associations of both clinical and genetic variables were evaluated with logistic regression analysis and subsequently receiver operating characteristic (ROC) curve was plotted. About 43% (92/216) of RCC patients that received sunitinib treatment developed severe grade 3 or grade 4 thrombocytopenia according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 3.0, the most common sunitinib-induced adverse reaction in this study. In the univariate analysis, both age (P = 7.77x10(-3), odds ratio (OR) = 1.04, 95% CI = 1.01-1.07) and ABCG2 421C> A (P = 1.87x10(-2), OR = 1.71, 95% CI = 1.09-2.68) showed association with sunitinib-induced severe thrombocytopenia. Multivariate analysis indicated that the variant ABCG2 421C> A is suggestively associated with severe thrombocytopenia (P = 8.41x10(-3), OR = 1.86, 95% CI = 1.17-2.94) after adjustment of age as a confounding factor. The area under curve (AUC) of the risk prediction model that utilized age and ABCG2 421C>A was 0.648 with sensitivity of 0.859 and specificity of 0.415. Severe thrombocytopenia is the most common adverse reaction of sunitinib treatment in Japanese RCC patients. ABCG2 421C>A could explain part of the inter-individual variability of sunitinib-induced severe thrombocytopenia.	[Low, Siew-Kee; Fukunaga, Koya; Takahashi, Atsushi; Kubo, Michiaki; Mushiroda, Taisei] RIKEN Ctr Integrat Med Sci, Core Genom Med, Yokohama, Kanagawa, Japan; [Low, Siew-Kee] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Hongo, Fumiya; Nakanishi, Hiroyuki; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Kyoto, Japan; [Kitamura, Hiroshi] Sapporo Med Univ, Sapporo, Hokkaido, Japan; [Inoue, Takamitsu] Akita Univ, Sch Med, Akita 010, Japan; [Kato, Yoichiro] Iwate Med Univ, Morioka, Iwate 020, Japan; [Tomita, Yoshihiko] Yamagata Univ, Fac Med, Yamagata 990, Japan; [Fukasawa, Satoshi] Chiba Canc Ctr, 666-2 Nitonacho, Chiba 2608717, Japan; [Tanaka, Tomoaki] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Nishimura, Kazuo] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Uemura, Hirotsugu] Kinki Univ, Fac Med, Osakasayama, Japan; [Hara, Isao] Wakayama Med Univ, Wakayama, Japan; [Fujisawa, Masato] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Matsuyama, Hideyasu] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Hashine, Katsuyoshi] Shikoku Canc Ctr, Matsuyama, Ehime, Japan; [Tatsugami, Katsunori] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	RIKEN; University of Sydney; University of Tokyo; Kyoto Prefectural University of Medicine; Sapporo Medical University; Akita University; Iwate Medical University; Yamagata University; Chiba Cancer Center; Osaka Metropolitan University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kindai University (Kinki University); Wakayama Medical University; Kobe University; Yamaguchi University; Kyushu University; Kagoshima University	Mushiroda, T (corresponding author), RIKEN Ctr Integrat Med Sci, Core Genom Med, Yokohama, Kanagawa, Japan.	mushiroda@riken.jp	Tanaka, Tomoaki/H-7837-2019; Kato, Yoichiro/H-8342-2019; Fukunaga, Koya/C-4180-2017; Matsuyama, Hideyasu/AAC-7487-2020; Nakanishi, Hiroyuki/AAD-9324-2020	Kato, Yoichiro/0000-0003-3778-9300; Fukunaga, Koya/0000-0002-5241-6062; Matsuyama, Hideyasu/0000-0001-5607-7769; Nakanishi, Hiroyuki/0000-0003-3982-3314; Inoue, Takamitsu/0000-0002-1362-4344; Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Science and Technology of Japan; Pfizer, Inc.; Center for Integrative Medical Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer, Inc.(Pfizer); Center for Integrative Medical Sciences	Supported in part by a Grant-in-Aid for Leading Project of Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. Kubo) and Pfizer, Inc. (to T. Miki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our heartfelt gratitude to all the patients who participate to this study. We would like to extend our gratitude to the members of the laboratory for statistical analysis, Center for Integrative Medical Sciences for their kind support and fruitful discussions.	Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Beuselinck B, 2013, BRIT J CANCER, V108, P887, DOI 10.1038/bjc.2012.548; Beuselinck B, 2014, ACTA ONCOL, V53, P103, DOI 10.3109/0284186X.2013.770600; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Cusatis G, 2008, PHARMACOGENOMICS, V9, P1005, DOI 10.2217/14622416.9.8.1005; Diekstra MHM, 2015, EUR UROL, V68, P621, DOI 10.1016/j.eururo.2015.04.018; Eechoute K, 2012, CLIN PHARMACOL THER, V92, P503, DOI 10.1038/clpt.2012.136; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Hong MH, 2009, CANCER RES TREAT, V41, P67, DOI 10.4143/crt.2009.41.2.67; Imai Y, 2002, MOL CANCER THER, V1, P611; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miyake H, 2013, INT J CLIN ONCOL, V18, P81, DOI 10.1007/s10147-011-0347-7; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Yoo C, 2010, JPN J CLIN ONCOL, V40, P980, DOI 10.1093/jjco/hyq073	29	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148177	10.1371/journal.pone.0148177	http://dx.doi.org/10.1371/journal.pone.0148177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914831	gold, Green Published			2022-12-26	WOS:000371175700004
J	Newman, JA; Cooper, CDO; Roos, AK; Aitkenhead, H; Oppermann, UCT; Cho, HJ; Osman, R; Gileadi, O				Newman, Joseph A.; Cooper, Christopher D. O.; Roos, Anette K.; Aitkenhead, Hazel; Oppermann, Udo C. T.; Cho, Hearn J.; Osman, Roman; Gileadi, Opher			Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MAGE PROTEINS; EXPRESSION; APOPTOSIS; GENES; MACROMOLECULES; SCATTERING; COMPLEXES; SYSTEM; FAMILY	The MAGE (melanoma associated antigen) protein family are tumour-associated proteins normally present only in reproductive tissues such as germ cells of the testis. The human genome encodes over 60 MAGE genes of which one class (containing MAGE-A3 and MAGE-A4) are exclusively expressed in tumours, making them an attractive target for the development of targeted and immunotherapeutic cancer treatments. Some MAGE proteins are thought to play an active role in driving cancer, modulating the activity of E3 ubiquitin ligases on targets related to apoptosis. Here we determined the crystal structures of MAGE-A3 and MAGE-A4. Both proteins crystallized with a terminal peptide bound in a deep cleft between two tandem-arranged winged helix domains. MAGE-A3 (but not MAGE-A4), is predominantly dimeric in solution. Comparison of MAGE-A3 and MAGE-A3 with a structure of an effector-bound MAGE-G1 suggests that a major conformational rearrangement is required for binding, and that this conformational plasticitymay be targeted by allosteric binders.	[Newman, Joseph A.; Cooper, Christopher D. O.; Roos, Anette K.; Aitkenhead, Hazel; Gileadi, Opher] Univ Oxford, ORCRB, Struct Genom Consortium, Roosevelt Dr, Oxford OX3 7DQ, England; [Oppermann, Udo C. T.] Univ Oxford, Botnar Res Ctr, NDORMS, Oxford OX3 7LD, England; [Cho, Hearn J.] Mt Sinai Sch Med, Tisch Canc Inst, Icahn 15-20B 1425 Madison Ave, New York, NY 10029 USA; [Osman, Roman] Mt Sinai Sch Med, Dept Struct & Chem Biol, Box 1677, New York, NY 10029 USA; [Cooper, Christopher D. O.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Roos, Anette K.] Uppsala Univ, BMC, Sci Life Lab, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden	University of Oxford; University of Oxford; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Huddersfield; Uppsala University	Gileadi, O (corresponding author), Univ Oxford, ORCRB, Struct Genom Consortium, Roosevelt Dr, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; newman, Joseph/0000-0003-4488-0516; Gileadi, Opher/0000-0001-6886-898X	AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; GlaxoSmithKline; Genome Canada; Janssen; Lilly Canada; Merck Co.; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust [092809/Z/10/Z]; NIH [1 R21 CA191898-01]; NATIONAL CANCER INSTITUTE [R21CA191898] Funding Source: NIH RePORTER	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck Co.(Merck & Company); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Merck & Co., the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust [092809/Z/10/Z]. This work was partially funded by NIH grant 1 R21 CA191898-01 to HJC, RO and OG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Chomez P, 2001, CANCER RES, V61, P5544; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DESMET C, 1995, IMMUNOGENETICS, V42, P282, DOI 10.1007/BF00176446; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Picard V, 2007, INT J CANCER, V120, P2170, DOI 10.1002/ijc.22282; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Sakurai T, 2004, J BIOL CHEM, V279, P15505, DOI 10.1074/jbc.M310437200; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tyagi P, 2009, CLIN LUNG CANCER, V10, P371, DOI 10.3816/CLC.2009.n.052; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Xiao TZ, 2014, ARCH BIOCHEM BIOPHYS, V563, P136, DOI 10.1016/j.abb.2014.07.026; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Zhao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048240	38	21	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148762	10.1371/journal.pone.0148762	http://dx.doi.org/10.1371/journal.pone.0148762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910052	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000371164700015
J	Sandoz, KM; Popham, DL; Beare, PA; Sturdevant, DE; Hansen, B; Nair, V; Heinzen, RA				Sandoz, Kelsi M.; Popham, David L.; Beare, Paul A.; Sturdevant, Daniel E.; Hansen, Bryan; Nair, Vinod; Heinzen, Robert A.			Transcriptional Profiling of Coxiella burnetii Reveals Extensive Cell Wall Remodeling in the Small Cell Variant Developmental Form	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA ENHC; Q-FEVER; STATIONARY-PHASE; ESCHERICHIA-COLI; PEPTIDOGLYCAN DEACETYLASE; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; CROSS-LINKING; PROTEIN; VIRULENCE	A hallmark of Coxiella burnetii, the bacterial cause of human Q fever, is a biphasic developmental cycle that generates biologically, ultrastructurally, and compositionally distinct large cell variant (LCV) and small cell variant (SCV) forms. LCVs are replicating, exponential phase forms while SCVs are non-replicating, stationary phase forms. The SCV has several properties, such as a condensed nucleoid and an unusual cell envelope, suspected of conferring enhanced environmental stability. To identify genetic determinants of the LCV to SCV transition, we profiled the C. burnetii transcriptome at 3 (early LCV), 5 (late LCV), 7 (intermediate forms), 14 (early SCV), and 21 days (late SCV) post-infection of Vero epithelial cells. Relative to early LCV, genes downregulated in the SCV were primarily involved in intermediary metabolism. Upregulated SCV genes included those involved in oxidative stress responses, arginine acquisition, and cell wall remodeling. A striking transcriptional signature of the SCV was induction (>7-fold) of five genes encoding predicted L, D transpeptidases that catalyze nonclassical 3-3 peptide cross-links in peptidoglycan (PG), a modification that can influence several biological traits in bacteria. Accordingly, of cross-links identified, muropeptide analysis showed PG of SCV with 46% 3-3 cross-links as opposed to 16% 3-3 cross-links for LCV. Moreover, electron microscopy revealed SCV with an unusually dense cell wall/ outer membrane complex as compared to LCV with its clearly distinguishable periplasm and inner and outer membranes. Collectively, these results indicate the SCV produces a unique transcriptome with a major component directed towards remodeling a PG layer that likely contributes to Coxiella's environmental resistance.	[Sandoz, Kelsi M.; Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Sturdevant, Daniel E.] NIAID, Genom Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA; [Hansen, Bryan; Nair, Vinod] NIAID, Electron Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Heinzen, RA (corresponding author), NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	rheinzen@niaid.nih.gov	Popham, David L/F-8066-2015	Popham, David L/0000-0002-2614-143X	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000931, ZICAI001052] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (RAH).	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abraham RT, 2015, SCIENCE, V347, P128, DOI 10.1126/science.aaa4570; Agafonov DE, 2004, BIOCHEM BIOPH RES CO, V320, P354, DOI 10.1016/j.bbrc.2004.05.171; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; AMANO KI, 1984, J BACTERIOL, V160, P989, DOI 10.1128/JB.160.3.989-993.1984; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Beare PA, 2014, J BACTERIOL, V196, P1925, DOI 10.1128/JB.01532-14; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; BURTON PR, 1975, J BACTERIOL, V122, P316, DOI 10.1128/JB.122.1.316-324.1975; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Chen DE, 2008, MICROBIOL-SGM, V154, P42, DOI 10.1099/mic.0.2007/010611-0; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; ENRIGHT JB, 1957, AM J PUBLIC HEALTH N, V47, P695, DOI 10.2105/AJPH.47.6.695; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; GonzalezCastro MJ, 1997, J CHROMATOGR SCI, V35, P181, DOI 10.1093/chromsci/35.4.181; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hackert VH, 2012, CLIN INFECT DIS, V55, P1591, DOI 10.1093/cid/cis734; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Jin LH, 2005, J MOL BIOL, V346, P43, DOI 10.1016/j.jmb.2004.11.031; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Kaoukab-Raji A, 2012, MICROBES INFECT, V14, P619, DOI 10.1016/j.micinf.2012.01.009; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; KHAVKIN T, 1988, INFECT IMMUN, V56, P1792, DOI 10.1128/IAI.56.7.1792-1799.1988; Kloosterman TG, 2011, J BIOL CHEM, V286, P44594, DOI 10.1074/jbc.M111.295832; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kroos L, 2003, J BACTERIOL, V185, P1128, DOI 10.1128/JB.184.4.1128-1146.2003; Kulkarni PR, 2006, NUCLEIC ACIDS RES, V34, P3361, DOI 10.1093/nar/gkl439; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; LENNETTE EH, 1951, AM J HYG, V54, P44, DOI 10.1093/oxfordjournals.aje.a119469; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Liu MY, 2008, CELL MICROBIOL, V10, P1906, DOI 10.1111/j.1462-5822.2008.01180.x; Liu MY, 2012, CELL HOST MICROBE, V12, P166, DOI 10.1016/j.chom.2012.06.004; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McCaul T. F., 1991, Q FEVER BIOL COXIELL, P223; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; MCCAUL TF, 1991, INFECT IMMUN, V59, P3243, DOI 10.1128/IAI.59.9.3243-3253.1991; McCaul TF, 1981, RICKETTSIAE RICKETTS, P267; Mertens K, 2012, ADV EXP MED BIOL, V984, P39, DOI 10.1007/978-94-007-4315-1_3; Million M, 2014, CLIN INFECT DIS, V59, P256, DOI 10.1093/cid/ciu259; Minnick MF, 2012, ADV EXP MED BIOL, V984, P231, DOI 10.1007/978-94-007-4315-1_12; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Newton HJ, 2011, MBIO, V2, DOI 10.1128/mBio.00226-11; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Omsland A, 2011, ANNU REV MICROBIOL, V65, P111, DOI 10.1146/annurev-micro-090110-102927; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; PISABARRO AG, 1985, J BACTERIOL, V161, P238, DOI 10.1128/JB.161.1.238-242.1985; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Quintela JC, 1997, MOL MICROBIOL, V23, P693, DOI 10.1046/j.1365-2958.1997.2561621.x; Ramond E, 2015, MOL CELL PROTEOMICS, V14, P870, DOI 10.1074/mcp.M114.044552; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sacco E, 2014, MBIO, V5, DOI 10.1128/mBio.01446-14; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Sanders AN, 2014, MICROBIOL-SGM, V160, P1795, DOI 10.1099/mic.0.078980-0; Sandoz KM, 2014, J MICROBIOL METH, V96, P104, DOI 10.1016/j.mimet.2013.11.010; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schoonmaker MK, 2014, J BACTERIOL, V196, P1394, DOI 10.1128/JB.01396-13; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shannon Jeffrey G., 2008, V431, P189; Stead CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-222; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; StJohn G, 1996, J BACTERIOL, V178, P1578, DOI 10.1128/jb.178.6.1578-1584.1996; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Tocheva EI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003442; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Warrier I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100147; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; WELSH HH, 1951, PUBLIC HEALTH REP, V66, P1473, DOI 10.2307/4587909; WILLIAMS JC, 1991, Q FEVER BIOL COXIELL, P21; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Zheng WH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-98	121	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149957	10.1371/journal.pone.0149957	http://dx.doi.org/10.1371/journal.pone.0149957			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909555	Green Submitted, gold, Green Published			2022-12-26	WOS:000371164700056
J	VanderBeek, BL; Shah, N; Parikh, PC; Ma, LY				VanderBeek, Brian L.; Shah, Neepa; Parikh, Purak C.; Ma, Liyuan			Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort	PLOS ONE			English	Article							DEFERRED LASER; RANIBIZUMAB; DEGENERATION; TRIAL; MANAGEMENT; PROMPT	Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME) has changed in a national sample. Design Retrospective cohort study. Methods Setting: Administrative medical claims data from a large, national U.S. insurer. Study population: Beneficiaries of a U.S. insurance company. Observation procedures: All incident cases of DME were found. Those in years 2002/3, 2006 and 2010 were followed for a 2-year observation period and those from 2009, 2010 and 2011 for a 1-year observation period. Main Outcome Measures: Types and frequencies of treatment were tallied and compared over each of the cohorts. Results Two-year cohorts had 233, 251 and 756 patients in 2002/3, 2006 and 2010 respectively. One-year cohorts had 1002, 1119 and 1382 patients in 2009, 2010 and 2011, respectively. Both percentage of patients receiving therapy and number of treatments given increased across the 2-year cohorts for both focal laser and anti-vascular endothelial growth factor (anti-VEGF) (p<0.001). The highest use of anti-VEGF agents in any of the cohorts was in the 2011 1-year group that only averaged 3.78 injections. Focal laser was used 2.5x as frequently as anti-VEGF injections in the most recent cohorts with only a high of 14.0% of DME patients receiving anti-VEGF therapy in any of the cohorts. Conclusion Regardless of treatment modality (laser or injection) DME patients received vastly fewer treatments than patients in randomized control trials. Despite the proven superior visual outcomes of anti-VEGF agents over focal laser in DME, focal laser was still used more frequently.	[VanderBeek, Brian L.; Shah, Neepa; Parikh, Purak C.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA; [VanderBeek, Brian L.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [VanderBeek, Brian L.; Ma, Liyuan] Univ Penn, Perelman Sch Med, Leonard Davis Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA.; VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.; VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Leonard Davis Inst, Philadelphia, PA 19104 USA.	brian.vanderbeek@uphs.upenn.edu		VanderBeek, Brian L./0000-0003-4953-118X	National Institutes of Health K12 Award [K12-EY015398]; Scheie Eye Institute; Paul and Evanina Mackall Foundation; NATIONAL EYE INSTITUTE [K23EY025729, K12EY015398] Funding Source: NIH RePORTER	National Institutes of Health K12 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scheie Eye Institute; Paul and Evanina Mackall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial Support: National Institutes of Health K12 Award (Dr. Brian VanderBeek, K12-EY015398). Additional funding was provided in the form of block grants for general research purposes to the Scheie Eye Institute by Research to Prevent Blindness (no grant #; website:https://www.rpbusa.org/rpb/?) and the Paul and Evanina Mackall Foundation (no website or grant #). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearelly S, 2008, ARCH OPHTHALMOL-CHIC, V126, P986, DOI 10.1001/archopht.126.7.986; Curtis LH, 2012, AM J OPHTHALMOL, V153, P1116, DOI 10.1016/j.ajo.2011.11.032; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Do DV, 2012, ARCH OPHTHALMOL-CHIC, P1; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Holekamp NM, 2014, AM J OPHTHALMOL, V157, P825, DOI 10.1016/j.ajo.2013.12.018; Jusufbegovic D, 2015, RETINA; Kiss S, 2014, CLIN OPHTHALMOL, V8, P1611, DOI 10.2147/OPTH.S60893; Lad EM, 2014, AM J OPHTHALMOL; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Mitchell P, 2012, BRIT J OPHTHALMOL, V96, P688, DOI 10.1136/bjophthalmol-2011-300726; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Schneider EW, 2014, INVEST OPHTH VIS SCI, V55, P542, DOI 10.1167/iovs.13-13034; The Diabetic Retinopathy Clinical Research Network, 2015, NEW ENGLAND J MED; Varma R, 2014, JAMA OPHTHALMOL	17	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149450	10.1371/journal.pone.0149450	http://dx.doi.org/10.1371/journal.pone.0149450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909797	gold, Green Published			2022-12-26	WOS:000371164700035
J	O'Brien, CC; Kolandaivelu, K; Brown, J; Lopes, AC; Kunio, M; Kolachalama, VB; Edelman, ER				O'Brien, Caroline C.; Kolandaivelu, Kumaran; Brown, Jonathan; Lopes, Augusto C.; Kunio, Mie; Kolachalama, Vijaya B.; Edelman, Elazer R.			Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERIES; IN-VIVO; INTRAVASCULAR ULTRASOUND; SCAFFOLD IMPLANTATION; ANGIOGRAPHIC DATA; DRUG DEPOSITION; FLOW; RECONSTRUCTION	Background Stacking cross-sectional intravascular images permits three-dimensional rendering of endovascular implants, yet introduces between-frame uncertainties that limit characterization of device placement and the hemodynamic microenvironment. In a porcine coronary stent model, we demonstrate enhanced OCT reconstruction with preservation of betweenframe features through fusion with angiography and a priori knowledge of stent design. Methods and Results Strut positions were extracted from sequential OCT frames. Reconstruction with standard interpolation generated discontinuous stent structures. By computationally constraining interpolation to known stent skeletons fitted to 3D 'clouds' of OCT-Angio-derived struts, implant anatomy was resolved, accurately rendering features from implant diameter and curvature (n = 1 vessels, r(2) = 0.91, 0.90, respectively) to individual strut-wall configurations (average displacement error similar to 15 mu m). This framework facilitated hemodynamic simulation (n = 1 vessel), showing the critical importance of accurate anatomic rendering in characterizing both quantitative and basic qualitative flow patterns. Discontinuities with standard approaches systematically introduced noise and bias, poorly capturing regional flow effects. In contrast, the enhanced method preserved multi-scale (local strut to regional stent) flow interactions, demonstrating the impact of regional contexts in defining the hemodynamic consequence of local deployment errors. Conclusion Fusion of planar angiography and knowledge of device design permits enhanced OCT image analysis of in situ tissue-device interactions. Given emerging interests in simulation-derived hemodynamic assessment as surrogate measures of biological risk, such fused modalities offer a new window into patient-specific implant environments.	[O'Brien, Caroline C.; Kolandaivelu, Kumaran; Brown, Jonathan; Lopes, Augusto C.; Kunio, Mie; Kolachalama, Vijaya B.; Edelman, Elazer R.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kolandaivelu, Kumaran; Lopes, Augusto C.; Kolachalama, Vijaya B.; Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA; [Kolachalama, Vijaya B.] Charles Stark Draper Lab Inc, 555 Technol Sq, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; The Charles Stark Draper Laboratory, Inc.	O'Brien, CC (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ccob@mit.edu	Kolachalama, Vijaya B./AAH-3528-2020	Kolachalama, Vijaya B./0000-0002-5312-8644; Brown, Jonathan/0000-0002-4821-832X; Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM-49039]; AHA FTF Award [12FTF12080241]; Arie Research Fellowship from the Brazilian Society of Interventional Cardiology; NSF [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA FTF Award; Arie Research Fellowship from the Brazilian Society of Interventional Cardiology; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by a grant from the NIH (R01 GM-49039) to ERE. KK is supported in part by an AHA FTF Award (12FTF12080241). ACL is supported in part by an Arie Research Fellowship from the Brazilian Society of Interventional Cardiology. Computational work used the Extreme Science and Engineering Discovery Environment (XSEDE) supported by NSF (OCI-1053575).	Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Bourantas CV, 2014, JACC-CARDIOVASC INTE, V7, P315, DOI 10.1016/j.jcin.2013.05.034; Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Bourantas CV, 2013, EUROINTERVENTION, V9, P582, DOI 10.4244/EIJV9I5A94; Bourantas CV, 2012, INT J CARDIOL, V155, pE24, DOI 10.1016/j.ijcard.2011.07.005; Capodanno D, 2014, EUROINTERVENTION; Coskun AU, 2003, CATHETER CARDIO INTE, V60, P67, DOI 10.1002/ccd.10594; Council NR., 2011, GUIDE CARE USE LAB A; Duraiswamy N, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118764; Ellwein LM., 2011, CARDIOVASC ENG TECHN, V2, P212, DOI [10.1007/s13239-011-0047-5, DOI 10.1007/S13239-011-0047-5]; Euthanasia APo, 2013, EUTH APO AVMA GUID E; Farooq V, 2013, EUR HEART J, V34, P875, DOI 10.1093/eurheartj/ehr409; Feldman CL, 2002, AM HEART J, V143, P931, DOI 10.1067/mhj.2002.123118; Foin N, 2014, CIRC-CARDIOVASC INTE, V7, P180, DOI 10.1161/CIRCINTERVENTIONS.113.000931; Gonzalo N, 2009, EUROINTERVENTION, V5, P224, DOI 10.4244/EIJV5I2A35; Grauer D, 2010, ANGLE ORTHOD, V80, P286, DOI 10.2319/030909-135.1; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VVolume 1; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kolachalama VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008105; Kolachalama VB, 2009, J CONTROL RELEASE, V133, P24, DOI 10.1016/j.jconrel.2008.09.075; Kolandaivelu K, 2014, J BIOMECH, V47, P908, DOI 10.1016/j.jbiomech.2014.01.006; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Maresca D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097215; Moller T., 1997, J GRAPH TOOL, V2, P21, DOI [DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Moore JE, 2002, ANN BIOMED ENG, V30, P498, DOI 10.1114/1.1458594; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; O'Brien CC, 2013, J CONTROL RELEASE, V168, P115, DOI 10.1016/j.jconrel.2013.03.014; Piegl L., 1997, MONOGRAPHS VISUAL CO; Prause GPM, 1997, INT J CARDIAC IMAG, V13, P451, DOI 10.1023/A:1005843222820; Slager CJ, 2000, CIRCULATION, V102, P511; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Tsantis S, 2012, MED PHYS, V39, P503, DOI 10.1118/1.3673067; Tu SX, 2011, INT J CARDIOVAS IMAG, V27, P197, DOI 10.1007/s10554-011-9809-2; Ughi GJ, 2012, INT J CARDIOVAS IMAG, V28, P229, DOI 10.1007/s10554-011-9824-3; Williams AR, 2010, J APPL PHYSIOL, V109, P532, DOI 10.1152/japplphysiol.00086.2010; Zhang L, 2002, PATTERN RECOGN LETT, V23, P1771, DOI 10.1016/S0167-8655(02)00151-4	38	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149178	10.1371/journal.pone.0149178	http://dx.doi.org/10.1371/journal.pone.0149178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906566	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000006
J	Rooney, C; Geh, C; Williams, V; Heuckmann, JM; Menon, R; Schneider, P; Al-Kadhimi, K; Dymond, M; Smith, NR; Baker, D; French, T; Smith, PD; Harrington, EA; Barrett, JC; Kilgour, E				Rooney, Claire; Geh, Catherine; Williams, Victoria; Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra; Al-Kadhimi, Katherine; Dymond, Michael; Smith, Neil R.; Baker, Dawn; French, Tim; Smith, Paul D.; Harrington, Elizabeth A.; Barrett, J. Carl; Kilgour, Elaine			Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN BREAST-CANCER; MESSENGER-RNA; EXPRESSION; SENSITIVITY; SURVIVAL	FGFR1 amplification occurs in similar to 20% of sqNSCLC and trials with FGFR inhibitors have selected FGFR1 amplified patients by FISH. Lung cancer cell lines were profiled for sensitivity to AZD4547, a potent, selective inhibitor of FGFRs 1-3. Sensitivity to FGFR inhibition was associated with but not wholly predicted by increased FGFR1 gene copy number. Additional biomarker assays evaluating expression of FGFRs and correlation between amplification and expression in clinical tissues are therefore warranted. We validated nanoString for mRNA expression analysis of 194 genes, including FGFRs, from clinical tumour tissue. In a panel of sqNSCLC tumours 14.4% (13/90) were FGFR1 amplified by FISH. Although mean FGFR1 expression was significantly higher in amplified samples, there was significant overlap in the range of expression levels between the amplified and non-amplified cohorts with several non-amplified samples expressing FGFR1 to levels equivalent to amplified samples. Statistical analysis revealed increased expression of FGFR1 neighboring genes on the 8p12 amplicon (BAG4, LSM1 and WHSC1L1) in FGFR1 amplified tumours, suggesting a broad rather than focal amplicon and raises the potential for codependencies. High resolution aCGH analysis of pre-clinical and clinical samples supported the presence of a broad and heterogeneous amplicon around the FGFR1 locus. In conclusion, the range of FGFR1 expression levels in both FGFR1 amplified and non-amplified NSCLC tissues, together with the breadth and intra-patient heterogeneity of the 8p amplicon highlights the need for gene expression analysis of clinical samples to inform the understanding of determinants of response to FGFR inhibitors. In this respect the nanoString platform provides an attractive option for RNA analysis of FFPE clinical samples.	[Rooney, Claire; Geh, Catherine; Al-Kadhimi, Katherine; Smith, Neil R.; Baker, Dawn; Smith, Paul D.; Harrington, Elizabeth A.; Kilgour, Elaine] AstraZeneca, Oncol Innovat Med, Alderley Pk, Macclesfield, Cheshire, England; [Williams, Victoria; French, Tim] AstraZeneca, Personalised Healthcare & Biomarkers Innovat Med, Alderley Pk, Cambridge, England; [Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra] Blackfield AG, Cologne, Germany; [Dymond, Michael] AstraZeneca, Discovery Sci Innovat Med, Alderley Pk, Macclesfield, Cheshire, England; [Barrett, J. Carl] AstraZeneca Oncol Innovat Med, Gatehouse Pk, Waltham, MA USA; [Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra] NEO New Oncol AG, Cologne, Germany	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Rooney, C (corresponding author), AstraZeneca, Oncol Innovat Med, Alderley Pk, Macclesfield, Cheshire, England.	claire.rooney@astrazeneca.com						Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Goke F, 2015, CLIN CANCER RES, V21, P4356, DOI 10.1158/1078-0432.CCR-14-3357; Kilgour E, 2014, J CLIN ONCOL S; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kohler LH, 2012, VIRCHOWS ARCH, V461, P49, DOI 10.1007/s00428-012-1250-y; Kotani H, 2016, ONCOGENE, V35, P3587, DOI 10.1038/onc.2015.426; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wolf J, P 103 M AM ASS CANC; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	26	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149628	10.1371/journal.pone.0149628	http://dx.doi.org/10.1371/journal.pone.0149628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905262	Green Published, gold, Green Submitted			2022-12-26	WOS:000371163000018
J	Hendrick, VJ; Hutchison, ZL; Last, KS				Hendrick, Vicki J.; Hutchison, Zoe L.; Last, Kim S.			Sediment Burial Intolerance of Marine Macroinvertebrates	PLOS ONE			English	Article							DREDGED MATERIAL; IMPACT; DYNAMICS; RECOVERY; COMMUNITIES; CESSATION; PATTERNS; SCALLOPS; BENTHOS; COAST	The marine environment contains suspended particulate matter which originates from natural and anthropogenic sources. Settlement of this material can leave benthic organisms susceptible to smothering, especially if burial is sudden i.e. following storms or activities such as dredging. Their survival will depend on their tolerance to, and their ability to escape from burial. Here we present data from a multi-factorial experiment measuring burial responses incorporating duration, sediment fraction and depth. Six macroinvertebrates commonly found in sediment rich environments were selected for their commercial and/or conservation importance. Assessments revealed that the brittle star (Ophiura ophiura), the queen scallop (Aequipecten opercularis) and the sea squirt (Ciona intestinalis) were all highly intolerant to burial whilst the green urchin (Psammichinus miliaris) and the anemone (Sagartiogeton laceratus), showed intermediate and low intolerance respectively, to burial. The least intolerant, with very high survival was the Ross worm (Sabellaria spinulosa). With the exception of C. intestinalis, increasing duration and depth of burial with finer sediment fractions resulted in increased mortality for all species assessed. For C. intestinalis depth of burial and sediment fraction were found to be inconsequential since there was complete mortality of all specimens buried for more than one day. When burial emergence was assessed O. ophiura emerged most frequently, followed by P. miliaris. The former emerged most frequently from the medium and fine sediments whereas P. miliaris emerged more frequently from coarse sediment. Both A. opercularis and S. laceratus showed similar emergence responses over time, with A. opercularis emerging more frequently under coarse sediments. The frequency of emergence of S. laceratus increased with progressively finer sediment and C. intestinalis did not emerge from burial irrespective of sediment fraction or depth. Finally, and perhaps unsurprisingly, the greatest ability to emerge from burial in all other species was from shallow (2 cm) burial. Although survival was consistently highly dependent on duration and depth of burial as expected, emergence behaviour was not as easily predictable thereby confounding predictions. We conclude that responses to burial are highly species specific and therefore tolerance generalisations are likely to be oversimplifications. These data may be used to inform environmental impact models that allow forecasting of the cumulative impacts of seabed disturbance and may provide mitigation measures for the sustainable use of the seabed.	[Hendrick, Vicki J.; Hutchison, Zoe L.; Last, Kim S.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland	UHI Millennium Institute	Last, KS (corresponding author), Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk		Hutchison, Zoe/0000-0003-1866-7877	Marine Aggregate Levy Sustainability Fund (MALSF) [08/P76]; research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund [RE011]; FP7 Tidal Demonstration for Energy Scheme (TIDES) [322428]	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES)	Funding was secured from the Marine Aggregate Levy Sustainability Fund (MALSF; grant number 08/P76) and the research consortium Marine Renewable Energy and the Environment (MaREE; grant number RE011) which was supported by the European Regional Development Fund. The work was also supported by the FP7 Tidal Demonstration for Energy Scheme (TIDES; grant number 322428). All funding was secured by KSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besio G, 2008, OCEAN ENG, V35, P653, DOI 10.1016/j.oceaneng.2008.01.002; Boyd SE, 2005, ICES J MAR SCI, V62, P145, DOI 10.1016/j.icesjms.2004.11.014; Boyd SE, 2003, ESTUAR COAST SHELF S, V57, P209, DOI 10.1016/S0272-7714(02)00346-3; Bromirski PD, 2003, J CLIMATE, V16, P982, DOI 10.1175/1520-0442(2003)016<0982:SVATCC>2.0.CO;2; Cottrell RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147534; Dale AC, 2011, MAR POLLUT BULL, V62, P2433, DOI 10.1016/j.marpolbul.2011.08.024; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; GLADFELTER WB, 1978, MAR BIOL, V47, P149, DOI 10.1007/BF00395636; Gooding S, 2012, ENV IMPACT SUBSEA TR; Green MO, 1997, MAR GEOL, V144, P97, DOI 10.1016/S0025-3227(97)00065-0; Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hinchey EK, 2006, HYDROBIOLOGIA, V556, P85, DOI 10.1007/s10750-005-1029-0; Holt TJ, 1998, BIOGENIC REEFS OVERV, P170; Hutchison ZL, 2015, PLOSONE IN PRESS; Jackson A, 2008, ROSS WORM SABELLARIA; James E, 2007, UK SEA FISHERIES STA; Kenny AJ, 1991E27 ICES CM; KIRTLEY DW, 1968, J SEDIMENT PETROL, V38, P73; Kotta Jonne, 2009, Estonian Journal of Ecology, V58, P286, DOI 10.3176/eco.2009.4.04; KRANZ PM, 1974, J GEOL, V82, P237, DOI 10.1086/627961; MAURER D, 1981, MAR ENVIRON RES, V4, P299, DOI 10.1016/0141-1136(81)90043-X; MBA UK, MAR LIF INF NETW BIO; Mikkelsen OA, 2000, MAR GEOL, V170, P443, DOI 10.1016/S0025-3227(00)00105-5; Miles JR, 2001, J COASTAL RES, V17, P195; Miller DC, 2002, ECOL ENG, V19, P211, DOI 10.1016/S0925-8574(02)00081-2; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Neill SP, 2009, RENEW ENERG, V34, P2803, DOI 10.1016/j.renene.2009.06.015; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 2004, J COASTAL RES, P115; Nicolaidou A, 2003, J MAR BIOL ASSOC UK, V83, P1223, DOI 10.1017/S0025315403008531; PICKENS PE, 1988, J EXP BIOL, V135, P133; Precht E, 2004, LIMNOL OCEANOGR, V49, P693, DOI 10.4319/lo.2004.49.3.0693; Rees I., 2009, ASSESSMENT MODIOLUS; Roberts DA, 2012, ENVIRON INT, V40, P230, DOI 10.1016/j.envint.2011.11.013; Seiderer LJ, 1999, ICES J MAR SCI, V56, P757, DOI 10.1006/jmsc.1999.0495; SHICK JM, 1979, PHYSIOL ZOOL, V52, P50, DOI 10.1086/physzool.52.1.30159931; SHUMWAY SE, 1978, MAR BIOL, V48, P235, DOI 10.1007/BF00397150; Smith R, 2006, ESTUAR COAST SHELF S, V70, P207, DOI 10.1016/j.ecss.2006.04.026; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Szostek CL, 2013, MAR ECOL PROG SER, V474, P155, DOI 10.3354/meps10088; Van Rijn L.C., 1993, PRINCIPLES SEDIMENT; Wilber DH, 2001, N AM J FISH MANAGE, V21, P855, DOI 10.1577/1548-8675(2001)021<0855:BEOSSA>2.0.CO;2; WILSON DOUGLAS P., 1929, JOUR MARINE BIOL ASSOC, V16, P221; WILSON DP, 1970, J MAR BIOL ASSOC UK, V50, P1, DOI 10.1017/S0025315400000576; Zuur Alain F., 2009, P1	51	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149114	10.1371/journal.pone.0149114	http://dx.doi.org/10.1371/journal.pone.0149114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901775	gold, Green Submitted, Green Published			2022-12-26	WOS:000371276100039
J	Lam, C; Kang, JH; Lin, HY; Huang, HC; Wu, CC; Chen, PL				Lam, Carlos; Kang, Jiunn-Horng; Lin, Hsiao-Yu; Huang, Hung-Chang; Wu, Chia-Chieh; Chen, Ping-Ling			First Fall-Related Injuries Requiring Hospitalization Increase the Risk of Recurrent Injurious Falls: A Nationwide Cohort Study in Taiwan	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; DWELLING OLDER-PEOPLE; HEALTH INSURANCE; FOLLOW-UP; POPULATION; MEN; VALIDATION; DIAGNOSIS; WOMEN; URBANIZATION	Objectives Recurrent falls not only have risk factors different from those of single falls but also have less favorable outcomes. The aim of our study was to determine the association between the injury characteristics of a first fall and the likelihood of recurrent injurious falls in a cohort of hospitalized patients. Methods We designed a nationwide retrospective cohort study and selected hospitalized patients who had injurious falls between 2001 and 2010. Cox proportional hazards models were used to estimate the hazard ratios (HRs) of recurrent injurious falls requiring hospitalization in the following year on the basis of the patients' demographic characteristics, comorbidities, and the characteristics of injuries from the first injurious fall requiring hospitalization. Results Among the 504 512 patients hospitalized for injurious falls, 19 442 experienced recurrent injurious falls requiring hospitalization. The 1-year incidence of recurrent injurious falls requiring hospitalization was 3.85%. The incidence density was the highest within the 3-month period after the first injurious fall. The risk of recurrent injurious falls among patients aged 40 to 64, 65 to 74, and >= 75 years increased progressively (HR: 2.11, 95% confidence interval [CI]: 1.90-2.34; HR: 2.80, 95% CI: 2.51-3.11; and HR: 3.80, 95% CI: 3.42-4.23, respectively). The length of hospitalization (LOH) >= 15 or >= 31 days (HR: 1.39, 95% CI: 1.30-1.48; and HR: 1.59, 95% CI: 1.43-1.77, respectively) and injury to the head (HR: 1.59, 95% CI: 1.53-1.65) or spine (HR: 1.66, 95% CI: 1.59-1.74) were also found to be major risk factors. Conclusions Our findings show that the LOH and head and spine injuries are associated with an increased risk of recurrent injurious falls leading to hospitalization. The risk of recurrent injurious falls requiring hospitalization increased significantly among adults older than 40 years. We suggest further research on the effects of injury characteristics associated with the first injurious fall requiring hospitalization and resultant anatomical damages on the risk of recurrent injurious falls requiring hospitalization. High-risk patients should receive tailored rehabilitation addressing their respective injuries within 3 months after hospital discharge.	[Lam, Carlos; Wu, Chia-Chieh] Taipei Med Univ, Wan Fang Hosp, Emergency Dept, Dept Emergency & Crit Care Med, Taipei, Taiwan; [Lam, Carlos; Chen, Ping-Ling] Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Lam, Carlos] Taipei Med Univ, Dept Emergency Med, Coll Med, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Taipei Med Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Kang, Jiunn-Horng] Taipei Med Univ, Sch Med, Dept Phys Med & Rehabil, Coll Med, Taipei, Taiwan; [Lin, Hsiao-Yu] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Huang, Hung-Chang] Taipei Med Univ Hosp, Div Acute Care Surg & Traumatol, Dept Surg, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital	Chen, PL (corresponding author), Taipei Med Univ, Grad Inst Injury Prevent & Control, Coll Publ Hlth & Nutr, Taipei, Taiwan.	plchen@tmu.edu.tw		Lam, Carlos/0000-0002-8051-7485	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan [E1020766]; Wan Fang Hospital, Taipei Medical University [103-wf-eva-26]	Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan; Wan Fang Hospital, Taipei Medical University	This research was supported by grants from the Health Promotion Administration, Ministry of Health and Welfare, Executive Yuan, Taiwan (grant number E1020766). PLC received the funding (the funder's website: http://www.hpa.gov.tw/Bhpnet/Web/Index/Index.aspx); and grants from the Wan Fang Hospital, Taipei Medical University (grant number 103-wf-eva-26). CL received the funding (the funder's website: http://www.wanfang.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Geriatrics Society British Geriatrics Society, 2010, AGS BGS CLIN PRACT G; Askari M, 2013, DRUG AGING, V30, P845, DOI 10.1007/s40266-013-0110-z; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Chen CS, 2008, EUR J OBSTET GYN R B, V141, P104, DOI 10.1016/j.ejogrb.2008.07.016; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chien WC, 2013, INT J INJ CONTROL SA, V20, P50, DOI 10.1080/17457300.2012.674042; de Vries OJ, 2013, OSTEOPOROSIS INT, V24, P2397, DOI 10.1007/s00198-013-2303-z; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Donald IP, 1999, AGE AGEING, V28, P121, DOI 10.1093/ageing/28.2.121; Gassmann KG, 2009, Z GERONTOL GERIATR, V42, P3, DOI 10.1007/s00391-008-0506-2; Hanlon JT, 2009, J GERONTOL A-BIOL, V64, P492, DOI 10.1093/gerona/gln043; Hoang PD, 2014, ARCH PHYS MED REHAB, V95, P480, DOI 10.1016/j.apmr.2013.09.017; Huang YL, 2013, J OCCUP SAF HLTH, V21, P38; Kanjwal K, 2015, J CARDIOVASC MED, V16, P75, DOI 10.2459/01.JCM.0000446386.01100.35; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Ku YC, 2013, INT J GERONTOL, V7, P80, DOI 10.1016/j.ijge.2012.07.004; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lin MR, 2014, OSTEOPOROSIS INT, V25, P863, DOI 10.1007/s00198-013-2549-5; Lin YJ, 2011, HEALTH POLICY, V103, P236, DOI 10.1016/j.healthpol.2011.08.007; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; LUUKINEN H, 1995, PUBLIC HEALTH, V109, P57, DOI 10.1016/S0033-3506(95)80076-X; Matinolli M, 2011, ACTA NEUROL SCAND, V123, P193, DOI 10.1111/j.1600-0404.2010.01386.x; Muraki S, 2013, BONE, V52, P516, DOI 10.1016/j.bone.2012.10.020; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Newgard CD, 2010, ACAD EMERG MED, V17, P142, DOI 10.1111/j.1553-2712.2009.00647.x; Okubo Y, 2015, ARCH GERONTOL GERIAT, V60, P45, DOI 10.1016/j.archger.2014.10.008; Pijpers E, 2012, AGE AGEING, V41, P358, DOI 10.1093/ageing/afr145; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Rossat A, 2010, J NUTR HEALTH AGING, V14, P787, DOI 10.1007/s12603-010-0089-7; Spector WD, 2012, MED CARE, V50, P863, DOI 10.1097/MLR.0b013e31825f2840; Spice CL, 2009, AGE AGEING, V38, P33, DOI 10.1093/ageing/afn192; Stel VS, 2003, J AM GERIATR SOC, V51, P1356, DOI 10.1046/j.1532-5415.2003.51452.x; Talbot LA, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-86; Tamburella F, 2013, EUR J PHYS REHAB MED, V49, P353; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; van Nieuwenhuizen RC, 2010, AM J EMERG MED, V28, P994, DOI 10.1016/j.ajem.2009.06.003; Wu TY, 2013, PREV MED, V57, P511, DOI 10.1016/j.ypmed.2013.07.012; Yoo IY, 2011, J GERONTOL NURS, V37, P28, DOI 10.3928/00989134-20110503-01	40	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149887	10.1371/journal.pone.0149887	http://dx.doi.org/10.1371/journal.pone.0149887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26900917	Green Published, gold			2022-12-26	WOS:000371276100175
J	Sun, KS; Tsai, CF; Chen, SCC; Chen, YY; Huang, WC				Sun, Kuo-Shao; Tsai, Ching-Fang; Chen, Solomon Chih-Cheng; Chen, Yih-Yuan; Huang, Wan-Chun			Galactomannan Testing and the Incidence of Invasive Pulmonary Aspergillosis: A 10-Year Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							CELL TRANSPLANT RECIPIENTS; GENDER-DIFFERENCES; MOLD INFECTIONS; FUNGAL DISEASE; EPIDEMIOLOGY; DIAGNOSIS; REGISTRY; THERAPY; IMPACT; ASSAY	Background The clinical impact of the galactomannan (GM) test for the diagnosis of invasive pulmonary aspergillosis (IPA) is controversial. Our study evaluated the incidence and trends of IPA and GM testing in patients with aspergillus infections. Methods We conducted a nationwide inpatient population study using the Taiwan National Health Insurance Research Database. A total of 346 IPA (62.14% male) patients from the years 2002 to 2011 were identified for inclusion in the study. Results The average incidence of IPA was 1.51 per million person-years. Over the study period, we observed an increasing trend from 0.94 to 2.06 per million person-years (P < 0.0001). We observed male predominance in IPA incidence (M/F: 1.85/1.15). Both males and females showed significantly increasing trends of IPA incidence over time (0.87 to 4.55 and 0.36 to 2.07 per million person-years for the males and females, respectively). GM testing for IPA significantly increased from 2002 to 2011, and the GM test was utilized more frequently for males than females. The increase in the incidence of IPA might be positively associated with the increase in GM testing over the past decade. Conclusion The incidence rates of both IPA and GM testing have increased over time. GM testing is recommended for the early diagnosis of patients with suspected aspergillosis.	[Sun, Kuo-Shao; Huang, Wan-Chun] Chia Yi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Sun, Kuo-Shao] Chung Jen Jr Coll Nursing Hlth Sci & Management, Chiayi, Taiwan; [Tsai, Ching-Fang; Chen, Solomon Chih-Cheng] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Med Res, Chiayi, Taiwan; [Chen, Solomon Chih-Cheng] Taipei Med Univ, Sch Med, Dept Pediat, Taipei, Taiwan; [Chen, Yih-Yuan] Chia Yi Christian Hosp, Ditmanson Med Fdn, Dept Internal Med, Chiayi, Taiwan	Taipei Medical University	Huang, WC (corresponding author), Chia Yi Christian Hosp, Dept Internal Med, Ditmanson Med Fdn, Div Pulm & Crit Care Med, Chiayi, Taiwan.	erick720730@gmail.com	Huang, Wan-Chun/L-8846-2019	Huang, Wan-Chun/0000-0002-3781-103X				Arvanitis M, 2015, EUR J CLIN INVEST, V45, P646, DOI 10.1111/eci.12448; Bulpa P, 2007, EUR RESPIR J, V30, P782, DOI 10.1183/09031936.00062206; Chamilos G, 2006, HAEMATOL-HEMATOL J, V91, P986; Chen HS, 2007, RHEUMATOLOGY, V46, P539, DOI 10.1093/rheumatology/kel343; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dorak M. Tevfik, 2012, Frontiers in Genetics, V3, P268, DOI 10.3389/fgene.2012.00268; Guinea J, 2010, CLIN MICROBIOL INFEC, V16, P870, DOI 10.1111/j.1469-0691.2009.03015.x; Hoenigl M, 2012, MED MYCOL, V50, P266, DOI 10.3109/13693786.2011.603102; Hsiue HC, 2012, EUR J CLIN MICROBIOL, V31, P1319, DOI 10.1007/s10096-011-1445-1; Jarrin I, 2008, AM J EPIDEMIOL, V168, P532, DOI 10.1093/aje/kwn179; Kim A, 2011, MYCOSES, V54, pE301, DOI 10.1111/j.1439-0507.2010.01903.x; Lortholary O, 2011, CLIN MICROBIOL INFEC, V17, P1882, DOI 10.1111/j.1469-0691.2011.03548.x; Marr KA, 2005, CLIN INFECT DIS, V40, P1762, DOI 10.1086/429921; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Montagna MT, 2014, INFECTION, V42, P141, DOI 10.1007/s15010-013-0539-3; Perkhofer S, 2010, INT J ANTIMICROB AG, V36, P531, DOI 10.1016/j.ijantimicag.2010.08.010; Pfeiffer CD, 2006, CLIN INFECT DIS, V42, P1417, DOI 10.1086/503427; Prasad P, 2014, TRANSPLANTATION, V98, P773, DOI 10.1097/TP.0000000000000131; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sinko J, 2008, TRANSPL INFECT DIS, V10, P106, DOI 10.1111/j.1399-3062.2007.00264.x; Steinbach WJ, 2012, J INFECTION, V65, P453, DOI 10.1016/j.jinf.2012.08.003; Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7; Vandewoude KH, 2006, CRIT CARE, V10, DOI 10.1186/cc4823; Walsh TJ, 2004, J CLIN MICROBIOL, V42, P4744, DOI 10.1128/JCM.42.10.4744-4748.2004	24	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149964	10.1371/journal.pone.0149964	http://dx.doi.org/10.1371/journal.pone.0149964			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900697	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100195
J	Van Hoeven, N; Joshi, SW; Nana, GI; Bosco-Lauth, A; Fox, C; Bowen, RA; Clements, DE; Martyak, T; Parks, DE; Baldwin, S; Reed, SG; Coler, RN				Van Hoeven, Neal; Joshi, Sharvari Waghmare; Nana, Ghislain Ismael; Bosco-Lauth, Angela; Fox, Christopher; Bowen, Richard A.; Clements, David E.; Martyak, Timothy; Parks, D. Elliot; Baldwin, Susan; Reed, Steven G.; Coler, Rhea N.			A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS VACCINE; NEUTRALIZING ANTIBODY-RESPONSE; RECOMBINANT ENVELOPE PROTEIN; CELLULAR IMMUNE-RESPONSES; AMINO-ACID SUBSTITUTION; VECTOR-BASED VACCINE; DNA VACCINE; DOMAIN-III; CRYSTAL-STRUCTURE; HUMORAL IMMUNITY	West Nile virus (WNV) is a mosquito-transmitted member of the Flaviviridae family that has emerged in recent years to become a serious public health threat. Given the sporadic nature of WNV epidemics both temporally and geographically, there is an urgent need for a vaccine that can rapidly provide effective immunity. Protection from WNV infection is correlated with antibodies to the viral envelope (E) protein, which encodes receptor binding and fusion functions. Despite many promising E-protein vaccine candidates, there are currently none licensed for use in humans. This study investigates the ability to improve the immunogenicity and protective capacity of a promising clinical-stage WNV recombinant E-protein vaccine (WN-80E) by combining it with a novel synthetic TLR-4 agonist adjuvant. Using the murine model of WNV disease, we find that inclusion of a TLR-4 agonist in either a stable oil-in-water emulsion (SE) or aluminum hydroxide (Alum) formulation provides both dose and dosage sparing functions, whereby protection can be induced after a single immunization containing only 100 ng of WN-80E. Additionally, we find that inclusion of adjuvant with a single immunization reduced viral titers in sera to levels undetectable by viral plaque assay. The enhanced protection provided by adjuvanted immunization correlated with induction of a Th1 T-cell response and the resultant shaping of the IgG response. These findings suggest that inclusion of a next generation adjuvant may greatly enhance the protective capacity of WNV recombinant subunit vaccines, and establish a baseline for future development.	[Van Hoeven, Neal; Joshi, Sharvari Waghmare; Nana, Ghislain Ismael; Fox, Christopher; Baldwin, Susan; Reed, Steven G.; Coler, Rhea N.] Infect Dis Res Inst, 1616 Eastlake Ave E, Seattle, WA 98103 USA; [Bosco-Lauth, Angela; Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Foothills Campus, Ft Collins, CO 80523 USA; [Clements, David E.; Martyak, Timothy; Parks, D. Elliot] Hawaii Biotech Inc, 99-193 Aiea Hts Dr, Aiea, HI 96701 USA	Colorado State University	Van Hoeven, N (corresponding author), Infect Dis Res Inst, 1616 Eastlake Ave E, Seattle, WA 98103 USA.	neal.vanhoeven@idri.org			Bill and Melinda Gates Foundation [OPP1055855]; IDRI; Hawaii Biotech Inc.	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); IDRI; Hawaii Biotech Inc.	This research was supported with funding from the Bill and Melinda Gates Foundation, under grant OPP1055855, and with unrestricted IDRI funds. The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hawaii Biotech Inc. provided support in the form of salaries for authors DEC, TM, and DEP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alving CR, 2012, CURR OPIN IMMUNOL, V24, P310, DOI 10.1016/j.coi.2012.03.008; Amanna IJ, 2014, EXPERT REV VACCINES, V13, P589, DOI 10.1586/14760584.2014.906309; Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Bakonyi T, 2013, VET MICROBIOL, V165, P61, DOI 10.1016/j.vetmic.2013.03.005; Barzon L, 2013, EXPERT REV ANTI-INFE, V11, P479, DOI [10.1586/ERI.13.34, 10.1586/eri.13.34]; Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003; Brandler S, 2013, VIRUSES-BASEL, V5, P2384, DOI 10.3390/v5102384; Brandler S, 2012, J INFECT DIS, V206, P212, DOI 10.1093/infdis/jis328; Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013; Centers for Disease Control and Prevention, 2015, W NIL VIR DIS CAS DE; Chang DC, 2008, NAT BIOTECHNOL, V26, P571, DOI 10.1038/nbt1400; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Chu JHJ, 2007, J IMMUNOL, V178, P2699, DOI 10.4049/jimmunol.178.5.2699; Chua AJS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-129; Clegg CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088979; Clegg CH, 2012, P NATL ACAD SCI USA, V109, P17585, DOI 10.1073/pnas.1207308109; Coler RN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016333; Coler RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013677; Coller BA, 2012, United States patent, Patent No. [US20120141520A1, 20120141520, US 20120141520]; Coutant F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003973; Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001; Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Demento SL, 2010, J IMMUNOL, V185, P2989, DOI 10.4049/jimmunol.1000768; Despres P, 2005, J INFECT DIS, V191, P207, DOI 10.1086/426824; Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064; Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098; Hall RA, 2003, P NATL ACAD SCI USA, V100, P10460, DOI 10.1073/pnas.1834270100; Iglesias MC, 2006, J GENE MED, V8, P265, DOI 10.1002/jgm.837; Ireton GC, 2013, EXPERT REV VACCINES, V12, P793, DOI 10.1586/14760584.2013.811204; Ishikawa T, 2007, MICROBES INFECT, V9, P1089, DOI 10.1016/j.micinf.2007.05.013; Iyer AV, 2009, VACCINE, V27, P893, DOI 10.1016/j.vaccine.2008.11.087; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06; Karaca K, 2005, VACCINE, V23, P3808, DOI 10.1016/j.vaccine.2005.02.020; Kim DY, 2014, P NATL ACAD SCI USA, V111, P10708, DOI 10.1073/pnas.1408677111; Ledizet M, 2005, VACCINE, V23, P3915, DOI 10.1016/j.vaccine.2005.03.006; Lieberman MM, 2007, VACCINE, V25, P414, DOI 10.1016/j.vaccine.2006.08.018; Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09; Lim CK, 2008, VIROLOGY, V374, P60, DOI 10.1016/j.virol.2007.12.021; Lindsey Nicole P., 2010, Morbidity and Mortality Weekly Report, V59, P1; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Long MT, 2007, EQUINE VET J, V39, P491, DOI 10.2746/042516407X217416; Lustig S, 2000, VIRAL IMMUNOL, V13, P401, DOI 10.1089/vim.2000.13.401; Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103; Morales MA, 2006, EMERG INFECT DIS, V12, P1559, DOI 10.3201/eid1210.060852; Morrey JD, 2013, ANTIVIR RES, V100, P535, DOI 10.1016/j.antiviral.2013.09.010; Muraki Y, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0282-8; Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06; O'Leary DR, 2004, VECTOR-BORNE ZOONOT, V4, P61, DOI 10.1089/153036604773083004; Orlinger KK, 2010, VACCINE, V28, P3318, DOI 10.1016/j.vaccine.2010.02.092; Pepperell C, 2003, CAN MED ASSOC J, V168, P1399; Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070; Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042; Petrovsky N, 2013, J VIROL, V87, P10324, DOI 10.1128/JVI.00480-13; Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004; Pinto AK, 2013, J VIROL, V87, P1926, DOI 10.1128/JVI.02903-12; Pletnev AG, 2003, VIROLOGY, V314, P190, DOI 10.1016/S0042-6822(03)00450-1; Qiao M, 2004, J INFECT DIS, V190, P2104, DOI 10.1086/425933; Ramanathan MP, 2009, VACCINE, V27, P4370, DOI 10.1016/j.vaccine.2009.01.137; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Samina I, 2007, VACCINE, V25, P8338, DOI 10.1016/j.vaccine.2007.09.055; Scheiermann J, 2014, VACCINE, V32, P6377, DOI 10.1016/j.vaccine.2014.06.065; Schepp-Berglind J, 2007, CLIN VACCINE IMMUNOL, V14, P1117, DOI 10.1128/CVI.00070-07; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606; Seligman SJ, 2014, VACCINE, V32, P5769, DOI 10.1016/j.vaccine.2014.08.051; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Shirota H, 2014, EXPERT REV VACCINES, V13, P299, DOI 10.1586/14760584.2014.863715; Siger L, 2004, AM J VET RES, V65, P1459, DOI 10.2460/ajvr.2004.65.1459; Siirin MT, 2008, AM J TROP MED HYG, V79, P955, DOI 10.4269/ajtmh.2008.79.955; Spohn G, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-146; Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3; Tesh RB, 2002, EMERG INFECT DIS, V8, P1392, DOI 10.3201/eid0812.020229; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Vasilakos JP, 2013, EXPERT REV VACCINES, V12, P809, DOI 10.1586/14760584.2013.811208; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Wang T, 2001, J IMMUNOL, V167, P5273, DOI 10.4049/jimmunol.167.9.5273; Whiteman MC, 2010, VACCINE, V28, P1075, DOI 10.1016/j.vaccine.2009.10.112; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310; Wiley SR, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002135; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014; Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064	91	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149610	10.1371/journal.pone.0149610	http://dx.doi.org/10.1371/journal.pone.0149610			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901122	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100110
J	Natalello, A; Mangione, PP; Giorgetti, S; Porcari, R; Marchese, L; Zorzoli, I; Relini, A; Ami, D; Faravelli, G; Valli, M; Stoppini, M; Doglia, SM; Bellotti, V; Raimondi, S				Natalello, Antonino; Mangione, P. Patrizia; Giorgetti, Sofia; Porcari, Riccardo; Marchese, Loredana; Zorzoli, Irene; Relini, Annalisa; Ami, Diletta; Faravelli, Giulia; Valli, Maurizia; Stoppini, Monica; Doglia, Silvia M.; Bellotti, Vittorio; Raimondi, Sara			Co-fibrillogenesis of Wild-type and D76N beta(2)-Microglobulin THE CRUCIAL ROLE OF FIBRILLAR SEEDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-B-CRYSTALLIN; INFRARED-SPECTROSCOPY; SYSTEMIC AMYLOIDOSIS; IN-VITRO; TRANSTHYRETIN; AGGREGATION; PROTEINS; AMYLOIDOGENESIS; GENERATION	The amyloidogenic variant of beta(2)-microglobulin, D76N, can readily convert into genuine fibrils under physiological conditions and primes in vitro the fibrillogenesis of the wild-type beta(2)-microglobulin. By Fourier transformed infrared spectroscopy, we have demonstrated that the amyloid transformation of wild-type beta(2)-microglobulin can be induced by the variant only after its complete fibrillar conversion. Our current findings are consistent with preliminary data in which we have shown a seeding effect of fibrils formed from D76N or the natural truncated form of beta(2)-microglobulin lacking the first six N-terminal residues. Interestingly, the hybrid wild-type/variant fibrillar material acquired a thermodynamic stability similar to that of homogenous D76N beta(2)-microglobulin fibrils and significantly higher than the wild-type homogeneous fibrils prepared at neutral pH in the presence of 20% trifluoroethanol. These results suggest that the surfaceofD76N beta(2)-microglobulinfibrilscanfavorthetransitionof the wild-type protein into an amyloid conformation leading to a rapid integration into fibrils. The chaperone crystallin, which is a mild modulator of the lag phase of the variant fibrillogenesis, potently inhibits fibril elongation of the wild-type even once it is absorbed on D76N beta(2)-microglobulin fibrils.	[Natalello, Antonino; Ami, Diletta; Doglia, Silvia M.] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Natalello, Antonino; Ami, Diletta; Doglia, Silvia M.] Consorzio Nazl Interuniv Sci Fis Mat CNISM, UdR Milano Bicocca, I-20126 Milan, Italy; [Mangione, P. Patrizia; Porcari, Riccardo; Bellotti, Vittorio] UCL, Div Med, Ctr Amyloidosis & Acute Phase Prot, Wolfson Drug Discovery Unit, London NW3 2PF, England; [Mangione, P. Patrizia; Giorgetti, Sofia; Marchese, Loredana; Faravelli, Giulia; Valli, Maurizia; Stoppini, Monica; Bellotti, Vittorio; Raimondi, Sara] Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy; [Zorzoli, Irene] Univ Pavia, Dept Internal Med & Therapeut, Via Palestro 3, I-27100 Pavia, Italy; [Relini, Annalisa] Univ Genoa, Dept Phys, I-16146 Genoa, Italy	University of Milano-Bicocca; University of London; University College London; University of Pavia; University of Pavia; University of Genoa	Raimondi, S (corresponding author), Univ Pavia, Inst Biochem, Dept Mol Med, Via Palestro 3, I-27100 Pavia, Italy.	sara.raimondi@unipv.it	Natalello, Antonino/B-9659-2012; Giorgetti, Sofia/AAD-4341-2019; Relini, Annalisa/AHC-3105-2022; Bellotti, Vittorio/A-6201-2014	Natalello, Antonino/0000-0002-1489-272X; Giorgetti, Sofia/0000-0001-9438-6511; Mangione, Palma/0000-0003-0260-1400; Bellotti, Vittorio/0000-0001-8678-662X; Faravelli, Giulia/0000-0002-7348-9404; RELINI, ANNALISA/0000-0002-4040-9279	United Kingdom Medical Research Council [MR/K000187/1]; Italian Ministry of University and Research Project FIRB [RBFR109EOS]; Telethon Grant [GG14127]; Cariplo Foundation [2013-0964, 2014-0700]; Istituto Nazionale di Biostrutture e Biosistemi; Medical Research Council [MR/K000187/1] Funding Source: researchfish; MRC [MR/K000187/1] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Ministry of University and Research Project FIRB; Telethon Grant(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Istituto Nazionale di Biostrutture e Biosistemi; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by United Kingdom Medical Research Council Grant MR/K000187/1, Italian Ministry of University and Research Project FIRB RBFR109EOS (to S. G.), Telethon Grant GG14127 (to V. B.), Cariplo Foundation Projects 2013-0964 (to A. N., S. G., D. A., and S. M. D.) and 2014-0700 (to V. B.), and grants from the Istituto Nazionale di Biostrutture e Biosistemi (to V. B., S. G., and M. S.). Core support for the Wolfson Drug Discovery Unit was provided by the UK National Institute for Health Research Biomedical Research Centre and Unit Funding Scheme. The authors declare that they have no conflicts of interest with the contents of this article.	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Baldwin AJ, 2011, J AM CHEM SOC, V133, P14160, DOI 10.1021/ja2017703; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bellotti V, 2008, CURR OPIN STRUC BIOL, V18, P771, DOI 10.1016/j.sbi.2008.10.001; Benson MD, 2012, AMYLOID, V19, P14, DOI 10.3109/13506129.2012.668501; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cox B, 2003, GENETICS, V165, P23; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Fabian H., 2012, MILLISECOND TO MINUT; Fabian H, 2013, BIOPHYS CHEM, V179, P35, DOI 10.1016/j.bpc.2013.05.001; Fabian H, 2008, J MOL BIOL, V376, P798, DOI 10.1016/j.jmb.2007.12.009; Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0; Haris PI, 2013, BBA-BIOMEMBRANES, V1828, P2265, DOI 10.1016/j.bbamem.2013.04.008; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Karamanos TK, 2014, MOL CELL, V55, P214, DOI 10.1016/j.molcel.2014.05.026; Mangione PP, 2014, P NATL ACAD SCI USA, V111, P1539, DOI 10.1073/pnas.1317488111; Mangione PP, 2013, J BIOL CHEM, V288, P30917, DOI 10.1074/jbc.M113.498857; Naiki H, 1997, AMYLOID, V4, P223, DOI 10.3109/13506129709003833; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Natalello A., 2015, INSOLUBLE PROTEINS; Natalello A, 2008, J MOL BIOL, V381, P1349, DOI 10.1016/j.jmb.2008.06.063; Natalello A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122449; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Piazza R, 2006, EUR BIOPHYS J BIOPHY, V35, P439, DOI 10.1007/s00249-006-0051-0; Regini JW, 2010, MOL VIS, V16, P2446; Richards DB, 2015, NEW ENGL J MED, V373, P1106, DOI 10.1056/NEJMoa1504942; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sarell CJ, 2013, J BIOL CHEM, V288, P7327, DOI 10.1074/jbc.M112.447524; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Schneider SW, 1998, PFLUG ARCH EUR J PHY, V435, P362, DOI 10.1007/s004240050524; Seshadri S, 1999, METHOD ENZYMOL, V309, P559; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Stoppini M, 2015, J BIOL CHEM, V290, P9951, DOI 10.1074/jbc.R115.639799; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Verdone G, 2002, PROTEIN SCI, V11, P487, DOI 10.1110/ps.29002; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Yamaguchi K, 2006, J MOL BIOL, V363, P279, DOI 10.1016/j.jmb.2006.08.030	43	22	22	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 29	2016	291	18					9678	9689		10.1074/jbc.M116.720573	http://dx.doi.org/10.1074/jbc.M116.720573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4JY	26921323	hybrid, Green Published			2022-12-26	WOS:000375602300026
J	Chevalier, C; Le Goffic, R; Jamme, F; Leymarie, O; Refregiers, M; Delmas, B				Chevalier, Christophe; Le Goffic, Ronan; Jamme, Frederic; Leymarie, Olivier; Refregiers, Matthieu; Delmas, Bernard			Synchrotron Infrared and Deep UV Fluorescent Microspectroscopy Study of PB1-F2 beta-Aggregated Structures in Influenza A Virus-infected Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROCHEMICAL DETECTION; FTIR-MICROSPECTROSCOPY; ESCHERICHIA-COLI; AMYLOID FIBRILS; PB1F2 PROTEIN; MEMBRANE; SEQUENCE; TISSUE; OLIGOMERIZATION; PATHOGENICITY	PB1-F2 is a virulence factor of influenza A virus (IAV) whose functions remain misunderstood. The different roles of PB1-F2 may be linked to its structural polymorphism and to its propensity to assemble into oligomers and amyloid fibers in the vicinity of the membrane of IAV-infected cells. Here, we monitored the impact of PB1-F2 on the biochemical composition and protein structures of human epithelial pulmonary cells (A549) and monocytic cells (U937) upon IAV infection using synchrotron Fourier-transform infrared (FTIR) and deep UV (DUV) microscopies at the single-cell level. Cells were infected with a wildtype IAV and its PB1-F2 knock-out mutant for analyses at different times post-infection. IR spectra were recorded in each condition and processed to evaluate the change in the component band of the spectra corresponding to the amide I (secondary structure) and the CH stretching region (membrane). The IR spectra analysis revealed that expression of PB1-F2 in U937 cells, but not in A549 cells, results in the presence of a specific beta-aggregate signature. Furthermore, the lipid membrane composition of U937 cells expressing PB1-F2 was also altered in a cell type-dependent manner. Using DUV microscopy and taking advantage of the high content of tryptophan residues in the sequence of PB1-F2 (5/90 aa), we showed that the increase of the autofluorescent signal recorded in monocytic cells could be correlated with the IR detection of beta-aggregates. Altogether, our results constitute an important step forward in the understanding of the cell type-dependent function of PB1-F2.	[Chevalier, Christophe; Le Goffic, Ronan; Leymarie, Olivier; Delmas, Bernard] Univ PARIS SACLAY, INRA, UR892, VIM, F-78350 Jouy En Josas, France; [Jamme, Frederic; Refregiers, Matthieu] Synchrotron SOLEIL, DISCO & SMIS Beamlines, F-91190 Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Chevalier, C (corresponding author), Univ PARIS SACLAY, INRA, VIM, Equipe Virus Influenza, F-78350 Jouy En Josas, France.	christophe.chevalier@jouy.inra.fr	Réfrégiers, Matthieu/A-4249-2011; LE GOFFIC, Ronan/B-7649-2008; Réfrégiers, Matthieu/AAE-2075-2022; Chevalier, Christophe/C-2575-2009; JAMME, Frederic/E-2170-2011; Chevalier, Christophe/AAW-5560-2020; LE GOFFIC, Ronan/M-3099-2019; Chevalier, Christophe/AAK-4461-2020	Réfrégiers, Matthieu/0000-0002-3281-2308; LE GOFFIC, Ronan/0000-0002-2012-0064; Chevalier, Christophe/0000-0003-3231-9027; JAMME, Frederic/0000-0002-7398-7868; LE GOFFIC, Ronan/0000-0002-2012-0064; Leymarie, Olivier/0000-0001-8670-3089	Synchrotron SOLEIL; SMIS; DISCO [20110735, 20120904]	Synchrotron SOLEIL; SMIS; DISCO	This work was supported in part by Synchrotron SOLEIL, SMIS, and DISCO beamlines proposals 20110735 and 20120904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. The authors declare that they have no conflicts of interest with the content of this article.	Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Arrondo JLR, 1998, CHEM PHYS LIPIDS, V96, P53, DOI 10.1016/S0009-3084(98)00080-2; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Batard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019440; Blankenberg FG, 1997, BLOOD, V89, P3778, DOI 10.1182/blood.V89.10.3778.3778_3778_3786; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Bucciantini M, 2012, FASEB J, V26, P818, DOI 10.1096/fj.11-189381; Bucciantini M, 2010, METHODS MOL BIOL, V648, P231, DOI 10.1007/978-1-60761-756-3_15; Chakrabarti AK, 2013, VIROLOGY, V440, P97, DOI 10.1016/j.virol.2013.02.025; Chan FTS, 2013, ANALYST, V138, P2156, DOI 10.1039/c3an36798c; Chen CJ, 2010, J VIROL, V84, P10051, DOI 10.1128/JVI.00592-10; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gibbs JS, 2003, J VIROL, V77, P7214, DOI 10.1128/JVI.77.13.7214-7224.2003; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hastings G, 2009, ANALYST, V134, P1462, DOI 10.1039/b902154j; Hiramatsu H, 2005, BBA-PROTEINS PROTEOM, V1753, P100, DOI 10.1016/j.bbapap.2005.07.008; Jamin N, 1998, P NATL ACAD SCI USA, V95, P4837, DOI 10.1073/pnas.95.9.4837; Jamme F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074421; Jamme F, 2013, BIOL CELL, V105, P277, DOI 10.1111/boc.201200075; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Kawaoka Y., 2006, INFLUENZA VIROLOGY C; Kretlow A, 2006, BBA-BIOMEMBRANES, V1758, P948, DOI 10.1016/j.bbamem.2006.05.026; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Loffhagen N, 2007, ENG LIFE SCI, V7, P67, DOI 10.1002/elsc.200620168; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Miller LM, 2010, CURR OPIN STRUC BIOL, V20, P649, DOI 10.1016/j.sbi.2010.07.007; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Pasricha G, 2013, INFLUENZA OTHER RESP, V7, P497, DOI 10.1111/j.1750-2659.2012.00400.x; Penicaud C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111138; Perisic N, 2011, J AGR FOOD CHEM, V59, P10052, DOI 10.1021/jf201578b; Rak M, 2007, BIOPOLYMERS, V87, P207, DOI 10.1002/bip.20820; Romeo M, 2006, BBA-BIOMEMBRANES, V1758, P915, DOI 10.1016/j.bbamem.2006.05.010; Saulou C, 2013, ANAL BIOANAL CHEM, V405, P2685, DOI 10.1007/s00216-013-6725-4; Schmolke M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002186; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrauwen EJA, 2014, EUR J CLIN MICROBIOL, V33, P479, DOI 10.1007/s10096-013-1984-8; TAKIZAWA T, 1993, J GEN VIROL, V74, P2347, DOI 10.1099/0022-1317-74-11-2347; Trifonov V., 2009, PLOS CURR, V1, P1006; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Vidic J, 2016, J BIOL CHEM, V291, P739, DOI 10.1074/jbc.M115.652917; VidicJ Chevalier C., 2013, J JOURNALOF ANALYTIC, VS7, P6; WHO, 2014, GLOB INFL SURV RESP; Wise HM, 2009, J VIROL, V83, P8021, DOI 10.1128/JVI.00826-09; Wood BR, 2008, ANAL CHEM, V80, P9065, DOI 10.1021/ac8015483; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zell R, 2007, J GEN VIROL, V88, P536, DOI 10.1099/vir.0.82378-0	63	10	10	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2016	291	17					9060	9072		10.1074/jbc.M115.710533	http://dx.doi.org/10.1074/jbc.M115.710533			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK3WV	26896002	Green Published, hybrid			2022-12-26	WOS:000374849000020
J	Van Calsteren, MR; Goyette-Desjardins, G; Gagnon, F; Okura, M; Takamatsu, D; Roy, R; Gottschalk, M; Segura, M				Van Calsteren, Marie-Rose; Goyette-Desjardins, Guillaume; Gagnon, Fleur; Okura, Masatoshi; Takamatsu, Daisuke; Roy, Rene; Gottschalk, Marcelo; Segura, Mariela			Explaining the Serological Characteristics of Streptococcus suis Serotypes 1 and 1/2 from Their Capsular Polysaccharide Structure and Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate structure; chemical biology; immunochemistry; polysaccharide; sialic acid; Streptococcus	GROUP-B STREPTOCOCCUS; SIALIC-ACID; VIRULENCE FACTOR; GENETIC-ANALYSIS; CELLS; NMR; EXPRESSION; SEQUENCE; LOCUS	The capsular polysaccharide (CPS) is a major virulence factor in many encapsulated pathogens, as it is the case for Streptococcus suis, an important swine pathogen and emerging zoonotic agent. Moreover, the CPS is the antigen at the origin of S. suis classification into serotypes. Hence, analyses of the CPS structure are an essential step to dissect its role in virulence and the serological relations between important serotypes. Here, the CPSs of serotypes 1 and 1/2 were purified and characterized for the first time. Chemical and spectroscopic data gave the following repeating unit sequences: [6)[Neu5Ac(alpha 2-6)GalNAc(beta 1-4)GlcNAc(beta 1-3)]Gal(beta 1-3)Gal(beta 1-4)Glc(beta 1-](n) (serotype 1) and [4)[Neu5Ac(alpha 2-6)GalNAc(beta 1-4)GlcNAc(beta 1-3)]Gal(beta 1-4)[Gal(alpha 1-3)]Rha(beta 1-4)Glc(beta 1-](n) (serotype 1/2). The Sambucus nigra lectin, which recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence, showed binding to both CPSs. Compared with previously characterized serotype 14 and 2 CPSs, N-acetylgalactosamine replaces galactose as the sugar bearing the sialic acid residue in the side chain. Serological analyses of the cross-reaction of serotype 1/2 with serotypes 1 and 2 and that between serotypes 1 and 14 suggested that the side chain, and more particularly the terminal sialic acid, constitutes one important epitope for serotypes 1/2 and 2. The side chain is also an important serological determinant for serotype 1, yet sialic acid seems to play a limited role. In contrast, the side chain does not seem to be part of a major epitope for serotype 14. These results contribute to the understanding of the relationship between S. suis serotypes and provide the basis for improving diagnostic tools.	[Van Calsteren, Marie-Rose; Gagnon, Fleur] Agr & Agri Food Canada, Food Res & Dev Ctr, St Hyacinthe, PQ J2S 8E3, Canada; [Van Calsteren, Marie-Rose; Goyette-Desjardins, Guillaume; Gottschalk, Marcelo; Segura, Mariela] Univ Montreal, Fac Vet Med, Swine & Poultry Infect Dis Res Ctr, St Hyacinthe, PQ J2S 2M2, Canada; [Goyette-Desjardins, Guillaume; Gottschalk, Marcelo; Segura, Mariela] Univ Montreal, Fac Vet Med, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 2M2, Canada; [Okura, Masatoshi; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki 3050856, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu 5011193, Japan; [Roy, Rene] Univ Quebec, Dept Chem, Montreal, PQ H3C 3P8, Canada	Agriculture & Agri Food Canada; Universite de Montreal; Universite de Montreal; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University; University of Quebec; University of Quebec Montreal	Segura, M (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 2M2, Canada.	mariela.segura@umontreal.ca	Segura, Mariela/AAG-5708-2020; Gottschalk, Marcelo/I-8116-2012; Goyette-Desjardins, Guillaume/I-1881-2019	Goyette-Desjardins, Guillaume/0000-0001-7158-9594	Natural Sciences and Engineering Research Council of Canada (NSERC) [342150]; NSERC fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant 342150 (to M. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of an NSERC fellowship.	Berti F, 2014, J BIOL CHEM, V289, P23437, DOI 10.1074/jbc.M114.567974; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Carpita N. C., 1989, ANAL CARBOHYDRATES G, P157; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; CHARLAND N, 1995, J CLIN MICROBIOL, V33, P2220, DOI 10.1128/JCM.33.8.2220-2221.1995; Charland N, 1998, MICROBIOL-SGM, V144, P325, DOI 10.1099/00221287-144-2-325; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; ELLIOTT SD, 1978, J EXP MED, V148, P1699, DOI 10.1084/jem.148.6.1699; GOTTSCHALK M, 1989, J CLIN MICROBIOL, V27, P2633, DOI 10.1128/JCM.27.12.2633-2636.1989; GOTTSCHALK M, 1991, J CLIN MICROBIOL, V29, P2590, DOI 10.1128/JCM.29.11.2590-2594.1991; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; HIGGINS R, 1995, J VET DIAGN INVEST, V7, P405, DOI 10.1177/104063879500700322; Higgins R, 1990, J Vet Diagn Invest, V2, P249; HOUGH L, 1972, CARBOHYD RES, V21, P9, DOI 10.1016/S0008-6215(00)81725-5; Lecours MP, 2012, MICROBES INFECT, V14, P941, DOI 10.1016/j.micinf.2012.03.008; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; MACHYTKA D, 1994, CARBOHYD RES, V254, P289, DOI 10.1016/0008-6215(94)84262-0; Okura M, 2013, APPL ENVIRON MICROB, V79, P2796, DOI 10.1128/AEM.03742-12; PERCH B, 1981, ACTA PATH MICRO IM B, V89, P167; PERCH B, 1983, J CLIN MICROBIOL, V17, P993, DOI 10.1128/JCM.17.6.993-996.1983; Roy D, 2015, CAN J VET RES, V79, P141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segura M, 2002, INFECT IMMUN, V70, P4312, DOI 10.1128/IAI.70.8.4312-4322.2002; SHIBUYA N, 1987, J BIOL CHEM, V262, P1596; Smith HE, 1999, INFECT IMMUN, V67, P1750; Van Calsteren MR, 2013, BIOCHEM CELL BIOL, V91, P49, DOI 10.1139/bcb-2012-0036; Van Calsteren MR, 2010, BIOCHEM CELL BIOL, V88, P513, DOI [10.1139/O09-170, 10.1139/o09-170]; Wang KC, 2011, FEMS MICROBIOL LETT, V324, P117, DOI 10.1111/j.1574-6968.2011.02394.x; Wang YC, 2013, INFECT IMMUN, V81, P4498, DOI 10.1128/IAI.00818-13; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wu NH, 2015, J GEN VIROL, V96, P2557, DOI 10.1099/jgv.0.000223; ZHU G, 1992, J MAGN RESON, V100, P202, DOI 10.1016/0022-2364(92)90379-L	32	21	21	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8387	8398		10.1074/jbc.M115.700716	http://dx.doi.org/10.1074/jbc.M115.700716			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912653	Green Published, hybrid			2022-12-26	WOS:000374773200007
J	Zhang, YH; Chen, SR; Laumet, G; Chen, H; Pan, HL				Zhang, Yuhao; Chen, Shao-Rui; Laumet, Geoffroy; Chen, Hong; Pan, Hui-Lin			Nerve Injury Diminishes Opioid Analgesia through Lysine Methyltransferase-mediated Transcriptional Repression of mu-Opioid Receptors in Primary Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE-INDUCED ANALGESIA; ROOT GANGLION NEURONS; NEUROPATHIC PAIN; SPINAL-CORD; HISTONE METHYLATION; SUBSTANTIA-GELATINOSA; IDIOPATHIC FORMS; G9A; GENE; CHROMATIN	The mu-opioid receptor (MOR, encoded by Oprm1) agonists are the mainstay analgesics for treating moderate to severe pain. Nerve injury causes down-regulation of MORs in the dorsal root ganglion (DRG) and diminishes the opioid effect on neuropathic pain. However, the epigenetic mechanisms underlying the diminished MOR expression caused by nerve injury are not clear. G9a (encoded by Ehmt2), a histone 3 at lysine 9 methyltransferase, is a key chromatin regulator responsible for gene silencing. In this study, we determined the role of G9a in diminished MOR expression and opioid analgesic effects in animal models of neuropathic pain. We found that nerve injury in rats induced a long-lasting reduction in the expression level of MORs in the DRG but not in the spinal cord. Nerve injury consistently increased the enrichment of the G9a product histone 3 at lysine 9 dimethylation in the promoter of Oprm1 in the DRG. G9a inhibition or siRNA knockdown fully reversed MOR expression in the injured DRG and potentiated the morphine effect on pain hypersensitivity induced by nerve injury. In mice lacking Ehmt2 in DRG neurons, nerve injury failed to reduce the expression level of MORs and the morphine effect. In addition, G9a inhibition or Ehmt2 knockout in DRG neurons normalized nerve injury-induced reduction in the inhibitory effect of the opioid on synaptic glutamate release from primary afferent nerves. Our findings indicate that G9a contributes critically to transcriptional repression of MORs in primary sensory neurons in neuropathic pain. G9a inhibitors may be used to enhance the opioid analgesic effect in the treatment of chronic neuropathic pain.	[Zhang, Yuhao; Chen, Shao-Rui; Laumet, Geoffroy; Chen, Hong; Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Ctr Neurosci & Pain Res, Houston, TX 77030 USA.; Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org	Zhang, Yuhao/HHN-6356-2022; Laumet, Geoffroy/O-7480-2019	Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [DE022015, NS073935]; N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); N. G. and Helen T. Hawkins Endowment; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (DE022015 and NS073935) and by the N. G. and Helen T. Hawkins Endowment (to H. L. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNER S, 1988, PAIN, V33, P11, DOI 10.1016/0304-3959(88)90198-4; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Chan KM, 2013, GENE DEV, V27, P985, DOI 10.1101/gad.217778.113; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen SR, 2014, J PHARMACOL EXP THER, V350, P301, DOI 10.1124/jpet.114.215855; Chen SR, 2009, J NEUROCHEM, V110, P352, DOI 10.1111/j.1471-4159.2009.06138.x; Chen SR, 2006, BRAIN RES, V1081, P119, DOI 10.1016/j.brainres.2006.01.053; Chen SR, 2006, J NEUROPHYSIOL, V95, P3086, DOI 10.1152/jn.01343.2005; Chen SR, 2002, J NEUROPHYSIOL, V87, P2726, DOI 10.1152/jn.2002.87.6.2726; Esteve PO, 2006, GENE DEV, V20, P3089, DOI 10.1101/gad.1463706; Hasegawa H, 2007, J NEUROSCI, V27, P14404, DOI 10.1523/JNEUROSCI.4908-07.2007; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jose CC, 2014, P NATL ACAD SCI USA, V111, P14631, DOI 10.1073/pnas.1406923111; Kohno T, 1999, J PHYSIOL-LONDON, V518, P803, DOI 10.1111/j.1469-7793.1999.0803p.x; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUPERS RC, 1991, PAIN, V47, P5, DOI 10.1016/0304-3959(91)90004-H; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laumet G, 2015, NAT NEUROSCI, V18, P1746, DOI 10.1038/nn.4165; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; OSSIPOV MH, 1995, NEUROSCI LETT, V199, P87, DOI 10.1016/0304-3940(95)12022-V; Pan HL, 2003, J NEUROSCI, V23, P2911; Pan YZ, 2004, J NEUROPHYSIOL, V91, P2413, DOI 10.1152/jn.01242.2003; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Rashid MH, 2004, J PHARMACOL EXP THER, V309, P380, DOI 10.1124/jpet.103.060582; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Roopra A, 2004, MOL CELL, V14, P727, DOI 10.1016/j.molcel.2004.05.026; Sanna MD, 2015, PAIN, V156, P1265, DOI 10.1097/j.pain.0000000000000164; Santos SFA, 2007, J PHYSIOL-LONDON, V581, P241, DOI 10.1113/jphysiol.2006.126912; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sora I, 1997, P NATL ACAD SCI USA, V94, P1544, DOI 10.1073/pnas.94.4.1544; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Uchida H, 2015, J PHARMACOL SCI, V128, P208, DOI 10.1016/j.jphs.2015.07.040; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Vedadi M, 2011, NAT CHEM BIOL, V7, P566, DOI [10.1038/NCHEMBIO.599, 10.1038/nchembio.599]; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Zhang X, 1998, NEUROSCIENCE, V82, P223; Zhang YH, 2015, J BIOL CHEM, V290, P14647, DOI 10.1074/jbc.M115.650218; Zhao YL, 2012, J BIOL CHEM, V287, P25073, DOI 10.1074/jbc.M112.378737; Zhou HY, 2010, J NEUROSCI, V30, P4460, DOI 10.1523/JNEUROSCI.5857-09.2010; Zhou XL, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-51	49	36	41	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8475	8485		10.1074/jbc.M115.711812	http://dx.doi.org/10.1074/jbc.M115.711812			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26917724	Green Published, hybrid			2022-12-26	WOS:000374773200014
J	Sun, XF; Deng, WB; Li, YJ; Tang, S; Leishman, E; Bradshaw, HB; Dey, SK				Sun, Xiaofei; Deng, Wenbo; Li, Yingju; Tang, Shuang; Leishman, Emma; Bradshaw, Heather B.; Dey, Sudhansu K.			Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes Inflammation-induced Preterm Birth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anandamide (N-arachidonoylethanolamine) (AEA); cannabinoid receptor type 1 (CB1); fatty acid metabolism; pregnancy; senescence	ONCOGENE-INDUCED SENESCENCE; ACID AMIDE HYDROLASE; CANNABINOID RECEPTOR; MOLECULAR CHARACTERIZATION; ANANDAMIDE; MICE; MOUSE; CB1; IMPLANTATION; ACTIVATION	Recent studies provide evidence that premature maternal decidual senescence resulting from heightened mTORC1 signaling is a cause of preterm birth (PTB). We show here that mice devoid of fatty acid amide hydrolase (FAAH) with elevated levels of N-arachidonyl ethanolamide (anandamide), a major endocannabinoid lipid mediator, were more susceptible to PTB upon lipopolysaccharide (LPS) challenge. Anandamide is degraded by FAAH and primarily works by activating two G-protein-coupled receptors CB1 and CB2, encoded by Cnr1 and Cnr2, respectively. We found that Faah(-/-) decidual cells progressively underwent premature senescence as marked by increased senescence-associated -galactosidase (SA--Gal) staining and H2AX-positive decidual cells. Interestingly, increased endocannabinoid signaling activated MAPK p38, but not p42/44 or mTORC1 signaling, in Faah(-/-) deciduae, and inhibition of p38 halted premature decidual senescence. We further showed that treatment of a long-acting anandamide in wild-type mice at midgestation triggered premature decidual senescence utilizing CB1, since administration of a CB1 antagonist greatly reduced the rate of PTB in Faah(-/-) females exposed to LPS. These results provide evidence that endocannabinoid signaling is critical in regulating decidual senescence and parturition timing. This study identifies a previously unidentified pathway in decidual senescence, which is independent of mTORC1 signaling.	[Sun, Xiaofei; Deng, Wenbo; Li, Yingju; Tang, Shuang; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Leishman, Emma; Bradshaw, Heather B.] Indiana Univ, Kinsey Inst Res Sex Gender & Reprod, Dept Psychol & Brain Sci, Bloomington, IN 47405 USA	Cincinnati Children's Hospital Medical Center; Indiana University System; Indiana University Bloomington	Sun, XF; Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, Reprod Sci, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA.	xiaofei.sun@cchmc.org; sk.dey@cchmc.org	唐, 爽/GXN-4370-2022; Tang, Shuang/G-5604-2016	Tang, Shuang/0000-0002-7078-7289; Tang, Shuang/0000-0002-5967-5593	NIDA/National Institutes of Health [DA006668]; March of Dimes Foundation [21-FY12-127, 22-FY13-543]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA006668, R01DA006668] Funding Source: NIH RePORTER	NIDA/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in parts by grants from NIDA/National Institutes of Health (DA006668, to S. K. D.) and March of Dimes Foundation (21-FY12-127 and 22-FY13-543). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alam SMK, 2015, REPRODUCTION, V149, P625, DOI 10.1530/REP-15-0107; [Anonymous], 2015, AM CHILDR KEY NAT IN; Behrman RE, 2007, PRETERM BIRTH CAUSES; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Casey ML, 1997, ANN NY ACAD SCI, V828, P273, DOI 10.1111/j.1749-6632.1997.tb48548.x; CAULFIELD MP, 1992, BRIT J PHARMACOL, V106, P231, DOI 10.1111/j.1476-5381.1992.tb14321.x; Cha J, 2013, J CLIN INVEST, V123, P4063, DOI 10.1172/JCI70098; CHAKRABORTY I, 1995, J ENDOCRINOL, V147, P339, DOI 10.1677/joe.0.1470339; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Dennedy MC, 2004, AM J OBSTET GYNECOL, V190, P2, DOI 10.1016/j.ajog.2003.07.013; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, BBA-LIPID LIPID MET, V1392, P153, DOI 10.1016/S0005-2760(98)00042-3; Fidel P I Jr, 1998, J Matern Fetal Med, V7, P222; Hirota Y, 2011, P NATL ACAD SCI USA, V108, P18073, DOI 10.1073/pnas.1108180108; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Houlihan DD, 2010, REPRODUCTION, V139, P783, DOI 10.1530/REP-09-0496; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Maccarrone M, 2002, MOL HUM REPROD, V8, P188, DOI 10.1093/molehr/8.2.188; Maccarrone M, 2000, LANCET, V355, P1326, DOI 10.1016/S0140-6736(00)02115-2; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; PARIA BC, 1995, P NATL ACAD SCI USA, V92, P9460, DOI 10.1073/pnas.92.21.9460; Park B, 2003, PLACENTA, V24, P990, DOI 10.1016/S0143-4004(03)00165-6; Pucci M, 2012, J BIOL CHEM, V287, P15466, DOI 10.1074/jbc.M111.314880; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; Smith WL, 1996, ADV IMMUNOL, V62, P167, DOI 10.1016/S0065-2776(08)60430-7; Sun XF, 2012, ACS CHEM NEUROSCI, V3, P349, DOI 10.1021/cn300014e; Sun XF, 2010, P NATL ACAD SCI USA, V107, P16887, DOI 10.1073/pnas.1010892107; Tan J, 1999, ENDOCRINOLOGY, V140, P5310, DOI 10.1210/en.140.11.5310; Thaxton JE, 2010, INFECT DIS OBSTET GY, V2010; Wang HB, 2007, J BIOL CHEM, V282, P37770, DOI 10.1074/jbc.M706577200; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Winchester SK, 2002, ENDOCRINOLOGY, V143, P2593, DOI 10.1210/en.143.7.2593; Wolfson ML, 2015, MOL CELL ENDOCRINOL, V411, P214, DOI 10.1016/j.mce.2015.04.032; Xie HR, 2012, J BIOL CHEM, V287, P32288, DOI 10.1074/jbc.M112.381145; Xu YX, 2014, TRENDS BIOCHEM SCI, V39, P268, DOI 10.1016/j.tibs.2014.04.004; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	49	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8231	8240		10.1074/jbc.M115.707836	http://dx.doi.org/10.1074/jbc.M115.707836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26900150	Green Published, hybrid			2022-12-26	WOS:000374056700038
J	Welzenbach, J; Neuhoff, C; Looft, C; Schellander, K; Tholen, E; Grosse-Brinkhaus, C				Welzenbach, Julia; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tholen, Ernst; Grosse-Brinkhaus, Christine			Different Statistical Approaches to Investigate Porcine Muscle Metabolome Profiles to Highlight New Biomarkers for Pork Quality Assessment	PLOS ONE			English	Article							MEAT QUALITY; DRIP LOSS; POSTMORTEM; MECHANISMS; REGRESSION; INDUCTION; GENES; PIGS	The aim of this study was to elucidate the underlying biochemical processes to identify potential key molecules of meat quality traits drip loss, pH of meat 1 h post-mortem (pH1), pH in meat 24 h post-mortem (pH24) and meat color. An untargeted metabolomics approach detected the profiles of 393 annotated and 1,600 unknown metabolites in 97 Duroc x Pietrain pigs. Despite obvious differences regarding the statistical approaches, the four applied methods, namely correlation analysis, principal component analysis, weighted network analysis (WNA) and random forest regression (RFR), revealed mainly concordant results. Our findings lead to the conclusion that meat quality traits pH1, pH24 and color are strongly influenced by processes of post-mortem energy metabolism like glycolysis and pentose phosphate pathway, whereas drip loss is significantly associated with metabolites of lipid metabolism. In case of drip loss, RFR was the most suitable method to identify reliable biomarkers and to predict the phenotype based on metabolites. On the other hand, WNA provides the best parameters to investigate the metabolite interactions and to clarify the complex molecular background of meat quality traits. In summary, it was possible to attain findings on the interaction of meat quality traits and their underlying biochemical processes. The detected key metabolites might be better indicators of meat quality especially of drip loss than the measured phenotype itself and potentially might be used as bio indicators.	[Welzenbach, Julia; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tholen, Ernst; Grosse-Brinkhaus, Christine] Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany	University of Bonn	Grosse-Brinkhaus, C (corresponding author), Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany.	cgro@itw.uni-bonn.de	Welzenbach, Julia/K-1794-2019; Große-Brinkhaus, Christine/AAF-6712-2020	Große-Brinkhaus, Christine/0000-0002-6190-4463	Federal Ministry of Education and Research (BMBF) Germany [0315536E]	Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF))	Authors are grateful to Dierk-Christoph Pother from Metabolomic Discoveries GmbH who performed the metabolite profiling. This work was a part of the Phanomics (Network of competence agricultural and nutritional research) project and supported by the Federal Ministry of Education and Research (BMBF) Germany (grant nr. 0315536E).; The work is part of the project Phanomics (Network of competence agricultural and nutritional research) project and was supported by the Federal Ministry of Education and Research (BMBF) Germany (grant nr.: 0315536E).	Acharjee A, 2011, ANAL CHIM ACTA, V705, P56, DOI 10.1016/j.aca.2011.03.050; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; Bertram HC, 2010, MEAT SCI, V84, P108, DOI 10.1016/j.meatsci.2009.08.031; Binke R, 2004, FLEISCHWIRTSCHAFT, V84, P224; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chagoyen M, 2013, BRIEF BIOINFORM, V14, P737, DOI 10.1093/bib/bbs055; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; D'Alessandro A, 2011, J PROTEOMICS, V75, P610, DOI 10.1016/j.jprot.2011.08.024; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Guyon I., 2006, FEATURE EXTRACTION F, V207; Hidalgo FJ, 2013, FOOD CHEM, V140, P183, DOI 10.1016/j.foodchem.2013.02.052; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; HONIKEL KO, 1986, FLEISCHWIRTSCHAFT, V66, P349; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; Jolliffe IT, 2003, J COMPUT GRAPH STAT, V12, P531, DOI 10.1198/1061860032148; Lambert IH, 2001, J AGR FOOD CHEM, V49, P4876, DOI 10.1021/jf010121y; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Muroya S, 2014, MEAT SCI, V98, P726, DOI 10.1016/j.meatsci.2014.07.018; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pas M. F. W. te, 2011, Journal on Chain and Network Science, V11, P155, DOI 10.3920/JCNS2011.Qpork6; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Poulsen KA, 2007, J AGR FOOD CHEM, V55, P1970, DOI 10.1021/jf062341n; Rohart F, 2012, J ANIM SCI, V90, P4729, DOI 10.2527/jas.2012-5338; Schafer A, 2002, MEAT SCI, V61, P355, DOI 10.1016/S0309-1740(01)00205-4; Scheffler TL, 2007, MEAT SCI, V77, P7, DOI 10.1016/j.meatsci.2007.04.024; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Terenina E, 2013, DOMEST ANIM ENDOCRIN, V44, P81, DOI 10.1016/j.domaniend.2012.09.004; Toldra F, 2000, FOOD CHEM, V69, P387, DOI 10.1016/S0308-8146(00)00052-2; Verbeke W, 2010, MEAT SCI, V84, P284, DOI 10.1016/j.meatsci.2009.05.001; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zentralverband der Deutschen Schweineproduktion ZDS, 2003, RICHTL STAT MASTL SC	44	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149758	10.1371/journal.pone.0149758	http://dx.doi.org/10.1371/journal.pone.0149758			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919205	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400044
J	Chmura, GL; Kellman, L; van Ardenne, L; Guntenspergen, GR				Chmura, Gail L.; Kellman, Lisa; van Ardenne, Lee; Guntenspergen, Glenn R.			Greenhouse Gas Fluxes from Salt Marshes Exposed to Chronic Nutrient Enrichment	PLOS ONE			English	Article							NITROUS-OXIDE FLUXES; CARBON; BAY; METHANE; FUNDY; WETLANDS; SOILS	We assessed the impact of nutrient additions on greenhouse gas fluxes using dark static chambers in a microtidal and a macrotidal marsh along the coast of New Brunswick, Canada approximately monthly over a year. Both were experimentally fertilized for six years with varying levels of N and P. For unfertilized, N and NPK treatments, average yearly CO2 emissions (which represent only respiration) at the microtidal marsh (13, 19, and 28 mmoles CO2 m(-2) hr(-1), respectively) were higher than at the macrotidal marsh (12, 15, and 19 mmoles m(-2) hr(-1), respectively, with a flux under the additional high N/low P treatment of 21 mmoles m(-2) hr(-1)). Response of CH4 to fertilization was more variable. At the macrotidal marsh average yearly fluxes were 1.29, 1.26, and 0.77 mu mol CH4 m(-2) hr(-1) with control, N, and NPK treatments, respectively and 1.21 mu mol m(-2) hr(-1) under high N/low P treatment. At the microtidal marsh CH4 fluxes were 0.23, 0.16, and -0.24 mu mol CH4 m(-2) hr(-1) in control, N, and NPK and treatments, respectively. Fertilization changed soils from sinks to sources of N2O. Average yearly N2O fluxes at the macrotidal marsh were -0.07, 0.08, and 1.70, mu mol N(2)Om(-2) hr(-1) in control, N, NPK and treatments, respectively and 0.35 mu mol m(-2) hr(-1) under high N/low P treatment. For the control, N, and NPK treatments at the microtidal marsh N2O fluxes were -0.05, 0.30, and 0.52 mu mol N(2)Om(-2) hr(-1), respectively. Our results indicate that N2O fluxes are likely to vary with the source of pollutant nutrients but emissions will be lower if N is not accompanied by an adequate supply of P (e.g., atmospheric deposition vs sewage or agricultural runoff). With chronic fertilization the global warming potential of the increased N2O emissions may be enough to offset the global cooling potential of the C sequestered by salt marshes.	[Chmura, Gail L.; van Ardenne, Lee] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Kellman, Lisa] St Francis Xavier Univ, Environm Sci Res Ctr, Antigonish, NS B2G 1C0, Canada; [Guntenspergen, Glenn R.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	McGill University; Saint Francis Xavier University - Canada; United States Department of the Interior; United States Geological Survey	Chmura, GL (corresponding author), McGill Univ, Dept Geog, Montreal, PQ, Canada.	gail.chmura@mcgill.ca		van Ardenne, Lee/0000-0002-2759-7869; Chmura, Gail/0000-0001-7163-3903	Natural Sciences and Engineering Research Council of Canada; US Geological Survey Climate and Land Use Research and Development program; St. Francis Xavier University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US Geological Survey Climate and Land Use Research and Development program; St. Francis Xavier University	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program GLC, LK. US Geological Survey Climate and Land Use Research and Development program GRG. St. Francis Xavier University James Chair Fellowship GLC. Natural Sciences and Engineering Research Council of Canada Graduate Fellowship LvA.	[Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; [Anonymous], 2000, CAN TID CURR TABL, V2; Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Byers SE, 2007, ESTUAR COAST, V30, P869; Canadian Hydrographic Survey, 2000, CAN TID CURR TABL, V1; Childers DL, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P391; Chmura GL, 2001, A312 NAT RES CAN; Connor RF, 2001, GLOBAL BIOGEOCHEM CY, V15, P943, DOI 10.1029/2000GB001346; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Daoust RJ, 1996, J COASTAL RES, V12, P520; Darby FA, 2008, MAR ECOL PROG SER, V363, P63, DOI 10.3354/meps07423; Davies J.L., 1964, Z GEOMORPHOL, V8, P27; Grunfeld S, 1999, AQUAT BOT, V64, P63, DOI 10.1016/S0304-3770(99)00010-8; Irvine IC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00090; Kronvang B, 2005, J ENVIRON QUAL, V34, P2129, DOI 10.2134/jeq2004.0439; Liikanen A, 2009, BOREAL ENVIRON RES, V14, P351; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Magenheimer JF, 1996, ESTUARIES, V19, P139, DOI 10.2307/1352658; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McVicar K, 2014, BIOGEOCHEMISTRY, V120, P225, DOI 10.1007/s10533-014-9992-z; Morris J. T., 2014, PERSPECTIVES RESTORA, P111; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Neubauer SC, 2014, LANDSCAPE ECOL, V29, P571, DOI 10.1007/s10980-014-9986-1; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P1977, DOI 10.4319/lo.2001.46.8.1977; Tobias C, 2019, COASTAL WETLANDS: AN INTEGRATED ECOSYSTEM APPROACH, 2ND EDITION, P539, DOI 10.1016/B978-0-444-63893-9.00016-2; Van Drecht G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003458; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Yu O, 2010, ENVIRON CONSERV, V36, P312, DOI DOI 10.1017/S0376892910000184; [No title captured]	34	30	30	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149937	10.1371/journal.pone.0149937	http://dx.doi.org/10.1371/journal.pone.0149937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914333	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700039
J	Li, QL; Xie, J; Wang, BJ; Li, R; Bai, J; Ding, L; Gu, R; Wang, L; Xu, BA				Li, Qiaoling; Xie, Jun; Wang, Bingjian; Li, Ran; Bai, Jian; Ding, Liang; Gu, Rong; Wang, Lian; Xu, Biao			Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy	PLOS ONE			English	Article							FAILING HEART; GROWTH; INHIBITION; MECHANISMS; PREVENTS	Pathological cardiomyocyte hypertrophy is associated with significantly increased risk of heart failure, one of the leading medical causes of mortality worldwide. MicroRNAs are known to be involved in pathological cardiac remodeling. However, whether miR-99a participates in the signaling cascade leading to cardiac hypertrophy is unknown. To evaluate the role of miR-99a in cardiac hypertrophy, we assessed the expression of miR-99a in hypertrophic cardiomyocytes induced by isoprenaline (ISO)/angiotensin-II (Ang II) and in mice model of cardiac hypertrophy induced by transverse aortic constriction (TAC). Expression of miR-99a was evaluated in these hypertrophic cells and hearts. We also found that miR99a expression was highly correlated with cardiac function of mice with heart failure (8 weeks after TAC surgery). Overexpression of miR-99a attenuated cardiac hypertrophy in TAC mice and cellular hypertrophy in stimuli treated cardiomyocytes through down-regulation of expression of mammalian target of rapamycin (mTOR). These results indicate that miR-99a negatively regulates physiological hypertrophy through mTOR signaling pathway, which may provide a new therapeutic approach for pressure-overload heart failure.	[Li, Qiaoling; Xie, Jun; Li, Ran; Bai, Jian; Ding, Liang; Gu, Rong; Wang, Lian; Xu, Biao] Nanjing Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Bingjian] Nanjing Med Univ, Drum Tower Clin Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Xu, BA (corresponding author), Nanjing Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China.	xubiao@medmail.com.cn	li, ran/GPW-6786-2022; xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242; Ding, Liang/0000-0002-1043-0923	Natural Science Foundations of China [81071859, 81000055, 81200148, 81270281, 81200092]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Jiangsu Provincial Special Program of Medical Science [BL2012014]; State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901]; Peak of Six Personnel in Jiangsu Province [2013-WSN-008]; Funds for Distinguished Young Scientists in Nanjing; Natural Science Foundation of Jiangsu Province Youth Fund Project [BK20150106]	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Jiangsu Provincial Special Program of Medical Science; State Key Laboratory of Pharmaceutical Biotechnology; Peak of Six Personnel in Jiangsu Province; Funds for Distinguished Young Scientists in Nanjing; Natural Science Foundation of Jiangsu Province Youth Fund Project	This work was supported by grants from the Natural Science Foundations of China [Research Grants 81071859, 81000055, 81200148, 81270281 and 81200092], and Jiangsu Key Laboratory for Molecular Medicine of Nanjing University [Research Grant 2008], Jiangsu Provincial Special Program of Medical Science (BL2012014), and the State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901], and the Peak of Six Personnel in Jiangsu Province (2013-WSN-008), and Funds for Distinguished Young Scientists in Nanjing (Xie Jun), Natural Science Foundation of Jiangsu Province Youth Fund Project, Qiaoling Li, BK20150106.	Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; BONNIN CM, 1983, J MOL CELL CARDIOL, V15, P245, DOI 10.1016/0022-2828(83)90279-1; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Buss SJ, 2006, ENDOCRINOLOGY, V147, P2526, DOI 10.1210/en.2005-1167; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Katz AM, 2002, CARDIOVASC DRUG THER, V16, P245, DOI 10.1023/A:1020604623427; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Lee A, 2014, ANTIOXID REDOX SIGNA; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Nanka O, 2012, CARDIOVASC RES, V93, pS92, DOI 10.1093/cvr/cvr336; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Qin FZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00084.2014; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sen S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004796; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Walker N, 2013, J HEART LUNG TRANSPL, V32, pS28, DOI 10.1016/j.healun.2013.01.054	35	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148480	10.1371/journal.pone.0148480	http://dx.doi.org/10.1371/journal.pone.0148480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914935	gold, Green Submitted, Green Published			2022-12-26	WOS:000371175700005
J	Saunders, A; Huang, KW; Sabatini, BL				Saunders, Arpiar; Huang, Kee Wui; Sabatini, Bernardo Luis			Globus Pallidus Externus Neurons Expressing parvalbumin Interconnect the Subthalamic Nucleus and Striatal Interneurons	PLOS ONE			English	Article							BASAL GANGLIA; RAT; OUTPUT; LIGHT; ELECTROPHYSIOLOGY; ORGANIZATION; OSCILLATIONS; CONNECTIONS; ANTEROGRADE; PROJECTIONS	The globus pallidus externus (GP) is a nucleus of the basal ganglia (BG), containing GABAergic projection neurons that arborize widely throughout the BG, thalamus and cortex. Ongoing work seeks to map axonal projection patterns from GP cell types, as defined by their electrophysiological and molecular properties. Here we use transgenic mice and recombinant viruses to characterize parvalbumin expressing (PV+) GP neurons within the BG circuit. We confirm that PV+ neurons 1) make up similar to 40% of the GP neurons 2) exhibit fast-firing spontaneous activity and 3) provide the major axonal arborization to the STN and substantia nigra reticulata/compacta (SNr/c). PV+ neurons also innervate the striatum. Retrograde labeling identifies similar to 17% of pallidostriatal neurons as PV+, at least a subset of which also innervate the STN and SNr. Optogenetic experiments in acute brain slices demonstrate that the PV+ pallidostriatal axons make potent inhibitory synapses on low threshold spiking (LTS) and fast-spiking interneurons (FS) in the striatum, but rarely on spiny projection neurons (SPNs). Thus PV+ GP neurons are synaptically positioned to directly coordinate activity between BG input nuclei, the striatum and STN, and thalamic-output from the SNr.	[Saunders, Arpiar; Huang, Kee Wui; Sabatini, Bernardo Luis] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu			Howard Hughes Medical Institute; NIH [R01 (NS046579)]; NIH F31 grant [MH093026-01A1]; Harvard Medical School/Boston Children's Hospital Cellular Imaging Core [NIH P30NS072030]; Boston Children's Hospital Viral Core [NIH P30EY012196]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH093026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, P30NS072030] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F31 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School/Boston Children's Hospital Cellular Imaging Core; Boston Children's Hospital Viral Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by Howard Hughes Medical Institute and an R01 (NS046579) from the NIH to BLS and an NIH F31 grant (MH093026-01A1) to AS. Funding for this work was also provided to the Boston Children's Hospital Viral Core (NIH P30EY012196) and the Harvard Medical School/Boston Children's Hospital Cellular Imaging Core (NIH P30NS072030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi A, 2015, J NEUROSCI, V35, P6667, DOI 10.1523/JNEUROSCI.4662-14.2015; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; BENNETT BD, 1994, J COMP NEUROL, V347, P340, DOI 10.1002/cne.903470303; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bevan MD, 1998, J NEUROSCI, V18, P9438; Castle MJ, 2014, HUM GENE THER, V25, P705, DOI 10.1089/hum.2013.189; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; CHANG HT, 1981, SCIENCE, V213, P915, DOI 10.1126/science.7256286; Chen MC, 2015, EUR J NEUROSCI, V41, P748, DOI 10.1111/ejn.12822; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; CORNWALL J, 1990, EXP BRAIN RES, V80, P157; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dejean C, 2011, J NEUROSCI, V31, P6098, DOI 10.1523/JNEUROSCI.3311-09.2011; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Dodson PD, 2015, NEURON, V86, P501, DOI 10.1016/j.neuron.2015.03.007; FALLS WM, 1983, J COMP NEUROL, V221, P229, DOI 10.1002/cne.902210210; Fujiyama F, 2016, BRAIN STRUCT FUNCT, V221, P4733, DOI 10.1007/s00429-015-1152-2; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; GROVE EA, 1986, BRAIN RES, V367, P379, DOI 10.1016/0006-8993(86)91623-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Henderson Z, 1997, NEUROSCIENCE, V78, P943, DOI 10.1016/S0306-4522(96)00636-7; Hernandez VM, 2015, J NEUROSCI, V35, P11830, DOI 10.1523/JNEUROSCI.4672-14.2015; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hoover BR, 2002, NEUROSCIENCE, V111, P111, DOI 10.1016/S0306-4522(01)00565-6; Ibanez-Sandoval O, 2011, J NEUROSCI, V31, P16757, DOI 10.1523/JNEUROSCI.2628-11.2011; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; KITA H, 1994, BRAIN RES, V657, P31, DOI 10.1016/0006-8993(94)90950-4; Kita H, 2001, J COMP NEUROL, V437, P438, DOI 10.1002/cne.1294; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Mastro KJ, 2014, J NEUROSCI, V34, P2087, DOI 10.1523/JNEUROSCI.4646-13.2014; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Nambu A, 1997, J COMP NEUROL, V377, P85; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Sato F, 2000, J COMP NEUROL, V417, P17; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; SMITH Y, 1990, J COMP NEUROL, V296, P47, DOI 10.1002/cne.902960105; Smith Y, 1998, NEUROSCIENCE, V86, P353; SMITH Y, 1987, J COMP NEUROL, V259, P50, DOI 10.1002/cne.902590105; STAINES WA, 1984, EXP BRAIN RES, V56, P217; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	58	48	48	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149798	10.1371/journal.pone.0149798	http://dx.doi.org/10.1371/journal.pone.0149798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905595	Green Submitted, Green Published, gold			2022-12-26	WOS:000371163000021
J	Bornhorst, C; Siani, A; Russo, P; Kourides, Y; Sion, I; Molnar, D; Moreno, LA; Rodriguez, G; Ben-Shlomo, Y; Howe, L; Lissner, L; Mehlig, K; Regber, S; Bammann, K; Foraita, R; Ahrens, W; Tilling, K				Boernhorst, Claudia; Siani, Alfonso; Russo, Paola; Kourides, Yannis; Sion, Isabelle; Molnar, Denes; Moreno, Luis A.; Rodriguez, Gerardo; Ben-Shlomo, Yoav; Howe, Laura; Lissner, Lauren; Mehlig, Kirsten; Regber, Susann; Bammann, Karin; Foraita, Ronja; Ahrens, Wolfgang; Tilling, Kate			Early Life Factors and Inter-Country Heterogeneity in BMI Growth Trajectories of European Children: The IDEFICS Study	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANCY-RELATED EVENTS; GESTATIONAL WEIGHT-GAIN; CHILDHOOD GROWTH; RISK-FACTORS; SOCIOECONOMIC DIFFERENCES; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; POSTNATAL FACTORS; YOUNG ADULTHOOD	Background Starting from birth, this explorative study aimed to investigate between-country differences in body mass index (BMI) trajectories and whether early life factors explain these differences. Methods The sample included 7,644 children from seven European countries (Belgium, Cyprus, Germany, Hungary, Italy, Spain, Sweden) participating in the multi-centre IDEFICS study. Information on early life factors and in total 53,409 repeated measurements of height and weight from 0 to <12 years of age were collected during the baseline (2007/2008) and follow-up examination (2009/2010) supplemented by records of routine child health visits. Country-specific BMI growth curves were estimated using fractional polynomial mixed effects models. Several covariates focussing on early life factors were added to the models to investigate their role in the between-countries differences. Results Large between-country differences were observed with Italian children showing significantly higher mean BMI values at all ages >= 3 years compared to the other countries. For instance, at age 11 years mean BMI values in Italian boys and girls were 22.3 [21.9; 22.8; 99% confidence interval] and 22.0 [21.5; 22.4], respectively, compared to a range of 18.4 [18.1; 18.8] to 20.3 [19.8; 20.7] in boys and 18.2 [17.8; 18.6] to 20.3 [19.8; 20.7] in girls in the other countries. After adjustment for early life factors, differences between country-specific BMI curves became smaller. Maternal BMI was the factor being most strongly associated with BMI growth (p<0.01 in all countries) with associations increasing during childhood. Gestational weight gain (GWG) was weakly associated with BMI at birth in all countries. In some countries, positive associations between BMI growth and children not being breastfed, mothers' smoking during pregnancy and low educational level of parents were found. Conclusion Early life factors seem to explain only some of the inter-country variation in growth. Maternal BMI showed the strongest association with children's BMI growth.	[Boernhorst, Claudia; Foraita, Ronja; Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Siani, Alfonso; Russo, Paola] CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy; [Kourides, Yannis] Res & Educ Inst Child Hlth, Strovolos, Cyprus; [Sion, Isabelle] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Molnar, Denes] Univ Pecs, Dept Pediat, Pecs, Hungary; [Moreno, Luis A.; Rodriguez, Gerardo] Univ Zaragoza, Fac Hlth Sci, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Rodriguez, Gerardo] IIS Aragon Aragon Hlth Res Inst, Zaragoza, Spain; [Ben-Shlomo, Yoav; Howe, Laura; Tilling, Kate] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Howe, Laura] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Lissner, Lauren; Mehlig, Kirsten; Regber, Susann] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Epidemiol & Social Med,Inst Med, Gothenburg, Sweden; [Regber, Susann] Halmstad Univ, Sch Hlth & Welf, Halmstad, Sweden; [Bammann, Karin] Univ Bremen, Fac Human & Hlth Sci, Inst Publ Hlth & Nursing Res IPP, D-28359 Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, D-28359 Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Ghent University; University of Pecs; University of Zaragoza; University of Bristol; University of Bristol; University of Gothenburg; Halmstad University; University of Bremen; University of Bremen	Bornhorst, C (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	boern@bips.uni-bremen.de	Mehlig, Kirsten/AAT-3468-2020; Tilling, Kate/AAY-1578-2021; Russo, Paola/AAW-8308-2020; Ben-Shlomo, Yoav/ABD-2004-2021; Molnár, Dénes/AAB-6820-2022; Siani, Alfonso/B-7925-2015; Moreno, Luis/S-1780-2019; Rodriguez, Gerardo/AAG-9855-2020; Ahrens, Wolfgang/A-2740-2012	Ben-Shlomo, Yoav/0000-0001-6648-3007; Moreno, Luis/0000-0003-0454-653X; Rodriguez, Gerardo/0000-0002-7985-9912; Howe, Laura/0000-0003-3357-2796; Ahrens, Wolfgang/0000-0003-3777-570X; Tilling, Kate/0000-0002-1010-8926; Bammann, Karin/0000-0002-5623-8160; Bornhorst, Claudia/0000-0001-9004-1540	European Community; Sixth RTD Framework Programme [016181]; Research Foundation - Flanders [1.2.683.14.N.00]; German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany) [FKZ: 01GI1121A]; Open Access fund of the Leibniz Association; MRC [MC_UU_12013/5, MR/M020894/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, MR/M020894/1] Funding Source: researchfish	European Community(European Commission); Sixth RTD Framework Programme; Research Foundation - Flanders(FWO); German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany); Open Access fund of the Leibniz Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Community and was funded within the Sixth RTD Framework Programme [Contract No. 016181 (FOOD)]. Isabelle Sioen is financially supported by the Research Foundation - Flanders (Grant no: 1.2.683.14.N.00). This analysis was supported by the German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany, FKZ: 01GI1121A). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Ahrens W, 2006, NUTR METAB CARDIOVAS, V16, P302, DOI 10.1016/j.numecd.2006.01.011; Ahrens W, 2014, INT J OBESITY, V38, pS99, DOI 10.1038/ijo.2014.140; Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; Bammann K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086914; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Belahsen R, 2006, PUBLIC HEALTH NUTR, V9, P1130, DOI 10.1017/S1368980007668517; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dello Russo M, 2013, INT J OBESITY, V37, P914, DOI 10.1038/ijo.2013.35; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Giles LC, 2015, INT J OBESITY, V39, P1049, DOI 10.1038/ijo.2015.42; Gracia-Marco L, 2013, J SPORT SCI, V31, P1831, DOI 10.1080/02640414.2013.803595; Hense S, 2013, EPIDEMIOLOGY RES INT, DOI [10. 1155/2013/936365, 10.1155/2013/936365, DOI 10.1155/2013/936365]; Herrmann D, 2011, INT J OBESITY, V35, pS52, DOI 10.1038/ijo.2011.35; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Macdonald-Wallis C, 2014, HYPERTENSION, V64, P36, DOI 10.1161/HYPERTENSIONAHA.113.02766; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Mendez Robert, 2013, FP Essent, V410, P20; Fernandez-Alvira JM, 2015, BRIT J NUTR, V113, P517, DOI 10.1017/S0007114514003663; Miyake Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-79; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Patel R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-932; Regber S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-418; Ridgers ND, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0245-x; Robinson SM, 2015, AM J CLIN NUTR, V101, P368, DOI [10.3945/ajcn.114.094268, 10.3945/ajcn.1]; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Shawe J, 2015, EUR J CONTRACEP REPR, V20, P77, DOI 10.3109/13625187.2014.990088; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Tilling K, 2014, ANN NUTR METAB, V65, P129, DOI 10.1159/000362695; Tilling K, 2011, AM J CLIN NUTR, V94, p1808S, DOI 10.3945/ajcn.110.001644; Tognon G, 2014, INT J OBESITY, V38, pS108, DOI 10.1038/ijo.2014.141; Tognon G, 2014, NUTR METAB CARDIOVAS, V24, P205, DOI 10.1016/j.numecd.2013.04.013; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Uauy R, 2008, ANN MED, V40, P11, DOI 10.1080/07853890701704683; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Van Rossem L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-722; Weber M, 2014, AM J CLIN NUTR, V99, P1041, DOI 10.3945/ajcn.113.064071; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-806; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1306, DOI 10.1079/PHN2001147; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1353, DOI 10.1079/PHN2001217; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	54	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149268	10.1371/journal.pone.0149268	http://dx.doi.org/10.1371/journal.pone.0149268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901773	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100050
J	Bohacsova, M; Mediannikov, O; Kazimirova, M; Raoult, D; Sekeyova, Z				Bohacsova, Monika; Mediannikov, Oleg; Kazimirova, Maria; Raoult, Didier; Sekeyova, Zuzana			Arsenophonus nasoniae and Rickettsiae Infection of Ixodes ricinus Due to Parasitic Wasp Ixodiphagus hookeri	PLOS ONE			English	Article							SON-KILLER BACTERIUM; HUNTERELLUS-HOOKERI; ACARI IXODIDAE; AMBLYOMMA-VARIEGATUM; SCAPULARIS ACARI; HYMENOPTERA ENCYRTIDAE; DERMACENTOR-VARIABILIS; MICROBIAL COMMUNITIES; HOWARD HYMENOPTERA; TICKS ACARI	Arsenophonus nasoniae, a male-killing endosymbiont of chalcid wasps, was recently detected in several hard tick species. Following the hypothesis that its presence in ticks may not be linked to the direct occurrence of bacteria in tick's organs, we identified A. nasoniae in wasps emerging from parasitised nymphs. We confirmed that 28.1% of Ixodiphagus hookeri wasps parasitizing Ixodes ricinus ticks were infected by A. nasoniae. Moreover, in examined I. ricinus nymphs, A. nasoniae was detected only in those, which were parasitized by the wasp. However, in part of the adult wasps as well as in some ticks that contained wasp's DNA, we did not confirm A. nasoniae. We also found, that in spite of reported male-killing, some newly emerged adult wasp males were also infected by A. nasoniae. Additionally, we amplified the DNA of Rickettsia helvetica and Rickettsia monacensis (known to be Ixodes ricinus-associated bacteria) in adult parasitoid wasps. This may be related either with the digested bacterial DNA in wasp body lumen or with a role of wasps in circulation of rickettsiae among tick vectors.	[Bohacsova, Monika; Sekeyova, Zuzana] Slovak Acad Sci, Inst Virol, Biomed Res Ctr, Dept Rickettsiol, Bratislava, Slovakia; [Mediannikov, Oleg; Raoult, Didier] Aix Marseille Univ, Inst Hosp Univ IHU Mediterranee Infect, Unite Rech Malad Infect & Trop Emergentes URMITE, CNRS 7278,INSERM 1095, Marseille, France; [Kazimirova, Maria] Slovak Acad Sci, Inst Zool, Dept Med Zool, Bratislava, Slovakia	Slovak Academy of Sciences; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Slovak Academy of Sciences	Sekeyova, Z (corresponding author), Slovak Acad Sci, Inst Virol, Biomed Res Ctr, Dept Rickettsiol, Bratislava, Slovakia.	viruseke@savba.sk	Mediannikov, Oleg/H-4018-2015; Danchenko, Monika/J-3347-2017; RAOULT, Didier/A-8434-2008; Sekeyova, Zuzana/E-5956-2018; Kazimirova, Maria/U-8222-2017	Mediannikov, Oleg/0000-0001-6039-2008; Danchenko, Monika/0000-0002-8505-2365; RAOULT, Didier/0000-0002-0633-5974; Kazimirova, Maria/0000-0001-6904-8342; Sekeyova, Zuzana/0000-0002-2597-4405	Slovak Research and Development Agency [APVV-028012]; VEGA from the Scientific Grant Agency of Ministry of Education [2/0005/15]; Slovak Academy of Sciences; EU [FP7-261504 EDENext]; Fondation - IHU Mediterranee Infection	Slovak Research and Development Agency(Slovak Research and Development Agency); VEGA from the Scientific Grant Agency of Ministry of Education; Slovak Academy of Sciences(Slovak Academy of Sciences); EU(European Commission); Fondation - IHU Mediterranee Infection	This work was supported by APVV-028012 from Slovak Research and Development Agency, VEGA Nos. 2/0005/15 from the Scientific Grant Agency of Ministry of Education and Slovak Academy of Sciences, by EU grant FP7-261504 EDENext and "Fondation - IHU Mediterranee Infection."	Ahantarig A, 2013, FOLIA MICROBIOL, V58, P419, DOI 10.1007/s12223-013-0222-1; [Anonymous], 2005, BERGEYS MANUAL BERGE; Balas MT, 1996, EVOL ECOL, V10, P593, DOI 10.1007/BF01237709; Boucek Z, 1954, FOLIA ZOOLOGICA ENTO, V3, P109; Chaves Sandra, 2009, Biotechnology Journal, V4, P1753, DOI 10.1002/biot.200800237; Clay K, 2008, MOL ECOL, V17, P4371, DOI 10.1111/j.1365-294X.2008.03914.x; Collatz J, 2011, J APPL ENTOMOL, V135, P351, DOI 10.1111/j.1439-0418.2010.01560.x; Collatz J, 2010, ENTOMOL EXP APPL, V134, P131, DOI 10.1111/j.1570-7458.2009.00943.x; Darby AC, 2010, INSECT MOL BIOL, V19, P75, DOI 10.1111/j.1365-2583.2009.00950.x; DAVIS A J, 1986, Tijdschrift voor Entomologie, V129, P181; DAVIS AJ, 1979, CAN J ZOOL, V57, P1164, DOI 10.1139/z79-147; Demas FA, 2002, J INSECT BEHAV, V15, P477, DOI 10.1023/A:1016377132585; Demas FA, 2000, J CHEM ECOL, V26, P1079, DOI 10.1023/A:1005497201074; Dergousoff SJ, 2010, EXP APPL ACAROL, V52, P85, DOI 10.1007/s10493-010-9340-5; Doube B M, 1975, J Med Entomol, V12, P433; ehuYek, 1998, ENVIROMAGAZIN, V3, P19; Ferree PM, 2008, CURR BIOL, V18, P1409, DOI 10.1016/j.cub.2008.07.093; GHERNA RL, 1991, INT J SYST BACTERIOL, V41, P563, DOI 10.1099/00207713-41-4-563; Grindle N, 2003, J INVERTEBR PATHOL, V83, P264, DOI 10.1016/S0022-2011(03)00080-6; Howard LO, 1908, CAN ENTOMOL, V40, P239; Hu RJ, 1998, J MED ENTOMOL, V35, P1050, DOI 10.1093/jmedent/35.6.1050; HU RJ, 1993, J MED ENTOMOL, V30, P277, DOI 10.1093/jmedent/30.1.277; HUGER AM, 1985, J INVERTEBR PATHOL, V46, P272, DOI 10.1016/0022-2011(85)90069-2; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Kagemann J, 2013, J MED ENTOMOL, V50, P155, DOI 10.1603/ME12086; Knipling EF, 2000, J MED ENTOMOL, V37, P645, DOI 10.1603/0022-2585-37.5.645; Liu LM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-310; Liu LM, 2013, APPL ENVIRON MICROB, V79, P2450, DOI 10.1128/AEM.03575-12; Lopes AJO, 2012, J ECON ENTOMOL, V105, P1979, DOI 10.1603/EC12012; MATHER TN, 1987, MED VET ENTOMOL, V1, P3, DOI 10.1111/j.1365-2915.1987.tb00317.x; Mediannikov O, 2012, TICKS TICK-BORNE DIS, V3, P366, DOI 10.1016/j.ttbdis.2012.10.016; Mwangi EN, 1997, EXP APPL ACAROL, V21, P117, DOI 10.1023/B:APPA.0000031790.30821.57; MWANGI EN, 1994, BIOL CONTROL, V4, P101, DOI 10.1006/bcon.1994.1017; Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Philip CB, 1931, PUBLIC HEALTH REP, V46, P2168, DOI 10.2307/4580173; Plantard O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030692; Ramos RA, 2015, TICKS TICK BORNE DIS; REHACEK J, 1992, ACTA VIROL, V36, P492; Renvoise A, 2012, FEMS IMMUNOL MED MIC, V64, P126, DOI 10.1111/j.1574-695X.2011.00899.x; Rynkiewicz EC, 2015, MOL ECOL, V24, P2566, DOI 10.1111/mec.13187; Sekeyova Z, 2000, J MED ENTOMOL, V37, P707, DOI 10.1603/0022-2585-37.5.707; SKINNER SW, 1985, GENETICS, V109, P745; Slovak M, 2003, BIOLOGIA, V58, P890; Socolovschi C, 2010, EMERG INFECT DIS, V16, P1140, DOI 10.3201/eid1607.100070; Sparagano OAE, 2011, WOODHEAD PUBL FOOD S, P394; Stafford KC, 2003, J MED ENTOMOL, V40, P642, DOI 10.1603/0022-2585-40.5.642; Stafford KC, 1996, J MED ENTOMOL, V33, P183, DOI 10.1093/jmedent/33.1.183; Subramanian G, 2012, TICKS TICK-BORNE DIS, V3, P405, DOI 10.1016/j.ttbdis.2012.10.001; Takasu K, 2008, BIOL CONTROL, V46, P114, DOI 10.1016/j.biocontrol.2008.04.013; Taylor GP, 2011, J INVERTEBR PATHOL, V106, P371, DOI 10.1016/j.jip.2010.12.004; Tijsse-Klasen E, 2011, PARASITES VECTORS, P4; WERREN JH, 1986, SCIENCE, V231, P990, DOI 10.1126/science.3945814; Wilkes TE, 2010, INSECT MOL BIOL, V19, P59, DOI 10.1111/j.1365-2583.2009.00963.x	54	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149950	10.1371/journal.pone.0149950	http://dx.doi.org/10.1371/journal.pone.0149950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901622	Green Submitted, gold, Green Published			2022-12-26	WOS:000371276100192
J	de Oliveira, C; Patel, K; Mishra, V; Trivedi, RN; Noel, P; Singh, A; Yaron, JR; Singh, VP				de Oliveira, Cristiane; Patel, Krutika; Mishra, Vivek; Trivedi, Ram N.; Noel, Pawan; Singh, Abhilasha; Yaron, Jordan R.; Singh, Vijay P.			Characterization and Predictive Value of Near Infrared 2-Deoxyglucose Optical Imaging in Severe Acute Pancreatitis	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CANCER; FAT; DIFFERENTIATION; NECROSIS; ATHEROSCLEROSIS; MOUSE; RAT	Background Studying the uptake of 2-deoxy glucose (2-DG) analogs such as 2-Deoxy-2-[18F] fluoroglucose (FDG) is a common approach to identify and monitor malignancies and more recently chronic inflammation. While pancreatitis is a common cause for false positive results in human studies on pancreatic cancer using FDG, the relevance of these findings to acute pancreatitis (AP) is unknown. FDG has a short half-life. Thus, with an aim to accurately characterize the metabolic demand of the pancreas during AP in real-time, we studied the uptake of the non-radioactive, near infrared fluorescence labelled 2-deoxyglucose analog, IRDye (R) 800CW 2-DG probe (NIR 2-DG; Li-Cor) during mild and severe biliary AP. Methods Wistar rats (300 g; 8-12/group) were administered NIR 2-DG (10 nM; I.V.). Mild and severe biliary AP were respectively induced by biliopancreatic duct ligation (DL) alone or along with infusing glyceryl trilinoleate (GTL; 50 mu L/100 g) within 10 minutes of giving NIR 2-DG. Controls (CON) only received NIR 2-DG. Imaging was done every 5-10 minutes over 3 hrs. Average Radiant Efficiency [p/s/cm(2)/sr]/[mu W/cm(2)] was measured over the pancreas using the IVIS 200 in-vivo imaging system (PerkinElmer) using the Living Image (R) software and verified in ex vivo pancreata. Blood amylase, lipase and pancreatic edema, necrosis were measured over the course of AP. Results NIR 2-DG uptake over the first hour was not influenced by AP induction. However, while the signal declined in controls and rats with mild AP, there was significantly higher retention of NIR 2-DG in the pancreas after 1 hour in those with GTL pancreatitis. The increase was > 3 fold over controls in the GTL group and was verified to be in the pancreas ex vivo. In vitro, pancreatic acini exposed to GTL had a similar increase in NIR 2-DG uptake which was followed by progressively worse acinar necrosis. Greater retention of NIR 2-DG in vivo was associated with worse pancreatic necrosis, reduced ATP concentrations and mortality, which were not predicted by the blood parameters. Conclusion In-vivo fluorescent imaging of a non-radioactive near infrared 2-DG optical probe can predict the AP severity early during the disease.	[de Oliveira, Cristiane; Patel, Krutika; Trivedi, Ram N.; Noel, Pawan; Singh, Abhilasha; Yaron, Jordan R.; Singh, Vijay P.] Mayo Clin, Dept Med, Scottsdale, AZ USA; [Mishra, Vivek] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Mayo Clinic; Mayo Clinic Phoenix; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, VP (corresponding author), Mayo Clin, Dept Med, Scottsdale, AZ USA.	singh.vijay@mayo.edu	Patel, Krutika/AAA-1302-2022; Yaron, Jordan R/S-1136-2019	Yaron, Jordan R/0000-0002-4133-474X; Singh, Abhilasha/0000-0002-8203-2895; Singh, Vijay/0000-0001-6611-1908	Department of Army (DOA) [PR110417, W81XWH-12-1-0327]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK092460, R01DK100358]; Mayo Clinic; Mayo Clinic Arizona, Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100358, R01DK092460] Funding Source: NIH RePORTER	Department of Army (DOA); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Clinic; Mayo Clinic Arizona, Department of Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support was provided by grant number PR110417 Award #W81XWH-12-1-0327 from the Department of Army (DOA) (VPS), and award number R01DK092460, R01DK100358 (VPS) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of DOA, NIDDK. Mayo Clinic provided support in the form of salaries for each of the authors listed, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Grant number PR110417 Award # W81XWH-12-1-0327 from the Department of Army (DOA) (VPS), award number R01DK092460, R01DK100358 (VPS) from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of the manuscript are solely the responsibility of the authors and do not necessarily represent the official view of DOA, NIDDK. Also supported by a startup package from the Mayo Clinic Arizona, Department of Medicine (VPS).	Acharya C, 2014, PANCREATOLOGY, V14, P403, DOI 10.1016/j.pan.2014.06.004; Acharya C, 2013, GASTROENTEROLOGY, V145, P466, DOI 10.1053/j.gastro.2013.05.012; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P1027, DOI 10.3109/00365528009181808; AHO HJ, 1986, ACTA PATH MICRO IM A, V94, P101; AHO HJ, 1980, SCAND J GASTROENTERO, V15, P411, DOI 10.3109/00365528009181493; Albano D, 2015, CLIN NUCL MED; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Dong AS, 2013, CLIN NUCL MED, V38, pE354, DOI 10.1097/RLU.0b013e3182708503; Durgampudi C, 2014, AM J PATHOL, V184, P1773, DOI 10.1016/j.ajpath.2014.02.015; Fitz RH, 1889, ACUTE PANCREATITIS C; Folco EJ, 2011, J AM COLL CARDIOL, V58, P603, DOI 10.1016/j.jacc.2011.03.044; Hotchkiss LW, 1912, ANN SURG, V56, P111, DOI 10.1097/00000658-191207000-00009; Imdahl A, 1999, BRIT J SURG, V86, P194, DOI 10.1046/j.1365-2168.1999.01016.x; Kang WJ, 2015, KOREAN J RADIOL, V16, P1257, DOI 10.3348/kjr.2015.16.6.1257; Kato K, 2013, CLIN NUCL MED, V38, P417, DOI 10.1097/RLU.0b013e3182817d9d; Kloppel G, 1984, PATHOMORPHOLOGY ACUT; Kovar JL, 2007, ANAL BIOCHEM, V367, P1, DOI 10.1016/j.ab.2007.04.011; Kovar JL, 2011, ANAL BIOCHEM, V416, P167, DOI 10.1016/j.ab.2011.05.011; Kovar JL, 2009, ANAL BIOCHEM, V384, P254, DOI 10.1016/j.ab.2008.09.050; Le TM, 2015, PANCREAS, V44, P493, DOI 10.1097/MPA.0000000000000285; Mishra V.N., 2013, J INEQUAL APPL, V2013, DOI DOI 10.1155/2013/814824; Mishra V, 2014, PANCREATOLOGY, V14, P459, DOI 10.1016/j.pan.2014.06.006; Mukheriee R, 2008, CELL CALCIUM, V44, P14, DOI 10.1016/j.ceca.2007.11.013; Navina S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002573; Nioka S, 2005, TECHNOL CANCER RES T, V4, P497, DOI 10.1177/153303460500400504; Noel P., 2014, GUT; NORDBACK I, 1986, J CLIN PATHOL, V39, P68, DOI 10.1136/jcp.39.1.68; Okuyucu K, 2015, Q J NUCL MED MOL IMA; Ozaki Y, 2008, J GASTROENTEROL, V43, P144, DOI 10.1007/s00535-007-2132-y; Panek J, 2001, Med Sci Monit, V7, P894; Patel K, 2015, AM J PATHOL, V185, P808, DOI 10.1016/j.ajpath.2014.11.019; Pery C, 2010, GASTROEN CLIN BIOL, V34, P465, DOI 10.1016/j.gcb.2009.04.014; Petersen OH, 2009, CELL CALCIUM, V45, P634, DOI 10.1016/j.ceca.2009.02.005; Pinnick KE, 2008, OBESITY, V16, P522, DOI 10.1038/oby.2007.110; RENNER IG, 1985, DIGEST DIS SCI, V30, P1005, DOI 10.1007/BF01308298; Saboury B, 2015, NUCL MED COMMUNICATI; Saisho Y, 2007, CLIN ANAT, V20, P933, DOI 10.1002/ca.20543; SCHMITZMOORMANN P, 1981, PATHOL RES PRACT, V171, P325, DOI 10.1016/S0344-0338(81)80105-7; SCHMITZMOORMANN P, 1981, PATHOL RES PRACT, V173, P45, DOI 10.1016/S0344-0338(81)80006-4; Singh VP, 2008, MOL BIOL CELL, V19, P2339, DOI 10.1091/mbc.E07-11-1130; Wu JC, 2011, J AM COLL CARDIOL, V58, P615, DOI 10.1016/j.jacc.2011.04.021; Yokoyama Y, 2005, PANCREAS, V31, P192, DOI 10.1097/01.mpa.0000168226.36085.58; Zhou HL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008051	43	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149073	10.1371/journal.pone.0149073	http://dx.doi.org/10.1371/journal.pone.0149073			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901564	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000371276100037
J	Kryza, D; Debordeaux, F; Azema, L; Hassan, A; Paurelle, O; Schulz, J; Savona-Baron, C; Charignon, E; Bonazza, P; Taleb, J; Fernandez, P; Janier, M; Toulme, JJ				Kryza, David; Debordeaux, Frederic; Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Schulz, Juergen; Savona-Baron, Catherine; Charignon, Elsa; Bonazza, Pauline; Taleb, Jacqueline; Fernandez, Philippe; Janier, Marc; Toulme, Jean Jacques			Ex Vivo and In Vivo Imaging and Biodistribution of Aptamers Targeting the Human Matrix MetalloProtease-9 in Melanomas	PLOS ONE			English	Article							CANCER THERAPEUTICS; NEXT-GENERATION; SELECTION; VITRO; THERAPY; PROBES	The human Matrix MetalloProtease-9 (hMMP-9) is overexpressed in tumors where it promotes the release of cancer cells thus contributing to tumor metastasis. We raised aptamers against hMMP-9, which constitutes a validated marker of malignant tumors, in order to design probes for imaging tumors in human beings. A chemically modified RNA aptamer (F3B), fully resistant to nucleases was previously described. This compound was subsequently used for the preparation of F3B-Cy5, F3B-S-acetylmercaptoacetyltriglycine (MAG) and F3B-DOTA. The binding properties of these derivatives were determined by surface plasmon resonance and electrophoretic mobility shift assay. Optical fluorescence imaging confirmed the binding to hMMP-9 in A375 melanoma bearing mice. Quantitative biodistribution studies were performed at 30 min, 1h and 2 h post injection of Tc-99m-MAG-aptamer and In-111-DOTA-F3B. Tc-99m radiolabeled aptamer specifically detected hMMP-9 in A375 melanoma tumors but accumulation in digestive tract was very high. Following i.v. injection of In-111-DOTA-F3B, high level of radioactivity was observed in kidneys and bladder but digestive tract uptake was very limited. Tumor uptake was significantly (student t test, p<0.05) higher for In-111-DOTA-F3B with 2.0% ID/g than for the In-111-DOTA-control oligonucleotide (0.7% ID/g) with tumor to muscle ratio of 4.0. Such difference in tumor accumulation has been confirmed by ex vivo scintigraphic images performed at 1h post injection and by autoradiography, which revealed the overexpression of hMMP-9 in sections of human melanomas. These results demonstrate that F3B aptamer is of interest for detecting hMMP-9 in melanoma tumor.	[Kryza, David; Taleb, Jacqueline; Janier, Marc] Univ Lyon 1, CNRS, LAGEP, UMR 5007, F-69622 Villeurbanne, France; [Kryza, David; Charignon, Elsa; Bonazza, Pauline; Janier, Marc] Hosp Civils Lyon, Imthernat Plateform, Lyon, France; [Debordeaux, Frederic; Schulz, Juergen; Savona-Baron, Catherine; Fernandez, Philippe] Univ Bordeaux, CNRS, INCIA, UMR 5287, Bordeaux, France; [Debordeaux, Frederic; Schulz, Juergen; Fernandez, Philippe] CHU Bordeaux, Serv Med Nucl, Bordeaux, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] INSERM, U1212, Bordeaux, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] CNRS, UMR5320, Pessac, France; [Azema, Laurent; Hassan, Aref; Paurelle, Olivier; Toulme, Jean Jacques] Univ Bordeaux, ARNA Lab, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux	Kryza, D (corresponding author), Univ Lyon 1, CNRS, LAGEP, UMR 5007, F-69622 Villeurbanne, France.; Kryza, D (corresponding author), Hosp Civils Lyon, Imthernat Plateform, Lyon, France.	david.kryza@chu-lyon.fr		Toulme, Jean-jacques/0000-0002-8432-5034; DEBORDEAUX, Frederic/0000-0003-3189-4679; Azema, Laurent/0000-0002-7087-6927; Janier, Marc/0000-0001-5937-9180	French Agence Nationale de la Recherche within the context of the Investments for the Future Program [ANR-10-LABX-57]; TRAIL	French Agence Nationale de la Recherche within the context of the Investments for the Future Program(French National Research Agency (ANR)); TRAIL	This study - Imelapt - was supported by a public grant from the French Agence Nationale de la Recherche within the context of the Investments for the Future Program, referenced ANR-10-LABX-57 and named TRAIL.	Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Chen HY, 2015, MOL IMAGING BIOL, V17, P38, DOI 10.1007/s11307-014-0763-y; Chen YH, 2012, J DERMATOL, V39, P339, DOI 10.1111/j.1346-8138.2011.01441.x; Cibiel A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087002; Dassie JP, 2013, THER DELIV, V4, P1527, DOI [10.4155/tde.13.118, 10.4155/TDE.13.118]; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Forget MA, 1999, CAN J PHYSIOL PHARM, V77, P465; Gomes SD, 2012, BIOCONJUGATE CHEM, V23, P2192, DOI 10.1021/bc300146c; Haubner R, 2005, PLOS MED, V2, P244, DOI 10.1371/journal.pmed.0020070; Hicke BJ, 2006, J NUCL MED, V47, P668; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hwang DW, 2009, CHEM-EUR J, V15, P9387, DOI 10.1002/chem.200900344; Jacobson O, 2015, J NUCL MED, V56, P616, DOI 10.2967/jnumed.114.149484; Javier DJ, 2008, BIOCONJUGATE CHEM, V19, P1309, DOI 10.1021/bc8001248; Kruspe S, 2014, CHEMMEDCHEM, V9, P1998, DOI 10.1002/cmdc.201402163; Lao YH, 2015, ACS NANO, V9, P2235, DOI 10.1021/nn507494p; Merdad A, 2014, ANTICANCER RES, V34, P1355; Meyer M, 2013, APPL MICROBIOL BIOT, V97, P7097, DOI 10.1007/s00253-013-5070-z; Nimjee SM, 2005, ANNU REV MED, V56, P555, DOI 10.1146/annurev.med.56.062904.144915; Noaparast Z, 2015, J DRUG TARGET, V12, P1; Okarvi SM, 2006, CANCER BIOTHER RADIO, V21, P49, DOI 10.1089/cbr.2006.21.49; Ozalp VC, 2015, CURR TOP MED CHEM, V15, P1125, DOI 10.2174/1568026615666150413154233; Parat A, 2015, J MATER CHEM B, V3, P2560, DOI 10.1039/c5tb00235d; Pestourie C, 2005, BIOCHIMIE, V87, P921, DOI 10.1016/j.biochi.2005.04.013; Piorek BD, 2012, ANAL CHEM, V84, P9700, DOI [10.1021/ac302497y, 10.1021/ac3026866]; ROBERTSON DL, 1990, NATURE, V344, P467, DOI 10.1038/344467a0; Rolland O, 2009, NEW J CHEM, V33, P1809, DOI 10.1039/b901054h; Shi H, 2010, CHEM-ASIAN J, V5, P2209, DOI 10.1002/asia.201000242; Shi JY, 2009, BIOCONJUGATE CHEM, V20, P1559, DOI 10.1021/bc9001739; Shigdar S, 2013, SENSORS-BASEL, V13, P13624, DOI 10.3390/s131013624; Shum Ka-To, 2013, J Cancer Ther, V4, P872; Smith AM, 2009, NAT BIOTECHNOL, V27, P732, DOI 10.1038/nbt0809-732; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Sun HG, 2015, SMALL, V11, P2352, DOI 10.1002/smll.201403073; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Tavitian Bertrand, 2009, V535, P241, DOI 10.1007/978-1-59745-557-2_15; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wang J, 2011, CURR MED CHEM, V18, P4107, DOI 10.2174/092986711797189628; Winnard P, 1997, NUCL MED BIOL, V24, P425, DOI 10.1016/S0969-8051(97)00027-9; Xiang DX, 2015, THERANOSTICS, V5, P23, DOI 10.7150/thno.10202; Yu MK, 2011, SMALL, V7, P2241, DOI 10.1002/smll.201100472; Zhang CL, 2013, ANAL CHEM, V85, P5843, DOI 10.1021/ac400606e; Zhu GZ, 2012, CHEM COMMUN, V48, P10472, DOI 10.1039/c2cc35042d	44	33	33	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149387	10.1371/journal.pone.0149387	http://dx.doi.org/10.1371/journal.pone.0149387			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901393	gold, Green Published, Green Submitted			2022-12-26	WOS:000371276100067
J	Kushwah, N; Jain, V; Deep, S; Prasad, D; Singh, SB; Khan, N				Kushwah, Neetu; Jain, Vishal; Deep, Satayanarayan; Prasad, Dipti; Singh, Shashi Bala; Khan, Nilofar			Neuroprotective Role of Intermittent Hypobaric Hypoxia in Unpredictable Chronic Mild Stress Induced Depression in Rats	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; TRKB MESSENGER-RNA; NEUROTROPHIC FACTOR; LIFE EVENTS; SUCROSE PREFERENCE; OXIDATIVE STRESS; DENTATE GYRUS; HIGH-ALTITUDE; BRAIN; BDNF	Hypoxic exposure results in several pathophysiological conditions associated with nervous system, these include acute and chronic mountain sickness, loss of memory, and high altitude cerebral edema. Previous reports have also suggested the role of hypoxia in pathogenesis of depression and related psychological conditions. On the other hand, sub lethal intermittent hypoxic exposure induces protection against future lethal hypoxia and may have beneficial effect. Therefore, the present study was designed to explore the neuroprotective role of intermittent hypobaric hypoxia (IHH) in Unpredictable Chronic Mild Stress (UCMS) induced depression like behaviour in rats. The IHH refers to the periodic exposures to hypoxic conditions interrupted by the normoxic or lesser hypoxic conditions. The current study examines the effect of IHH against UCMS induced depression, using elevated plus maze (EPM), open field test (OFT), force swim test (FST), as behavioural paradigm and related histological and molecular approaches. The data indicated the UCMS induced depression like behaviour as evident from decreased exploration activity in OFT with increased anxiety levels in EPM, and increased immobility time in the FST; whereas on providing the IHH (5000m altitude, 4hrs/day for two weeks) these behavioural changes were ameliorated. The morphological and molecular studies also validated the neuroprotective effect of IHH against UCMS induced neuronal loss and decreased neurogenesis. Here, we also explored the role of Brain- Derived Neurotrophic Factor (BDNF) in anticipatory action of IHH against detrimental effect of UCMS as upon blocking of BDNF-TrkB signalling the beneficial effect of IHH was nullified. Taken together, the findings of our study demonstrate that the intermittent hypoxia has a therapeutic potential similar to an antidepressant in animal model of depression and could be developed as a preventive therapeutic option against this pathophysiological state.	[Kushwah, Neetu; Jain, Vishal; Deep, Satayanarayan; Prasad, Dipti; Singh, Shashi Bala; Khan, Nilofar] Def Inst Physiol & Allied Sci, Div Neurobiol, DRDO, Lucknow Rd, Delhi 110054, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS)	Khan, N (corresponding author), Def Inst Physiol & Allied Sci, Div Neurobiol, DRDO, Lucknow Rd, Delhi 110054, India.	nilofarkhan2003@yahoo.com	Singh, Shashi Bala/AAS-9889-2021; Khan, Nilofar/J-4489-2019	Khan, Nilofar/0000-0003-0098-0072	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India [DIP-251]	Defence Research and Development Organization (DRDO), Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO))	The study was fully supported by Defence Research and Development Organization (DRDO), project no. DIP-251, Ministry of Defence, Government of India.	Adams RD, 1991, PRINCIPLES NEUROLOGY; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; ANISMAN H, 1990, PHARMACOL THERAPEUT, V46, P119, DOI 10.1016/0163-7258(90)90039-5; Barhwal K, 2007, EUR J PHARMACOL, V570, P97, DOI 10.1016/j.ejphar.2007.05.063; Bath KG, 2008, J NEUROSCI, V28, P2383, DOI 10.1523/JNEUROSCI.4387-07.2008; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Birbrair A, 2013, EXP CELL RES, V319, P45, DOI 10.1016/j.yexcr.2012.09.008; Bondi CO, 2006, SOC NEUROSCI; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown TA, 1998, J ABNORM PSYCHOL, V107, P179, DOI 10.1037/0021-843X.107.2.179; Chen B, 2001, BIOL PSYCHIAT, V50, P260, DOI 10.1016/S0006-3223(01)01083-6; Chen J, 2013, J CHILD PSYCHOL PSYC, V54, P1066, DOI 10.1111/jcpp.12099; Choi DW, 1996, CURR OPIN NEUROBIOL, V6, P667, DOI 10.1016/S0959-4388(96)80101-2; Costa DC, 2013, J MOL NEUROSCI, V50, P402, DOI 10.1007/s12031-012-9945-8; Coles ME, 2002, CLIN PSYCHOL REV, V22, P587, DOI 10.1016/S0272-7358(01)00113-1; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; DSM-IV, 2000, DSM 4 DIAGN STAT MAN; Duman RS, 2000, BIOL PSYCHIAT, V48, P732, DOI 10.1016/S0006-3223(00)00935-5; Farooq RK, 2012, BEHAV BRAIN RES, V231, P130, DOI 10.1016/j.bbr.2012.03.020; Gu HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112683; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Itoh T, 2004, EUR J PHARMACOL, V498, P135, DOI 10.1016/j.ejphar.2004.07.084; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KENDLER KS, 1995, AM J PSYCHIAT, V152, P833; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; Lang UE, 2004, NEUROPSYCHOPHARMACOL, V29, P795, DOI 10.1038/sj.npp.1300382; Lin AMY, 2002, EXP NEUROL, V176, P328, DOI 10.1006/exnr.2002.7938; Liu J, 2005, STROKE, V36, P1264, DOI 10.1161/01.STR.0000166180.91042.02; Liu W, 2006, BLOOD, V107, P698, DOI 10.1182/blood-2005-03-1278; Maiti P, 2007, BRAIN RES, V1175, P1, DOI 10.1016/j.brainres.2007.06.106; Malberg JE, 2005, CURR PHARM DESIGN, V11, P145, DOI 10.2174/1381612053382223; Malberg JE, 2004, J PSYCHIATR NEUROSCI, V29, P196; Mathews A, 1998, COGNITIVE THER RES, V22, P539, DOI 10.1023/A:1018738019346; MCGONAGLE KA, 1990, AM J COMMUN PSYCHOL, V18, P681, DOI 10.1007/BF00931237; Mineur YS, 2003, BEHAV GENET, V33, P513, DOI 10.1023/A:1025770616068; Moller P, 2001, FASEB J, V15, P1181, DOI 10.1096/fj.00-0703com; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; Nibuya M, 1999, NEUROSCI LETT, V267, P81, DOI 10.1016/S0304-3940(99)00335-3; NIBUYA M, 1995, J NEUROSCI, V15, P7539; O'Connor JC, 2009, J IMMUNOL, V182, P3202, DOI 10.4049/jimmunol.0802722; Pizarro JM, 2004, BRAIN RES, V1025, P10, DOI 10.1016/j.brainres.2004.06.085; Pothion S, 2004, BEHAV BRAIN RES, V155, P135, DOI 10.1016/j.bbr.2004.04.008; Rasmusson AM, 2002, NEUROPSYCHOPHARMACOL, V27, P133, DOI 10.1016/S0893-133X(02)00286-5; RASOOL CG, 1986, ANN NEUROL, V20, P482, DOI 10.1002/ana.410200407; Russo-Neustadt A, 2001, BEHAV BRAIN RES, V120, P87, DOI 10.1016/S0166-4328(00)00364-8; Rybnikova E, 2005, BEHAV BRAIN RES, V160, P107, DOI 10.1016/j.bbr.2004.11.023; Rybnikova E A, 2008, Neurosci Behav Physiol, V38, P721, DOI 10.1007/s11055-008-9038-x; Rybnikova E, 2006, BRAIN RES, V1089, P195, DOI 10.1016/j.brainres.2006.03.053; Serebrovskaya TV, 2008, EXP BIOL MED, V233, P627, DOI 10.3181/0710-MR-267; Shalaby Amany, 2009, Int J Physiol Pathophysiol Pharmacol, V1, P154; Shi SS, 2010, YONSEI MED J, V51, P661, DOI 10.3349/ymj.2010.51.5.661; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; UHL GR, 1985, NEUROLOGY, V35, P1215, DOI 10.1212/WNL.35.8.1215; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; Willner P, 1996, PHYSIOL BEHAV, V60, P129, DOI 10.1016/0031-9384(95)02256-2; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; Wong ML, 2001, NAT REV NEUROSCI, V2, P343, DOI 10.1038/35072566; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yalcin I, 2005, EUR J PHARMACOL, V514, P165, DOI 10.1016/j.ejphar.2005.03.029; Yasuda S, 2009, MOL PSYCHIATR, V14, P51, DOI 10.1038/sj.mp.4002099; Zhen JL, 2014, BRAIN RES, V1563, P122, DOI 10.1016/j.brainres.2014.03.032; Zhu WZ, 2006, J MOL CELL CARDIOL, V40, P96, DOI 10.1016/j.yjmcc.2005.09.016; Zhu XH, 2010, J NEUROSCI, V30, P12653, DOI 10.1523/JNEUROSCI.6414-09.2010	67	34	40	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149309	10.1371/journal.pone.0149309	http://dx.doi.org/10.1371/journal.pone.0149309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901349	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100057
J	Li, LL; Wang, HR; Zhou, ZY; Luo, J; Wang, XL; Xiao, XQ; Zhou, YB; Zeng, Y				Li, Li-Li; Wang, He-Rong; Zhou, Zhi-Yi; Luo, Jing; Wang, Xiao-Li; Xiao, Xiang-Qian; Zhou, Yu-Bai; Zeng, Yi			C3-Luc Cells Are an Excellent Model for Evaluation of Cellular Immunity following HPV16L1 Vaccination	PLOS ONE			English	Article							CERVICAL-CANCER; HPV; RISK; ONCOGENE; PROTEIN; MICE; E6	C3 and TC-1 are the two model cell lines most commonly used in studies of vaccines and drugs against human papillomavirus (HPV) infection. Because C3 cells contain both the HPV16 E and L genes, but TC-1 cells contain only the HPV16 E genes, C3 cells are usually used as the model cell line in studies targeting the HPV16 L protein. However, expression of the L1 protein is difficult to detect in C3 cells using common methods. In our study, Short tandem repeat analysis (STR) was used to demonstrate that C3 cells are indeed derived from mice, PCR results show that HPV16 L1, E6 and E7 genes were detected in C3 genomic DNA, and RT-PCR results demonstrated that L1 transcription had occurred in C3 cells. However, the expression of C3 protein was not found in the results of western blot and immunohistochemistry (IHC). Growth and proliferation of C3 were inhibited by mice spleen lymphocytes that had been immunized with a vaccine against HPV16L1. The luciferase gene was integrated into C3 cells, and it was confirmed that addition of the exogenous gene had no effect on C3 cells by comparing cell growth and tumor formation with untransformed cells. Cells stably expressing luciferase (C3-luc) were screened and subcutaneously injected into the mice. Tumors became established and were observed using a Spectrum Pre-clinical in Vivo Imaging System. Tumor size of mice in the different groups at various time points was calculated by counting photons. The sensitivity of the animals to the vaccine was quantified by statistical comparison. Ten or 30 days following injection of the C3-luc cells, tumor size differed significantly between the PBS and vaccine groups, indicating that C3 cells were susceptible to vaccination even after tumors were formed in vivo.	[Li, Li-Li; Wang, He-Rong; Zhou, Zhi-Yi; Luo, Jing; Wang, Xiao-Li; Xiao, Xiang-Qian; Zhou, Yu-Bai] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China; [Li, Li-Li; Zeng, Yi] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Yu-Bai] 100 Pingleyuan, Beijing 100124, Peoples R China; [Zeng, Yi] 100 YingXin St, Beijing 100032, Peoples R China	Beijing University of Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Zhou, YB (corresponding author), Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing Key Lab Environm & Viral Oncol, Beijing, Peoples R China.; Zeng, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.; Zhou, YB (corresponding author), 100 Pingleyuan, Beijing 100124, Peoples R China.; Zeng, Y (corresponding author), 100 YingXin St, Beijing 100032, Peoples R China.	zhouyobai@bjut.edu.cn; zengy@public.bta.net.cn	周, 玉柏/AAG-3933-2020		independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control [2011SKLID103]; National High Technology Research Program of China (863 program) [2012AA02A404]; Major National Research and Development Projects [2012ZX10001005-007]	independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control; National High Technology Research Program of China (863 program); Major National Research and Development Projects	Funding was provided by an independent research fund from the State Key Laboratory for Infectious Disease Prevention and Control (Grant No. 2011SKLID103); National High Technology Research Program of China (863 program)(Grant No. 2012AA02A404); Major National Research and Development Projects (2012ZX10001005-007).	Blioumi E, 2014, ORAL ONCOL, V50, P840, DOI 10.1016/j.oraloncology.2014.06.011; Cheah P L, 1998, Malays J Pathol, V20, P1; De Bruijn MLH, 1998, VIROLOGY, V250, P371, DOI 10.1006/viro.1998.9372; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; Hsu LC, 2004, BIOCHEM BIOPH RES CO, V320, P249, DOI 10.1016/j.bbrc.2004.05.160; Kaczmar JM, 2016, HEAD NECK-J SCI SPEC, V38, P59, DOI 10.1002/hed.23850; Kenter GG, 2008, CLIN CANCER RES, V14, P169, DOI 10.1158/1078-0432.CCR-07-1881; Khurshid A, 1998, J Pak Med Assoc, V48, P138; Klaes R, 1999, CANCER RES, V59, P6132; Kuroda M, 2005, BRIT J CANCER, V92, P290, DOI 10.1038/sj.bjc.6602329; Lin KY, 1996, CANCER RES, V56, P21; Luker GD, 2011, METHODS MOL BIOL, V680, P29, DOI 10.1007/978-1-60761-901-7_2; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Mydlarz WK, 2015, ORAL ONCOL, V51, P305, DOI 10.1016/j.oraloncology.2014.10.005; Ohlschlager P, 2003, J VIROL, V77, P4635, DOI 10.1128/JVI.77.8.4635-4645.2003; Pinto LA, 2005, VACCINE, V23, P3555, DOI 10.1016/j.vaccine.2005.01.146; Qi Z, 2013, DIS ESOPHAGUS, V26, P61, DOI 10.1111/j.1442-2050.2012.01334.x; Schmitt M, 2011, MOL CELL PROBE, V25, P108, DOI 10.1016/j.mcp.2011.03.003; Wang XQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-19; Xiao W, 2010, ACTA CYTOL, V54, P661, DOI 10.1159/000325229; Zhi Huijun, 2002, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V16, P124	21	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149748	10.1371/journal.pone.0149748	http://dx.doi.org/10.1371/journal.pone.0149748			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900913	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100142
J	Logan, CA; Thiel, L; Bornemann, R; Koenig, W; Reister, F; Brenner, H; Rothenbacher, D; Genuneit, J				Logan, Chad A.; Thiel, Larissa; Bornemann, Rebecca; Koenig, Wolfgang; Reister, Frank; Brenner, Hermann; Rothenbacher, Dietrich; Genuneit, Jon			Delivery Mode, Duration of Labor, and Cord Blood Adiponectin, Leptin, and C-Reactive Protein: Results of the Population-Based Ulm Birth Cohort Studies	PLOS ONE			English	Article							CESAREAN-SECTION; GUT MICROBIOTA; RISK; DISEASE; OVERWEIGHT; GROWTH	Background Numerous studies have reported associations between delivery mode and health outcomes in infancy and later life. Previous smaller studies indicated a relationship between delivery mode and newborn inflammation potentially constituting a mediating factor. We aimed to determine the influence of delivery mode and duration of labor on cord blood concentrations of adiponectin, leptin, and high-sensitivity C-reactive protein (hs-CRP). Methods In the Ulm SPATZ Health Study, 934 singleton newborns and their mothers were recruited during their hospital stay in the University Medical Center Ulm, Southern Germany, from 04/2012-05/2013. Inflammatory biomarkers were measured by ELISAs (n = 836). Delivery mode was analyzed categorically (elective cesarean (reference), active labor delivery: emergency cesarean, assisted vaginal, and spontaneous vaginal); duration of labor continuously. Following log-transformation, linear regression was used to estimate geometric means ratios (GMR) adjusted for potential confounders for the effects of delivery mode and duration of labor on each biomarker separately. Independent replication was sought in the similarly conducted Ulm Birth Cohort Study recruited from 11/2000-11/2001. Results Individually, active labor delivery modes as well as increasing duration of labor were associated with higher leptin and hs-CRP concentrations. After mutual adjustment, the associations with delivery modes were attenuated but those for duration of labor remained statistically significant (GMR (95% CI) 1.10 (1.00; 1.21) and 1.15 (1.04; 1.27) for leptin and hs-CRP per hour of labor, respectively). No significant adjusted associations were observed between delivery modes and adiponectin concentrations. These findings were replicated in an independent birth cohort study. Conclusions Cord blood leptin and hs-CRP concentrations were associated with duration of labor rather than delivery mode. Further research is warranted to investigate these associations with additional cytokines involved in inflammatory response to delineate the inflammatory profile. Subsequently, research on determinants of these associations and their role in development of chronic disease is needed.	[Logan, Chad A.; Thiel, Larissa; Bornemann, Rebecca; Rothenbacher, Dietrich; Genuneit, Jon] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Koenig, Wolfgang] Univ Med Ctr Ulm, Dept Internal Med Cardiol 2, Ulm, Germany; [Reister, Frank] Univ Med Ctr Ulm, Dept Gynecol & Obstet, Ulm, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Genuneit, Jon] World Univ Network WUN, In FLAME, Ulm, Germany	Ulm University; Ulm University; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ)	Genuneit, J (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.; Genuneit, J (corresponding author), World Univ Network WUN, In FLAME, Ulm, Germany.	jon.genuneit@uni-ulm.de	Genuneit, Jon/I-9323-2012; Brenner, Hermann/ABE-6383-2020; Brenner, Hermann/B-4627-2017	Genuneit, Jon/0000-0001-5764-1528; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603; Logan, Chad/0000-0002-6157-3641	Medical Faculty of Ulm University; German Research Council [BR 1704/3-1, BR1704/3-2, BR1704/3-3]	Medical Faculty of Ulm University; German Research Council(German Research Foundation (DFG))	The Ulm SPATZ Health Study was funded through an unrestricted grant by the Medical Faculty of Ulm University. The Ulm Birth Cohort Study was supported by grants of the German Research Council (BR 1704/3-1, BR1704/3-2, BR1704/3-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Bager P, 2012, INFLAMM BOWEL DIS, V18, P857, DOI 10.1002/ibd.21805; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; Cardwell CR, 2008, DIABETOLOGIA, V51, P726, DOI 10.1007/s00125-008-0941-z; Collado MC, 2015, PEDIATR RES, V77, P182, DOI 10.1038/pr.2014.173; Cho CE, 2013, AM J OBSTET GYNECOL, V208, P249, DOI 10.1016/j.ajog.2012.08.009; Decker E, 2010, PEDIATRICS, V125, pE1433, DOI 10.1542/peds.2009-2260; Gronlund MM, 1999, J PEDIATR GASTR NUTR, V28, P19, DOI 10.1097/00005176-199901000-00007; Hermansson H, 2014, NEONATOLOGY, V105, P172, DOI 10.1159/000357178; Hyde MJ, 2012, EARLY HUM DEV, V88, P943, DOI 10.1016/j.earlhumdev.2012.09.006; Ishibashi M, 2002, CLIN CHEM, V48, P1103; Ismail AQT, 2015, J MATERN-FETAL NEO M, V28, P3, DOI 10.3109/14767058.2014.885499; Kaar JL, 2014, J DEV ORIG HLTH DIS, V5, P214, DOI 10.1017/S204017441400021X; Lappas M, 2015, J PERINATOL, V35, P32, DOI 10.1038/jp.2014.144; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096603; Leung JYY, 2015, CLIN EXP ALLERGY, V45, P1109, DOI 10.1111/cea.12548; Li HT, 2013, INT J OBESITY, V37, P893, DOI 10.1038/ijo.2012.195; Luo ZC, 2013, OBESITY, V21, P210, DOI 10.1002/oby.20250; Malek A, 2006, PLACENTA, V27, P619, DOI 10.1016/j.placenta.2005.05.009; Mantzoros CS, 2009, PEDIATRICS, V123, P682, DOI 10.1542/peds.2008-0343; Morales E, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.056; Negele K, 2004, PEDIAT ALLERG IMM-UK, V15, P48, DOI 10.1046/j.0905-6157.2003.00101.x; Odegard RA, 2002, AM J OBSTET GYNECOL, V186, P427, DOI 10.1067/mob.2002.120486; Rothenbacher D, 2007, CLIN EXP ALLERGY, V37, P1143, DOI 10.1111/j.1365-2222.2007.02759.x; Sanz Y, 2015, PEDIATR RES, V77, P236, DOI 10.1038/pr.2014.170; Sevelsted A, 2015, PEDIATRICS, V135, pE92, DOI 10.1542/peds.2014-0596; Wang L, 2013, EUR J PEDIATR, V172, P1341, DOI 10.1007/s00431-013-2043-2; West CE, 2015, CLIN EXP ALLERGY, V45, P43, DOI 10.1111/cea.12332; Weyermann M, 2006, CLIN CHEM, V52, P2095, DOI 10.1373/clinchem.2006.071019; Yoon B H, 2003, J Matern Fetal Neonatal Med, V14, P85; Yoshimitsu N, 2000, OBSTET GYNECOL, V96, P342, DOI 10.1016/S0029-7844(00)00927-3; 조현희, 2005, Obstetrics & Gynecology Science, V48, P709	33	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149918	10.1371/journal.pone.0149918	http://dx.doi.org/10.1371/journal.pone.0149918			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900695	gold, Green Published			2022-12-26	WOS:000371276100184
J	Migliaccio, R; Boutet, C; Valabregue, R; Ferrieux, S; Nogues, M; Lehericy, S; Dormont, D; Levy, R; Dubois, B; Teichmann, M				Migliaccio, Raffaella; Boutet, Claire; Valabregue, Romain; Ferrieux, Sophie; Nogues, Marie; Lehericy, Stephane; Dormont, Didier; Levy, Richard; Dubois, Bruno; Teichmann, Marc			The Brain Network of Naming: A Lesson from Primary Progressive Aphasia	PLOS ONE			English	Article							ANTERIOR TEMPORAL INVOLVEMENT; SEMANTIC DEMENTIA; LEXICAL RETRIEVAL; SPEECH PRODUCTION; 3 VARIANTS; WORD; LANGUAGE; ANATOMY; MRI; PERFORMANCE	Objective Word finding depends on the processing of semantic and lexical information, and it involves an intermediate level for mapping semantic-to-lexical information which also subserves lexical-to-semantic mapping during word comprehension. However, the brain regions implementing these components are still controversial and have not been clarified via a comprehensive lesion model encompassing the whole range of language-related cortices. Primary progressive aphasia (PPA), for which anomia is thought to be the most common sign, provides such a model, but the exploration of cortical areas impacting naming in its three main variants and the underlying processing mechanisms is still lacking. Methods We addressed this double issue, related to language structure and PPA, with thirty patients (11 semantic, 12 logopenic, 7 agrammatic variant) using a picture-naming task and voxel-based morphometry for anatomo-functional correlation. First, we analyzed correlations for each of the three variants to identify the regions impacting naming in PPA and to disentangle the core regions of word finding. We then combined the three variants and correlation analyses for naming (semantic-to-lexical mapping) and single-word comprehension (lexical-to-semantic mapping), predicting an overlap zone corresponding to a bidirectional lexical-semantic hub. Results and Conclusions Our results showed that superior portions of the left temporal pole and left posterior temporal cortices impact semantic and lexical naming mechanisms in semantic and logopenic PPA, respectively. In agrammatic PPA naming deficits were rare, and did not correlate with any cortical region. Combined analyses revealed a cortical overlap zone in superior/middle mid-temporal cortices, distinct from the two former regions, impacting bidirectional binding of lexical and semantic information. Altogether, our findings indicate that lexical/semantic word processing depends on an anterior-posterior axis within lateral-temporal cortices, including an anatomically intermediate hub dedicated to lexical-semantic integration. Within this axis our data reveal the underpinnings of anomia in the PPA variants, which is of relevance for both diagnosis and future therapy strategies.	[Migliaccio, Raffaella; Boutet, Claire; Valabregue, Romain; Lehericy, Stephane; Levy, Richard; Dubois, Bruno; Teichmann, Marc] UMR INSERM CNRS UPMC 1127, Inst Cerveau & Moelle Epiniere, Paris, France; [Migliaccio, Raffaella; Ferrieux, Sophie; Nogues, Marie; Dubois, Bruno; Teichmann, Marc] Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr PPA & Rare Dementias, Dept Neurol, Paris, France; [Boutet, Claire; Valabregue, Romain; Lehericy, Stephane] Ctr Neuroimagerie Rech CENIR, Inst Cerveau & Moelle Epiniere, Paris, France; [Dormont, Didier] Univ Paris 06, INSERM, UMR S 678, Paris, France; [Dormont, Didier] Hop La Pitie Salpetriere, AP HP, Serv Neuroradiol Diagnost & Fonct, Paris, France; [Levy, Richard] Hop St Antoine, AP HP, Dept Neurol, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Teichmann, M (corresponding author), UMR INSERM CNRS UPMC 1127, Inst Cerveau & Moelle Epiniere, Paris, France.; Teichmann, M (corresponding author), Hop La Pitie Salpetriere, AP HP, Natl Reference Ctr PPA & Rare Dementias, Dept Neurol, Paris, France.	marc.teichmann@psl.aphp.fr	valabregue, romain/GWQ-7484-2022; Levy, Richard/D-8411-2011	valabregue, romain/0000-0002-1814-9570; Migliaccio, Raffaella/0000-0002-6960-8474	"France Alzheimer" Foundation; "Philippe Chatrier" Foundation	"France Alzheimer" Foundation; "Philippe Chatrier" Foundation	We would like to thank Dalila Samri, Tiffany Landure and Richard Gnassounou for assessing patients with general cognitive tests. Raffaella Migliaccio was supported by the "France Alzheimer" and "Philippe Chatrier" Foundations; however no specific funding for this study was received by the author.	Agniel Aau, 1992, PROTOCOLE MONTREAL T; Agosta F, 2010, BRAIN, V133, P286, DOI 10.1093/brain/awp233; Amici S, 2007, COGN BEHAV NEUROL, V20, P203, DOI 10.1097/WNN.0b013e31815e6265; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bozeat S, 2000, NEUROPSYCHOLOGIA, V38, P1207, DOI 10.1016/S0028-3932(00)00034-8; Brambati SM, 2006, J COGNITIVE NEUROSCI, V18, P1644, DOI 10.1162/jocn.2006.18.10.1644; Brambati SM, 2015, NEUROIMAGE-CLIN, V8, P345, DOI 10.1016/j.nicl.2015.01.011; CARDEBAT D, 1990, ACTA NEUROL BELG, V90, P207; Caviness VS, 2002, STROKE, V33, P2549, DOI 10.1161/01.STR.0000036083.90045.08; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; DeLeon J, 2007, BRAIN, V130, P1408, DOI 10.1093/brain/awm011; Deloche G, 1997, TEST DENOMINATION OR; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Gesierich B, 2012, CEREB CORTEX, V22, P2217, DOI 10.1093/cercor/bhr286; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Gorno-Tempini ML, 2004, ANN NEUROL, V55, P335, DOI 10.1002/ana.10825; Grande M, 2012, NEUROIMAGE, V61, P702, DOI 10.1016/j.neuroimage.2012.03.087; Graves WW, 2008, J COGNITIVE NEUROSCI, V20, P1698, DOI 10.1162/jocn.2008.20113; Graves WW, 2007, J COGNITIVE NEUROSCI, V19, P617, DOI 10.1162/jocn.2007.19.4.617; Grossman M, 2004, BRAIN, V127, P628, DOI 10.1093/brain/awh075; Henry ML, 2010, CURR OPIN NEUROL, V23, P633, DOI 10.1097/WCO.0b013e32833fb93e; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hillis AE, 2004, ANN NEUROL, V55, P268, DOI 10.1002/ana.10812; Hillis AE, 2006, J NEUROSCI, V26, P8069, DOI 10.1523/JNEUROSCI.2088-06.2006; Hurley RS, 2012, J NEUROSCI, V32, P4848, DOI 10.1523/JNEUROSCI.5984-11.2012; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; Leyton CE, 2013, NEUROLOGY, V80, P897, DOI 10.1212/WNL.0b013e318285c15b; Leyton CE, 2011, BRAIN, V134, P3030, DOI 10.1093/brain/awr216; Mahoney CJ, 2013, NEUROBIOL AGING, V34, P1687, DOI 10.1016/j.neurobiolaging.2012.12.002; Mazaux JM, 1982, BOSTON DIAGNOSTIC AP; Mesulam MM, 2014, NAT REV NEUROL, V10, P554, DOI 10.1038/nrneurol.2014.159; Mesulam MM, 2013, BRAIN, V136, P601, DOI 10.1093/brain/aws336; Mesulam MM, 2003, ANN NEUROL, V54, pS11, DOI 10.1002/ana.10569; Migliaccio R, 2012, ALZHEIMERS DEMENT S, V8, pS78; Miller ZA, 2013, BRAIN, V136, P3461, DOI 10.1093/brain/awt242; Miozzo M, 2015, CEREB CORTEX, V25, P3343, DOI 10.1093/cercor/bhu137; Nestor PJ, 2003, BRAIN, V126, P2406, DOI 10.1093/brain/awg240; New B, 2004, BEHAV RES METH INS C, V36, P516, DOI 10.3758/BF03195598; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Powers JP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00212; Race DS, 2013, BRAIN LANG, V127, P167, DOI 10.1016/j.bandl.2013.09.004; Ralph MAL, 2001, J COGNITIVE NEUROSCI, V13, P341, DOI 10.1162/08989290151137395; Ralph MAL, 2008, ANN NY ACAD SCI, V1124, P61, DOI 10.1196/annals.1440.006; Ralph MAL, 2007, BRAIN, V130, P1127, DOI 10.1093/brain/awm025; Raymer AM, 1997, BRAIN LANG, V58, P137, DOI 10.1006/brln.1997.1786; ROELOFS A, 1992, J EXPT PSYCHOL LEARN, V42, P107, DOI DOI 10.1016/0010-0277(92)90041-F; Rohrer JD, 2010, NEUROIMAGE, V49, P984, DOI 10.1016/j.neuroimage.2009.08.002; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Schwartz MF, 2009, BRAIN, V132, P3411, DOI 10.1093/brain/awp284; Teichmann M, 2013, BRAIN, V136, P3474, DOI 10.1093/brain/awt266; Walker GM, 2011, BRAIN LANG, V117, P110, DOI 10.1016/j.bandl.2010.09.008; Wilson SM, 2010, BRAIN, V133, P2069, DOI 10.1093/brain/awq129; Wilson SM, 2009, HUM BRAIN MAPP, V30, P3596, DOI 10.1002/hbm.20782; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95	60	35	36	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148707	10.1371/journal.pone.0148707	http://dx.doi.org/10.1371/journal.pone.0148707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901052	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100022
J	Vilaca, M; Aragao, I; Cardoso, T; Dias, C; Cabral-Campello, G				Vilaca, Marta; Aragao, Irene; Cardoso, Teresa; Dias, Claudia; Cabral-Campello, Gloria			The Role of Noninvasive Ventilation in Patients with "Do Not Intubate" Order in the Emergency Setting	PLOS ONE			English	Article							ACUTE RESPIRATORY-FAILURE; POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; PALLIATIVE USE; CARE; PREDICTORS	Background Noninvasive ventilation (NIV) is being used increasingly in patients who have a "do not intubate" (DNI) order. However, the impact of NIV on the clinical and health-related quality of life (HRQOL) in the emergency setting is not known, nor is its effectiveness for relieving symptoms in end-of-life care. Objective The aim of this prospective study was to determine the outcome and HRQOL impact of regular use of NIV outcomes on patients with a DNI order who were admitted to the emergency room department (ED). METHODS: Eligible for participation were DNI-status patients who receive NIV for acute or acute-on-chronic respiratory failure when admitted to the ED of a tertiary care, university-affiliated, 600-bed hospital between January 2014 and December 2014. Patients were divided into 2 groups: (1) those whose DNI order related to a decision to withhold therapy and (2) those for whom any treatment, including NIV, was provided for symptom relief only. HRQOL was evaluated only in group 1, using the 12-item Short Form Health Survey (SF-12). Long-term outcome was evaluated 90 days after hospital discharge by means of a telephone interview. Results During the study period 1727 patients were admitted to the ED, 243 were submitted to NIV and 70 (29%) were included in the study. Twenty-nine (41%) of the 70 enrollees received NIV for symptom relief only (group2). Active cancer [7% vs 35%, p = 0,004] and neuromuscular diseases [0% vs. 17%] were more prevalent in this group. NIV was stopped in 59% of the patients in group 2 due to lake of clinical benefit. The in-hospital mortality rate was 37% for group 1 and 86% for group 2 0,001). Among patients who were discharged from hospital, 23% of the group 1 and all patients in group 2 died within 90 days. Relative to baseline, no significant decline in HRQOL occurred in group 1 by 90 days postdischarge. Conclusion The survival rate was 49% among DNI-status patients for whom NIV was used as a treatment in ED, and these patients did not experience a decline in HRQOL throughout the study. NIV did not provide significant relief of symptoms in more than half the patients who receive it for that purpose.	[Vilaca, Marta] Univ Porto, MIM, ICBAS, Oporto, Portugal; [Aragao, Irene; Cardoso, Teresa; Cabral-Campello, Gloria] Oporto Hosp Ctr, Intens Care Unit UCIP, Oporto, Portugal; [Dias, Claudia] Univ Porto, Fac Med, Ctr Hlth Technol & Serv Res CINTESIS, Oporto, Portugal; [Dias, Claudia] Univ Porto, Fac Med, Informat Sci & Decis Hlth Dept CIDES, Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto	Vilaca, M (corresponding author), Univ Porto, MIM, ICBAS, Oporto, Portugal.	martarnvilaca@gmail.com	Dias, Claudia Camila/N-7130-2014	Dias, Claudia Camila/0000-0001-9356-3272; Aragao, Irene/0000-0001-5750-2739	Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar; ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal)	Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar; ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal)	Supported, in part, by grants from the Discipline of Initiation to Clinical Investigation (Disciplina de Iniciacao a Investigacao Clinica) of Instituto de Ciencias Biomedicas Abel Salazar and in part by ASSUCIP (Associacao dos Amigos da Unidade de Cuidados Intensivos Polivalente, Hospital de Santo Antonio, Porto, Portugal).	Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Azoulay E, 2014, INTENS CARE MED, V40, P305, DOI 10.1007/s00134-014-3217-8; Azoulay E, 2013, INTENS CARE MED, V39, P292, DOI 10.1007/s00134-012-2746-2; Azoulay E, 2011, INTENS CARE MED, V37, P1250, DOI 10.1007/s00134-011-2263-8; Baudouin S, 2002, THORAX, V57, P192; Brochard L, 2014, SEMIN RESP CRIT CARE, V35, P492, DOI 10.1055/s-0034-1383863; Cabrini L, 2012, RESP CARE, V57, P704, DOI 10.4187/respcare.01474; Chiumello D, 2009, RESP CARE, V54, P1302; Curtis JR, 2007, CRIT CARE MED, V35, P932, DOI 10.1097/01.CCM.0000256725.73993.74; Fiorino S, 2015, INTERN MED J, V45, P527, DOI 10.1111/imj.12726; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Hill NS, 2009, RESP CARE, V54, P62; L'Her E, 2004, INTENS CARE MED, V30, P882, DOI 10.1007/s00134-004-2183-y; Nava S, 2009, MINERVA ANESTESIOL, V75, P31; Nava S, 2013, LANCET ONCOL, V14, P219, DOI 10.1016/S1470-2045(13)70009-3; Phua J, 2005, INTENS CARE MED, V31, P533, DOI 10.1007/s00134-005-2582-8; Quill CM, 2014, J PALLIAT MED, V17, P657, DOI 10.1089/jpm.2014.0010; Scarpazza P, 2011, INT J CHRONIC OBSTR, V6, P253, DOI 10.2147/COPD.S18501; Scarpazza Paolo, 2008, Int J Chron Obstruct Pulmon Dis, V3, P797; Schnell D, 2014, INTENS CARE MED, V40, P582, DOI 10.1007/s00134-014-3222-y; Schortgen F, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-5; Shreves Ashley, 2013, Emerg Med Pract, V15, P1; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Squadrone E, 2004, INTENS CARE MED, V30, P1303, DOI 10.1007/s00134-004-2320-7; Thille AW, 2013, CRIT CARE, V17, DOI 10.1186/cc13103	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149649	10.1371/journal.pone.0149649	http://dx.doi.org/10.1371/journal.pone.0149649			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901060	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100121
J	Isakova, A; Berset, Y; Hatzimanikatis, V; Deplancke, B				Isakova, Alina; Berset, Yves; Hatzimanikatis, Vassily; Deplancke, Bart			Quantification of Cooperativity in Heterodimer-DNA Binding Improves the Accuracy of Binding Specificity Models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOID-X-RECEPTOR; BHLH TRANSCRIPTION FACTORS; GENE REGULATORY NETWORKS; PPAR-GAMMA-RXR; NUCLEAR RECEPTOR; TARGET GENES; ADIPOCYTE DIFFERENTIATION; ESCHERICHIA-COLI; GENOME-WIDE; ADIPOGENESIS	Many transcription factors (TFs) have the ability to cooperate on DNA elements as heterodimers. Despite the significance of TF heterodimerization for gene regulation, a quantitative understanding of cooperativity between various TF dimer partners and its impact on heterodimer DNA binding specificity models is still lacking. Here, we used a novel integrative approach, combining microfluidics-steered measurements of dimer-DNA assembly with mechanistic modeling of the implicated protein-protein-DNA interactions to quantitatively interrogate the cooperative DNA binding behavior of the adipogenic peroxisome proliferator-activated receptor gamma (PPAR gamma): retinoid X receptor alpha (RXR alpha) heterodimer. Using the high throughput MITOMI (mechanically induced trapping of molecular interactions) platform, we derived equilibrium DNA binding data for PPAR gamma, RXR alpha, as well as the PPAR gamma: RXR alpha heterodimer to more than 300 target DNA sites and variants thereof. We then quantified cooperativity underlying heterodimer-DNA binding and derived an integrative heterodimer DNA binding constant. Using this cooperativity-inclusive constant, we were able to build a heterodimer-DNA binding specificity model that has superior predictive power than the one based on a regular one-site equilibrium. Our data further revealed that individual nucleotide substitutions within the target site affect the extent of cooperativity in PPAR gamma:RXR alpha-DNA binding. Our study therefore emphasizes the importance of assessing cooperativity when generating DNA binding specificity models for heterodimers.	[Isakova, Alina; Berset, Yves; Deplancke, Bart] Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Berset, Yves; Hatzimanikatis, Vassily] Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland; [Isakova, Alina; Berset, Yves; Hatzimanikatis, Vassily; Deplancke, Bart] SIB, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Deplancke, B (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.; Hatzimanikatis, V (corresponding author), Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.; Hatzimanikatis, V; Deplancke, B (corresponding author), SIB, CH-1015 Lausanne, Switzerland.	vassily.hatzimanikatis@epfl.ch; bart.deplancke@epfl.ch	Hatzimanikatis, Vassily/G-6505-2010	Hatzimanikatis, Vassily/0000-0001-6432-4694; Isakova, Alina/0000-0003-1113-6889; Deplancke, Bart/0000-0001-9935-843X	Swiss National Science Foundation [SNSF 31003A_122552]; Ecole Polytechnique Federale de Lausanne; SystemsX.ch (Swiss Initiative in Systems Biology); Swiss National Science Foundation within the initiative SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; SystemsX.ch (Swiss Initiative in Systems Biology); Swiss National Science Foundation within the initiative SystemsX.ch	This work was supported in part by Swiss National Science Foundation Grant SNSF 31003A_122552, the Ecole Polytechnique Federale de Lausanne, and SystemsX.ch (i.e. the Swiss Initiative in Systems Biology). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Interdisciplinary Ph.D. grant from the Swiss National Science Foundation within the initiative SystemsX.ch.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Ben-Naim A., 2010, COOPERATIVITY REGULA, P67; Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Castelein H, 1996, MOL CELL ENDOCRINOL, V119, P11, DOI 10.1016/0303-7207(96)03794-X; Chakrabarti A, 2013, BIOTECHNOL J, V8, P1043, DOI 10.1002/biot.201300091; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Deplancke Bart, 2009, Briefings in Functional Genomics & Proteomics, V8, P12, DOI 10.1093/bfgp/elp001; Ecevit O, 2010, BIOCHEMISTRY-US, V49, P2627, DOI 10.1021/bi901913a; Ethayathulla AS, 2013, J BIOL CHEM, V288, P4744, DOI 10.1074/jbc.M112.408039; Fordyce PM, 2012, P NATL ACAD SCI USA, V109, pE3084, DOI 10.1073/pnas.1212457109; Funnell APW, 2012, ADV EXP MED BIOL, V747, P105, DOI 10.1007/978-1-4614-3229-6_7; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GLASS CK, 1994, ENDOCR REV, V15, P391, DOI 10.1210/er.15.3.391; Gordan R, 2013, CELL REP, V3, P1093, DOI 10.1016/j.celrep.2013.03.014; Griggs AJ, 2012, BIOTECHNOL BIOENG, V109, P665, DOI 10.1002/bit.23355; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Gubelmann C, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.38; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hill T. L., 1985, COOPERATIVITY THEORY, P167; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; IJpenberg A, 2004, EMBO J, V23, P2083, DOI 10.1038/sj.emboj.7600209; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2011, SUBCELL BIOCHEM, V52, P155, DOI 10.1007/978-90-481-9069-0_7; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klemm JD, 1998, ANNU REV IMMUNOL, V16, P569, DOI 10.1146/annurev.immunol.16.1.569; Kohler JJ, 2001, BIOCHEMISTRY-US, V40, P130, DOI 10.1021/bi001881p; LEE SB, 1984, BIOTECHNOL BIOENG, V26, P1372, DOI 10.1002/bit.260261115; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Maerkl SJ, 2009, P NATL ACAD SCI USA, V106, P18650, DOI 10.1073/pnas.0907688106; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Metallo SJ, 1997, NAT STRUCT BIOL, V4, P115, DOI 10.1038/nsb0297-115; Nakachi Y, 2008, BIOCHEM BIOPH RES CO, V372, P362, DOI 10.1016/j.bbrc.2008.05.037; Ng CKL, 2012, NUCLEIC ACIDS RES, V40, P4933, DOI 10.1093/nar/gks153; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Okuno M, 2001, BIOCHEM J, V353, P193, DOI 10.1042/0264-6021:3530193; Orenstein Y, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku117; Osz J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08216; Park S, 2004, BBA-GEN SUBJECTS, V1670, P217, DOI 10.1016/j.bbagen.2003.12.007; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; RASTINEJAD F, 1995, NATURE, V375, P203, DOI 10.1038/375203a0; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reece-Hoyes JS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r110; Reginato MJ, 1996, J BIOL CHEM, V271, P28199, DOI 10.1074/jbc.271.45.28199; Shultzaberger RK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002614; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Siggers T, 2014, NUCLEIC ACIDS RES, V42, P2099, DOI 10.1093/nar/gkt1112; Siggers T, 2012, NAT IMMUNOL, V13, P95, DOI 10.1038/ni.2151; Simicevic J, 2013, NAT METHODS, V10, P570, DOI [10.1038/NMETH.2441, 10.1038/nmeth.2441]; Slattery M, 2011, CELL, V147, P1270, DOI 10.1016/j.cell.2011.10.053; STORMO GD, 1982, NUCLEIC ACIDS RES, V10, P2997, DOI 10.1093/nar/10.9.2997; Todorov VT, 2008, ENDOCRINOLOGY, V149, P4647, DOI 10.1210/en.2008-0127; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WAHLI W, 1995, CHEM BIOL, V2, P261, DOI 10.1016/1074-5521(95)90045-4; Weirauch MT, 2013, NAT BIOTECHNOL, V31, P126, DOI 10.1038/nbt.2486; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; ZECHEL C, 1994, EMBO J, V13, P1414, DOI 10.1002/j.1460-2075.1994.tb06395.x; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhou J, 2006, P NATL ACAD SCI USA, V103, P9238, DOI 10.1073/pnas.0603324103	65	18	18	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10293	10306		10.1074/jbc.M115.691154	http://dx.doi.org/10.1074/jbc.M115.691154			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26912662	hybrid, Green Published			2022-12-26	WOS:000375602800036
J	Farcet, A; de Decker, L; Pauly, V; Rousseau, F; Bergman, H; Molines, C; Retornaz, F				Farcet, Anais; de Decker, Laure; Pauly, Vanessa; Rousseau, Frederique; Bergman, Howard; Molines, Catherine; Retornaz, Frederique			Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; OLDER CANCER-PATIENTS; MINI-MENTAL-STATE; ELDERLY-PATIENTS; COGNITIVE IMPAIRMENT; FUNCTIONAL STATUS; ONCOLOGY; HEALTH; IMPACT; CHEMOTHERAPY	Background Comprehensive Geriatric Assessment (CGA) is the gold standard to help oncologists select the best cancer treatment for their older patients. Some authors have suggested that the concept of frailty could be a more useful approach in this population. We investigated whether frailty markers are associated with treatment recommendations in an oncogeriatric clinic. Methods This prospective study included 70 years and older patients with solid tumors and referred for an oncogeriatric assessment. The CGA included nine domains: autonomy, comorbidities, medication, cognition, nutrition, mood, neurosensory deficits, falls, and social status. Five frailty markers were assessed (nutrition, physical activity, energy, mobility, and strength). Patients were categorized as Frail (three or more frailty markers), pre-frail (one or two frailty markers), or not-frail (no frailty marker). Treatment recommendations were classified into two categories: standard treatment with and without any changes and supportive/palliative care. Multiple logistic regression models were used to analyze factors associated with treatment recommendations. Results 217 patients, mean age 83 years (+/- Standard deviation (SD) 5.3), were included. In the univariate analysis, number of frailty markers, grip strength, physical activity, mobility, nutrition, energy, autonomy, depression, Eastern Cooperative Oncology Group Scale of Performance Status (ECOG-PS), and falls were significantly associated with final treatment recommendations. In the multivariate analysis, the number of frailty markers and basic Activities of Daily Living (ADL) were significantly associated with final treatment recommendations (p<0.001 and p = 0.010, respectively). Conclusion Frailty markers are associated with final treatment recommendations in older cancer patients. Longitudinal studies are warranted to better determine their use in a geriatric oncology setting.	[Farcet, Anais; Molines, Catherine; Retornaz, Frederique] Ctr Gerontol Dept, Unite Coordinat Oncol Geriatr, Marseille, France; [de Decker, Laure] Ctr Hosp Univ, Dept Geriatrie, Nantes, France; [Pauly, Vanessa; Retornaz, Frederique] Aix Marseille Univ, Lab Sante Publ EA 3279, Ctr Evaluat Pharmacodependance Addictovigilance C, Fac Med, Marseille, France; [Rousseau, Frederique] Inst J Paoli I Calmettes, Unite Coordinat Oncol Geriatr, F-13009 Marseille, France; [Bergman, Howard] McGill Univ, Dept Family Med, Montreal, PQ H3T 1E2, Canada; [Retornaz, Frederique] Hop Europeen, Unite Soins & Rech Med Interne & Malad Infect, Marseille, France	Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); McGill University	Farcet, A (corresponding author), Ctr Gerontol Dept, Unite Coordinat Oncol Geriatr, Marseille, France.	afarcet.cgd13@e-santepaca.fr			Association Sud de Recherche en Oncogeriatrie (ASRO); Unite de Coordination en Oncogeriatrie PACA Quest	Association Sud de Recherche en Oncogeriatrie (ASRO); Unite de Coordination en Oncogeriatrie PACA Quest	Dr Farcet was supported in part by the Association Sud de Recherche en Oncogeriatrie (ASRO). Dr Retornaz was supported in part by the Unite de Coordination en Oncogeriatrie PACA Quest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2011, CRIT REV ONCOL HEMAT, V77, P64, DOI 10.1016/j.critrevonc.2010.01.003; Balducci Lodovico, 2007, Cancer Control, V14, P7; Balducci L, 2013, INTERD T GERONT GERI, V38, P61, DOI 10.1159/000343586; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Barthelemy P, 2011, CRIT REV ONCOL HEMAT, V79, P196, DOI 10.1016/j.critrevonc.2010.06.005; Bernabei R, 2000, CRIT REV ONCOL HEMAT, V33, P45, DOI 10.1016/S1040-8428(99)00048-7; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Borson S, 2005, J AM GERIATR SOC, V53, P871, DOI 10.1111/j.1532-5415.2005.53269.x; Boulahssass R, 2014, J CLIN ONCOL, V32, p5s; Cahn DA, 1996, ARCH CLIN NEUROPSYCH, V11, P529, DOI 10.1016/0887-6177(95)00041-0; Caillet P, 2011, J CLIN ONCOL, V29, P3636, DOI 10.1200/JCO.2010.31.0664; Chaibi P, 2011, CRIT REV ONCOL HEMAT, V79, P302, DOI 10.1016/j.critrevonc.2010.08.004; Chen CCH, 2004, CRIT REV ONCOL HEMAT, V49, P53, DOI 10.1016/S1040-8428(03)00098-2; Cook Z, 2005, P NUTR SOC, V64, P313, DOI 10.1079/PNS2005437; Cornali C, 2005, J AM GERIATR SOC, V53, P354, DOI 10.1111/j.1532-5415.2005.53126_4.x; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Falandry C, 2013, ANN ONCOL, V24, P2808, DOI 10.1093/annonc/mdt360; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Girre V, 2008, J GERONTOL A-BIOL, V63, P724, DOI 10.1093/gerona/63.7.724; Guo CB, 1996, BRIT J ORAL MAX SURG, V34, P325, DOI 10.1016/S0266-4356(96)90012-1; KALFARENTZOS F, 1989, JPEN-PARENTER ENTER, V13, P34, DOI 10.1177/014860718901300134; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kristjansson SR, 2012, J GERIATR ONCOL, V3, P1, DOI 10.1016/j.jgo.2011.09.002; Liu JJ, 2012, CLIN GERIATR MED, V28, P19, DOI 10.1016/j.cger.2011.10.001; Maas HAAM, 2007, EUR J CANCER, V43, P2161, DOI 10.1016/j.ejca.2007.08.002; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pal SK, 2010, CA-CANCER J CLIN, V60, P120, DOI 10.3322/caac.20059; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285; Puts MTE, 2011, CRIT REV ONCOL HEMAT, V78, P138, DOI 10.1016/j.critrevonc.2010.04.003; Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V; Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5; Retornaz F, 2014, J CLIN ONCOL S, V32, p5s; Retornaz F, 2008, J GERONTOL A-BIOL, V63, P518, DOI 10.1093/gerona/63.5.518; Retornaz F, 2007, J GERONTOL A-BIOL, V62, P917, DOI 10.1093/gerona/62.8.917; Rouge-Bugat ME, 2013, J NUTR HEALTH AGING, V17, P473, DOI 10.1007/s12603-012-0435-z; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Sourial N, 2013, J GERONTOL A-BIOL, V68, P1505, DOI 10.1093/gerona/glt053; Tan KY, 2012, AM J SURG, V204, P139, DOI 10.1016/j.amjsurg.2011.08.012; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735, DOI 10.1111/j.1532-5415.1997.tb01479.x	47	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149732	10.1371/journal.pone.0149732	http://dx.doi.org/10.1371/journal.pone.0149732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918947	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400042
J	Lee, JH; Om, JY; Kim, YH; Kim, KM; Choi, EH; Kim, KN				Lee, Jung-Hwan; Om, Ji-Yeon; Kim, Yong-Hee; Kim, Kwang-Mahn; Choi, Eun-Ha; Kim, Kyoung-Nam			Selective Killing Effects of Cold Atmospheric Pressure Plasma with NO Induced Dysfunction of Epidermal Growth Factor Receptor in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; OXIDATIVE STRESS; DOWN-REGULATION; CANCER CELLS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; CYTOTOXIC DRUGS; LUNG-CANCER; NECK-CANCER; GLUTATHIONE	The aim of this study is to investigate the effects of cold atmospheric pressure plasma (CAP)-induced radicals on the epidermal growth factor receptor (EGFR), which is overexpressed by oral squamous cell carcinoma, to determine the underlying mechanism of selective killing. CAP-induced highly reactive radicals were observed in both plasma plume and cell culture media. The selective killing effect was observed in oral squamous cell carcinoma compared with normal human gingival fibroblast. Degradation and dysfunction of EGFRs were observed only in the EGFR-overexpressing oral squamous cell carcinoma and not in the normal cell. Nitric oxide scavenger pretreatment in cell culture media before CAP treatment rescued above degradation and dysfunction of the EGFR as well as the killing effect in oral squamous cell carcinoma. CAP may be a promising cancer treatment method by inducing EGFR dysfunction in EGFR-overexpressing oral squamous cell carcinoma via nitric oxide radicals.	[Lee, Jung-Hwan; Om, Ji-Yeon; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Dept & Res Inst Dent Biomat & Bioengn, 50-1 Yonsei Ro, Seoul 120752, South Korea; [Lee, Jung-Hwan] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Kim, Yong-Hee; Choi, Eun-Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, 20 Kwangwoon Gil, Seoul 139701, South Korea	Yonsei University; Yonsei University Health System; Dankook University; Kwangwoon University	Kim, KN (corresponding author), Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Dept & Res Inst Dent Biomat & Bioengn, 50-1 Yonsei Ro, Seoul 120752, South Korea.; Choi, EH (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, 20 Kwangwoon Gil, Seoul 139701, South Korea.	ehchoi@kw.ac.kr; kimkn@yuhs.ac	Choi, Eun Ha/AFN-9488-2022; Lee, Jung-Hwan/AFK-0831-2022	Choi, Eun Ha/0000-0001-5385-1878; Lee, Jung-Hwan/0000-0001-8678-5459; KIM, KWANG-MAHN/0000-0002-5235-0294	National Research Foundation of Korea (NRF) - Korea government (MSIP; Ministry of Science, ICT & Future Planning) [NRF-2010-0027963]; National Research Foundation of Korea(NRF) - Ministry of Education [2009-0093829]	National Research Foundation of Korea (NRF) - Korea government (MSIP; Ministry of Science, ICT & Future Planning); National Research Foundation of Korea(NRF) - Ministry of Education	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP; Ministry of Science, ICT & Future Planning) (NRF-2010-0027963) and by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(grant number: 2009-0093829).	Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bruno M, 2009, J PROTEOME RES, V8, P2070, DOI 10.1021/pr801061r; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YJ, 2013, MOL CELL BIOCHEM, V375, P59, DOI 10.1007/s11010-012-1528-z; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Chrapko W, 2006, NEUROPSYCHOPHARMACOL, V31, P1286, DOI 10.1038/sj.npp.1300961; CHRISTENSEN ME, 1992, EUR ARCH OTO-RHINO-L, V249, P243, DOI 10.1007/BF00714485; COOK JA, 1991, CANCER RES, V51, P4287; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Florian J, 2015, IEEE T PLASMA SCI, V43, P3332, DOI 10.1109/TPS.2015.2404879; Foltin V, 2006, CZECH J PHYS, V56, pB712, DOI 10.1007/s10582-006-0276-2; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Gweon B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3352316; He YY, 2003, J BIOL CHEM, V278, P42457, DOI 10.1074/jbc.M303376200; Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jin DJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4819246; Jung-Hwan L, 2014, JPN J APPL PHYS, V53; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kaushik NK, 2013, CURR APPL PHYS, V13, P176, DOI 10.1016/j.cap.2012.07.002; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kwon J, 2014, ONCOL REP, V32, P1188, DOI 10.3892/or.2014.3302; Lee EJ, 2007, ANN NY ACAD SCI, V1095, P113, DOI 10.1196/annals.1397.015; Lee JH, 2013, THIN SOLID FILMS, V547, P99, DOI 10.1016/j.tsf.2013.04.105; Lee JH, 2013, ACTA ODONTOL SCAND, V71, P168, DOI 10.3109/00016357.2011.654256; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lunov O, 2014, SCI REP-UK, V4, DOI 10.1038/srep07129; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; MCALLISTER BS, 1993, ARCH BIOCHEM BIOPHYS, V304, P294, DOI 10.1006/abbi.1993.1352; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Nims Raymond W., 1995, Methods (Orlando), V7, P48, DOI 10.1006/meth.1995.1007; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Park SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129931; PETTENGELL R, 1994, BONE MARROW TRANSPL, V14, P703; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Schlegel J, 2013, CLIN PLASMA MED, V1, P2, DOI 10.1016/j.cpme.2013.08.001; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Vacaresse N, 2001, BRIT J PHARMACOL, V132, P1777, DOI 10.1038/sj.bjp.0703981; Verhaar R, 2008, BLOOD, V112, P4935, DOI 10.1182/blood-2008-04-151043; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wartenberg M, 2003, INT J CANCER, V104, P274, DOI 10.1002/ijc.10928; Yi YW, 2015, INT J ONCOL, V47, P122, DOI 10.3892/ijo.2015.2982; Zhang S, 2004, CANCER LETT, V208, P143, DOI 10.1016/j.canlet.2003.11.028; Zhuang SG, 2003, ONCOGENE, V22, P4413, DOI 10.1038/sj.onc.1206604	62	32	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150279	10.1371/journal.pone.0150279	http://dx.doi.org/10.1371/journal.pone.0150279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919318	Green Published, Green Submitted, gold			2022-12-26	WOS:000371274400116
J	Shen, ZJ; Hu, J; Shiizaki, K; Kuro-o, M; Malter, JS				Shen, Zhong-Jian; Hu, Jie; Shiizaki, Kazuhiro; Kuro-o, Makoto; Malter, James S.			Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1	PLOS ONE			English	Article							DIETARY PHOSPHORUS; TGF-BETA; PROTEIN; PROGRESSION; KIDNEY; CALCIFICATION; EXPRESSION; RESTRICTION; ACTIVATION; INDUCTION	Tubulo-interstitial fibrosis is a common, destructive endpoint for a variety of kidney diseases. Fibrosis is well correlated with the loss of kidney function in both humans and rodents. The identification of modulators of fibrosis could provide novel therapeutic approaches to reducing disease progression or severity. Here, we show that the peptidylprolyl isomerase Pin1 is an important molecular contributor that facilitates renal fibrosis in a well-characterized animal model. While wild-type mice fed a high phosphate diet (HPD) for 8-12 weeks developed calcium deposition, macrophage infiltration and extracellular matrix (ECM) accumulation in the kidney interstitium, Pin1 null mice showed significantly less pathology. The serum Pi in both WT and KO mice were significantly increased by the HPD, but the serum Ca was slightly decreased in KO compared to WT. In addition, both WT and KO HPD mice had less weight gain but exhibited normal organ mass (kidney, lung, spleen, liver and heart). Unexpectedly, renal function was not initially impaired in either genotype irrespective of the HPD. Our results suggest that diet containing high Pi induces rapid renal fibrosis before a significant impact on renal function and that Pin1 plays an important role in the fibrotic process.	[Shen, Zhong-Jian; Hu, Jie; Shiizaki, Kazuhiro; Kuro-o, Makoto; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shen, ZJ; Malter, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	Zhong.Shen@UTsouthwestern.edu; James.Malter@UTsouthwestern.edu			National Institutes of Health [P01HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K09269] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grant P01HL088594 (to J.S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1995, AM J PATHOL, V146, P742; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Cao Q, 2014, KIDNEY INT SUPPL, V4, P16, DOI 10.1038/kisup.2014.4; Chakrabarti S, 2013, VET PATHOL, V50, P147, DOI 10.1177/0300985812453176; Chen ZH, 2012, CELL PHYSIOL BIOCHEM, V30, P151, DOI 10.1159/000339054; Cozzolino M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025782.24383.0D; CRAIG JM, 1959, ARCH PATHOL, V68, P306; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Earl GL, 2012, J AM PHARM ASSOC, V52, P637, DOI 10.1331/JAPhA.2012.10241; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Eraranta A, 2012, AM J NEPHROL, V35, P401, DOI 10.1159/000337942; Finch JL, 2013, KIDNEY INT, V84, P1145, DOI 10.1038/ki.2013.213; FINCO DR, 1992, AM J VET RES, V53, P2264; GIMENEZ LF, 1987, KIDNEY INT, V31, P93, DOI 10.1038/ki.1987.14; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Huen SC, 2013, AM J PHYSIOL-RENAL, V305, pF477, DOI 10.1152/ajprenal.00624.2012; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Koizumi T, 2002, BIOCHEM BIOPH RES CO, V295, P917, DOI 10.1016/S0006-291X(02)00793-3; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; LAU K, 1989, KIDNEY INT, V36, P918, DOI 10.1038/ki.1989.281; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LOGHMANADHAM M, 1993, J LAB CLIN MED, V122, P16; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; LUMLERTGUL D, 1986, KIDNEY INT, V29, P658, DOI 10.1038/ki.1986.49; MacKay EM, 1935, J EXP MED, V61, P319, DOI 10.1084/jem.61.3.319; Maschio G, 1983, Kidney Int Suppl, V16, pS273; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; ROSS LA, 1982, AM J VET RES, V43, P1023; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2012, J BIOL CHEM, V287, P23294, DOI 10.1074/jbc.M111.313684; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Sun Y., 2014, ADV ENERGY MATER, V4, P1, DOI [DOI 10.1038/SREP06563, DOI 10.1002/aenm.201300611]; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Tan RJ, 2013, AM J PHYSIOL-RENAL, V305, pF821, DOI 10.1152/ajprenal.00356.2013; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yang JW, 2014, J HEPATOL, V60, P1235, DOI 10.1016/j.jhep.2014.02.004; Yung S, 2003, PERITON DIALYSIS INT, V23, pS37; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175	49	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150093	10.1371/journal.pone.0150093	http://dx.doi.org/10.1371/journal.pone.0150093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914452	Green Submitted, Green Published, gold			2022-12-26	WOS:000371175700052
J	Dennis, B; Kemp, WP				Dennis, Brian; Kemp, William P.			How Hives Collapse: Allee Effects, Ecological Resilience, and the Honey Bee	PLOS ONE			English	Article							POPULATION-DYNAMICS; COLONY; DISORDER; POLLINATION; STATES; SCALE; MODEL	We construct a mathematical model to quantify the loss of resilience in collapsing honey bee colonies due to the presence of a strong Allee effect. In the model, recruitment and mortality of adult bees have substantial social components, with recruitment enhanced and mortality reduced by additional adult bee numbers. The result is an Allee effect, a net per-individual rate of hive increase that increases as a function of adult bee numbers. The Allee effect creates a critical minimum size in adult bee numbers, below which mortality is greater than recruitment, with ensuing loss of viability of the hive. Under ordinary and favorable environmental circumstances, the critical size is low, and hives remain large, sending off viably-sized swarms (naturally or through beekeeping management) when hive numbers approach an upper stable equilibrium size (carrying capacity). However, both the lower critical size and the upper stable size depend on many parameters related to demographic rates and their enhancement by bee sociality. Any environmental factors that increase mortality, decrease recruitment, or interfere with the social moderation of these rates has the effect of exacerbating the Allee effect by increasing the lower critical size and substantially decreasing the upper stable size. As well, the basin of attraction to the upper stable size, defined by the model potential function, becomes narrower and shallower, indicating the loss of resilience as the hive becomes subjected to increased risk of falling below the critical size. Environmental effects of greater severity can cause the two equilibria to merge and the basin of attraction to the upper stable size to disappear, resulting in collapse of the hive from any initial size. The model suggests that multiple proximate causes, among them pesticides, mites, pathogens, and climate change, working singly or in combinations, could trigger hive collapse.	[Dennis, Brian] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA; [Dennis, Brian] Univ Idaho, Dept Stat Sci, Moscow, ID 83844 USA; [Kemp, William P.] ARS, USDA, Red River Valley Agr Res Ctr, 1605 Albrecht Blvd North, Fargo, ND 58102 USA	Idaho; University of Idaho; Idaho; University of Idaho; United States Department of Agriculture (USDA)	Dennis, B (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA.; Dennis, B (corresponding author), Univ Idaho, Dept Stat Sci, Moscow, ID 83844 USA.	brian@uidaho.edu			US Department of Agriculture	US Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by US Department of Agriculture (http://www.ars.usda.gov/main/site_main.htm?modecode=30-00-00-00 58-5442-2-327) to BD.	Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Case T. J, 2000, ILLUSTRATED GUIDE TH; Clark C.W., 2010, MATH BIOECONOMICS, V3rd; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Deguines N, 2014, FRONT ECOL ENVIRON, V12, P212, DOI 10.1890/130054; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Eberl HJ, 2010, ELECTRON J DIFFER EQ, P85; Gallant AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099268; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Kribs-Zaleta CM, 2014, MATH BIOSCI ENG, V11, P1275, DOI 10.3934/mbe.2014.11.1275; Kritsky Gene, 2010, QUEST PERFECT HIVE H; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Lidicker William Z. Jr, 2010, Open Ecology Journal, V3, P71; Lu CS, 2014, B INSECTOL, V67, P125; Ludwig D., 1997, CONSERV ECOL, V1, P1; Luque GM, 2013, J ANIM ECOL, V82, P956, DOI 10.1111/1365-2656.12091; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Mikheyev AS, 2008, DIVERS DISTRIB, V14, P301, DOI 10.1111/j.1472-4642.2007.00463.x; ODUM HT, 1954, ECOLOGY, V35, P95, DOI 10.2307/1931412; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; PHILIP JR, 1957, ECOLOGY, V38, P107, DOI 10.2307/1932132; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Sanford MT, 2010, STOREYS GUIDE KEEPIN; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stankus T, 2008, J AGRIC FOOD INF, V9, P115, DOI 10.1080/10496500802173939; Stankus Tony, 2014, Science & Technology Libraries, V33, P228, DOI 10.1080/0194262X.2014.912573; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Volterra V., 1938, HUM BIOL, V3, P1; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503	54	24	24	4	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150055	10.1371/journal.pone.0150055	http://dx.doi.org/10.1371/journal.pone.0150055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910061	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700059
J	Kumar, G; Rattan, UK; Singh, AK				Kumar, Gulshan; Rattan, Usha Kumari; Singh, Anil Kumar			Chilling-Mediated DNA Methylation Changes during Dormancy and Its Release Reveal the Importance of Epigenetic Regulation during Winter Dormancy in Apple (Malus x domestica Borkh.)	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; AMPLIFICATION POLYMORPHISM MSAP; GENOME-WIDE ANALYSIS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FLOWERING TIME; ZEA-MAYS; HISTONE METHYLTRANSFERASE; CYTOSINE METHYLATION; PLANT GENOMES	Winter dormancy is a well known mechanism adopted by temperate plants, to mitigate the chilling temperature of winters. However, acquisition of sufficient chilling during winter dormancy ensures the normal phenological traits in subsequent growing period. Thus, low temperature appears to play crucial roles in growth and development of temperate plants. Apple, being an important temperate fruit crop, also requires sufficient chilling to release winter dormancy and normal phenological traits, which are often associated with yield and quality of fruits. DNA cytosine methylation is one of the important epigenetic modifications which remarkably affect the gene expression during various developmental and adaptive processes. In present study, methylation sensitive amplified polymorphism was employed to assess the changes in cytosine methylation during dormancy, active growth and fruit set in apple, under differential chilling conditions. Under high chill conditions, total methylation was decreased from 27.2% in dormant bud to 21.0% in fruit set stage, while no significant reduction was found under low chill conditions. Moreover, the demethylation was found to be decreased, while methylation increased from dormant bud to fruit set stage under low chill as compared to high chill conditions. In addition, RNA-Seq analysis showed high expression of DNA methyltransferases and histone methyltransferases during dormancy and fruit set, and low expression of DNA glcosylases during active growth under low chill conditions, which was in accordance with changes in methylation patterns. The RNA-Seq data of 47 genes associated with MSAP fragments involved in cellular metabolism, stress response, antioxidant system and transcriptional regulation showed correlation between methylation and their expression. Similarly, bisulfite sequencing and qRT-PCR analysis of selected genes also showed correlation between gene body methylation and gene expression. Moreover, significant association between chilling and methylation changes was observed, which suggested that chilling acquisition during dormancy in apple is likely to affect the epigenetic regulation through DNA methylation.	[Kumar, Gulshan; Rattan, Usha Kumari; Singh, Anil Kumar] CSIR Inst Himalayan Bioresource Technol, Dept Biotechnol, Palampur 176061, Himachal Prades, India; [Kumar, Gulshan; Singh, Anil Kumar] Acad Sci & Innovat Res, New Delhi, India; [Singh, Anil Kumar] IINRG, ICAR Indian Inst Agr Biotechnol, PDU Campus, Ranchi 834010, JH, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT); Academy of Scientific & Innovative Research (AcSIR); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Agricultural Biotechnology; ICAR - Indian Institute of Natural Resins & Gums	Singh, AK (corresponding author), CSIR Inst Himalayan Bioresource Technol, Dept Biotechnol, Palampur 176061, Himachal Prades, India.; Singh, AK (corresponding author), IINRG, ICAR Indian Inst Agr Biotechnol, PDU Campus, Ranchi 834010, JH, India.	anils13@gmail.com		Singh, Anil/0000-0002-3569-5207	Council of Scientific and Industrial Research, New Delhi [BSC0107]; University Grants Commission, India	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, India(University Grants Commission, India)	This study was supported by the grants from Council of Scientific and Industrial Research, New Delhi, in the form of Network Project PlaGen (BSC0107) to AKS at CSIR-IHBT, Palampur.; We gratefully acknowledge Director, CSIR-Institute of Himalayan Bioresource Technology, Palampur for the constant support. GK acknowledges senior research fellowship received from University Grants Commission, India. We kindly acknowledge Associate Director, Hill Agricultural Research & Extension Centre, Bajaura, Kullu (HP) and Director, SASE (DRDO) station Bahang, Manali (HP) for providing the temperature data. This manuscript represents CSIR-IHBT communication number 3952.	Abedi T, 2016, J BIOSCI BIOENG, V121, P573, DOI 10.1016/j.jbiosc.2015.09.014; Anderson JV, 2005, PLANT CELL ENVIRON, V28, P1567, DOI 10.1111/j.1365-3040.2005.01393.x; Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Bassa C, 2012, PLANT CELL PHYSIOL, V53, P1583, DOI 10.1093/pcp/pcs101; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bond DM, 2007, TRENDS PLANT SCI, V12, P211, DOI 10.1016/j.tplants.2007.03.010; BURN JE, 1993, P NATL ACAD SCI USA, V90, P287, DOI 10.1073/pnas.90.1.287; Caro E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002995; Causevic A, 2005, PLANT PHYSIOL BIOCH, V43, P681, DOI 10.1016/j.plaphy.2005.05.011; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Deng WW, 2007, PLANT PHYSIOL, V143, P1660, DOI [10.1104/pp.107.095521, 10.1104/pp.106.095521]; Du JM, 2012, CELL, V151, P167, DOI 10.1016/j.cell.2012.07.034; DUFF SMG, 1994, PHYSIOL PLANTARUM, V90, P791, DOI 10.1111/j.1399-3054.1994.tb02539.x; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Ebbs ML, 2005, MOL CELL BIOL, V25, P10507, DOI 10.1128/MCB.25.23.10507-10515.2005; Santamaria ME, 2011, ANN BOT-LONDON, V108, P485, DOI 10.1093/aob/mcr185; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Fulnecek J, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-2; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; GEORGIEVA EI, 1991, J BIOL CHEM, V266, P18751; Hashida SN, 2006, PLANT CELL, V18, P104, DOI 10.1105/tpc.105.037655; Hedley PE, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-202; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Hsieh MH, 2002, PLANT PHYSIOL, V130, P1797, DOI 10.1104/pp.007484; Phan HA, 2011, PLANT CELL, V23, P2209, DOI 10.1105/tpc.110.082651; Jangra MS, 2013, INT J FARM SCI, V3; Jeddeloh JA, 1996, PLANT J, V9, P579, DOI 10.1046/j.1365-313X.1996.9050579.x; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Karan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040203; Ko JH, 2011, TREE PHYSIOL, V31, P208, DOI 10.1093/treephys/tpq109; Kovarik A, 1997, GENE, V204, P25, DOI 10.1016/S0378-1119(97)00503-9; Kumar G, 2015, SCI HORTIC-AMSTERDAM, V197, P597, DOI 10.1016/j.scienta.2015.10.025; LANG GA, 1987, HORTSCIENCE, V22, P817; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Law RD, 2003, PLANT MOL BIOL, V51, P437, DOI 10.1023/A:1022002304479; Leida C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035777; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu ZW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003948; Lizal P, 2001, PHYSIOL PLANTARUM, V113, P121, DOI 10.1034/j.1399-3054.2001.1130116.x; Luca M, 2007, J EXP BOT, V58, P1035; LUND G, 1995, MOL GEN GENET, V246, P716, DOI 10.1007/BF00290717; Mazzitelli L, 2007, J EXP BOT, V58, P1035, DOI 10.1093/jxb/erl266; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; MESSEGUER R, 1991, PLANT MOL BIOL, V16, P753, DOI 10.1007/BF00015069; Muoki RC, 2012, MOL BIOTECHNOL, V52, P82, DOI 10.1007/s12033-011-9476-5; Ning YQ, 2015, NUCLEIC ACIDS RES, V43, P1469, DOI 10.1093/nar/gku1382; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Ortega-Galisteo AP, 2008, PLANT MOL BIOL, V67, P671, DOI 10.1007/s11103-008-9346-0; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; PRADHAN S, 1995, PLANT J, V7, P471, DOI 10.1046/j.1365-313X.1995.7030471.x; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; REISER L, 1995, CELL, V83, P735, DOI 10.1016/0092-8674(95)90186-8; Rowland LJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-46; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Sherman JD, 2002, GENOME, V45, P253, DOI 10.1139/g01-147; Shim D, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.59; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Sugiura T, 2012, JARQ-JPN AGR RES Q, V46, P7, DOI 10.6090/jarq.46.7; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tang XM, 2014, MOL GENET GENOMICS, V289, P1075, DOI 10.1007/s00438-014-0869-6; Thorstensen T, 2006, NUCLEIC ACIDS RES, V34, P5461, DOI 10.1093/nar/gkl687; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Ulian EC, 1996, THEOR APPL GENET, V92, P976, DOI 10.1007/BF00224037; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Walton EF, 2009, J EXP BOT, V60, P3835, DOI 10.1093/jxb/erp231; Wang WS, 2011, J EXP BOT, V62, P1951, DOI 10.1093/jxb/erq391; Woo HR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000156; Wrobelska JG, 2013, ACTA PHYSIOL PLANT, V35, P817; Xin ZG, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-26; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Yu QB, 2014, MOL PLANT, V7, P206, DOI 10.1093/mp/sst092; Zhang MS, 2011, PLANT PHYSIOL, V156, P1955, DOI 10.1104/pp.111.176842; Zhang XY, 2008, SCIENCE, V320, P489, DOI 10.1126/science.1153996; Zhang XY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r62; Zhou JL, 2010, PLANT MOL BIOL, V72, P585, DOI 10.1007/s11103-009-9594-7; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	85	58	62	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149934	10.1371/journal.pone.0149934	http://dx.doi.org/10.1371/journal.pone.0149934			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901339	gold, Green Submitted, Green Published			2022-12-26	WOS:000371276100189
J	Romanelli, AM; Raciti, M; Protti, MA; Prediletto, R; Fornai, E; Faustini, A				Romanelli, Anna Maria; Raciti, Mauro; Protti, Maria Angela; Prediletto, Renato; Fornai, Edo; Faustini, Annunziata			How Reliable Are Current Data for Assessing the Actual Prevalence of Chronic Obstructive Pulmonary Disease?	PLOS ONE			English	Article							GLOBAL BURDEN; DIAGNOSED COPD; SPIROMETRY USE; RISK-FACTORS; VALIDITY; POPULATION; VALIDATION; MORTALITY	Background Estimating COPD occurrence is perceived by the scientific community as a matter of increasing interest because of the worldwide diffusion of the disease. We aimed to estimate COPD prevalence by using administrative databases from a city in central Italy for 20022006, improving both the sensitivity and the reliability of the estimate. Methods Multiple sources were used, integrating the hospital discharge register (HDR), clinical charts, spirometry and the cause-specific mortality register (CMR) in a longitudinal algorithm, to reduce underestimation of COPD prevalence. Prevalence was also estimated on the basis of COPD cases confirmed through spirometry, to correct misclassification. Estimating such prevalence relied on using coefficients of validation, derived as the positive predictive value (PPV) for being an actual COPD case from clinical and spirometric data at the Institute of Clinical Physiology of the National Research Council. Results We found that sensitivity of COPD prevalence increased by 37%. The highest estimate (4.43 per 100 residents) was observed in the 5-year period, using a 3-year longitudinal approach and combined data from three sources. We found that 17% of COPD cases were misclassified. The above estimate of COPD prevalence decreased (3.66 per 100 residents) when coefficients of validation were applied. The PPV was 80% for the HDR, 82% for clinical diagnoses and 91% for the CMR. Conclusions Adjusting the COPD prevalence for both underestimation and misclassification of the cases makes administrative data more reliable for epidemiological purposes.	[Romanelli, Anna Maria; Raciti, Mauro; Protti, Maria Angela; Prediletto, Renato; Fornai, Edo] CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy; [Prediletto, Renato] Fdn Gabriele Monasterio, CNR Reg Toscana, Pisa, Italy; [Faustini, Annunziata] Reg Hlth Serv, Dept Epidemiol, Rome, Lazio Region, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Faustini, A (corresponding author), Reg Hlth Serv, Dept Epidemiol, Rome, Lazio Region, Italy.	a.faustini@deplazio.it		Raciti, Mauro/0000-0001-8748-5511				Arne M, 2010, RESP MED, V104, P550, DOI 10.1016/j.rmed.2009.10.023; Atsou K, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-7; Bauleo L, 2014, 38 C IT EP ASS NAPL; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Cooke CR, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-37; Cricelli C, 2003, J PUBLIC HEALTH MED, V25, P254, DOI 10.1093/pubmed/fdg060; Damarla M, 2006, RESP CARE, V51, P1120; Eisner MD, 2010, CHEST, V137, P846, DOI 10.1378/chest.09-1855; Faustini A, 2012, COPD, V9, P184, DOI 10.3109/15412555.2011.654014; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gupta RP, 2014, INT J TUBERC LUNG D, V18, P998, DOI 10.5588/ijtld.13.0910; Han MK, 2007, CHEST, V132, P403, DOI 10.1378/chest.06-2846; Hansell A, 2003, EUR RESPIR J, V21, P279, DOI 10.1183/09031936.03.00006102; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; Hill K, 2010, CAN MED ASSOC J, V182, P673, DOI 10.1503/cmaj.091784; Hoesein FAAM, 2011, RESP MED, V105, P907, DOI 10.1016/j.rmed.2011.01.008; ISRAEL RA, 1986, AM J EPIDEMIOL, V124, P161, DOI 10.1093/oxfordjournals.aje.a114375; Joo MJ, 2008, CHEST, V134, P38, DOI 10.1378/chest.08-0013; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Lacasse Yves, 2005, Can Respir J, V12, P251; Lacasse Y, 2012, CAN RESPIR J, V19, pE5, DOI 10.1155/2012/260374; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Merry AHH, 2009, EUR J EPIDEMIOL, V24, P237, DOI 10.1007/s10654-009-9335-x; Mohammed MA, 2007, BMJ-BRIT MED J, V334, P1014, DOI 10.1136/bmj.39211.453275.80; Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Quint JK, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005540; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; Saydah SH, 2004, ANN EPIDEMIOL, V14, P507, DOI 10.1016/j.annepidem.2003.09.016; Simonato L, 2008, EPIDEMIOL PREV, V32, P5; Soriano JB, 2001, EUR J EPIDEMIOL, V17, P1075, DOI 10.1023/A:1021235123382; STOCKS J, 1995, EUR RESPIR J, V8, P492, DOI 10.1183/09031936.95.08030492; Thomsen RW, 2011, RESP MED, V105, P1063, DOI 10.1016/j.rmed.2011.01.012; Wirehn ABE, 2007, SCAND J PUBLIC HEALT, V35, P424, DOI 10.1080/14034940701195230; Zhao YJ, 2008, AUST NZ J PUBL HEAL, V32, P307, DOI 10.1111/j.1753-6405.2008.00245.x	39	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149302	10.1371/journal.pone.0149302	http://dx.doi.org/10.1371/journal.pone.0149302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901166	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100056
J	Sharma, VK; Kudva, IT; Bearson, BL; Stasko, JA				Sharma, Vijay K.; Kudva, Indira T.; Bearson, Bradley L.; Stasko, Judith A.			Contributions of EspA Filaments and Curli Fimbriae in Cellular Adherence and Biofilm Formation of Enterohemorrhagic Escherichia coli O157:H7	PLOS ONE			English	Article							ENTEROCYTE EFFACEMENT GENES; O157-H7 REQUIRES INTIMIN; III SECRETION SYSTEM; BUNDLE-FORMING PILI; EPITHELIAL-CELLS; TRANSCRIPTIONAL REGULATION; PROTEIN TRANSLOCATION; PATHOGENICITY ISLAND; ABIOTIC SURFACES; TERMINAL RECTUM	In Escherichia coli O157:H7 (O157), the filamentous structure of the type III secretion system is produced from the polymerization of the EspA protein. EspA filaments are essential for O157 adherence to epithelial cells. In previous studies, we demonstrated that O157 hha deletion mutants showed increased adherence to HEp-2 cells and produced abundant biofilms. Transcriptional analysis revealed increased expression of espA as well as the csgA gene, which encodes curli fimbriae that are essential for biofilm formation. In the present study, we constructed hha espA, hha csgA, and hha csgA espA deletion mutants to determine the relative importance of EspA and CsgA in O157 adherence to HEp-2 cells and biofilm formation. In vitro adherence assays, conducted at 37 degrees C in a tissue culture medium containing 0.1% glucose, showed that HEp-2 cell adherence required EspA because hha espA and hha csgA espA mutants adhered to HEp-2 cells at higher levels only when complemented with an espA-expressing plasmid. Biofilm assays performed at 28 degrees C in a medium lacking glucose showed dependency of biofilm formation on CsgA; however EspA was not produced under these conditions. Despite production of detectable levels of EspA at 37 degrees C in media supplemented with 0.1% glucose, the biofilm formation occurred independent of EspA. These results indicate dependency of O157 adherence to epithelial cells on EspA filaments, while CsgA promoted biofilm formation under conditions mimicking those found in the environment (low temperature with nutrient limitations) and in the digestive tract of an host animal (higher temperature and low levels of glucose).	[Sharma, Vijay K.; Kudva, Indira T.] USDA ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, Ames, IA USA; [Bearson, Bradley L.] USDA ARS, Agroecosyst Management Res Unit, Natl Lab Agr & Environm, Ames, IA USA; [Stasko, Judith A.] USDA ARS, Microscopy Serv Lab, Natl Anim Dis Ctr, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Sharma, VK (corresponding author), USDA ARS, Food Safety & Enter Pathogens Res Unit, Natl Anim Dis Ctr, Ames, IA USA.	vijay.sharma@ars.usda.gov						Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106; Bearson BL, 2009, MICROBIOL-SGM, V155, P805, DOI 10.1099/mic.0.022905-0; Beltrametti F, 1999, J BACTERIOL, V181, P3409, DOI 10.1128/JB.181.11.3409-3418.1999; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Bertin Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098367; Bertin Y, 2013, ENVIRON MICROBIOL, V15, P610, DOI 10.1111/1462-2920.12019; Besser TE, 2001, EPIDEMIOL INFECT, V127, P555, DOI 10.1017/S095026880100615X; Brombacher E, 2006, J BACTERIOL, V188, P2027, DOI 10.1128/JB.188.6.2027-2037.2006; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Cookson AL, 2003, INT J MED MICROBIOL, V292, P547, DOI 10.1078/1438-4221-00235; Cookson AL, 2002, INT J MED MICROBIOL, V292, P195, DOI 10.1078/1438-4221-00203; Daniell SJ, 2003, MOL MICROBIOL, V49, P301, DOI 10.1046/j.1365-2958.2003.03555.x; Daniell SJ, 2001, INFECT IMMUN, V69, P4055, DOI 10.1128/IAI.69.6.4055-4064.2001; Dean-Nystrom EA, 1998, INFECT IMMUN, V66, P4560; Delahay RM, 2002, MOL MICROBIOL, V45, P905, DOI 10.1046/j.1365-2958.2002.03083.x; DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999; Ebel F, 1998, MOL MICROBIOL, V30, P147, DOI 10.1046/j.1365-2958.1998.01046.x; Elliott SJ, 1999, INFECT IMMUN, V67, P4260, DOI 10.1128/IAI.67.8.4260-4263.1999; Farfan MJ, 2012, INFECT IMMUN, V80, P903, DOI 10.1128/IAI.05907-11; Fitzhenry RJ, 2002, GUT, V50, P180, DOI 10.1136/gut.50.2.180; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705, DOI 10.7326/0003-4819-109-9-705; Gualdi L, 2007, J BACTERIOL, V189, P8034, DOI 10.1128/JB.00900-07; Hammar M, 1995, MOL MICROBIOL, V18, P661, DOI 10.1111/j.1365-2958.1995.mmi_18040661.x; Hancock DD, 1997, EPIDEMIOL INFECT, V118, P193, DOI 10.1017/S0950268896007212; Hansen AM, 2009, MOL MICROBIOL, V73, P446, DOI 10.1111/j.1365-2958.2009.06781.x; Hu J, 2013, VET MICROBIOL, V164, P344, DOI 10.1016/j.vetmic.2013.02.023; Iyoda S, 2004, MICROBIOL-SGM, V150, P2357, DOI 10.1099/mic.0.27100-0; Iyoda S, 2011, INFECT IMMUN, V79, P4628, DOI 10.1128/IAI.05023-11; Jackson DW, 2002, J BACTERIOL, V184, P3406, DOI 10.1128/JB.184.12.3406-3410.2002; Jarvis KG, 1996, INFECT IMMUN, V64, P4826, DOI 10.1128/IAI.64.11.4826-4829.1996; JARVIS KG, 1995, P NATL ACAD SCI USA, V92, P7996, DOI 10.1073/pnas.92.17.7996; JERSE AE, 1991, INFECT IMMUN, V59, P4302, DOI 10.1128/IAI.59.12.4302-4309.1991; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Kaper JB, 1998, CURR OPIN MICROBIOL, V1, P103, DOI 10.1016/S1369-5274(98)80149-5; KARMALI MA, 1988, PEDIATR NEPHROL, V2, P409, DOI 10.1007/BF00853433; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Kikuchi T, 2005, MICROBIOL IMMUNOL, V49, P875, DOI 10.1111/j.1348-0421.2005.tb03678.x; Larsen P, 2007, ENVIRON MICROBIOL, V9, P3077, DOI 10.1111/j.1462-2920.2007.01418.x; LETOURNEAU J, 2011, JOVE-J VIS EXP   MAY, DOI DOI 10.3791/2783; Li YL, 2000, INFECT IMMUN, V68, P5090, DOI 10.1128/IAI.68.9.5090-5095.2000; Loferer H, 1997, MOL MICROBIOL, V26, P11, DOI 10.1046/j.1365-2958.1997.5231883.x; Macarisin D, 2014, INT J FOOD MICROBIOL, V173, P48, DOI 10.1016/j.ijfoodmicro.2013.12.004; MCKEE ML, 1995, INFECT IMMUN, V63, P3739, DOI 10.1128/IAI.63.9.3739-3744.1995; Melton-Celsa AR, 1998, JPN J MED SCI BIOL, V51, pS108, DOI 10.7883/yoken1952.51.Supplement1_S108; MOON HW, 1983, INFECT IMMUN, V41, P1340, DOI 10.1128/IAI.41.3.1340-1351.1983; Moreira CG, 2006, J BACTERIOL, V188, P3952, DOI 10.1128/JB.00177-06; Naylor SW, 2005, MICROBIOL-SGM, V151, P2773, DOI 10.1099/mic.0.28060-0; Naylor SW, 2003, INFECT IMMUN, V71, P1505, DOI 10.1128/IAI.71.3.1505-1512.2003; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Pawar DM, 2005, J APPL MICROBIOL, V99, P418, DOI 10.1111/j.1365-2672.2005.02499.x; Perna NT, 1998, INFECT IMMUN, V66, P3810, DOI 10.1128/IAI.66.8.3810-3817.1998; Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808; Prigent-Combaret C, 2001, J BACTERIOL, V183, P7213, DOI 10.1128/JB.183.24.7213-7223.2001; Roe AJ, 2003, INFECT IMMUN, V71, P5900, DOI 10.1128/IAI.71.10.5900-5909.2003; Romling U, 1998, J BACTERIOL, V180, P722; Rosser T, 2008, INFECT IMMUN, V76, P5598, DOI 10.1128/IAI.01180-08; Russell RM, 2007, J BACTERIOL, V189, P5387, DOI 10.1128/JB.00553-07; Saldana Z, 2009, ENVIRON MICROBIOL, V11, P992, DOI 10.1111/j.1462-2920.2008.01824.x; Sharma VK, 2012, INFECT IMMUN, V80, P1333, DOI 10.1128/IAI.05869-11; Sharma VK, 2013, APPL ENVIRON MICROB, V79, P2384, DOI 10.1128/AEM.02998-12; Sharma VK, 2005, FEMS MICROBIOL LETT, V243, P189, DOI 10.1016/j.femsle.2004.12.003; Sharma VK, 2004, J BACTERIOL, V186, P7290, DOI 10.1128/JB.186.21.7290-7301.2004; Shaw RK, 2001, CELL MICROBIOL, V3, P213, DOI 10.1046/j.1462-5822.2001.00105.x; Sperandio V, 2001, J BACTERIOL, V183, P5187, DOI 10.1128/JB.183.17.5187-5197.2001; Sperandio V, 1999, P NATL ACAD SCI USA, V96, P15196, DOI 10.1073/pnas.96.26.15196; Torres AG, 2005, APPL ENVIRON MICROB, V71, P8008, DOI 10.1128/AEM.71.12.8008-8015.2005; Uhlich GA, 2006, APPL ENVIRON MICROB, V72, P2564, DOI 10.1128/AEM.72.4.2564-2572.2006; Uhlich GA, 2009, INFECT IMMUN, V77, P1543, DOI 10.1128/IAI.00949-08; Vlisidou I, 2006, INFECT IMMUN, V74, P758, DOI 10.1128/IAI.74.1.758-764.2006; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Wolff C, 1998, MOL MICROBIOL, V28, P143, DOI 10.1046/j.1365-2958.1998.00782.x; YU J, 1992, MOL MICROBIOL, V6, P411, DOI 10.1111/j.1365-2958.1992.tb01484.x; Zhang LH, 2004, INFECT IMMUN, V72, P7282, DOI 10.1128/IAI.72.12.7282-7293.2004	74	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149745	10.1371/journal.pone.0149745	http://dx.doi.org/10.1371/journal.pone.0149745			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900701	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100140
J	Choi, EB; Yang, AY; Kim, SC; Lee, J; Choi, JK; Choi, C; Kim, MY				Choi, E-B; Yang, A-Y; Kim, S. C.; Lee, J.; Choi, J. K.; Choi, C.; Kim, M-Y			PARP1 enhances lung adenocarcinoma metastasis by novel mechanisms independent of DNA repair	ONCOGENE			English	Article							BREAST-CANCER CELLS; HUMAN PROSTATE-CANCER; E-CADHERIN EXPRESSION; GENE-EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE; CHROMATIN-STRUCTURE; ANOIKIS RESISTANCE; TRANSCRIPTION; INHIBITION; INCREASES	The role of poly (ADP-ribose) polymerase 1 (PARP1) in cancer has been extensively studied in the context of DNA repair, leading to clinical trials of PARP1 inhibitors in cancers defective in homologous recombination. However, the DNA repair-independent roles of PARP1 in carcinogenesis and metastasis, particularly in lung cancer metastasis, remain largely uncharacterized. Here, we report that PARP1 promotes lung adenocarcinoma relapse to the brain and bones by regulating several steps of the metastatic process in a DNA repair-independent manner. We find that PARP1 expression is associated with overall and distant metastasis-free survival in lung adenocarcinoma patients. Consistent with this, genetic knockdown and pharmacological inhibition of PARP1 significantly attenuated the metastatic potential of lung adenocarcinoma cells. Further investigation revealed that PARP1 potentiates lung adenocarcinoma metastasis by promoting invasion, anoikis resistance, extravasation and self-renewal of lung adenocarcinoma cells and also by modifying the brain microenvironment. Finally, we identified S100A4 and CLDN7 as novel transcriptional targets and clinically relevant effectors of PARP1. Collectively, our study not only revealed previously unknown functions of PARP1 in lung adenocarcinoma metastasis but also delineated the molecular mechanisms underlying the pro-metastatic function of PARP1. Furthermore, these findings provide a foundation for the potential use of PARP1 inhibitors as a new treatment option for lung adenocarcinoma patients with elevated PARP1 expression.	[Choi, E-B; Yang, A-Y; Kim, M-Y] Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 305701, South Korea; [Kim, S. C.] KCDC, Natl Inst Hlth, Ctr Genome Sci, Dept Biomed Informat, Choongchung Buk Do, South Korea; [Lee, J.; Choi, J. K.; Choi, C.] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Daejeon, South Korea; [Choi, C.; Kim, M-Y] Korea Adv Inst Sci & Technol, Canc Metastasis Control Ctr, Inst BioCentury, Daejeon, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, MY (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Daejeon 305701, South Korea.	miyoungkim@kaist.ac.kr	Kim, Sun Chang/C-2026-2011; Choi, Chulhee/C-1642-2011; Kim, Sun/GSN-4867-2022; Kim, Mi Young/C-1829-2011; Choi, Jung Kyoon/C-2070-2011	Choi, Chulhee/0000-0001-5542-9136; 	Converging Research Center Program [2014048778]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT & Future Planning [2011-0031955]; Basic Science Research Program through the National Research Foundation of Korea [NRF-2011-0020334]	Converging Research Center Program; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Science, ICT & Future Planning; Basic Science Research Program through the National Research Foundation of Korea(National Research Foundation of Korea)	We thank for Drs Joan Massague, Incheol Shin, Michael Davidson and W Lee Kraus for providing NCI-H2030, PC9 and their metastatic derivatives; pBabe-S100A4; mEmerald-Claudin7-C-12 (CLDN7, Addgene plasmid #54041); and PARP1 shRNA constructs and antibody, respectively. We also thank Dr Sun Kyu Kim for help with bioinformatics analysis, Dr David M Helfman for helpful discussion. This research was supported by the Converging Research Center Program (2014048778), the Intelligent Synthetic Biology Center of Global Frontier Project (2011-0031955) funded by the Ministry of Science, ICT & Future Planning, and the Basic Science Research Program through the National Research Foundation of Korea (NRF-2011-0020334).	Akiyama T, 2001, P NATL ACAD SCI USA, V98, P48, DOI 10.1073/pnas.240458597; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Berezovskaya O, 2005, CANCER RES, V65, P2378, DOI 10.1158/0008-5472.CAN-04-2649; Botling J, 2013, CLIN CANCER RES, V19, P194, DOI 10.1158/1078-0432.CCR-12-1139; Brenner JC, 2012, CANCER RES, V72, P1608, DOI 10.1158/0008-5472.CAN-11-3648; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cataldo VD, 2011, NEW ENGL J MED, V364, P947, DOI 10.1056/NEJMct0807960; Chen N, 2014, BIOCHEM BIOPH RES CO, V447, P459, DOI 10.1016/j.bbrc.2014.04.025; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Cheng HY, 2013, CARCINOGENESIS, V34, P739, DOI 10.1093/carcin/bgs393; Cheung WKC, 2013, CANCER CELL, V23, P725, DOI 10.1016/j.ccr.2013.04.009; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; Cohen-Armon M, 2007, MOL CELL, V25, P297, DOI 10.1016/j.molcel.2006.12.012; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Dahiya N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022119; Darido C, 2008, CANCER RES, V68, P4258, DOI 10.1158/0008-5472.CAN-07-5805; Davies MPA, 1996, ONCOGENE, V13, P1631; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Elser M, 2008, MOL CANCER RES, V6, P282, DOI 10.1158/1541-7786.MCR-07-0377; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Hoffman PC, 2000, LANCET, V355, P479, DOI 10.1016/S0140-6736(00)82038-3; Hsieh HL, 2004, BIOCHEM BIOPH RES CO, V316, P949, DOI 10.1016/j.bbrc.2004.02.135; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Rodriguez MI, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003531; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kim JH, 2014, CANCER RES, V74, P1705, DOI 10.1158/0008-5472.CAN-13-1896; Kim MY, 2009, CELL, V139, P1315, DOI 10.1016/j.cell.2009.11.025; Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kim SK, 2014, BIOINFORMATICS, V30, P3284, DOI 10.1093/bioinformatics/btu521; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Lee MH, 2012, ONCOGENE, V31, P5099, DOI 10.1038/onc.2012.2; Lioni M, 2007, AM J PATHOL, V170, P709, DOI 10.2353/ajpath.2007.060343; Lonn P, 2010, MOL CELL, V40, P521, DOI 10.1016/j.molcel.2010.10.029; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Matsubara D, 2005, CANCER SCI, V96, P844, DOI 10.1111/j.1349-7006.2005.00121.x; McPhee TR, 2008, DEV DYNAM, V237, P2737, DOI 10.1002/dvdy.21685; Michels J, 2015, ANN ONCOL, V26, P2470, DOI 10.1093/annonc/mdv393; Michels J, 2013, CANCER RES, V73, P2271, DOI 10.1158/0008-5472.CAN-12-3000; Michels J, 2013, CELL CYCLE, V12, P877, DOI 10.4161/cc.24034; Minami D, 2013, MOL CANCER RES, V11, P140; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Nowsheen S, 2012, CANCER RES, V72, P4796, DOI 10.1158/0008-5472.CAN-12-1287; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; OGATA N, 1981, J BIOL CHEM, V256, P4135; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Piccolo SR, 2013, P NATL ACAD SCI USA, V110, P17778, DOI 10.1073/pnas.1305823110; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez MI, 2011, ONCOGENE, V30, P4365, DOI 10.1038/onc.2011.153; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ryu KW, 2015, CHEM REV, V115, P2453, DOI 10.1021/cr5004248; Saleem M, 2006, P NATL ACAD SCI USA, V103, P14825, DOI 10.1073/pnas.0606747103; Senra JM, 2011, MOL CANCER THER, V10, P1949, DOI 10.1158/1535-7163.MCT-11-0278; Shan L, 2014, ONCOGENE, V33, P3205, DOI 10.1038/onc.2013.270; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shen W, 2011, CANCER SCI, V102, P1014, DOI 10.1111/j.1349-7006.2011.01915.x; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tentori L, 2008, EUR J CANCER, V44, P1302, DOI 10.1016/j.ejca.2008.03.019; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yu WQ, 2004, NAT GENET, V36, P1105, DOI 10.1038/ng1426	79	36	40	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 1	2016	35	35					4569	4579		10.1038/onc.2016.3	http://dx.doi.org/10.1038/onc.2016.3			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU6PE	26898760				2022-12-26	WOS:000382336300003
J	Smith, GA; Howell, GJ; Phillips, C; Muench, SP; Ponnambalam, S; Harrison, MA				Smith, Gina A.; Howell, Gareth J.; Phillips, Clair; Muench, Stephen P.; Ponnambalam, Sreenivasan; Harrison, Michael A.			Extracellular and Luminal pH Regulation by Vacuolar H+-ATPase Isoform Expression and Targeting to the Plasma Membrane and Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; membrane trafficking; receptor internalization; receptor recycling; vacuolar ATPase	BREAST-CANCER CELLS; ACCESSORY SUBUNIT AC45; PROTON-TRANSLOCATING ATPASE; HUMAN PANCREATIC-CANCER; RENAL TUBULAR-ACIDOSIS; IN-VIVO DISSOCIATION; V-ATPASE; A3 ISOFORM; OSTEOCLAST DIFFERENTIATION; NEUROTRANSMITTER RELEASE	Plasma membrane vacuolar H+-ATPase (V-ATPase) activity of tumor cells is a major factor in control of cytoplasmic and extracellular pH and metastatic potential, but the isoforms involved and the factors governing plasma membrane recruitment remain uncertain. Here, we examined expression, distribution, and activity of V-ATPase isoforms in invasive prostate adenocarcinoma (PC-3) cells. Isoforms 1 and 3 were the most highly expressed forms of membrane subunit a, with a(1) and a(3) the dominant plasma membrane isoforms. Correlation between plasma membrane V-ATPase activity and invasiveness was limited, but RNAi knockdown of either a isoform did slow cell proliferation and inhibit invasion in vitro. Isoform a(1) was recruited to the cell surface from the early endosome-recycling complex pathway, its knockdown arresting transferrin receptor recycling. Isoform a(3) was associated with the late endosomal/lysosomal compartment. Both a isoforms associated with accessory protein Ac45, knockdown of which stalled transit of a(1) and transferrin-transferrin receptor, decreased proton efflux, and reduced cell growth and invasiveness; this latter effect was at least partly due to decreased delivery of the membrane-bound matrix metalloproteinase MMP-14 to the plasma membrane. These data indicate that in prostatic carcinoma cells, a(1) and a(3) isoform populations predominate in different compartments where they maintain different luminal pH. Ac45 plays a central role in navigating the V-ATPase to the plasma membrane, and hence it is an important factor in expression of the invasive phenotype.	[Smith, Gina A.; Howell, Gareth J.; Ponnambalam, Sreenivasan] Univ Leeds, Fac Biol Sci, Endothelial Cell Biol Unit, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Phillips, Clair; Muench, Stephen P.; Harrison, Michael A.] Univ Leeds, Fac Biol Sci, Sch Biomed Sci, Leeds LS2 9JT, W Yorkshire, England; [Howell, Gareth J.] Univ Manchester, Manchester Collaborat Ctr Inflammat Res Flow Cyto, Oxford Rd, Manchester M13 9PT, Lancs, England	University of Leeds; University of Leeds; University of Manchester	Harrison, MA (corresponding author), Univ Leeds, Sch Biomed Sci, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	m.a.harrison@leeds.ac.uk	Muench, Stephen/AAI-9529-2020	Muench, Stephen/0000-0001-6869-4414; Harrison, Michael/0000-0002-7826-7472; Ponnambalam, Sreenivasan/0000-0002-4452-7619; Smith, Gina/0000-0003-3601-3025	British Heart Foundation [FS/12/20/29462]; Medical Research Council [G1000567]; Heart Research UK; British Heart Foundation; Leverhulme Trust; MRC [G1000567] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Heart Research UK; British Heart Foundation(British Heart Foundation); Leverhulme Trust(Leverhulme Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Recipient of British Heart Foundation Ph.D. Studentship FS/12/20/29462.; Medical Research Council Career Development Fellow supported by Grant G1000567.; Supported by grants from Heart Research UK, British Heart Foundation, and Leverhulme Trust.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Baravalle G, 2005, CELL TISSUE RES, V320, P99, DOI 10.1007/s00441-004-1060-x; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Breton S, 2013, PHYSIOLOGY, V28, P318, DOI 10.1152/physiol.00007.2013; Chung C, 2010, PANCREAS, V39, P1315; Chung CH, 2011, LAB INVEST, V91, P732, DOI 10.1038/labinvest.2011.8; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; Cotter K, 2015, J BIOL CHEM, V290, P3680, DOI 10.1074/jbc.M114.611210; De Milito A, 2012, CURR PHARM DESIGN, V18, P1395, DOI 10.2174/138161212799504911; Di Giovanni J, 2010, NEURON, V67, P268, DOI 10.1016/j.neuron.2010.06.024; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; GILLIES RJ, 1990, P NATL ACAD SCI USA, V87, P7414, DOI 10.1073/pnas.87.19.7414; Gleize V, 2012, GLIA, V60, P1004, DOI 10.1002/glia.22332; Hernandez A, 2012, CURR PHARM DESIGN, V18, P1383, DOI 10.2174/138161212799504821; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Ishisaki A, 1999, BIOL CELL, V91, P507, DOI 10.1016/S0248-4900(00)88207-6; Jansen EJR, 1998, J CELL SCI, V111, P2999; Jansen EJR, 2012, J BIOL CHEM, V287, P27537, DOI 10.1074/jbc.M112.356105; Jansen EJR, 2008, BBA-MOL CELL RES, V1783, P2301, DOI 10.1016/j.bbamcr.2008.06.020; JOHNSON LS, 1993, MOL BIOL CELL, V4, P1251, DOI 10.1091/mbc.4.12.1251; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kozik P, 2013, NAT CELL BIOL, V15, P50, DOI 10.1038/ncb2652; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Marshansky V, 2007, BIOCHEM SOC T, V35, P1092, DOI 10.1042/BST0351092; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MARTINEZZAGUILAN R, 1993, AM J PHYSIOL, V265, pC1015, DOI 10.1152/ajpcell.1993.265.4.C1015; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Michel V, 2013, INT J CANCER, V132, pE1, DOI 10.1002/ijc.27811; Montcourrier P, 1997, CLIN EXP METASTAS, V15, P382, DOI 10.1023/A:1018446104071; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Niikura K, 2004, BRIT J PHARMACOL, V142, P558, DOI 10.1038/sj.bjp.0705812; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Nishisho T, 2011, MOL CANCER RES, V9, P845, DOI 10.1158/1541-7786.MCR-10-0449; Nyman JKE, 2010, CALCIFIED TISSUE INT, V87, P273, DOI 10.1007/s00223-010-9395-7; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Paunescu TG, 2007, AM J PHYSIOL-RENAL, V293, pF1915, DOI 10.1152/ajprenal.00160.2007; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Presley JF, 1997, J BIOL CHEM, V272, P13929, DOI 10.1074/jbc.272.21.13929; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; ROZHIN J, 1994, CANCER RES, V54, P6517; Sabbota AL, 2010, CANCER RES, V70, P5558, DOI 10.1158/0008-5472.CAN-09-4416; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Sasazawa Y, 2009, CANCER SCI, V100, P1460, DOI 10.1111/j.1349-7006.2009.01194.x; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Saw NMN, 2011, MOL BIOL CELL, V22, P3394, DOI 10.1091/mbc.E11-02-0155; Sennoune SR, 2007, J BIOENERG BIOMEMBR, V39, P427, DOI 10.1007/s10863-007-9108-8; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2010, HISTOL HISTOPATHOL, V25, P1611, DOI 10.14670/HH-25.1611; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Towler MC, 2000, EXP CELL RES, V259, P167, DOI 10.1006/excr.2000.4958; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; VANWEERT AWM, 1995, J CELL BIOL, V130, P821, DOI 10.1083/jcb.130.4.821; Wang D, 2014, J CELL BIOL, V205, P21, DOI 10.1083/jcb.201312109; Wang YR, 2005, J BIOL CHEM, V280, P40481, DOI 10.1074/jbc.M509106200; Xu XY, 2012, J CELL BIOCHEM, V113, P2356, DOI 10.1002/jcb.24106; You HY, 2009, CANCER LETT, V280, P110, DOI 10.1016/j.canlet.2009.02.023	80	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8500	8515		10.1074/jbc.M116.723395	http://dx.doi.org/10.1074/jbc.M116.723395			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26912656	hybrid, Green Published			2022-12-26	WOS:000374773200016
J	Kothur, K; Wienholt, L; Tantsis, EM; Earl, J; Bandodkar, S; Prelog, K; Tea, F; Ramanathan, S; Brilot, F; Dale, RC				Kothur, Kavitha; Wienholt, Louise; Tantsis, Esther M.; Earl, John; Bandodkar, Sushil; Prelog, Kristina; Tea, Fiona; Ramanathan, Sudarshini; Brilot, Fabienne; Dale, Russell C.			B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination	PLOS ONE			English	Article							MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; T-CELLS; CXCL13; CHEMOKINES; INTERLEUKIN-17; INFLAMMATION; MECHANISMS; FOLLICLES	Background Myelin oligodendrocyte glycoprotein antibody (MOG Ab) associated demyelination represents a subgroup of autoimmune demyelination that is separate from multiple sclerosis and aquaporin 4 IgG-positive NMO, and can have a relapsing course. Unlike NMO and MS, there is a paucity of literature on immunopathology and CSF cytokine/chemokines in MOG Ab associated demyelination. Aim To study the differences in immunopathogenesis based on cytokine/chemokine profile in MOG Ab-positive (POS) and -negative (NEG) groups. Methods We measured 34 cytokines/chemokines using multiplex immunoassay in CSF collected from paediatric patients with serum MOG Ab POS [ acute disseminated encephalomyelitis (ADEM = 8), transverse myelitis (TM = 2) n = 10] and serum MOG Ab NEG (ADEM = 5, TM = 4, n = 9) demyelination. We generated normative data using CSF from 20 non-inflammatory neurological controls. Results The CSF cytokine and chemokine levels were higher in both MOG Ab POS and MOG Ab NEG demyelination groups compared to controls. The CSF in MOG Ab POS patients showed predominant elevation of B cell related cytokines/chemokines (CXCL13, APRIL, BAFF and CCL19) as well as some of Th17 related cytokines (IL-6 AND G-CSF) compared to MOG Ab NEG group (all p<0.01). In addition, patients with elevated CSF MOG antibodies had higher CSF CXCL13, CXCL12, CCL19, IL-17A and G-CSF than patients without CSF MOG antibodies. Conclusion Our findings suggest that MOG Ab POS patients have a more pronounced CNS inflammatory response with elevation of predominant humoral associated cytokines/chemokines, as well as some Th 17 and neutrophil related cytokines/chemokines suggesting a differential inflammatory pathogenesis associated with MOG antibody seropositivity. This cytokine/chemokine profiling provides new insight into disease pathogenesis, and improves our ability to monitor inflammation and response to treatment. In addition, some of these molecules may represent potential immunomodulatory targets.	[Kothur, Kavitha; Tantsis, Esther M.; Tea, Fiona; Ramanathan, Sudarshini; Brilot, Fabienne; Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Neuroimmunol Grp, Sydney, NSW 2006, Australia; [Wienholt, Louise] Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia; [Earl, John; Bandodkar, Sushil] Childrens Hosp Westmead, Dept Biochem, Sydney, NSW, Australia; [Prelog, Kristina] Childrens Hosp Westmead, Dept Med Imaging, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Dale, RC (corresponding author), Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Neuroimmunol Grp, Sydney, NSW 2006, Australia.	russell.dale@health.nsw.gov.au	kothur, kavitha/M-3330-2018; Ramanathan, Sudarshini/D-4303-2013; Brilot, Fabienne/AAT-3138-2020	kothur, kavitha/0000-0002-0109-8877; Ramanathan, Sudarshini/0000-0002-0294-9768; Brilot, Fabienne/0000-0002-7025-2276; Tea, Fiona/0000-0002-0451-6296; Wienholt, Louise/0000-0002-5618-4772; Bandodkar, Sushil/0000-0001-5000-4518	Petre Foundation; Australian Postgraduate award; Multiple Sclerosis Research Australia	Petre Foundation; Australian Postgraduate award(Australian Government); Multiple Sclerosis Research Australia	This work was supported by a scholarship from the Petre Foundation, an Australian Postgraduate award, and Multiple Sclerosis Research Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2015, MULTIPLE SCLEROSIS H; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Aloisi F, 2008, J NEUROIMMUNOL, V198, P106, DOI 10.1016/j.jneuroim.2008.04.025; Araki M, 2013, MOD RHEUMATOL, V23, P827, DOI 10.1007/s10165-012-0715-9; Baumann M, 2015, J NEUROL NEUROSUR PS, V86, P265, DOI 10.1136/jnnp-2014-308346; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Brandes M, 2000, INT IMMUNOL, V12, P1285, DOI 10.1093/intimm/12.9.1285; Brilot F, 2009, ANN NEUROL, V66, P833, DOI 10.1002/ana.21916; Carotenuto A, 2001, J MED CHEM, V44, P2378, DOI 10.1021/jm010811t; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Dale RC, 2003, NEUROPEDIATRICS, V34, P141; Dale RC, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000012; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hacohen Y, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000081; Hoftberger R, 2015, MULT SCLER J, V21, P866, DOI 10.1177/1352458514555785; Horellou P, 2015, J NEUROIMMUNOL, V289, P1, DOI 10.1016/j.jneuroim.2015.10.002; Jarius S, 2014, CLIN EXP IMMUNOL, V176, P149, DOI 10.1111/cei.12271; Ketelslegers IA, 2015, MULTIPLE SCLEROSIS H; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kim SH, 2013, JAMA NEUROL, V70, P1110, DOI 10.1001/jamaneurol.2013.3071; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leypoldt F., 2014, JAMA NEUROL; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marta CB, 2003, J NEUROSCI, V23, P5461; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Mitsdoerffer M, 2013, ANN NY ACAD SCI, V1283, P57, DOI 10.1111/nyas.12118; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; Patakas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049715; Peter Delves J, 2011, ROITTS ESSENTIAL IMM; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Pranzatelli MR, 2013, J NEUROL SCI, V326, P53, DOI 10.1016/j.jns.2013.01.011; Probstel AK, 2011, NEUROLOGY, V77, P580, DOI 10.1212/WNL.0b013e318228c0b1; Ramanathan S, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000040; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118; Rostasy K, 2012, ARCH NEUROL-CHICAGO, V69, P752, DOI 10.1001/archneurol.2011.2956; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Uzawa A, 2014, BRAIN PATHOL, V24, P67, DOI 10.1111/bpa.12097; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Zhong XN, 2011, J NEUROIMMUNOL, V240, P104, DOI 10.1016/j.jneuroim.2011.10.001; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	53	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149411	10.1371/journal.pone.0149411	http://dx.doi.org/10.1371/journal.pone.0149411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919719	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400022
J	Lee, HB; Kim, J; Oh, SH; Kim, SH; Kim, HS; Kim, WC; Kim, S; Kim, OJ				Lee, Han-Bin; Kim, Jinkwon; Oh, Seung-Hun; Kim, Sang-Heum; Kim, Hyun-Sook; Kim, Won-Chan; Kim, Soonhag; Kim, Ok-Joon			Red Blood Cell Distribution Width Is Associated with Severity of Leukoaraiosis	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; ISCHEMIC-STROKE; DISEASE; RDW; INFLAMMATION; MARKERS	Red blood cell distribution width (RDW) is one of the routine hematologic parameters reported in the complete blood count test, which has been recognized as strong prognostic marker for various medical conditions, especially cardiovascular disease. We evaluated that RDW was also associated with the leukoaraiosis; common radiological finding of brain and that has been strongly associated with risk of stroke and dementia. In the present study, we included 1006 non-stroke individuals who underwent brain MRI and routine complete blood count test including RDW. Fazekas scale was used to measure the severity of leukoaraiosis based on fluid-attenuated inversion recovery image, and the severity was dichotomized to mild-degree (Fazekas scale: 0-1) and severe-degree leukoaraiosis (Fazekas scale: 2-3). Univariate and multivariate logistic regression models were constructed to evaluate independent risk factor for severe-degree of leukoaraiosis. Mean age of 1006 subjects was 64.34 +/- 9.11 year, and mean of RDW was 12.97 +/- 0.86%. The severe-degree of leukoaraiosis (Fazekas scale >= 2) was found in 28.83%. In the multivariate logistic regression, 4th quartile of RDW(> 13.3%) were significantly associated with the presence of severe-degree of leukoaraiosis (adjusted odds ratio, 1.87; 95% confidence interval, 1.20-2.92) compared to the 1st quartile of RDW (< 12.5%). The significance was not changed after adjustments for hemoglobin and other hematologic indices. These findings suggest that RDW is independently associated with severity of leukoaraiosis.	[Lee, Han-Bin; Kim, Jinkwon; Oh, Seung-Hun; Kim, Hyun-Sook; Kim, Won-Chan; Kim, Ok-Joon] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Kim, Sang-Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Gangneung Si, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Int St Marys Hosp, Inchon, South Korea	Pochon Cha University; Pochon Cha University; Catholic Kwandong University; Catholic Kwandong University	Oh, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea.	ohsh72@chamc.co.kr	KIM, WON CHAN/AAJ-4506-2020		National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A1002067]; National Research Foundation of Korea (NRF) - Ministry of Science and Technology [2011-0021344]; Ministry for Health, Welfare & Family Affairs, Republic of Korea [HC14C3297]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Ministry of Science and Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A1002067), and by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and Technology (2011-0021344), and a grant of the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HC14C3297).	Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; Cavalieri M, 2012, STROKE, V43, P3266, DOI 10.1161/STROKEAHA.112.665703; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Cines DB, 2014, BLOOD, V123, P1596, DOI 10.1182/blood-2013-08-523860; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fornal M, 2014, CLIN HEMORHEOL MICRO, V56, P325, DOI 10.3233/CH-131745; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; Hammarsten O, 2010, EUR J HEART FAIL, V12, P213, DOI 10.1093/eurjhf/hfp208; Henninger N, 2014, STROKE, V45, P689, DOI 10.1161/STROKEAHA.113.002855; Hernandez MDV, 2013, NEUROEPIDEMIOLOGY, V40, P13, DOI 10.1159/000341859; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Park SY, 2013, THROMB RES, V131, pE12, DOI 10.1016/j.thromres.2012.11.011; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; Poludasu S, 2009, THROMB HAEMOSTASIS, V102, P581, DOI 10.1160/TH09-02-0127; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; SIMCHON S, 1987, AM J PHYSIOL, V253, pH898, DOI 10.1152/ajpheart.1987.253.4.H898; Solak Y, 2014, AM J MED SCI, V347, P118, DOI 10.1097/MAJ.0b013e3182996a96; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Umemura T, 2011, J NEUROL NEUROSUR PS, V82, P1186, DOI 10.1136/jnnp.2010.217380; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Zalawadiya SK, 2012, VASC MED, V17, P155, DOI 10.1177/1358863X12442443	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150308	10.1371/journal.pone.0150308	http://dx.doi.org/10.1371/journal.pone.0150308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918441	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400122
J	Mohanta, TK; Mohanta, N; Parida, P; Panda, SK; Ponpandian, LN; Bae, H				Mohanta, Tapan Kumar; Mohanta, Nibedita; Parida, Pratap; Panda, Sujogya Kumar; Ponpandian, Lakshmi Narayanan; Bae, Hanhong			Genome-Wide Identification of Mitogen-Activated Protein Kinase Gene Family across Fungal Lineage Shows Presence of Novel and Diverse Activation Loop Motifs	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; STATISTICAL TESTS; SIGNALING PATHWAY; MAPK CASCADE; PHOSPHORYLATION; PLANTS; GROWTH; YEAST; SENSITIVITY	The mitogen-activated protein kinase (MAPK) is characterized by the presence of the T-E-Y, T-D-Y, and T-G-Y motifs in its activation loop region and plays a significant role in regulating diverse cellular responses in eukaryotic organisms. Availability of large-scale genome data in the fungal kingdom encouraged us to identify and analyse the fungal MAPK gene family consisting of 173 fungal species. The analysis of the MAPK gene family resulted in the discovery of several novel activation loop motifs (T-T-Y, T-I-Y, T-N-Y, T-H-Y, T-S-Y, K-G-Y, T-Q-Y, S-E-Y and S-D-Y) in fungal MAPKs. The phylogenetic analysis suggests that fungal MAPKs are non-polymorphic, had evolved from their common ancestors around 1500 million years ago, and are distantly related to plant MAPKs. We are the first to report the presence of nine novel activation loop motifs in fungal MAPKs. The specificity of the activation loop motif plays a significant role in controlling different growth and stress related pathways in fungi. Hence, the presences of these nine novel activation loop motifs in fungi are of special interest.	[Mohanta, Tapan Kumar] Yeungnam Univ, Free Major Nat Sci, Coll Basic Studies, Gyongsan 712749, Gyeongsangbuk D, South Korea; [Mohanta, Nibedita] North Orissa Univ, Dept Biotechnol, Takatpur 757003, Baripada, India; [Parida, Pratap] Indian Council Med Res, Reg Med Res Ctr, NE Reg, Dibrugarh 786001, Assam, India; [Panda, Sujogya Kumar] North Orissa Univ, Dept Zool, Baripada 757003, Odisha, India; [Ponpandian, Lakshmi Narayanan; Bae, Hanhong] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongsangbuk D, South Korea	Yeungnam University; Indian Council of Medical Research (ICMR); Yeungnam University	Mohanta, TK (corresponding author), Yeungnam Univ, Free Major Nat Sci, Coll Basic Studies, Gyongsan 712749, Gyeongsangbuk D, South Korea.; Bae, H (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongsangbuk D, South Korea.	nostoc.tapan@gmail.com; hanhongbae@ynu.ac.kr	Mohanta, Tapan Kumar/F-9907-2018; PANDA, SUJOGYA KUMAR/AAA-8392-2021; PANDA, SUJOGYA KUMAR/V-7750-2018; Parida, Pratap/J-6727-2015	Mohanta, Tapan Kumar/0000-0002-3196-7746; PANDA, SUJOGYA KUMAR/0000-0003-3123-1218; PANDA, SUJOGYA KUMAR/0000-0003-3123-1218; Parida, Pratap/0000-0002-8193-335X	"Forest Science and Technology" project by Korea forest service [S121414L030110]	"Forest Science and Technology" project by Korea forest service	This study was carried out with the support of the "Forest Science and Technology" project (Project No. S121414L030110) provided by Korea forest service. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cherkasova V, 1999, GENETICS, V151, P989; Ciesla J, 2011, ACTA BIOCHIM POL, V58, P137; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FU YX, 1993, GENETICS, V133, P693; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Humphreys CP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1105; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Kontopoulos DG, 2013, COMPUT METH PROG BIO, V111, P711, DOI 10.1016/j.cmpb.2013.05.021; Kumar K, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28502; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin CH, 2010, FUNGAL GENET BIOL, V47, P381, DOI 10.1016/j.fgb.2009.12.009; Mohanta TK, 2015, J PLANT INTERACT, V10, P21, DOI 10.1080/17429145.2015.1005180; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Mohanta TK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1244-7; Moriwaki A, 2006, FEMS MICROBIOL LETT, V257, P253, DOI 10.1111/j.1574-6968.2006.00178.x; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Roman E, 2013, MAP KINASE, V2, pe5; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMONSEN KL, 1995, GENETICS, V141, P413; Singh P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123620; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor TN, 1996, REV PALAEOBOT PALYNO, V90, P249, DOI 10.1016/0034-6667(95)00086-0; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	59	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149861	10.1371/journal.pone.0149861	http://dx.doi.org/10.1371/journal.pone.0149861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918378	Green Published, gold			2022-12-26	WOS:000371274400050
J	Yu, ZL; Lee, VYW; Kang, AWC; Chan, S; Foo, M; Chan, CM; Griva, K				Yu, Zhen Li; Lee, Vanessa Yin Woan; Kang, Augustine Wee Cheng; Chan, Sally; Foo, Marjorie; Chan, Choong Meng; Griva, Konstadina			Rates of Intentional and Unintentional Nonadherence to Peritoneal Dialysis Regimes and Associated Factors	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-EFFICACY; HEMODIALYSIS-PATIENTS; HOSPITAL ANXIETY; HEALTH-STATUS; DEPRESSION SCALE; ADHERENCE; NONCOMPLIANCE; MEDICINES; BELIEFS	With increasing emphasis on expanding home-based dialysis, there is a need to understand adherence outcomes. This study set out to examine the prevalence and predictors of non-adherence among patients undergoing peritoneal dialysis. A cross sectional sample of 201 peritoneal dialysis patients recruited between 2010-2011 from Singapore General Hospital completed measures of quality of life, medication beliefs, self-efficacy and emotional distress. Nonadherence rates were high; 18% for dialysis, 46% for medication and 78% for diet. Intentional nonadherence was more common for dialysis (p = .03), whereas unintentional nonadherence was more common for medication (p = .002). Multivariate models indicated significant associations for higher education (intermediate vs low OR = 3.18, high vs low OR = 4.70), lower environment quality of life (OR = 0.79), dialysis self-efficacy (OR = 0.80) with dialysis nonadherence; higher education (OR = 2.22), self-care peritoneal dialysis (OR = 3.10), perceived necessity vs concerns over medication (OR = 0.90), self-efficacy (OR = 0.76) with nonadherence to medication. The odds for nonadherence to diet were higher among patients who were younger (OR = 0.96), of Chinese ethnicity (OR = 2.99) and those reporting better physical health (OR = 1.30) and lower self-efficacy (OR = 0.49). Nonadherence is common in peritoneal dialysis. Self-efficacy and beliefs about medication are promising targets for interventions designed to improve adherence.	[Yu, Zhen Li; Lee, Vanessa Yin Woan; Kang, Augustine Wee Cheng; Griva, Konstadina] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Chan, Sally] Natl Univ Singapore Hosp, Alice Lee Ctr Nursing Studies, Singapore, Singapore; [Foo, Marjorie; Chan, Choong Meng] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Griva, Konstadina] City Univ London, Hlth Serv Res Grp, London EC1V 0HB, England	National University of Singapore; National University of Singapore; Singapore General Hospital; City University London	Griva, K (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.; Griva, K (corresponding author), City Univ London, Hlth Serv Res Grp, London EC1V 0HB, England.	psygk@nus.edu.sg	Barretti, Pasqual/K-4156-2012; Chan, Sally Wai Chi/ABB-8520-2020; Griva, Konstadina/A-6549-2018; Barretti, Pasqual/AAK-7934-2021	Barretti, Pasqual/0000-0003-4979-4836; Chan, Sally Wai Chi/0000-0001-5484-4645; Barretti, Pasqual/0000-0003-4979-4836; GRIVA, KONSTADINA/0000-0001-8173-5663; Kang, Augustine/0000-0002-4268-993X	National University of Singapore (NUS-Cross Faculty Research Grant) [CFG11P3]	National University of Singapore (NUS-Cross Faculty Research Grant)	This research was supported by a grant from the National University of Singapore (NUS-Cross Faculty Research Grant - CFG11P3) awarded to Associate Professor KG and Professor SC, which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2011, SOC SCI MED, V73, P129, DOI 10.1016/j.socscimed.2011.05.018; [Anonymous], 2013, US REN DAT SYST USRD; Arramreddy R, 2014, AM J KIDNEY DIS, V63, P390, DOI 10.1053/j.ajkd.2013.09.018; Bandura Albert, 1977, SOCIAL LEARNING THEO; Beddhu S, 2002, AM J MED, V112, P696, DOI 10.1016/S0002-9343(02)01097-5; Bernardini J, 2000, AM J KIDNEY DIS, V35, P1104, DOI 10.1016/S0272-6386(00)70047-3; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Browne T, 2010, AM J KIDNEY DIS, V56, P547, DOI 10.1053/j.ajkd.2010.03.002; Choong HL, 2013, 8 MIN HLTH SING NAT; Chow SKY, 2010, J ADV NURS, V66, P1780, DOI 10.1111/j.1365-2648.2010.05324.x; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Clifford S, 2006, PHARM WORLD SCI, V28, P165, DOI 10.1007/s11096-006-9026-6; DENOUR AK, 1972, PSYCHOSOM MED, V34, P333; Arenas MD, 2010, J NEPHROL, V23, P525; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Fernandes GV, 2010, J SEX MED, V7, P4003, DOI 10.1111/j.1743-6109.2010.01993.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Garcia-Llana H, 2013, PSICOTHEMA, V25, P79, DOI 10.7334/psicothema2012.96; Ghaffari A, 2012, AM J KIDNEY DIS, V59, P400, DOI 10.1053/j.ajkd.2011.08.034; Griva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089001; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hays RD, 1997, KIDNEY DIS QUALITY L; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Jiwakanon S, 2010, CURR OPIN NEPHROL HY, V19, P573, DOI 10.1097/MNH.0b013e32833d67a3; Karamanidou C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-2; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Kutner NG, 2001, SEMIN DIALYSIS, V14, P324, DOI 10.1046/j.1525-139X.2001.00080.x; Lam LW, 2010, J ADV NURS, V66, P763, DOI 10.1111/j.1365-2648.2009.05235.x; Leung C M, 1993, Int J Psychosom, V40, P29; Leventhal H., 2003, SELF REGULATION HLTH, P138; Lindberg M, 2010, J REN CARE, V36, P133, DOI 10.1111/j.1755-6686.2010.00182.x; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mawar S, 2012, INT UROL NEPHROL, V44, P1243, DOI 10.1007/s11255-011-0079-7; McCarthy A, 2009, INT J NURS PRACT, V15, P219, DOI 10.1111/j.1440-172X.2009.01747.x; Mo PKH, 2009, AIDS CARE, V21, P785, DOI 10.1080/09540120802511968; Moe SM, 2005, KIDNEY INT, V67, P760, DOI 10.1111/j.1523-1755.2005.67139.x; NOLPH KD, 1995, PERITON DIALYSIS INT, V15, P22; Plantinga LC, 2004, J AM SOC NEPHROL, V15, P3144, DOI 10.1097/01.ASN.0000146424.91128.2A; Polaschek N, 2007, J CLIN NURS, V16, P51, DOI 10.1111/j.1365-2702.2006.01622.x; Rees G, 2010, OPHTHALMOLOGY, V117, P903, DOI 10.1016/j.ophtha.2009.10.038; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Sayin A, 2007, TRANSPL P, V39, P3047, DOI 10.1016/j.transproceed.2007.09.030; Schuz B, 2011, J PSYCHOSOM RES, V70, P179, DOI 10.1016/j.jpsychores.2010.07.014; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Su CY, 2009, J ADV NURS, V65, P1381, DOI 10.1111/j.1365-2648.2009.04993.x; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; TAAL E, 1993, PATIENT EDUC COUNS, V20, P63, DOI 10.1016/0738-3991(93)90122-D; Tsay SL, 2003, J ADV NURS, V43, P370, DOI 10.1046/j.1365-2648.2003.02725.x; Unni EJ, 2011, PATIENT EDUC COUNS, V83, P265, DOI 10.1016/j.pec.2010.05.006; *USRDS, 1997, AM J KIDNEY DIS S, V30, pS67; Warde A., 2000, EATING OUT SOCIAL DI; Yu ZL, 2012, SINGAP MED J, V53, P474; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zrinyi M, 2003, NEPHROL DIAL TRANSPL, V18, P1869, DOI 10.1093/ndt/gfg307	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149784	10.1371/journal.pone.0149784	http://dx.doi.org/10.1371/journal.pone.0149784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919323	Green Submitted, gold, Green Published			2022-12-26	WOS:000371274400045
J	Kaczmarczyk, L; Labrie-Dion, E; Sehgal, K; Sylvester, M; Skubal, M; Josten, M; Steinhauser, C; De Koninck, P; Theis, M				Kaczmarczyk, Lech; Labrie-Dion, Etienne; Sehgal, Kapil; Sylvester, Marc; Skubal, Magdalena; Josten, Michele; Steinhaeuser, Christian; De Koninck, Paul; Theis, Martin			New Phosphospecific Antibody Reveals Isoform-Specific Phosphorylation of CPEB3 Protein	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; XENOPUS OOCYTE MATURATION; LONG-TERM FACILITATION; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; KINASE-II; CELLULAR SENESCENCE; MEIOTIC PROGRESSION; ELEMENT; EXPRESSION	Cytoplasmic Polyadenylation Element Binding proteins (CPEBs) are a family of polyadenylation factors interacting with 3'UTRs of mRNA and thereby regulating gene expression. Various functions of CPEBs in development, synaptic plasticity, and cellular senescence have been reported. Four CPEB family members of partially overlapping functions have been described to date, each containing a distinct alternatively spliced region. This region is highly conserved between CPEBs-2-4 and contains a putative phosphorylation consensus, overlapping with the exon seven of CPEB3. We previously found CPEBs-2-4 splice isoforms containing exon seven to be predominantly present in neurons, and the isoform expression pattern to be cell type-specific. Here, focusing on the alternatively spliced region of CPEB3, we determined that putative neuronal isoforms of CPEB3 are phosphorylated. Using a new phosphospecific antibody directed to the phosphorylation consensus we found Protein Kinase A and Calcium/Calmodulin-dependent Protein Kinase II to robustly phosphorylate CPEB3 in vitro and in primary hippocampal neurons. Interestingly, status epilepticus induced by systemic kainate injection in mice led to specific upregulation of the CPEB3 isoforms containing exon seven. Extensive analysis of CPEB3 phosphorylation in vitro revealed two other phosphorylation sites. In addition, we found plethora of potential kinases that might be targeting the alternatively spliced kinase consensus site of CPEB3. As this site is highly conserved between the CPEB family members, we suggest the existence of a splicing-based regulatory mechanism of CPEB function, and describe a robust phosphospecific antibody to study it in future.	[Kaczmarczyk, Lech; Skubal, Magdalena; Steinhaeuser, Christian; Theis, Martin] Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Labrie-Dion, Etienne; Sehgal, Kapil; De Koninck, Paul] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Sylvester, Marc] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany; [Josten, Michele] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Kaczmarczyk, Lech] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Bonn; Laval University; Laval University; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kaczmarczyk, L (corresponding author), Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany.	lech@dzne.de	Kaczmarczyk, Lech/AAK-2892-2020	Kaczmarczyk, Lech/0000-0003-2747-3134; Sylvester, Marc/0000-0002-4275-0200	German Research Foundation [SFB/TR3, STE 552/3, N01]; Else-Kroner-Fresenius-Stiftung; Canadian Institute of Health Research; European Community [FP7-202167]	German Research Foundation(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); European Community(European Commission)	This work was supported by grants of the German Research Foundation SFB/TR3, N01, C9 (to MT), SFB/TR3, C1, C9 (to CS); STE 552/3 (to CS); the Else-Kroner-Fresenius-Stiftung (to MT); Canadian Institute of Health Research (to PDK) and of the European Community FP7-202167 (to CS and MT).	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Flynn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041185; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hodgman R, 2001, DEVELOPMENT, V128, P2815; Huang WH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00367; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; JENO P, 1995, ANAL BIOCHEM, V224, P75, DOI 10.1006/abio.1995.1010; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Makhinson M, 1999, J NEUROSCI, V19, P2500; McEvoy M, 2007, J NEUROSCI, V27, P6400, DOI 10.1523/JNEUROSCI.5211-06.2007; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Morgan M, 2010, NUCLEIC ACIDS RES, V38, P7698, DOI 10.1093/nar/gkq635; Nault F, 2010, SPRINGER PROTOC HAND, P137, DOI 10.1007/978-1-60761-292-6_8; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Souaze F, 1996, BIOTECHNIQUES, V21, P280; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Turimella SL, 2015, HIPPOCAMPUS, V25, P630, DOI 10.1002/hipo.22399; Wang XP, 2010, BIOINFORM BIOL INSIG, V4, P61, DOI 10.4137/BBI.S5087; Wang XP, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-109; Whalley K, 2012, NAT REV NEUROSCI, V13, P73, DOI 10.1038/nrn3175; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	61	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150000	10.1371/journal.pone.0150000	http://dx.doi.org/10.1371/journal.pone.0150000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915047	Green Published, gold, Green Submitted			2022-12-26	WOS:000371175700045
J	Lane, J; Verani, A; Hijazi, M; Hurley, E; Hagopian, A; Judice, N; MacInnis, R; Sanford, S; Zelek, S; Katz, A				Lane, Jeffrey; Verani, Andre; Hijazi, Mai; Hurley, Erin; Hagopian, Amy; Judice, Nicole; MacInnis, Ron; Sanford, Sallie; Zelek, Sarah; Katz, Aaron			Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries	PLOS ONE			English	Article							SOUTH-AFRICA; PROGRAMS; HIV/AIDS; IMPACT	Achieving an AIDS-free generation will require the adoption and implementation of critical health policy reforms. However, countries with high HIV burden often have low policy development, advocacy, and monitoring capacity. This lack of capacity may be a significant barrier to achieving the AIDS-free generation goals. This manuscript describes the increased focus on policy development and implementation by the United States President's Emergency Plan for AIDS Relief (PEPFAR). It evaluates the curriculum and learning modalities used for two regional policy capacity building workshops organized around the PEPFAR Partnership Framework agreements and the Road Map for Monitoring and Implementing Policy Reforms. A total of 64 participants representing the U.S. Government, partner country governments, and civil society organizations attended the workshops. On average, participants responded that their policy monitoring skills improved and that they felt they were better prepared to monitor policy reforms three months after the workshop. When followed-up regarding utilization of the Road Map action plan, responses were mixed. Reasons cited for not making progress included an inability to meet or a lack of time, personnel, or governmental support. This lack of progress may point to a need for building policy monitoring systems in high HIV burden countries. Because the success of policy reforms cannot be measured by the mere adoption of written policy documents, monitoring the implementation of policy reforms and evaluating their public health impact is essential. In many high HIV burden countries, policy development and monitoring capacity remains weak. This lack of capacity could hinder efforts to achieve the ambitious AIDS-free generation treatment, care and prevention goals. The Road Map appears to be a useful tool for strengthening these critical capacities.	[Lane, Jeffrey; Hagopian, Amy; Zelek, Sarah; Katz, Aaron] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lane, Jeffrey; Sanford, Sallie] Univ Washington, Sch Law, Seattle, WA 98195 USA; [Lane, Jeffrey] Foster Pepper PLLC, Seattle, WA USA; [Verani, Andre; Hurley, Erin] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Hijazi, Mai] US Agcy Int Dev, Washington, DC 20523 USA; [Judice, Nicole; MacInnis, Ron] Hlth Policy Project, Futures Grp, Washington, DC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID)	Lane, J (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lanej3@u.washington.edu			Centers for Disease Control and Prevention (CDC.) [U48-DP001911]; Health Policy Project - U.S. Agency for International Development; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-10-00067]; United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention; United States Agency for International Development; Foster Pepper, PLLC; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001911] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC.)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Health Policy Project - U.S. Agency for International Development; U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention; United States Agency for International Development(United States Agency for International Development (USAID)); Foster Pepper, PLLC; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research is a product of the University of Washington Health Promotion Research Center and was supported by Cooperative Agreement Number U48-DP001911 from the Centers for Disease Control and Prevention (CDC.) Support for the study was also provided through the Health Policy Project, which is funded by the U.S. Agency for International Development and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) under Agreement No. AID-OAA-A-10-00067, beginning 30th September 2010. This work was supported by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention and the United States Agency for International Development. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or of the U.S. Agency for International Development. Foster Pepper, PLLC, provided support in the form of salary for author Jeffrey Lane, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Jeffrey Lane are articulated in the 'author contributions' section.	[Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], [No title captured]; Attaran A, 2001, WASHINGTON POST; *BILL MEL GAT FDN, 2005, GLOB HLTH PARTN ASS; Brewer G. D., 1983, FDN POLICY ANAL; Brugha R., 2005, GLOBAL FUND TRACKING; Butler A, 2005, AFR AFFAIRS, V104, P591, DOI 10.1093/afraf/adi036; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2046, DOI 10.1001/jama.2008.588; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Holmes CB, 2012, HEALTH AFFAIR, V31, P1553, DOI 10.1377/hlthaff.2012.0562; Kaiser Family Foundation, 2013, US GLOB HLTH POL FAC; KENDALL ALEXANDRA, 2012, US RESPONSE GLOBAL T; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kruk ME, 2012, HEALTH AFFAIR, V31, P1478, DOI 10.1377/hlthaff.2012.0197; Lasswell H. D, 1956, DECISION PROCESS 7 C; Leite G., 2012, MOZAMBIQUE NATL COMM; Nunn A, 2012, GLOB PUBLIC HEALTH, V7, P1031, DOI 10.1080/17441692.2012.736681; Office of the President National AIDS Control Council Kenya (NACC Kenya), 2011, KEN AIDS EP UPD 2011; OGAC, 2012, PEPFAR BLUEPR CREAT; PEPFAR, 2008, POW PARTN PRES EM PL; PEPFAR, 2012, SUPP COUNTR OWN KEY; PEPFAR, 2013, NEXT GEN IND REF GUI; PEPFAR (The U.S. President's Emergency Plan for AIDS Relief), 2009, GUID PEPFAR PARTN FR; Pisani E, 1999, ACTING EARLY PREVENT; Renaud-Thery F, 2010, AIDS RES TREATMENT, V2011, P1; Renaud-Thery F., 2011, ANN 2010 SURVEY ARV; South Africa and U.S.A, 2012, PARTN FRAM IMPL PLAN; UNAIDS, 2012, SEN SUCC STOR AIDS I; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2012, 2012 UNAIDS WORLD AI; UNICEF, 2001, HIV AIDS	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0146720	10.1371/journal.pone.0146720	http://dx.doi.org/10.1371/journal.pone.0146720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914708	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700003
J	Chandler, HC; Rypel, AL; Jiao, Y; Haas, CA; Gorman, TA				Chandler, Houston C.; Rypel, Andrew L.; Jiao, Yan; Haas, Carola A.; Gorman, Thomas A.			Hindcasting Historical Breeding Conditions for an Endangered Salamander in Ephemeral Wetlands of the Southeastern USA: Implications of Climate Change	PLOS ONE			English	Article							FLATWOODS SALAMANDER; AMBYSTOMA-CINGULATUM; COASTAL-PLAIN; AMPHIBIAN DECLINES; FLORIDA POPULATION; HYDROLOGY; HYDROPERIOD; HABITAT; SIZE; ECOSYSTEMS	The hydroperiod of ephemeral wetlands is often the most important characteristic determining amphibian breeding success, especially for species with long development times. In mesic and wet pine flatwoods of the southeastern United States, ephemeral wetlands were a common landscape feature. Reticulated flatwoods salamanders (Ambystoma bishopi), a federally endangered species, depend exclusively on ephemeral wetlands and require at least 11 weeks to successfully metamorphose into terrestrial adults. We empirically modeled hydroperiod of 17 A. bishopi breeding wetlands by combining downscaled historical climate- model data with a recent 9-year record (2006-2014) of observed water levels. Empirical models were subsequently used to reconstruct wetland hydrologic conditions from 1896-2014 using the downscaled historical climate datasets. Reconstructed hydroperiods for the 17 wetlands were highly variable through time but were frequently unfavorable for A. bishopi reproduction (e.g., only 61% of years, using a conservative estimate of development time [12 weeks], were conducive to larval development and metamorphosis). Using change-point analysis, we identified significant shifts in average hydroperiod over the last century in all 17 wetlands. Mean hydroperiods were shorter in recent years than at any other point since 1896, and thus less suitable for A. bishopi reproduction. We suggest that climate change will continue to impact the reproductive success of flatwoods salamanders and other ephemeral wetland breeders by reducing the number of years these wetlands have suitable hydroperiods. Consequently, we emphasize the importance of conservation and management for mitigating other forms of habitat degradation, especially maintenance of high quality breeding sites where reproduction can occur during appropriate environmental conditions.	[Chandler, Houston C.; Rypel, Andrew L.; Jiao, Yan; Haas, Carola A.; Gorman, Thomas A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Chandler, HC (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA.	houstonc@vt.edu	Haas, Carola A./B-5056-2009	Haas, Carola A./0000-0002-5490-6882; Jiao, Yan/0000-0002-8804-5005	Eglin Air Force Base [F14AC00068]; DoD Legacy Resource Management Program [W9132T-11-2-0028]; Hurlburt Field [W9126G-12-2-0004]; Virginia Tech Open Access Subvention Fund	Eglin Air Force Base; DoD Legacy Resource Management Program; Hurlburt Field; Virginia Tech Open Access Subvention Fund	The authors received funding from three sources for this study: 1) Government Award, Issued by U.S. Fish and Wildlife Service (http://www.fws.gov/), through Cooperative Agreement #F14AC00068 to CAH and TAG. Sponsored by Eglin Air Force Base. 2) Government Award, Issued by Army Corps of Engineers (http://www.usace.army.mil/), through Cooperative agreement #W9132T-11-2-0028 to TAG and CAH. Sponsored by DoD Legacy Resource Management Program (https://www.dodlegacy.org/legacy/). 3) Government Award, Issued by Army Corps of Engineers (http://www.usace.army.mil/), through Cooperative agreement #W9126G-12-2-0004 to TAG and CAH. Sponsored by Hurlburt Field. 4) Open access publishing costs were funded by the Virginia Tech Open Access Subvention Fund (http://www.lib.vt.edu/oafund/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J D, 1976, Herpetologica, V32, P214; Ashton Jr R.E., 1992, RARE ENDANGERED BIOT, V3, P39; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bishop DC, 2005, NAT AREA J, V25, P290; Bishop DC, 2005, THESIS VIRGINIA POLY; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; Brooks RT, 2004, WETLANDS, V24, P104, DOI 10.1672/0277-5212(2004)024[0104:WEOWVP]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Chandler HC, 2015, WETLANDS, V35, P1201, DOI 10.1007/s13157-015-0707-6; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; CROWNOVER SH, 1995, SOIL SCI SOC AM J, V59, P1199, DOI 10.2136/sssaj1995.03615995005900040036x; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Dodd CK, 1998, CONSERV BIOL, V12, P331, DOI 10.1046/j.1523-1739.1998.97183.x; Finlayson CM, 1999, WETLANDS INT PUBLICA, V53; Gorman TA, 2014, HERPETOL CONSERV BIO, V9, P543; Gorman TA, 2013, FIRE ECOL, V9, P96, DOI 10.4996/fireecology.0901096; Gorman TA, 2009, WETLANDS, V29, P323, DOI 10.1672/08-155.1; Greenberg CH, 2015, WETLANDS, V35, P899, DOI 10.1007/s13157-015-0680-0; Hill E. Pierson, 2013, Herpetological Review, V44, P112; Ingram K. T., 2013, CLIMATE SE US VARIAB; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Karl T. R., 2009, Global climate change impacts in the United States; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Killick R, 2014, R PACKAGE CHANGEPOIN; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Kirkman LK, 1995, FIRE WETLANDS MANAGE, V19, P10; Leibowitz Scott G., 2007, P31, DOI 10.1201/9781420005394.ch3; LIDE RF, 1995, WETLANDS, V15, P47, DOI 10.1007/BF03160679; Lu JB, 2003, J AM WATER RESOUR AS, V39, P887, DOI 10.1111/j.1752-1688.2003.tb04413.x; Lu JB, 2009, WETLANDS, V29, P826, DOI 10.1672/07-162.1; Mansell RS, 2000, SOIL SCI, V165, P384, DOI 10.1097/00010694-200005000-00002; Martin MD, 2011, AM MIDL NAT, V166, P404, DOI 10.1674/0003-0031-166.2.404; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Means D. Bruce, 1996, P210; Means DB, 1996, CONSERV BIOL, V10, P426, DOI 10.1046/j.1523-1739.1996.10020426.x; Means DB, 2004, CONSERV BIOL, V18, P1149, DOI 10.1111/j.1523-1739.2004.00017.x; Miller RC, 2003, PLANT ECOL, V167, P57, DOI 10.1023/A:1023918619073; Mulholland PJ, 1997, HYDROL PROCESS, V11, P949; Palis JG, 2006, SOUTHEAST NAT, V5, P1, DOI 10.1656/1528-7092(2006)5[1:BBOAFP]2.0.CO;2; Palis JG, 1996, NAT AREA J, V16, P49; Palis JG, 1997, J HERPETOL, V31, P71, DOI 10.2307/1565331; Palis JG, 2005, AMPHIBIAN DECLINES C, P608; Palis JG, 1995, FINAL REPORT; Palis John G., 1995, Florida Scientist, V58, P352; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; Petranka J.W, 1998, SALAMANDERS US CANAD; R Core Team, 2021, R LANGUAGE ENV STAT; Riekerk H, 2000, WETLANDS, V20, P448, DOI 10.1672/0277-5212(2000)020[0448:THOCWI]2.0.CO;2; Rohr JR, 2013, CONSERV BIOL, V27, P741, DOI 10.1111/cobi.12086; Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439; Russell KR, 2002, FOREST ECOL MANAG, V163, P43, DOI 10.1016/S0378-1127(01)00526-6; Rypel AL, 2012, ECOSYSTEMS, V15, P555, DOI 10.1007/s10021-012-9528-0; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; SEMLITSCH RD, 1988, COPEIA, P978; Sim LL, 2013, FRESHW SCI, V32, P327, DOI 10.1899/12-024.1; Skelly DK, 2014, ECOL APPL, V24, P340, DOI 10.1890/13-1042.1; Skelly DK, 1997, AM SCI, V85, P36; Skelly DK, 1996, COPEIA, P599; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Southard LF, 2011, FOREST HIST TODA SPR, P17; Strzepek K, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044012; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sun G, 2002, J HYDROL, V263, P92, DOI 10.1016/S0022-1694(02)00064-1; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Trenham PC, 2000, COPEIA, P365, DOI 10.1643/0045-8511(2000)000[0365:LHADVI]2.0.CO;2; Turner AM, 2009, FRESHWATER BIOL, V54, P1189, DOI 10.1111/j.1365-2427.2009.02168.x; United States Department of the Interior Fish and Wildlife Service, 2009, FED REGISTER, V74, P6700; Walls Susan C., 2013, Biology - Basel, V2, P399, DOI 10.3390/biology2010399; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Westervelt JD, 2013, ECOL MODEL, V268, P18, DOI 10.1016/j.ecolmodel.2013.07.026	75	23	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150169	10.1371/journal.pone.0150169	http://dx.doi.org/10.1371/journal.pone.0150169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910245	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700072
J	Abdellatif', AM; Oishi, H; Itagaki, T; Jung, YS; Shawki, HH; Okita, Y; Hasegawa, Y; Suzuki, H; El-Morsy, SE; El-Sayed, MA; Shoaib, MB; Sugiyama, F; Takahashi, S				Abdellatif', Ahmed M.; Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Okita, Yukari; Hasegawa, Yoshikazu; Suzuki, Hiroyuki; El-Morsy, Salah E.; El-Sayed, Mesbah A.; Shoaib, Mahmoud B.; Sugiyama, Fumihiro; Takahashi, Satoru			beta-Cell-Specific Mafk Overexpression Impairs Pancreatic Endocrine Cell Development	PLOS ONE			English	Article							GENE-EXPRESSION; ALPHA-CELL; INSULIN; TRANSCRIPTION; CONTRIBUTES; NEUROGENIN3; REPRESSION; C57BL/6N; IDENTITY; BINDING	The MAF family transcription factors are homologs of v-Maf, the oncogenic component of the avian retrovirus AS42. They are subdivided into 2 groups, small and large MAF proteins, according to their structure, function, and molecular size. MAFK is a member of the small MAF family and acts as a dominant negative form of large MAFs. In previous research we generated transgenic mice that overexpress MAFK in order to suppress the function of large MAF proteins in pancreatic beta-cells. These mice developed hyperglycemia in adulthood due to impairment of glucose-stimulated insulin secretion. The aim of the current study is to examine the effects of beta-cell-specific Mafk overexpression in endocrine cell development. The developing islets of Mafk-transgenic embryos appeared to be disorganized with an inversion of total numbers of insulin+ and glucagon+ cells due to reduced beta-cell proliferation. Gene expression analysis by quantitative RT-PCR revealed decreased levels of beta-cell-related genes whose expressions are known to be controlled by large MAF proteins. Additionally, these changes were accompanied with a significant increase in key beta-cell transcription factors likely due to compensatory mechanisms that might have been activated in response to the beta-cell loss. Finally, microarray comparison of gene expression profiles between wild-type and transgenic pancreata revealed alteration of some uncharacterized genes including Pcbd1, Fam132a, Cryba2, and Npy, which might play important roles during pancreatic endocrine development. Taken together, these results suggest that Mafk overexpression impairs endocrine development through a regulation of numerous beta-cell-related genes. The microarray analysis provided a unique data set of differentially expressed genes that might contribute to a better understanding of the molecular basis that governs the development and function of endocrine pancreas.	[Abdellatif', Ahmed M.; Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan; [Abdellatif', Ahmed M.; El-Morsy, Salah E.; El-Sayed, Mesbah A.; Shoaib, Mahmoud B.] Mansoura Univ, Dept Anat & Embryol, Fac Vet Med, Mansoura, Egypt; [Oishi, Hisashi; Itagaki, Takahiro; Jung, Yunshin; Shawki, Hossam H.; Hasegawa, Yoshikazu; Sugiyama, Fumihiro; Takahashi, Satoru] Univ Tsukuba, Lab Anim Resource Ctr, Fac Med, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Takahashi, Satoru] Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan; [Okita, Yukari; Suzuki, Hiroyuki] Univ Tsukuba, Dept Expt Pathol, Fac Med, Tsukuba, Ibaraki, Japan; [Takahashi, Satoru] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan	University of Tsukuba; Egyptian Knowledge Bank (EKB); Mansoura University; University of Tsukuba; University of Tsukuba; University of Tsukuba; University of Tsukuba	Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Dept Anat & Embryol, Fac Med, Tsukuba, Ibaraki, Japan.; Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Lab Anim Resource Ctr, Fac Med, Tsukuba, Ibaraki, Japan.; Oishi, H; Takahashi, S (corresponding author), Univ Tsukuba, Life Sci Ctr, TARA, Tsukuba, Ibaraki, Japan.; Takahashi, S (corresponding author), Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan.	hoishi@md.tsukuba.ac.jp; satoruta@md.tsukuba.ac.jp	Abdellatif, Ahmed M./Y-2793-2018	Abdellatif, Ahmed M./0000-0001-9235-2449; Jung, Yunshin/0000-0001-8093-5620; Shawki, Hossam/0000-0002-1962-9701; Shoeib, Mahmoud/0000-0003-4897-4755; El-Sayed, Mesbah/0000-0001-9642-1931	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [26221004]	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (26221004) from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to S.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Akpinar P, 2005, CELL METAB, V2, P385, DOI 10.1016/j.cmet.2005.11.001; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Artner I, 2010, DIABETES, V59, P2530, DOI 10.2337/db10-0190; Benitez C.M., 2012, COLD SPRING HARB PER, V4, DOI DOI 10.1101/CSHPERSPECT.A012401; Cho YR, 2004, BIOCHEM BIOPH RES CO, V314, P773, DOI 10.1016/j.bbrc.2003.12.170; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Crawford LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001611; DEKRIJGER RR, 1992, DEV BIOL, V153, P368, DOI 10.1016/0012-1606(92)90121-V; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Dhawan S, 2011, DEV CELL, V20, P419, DOI 10.1016/j.devcel.2011.03.012; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Eto K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104184; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Fukui K, 2005, CELL METAB, V2, P373, DOI 10.1016/j.cmet.2005.11.003; Gannon M, 2008, DEV BIOL, V314, P406, DOI 10.1016/j.ydbio.2007.10.038; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hang Y, 2011, TRENDS ENDOCRIN MET, V22, P364, DOI 10.1016/j.tem.2011.05.003; Hasegawa Y, 2014, EXP ANIM TOKYO, V63, P183, DOI 10.1538/expanim.63.183; Hasegawa Y, 2013, EXP ANIM TOKYO, V62, P295; HASHIMOTO T, 1988, ANAT EMBRYOL, V178, P489, DOI 10.1007/BF00305036; Hoffman BG, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r99; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Kajihara M, 2003, BIOCHEM BIOPH RES CO, V312, P831, DOI 10.1016/j.bbrc.2003.10.196; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Katsuoka F, 2005, MOL CELL BIOL, V25, P8044, DOI 10.1128/MCB.25.18.8044-8051.2005; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Kotkow KJ, 1996, P NATL ACAD SCI USA, V93, P3514, DOI 10.1073/pnas.93.8.3514; Lecoin L, 2004, GENE EXPR PATTERNS, V4, P35, DOI 10.1016/S1567-133X(03)00152-2; Liu ZT, 2011, EURASIP J ADV SIG PR, DOI 10.1155/2011/490289; Matsuoka T, 2004, P NATL ACAD SCI USA, V101, P2930, DOI 10.1073/pnas.0306233101; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; MyrsenAxcrona U, 1997, REGUL PEPTIDES, V68, P165, DOI 10.1016/S0167-0115(96)02113-1; Nishimura W, 2015, DIABETOLOGIA, V58, P566, DOI 10.1007/s00125-014-3464-9; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; NISHIZAWA M, 1989, P NATL ACAD SCI USA, V86, P7711, DOI 10.1073/pnas.86.20.7711; Nomoto H, 2015, ENDOCRINOLOGY, V156, P3570, DOI 10.1210/en.2014-1906; Obermuller S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008936; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Onodera K, 1999, J BIOL CHEM, V274, P21162, DOI 10.1074/jbc.274.30.21162; Petri A, 2006, J MOL ENDOCRINOL, V37, P301, DOI 10.1677/jme.1.02096; Puk O, 2011, INVEST OPHTH VIS SCI, V52, P2571, DOI 10.1167/iovs.10-6443; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Shavit JA, 1998, GENE DEV, V12, P2164, DOI 10.1101/gad.12.14.2164; Shields BM, 2010, DIABETOLOGIA, V53, P2504, DOI 10.1007/s00125-010-1799-4; Shimohata H, 2006, BIOCHEM BIOPH RES CO, V346, P671, DOI 10.1016/j.bbrc.2006.05.184; Shimohata H, 2009, BIOCHEM BIOPH RES CO, V389, P235, DOI 10.1016/j.bbrc.2009.08.124; Simaite D, 2014, DIABETES, V63, P3557, DOI 10.2337/db13-1784; SLACK JMW, 1995, DEVELOPMENT, V121, P1569; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Whim MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019478; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Yoh K, 2001, GENES CELLS, V6, P1055, DOI 10.1046/j.1365-2443.2001.00489.x; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	59	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150010	10.1371/journal.pone.0150010	http://dx.doi.org/10.1371/journal.pone.0150010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901059	gold, Green Published			2022-12-26	WOS:000371276100198
J	Hatakeyama, S; Koie, T; Narita, T; Hosogoe, S; Yamamoto, H; Tobisawa, Y; Yoneyama, T; Yoneyama, T; Hashimoto, Y; Ohyama, C				Hatakeyama, Shingo; Koie, Takuya; Narita, Takuma; Hosogoe, Shogo; Yamamoto, Hayato; Tobisawa, Yuki; Yoneyama, Tohru; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Ohyama, Chikara			Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							SHORT ILEAL SEGMENT; RADICAL CYSTECTOMY; ORTHOTOPIC NEOBLADDER; CONDUIT; HYDRONEPHROSIS; EXPERIENCE; CONTINENT; GRADE	Objectives To assess the effects of urinary diversion on renal function, we retrospectively investigated renal function over 5 years after urinary diversion using a propensity score matching strategy. Methods Between May 1996 and November 2013, 345 consecutive adult patients underwent radical cystectomy and urinary diversion in our hospital; one hundred and fifteen patients with more than a 5-year follow-up were enrolled. Propensity scores were calculated using logistic analysis, and the data used in the analyses included age, gender, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), clinical tumor stage, presence of cardiovascular disease; hypertension; and type 2 diabetes and preoperative eGFR at the initial visit. Multivariate logistic regression analysis was used to assess the risk factors for stage 3B chronic kidney disease (CKD) after the different types of urinary diversion. Results Continent and incontinent diversion were performed in 68 and 47 patients, respectively. The mean preoperative eGFR was significantly lower in the incontinent than in the continent group (P < 0.001). In propensity score-matched patients (n = 34 each), no significant differences were observed in pre- and postoperative eGFR and 5-year eGFR decrease rates between the groups. In the incontinent group, the number of postoperative stage 3B CKD patients was significantly increased than the continent group. Using multivariate analysis, independent risk factors significantly associated with stage 3B CKD at 5 years after surgery were older age, eGFR before surgery, incontinent diversion (cutaneous ureterostomy), and postoperative hydronephrosis. Conclusions The types of urinary diversion had no significant impact on renal function decline, whereas older age, preexisting impaired renal function, postoperative hydronephrosis, and cutaneous ureterostomy were independent risk factors for stage 3B CKD at 5 years after radical cystectomy.	[Hatakeyama, Shingo; Koie, Takuya; Narita, Takuma; Hosogoe, Shogo; Yamamoto, Hayato; Tobisawa, Yuki; Yoneyama, Takahiro; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan; [Yoneyama, Tohru; Hashimoto, Yasuhiro; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Hatakeyama, S (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan.	shingorilla2@gmail.com	Hatakeyama, Shingo/AAQ-2583-2020; Yoneyama, Tohru/P-7820-2016; Yoneyama, Tohru/ABG-2670-2020; Hatakeyama, Shingo/E-9234-2013; Narita, Takuma/AAV-1693-2021; Tobisawa, Yuki/G-3802-2014	Hatakeyama, Shingo/0000-0002-0026-4079; Yoneyama, Tohru/0000-0002-1098-407X; Narita, Takuma/0000-0003-2572-3590; Tobisawa, Yuki/0000-0001-8026-9541; Hashimoto, Yasuhiro/0000-0003-0967-6835	Japan Society for the Promotion of Science [23791737]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research No. 23791737 from the Japan Society for the Promotion of Science. URL: https://www.jsps.go.jp/english/index.html.	Aleksic P, 2010, INT J UROL, V17, P768, DOI 10.1111/j.1442-2042.2010.02599.x; BRICKER EM, 1950, SURG CLIN N AM, V30, P1511; Canter D, 2011, UROLOGY, V77, P160, DOI 10.1016/j.urology.2010.03.091; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; COLOGNE JB, 1995, EPIDEMIOLOGY, V6, P271, DOI 10.1097/00001648-199505000-00014; Eisenberg MS, 2014, J UROLOGY, V191, P619, DOI 10.1016/j.juro.2013.09.011; Gershman B, 2015, INT J UROL, V22, P651, DOI 10.1111/iju.12770; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Hautmann RE, 2011, J UROLOGY, V185, P2207, DOI 10.1016/j.juro.2011.02.006; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ito Y, 2011, J UROLOGY, V185, P1621, DOI 10.1016/j.juro.2010.12.035; Jin XD, 2012, EUR UROL, V61, P491, DOI 10.1016/j.eururo.2011.09.004; Jonsson O, 2001, EUR UROL, V40, P632, DOI 10.1159/000049849; Koie T, 2012, EJSO-EUR J SURG ONC, V38, P1101, DOI 10.1016/j.ejso.2012.07.115; Koie T, 2006, INT J UROL, V13, P1175, DOI 10.1111/j.1442-2042.2006.01525.x; Koie T, 2013, INT J CLIN ONCOL, V18, P724, DOI 10.1007/s10147-012-0447-z; Koie T, 2010, INT J UROL, V17, P774, DOI [10.1111/j.1442-2042.2010.02600.x, 10.1111/j.1442-2042.2010.02601.x]; Koie T, 2010, UROLOGY, V75, P1499, DOI 10.1016/j.urology.2009.08.083; Kristjansson A, 1999, BJU INT, V84, P905; Lawrentschuk N, 2010, EUR UROL, V57, P983, DOI 10.1016/j.eururo.2010.02.024; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Osawa T, 2013, UROL J, V10, P784; Samuel JD, 2006, J UROLOGY, V176, P2518, DOI 10.1016/j.juro.2006.07.146; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Shimko MS, 2011, J UROLOGY, V185, P562, DOI 10.1016/j.juro.2010.09.096; Sobin L, 2009, TNM CLASSIFICATION M; TOYODA Y, 1977, J UROLOGY, V117, P276, DOI 10.1016/S0022-5347(17)58431-1; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	30	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149544	10.1371/journal.pone.0149544	http://dx.doi.org/10.1371/journal.pone.0149544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901860	gold, Green Published			2022-12-26	WOS:000371276100095
J	Langan, LM; Dodd, NJF; Owen, SF; Purcell, WM; Jackson, SK; Jha, AN				Langan, Laura M.; Dodd, Nicholas J. F.; Owen, Stewart F.; Purcell, Wendy M.; Jackson, Simon K.; Jha, Awadhesh N.			Direct Measurements of Oxygen Gradients in Spheroid Culture System Using Electron Parametric Resonance Oximetry	PLOS ONE			English	Article							MULTICELLULAR TUMOR SPHEROIDS; PARAMAGNETIC-RESONANCE; LITHIUM PHTHALOCYANINE; CELL-CULTURE; FISH CELLS; IN-VITRO; BIOCHEMICAL REACTIONS; CANCER-CELLS; CONSUMPTION; EPR	Advanced in vitro culture from tissues of different origin includes three-dimensional (3D) organoid micro structures that may mimic conditions in vivo. One example of simple 3D culture is spheroids; ball shaped structures typically used as liver and tumour models. Oxygen is critically important in physiological processes, but is difficult to quantify in 3D culture: and the question arises, how small does a spheroid have to be to have minimal micro-environment formation? This question is of particular importance in the growing field of 3D based models for toxicological assessment. Here, we describe a simple non-invasive approach modified for the quantitative measurement and subsequent evaluation of oxygen gradients in spheroids developed from a non-malignant fish cell line (i.e. RTG-2 cells) using Electron Paramagnetic Resonance (EPR) oximetry. Sonication of the paramagnetic probe Lithium phthalocyanine (LiPc) allows for incorporation of probe particulates into spheroid during its formation. Spectra signal strength after incorporation of probe into spheroid indicated that a volume of 20 mu l of probe (stock solution: 0.10 mg/mL) is sufficient to provide a strong spectra across a range of spheroid sizes. The addition of non-toxic probes (that do not produce or consume oxygen) report on oxygen diffusion throughout the spheroid as a function of size. We provide evidence supporting the use of this model over a range of initial cell seeding densities and spheroid sizes with the production of oxygen distribution as a function of these parameters. In our spheroid model, lower cell seeding densities (similar to 2,500 cells/spheroid) and absolute size (118 +/- 32 mu m) allow control of factors such as pre-existing stresses (e.g. similar to 2% normoxic/hypoxic interface) for more accurate measurement of treatment response. The applied methodology provides an elegant, widely applicable approach to directly characterize spheroid (and other organoid) cultures in biomedical and toxicological research.	[Langan, Laura M.; Dodd, Nicholas J. F.; Purcell, Wendy M.; Jha, Awadhesh N.] Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England; [Jackson, Simon K.] Univ Plymouth, Sch Biomed & Healthcare Sci, Plymouth PL4 8AA, Devon, England; [Owen, Stewart F.] AstraZeneca, Alderley Pk, Macclesfield SK10 4TF, Cheshire, England	University of Plymouth; University of Plymouth; AstraZeneca	Jha, AN (corresponding author), Univ Plymouth, Sch Biol Sci, Plymouth PL4 8AA, Devon, England.	A.Jha@plymouth.ac.uk	PURCELL, WENDY M/O-4082-2018; Owen, Stewart/ABF-1216-2021	PURCELL, WENDY M/0000-0002-9820-1526; Owen, Stewart/0000-0003-1398-7142; Jha, Awadhesh/0000-0001-9660-4308	Plymouth University, UK; AstraZeneca Global Environment Research programme; AstraZeneca; EU-INTERREG IVA [4059]; Biotechnology and Biological Sciences Research Council [BB/L01016X/1] Funding Source: researchfish; BBSRC [BB/L01016X/1] Funding Source: UKRI	Plymouth University, UK; AstraZeneca Global Environment Research programme; AstraZeneca(AstraZeneca); EU-INTERREG IVA; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by Plymouth University, UK as a PhD Studentship to LML. Part of the funding to support salary and consumable costs of this PhD studentship came from AstraZeneca Global Environment Research programme. AstraZeneca supported LML's studentship but did not play any additional role in the study design, data collection and analysis, decision to publish, or preparation of manuscript. NJFD's contribution to this work was supported by EU-INTERREG IVA (Grant No. 4059) awarded to ANJ. The specific roles of these authors are articulated in the "Authors Contributions" section.	Abu-Absi SF, 2004, CYTOTECHNOLOGY, V45, P125, DOI 10.1007/s10616-004-7996-6; Ahmad R, 2010, CHEM REV, V110, P3212, DOI 10.1021/cr900396q; BACKER JM, 1977, BIOCHIM BIOPHYS ACTA, V460, P152, DOI 10.1016/0005-2728(77)90161-X; Baron MG, 2012, ECOTOXICOLOGY, V21, P2419, DOI 10.1007/s10646-012-0965-5; Bobko AA, 2009, FREE RADICAL BIO MED, V47, P654, DOI 10.1016/j.freeradbiomed.2009.06.007; Breslin S, 2013, DRUG DISCOV TODAY, V18, P240, DOI 10.1016/j.drudis.2012.10.003; Carmel Mothersill, 2003, IN VITRO METHODS AQU; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Diepart C, 2010, ANAL BIOCHEM, V396, P250, DOI 10.1016/j.ab.2009.09.029; DOBRUCKI JW, 1991, MAGNET RESON MED, V19, P42, DOI 10.1002/mrm.1910190105; Fennema E, 2013, TRENDS BIOTECHNOL, V31, P108, DOI 10.1016/j.tibtech.2012.12.003; Friedrich J, 2007, J BIOMOL SCREEN, V12, P925, DOI 10.1177/1087057107306839; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Grimes DR, 2014, OXYGEN CONSUMPTION D; Hashem M, 2015, J MAGN RESON, V256, P77, DOI 10.1016/j.jmr.2015.04.012; Haycock JW, 2011, METHODS MOL BIOL, V695, P1, DOI 10.1007/978-1-60761-984-0_1; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Ho WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044640; Hyodo F, 2010, METHODS MOL BIOL, V610, P29, DOI 10.1007/978-1-60327-029-8_2; IKEYA M, 1989, ANAL SCI, V5, P5, DOI 10.2116/analsci.5.5; Ilangovan G, 2001, J PHYS CHEM B, V105, P5323, DOI 10.1021/jp010130+; JAMES PE, 1995, FREE RADICAL BIO MED, V18, P641, DOI 10.1016/0891-5849(94)00179-N; Khramtsov VV, 2012, IN VIVO SPECTROSCOPY; KOCAN RM, 1982, ENVIRON MUTAGEN, V4, P181, DOI 10.1002/em.2860040208; Krohn KA, 2008, J NUCL MED S2, V49, p129S, DOI DOI 10.2967/JNUMED.107.045914; Lin Ruei-Zhen, 2008, Biotechnology Journal, V3, P1172, DOI 10.1002/biot.200700228; Liu J, 2007, J CELL BIOCHEM, V102, P1180, DOI 10.1002/jcb.21345; LIU KJ, 1993, P NATL ACAD SCI USA, V90, P5438, DOI 10.1073/pnas.90.12.5438; Ma HL, 2012, MOL IMAGING, V11, P487, DOI 10.2310/7290.2012.00012; Ma MW, 2003, J CELL BIOCHEM, V90, P1166, DOI 10.1002/jcb.10730; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Miniaev MV, 2013, J ANAL METHODS CHEM, V2013, DOI 10.1155/2013/249752; MUELLERKLIESER W, 1984, BIOPHYS J, V46, P343, DOI 10.1016/S0006-3495(84)84030-8; MUELLERKLIESER WF, 1982, BRIT J CANCER, V45, P256, DOI 10.1038/bjc.1982.41; Naciri M, 2008, CYTOTECHNOLOGY, V57, P245, DOI 10.1007/s10616-008-9160-1; Nagelkerke A, 2013, ANAL BIOCHEM, V437, P17, DOI 10.1016/j.ab.2013.02.004; NICHOLS MG, 1994, PHYS MED BIOL, V39, P2161, DOI 10.1088/0031-9155/39/12/003; Pandian RP, 2003, FREE RADICAL BIO MED, V35, P1138, DOI 10.1016/S0891-5849(03)00496-9; Papis E, 2011, ECOTOXICOLOGY, V20, P208, DOI 10.1007/s10646-010-0572-2; Perkel JM, 2007, SCIENCE; Presley T, 2006, BIOPHYS J, V91, P4623, DOI 10.1529/biophysj.106.090175; Raisuddin S, 2004, ENVIRON MOL MUTAGEN, V44, P83, DOI 10.1002/em.20027; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Sceats E, 2010, INNOVAT PHARM TECHNO, P28; Schulz M, 1995, ALTEX, V12, P95; SMITH RW, 1995, J COMP PHYSIOL B, V165, P93, DOI 10.1007/BF00301473; Subczynski WK, 2005, MET MED PHYSL, P229, DOI [10.1007/0-387-26741-7_10, DOI 10.1007/0-387-26741-7_10]; SUTHERLAND R, 1981, CANCER RES, V41, P2980; Tung YC, 2011, ANALYST, V136, P473, DOI 10.1039/c0an00609b; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallace DI, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00051; Wartenberg M, 2001, FASEB J, V15, P995, DOI 10.1096/fj.00-0350com; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065	55	48	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149492	10.1371/journal.pone.0149492	http://dx.doi.org/10.1371/journal.pone.0149492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900704	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100085
J	McMahon, CM; Ibrahim, RK; Mathur, A				McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit			Cortical Reorganisation during a 30-Week Tinnitus Treatment Program	PLOS ONE			English	Article							ENRICHED ACOUSTIC ENVIRONMENT; AUDITORY-CORTEX; HEARING-LOSS; PSYCHOMETRIC PROPERTIES; FREQUENCY ORGANIZATION; NEURAL ACTIVITY; PLASTICITY; SYSTEM; GAIN; HYPERACTIVITY	Subjective tinnitus is characterised by the conscious perception of a phantom sound. Previous studies have shown that individuals with chronic tinnitus have disrupted sound-evoked cortical tonotopic maps, time-shifted evoked auditory responses, and altered oscillatory cortical activity. The main objectives of this study were to: (i) compare sound-evoked brain responses and cortical tonotopic maps in individuals with bilateral tinnitus and those without tinnitus; and (ii) investigate whether changes in these sound-evoked responses occur with amelioration of the tinnitus percept during a 30-week tinnitus treatment program. Magneto-encephalography (MEG) recordings of 12 bilateral tinnitus participants and 10 control normal-hearing subjects reporting no tinnitus were recorded at baseline, using 500 Hz, 1000 Hz, 2000 Hz, and 4000 Hz tones presented monaurally at 70 dBSPL through insert tube phones. For the tinnitus participants, MEG recordings were obtained at 5-, 10-, 20- and 30-week time points during tinnitus treatment. Results for the 500 Hz and 1000 Hz sources (where hearing thresholds were within normal limits for all participants) showed that the tinnitus participants had a significantly larger and more anteriorly located source strengths when compared to the non-tinnitus participants. During the 30-week tinnitus treatment, the participants' 500 Hz and 1000 Hz source strengths remained higher than the non-tinnitus participants; however, the source locations shifted towards the direction recorded from the non-tinnitus control group. Further, in the left hemisphere, there was a time-shifted association between the trajectory of change of the individual's objective (source strength and anterior-posterior source location) and subjective measures (using tinnitus reaction questionnaire, TRQ). The differences in source strength between the two groups suggest that individuals with tinnitus have enhanced central gain which is not significantly influenced by the tinnitus treatment, and may result from the hearing loss per se. On the other hand, the shifts in the tonotopic map towards the non-tinnitus participants' source location suggests that the tinnitus treatment might reduce the disruptions in the map, presumably produced by the tinnitus percept directly or indirectly. Further, the similarity in the trajectory of change across the objective and subjective parameters after time-shifting the perceptual changes by 5 weeks suggests that during or following treatment, perceptual changes in the tinnitus percept may precede neurophysiological changes. Subgroup analyses conducted by magnitude of hearing loss suggest that there were no differences in the 500 Hz and 1000 Hz source strength amplitudes for the mild-moderate compared with the mild-severe hearing loss subgroup, although the mean source strength was consistently higher for the mild-severe subgroup. Further, the mild-severe subgroup had 500 Hz and 1000 Hz source locations located more anteriorly (i.e., more disrupted compared to the control group) compared to the mild-moderate group, although this was trending towards significance only for the 500Hz left hemisphere source. While the small numbers of participants within the subgroup analyses reduce the statistical power, this study suggests that those with greater magnitudes of hearing loss show greater cortical disruptions with tinnitus and that tinnitus treatment appears to reduce the tonotopic map disruptions but not the source strength (or central gain).	[McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit] Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia; [McMahon, Catherine M.; Ibrahim, Ronny K.; Mathur, Ankit] HEARing Cooperat Res Ctr, Carlton, Vic, Australia	Macquarie University	McMahon, CM (corresponding author), Macquarie Univ, Fac Human Sci, Dept Linguist, Sydney, NSW 2109, Australia.; McMahon, CM (corresponding author), HEARing Cooperat Res Ctr, Carlton, Vic, Australia.	cath.mcmahon@mq.edu.au		McMahon, Catherine/0000-0001-7312-6593; Ibrahim, Ronny Kurniawan/0000-0003-1023-6351	HEARing CRC; Cooperative Research Centres Programme-Business Australia	HEARing CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Cooperative Research Centres Programme-Business Australia(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the HEARing CRC, established and supported under the Cooperative Research Centres Programme - Business Australia (http://www.hearingcrc.org) (CM RI AM), as well as the clinical and technical support from Neuromonics Pty Ltd, specifically from Professor Paul Davis and Kris Robinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge the tinnitus participants for their commitment to this longitudinal study, Christopher Sewell and John Newall in assisting with the study design, the recruitment of participants and collection of data, and Associate Professor Blake Johnson, ARC Centre of Excellence in Cognition and its Disorders for guidance in the data analysis. The authors acknowledge the funding from the Cooperative Research Centres Programme-Business Australia, as well as the clinical and technical support from Neuromonics Pty Ltd, specifically from Professor Paul Davis and Kris Robinson.	Ali R, 2002, ADDICTION, V97, P1183; Auerbach BD, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00206; Baguley DM, 2002, BRIT MED BULL, V63, P195, DOI 10.1093/bmb/63.1.195; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Davis A., 2000, TINNITUS HDB, P1; Davis PB, 2008, ENT-EAR NOSE THROAT, V87, P330, DOI 10.1177/014556130808700611; Davis PB, 2007, EAR HEARING, V28, P242, DOI 10.1097/AUD.0b013e3180312619; Dietrich V, 2001, HEARING RES, V158, P95, DOI 10.1016/S0378-5955(01)00282-9; Eggermont JJ, 2006, ACTA OTO-LARYNGOL, V126, P9, DOI 10.1080/03655230600895259; Eggermont JJ, 2007, HEARING RES, V229, P69, DOI 10.1016/j.heares.2007.01.008; Flor H, 1997, NEUROSCI LETT, V224, P5, DOI 10.1016/S0304-3940(97)13441-3; Hays RD, 2005, SLEEP MED, V6, P41, DOI 10.1016/j.sleep.2004.07.006; HELLER MF, 1953, ANN OTO RHINOL LARYN, V62, P73, DOI 10.1177/000348945306200107; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Ille N, 2002, J CLIN NEUROPHYSIOL, V19, P113, DOI 10.1097/00004691-200203000-00002; JASTREBOFF PJ, 1994, HEARING RES, V80, P216, DOI 10.1016/0378-5955(94)90113-9; Kaltenbach JA, 2004, NEUROSCI LETT, V355, P121, DOI 10.1016/j.neulet.2003.10.038; Kaltenbach JA, 2002, J NEUROPHYSIOL, V88, P699, DOI 10.1152/jn.2002.88.2.699; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kopp B, 1999, NEUROREPORT, V10, P807, DOI 10.1097/00001756-199903170-00026; KRAUS N, 1995, J COGNITIVE NEUROSCI, V7, P25, DOI 10.1162/jocn.1995.7.1.25; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Langguth B, 2006, ACTA OTO-LARYNGOL, V126, P84, DOI 10.1080/03655230600895317; Leaver AM, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00021; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; Liepert J, 2000, MUSCLE NERVE, V23, P1761, DOI 10.1002/1097-4598(200011)23:11<1761::AID-MUS14>3.0.CO;2-M; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Menning H, 2000, NEUROREPORT, V11, P817, DOI 10.1097/00001756-200003200-00032; Moller AR, 2007, PROG BRAIN RES, V166, P3, DOI 10.1016/S0079-6123(07)66001-4; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Nenonen J, 2010, 17 INT C BIOM ADV BI; Nondahl DM, 2007, J AM ACAD AUDIOL, V18, P257, DOI 10.3766/jaaa.18.3.7; Norena AJ, 2005, J NEUROSCI, V25, P699, DOI 10.1523/JNEUROSCI.2226-04.2005; Norena AJ, 2007, NEUROREPORT, V18, P1251, DOI 10.1097/WNR.0b013e3282202c35; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Pienkowski M, 2012, EAR HEARING, V33, P305, DOI 10.1097/AUD.0b013e318241e880; Platz T, 2005, J NEUROL, V252, P1363, DOI 10.1007/s00415-005-0868-y; ROBERTSON D, 1989, J COMP NEUROL, V282, P456, DOI 10.1002/cne.902820311; Robertson IH, 1999, PSYCHOL BULL, V125, P544, DOI 10.1037/0033-2909.125.5.544; RODIECK RW, 1962, BIOPHYS J, V2, P351, DOI 10.1016/S0006-3495(62)86860-X; Rossini PM, 2003, LANCET NEUROL, V2, P493, DOI 10.1016/S1474-4422(03)00485-X; Rossini PM, 1998, NEUROREPORT, V9, P2141, DOI 10.1097/00001756-199806220-00043; Rossiter S, 2006, J SPEECH LANG HEAR R, V49, P150, DOI 10.1044/1092-4388(2006/012); Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; Sarkar S, 2001, AM J PHYSIOL-GASTR L, V281, pG1196, DOI 10.1152/ajpgi.2001.281.5.G1196; Schaette R, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00034; Schaette R, 2011, J NEUROSCI, V31, P13452, DOI 10.1523/JNEUROSCI.2156-11.2011; Shiomi Y, 1997, HEARING RES, V108, P83, DOI 10.1016/S0378-5955(97)00043-9; Sindhusake D, 2003, EAR HEARING, V24, P501, DOI 10.1097/01.AUD.0000100204.08771.3D; Spielberger C. D., 1983, MIND GARDEN; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Tavora-Vieira D, 2011, INT J AUDIOL, V50, P881, DOI 10.3109/14992027.2011.606286; Traversa R, 1997, STROKE, V28, P110, DOI 10.1161/01.STR.28.1.110; Tremblay K, 2001, EAR HEARING, V22, P79, DOI 10.1097/00003446-200104000-00001; Tremblay K, 1998, NEUROREPORT, V9, P3557, DOI 10.1097/00001756-199811160-00003; Tremblay K, 1997, J ACOUST SOC AM, V102, P3762, DOI 10.1121/1.420139; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Wang JA, 2002, HEARING RES, V168, P238, DOI 10.1016/S0378-5955(02)00360-X; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Weisz N, 2005, BRAIN, V128, P2722, DOI 10.1093/brain/awh588; Wienbruch C, 2006, NEUROIMAGE, V33, P180, DOI 10.1016/j.neuroimage.2006.06.023; WILSON PH, 1991, J SPEECH HEAR RES, V34, P197, DOI 10.1044/jshr.3401.197; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zeng FG, 2013, HEARING RES, V295, P172, DOI 10.1016/j.heares.2012.05.009	69	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148828	10.1371/journal.pone.0148828	http://dx.doi.org/10.1371/journal.pone.0148828			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901425	Green Published, gold			2022-12-26	WOS:000371276100025
J	Golnik, R; Lehmann, A; Kloetzel, PM; Ebstein, F				Golnik, Richard; Lehmann, Andrea; Kloetzel, Peter-Michael; Ebstein, Frederic			Major Histocompatibility Complex (MHC) Class I Processing of the NY-ESO-1 Antigen Is Regulated by Rpn10 and Rpn13 Proteins and Immunoproteasomes following Non-lysine Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antigen processing; proteasome; protein degradation; tumor immunology; ubiquitin	26S PROTEASOME; MEDIATED PROTEOLYSIS; STANDARD PROTEASOME; DRIP HYPOTHESIS; DENDRITIC CELLS; DEGRADATION; SITE; UBIQUITYLATION; RECOGNITION; MECHANISMS	The supply of MHC class I-restricted peptides is primarily ensured by the degradation of intracellular proteins via the ubiquitin-proteasome system. Depending on the target and the enzymes involved, ubiquitination is a process that may dramatically vary in terms of linkages, length, and attachment sites. Here we identified the unique lysine residue at position 124 of the NY-ESO-1 cancer/testis antigen as the acceptor site for the formation of canonical Lys-48-linkages. Interestingly, a lysine-less form of NY-ESO-1 was as efficient as its wild-type counterpart in supplying the HLA-A*0201-restricted NY-ESO-1(157-165) antigenic peptide. In fact, we show that the regulation of NY-ESO-1 processing by the ubiquitin receptors Rpn10 and Rpn13 as a well as by the standard and immunoproteasome is governed by non-canonical ubiquitination on non-lysine sites. In summary, our data underscore the significance of atypical ubiquitination in the modulation of MHC class I antigen processing.	[Golnik, Richard; Lehmann, Andrea; Kloetzel, Peter-Michael; Ebstein, Frederic] Charite, Inst Biochem, Charite Pl 1-Virchowweg 6, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ebstein, F (corresponding author), Charite, Inst Biochem, Charite Pl 1-Virchowweg 6, D-10117 Berlin, Germany.	frederic.ebstein@charite.de			Berlin Institute of Health (CRG Project); Einstein Foundation Berlin	Berlin Institute of Health (CRG Project); Einstein Foundation Berlin	This work was supported by grants from the Berlin Institute of Health (CRG Project) (to P. M. K.) and from the Einstein Foundation Berlin (to P. M. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Batchu RB, 2005, CANCER RES, V65, P10041, DOI 10.1158/0008-5472.CAN-05-1383; Bedford L, 2011, NEUROSCI LETT, V491, P44, DOI 10.1016/j.neulet.2010.12.064; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Chen JL, 2000, J IMMUNOL, V165, P948, DOI 10.4049/jimmunol.165.2.948; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Dammer EB, 2011, J BIOL CHEM, V286, P10457, DOI 10.1074/jbc.M110.149633; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; DEVERAUX Q, 1995, J BIOL CHEM, V270, P29660; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2443, DOI 10.1007/s00018-012-0933-5; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Livnat-Levanon N, 2014, CELL REP, V7, P1371, DOI 10.1016/j.celrep.2014.04.030; McDowell GS, 2010, BIOCHEM BIOPH RES CO, V400, P655, DOI 10.1016/j.bbrc.2010.08.122; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Myung J, 2001, MOL CELL, V7, P411, DOI 10.1016/S1097-2765(01)00188-5; Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; vanNocker S, 1996, P NATL ACAD SCI USA, V93, P856, DOI 10.1073/pnas.93.2.856; Vosper JMD, 2009, J BIOL CHEM, V284, P15458, DOI 10.1074/jbc.M809366200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008	32	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 15	2016	291	16					8805	8815		10.1074/jbc.M115.705178	http://dx.doi.org/10.1074/jbc.M115.705178			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DK2VT	26903513	Green Published, hybrid			2022-12-26	WOS:000374773200041
J	Dore, S; Fry, DL; Collins, BM; Vargas, R; York, RA; Stephens, SL				Dore, Sabina; Fry, Danny L.; Collins, Brandon M.; Vargas, Rodrigo; York, Robert A.; Stephens, Scott L.			Management Impacts on Carbon Dynamics in a Sierra Nevada Mixed Conifer Forest	PLOS ONE			English	Article							PONDEROSA PINE PLANTATION; SOIL CO2 EFFLUX; FUEL REDUCTION TREATMENTS; PRESCRIBED FIRE; THINNING TREATMENT; TREE MORTALITY; NATIONAL FIRE; DRY FORESTS; CLEAR-CUT; RESPIRATION	Forest ecosystems can act as sinks of carbon and thus mitigate anthropogenic carbon emissions. When forests are actively managed, treatments can alter forests carbon dynamics, reducing their sink strength and switching them from sinks to sources of carbon. These effects are generally characterized by fast temporal dynamics. Hence this study monitored for over a decade the impacts of management practices commonly used to reduce fire hazards on the carbon dynamics of mixed-conifer forests in the Sierra Nevada, California, USA. Soil CO2 efflux, carbon pools (i.e. soil carbon, litter, fine roots, tree biomass), and radial tree growth were compared among un-manipulated controls, prescribed fire, thinning, thinning followed by fire, and two clear-cut harvested sites. Soil CO2 efflux was reduced by both fire and harvesting (ca. 15%). Soil carbon content (upper 15 cm) was not significantly changed by harvest or fire treatments. Fine root biomass was reduced by clear-cut harvest (60-70%) but not by fire, and the litter layer was reduced 80% by clear-cut harvest and 40% by fire. Thinning effects on tree growth and biomass were concentrated in the first year after treatments, whereas fire effects persisted over the seven-year post-treatment period. Over this period, tree radial growth was increased (25%) by thinning and reduced (12%) by fire. After seven years, tree biomass returned to pre-treatment levels in both fire and thinning treatments; however, biomass and productivity decreased 30%-40% compared to controls when thinning was combined with fire. The clear-cut treatment had the strongest impact, reducing ecosystem carbon stocks and delaying the capacity for carbon uptake. We conclude that post-treatment carbon dynamics and ecosystem recovery time varied with intensity and type of treatments. Consequently, management practices can be selected to minimize ecosystem carbon losses while increasing future carbon uptake, resilience to high severity fire, and climate related stresses.	[Dore, Sabina; Fry, Danny L.; York, Robert A.; Stephens, Scott L.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Collins, Brandon M.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA USA; [Collins, Brandon M.] Univ Calif Berkeley, Ctr Fire Res & Outreach, Coll Nat Resources, Berkeley, CA 94720 USA; [Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [York, Robert A.] Univ Calif Berkeley, Ctr Forestry, Georgetown, CA USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Berkeley; University of Delaware; University of California System; University of California Berkeley	Dore, S (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	sabina.dore@gmail.com	Vargas, Rodrigo/C-4720-2008	Vargas, Rodrigo/0000-0001-6829-5333; York, Robert/0000-0002-1277-8704	Joint Fire Sciences Program Project [10-1-10-21]; USDA [2014-67003-22070]	Joint Fire Sciences Program Project; USDA(United States Department of Agriculture (USDA))	This work was supported by the Joint Fire Sciences Program Project #10-1-10-21, received by SS. RV acknowledges partial support from USDA (2014-67003-22070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Campbell JL, 2011, FRONTIERS ECOLOGY EN; Campbell J, 2009, FOREST ECOL MANAG, V257, P453, DOI 10.1016/j.foreco.2008.09.021; Collins BM, 2014, ECOL APPL, V24, P1879, DOI 10.1890/14-0971.1; Concilio A, 2006, FOREST ECOL MANAG, V228, P82, DOI 10.1016/j.foreco.2006.02.029; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Dore S, 2012, GLOBAL CHANGE BIOL, V18, P3171, DOI 10.1111/j.1365-2486.2012.02775.x; Finkral AJ, 2008, FOREST ECOL MANAG, V255, P2743, DOI 10.1016/j.foreco.2008.01.041; Grady KC, 2006, FOREST ECOL MANAG, V234, P123, DOI 10.1016/j.foreco.2006.06.031; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Hartsough BR, 2008, FOREST POLICY ECON, V10, P344, DOI 10.1016/j.forpol.2008.02.001; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hirano T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003766; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Humphreys ER, 2006, AGR FOREST METEOROL, V140, P6, DOI 10.1016/j.agrformet.2006.03.018; Hurteau MD, 2011, BIOSCIENCE, V61, P139, DOI 10.1525/bio.2011.61.2.9; Irvine J, 2007, GLOBAL CHANGE BIOL, V13, P1748, DOI 10.1111/j.1365-2486.2007.01368.x; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jenkins JC, 2003, FOREST SCI, V49, P12; Kobziar LN, 2006, AGR FOREST METEOROL, V141, P161, DOI 10.1016/j.agrformet.2006.09.008; Laudenslayer W.F., 1990, T W SECTION WILDLIFE, V26, P12; Ma SY, 2004, ENVIRON MANAGE, V33, pS148, DOI 10.1007/s00267-003-9125-2; McIver J, 2009, ECOL APPL, V19, P283, DOI 10.1890/07-1785.1; Metlen KL, 2004, NORTHWEST SCI, V78, P175; Miesel JR, 2012, FOREST ECOL MANAG, V284, P163, DOI 10.1016/j.foreco.2012.07.054; Misson L, 2005, AGR FOREST METEOROL, V130, P207, DOI 10.1016/j.agrformet.2005.04.001; Moghaddas JJ, 2007, INT J WILDLAND FIRE, V16, P673, DOI 10.1071/WF06066; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; North M, 2009, ECOL APPL, V19, P1385, DOI 10.1890/08-1173.1; Olson CM, 1996, FOREST GROWTH STAND, VIII, P681; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng YY, 2008, ENVIRON REV, V16, P93, DOI 10.1139/A08-003; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Restaino JC, 2013, FOREST ECOL MANAG, V303, P46, DOI 10.1016/j.foreco.2013.03.043; Savage KE, 2003, J EXP BOT, V54, P891, DOI 10.1093/jxb/erg121; Smith TF, 2005, FOREST SCI, V51, P266; Stark DT, 2013, FOREST ECOL MANAG, V306, P61, DOI 10.1016/j.foreco.2013.06.018; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stephens SL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00289.1; Stephens SL, 2009, CAN J FOREST RES, V39, P1538, DOI 10.1139/X09-081; Stephens SL, 2005, FOREST ECOL MANAG, V215, P21, DOI 10.1016/j.foreco.2005.03.070; Stephens SL, 2004, NORTHWEST SCI, V78, P12; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Sullivan B, 2008, FOREST ECOL MANAG, V255, P4047, DOI 10.1016/j.foreco.2008.03.051; Tang JW, 2005, AGR FOREST METEOROL, V132, P212, DOI 10.1016/j.agrformet.2005.07.011; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Wagner F., 2003, IPCC GOOD PRACTICE G; Williams CA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003947; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x	55	8	8	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150256	10.1371/journal.pone.0150256	http://dx.doi.org/10.1371/journal.pone.0150256			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918460	Green Published, gold			2022-12-26	WOS:000371274400110
J	Karch, CM; Ezerskiy, LA; Bertelsen, S; Goate, AM				Karch, Celeste M.; Ezerskiy, Lubov A.; Bertelsen, Sarah; Goate, Alison M.		ADGC	Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; PILR-ALPHA; PROTEIN; CD33; PICALM; CELLS; CD2AP; EPHA1	Late onset Alzheimer's disease (LOAD) is a genetically complex and clinically heterogeneous disease. Recent large-scale genome wide association studies (GWAS) have identified more than twenty loci that modify risk for AD. Despite the identification of these loci, little progress has been made in identifying the functional variants that explain the association with AD risk. Thus, we sought to determine whether the novel LOAD GWAS single nucleotide polymorphisms (SNPs) alter expression of LOAD GWAS genes and whether expression of these genes is altered in AD brains. The majority of LOAD GWAS SNPs occur in gene dense regions under large linkage disequilibrium (LD) blocks, making it unclear which gene(s) are modified by the SNP. Thus, we tested for brain expression quantitative trait loci (eQTLs) between LOAD GWAS SNPs and SNPs in high LD with the LOAD GWAS SNPs in all of the genes within the GWAS loci. We found a significant eQTL between rs1476679 and PILRB and GATS, which occurs within the ZCWPW1 locus. PILRB and GATS expression levels, within the ZCWPW1 locus, were also associated with AD status. Rs7120548 was associated with MTCH2 expression, which occurs within the CELF1 locus. Additionally, expression of several genes within the CELF1 locus, including MTCH2, were highly correlated with one another and were associated with AD status. We further demonstrate that PILRB, as well as other genes within the GWAS loci, are most highly expressed in microglia. These findings together with the function of PILRB as a DAP12 receptor supports the critical role of microglia and neuroinflammation in AD risk.	[Karch, Celeste M.; Ezerskiy, Lubov A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Karch, Celeste M.] Washington Univ, Sch Med, Hope Ctr, Program Prot Aggregat & Neurodegenerat, St Louis, MO 63110 USA; [Bertelsen, Sarah; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, 1425 Madison Ave, New York, NY 10029 USA	Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Karch, CM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Karch, CM (corresponding author), Washington Univ, Sch Med, Hope Ctr, Program Prot Aggregat & Neurodegenerat, St Louis, MO 63110 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, 1425 Madison Ave, New York, NY 10029 USA.	karchc@psychiatry.wustl.edu; alison.goate@mssm.edu	Tsuang, Debby/L-7234-2016; Hardy, John/C-2451-2009; Saykin, Andrew/A-1318-2007	Tsuang, Debby/0000-0002-4716-1894; Hardy, John/0000-0002-3122-0423; Lin, Chiao-Feng/0000-0002-6177-8807; Saykin, Andrew/0000-0002-1376-8532; Lunetta, Kathryn/0000-0002-9268-810X; DeKosky, Steven/0000-0003-3743-2758; Goate, Alison/0000-0002-0576-2472; Ezerskiy, Lubov/0000-0002-1869-0658; Demirci, F. Yesim/0000-0001-6907-9843; Barmada, M Michael/0000-0002-3604-6460; Cao, Chuanhai/0000-0002-5765-6401; Kamboh, M. Ilyas/0000-0002-3453-1438; Buxbaum, Joseph/0000-0001-8898-8313; Poon, Wayne/0000-0003-0625-3968; Karch, Celeste/0000-0002-6854-5547; Leverenz, James/0000-0002-0896-0749	Barnes Jewish Foundation; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm; Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council [503480]; Alzheimer's Research UK [503176]; Wellcome Trust [082604/2/07/Z]; German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) [01GI0102, 01GI0711, 01GI0420]; NIH/NIA [R01 AG033193, U01 AG032984, U24 AG021886, U01 AG016976]; NIA [AG081220, AG041232]; AGES [N01-AG-12100]; NHLBI [R01 HL105756]; Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association [ADGC-10-196728, IIRG-08-89720, IIRG-05-14147]; National Institutes of Health, National Institute on Aging (NIH-NIA) [U01 AG032984, ADGC, RC2 AG036528]; National Institute on Aging (NIA) [U24 AG21886]; NINDS [NS39764]; NIMH [MH60451]; Glaxo Smith Kline; Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council; state of Arizona; NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; National Institutes of Health [U01 AG024904]; Department of Defense [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health Research;  [NIH-AG035083];  [NIH-AG049508];  [NIH-AG046374]; NATIONAL CANCER INSTITUTE [R01CA129769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451, R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, R01NS059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P30AG012300, P30AG008051, P01AG010491, P30AG010133, P50AG005146, P50AG005144, P50AG005142, U01AG016976, P50AG008671, P50AG023501, P50AG005134, R01AG041797, P50AG008702, P30AG019610, U24AG041689, P01AG003991, P50AG005128, P50AG016570, P30AG010161, U01AG010483, R01AG026916, P30AG010129, R01AG020688, P50AG005138, P50AG005133, R01AG041232, P50AG005131, P01AG019724, P50AG025688, P50AG005136, P50AG016574, R01AG013616, R01AG035137, K01AG046374, R01AG030146, R01AG041718, R01AG022374, R01AG025259, U24AG021886, R01AG035083, U01AG032984, R01AG012101, R37AG015473, R01AG021547, P50AG016573, P01AG002219, P30AG013846, R01AG017173, R01AG027944, P30AG008017, U01AG024904, R01AG019757, U24AG026395, R01AG019085, R01AG031581, RC2AG036528, U01AG049508, P30AG013854, R01AG030653, P50AG033514, N01AG012100, P50AG016582, P30AG028377, R01AG007562, U01AG006781, RC2AG036502, P50AG005681, P30AG028383, R01AG033193, R01AG015819, R01AG017917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006849] Funding Source: NIH RePORTER	Barnes Jewish Foundation; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Wellcome Trust(Wellcome Trust); German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND)(Federal Ministry of Education & Research (BMBF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGES; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association(Alzheimer's Association); National Institutes of Health, National Institute on Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Glaxo Smith Kline(GlaxoSmithKline); Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); state of Arizona; NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH-AG035083 (AMG), NIH-AG049508 (AMG) NIH-AG046374 (CMK), and the Barnes Jewish Foundation (AMG). This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by NIH-AG035083 (AMG), NIH-AG049508 (AMG) NIH-AG046374 (CMK), and the Barnes Jewish Foundation (AMG). This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine.; We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Universite de Lille 2 and the Lille University Hospital. GERAD was supported by the Medical Research Council (Grant no 503480), Alzheimer's Research UK (Grant no 503176), the Wellcome Trust (Grant no 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grant no 01GI0102, 01GI0711, 01GI0420. CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01-AG-12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants: U01 AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association grant ADGC-10-196728.; The National Institutes of Health, National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; Samples from the National Cell Repository for Alzheimer's Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible; Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689-01); NACC, U01 AG016976; NIA LOAD, U24 AG026395, R01AG041797; Banner Sun Health Research Institute P30 AG019610; Boston University, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01 AG025259, R01AG33193; Columbia University, P50 AG008702, R37 AG015473; Duke University, P30 AG028377, AG05128; Emory University, AG025688; Group Health Research Institute, UO1 AG006781, UO1 HG004610, UO1 HG006375; Indiana University, P30 AG10133; Johns Hopkins University, P50 AG005146, R01 AG020688; Massachusetts General Hospital, P50 AG005134; Mayo Clinic, P50 AG016574; Mount Sinai School of Medicine, P50 AG005138, P01 AG002219; New York University, P30 AG08051, UL1 RR029893, 5R01AG012101, 5R01AG022374, 5R01AG013616, 1RC2AG036502, 1R01AG035137; Northwestern University, P30 AG013854; Oregon Health & Science University, P30 AG008017, R01 AG026916; Rush University, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146; TGen, R01 NS059873; University of Alabama at Birmingham, P50 AG016582; University of Arizona, R01 AG031581; University of California, Davis, P30 AG010129; University of California, Irvine, P50 AG016573; University of California, Los Angeles, P50 AG016570; University of California, San Diego, P50 AG005131; University of California, San Francisco, P50 AG023501, P01 AG019724; University of Kentucky, P30 AG028383, AG05144; University of Michigan, P50 AG008671; University of Pennsylvania, P30 AG010124; University of Pittsburgh, P50 AG005133, AG030653, AG041718, AG07562, AG02365; University of Southern California, P50 AG005142; University of Texas Southwestern, P30 AG012300; University of Miami, R01 AG027944, AG010491, AG027944, AG021547, AG019757; University of Washington, P50 AG005136; University of Wisconsin, P50 AG033514; Vanderbilt University, R01 AG019085; and Washington University, P50 AG005681, P01 AG03991. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant # NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. The TGen series was also funded by NIA grant AG041232 to AJM and MJH, The Banner Alzheimer's Foundation, The Johnnie B. Byrd Sr.; Alzheimer's Institute, the Medical Research Council, and the state of Arizona and also includes samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University), MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council), South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer's Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN), The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. ADNI data collection and sharing was funded by the National Institutes of Health Grant U01 AG024904 and Department of Defense award number W81XWH-12-2-0012. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. We thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-officio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. P.S.G.-H. is supported by Wellcome Trust, Howard Hughes Medical Institute, and the Canadian Institute of Health Research.	Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lu Q, 2014, P NATL ACAD SCI USA, V111, P8221, DOI 10.1073/pnas.1320716111; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Woulfe JM, 2002, BRAIN PATHOL, V12, P300; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	37	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148717	10.1371/journal.pone.0148717	http://dx.doi.org/10.1371/journal.pone.0148717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919393	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400009
J	Potter, EE; Thornber, CS; Swanson, JD; McFarland, M				Potter, Elaine E.; Thornber, Carol S.; Swanson, John-David; McFarland, Malcolm			Ploidy Distribution of the Harmful Bloom Forming Macroalgae Ulva spp. in Narragansett Bay, Rhode Island, USA, Using Flow Cytometry Methods	PLOS ONE			English	Article							GRAZING FACILITATES GROWTH; NUCLEAR-DNA CONTENT; LIFE-HISTORY; TEMPORAL VARIATION; MARINE MACROALGAE; CHLOROPHYTA; NITROGEN; POPULATION; ESTUARIES; EVOLUTION	Macroalgal blooms occur worldwide and have the potential to cause severe ecological and economic damage. Narragansett Bay, RI is a eutrophic system that experiences summer macroalgal blooms composed mostly of Ulva compressa and Ulva rigida, which have biphasic life cycles with separate haploid and diploid phases. In this study, we used flow cytometry to assess ploidy levels of U. compressa and U. rigida populations from five sites in Narragansett Bay, RI, USA, to assess the relative contribution of both phases to bloom formation. Both haploid gametophytes and diploid sporophytes were present for both species. Sites ranged from a relative overabundance of gametophytes to a relative overabundance of sporophytes, compared to the null model prediction of root 2 gametophytes: 1 sporophyte. We found significant differences in cell area between ploidy levels for each species, with sporophyte cells significantly larger than gametophyte cells in U. compressa and U. rigida. We found no differences in relative growth rate between ploidy levels for each species. Our results indicate the presence of both phases of each of the two dominant bloom forming species throughout the bloom season, and represent one of the first studies of in situ Ulva life cycle dynamics.	[Potter, Elaine E.; Thornber, Carol S.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Swanson, John-David] Salve Regina Univ, Dept Biol & Biomed Sci, Newport, RI USA; [McFarland, Malcolm] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [McFarland, Malcolm] Florida Atlantic Univ, Harbor Branch, Oceanog Inst, Ft Pierce, FL USA	University of Rhode Island; University of Rhode Island; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University	Thornber, CS (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	thornber@uri.edu	Thornber, Carol/B-5786-2014	Thornber, Carol/0000-0003-0034-1035	Rhode Island Science and Technology Advisory Committee; Quebec-Labrador Foundation Sounds Conservancy; University of Rhode Island; National Science Foundation [EPS-1004057]	Rhode Island Science and Technology Advisory Committee; Quebec-Labrador Foundation Sounds Conservancy; University of Rhode Island; National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by a 2012 Rhode Island Science and Technology Advisory Committee award to CST and JDS (http://stac.ri.gov/), the Quebec-Labrador Foundation Sounds Conservancy to EEP (http://www.qlf.org/), and the University of Rhode Island to EEP (http://ww2.uri.edu/). This material is based upon work conducted at the Rhode Island NSF EPSCoR Marine Life Science Center, supported in part by the National Science Foundation Experimental Program to Stimulate Competitive Research, Cooperative Agreement #EPS-1004057 (http://www.nsf.gov/od/iia/programs/epscor/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELFATTAH AF, 1972, QUAL PLANT MATER VEG, V22, P15, DOI 10.1007/BF01099733; ADAMS J, 1974, GENETICS, V76, P327; Alstrom-Rapaport C, 2010, AQUAT BOT, V93, P244, DOI 10.1016/j.aquabot.2010.08.003; BLIDING C., 1963, CRITICAL SURVEY EURO; CLAYTON MN, 1992, BRIT PHYCOL J, V27, P219, DOI 10.1080/00071619200650231; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Deacutis CF, 2008, SPRINGER SER ENV MAN, P349, DOI 10.1007/978-0-387-35299-2_12; Deacutis CF, 2006, NORTHEAST NAT, V13, P173, DOI 10.1656/1092-6194(2006)13[173:HITUHO]2.0.CO;2; DESTOMBE C, 1993, HYDROBIOLOGIA, V261, P131; Doleel J., 2007, FLOW CYTOMETRY PLANT; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DYCK LJ, 1995, PHYCOLOGIA, V34, P390, DOI 10.2216/i0031-8884-34-5-390.1; Fulton John P, 2003, Med Health R I, V86, P365; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Guidone M., 2012, THESIS U RHODE ISLAN; Guidone M, 2013, J PHYCOL, V49, P979, DOI 10.1111/jpy.12108; Guidone M, 2013, HARMFUL ALGAE, V24, P1, DOI 10.1016/j.hal.2012.12.007; Guidone M, 2012, J ECOL, V100, P1105, DOI 10.1111/j.1365-2745.2012.02002.x; Guidone M, 2010, MAR ECOL PROG SER, V420, P83, DOI 10.3354/meps08894; Guillemin ML, 2013, J APPL PHYCOL, V25, P215, DOI 10.1007/s10811-012-9855-8; HANNACH G, 1985, MAR ECOL PROG SER, V22, P291, DOI 10.3354/meps022291; Hauxwell J, 2003, MAR ECOL PROG SER, V247, P59, DOI 10.3354/meps247059; Hauxwell J, 1998, ESTUARIES, V21, P347, DOI 10.2307/1352481; Hiraoka M, 2010, J PHYCOL, V46, P882, DOI 10.1111/j.1529-8817.2010.00873.x; Hughes JS, 1999, AM NAT, P154; Jahns H. M., 1995, ALGAE INTRO PHYCOLOG; Kagami Y, 2005, PHYCOL RES, V53, P77, DOI 10.1111/j.1440-183.2005.00375.x; Kim JH, 2011, J APPL PHYCOL, V23, P421, DOI 10.1007/s10811-010-9590-y; LEGALL Y, 1993, PROTOPLASMA, V173, P123; Leletkin V. A., 2004, Biologiya Morya (Vladivostok), V30, P393; LEWIS J, 1979, J THEOR BIOL, V78, P425, DOI 10.1016/0022-5193(79)90341-2; LEWIS WM, 1985, AM NAT, V125, P692, DOI 10.1086/284372; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Lyons P, 2009, NORTHEAST NAT, V16, P53, DOI 10.1656/045.016.0105; Management RIDoE, 2003, GREENW BAY FISH KILL; Mao YX, 2014, J OCEAN U CHINA, V13, P865, DOI 10.1007/s11802-014-2419-6; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morand P, 2004, RECENT RES DEV ENV B, V1, P395; Morgan JA, 2003, BIOL BULL-US, V205, P252, DOI 10.2307/1543280; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Nixon SW, 2008, SPRINGER SER ENV MAN, P101, DOI 10.1007/978-0-387-35299-2_5; Nixon SW, 1995, BIOGEOCHEMISTRY, V31, P15; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PECKOL P, 1994, MAR BIOL, V121, P175, DOI 10.1007/BF00349487; PHILLIPS JA, 1990, BOT MAR, V33, P79, DOI 10.1515/botm.1990.33.1.79; PRINGLE JD, 1986, OCEAN MANAGE, V10, P11, DOI 10.1016/0302-184X(86)90003-X; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy CRK, 2006, AQUACULTURE, V260, P290, DOI 10.1016/j.aquaculture.2006.06.034; RIVERS JS, 1995, J PHYCOL, V31, P223, DOI 10.1111/j.0022-3646.1995.00223.x; ROSENBERG R, 1985, MAR POLLUT BULL, V16, P227, DOI 10.1016/0025-326X(85)90505-3; Sankaranarayanan S, 2006, CONT SHELF RES, V26, P1571, DOI 10.1016/j.csr.2006.04.004; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Thomsen MS, 2006, J EXP MAR BIOL ECOL, V328, P22, DOI 10.1016/j.jembe.2005.06.016; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; Thornber CS, 2006, INTEGR COMP BIOL, V46, P605, DOI 10.1093/icb/icl018; Thornber CS, 2004, ECOLOGY, V85, P1661, DOI 10.1890/02-4101; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; ULRICH I, 1991, PROTOPLASMA, V165, P212, DOI 10.1007/BF01322292; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Worm B, 2006, LIMNOL OCEANOGR, V51, P569, DOI 10.4319/lo.2006.51.1_part_2.0569; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8	68	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149182	10.1371/journal.pone.0149182	http://dx.doi.org/10.1371/journal.pone.0149182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918869	Green Published, gold, Green Submitted			2022-12-26	WOS:000371274400015
J	Song, FJ; Zeng, KW; Liao, LX; Yu, Q; Tu, PF; Wang, XM				Song, Fangjiao; Zeng, Kewu; Liao, Lixi; Yu, Qian; Tu, Pengfei; Wang, Xuemei			Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-kappa B and Jak2-Stat3 Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; IMMUNE-SYSTEM; CELLS; INFLAMMATION; ACTIVATION; KINASE	Microglial-mediated neuroinflammation has been established as playing a vital role in pathogenesis of neurodegenerative disorders. Thus, rational regulation of microglia functions to inhibit inflammation injury may be a logical and promising approach to neurodegenerative disease therapy. The purposes of the present study were to explore the neuroprotective effects and potential molecular mechanism of Schizandrin A (Sch A), a lignin compound isolated from Schisandra chinesnesis. Our observations showed that Sch A could significantly down-regulate the increased production of nitric oxide (NO), tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 induced by lipopolysaccharide (LPS) both in BV-2 cells and primary microglia cells. Moreover, Sch A exerted obvious neuroprotective effects against inflammatory injury in neurons when exposed to microglia-conditioned medium. Investigations of the mechanism showed the anti-inflammatory effect of Sch A involved the inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expression levels and inhibition of the LPS-induced TRAF6-IKK beta-NF-kappa B pathway. Furthermore, inhibition of Jak2-Stat3 pathway activation and Stat3 nuclear translocation also was observed. In conclusion, SchA can exert anti-inflammatory and neuroprotective effects by alleviating microglia-mediated neuroinflammation injury through inhibiting the TRAF6-IKK beta-NF-kappa B and Jak2-Stat3 signaling pathways.	[Song, Fangjiao; Yu, Qian; Wang, Xuemei] Peking Univ, Hosp 1, Res Studio Integrat Tradit & Western Med, Beijing 100034, Peoples R China; [Zeng, Kewu; Liao, Lixi; Tu, Pengfei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, XM (corresponding author), Peking Univ, Hosp 1, Res Studio Integrat Tradit & Western Med, Beijing 100034, Peoples R China.	wangxuemeibjmu@163.com	Tu, Peng Fei/E-2089-2018; Wang, Xuemei/GXF-3702-2022; Ke-wu, Zeng/U-6930-2019		National Natural Science Foundation of China [81173369, 81303253]; Natural Science Foundation of Beijing [7132210]; Doctoral Scientific Fund Project of the Ministry of Education of China [20120001110105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Doctoral Scientific Fund Project of the Ministry of Education of China	This work was funded by the National Natural Science Foundation of China (81173369) to WXM, the National Natural Science Foundation of China (81303253) to ZKW, the Natural Science Foundation of Beijing (7132210) to WXM, and the Doctoral Scientific Fund Project of the Ministry of Education of China (20120001110105) to WXM.	Androsova LV, 2013, ZH NEVROL PSIKHIATR, V113, P49; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Datla P, 2010, BRIT J PHARMACOL, V160, P1158, DOI 10.1111/j.1476-5381.2010.00780.x; Dilshara MG, 2014, INT IMMUNOPHARMACOL, V18, P203, DOI 10.1016/j.intimp.2013.11.020; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Kim SR, 2004, J NEUROSCI RES, V76, P397, DOI 10.1002/jnr.20089; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lin XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067633; Liu PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050363; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; McBerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038384; Panaro MA, 2012, CURR PHARM DESIGN, V18, P200; Park HY, 2013, INT J MOL MED, V32, P1171, DOI 10.3892/ijmm.2013.1478; Picchianti-Diamanti A, 2014, INT J MOL SCI, V15, P4965, DOI 10.3390/ijms15034965; Ren DY, 2013, AM J CHINESE MED, V41, P601, DOI 10.1142/S0192415X13500420; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CP, 2014, J PHYSIOL BIOCHEM, V70, P735, DOI 10.1007/s13105-014-0342-3; Wang SX, 2012, CHINESE J PHYSIOL, V55, P428, DOI [10.4077/CJP.2012.BAA045, 10.4077/CJP.2011.AMM045]; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	26	71	81	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149991	10.1371/journal.pone.0149991	http://dx.doi.org/10.1371/journal.pone.0149991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919063	gold, Green Published, Green Submitted			2022-12-26	WOS:000371274400066
J	Ferreira, VM; Passos, CS; Maquigussa, E; Pontes, RB; Bergamaschi, CT; Campos, RR; Boim, MA				Ferreira, Vanessa Meira; Passos, Clevia Santos; Maquigussa, Edgar; Pontes, Roberto Braz; Bergamaschi, Cassia Toledo; Campos, Ruy Ribeiro; Boim, Mirian Aparecida			Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SYMPATHETIC-NERVE ACTIVITY; CIGARETTE-SMOKING; BLOOD-PRESSURE; NITRIC-OXIDE; GLOMERULAR-FILTRATION; BARORECEPTOR REFLEX; REPLACEMENT THERAPY; KIDNEY-DISEASE; CONSCIOUS RATS	Pregnancy is characterized by maternal systemic and intrarenal vasodilation, leading to increases in the renal plasma flow (RPF) and glomerular filtration rate (GFR). These responses are mainly mediated by nitric oxide (NO) and relaxin. The impact of cigarette smoking on the maternal adaptations to pregnancy is unclear. Here we evaluated the effects of chronic exposure to nicotine on systemic and intrarenal parameters in virgin (V) and 14-day pregnant (P) Wistar rats. V and P groups received saline or nicotine (6 mg.kg(-1).day(-1)) respectively, via osmotic minipumps for 28 days, starting 14 days before pregnancy induction. Nicotine induced a 10% increase in blood pressure in the V group and minimized the characteristic pregnancy-induced hypotension. Renal sympathetic nerve activity (rSNA) and baroreflex sensitivity were impaired by nicotine mainly in the P group, indicating that the effect of nicotine on blood pressure was not mediated by nervous system stimulation. Nicotine had no effect on GFR in the V rats but reduced GFR of the P group by 30%. Renal expression of sodium and water transporters was downregulated by nicotine, resulting in increased fractional sodium excretion mainly in the P group, suggesting that nicotine compromised the sodium and water retention required for normal gestation. There was a reduction in the expression of inducible NO synthase (iNOS) in both the kidney tissue and renal artery, as well as in the expression of the relaxin receptor (LGR7). These results clearly show that nicotine induced deleterious effects in both virgin and pregnant animals, and abolished the maternal capacity to adapt to pregnancy.	[Ferreira, Vanessa Meira; Passos, Clevia Santos; Maquigussa, Edgar; Boim, Mirian Aparecida] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Pontes, Roberto Braz; Bergamaschi, Cassia Toledo; Campos, Ruy Ribeiro] Univ Fed Sao Paulo, Dept Physiol, Cardiovasc Div, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	maboim@unifesp.br	Campos, Ruy R/H-8339-2017; Boim, Mirian A/L-6574-2013; Maquigussa, Edgar/G-7685-2016; Pontes, Roberto B/D-1211-2014; Campos, Ruy R R/I-3691-2015; Bergamaschi, Cassia/AAZ-9441-2020; Passos, Clevia/B-8463-2014	Campos, Ruy R/0000-0002-9404-0817; Pontes, Roberto B/0000-0002-2937-575X; Campos, Ruy R R/0000-0002-9404-0817; Passos, Clevia/0000-0001-6954-2535; Maquigussa, Edgar/0000-0003-1756-1579; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11953-0, 2010/098490]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - Grant no. 2010/11953-0 and 2010/098490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NP, 2008, HYPERTENS PREGNANCY, V27, P49, DOI 10.1080/10641950701825887; Agbor LN, 2014, J PHARMACOL EXP THER, V351, P688, DOI 10.1124/jpet.114.219535; Agbor LN, 2012, TOXICOL APPL PHARM, V264, P351, DOI 10.1016/j.taap.2012.09.007; Alexander BT, 1999, HYPERTENSION, V33, P435, DOI 10.1161/01.HYP.33.1.435; ARMITAGE AK, 1965, BRIT J PHARM CHEMOTH, V25, P515, DOI 10.1111/j.1476-5381.1965.tb02069.x; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; BAYLIS C, 1994, BAILLIERE CLIN OB GY, V8, P235, DOI 10.1016/S0950-3552(05)80320-7; BAYLIS C, 1987, AM J KIDNEY DIS, V9, P260, DOI 10.1016/S0272-6386(87)80119-1; BAYLIS C, 1980, J PHYSIOL-LONDON, V305, P405, DOI 10.1113/jphysiol.1980.sp013372; BERTA L, 1992, HORM RES, V37, P45, DOI 10.1159/000182280; Bobadilla RA, 2003, CAN J PHYSIOL PHARM, V81, P1, DOI 10.1139/Y02-168; BOIM MA, 1994, BRAZ J MED BIOL RES, V27, P1431; Brooks VL, 2010, AM J PHYSIOL-REG I, V299, pR439, DOI 10.1152/ajpregu.00059.2010; Cadnapaphornchai MA, 2001, AM J PHYSIOL-RENAL, V280, pF592, DOI 10.1152/ajprenal.2001.280.4.F592; Conrad KP, 1999, AM J PHYSIOL-RENAL, V276, pF767, DOI 10.1152/ajprenal.1999.276.5.F767; Conrad KP, 2005, ANN NY ACAD SCI, V1041, P147, DOI 10.1196/annals.1282.022; Cooper RG, 2006, INDIAN J MED RES, V124, P261; Cornelis T, 2011, SEMIN NEPHROL, V31, P4, DOI 10.1016/j.semnephrol.2010.10.002; Danielson LA, 1996, CIRC RES, V79, P1161, DOI 10.1161/01.RES.79.6.1161; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; EASTERLING TR, 1988, OBSTET GYNECOL, V72, P550; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; El-Mas MM, 2011, TOXICOL APPL PHARM, V254, P229, DOI 10.1016/j.taap.2011.04.014; El-Sherbeni AA, 2014, DRUG METAB DISPOS, V42, P1498, DOI 10.1124/dmd.114.057836; Ferreira VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004845; Franken R A, 1996, Arq Bras Cardiol, V66, P371; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; HAMMOND DK, 1991, DRUG METAB DISPOS, V19, P804; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hukkanen J, 2011, BRIT J CLIN PHARMACO, V72, P836, DOI 10.1111/j.1365-2125.2011.04023.x; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jain G, 2013, BIOCHEM PHARMACOL, V86, P1215, DOI 10.1016/j.bcp.2013.07.014; JENSEN J, 1985, NEW ENGL J MED, V313, P973, DOI 10.1056/NEJM198510173131602; Kubo T, 1987, CENTRAL NICOTINIC RE; Lauritzen L, 2011, MATERN CHILD NUTR, V7, P41, DOI 10.1111/j.1740-8709.2011.00303.x; Malpas SC, 2004, AM J PHYSIOL-REG I, V286, pR1, DOI 10.1152/ajpregu.00496.2003; MASSICOTTE G, 1987, CAN J PHYSIOL PHARM, V65, P2466, DOI 10.1139/y87-391; Murphy JG, 2001, AM J PHYSIOL-REG I, V280, pR87, DOI 10.1152/ajpregu.2001.280.1.R87; Najem B, 2006, HYPERTENSION, V47, P1162, DOI 10.1161/01.HYP.0000219284.47970.34; Nasr SH, 2007, J AM SOC NEPHROL, V18, P2032, DOI 10.1681/ASN.2006121328; Nishi EE, 2010, AM J HYPERTENS, V23, P473, DOI 10.1038/ajh.2010.11; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Ohara M, 1998, J CLIN INVEST, V101, P1076, DOI 10.1172/JCI649; Orth SR, 2004, J AM SOC NEPHROL, V15, pS58, DOI 10.1097/01.ASN.0000093461.36097.D5; Paller MS CJ, 2004, KIDNEY, V2, P1659; Pontes RB, 2015, AM J PHYSIOL-RENAL, V308, pF848, DOI 10.1152/ajprenal.00515.2014; Rieg T, 2013, JOVE-J VIS EXP, DOI 10.3791/50330; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; Rosembert J RA, 2003, NICOTINA; Shimokawa A, 1998, J AUTONOM NERV SYST, V72, P46, DOI 10.1016/S0165-1838(98)00084-8; Smith CA, 2010, AM J PHYSIOL-RENAL, V299, pF830, DOI 10.1152/ajprenal.00300.2010; Tamaoki L, 2009, AM J NEPHROL, V30, P377, DOI 10.1159/000235622; WHITESCARVER SA, 1991, HYPERTENSION, V17, P179, DOI 10.1161/01.HYP.17.2.179; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2007, J PHARMACOL EXP THER, V320, P654, DOI 10.1124/jpet.106.113332; Yang Z, 2007, EXP PHYSIOL, V92, P109, DOI 10.1113/expphysiol.2006.034884; ZACNY JP, 1990, BRIT J ADDICT, V85, P555	59	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150096	10.1371/journal.pone.0150096	http://dx.doi.org/10.1371/journal.pone.0150096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914675	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700054
J	Fonseca, MI; Chu, SH; Pierce, AL; Brubaker, WD; Hauhart, RE; Mastroeni, D; Clarke, EV; Rogers, J; Atkinson, JP; Tenner, AJ				Fonseca, Maria I.; Chu, Shuhui; Pierce, Aimee L.; Brubaker, William D.; Hauhart, Richard E.; Mastroeni, Diego; Clarke, Elizabeth V.; Rogers, Joseph; Atkinson, John P.; Tenner, Andrea J.			Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; COMPLEMENT ACTIVATION; PERIPHERAL CLEARANCE; PRION DISEASE; MOUSE MODELS; A-BETA; RECEPTOR; C1Q; BRAIN; MICE	Chronic activation of the complement system and induced inflammation are associated with neuropathology in Alzheimer's disease (AD). Recent large genome wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in the C3b/C4b receptor (CR1 or CD35) that are associated with late onset AD. Here, anti-CR1 antibodies (Abs) directed against different epitopes of the receptor, were used to localize CR1 in brain, and relative binding affinities of the CR1 ligands, C1q and C3b, were assessed by ELISA. Most Abs tested stained red blood cells in blood vessels but showed no staining in brain parenchyma. However, two monoclonal anti-CR1 Abs labeled astrocytes in all of the cases tested, and this reactivity was preabsorbed by purified recombinant human CR1. Human brain-derived astrocyte cultures were also reactive with both mAbs. The amount of astrocyte staining varied among the samples, but no consistent difference was conferred by diagnosis or the GWAS-identified SNPs rs4844609 or rs6656401. Plasma levels of soluble CR1 did not correlate with diagnosis but a slight increase was observed with rs4844609 and rs6656401 SNP. There was also a modest but statistically significant increase in relative binding activity of C1q to CR1 with the rs4844609 SNP compared to CR1 without the SNP, and of C3b to CR1 in the CR1 genotypes containing the rs6656401 SNP (also associated with the larger isoform of CR1) regardless of clinical diagnosis. These results suggest that it is unlikely that astrocyte CR1 expression levels or C1q or C3b binding activity are the cause of the GWAS identified association of CR1 variants with AD. Further careful functional studies are needed to determine if the variant-dictated number of CR1 expressed on red blood cells contributes to the role of this receptor in the progression of AD, or if another mechanism is involved.	[Fonseca, Maria I.; Chu, Shuhui; Clarke, Elizabeth V.; Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Pierce, Aimee L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Pierce, Aimee L.; Tenner, Andrea J.] Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA; [Brubaker, William D.; Rogers, Joseph] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Hauhart, Richard E.; Atkinson, John P.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Mastroeni, Diego] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Mastroeni, Diego] Maastricht Univ, Med Ctr, European Grad Sch Neurosci EURON,Sch Mental Hlth, Dept Psychiat & Neuropsychol,Fac Hlth Med & Life, NL-6200 MD Maastricht, Netherlands; [Tenner, Andrea J.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Dept Pathol & Lab Sci, Irvine, CA 92697 USA; [Mastroeni, Diego] Arizona State Univ, NDRC, Biodesign Inst, Tempe, AZ 85287 USA; [Clarke, Elizabeth V.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; SRI International; Washington University (WUSTL); Banner Research; Banner Health; Banner Sun Health Research Institute; Maastricht University; University of California System; University of California Irvine; University of California System; University of California Irvine; Arizona State University; Arizona State University-Tempe; Oregon Health & Science University	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Sci, Irvine, CA 92697 USA.	atenner@uci.edu		Clarke, Elizabeth/0000-0002-4447-0077; Atkinson, John/0000-0002-2514-3441	National Institutes of Health [AG 00538, NS35144, P50 AG16573, R01 AI041592, P30 AR048335, AG039750, AG007367]; NIH/NIA [P50 AG16573, R01 AI041592, P30 AR048335, AG039750, AG007367]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538, R01AG039750, R01AG007367, R56AG007367, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG 00538 and NS35144 (AT), National Institutes of Health Grant P50 AG16573 (AIP), R01 AI041592 and P30 AR048335 (JPA), and AG039750 and AG007367 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants AG 00538 and NS35144 (AT), NIH/NIA Grant P50 AG16573 (UCI-ADRC), R01 AI041592 and P30 AR048335 (JPA), and AG039750 and AG007367 (JR). The authors thank Drs. Ronald Kim, Wayne Poon and Edwin Monuki and the Tissue Repository of the UCI Institute for Memory Impairments and Neurological Disorders for preparing and providing brain tissue samples with pathological diagnosis, and Marwan Sabbagh, M.D. (Banner Sun Health Research Institute) who provided RBC samples. The authors thank Dr Jonathan Hannan University of Colorado, Denver for kindly providing K562 cells expressing CR2 and mAb (M171) against CR2, and Drs. Changiz Geula and Aras Rezvanian of Northwestern University Alzheimer's Disease Center for a generous gift of human brain derived microglia. The authors also thank Pooja Selvan (UCI) and Eric Nguyen (UCI) for excellent technical assistance.	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; BERGER M, 1984, J CLIN INVEST, V74, P1566, DOI 10.1172/JCI111572; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Brouwers N, 2012, MOL PSYCHIATR, V17, P223, DOI 10.1038/mp.2011.24; Canova C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-22; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Chen CH, 2007, CLIN EXP IMMUNOL, V148, P546, DOI 10.1111/j.1365-2249.2007.03355.x; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Daborg J, 2012, J NEURAL TRANSM, V119, P789, DOI 10.1007/s00702-012-0797-8; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DYKMAN TR, 1983, P NATL ACAD SCI-BIOL, V80, P1698, DOI 10.1073/pnas.80.6.1698; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Gasque P, 1996, J IMMUNOL, V156, P2247; Hazrati LN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.001; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karthikeyan G, 2007, J THROMB THROMBOLYS, V23, P115, DOI 10.1007/s11239-006-9040-5; Keenan BT, 2012, HUM MOL GENET, V21, P2377, DOI 10.1093/hmg/dds054; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kovacs GG, 2004, NEUROBIOL DIS, V15, P21, DOI 10.1016/j.nbd.2003.09.010; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larvie M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/929803; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Lue LF, 1996, NEUROBIOL AGING, V17, P421, DOI 10.1016/0197-4580(96)00006-1; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mahmoudi R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.01.006; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Michel B, 2012, J IMMUNOL, V189, P4520, DOI 10.4049/jimmunol.1201579; MOLDENHAUER F, 1988, CLIN EXP IMMUNOL, V72, P74; Moulds JM, 1998, EXP CLIN IMMUNOGENET, V15, P291, DOI 10.1159/000019084; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; PASCUAL M, 1993, J IMMUNOL, V151, P1702; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; RAFF MC, 1983, J NEUROSCI, V3, P1289; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; Sadallah S, 1999, EUR J IMMUNOL, V29, P3754, DOI 10.1002/(SICI)1521-4141(199911)29:11<3754::AID-IMMU3754>3.3.CO;2-X; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Singhrao SK, 1999, LAB INVEST, V79, P1247; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tetteh-Quarcoo PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034820; Valazquez P, 1997, NAT MED, V3, P77, DOI 10.1038/nm0197-77; Van Cauwenberghe C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.008; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Villiers MB, 1996, IMMUNOLOGY, V89, P348, DOI 10.1046/j.1365-2567.1996.d01-747.x; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	65	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149792	10.1371/journal.pone.0149792	http://dx.doi.org/10.1371/journal.pone.0149792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914463	Green Published, Green Submitted, gold			2022-12-26	WOS:000371175700027
J	Maltman, C; Walter, G; Yurkov, V				Maltman, Chris; Walter, Graham; Yurkov, Vladimir			A Diverse Community of Metal(loid) Oxide Respiring Bacteria Is Associated with Tube Worms in the Vicinity of the Juan de Fuca Ridge Black Smoker Field	PLOS ONE			English	Article							HYDROTHERMAL VENT; SP NOV.; GEN. NOV.; ANAEROBIC RESPIRATION; MICROBIAL COMMUNITIES; THAUERA-SELENATIS; WELL WATER; GOLD MINE; MONO LAKE; REDUCTION	Epibiotic bacteria associated with tube worms living in the vicinity of deep sea hydrothermal vents of the Juan de Fuca Ridge in the Pacific Ocean were investigated for the ability to respire anaerobically on tellurite, tellurate, selenite, selenate, metavanadate and orthovanadate as terminal electron acceptors. Out of 107 isolates tested, 106 were capable of respiration on one or more of these oxides, indicating that metal(loid) oxide based respiration is not only much more prevalent in nature than is generally believed, but also is an important mode of energy generation in the habitat. Partial 16S rRNA gene sequencing revealed the bacterial community to be rich and highly diverse, containing many potentially new species. Furthermore, it appears that the worms not only possess a close symbiotic relationship with chemolithotrophic sulfide-oxidizing bacteria, but also with the metal(loid) oxide transformers. Possibly they protect the worms through reduction of the toxic compounds that would otherwise be harmful to the host.	[Maltman, Chris; Walter, Graham; Yurkov, Vladimir] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Yurkov, V (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	vyurkov@umanitoba.ca			NSERC; University of Manitoba GETS grant	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba GETS grant	This work was supported by a NSERC Discovery grant and a University of Manitoba GETS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar SE, 2002, J BACTERIOL, V184, P1349, DOI 10.1128/JB.184.5.1349-1358.2002; Baesman SM, 2009, EXTREMOPHILES, V13, P695, DOI 10.1007/s00792-009-0257-z; Baesman SA, 2007, APPL ENVIRON MICROB, V73, P2135, DOI 10.1128/AEM.02558-06; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Blum JS, 2001, ARCH MICROBIOL, V175, P208; Bouroushian M, 2010, MONOGR ELECTROCHEM, P1, DOI 10.1007/978-3-642-03967-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Csotonyi JT, 2006, APPL ENVIRON MICROB, V72, P4950, DOI 10.1128/AEM.00223-06; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding LX, 2010, J GEN APPL MICROBIOL, V56, P267, DOI 10.2323/jgam.56.267; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Duperron S, 2014, DEEP-SEA RES PT 1, V2, P225; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Etezad SM, 2009, ENZYME MICROB TECH, V45, P1, DOI 10.1016/j.enzmictec.2009.04.004; Evtushenko LI, 2002, INT J SYST EVOL MICR, V52, P987, DOI 10.1099/00207713-52-3-987; Fontaine Kyle M., 2012, Plants-Basel, V1, P39, DOI 10.3390/plants1020039; Guzzo J, 2000, APPL ENVIRON MICROB, V66, P4972, DOI 10.1128/AEM.66.11.4972-4978.2000; HESSLER RR, 1988, DEEP-SEA RES, V35, P1681, DOI 10.1016/0198-0149(88)90044-1; Holden JF, 2003, CURR OPIN CHEM BIOL, V7, P160, DOI 10.1016/S1367-5931(03)00026-7; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; James G, 2010, PCR FOR CLINICAL MICROBIOLOGY: AN AUSTRALIAN AND INTERNATIONAL PERSPECTIVE, P209, DOI 10.1007/978-90-481-9039-3_28; JEANTHON C, 1990, APPL ENVIRON MICROB, V56, P3308, DOI 10.1128/AEM.56.11.3308-3314.1990; Jeanthon C, 2000, ANTON LEEUW INT J G, V77, P117, DOI 10.1023/A:1002463825025; Jewett MC, 2009, J BACTERIOL, V191, P1083, DOI 10.1128/JB.00852-08; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769, DOI 10.1099/00207713-49-2-769; Knott R, 1995, MINERALOGY SULFUR IS, P207; Lopez-Garcia P, 2002, ENVIRON MICROBIOL, V4, P204, DOI 10.1046/j.1462-2920.2002.00286.x; LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403; MACY JM, 1993, INT J SYST BACTERIOL, V43, P135, DOI 10.1099/00207713-43-1-135; Maltman C, 2015, EXTREMOPHILES, V19, P1013, DOI 10.1007/s00792-015-0776-8; Michibata H, 2003, COORDIN CHEM REV, V237, P41, DOI 10.1016/S0010-8545(02)00278-3; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Myers JM, 2004, APPL ENVIRON MICROB, V70, P1405, DOI 10.1128/AEM.70.3.1405-1412.2004; Narasingarao P, 2007, INT J SYST EVOL MICR, V57, P1937, DOI 10.1099/ijs.0.64980-0; Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06; Narasingarao P, 2006, SYST APPL MICROBIOL, V29, P382, DOI 10.1016/j.syapm.2005.12.011; Ortiz-Bernad I, 2004, APPL ENVIRON MICROB, V70, P3091, DOI 10.1128/AEM.70.5.3091-3095.2004; Page A, 2004, GEOBIOLOGY, V2, P225, DOI 10.1111/j.1472-4677.2004.00034.x; Rauschenbach I, 2011, INT J SYST EVOL MICR, V61, P654, DOI 10.1099/ijs.0.022392-0; Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765; Stolz JF, 1999, FEMS MICROBIOL REV, V23, P615, DOI 10.1016/S0168-6445(99)00024-8; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; TUNNICLIFFE V, 1990, PROG OCEANOGR, V24, P1, DOI 10.1016/0079-6611(90)90015-T; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 2003, RECENT RES DEV BACTE, V1, P247; YURKOVA N A, 1990, Mikrobiologiya, V59, P968	54	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149812	10.1371/journal.pone.0149812	http://dx.doi.org/10.1371/journal.pone.0149812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914590	gold, Green Published			2022-12-26	WOS:000371175700028
J	Liu, HQ; Dong, CL; Zhao, TC; Han, JC; Wang, TL; Wen, XZ; Huang, Q				Liu, Huiqin; Dong, Chunling; Zhao, Tingchang; Han, Jucai; Wang, Tieling; Wen, Xiangzhen; Huang, Qi			Functional Analysis of the Ferric Uptake Regulator Gene fur in Xanthomonas vesicatoria	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; ORYZAE PV. ORYZAE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; MOLECULAR ANALYSIS; VIRULENCE FACTORS; SMALL RNAS; IRON; MOTILITY; POLYSACCHARIDES	Iron is essential for the growth and survival of many organisms. Intracellular iron homeostasis must be maintained for cell survival and protection against iron toxicity. The ferric uptake regulator protein (Fur) regulates the high-affinity ferric uptake system in many bacteria. To investigate the function of the fur gene in Xanthomonas vesicatoria (Xv), we generated a fur mutant strain, fur-m, by site-directed mutagenesis. Whereas siderophore production increased in the Xv fur mutant, extracellular polysaccharide production, biofilm formation, swimming ability and quorum sensing signals were all significantly decreased. The fur mutant also had significantly reduced virulence in tomato leaves. The above-mentioned phenotypes significantly recovered when the Xv fur mutation allele was complemented with a wild-type fur gene. Thus, Fur either negatively or positively regulates multiple important physiological functions in Xv.	[Liu, Huiqin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Huiqin; Dong, Chunling; Zhao, Tingchang; Wang, Tieling] Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China; [Liu, Huiqin; Han, Jucai] Shanxi Agr Univ, Agron Coll, Taigu, Shanxi, Peoples R China; [Wen, Xiangzhen] Shanxi Agr Univ, Hort Coll, Taigu, Shanxi, Peoples R China; [Huang, Qi] ARS, Floral & Nursery Plants Res Unit, USDA, Beltsville, MD USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Tianjin Agricultural University; Shanxi Agricultural University; Shanxi Agricultural University; United States Department of Agriculture (USDA)	Zhao, TC (corresponding author), Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China.	tzhaotgcg@163.com		Dong, Chunling/0000-0003-3968-5556	earmarked fund for Modern Agro-industry Technology Research System [CARS-26]; Special Fund for Agro-scientific Research in the Public Interest [201003066]; ARS [ARS-0423161] Funding Source: Federal RePORTER	earmarked fund for Modern Agro-industry Technology Research System; Special Fund for Agro-scientific Research in the Public Interest; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-26) and Special Fund for Agro-scientific Research in the Public Interest (201003066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Brown I, 1995, MOL PLANT MICROBE IN, V8, P825, DOI 10.1094/MPMI-8-0825; Buttner D, 2003, J BIOTECHNOL, V106, P203, DOI 10.1016/j.jbiotec.2003.07.012; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Cha JY, 2008, BIOCHEM BIOPH RES CO, V366, P281, DOI 10.1016/j.bbrc.2007.11.021; Chen X, 2010, SPECIES PHYSL RACES; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; COHEN MS, 1987, ANTIMICROB AGENTS CH, V31, P1507, DOI 10.1128/AAC.31.10.1507; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Ichinose Y, 2013, J GEN PLANT PATHOL, V79, P285, DOI 10.1007/s10327-013-0452-8; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; KAY E, 2006, MICROBE, V1, P63; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kazy SK, 2002, WORLD J MICROB BIOT, V18, P583, DOI 10.1023/A:1016354713289; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Liu HQ, 2004, FUNCTION ANAL FUR GE; MacLean AA, 2006, APPL ENVIRON MICROB, V72, P5403, DOI 10.1128/AEM.00580-06; Marcotte L, 2007, ANAL BIOCHEM, V361, P7, DOI 10.1016/j.ab.2006.11.009; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Rui HP, 2008, FEMS MICROBIOL LETT, V285, P155, DOI 10.1111/j.1574-6968.2008.01185.x; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Venisse JS, 2001, PLANT PHYSIOL, V125, P2164, DOI 10.1104/pp.125.4.2164; Wang F, 2008, J MICROBIOL, V46, P350, DOI 10.1007/s12275-008-0038-x; Windgassen M, 2000, FEMS MICROBIOL LETT, V193, P201, DOI 10.1016/S0378-1097(00)00476-6; Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999	55	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149280	10.1371/journal.pone.0149280	http://dx.doi.org/10.1371/journal.pone.0149280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910324	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700028
J	Ribacke, KJB; van Duinen, AJ; Nordenstedt, H; Hoijer, J; Molnes, R; Froseth, TW; Koroma, AP; Darj, E; Bolkan, HA; Ekstrom, A				Ribacke, Kim J. Brolin; van Duinen, Alex J.; Nordenstedt, Helena; Hoijer, Jonas; Molnes, Ragnhild; Froseth, Torunn Wigum; Koroma, A. P.; Darj, Elisabeth; Bolkan, Hakon Angel; Ekstrom, AnnaMia			The Impact of the West Africa Ebola Outbreak on Obstetric Health Care in Sierra Leone	PLOS ONE			English	Article								Background As Sierra Leone celebrates the end of the Ebola Virus Disease (EVD) outbreak, we can begin to fully grasp its impact on already weak health systems. The EVD outbreak in West Africa forced many hospitals to close down or reduce their activity, either to prevent nosocomial transmission or because of staff shortages. The aim of this study is to assess the potential impact of EVD on nationwide access to obstetric care in Sierra Leone. Methods and Findings Community health officers collected weekly data between January 2014-May 2015 on inhospital deliveries and caesarean sections (C-sections) from all open facilities (public, private for-profit and private non-profit sectors) offering emergency obstetrics in Sierra Leone. This was compared to official data of EVD cases per district. Logistic and Poisson regression analyses were used to compute risk and rate estimates. Nationwide, the number of inhospital deliveries and C-sections decreased by over 20% during the EVD outbreak. The decline occurred early on in the EVD outbreak and was mainly attributable to the closing of private not-for-profit hospitals rather than government facilities. Due to difficulties in collecting data in the midst of an epidemic, limitations of this study include some missing data points. Conclusions Both the number of in-hospital deliveries and C-sections substantially declined shortly after the onset of the EVD outbreak. Since access to emergency obstetric care, like C-sections, is associated with decreased maternal mortality, many women are likely to have died due to the reduced access to appropriate care during childbirth. Future research on indirect health effects of health system breakdown should ideally be nationwide and continue also into the recovery phase. It is also important to understand the mechanisms behind the deterioration so that important health services can be reestablished.	[Ribacke, Kim J. Brolin; Nordenstedt, Helena; Ekstrom, AnnaMia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [van Duinen, Alex J.; Bolkan, Hakon Angel] St Olav Hosp, Dept Surg, Trondheim, Norway; [van Duinen, Alex J.; Bolkan, Hakon Angel] CapaCare, Trondheim, Norway; [Hoijer, Jonas] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Molnes, Ragnhild; Froseth, Torunn Wigum; Darj, Elisabeth] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Koroma, A. P.] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Darj, Elisabeth] St Olav Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Bolkan, Hakon Angel] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Ekstrom, AnnaMia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Ministry of Health & Sanitation Sierra Leone; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska University Hospital	Ribacke, KJB (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	kim.brolin@ki.se	van Duinen, Alex/Q-2504-2019	van Duinen, Alex/0000-0002-6943-0100; Bolkan, Hakon Angell/0000-0002-9609-4093	Swedish National Board of Health and Welfare; Wallenberg Foundation; CapaCare; Norwegian University of Science and Technology	Swedish National Board of Health and Welfare; Wallenberg Foundation(European Commission); CapaCare; Norwegian University of Science and Technology	This study was funded by the Swedish National Board of Health and Welfare, The Wallenberg Foundation, CapaCare and the Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden-O'Fallon J, 2015, PLOS CURRENTS, V7; Bolkan HA, 2014, PLOS CURRENTS, V6; Bolkan HA, 2015, SURGERY, V157, P992, DOI 10.1016/j.surg.2014.12.028; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Dorwie FM, 2014, J TRANSCULT NURS, V25, P33, DOI 10.1177/1043659613503874; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Hayden EC, 2015, NATURE, V519, P24, DOI 10.1038/519024a; Hayden EC, 2014, NATURE, V516, P294, DOI 10.1038/516295a; Iyengar P, 2015, PLOS CURRENTS, V7; Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540; Lori JR, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0694-x; Ministry of Health and Sanitation SL, EB VIR DIS UPD 2015; *UNICEF, STAT WORLDS CHILDR 2; UNICEF, 2015, SIERR LEON HLTH FAC; WHO, 2015, EB SIT REP; WHO, 2015, EB VIR DIS SIERR LEO; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization Human Reproduction Programme 10 April 2015, 2015, Reprod Health Matters, V23, P149, DOI 10.1016/j.rhm.2015.07.007; Ye J, 2015, BJOG INT J OBSTET GY	19	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150080	10.1371/journal.pone.0150080	http://dx.doi.org/10.1371/journal.pone.0150080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910462	Green Published, Green Submitted, gold			2022-12-26	WOS:000371164700062
J	Yang, YH; Buhamrah, A; Schneider, A; Lin, YL; Zhou, H; Bugshan, A; Basile, JR				Yang, Ying-Hua; Buhamrah, Asma; Schneider, Abraham; Lin, Yi-Ling; Zhou, Hua; Bugshan, Amr; Basile, John R.			Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer	PLOS ONE			English	Article							TUMOR-INDUCED ANGIOGENESIS; BONE HISTOMORPHOMETRY; PROSTATE-CANCER; OSTEOCLASTOGENESIS; PLEXIN-B1; EXPRESSION; CELLS; MICE; IL-8; NOMENCLATURE	Bone density is controlled by interactions between osteoclasts, which resorb bone, and osteoblasts, which deposit it. The semaphorins and their receptors, the plexins, originally shown to function in the immune system and to provide chemotactic cues for axon guidance, are now known to play a role in this process as well. Emerging data have identified Semaphorin 4D (Sema4D) as a product of osteoclasts acting through its receptor Plexin-B1 on osteoblasts to inhibit their function, tipping the balance of bone homeostasis in favor of resorption. Breast cancers and other epithelial malignancies overexpress Sema4D, so we theorized that tumor cells could be exploiting this pathway to establish lytic skeletal metastases. Here, we use measurements of osteoblast and osteoclast differentiation and function in vitro and a mouse model of skeletal metastasis to demonstrate that both soluble Sema4D and protein produced by the breast cancer cell line MDA-MB-231 inhibits differentiation of MC3T3 cells, an osteoblast cell line, and their ability to form mineralized tissues, while Sema4D-mediated induction of IL-8 and LIX/CXCL5, the murine homologue of IL-8, increases osteoclast numbers and activity. We also observe a decrease in the number of bone metastases in mice injected with MDA-MB-231 cells when Sema4D is silenced by RNA interference. These results are significant because treatments directed at suppression of skeletal metastases in bone-homing malignancies usually work by arresting bone remodeling, potentially leading to skeletal fragility, a significant problem in patient management. Targeting Sema4D in these cancers would not affect bone remodeling and therefore could elicit an improved therapeutic result without the debilitating side effects.	[Yang, Ying-Hua; Buhamrah, Asma; Schneider, Abraham; Zhou, Hua; Bugshan, Amr; Basile, John R.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Schneider, Abraham; Basile, John R.] Greenebaum Canc Ctr, Baltimore, MD USA; [Lin, Yi-Ling] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles	Basile, JR (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.; Basile, JR (corresponding author), Greenebaum Canc Ctr, Baltimore, MD USA.	jbasile@umaryland.edu	Schneider, Abraham/AAR-5941-2021; Bugshan, Amr/AAH-8565-2019		National Cancer Institute [R01-CA133162]; NATIONAL CANCER INSTITUTE [R01CA133162] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.R.B was supported by a National Cancer Institute grant R01-CA133162 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Meenakshi A. Chellaiah of the University of Maryland Dental School for the luciferase-expressing breast cancer cell lines and Ernest Smith and Maurice Zauderer of Vaccinex, Inc., for providing the anti-SEMA4D antibody and offering technical support. J.R.B was supported by a National Cancer Institute grant R01-CA133162.	Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; Ch'ng E, 2007, CANCER-AM CANCER SOC, V110, P164, DOI 10.1002/cncr.22764; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Evans EE, 2015, CANCER IMMUNOL RES, V3, P689, DOI 10.1158/2326-6066.CIR-14-0171; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hernandez M, 2011, J PERIODONTAL RES, V46, P58, DOI 10.1111/j.1600-0765.2010.01310.x; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Hwang YS, 2012, ORAL ONCOL, V48, P40, DOI 10.1016/j.oraloncology.2011.08.022; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; Moriarity BS, 2015, NAT GENET; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Verlinden L, 2013, BONE, V55, P465, DOI 10.1016/j.bone.2013.03.023; Wang JS, 2015, WORLD J GASTROENTERO, V21, P2191, DOI 10.3748/wjg.v21.i7.2191; Wang S, 2015, INNATE IMMUN-LONDON, V21, P726, DOI 10.1177/1753425915593162; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025826; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yoshida Y, 2015, ARTHRITIS RHEUMATOL; Zhou H, 2012, ANGIOGENESIS	50	26	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150151	10.1371/journal.pone.0150151	http://dx.doi.org/10.1371/journal.pone.0150151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910109	gold, Green Published, Green Submitted			2022-12-26	WOS:000371164700071
J	Agallou, M; Athanasiou, E; Samiotaki, M; Panayotou, G; Karagouni, E				Agallou, Maria; Athanasiou, Evita; Samiotaki, Martina; Panayotou, George; Karagouni, Evdokia			Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; POTENTIAL VACCINE CANDIDATES; LONG-LASTING PROTECTION; FACTOR-ALPHA PRODUCTION; PROTEOMIC ANALYSIS; CUTANEOUS LEISHMANIASIS; DONOVANI PROMASTIGOTES; INTRANASAL VACCINATION; SYSTEMIC CANDIDIASIS; VIANNIA BRAZILIENSIS	Leishmania infantum is the etiologic agent of zoonotic visceral leishmaniasis (VL) in countries in the Mediterranean basin, where dogs are the domestic reservoirs and represent important elements in the transmission of the disease. Since the major focal areas of human VL exhibit a high prevalence of seropositive dogs, the control of canine VL could reduce the infection rate in humans. Efforts toward this have focused on the improvement of diagnostic tools, as well as on vaccine development. The identification of parasite antigens including suitable major histocompatibility complex (MHC) class I-and/or II-restricted epitopes is very important since disease protection is characterized by strong and long-lasting CD8(+) T and CD4(+) Th1 cell-dominated immunity. In the present study, total protein extract from late-log phase L. infantum promastigotes was analyzed by two-dimensional western blots and probed with sera from asymptomatic and symptomatic dogs. A total of 42 protein spots were found to differentially react with IgG from asymptomatic dogs, while 17 of these identified by Coommasie stain were extracted and analyzed. Of these, 21 proteins were identified by mass spectrometry; they were mainly involved in metabolism and stress responses. An in silico analysis predicted that the chaperonin HSP60, dihydrolipoamide dehydrogenase, enolase, cyclophilin 2, cyclophilin 40, and one hypothetical protein contain promiscuous MHCI and/or MHCII epitopes. Our results suggest that the combination of immunoproteomics and bioinformatics analyses is a promising method for the identification of novel candidate antigens for vaccine development or with potential use in the development of sensitive diagnostic tests.	[Agallou, Maria; Athanasiou, Evita; Karagouni, Evdokia] Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece; [Athanasiou, Evita] Aristotle Univ Thessaloniki, Dept Chem Engn, Chem Engn Lab, Dept Anal Design & Control Chem Proc, GR-54006 Thessaloniki, Greece; [Samiotaki, Martina; Panayotou, George] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece	Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center	Karagouni, E (corresponding author), Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece.	ekaragouni@pasteur.gr	Samiotaki, Martina/B-3851-2018; Agallou, Maria/AAC-6502-2020	Samiotaki, Martina/0000-0001-9952-0636; Agallou, Maria/0000-0003-0241-1340; Karagouni, Evdokia/0000-0002-0987-4877	Actions "KRIPIS" [MIS 450598, MIS448143]; European Union; National Ministry of Education and Religion Affairs; General Secretariat of Research and Technology (GSRT)	Actions "KRIPIS"; European Union(European Commission); National Ministry of Education and Religion Affairs; General Secretariat of Research and Technology (GSRT)(Greek Ministry of Development-GSRT)	This work was supported by grants from the Actions "KRIPIS" (MIS 450598 and MIS448143) awarded to EK and GP, respectively. These two Actions were co-financed by European Union and the National Ministry of Education and Religion Affairs under the Operational Strategic Reference Framework (NSFR 2007-2013) and the General Secretariat of Research and Technology (GSRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanades DR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001687; Alexandre-Pires G, 2010, VET IMMUNOL IMMUNOP, V137, P275, DOI 10.1016/j.vetimm.2010.06.007; ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Athanasiou LV, 2012, ACTA TROP, V122, P291, DOI 10.1016/j.actatropica.2012.02.003; Barhoumi M, 2013, PARASITE IMMUNOL, V35, P194, DOI 10.1111/pim.12026; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Braga MS, 2014, MOL BIOCHEM PARASIT, V195, P43, DOI 10.1016/j.molbiopara.2014.07.001; Bras-Goncalves R, 2014, INFECT GENET EVOL, V24, P1, DOI 10.1016/j.meegid.2014.02.017; Brotherton MC, 2014, INT J PARASITOL-DRUG, V4, P126, DOI 10.1016/j.ijpddr.2014.05.002; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Cardoso L, 2007, VET IMMUNOL IMMUNOP, V117, P35, DOI 10.1016/j.vetimm.2007.01.014; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; Cunningham DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/j.1365-2958.2005.04840.x; Dantas-Torres F, 2016, TRENDS PARASITOL, V32, P43, DOI 10.1016/j.pt.2015.09.004; Gomes DCD, 2012, PARASITOLOGY, V139, P1562, DOI 10.1017/S0031182012000868; Dea-Ayuela MA, 2006, PROTEOMICS, V6, P4187, DOI 10.1002/pmic.200600101; do Monte-Neto RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001167; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Duarte MC, 2015, CLIN VACCINE IMMUNOL, V22, P1187, DOI 10.1128/CVI.00465-15; Dubois ME, 2005, INFECT IMMUN, V73, P2690, DOI 10.1128/IAI.73.5.2690-2697.2005; Dunston CR, 2015, J PHARM PHARMACOL, V67, P290, DOI 10.1111/jphp.12383; Esgleas M, 2009, FEMS MICROBIOL LETT, V294, P82, DOI 10.1111/j.1574-6968.2009.01551.x; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Fernandez-Perez FJ, 2003, ACTA TROP, V86, P83, DOI 10.1016/S0001-706X(03)00004-4; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Frank SA, 2006, INFECT GENET EVOL, V6, P141, DOI 10.1016/j.meegid.2004.10.005; Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033; Gradoni L, 2015, VET PARASITOL, V208, P94, DOI 10.1016/j.vetpar.2015.01.003; Gupta R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086073; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Kamoun-Essghaier S, 2005, CLIN DIAGN LAB IMMUN, V12, P310, DOI 10.1128/CDLI.12.2.310-320.2005; Kaur H, 2015, PARASITE IMMUNOL, V37, P192, DOI 10.1111/pim.12176; Koutsoni O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097319; KRAUTHSIEGEL RL, 1995, FASEB J, V9, P1138, DOI 10.1096/fasebj.9.12.7672506; Kumar A, 2015, PARASITE IMMUNOL, V37, P368, DOI 10.1111/pim.12189; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE F, 1985, P NATL ACAD SCI USA, V82, P4414, DOI 10.1073/pnas.82.13.4414; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Maalej IA, 2003, AM J TROP MED HYG, V68, P312, DOI 10.4269/ajtmh.2003.68.312; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Ntais P, 2013, AM J TROP MED HYG, V89, P906, DOI 10.4269/ajtmh.13-0070; Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Palatnik-de-Sousa CB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00069; Pinto EF, 2004, INFECT IMMUN, V72, P4521, DOI 10.1128/IAI.72.8.4521-4527.2004; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Requena JM, 2001, TRENDS PARASITOL, V17, P64, DOI 10.1016/S1471-4922(00)01769-4; ReyLadino JA, 1997, EXP PARASITOL, V85, P249, DOI 10.1006/expr.1996.4137; Sacks D. L., 1998, CURR PROTOC IMMUNOL, V29; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos-Gomes GM, 2014, VACCINE, V32, P1247, DOI 10.1016/j.vaccine.2014.01.024; Schluter A, 2000, BBA-GENE STRUCT EXPR, V1491, P65, DOI 10.1016/S0167-4781(00)00028-2; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sideris V, 1999, EUR J EPIDEMIOL, V15, P271, DOI 10.1023/A:1007526401175; Singh AK, 2014, J PROTEOMICS, V102, P44, DOI 10.1016/j.jprot.2014.02.030; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Tarcha EJ, 2006, INFECT IMMUN, V74, P516, DOI 10.1128/IAI.74.1.516-527.2006; Tarcha EJ, 2006, INFECT IMMUN, V74, P5802, DOI 10.1128/IAI.00961-06; Thakur CP, 2001, T ROY SOC TROP MED H, V95, P187, DOI 10.1016/S0035-9203(01)90160-9; Todoli F, 2009, VET PARASITOL, V164, P154, DOI 10.1016/j.vetpar.2009.05.032; TZAMOURANIS N, 1984, ANN TROP MED PARASIT, V78, P363, DOI 10.1080/00034983.1984.11811833; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Wagner JL, 2003, J HERED, V94, P23, DOI 10.1093/jhered/esg002; World Health Organization, 2010, TECH REP SER, V949, P186; Yau WL, 2014, MOL MICROBIOL, V93, P80, DOI 10.1111/mmi.12639	88	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149894	10.1371/journal.pone.0149894	http://dx.doi.org/10.1371/journal.pone.0149894			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906226	Green Published, Green Submitted, gold			2022-12-26	WOS:000371163000025
J	Ash, C; Drabek, O; Tejnecky, V; Jehlicka, J; Michon, N; Boruvka, L				Ash, Christopher; Drabek, Ondrej; Tejnecky, Vaclav; Jehlicka, Jan; Michon, Ninon; Boruvka, Lubos			Sustainable Soil Washing: Shredded Card Filtration of Potentially Toxic Elements after Leaching from Soil Using Organic Acid Solutions	PLOS ONE			English	Article							LEAD; ADSORPTION; CHROMIUM; SLUDGE; NICKEL; IMMOBILIZATION; REMEDIATION; ENVIRONMENT; COPPER; IONS	Shredded card (SC) was assessed for use as a sorbent of potentially toxic elements (PTE) carried from contaminated soil in various leachates (oxalic acid, formic acid, CaCl2, water). We further assessed SC for retention of PTE, using acidified water (pH 3.4). Vertical columns and a peristaltic pump were used to leach PTE from soils (O and A/B horizons) before passing through SC. Sorption onto SC was studied by comparing leachates, and by monitoring total PTE contents on SC before and after leaching. SC buffers against acidic soil conditions that promote metals solubility; considerable increases in solution pH (+4.49) were observed. Greatest differences in solution PTE content after leaching with/without SC occurred for Pb. In oxalic acid, As, Cd, Pb showed a high level of sorption (25, 15, and 58x more of the respective PTE in leachates without SC). In formic acid, Pb sorption was highly efficient (219x more Pb in leachate without SC). In water, only Pb showed high sorption (191x more Pb in leachate without SC). In desorption experiments, release of PTE from SC varied according to the source of PTE (organic/mineral soil), and type of solvent used. Arsenic was the PTE most readily leached in desorption experiments. Low As sorption from water was followed by fast release (70% As released from SC). A high rate of Cd sorption from organic acid solutions was followed by strong retention (similar to 12% Cd desorption). SC also retained Pb after sorption from water, with subsequent losses of <= 8.5% of total bound Pb. The proposed use of this material is for the filtration of PTE from extract solution following soil washing. Low-molecular-mass organic acids offer a less destructive, biodegradable alternative to strong inorganic acids for soil washing.	[Ash, Christopher; Drabek, Ondrej; Tejnecky, Vaclav; Michon, Ninon; Boruvka, Lubos] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic; [Jehlicka, Jan] Czech Univ Life Sci, Fac Environm Sci, Dept Environm Geosci, Prague, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Ash, C (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Soil Sci & Soil Protect, Prague, Czech Republic.	ash@af.czu.cz	Tejnecký, Václav/K-9043-2013; Drábek, Ondřej/AAU-3496-2021; Boruvka, Lubos/U-8869-2019	Tejnecký, Václav/0000-0003-0296-4981; Boruvka, Lubos/0000-0001-5317-0933	Internal Grant Agency of Czech University of Life Sciences (CIGA) [20132005]; Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague	Internal Grant Agency of Czech University of Life Sciences (CIGA); Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague	The research was supported by a grant from the Internal Grant Agency of Czech University of Life Sciences (CIGA) (no. 20132005) and was also financed by a grant issued by the Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences in Prague.	Andrabi SMA, 2010, J INDIAN CHEM SOC, V87, P963; Battaglia A, 2007, BIORESOURCE TECHNOL, V98, P2993, DOI 10.1016/j.biortech.2006.10.007; Battaglia A, 2003, MICROCHEM J, V75, P97, DOI 10.1016/S0026-265X(03)00074-2; Bulut Y, 2007, J ENVIRON SCI, V19, P160, DOI 10.1016/S1001-0742(07)60026-6; Calace N, 2005, ENVIRON POLLUT, V136, P485, DOI 10.1016/j.envpol.2004.12.014; Ettler V, 2010, GEODERMA, V155, P409, DOI 10.1016/j.geoderma.2009.12.027; He XJ, 2010, J ENVIRON SCI-CHINA, V22, P413, DOI 10.1016/S1001-0742(09)60123-6; Hesse PR, 1998, TXB SOIL CHEM ANAL, P101; Houben D, 2012, J GEOCHEM EXPLOR, V123, P87, DOI 10.1016/j.gexplo.2011.10.004; Jean-Soro L, 2012, ENVIRON POLLUT, V164, P175, DOI 10.1016/j.envpol.2012.01.022; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Kim KH, 2013, COLLOID SURFACE A, V425, P6, DOI 10.1016/j.colsurfa.2013.02.044; Lestan D, 2008, ENVIRON POLLUT, V153, P3, DOI 10.1016/j.envpol.2007.11.015; Lodenius M., 1989, Ecological impact of acidification., P131; Meuser H, 2013, SOIL REMEDIATION REH; Nathanail C.P., 2004, RECLAMATION CONTAMIN; Novozamski I, 1993, HARMONIZATION LEACHI, V51, P47; Perelomov LV, 2011, EURASIAN SOIL SCI+, V44, P22, DOI 10.1134/S1064229311010091; Podlesakova E, 1992, 2783 RES I SOIL IMPR; Prica M, 2012, ARCH ENVIRON PROT, V38, P109, DOI 10.2478/v10265-012-0039-z; Rafatullah M, 2009, J HAZARD MATER, V170, P969, DOI 10.1016/j.jhazmat.2009.05.066; Sillerova H, 2013, J COLLOID INTERF SCI, V396, P227, DOI 10.1016/j.jcis.2013.01.029; Smith E, 1998, ADV AGRON, V64, P149, DOI 10.1016/S0065-2113(08)60504-0; Tejnecky V, 2013, SCI TOTAL ENVIRON, V442, P165, DOI 10.1016/j.scitotenv.2012.10.053; Wang F, 2002, J PULP PAP SCI, V28, P347; Wang SL, 2006, ENVIRON GEOCHEM HLTH, V28, P197, DOI 10.1007/s10653-005-9032-y	26	11	11	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149882	10.1371/journal.pone.0149882	http://dx.doi.org/10.1371/journal.pone.0149882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900684	gold, Green Published			2022-12-26	WOS:000371276100173
J	Fernandez-Garcia, A; Delgado, E; Cuevas, MT; Vega, Y; Montero, V; Sanchez, M; Carrera, C; Lopez-Alvarez, MJ; Miralles, C; Perez-Castro, S; Cilla, G; Hinojosa, C; Perez-Alvarez, L; Thomson, MM				Fernandez-Garcia, Aurora; Delgado, Elena; Teresa Cuevas, Maria; Vega, Yolanda; Montero, Vanessa; Sanchez, Monica; Carrera, Cristina; Jose Lopez-Alvarez, Maria; Miralles, Celia; Perez-Castro, Sonia; Cilla, Gustavo; Hinojosa, Carmen; Perez-Alvarez, Lucia; Thomson, Michael M.			Identification of an HIV-1 BG Intersubtype Recombinant Form (CRF73_BG), Partially Related to CRF14_BG, Which Is Circulating in Portugal and Spain	PLOS ONE			English	Article							INJECTING DRUG-USERS; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; SUBTYPE-G; TYPE-1; SEQUENCES; GALICIA; INFECTION; INFERENCE; STRAINS	HIV-1 exhibits a characteristically high genetic diversity, with the M group, responsible for the pandemic, being classified into nine subtypes, 72 circulating recombinant forms (CRFs) and numerous unique recombinant forms (URFs). Here we characterize the near full-length genome sequence of an HIV-1 BG intersubtype recombinant virus (X3208) collected in Galicia (Northwest Spain) which exhibits a mosaic structure coincident with that of a previously characterized BG recombinant virus (9601_01), collected in Germany and epidemiologically linked to Portugal, and different from currently defined CRFs. Similar recombination patterns were found in partial genome sequences from three other BG recombinant viruses, one newly derived, from a virus collected in Spain, and two retrieved from databases, collected in France and Portugal, respectively. Breakpoint coincidence and clustering in phylogenetic trees of these epidemiologically-unlinked viruses allow to define a new HIV-1 CRF (CRF73_BG). CRF73_BG shares one breakpoint in the envelope with CRF14_BG, which circulates in Portugal and Spain, and groups with it in a subtype B envelope fragment, but the greatest part of its genome does not appear to derive from CRF14_BG, although both CRFs share as parental strain the subtype G variant circulating in the Iberian Peninsula. Phylogenetic clustering of partial pol and env segments from viruses collected in Portugal and Spain with X3208 and 9691_01 indicates that CRF73_BG is circulating in both countries, with proportions of around 2-3% Portuguese database HIV-1 isolates clustering with CRF73_BG. The fact that an HIV-1 recombinant virus characterized ten years ago as a URF has been shown to represent a CRF suggests that the number of HIV-1 CRFs may be much greater than currently known.	[Fernandez-Garcia, Aurora; Delgado, Elena; Teresa Cuevas, Maria; Vega, Yolanda; Montero, Vanessa; Sanchez, Monica; Carrera, Cristina; Perez-Alvarez, Lucia; Thomson, Michael M.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Fernandez-Garcia, Aurora] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Jose Lopez-Alvarez, Maria] Hosp Univ Lucus Augusti, Lugo, Spain; [Miralles, Celia; Perez-Castro, Sonia] Complejo Hosp Univ Vigo, Vigo, Pontevedra, Spain; [Cilla, Gustavo] Hosp Univ Donostia, San Sebastian, Spain; [Hinojosa, Carmen] Hosp Clin Univ Valladolid, Valladolid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario Lucus Augusti-Lugo; Complexo Hospitalario Universitario de Vigo; Universidad de Valladolid	Thomson, MM (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	mthomson@iscii.es	gonzalez-nico, maria teresa cuevas/E-2001-2014; Thomson, Michael M/P-8949-2017; CARRERA, CRISTINA/N-1887-2019; Delgado, Elena/E-2785-2019	gonzalez-nico, maria teresa cuevas/0000-0002-4195-1975; Thomson, Michael M/0000-0002-0622-7527; CARRERA, CRISTINA/0000-0003-1608-8820; Delgado, Elena/0000-0002-0754-8533; PEREZ CASTRO, SONIA/0000-0003-1734-1904	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain [EC11-272]; Instituto de Salud Carlos III; Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I [RD12/0017/0026]; Conselleria de Sanidade, Government of Galicia, Spain [MVI 1291/08]; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain [MVI-1255-08]	Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I; Conselleria de Sanidade, Government of Galicia, Spain; Osakidetza-Servicio Vasco de Salud, Basque Country, Spain	Funded by Direccion General de Farmacia, Ministerio de Sanidad, Servicios Sociales e Igualdad, Government of Spain (Grant EC11-272 URL: http://www.msssi.gob.es/); Instituto de Salud Carlos III, Subdireccion General de Evaluacion, and Fondo Europeo de Desarrollo Regional (FEDER), Plan Nacional I + D + I (Grant RD12/0017/0026 URL: http://www.isciii.es/); Conselleria de Sanidade, Government of Galicia, Spain (Grant MVI 1291/08 URL: http://www.sergas.es/); Osakidetza-Servicio Vasco de Salud, Basque Country, Spain Grant: MVI-1255-08 URL: http://www.osakidetza.euskadi.eus/r85-ghhome00/es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2011, AIDS RES HUM RETROV, V27, P803, DOI [10.1089/aid.2010.0312, 10.1089/AID.2010.0312]; Bartolo I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024130; Cuevas M, 2009, EUROSURVEILLANCE, V14; Delgado E, 2002, J ACQ IMMUN DEF SYND, V29, P536, DOI 10.1097/00126334-200204150-00016; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Esteves A, 2003, AIDS RES HUM RETROV, V19, P511, DOI 10.1089/088922203766774568; Esteves A, 2002, AIDS RES HUM RETROV, V18, P313, DOI 10.1089/088922202753519089; Fernandez-Garcia A, 2010, AIDS RES HUM RETROV, V26, P827, DOI 10.1089/aid.2009.0311; Harris B, 2005, AIDS RES HUM RETROV, V21, P654, DOI 10.1089/aid.2005.21.654; HIV Sequence Database, HIV SEQ DAT; Holguin A, 2008, CURR HIV RES, V6, P327, DOI 10.2174/157016208785132455; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Munoz-Nieto M, 2008, AIDS RES HUM RETROV, V24, P337, DOI 10.1089/aid.2007.0230; Perez-Alvarez L, 2014, J ANTIMICROB CHEMOTH, V69, P246, DOI 10.1093/jac/dkt305; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schultz AK, 2009, NUCLEIC ACIDS RES, V37, pW647, DOI 10.1093/nar/gkp371; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Shcherbakova NS, 2014, AIDS RES HUM RETROV, V30, P912, DOI [10.1089/aid.2014.0075, 10.1089/AID.2014.0075]; Sierra Maria, 2005, Infection Genetics and Evolution, V5, P209, DOI 10.1016/j.meegid.2004.07.010; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thomson MM, 2007, J INFECT DIS, V196, P1120, DOI 10.1086/521683; Thomson MM, 2012, JAIDS-J ACQ IMM DEF, V59, pE49, DOI 10.1097/QAI.0b013e3182400fc4; Thomson MM, 2002, LANCET INFECT DIS, V2, P461, DOI 10.1016/S1473-3099(02)00343-2; Thomson MM, 2001, CLIN INFECT DIS, V32, P1732, DOI 10.1086/320764; Thomson MM, 2001, AIDS, V15, P509, DOI 10.1097/00002030-200103090-00010	28	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148549	10.1371/journal.pone.0148549	http://dx.doi.org/10.1371/journal.pone.0148549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900693	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100019
J	Koga, H; Iida, K; Maeda, T; Takahashi, M; Fukushima, N; Goshi, T				Koga, Hiroshi; Iida, Koichi; Maeda, Tomoki; Takahashi, Mizuho; Fukushima, Naoki; Goshi, Terufumi			Epidemiologic Research on Malformations Associated with Cleft Lip and Cleft Palate in Japan	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; EXPERIENCE; CHILDREN; POPULATION; EUROPE	To investigate malformations associated with cleft lip and cleft palate, we conducted surveys at neonatal intensive care units (NICUs) and other non-NICU facilities and to determine whether there are differences among facilities. The regional survey investigated NICU facilities located in Oita Prefecture, including 92 patients with cleft lip and palate (CLP) or cleft palate (CP) that occurred between 2004 and 2013, and the national survey investigated oral surgery, plastic surgery, and obstetrics and gynecology facilities located in Japan, including 16,452 patients with cleft lip (CL), CLP, or CP that occurred since 2000. The incidence per 10,000 births was 4.2, 6.2, and 2.8 for CL, CLP, and CP, respectively, according to the national survey, and 6.3 and 2.9 for CLP and CP, respectively according to the regional survey. These results indicated comparable incidences between the two surveys. In contrast, when the survey results on malformations associated with CLP and CP according to the ICD-10 classification were compared between the national survey conducted at oral surgery or plastic surgery facilities and the regional survey conducted at NICU facilities, the occurrence of associated malformations was 19.8% vs. 41.3% for any types of associated malformation, 6.8% vs. 21.7% for congenital heart disease, and 0.5% vs. 16.3% for chromosomal abnormalities. These results indicated that the incidences of all of these associated malformations were significantly greater in the survey conducted at NICU facilities and similar to the findings from international epidemiological surveys. When comparing the survey conducted at obstetrics facilities vs. NICU facilities, the occurrence of associated malformations was similar results as above. The incidence of CLP and CP was not different between surveys conducted at NICU facilities vs. non-NICU facilities; however, when conducting surveys on associated malformations, it is possible to obtain accurate epidemiological data by investigating NICU facilities where detailed examinations are thoroughly performed.	[Koga, Hiroshi] Natl Hosp Org Beppu Med Ctr, Dept Pediat, Oita, Japan; [Iida, Koichi] Oita Prefectural Hosp, Dept Neonatol, Oita, Japan; [Maeda, Tomoki; Takahashi, Mizuho] Oita Univ, Fac Med, Dept Pediat, Oita 87011, Japan; [Fukushima, Naoki] Almeida Hosp, Dept Pediat, Oita, Japan; [Goshi, Terufumi] Nakatsu Municipal Hosp, Dept Pediat, Oita, Japan	Oita University	Koga, H (corresponding author), Natl Hosp Org Beppu Med Ctr, Dept Pediat, Oita, Japan.	sakuraliberty@beppu2.hosp.go.jp	Koga, Hiroshi/AAR-3755-2020	Koga, Hiroshi/0000-0001-9583-9842				[Anonymous], 2016, ICD 10 VERS 2016; Boyd PA, 1998, LANCET, V352, P1577, DOI 10.1016/S0140-6736(98)03202-4; Calzolari E, 2004, CLEFT PALATE-CRAN J, V41, P244, DOI 10.1597/02-074.1; Calzolari E, 2007, AM J MED GENET A, V143A, P528, DOI 10.1002/ajmg.a.31447; Chen YW, 2012, LARYNGOSCOPE, V122, P220, DOI 10.1002/lary.22425; de Vries IAC, 2014, CLIN ORAL INVEST, V18, P1507, DOI [10.1007/s00784-014-1190-9, 10.1007/s00784-013-1117-x]; Funayama E, 2014, INT J PEDIATR OTORHI, V78, P2127, DOI 10.1016/j.ijporl.2014.09.021; Gundlach KKH, 2006, J CRANIO MAXILL SURG, V34, P1; Hardin-Jones MA, 2005, CLEFT PALATE-CRAN J, V42, P7, DOI 10.1597/03-134.1; Jordan VA, 2014, LARYNGOSCOPE, V124, pE384, DOI 10.1002/lary.24727; Kogo M, 1997, CLEFT PALATE-CRAN J, V34, P351, DOI 10.1597/1545-1569(1997)034<0350:BFFCLA>2.3.CO;2; Mossey P., 2003, GLOBAL REGISTRY DATA; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Natsume N, 2000, BRIT J ORAL MAX SURG, V38, P605, DOI 10.1054/bjom.2000.0539; Paterson P, 2011, CLEFT PALATE-CRAN J, V48, P608, DOI 10.1597/09-238; Prahl C, 2005, CLEFT PALATE-CRAN J, V42, P171, DOI 10.1597/03-111.1; Richmond S, 2005, BJOG-INT J OBSTET GY, V112, P1349, DOI 10.1111/j.1471-0528.2005.00660.x; Sago H, 2015, PRENATAL DIAG, V35, P331, DOI 10.1002/pd.4539; Uzel A, 2011, CLEFT PALATE-CRAN J, V48, P587, DOI 10.1597/10-008; Vettore MV, 2011, EUR J ORTHODONT, V33, P311, DOI 10.1093/ejo/cjq078	20	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149773	10.1371/journal.pone.0149773	http://dx.doi.org/10.1371/journal.pone.0149773			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901758	Green Published, gold			2022-12-26	WOS:000371276100149
J	Lefebvre, A; Rochefort, GY; Santos, F; Le Denmat, D; Salmon, B; Petillon, JM				Lefebvre, Alexandre; Rochefort, Gael Y.; Santos, Frederic; Le Denmat, Dominique; Salmon, Benjamin; Petillon, Jean-Marc			A Non-Destructive Method for Distinguishing Reindeer Antler (Rangifer tarandus) from Red Deer Antler (Cervus elaphus) Using X-Ray Micro-Tomography Coupled with SVM Classifiers	PLOS ONE			English	Article							SPECIES IDENTIFICATION; MECHANICAL-PROPERTIES; BONE MICROSTRUCTURE; COMPUTED-TOMOGRAPHY; IVORY; HUMANS; MICROTOMOGRAPHY; QUANTIFICATION; EMPHASIS; NORTHERN	Over the last decade, biomedical 3D-imaging tools have gained widespread use in the analysis of prehistoric bone artefacts. While initial attempts to characterise the major categories used in osseous industry (i.e. bone, antler, and dentine/ivory) have been successful, the taxonomic determination of prehistoric artefacts remains to be investigated. The distinction between reindeer and red deer antler can be challenging, particularly in cases of anthropic and/or taphonomic modifications. In addition to the range of destructive physicochemical identification methods available (mass spectrometry, isotopic ratio, and DNA analysis), Xray micro-tomography (micro-CT) provides convincing non-destructive 3D images and analyses. This paper presents the experimental protocol (sample scans, image processing, and statistical analysis) we have developed in order to identify modern and archaeological antler collections (from Isturitz, France). This original method is based on bone microstructure analysis combined with advanced statistical support vector machine (SVM) classifiers. A combination of six microarchitecture biomarkers (bone volume fraction, trabecular number, trabecular separation, trabecular thickness, trabecular bone pattern factor, and structure model index) were screened using micro-CT in order to characterise internal alveolar structure. Overall, reindeer alveoli presented a tighter mesh than red deer alveoli, and statistical analysis allowed us to distinguish archaeological antler by species with an accuracy of 96%, regardless of anatomical location on the antler. In conclusion, micro-CT combined with SVM classifiers proves to be a promising additional non-destructive method for antler identification, suitable for archaeological artefacts whose degree of human modification and cultural heritage or scientific value has previously made it impossible (tools, ornaments, etc.).	[Lefebvre, Alexandre; Santos, Frederic] Univ Bordeaux, Prehist Actuel, Culture, Environm,Anthropol,UMR 5199, Bordeaux, France; [Rochefort, Gael Y.; Le Denmat, Dominique; Salmon, Benjamin] Univ Paris 05, Sorbonne Paris Cite, EA Pathol Imagerie & Biotherapies Orofaciales 249, Plateforme Imagerie Vivant,Dent Sch, Montrouge, France; [Salmon, Benjamin] Hop Univ PNVS, AP HP, Serv Odontol Bretonneau, Paris, France; [Petillon, Jean-Marc] Univ Toulouse Jean Jaures, Travaux & Rech Archeol Cultures, Espaces & Soc UMR 5608, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Lefebvre, A (corresponding author), Univ Bordeaux, Prehist Actuel, Culture, Environm,Anthropol,UMR 5199, Bordeaux, France.	alexandre.lefebvre@u-bordeaux.fr	Lefebvre, Alexandre/ABG-2400-2020; Rochefort, Gaël Y./H-3359-2019; SALMON, Benjamin/X-4286-2019; Santos, Frédéric/I-3565-2019	Lefebvre, Alexandre/0000-0003-1980-4546; Rochefort, Gaël Y./0000-0001-6428-3570; SALMON, Benjamin/0000-0001-8739-2753; Santos, Frédéric/0000-0003-1445-3871; Petillon, Jean-Marc/0000-0003-4123-2361	Research National Agency [ANR 2011 BSH3 0005]; "Pathologie, Imagerie et Biotherapies orofaciales" laboratories [EA2496]; Ministere de l'Enseignement Superieur et de la Recherche; laboratory PACEA in Bordeaux (UMR 5199, CNRS); MAGDATIS Project [ANR 2011 BSH3 0005]; Pacea (UMR 5199, CNRS)	Research National Agency; "Pathologie, Imagerie et Biotherapies orofaciales" laboratories; Ministere de l'Enseignement Superieur et de la Recherche; laboratory PACEA in Bordeaux (UMR 5199, CNRS); MAGDATIS Project; Pacea (UMR 5199, CNRS)	This research is funded by a ministerial grant from the Research National Agency as a program of prospects investments (the MAGDATIS Project [ANR 2011 BSH3 0005]) (project 'Des chasseurs-cueilleurs face aux changements environnementaux 18-14 kyr cal BP'; dir: JMP), "Pathologie, Imagerie et Biotherapies orofaciales" laboratories (EA2496), and has also been performed thanks to the PhD research grant from the Ministere de l'Enseignement Superieur et de la Recherche for AL. The acquisition of the experimental material is supported by the laboratory PACEA in Bordeaux (UMR 5199, CNRS). All the experiments presented were performed at the IDV platform in the Universite Paris Descartes Sorbonne Cite. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Catherine Schwab, curator at the Palaeolithic Department of MAN, for her support. Many thanks also to the micro-CT IDV Platform (EA2496, Montrouge, France) and particularly to Jeremy Sadoine. We would also like to thank Brad Gravina, Marie-Claire Dawson and Sarita Jannin for helping with the translation. We are indebted to the anonymous reviewers whose comments helped to improve the manuscript significantly. Finally we would like to thank the MAGDATIS Project (ANR 2011 BSH3 0005), Pacea (UMR 5199, CNRS) and the "Pathologie, Imagerie et Biotherapies orofaciales" (EA2496) laboratories for supporting this study.	Akhtar R, 2008, ACTA BIOMATER, V4, P1677, DOI 10.1016/j.actbio.2008.05.008; Albrecht G., 1977, METHODOLOGIE APPLIQU, P119; Altuna J, 1995, FINAL PALEOLITICO CA, P77; [Anonymous], 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1; Averbouh A, 2000, THESIS U PARIS 1 PAN, P500; Averbouh A., 2005, COMPORTEMENTS HOMMES, P59; Bartos L., 1990, P442; Bello SM, 2013, J ARCHAEOL SCI, V40, P2464, DOI 10.1016/j.jas.2012.12.016; Bello SM, 2013, J ARCHAEOL SCI, V40, P4528, DOI 10.1016/j.jas.2013.07.016; Benazzi S, 2011, NATURE, V479, P525, DOI 10.1038/nature10617; Bernardini F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044904; Bjorck S., 1998, J QUATERNARY SCI, V13, P238, DOI [10.1002/(SICI)1099-1417(199807/08)13:4&LT;283::AID-JQS386&GT;3.0.CO;2-A, DOI 10.1002/(SICI)1099-1417(199807/08)13:4<283::AID-JQS386>3.0.CO;2-A]; Blosseville R, 2014, MEMOIRE DE MASTER, V2; Bocherens H, 2006, J HUM EVOL, V50, P370, DOI 10.1016/j.jhevol.2005.12.002; Boschin F, 2015, ARCHAEOMETRY, V57, P194, DOI 10.1111/arcm.12122; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bradfield J, 2013, J ARCHAEOL SCI, V40, P2606, DOI 10.1016/j.jas.2013.02.007; Buckley M, 2014, J ARCHAEOL SCI, V41, P631, DOI 10.1016/j.jas.2013.08.021; Buckley M., 2011, ANTIQUA, V1, pe1, DOI [10.4081/antiqua.2011.e1.-e1, DOI 10.4081/ANTIQUA.2011.E1.-E1, DOI 10.4081/ANTIQUA.2011.E1]; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2011, ARCHAEOL ANTHROP SCI, V3, P271, DOI 10.1007/s12520-011-0066-z; CHAPMAN D I, 1975, Mammal Review, V5, P121, DOI 10.1111/j.1365-2907.1975.tb00194.x; Colombo A., 2013, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V25, P127, DOI 10.1007/s13219-012-0076-4; Colombo A, 2014, THESIS U BORDEAUX, P283; Criegel MH, 2001, ANN MED VET, V145, P25; CURREY JD, 1989, J BIOMECH, V22, P469, DOI 10.1016/0021-9290(89)90207-8; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; DeSilva JM, 2012, J HUM EVOL, V63, P536, DOI 10.1016/j.jhevol.2012.06.006; Enzmann F, 2008, SKRIPTEN, V228, P81; Fennessy P.F., 1985, Royal Society of New Zealand Bulletin, P239; Franklin D, 2005, HOMO, V56, P17, DOI 10.1016/j.jchb.2004.07.004; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B; Heinz C, 2001, HIST HOMMES HIST PLA, P57; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Izenman AJ, 2008, MODERN MULTIVARIATE, V25, P733; JALUT G, 1992, QUATERNARY SCI REV, V11, P449, DOI 10.1016/0277-3791(92)90027-6; Jalut G, 2000, PALEOECOLOGICAL EVEN, P612; Krauss S, 2011, J STRUCT BIOL, V175, P457, DOI 10.1016/j.jsb.2011.06.005; Kulin RM, 2011, MAT SCI ENG C-MATER, V31, P1030, DOI 10.1016/j.msec.2011.03.002; Leonard A, 2007, J MICROSC-OXFORD, V225, P258, DOI 10.1111/j.1365-2818.2007.01740.x; Li C, 2003, GEN COMP ENDOCR, V131, P21, DOI 10.1016/S0016-6480(02)00625-1; Macchiarelli R., 2013, ANTHR PERSPECTIVES T, P250, DOI DOI 10.1017/CBO9780511984464.011; Macho GA, 2005, INT J OSTEOARCHAEOL, V15, P421, DOI 10.1002/oa.797; Martiniakova M, 2006, J FORENSIC SCI, V51, P1235, DOI 10.1111/j.1556-4029.2006.00260.x; Mazurier A, 2006, APPL PHYS A-MATER, V83, P229, DOI 10.1007/s00339-006-3511-6; Meyer D., 2015, E1071 MISC FUNCTIONS; Muller BR, 2009, ADV ENG MATER, V11, P435, DOI 10.1002/adem.200800346; Muller K, 2011, J ARCHAEOL SCI, V38, P3234, DOI 10.1016/j.jas.2011.06.029; ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Paral V, 2007, INT J OSTEOARCHAEOL, V17, P627, DOI 10.1002/oa.912; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Patou-Mathis M, 2005, ERAUL, V111, P27; Penniman TK, 1952, PICTURES IVORY OTHER, V5, P60; Petillon JM, 2013, J HUM EVOL, V65, P525, DOI 10.1016/j.jhevol.2013.06.006; Pokines JT, 1998, J ARCHAEOL SCI, V25, P875, DOI 10.1006/jasc.1997.0269; R Core Team, 2013, R LANG ENV STAT COMP; RAJARAM A, 1982, CALCIFIED TISSUE INT, V34, P301, DOI 10.1007/BF02411255; Reiche I, 2011, J ANAL ATOM SPECTROM, V26, P1802, DOI 10.1039/c0ja00246a; Rolf HJ, 1996, COMP BIOCHEM PHYS A, V115, P207, DOI 10.1016/0300-9629(96)00051-5; Rolf HJ, 1999, ANAT REC, V255, P69, DOI 10.1002/(SICI)1097-0185(19990501)255:1<69::AID-AR8>3.0.CO;2-R; Sanchez-Goni M.F., 1996, ZEPHYRUS, V49, P3; Smith TM, 2012, J HUM EVOL, V62, P395, DOI 10.1016/j.jhevol.2011.12.004; Stewart D, 2002, ANTLEROGENESIS ANTLE, P28; SUTTIE JM, 1984, J REPROD FERTIL, V71, P7, DOI 10.1530/jrf.0.0710007; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Tafforeau P, 2008, J HUM EVOL, V54, P272, DOI 10.1016/j.jhevol.2007.09.018; Tolksdorf JF, 2015, ARCHAEOL ANTHROP SCI, V7, P351, DOI 10.1007/s12520-014-0197-0; Villa P, 2001, J HUM EVOL, V41, P69, DOI 10.1006/jhev.2001.0479; von Holstein ICC, 2014, J ARCHAEOL SCI, V41, P1, DOI 10.1016/j.jas.2013.07.026; Zanolli C, 2013, CR PALEVOL, V12, P293, DOI 10.1016/j.crpv.2013.06.004; Zioupos P, 1996, J BIOMECH, V29, P969, DOI [10.1016/0021-9290(96)00001-2, DOI 10.1016/0021-9290(96)00001-2]	75	3	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149658	10.1371/journal.pone.0149658	http://dx.doi.org/10.1371/journal.pone.0149658			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901355	Green Published, gold, Green Submitted			2022-12-26	WOS:000371276100123
J	Ordonez-Gomez, JD; Cristobal-Azkarate, J; Arroyo-Rodriguez, V; Santillan-Doherty, AM; Valdez, RA; Romano, MC				Ordonez-Gomez, Jose D.; Cristobal-Azkarate, Jurgi; Arroyo-Rodriguez, Victor; Santillan-Doherty, Ana M.; Valdez, Ricardo A.; Romano, Marta C.			Proximal and Distal Predictors of the Spider Monkey's Stress Levels in Fragmented Landscapes	PLOS ONE			English	Article							FECAL CORTISOL-LEVELS; ALOUATTA-PALLIATA-MEXICANA; LACANDONA RAIN-FOREST; ATELES-GEOFFROYI; HOWLER MONKEYS; LOS-TUXTLAS; HABITAT FRAGMENTATION; ACTIVITY PATTERNS; TROPICAL FOREST; IMPACT	The rapid loss, fragmentation and degradation of tropical forests threaten the survival of many animal species. However, the way in which these phenomena affect animal health has been poorly explored, thus limiting the design of appropriate conservation strategies. To address this, here we identified using linear mixed models the effect of proximal (diet, activity pattern, hunting and logging) and distal (sum of the basal areas of fruiting-tree species [SBAFS], landscape forest cover and degree of forest fragmentation) variables over fecal glucocorticoid metabolite (fGCM) levels-hormones associated with animal health and fitness-of six groups of spider monkeys (Ateles geoffroyi) inhabiting six landscapes with different spatial structures in Mexico. Proximal variables showed a stronger predictive power over fGCMs than distal. In this sense, increases in travel time, the occurrence of hunting, and reductions in rest time and fruit consumption resulted in higher fGCM levels. Regarding distal variables, increases in SBAFS were negatively related to fGCM levels, thus suggesting that food scarcity increases stress hormone levels. Nevertheless, contrary to theoretical expectations, spider monkeys living in smaller tracts of forest spent less time travelling, but the same time feeding on fruit as those in more forested areas. The lower net energy return associated with this combination of factors would explain why, contrary to theoretical expectations, increased forest cover was associated with increased levels of fGCMs in these groups. Our study shows that, at least in the short term, spider monkeys in fragmented landscapes do not always present higher levels of stress hormones compared to those inhabiting continuous forest, and the importance of preserving fruit sources and controlling hunting for reducing the levels of stress hormones in free ranging spider monkeys.	[Ordonez-Gomez, Jose D.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Mexico City 04510, DF, Mexico; [Cristobal-Azkarate, Jurgi] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Santillan-Doherty, Ana M.] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Neurociencias, Mexico City, DF, Mexico; [Valdez, Ricardo A.; Romano, Marta C.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Cambridge; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Ordonez-Gomez, JD (corresponding author), Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Mexico City 04510, DF, Mexico.	josed_ordonez@hotmail.com	Arroyo-Rodríguez, Víctor/C-9255-2009	Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Ordonez Gomez, Jose Domingo/0000-0002-6929-1470; Cristobal-Azkarate, Jurgi/0000-0002-2799-8638; VALDEZ, RICARDO/0000-0002-0278-4940; Romano Pardo, Marta Catalina/0000-0003-2932-0801	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [VER-2008-C02-109147]; CONACyT, Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT Project VER-2008-C02-109147). JDOG obtained a scholarship from the CONACyT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2007, BIOTROPICA, V39, P760, DOI 10.1111/j.1744-7429.2007.00330.x; Arroyo-Rodriguez V, 2007, BIOL CONSERV, V138, P198, DOI 10.1016/j.biocon.2007.04.016; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Balestri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107698; Barton K, 2015, PACKAGE MUMIN VERSIO; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Brousset DM, 2003, THESIS U NACL AUTONO; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Carrara E, 2015, BIOL CONSERV, V184, P117, DOI 10.1016/j.biocon.2015.01.014; Cavigelli SA, 1999, ANIM BEHAV, V57, P935, DOI 10.1006/anbe.1998.1054; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chatterjee S., 2012, REGRESSION ANAL EXAM; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Chaves OM, 2011, INT J PRIMATOL, V32, P960, DOI 10.1007/s10764-011-9515-x; Couturier S, 2012, TROPICAL FORESTS, P269; Cristobal-Azkarate J, 2005, AM J PRIMATOL, V67, P209, DOI 10.1002/ajp.20178; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Cuaron A. D., 2008, ATELES GEOFFROYI IUC, V2008; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Duarte-Quiroga A, 2003, AM J PRIMATOL, V61, P53, DOI 10.1002/ajp.10108; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Ellis EC, 2013, CURR OPIN ENV SUST, V5, P368, DOI 10.1016/j.cosust.2013.07.002; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Foerster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050108; Foerster S, 2010, HORM BEHAV, V58, P685, DOI 10.1016/j.yhbeh.2010.06.002; Fox J., 2019, R COMPANION APPL REG, V.; Garber PA, 2006, DEV PRIMATOL-PROG PR, P563, DOI 10.1007/0-387-25872-8_27; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; GENUTH SM, 1993, PHYSIOLOGY, P813; Gesquiere LR, 2008, HORM BEHAV, V54, P410, DOI 10.1016/j.yhbeh.2008.04.007; Gomez-Espinosa E, 2014, AM J PRIMATOL, V76, P362, DOI 10.1002/ajp.22240; Gonzalez-Zamora A, 2015, J TROP ECOL, V31, P305, DOI 10.1017/S026646741500022X; Gonzalez-Zamora A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089346; Gonzalez-Zamora A, 2011, AM J PRIMATOL, V73, P1189, DOI 10.1002/ajp.20989; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hernandez-Ruedas MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098931; Hothorn T, 2015, SIMULTANEOUS INFEREN; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Lenth RV, 2013, USING ISMEANS PACKAG; Martinez E, 2003, DEFORESTACION 24 REG, P124; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Ordonez-Gomez JD, 2015, AM J PRIMATOL, V77, P56, DOI 10.1002/ajp.22310; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Rimbach R, 2014, AM J PRIMATOL, V76, P1049, DOI 10.1002/ajp.22292; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Russildi G, 2016, BIODIVERS CONSERV, V25, P375, DOI 10.1007/s10531-016-1056-3; SAGARPA, PROYECT ESTR TROP HU; Sanchez-de-Jesus HA, 2016, LANDSCAPE ECOL, V31, P843, DOI 10.1007/s10980-015-0293-2; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Stevenson PR, 1998, BIOTROPICA, V30, P129, DOI 10.1111/j.1744-7429.1998.tb00376.x; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Wieczkowski J, 2004, AM J PRIMATOL, V63, P125, DOI 10.1002/ajp.20046; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; Rodas-Martinez AZ, 2013, ZOO BIOL, V32, P641, DOI 10.1002/zoo.21101	80	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149671	10.1371/journal.pone.0149671	http://dx.doi.org/10.1371/journal.pone.0149671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901767	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100126
J	Raab, RW; Moore, JE; Vargo, EL; Rose, L; Raab, J; Culbreth, M; Burzumato, G; Koyee, A; McCarthy, B; Raffaele, J; Schal, C; Vaidyanathan, R				Raab, Ronald W.; Moore, Julia E.; Vargo, Edward L.; Rose, Lucy; Raab, Julie; Culbreth, Madeline; Burzumato, Gracie; Koyee, Aurvan; McCarthy, Brittany; Raffaele, Jennifer; Schal, Coby; Vaidyanathan, Rajeev			New Introductions, Spread of Existing Matrilines, and High Rates of Pyrethroid Resistance Result in Chronic Infestations of Bed Bugs (Cimex lectularius L.) in Lower-Income Housing	PLOS ONE			English	Article							HEMIPTERA-CIMICIDAE; UNITED-STATES; INSECTICIDE RESISTANCE; MOLECULAR MARKERS; POPULATIONS; BEDBUGS	Infestations of the common bed bug (Cimex lectularius L.) have increased substantially in the United States in the past 10-15 years. The housing authority in Harrisonburg, Virginia, conducts heat-treatments after bed bugs are detected in a lower-income housing complex, by treating each infested unit at 60 degrees C for 4-6 hours. However, a high frequency of recurrent infestations called into question the efficacy of this strategy. Genetic analysis using Bayesian clustering of polymorphic microsatellite loci from 123 bed bugs collected from 23 units from May 2012 to April 2013 in one building indicated that (a) 16/21 (73%) infestations were genetically similar, suggesting ineffective heat-treatments or reintroductions from within the building or from a common external source, followed by local spread of existing populations; and (b) up to 5 of the infestations represented new genotypes, indicating that 5 new populations were introduced into this building in one year, assuming they were not missed in earlier screens. There was little to no gene flow among the 8 genetic clusters identified in the building. Bed bugs in the U.S. often possess one or both point mutations in the voltage-gated sodium channel, termed knockdown resistance (kdr), from valine to leucine (V419L) and leucine to isoleucine (L925I) that confer target-site resistance against pyrethroid insecticides. We found that 48/121 (40%) bed bugs were homozygous for both kdr mutations (L419/I925), and a further 59% possessed at least one of the kdr mutations. We conclude that ineffective heat treatments, new introductions, reintroductions and local spread, and an exceptionally high frequency of pyrethroid resistance are responsible for chronic infestations in lower-income housing. Because heat treatments fail to protect from reintroductions, and pesticide use has not decreased the frequency of infestations, preventing new introductions and early detection are the most effective strategies to avoid bed bug infestations in multistory apartment buildings.	[Raab, Ronald W.; McCarthy, Brittany; Raffaele, Jennifer] James Madison Univ, Coll Integrated Sci & Technol, Harrisonburg, VA 22807 USA; [Moore, Julia E.; Vaidyanathan, Rajeev] SRI Int, Ctr Immun & Infect Dis, Harrisonburg, VA USA; [Vargo, Edward L.; Schal, Coby] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Rose, Lucy; Raab, Julie; Culbreth, Madeline; Burzumato, Gracie; Koyee, Aurvan] Harrisonburg High Sch, Harrisonburg, VA USA; [Vargo, Edward L.] Texas A&M Univ, Bldg 1804 F&B Rd 2556, College Stn, TX 77843 USA; [Moore, Julia E.] Clarke Mosquito, 675 Sidwell Court, St Charles, IL 60175 USA	James Madison University; SRI International; University of North Carolina; North Carolina State University; Texas A&M University System; Texas A&M University College Station	Vaidyanathan, R (corresponding author), SRI Int, Ctr Immun & Infect Dis, Harrisonburg, VA USA.	rvadyanathan@clarke.com	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	U.S. Department of Housing and Urban Development [NCHHU0001-11]; Blanton J. Whitmire Endowment at North Carolina State University; SRI International	U.S. Department of Housing and Urban Development; Blanton J. Whitmire Endowment at North Carolina State University; SRI International	CS was supported by a grant from U.S. Department of Housing and Urban Development (NCHHU0001-11) and by the Blanton J. Whitmire Endowment at North Carolina State University. JEM and RV were supported by internal R&D funding from SRI International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was possible because of the cooperation of residents who allowed us to collect samples in their homes. We thank Michael Wong, Duane Bontrager, Lisa Benasher, and Paul Harlow of the Harrisonburg Redevelopment and Housing Authority (HRHA) for their kind help. The HRHA reviewed our protocol and granted us access to the field site. We thank Deb Berger, Jim Boggs, Vitaliy Makayev, and John Hall of Pure Environmental Services who allowed us to collect bed bugs before and after heat-treatment. We thank Paul Labadie for technical assistance with the microsatellite genotyping and analysis. CS was supported by a grant from U.S. Department of Housing and Urban Development (NCHHU0001-11) and by the Blanton J. Whitmire Endowment at North Carolina State University. JEM and RV were supported by internal R&D funding from SRI International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Adelman ZN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026228; Anderson AL, 2008, J ENVIRON HEALTH, V70, P24; Booth W, 2012, J MED ENTOMOL, V49, P535, DOI 10.1603/ME11256; Brown AW, 1973, OMS SERIE MONOGR, V38; Busvine J R, 1958, Bull World Health Organ, V19, P1041; Corander J, 2003, GENETICS, V163, P367; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Davies TGE, 2012, MED VET ENTOMOL, DOI [10.1111/j.1365-2915.2011.1006.x, DOI 10.1111/J.1365-2915.2011.1006.X]; Doggett S, 2004, ENVIRON HEALTH-GLOB, V4, P30; FEROZ M, 1971, B WORLD HEALTH ORGAN, V45, P795; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GRATZ N G, 1959, Bull World Health Organ, V20, P835; Harlan HJ, 2006, BED BUGS IMPROTANCE; Herborg LM, 2007, MOL ECOL, V16, P231, DOI 10.1111/j.1365-294X.2006.03133.x; Johnson M. S., 1948, MED NEWS LETT, V12, P26; Krueger L, 2000, PEST CONTROL, V68, P58; Madden AH, 1944, J ECON ENTOMOL, V37, P127, DOI 10.1093/jee/37.1.127; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Pereira RM, 2009, J ECON ENTOMOL, V102, P1182, DOI 10.1603/029.102.0342; Potter Michael F., 2011, American Entomologist, V57, P14; Puckett RT, 2012, PEST MANAG SCI; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Saenz VL, 2012, J MED ENTOMOL, V49, P865, DOI 10.1603/ME11202; Steelman CD, 2008, J AGR URBAN ENTOMOL, V25, P41, DOI 10.3954/1523-5475-25.1.41; Tawatsin A, 2011, J MED ENTOMOL, V48, P1023, DOI 10.1603/ME11003; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Wong M., 2013, J HOUSING COMMUN MAY, V70, P20; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2013, SCI REP-UK, V3, DOI 10.1038/srep01456; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355	32	10	11	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0117805	10.1371/journal.pone.0117805	http://dx.doi.org/10.1371/journal.pone.0117805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901153	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100001
J	Ward, DG; Baxter, L; Gordon, NS; Ott, S; Savage, RS; Beggs, AD; James, JD; Lickiss, J; Green, S; Wallis, Y; Wei, WB; James, ND; Zeegers, MP; Cheng, KK; Mathews, GM; Patel, P; Griffiths, M; Bryan, RT				Ward, Douglas G.; Baxter, Laura; Gordon, Naheema S.; Ott, Sascha; Savage, Richard S.; Beggs, Andrew D.; James, Jonathan D.; Lickiss, Jennifer; Green, Shaun; Wallis, Yvonne; Wei, Wenbin; James, Nicholas D.; Zeegers, Maurice P.; Cheng, K. K.; Mathews, Glenn M.; Patel, Prashant; Griffiths, Michael; Bryan, Richard T.			Multiplex PCR and Next Generation Sequencing for the Non-Invasive Detection of Bladder Cancer	PLOS ONE			English	Article							TERT PROMOTER MUTATIONS; VOIDED URINE; DISEASE RECURRENCE; CARCINOMA; FGFR3	Background Highly sensitive and specific urine-based tests to detect either primary or recurrent bladder cancer have proved elusive to date. Our ever increasing knowledge of the genomic aberrations in bladder cancer should enable the development of such tests based on urinary DNA. Methods DNA was extracted from urine cell pellets and PCR used to amplify the regions of the TERT promoter and coding regions of FGFR3, PIK3CA, TP53, HRAS, KDM6A and RXRA which are frequently mutated in bladder cancer. The PCR products were barcoded, pooled and paired-end 2 x 250 bp sequencing performed on an Illumina MiSeq. Urinary DNA was analysed from 20 non-cancer controls, 120 primary bladder cancer patients (41 pTa, 40 pT1, 39 pT2+) and 91 bladder cancer patients post-TURBT (89 cancer-free). Results Despite the small quantities of DNA extracted from some urine cell pellets, 96% of the samples yielded mean read depths >500. Analysing only previously reported point mutations, TERT mutations were found in 55% of patients with bladder cancer (independent of stage), FGFR3 mutations in 30% of patients with bladder cancer, PIK3CA in 14% and TP53 mutations in 12% of patients with bladder cancer. Overall, these previously reported bladder cancer mutations were detected in 86 out of 122 bladder cancer patients (70% sensitivity) and in only 3 out of 109 patients with no detectable bladder cancer (97% specificity). Conclusion This simple, cost-effective approach could be used for the non-invasive surveillance of patients with non-muscle-invasive bladder cancers harbouring these mutations. The method has a low DNA input requirement and can detect low levels of mutant DNA in a large excess of normal DNA. These genes represent a minimal biomarker panel to which extra markers could be added to develop a highly sensitive diagnostic test for bladder cancer.	[Ward, Douglas G.; Gordon, Naheema S.; Beggs, Andrew D.; James, Jonathan D.; Wei, Wenbin; Zeegers, Maurice P.; Mathews, Glenn M.; Patel, Prashant; Griffiths, Michael; Bryan, Richard T.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Baxter, Laura; Ott, Sascha; Savage, Richard S.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Lickiss, Jennifer; Green, Shaun; Wallis, Yvonne; Griffiths, Michael] Birmingham Womens Hosp NHS Fdn Trust, West Midlands Reg Genet Lab, Birmingham B15 2TG, W Midlands, England; [James, Nicholas D.] Univ Warwick, Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Zeegers, Maurice P.] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Cheng, K. K.] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Savage, Richard S.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England	University of Birmingham; University of Warwick; Birmingham Women's Hospital; University of Warwick; Maastricht University; Maastricht University Medical Centre (MUMC); University of Birmingham; University of Warwick	Bryan, RT (corresponding author), Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England.	r.t.bryan@bham.ac.uk	Baxter, laura/GWD-1304-2022; Cheng, Kar/AAL-8899-2021; Beggs, Andrew D/A-6912-2013; Ott, Sascha/A-1180-2011; Bryan, Richard T/AAJ-9325-2021	Cheng, Kar/0000-0002-1516-1857; Beggs, Andrew D/0000-0003-0784-2967; Bryan, Richard T/0000-0003-2853-4293; Zeegers, Maurice/0000-0002-2387-083X; Patel, Prashant/0000-0002-2882-5990; Wei, Wenbin/0000-0003-1288-6999	Wellcome Trust follow-on-fund grant; Cancer Research UK; University of Birmingham; Birmingham Comprehensive Local Research Network; Black Country Comprehensive Local Research Network; West Midlands North and South Comprehensive Local Research Network; Birmingham ECMC; MRC [MR/M009157/1] Funding Source: UKRI; Medical Research Council [MR/M009157/1] Funding Source: researchfish	Wellcome Trust follow-on-fund grant; Cancer Research UK(Cancer Research UK); University of Birmingham; Birmingham Comprehensive Local Research Network; Black Country Comprehensive Local Research Network; West Midlands North and South Comprehensive Local Research Network; Birmingham ECMC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by a Wellcome Trust follow-on-fund grant administered by the University of Birmingham. BCPP is funded by Cancer Research UK, the University of Birmingham and the Birmingham and The Black Country and West Midlands North and South Comprehensive Local Research Networks, and sponsored by the University of Birmingham. The BCPP biospecimen collection is supported by funding from the Birmingham ECMC. DGW is funded by a philanthropic donation to the University of Birmingham in support of bladder cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allory Y, 2013, EUR UROL; [Anonymous], 2014, NATURE, V507, P315, DOI DOI 10.1038/NATURE12965; Babjuk M, 2013, EUR UROL, V64, P639, DOI 10.1016/j.eururo.2013.06.003; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; de Martino M, 2015, EUR UROL, V68, P552, DOI 10.1016/j.eururo.2015.06.015; Hurst CD, 2014, EUR UROL, V65, P367, DOI 10.1016/j.eururo.2013.08.057; Kandimalla R, 2013, CLIN CANCER RES, V19, P4760, DOI 10.1158/1078-0432.CCR-12-3276; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Liu XL, 2013, CELL CYCLE, V12, P1637, DOI 10.4161/cc.24662; MILLHOLLAND J, 2012, RES REPORTS UROLOGY, V2012, P33; Rachakonda PS, 2013, P NATL ACAD SCI USA, V110, P17426, DOI 10.1073/pnas.1310522110; Reinert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046297; Rieger-Christ KM, 2003, CANCER-AM CANCER SOC, V98, P737, DOI 10.1002/cncr.11536; Schmitz-Drager BJ, 2015, UROL INT, V94, P1, DOI 10.1159/000369357; Tognieri F, 2016, EUROPEAN J IN PRESS; van Kessel K, 2015, J UROL; van Rhijn BWG, 2003, CLIN CANCER RES, V9, P257; Williamson SR, 2010, CRIT REV ONCOL HEMAT, V76, P112, DOI 10.1016/j.critrevonc.2010.01.005; Zeegers MP, 2010, BJU INT, V105, P784, DOI 10.1111/j.1464-410X.2009.08849.x; Zheng CJ, 2012, BJU INT, V110, pE680, DOI 10.1111/j.1464-410X.2012.11500.x	22	56	59	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149756	10.1371/journal.pone.0149756	http://dx.doi.org/10.1371/journal.pone.0149756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901314	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000371276100145
J	Wolinski, K; Stangierski, A; Szczepanek-Parulska, E; Gurgul, E; Budny, B; Wrotkowska, E; Biczysko, M; Ruchala, M				Wolinski, Kosma; Stangierski, Adam; Szczepanek-Parulska, Ewelina; Gurgul, Edyta; Budny, Bardomiej; Wrotkowska, Elzbieta; Biczysko, Maciej; Ruchala, Marek			VEGF-C Is a Thyroid Marker of Malignancy Superior to VEGF-A in the Differential Diagnostics of Thyroid Lesions	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; MESSENGER-RNA; EXPRESSION; CANCER; FEATURES; NODULES; ULTRASOUND; BENIGN; BIOPSY	Introduction Thyroid nodular goiter is one of the most common medical conditions affecting even over a half of adult population. The risk of malignancy is rather small but noticeable-estimated by numerous studies to be about 3-10%. The definite differentiation between benign and malignant ones is a vital issue in endocrine practice. The aim of the current study was to assess the expression of vascular endothelial growth factor A (VEGF-A) and VEGF-C on the mRNA level in FNAB washouts in case of benign and malignant thyroid nodules and to evaluate the diagnostic value of these markers of malignancy. Materials and Methods Patients undergoing fine-needle aspiration biopsy (FNAB) in our department between January 2013 and May 2014 were included. In case of all patients who gave the written consent, after ultrasonography (US) and fine-needle aspiration biopsy (FNAB) performed as routine medical procedure the needle was flushed with RNA Later solution, the washouts were frozen in -80 Celsius degrees. Expression of VEGF-A and VEGF-C and GADPH (reference gene) was assessed in washouts on the mRNA level using the real-time PCR technique. Probes of patients who underwent subsequent thyroidectomy and were diagnosed with differentiated thyroid cancer (DTC; proved by post-surgical histopathology) were analyzed. Similar number of patients with benign cytology were randomly selected to be a control group. Results Thirty one DTCs and 28 benign thyroid lesions were analyzed. Expression of VEGF-A was insignificantly higher in patients with DTCs (p = 0.13). Expression of VEGF-C was significantly higher in patients with DTC. The relative expression of VEGF-C (in comparison with GAPDH) was 0.0049 for DTCs and 0.00070 for benign lesions, medians -0.0036 and 0.000024 respectively (p<0.0001). Conclusions Measurement of expression VEGF-C on the mRNA level in washouts from FNAB is more useful than more commonly investigated VEGF-A. Measurement of VEGF-C in FNAB washouts do not allow for fully reliable differentiation of benign and malignant thyroid nodules and should be interpreted carefully. Further studies on larger groups are indicated. However, measurement of VEGF-C on mRNA level can bring important information without exposing patient for additional risk and invasive procedures.	[Wolinski, Kosma; Stangierski, Adam; Szczepanek-Parulska, Ewelina; Gurgul, Edyta; Budny, Bardomiej; Wrotkowska, Elzbieta; Ruchala, Marek] Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland; [Biczysko, Maciej] Poznan Univ Med Sci, Dept Gen Gastroenterol & Endocrine Surg, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Wolinski, K (corresponding author), Poznan Univ Med Sci, Dept Endocrinol Metab & Internal Med, Poznan, Poland.	kosma1644@poczta.onet.pl	Budny, Bartlomiej/AIC-4615-2022; Budny, Bartlomiej/ABF-5760-2021	Budny, Bartlomiej/0000-0002-2860-395X; Wrotkowska, Elzbieta/0000-0003-0965-7300; Wolinski, Kosma/0000-0001-9800-7881	State Committee for Scientific Research (Polish-Komitet Badan Naukowych) [N N402 545540]; Poznan University of Medical Sciences, Faculty of Medicine II [502-14-02221354-41127]	State Committee for Scientific Research (Polish-Komitet Badan Naukowych); Poznan University of Medical Sciences, Faculty of Medicine II	This study was supported by the State Committee for Scientific Research (Polish-Komitet Badan Naukowych), grant no. N N402 545540 and Poznan University of Medical Sciences, Faculty of Medicine II, grant no. 502-14-02221354-41127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Maqbali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049078; Brito JP, 2014, J CLIN ENDOCR METAB, V99, P1253, DOI 10.1210/jc.2013-2928; Carpi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047758; Choi YJ, 2008, YONSEI MED J, V49, P748, DOI 10.3349/ymj.2008.49.5.748; Durante C, 2011, EUR J ENDOCRINOL, V165, P455, DOI 10.1530/EJE-11-0283; Garcia EA, 2010, ENDOCR PATHOL, V21, P101, DOI 10.1007/s12022-010-9116-9; Goel HL, 2013, NAT REV CANCER, V13, P871, DOI 10.1038/nrc3627; Hung CJ, 2003, J CLIN ENDOCR METAB, V88, P3694, DOI 10.1210/jc.2003-030080; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P456; Kansakar E, 2009, AM SURGEON, V75, P785; Klubo-Gwiezdzinska J, 2007, EUR J ENDOCRINOL, V157, P521, DOI 10.1530/EJE-07-0252; Konturek A, 2005, LANGENBECK ARCH SURG, V390, P216, DOI 10.1007/s00423-004-0529-0; Kushner EJ, 2013, CURR OPIN HEMATOL, V20, P231, DOI 10.1097/MOH.0b013e328360614b; Liang HS, 2011, ANTICANCER RES, V31, P3433; Lin SY, 2003, CLIN ENDOCRINOL, V58, P513, DOI 10.1046/j.1365-2265.2003.01749.x; Salajegheh A, 2011, EJSO-EUR J SURG ONC, V37, P93, DOI 10.1016/j.ejso.2010.10.010; Salajegheh A, 2013, HUM PATHOL, V44, P2204, DOI 10.1016/j.humpath.2013.04.014; Stangierski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109612; Stangierski A, 2013, NEUROENDOCRINOL LETT, V34, P798; Stanicic J, 2009, ACTA CLIN CROAT, V48, P413; Szczepanek-Parulska E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081532; Takahashi M, 2004, INT J HEMATOL, V80, P29, DOI 10.1532/IJH97.04042; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tanaka K, 2002, SURG TODAY, V32, P761, DOI 10.1007/s005950200146; Tian X, 2008, J INT MED RES, V36, P699, DOI 10.1177/147323000803600411; Waligorska-Stachura J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100534; Wolinski K, 2014, ENDOKRYNOL POL, V65, P314, DOI 10.5603/EP.2014.0043; Wolinski K, 2014, ENDOKRYNOL POL, V65, P114, DOI 10.5603/EP.2014.0016; Wolinski K, 2014, POL ARCH MED WEWN, V124, P97, DOI 10.20452/pamw.2132; Yoon JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058592; Yu XM, 2008, ANN SURG, V247, P483, DOI 10.1097/SLA.0b013e31815fa447	31	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150124	10.1371/journal.pone.0150124	http://dx.doi.org/10.1371/journal.pone.0150124			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900960	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100208
J	Zhang, XY; Ding, LL; Yang, L; Qin, W; Yuan, JL; Li, SJ; Hu, WL				Zhang, Xiaoyu; Ding, Lingling; Yang, Lei; Qin, Wei; Yuan, Junliang; Li, Shujuan; Hu, Wenli			Brain Atrophy Correlates with Severe Enlarged Perivascular Spaces in Basal Ganglia among Lacunar Stroke Patients	PLOS ONE			English	Article							VIRCHOW-ROBIN SPACES; SMALL VESSEL DISEASE; WHITE-MATTER; BLOOD-PRESSURE; MRI MARKER; PARKINSONISM; DILATATION; STRIATUM	Background Enlarged perivascular spaces (EPVS) correlate with cognitive impairment and incident dementia. However, etiologies for severe basal ganglia EPVS (BG-EPVS) are still unclear. Our aim was to investigate the independent risk factors for severe BG-EPVS in patients with acute lacunar stroke. Methods We prospectively identified patients with lacunar stroke (diameter on DWI <= 20mm) from Jan 2011 to May 2015. Patients with severe BG-EPVS were identified on T2 weighted MRI. Age (+/- 1 year) and sex matched controls were also recruited in the same population (two controls for one case). Vascular risk factors, clinical data, EPVS in centrum semiovale (rated 0 to 4), white matter hyperintensities (WMH) (by Fazekas scale), brain atrophy (rated 0 to 6) were compared between two groups. Logistic regression was performed to determine independent risk factors for severe BG-EPVS. Results During study period, 89 patients with severe BG-EPVS and 178-matched controls were included. Vascular risk factors did not differ between two groups. Patients with severe BG-EPVS had lower level of HbA1c and diastolic BP at admission, but presented with larger infarct size, more severe WMH (including total WMH, periventricular WMH and deep WMH) and brain atrophy. In logistic regression, brain atrophy (OR = 1.40; 95% CI 1.13, 1.73) and deep WMH (OR = 1.88; 95% CI 1.24, 2.83) were independent risk factors for severe BG-EPVS. Conclusions Brain atrophy and deep WMH are independent risk factors for severe BG-EPVS, supporting the hypothesis that brain atrophy may be associated with the development of EPVS in basal ganglia.	[Zhang, Xiaoyu; Ding, Lingling; Yang, Lei; Qin, Wei; Yuan, Junliang; Li, Shujuan; Hu, Wenli] Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China	Capital Medical University	Hu, WL (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Neurol, Beijing, Peoples R China.	huwenli@sina.com	Zhang, xiaoyu/GXA-3206-2022		National Natural Science Foundation of China [81271309]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (Grant No 81271309) supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aribisala BS, 2014, STROKE, V45, P605, DOI 10.1161/STROKEAHA.113.004059; Berezuk C, 2015, SLEEP, V38, P853, DOI 10.5665/sleep.4726; Burnett MS, 2014, JAMA NEUROL, V71, P735, DOI 10.1001/jamaneurol.2014.286; Charidimou A, 2015, STROKE, V46, P1707, DOI 10.1161/STROKEAHA.115.009090; Charidimou A, 2014, NEUROLOGY, V82, P57, DOI 10.1212/01.wnl.0000438225.02729.04; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Doubal FN, 2010, STROKE, V41, P450, DOI 10.1161/STROKEAHA.109.564914; Duker AP, 2007, NEUROLOGY, V68, P1540, DOI 10.1212/01.wnl.0000261483.49248.b8; Farrell C, 2009, EUR RADIOL, V19, P177, DOI 10.1007/s00330-008-1119-2; Fenelon G, 1995, MOVEMENT DISORD, V10, P754, DOI 10.1002/mds.870100609; Gutierrez J, 2013, AM J NEURORADIOL, V34, P1711, DOI 10.3174/ajnr.A3498; Klarenbeek P, 2013, J NEUROL, V260, P115, DOI 10.1007/s00415-012-6598-z; Kolominsky-Rabas PL, 2001, STROKE, V32, P2735, DOI 10.1161/hs1201.100209; Kwee RM, 2007, RADIOGRAPHICS, V27, P1071, DOI 10.1148/rg.274065722; MacLullich AMJ, 2004, J NEUROL NEUROSUR PS, V75, P1519, DOI 10.1136/jnnp.2003.030858; MANCARDI GL, 1989, EUR NEUROL, V29, P16, DOI 10.1159/000116459; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Potter GM, 2015, INT J STROKE, V10, P376, DOI 10.1111/ijs.12054; Sahin N, 2015, ACTA RADIOL, V56, P852, DOI 10.1177/0284185114544243; Satizabal CL, 2013, J ALZHEIMERS DIS, V33, P323, DOI 10.3233/JAD-2012-120874; van Straaten ECW, 2006, STROKE, V37, P836, DOI 10.1161/01.STR.0000202585.26325.74; VANSWIETEN JC, 1991, BRAIN, V114, P761; Wuerfel J, 2008, BRAIN, V131, P2332, DOI 10.1093/brain/awn171; Xiao LL, 2015, STROKE, V46, P2081, DOI 10.1161/STROKEAHA.114.008155; Yakushiji Y, 2014, NEUROLOGY, V83, P2116, DOI 10.1212/WNL.0000000000001054; Zhang CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105505; Zhu YC, 2011, AM J NEURORADIOL, V32, P709, DOI 10.3174/ajnr.A2366; Zhu YC, 2010, J ALZHEIMERS DIS, V22, P663, DOI 10.3233/JAD-2010-100378; Zhu YC, 2010, STROKE, V41, P2483, DOI 10.1161/STROKEAHA.110.591586	29	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149593	10.1371/journal.pone.0149593	http://dx.doi.org/10.1371/journal.pone.0149593			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26900696	Green Submitted, Green Published, gold			2022-12-26	WOS:000371276100107
J	Zhao, X; Han, YM; Liang, Y; Nie, C; Wang, J				Zhao, Xin; Han, Yingmin; Liang, Yu; Nie, Chao; Wang, Jian			RNA-Seq Reveals the Angiogenesis Diversity between the Fetal and Adults Bone Mesenchyme Stem Cell	PLOS ONE			English	Article							TUMOR ANGIOGENESIS; GENE; TRANSCRIPTOME; HETEROGENEITY; EXPRESSION; MARROW	In this research, we used RNA sequencing (RNA-seq) to analyze 23 single cell samples and 2 bulk cells sample from human adult bone mesenchyme stem cell line and human fetal bone mesenchyme stem cell line. The results from the research demonstrated that there were big differences between two cell lines. Adult bone mesenchyme stem cell lines showed a strong trend on the blood vessel differentiation and cell motion, 48/49 vascular related differential expressed genes showed higher expression in adult bone mesenchyme stem cell lines (Abmsc) than fetal bone mesenchyme stem cell lines (Fbmsc). 96/106 cell motion related genes showed the same tendency. Further analysis showed that genes like ANGPT1, VEGFA, FGF2, PDGFB and PDGFRA showed higher expression in Abmsc. This work showed cell heterogeneity between human adult bone mesenchyme stem cell line and human fetal bone mesenchyme stem cell line. Also the work may give an indication that Abmsc had a better potency than Fbmsc in the future vascular related application.	[Zhao, Xin; Wang, Jian] Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Guangdong, Peoples R China; [Zhao, Xin; Nie, Chao; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China; [Han, Yingmin; Liang, Yu] BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China; [Han, Yingmin; Liang, Yu] Geneis, Beijing 100094, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Beijing Genomics Institute (BGI); Beijing Genomics Institute (BGI)	Wang, J (corresponding author), Univ Chinese Acad Sci, BGI Educ Ctr, Shenzhen 518083, Guangdong, Peoples R China.; Nie, C; Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Guangdong, Peoples R China.; Liang, Y (corresponding author), BGI Tianjin, Binhai Genom Inst, Tianjin 300308, Peoples R China.; Liang, Y (corresponding author), Geneis, Beijing 100094, Peoples R China.	liangyu@genomics.cn; niechao@genomics.cn; wangjian@genomics.cn		Zhao, Xin/0000-0001-8502-0139	BGI Education Center, University of Chinese Academy of Sciences; Shenzhen Municipal of Government of China [CXB201108250094A]	BGI Education Center, University of Chinese Academy of Sciences; Shenzhen Municipal of Government of China	XZ was supported by a PhD studentship from the BGI Education Center, University of Chinese Academy of Sciences, and the authors thank the support of the Shenzhen Municipal of Government of China (CXB201108250094A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, CIRCULATION, V107, P2134, DOI 10.1161/01.CIR.0000062649.63838.C9; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Brown KC, 2012, ANGIOGENESIS, V15, P99, DOI 10.1007/s10456-011-9246-9; Chai ZT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077957; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Copland Ian B, 2011, J Cardiovasc Dis Res, V2, P3, DOI 10.4103/0975-3583.78581; De Kock J, 2012, STEM CELLS DEV, V21, P3309, DOI 10.1089/scd.2011.0723; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Han Hui, 2014, ScientificWorldJournal, V2014, P878209, DOI 10.1155/2014/878209; Hua J, 2014, INT J CLIN EXP PATHO, V7, P3580; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang W, 2010, J MOL CELL CARDIOL, V48, P702, DOI 10.1016/j.yjmcc.2009.10.032; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lee MCW, 2014, P NATL ACAD SCI USA, V111, pE4726, DOI 10.1073/pnas.1404656111; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Samper E, 2013, STEM CELL REV REP, V9, P266, DOI 10.1007/s12015-012-9353-z; Scotti L, 2014, REPROD FERTIL DEV; Shen KK, 2014, CHEM-BIOL INTERACT, V218, P99, DOI 10.1016/j.cbi.2014.04.020; Streets AM, 2014, NAT BIOTECHNOL, V32, P1005, DOI 10.1038/nbt.3039; Strioga M, 2012, STEM CELLS DEV, V21, P2724, DOI 10.1089/scd.2011.0722; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Xue G, 2015, ONCOGENE, V34, P1393, DOI 10.1038/onc.2014.82; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	31	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149171	10.1371/journal.pone.0149171	http://dx.doi.org/10.1371/journal.pone.0149171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901069	Green Published, Green Submitted, gold			2022-12-26	WOS:000371276100044
